>IFAGANLK_00001 Fumarate reductase iron-sulfur subunit
MKLNLKIWRQENATAKGKIVDYPIDGVDGDMSFLEMLDILNEQLVEKGEDTIEFDHDCRE
GICGSCSLQINGEPHGPDKLIATCQLHMRSFKDGDTIYIEPFRAKAFPVIKDLIVDRTAF
DRIQQAWGYVSVNTSGNTVDANTIPVEKEKADESFNAATCIGCGACVAACKNASAMLFTS
AKVSQYALLPQGRVEATERVRAMVRQMDEEGFGNCSNTGACEIECPKGISLENIARMNRE
YLAASVKG
>IFAGANLK_00002 Fumarate reductase flavoprotein subunit
MSVLDSKIPKGPLAEKWTNHKNDINLVNPANKRNIDIIVIGTGLAGGAAAATLAELGYNV
KTFCYQDSPRRAHSIAAQGGINASKNYQGDGDSDYRLFYDTVKGGDYRSREGNVYRLAEV
SGNIIDQCVAQGVPFAREYGGYLDNRSFGGVLVSRTFYAKGQTGQQLLLGAYSAMNRQIN
RGKIKPYNRHEMMDLVLVDGKARGIIARNMITGEIERHSAHAVVLASGGYGNVFFLSTNA
MGSNVTAAWRAHRRGAYFANPCYTQIHPTCIPVSGDHQSKLTLMSESLRNDGRIWVPKKK
EDAEAIRAGKKKPTELAEEDRDYYLERRYPAFGNLVPRDVASRAAKERCDAGYGVNKTGQ
AVYLDFSNAIERYGKEKAFTSGHKNPSKEEVVKLGKAVVEAKYGNLFDMYQKIVDQNPYE
TPMMIYPAVHYTMGGLWVDYNLQTTIPGCYAAGEANFSDHGANRLGASALMQGLADGYFV
LPYTIGDYLSEDIRTGAIPTDSPEFEETERAVKERIDKLMNAGGKKSVDSYHKELGLIMW
NKCGMARNAEGLKEAIEEISALREDFWKNVKIPGSAASKNAELEKAGRVADFLELGELFA
KDALHRDESCGGHFREEYQTEEGEALRDDENFRYVAAWEYKGKPSDAVLHKEDLVFENIE
LKTRSYK
>IFAGANLK_00003 hypothetical protein
MGGFLNSTIARKVAMALSGLFLVLFLAQHFTINFLSVFSKDLFNEVSHFMGTNFFVQALL
QPVLIFGVIFHFVMGFILEAKNRSARNIKYVKFAGNANSSWVSRNMIYTGLVVLAFLALH
FYDFWFPEMIHKYIESHPEDTARYYEELIAKFQSPVRTILYVVSFVFLALHLYHGFSSSF
QSVGWRNKYAKGLRGFTQVYAIIIPLGFIFIALFHYINNL
>IFAGANLK_00004 Chaperone protein DnaJ
MAFIDYYKLLELDKSASQADIKKAYRKLARKYHPDLNPNDKEAQLRFQQINEANEVLSDP
EKRKKYDQYGKDWQHADAYEEARKQQQASGGRAYSGGGFGGSGFGGGQAGGYSYSGNFDD
DTFSDFFEEMFGSSARAQGSGRGRHYKGQDFNAELQLNLSDVYTSHKQTLTVNGKNIRLT
IPAGVENGQTIKIKGHGGPGVQGGPKGDLFITFNIVNNTKFKREKENLFTTIEIDFYTAL
LGGEITVDTFSGKVKLNVNPETQPGTKVKLKGKGFPKYKKEGQFGDLIITYNIKIPTNLS
NREKELFKELQKLRS
>IFAGANLK_00005 Chaperone modulatory protein CbpM
MNLEDLIPTDEICSRYKVERTFVSSLYESGLIEIVTVEETEYVHCDEISEFERLRRLHYD
LDINVEGLEAIQHLIRQVKILQKQNRKLKNRLGLYE
>IFAGANLK_00006 Xaa-Pro aminopeptidase
MRYDQIDSKLFIKNRKSFMAGMKANSLAVFNANDIFPIGADSTMPFQQNRDLFYLSGVDQ
EEAILVLFPDAPKPEHREILFLTETNPHIAVWEGAKLDKEKALEVSGVETVYWLQDFEKI
FFEVMSQCETVYFNTNEHYRANVQTETRDDRFIKWCKEKYPAHQVAKSNPILQRLRSVKD
PVELDLMQKACDITEKAFRRALKFTKPGVWEHEIEAEYWHEMIRNRSRGFAYTPIIASGN
NANVLHYTENNQQCKEGDLILLDTGAEYANYSSDMTRTIPVSGKFSDRQKQIYKTVNKVK
KEATKWLVPGTIWADYHKEVGELMTSELLDLGLLDKADVQNEDPKWPAYKKYFMHGTAHN
IGLDTHDYGILTEPMKPNQVFTVEPGIYLPDEGFGIRLEDDVVIQPEGEPFNLMRNIPIE
VEEIEEVMNS
>IFAGANLK_00007 AB hydrolase superfamily protein YdjP
MKITYKNTQISFTSQGTGNPLVLLHGFLESKEIWKDFAEELSVKRQVICIDLPGHGESGN
ISEVHSMAEMAETVKSVLDELEIKKASFAGHSMGGYVSLEFQNIFPTMCNSLVLVNSTPQ
ADSEERKANRDRAVALVLKNKRAFVSMAISNLLTPENNKIFKSQIEELKNRALKFSTEGI
YAAIKGMKIRTDHTGLFAKFNGQKIIIAGKQDSVMDFNTIKAIAIRCESEFESLPGGHLA
FLENKDNLSKILHFID
>IFAGANLK_00008 hypothetical protein
MKDKNPTRFSFGKVFCSIFGHKLRVSKNVTDHVHEYKCGKCGMEMTDTANGFLARLTPKF
KETNDYISKIHQKRKRKHYAHAS
>IFAGANLK_00009 Thiamine-monophosphate kinase
MFQDSQDMRTNLSELGEFGLIDHLTKGFEPKLSSTVKAIGDDAAVLNFENKHTIVTTDLL
VEGVHFDLAYMPLKHLGYKAVMVNASDVYAMNAKATQITVSIAASNRFPVEALEELYSGI
ELAAKLYNIDVVGGDTTSSTSGLLISITALGIAEKEDIVYRSGAKPNDLLVVTGDLGAAY
MGLQILEREKEVFKANPNAQPDLDPYTYLIERQLKPEARKDIAPLLKELGVKPTSMIDIS
DGLSSEIIHLCKNSQVGANLYEEKIPLDPAVISVCEEFDIDSTTIALSGGEDYELLFTIS
QDDFDKIKANPNLSVIGHMTEEKEGMHLITRANQKLPLIARGWNSMEDKNENSEKKE
>IFAGANLK_00010 Iron-sulfur cluster insertion protein ErpA
MIKVSESAKKKIAALMSEEGFDNLQDFVRVGVKSGGCSGLSYELNFDKSKAEDDKLFEDN
DIKIVVDKRSVLYLAGTVLEFSGGLNGKGFVFNNPNAQRTCGCGESFSL
>IFAGANLK_00011 FeS cluster assembly protein SufB
MAYTEDDLKKELETKEYEYGFYTDIESDTFPVGLNEDIVRAISKKKEEPEWMTEWRLKAY
RHWKTMKEPEWANVHYEKPNFQNISYYSAPNKKPKYESLDEVDPELLDTFKKLGISVDEQ
KKLAGVAVDVVMDSVSVTTTFKKTLAEKGIIFCSISEAIREHPELVKKYIGSVVPTTDNF
YAALNSAVFSDGSFCYIPKGVRCPMELSTYFRINQAGTGQFERTLVVAEPGSYVSYLEGC
TAPTRDENQLHAAVVELVALDEAEIKYSTVQNWFPGSKEGKGGVYNFVTKRGICEKGAKI
SWTQVETGSAVTWKYPSCILKGDNSIGEFYSIAVTNNHQQADTGTKMVHLGKNTKSTIIS
KGISAGQSQNSYRGLVQINARAENARNFSQCDSLLMGNKCGAHTFPYIEVKNKTGQVEHE
ATTSKIGEDQIFYCNQRGIDTEKAIALIVNGFSKEVLNKLPMEFAVEAQKLLEISLEGSV
G
>IFAGANLK_00012 hypothetical protein
MKIEEMKKFLLILTLAVTAFSCQDEGRQDLMNQPETEKVPDSIQTLTGEFIYAGDAAILR
GTDFVYGVTIDSMSKVLAEQVQPFQKEEFDMVPVRVKGKIVPNPRQEGWDENIEIREIIE
ILESEKALENQEEE
>IFAGANLK_00013 Vegetative protein 296
MLKVKNLHASIEDKEILKGINLEINPGEVHAIMGPNGSGKSTLSSVIAGKEEFEQTQGEI
LFENTEISEMDPEERAHKGIFLSFQYPVEIPGVSVTNFMRTAINAHRKANGLEDMPANEM
LKKIREKSESLEIDRKFLSRSLNDGFSGGEKKRNEIFQMAMLEPKLAILDETDSGLDIDA
LKIVADGVNKLRSKDNAVLLITHYQRLLNYIVPDVVHVMIDGKIVKSGGKELALELEERG
YEWVKAEKAI
>IFAGANLK_00014 FeS cluster assembly protein SufD
MELKEKLVSSFLAFEEEYTGTNDDLHKIRNQAIKDFETIGFPSRKEEDYKYTSLKSILKE
DYSLFPKKENALEYKDIKKYFIHEIDTYDLVFIDGIYSSHLSSTTHDKIDVCLMSSALNK
DLYKPVIDNYFNKLAPKNGLNSLNTAFTKEGAFIHIHKNTLADKPIQIINFSTGNESSLL
VQPRNLIVVDENSHCQIIERHQSLTDQPVLTNSVTEIFADKRAIVDYYKVQNDKLSASLI
DNTYIEQKSESFCSVHTFSLGGKLTRNNLNFYQRGERIDSTMKGITIIEGKQHVDHNTLV
HHIEPNCESHQDYKGIFDEKSVGVFNGKVVVEKEAQKTNAYQSNNNVLLNDKATINSKPQ
LEIFADDVKCSHGCTIGQLDEEALFYLQSRGIPRKEASGLLMYAFANNVLASVKIPEIKK
RINKLIALKLGVELGFNL
>IFAGANLK_00015 putative cysteine desulfurase
MSIATNNIAFNVEEIRKDFPILNREVNGYPLVYLDNAATSQTPKQVMNAIVDYYSNYNAN
IHRGVHSLSQEATDKYEGARKKIQQHFNAEKTHEIIFTSGTTHGINLVASGFASVLKEGD
EILVSALEHHSNIVPWQMLCEKTGAILKVIPMNEQGELIYESFEKLLSEKTKMVFLNHVS
NALGTINPIKKIIDKAHEKGAAVLIDGAQAAPHIKADVQALNVDFYVVSAHKMCGPTGVG
VLYGKEEWLNKLPPYQGGGEMIATVSFEKTTYAELPHKFEAGTPNICGGIAFAAALDYMN
AIGFEAISRYEEELLGYATLKLQEIEGMKLYGTARDKTAVISFNIEGLHPYDIGTLVDKM
GIAVRTGHHCAQPIMDFYKIPGTVRASFSFYNTKEEIDRFIDAVKKAKSMLS
>IFAGANLK_00016 hypothetical protein
MKKLLFILSLFLIVSCGNSEEKISEDPADLNSLNGDYELLEMDGEDISSEGFILNFNGSE
QRLSGKTGCNNFVTAYKIEDSIVKFNPPLGTKMYCEGQMEYEEIFNEVIPEIRNVKISDK
DLIFLSEENQELLNLQKKENSE
>IFAGANLK_00017 Cysteine desulfuration protein SufE
MSKTIQEIQEEIVDEFAMFDDWMQRYEYMIELGKALPLIDEKYKIDENLIKGCQSKVWVH
AELENEKLIFTADSDAIITKGIVAILIRAFSNHHPSAIIEADTQFIDDIGLKEHLSPTRA
NGLVSMIKQLKMYAVAYQTQLN
>IFAGANLK_00018 hypothetical protein
MPWHTKHNSIKMEKEINTEELGEKIVTVLKTIYDPEIPVDIYELGLIYDVMVNTDHEVKI
LMTLTTPNCPVAESLPQEVKERVASIDTVKDAEVEITFDPPWNQDLISEEAKLELGLL
>IFAGANLK_00019 hypothetical protein
MAEEIVNRIANSKLITFNLEDYYPEGERVVFDVKDWLLEGFVLREGEFREHAKNHDWSQY
QGKFIALTCSSDAIIPAWAFMLLATYLQPYAKKVITGNLETLETVLYTEAINKMDVSDLT
DKPVIIKGCSHKPVPKNAYLLLIEKLQPVVKSLMYGEACSSVPLYKKPKN
>IFAGANLK_00020 hypothetical protein
MKKLVLAFALFGGIFNLSAQEEEEEQKQGWTKEGNIALLFNQSAFNEEWTGGGTSNIAGN
FLFDYDFNYLKNDFTWDNKLLLDYGITKQRSDEFARKTSDRLEFNSIAGKQVQESNWFYS
LFLNFRTQITKGYKFGEDPESGQTTRTEYTNFLSPAYLQFGPGMMWKKSENLYLNLAPAT
GRMVFVDKDFTSGPDYVDGDYFGVDAEKAMRFEFGASVSGYAQFNIIENVTMENLINLYS
NYLEDPQNVDIDYTMNMKMKINDYLSTNLIFQAIYDDNAVKGFQIREVFGLGFNYGF
>IFAGANLK_00021 GTPase HflX
MIEKTDLTHEKAVLIGIVTKEQGHDKLKEYLDELEFLTYTAGGEVIKRFSQNMDKPNPKT
FIGTGKMNELKQFVDENEVGTAIFDDELSPAQQKNIEKILKCKVLDRTTLILDIFAQRAQ
TSYARTQVELAQYEYLLPRLAGMWTHLERQRGGIGMRGPGETEIETDRRIVRDKIALLKK
KLETIDKQMEVQRGNRGQLVRVALVGYTNVGKSTLMNTISKSEVFAENKLFATLDTTVRK
VVIRNLPFLLTDTVGFIRKLPTQLVESFKSTLDEVREADLLLHVVDISHPNFEDHIESVN
QIMSEIKSNDKPTIMVFNKIDQYEAEEIEDDDLITEKTKAHYTLKEWKQTWMNKMGDNVL
FISALNKENMEDFRRKVYEAVRKIHITRFPYNNFLYPEYDKYGEEK
>IFAGANLK_00022 hypothetical protein
MKKLILLPLLFFFGIITAQELDGAWKLTEKDGKAVNDREVIKIIQDGYFALGSKNLSNNE
FLGAAGGELSLEDETLTELRDFDTYDTEEIGAEHDYNISWDGEDKMEISDGNTTKIWERV
SEKSDALTGTWVITGRERNGEMNTMTPGDRRTVKILSGGRFQWIAFNSATKEFNGTGGGT
YTAENGKYTENIEFFSRDASRVGASLEFQYEVKDGKWHHKGKSSKGDPIYEIWSPYSEAY
QK
>IFAGANLK_00023 hypothetical protein
MKQTLLFLFLIATSLGFAQHSQDFAGNWFWESPDGQNTMELELEYESQGSIKGNHCVIFS
QGENTDCKRNNGNSFTINLVKIAEGVYDGTIESAVSFTSGKIRLQYIDSEKAIRFYLKEV
PPGEFYMPKEAFLVR
>IFAGANLK_00024 hypothetical protein
MYPTVQFIHSYWAYLVLIVLFVASINAIIGYASNKEYGATNFRIALFTLITSHIQLLIGI
VLYFVSPYFSVLLEEGMGTVMPDPTLRLYILEHPLMMIIAVALITIGYSKHKSKLTSKPK
FKILAIFYTLGLLIMLSRIPWNAWF
>IFAGANLK_00025 hypothetical protein
MKPKKNAKADLRKKSNLFLSFGLILALLASLLLIEWKTYDKEEFTKEQVYLDELEEEVIP
ITELANTPPPKPPVIPDEIEVIKDDPEAKEDEIESTETNLDDIVEPEEIIEHEPDEEIET
VPFTLIEDVPIFPGCEALEDNSARKSCMSEKITAYVNKNFNKDLGSELGLSGVNRINILF
QINTEGEIVNIQARAPHPELEKEAENIIKSLPKMQPGKQRGKPVNVNYALPIIFQVQE
>IFAGANLK_00026 TonB-dependent receptor SusC
MRKLLALALFLTSATIFAQGTLTGTVIDSEMDGPLPGATVMVVGTNNGTTTDFDGNFSLD
VESTSGKVSVTFVGYQKQTINFDVASGATQDLGTITLGPDADALSEVVVIGKGVIDVAIG
RQTPVAVSTVRAEEIQKSAGNMEFPQLLRSVPSVYANTQGGGYGDSEIRVRGFDQSNTAF
LLNGQPINGMEDGNMYWSNWQGVKDIANAVQVQRGLGASKLAISSVGGTINIVTQTYNNI
ERGYVQQEIANNNYTKSTAYYSTGKNDKGWSSTYMLSYWQGDGNFYKGTQGKGITYFFSV
GYKPSNEHAFNLLLTGAPQTHGQAYQGSIGDALTYGRDYNENWGYRDGSLYNERTNFYHK
PVLNFNWDWNINSRTDLSTVVYASTGSGGGTGPLGYYENKFNSNGQINFDQIIDHNRNLP
ATDINGTNYKVGDHPDLDEELGNGYITRASMNNHYWVGAVSNFNHEINENLEFNIGGDYR
FYHGDHYRQVVDFMGLDGWYVDNNASIPQGQTVFANYDVNLLDPTFNRARADQQIGYSNS
EDISYIGGFGQLEYKNDEFSAFVQGALSSQSHTRYDYFVYSRPENQESDKITNTGYNVKA
GVNYNINEQHNVFVNTGFYSRQPFHDNLFLNFSNDINPLTENEEITGIEVGYGFQGENFG
LNLNGYYTKWGNRTDTRTSFFDFDEDGVDEEYLANFNLLEQTHMGVELDFLFKPTNALTI
NGMASLGDWTYSDNPIQSLFDAEDLTVVPGFDNVESFIDGEKVGNAPQTSLGVGVDYAIM
DNLSIDGDWFYYGDLYAGIDPVSFTEEGGEVVKLPSYDLVRIGASYNLPLGNNTSLDFRA
NVDNLFNEVYLTSLATNRPGSAGDDLYKGINIANRGYFGFDRQWSLSVKYNF
>IFAGANLK_00027 Glucose-6-phosphate isomerase
MKNINPTQTTAWKKLEKHFNEVQQLQLKELFEKDPERASAFTIAWEDFYLDYSKNLITKE
TRDLLLELAEECELKSAIDSYFGGDAINQTENRAVLHTALRAPADVKITLEGENVVPEVQ
EVKEKIRKFSDKIISGEKKGFTGKAFTDVVNIGIGGSDLGPVMVTESLQFYQNHLKVHYV
SNVDGDHVYEILKNLNPETTLFLVVSKTFTTQETLTNATTIRNWFRKTAPQEAVAEHFAA
VSSNLKNVEEFGITIENVFPMWDWVGGRFSLWSAVGLSISLAVGYGNFEALLNGAHIMDE
HFKTSDFKENIPVQLALLSIWYNNFYKAESEAVIPYTQYLHRLPAYLQQAIMESNGKSVD
RNGEKVDYQTGTLIWGEPGTNSQHAFFQLIHQGTKLIPADFIGFKKSLHKDEDHHNKLMA
NFFAQTEALLQGKSKAEVKQELEAQGLSKDAVEKLLPFKEFDGNKPTNSLLINKLTPESL
GKLIAMYEHKIFVQGVIWNIFSYDQWGVELGKQLASKILAEIESKSTDSHDSSTKNLLSF
FLK
>IFAGANLK_00028 Murein DD-endopeptidase MepM
MLAFTACEDDTKETALNEEKVEKKVPKPVKKEFGFILDNFEVVDGTVESGDSFGYILDQH
GVDRGKIYQISEKVKDTFNPARITTGKKYKILKAKDSANTPEFFIYQNDRVNYTVLGIGD
SISVERKKKPVSVKRREVSGVITSSLSEAVQAQGLSNLLVYELSDIYQWSIDFFKLQKGD
QFKMIYSEKYIDDTIFVGIENVEAAVFKHGDKPFYAFEYETDSLTGQPSFYDEEAKALQS
FFLKAPLNYSRISSRYTKRRFHPVQKRWKAHLGTDYAAAHGTPIVSTADGTVIAASYTSG
NGNYVKVRHNDKYTTQYLHMSKRNVRSGQRVKQGDVIGYVGSTGLATGPHVCYRFWVHGK
QVDPYRQNLPTAKHIEPEHKEQYFAAIEDLKTSLDEIPYKDYKK
>IFAGANLK_00029 Tryptophan 2,3-dioxygenase
MEIKPEIAERIFALEEKFKNSGQDLASYLDGLLYDRYLTYWDYLSIDTLLSLQKTLTHFP
DEKIFITYHQITELYFKLIIHEQKQIIEAKAPDAGFLIEKYNRLNRYFRILTDSFDVMIK
GMEREQFLKFRMSLLPASGFQSAQFRMIEIYSTPLENLVSFKIREQFSKENSLEDLYENI
YWKKGGIDLKTGEKTLTLRQFEKRYTARFLRIASEYKGRTLFHKYQELPDSVKNNKGLKE
ALRNFDANVNINWPLMHMGAAYRYLNKDKETIAATGGTNWKEFLPAGFQRVSFFPYLWSE
EELEDWGKEWVNHMFNTQKENC
>IFAGANLK_00030 hypothetical protein
MKKSIFTIFLLLLTGVALQAQSQKAFSAGEWFKFRIHYGPFNASFATLEVDETSINGKPV
YHVEGKGKSTGLLHWFFKVDDNYQTYIDKQDGKPYKFIRKIDEGGYTKDLEIDFDHSDNK
AYVFDRKHNENHTYTTKPKVHDMLSAFYYIRNNINTDELQPGDDMNLNLFIDDENMDFKL
KFLGREVIKTKFGKVATLKFRPYVMAGRVFKEKESLTFWVSDDANKLPIKIEANLAVGSL
DADLDEYKGLKHPFKIIME
>IFAGANLK_00031 4-hydroxyphenylpyruvate dioxygenase
MSTDNTSLKLEKVMQDAEDFLPILGTDFVELYVGNAKQAAYYYQHAWGFQPVAYSGLETG
RKDSVSYVLQQGKIRIVLTSPLQPEGDINAHINKHGDGVKMVALWVDDARKSYEETTKRG
AKSFVAPYEMEDEHGKAVISGIHTYGETIHLFVERKDYEGPFLPGYKTYATKVQAEDTGL
KYIDHMVGNVGWNEMNKWVDFYAKVMGFAQMVSFDDKDISTDYTALMSKVMSNGNGRIKF
PINEPAEGKKKSQIEEYIDFYNGAGVQHIALATDNIIETVTQLRDRGVEFLYVPETYYDT
LLDRVGKIDEDLEPLKELGVLVDRDDEGYLLQIFTKPVLDRPTMFFEIIQRKGAQSFGKG
NFKALFEAIEREQDLRGTLQ
>IFAGANLK_00032 Homogentisate 1,2-dioxygenase
MPFYHKLGKIPHKRHTIFKKPDGSLYYEQLFGTIGFDGMSSNLYHEHRPTQVKEVRGSYS
VKPKIATENNIKSYRLKGFQVKPDPDYLESRKVVLTNSDVDITLASPQGSTDDYFYKNAD
SDELLFIHKGSGKLRTHLGNLDFKYGDYLLIPRGTIYKIDFDDENNRLFIVESRRPIYTP
KRYRNWFGQLLEHSPFCERDLRQPHELETNDETGDFLIKIKKQGEIFDMVYATHPFDVVG
YDGYNYPYAFSIHDFEPITGRIHQPPPVHQTFETDAFVVCSFCPRKYDYHPESIPAPYSH
SNIDSDEVLYYVDGDFMSRNDIEAGHISLHPAGIPHGPHPGAVERSIGQVETEELAVMVD
TFKPLMLTEDAMEIADETYHKSWLEDNHN
>IFAGANLK_00033 putative NTE family protein
MRKLLLLLFLFVMLPGISQEQEDLKVGLVLSGGGAKGLAHIGALKVIEEAGIRIDYIGGS
SMGAIIGGLYASGYTAHELDSIFHETNFNILIQDNIPRSAKSFYEKEDAEKYAISLPFDD
FKIGFPAGLSRGQNIYNLMSQLTMHLGNVDDFKELPIPFFCVAADVETGEEVILDEGSLA
QAVSASGAIPSIFSPVSLNGRLLTDGGVANNYPVEELRKRGAEVIIGVDVQDSLVNKDDL
RNVFDILAQISNFRTISDMKEKIPKTDIYIKPDISPFSVLSFEKGEAIIDSGRVASLKRK
DDLEKLAARQNSSPRNILIPEMDTLQISTLTLEGNNNYPRSYILGKLRLNYFTDFTFKEL
NEGINNLSATGNFNRINYRLIPNNDDHLYTLSLQIEESENKSQLRLGVHYDELYQIGALI
NYTHKSLLFTNDVTSLDVVVGDQFRYNFDYYIDKGFYWSIGVKSRYNNFDHPVSFDFASE
NAQLQDIGVNRIDIDYRDFTNQFYAETLFKQVFSFGLGAEHKFLRIASETLNNPNPEISD
NRLFENSHYYSAFSYLKYDSYDNKYFPSRGVYFDGIFHLYLFSSDFNNDFSEFSIAKGTL
GYAFSPLNRFSTRIVTEAGFKIGNDGVNTLDFFLGGYGNNLINNFVPFYGYDFISLSGDS
YIKGLVEFDYEIFRKNHVIASANIANVGNKLYSSGDWFSMPDFTGYALGYGIDTFIGPLE
VKYTYSPEIKSSQWFFSLGFWF
>IFAGANLK_00034 UvrABC system protein C
METLALEVQLQTLPNSPGVYQYYDKNGKILYVGKAKNLKKRVTSYFTKRHDSHRIGVMVK
KIKEIKHIVVASETDALLLENNLIKKHQPRFNVMLKDDKTYPWICIKNERFPRVFPTRKL
IKDGSEYYGPFTSFKTVNTLLDLIKGLYKLRTCNYDLSEEKIRNGKYKVCLEYHLGNCKG
PCEGKQAEAEYNNNIEAIRQIVKGNFKDSLQQFREQMKAHAEKMEFEDAQRIKNKIDVLE
NYQSKSTVVNPKITNVDVFSIISDEGYGYVNFLQLSHGAIIRSHTIEMKKKLEETDEELL
ELAITEIRQRFSSNSKEIYVPFKVDAGEEVKVTIPKLGDKKKIVDLSLRNAKYYRQERFK
QMKIVDPDRHVKRIMAQMKEDLRLNVEPRHIECFDNSNIQGTNPVAACVVFRNGKPSKKD
YRKFNIKTVEGPDDFASMEEVVFRRYKRLMNEGEELPQLIIVDGGKGQLSSGVKALETLG
LRGKIAIIGIAKRLEEIFYPGDTIPLYLDKKSETLKIIQQLRNEAHRFGITFHRNKRSKT
ALNTELEEITGIGEKTVVELLKQFRSVKRIKEASEKELAEVIGVSKAGIIYNHYQSKK
>IFAGANLK_00035 hypothetical protein
MGILLPCGMEKTVIGRFDKADFPALHLNDIAIKIDTGAYTSSIHCENIVEKDGILECTFL
DEEHPLYNGKKFTFTDYDIVFVRSSNGIIQKRYQVTSTIKIFNKVYKISLSLSSRQEMRF
PVLIGRKFLTKKFIVDTELTDVSYNLKQK
>IFAGANLK_00036 Ribosomal protein S6--L-glutamate ligase
MKIKILSRNSHLYSTKRLVEAATKRKHEVEVIDPLKCDIVIEKRKPNIYYKGGYIEGVDA
VIPRIGASVTFYGTAVVRQFEMMGAFTTTESESLVRSRDKLRSLQVLSRAKIGLPKTVFT
NYSRDVSGVIKQVGGTPLVIKLLEGTQGVGVVLAETNNAAESVIEAFNGLQARVIVQEFI
EEAKGGDIRAFVVDGHVVGAMKRQGKEGEFRSNLHRGGSAQVVELTDEEEIAAVKATKAM
GLGVAGVDMLQSARGPLILEVNSSPGLEGIEKATGKDIAKSIIRYIERNV
>IFAGANLK_00037 N-alpha-acetyl-L-2,4-diaminobutyric acid deacetylase
MSKITSDNVLEILGEKVKPGKSATINFNMAKLYTTTSVEVPVIIERSKKPGPVVLITAGI
HGDEINGVEIVRQIISKGINRPQKGTIICIPVVNIFGFLNLHREFPDGRDLNRMFPGTKH
GSLASRFAFQFVKKILPLANFCLDFHTGGASRFNAPQIRVKRGDEQSLKYARIFSAPFTI
YSKTITKSYRETCAKKGIPVLLFEGGKSQDSNKDIAKHGVEGAMRILSFLEMLNPKFEYP
DAITETVVIENTNWMRAKYSGLLHIKIPCGKHVEKGEYIGTITDPYGKFRHKIKAVNTGY
VININESPIVYQGDAVFHISAPPKDE
>IFAGANLK_00038 5-formyltetrahydrofolate cyclo-ligase
MNKAKLRKKYKALRLELSEEKIEELSLEIANQLLNLPVWEKEFYHLFLSIAEQKEIDTEN
ILHILQGKDKNVVLSKTNVKDHKLEHFLLTDTSIIKKNNWNIPEPEGGIPIPPKQIDVVF
VPLLAFDEHGHRIGYGKGFYDNFLSECKPEVIKIGLSFFEAETPFKEIFSSDIPLDFCVT
PNKIYSFKN
>IFAGANLK_00039 Aerobic respiration control sensor protein ArcB
MLNDLQLNSILEDFDIAYWKINLLNKEVSWSEHFDTLVGKPIFSESHFEYFLKEILHQDY
RYDFRLYFDKLTEENEAFSIELKLKLNNGKYRWFECRNLKNKENKKETAVLLFVNIHQNK
RDQYTIEENFFYYRETAQMTNTGGWYIDTQNKNIYWDNVTKKIIGCPLDYQPPYEEHLRF
YAPEEHPEVTSAFDKCEKYGIPFKVELKMRNLYDKDFWVRATGKPVYNEEQDIIGIRGVF
QDINDQKINELNLQNSLDLVASQNSRLFNFAHIVSHHLRSHSSNLCLIVELLKDAKTDKD
KIELIPNVADISENLDLAINELNEIVNKQTVLEKERRIVSFERALSGVMASTSSLINREN
AKIVAEFHALKEISYISEYLESILLNLITNAIKYKHPGRRPVIYIQTYLKNETPFLEVSD
NGLGIDLDQYGDKMFGMYKTFHENLDSRGIGLFITKNQVETLGGSISVTSTVDVGTTFKI
KF
>IFAGANLK_00040 Response regulator rcp1
MGQKVELACIIDDDKIYVNLVKKIIEIKKLSNNLLIFKNGMEALDHFKLILENATEERLP
DIIFLDINMPVMDGWEFLNEFIKIKNNFEKKITLYVVSSSIDPRDLERAKSINLVTDYLI
KPIELKKFEKIFERNGNAAA
>IFAGANLK_00041 Lipoprotein signal peptidase
MSLKKAGIIIVLVLLIDQISKFYIKTNFSLGEEVPVFDWFRILFVENEGMAWGTKIPGEY
GKLFLTLFRLVAIVGIGYWLWDSVRKNGSRILITAIALIFAGAFGNIIDSVFYGIVFNDS
YGQVAEFMPAEGGYGTLFHGKVVDMLYFPLWQGNLPEWIPFWGGNYFTFFEPVFNIADTA
ISAGVILLLLFNKRAFPKEEEDVKESK
>IFAGANLK_00042 General stress protein 16O
MATEVKERYSDAELAEFKALIKGKIAKAQEQLEIYENAYKNDGNNGTDDTAPTFKAFEEG
SETMSKEANSQLAIRQEKFIRDLKNALTRIENKTYGICRVTGKLIAKERLKLVPHATLSI
EAKNMQK
>IFAGANLK_00043 Isoleucine--tRNA ligase
MSNKFPEYKGLDLPKVAEEILSYWKENDIFEKSVSTREGKEPFVFFEGPPSANGLPGIHH
VMARAIKDIFCRYKTQKGFQVKRKAGWDTHGLPVELGVEKELGITKEDIGTKISVEKYND
ACKNAVMRYTDVWNDLTEKIGYWVDMEDPFITYKSKYMETVWWLLSEIYKKGLIYKGYTI
QPYSPKAGTGLSSHELNQPGTYQDVTDTTVTAMFKIADASAAVINNLEGAYLIAWTTTPW
TLPSNTALTVGPKIEYVSVKTYNQYTFEPITILVAKALAKKQFDKKFTEVQTEEDLKAYT
EGDKKIPFLIGETFLGKDLVGIKYEQLLPYVLPAENPENAFRVISGDFVTTEDGTGIVHT
SPTFGADDAMVAKQATPQVPPLLVKDENGNLVPLVDLQGKFRPEMGEFAGKYVKNEYYDD
GQAPEKSVDVELAIKLKEENRAFKVEKYVHSYPNCWRTDKPILYYPLDSWFIKVTEFKDR
MHELNQGINWKPKSTGEGRFGNWLANANDWNLSRSRYWGIPLPIWRTDDGKEEKLIGSIA
ELKEEMAKAVKAGVMDKDIFEGFEPGNMSEENYNLVDLHKNVVDEITLVTDSGKPMKREA
DLIDVWFDSGSMPYAQWHYPFENKEKVEGGDRQADFIAEGVDQTRGWFYTLHAIATMIFD
DVAYKNVVSNGLVLDKNGQKMSKRLGNAVDPFETLAAYGPDATRWYMISNANPWDNLKFD
IEGIAEVRRKFFGTLYNTYSFFTLYANIDNFTYEEKDVPLEERPEIDRWILSELHTLIRK
VDKFYADYEPTKATRAISEFVQENLSNWFVRLSRRRFWKGDYQQDKISAYQTLYTCLVEV
AKLGAPVAPFFMDRLYKDLNHSTHKENFDSVHLAEFSKYDDKFVDKSLERKMEKAQTISS
LVLSLRKKEMIKVRQPLQRVMIPVLDEQQREEIQAVEDLIKSEVNVKELQLIDDASGLLV
KQIKPNFKVLGPRFGKDMKLVVNEINKLAPEDIKMIEREGGIAINLNGEMIKLAAEEVEI
TSQDIEGWLVASSGNITVALDVSISEELKKEGIARELVNRIQNMRKDSGFEVTDTIDVTL
QKDGIVEDAVNQNITYIKNETLTASLEFVEVVTEGAEVAFDDITTKMFIKKH
>IFAGANLK_00044 Colicin I receptor
MVNCIYAQQIQVLDEESHEPLTSVAIYNANKSKSALTNFDGEADISAFDLDEIIQFSHVN
YSNRSLQKSQILQDENKVYLKGNDNELEQVVLSVAKFEMNNDEIPQKIVSFSANDIIMAS
PQTSADLLESSGQVYVQKSQLGGGSPIIRGFSTNRLLITVDGVRMNTAIFRSGNLQNIIS
IDPLAVENTEVILGPGSVVYGSDAVGGVMNFYTLKPKFSFGDKASVSGNAYSRYASANNE
KTLHADVNIGLENWAFVSSVTYSDFEDLKMGSHGPEEYLRNEYAVRRNGEDVIVSNDNPR
VQKPTGYNQINLLQKVKFMPHKDWDLNLGLIYSTTSNFPRFDRLYRKRDGELRSAEWYYG
PQEWFMGNFKINKKGYGALYDKAQMTAAYQFFEESRHNRDFGEDWLYNTQENVNAYSVNF
DFEKTFEESRLFYGAEYVFNKVNSIGNAQNILTEEENLTASRYPDGSTWQSIAAYTTYQW
KIQEDFSFQSGLRYNYILVDAEFDENLYDFPFQEAKINTGALTGSAGINWQQNRFIGWRL
NLSTAFRAPNIDDVGKIFDSEPGAVVVPNPDLKPEYAYSSELGFDWKPAENISFIATAFY
TYLNDAMVRRDFNLNGETEIDYRGEPSRVQAIQNTSKAHVYGFESGIEIDLSVALRFSSQ
INITEGKEEQEDGSTAPLRHAAPIFGNTHLTWHKKRLKLDLFAEYNGQFDYEDLAPSEQG
KAFLYAVDNNGNPYSPSWYTINLTGQYNISKDLLATVSLENITDQRYRTYSSGIAAAGRN
LILALRYSF
>IFAGANLK_00045 DNA repair protein RecO
MLVTTPAIVISALKYGEADLIVKAYTYSDGLKTYMLKGVLKSKKGKFKASQFQLLTQLEI
VANHRNQGKMEYLKDAKVLHTYTSLHTNMVKGAMLMFLAEVLKNAIREEETNPQLFNYLE
NSLMWLDLNDKIANFHLLFLLNLTRYLGFYPDVAFKNQNYFNLLDGVFEMNSINNYCREG
QNVAILRQLLGINFDTLNEVKLNQQSRSNFLSMLLLYYELHIEGFKKPKSLAVLNEIFS
>IFAGANLK_00046 NAD(P)-specific glutamate dehydrogenase
MEQNIQDFLDKVSKRNQNEPEFMQAVHEVAETIIPFIEENKKYQNKQLLERMVEPERVIM
FRVSWLDDEGNIQVNRGFRIQMNSAIGPYKGGLRFHPSVNLSILKFLAFEQVFKNSLTTL
PMGGGKGGSDFNPKGKSDNEVMRFCQSFMTELYRHIGADTDVPAGDIGVGAREVGYMFGQ
YKRLQNEFTGILTGKGLSYGGSLIRPEATGYGNVYFTQNMLKTRDESLEGKTVVVSGSGN
VAQYAAEKALEFGAKILTMSDSGGYIYDTAGIDSEKLQFIMDLKNVRRGRISEYVDQYPS
AKYYEGETPWGVKCDVALPCATQNELQKADAEKLIENGCMCVGEGANMPCTPDAVEVFKE
AKILFSPGKASNAGGVATSGLEMSQNSMRYNWTSQEVDQKLHAIMNDIHDRCVEFGKEED
GYIDYVKGANIAGFVKVADAMLAQGVV
>IFAGANLK_00047 hypothetical protein
MHNCKIFTALLVFTLFFQGKSYAQFGIAHEIGVKAGPASFFTDYGERWNVRNNLNNAGYG
IGISHYMNFAYKTDCHYSQATSFFTNHFRIRTELDYFYSKLEHFGPVASKPTLGGQLLRA
MHGESEIIEGGIHLEYHPFRIRDFTHSGYMFSPYISLGGHYVSHKADAYSDLGSLENPKN
VFPTFIGGINFERGSTYSIIGGLGLRYRLGFRHDLLIEARGQYYGSDWLDGLNIDAPQNK
FNDYIFWVNVGYVYYINFQ
>IFAGANLK_00048 Nicotinamidase
MKTLIIIDPQNDFMPGGSLAVPNGDEIIPAINKLQEKFDLVIASQDWHPNGHASFASSHK
GKKEFETIDLNGIEQVMWPQHCVENTAGAEFHSDLKTSKIEAIFRKGTNPEIDSYSAFYD
NQHLKSTGLSGYLKEKKAEDLYFCGLAAEICVHFTAKDAIKEGFKATIIEDATRALNKEA
FKKAKDELKEMGGKIITSKAIEN
>IFAGANLK_00049 Nicotinate phosphoribosyltransferase pncB2
MLNFSATYTDQYQLAMSQVYFKNGQKDHTAIFDYYFRKLPYHGGYAIFAGLQDLLKIIEN
LRFSDKDLEYLKKQDFDDDFLEYLKDFKFRGNIYSVQEGDVVFPTRPILQVEANIIEAQI
IETILLNLLNFQTLIATKASRIKLVSGERTLLDFGLRRAQGPGGYYATRAAIIGGFNGTS
NVIAGRDFNIPVSGTMAHSFIQSYDDELSAFRDFAEGRPKDCVLLVDTYDTLKSGVPNAI
KVAKEMEEHGQKLMAIRLDSGDLAYLSKQSRKILDSAGLDYVKIAASNQLDENVIKSLLE
QGAKIDVFGVGTNLVIGSPDAALDGVYKLAYSNGKPRIKISESIVKVTLPHKKQVYRLRD
TEGNCVGGDLVALFEEENIKNMIHPFEPYKQMRIDSLEKEALLKPVMDNGENKLEEKSLQ
EIAEYSKDRLAELSIEYKRFNNPHIYKVGISEALKAERDILIASFKN
>IFAGANLK_00050 O-acetyl-ADP-ribose deacetylase
MKKTIQNIKIEVSRGDITNQPDLEAVVNAANAELASGGGVAGAIHRAAGPELYEECKPLA
PIAPGEAVITGAYNLPNRFVIHCLGPVYGRDKPEDKLLEDCYRNALKRAEGKKVKSIAFP
AISTGAFGYPIKEATMISFNTILAEIPKLKHLQKLKFVLFSEADLEIYEAMLAEV
>IFAGANLK_00051 Nitrogen fixation regulatory protein
MKKNLMNMQCLDIYLSSLSQEEYEEIEDEITVSDIKLMPLRSWDIYNEHFANQILSLKQQ
KAINSFKELARKFDWKNNWNEIFKDKTFDALVLTNQEVKIQWVSEGFTDMTGYSSRFAIN
KTPHFLQGKDTDRVVLNRIKHKLSRDEPFTEVLVNYKKDKTPYKCEISVIPLINERTTHY
LALERQA
>IFAGANLK_00052 hypothetical protein
MSQFWLYFRLGLEHVLDWQAYDHILFLIVLVAAYTFSSWKRILWLVTLFTIGHTLALFLS
VYEIVKVDSAWVELLIPVTIILTALYNIITASRKERNKNHNPLYFTTVFFGLIHGLGFSS
YFKMVASNTESKFLPLLEFALGIETAQVLVVIAVIILSFIAQNIFSVSKRDWILVTSAIV
IGIILPILQENFQAI
>IFAGANLK_00053 tRNA-specific adenosine deaminase
MPDYTANMDQKKQLKYDKAYLRIAREWSKLSHCKRKQVGAVIVKDRMIISDGYNGTPTGF
ENYCEDDEGYTKWYVLHAEANAILKVAGSTQSCNGATLYITMSPCKECSKLIHQAGITRL
VYHIDYKDNSGLDFLKKAGVTLEQINDLED
>IFAGANLK_00054 Carboxy-terminal processing protease CtpB
MNTRQKILIPILLATACAAGVLLGGKLDFSSSDALFSSNPKKQKLNRLIDYIDYEYVDDV
NTDSIVDITVNKILENLDPHSVYIPKEEYAGVIENMQGDFVGIGVSFYNVNDTVVVIQAL
EGGPSEKIGIRGGDRILYADGTPLFNKDITNDSLTKHLKGEEDSRVTLKVKRKGIKDLLT
FKVKRGRVPLKSVDAAYMLSPELGYIKVNRFSETTYKEFEEALEKLKKEGANQIALDLRD
NPGGYLSEAIKIVDEFLEDDKLILYTKNKSGSVEETFSKRKGLLEKGDLFVLINENSASA
SEVVAGALQDNDRGTIVGRRSYGKGLVQREMDLGDGSAVRLTIARYYTPTGRSIQKPYDN
GNESYFKDYMRRYKNGELSNADSINVDDSLRYETPEGKIVYGGGGIIPDVFIPQDSNNER
NNIKLLLHGGYMSRFIFNVLEENRTFYNNVKREDFDEKVTISNEMVQDFVRFVGNGNIRL
SVNNHTTLLKQYLKAVIAQQLYGTTAFEKLINENDPAIEKVLELSQKN
>IFAGANLK_00055 Anaerobic glycerol-3-phosphate dehydrogenase subunit B
MKFDVLIIGGGAAGMSCALILGSALQNNIVSNKKVGILIHQKASHLNSALLNNVLGVVPG
TPGQQILKEGILHLEEQYPEIEQLAKEKVKDIIQLNEGFRVVTNKNTYDAENVVIATGYT
SPFRITGLEDEIIQHQKAKASKDRIQLKNEDHLVKPGLYVAGSLAGWRSQFSIACGSGAS
VATDILSLWKGEHTKVHDKLL
>IFAGANLK_00056 hypothetical protein
MKLFIYTVIFFAVVIIGYSATVLNFDDLLKGDSGTSVLVIVASLCVIILMGILLTSRSIA
KKHNS
>IFAGANLK_00057 hypothetical protein
MWKLLDAKQIFTAGMILFAVIDIIGSIPIIIDLRRKVGHIQSEKASVVAGFIMIVFLFVG
KEILNLIGIDVNSFAVAGAFILFFLALEMILGITLYKDDEPETASVVPLAFPLIAGAGTL
TTLVSLQAEYETVNIIVAILINIIFVYVVLKSSTRMEKVLGSQGISVIRKVFGVILLAIA
VKLFATNIQSLFS
>IFAGANLK_00058 hypothetical protein
MFQIGKTIVSEEILTKDFVCNLSACKGACCVDGDAGAPVTPEERQILDEIYPKVKPYLRQ
KGIDAIEKQGTYITTDLDEIETPLIDGADCAYVTFDDNGIALCGIEEAYNQGDIDFKKPI
SCHLYPIRIQEYSEFSAVNYHKWQICDDACSLGAELQVPVYKFTKDALIRKFGEDWYNQL
EAAAKDL
>IFAGANLK_00059 hypothetical protein
MKKLILLGCSLLLCVSTTEAQFLKKLKEKVEKKVEHAVTENISDKAANEANKSLNKMWET
DLKNSPIPMGANRVDVSEVPQSYDFNWEYQLSMETKDGNVDMTYLLKEDAPYFGMRVPQA
EGMFMVLDMDKKLTVMYLSSEDTNFITASKIDLSNTEEEANPYENSELKKIGTKNILGYE
CQGYETETEEHKFTFYLTREAPISFANMYSDEKSNIPKGWNADWLEDGDALMMEMIMVDK
NNSDHNTNMRCTSLEKKSFSINKENYSALGASK
>IFAGANLK_00060 hypothetical protein
MENSNTQHTNDAKSTFDPKTIAIIAYLTIIGLVVAFVLNNDKKDEFAGFHIKQSLGLVVL
SLGLFIIGMIPILGWILSFLGSIFLLYLWIMGLINAVNHKTKPVPILGHQFEKWFANI
>IFAGANLK_00061 hypothetical protein
MKTLILSLLTCFLFSFNAISQNLIEANVENWEYGTAKIGVLDFISGSTQEFGSIDENGNL
TLELQPGFLQKMKEQMEKEQEKSPDDWQASLKTVSGTFPCLSGGLSYKNGETNLSSLPRQ
LVVFKNEKEILGLLMPASNKAVADFFFTFSEKNSDTGKYLEWTYLDEPATVEGTCINTTF
TKNQNESFKASKNYSLDLKEGWNLIEYHITEVFEDSTGKIFPKTTEIQRIENIPSEINWY
FSAEK
>IFAGANLK_00062 Ribonucleoside-diphosphate reductase subunit beta
MSKQEPLLRDNKDRFVIFPVKHNDIWDAYKAIEANFWTLGQIDIQKDLVAWEELNGEKRQ
FLNKVLGLILSTEKNLSGLTKKISEKINLPEARSFLDLQLVMENTHTEAYSMCINSFFNT
TLQEEIFKEIQKHPATIAREEWLQKWSNSTSFAEKLVALATAKSIFSYSSFASIFWIKNC
GLIPGLCYTYEMIYRDKALHRDFAVQLFRDHLLEEISDKKIQQIIGEAVAIEKEFIAEFL
PLDLIELKTKSLTEYLEYESRRLFTDLMLNRSIIREDLAKEILVSKRAQDFSQINKTDKE
FNKVSKKTDL
>IFAGANLK_00063 Deoxyguanosinetriphosphate triphosphohydrolase
MNWEQLLSLKRFGDTNKRLRKEQNETRLGFEVDYDRIIFSSAFRSLQDKTQVIPLSKTDF
VHTRLTHSLEVSVVGRSLGRLAGQKILEKHPQLEKTHAYRMNDFGAIVAAAALAHDIGNP
PFGHSGEKAIGEYFSHGNGKRFKDELSLKEYQDLVKFEGNANGFKILTQNRPGSDGGLRL
SYATLGAFIKYPKESLPHKPTQNVADKKFGFFQTEKEIFEELATELGLIKTGKGGDVSYY
RHPLAFLVEAADDICYTIIDFEDGINLGLIDEDYALEYLIKLVKDNINTGKYNSLTNTAD
RLSYLRALAINTLITEAVETFLKNEDAILSGKFHQGLLDRSKYEAQIDDIIKISIEKIYE
SEEVISKEIAGYKMLSHLLDTYTEALLPQKAEENSNFNKLVLKSVPNLAYLQDENSVYRR
LLAICSHTASLTDGFTVASFEKYKGIKL
>IFAGANLK_00064 hypothetical protein
MKTKVLCLLACLIYLTTTANNSISDYYFDIYNDTIKPSDSIKVVQDTTEVDSVVVTFWTE
KNEVGVNLSEVAFINWNAGGNNSISALVYGNVERNYNKDHLNWRNRATVRYGINSQEGQE
LRKTEDELRLNSSFGYRKDSVSNWFYSAKFNFNTQFTNGYKYPDTDSPISKFMAPGYLFL
GIGTEYSDPVEDLTIYISPVTQKSTFVLDQRLANEGMFGVTGAVRDTLGNIVEEGENVRT
EFGFLVTSDFSKEVFENVELDNQLSLYSDYLNKFGNIDVEWQLNVNLRVNDFIKANVGSH
LRYDDDVKFKEDTNGDGELETTGPRVQFKQMLGVGLVYEF
>IFAGANLK_00065 1-deoxy-D-xylulose-5-phosphate synthase
MNLKILEDINSPEELRKLPAEKLQEVSAALRKFIIDIVATKEGHLGASLGVVELTLALHY
AFNTPEDLLVWDVGHQAYGHKILTGRRENFHTNRRLNGISGFPKREESQYDTFGVGHSST
AISAALGMAIASNLNGKFKKHHIAVVGDASIASGMAFEGLNHAGVTKANLLVVLNDNAIG
IDPSVGALKQYLTKARVGFKPKQSNIIEALNFKYFGPVDGHDITGLLEVFEQMKQIEGPK
FLHVITTKGKGLKKAEEDQVKYHAPGKFSPDTGELLPYDTAGLPLKYQDVFGLTLVELAK
NNEKIIGITPAMPTGSSLKFMMQAFPERAFDVGIAEQHAVTLSAGMATQGFKVFCAIYST
FLQRAYDQVIHDVAIQKLPVVFCLDRAGLVGEDGATHHGVFDIAYLRCIPNIIIAAPSDE
NELRNLLYTAQLDLKLPMAIRYPRGRGIKTDWETPFKEIAIGKARRLKEGDRIAVLSIGN
MAQNAVKAIENITTEKIGHFDMRFVKPLDEELLHILFQKYQAFITIEDGAVVGGFGSAIL
EFASKHDYNVKIRNLGLPDKFIEQGNIDELQEIAKISVEYIEKEIVTLLQNL
>IFAGANLK_00066 tRNA-specific adenosine deaminase
MLQPYDDEYFMRKALDEAEKAFERGEIPVGVVVVINNQVIARGHNLTETLNDVTAHAEMQ
AITAAASFIGGKYLKDCTMYVSLEPCQMCAGALYWSQISKLIFAAEDKQRGYRKTGVKLH
PKTEVKSGILAKEASALLKRFFIEKRNLN
>IFAGANLK_00067 hypothetical protein
MGKINTLLFLNIFILTVFFAGAQENGPAENQNAKALEHTFYVAGNIGNDLEGDAGKIMKS
IVEASQKEEKATLLVPGNFLKPKGYPKNEREREAYQELLKKYLLEPLKDFNGDVIFTPGY
NEWTKEGQGAIDDLESFLQDNQSNIEVWPDDGCPLERNGITDQVELITVDSQWYLEDWDE
HPIINTKCEIKTREQFFIEFKDDIKDNHGKTIVVSVPHPVLSNTKNGFFEKIGGFSPQAY
YNEEYSYLRGRLETIASQFDDVIFVSGNDANMQFLKDDGIPQIISGYTKDIQKAKVRKDE
HFASTKMGYAKLKIFKDRSSLAEFYEVKPLEDSLIFTAPIKRKESRMEEVSYKTKEQVGD
TVSASIYSEEETDKSKFYSLIWGDHYRDVYSKKIDARVLFLDTLDGDLEPLKEGGGMQSR
SLRFIGEEDHEFTIRALRKSATRFLQAAAIKDHYIKDYIENTVAQRYALDLFTTAHPYAP
FSLNRITETLDIIAGHPDIYYVPKQKALGTNNDDYGDELYMFEAHVGDENKQFERFGQPN
DILSTTDFLIALKESKDNQPDEGEFIKARLLDMLVGDWDRHFDQWRWAEFEEDNGKKSYR
PIPRDRDFAFPKYDGPVLDLVKLGFPLVRKMETYDENVDNVKWFNLSGYSLDQRIIKNAG
WNQWKEQVDFIQEKLTDEEIEKSFALLPENVQDETIDSIKANLKKRRENLEDIARRYYKY
LNDFQVLTGTKEDDSFIITRKNDGLTEVIVKDEDGNETFNHTYKADETEEIWIYGLDNED
SFSVTGEGDNPIKLKIVGGEGKDIYNFENTRNVKLFDQKSKENIIENPKSKKWLVDSYEI
NAFDPDKRKKSENKIMPQVDYNGDEGLSLGLRDTFTTYGLTNNPFNTQHTFDASYYFATN
GFEVGYFGEFAHIFYNWNLGIAARYTSPNFAVNYFGEGINSEYDRDADGRDYNRVRIEQW
EIAPSLIWRGNSGGSFYAKPFLQSREVSYDEERFIADAFSEDNDLFERQLYAGGEVNYHY
ENRDNPSYPSRGFEADITTGYKTNIDGYNNEFAYLSPSLAIDYPLHESGIAVLATKVGGK
AIFGDNYEYYDGAILGGNENLRAYRWERFNGKQSFYHSTDLRVGISRIRTNFIPLQIGVS
AGFDYGRVWEEDSTSDKWRNNYGGSIWINGFNAFTANTGYYYGDDGGRLTFTFGFKF
>IFAGANLK_00068 hypothetical protein
MSPDINLIHNLLQAVMLIPFLHLANQYIFKMISEKHDFFSANLMNKLFYYHLIFAGVYYT
YAFFNPSDSKRYFSVSGKEGKTWSGFLETGTSFIDFLSYPFINFFGFSYEMMMLLFSWIG
FMGFVYAYLFFKENIAINIKIFKKIDFLVLILFLPNMHFWTASLGKGAPIFLGLMLFAYA
LRKPQTRIYSLSLGSLLVFAIRPHMFLLLAGAGLLSIFINKNQISLKQKAIFVGAITGVL
LLFHKQILDVVNLGNSQNLIADFLSFTENRSNNLDNATSGVPMTDYSLLEKFFTFWFRPL
FFDAPGIMGVIVSIENLVYLLLFGKLFKKSFFGFLKTAPGHVKLSLILFFTTSFAMTFVM
SNLGIILRQKSMIMYFLFFVIYYFLAYEKDTVFRLKQEVTGRQHLRKAA
>IFAGANLK_00069 hypothetical protein
MVPPKNNPIKRHEAIQPLSREHHQGLLLCWKIRKGIETGVELQRIKNYTDWFWKNQLQEH
FRIEEKYVFPVLGAKNVLVKQALEEHEHLASLFCQNNDIALALEMIKNDLEGHIRFEERV
LFNEIQEKASAEELQYIEQHHGKEISCGVWEDEFWD
>IFAGANLK_00070 Putative short-chain fatty acid transporter
MVWHGGMSGSAPLKAAQNGHLASLFPGADSEFLSQLPNNLPTSCTIFSYWNLLIFAILLV
LIPLTLYLLSRISGIKTVKTEYETKSHHIARITGAEKLDHSKWLRLVFGILLLTAFFASY
SEELLIGNLTPNMLNFLMLCLCILLHDSFFSFLKALQEAIGGAAAILIQFPLYFGIMGVM
RETGLVGDISSFFASIATDVSLPVYSFFSAGLVNIFVPSGGGQWAVQGPIILESALKLGV
PLNKAVMALAYGDQITNMLQPFWALPLLAITKLKAREILPYTLVMMLVGTLVYITGLLLV
>IFAGANLK_00071 Putative short-chain fatty acid transporter
MNISQFIENTFKNLIPAPFTLAVLLTLITLFVAFFFTDQTSITSAIQILDFWQTGMWDPA
LIVFMVQMMLILVLGHVLVLSKPVSWLTSQLTKIVTGNASAVIIVSVSTMLVAFFNWGLG
LIFGAIMARKVAEAAPPADLKLIIP
>IFAGANLK_00072 Glucan 1,4-alpha-glucosidase SusB
MKSRLILSLFYLAVLGSLQAQTLESPNGNLQLNFSLEEDGTPVYKLDYEGKTVVETSKLG
VELKNEEHALTSNFSIENTEEYAFDETWTPVWGEENEIRNHYNELVVHLNQEDSERKMLI
RFRLFNDGLGFRYEFPQQNNLAHFVISDEKTEFAMTGDHTAFWIAGDYDTQEYDYTESKL
SEIRGLMEKAVTANVSQKSFSPTGVQTSLMLKTEDGIYINLHEAALLDYPAMHLNLDDES
MVFESWLTPDVNGDKAFMISPGQTPWRTVIVSDNAKDILSSRITYNLNEPNKIEDPSWIK
PMKYMGVWWEMITGMSSWDYTDEFAAVKLGETDFEAAEPNDTHAATTENVKYYIDFASEH
GFDGLLVEGWNVGWEDWFGNSKDYVFDFVTPYPDFDVDEIREYAKSKDVEMIMHHETSAS
VRNYERHLDTAYQFMKANNYNAVKTGYVGDILPRGENHYSQWIVNHYQYALEKAAEYEIM
INAHEAVRPTGIARTWPNLIANESARGTEYQAFGGNKPNHVTVLPFTRLIGGPMDYTPGI
FEMDISKLNPDNNSHVNSTLANQLALYVTMYSPLQMAADLPKHYEQFMDAFQFIKDVAID
WDKSVYLEAEPGDYITIARKEKDGNNWFVGNVNGETPRISEIEFDFLEKGKSYIATVYAD
AEDAHYKENPQAYEIKKYRVNSKSELSQKSAPGGGYAISIMEADKSEIRDLEKL
>IFAGANLK_00073 hypothetical protein
MNNLFKILLVFLPLCEMWAQPVTSNMQLQESFKELPQEEVFVHYNSSLLMPGAQFYYKVY
VLNTAENKLSGLSKVAYVALIDKNGEEVFKHKIYLENGVGASDFFIPNSVNSGHYKLVAY
TQWMQNGGVKNSFRADLLSINPYQNEQDIIDTDKEISAVNLKDNNSGEFLSLSVLKTTYE
KREKVILEILNTEKIIGNFSISVNKLEEFEVPEKPTSANYGRNYEIENKSNSEYFIPELR
GELLLGSISPMPINSNRKPQVALSINGNQQIFRTSVVNNTGEFFVNLDEKFDGETALLQV
LNDEDSNYKIQLRKKEKINTSALVFKDYKISAEANDEILQRSIHHQIENAFFEVKADSLP
VAEMENKELYPGESQLYVLDKYTRFKTLEETFVEFIYLARIRKDEQGEPEFRVSGIQNSL
DYGLPPLLLVDNVLVEDHSHFINYPSEKVESIEVFRNNFYLGPTVAQGLIKVKTIEGDYV
ESLDKLTEIKIKSPQLDKNYSFQNYNQPEKFNRIPDFRYQLFWMPHIELEEKNKAIEFFT
SDVTGTFEISLEGFTRDGEPISLKKQFEVK
>IFAGANLK_00074 hypothetical protein
MFSKQQILILLFTGFCLFQSCVEPIEFETDEYENILAVRATITDDLETQKVYLSRTFLFG
EDGPAPESNASVRITDEVGNEYEFREAENGEYHSVDQFKAQPETDYQLQIETANGVSYTS
EPTQLASSSPIDNVEAQRLTVNGENGIAIEVDNYNTNDATQFYRYEYEETYKIVSRYSSD
SDLIYENGQFKVIPKTREERVCYNTLNSTNYILANTSNLSENNVEKFLVKFVETANPKLS
QRYSLLVRQIGISRDAHYYYNAMERLSGSDNLFSQNQPGFVEGNIISENPDVKVLGYFNV
SSVSTKRIFFDYQDFYSIEDPRPYFSEDCNPAHPVTPADLEKLIPVLQSGYVKLLRTKFP
TFEVVETECIDCNVWGTNVKPDFWEE
>IFAGANLK_00075 hypothetical protein
MRIFLIFLFFLCNVLKLSAQENPRIDLSFEDATVEEVMMMIEDRTAYKFFYSEEWIDDSL
ISGSYNNEDIETVLTEIFNATNLNFFILNDQIIITRNNVIYDELPTSFYPERSADTLAND
KPVAVSEDSEERNHQPVFYRESGTVAAEEIETIYIGKEDKSNPKNRFILSGIVTNAETGL
PISNLSVVTASGNQGSVTNEEGYYELELPAGASIIETISLGNLDVKKRIVIYNDGQLNLS
LDESFEQLGEVLVDSEADRNVRSVIAGVESIDVSQIKNIPLVLGERDILKVATTLPGITT
AGEGAAGYNVRGGKTDQNLILLDDAVIYNPAHFFGIFSGINPFTTGEVDIYKGNIPAEYG
GRLSSVFDIKSKDANTEKFVGEVSVGPVTSNVALEIPIVKDKSGLMLGGRSTYSDWILRN
LDEESLSNSSASFYDLIAKYNHKFSEKTSLRTTGYYSRDVFSITSDSLFRYSNLVFSANL
NHKFNERNEMEVVVSNSGYQFDIDYESEFNNNFTSGYNINETEAKIKMNYRHSSAHNFEY
GLSSKLYLVDPGEISPLGSESIVEPFQIDREQGLESAIFISDNFKVNDELLISAGLRYSL
YAAMGPKSQNTYEEGLPRNESTLTGSREVGNGEVIETYARPEFRLSARYAFLPDFSTKIS
YNNTYQYIHTLSNNTTISPTDTYKLTDLNIKPQQAKQYSLGLYKNFKENMYEFSVEGYYK
ESDNILDYKVGAQLFLNENVETEVLQGDGKAYGVEFLLKKSEGRLNGWLGYTYSRSLLRL
DGEFREQRVNNGDFFPANFDKPHDVSLVANYKLTKRFSFSANFVYQTGRPVTIPVGKFNP
GTGQLPVYSDRNQFRIPDYYRLDLSFNVEGNHKIEKFAHSFWNISVYNVLGRNNPYSVFF
VTDDGDIQAYQSSIFSIPIPTITYNFRF
>IFAGANLK_00076 hypothetical protein
MRQQFILLFSLALLSTNLSVFSQEYREVFKNFDELVNIENTNLLYGKEYVEQHATINNKH
KFFQTSGFLNGDVVYSGETYYDLDLKYNVFEDLLIVRVKKEGGEATYQLFKNRIESFRID
GRNFINISPKKNAEIQGFFEIFSEDASLKLLKNHRKKLKKILTTNFTYFEFEPEPTQYAV
AISGKYFKVNSQAGWLDVFPEHKEKIESYFSSNQALKETDPDNFLLRLFSEISESYKSNN
S
>IFAGANLK_00077 hypothetical protein
MTSNEKNNLALETLKFPVRYDNRQQTIWDAKDMMVCDIRGWGKIQFMNKSEARQDAIGEL
IANLLNKFHRNENSKIDEELFRMLAS
>IFAGANLK_00078 Glucose--fructose oxidoreductase
MKKACTLFLFSLFVSQSFSQEKIKVAVAGLTHGHVNWIFNREGKNDIEIVGIYETNKELI
KKYSENYDLDKSLFYTDFEEMLDKVKPDAVSAFGATNEHINVMRACAPRKIHVMVEKPLA
TTVKDAKEIEKLAKQHSIQVLTNYETSWYASNQYIKDLVEEDQLGDISKVMVNSGHQGPK
EIGVSEEFLEILVNPEKNGAGALMDFGCYGANLMTWLMKGEKPVSVTAVTNQNKPEIYKE
VDDEATIILQYGKAQAVIQASWDWTFSRKDMEVYGENSYAIASDATTVKMRTDADKPENI
VKLDSLEAPYDDPFSYLAAVVNGEIEVNDFGLYSLPLNLIVVEILEKAMESAKTGKTIHF
QKNDF
>IFAGANLK_00079 hypothetical protein
MKTTFLQFLALTLLFVSCSTDNNNPGGSENPETEIEDTFNYLALRADGNLYEIGNKTGEV
SAVGSISAMQNNLNMIPNAVTASEEKIFIYEHLFDPFQGRVLVMDKETRSVEVFVLDFPV
EVYGENAGLNSLDWDAGQGNLVGIVKDEMDYNNNNTSRVVRIDPETMTLSYEEISFEHNF
TLSTSLLGNKLFALSSTTGELEKAELLQIDLSAKTLKPLEISDTELFISNLANNGTDDFL
FGLLPVRGSSLMGEMEAYKLNLDNNEFEALPEVGRFSARQLARKSFCNKKFNEFAELVFK
EGKNHLLQYNHQENDLSLLELSGAEDFGSSIIIIDYVEVQ
>IFAGANLK_00080 hypothetical protein
MKYKINIEKVQTVDEIREYWSKEDYIELLKRFDYPDAEDSDPESLRELLFMAITDFEPGE
AAKVILDYKLGEELSEGQIEQISNDMLIDTVCEEYPEMELQSRLFHVNQLLFKAYNGKFP
SSSATIINCSITSSNSDSSLDEATILRILNDGLSDRNIVKRLFEEQLNGNAEFPEAENII
WDLEVSENAQYKIITSGNLIKKDEVIASEWEKEIEEDSDK
>IFAGANLK_00081 Flavin-dependent monooxygenase, oxygenase subunit HsaA
MKEDNKQQALRELCLGIDIFPDEVLSWIVAENLWNIWVPKKYGGLEYTLTEGLSKLQELA
RIDGSLGWTVTLCSGANFFIGNLEPEVAEQIFKIPKSTILGGSGGVFGTAEKIGDNYKIS
GTWRYATGANYLTHFTLNAEIYENGKALLNEDGSPYIRSFILPKNEVKIIEDWNTMGLKA
SVTHSFEVKNILVPAGFSFIYNEFYQPQDIFKIPFSFFADLTLWVNYVGMAEHFLEEARS
FTSASILKNLEKCIAVSQDEVSAYSKAIEDEIAAGNKILDPYSEEIHSSASHSVKNLSKN
IIEIYPFLGVKASINGHHSNQVFSDYFTATQHHIFTK
>IFAGANLK_00082 Nicotinamide riboside transporter PnuC
MIEDFFTQLTWLQALGTTFGVVQVLLARKNNIHNYLFGIVSILISLFVMYQSKLYADIIL
NLYYLVMSIYGWFYWRYGKKEEETPISYSSKSEHLKALGIVLTCFAIMSYWLRIHTDSDV
PFWDAAVSGFAWAGMWLMAKRKMENWIFLNISNSIAIPLLIYKELYIYAGLTVFLFIVGT
SGYFKWRKIVKNERRQQAASA
>IFAGANLK_00084 hypothetical protein
MKAIILSLVTGLIFLSTNCDRQNSEEQMQITGTIESQGITSYQYGTHTLNTEDEFYALKS
EKVSLDEYVGKEVTISGSKIEGYPVDGGPDYILVTEVKE
>IFAGANLK_00085 hypothetical protein
MKKSLLSAVLFSLFMSFSVHAQIDEEQTGAWYMYFWNTNFGESEWGLQGDIQYRNWDLGG
DLEQLLIRGGLTYSPKNADVKFTLGYGNITSGEFGEGNNTAGESRIYQETLLPHKLSDRF
YLTHRFRYEQRWVEDQDFRTRYRYNLFLNIPLNQPNLNKDAIYLALYNELFINGEREIGN
GRSVELFDRNRFYSALGYALKDNLKVQAGYMKQTTDAVSKGQIQLSLHHTF
>IFAGANLK_00086 hypothetical protein
MKQFLLFFALIFISTINTKAQTAEISGDAFAHTYSIVARDAKTGEMVVGVQSHWFSVGPL
VAWGKSGVGVVATQSFVNPAFGPEGLKLLDQGYTPEEAVESLINNDEGRDFRQLAILGKS
GDNAAYTGQKCVAEAEHLNGDNFSVQANMMLNDEVVPAMAEAFVENANLPLAERVIAVLK
AAQDAGGDIRGKQSAALIVVGPDKVEEVWKDKKIDLRVDDHENPIEELDRLLKTARAYEF
MNRGDLAMEEGNVEKALEEYGTAESMFPDNLEMRFWKAVALANSDRLDEAKQIFDRIFEE
DENWRTMLKRLPKAGLIDVSEEEMEMLTE
>IFAGANLK_00087 hypothetical protein
MKINFNKVMLGLAVVSLAAFTSCKDAEEKTTEETQTVPNTEMSGNTSGNAETPDINPPHG
EPGHRCDMPVGASLSGASSNNNTNAGSDSEMTSSPIRLKESKPTKNPAHGEPYHDCSIPV
GADLEG
>IFAGANLK_00088 Bacterial leucyl aminopeptidase
MKKNLRTLFSLFLVVGALQVQAQEEMVDKIVNEANENSKLEDLAHELVDVVGPRLVGTPQ
MKNAHDWAVKKYDSWGISAENEEYGTWRGWERGITHIDLVEPRVRTLQGRQLAWSPSTGK
KGVTAEVVLLPEASDSTDFANMLSLVKGKFVMISVNEPTGRPPYNWEEWGTEKSWKKMQG
SIKETDSLWRDRIGKTGYGYRELPKALENAGAVGIITSNWSHGFGANKVFGGYTSEIPTL
DINLEDYGLLYRLAENDNAPKLKVVAQSKDLGEMPTFNTIARIEGSEKPEEYIILSAHFD
SWDGGTGATDNGTGTIVMMETMRILKKLYPNPKRTIIAGHWGGEEQGLNGSRAFVKDNPE
IVANVQALFNQDNGTGRVKNINGQGFLHAYDYIRRWLEPVPQEIKGEIETSFPGTPSSGG
TDHASFVAAGAPAFMLNSLNWSYWDYTWHTNLDTYDKIVFDDVRSNVILTAIMTYMASED
PETTSREKAVLPISRRSGEQMTWPEPRDAERKGGLD
>IFAGANLK_00089 Prolyl tripeptidyl peptidase
MKKTLQNPFNFKFQFLFLIFIGLSFSGISQTSELSLEKIMQDPNWMGTFPSNVKWSADSE
TIYFDYNPEKNAEDSLYKIELNNTSKISKVSLEEERGIIPTYGDFNKNRSKKIFSKDGNL
VIYDVKSRETIQLLDLSEAISNAEFLAEENKISFNSSDNAFIYDRKAGSIKQLTNIAEGK
AEEEKEDETSEKDAWVRDENLELLKVVNQRKSEKENREAYQEATAEKEDYTFYLEDRDIS
NLQVSPNAKFATFKLITRKQDGSTDVPNYVDESGYTANLPARSKVGEDKTSIELAIYNLE
KDTVYTLKTDDLPGITDLPDYVKDYPDKEWEETKREVAPTTVYFSENGEHAVVNLRSKDN
KDRWIAKIDLETGKLNTLDRQRDEAWIAGPGVGYAYYGGEEMGWLPDNKHIYFQSEETGY
SHLYLLDVTTGSKKALTEGDFEVFDPELSNNKKHWFLTTSEVGPGERHFYKMPVLGGKME
KLTQMEGNNDVYLSPDEKNMAILHSYSNKPWELYLKKTRANAEAKQLTEGKSEAFSNYEW
REPELIEFEAEDGAMVPARLYKPEADVKNDAAVVFVHGAGYLQNAHKWWSSYFREYMFHN
LLTDLGYTVIDIDYRGSAGYGRDWRTGIYRHMGGKDLSDQVDGVEYLVENHGVNPEKVGI
YGGSYGGFITLMGMFTEPETFKAGAALRSVTDWAHYNHGYTSNILNEPAADPIAYKRSSP
IYFAEGLEGDLLIAHGMVDVNVHFQDVVRLSQRLIELGKEDWEMAIYPVEDHGFVEPSSW
TDEYRRILELFNESLLD
>IFAGANLK_00090 Cysteine desulfurase SufS
MDIEFVRSQFPALQREFTFMDNAGGSQTLKKVAERISGYLLHHNVQLGASYKVSREAGEK
LTYATKQVSRFINAGKPEEVVIGSSSSMLLRILSICISKQWEEGDEVIVTNTDHEANVSP
WTDLKEKGINVKIWKANPDTLELEISDLNKLLSNRTKLVAVTHASNILGSINPIKEIAKT
VHKAGALICVDGVAYAPHRRVDVRKLDVDFYVFSWYKTYGPHLAVMYGKYNQLYKMEGFN
HYFFTKKDVPYKFQPGNFNFELTYSLLGITEYFDHLFKHEFPKEKKAEFQEKMDKVFELI
GRHEERISKPLLTYLDEHPDIKIIGRNIAEREKRVPTISFVHTELSSDQIVEKVDDYRIG
IRFGDFYAKKLIEDAGLKEKNGVVRVSLVHYNTLDEVQRLIWILKKIL
>IFAGANLK_00091 Cystathionine beta-lyase
MLKDNEHATFAINARIMKFNTKTIHGGQENIDPAYGSVMPPIYQTTTYSQSTPGGHKGFE
YSRSGNPTRSALEKSLASLENGKFGLGFGSGLAAIDAVMKLFKPGDEIISTNDLYGGSYR
LFTSIFENMGIKFNFIAMNEAGNIEKYINDNTKMLWIETPTNPMMNIIDIEAVSKLSQTY
NLLLAVDNTFATPYLQQPLDLGADIVMHSATKYLGGHSDVVLGGLVVKDEELAEKLHFIQ
KASGAICGPQDSFLVLRGIKTLHLRMQRHCENGEAVARFLRSHPRVGKVYWPGFEDHPNH
DIAKKQMKGFGGMISFSTTEDTLKSATNLIEKLKVFTLAESLGGVESLAGHPATMTHASI
PKEDRAKTGVVDSLIRLSVGIEDEEDLINDLKQALE
>IFAGANLK_00092 hypothetical protein
MSQKILSLLVIFLIFTSCRDEKSEAGVKQVKGDTEALSFYEESFLPKDFEACKTEKCPKI
RVNYLKFREDREAAKEMNSYNQERLIKIFNNTEVASEAENVKAAVSEFIQDFQNFKRDFP
EAQAEYEVEISQSVLSQTKKLLVLETNFYLFTGGAHGYGATRYANYDITSGELLYKKDLF
SDLDAFTEFAEKEFRKKYEIPEGENINSNGFFFEKDSFALPENIAVTKNRVILVYNRYEA
ASYAEGELKLSFPKNKVSKWLNY
>IFAGANLK_00093 Regulatory protein Spx
MKKVYHLSTCSTCQKILKELELPDSFKIQDIKEEEITAEQLEEMKALAGSYEALFSRRAR
LYRERELNKKELSETDYKKLILDHYTFLKRPIIINNNEIFIGNSKKTVAAAKAAVHG
>IFAGANLK_00094 hypothetical protein
MDNKRILAIFAAIGASAIYGLNHTIAKGVMPTYIEPFGFIFLRVFGAAVLFWGISFLGPK
EKIATSDWPRILGCAVFGMVINMLFFFKGLSLSTPINSSVIVTLSPVMVLILASVLIRER
ITLLKTLGIIVGLAGALVLVLFSAESTGNAPNIPMGNVLFIVNAFSYGLYLILVKPLTAK
YHAFTLMKWLFLIGVIINFPITIGEFTDVNWTSLPFDAIWKMAFVVAGTTFSTYLLNIYA
LKQLSASTISVFIYMQPLIAITYAILTGADQLNMVKIVAAILVFVGVYMVTKKKTEIRP
>IFAGANLK_00095 hypothetical protein
MLEWYLLPIFVAPLILSVLAPFIDTPQGKKQGKLIYHSPLFITEREKNGKIIIHGGTLFD
YYYLIDRNWKAKQRIRYILRQYILGLVKLTESYNENEAAEITLEGTSYILNERTAQKLGF
TKKRTDILQQIILTYNYLQILLANSLAKNKLSFPAVGKVNTYTASLSTIKRNKNYLKKLA
EKLRD
>IFAGANLK_00096 hypothetical protein
MLNFIKKIERMYTKEFEIRWSDIDANRHLANTAYVNFMSHTRMAFLMENGFGQKDLAKNN
IGPVVFYEHIYYFKEVFAGKPIKVTLQLKGLAEDGMYFEFLHNFYDEKGRNFASCEMMGA
WIDLKERKLTKLPKALRDNLDSLGHTDDFKILTKEDTRRFGKRPQHLEPEKLGF
>IFAGANLK_00097 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MPLIKTEYNAPGIFKNAHVSSIYAATLRKVDFRFKVKNRIELSDGDFLDLERSFYSTENE
KIIILLHGLAGNANRPYMLGMAKHFQDNAWDVASMNFRSCSGKINRLYRSYHAGATEDLE
AVINHLQQENKYKEIGLVGFSLGGNLMLKYLGEQNEIPSEIKSAVAVSTPCDLGASLEEL
NKTHNFLYSKRFIKNLKKELQLRQTYFPSEITKEEITQCNSLLAIDELYTSRAHGFKDAS
DYYKKCSCIGFLPKIKIPTLLLNAQNDTFLSPHSYPVEVAKNSEFLHLEIPKHGGHVGFF
QRKKLYYHEQRALKFISERNQ
>IFAGANLK_00098 hypothetical protein
MIQSMTGFGKSITQLPSKKVTVEIKSLNSKNLDVNARIPSQYREKELQLRNTISKSLTRG
KVDFSLFVEITGEETSASVNQGVVKNYMQQLKSIVDGDETELLKMAVRMPDAVTTEREEI
DESEFKAIEAAVIEALEEINQFRTDEGEALEKDLKLRVNNIEALLQEVLRIDPERVNAVK
ERLRKGVADLKENVDDNRFEQELVYYIEKFDITEEKVRLENHLAYFNESINSQDSNGRKL
GFISQEMGREINTIGSKSNYAPMQQLVVQMKDELEKIKEQLLNVL
>IFAGANLK_00099 Guanylate kinase
MSDGKLIVFSAPSGSGKTTIVQHLLKHKELDLEFSISATSREPRGEEKDGQHYYFLSLED
FKKKIKNDEFLEWEEVYRDNFYGTLKSEVERIWSHGKNVIFDIDVVGGLDIKNIYPEKTL
AVFVKPPSIEELKIRLKKRKTESDDKINMRVAKASIELATAPQFDFIIENHHLDTALQEA
YDLVATYVGVKNSAKNE
>IFAGANLK_00100 putative nicotinate-nucleotide adenylyltransferase
MNRKVGLFFGTFNPIHIGHLIIANHMAEFSDLDEVWLVVTPHNPHKKKSTLLENHHRLEM
VYKACEGFEHLKPSNVEFGLPQPNYTSTTLAHLQEKYPTNEFCPIMGEDNLKTFHKWKNY
EVILENHQIYVYPRISGGKVENEFKDHPKITRVMAPVVEISSTFIRKAVKEGKFIKPMLP
DAVWDYIKLMNFYK
>IFAGANLK_00101 hypothetical protein
MGIFSFIKDAGEKIFGKEKEQEEENIEISEAKKEVIRKENAKAADKLLNTIKSLDLKVEN
PVINIENSSAIVYGLADSQAVREKIVLVIGNSGGIAKVDDRLAVKKEEPESGFHTVERGE
NLSKIAKEHYGDANKYTVIFEANKPMLKDPDKIFPGQVLRIPRLDKK
>IFAGANLK_00102 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MDKSPKFAVIGGGSWATAIVKMLSENVDTIFWYMRSTYAIEHIKRQEHNPNYLSSVEFDN
DQLELSSDINKTIAAADYLIFAIPSAFLKRELDALTVSLEDKIIFSAIKGIVPESSLIVG
EHFEEFHHVPADNIGVITGPCHAEEVALERLSYLTIACTDEEKAKIVAKNLDSEYIKCKI
SDDVTGTEYAAMLKNIYAIAAGIAHGLGYGDNFQSVLMSNAIKEMKRFIKKVHKMKRNIN
DSAYLGDLLVTGYSVFSRNRMFGNMIGKGYTVKSAQMEMSMIAEGYYATESAYKINKDKG
AKTPIINAVYGILYEGKNPKKVIKKLAEKLT
>IFAGANLK_00103 hypothetical protein
MKKDINIPKLEKVYVAAVKVYNEAFKVEEWNAYLINDKDEAIEMALIVSKGFDENKVTST
IRHKLEHLPAKSFAKIEFIQDEVLALNNQFQVTFFSEGKMYEKKYVFRKNSVNEKALREL
PIIPNKGILAE
>IFAGANLK_00104 hypothetical protein
MKKIGLVIFGILALGVIIILVAVEIIEFALGAILLVIAALILWGLFKWAKNKIED
>IFAGANLK_00105 Phenylalanine--tRNA ligase alpha subunit
MIDKIKQHIAEVEAFKTESAKEVEAFRIKYLGKKGILNDFFASFKKVPNEQKKEFGQAVN
SLKKASEIKVAELKEILESKEEESGVYGDLSRPGEPIEIGARHPISIVKNQIIEIFSNIG
FNVSEGPEMEDDWHNFTALNLPEYHPARDMQDTFFIQTDPDILLRTHTSSVQVRYMEDNK
PPIRTISPGRVFRNEAISARSHCIFHQVEGLYIDKNVSFADLKQTLLYFTEQLFGKSKIR
LRPSYFPFTEPSAEVDIYWGLETETDYRITKGTGWLEIMGCGMVDPNVLRNCNIDPKEYS
GFAFGMGIERIAMLLYQIGDIRMFYENDLRFLEQFKSSF
>IFAGANLK_00106 hypothetical protein
MTRDENLKGRWEGLQKKLSNQFADGEAMDLDAIIYVIGVQELGQPHKKFKKDHKIDLMHI
AICRLLEPYGYYEFDYFDEEGWPHYKILEQLPTLKAGEQSVLMKEAIVNYFINNGYID
>IFAGANLK_00107 hypothetical protein
MNTVDIVLALILLYGLVRGFFRGLLAEIASLVGIVAGIYGAIHFSHILSDFFSENMNWDS
DYVNLIAFAITFILIVFLISLAGKILTKMAGFAALGIVNKLLGGAFGLLKMAFLTSVVIM
FFGATNEEIDLVSEESLEESKLYAPVKTIAPAILPSIIREARERDILNEENDFFGNEKEE
V
>IFAGANLK_00108 C4-dicarboxylic acid transporter DauA
MFKHFNKDFPASIVVFFVAIPLCLGIALASGAPLFSGLIAGMVGGIVVGSISNSQLGVSG
PAAGLAVIVLGAIQSLGSFEIFLVAVVLSGIIQIIMGALKAGIIGYYFPSSVIKGMLAGI
GITIAISQIPNALGFASDMEIFSIDQGVGPAFSQLASSLHFGAILITLVAIAILLLWEKV
LTGKHKIFSIVPGPLVAVAIGVIYYLVVEGPAFGIQDYQLVTVPVPDSAASFIGQFSFPN
FAEIVNSEVWIVAITLAIVASLETLLSVEAIDKLDPLKRTTNTNRELYAQGAGNMISGLI
GGLPVTQVIVRSSTNMQSGGRTKLSAILHGFLILISIIAIPTVLNMIPLAVLAAVLLMVG
YKLAKPALFKQMFKLGKGQFLPFIITILGVVFLDLLMGIGLGLAVGIAVILINSYKNSHF
LHKEGYDVNDGEYKITLAEELSFLNKGAILRELNEIPENSTVIIDVRKTRVLDYDVLEIL
DEFAIKAKRKNITIKLIANKGEVVNPDSFRRFFGLDVPV
>IFAGANLK_00109 hypothetical protein
MAFLATPSIVAYIDNSVDVSFAFNVNEEESSSKNQISLEFNVEEQNTNYASIHFLQEQDY
TGDFYTESYPVVFLDVIFPPPKNA
>IFAGANLK_00110 hypothetical protein
MKKLVLFFLVLVSATSQAQNSTLFEEANEAYSNDDFETAIAKYEEILENGETSVATYYNL
GNAHYKLNNVAPSIYYYEKALQLDPTDEDVQNNIEFARSMTIDDIPVVEETGFEKRINQF
LSTFSYNTWAYFSIALSIIFVVLFLFYYFSRKPLIKRTLFASAVFVFLLGGISVFFAFHQ
QEIQFNNQFAIIFTEEAAVKNEPSPRAETAFSLHEGTKAKVLEDYQGWVKLELSNGTQGW
IENNNLKRL
>IFAGANLK_00111 hypothetical protein
MKLKFLILSILLFAGFGLQAQVKFEAKVSKDKLGVNERLRVDFEMNQDGDNFRPPSFDGF
TVVGGPNQSVSNRWINGDRTYSKTYSYYLQPNSRGSKTIAQAEITIDDKTYKTTPIDIQV
TAAVDEPKDGDNSDLIASDNLHLVAEVSNPNPYLNEGITVVYKLFVSPRISVSNFREVDS
PKFSDFWSQNIEIRELRPENGEYRGEPYRYVVLKKAVLYPQKTGELELEPLTLSVSVDVP
SDRRDIFGSRIYKTVNKTVAAGTRTIDVKPLPDGKPAGFTGAVGQFSLDVSTTKDKLDAS
ESLEAKVEIRGNGNLNLFELPSLQVPSSLEMYDPQRAENVTTTLNGKQGSIIDSYTIVPT
RKGQYPIQPLTFSYFDPETQTYKSVSSQEILIDVEEGPVNTSGGGIAENNKRSVNLPSEQ
FRFIKTQTNLRLLEQQAFFRSWTYWSSLLLPLAAIPLFILFGKKREAIAADVHGNRLKKA
NKLARKYLSEAKKNLGDQQAFYESLERAMHNYLKAKLQIQTSEMSKERILEILNEKNVPD
ETSTEFIEVLKSCEFARYTPASNSTQQEDYDKAVKVIAKLDKEI
>IFAGANLK_00112 hypothetical protein
MLSLPVVAQQQSDKERERAQKEARQLMQDADVALGENNFPEAEAAYRKAIAKDPENAEAR
YNMGNMYYTRENTPQAAQRFKEAAEVADTKTAKHKAHHNLGNAYMKQKMYQEAVDAYKDA
LRNDPTDDETRYNLALAKKMLEEEQEQQDDNQDGGDDENEDQDEQDQENQDQDQEQENED
QQDQDGEGNNEGDQDQQNQDQEEQEGDQDEQEQPEGQGNQEDEEQQPEDGQPQPSQGQLS
PEQIQSLLEAMSNEERKVQDKVNAEKQKGAKVQSEKDW
>IFAGANLK_00113 hypothetical protein
MILEEKIYLWLLLLIPVVILLYLIFRLWQKRSRSRFAKPELLIFLSPNKSAFKPVVKLLL
ILGAFASLIFGLVNPKLGSQLETVKREGVDIVFAVDVSKSMEAEDIAPNRLEKSKQLVRQ
IIGNLGSDRVGIIAYAGSAFPQLPITTDYGSAEMFLESLNTDMISSQGTAIGDAIDLATG
FFDDNQQTNRVMFILSDGEDHEGNVEDMAERAAEAGIRIYTIGVGTTKGGPIPIKRNGVV
QNYKKDSQGETVITKLDPAILEEIAKETNGEYIDGSVTAEVTEKVQEELLTIEKTEFEAK
QFADYKSQFQWFVGLAILLLLLDVFMLERKTGWIRKLNLFNEKRKTEE
>IFAGANLK_00114 hypothetical protein
MFANYTFENPEFFWLFLLLLPATAWYFWKRKQQTPELRMSSVKGFKVKQSLLSKLKPILF
VLRLLALALLIVAMARPRTVDVTTQSSNIRGIDIVMAIDVSASMLARDFEPNRLESVKEV
GAEFIENRPTDRIGLVLFAGESFTKTPITSDKGIALRAIEEIEYSDVLQNGTAIGSGLAT
SVNRLKDSDAESKVIILLTDGVNNSGFIDPKTASELAVEFDIKTYTIGVGSNGNALTPVN
ILANGKFQYGVQKVEIDEALLQQIAADTGGKYFRATDNETLEEIYEEIDSLEKSEIEEFR
YYNYTEKFRPYALLALGLLLFEVILRYTLFRGFI
>IFAGANLK_00115 hypothetical protein
MNKRFTTTIKSYKAAALLLFLLLSFQVFAQQPQINAEIDSSSIKIGEQIIFSIEVETDST
DLVVFPEGQTFDPMEMVESLGADTTTVEDRYRLLKKYSLTRFDSGAYTIPQQKVIIQNRE
YLTDSFRVEVADVKVDTTRQKMYPIKPAVDVPKPFSIPNWIWWLLAALVILGLAFYFFRR
RKKRKEAEPELPPYEQAMFELKQLDNSSLLQDREIKEYYSQLAFIVRKYLDRKIYDRALE
STTSELIAYLELRKQSGELSLKDKSIDNLQQLLKRADLAKFANSRPDVITAKSDRTKAEH
LIKDIRQVVPEPTEEELMLDEKYRTEKLKRKRRNKILAIIGGVLILGIIVIVVLVNTRGF
DYVKDSVLGNETKELLEGDWIRSEYGTPTVTITTPEVLVRKAVDRDDELQEMLLGSETFD
SGTLESNLYILLITGPVNPEGDFNLDKAVDGIYENLENQGASNIIMKEEDFSTINNAEGI
KVFGTFNLENPITGGPIQKEYAILNFGENGGFQQVMVVFDEDDEYAEEILQRVENSIELK
NQSN
>IFAGANLK_00116 hypothetical protein
MDTKELLKKVRKIEIKTRRLSDHVFGGEYHSTFKGRGMTFSEVRQYQFGDDVRNIDWNVT
ARYSEPFIKVFEEERELTMMLMVDVSGSEFFGTQNQLKKDVITEIAATLAFSATQNNDKI
GLMLFSDKIELYIPPKKGRYHVLRIIRELIEFKPTSKKTDIAVAIKYLSNVMKKKAIVFM
LSDFMDDNYQQTLKIAGNKHDVTGIRVYDSAEEEIPNLGLVQMLDEETGEYVTVNTGSKS
VRRNYAEYYRGRAAYFNESFTLSGAGVINNRVDESYVKKLLGYFKRRG
>IFAGANLK_00117 hypothetical protein
MIDNNASVDIASLNEKIERESAFVDLLNTEVNKVIVGQKHMMERLLIGLLGQGHILLEGV
PGLAKTLAINTLSQAVHGSFSRIQFTPDLLPADVVGTMIYNMKLNDFSIKKGPIFANFVL
ADEINRAPAKVQSALLEAMQEKQVTIGEETFILDKPFLVMATQNPVEQEGTYPLPEAQVD
RFMLKTVIDYPEINDEQLIMRANLRGEFPKVNPVVSIEQILRAQQAAREVYMDEKIEKYI
LDIIFATRNPEKYNLKDLKPLISFGASPRGSINLARASKCYAFIKRRGYVIPEDVRAVVL
DVLRHRIGITYEAEAENVTSEDIVHKIVNEIEVP
>IFAGANLK_00118 hypothetical protein
MKRTMKNLKLKSLLLAAVVAFGFTSCSDDDENGIEEGNAQLTVRMTDAPGDYDEVWVDVQ
DVMIKTEAEVGEEEGEWESLSNVETGRYDLLELTGGVSQLLADVEIPAGYLDQIRLVLGP
DNVVVIDGEENPMATPSAQQSGLKLNIQQELEAGESYEYLLDFDVDESIGTTGNGGYILK
PVIRMSAMANTGSIVGEVHPSDTRSLVKAQNASHTISAYTDEGGNFALHGVPAGTYQVTI
TPDAETGLEMVPVDNVEVVQGEAKDLEIIYLE
>IFAGANLK_00119 hypothetical protein
MINKRLLIKNLLAHNDENSFYDKKLKLNIGEREGKAKFLKHVCALSNSNPENNSYIVIGV
QDEDNSIVGTDFFDDSKIQNLVNAYLSNPPLISYENIPFPHLPGNLVVGLVTIKPNHGKI
CSLRKNIWKYYGGSVFLRDGSISMPKVFDIKITDVNSETVDSIEKHSHNNIELTLDGVFD
FLQKRKDYNATYKVFKEYFVVCWAGKKIQAKNETFYSRVDIELINEQVKLFYSDLDQVSI
SLTEEQFIILEYVQLGLHDKYQFYPLEEVIIRFKDSVSYDIESKLLFEPPDFDKKTLYHI
YNINNTLLERLKKKLPLDKQQTKDLKNLPSTYLLCYLNNFEKAIDKLEEAKPFLKQYSQE
VYNYYKESMRILRKVKYN
>IFAGANLK_00120 Serine/threonine-protein phosphatase 1
MGRSIAIGDIHGGLKALIQLLEKIKITPDDELIFLGDYVDGWSDSANVVSYLIEFAKQNT
CIFIRGNHDDLTHRWLESDELNEKWLEHGGQSSIDAYRSFSSEEIKAHIQFFKQMVNYYV
DKKNRLFVHAGFTNQHGPEQEYHDTGFYWDRTLWEMALSLDKNIKPDDMNYPKRLRLFDE
IFIGHTPVTRINEDVPVKRANIWNVDTGAAFMGKLSAIDVNSKEIWQSEPVFKLYPDEEG
RN
>IFAGANLK_00121 Putative acyl-[acyl-carrier-protein] desaturase DesA1
MALDNIRLEVMNTVEKEVDGFIEKYLIPVEEIWQPTDLLPNLQGEDYMNELTQIREEAKE
LEYDFWVVLVADMVTEEALPTYESWLMDMEGVKQHGKSRGEENAWSKWVRHWTGEENRHG
DTLNKYLYLSGRVNMREIEKTTQYLINDGFDIGTGRDPYRNFVYTSFQELATNISHKRVG
QLAKKKGNKMLGKMCNIIAGDEMRHYMAYREFVKTIFEHDPSQMMLAFHDMMKKKIVMPA
QFLRESGQGIAEAFENFSNAAQRLGVYTTYDYIEILEKLNGYWEIDKMRSLTDEAEKARD
YLMRLPDRMRRIADRMAIPEDQHIFKWVEPNGRI
>IFAGANLK_00122 hypothetical protein
MSKIDKETIRKEHKKRQDDFEEEDIDDVLEDEDAIKSKFENKGKLQRYLDDAVILFSLLK
DYAKGNYREVPFNVIAAIGGALLYVLSPIDLIPDFIPIIGYLDDAAVVAFCLNLIEKDLI
TYKLWKKKKV
>IFAGANLK_00123 hypothetical protein
MRYFYSIILCSLFIFNSVNAQNNEELQKMADADQEERMSGTDWKTINTNDSIRLAKVTQM
FKDRNLNTAKDYFNAGIIFQHGRDTLASGRAVKTFKKAIEIDSTLNRWWYAAAVDRDLMR
RGEPQIYGTQHVLDSEGNPVKYKMDTTRVSDAERKYYRVPSLAQQRENDRLRGLKQVSSF
YAENSDINKTISLIESQFKKGDESEYNVSENTINSFGYQLISENKLEEALKVLQLNTELY
PEASNPWDSYGEILLKLGREKAAIKAYQKSLELDPNNENAIKVLEGSE
>IFAGANLK_00124 NAD/NADP-dependent betaine aldehyde dehydrogenase
MSEVAQKFGIKQALKDLGLQETNNGTSTGKDFFSSGEVIESYSPVDGALIGKVKATTKED
YEKVIKTAEAGFKEWRTWPSPQRGEVVRQFNDELRRLKEPLGKLVSYEMGKSYQEGLGEV
QEMIDICDFAVGLSRQLHGLTMHSERPGHRMYEQYHPLGVVGIISAFNFPVAVWSWNTAL
AWVCGDACIWKGSEKTPLTSVACQNIAARVFAENDVPAGISSLITGDYTVGEMMTNDKRV
PLISATGSIRMGKIVAQAVAARLGKSLLELGGNNAIIVTPDADIKNTVIGAVFGAVGTCG
QRCTSTRRLIIHESIYDKVRDAIVKAYKQLRIGNPLDENNHVGPLIDKDAVKNYQNALDK
VVEEGGNILVKGGVLEGEGYESGCYVKPAIAEAKNEFKIVQHETFAPVLYIMKYSGDVSN
AIELQNGVVQGLSSAIMTNNLREAERFLSVEGSDCGIANVNIGTSGAEIGGAFGGEKETG
GGRESGSDAWKIYMRRQTNTINYTTELPLAQGIKFDL
>IFAGANLK_00125 3-hydroxyanthranilate 3,4-dioxygenase
MAVNKPFNLNKWIDQNRESLKPPVGNRNLYKESEDYIVMVVAGPNARKDYHYNETEELFY
QLEGEIEVHIQEDGKKKTMRLGPGDMYLHPAKVPHSPVRKEGSIGLVVERKRVQLEAKDG
LLWFCDNCNHKLYEVYFPLEDIETDFLKHFKHFYGSKELRTCDNCGEVMPVDERFVAETD
>IFAGANLK_00126 Isoaspartyl peptidase
MKKIFILLSLSFILACNTSTEKETEINQTSEAEKVQDSVENFAIVIHGGAGTILKENMSD
SLERAYKAKLEEAIRTGHEILANGGTAIEAVQRTINVMENSPLFNAGKGAVFTNEGKNEL
DASIMDGETLNAGAVSGVTTVKNPINLAWEVMENSEHVMLSGKGAEQFAEERSLEIVDPE
YFFTENRFKSLERLKAKDSEKTELDHDGKTAFVDPFIKDSKFGTVGCAALDKNGNLAAGT
STGGMTNKKWGRIGDAPIIGAGTYANNKTAAISATGWGEFFIRGVVAYDISAMMEYKGIS
LAEASKEVIQNKNPDLGGNGGIIAIDHEGNVSMEFNTAGMYRAKMNKDGELEIGIYSE
>IFAGANLK_00127 Phospholipase A1
MKNNYTVILILVFNFCYGQVFSQRLSREKINDTIEKMPTFSNHKDNYFITGISTNKDLNS
KTADAKYQISFKALLTRNTLPFDTHLFLTYTQKAFWNVYEFSSPFRELNFNPGVGLGKPV
YNKSNRMAGMAYLQLEHESNGRDSIYSRSWNSLSLSYHTAINENLLLSIKGWLPFRYKKD
NPELIDYVGYGKLSLTYNIIPDKLLVDLMLRKGIKDWNGTVRTRLLYKPFDSSNFNLMLE
WYKGNAESLINFEENRSMIRAGFVLKADELNFLKSLPDAI
>IFAGANLK_00128 hypothetical protein
MKMNKTDLQAQRTRLIEKLGVQFEKEHQLAPVAARIFATLIVTGKKGITFEQLVTDLNAG
KSTVSTHLEHLQTTNRIEYYTKSGDRKRYFIVKPDLMENHVDELTAKWEAQKCIHKEVLE
YKQRSNELNKEDPPFDLEFQKSLLDFLDEATAALNKLKKNINIY
>IFAGANLK_00129 Solvent efflux pump periplasmic linker SrpA
MKKIIYFSLFISAAVFTSCSNGKEEQEAQQAAQAQGPQPHPVLEVQTKTVTGYTSYPTSI
EGVVNSEVRAKVSGYITDVLVDAGEKVTKGQRLFKLETESLSGDAEAAQANVNAARVEVE
KLKPLVEKDIISEVQLETAKAQLSQAQANYNSIAANIDYANIKSPVDGYVGNINFRNGAL
VSPGDPTPLTTVSQTDEVYAFFSMNEKDYMSFLQETSGSSIQEKIANFPEVSLILANGKE
YEEKGRIQTISGQIDPSTGTVTFRAKFPNPNQLLSNGNSGKIRVPQTFEDVIVVPEISSF
EQQGRTYVYKVQGDSLAVSTPITETSRVNNLIVVESGLKKGDKIVAQGVAKLRNNTPIKP
QEIPFDSIANSINTVFK
>IFAGANLK_00130 Efflux pump membrane transporter BepE
MLKKFIERPVLSTVVSIIIVVLGVLGISTLPVTQYPDIAPPTVQVSANFPGANAQTVLES
VIIPIEEQINGVEGMDYITSTASNNGSASIQIFFDQGVDPDIAAVNVQNRVARATPLLPQ
EVTQSGVTTQKEQTSALMFFTVLSDNQEYDATFIQNYLNINVIPELQRINGVGNVNVFGA
KKYAMRIWLQPEKLAAYNLIPSDVIAAINEQSQEAAAGSLGQNNAEAFEYVLRYSGRYQD
EDQYRDIIIKALDNGQYLRLDDVAEVELDAEGYNVIGYTNGKPGVNMAVYQTPGSNAQEI
IENIHQKLDEMEKDFPTGLSVYINFDTNEFLTASIDKVILTLIEAFILVFIVVFIFLQDF
RSTLIPAIAVPVSIIGTFFFLNLFGYSINLLTLFALVLAIGIVVDDAIVVVEAVHAKMEE
GAKDAVSGTRKAMDEITGAIISITLVMGAVFIPVTFITGPTGVFYEQFGVTLIVAIAISA
VNALTLSPALCAIFLKPHREDEEHKKKNFLQRFFSSFNTAFKVTTDKYVNSLSFLSKNKW
ITGLIILAAVLAIVWGAKTTPTGFVPDEDRGILFVNVELPAGASLDRTVGITSELEKKAQ
QIEGVQGVSLVNGYSLIGGAGSNYALGFIKLDDWSEREEDHLSVESIQGQLFQIGASFSD
AEMLFFSPPSIPGFGVSGGFEAKLLDRSGGTFQELDNQTQNYIAALSQRPEIQYAQSSFN
TNYPQYEMDLNIPKAKEAGVDISTIFSTLQGYIGSIYAADFSRFGKQYRVYVQALPEDRA
GTDDLNSLFVRNSNGEMAPLSEFVSLKRVYGPQSVTRFNLFNSATINGAPAPGYSSGDAI
AAVQEVSAESLPSNFSVDYSGLTREEVSAGSQSTFILILSILFVYFILSAQYESYLIPFA
VLLSLPVGVMGSYLVTKFTGLQANIYFQIALIMLLGLLAKNAILIVEFAMQRRKAGLSIV
DAALDGARVRLRPILMTSFAFIIGLLPLVFAGGTGAAGNRSIGTGAVGGLLVGTILGVFI
IPILYIIFQHLQEKITGVPEAAKTENKSISEKE
>IFAGANLK_00131 Outer membrane protein OprM
MRKNSIYKLLLGGALPFLLVSCFAAKEYDRPEIEEISEELYRTDNLPQDSLNMATISWTE
IFTDPILKNHIEDGLENNIDIRIAIQQMLAAEAYVKQGKASYFPTLSAGPSVNHQILSPN
SQFGSFFDGSITQYDITGNLSWEADIWGKIRSNDRAFTAAYLQSEAAHKAVKTQLISNIA
NNYYQLLSLDEQLRIAKETLETRKSSLETTEALKDAGNVTEVGVQQTKAQLHTAEALVVQ
LENQIRLLENSFSILLGAGPQEIERTDLSDQNIVSPLNTGVPAQLLRNRPDVIAAEYGLI
NAFELTNAARANFYPSLTLTAAGGFQSLELDKLLNANSLFANLGASLLQPIVNKRQIRTQ
YEVSQAQQEEALLNFKQAILVAGREVSDALSNYQASTERIEILENEFEAYNKASGYSEEL
LNNGMVNYLEVLTARENALNSQLNLINAEYNKLNSIVNLYKALGGGWQ
>IFAGANLK_00132 Thioredoxin C-1
MKSSFSDIIKDEKPVLVDFFADWCGPCKTLAPILKDVKAELGDGVKIVKIDVDKNQELAG
KYQVRGVPTMMLFKNGEQLWRQSGVLQKAEIIEVINSNS
>IFAGANLK_00133 hypothetical protein
MENTLLPDLKYVGFEKEKLTLHLFLQIVGKIKLKLTPRKNHWWFVTHYITEKGFSSGSIP
YNNGFSSFSIAFNIVTHQLEIHTSEGDLRTLNLENGLSIADFYTQVFAVLKELDIWVKIL
DKPYDLGIEKEFSVISEYYHYDESYVEKLWKTLLWTESVFKEFSGRFYGKTSPVHLYWHS
MDLAVTRFSGKKAPKMPAEARISDKDAYSHECISFGFWPGDDKVLEPAFYSYTFPKPENI
QNEKLRPASASWEMSNGSPMAILTYANLREEENPRQVLLDFMESAYQAGARLADWPIDDL
NVQDLKDL
>IFAGANLK_00134 hypothetical protein
MKIEQHDEEKKGFFQALINEKQAGKITYTWAGKNKFIIDHTEVDPDFKGEGVGKKMVKAA
VDFAKENKLKVIPLCPFAKKIIEKTPEFQEVLA
>IFAGANLK_00135 hypothetical protein
MKKLIYILVIPFLINSCKDIPKQERGIPGPEVVEEKKPKINIDSIANNLNEKGYQTFSYQ
DSDSTYLMQQYYMVFLKKGENRSQDSTEAANLQKEHLAYLSRMAEEGYASLVGPFGDDDE
IRGIVVYNTATQEEADSLANQDPMVKSGRLKVEVHPWWTAKGGKLN
>IFAGANLK_00136 Inorganic triphosphatase
MQEIERKYLVLSEDFKKESFKNFSIKQGFLNTDPERTVRLRITGDQAFLTIKGKTSKNGL
TRFEWEKKIDKKDAEALFDLCEPGIIEKTRYLVKVGDFVCEIDEFRGENKGLIVAEIELK
KETDTFKKPGWLGEEVTGDIKYYNSQLSQNPYKNW
>IFAGANLK_00137 hypothetical protein
MPKTAIILGATGLTGGMLLEQLLEDDRYEKIKLFSRNSVEKNHPKIEEHLIDLFKLEEQK
DKFTGDEVFCCVGTTKKKTPDQKTYTKVDHGIPVTAAKLCKANNINTFLVVSALGANPES
RVFYNRTKGKMEKEVLAQEIKNTYILQPSLITGERKESRTFEKIGKVMLNFINPFFLGTL
RKYKSISAESIARAMVAIANKPELDVVRIPSDEIKNIAHNN
>IFAGANLK_00138 hypothetical protein
MVKEKKLKQRVLAYVQEADDELLHLIAKVAEIYNEQKKEDWWDKLSDIEKAAIQKGLDDA
DNDKVLPNEEVMRMFKKWH
>IFAGANLK_00139 DNA polymerase IV
MIENLPLRKIIHIDMDAFYASVEQLDNPDLRGKAIAVGGSSQRGVVSAASYEARKFGVKS
AMSSVIAKRNCPHLIFVKPRFERYREISQRIREIFFEYTDLVEPLSLDEAYLDVTENKKG
NPSASLIAKEIRGKIKKKTGLNASAGISVNKFIAKIASDFNKPNGQKTVNPEEVEEFLEI
LDIRKFHGVGKVTAEKMYMLGIFTGKDLKQKSQEYLTEKFGKSGAHYYNVVRGIHLSEVK
PNRIRKSLGAERTFNENISSEIFMLERLENIAEEIERRLIKSNVAGKTITLKIKYSDFTL
QTRSKTISFYVSSKELILENAKELLYQEKMKNSVRLLGISLSNLNTDKNEKKPEGVKKVE
VQLKFEF
>IFAGANLK_00140 Pyruvate kinase
MPTNKKTKIVATLGPATSSKETLDKMLQAGVNVFRVNFSHANYEDVRERIKMIRDLNKEK
GYNAAILGDLQGPKLRVGVMKDEVVVSEGDEIIFATGKEFKGTAERVYMNYETFPQDVSA
GERILLDDGKLIFEVVSTNKKDEVKTLVIQGGPLKSKKGVNLPNTNISLPALTEKDVKDA
IFACEMQVDWMALSFVRHAEDLKELQDLIKKHSEYKIPIIAKIEKPEGVANIDKIVAYCD
GLMVARGDLGVEIPAQEVPLIQKKLVLTAKKARIPVIIATQMMETMITSLTPTRAEVNDV
ANSVMDGADAVMLSGETSVGQYPVQVIQKMTQILESVENSPLIKVPHDPPHVRTKRYITK
SVCYHAAHMANEIKAKAICTLTNSGYTAFQISAWRPEAHILVYTSNNRILSQLSLLWGVK
AFHYDKFVSTDETIEDINRIAKEKSFVEVGDFTINLAAMPIGEKGMVNTLRISEIE
>IFAGANLK_00141 hypothetical protein
MQSHKMLLEDVEEDDFGLIALYGDLEEYKMAYLLNKHLKLQLKRERRDIDFNHKSVEAFY
AHYTFKDLANFRSYHLVANKFKGEPKKILSSGSLFEEEEVRPLQVNLVPEYKKVDFFLKI
DEELNQKDLNLLVNAISQIPQVIAVYKIDTDLLKSKQNLIFE
>IFAGANLK_00142 Ribonuclease 3
MGVLRNILNSRSDKGGNFFSILYKILGFKPKNILHYRKAFTHRSLNIKDEKGNAVSFERL
EFLGDAMLSAVIASHLFKAVPGGNEGYLTKMRSKVVSRKHLNELGKDLNLIDHVQTNIPK
DQFGSNIHGNLFEALIGAIYLDRGYKYCKRFIYERVIDPYVDIEQLEGQVISYKSLFIEW
CQKEKREFDFEVYEDTGNDEIKHFAVKLRLDDKVVAKARATSKKKAEEKTAKRAYYALQN
KIT
>IFAGANLK_00143 3-oxoacyl-[acyl-carrier-protein] synthase 2
MELKRVVVTGLGALTPIGNNIEEYWEALVAGKSGGAPITYFDTEKFKTKFACELKNFDPL
DFFDRKEVRRLDRFAQYAIVASDEAIKDSGINLETVDKYRVGVIWGAGIGGLETFQNEVI
NFATGDGTPRFNPFFIPKMIADIAPGNISIRHGFMGANYTTVSACASAANAMIDALNNIR
LGHSDIIVSGGSEAAVTMAGMGGFNAMHALSTQNENPETASRPFDATRDGFVLGEGAGTL
ILEEYEHAKARGAKIYAEVLGGGLSSDAYHMTAPHPEGNGVVAVMENCLRNAEMKPEDVD
AINTHGTSTPLGDVAELKAISKVFGEHAKTMNINSTKSMTGHLLGAAGAVEAISAILSMK
HGIVPPTINHEHKDENIDPELNLTLNKAQKRDVKVVMSNTFGFGGHNACLLFKRFDE
>IFAGANLK_00144 Acyl carrier protein
MSDIASRVKAIIVDKLGVDENEVVNEASFTNDLGADSLDTVELIMEFEKEFDIQIPDDQA
ENIATVGQAISYIEDAKK
>IFAGANLK_00145 Phosphoribosylglycinamide formyltransferase
MSNPTHTAQKKIVVFASGSGTNAENIIKYFQKQPDASVVAVFSNKRSAKVLKRAHDLNVK
ALYFDRDALYNSHDVLHILEDINPDLIVLAGFMWIFPTDILKRFPNRIINIHPALLPKYG
GKGMYGMHVHQAIIQNKEKESGISIHYVNENYDEGEVIFQAKTEISEEDTPDTLAQKIHK
LEYRHFPEILQQILQKKSQ
>IFAGANLK_00146 Ribonuclease HI
MQTAQVHIYTDGAARGNPGPGGYGIVMEWVGKAYRKEFAKGFKHTTNNRMELLAVIEALK
KLKKPGVSAVVFTDSKYVADAVNKKWIFGWEKKNFKDRKNADLWIEFLKEFRKHNVSFKW
IKGHNDHPQNERCDALAVAASKEKRLLIDEGFQQS
>IFAGANLK_00147 putative sugar kinase YdjH
MSKLLIVGTVAFDAIETPFGKTDKILGGAGTYIGLSASQFNVDSAVVSIVGDDFPQKYLD
LLTKNNINIDGIEVVPGGKTFFWSGRYHNDLNSRDTLDTQLNVLADFNPVVPNAYKDAEI
VMLGNLHPLVQLSVLEQIKSPKLAILDTMNFWMDNALEDLMKVIAKVDVITINDEEARQL
SGEYSLAKAAKKIATMGPKYVVIKKGEHGALLFHKEQVFFAPALPLEEVFDPTGAGDTFA
GGFAGYLAKTGDISFENMKNAIIYGSNLASFCVEKFGTERMEELSGAEVNSRLAEFKKLT
QFEIKLT
>IFAGANLK_00148 Amidophosphoribosyltransferase
MSDALKHECGIAQIRLLKPLDYYKEKYGTAFYGINKMYLMMEKQHNRGQDGAGFANIKLN
TAPGDRYISRIRSNAAQPIQDIFEQINGRINEEIKANPEYADNVSLQKKNLPYVGEVYLG
HVRYGTFGKNSIESVHPFLRQNNWMHRNLIVAGNFNMTNVNQLFNNLVELGQHPKEKADT
VTVMEKIGHFLDSEVQKLYKKLKKEGYSKVSASPIIAEKLNVAKILRKSSKNWDGGYAMA
GLLGHGDSFVLRDPAGIRPAYYYKDDEVVVVASERPVIQTAFNVDFNDVHELPPGHAIIT
KKSGEVNITQILEPLERKACSFERIYFSRGSDAEIYKERKMLGRLLMPEVLKSINHDTIN
TVFSFIPNTAETSFYGMVEAAQDELNKQKNDAILAERDTLTDARLQEILAHRLRTEKIAI
KDVKLRTFITEDSSRDDLVAHVYDVTYGVVKPEDSLVIIDDSIVRGTTLKKSIIKMMDRL
NPKQIVVVSSAPQIRYPDCYGIDMARLEDLVAFRAALDLLKDNNQYDIVEKVYEKCKLQV
DLADVDVKNFVKEIYEPFTDGQISDKISKLLCDTDVKAKVKVIYQTVDNLHTACPKNLGD
WYFTGNYPTFGGNRVVNRAFINFYEGNAGRAY
>IFAGANLK_00149 hypothetical protein
MVDLGQKKVDLKIRLFLFLPEFENSSEIKTLHNSPTQKFELSYIKY
>IFAGANLK_00150 Superoxide dismutase [Mn]
MAFELPKLKYAFDALEPHIDAKTMEIHHGKHHAGYTKKLNAAVEGTDLEGKTIENILENL
DKENTAVRNNGGGFYNHNLFWEIMSPDGGGKPEGDLAKAIDTAYGSFEAFKDEFAKAAAG
QFGSGWAWLCVHQGGKVEICSTANQDNPLMPGIGCGGTPILGLDVWEHAYYLNYQNRRPD
YIDAFFNVIDWKEVGSRYAKQK
>IFAGANLK_00151 ATP-dependent helicase/nuclease subunit A
MTNNFTIYNASAGSGKTFTLVKEYLLLLFKSKKPDAYKNILAITFTNKAVDEMKSRIISS
LRDFTAEETSTTTNPLFKIIAEETGLSEAELKIKAAKILKNIIHNYAAFEVSTIDGFTHR
VLRTFAKDLGLPVNFEIALNTQQILMEAVERLISKAGTDKDLTKVLIAFAISKTDDDKSW
DIAKDLFEISELLIGENHQEALKKLKGKTPEDFRKFKERISSEIKKTEALIAETSHEFFD
LVESNNIEEKDFSGGYVYKHFVKLRDQKSIDGFEKAWMQKLETAPLYAKSHKNQAVKDAL
DSIQSLIFSLFEISKRAYLNLDFLSAIKKNLTQLSLLNAINKEVELIKKERNLILISEFN
PKISAQVKNQPAPFIYERLGERYQNYFIDEFQDTSQMQWENLIPLIDNKLSSENIQDPAS
AMLVGDAKQSIYRWRGGKAEQFIDLCLDTNPFSIEKCVENLPDNYRSGSQIVNFNNSLFN
FAAGTLQHPAYSNLFQESGQKPKKGNFGYVNIDFIEAENAAKEHEIYPEKILEIIQNLEE
KKFKKGDICILTRKKKEGITIAGYLSENDIPVVSSETLLVANSPKVNFIANLLEFSLSPK
DNTLKLELFDFLADFLKIENRYPIISSNLPKDGKLFFHWLKDYDIGFDLDEIRHLSVYEA
AEYIIRSFSLVGTSNAYVQFFLDFIFESTQKATAGISDFIDLWLQEKESLSIVVPKAEDA
VQIMTIHKSKGLEFPVVIYPYANSDSKSTRMDSLWLPMEPPLNEIPMSYLSASDKMLNWG
PKASDIYTELLHQKELDTLNVLYVACTRASQQLYLLSKKEIDSKGNEKSYKTSGLLIGFL
KEIGRWDTNINTYEFGEIGVPKTSEETQSANIISEKFYSSATQNQAVNIVTKSGMLWDSK
QEEAIEKGEILHELLAQIDYKEQVKPVVAQAVNDGIITKDSAEKIEKLLIEITSHPQLSE
YYTENATSFNERDILTPEGKRLRPDRINFAGNTVNIIDYKTGKFDVSHEAQINSYAGILL
DMGYQIGSKNLVYTNKALKVRLV
>IFAGANLK_00152 2-amino-3-ketobutyrate coenzyme A ligase
MYGKIKEHLQEELKQIEEDGLFKKERIITGPQDAVIKISTGQEVINFCANNYLGLSSHPE
VIKAAKDTMDTHGFGMSSVRFICGTQDIHKELEQKIADFYGTEDTILYAACFDANGGIFE
PLLTKEDAIISDSLNHASIIDGVRLCKAARYRYQNGDMADLEKQLQDANEKGARFKLIVT
DGVFSMDGLVAPLDKICDLADKYDALVMIDECHATGFIGEKGIGTLEEKGVMDRVDIITG
TLGKALGGAMGGYTTAKKEIIELLRQRSRPYLFSNSLAPSIVGASLKVFDMLKNDNSLRE
KLKSNTQYFKKGIKDAGFDIIDGESAIVPVMLYDAKLSQKMAERLLEEGIYVIGFFYPVV
PKEKARIRVQLSAAHEQEHLDKAIAAFTKVGKELEVI
>IFAGANLK_00153 Outer membrane porin F
MKHLSKILFATMLVLGITSVSAQDANNPWSIGIQTNAVDFHPTTDVGGTFDDYFNVGDHW
NILPSMSRLTVGRYIGSGFVFELAGSVNQIEQYGAEAVPQMAYYAVDGSFNYSLRALLND
GWLDPFVGIGGGYTSIADNGDYPISDLSAATLNGKFGLNFWFTDNVALTLESNYKHVFDV
DGATHFQHAGGVKFMFGGTDSDGDGIYDKDDECPETPGLPEFNGCPDSDGDGIEDRMDAC
PNEAGLAEFDGCPDTDGDGIADPNDDCPEVAGLAELNGCPDADGDGVADNEDDCPNEAGP
AENDGCPYEDMDGDGVLDKDDDCPEVAGTAANNGCPEPDVEVISELNEYSKTVLFDLNKA
TIRDDSEEALQSIADIMNEYPNTIFHIEGHTDSTGSAEYNEKLSRERAASVESWLEENGV
PSNRLTSEGYGEERPIATNNTAAGRQDNRRVEISLDKNKEVKDSESSMEDDNQ
>IFAGANLK_00154 hypothetical protein
MVSFISGVLKELISSEENISEIIFILPSKRAGSFLLKELSALSENHIFAPKVYSIEEFTE
VISETKTVDNTLTLFEFYNVYKKITPLEEQEDFETFTAWAQSLIHDFNEIDRYLIDYKSF
FNYLADIQDLKHWSIQEPKTDLINNYLSFWNSLPAFYEALKEELLSKNTGYQGLIYRKAS
ENIPEYTQKHTAKHVFIGFNALNTAEQLIVQHLVENDRAEIYWDLDEVFVKDRQHDASLF
INQYVKDWPVYREKEAKLNVSEYSKPKNIQVTGVPKNVGQAKYLGELLANLDKETLQETA
VVLGEEDLLLPVLNSLPPNVKDLNITMGFPLKNAPIASLFDRLFQIHQNTASGYYYKDVI
SVINHPALHELLKQETEIFIEKIQSENTVNLSEKEIISSFSAGAKPLIEACFKDLENSPL
KAIEAFQQIINQIKDHYKTDQNKLGLEFLYQFHVLFNKLENLNQTYPHLKSVKSLYQFYK
EIMSTQSLDFQGRPFKGLQLMGMLESRALDFKNVIICSVNEGVLPSGKSGSSFIPFDLKQ
TYKLPTYKEKDAVYTYHFYRLLQRAQNVHLLYNTETDGLNSGEKSRFLTQLEIEKQPAHQ
LTHTMVSPKVPAIKNELREVKKTPEIMEKLKSLAGSGFSPSALTSYIRNPLDFYRQYVLG
VRDREEVEETVAYNTLGTVVHDSLENFYKPLEDKILTAENIKAFKARIEEEITLQFKKSY
MNGPVNQGKNLLIYEVAKRYLRNFLNLELNRLETEEIKILKIEKTLKSEIRIEHLDFPIF
MRGKVDRAENSNGTTRIIDYKTGKVTQDKIEIVDWEDLTSDYDKYSKSFQVLAYTKMMED
QNLLELPVEAGIISFKNLKSGFLKFGKKDKPRTKNKETAINKEILDAFEIELKKLITEIC
DPEIPFKEKEL
>IFAGANLK_00155 hypothetical protein
MEITKRTNIQIDGKHNKPILIDLIYNDDKKPKPIVIFCHGYKGFKDWGAWDKMGEFYAEK
GYFFVKFNFSHNGTSPDNPTEFLNIEAFGDNNYIKELDDLQTVIDWLLTPDFNEAQQIDV
KSINLIGHSRGGGIAILKAAEEERINKLITLAAVSDFASRFPKEKELEAWEKKGVQYIKN
TRTGQQLPHHYQFYKNFRENRERLNIQKATKKLGIPHFIAHGSNDTTVSIADAGNLFEWS
AISKLLLVENADHVFGISHPWNKDELTKEFQHVLNRTATFLDASVQDLKDEYIDNDEADS
>IFAGANLK_00157 hypothetical protein
MIRNASLEDLNKIKELTEACAEALQEQNIFQWNENYPSREKLKNDIQREDLFVYEDQDRI
IAIMVLTSKMEAVYENIEWLTETGNNLYVHRLATHPEFWGYGYARKMMDFAEELAKKSNF
ISIRLDTFSKNLRNQKFYENRGYRKLGDVYFPHKNEHPFHCYELILNQV
>IFAGANLK_00158 DNA damage-inducible protein F
MESSVSFKNINRIAIPAIIAGIAEPLISLTDIAVIGNVENNSVEALAAAGIVGSFLSAII
WIVAQTKTAISAIVSQHLGANRLHAVKTLIPQAIYFNFAFSLVIYFTTAFFAESIFSAYN
ADGLILQYSEEYYQIRALGYPLTLVTFAIFGVFRGLQNTLWAMKCSLAGAGINVALDFLL
VYGIDGIIPAMHLKGAAYASLAAQATMLIMALWFFFKKTPFHLKLSFNINPRLKGLLLMA
ANLFVRTAALNFAIYLANAYATDYGKNYIAAQSILMNIWLFFSFFIDGYANAGNAIGGKL
LGANDYRNLWELSKKISKYAVLIAFMLMAICGIFYSQIGLVFNKDVAVLAIFSSVFWIVL
LMQPVNAIAFMFDGIFKGLGEAKYLRNLLLVATFLGFTPALLISDYFGLKLYGIWIAFFV
WMLIRSAGLVIKFRRKYLQKEV
>IFAGANLK_00159 Short-chain-enoyl-CoA hydratase
MSTTRENGSLYTNIQNGIAHLEFGHPASNSFPSELLDRLEKEFQKLSEDESVKVVLLKSE
GEKAFCAGASFDELVAIETMQAGKLFFSGFAKVLNAMRRCKKLIVGRVQGKTVGGGVGLV
AACDYAMATDAAAVKLSEISIGIGPFVIAPAVERKIGVGALGELSLAAHEWKNAYWAKDK
GLYARVFESLKDLDKEIDIFTGKLASYNPEALYEMKQMLWKNTSHWDELLAERAAISGEL
VLSDFTKNALNKYKK
>IFAGANLK_00160 hypothetical protein
MLLLYFDQTGDKAHSLGYSIGYFIGDNLLFILLGLLIIAGLFVFFLYKIIKNNKRQIKN
>IFAGANLK_00161 hypothetical protein
MSLPQQHLPKDRDATREEEWGFTIWEFIADNWLYLVGILIILAIFFYARYNWRRRQEKNR
MN
>IFAGANLK_00162 hypothetical protein
MGEDTWEFLSFLSGMGFWLILALVLIVVVLYKKFNK
>IFAGANLK_00163 hypothetical protein
MESQNSTELFEQLDFKENPFYENIITDLVENQYSIVDDFFDAEEVEMLRNSLKSKFEEEQ
FKKAAIGNKTNEIVAKSIRGDFILWLNEAEAGKAENLFFSKIHSLVEYLNKTCFLGILTK
EFHYALYPEGTFYQRHLDTFQNDGRRKLSMVCYLNEEDWKPENGGELVIYSEENGAEVSK
AIYPLPGRVVIFESQVLEHEVKPVKTARLSITGWLKTR
>IFAGANLK_00164 hypothetical protein
MSKIRITKKFSFETGHALYGYDGKCRNVHGHSYKLSVCVIGEPITDKDNVKFGMVIDFGD
LKKIVKAEIVDQFDHATVFNKNTPHVELAEELKNRGHHVILVGYQPTSENMVVDFAKKIQ
KHLPDHIKLHSLKLQETESSFAEWYASDQ
>IFAGANLK_00165 UDP-2,3-diacylglucosamine hydrolase
MTIPEGKKVYFSSDNHLGAPTREESRPREVRFVKWLDEIKEDAAAIFLLGDLFDFWFEYK
HAIPKGFVRVLGKLAEIKDNGTPVYFFVGNHDLWMRDYFKEELNIPVYHQPKEFEFNNKT
FLVGHGDGLGPGDHGYKRMKKVFTNPLSKWLYRWLHPDLGIPLAQYFSVKNKAISGDQEQ
EFLGEEKEWLIQYCRRKLEEKHYDYFLFGHRHLPLEIDLNGKSTYINTGDWLNFYTYAVF
DGEKIVLKKIEK
>IFAGANLK_00166 Toxin YoeB
MRLVWSLTSWEDYLYWQKVDKKVLKRINTLIKSCLITPQEGIGKLEALKGDLQGYWSRRI
TSEHRLVYKFEKDQLMIAACRYHYRK
>IFAGANLK_00167 Antitoxin YefM
METVNYSNFRSNLKYWFDKVINDVSDVIIKRKGGKDLVLISLDEYNSLKETTYLLSGNNR
DILLKSIQELESGSVVQKDIIE
>IFAGANLK_00168 Single-stranded-DNA-specific exonuclease RecJ
MRWTLKPKPNSLVVNKLAGELGVSPAIAKLLVQRGIDTFEAAKKFFRPSLEDLHDPFLMK
DMDVAVNRIQQAIASEENIMVYGDYDVDGATSVALMSSYLKTLTPNVATYIPDRYAEGYG
VSFQGIDFASDNEISLIIALDCGIKAIDKVGYAAKKGIDFIICDHHWPGEAIPEAVAVLD
PKREDCEYPYKELCGCGVGFKLIQALNFKRGGTPEVLLPYLDLVATAIGADIVPITGENR
ILAYHGLNVMNVAPRTGFKAILAQVKKEKLTMSDVVFIIAPRINAAGRMKHGLHAVNLLT
EEDEATALEFAAEIENFNSERKTTDKEITVEALAQIEDLKEQGRNTTVVYQDNWHKGVIG
IVASRLTETYYRPTLVFTKSGEKLAASARSVKGFDVYNALEACKEHIEQFGGHKYAAGLT
LEASEYENFKARFESVVSETIDKRLLIPEISVDAEIDLDEITPKFFRILKQFAPFGPGNM
TPVFMTQNLTDTGFGKCVGADEAHLKCQVKQQGKLGVFDMIGFGLGEKFETISLKKTFKA
VYSLDENEWNGNVSIQLRLRDMSE
>IFAGANLK_00169 Adenine deaminase
MTKIIQGQLVDIENRKIFPAEISIENGKITKIEEKEHGVKNFLLPGFIDAHIHIESSMLV
PTEFARLAVMHGTVATVSDPHEIANVLGKDGVKFMIENGNKSPLKFNFGAPSCVPATSFE
TSGAVINAEDIKELLALPEIKYLAEMMNYPGVIYKDEEVLKKISWAKHFNKPTDGHAPGL
RGEDAKKYAEAGISTDHECYTAEEAEEKLGLGMKVIIREGSAAKNFEALIDLLPEHYKNM
MFCSDDKHPDDLVLGHINQVCARTVAKGIDVFKVLEVACINPKEHYNLEVGQLKVGDPAD
FIAIKDLTNFEVLQTYINGKLVAENGESYIQSSSFEKPNNFNTSLKNPENFKVKATGKTV
KVIEAMDGELITNELQSPALEKDGNLISDVENDVLKITVVNRYENNPPAVAFIKNFGLKK
GAIASSVAHDSHNIIAVGTSDEEICNAVNLIIKHKGGICSVDKNDEKVLPLPIAGIISDK
DGWETGKLYQEIDKMAKDLGSTLKAPFMTLSFMALLVIPDLKLSDKGLFSGKKFDFIDLV
SKQE
>IFAGANLK_00170 hypothetical protein
MQQLLKEARNCTFCEKYLPLVPKPIVKATKNSKIVLISQAPGRIVHQTGIAWNDQSGKKL
REWLGVDETTFYNTNNFAILPMGFCYPGKAKTGDAPPRKECAPLWHNPILSELKNIQLKI
LIGAYAANYYLPGNLNLTQKVSNYEDFLPEYWCLPHPSPVNRFWRSKNPWFEKDVVPTLQ
KKIAEILD
>IFAGANLK_00171 Ribosomal RNA small subunit methyltransferase I
MGKLFLVPTPIGNLEDMTFRAVRVLKEVNTILAEDTRNSGKLLKHFEIGTNMQSHHMHNE
HRTVDRIVERIKNGENIALISDAGTPAISDPGFLLTRACVEAGIEVDCLPGATAFVPALV
NSGFPNDKFIFEGFLPVKKGRQTRLNILAEESRTIIFYESPHKLLKTLQHFVKYFGEDRP
VSVSREITKLHEETIRGTAAEVLEHYTQKPPKGEIVIVVKGKS
>IFAGANLK_00172 hypothetical protein
MKNRLKKELVKLAEEIISEKENLDTKALKLKAATLYEQLSILNFTEQNLKAFEAPEATPT
PKIEKKEALKVAVEQETSHHVPDGTEYREDADAITEPNTEKIKDIVAQMPAESERVDELI
EQANPKPQAPPMQQQASKVKEEPQQPKPEAPKNDFRNIGVDYDNLPDFEPLNNRQKDQKP
RSVNDRLKKGINIGLNERLSFIKNLFDGNSSDYNRVLSQLNTFSSLDEAQKFIQLVVKPD
YNHWQGKEDYEERFMAKIENKFQ
>IFAGANLK_00173 Thymidine kinase
MFLENTVNHEEQFGWIEVICGSMFSGKTEELIRRLKRAQFAKQTVEIFKPAIDTRYDEEM
VVSHDSNEIRSTPVPSASNIRILADGCDVVGIDEAQFFDDEIVTVCNDLANRGIRVIVAG
LDMDFKGNPFGPMPYLMATAEYVTKVHAVCTRTGNLAQFSYRKAINDDLVFLGENEEYEP
LSRGAYYKAMLQERVKKLDVNDAEELHPNLKKKNA
>IFAGANLK_00174 Alanine racemase 1
MPKAEESVLEIDLNALAHNFKTIKSQLSPGVKFMSVIKAYAYGNDSVAMAKKLEELDTDY
FAVAYTEEGIKLREAGVSKPILILHPQPVNYPEIIENCLEPNLYSARTLQLFIDIAEKQK
QKNYPVHLKFNTGMNRLGFTETNYHHIPEKIGKTESVKVVSAFSHLAASEDWKEREFTLS
QIYKFKDLAGKLIDDIRYEPLLHLCNTSAIFNYPSATFSMVRSGLGLYGFANDPNLDEKL
KPVGTLKTVISQIQNLKEGDTVGYSRAFKAEKITKTATIPIGHADGIKRIYGHGKAGVFV
NGEYAPIVGNVCMDIIMIDVTHIDCQEGDEVIIFGGPQHVTKLAGAGGTISYELITGISQ
RVKRVIIQ
>IFAGANLK_00175 Large-conductance mechanosensitive channel
MSFIKDFRAFMLKGDIIALATAVVIGAAFNKIVASVVADVIMPILGLLTGGTDFTQQFIS
LDGVSYETLEAAKEAEAAVITYGNLIDTIIHFIIVAFFIFLVLRAYEKTKKEKEAPKLVE
PKGPTQEDLLTQIRDELKKQGNTP
>IFAGANLK_00176 Aspartate-semialdehyde dehydrogenase
MRIAVVGATGMVGQVMLQVLAERNFPVTELYPVASERSVGKKINYQGKDYEVIGLQAAVD
IKPDIALFSAGGDTSLEWAPKFAENGTTVVDNSSAWRMDETKKLVIPEINASELTKEDKI
IANPNCSTIQLLMALKPLHDAFKIKRVIVSTYQSITGTGVKAVEQLENEYKGEKGEMAYP
YPIHKNALPHCDVFQDNGYTKEEMKLTKETKKILGDDSVLVSATAIRIPVVGGHSESVNV
EFEKEFDEAEVRKILSQFPGVTVQDNPETNTYPMPIYAEGKDDVFVGRIRRDYSQPKTLN
MWVVADNLRKGAATNTVQIAEYLIKNKLV
>IFAGANLK_00177 Prolyl endopeptidase
MKKTFSGIFALAVLASCNDSKTEKEISLNYPETKKVDTVTDYFGTEVKDPYRWLEDDRSE
ETEDWVKAQNEVTFDYLNSIPYKKELEERLSEIWNYEKIGAPFVEGDYTYFYKNDGLQNQ
YVVYRKKGDDAETEVFLDPNNFSEDGTTSLAGLSFSKDGSKAAYAISESGSDWRKIIIID
AQNKERVEDTLQNVKFSGISWQGDEGFYYSSYEKPEGSELSAKTDQHRLFYHKLGTPQSE
DKVIFGDSEEQKHRYVGGSVSEDDRFLFISARNSTSGGKLFMMDLSKNNPELVTILDHED
TDTGVIENDGSKLFIVTNMDAPNRKIVTVDAANPSPENWEDFIPETENVLSPSTGGGYFF
AEYMVDAVSEVKQYDYNGELVREVELPGIGSAGGFGTKKENEELYYSFTNYVTPGTIYKY
NIEEGTSEVYNKPNIKFNPDDYESKQVFYTSKDGTKVPMIITHKKGLELNGKNPTMLYGY
GGFNISLTPSFSTANAIWMEQGGIYAVPNLRGGGEYGKEWHDAGIKLKKQNVFDDFIAAA
EYLIEENYTSSDYLAIRGGSNGGLLVGATMTQRPDLMKVALPAVGVMDMLRYHTFTAGAG
WAYDYGTAEDSEKMFNYLLEYSPVHNLEEGTEYPATLVTTGDHDDRVVPAHSFKFAAELQ
DKQTGDNPALIRIETKAGHGAGKPTKMIIEEYADIFGFTLYNMGFDVLPNKTEEEVKG
>IFAGANLK_00178 hypothetical protein
MQEIIVYDLNQTLYKKSSKDEFFKFICYKKGYKLLHLFQIGWLHVLGKLHITSKTYFKEN
FYDYLNKLPPEKVKKYAKQFWDIEFPEHFEDDMIADIREKDKAGIKVYIVTGGFEVYTKY
LEELLPLKVIGTITKYENKDYKIIGKTCNDAEKVKRLNSEMNGEYRLLEAYSDDDEEILY
KAEKGYLLEDGELKLVQNKNV
>IFAGANLK_00179 ADP-heptose--LPS heptosyltransferase 2
MSQTTQNMNDSSFIKDEQLHILVIRLSAMGDVAMTVPVLRVLTATYPHLKVTVLTRGFFE
PMFKGIPRVSVYEADVNGVHSGVFGLCRLAKDLRDLEVDKVADLHDVLRSNILKSVFYMF
GIPVKQIDKGRNEKKALTRENNKIFKQLKPTVQRYADVFNALGYPIDLNIHQFPEKEKIS
EKIRSLVGTEPKKWLGIAPFAQHSSKAYPADLMEEVLGKLSENSRIKILLFGGRNKEKQQ
LEIWAARFNDTISIAGKLTLAEELALISNLDAMLSMDSGNGHMAAMYGIPVISIWGVTHP
YAGFRPFNQPPKNSLLPDLTQYPKIPTSVYGSKFPEGYENAIKTVTPQTVLEKIQEVLF
>IFAGANLK_00180 hypothetical protein
MFSDKANKIFQEVIEKYHEKDSVEQPFTNPYDSESELIEHLLYRKCWIDTVQWHYEDIIR
DKHIDPVDALALKRQIDASNQDRTDTVEYIDSYFLEKFKNVKPKEDATINSESPAWAIDR
LSILALKVYHMNEEANRKDASQDHQMKCKAKLDVLLEQRVDLSTAINQLLEDIAAGNKYM
KVYRQMKMYNDDELNPVLRKK
>IFAGANLK_00181 Modification methylase FokI
MNYIGSKHKLGDFIKSTVKEVVGEDLSQLVFCDLFAGTGSVGRKFKTSVKSVIANDVEYY
SYVLLKNYIENHQKLEAENLLAELNNLEEKQGFIFEEYSENGKSNRLYFSETNGMKIDAV
RQQIENWKLNKEIGANQYFFLLASLLESADKVANTASVYGAFLKKVKLSAQKELVIRPAN
FQITKHSHRVFQKDANQLIKEIEGDILYLDPPYNARQYGANYHILNTIAKYDTFAPQGKT
GLRDYYRSNYCSRTKVKNSFQDLLENVNFRYIFFSYNNEGLMPSAEIKKIMSRFGNYDLV
TRNYQRFKADKTENRNHTARNTTEYLHILEKK
>IFAGANLK_00182 hypothetical protein
MLTSFFGKSKPVNGVAITIFLIIFFIIANFKEWFLDFNLLVFLEKLAVLLSLIVSVFTLN
FIAKKNELTQRSAYKILFFAIFTASFFALLKNHQVIFANLLVLLALRRIISLKSKKVMQK
KVFDATFWICIASLFYFWSILFLVVVYAGILYYLPKPKNWLIPPIAALAVAVLTLSFHII
AYDQFYTFSQWFEWSNFDYSNYQNLEILIPVSIILTLTLWTLVQFFAVVNKASVSMKPSL
NLVLLSLLTAVAVAIFAPTKDGSELIFFFVPLSIITSIYFDQREDKVFREVLLVLLILMP
LCIPFIF
>IFAGANLK_00183 hypothetical protein
MLRDIFEGIAYLFEEILFVPLDALRSLELDSWWAANALNFIFILVGLAAFAFWMKQLKHY
NEVNDEDRDPTAHSFLG
>IFAGANLK_00184 Phosphoribosylamine--glycine ligase
MKILILGAGGREHTFAYKLAQSPKCSQLFVAPGNAGTAQIAKNIDLKVTNFKAIKEFVLK
EEIEMLVVGPEDPLVEGITDFFTEDEALKNVKVIGPSKRGALLEGSKERAKEFMAIHKIP
TAAYESFTEKSLEAGKEFLETLNPPYVLKADGLAAGKGVLIINDLEEAKEELQNMLAEKK
FGAASAKVVIEEFLDGIELSVFVLTDGKNYKILPTAKDYKRIGEGDTGLNTGGMGAISPV
PFVYDELMQKIEERIVKPTVNGLQEEEIDYKGFIFIGLIMVRNEPYVIEYNVRMGDPETE
VVLPRIKSDLVEILEKVSEEKLNEVALEIDERAATTVMLVSGGYPEAYEKSKEITGFDKV
EDSLVFHAGTKLEGDKVVTSGGRVLAVTSFGKDYKEALKKSYQNAEKIHFDKMYYRKDLG
FDLS
>IFAGANLK_00185 Phenylacetate-coenzyme A ligase
MDWFKLSLQLNKFPINRAQKTLQEIQKIPAENYENYLSEKRKEIVEYHLNNNRFYKNFFG
KSSFSNWNEVPVMAKTNLQQKLQNRLSKGFSKSTVYIGKTSGSSGTPFIFAKDKFAHALS
WAGFQDRYQWHNIDLNKSLQARFYGIPLDFYGNAQERIKDRISLRRRFPIFDLSEQKMEK
FLKRFHHSNFSYINGYTSAVLLFAKFLKNRNLILKEVCPSLKLCIVTSERLFKEDKKLME
TVFGVPVVNEYGASEVGLIAFENKENEWVVNSEDLFVEILDKNNNPVPNGTEGRIVITSL
YNQAHPMIRYDIGDTGILSEKSTLKKPILEKLIGRTNDIATLSDGKVVPGLTFYYVTKSI
IGDTGSIKEFVINQNAADAFKIEYVSKTDFSENQKQKILQAIETYVGKNLKVAFERKEKL
TRSKSGKLKQFTSDL
>IFAGANLK_00186 Putative teichuronic acid biosynthesis glycosyltransferase TuaG
MGSPLVSVIMPAFNAENFIEAAVNSVIAQTYSNWELFIIDDASTDATLSKVEKFAKQDSR
IKIIQNKKNQGTGVSRNKGIKAAQGDFIAFLDADDQWKPRKLEIQLEVMQQQDAAVCFSS
YQPIEENGNSRSEIIEALPILTHQKLLKSNYLGNLTGIYSAKKLGKIYAPEIRKRQDWAL
WLEAVEGGGPAIGVQRCLAKYRVRKGSISGNKLEMLKYNFNVYHKVLGFSFFKSVGYMLV
FLKEHFFIKPKQVKRI
>IFAGANLK_00187 UDP-N-acetylglucosamine 4-epimerase
MAKRILITGAAGFLGSHLCDRFIKEGYEVIAMDNLITGDLKNIEHLFKLDKFEFFHHDIT
KFIHVPGQLDYILHFASPASPIDYLKIPIQTLKVGSVGTLHCLGLAKEKNARILIASTSE
VYGDPQVHPQNEEYYGNVNTIGPRGVYDEAKRFQESITMAYHRFHGLETRIARIFNTYGP
RMRLNDGRVVPAFIGQALRGEDLTIFGDGLQTRSFCYVDDQIEGIYRLLLSDYADPVNIG
NPEEITIKDFAEEILKLTGTDQKIVYKELPEDDPLKRQPDISKAKEVLGWEPTVSRSEGM
KITYNYFKSLSPEELEKSEHKDFSNHIRR
>IFAGANLK_00188 dTDP-4-dehydrorhamnose reductase
MKNILVTGANGQLGACFKKIEGNYPDFNFEFKSSAEADITDKSKLQQLFSEMNFDWIINC
AAYTNVEKAESEEEKAFKINAEAGKKLAEVCEENQAILVHFSTDYVFDGKAEKPYKETDK
TNPINVYGASKLKGELAIAEVLKEHFIFRTSWLYSEFGHNFYKTILRKIEEKAELNITTS
QTGTPTNANDLAEFVMEIIATENKNFGLYHFSNSGKATWYDFAKAILEFTGNSKKIRLNE
SNKFKTIAARPDYSVLDKTKIQQKFQKQIPEWKVSLKTLILS
>IFAGANLK_00189 dTDP-4-dehydrorhamnose 3,5-epimerase
MHVEESPLKDCFIIKPDIFRDKRGLFLESYHKKKFIELTGIEKEFVQDNQSISKKGVLRG
LHYQTGELAQTKLVRAIYGKVLDVVVDLRPESSTFKQSFKIILDDENLYQLYIPKGFGHG
FVTLSETSVFAYKCDEYYYPGYEAGIIYNDPDLAIDWGFPEEDMIISDKDLKQPRLKEVF
K
>IFAGANLK_00190 hypothetical protein
MTNLKLLGRTRAQESTHAIERMYITMRHLFNRGFYKPMGVSGETLREALLILRPEIYGSI
ADDKAELSGLLYVVDRLPKGIEECRFINLTSDEGYGNSHFKPIVPPKRRRNCYRIDEEQM
NIEITRGRSEIYDILTHLTFLFVESHKIMRRVIIDEEGSVTRDWQKLEKSVLQEGPLDQA
QREIALTHTANILGRTFFEVQDIYPKFSLPGNPERFLNIIYWLGKLAIAETIHNDKRIIT
FSPVLRERLGHHIHGEIWADNIKQHLIKQNLMHRPLHIISANMHSVMNTLYTPSALKTEL
KKKKPLEIYELLSNSANGDLRSKVMKSALDNGMTFLDDKSGTNIDVQIFDTAKLNGKYGS
CDIKTEEDAPVIIVMDYAFGEQAYETMDELLKPYNFEGNEIKMNVESISIMGKAGILEGG
KGDIMIPSAHLFEGTADNYPFKNELSPADLEGSGIDIVDGAMITVLGTSLQNRDILKFFH
DSTWNVSGLEMEGAHYQKAIQAASKLRGSIDSEVKVRYAYYASDNPLETGSTLASGGLGT
TGVKPTYLITEKILEQIFKS
>IFAGANLK_00191 hypothetical protein
MSLKSFGAKIFASYIRKKIDKWASQPEATQQKVFRELIEKGKNTKFGQDHDFKNIKTYKD
FTQKVPIRDYEELRFYVDKMVAGEVDVLWPGKPLYYAKTSGTTSGAKYIPLTKDSMPAHI
NAARNAILCYIDETGNAKFVDGKMIFLQGSPEMDEKNGVKLGRLSGIVAHYVPAYLQKNR
MPSWKTNCIEDWETKVDAIVEETIHEDMSVISGIPSWVQMYFERLQQKTGKKVGELFPNF
NLFIYGGVHYEPYRAKFENLIGRRVASIELYPASEGFFAFQDKQNEKGMLLQLDSGMFYE
FIRSDEFFEENPKRLTIGDVEKGVNYVIIVSTNAGLWGYNMGDTIQFTSLKPYRVIVSGR
IKHYISAFGEHVIGKEVEEAMQEAMRSTKARISEFTVAPQITPENDELPYHEWFIEFEEE
PENMDEFHRILEKTLQEQNSYYFDLIEGKILQPLKITTIPRGGFNHYMKSIGKLGGQFKL
ARLSNDRKIAEVLEENLRKYNK
>IFAGANLK_00192 Murein DD-endopeptidase MepM
MAENKKERKKFTKKLLHKYRMVVLNEDTFEEKLSFKLTRLNVFVTITLSAIILIAATTFI
IAFTPLKEYIPGYSSAQLKRQASELAYKSDSLQQVLKMNNQYLSSIKNVLTGKADTSSLS
RDSMVENPIMGQEIEAIEPSRADSLLREEVAQEDKYNVLPSATDNIDFSLFPPVKGSISE
EYDAKEKHYAVDIVVAKNTPVKSVADGRVILSEWTTETGYIIIIKHEYGLLSVYKHNASI
AKEQGENVRRGEVIATAGSTGEYTTGPHLHFELWNEAVPVDPTDYIDFD
>IFAGANLK_00193 Sec-independent protein translocase protein TatAd
MNALILPLAIGAPQIILIVVVILLLFGGRKIPELMRGLGSGIKEFKDASKDENGDKTVTS
DDKNFSEEKK
>IFAGANLK_00194 hypothetical protein
MKKTLFLLFGLIFLVSCNENGDKEEERILSDSSGNINQITLIIKNDLWEGPVGEAIRDNF
AATVEGLPQEEPMFSLSQVPPETFSGFVRKNRSFISVQEGKETEARIIKDLYARPQTGVI
ISGENEEELIHIINESSEKLVSAFKETEMKEKQRRMKKSLKKDGKLEEKFGLSLDFPSAY
RYALEEEDFVWIRKEIPKGNMEILIYEVPINQIESDTNTIGNIIKMRDSIGKAHIPGPTE
GTHMITEEAYAPYLFESEIDGKFAYETRGTWEVKGAFMAGPFLNYAIKDEANNRFLVVEG
FVFSPSRSKRDNIFEIDAILQSADIE
>IFAGANLK_00195 Membrane-bound lytic murein transglycosylase D
MGRYIILSLVFLFGISLQAQEGEKGKQVEKANFRVQIFQKVDSSEIILAHPDPEFKDKLP
ISAVIRDSSAVSLEDLPRAAEIDSVWKAQLTNSDLFDEMYKSIREQDYEDEVNRELPTDT
LKARLAKLNARTPFNVEYHPILESVINSYLKRNKKAMERLMALSEYYFPMFEQQLDRYDI
PLEIKYLAIVESALNPRAKSWVGATGLWQFMYRTGKAHGLDVSSYVDERMDPQMSTEAAA
QYLANLYRSFEDWDLVLASYNSGPGNVSKAIRRSGGSNNYWELRRFLPRETAGYVPAFLA
TLYLFEYADAHNFQPQGPDIAFFETDTIKVKKLITFDQISKVTGVEKEMLQFLNPSYKLD
VIPFVEDENYMIRLPATVSGAFVSNEAAIYNFAEEDIKNKAEAFPEFVKAEEQIRYRVKS
GDYLGRIAERYGVGVSSIKRWNNLRGNNLRIGQYLTIYPRKPGAETQNASTGNSQKNNEK
TYTVKKGDSLWSISRKFPGVTVQNLRAWNDMGNSSLKPGMELKLSKG
>IFAGANLK_00196 Phosphoglycerate kinase
MKTLNDFNFKNKQALIRVDFNVPLNKDQEVTDANRIEAAKPTILKILEDGGSVVLMSHLG
RPEGKEDKYSLKHIVKKVAEVIGVEPKFVNDCVGDEVKTAADNLHPGEILLLENLRFHKE
EKGGDEDFAKQLSQLGDIYVNDAFGTAHRAHASTTVVAKYFDDKCFGYLLEKEIKNLDKV
LHSKEKPVTAVLGGAKVSSKITVIENILDKVDHLIIGGGMAYTFILAKGGKIGNSLVEED
KQELALEILKKAEAKNVQVHLPVDSIIADSFSEQASTDTAKIQEIPDGWMGLDAGPESIK
NFDAVIQESRIILWNGPLGVFEMDKFSKGTIALGNSIAEATKKGAFSLVGGGDSVAAVKK
FGFEEKVSYVSTGGGAMLEMLEGKSLPGIEAIGK
>IFAGANLK_00197 DNA polymerase III subunit delta'
MLFEEIIGLQHLKKHLTTTADNGRVPHAQLFVGKSGSGTLPLAIAYAQYLLCKNKDGENL
AGNEKCNERFRKLAHPDLHFAFPVAANQKVKKHPVSSHFLEEWREFVKTNPYGSLFEWYQ
KLGIENKQGQIGVNEAQEVVKSLSLKAYEGGFKIMIIWMAEKINTAAANKLLKLIEEPPK
NTLFLLITEDEEQIIQTIRSRCQKLHFPPLPEDEIAAFLNKNENCTKPDALKIAHQANGS
YTRALHLLQKDSGDQQFETWFINWVRTAFKAKGNRATVLELISWSEEIAGMGRESQKSFL
LYCIDFFRQALMLNYKADKLVYLEPATPGFKLDKFAPFVHGNNIKDIISALEEAIYHIER
NGNAKIILTDLSIRLTRYLHKKAA
>IFAGANLK_00198 hypothetical protein
MENLYANVTEILILIFILITFLQSGIDKAADWKGNTGWLKEHFSGTFLAGQVSLMVGIIM
ILEIITGIIAILGLIWLIGYNDPTMALYTCILAAITLLMLLFGQRIAKDYAGAFTLTGYF
IVVIFGVYLMS
>IFAGANLK_00199 Outer membrane protein 26
MMKKLLMILVVAVLLTSCDQEKTAYVDTTKLIQEYKEMKDVEAEFSTQSDSVKRQLDSIA
RTFQQEVQAYQEEMNSLSQAQRQEKEQELMQKQQRIQQQQQMQGNRLREQSDAVIDSIVD
KVKDYVADYGEENGYTYIFGSNESANIMYAKDGKDLTEEILENLNETYNQN
>IFAGANLK_00200 Demethylmenaquinone methyltransferase
MPDKNLPLKCKDHLVSGEEFRLEMRNDFEILETLPKPKNLSAYYESEDYISHTDSKKSIT
DKVYRAVKKYMLSEKLKWILQVSNGNKILDIGAGTGDFLEAAKEKKFEVSGIEPNDHARK
LAFQKGIELQKELAYFDDISFNVITMWHVLEHVPDLEFQLKELHRLLTPNGVVVIAVPNF
KSFDANYYKEFWAAYDVPRHLWHFSQNGISELFKNYNFQKLQTKPLVFDSFYVSLLSEKH
KTGKGNFIKAFNIGLNSNLKAKTTSEYSSLVYFFQKS
>IFAGANLK_00201 hypothetical protein
MFLLFSMFWLFDSCVITTHSVKEIDTSEMAQPDALSEYTSFKFSSAVKPQKTKDWFRNYF
GLDRKDDLVNFKSSFLEDSNHEFIITISDYSDKEEYMDLTGLFFGGGVKNRVGDLKFFIE
ITITDKSGVDHLAEDSIFQKPILEKLSEMRNEFQSFTGSNPDQKFF
>IFAGANLK_00202 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MFEDEYDVIVVGAGHAGSEAAAAAANLGSKTLLVTMNLQNIAQMSCNPAMGGIAKGQILR
EIDAMGGYSGLVSDTSAIQFKMLNKSKGPAMWSPRVQSDRMMFAEHWRLRLEQTPNLDFY
QEMVAGIIMEGNQLKGVKTSLGLEIRAKSVVLTNGTFLNGLIHIGDKNFGGGRAGERAAT
GITKDLVDVGFESGRMKTGTPPRVDGRSLDYSKMIEQPGDKEPSKFSFLDETQPLKKQRS
CYMTYTSPEVHEILKDGFERSPMFNGRIKSIGPRYCPSIEDKINRFADKDRHQLFVEPEG
WNTVEVYVNGFSTSLPEDVQFKALRSVAGFENVKFFRPGYAIEYDYFPPTQLKHTLETKL
VDRLYFAGQINGTTGYEEAACQGLMAGINAALKVQEKEEFIIKRNEAYIGVLIDDLITKG
TEEPYRMFTSRAEYRTLLRQDNADFRLTERSYKIGLATEERMRKMEEKKEKSSNFVEFLR
NKSVSHEDSNPVLEANNSALMTQSDKIFKIFSRPNITMKDVRKFPGVEEYIEENNLNNEI
MEQTEIQVKYSGYIEKEKNNADKLNRLEDVKIPNDFDYSKIKSMSYEAREKLNKVQPISI
SQASRISGVSPNDISVLLVYMGR
>IFAGANLK_00203 Endoribonuclease YbeY
MNEQTINFHSENDFQLEDEKSFDNWIREIIESEKKELGEINYIFCDDHYLYKINLKFLDH
DTYTDIISFDNSEGNELNGDIFISTDRVTENAKEYNVDFSEELKRVMSHGILHLCGYGDK
SESEAKEMRQKEDEKIALFHVEQ
>IFAGANLK_00204 hypothetical protein
MESYKQVRRKLEAFIRKFYLNKLLKGLILFFAIGLLYFLVVLAIEHFLWLEPASRTFLFW
IFVGVEVILLGYFILIPLTKLFKFSNGINDEEASKIIGAHFPEVDDKLLNVLQLKKDAHQ
SELLLAGIEQKSAELNKVPFTRAVDYKENSKYLKYALFPLILILGLLVTGNINLVAAPLG
RLAKHNTAFEAPAPFRFLILNDSLMARENTEYKILVKTEGNITPEKPEISYNGQTYFLKQ
IAPGSFEYTFKRLQNDVDFRLSANGISSEEYNLETLKVPKLLDFNMKFDYPDYIGKVDDS
LSGTGNVNVPEGTKITWDFNTRNTDILNFSTKDSLVKISAENTDFQYSQAVYSRLDYRVS
TSNNAIKNFEALDYSVRVIKDEYPEMEIQQKLDSIDKSTQYFYGKLSDDYGLNRLNLVYY
IENKEDSLKKQEITISKTAFDEFHYTFPGDLDLEPGETYNFYFQLWDNDGVNGSKSTKSS
TFSFRRKTADEIEAEKLKQQRESIDNLGESLRDIKSSEEELNELNRLQKENENLDYNQRK
KFENFIQRQKQQSEMMRNYSEKFKKSFEEEQDELNSDSAEKEELKKRLDRNEERLKENEA
LLKELQEIADKINREELGEKLEELSKRNQSEERNLEQLLELTKRYYVEEKLQKLARDLDK
LSEKQEGLAENSDDNSLDEQEEISEKFEEFQEEMNQLEKDNNELRKPTGLPRDEVDEESI
KNELNEAKENLENKEEEKAKEKQKNAAQQMKKMSQRMQQISMQQSGEELKADIKTLRQIL
DNLIAFSFQQEDLLDDFNSIEINNPGYAAKLRRQSDLRENFRHIDDSLYSLALSNPMITE
EITKGLTDIEFDINKSLERLAENELPQGTASQQYVVTGANDLAYMLSEILSMMQQQANPQ
MGKGDGKDSEFQLRDIIKKQQGINKEFQEKGEQQKQQQKGKKPGEGMGEGEMEELFEIYK
DQQELRQRLQELNKKEGSQQGKQIEEQMKEAEEQLLDKGFDPQNLRQLQQLEHELMELED
AKLQQGENNKRESKTNLREFDNTTKDQSIKAKEYFNSIEILNRQTLPLREIYKQKVKTYF
ERTNN
>IFAGANLK_00205 Glutamate--tRNA ligase
MSAKVRVRFAPSPTGPLHIGGVRTALYNYLFAKKHKGDFVLRIEDTDQNRYVEGAEDYII
ESLNWCGIPFDEGPGKEGDYGPYRQSERKEMYRKYAEELIKTDNAYYAFDTAEELDAHRK
DHEEKGKTFIYNWHNRQKLKNSLALSEDEIRDKLDADEDYVIRFKSPADENLHIKDEIRG
NMDIDTSTLDDKVLFKSDGMPTYHLANIVDDHLMEISHVIRGEEWLPSLALHFMLYRAFG
WDAPKFAHLPLILKPQGKGKLSKRDGDKLGFPVFPLEWKDPNSGDISAGYREDGYFPEAV
TNMLAFLGWNPGTEQEFFKLNKLVEAFEISRVHKGGAKFDPEKTKWFQQHYMHEADDKII
AEKLEKILQLKEIEASSDYVLEVVKLMKERAVFVNDIWEQGYFFFVAPTSYDPKNVKKAW
KEDTSNLMQELIKVLKEQENFKAEGLQAKVKAWIQDKEVGFGKVMQPFRLALVGAMQGPD
LYEIAEMIGKQETISRLENAIKTLG
>IFAGANLK_00206 Modulator of FtsH protease HflK
MISYVFIPIFLVLFLVILFSGIFTVRQQKAAILERFGKFKSIKNSGLHLKIPIIDQIAGR
INLKVQQLDVLVETKTKDNVFVKLKISVQFQVIRTNIYDAFYKLESPSDQITSYVFDVVR
AEVPKMILDDVFERKDDIAIAVNRELNQSMQDYGYDIIKTLVTDIDPDEQVKHAMNRINS
AEREKVAAEYEGEAERIRIVAKARAEAESKRLQGQGIADQRREIARGLEESVDVLNNVGI
NSQEASALIVVTQHYDTLQAIGEETNSNLILLPNSPQAGSDMLNNMVASFTASNQIGEAM
RKKNEEIEQEKKNKPDTKRR
>IFAGANLK_00207 hypothetical protein
MKEYSSFKEIDRDLKILKLQTKIDQEEIKLNIERTKSALSPLSLMGSMAGSILQKAFILK
AVTKLTGLKKVTASVKK
>IFAGANLK_00208 hypothetical protein
MAFEKLSRSIDELNYNLKAFAHSNAEYYKLEFFKQAMKGAIGLVQGLLLGIFFIFALILL
SVAVAILISEAIGTPSSGYFIVGGFYFLLFLGILFFGRKPIEKILLLKVSRKFFND
>IFAGANLK_00209 hypothetical protein
MANTGSTLLALITGAAIGAGVGLLYAPDSGEKTRKKLKDESKKAQDRLNKKYTETSSNLT
EKAKQARVDFEARLEETLSSASHKADDILTAMETKLEELRKQNAKLQKEGKGGDSKDKPN
KAVV
>IFAGANLK_00210 Glutamine--tRNA ligase
MAEERKSLNFIEQIIEEDLQTTHKKEELKFRFPPEPNGYLHIGHASSICLNFGLGEKYNS
PVNLRFDDTNPIKEEQEFVDAIKEDVLWLGFKWEKECYASDYFQQLYDWAVEMIKNGEAY
VDSQTSEDIALQKGTPTEPGKESPFRNRSVEENLELFAKMKNGETPERGHVLRAKIDMAS
TNMLMRDPVMYRCLHKSHHRTKDIWKIYPMYDWAHGESDFIESISHSFCTLEFLPHRELY
NWFVEKVSKEGELKPKQREFARRNLSHTVVSKRKLMQLVEKGVVKSWDDPRMPTISGLRR
RGYTPNAIRKFADSIGVGKRENMIDVAHLEFCAREDLNKTAPRVMGVLDPIKLVITNYEE
GKEEWLEAENNPEDESAGSREIPFSRELYIEKEDFKESANRKFFRLTLGKEVRLKNAYII
KGEEVVKDSEGNITEIHCTYDPKSKSGSGTEESMRKVKGTLHWVSSKHALETEIRLYDRL
FSVENPDGDKEKDYMEFVNPDSLEVIKGYVEPSLKSAGIQDKFQFQRIGYFCVDKDSKEG
QPIFNRTVTLRDSWAKIK
>IFAGANLK_00211 Dihydroneopterin aldolase
MGSIKLKNIRVFAYHGCLDEEGKIGSDYRVDLKVKGDLSHSAKTDSLGDTIDYVHLNKIV
KEEMAIRSKLLENVAERILKRVLDEIILVQKAKVEVSKINPPIGGNVAMVSVIRSKSR
>IFAGANLK_00213 hypothetical protein
MFQDVLAALPLGLFLAFLLGPVFFVLLETAAIKGFRAAFAFDLGVIVADIVFLFVAYLST
TKLLASIKDDPALFIFGGMILATYGVMSFVQTKKVLRQEDDTPEIRKLSKSDYFGLAVKG
FLLNFINIGVLGFWLGLIIIFGPKLEMEQNRIIVFFGSVLGTYLVLDIFKILLAKKLNRK
LTPNRIYLMKKGISILLIVFGAMLIFQGLFPNQVNGIQNQIETISPNDTLRENPN
>IFAGANLK_00214 hypothetical protein
MKKYLFVLFLLGVGLLSAQELTQDLEDFNEIKVYNGLDVILKEANQNKATITGENRTDVK
FKIDNGILKVRMSIDEILDNDNTQITIQFKKLDKIDARQNASIKIDSKLEQDLLHLNASE
GADIFADVNLSKLYVDSNTGGEIEVQGKTEDQEIDINTGGKFFAKNLKSINTQISIKAGG
VADITASGNVEAKVRAGGTVNVYGNPKTLDQNTLFGGKIIRKN
>IFAGANLK_00215 Ribonuclease R
MSKKNKNKSQHQGDLAKSIIDILRKEPGKTFNHKQIAAKLGVNDATSRNSIIKKLAQLIA
KKQIEEEERGKFKISRKSNDYYNAVIDMTTKGYAYALVDELEDDVFISPKDLNTAFNGDE
VEIYIYNRKRNKKSEGEVTQILKRKRTEFVGVLDMQKDFGFVVIGDPKMYTDVFVQKNKM
GDAKNGDKVVVEIEEWPEKADSPFGKIIQVLGTPGEHHTEIHSILAQYGLPHEFPKEIED
FADEIDTSIQPDEIKKRRDMRDVLTFTIDPADAKDFDDALSFRKLENGNVEIGIHIADVS
HYVQPGTILDDEAYERATSVYLVDRVVPMLPEVLSNNACSLRPNEEKYTFSAVFEIDKTT
KVVNEWFGRTVTYSDARFAYEEAQQIIETEKGEVPEGISIQDKAYTVKDEIVEAVLTMNK
MAKKMRSARMRQGAISFDKVEVKFQLDEENEPVGVYFKTAKDANKLIEEFMLLANRKVAE
FIGKREEKKTFIYRCHDEPDEEKLVSLNSLVSRFGHGLNLKNRKTVSSSLNQLLQDVQGK
KEQNLIDTLAIRTMSKAYYGTENIGHYGLAFDYYSHFTSPIRRYPDVMVHRLLQRYLDGQ
PSAKEEEYEEKCHHSSEMENLSTNAERDSIKYMQVKFMIDHQDKEFVGVISGVTDFGIFV
EIIENKCEGMIRLRDIKGDHYDFDAENYAIVGRKTKKAYQLGDEVIVKVKNADLVKRHLD
FTLIGKNEE
>IFAGANLK_00216 Putative sugar phosphate isomerase YwlF
MKIAIGNDHAGTGYKKSVVDYLKNKGIEVINYGTNSGDSVDYPDFVHPVADDVENKKVDF
GIIICGSGNGANMTANKHQGVRSALCWMGEITKLAREHNDANILSIPARFVSEHQAVDMV
KIFLETPFEGGRHQKRVDKIPVEN
>IFAGANLK_00217 Acetyltransferase
MEILIKTFNELSLEELYQVLQLRSEVFVVEQNCVYQDIDGKDQKALHILGTKAGKVVAYT
RCFDKGFYFDEAAIGRVVVKEFERKNAYGHLILKASILAIEERFETNNIKLSAQQYLTDF
YENHGFMQVGEGYLEDGIPHIAMIK
>IFAGANLK_00218 putative CtpA-like serine protease
MKKKLAKKIALVTLGATLIFSSFGFKSDFFEIAKQIEIFTTLFKEINMNYVEETNPAALM
DTAIKAMLADLDPYTNYWNEQDVEAARINNSGEYSGIGATVQVIEDALLIMEPYKGYPAD
EAGLKAGDEIIEIEGIKVADYTDDVGELLNGSPDSQINIKYRRQGEIKSTELTRSAIKLK
AVPFYELLDQKTGYIVLSRFNTKASSETIRALKDLKNQGAEEIILDLRGNPGGLLTEAIN
VSNIFLPKGELITTTKSVIEKYNRAYQTQKEPVDTQIPLVVLVNGRSASASEIVAGAIQD
LDRGVVVGARSFGKGLVQRPKELAYGTQLKITISRYYTPSGRCIQSLNYAERDEEGNAIK
TNKEDYNEFKTRNGRSVFDGGGISPDVKLETSEYSNITNALLSENAIFDFATEYYYKNEL
SDPEAFEFTDADFNNFKSYLKTSDFDYKTATEKELGELLATASQEGYEQDILDHYKSIST
EIDAQKKKELDEKKHEIVSILTDEIIKRYFYKEGLHEYYVDHNPEILEAKSILNNTQRYS
EILK
>IFAGANLK_00219 Ribonuclease P protein component
MDESFGKDEKLKSKKLIDILFQEGKSVKKYPLKLIYLPITNPEITNFKTGVSVPKKLVKT
AVGRNRIKRLMREAFRKNKYLVTSNFPKPYALMFIYISRDEISLEELKKVMIKVMEKFNE
AENKQR
>IFAGANLK_00220 Aminopeptidase N
MKKLILSIALVASSLAGAQNNTGYWQQHVDYEMEVDMNVENFQYTGTQELVYTNNSPDTL
NRVFYHLYFNAFQPGSEMDVRSLTIQDADRRVADRISKLTEDQQGYLRVSSLDQNGNDLS
YEEVGTVLEVELDEPILPGEKATFNMEFKGQVPEQVRRAGRNSSEGVALSMSQWFPKMAE
YDFEGWHAAPYIGREFHGVWGDYDVKLTIDKDYTVAASGYLQNPDEIGHGYSDEEVEAEG
DTHTWHFVAPKVHDFTWAADPEYIHDKRTAADGTVLHFFYKDNDEIKENWKNLQQKTEDL
LIFFNENIGPYPWDQYTVAQGGDGGMEYAMLTLITGERNFGSLVGVTAHELAHAWFQHLM
ATNESKHEWMDEGFTSYISSRAMNQVMETYAENPHTGSYRSYMGLANSGMEQPQTTQADR
YALNAAYGASAYSKGAVFLAQLGYVIGEDNLDKTLKRYYDEWKFKHPTPNDFIRIAEKVS
GAELDWYLNDWTRTTATIDYGIKEVTEADENSTKVILERNKLMPMPIDLTVRYTNGEEEM
IYIPLQIMRWEKSAEHENWTVADDWAWARPTYELNIDKPLSEIESIEIDESQLMADVNRD
NNLYTPETPEETSEEEGQE
>IFAGANLK_00221 Thermophilic serine proteinase
MGSALILASCGSGSPKIVSTPIANIDSIPLKITDLSDTQLQGWGGADLVNDTIPGMSVDK
AYSEIIKNNKGQKTIVAVIDSGVDIEHEDLDGVIWTNTDEIPGNGKDDDNNGYIDDMHGW
NFLGHAVEENMEYTRIYKRLKPKYEGKSASSISTADRAEFIYYQEAKEEYEKEYEETVQN
KNQYEQIKKQLVAAHQAVSSQLGKEDYTKKELNEMEATGQLAQYKAMLQQIQNNVNENIP
EALDELDEGIEYYAGRLDTHFNLELNGRAPVGDDPYDITDTDYGNGNVMGPSQDKEDLKH
GTHVAGIIAAERNNNTGINGVANNAEIMVLRAVPDGDEYDKDIALAIRYAVDNGAKIINT
SFGKYFSPNPEWVTEAIQYAAENDVLIVNAGGNEGLNLDENTVYPNDQTPEAPEEISDNF
LTVGALNFDYGSQLVADFSNYGKTNVDVFAPGTKIWSTTPNNEYEYLQGTSMAAPAVAGV
AAIIRSFYPKLSAAQVKQIIMDSGLTTNADVILGGDRSNTKDFKEISTSGKMVNLYNALI
LASQTK
>IFAGANLK_00222 putative quorum-quenching lactonase YtnP
MKLYPIESGNFKLDGGAMFGVVPKSLWSRTNPADSNNMIDMAARCLLIEDGDKLSLIDTG
MGDKQSDKFFSYYYPWGEHSLDKSLKKHGFHSDDITDVFLTHLHFDHVGGAIQWNKDKTG
YESAFKNAKFWSNKDHWKWATEPNAREKASFLKENILPMEESGQLHFLDRIENKNFIHSQ
EFDFGVLFVDGHTDKQMIPHIQYKDKTLVFMADLLPTAGHIPLPYVMGFDTRPLLTLTEK
EKFLKEAADKGYYLFLEHDAHNEIITLKNTEKGVRLDKTFTFNELFN
>IFAGANLK_00223 Na(+)/H(+)-K(+) antiporter GerN
MEELNILSLLIILFSAWLGGSAAKKLGYPAILGELIIGILLGPALLGIMETSEMINVLAE
VGIILLMVYIGMEINFRDLGKASWPGLLAAIGGFIVPFVLGYYSIIYFGGTQMAAIFVAI
AVAVTSLATKSRILVDLKLLNTRIAYVLMAGALISDTLALVIFAGIVSYVDAGSIDTLGL
VWVAGKAILFFVFTALAGIYLLPLLGKFLMKSNLTSRTLHFTLILIIVLAFSELAEIAGL
HSILGAFMAGLFIRDGVFNRQISKDINHIFHDISIGFLAPIFFVSAGFNVTLEVFQTDLL
MLIVVTLVAMVGKILGTAIFYLPSGYGWREGIAVGTGMNGRGAVEIIIAGIGLQMGIITN
EIFSILVFMAIFTTLTVPLFLTWTTTWLRNRNELVHQESRGGYIILGANPLGLYMAKQLQ
QKDDDVIIIDANREMVAEAKKQGFNSMYGNILKEETMEDAKAIEKGTFIGLTGNSEINFL
AAQLADDAFYIPNKIVLVSPSESGTDVDMLDKINATSLFANKTELKPWAAKISNGNFEEK
TQTVEEEITTREWVKQHKDDKNSILPFFIINSEGIKRPFHYNDTIDEGEKVVYLE
>IFAGANLK_00224 K(+)/H(+) antiporter NhaP
MLELASLVILGILAQWLAWKIKTPAILPLILIGLLVGPISTLISEDGTKWVEPIWNGSEG
LFPGESLFYFVSLAISVILFEGGLTLKRSEVGNIGPVILKLISIGSMVTFLGAGLAAHFI
FDLSWQISFLFSALIIVTGPTVISPILRNIPLKTHVSSILKWEGILIDPIGALISVLMFE
FIRVEGGQDFTQTALIEFGKILLFGFTFGFTFAYLLAFLIKRQIIPHYLLNVFILATVLG
VFVLADTFAHESGLLAVVIMGMVMGNQKLPNIKELLYFKESLSVLLISILFILLAANIEI
EELLLVFNWNSLILFGVVVLLIRPLGVILSSLGSGLKINEIAFVSWVGPRGIVAAGIASL
FGLRLAREGIAGAEYITPLVFMIVLCSVLLNAATARLFARLVGVFIKDSQGILIIGASSI
ARLIGKYLHDNERHVVLLDNNSDNVNKARDLGIDAIEGSVYSDDLMNNIELNDIGYLMAM
TGNSDINKTAITKFKKQFGENGSFRVITADEMNNPEKNPTEGLFSHTDDYIKLTEVSRSY
PKIHELVLNSKEHYEGLIEISKTDPDIIPLFVKNKNGGLTIIPSHSSDVEIEEGFQLVYL
GKQIQREEKDEEDYEETVDANEDANS
>IFAGANLK_00225 Na(+)/H(+)-K(+) antiporter GerN
MNEFLEILKHEFELPLSNPVLVFALILLIILVSPVLLRRIKIPGIIVLIISGIIIGPYGT
GLLEQNTAIDLFSKIGLLYIMFIAGLELDMNQFKVNRNKSLLFGLFTFAIPLIVGYPVCY
YLLGYDFNASFLTASMFATHTLIAYPIVSKMGVSKNEAIAITVGGTILTDTAVLIILAVI
MGNAQDGGLTMDFWIRLVVSLTIFCGIMFYLVPKIAKWFFTRLEKEKHSHYIFVLTVVFL
AAFLAELAGVEDIIGAFLAGLALNRLIPHSSALMNRIEFMGNSLFIPFFLISVGMLVDIS
VILSGYMAIVVALTLSAVALFGKWAAAFFTQLVFKYCAAQRKVIFGLSSGHAAATLAVII
VGFNAGIIDKNILNGTIILILITSIIATFATEKAAEKLLLENQESDPEVIKNSENYKKES
ILLPLANIVNFEKLLEFAILIKDKVSDNPVSILSVVPNDEEAEVNIAQAQNKLEDFVRQA
SASETDVDVTATIDQDVASGISRKSREIIADLTVLGWPASSTNENDIIGDKMAGIIRGTR
NTIFICETHTPWATHERLIVAAPQKSAEMAGFELWVKKVIKFSEELSIPILLYCDKETQT
AVEKLVEKLKLRAPFEFKEFKNWEDFLIISKNLSAEDIIMFISARTGSIAHRGILEQIPQ
KMGMYFKENTKIIVYPREK
>IFAGANLK_00226 putative transcriptional regulatory protein
MAGHSKWANIKHRKGAQDKRRAKQFTRAIKEISVAVKEGAGPDPEANPALRNAISNAKGV
NMPKDTIERAIKKASGADADNYELVTFEGYGPNGIAFFIECTTDNTNRTVASVRSIFSKN
GGNLGTNGSLEFLFDKKGVFTIEREMIEMNLEEFELELIEGGASKIEKEDDYITIYTNFN
DFGLMSAKLEELEIEVKSSEIQRIPMNTVELPVEDAKNILNLVEKFEDDDDVQNVYHNME
ITDELVEEMEKEA
>IFAGANLK_00227 Elongation factor 4
MKHIRNFCIIAHIDHGKSTLADRLLDFTGSVTDREKQEQLLDSMDLERERGITIKSHAIQ
MDYEYEGEQYVLNLIDTPGHVDFSYEVSRSIAACEGALLVVDAAQSIQAQTISNLYLALE
NDLEIIPVLNKVDLPSANPEVVSDDIVDLLGCEHSDIIPASAKTGLGIEEILAAIITRVP
PPSGKVDAPLRALIFDSVYNPFRGVETYFRVINGSIKKGQNIKFVATNKNYFADEVGTLR
LKQFPRQEIKTGDVGYLITGIKDAREVKVGDTITDAKNPTTEAVAGFEDVKPMVFAGIYP
VDTEDYEELRSSMEKLQLNDASLVFLPESSAALGFGFRCGFLGMLHLEIIQERLEREFDM
TVITTVPNVSYHAYTNKNPDERILVNNPSDLPEPSSLNRVEEPYIKATIITKADYVGNVM
SLCIEKRGEITNQTYLTTERVELSFDMPLAEIVFDFYDRLKTVSRGYASFDYSPIGMRQS
KLVKVDVLLNGNIVDALSALLHVDNAYDIGKKMCEKLKELIPRQQFDIPIQAAIGAKIIA
RETVKALRKDVTAKCYGGDISRKRKLLEKQKKGKKRMRQVGNVEIPQEAFMAVLKLND
>IFAGANLK_00228 L-fucose-proton symporter
MAVETATNQNNTSRSIVIIGVLFFIFGFVTWLNSVLIPFLKTASQLNNFESYLVAFASYI
SYFVMAIPSAWVLKKTGFKNGMSLGLVVMAIGALIFIPAAMSRTYAMFLFGLFVQGTGLA
LLQSAANPYITILGPIESAAKRISIMGICNKVAGALAPIIFGAILLKNMDAVEARLEGMG
ASAKAAELDELASLVITPYIVMAVILVGLSVLIYYSALPEIETDGEDDTLAAANKSKTSV
LQFPNLLLGTLAMFLYVGVEVIAGDTVISYARDGHDIATDVAKYFTTYTLIAMIVGYLIG
TVTIPKYISQQKALQISGILGIILGLAAIFTDGYVSVLCISLLGLANALVFPAIWPLALH
GLGRFTKMGSSFLIMALAGGAILPLIYGYLADTFDPQSAYWIVIPSYLYIWFFAAKGHKI
K
>IFAGANLK_00229 Beta-N-acetylhexosaminidase
MKSLKLSVSLVFLMLFQWGSSAQEPQTEKPAIIPQPAEIEWKEDFFTLQERTVVCFNSGA
EASAAWLQRLLKNTYTQSYTMRGENCNGFNLNLDPNLEETLGQEGYNLDISSSVVSLEAA
SEAGLFYGIQTIRQMFPAEIENKKVSEEIKLPQGTISDRPKYEWRGSMLDIARSFFGPDY
IKKHLDRMAFYKLNRLHLHLTDDQGWRIEIKQKPKLTELGSKGAVKGGRSGYLTQEEYKE
IQEYATARNIVIVPEIDMPGHIYSALMTYPELNCDEFANIEPSLATPPELYHDYTVGWSK
LCLEKPEIYDFVATILGEMAEITTGEYLHIGGDEIEDERYKEFVVKADSIVRGLGKTTIG
WEEVTQAEVDSTFISQRWTGKTESVVNTRVIESICSSFYFDHANIPGQEFTNNWCQERGV
SLKDAYTFKAKNPNTIGVEAPVWTEKVLSNEAADDRFWPRTIALAEVGWSEDENKDYIKF
LKRLGEHGLRLDLMDVHYFRTPDVEWNSDRNKGVFSEYMPESRW
>IFAGANLK_00230 N-acetylmuramic acid 6-phosphate etherase
MENKNPDTERTSNYNDLEKMSTADLLRNINKEDKTVPESVEKQIPAIETLVDKIVTKMEV
GGRLFYIGAGTSGRLGVLDASECPPTFGVSDQMVIGLIAGGDTALRNAVENAEDDTAQAW
KDLQSYNVSEKDVLVGIAASGTTPYVIGGIKEARKNGIITGCVTCSSGSPLAEASEFPVE
VVTGPEFVTGSTRMKAGTAQKLVLNMISTSVMIKLGRVKGNKMVDMQLSNKKLVSRGTRM
IMEELGIGEKEAAGLLQEYGNVRKAVLAYRKA
>IFAGANLK_00231 hypothetical protein
MKKTILSLLVLFMFFFSCKTAKDAPQPQPPVTPEPEEVVEEIPEEIEAPETPKDEVKWDP
KTPKNIEEFRAAWVATVANINWPSKPGLSTSEQQKEALELLDFLEEHNFNAVVFQVRPQA
DALYDSEIEPWSYYLTGEQGEAPEPYYDPLKFWVNAAHERGLELHVWLNPYRAHHTAGKE
ISEKSVIKTNPDLVVELENGMWWMDPAQKGTQDRSSEVVMDIVKRYDIDGVHFDDYFYPY
DSYNNGKDFPDDLSWRAYQTAGGKLSRGDWRRESVNVFIKRIYEEIKAEKPHVKFGLSPF
GIWRPGYPESIQGYDQYDKLYADAKLWLNEGWIDYYTPQLYWKISQLGQSFPELLGWWKS
ENTKNRHLWPGMNVGGEGDEMHITEVINQIMITRGMLPENKGAVHWSIAPLLKYNKLAEA
IKEGPYKKKMLVPPSPWLDNTPPAIPSVTANENRDKIEITWGVENDSDIKQWVVYFKYET
GNWDYKILNADKRSQDLQKEVGEKKRKLQKIGVTAVDRTGNQSEFIEIEIN
>IFAGANLK_00232 Sodium/glucose cotransporter
MSPILVFGVIAGYFALLLVISHYTSKQADNNTFFTANRQSPWFLVAYGMVGATLSGVTFI
SVPGEVGNSNWTYLQFVMGNMVGYTVIALVLIPLFYKLKLISIYEYLKDRFGQNSYYTGA
TFFLISQTIGASFRLFLAALVLQIAFFDAFGIPFWVTVLITIALIWIYTFRGGIKTIVWT
DTLQTTFLLLAVVISIFMIVDQMELKFTDVFSIVANSEMSTIFDWNWRSNTAFFKSFLAG
IFITIAMNGLDQNVMQKNLTCKNKGEAQKNIFWFSIVFFFSTVLFLALGVLLYKFAMDQG
IAIPQRTDDLYPLLALNHFGILAGVVFLLGIIAAAFSSADSALTALTTSFCVDILDIQKK
EKNQKKTRLLVHIGFTILMFLVIIAFNAVNDSSVVSAVFKVAGFTYGPLLGLFAYGLLSK
NPVRDKWVPLVCILSPVISVILDFNSETWFRGYQFGFEILLVNAAITMVGLLAIYRSKAE
KRLSE
>IFAGANLK_00233 L-Ala-D/L-Glu epimerase
MQLKFYPYNLELKNTFTISHGSRDFQPTLIVAVTDGGFTGYGEATATSYYGVSIERMQED
IQSLEPLLAENIDKTPEEIWELTWPRLKHNPFAQCALDIALHDLHGKRNEMPLYQLWGLN
LENIPLTNYTIGIDSVEKMVQKIEEFPWPLYKIKLGTEDDVAIVKELRKHTYAIFRVDAN
AAWTADQAIENAKALKELNVEFLEQPLKADDWDGMKKLYKESVLPLIADESCIEESDVEK
CSGYFHGINIKLTKCGGLTPGKRMILKGKSLGLKVMVGCMTESTVGISAIAQLLPLLDYV
DMDGGLLIKNDIADGVKVYDEKVHFPKRNGTGVELYEK
>IFAGANLK_00234 Gamma-D-glutamyl-L-lysine endopeptidase
MNILKKPYLILFLTLFLFASCEEKVEKEEENPLENQIAQVEEEYAPDGRVALFDVRAEKD
GESYILKGESNDPEAVAFLKEKLQSENIKFTDSIRMLPDTEGLENKTHGVVKISVANLRD
APKHSAQLVTQATLGMPVKVYKKEGSWYYIQTPEGYLAWVDYGGIKNMTEEEFSDWKSKE
KLIFTEPTGNSYFEPNPNSQTVSDLVAGNILELLNKQNNFYEVEYPNGKKAFIEEAYAQP
YEDWLTSLDQTEEDLVATSKKLMGLPYLWGGTSPKGVDCSGYTKTIFFLNGMVIPRDASQ
QIHTGDVVDTDKNFENLEKGDLLFFGKPATDSTSERVIHVGMWIGDNKFIHSMGEVHISN
FDTEAEDFDEYNYNRYLRTKRILNKEDKGLIYLKDSDLFTNSEGEKVKM
>IFAGANLK_00235 N-acetylmuramoyl-L-alanine amidase AmiD
MKKLIPVFYLIMAVAIISCGNNPYAKTNRLHKKQAKAYSKQLQQFPTPENQKESALNYGD
YWVGTTNFNLRKPNYVVIHHTAQDSIGQTLATFTLPRTQVSSHYVIAKNGEIFHMLNDYY
RAWHGGIGKWGNNTDLNSSSLGIEIDNNGEEVFTDLQINSLIELLKQIKEKYSIPAENFI
GHSDIAPSRKVDPNANFPWKRLAEEGFGLWYDEADVENLKLEAEFFKPNPLAIRLNSRLT
TRIPFLDKLVFPEVIPADFNTENALKIIGFDTTDLEAAKSAFKLHFIQENLDQPFNHYDL
KVLYQLHKKYL
>IFAGANLK_00236 Glucosamine-6-phosphate deaminase 1
MARLNLLEETRFEKLPVKVYEDEHIASKKVAKRIADLIRRKQDKHENAVLGLATGATPVE
VYDELIRMHKEEGLSFKNVITFNLDEYYPMQPDAKQSYVKFMDENLFNHIDIKRENIHIP
DGTLAKEDITDYCLSYENQIGAVGGLDLQLLGIGRTGHIGFNEPGSAPNSGTRLVTLDDL
TRRDASRDFGGKENVPTKAITMGIGTIFKAKEIILMAWSKKKAPIIKKAVEGEMSGNVPA
TYLQLSDNVEFILDEDAASELTRFNTPWLVKDCSWDKALIKKAVIWLSSEVKKPILKLTD
EDYNNNGMAQLATEQGPAYDINIDVFNQLQHSITGWPGGKPNADDSQRPERKSPAKKRSL
IFSPHPDDDVISMGGTFIRLVDQGHDVHVAYQTSGNTAVWDTDVLRYVEFAIDFKKSTGE
DTEKLEATYEKMRAFIDKKEPNEIDLDEIRDVKAFIRKSEAIAGARYAGLKDKNIHFMAL
PFYETGKKVKNPVTDKDVELTMDLLKEIKPHQIFAAGDFADPHGTHIVCFRIILEAMKRL
RKTEAWTKDCWLWMYRGAWQEFEVHEIEMAVPLSPKEVQRKRNAIFQHQSQKDRPVFPGD
DEREFWVRAEERNRETAESYDKLGLANYEAMEAFVKWKFE
>IFAGANLK_00237 N-acetylglucosamine repressor
MTTQTMPTDLHDFFIDEKKLSTINNVERKKFLQKLKIIKHLFLNGETSNAEVCQRFNVSL
PTSMSLLNQLIEEGIVIKKGRGKSEGGRKPDLYGLVENSFFVVSIHIERFRIKLAVIDNN
HTILHEKSWPAEISSDSNIVDLLFGWTQELLKEAKVKLDQVMGVGISMPGLVSAEAGKNF
TYYLSEQEPESLKNKFEKKFKKPVAILNDAKSACLAEFRFGTAKNKSNVLVISMDWGIGL
GIIMGGRMHSGESGFAGEFGHIPMTEDGLLCHCGKRGCLETEASGLALVRKTKEGLKAGQ
TSVLNNLKKEELEKLEPETIIDAANRGDQFAINVLSEIGINLGKGIAILIQIFNPELVIL
EGKIAEAKQFITTPIQQSMNTYCMMQLKERTKIELSTLGANSSLYGGTIAVMDDIFKDQV
SLVKSQIS
>IFAGANLK_00238 hypothetical protein
MTEANKLFKQAKIGKNQRYLALDVLRGLTVALMILVNTPGSWSHIYAPFKHAAWNGFTPT
DWVFPSFLFVIGNAMSFSLRKYESISESAFLRKVFKRTGLIFLIGLFLSAFPFVFRQEGE
LVFKNLANMRIMGVLQRIALCYLFASLILHYLKLKKSIIVGILILLAYWVIMWFFGDQPN
PLSLENNAALKFDRLIFNDANLYKGYGLPFDPEGLLSTLPAVVNVIAGYVAGVFIQKSGN
NIRTVIKLSIVGVVLLVVAQIWGIWFPINKPIWSSSYVIYSTGWTLFVLSVLILIIEIFG
FKKWTSFFEAFGKNPLFVFVMSGLVVMLMNIIYVNGQALKPWLYQNLYLSWLNNYNASLL
FAISYMLLMWLLGYWLHKKRIYIKV
>IFAGANLK_00239 Beta-hexosaminidase
MKNKTSLLFIIAMAFFGLSLQAQEKAKKSPEFLQYTNSKWVDSIMQELTPKERIAQLIMV
AAYSNRDNAHKEEILKLINDQKIGGLIFFQGDPESQLKMMNDYQLASEVPLLGAIDAEWG
LGMRLDNTISYPYQMALGAIREDSLVYGLGKEVARQIKRTGLHLNFAPVVDVNNNPNNPV
INYRSFGENKENVSAKGIAYMRGMQDANLLTTAKHFPGHGDTDTDSHYALPQINHPFERL
DSLEMYPFKELIDAGIGGVMVAHLNIPALDSTGVPSTLSKSIITGILKDSLGFEGLIVTD
AMNMKGVTKGNEPGIVDKDAILAGNDLLEFTEDVPKAIDEISKAIKQGLISQKQLDERVR
KILAVKQWVGLNKYKEQSPKNILKEINTGEAKFLNRKLVEASLTVIKNEKSILPLRKLDT
LKIAAISFGAAKQTEFQKTLNLYTEVKNFQLKADANASEIEKIKEKLSEYNLVIGGIHDD
SRFPRNTMKFSKPVQDFIAELSEERNTVFSYFKNPYSINKLDKIENAAGLILTYQDTKTT
QDLAAQLIFGGVGANGRLPVSVGEKFKSGDGLDVKGKIRLKYTMPEDVGMNSEKLYDGVD
SLMQEAIKKKATPGGQILVAKDGKIVLHKAYGYHEYSDTVKVKKTDLYDLASVTKISSAL
PALMKLQDEGKFDLEAGIDDYLPYFKNSNKAGVPFRQILTHQARFKPWIPYWKNTLRKNG
SFKWYTFKKDSSARFPVKVSENLWLHRNYQKKMFRAIKKSELEEEAKYKYSGLTFYLLPS
IVEEISGEDFRKYINENFYDKLGATTLGYNPLERFEKSRIVPTEHDYLFRKKPIHGMVHD
EGAIMMGGVSANAGLFSTANDLAKLMQMYLNMGEYAGERYIEEETLNEWSTTQFPENDNH
RGIGFDKPYLEYKGESSNTAKDASKASFGHTGFTGIYAWVDPEEDLLYLFLSNRVLPSRS
NTRLYQLNTRTNIQQVVYDAIE
>IFAGANLK_00240 hypothetical protein
MTRTFLPILVALLFLFTNSLIAQHTLQGKLVTETNEPIAFANVVLLNAEDSTSVYKGTIS
EDNGAFVLEEITTNDYLLKVSFVGYEKFLKQISIKSDKKLGEITIKEGASNLDEVTINTR
KPKITRSIDRITFDVENSMLSSGNSWDVLRQTPGVIMSQGQLQVRNSSVTVYINDRKVQL
TADELQTLLQSYSAENIKSVEVITNPPARYEAEGGAILNINTTSAISPGYKGSLEGAYTQ
GIVPKYQFGTSHYWKGDKLNVFANYTFSPRKEIKRDDSYINFSPNQEGGQRWESDFERIT
LSQAHNANVILDYDFDEKNKLSFSSNFMYSPDKTFDNSVQTDVSAMGNTAFSNFITDSDV
NTDDSNIALDLTYTHTFGNGGNVSAGAHYTKFDQERDQRVATEYFSENGELVDNIAFNTE
AIQNIDIFTAQIDLSTSLGETAFESGIKFSHIDSESGIDFFDAESLEDLYENLSDQFHYN
ETVSAVYASASRDWEKWSVQGGLRGEYTDLLGMSFSTDQRNRQEYFELFPTAYLQYRASD
NHSFTLDYSRRIERPRYESLNPFRYFLNENDFNAGNPNLRAAISNNINLNYTLLGQYFLD
FYYRDNGRSPASLAFQDNQNLTIRRLQANLLESKSYGLDILHGRSITSWWYAQLYASLFH
EENNFLAVESGNVEVTNEIDAVFGQLYNSFTLSKDGTFSGALTFTYVSDYISGSYNFDPF
STLSLGFRKTLWNNRAELSLNINDIFNNTNTRLTSQYLNQDNSFFAREETRYVRVGFKYN
FGNFRLEDNQRSIDAAERDRL
>IFAGANLK_00241 putative tRNA-dihydrouridine synthase
MAKIGNIDVGDFPLLLAPMEDVSDPPFRALCKEQGADVVYTEFISSEGLIRDAAKSTMKL
DIYEKERPVGIQIFGAELDSMLKSVEIVEKSNPDIIDINFGCPVKKVVSKGAGAGILKNI
DLMVSLTEAMVKHTNLPITVKTRLGWDNDSIKILEVAERLQDVGCKAISIHGRTRVQMYK
GEANWAPIAEVKNNPRMHIPVFGNGDVDTPERAMEMRDKFGLDGAMIGRASIGYPWFFRE
VKHYFETGIHLAPPNMLERLDAARRHLQMAIDWKGEKLGVFETRRHYTNYFKGIPHFKEY
RMKMVTSDDAADVFAAFDEVERDFADFQFA
>IFAGANLK_00242 Lipoprotein-releasing system transmembrane protein LolE
MKFPFYIARRYLFSKSSNNAINIITIIAAIGVFAGAFSLFIVLSGFAGLKDFSLSFSNKF
DPDLKILPSSGKTFQFPEDKAVKLAEISGIAGFSKIIEERIFLDYRNKNHTAFIKGVDDN
YRQVTQIDSAVSGSWLTNSEAQVVVGNRISRKLGLSIFNYQDLLNVMVPRPGKGQITGLD
PGQAFNQEKVIVSGIYSVNEELDDKYVFSNLNFARNLLELDENTFSAVEIKTTPNADADA
VTAEINELFDNEIIIKNRAQLNETLYKMLNTENLAVYLIFTLVLIIALFNVAGSIIMVIL
DKRENIKTLFSLGASERQIKKIFFTQGILMTIIGGAVGLSAAVLIVYLQLQFNLVMITPS
LPYPVAITLENIFIVIFTIGILGLIASFIASGSSRKALKAV
>IFAGANLK_00243 Ribosome-binding factor A
MEETNRQKKIGGVLQRDLADILQKNLKDAGRTGVIISVSKVKVTTDLSIAKAYISIFPQK
HAQEVIEEINLGKSKIKHEMAQRTKNQLRKMPEINYYLDDSLEYIENIEKSIKGEENPIS
DPNLLERRKKS
>IFAGANLK_00244 hypothetical protein
MKKIEHIGIAVRDLEAANATYKAVLGSEHYKTETVESEGVNTSFFRIGDSKIELLSATNS
ESPIAKFIEKRGEGIHHLAFAVDNIKAEIARLEKEGFKLINTEPKTGADNKLVAFMHPKS
ANGVLIELCQEASTANQKESLLND
>IFAGANLK_00246 hypothetical protein
MGKPKKEIKHSCIEDGQYLYGENFALSCYSLLNKPIIKMFIFILKSKR
>IFAGANLK_00247 hypothetical protein
MESQQDQILIYKTETGQTQIDVRLGEETVWLTQAQIISLFESSKANISEHIKHIFTSGEL
DDNSTVRKFRTVQREGKREVSRDRMHYNLDVVISVGYRVNSKRGILFRQWANKVLKEFLL
QGYSINEKILREKTRQLEELKNVVRLQEKVISEHDLNTDESAGLIKIIAQYSRALDLLDD
YDHQRLEVPEEGSREVFQITYIEARKAIDELGRQTKFEGLFGREKDDSFKGSLENIYQTF
GGEDLYPTTEEKAAHLLYFVVKNHSFSDGNKRIAAFLFVWFLDRNQILYTQTGNKVIPDN
ALVALTLLIAESHPGDKEMMIKVIVNLISRH
>IFAGANLK_00248 N-acetylmuramic acid 6-phosphate etherase
MDNNNPDTEKTSKYNDLEKMSTSTLLHNIHKEDKTVPESVEKELPVIEKLVDAIVPKMEA
DGRLFYIGAGTSGRLGVLDASECPPTFGVSDELVIGLIAGGDIALRNAIENAEDDTNQAW
KDLQKFEVSEKDVMVGIAASGTTPYVIGGIKDARAKGIITGCVTCSSGSPLAKASEFLIE
VLTGPEFVTGSTRMKAGTAQKLVLNMISTSVMIKLGRVKGNKMVDMQLSNKKLVGRGIRM
IMEELNVDEAEASRLLQTYKSVRNVLSKISLNKTFLT
>IFAGANLK_00249 hypothetical protein
MKKYYKYFLLLSTVIIAGSCSDDYFDVNDSVTQPTTTELPPQYRIEGAIENAVATAQYRG
VREVLGVVQYGSQNTPAYYSESWNTFLTTGSYFLWQNVYVYALPNTADLIYLGEKFNSPH
YTAIGKILRAYLLGMTTDQYGSIVLDDSYNPEESIKLEPEFVSQEVVYEKIFKILDEAVV
ELDQESELGLNDEGGDILYNGDVEQWKKFAYSIKARYLNHLTKKTSGEHAYSPQMVLEAV
QKGFSSNADNAYITYGGGEASNDNQPFSTSGYGSTRFDYFSEFFVDLLQDPLNEYADVQD
PRLPVIVTEAVNGGYQGVKTGAGVPGGEGDNYSIGYGGFYTSPDSPTFMMTYSEVKFIEA
EAKFRSNDESGAYQAYLEGVEADLNKLDISQEKTSAYLETIDEEISMDEFGLSQIFVQKY
IANMLNPETWVDFRRMDYSSDIYPGLKRPENVNVTLFPGENDWIRAMMYEYNEEDRNYEN
MPDNDPYVRLTTPLWWDTEE
>IFAGANLK_00250 TonB-dependent receptor SusC
MGKKFRTSILILFCLFSIQVWAQEREVSGTVVDEKGLPLPGVNVIEKNTSNGTVTDFDGN
FSLTIPDKDETILVFSSLGFVEEEIIIGDRTNIEVSMGTDTESLNEVVVTAFGIERQEKA
LGYAVQEVQSDEILEGNQTNVVSGLQGKVSGVTISNSGGAPGSSTAILIRGGTSITGNNQ
PLFVVDGIPIDNSTSSSLTVASINRAADLNPEDIESISVLKGPAAAALYGIQAAEGAIII
TTKKGKAGVSTISYSGTFSVDEVLGTPNVQQEFGQGTQILSTDGFSYENESNFSWGPSVG
SEETYNHIDNFYETAITQNHNVSYSGGTEKSTLYLSIGDLSQNGVIEGTNYDKTSFKINT
SSQLGDNLTVGASANYIVTEVGSTKQGNASGSSYSSLLSYPINVDIQDFYAEDGSQRMFY
SDQTFDNPYWSLENSPNDNKVNRLIGIVSINYNFLNDFNLSYKLGTDYFSETSKRVIGTG
SLIENRSEGYISQFQRENRKTTSNLILSYNKEISEDFEIDALVGNMVEDYRVHSVYTYGD
GFQAPGIYSIGNVSQENQSITELITRRRAVGVFGELKFGWRDAVFLNLTGRNDWSSTLPE
DKRSFFYPSIGSSVVITDLFEQAGNDITSDNGLSFMKFRATWAQAGKDAPIGALNSFLGT
NINPLASSAYTYNGVDIGNPALEPEFTDSYEGGIDARFFKNRLGLDLSVYYSKSKNQILE
DIRVPPSAGTFYATLNGGSIINKGIEALITAKLFDRNNVFQWNMTYNFGLNKSDVVELPG
QLDEVYLSDSWTFSNTAAGAAILDGSLFGLRGYKAVRNEQNELIIGADGLPELETVIFED
VNRLPDWTLGITNNLSYKNFNFSFLLDLVQGQEAYNATNSAFIYYGLGEETLNRSQDGVR
VVEGVLANGEPNTTQVTDQQYYQQYYSQNAENFIEDASFARLRYATLSYNLPTTLLDRLN
IVSGQISVTGRNLFTITDYSGVDPEVNTYGAGIQGAGSMGIDNLGTPNTTGFDLGLRFKF
>IFAGANLK_00251 Glucitol operon repressor
MKKTERHQIILDEVHLHNRVLLSDLTRTLNVSMDTVRRDLMELDKSKHLKKVHGGAVSNG
FNLHSDNTREVYEYENKSIIAKKGVELLNHGDVLLISGGSTNLELAKLLPKKMNLTFFTP
SLPMAVELLNNASKNDEVHLIGGKLSRGSQLAAGGSAINLLSEITADICFLGTGYMDIAK
GVTELDWEVAQMKKAMVKSSKKLVSLTISKKLNTYNRFKVCDTMAVDTLITELDPNAPEL
QKYRSIGLALL
>IFAGANLK_00252 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MKILFTKCVLCFSLNLLAQTTAMGYVFEDTNENGKKDRREQGIAEVAVTNGIKVVLTNQE
GKYELPVGEDNIISVIKPSGYKVGINEGNLPQFFYIHKPNGSPDLKFKGVEPTGILPNSV
DFALISSEEKEDFTALIFGDPQPYTQQQVNYFAEGIVAELEGIEKVPFGLSLGDLVGDDL
DLFNPYIKAVKNVSIPWYNLLGNHDINFDLENDTLSDETYEAHFGPANYAFNYGKVHFLV
LDDVLYPDPRDGKGYWGGFREDQFQFIENDLKHVTKDHLIVVALHIPLSEPDGRDTFRDE
DRERLFKLLKYFPNTLSLSAHTHIQRQDFFQKEEGWQQDKPHHHYNVGTTFGDWYSGKLD
EKNVPISTMRDGTPKGYAFINFDGNEYSIDYKVAGKPADYQMEVFASKVVAKGRGTKAGI
YVNFFMGTEGDEVLYRIDDGEWKEMQYMEDYDPSYIEMVYEWDSTEELMPGRRSSNPIIS
EHLWRGNIPTKLEAGEHSIEIKAADIFEKTHTAKSSYRLAEPVE
>IFAGANLK_00253 hypothetical protein
MIVAGDFNAPPNSKVINILEKNFTRTCTSCEPTIPVQNPVKAIDFIALKSKEIFSIKCHK
VINEIYASDHLPILAVLKVKQLQTLSK
>IFAGANLK_00254 hypothetical protein
MKSLTLIQVVLYMIPTFLSTPENKDIFYSHSEKGILDLNENQVNLKVMAYNIHHANPPSK
PDTIDIDAIIKTIQGQDPDIVALQEIDANTTRSGEGNQAEILEERLGMNVFFSKAINYDG
>IFAGANLK_00255 hypothetical protein
MVMKKLIIIAFLLFGIVINAQNDESDLTVASYNIRWNSPDDGINIWENRKEWLTQSIKFF
EVDIFGAQEVTFTQLKDMAGFLPAYQYIGEGREGGAKGEYSPIFYAKDRLEVLDSSTFWL
SETPQTTASKGWDAALPRIVTWAKFRDKKDGDIFYFFNTHFDHRGVIARKKSAELIAYKI
NEIAGDGPVILSGDFNTAPDSKPHKILLKNKLEDTFLSLSQEQRYTPGYTFNSWDVEASG
DRYRIDYIFYRGEELSPLKYHVLDGQRGKRFISDHFPVIVKFEWTNTAEK
>IFAGANLK_00256 hypothetical protein
MNYKRLLFIAAICFSLFACSKEFLDKEPLSEVTPENFFSTASDLQLYTNGFYRMFPHTSI
YNGDSRTDNIIQNQLSDEMRGTRLIPTSGGGWSWEYLRDINFFLENYERSNDEAAKNHYG
GVARFFRAYFYFEKLQRFGKVPWYDSTIDPTDKESLTKPRDNRQFVVDKILEDLDWAIEN
MKADQQVYEITKYTALALKSRVGLYEGTYEKYRDIDGYQKYLEASIKASEELINNSPYAV
YNTGNAQADYSSLFNSHAAIDTEIILAKAYSEALNIGHNVNYYTTTSSYGRPGMPKDLVN
SYLNTDGSRFTDQENYNQIFFTDEVDNRDLRLSQTIRTPGYSRKGQSMELAPNLGATVTG
YQITKYVTEPVYDTNGQSITDLPLFRFGEVVLNYAEAKAELNTLSQEDLDHSLNLLRSRV
DMPSLSLEMANNNPDPFIGYQYPNVDGSNKGAILEIRRERRIELYMENFRWDDIVRWKAG
EALTQPIRGMYLPGPGEYDLTEDGEINVVLYEGERPDNLITGIQYYEVGSDLSLDENNLI
EPHPDFDNRTFNENKDYLYPIPRIELQLNPNIEQNPGW
>IFAGANLK_00257 TonB-dependent receptor SusC
MDTKIHFFLKKAYIICFLLIFTEAFPSNFNPKAIPGFGDFQQTVQGKVLDEQGLPLPGAT
VREKGSSNGTNTDFDGNFSIETTSNSSVLEISFMGYITQELIPQGTEEITVKLMPDKNAL
EEVVVVGYGETSRENLSTAVSTVNTTNIAERPVADISSSLQGLSPGLNVTQSTGKVGADP
RINIRGFTSINGGTPLILIDGVEGDLSNLNPNDVESISVLKDAGSAAIYGARAAFGVVLV
TTKNAKKGNIVVNMGATMAVSYPTMNTDFVTDPYQAVSIVDEAFRNNSGASYTGYTEDDM
EALLEVSQDPSLARVIVDQRNGREQYVHYGSTDWWNTFFRKTYPSQIYTGSISGGSEKIN
AYFSYRNFQSTGILKVQDDKYQKYNLRGKLDIEATDWLTFSTNMQYNSSSDLEHGGTQYG
YRDVWGSMIWVHALPSYMPTNPDGSALWRTELNNYTIGDGIYASLLQGSSQQETNDNGFS
NIATAEIKPFDFLTFNASYAIRRNNYSQYERSTRIPYSIYPGQIDLMGYDYLNEYRTESK
YDALNVYGEYRTFLGNHSLKAVLGYNHETFLRKSISAGKQNLISNDLNSLGLATISPSAD
GSASEWALQGLFYRLSYDYNDKYLLELNGRYDATSRFPSDYRWGFFPSASAGWLLNKEKF
FSEFTNDSFDIFKLRGSYGSLGNQNINDYAYFATLPNGLYDYPMNGSRLNYIESPALNPT
EITWEEVSTFNLGTDIALFNNRLSMVFDWFQRDTEGMLAPGATLPSVLGAESPLENAADL
RTRGFEISLTYGDSFNVAKNPLSFSITGNLSNSVTKITRFENPNLSLFDFYEGMTIGELW
GYRLDGLFISEEEIANHADQSFVSNRITSGGGLKPGDLKYFDLNGDGVINEGENTVNNPG
DKEIIGNSAPQYLYSFNLNTHWKGFDLSAFFQGVGKQDWYPNSDSRLFWGPFNRPYNSFI
RKDLANNIWSPENPDAYFPRNYGYIALGGSLEKVNDRYLQSVAYLRLKNLTLGYTLPKGV
ISNSDSTKLRIYFSGENILTFSPLTDYIDPEAASNSVNLNQPTTSSNRSTAQTVPFSKTY
SLGVSFQF
>IFAGANLK_00258 Sulfur carrier protein ThiS
MITVNVNNTAHTFNSLSNLQDLLTQLDISETGIAVAVNNQIISKSDWNRRELGDGENILI
IRATQGG
>IFAGANLK_00259 Phosphomethylpyrimidine synthase
MKKDQSPKLQTISRAPFPNSEKIYVNGKIHPNIKVPMRKISLSDTVDKFNGKVEKNEGVL
VYDTSGAYTDPSIEIDVRKGLHPVRNSWIAGREDVEQLRGLSSGYGRERENNEKLDEFRF
KRNRKPLKAKPGQNVTQMHYARKGIITPEMEYIAIRENQKLEEINLISEQHPGNSFGASI
PKVITPEFVRDEVARGRAIIPSNINHPENEPMIIGRNFLVKINANIGNSAVSSSIEEEVE
KAVWACRWGADTIMDLSTGKNIHETREWILRNSPVPIGTVPIYQALEKVNGKAEDLTWDI
FRDTLIEQAEQGVDYLTIHAGVRLAYVPHTAKRVTGLVSRGGSIMAKWCLAHHKESFLYT
HFEEICKIMKAYDVSFSLGDGLRPGSIADANDYAQFAELETLGELTKIAWKHDVQCIIEG
PGHIPMHMIKENMDKQLEVCGEAPFYTLGPLTTDIAPGYDHITSGIGAAMIGWFGCAMLC
YVTPKEHLGLPNRDDVKEGVITYKIAAHAADLAKGHPGAQHRDDALSKARFEFRWEDQFN
LALDPDTARSYHDETLPSENAKVAHFCSMCGPNFCSMKITQDVRKFAEENGMDTQEAIEE
GMKKKSEEFKAKGSEVYL
>IFAGANLK_00260 Thiazole tautomerase
MLILITSEKSNSVEKEQLLHFFENGLPLLHVRKPGMVEEEMKCWLSKFEEKYLQKMVLHH
HHHLAEIFPVKGIHLKESFRSNQKDLAGYVEGYKSKGFTVSSSFHDLEQLKNNASSFDYV
FLSPVFTSVSKKGYEGQTFNVENISCKALALGGIEADKIRRTKELRYAGVAVLGAVWLAK
NKEEAFIGIYNEYRNVYH
>IFAGANLK_00261 Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase
MSTTKRPFVLSIAGFDPSGGAGLLADTKTFEMLGCYGLAVNTANTIQNDKKFDTCHWTSD
AIILQQLELLLERFPVGVVKIGIVENLQVLNKVIDKLLLKNKSMRIIWDPVIKSSSGFSF
QELIEFQNNMESVLVRVFLFTPNFNELQLFYPELNMEETIRKISSQTNLYFKGGHRQEAV
GLDELFTKDGEYLSFKPGRTDCSEKHGSGCVLSSALAAQLALGDSLPTAAQKTKDYIEKI
LASNKTLLAYHNL
>IFAGANLK_00262 Thiamine-phosphate synthase
MISNLHYISQGETPEEHLKNIRRICIAGADWVQLRLKNEAYEVVLETAKAAKVICDEFKV
KLIINDFTEITQKINANGVHLGKEDSCPLQARKLLGPDKIIGGTANTLEDCEKLCEKEVD
YIGLGPFHFTTTKKKLSPILGAAGYRKLLSNLNARGRSMPVIAIGGIVPEDLPVLAECGV
HGVAISGWLTTHPKPELILRKIQQQFSEKQL
>IFAGANLK_00263 Thiazole synthase
MSNTDQLKIADKTFSSRLFTGTGKFSSSEVMQQAVLGSESELVTVALKRVEPGNDDDQMI
AALKNTRLSLLPNTSGVRDAKEAVFAALMAREALETNWVKVEIHPDPKYLLPDPIETLKA
CEELVKLGFVVMPYIHADPVLCKRLEEVGAQCVMPLGAPIGSNKGLKTQDFLEIIIEQSN
VPVIVDAGIGSPSHAAQAMEIGADAVLVNTAIAVSPNPVEIAKAFKLAVEAGRLAYTAKL
AQQRQQAQASSPLTQFLYE
>IFAGANLK_00264 2-iminoacetate synthase
MSSFKDTLSKYSWNEVLQSIFSKTEADVRSALQSRKRNLEDFKAHISPSAKPFLEQMAQQ
SKTISKKRFGNTIQMYAPMYLSNECQNICTYCGFSMTNKIPRKTLSDAEIIKEAEFLKSK
GYDHILLVTGEANKTVGVDYMCNAVKLLRPYFSNISIEIQPLDQDEYEKLIENGLYATLV
YQETYHRETYKIHHPKGKKSNFDYRLETADRLGRAGIHKIGIGALFGLEDWRADSFFTAL
HLKYLQKTYWKTRYSISFPRLRPFSGGLEPKIEMTDPDLLQVICAYRLLDEEVELSISTR
ESEIFRNNVVHLGITSMSAESKTNPGGYVVEPQSLEQFEISDERSTEIIAKMLSKSGIEP
VWKDWEKSW
>IFAGANLK_00265 putative adenylyltransferase/sulfurtransferase MoeZ
MLTKKEKQRYLRHILLKEIGEVGQLKLKKARVLVIGAGGLGCPVLQYLTAAGVGKIGVID
DDVVDSSNLHRQILFSEKNIGEPKVITAKNRLQEMNSSIEIEAYNERLTAKNAVDLFFLY
DIIVEGSDNFTTKYLANDAAVLAGKPLVFGSIFKFEGQVSVFNYRNGPTYRCLFPEPGSV
EEMPSCSEVGVLGILPGIVGNLQANEVLKMVLGIGNVLSGKLLIFDSLEMQIRILPFSKN
SGLRITRLKEITFSCETIPGDSISYQEYLESSSSFTLLDVRNPEERNSFNLGGLHIPLSE
LRNRSEELASEDNLVVYCASGLRSSRAISELKNKFSDKKIYNLEGGLKNVKN
>IFAGANLK_00266 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MQTHILGYPRIGSNRELKKACEQYWSGKNELQDLLQAGRESRRENWKLQQEAGIDLIPCN
DFSYYDQVLDMTLSVGAIPERYKVIAEKSSIAQLDLYFAMARGFQKDGFDITAMEMTKWF
DTNYHYIVPEFTKNQQFQLSDDKILDEFIEAKKAGIKPKPVIIGLVSYLLLGKEKEEGFD
KLDLVDRLIPVYIDLLAALQKEGAEYIQFDEPFLALDLDEKSRAAFTFVYEEIRKQFPDL
KFILATYFEGLKDNRSFCLNLPVDVLHIDLVRGPSELDAIIRELPKDLSLSLGIVDGRNI
WKNDFAKSLELIQKTKEKLDSNRIFLAPSCSLLHVPYDLELETGLIPEIKNWMAFAKQKL
QELKVLQDLADGNAEKRIGEFKDNQNAHKSRRTSSLIHNLSVKSRLEEISEDDTLRKNPF
SLRKTQQQEALGLPQFPTTTIGSFPQTKEVRSWRAKFKKGELNAQQYDTLIKGETEKAIR
RQEEIGLDVLVHGEYERNDMVEYFGEQLEGVLFSKRGWVQSYGSRCVKPPIIYGDVSRPE
SMTVYWSQYAQSLTKKWVKGMLTGPVTILQWSFVRDDQPRSQTCKQIALAIRDEVRDLEK
AGIRIIQIDEPAIREGLPLRKAEWQDYLKWAIDCFKIASSAVGDSTQIHTHMCYSEFNDI
IENIAYMDADVITIECSRSQMELLNAFSTYNYPNEIGPGVYDIHSPRVPSTEEILSLLDK
AQKVIPAEQLWVNPDCGLKTRKWEETEKALKAMVNAAKMARVTVVTN
>IFAGANLK_00267 hypothetical protein
MKHEEKYCPRCKTAFECKVGSIQLCQCADIKLDNEELEYIRDLYENCLCASCMKELKTEF
HNRNYQDKLKNILGVFYRSPKNQK
>IFAGANLK_00268 hypothetical protein
MRLFILLLFLSPIYEVNSQERLSQEIAFVADIHFQDIYGVYENFEGLRVPGRDRKAKIRT
MHAQLHSTRLFNENYFVLKAVLDNIASRGIKLVAFPGDYTDDGQPVNLNGLDKILKEYNE
THEINFFITTGNHDPVRPTSVPGGKHDFLGSDGRNQPIYSEPGLYNAKPGENEVIIEPKL
SMAGYKEILKTLGEHGFFPQRNYIYWETPFSDYTAKTYSFENAQKASLITNRMYQQTDSL
QIPDASYLVEPVKDLWLLAIDGNTYVPTKNVNLSGAREGYNNAINHKKHLFKWIKDVADR
AKKSGKILVAFSHYPAVDFNDDASVDLREFLGENKWQLNRVPEEGIAKTLAEAGIKIHFS
GHMHINDTGKRDFKEGEFLINIQTPSLAAYIPGYKILRLNKTFAEIETVNIKEVSGFKEL
FPLYRLEHKYLKESGKEVWNDDILDSRNYHDFTVHHLKNLVKLRFLPNDWPAEFREFLSG
LSGKEILLLSTYTGKKTSSEFLNNKKAIAKQAKKLSTTINLQDYEHWKGDTMILDFYKIR
NADKLAFNDINTERIDQYSTIISYALNNPNLASSKNGNAQKLYEFLSIFNKFINGLPANN
LSIDLKTGEIKEVK
>IFAGANLK_00269 Alkaline phosphatase H
MKNKIIMWASLFFYLCNFFLPVEAQESYQFHSHNDYKQEFPFWKAYTNKAASIEVDVFLK
DNRLYVAHTEDEIQDENRLENLYLDPLKSLAKSTQLREIQLLIDIKTEAENTLTKLMEVL
EGYPQLTQAKQLSIVISGNRPKVVNYSDYPDFVKFDHQDLNNLEQINLAKIALISTNFRT
YSQWNGLGRLTAEDLEKVKNVIAKVKKVDKPFRFWGAPDTKTAWSRFAKMGVDLINTDNP
AGASAYLQSLDKHTFRLKDAVPVYKPEFKIPTAARPENIILMIGDGNGLNQISSGMIANQ
GELTLTQLKDIGLVKTSSYDDLVTDSAAGGTAIATGNKTNNRAIGTGPMGESLKGLPEIL
APRGFINGIITNDKITGATPSSFYAHVKERDNSAQILEDLKQSHINFFIANGKDTFNTVA
DVFNKKELSDFVAVKGRTAIFLSNDERLYKGNQFAFHVKKALQNLESQDKPYFLMIEGAK
IDSNGHTNNFAGIVQEVIDFDLAVAEALKVADNNKKTLVVVTADHETSGLGIMQGDLETR
KLEAGFLTNDHTATMVPIFSYGPKSGIFRGVYENTAIFSKILEALEIPE
>IFAGANLK_00270 Alkaline phosphatase 3
MKKIKINFSLLVLATTLWSCGNISEEKDSENKEKGNHQALNIILMVGDGMGIPQVSSAFY
FGENTPNFKQFKTIGLSNTTSLSHLITDSASGGTAIATGEKTYKRAIGVSKDSLPLPSIL
ENLQERNYKTGLVSLTSITHATPASFYAHVKDRDMHVEIAEQLVEANIDFFTGGGRKYFG
TSKDGVSLFDKLIDKNYHLDTLELGSVDLSRKNAFILAEDGLPSKTQGRKDYLQTATQKG
LDYFSKHEQPFFFMIEGSYIDWGGHAKDDEMMIQEVLDFDKTLGVVLDFIASHPNTLLVV
TADHETGGVSIGKSYDEQQQEVPKKVQVYFNDDQHSAELVPVFAKGSQEQLFSGIYENNE
IYHKLIQAINNHSYEK
>IFAGANLK_00271 Starch-binding protein SusD
MKNKILTVIFGLGALVFTSCTDLEEEILDESLTGTDGLAEPVSGTLAAAYGILPQTFRHT
RYFGLQEIASDEAILPPRTGLGGTQWADNDVYTTAHRHTMSANNSLVTGTWSYLTTALFR
TVAAIEVLTPLADKGNMEAQQALAEMKALRAYENMLFLDSWGLAFKKESTSGTSEILRGE
DAVNYIEDEFLSIVDVINTDKGPGRMTQSAVYGFLAKLYLNAGVYRAPYGTPNFTNSDMD
NVITYTSLVINEGGFSLSPEYFDLFNDENHNNSEIIFSLDQRGVLNNDHNRWAYWSMSGS
LFPRPGEDYLSMDGTDGPAATPDFYQTWVDAYGDVDPADADARFYQKNAMVPEELEDIEG
LTPYKNDTLGLRSDKDHYFLADADFEIDRGIIRGTMWAPRKENFRSGDFMTGSGGQYRIY
PLAEARENGSDIEDIWYYVDHTLDISIQNQNSYAGGYRFAKWQFSKTSPNGNNYSNVDLI
LLRLADIYLMRAEANLRKGDNASALADVNTVRTSRNARPEQTPAELSSINLETLYRERGF
EFYWEMSRRTDQIRFGTYEDSWTSKTDSDVNHRLFPIPQEAIDGASNVDGYLEQNSGY
>IFAGANLK_00272 TonB-dependent receptor SusC
MYFKFKQKKPNRLIIGLSVLLITQAGNSAPIFDESFLIKKNNEESIQQTINGTVLDENGI
PLPGATVQVKETNRGVTTNFDGEFSIEAQEGDTLQISFVGFETHEILISDKSYFEIQLET
DSASLDEVVIVGYGTQKKSDLTGAVSSVDSEEFNKGIVSNPGDLLQGKVSGLNVTNSSGE
PGAGQDIVIRGVSTLRSGTSPLYVIDGFVLDNSSIGVPTNPLNFINTQDIESINVLKDAS
AAAIYGSRAANGVVVITTKQGKKGRAQMNLTASTGISNIANKIDVFSAEEFRNVVQEIGG
SLSDNGGNTDWQEELTRTAVSNNINFSMSGGSEQTSYFASLGAQDQEGILNNSELQRYSA
RVNVSQTGLKDRLKVDLNLTASRVENERPNANSIIPGMLQLNPTTPAYTNGEPTVFGTGI
NPLIIENIFGDYSNNNRMIANISPSLEILEGLTYKLNFGVDYSKTDRDIQFIPYSQDPDF
ALGSLETSFTTNRNTLIENTLNYEVERGDHSLNLLAGHSFQQFFIEAKGFYFSDFPDNGV
EPRYQLGEARGEDATHWSNATKNELQSVFGRVNYTFKDRYLITGTLRSDGSTKFGENNKY
ATFPSLALGWNIHRESFMENSIFSNLKLRASWGKSGNQEIPSKQTQPSYGESFEDNDIYP
LDENILTRENYPYGLVFARTANPDLQWEETTQSNIGIDFGILNSRFTGTFDYFIKETNDV
LLYFSTQDPIDEVGFRWQNIPGMKIKNNGLEVALDYQSDQSRNFSYNLGGNFSYITNEIT
DSPFTIVTTGSASGAGQTGATINGYMNNRPIGNFFLREFNGIGEDGFNSFTDVNGDGQID
NSDRISAGSAIPDIIYAFYTNFRYKNFDLGLNFNGVSGNKIYNHTRMSLFNKTQISNSLN
TTEQAIEFPNEDPSNSNTVSTRYLEDGSFLRLNNATLAYNLDPNLIGLNNMFTNIGFSLT
GQNLFVITDYSGFDPELNTGNSGDSKSYGIDYYTYPTPRTFTFGLNIAF
>IFAGANLK_00273 hypothetical protein
MITATKKRIIESAIQVFNEDLSAPLQRVADKASVTRRTLHRYFSDRNELVAVCEKAIETS
CRKAMIAAIQSSNDPLTQLENMLYAGIDCGAKYSFFYKLHQSKDHKHNTENKNCADYDYI
YQHFHQIILQLQKNGKVNSDMSAQWIQVLHSGIIESTVNARHHPTKDFQEIKTLAWTSYI
KAIAP
>IFAGANLK_00274 Thioredoxin reductase
MKTSNYDVIIIGGSYAGLSAAMALGRSMRKVLIIDSEKPCNQQTPKSHNFITQDGVAPGE
ISAIARKQVLEYKTVESLKDLAVGAKKKKNNFHITTKSNGDFIGKKLIFATGIKDMIPEI
KGFKECWGISMIHCPYCHGYEFRNKRTGILTNGDRAFHLASLVKNLTDKVSILTNGNPDF
TQEQIAKLKANNVDIIENKISELEHKDGAIKSLIFTDGKEISFDAIYAGFPFEQHSSIPV
SLGCELTEHGYIKINELQQTTIEGVYSCGDNSAMMRSVASAVASGNLTGAMVNHNLTQEQ
F
>IFAGANLK_00275 hypothetical protein
MIEVFTTDIPTQTVGDQIMKNIKAIFPELETDFDLEVPIINYPCDHSIIRVEGSIIDSEK
LISLVNNHGFQCHILEDKICIRSQSKK
>IFAGANLK_00276 hypothetical protein
MERIKINISAFLGIAILIASLLPALHSLSHETSLAEDDISSVHISHLDAELGCDVCSFHL
TTSDVPEFYSYTLYAPLKEEIYIVSLEDKVNPYPFRLFQLRAPPAMIG
>IFAGANLK_00277 putative TonB-dependent receptor
MKQTQFVLLLFTILPFFTYSQHLNLQGKVVDREERPLESAHVHINNRFVLANEDGLYRIG
NLKRGEYRIRVSFIGFRTSDTIISLRENTVVNFKLQEDAAALEAILLNGSARRSSSENTE
KVNKEFLQEQFSGSLANTLERLPGVNAAEIGSGSSKPIIRGLGFNRVAVSENGIKQEGQQ
WGADHGLEIDAFSVENIEIIKGVGAIEHGSDAIGGVIKIINDGVPKDDGISGEVIGLTKS
VNNTLAISTNLALKEDKFFYKIKATASEFGDYSVPTNNIVYLSRNIPIYNQKLKNTAGKE
NDLYGQIGFQGTHYKGTFSVSNVYMKSGFFPGSHGIPSTSRVQHDGDYRNIEYPFQRVNH
MKFINKNEWFFHDSSLEVVLGFQNNHRQEWSRFHTHYTGQVAPSVNPDLELNFNLNTYDL
QAKFSKDLGENHTTSLGLQTQLQDNNISGFNFLLPEYVRINQGIYGTHSYQLTEKLKLNF
GGRLDISKIDIEGFYDENLYQYLIENGSTEASANENATRSSPTQRNFNNMNLMGGLLYNF
KKHWDFSINTGTSFRLPTAIELGANGIHHGSFRHEQGDPNLEAEKGYVFDAKLNYKKKSF
QVSLSPYAYYFDNYIFLNPSGQFSILPHAGQIYKFTQSEAVLAGIEFDVSTNFFRNWHTQ
LTFEYLYNQQLTSDTSRNFPLPFTPPVNGFAEIGYDFLEGSKTFEDTEIFGNTVFAFEQD
RIAQNEEITPGYSIFGGGFRTNLKIGNFRASVNLQATNIFNTKYFNHTSFYRALEIPEMG
RNIQLLVKIPIK
>IFAGANLK_00278 hypothetical protein
MSRFKIHITIFLLVGFLIPQVTSALHYWVVPHNNYKSGKKITIKVSNNFEYHSCTYHLNG
VSPSILGNSGSEKFIKTNLQGVKIKFCCLENYVHQPDYNFLLRGPPVTVLTALLN
>IFAGANLK_00279 hypothetical protein
MKTRLIYLFSITATLLITSCSEDDDANMDTQAPEISIADPVEEEEIAPGGEIHFDAIFTD
NVELASFKLEVHNSFDDHTHASVKQSESENNPWSYNEVFEIEAGNTIHEAHMHIPVPAEI
NGQPISEGHYHFGVFVTDTAGNESQAFLELHIEGEEDHDDHEDEDHDHDH
>IFAGANLK_00280 hypothetical protein
MTFNNQHSKSLMQNFKLIIVLIALSLATKIQAQQTSFSFNGEEINGVNF
>IFAGANLK_00281 hypothetical protein
MVLISERTTVESNHEGFFYSNISSGVYIKKGMELGYVTDLFGNKLETIYAPVDGFILYKS
F
>IFAGANLK_00282 Sensor histidine kinase TodS
MIRALIILFTYVFSPVVLAQSPEEKEAYRFSHISVSDGLSPGSINSFFKDSKGFLWIGTS
SGLNRYDGYEVKVFNPRPADTLTIHSKNYSNIFEDPVGNIWAVTSWGTYIFDPTTSNFSS
DQFKILQKFGIPLKEVENIKQDSKGNFLFIHSNGGLTRYNPNNEEVEQIDVSKNENSLAI
SRISDFEENSEGDFWVLYANGILEKLDGNTLKVKAKEDFLNNRFNNDLQEYKLVVDKDDD
LWIHLYGEHGMFYYNQGKSEFKHFDKESSQLKLNSNLISDIVVAPNGRIWVATDHGGITV
IDKEKAETTYILNQVEIENSLSHNSLTSLYKDYDGIIWIGTFKNGVDYYHENILRFPNYE
NLISDDKSLPFNDVNVFSEDNEGDLWIGTNGGGLIEYNREKKSYTQYKNLPENSKSISSD
IVVSLLQENNHLWIGTYLGGLCRYNGNEFEKLKFKNTDSSSVEVKSVWELYRDSRGILWA
GTLQGGLYLLRQDENEFQHINDVYKGTQLQNDGYISAITEDKDGNIWVGGVNGIDVFNPD
TQKHTRISSDTEKNSIGSNYIISIYRDSKDLIWIGTEDGLDLFNPTTTCFYNYNENDGLP
GTNVLAIIEDNNEDLWLSSSYGLIQFHKDSLVEGSGRLFPDFRVYDNKDGLQGKLFNANA
LFKTSKGEILAGGLNGYNLFLPDSFNFNQNKPEIVFTSFDLFNQSLKPRQEVNGRVILNK
SIDETSNITLKHNENLFSIEFAALDFFQPSKNSYKYKLDGFDLNWQETGSNNRKVTYTNL
DPGTYTFLVKASNNDKIWNNNPASLNIEVLPPWYQTYYAYLVYFLVLVMILYLARKRIIE
KHRRQFQIEQEKREADYLHKMDLMKIRFFTNISHEFKTPLSLILAIVEKLKTRSLQQATK
EQLELVNKNADRLLNLINQVLDLGNIKNESLLATSKANIIKSIEESAKSFESLAEKKDIN
YKIQLEEKDFFTSFDRDKLDKIIFNLLSNAFKFTPKGGEITIKCLVKNSARTEYKDLNIL
VKDSGIGISKEDQENIFERFYKVDDPNFKSTSGSGIGLSLVKEYVALYKGEIKVESKQGF
GTTFLLQLPLPIIKEEQKVAQEIKNDWKEEVTGLKESDIEENVSSILIIEDDIDFLNYLT
REFEQFYDVFVATNGEKGWKKTLSVQPDLIISDWAMREMNGVDLCRKIRRDNRTKHIPFI
LLTANKQEEKKLFALKTGVSDYITKPFNFESLLSRVKNLIAQRKAFQSAYSKKINIEEKE
ITIESQEEKFIRRVLNVIEENIGNPEFSVESLSCQLGVSRTFLYNKLVTKMEKSPQELIR
DIRLSRGKELLIKSNLTISEIAFEVGFNNPKYFTKNFKKQFHILPSQYRSKVRRNTPR
>IFAGANLK_00283 TonB-dependent receptor SusC
MIRKLQKHSRFLFLMILSFLVFTGTVKAQEDELIITGTVTSADDGLPIPGVTILIQGTNQ
GTSTDFDGNYEITAAPNSVLVFSYMGFTTKEVPVNGQSELNISMEVDSSELDEVIVVGYG
TQRRTLVTGANVQVDGDDIQNQSTTNALQALQGQTPGVQITSTSGQPGSGMDVVIRGMGS
TGDNSPLYVVDGVLTGDISYLNNADIESISVLKDAASAAIYGSQASNGVVLVTTKSGKSG
TSRITLDTYYGFQSVPDKIDLLDSREYATIINEAALNSGSQRFFSNEEIAELGEGTNWMD
EMFVDNAITENYTLSFSGGSETSTFSSSLAYTGDEGVVGGKDLSNYERINFRLNSEHKLY
DGLITFGENLTFAYINSNGVSVGNQYSNTLRNAFGVPSLVPMYNEEGDYYDTSNDSDPWL
TQWANPYASMVYNNQNESNNQKLLGNVYAEIQILDNLKFRTSLGLDYFASEGHSYQPIYQ
LSVYSFRNRDRVYQSQSKGHSLLWNNLLTYDFNLFEDHEFEVLLGSEAYSYKGTYMDGSN
VDLIFNDLKHSWLDNALNNSDASQIQIGGGPNAENKRMSYFGRLNYSYLDKYLINATFRA
DGSSNFGQGNRWGYFPSISAGWIASEEDFLIDSETISFLKFRASWGQVGNQNAGAFQYLA
PITFANTNYNFGDEEGVLTPGAYPSRLANPDLQWETSEQANIGLDARLFNNSLNINLDLY
NKTTRDWLIRAPILATAGADAPFINGGDVTNRGIELAIGYGKSHGDFSYNVSVNGAYNEN
EVGNIPTEDGIIHGATNQLFDNAPEFYRAESGFPLGYFWGLETGGVFQNEAEVSNHTANG
ELIQPSASPGDLRYIDQNNDGVINDMDKINIGDPNPDLTYGINLSFTYKALDFSLRANGV
AGNQIVQSYRNQSSQFANHTTAIFDRWTGEGSSNTMPRLTLDNRNFTRFSDIYVQDGDFL
RLSNLTIGYDIAQVAENIGLTKMRIYASALNLYTFTNYDGMDPEVGYGISENNYSFSSGV
DLGYYPRPRTLMLGLNVTF
>IFAGANLK_00284 SusD-like protein
MKRIYFYSIISLLILSAGACTDEFLEAEQLTEVNDENFYSTPSDAYSALVGCYDGLQRAS
GGVAGLSYPVASMVLSDNFYGGTGNADGYGFQAVDEFDISRSPVDANLYETLWVSYYQAI
YRCNVLINKMDQIDWSEDPELRATYESEARTIRAYLYFQMVKLWGNVPLLTEATTENLPQ
ADPEEVYTVIAEDLAFASENLPNQSYTAVEAGRITKWAAKSMLARVYLYYTGYYGQSDLV
GLVSQQDALQHLEDVISSSGHGLLPDYANLWPAASLENFAGENNEEIVFSVKHTYTSDYN
GNTDGNHWMVMLGMREFTHYPYANGWGITVSDKIYDAFDENDTRQEASIIAIEEEEIPFD
KVDSQREYTGYYTKKYTPMANEDGGSVVIDLGGEDFQIGQFQDFYVIRYADVLLMAAELG
SQNAQDYFDQVRERAYQDDFSSITVNLERIQEERRLEFALEGIRYWDLLRRGVDEAAEVI
SEDRTLLSGGNEVNKTISASNVLATEGLQQIPNNQITLSDGTLIQNPGW
>IFAGANLK_00285 hypothetical protein
MKNIKLFSIVLLGAFLVLFSSCENDDMELGETMSPSEIDFEVVQDLETDPGGNTVILRFN
TPKATPVWNYGTGRSTKVVDTVRYAFQGDYTINLSVITPGGVVDLEPVTVSVTEENLNYV
NDPLWTSLTGGVGESKTWLLDLNEEGESIYFAGPLYFFGTDNAWLEGGEAWDGGDTGCYG
EDCWTWQPEYESNTWLMPAGDYGSITFNLQGGPNVTANHLMLPELGEQSGTFFLDKDNHT
LSLNDVELLHSTNNDACVDNWTETRVLSLTEDTMQLGVIRRDDCDGAALLVYNFISQEYA
DNYVPEEEEPSIDEGFEPTFEQGELLQILTGGQSSGRVWELDADGNPIDWIIGGMGWTEN
ADSSRDWGWNADWDAVAEDSWIRFDQWNGMNYTRYQNGEETSGTFSINEETNEITLEENS
LIQVDGHWMSPATNVITVIKATEDYENDGLWFGTSYNPDSDEWLAFHYELLD
>IFAGANLK_00286 Beta-galactosidase BoGH2A
MIFRKNISLFAIIAVSLLISCSDQESEMEFEPEDRRISFNENWSFSLNKNENDSISNNSE
WKNLNLPHEWSIEGEFSKDHPAGAGGGALPGGTGWYKKKFQKKLEDTSSITKIIFDGVYR
DSEVWINGTYLGNRPNGYVSFQYDLTPYLNYGEEKNEILVKVNNADQPNSRWYSGSGIYR
NVWLTTTNKLHIAHWGTFITTPQVTKDSAEAELQIEIENRFASPKEAEVTTTIYFDDKEI
TSRNDEIQISSEKKKEIKQSFQVENPQLWSVENPQLYKAVTQIKLEDEIIDEYTTIFGIR
DFEFDLDQGFILNGKPIKIKGVCMHHDLGPLGAAVNTRAIERQLEILKEMGVNGIRTAHN
MPAPELLDLCDKMGFIVMDEVFDIWSQHKTENDYAGDWKEWHEEDLKSMVLRDRNHPSVF
MWSIGNEIQEQWNEKGAEIGRELSAIVKELDTTRPVTAGMNPPIHTNDENVTLQFEEAAE
PNSLAGSGALDLIGYNYAHQTYTQHQTNFPNTPFIATETTSGLATRGYYEFPSDTTKIWP
VRWDIPFDGGNPDNTISAFDQVRTPWGSLHETTWKIIKKHDYLSGFFIWTGFDYLGEPTP
YGWPSRSSYFGIVDLAGFPKDVYYMYKSEWTDEDVLHIFPHWNWEEGQMVDVWAYYNNAD
EVELFLNNESLGTKSKEDDDLHVMWRLPYTAGTLKAVSRKDGKTVLEKEINTAGEPAKLN
LEADRKTIKADGNDLVFISVYINDEGGNLAPRAGNLVNFEVSDKAEIVGVASGDPTNHES
FKGKKHKALNGKCLVIVKAGKEAGTVSLSAKSEGLEEASITITLE
>IFAGANLK_00287 Alpha-xylosidase
MKTIFNTKRNKSGKTLSTIFLSICSLAVMGELEAQIQNADVLNAPIDVSKDFEDYANTFY
FADELASFDPETGKGTVKYRRYNFQTSQAFNNMLMKPNPVPANEFPATEYEASPELPFEI
QFASDRAIRIKMATGPQFHNQKESLMLIDGTAPNHPEAWNYSKIEAGHEYTSDHGKVEII
TKPWHVKIYDAEGKLLTSTIHTSDVANTYTPVLPFSYVRRNSDYSRSMAAVFSLEPNEKI
FGMGESFTQFNKRGQKVVLWVDDANGVQNETMYKPIPFYMSSRGYGVFMHTSSPITVDVG
KYFNAANNMMIGDDEADLFVFLGDPKDILDEYTNLTGKTEMPPLWSFGFWMSRITYFSED
EGREIAANLRKHKIPSDVIHFDTGWFDVDWRNNYEFAENRFEDPVDMMEDLKEDGFHVSL
WQLPYFTPKNTLFNEIVENDLAVKDAKGNLPYEDAVLDFSNPETVSWYQNKLKKLFDQGV
DVFKVDFGEAAPGNGIYHSGRTGFYEHNLYPLRYNKAVAELTKEVKGYSLIWARSTWAGS
QRYPLHWGGDAATTNTAMAATLRGGLSLGLSGFSFWSHDVGGFVTKAPEDLYRRWTPFGM
LSSHVRSHGEPPTEPWLYNESFLQAFRKADNMRYELMPYIYAQAKESSENGLPMMRALFV
EFPNDAGSWLIDNQYLFGSDMLVAPLFEEQTERDVYLPEGTWIDYQTKKVYKAGWHTIEA
GEIPIIALVKDGAIIPHIKLAQSTQDMDWNEINLKVFASEDTNSASGKLFLPDGEELQTI
SVSKKGDEFEVDENPLSGQTTFKTEWVK
>IFAGANLK_00288 Glucan 1,4-alpha-glucosidase SusB
MIKKILFPCLILSFLACDKQQEPADSFKLASPNGENKISFKLDNNKPEYAVSHGDIEVLS
PSAMGFVLRDNDSLNNFEIVNTKESSFDETWEQVWGEKHEIRNYYNELVVELQEKNDSKR
KLEIQFRSYDDGIAFRYIFPEQEIEDSIFIMDELTTFNLKEDGKAWWIPAYAEQRYEYLF
ENSKVSALDTVHTPLTIESESGLALSFHEANLIDFASMTLEHTSGTQLKANLVPWADGVK
VRTKGTFKSSWRTLQIAEKPTDLITSYLILNLNEPNQIADTSWINTYKYLGIWWGMHIGK
YTFWESETQGATTKNAKEHIDYANELGIDHLLIEGWNKGWTPSWYENAMHQFSFTKEADN
FDLKEVTDYASENDVRIIGYHETGSNLDNYLEQIDSAFALYNKMGIHDVKIGHVGSKLNM
KEWHHGQFGVNYFRYVLEKAAEYKLTVLFHEPIKDTGERRTLPNIMAREGARGNEYNAWS
DGNPANYTTILPFTRLLSGPMDYTAGILDVEVSQGYDGRRVHSTSAKQMALLVTVYSPIQ
MLADLPENYVDKPEFQFLKDVPVDWENTKVLNGAIGEFITTVRKDIDSDDWYLGSITNEE
SRELEIPLSFLDENATYEAQIYADAEGTGYQNNPAKIAISKKEVTSKDSLNLELGESGGA
AIRFKKL
>IFAGANLK_00289 Xyloglucan-specific endo-beta-1,4-glucanase BoGH5A
MKETNSKLKALFLVFFISLGCLACSEDDDVTEETPIQEPTLEASPASLSFEASEQTRTVE
ISSNSNWEITTSSLEWITVTPLSGEEDATVNLTVASNENTEARSGSIIITSGDISREVSV
SQEATEEAEEDVESNIPPDDSNMRNLTSVELTAEMGVGWNLGNSLEAIGGETAWGNPIVS
KRLIDSVKNAGFDAVRIPVAWSKFSDEANFEIRESWMQRVKEVVNYVLDNDMYAIVNIHW
DNGWMQPTYEDQEYVNDRLEIMWKQIAINFRDYDDRLLFAGTNEVMVEGDYGTPTEEYYT
VQNSFNQTFVDAVRETGGRNHYRHLVVQGFNTNIDHTVNFAEIPEDVLEERLMVEVHYYD
PYDFTLNENSDVYEWGENAENSQEWANESFVDEQFNRMKTNFIDKGIGVILGEYGAMARL
NVEDHAAYRKAYVEYVTDAALEYGLVPFYWDNGFVGDHGFALFDRDSGAVEFPEILKAIV
E
>IFAGANLK_00290 hypothetical protein
MKLATNFSLLISTFLGLLSFSVFSQEEEELIWYNSPAENWDNALPVGNGRLGAMVFGDPK
KERIQLNEDSLWPGGPDWGNSKGNPEDLAKIRKLVKEGKLKLADSLMVERFSYKGVTRSH
QTMGDLFIDYNHKNISDYRRQLNLATAIAESSFKADGYQFSQEVFSSAEDDVMVIHIKTS
NPEGMDFEVFLDRPDDKGHKTVSVSSPNNDILRMEGMITQFGGAKNSEKAALDYGVKFET
LLKANSNKGKISAHEGALKFENVDEVTLYLVCNTSFYDENYPSKNTETLKSLKNKDVNEI
RKSHIKDYQKFYHRTSFKIAQKDIDSIPTDRRLEYVKDGKEDLGLIEKLFQYGRYLLISS
SRPGTNPANLQGIWNEHIEAPWNADYHLNINLQMNYWPSGPANLSELQEPLFDLTDRLIE
RGKILAKEQYGMKGTVAHQTTDLWATPWMRAERANWGAWIHGGGWIAQHYWEHFQFTQDT
LFLKERAYPALKSFAEFYADWLSKDPQTNKLVSFPETSPENNYINKQGDTVAISYGTTMG
YQIMAEVFDNTIAASEIIGVENDKFIEEIKSKREKLTSGIEIGEDGRLLEWNEAFEEPEK
GHRHISQLYALHPGDDITSGQPELFEAARKTIDYRLEHGGAGPGWSRAWIINYYARLLDA
REAYKHIEIFMQRSIYPNLLDIHPPFQIDGNFGFTAGIAEMLLQSHEGFLRILPALPKEW
ANGEIKGLKARGNVEVDISWQDAKLTKLVLKSIKKQRLKVRYQDEEIEVLLEEGENKSII
F
>IFAGANLK_00291 Transcriptional regulatory protein UhpA
METLSLKSKVINNFYTSFLDKENVLNYKNIFSYRMEDASGQVRTMLYQAFPLSVLENGTP
ENVLCIQTDVSHLKVTSTNAVSFIHMNGGKSYFNVDISKGEFDAGENAATDFSELLTEKE
KLIVIRLSRGLNAEQIAKELNLSPHTIKTHRRNVLQKSGCRNTTELVAKCLTTGIISPGL
N
>IFAGANLK_00292 hypothetical protein
MQKDFEKISEYWKEMYSRQVKEYRPFEISEEFKRFASIFAPGDSYLYIVNLHHFGLEYVS
DSVERFLGKKARDINLQDLLQTVIA
>IFAGANLK_00293 Xyloglucan-specific endo-beta-1,4-glucanase BoGH9A
MKPLLLPFLICFSITTIFAQNQGDSLRINDQEYLEMRGLNVMLAHDFYPESHQGGVGIIQ
NGIRVATNGDLRLEPTPGQWQPVPKVGERVVDREKNTISVKMAYPDEAKNRKGFNPIEYP
NLEFSYNLKIIPQGKSFKIVVDLDEALPEEWIGKVGMNIEFFPGYLFGKSYYMDNEFGLF
NRQANGPGAYDDKDEYQIEPMAMGKELVIAPGTPKQTLKIENLKGNQLELIDGRAQHSNG
WFVVRSLVPSGATSNAIEWLITPNTMEGYTYDPVVQISQVGYHPAQEKIAVIETEQNDTN
LKEAKLLRVNNKGGFTEIISQNPSEWGEFLRYKYYQLDFTNIKEPGMYVVKYGDYTTEAF
KVSKDVYKREVWQPTLEYFLPVQMCHMLVNDRYKIWHGRCHLDDARMAPVDTNHFDGYLQ
GSETLTNFEPGEHVPGLDAGGWHDAGDYDLRIESQASTIQGLSHIYEIFQEDYDNTTINQ
ETKTVNILQPDGKPDFLQQIEHGTIHIVNGYKSLGRFYRGVIVPTLDQYVLLGDPVNHSD
GEIYKETETSADIPLGQEGAPDDRWVFTEDNPRRELQSAAALAATYRTLEDFNTELAEDA
LEIAKKTWENTGTDNPVDKLSLSVELLKSTSEDKYEDFITENTDIFSENIAQTGWVIAPV
FDEIQDENFRNKIKASVENYYQQVEKLGAQTPYGMPYEPDIWGAGWGIQNFGMKQYFLHT
AFPEIFPKKYMLNALNFVLGTHPGVNTSSFASGVGSRSLTQAYGMNRGDFSFTPGGIGSG
TALIRPDFPELLEWPFLWQQTEYVLGGGTTDYLFLVLAADKLLNE
>IFAGANLK_00294 hypothetical protein
MHQKSSVQNWVLIVFCTLCTGQIFAQLELNEKEYFETHGLNVLVFSNEYNGFFFDEKNAG
IELIHHGMRSSTGGAVRLQNTPEQWDLVPSLVERMVDPSSNTIEVITRYEQLDFTSKIIV
KPEGEGMNISVYLDEPLPDDLEGKAGFNLEFLPAAYFEKTYLVNGNPGIFPLYPSGNTRI
KPISEKVTQFAGHSTLDTRGEEEFIEPQPLASGNTIILAPEDPYHHVELTSETEISLFDG
RSLAQNGWFVTRSILPANKTGKVLEWHLKANTVSNWTRDPNIGFSQVGYHPEQEKVAIIE
LDKNDNQLQTASLYQVTPEGNTVEKLSNKVTEWGKHFRYNYAEFDFSDVAETGIYYIKYG
DQTTNTFPISEQVYETAWHPTLDIFFPVQMDHMKVNEAYRTWHGRPFMDDALQAPLDQEH
FDGYSMGSSTDTKFEPYEHIPGLDVGGWFDAGDYDIQTGTHCLTITDLVASWEEFGLERD
QTHINQENRYVDIHRPDGKIDILQQIEHGTLNLVAQINNIGHPVRGIVVPNLHQYHHLGD
ASTETDNLPYNPELEPFESDGLSSGTLDDRWVFTERSPYLDYRTAGALAAASRALKDYNS
SLSEECNALAKKLWAENENMPPQEASSGYFARFLKLSEMNASMQLYVTTKDEKYAKAFEA
KIWKAMDESLERTIDIALHAAPHMDGNFNNKLKDYVQKYVSEIDQLEKDNPYGVPMFRRP
GWGGNHGIIDFAIANYRAHKLYPDLVDKEHVFKGLHYIFGRHPHSNLSFVSGVGTKTKKV
AYGSNRADFSFIAGGVVPGILLMNPDFPENKENWPFFWGENEYIVDIGASYIFLVNATNE
LLNE
>IFAGANLK_00295 hypothetical protein
MKRSTILLIVGFVLLWNSGFIGAEYGLPYTGPFTLIFLRYLVITVLLVIYLIIRKRLKWV
GFKAASLNMLIGFLAHGVWLTCVLLALVEEVPAGIVALIVALQPLATGALSGYVTNEKTN
KYQWWGLIMGFLGVVLTVAFRIDFSNSSSIFGYLIPLASVIGITIATLIQRKMEINDKNE
KLPLDQTLFYQSFATMLALAIPAIFVENLAAKWVSEFTFAMIWLILAVSLGAYIFMWRLI
ERLDATRVASLFYLGPPVTMLMAWLAFGDTIKIMDIVGLSVVFIGVILTSRVKSN
>IFAGANLK_00296 hypothetical protein
MKEQEVLNYIEDVIENVPNDWLQLTTHRLDIYNEKLAKTEFLERFETLFAEKNAKTSTLK
ELPTAFDYIRLGHPLSSVLEWGIAKLNNLKPDNIISFSSRTMPVLAVLRKNLFANKTTQI
IYTGSLPEYFDAETLKKVYGYNFELKQVENAEEVPEFNGSTVFISQKDEIGKVDLNPNID
FWLSVYPNLGSILLVNGEKNESYISEIQHVRRRESIAMTPADSFSALKQLVGKPSSNRNN
IENNKASVIASIQNITGTNSHALLASCGLSMQYAIMMGLIDEALEKHPGKVIKIVVPPNC
YGGTNDQARRVAASLENVEIVDLPVDGDNDMVQSTALVLDQVAKEDAVPYIIAEIPTNPR
VEVPDLQKLRDALSKERKTARGKTAIDPVFILDQTFCPNVQFLAKDGILSSIRTISYVSG
SKFPSGGKCTAGYCVANEKAENLLSKIEKHLVFCDNEATALQVEILAEQLPSMNQRIADA
YKNTREFVNFIRKTLPEAKINFVSEELADQGFTPSVFSLDLPTKGNTAEEREAYKRGLNQ
KLINMMISEIPNESKYCVSYGQLKGCYWTIPATSTQGTTKEADKDYIARVSVSPNLNLEL
HKKVFLDFVEQI
>IFAGANLK_00297 hypothetical protein
MNQFHLFNRAFCLLVFLSLQQHLCSQELRFKKDTEGVLLLEDSKPRYFYQVKTKSLDGKY
GRANYVHPLYSNNGKVITEDFPEDHLHHHGIFWSWHQLYAEGKRVGDPWLSKEIYWEAEV
IETFVNEKTATLKSEIKWFGATDKKAVLKEHLELTYERFNQETYALTFKIELSALKDGVC
IGGSEDAKGYGGFSPRIKLPGDVVFESTNGIITPQNLPVQAGTWINLKGSFNNSGKISGI
VIMGEPEKLPNYQGWILRSANSMQNMAFPGREPIAIKNGEKLEFRNQILVHKNINISEIE
DYYKKFKGGK
>IFAGANLK_00298 hypothetical protein
MRLLALFFFFSFSLFAQELPPITNFDPGIYNAGNQNWMMTQAENNHIYIANNLGLLSFNG
EHWDLHKVPNASAVRSVLAKHKRIYTGSYMDFGFWEADEKGELDYTSLKNISDEKILDGE
QFWHIEALEEYIIFQSLRRLYSYNRDTEEINTINAGNIISNLFKVNSKLYYQVAEDGLYT
IENGRIEQVISNTKIKDKPIAGLFSFEENKMLAVTRDDGLFTIEGTNWQPFQFKDYPLDE
SIFTAKLLEDQTLVLGSIGNGLHVYNLETSQNYQLLQPVINNNTVLSILEDKAGNIWGGL
DNGLVLINRKSPFRLFTDISGKVGTVYCSHQFGDNLYLGTNQGLYFKTGISSNYELIPGT
SGQVWSINEIKGKLYAGHDRGIFAIEGNSATHISDGPGVWEIREFKNGLLQGHYDGISFW
EEENVENDPVYLSNFDLSSRNLVVENDSTIWVGHDHKGVFKLKINAEVTEVSNLENYSVS
YDGGMGLKVFQFNDSIYYSTEDEIYKYEPETDTFSPENELNNLIKEQRISGISQVLQDNT
WWGFGQDNLLYVTRDAFQDRLSAKSAAIPLEYRSIAKGFENISLIGESKYLVGSNVGYTI
FSTPLDLPSMEDLNINKVSTAALEEEFKSHELNLNQLELPNSVNNINFEFSIPAYSKLAK
PVYSYRIKGFSTGWSTWQRNGNATFENLPAGDYVFEVRGKYDNYISEIATYAFSIALPWY
ATTVAIIVYVLLFLLLIFILHKIYTGYYRKQRQRLLEQNKKKLEIKQLESQQEIITLQNQ
KLESDVASKNRELAASTMNIIKKNEFLTQLKNKLAEANKKEDIQEVISIINKNIAEKDNW
KLFKEAFDNADKDFLQSVKKEHPNLTSNDLKLCAYLRLNLSSKEIAPLLNISVRSVEIKR
YRLRKKMNLKHNQGLVEYILKF
>IFAGANLK_00299 TonB-dependent receptor SusC
MNKILVLILFCIGTFSLQAQTFSVSGTVDEADTGLPLPGVNIIVKNTSNGVVTDFDGNYT
INEVSAGDVLVFSYVGFLPQEITVDENQTEINATLKTDSEALEEVVVIGYGTQQRKDITG
AVSVVSSETIEELNPIKIEQALQGTAAGVNVTPSSGAPGAGINVNIRGIASNSENGPLIL
IDGYQGDLNTINPNDIESISILKDAQAAIYGIAGANGVVLVTTKSGKKNTAPTIQYDAYV
GMQETSRQLPLLNATEYGLLLNESYANNGQDLPYPNVSEVGRGTDFQDEVFETSPIMSHN
LTLNGGSEKVTYSFGVSHLDQEGIIGAEKSDFQRSTARFNIGVDISDEFTFTANSIYTSL
NRRSINENGLGSVLFNALNIPPTFGRDQEDLDGRLGNEIINPLSQIENTFNDYNLNKFNG
SFSLDYTPIEELTFTSRIGYSLSNSKEKDFAPIIDYGPGKVFNNVRSTVNQNRINDNSYT
YDLFGTYENTFNETHHLTGTAGMTVIRDWGDGLYATGYDVPNNSWDFADISLTTGTNDGL
NNSAYKYDIRKLSFFGRLQYDFQGKYLVSGMLRRDASTRFGPENRVGYFPSATAGWILSE
EDFLEDSNVISFLKLRGSFGILGNDEAGGAEFYRSLLDGEATYVLDGNLVNGTALGRIAN
PGAGWEEAEKTNIGIDLRLFNNRVDIAADIFREDRKDLLVAGIPVSGIFGGGAPGSGAPT
INAGTTRNEGFEFAINYKENFGDDIRVGIGYNATFLRNEVTEVNGTEFLPGGQFGVGQPQ
PARFQEGFPIGYFYGYKTDGIFQTQEEVDAHPSQESLGAEASPGDIRYVDTNGDGVINVD
DRTNIGDPIPTATMGLNLNFNYKNFDFTAYTYASLGNDMVRNYERNQPNVNRHAYYLERW
TGPGTSNEVPRVTTGATSNVAFSDFYVEDASYARIQNVQLGYSLPETFLEQVGINRLRVY
ASVQNLYTFTNYKGFDPSASTGEAIGGGIDYGFYPVPRIFLAGLNLNF
>IFAGANLK_00300 SusD-like protein
MKRYNNIFKKMLLLLLLAFSFGCSEDYLEKTEEYNIDSENYFNSEEDYYNALIGVYDILQ
STYVNVLLGEIASDNTLSGGESANDVIGFQQVDEMSHTPVNDNLDDVWDWNFAGVQRANY
VLEFEDKTDFEGRETIIAEVRFLRAYFTFELLKWFGPIPLKDSRFELGDETSIPRASTED
VYAQIESDLQFAIDNLDYTAPQTGRATKGAAMALLGKAHLYQEEFDDAAEVLTELIDNGP
YALADFDTLFEQEGENNEESVFEVQYTGEEGAGFDCLQCSEGNVAVGFQGIRNYSGPVFE
PGFSFNVPTQEAYDMFSEDDIRRDLSVLDIEAWSAETGATYAEGYKHTGYFNRKYLPRDN
DNVGDANLTQPNNYRSIRYADVLLMAAEALNRGGIDDSQARNYLNEVRERAGLDEAEVSG
SNLTEAIYDERRKELVGEGHRFFDLVRTGRAADNIEGFTAGKNELFPIPLEEIEFSQGNW
EQNPGY
>IFAGANLK_00301 hypothetical protein
MKKYYKIIFAFLLALPFAGCESDDRELVDLEQVEAPANLGATFQITQDNSGLVEITPTGE
GAALYSVDFGDGSTPSEEIKVGESVEHIYEEGEYEIEVTGTNINGKTATGTQPLTVSFLA
PEDLETEIIKDADDNYTVTVSASATNAAMFEVYFGENEDEEAALLMPGETVSYTYSSIGA
YNIRVVALSGGAATTEVTEEISITDPLFLPIDFESETLNYTFNNFGGGEGAGAPIIDNPD
PSGVNTSDKVASYTKPEGSETWAGTTIALDEPINFSSERYISMDVWSPEAGTDVVFKVEN
LENADLFVEATATTKVDEGWETLTFDMNEFDPSIEYGRIVLFFNFDVPGSGETYYFDNIE
TTRLELIKLPIDFESENLTYEWGGFGGAGAGVIDNPDMSGINSSTKVTELGKGEGAEGWA
GVSLNLDEPLSYENGTIVKMKTWSPEAGVPILLKFEDSDSEPDGNGNPSVFVEVTQNTTV
AEEWEELSFDLSTFEAFDENIDYDRLIVFYDFNSPGEGTNFYFDDVRMTSEDEPTSVMLP
VGFENSGLNYELTPFEGADSTVEENPFQEGINTSSTVVRSTKTEGALFYAGTTLQLDGPI
EFNGNNKISVKVYSPKADIPVRVKLENNDDSGIFAEVDANTTVANQWEELVFEFSDEQIA
QEYSKVILFFEIIEGVPGDGSTYYYDDIQLTN
>IFAGANLK_00302 Beta-glucanase
MKNIIKTSLTALSLVFFSACSNDDYDIGDITTPSNLNVTAEIVGQSEEMPHGDGSGTVNF
SASADNAMTYKFIYGDGFEEVSASGETSHSFNENGVNDYTVTVIASGTGGASSNMTTTVT
VFSDFNDPETKELLTGGSSKTWYVAASQPAHLGVGPSAGEGFTSPIYYAAAPFEKAAAEV
SSCFYTDELNFSLNENDNIVYNYNNNGLTFINVDFTGDFGGDGSEDQCLEFDRTGEFNAS
LSPSTSGLPEDATTGTVINISGGGTMSYYVGSSSYEILEITPTTMHVRVIPGSNPELAWY
LKFTTSQDEEEEEPEEFQTDYENLVWEQDFDNDGPVDTSIWNFEIGNNNGWGNQESQYYT
EENAVIEDGNLVITAKAEETSGFDYSSSRITTKDNFEFQYGRIEARAKLPEGAGTWPAIW
LLGSDFDEVGWPETGEIDIMEHVGNQQDEIHGTLHYPGRSGGNADGGSIEVPGVSDEFHT
YTVEWSPERILFLVDGEVYHTYENNPDSPFNKDFFIILNVAMGGTFGGEIDPAFEESSME
IDYIRVYQEE
>IFAGANLK_00303 Beta-glucosidase BoGH3B
MKKLNLLGFFLLGCFMVNAQDSTIKSSVRNVETKVDSVLALMTLEEKVGQLVQYNGSWDL
TGPASEMNNKQKEDNLKAGKVGAMLNVLSVEATREAQKLVMENSRLKIPLMFGYDVIHGY
TTIFPVPLAETASWDLEAMEKTAQIAALESAANGVNWTFSPMIDVSRDARWGRIMEGSGE
DPYLTSKVAVAKVKGYQSDDLSNPKSIAASAKHFAGYGFGEAGRDYNTVHIGENELHNTI
LPPFEAAAEAGVATFMNAFNDLDGIPATGHKTLQRDILKRDWDWNGFVVSDWGSIPEMIA
HGVAKDKKEAAKIALNAGSDMDMEGGAYESSLVGLVKEGEVSEDYINDAVKRVLRVKFKL
GLFDDPYLYSNAELLEEISFEEHKNVARDVAKKSIVLLKNEKDLLPIKESAQKIAVIGPL
ADDKDTPIGNWRAQGEANSAVSLLEGLQNNISENVEISYAKGADLGVGERSFLMPLEINE
TDKSGFEEAINTASEADLVIMALGEDAFQTGEGRSQVNIGLAGVQQELLEEIYKVNQNIV
LVLINGRPLEITWASENIPAIVEAWQLGSESGNAIADVLVGDYNPSGKLPVSFPRAVGQE
PLYYNQKSTGRPSNPIHVTYSGYTDEKKDALYPFGFGLSYTDFEYEGLQLSSEEMDTDGS
IQASITLKNTGDVEGKEIVQLYLRDLVASTTRAVKELKGFETVSLAPGESKTVTFEIDEK
MLQFYSANRKWESEEGEFEVLIGGNSRDLQKATFSLKK
>IFAGANLK_00304 Beta-glucanase
MKKNNILLSLILCMGLQVSSQELIWEEDFEGDSLNMENWSYETGDGCPDLCGWGNNERQI
YSQDYVKVKDGNLVLTADKVGDKYYSGKVNTRDKFEFQYGTVEVRAKLPDGHGLWPAIWM
LGDNIDEVGWPASGEIDIMEFVGRQPDTIHNALHTPASHGDTENIKTTPVKNATSKFHIF
KMNWTEDAITFYIDGKKTYTFSPSEKNEETYPYRHPFYFLLNLAVGGNFGGPEVDDSIFP
KQFLIDYVKVYK
>IFAGANLK_00305 hypothetical protein
MRNLFILLISALIFTGCADSEKEETPWTKLFSEESLDGWTKKGGDAEYRVENSTIIGTTA
HNTPNTFLTTNKDYEDFILELDFKVHPSMNSGVQIRSNSLDDYMDGRVHGYQVEIDPSER
AWTGGIYDEARRGWLVDLGANLEAQDAFKQDEWNSFRVEAIGDTIKTWINGVPAAHLIDD
KTSEGFIALQVHSIGEDAEAGTEVMWKNIKILTEDLDKYSTETPLEPVKTKNTLTSAEKD
NGWEMLWDGETTDGWRGARLDEFPEEGWKIEDGVLTVLASGGGESEAGGDIVTKELYGDF
ELKVDFKITEGANSGIKYFVDTDLNKGPGSSIGLEYQILHDERHPDAKLGNHEGSRTMAS
LYDLIQADPDKPVNPIGKWNTARIVSQGNKVEHWLNGEKVLEYERKSEEYRKLVSESKYV
DWPNFGEAEEGHILLQDHGNEVSFKNIKIKSE
>IFAGANLK_00306 Inositol 2-dehydrogenase
MNSRRDFIKKTALGGTAIAVGSSAMAMSAKSYRKIIGSNDRIHVAIAGLGRRLGAYFDPI
ANKDSNVELLYLCDVMESQRVNALERFSEHINYKPKLENDIRKVFDDKKVDAIINATPDH
WHTPGSIMAMKAGKHVYVEKPSSHNMFENELLVEATKKYGKVVQMGNQQRSSNHTIEIIK
DIHDGAIGEVYKAVAFYTNGRGEVPNQKRAPVPQGLDWDLWQGPAPRREYTEETWDYNWH
WYGWAYGTAESGNNGTHEMDVARWALQVGIPLRTDVQSAKRHFKDDGWEMYDTMDATFKF
ANDKVIQWDSKSRNAYDTYGGGRGTIIYGTDGGVFVDREKYVLTNRNGEIIKEYNSESDE
AGTALGGGGDMSTAHMVNFFDGIRGTAKLNAPIDDANISMTMVHYTNIADQLGRGFDIDN
KTGRIFDRDAMKLWGREYAPGWKPEI
>IFAGANLK_00307 Autoinducer 2 sensor kinase/phosphatase LuxQ
MNNTKIDENKEIKRLQTLLSYNILDTPYEKDFNELAQLIALICDVPVAFIAMIDDKRQWY
KAKVGLDGKETPLEETFCQYTVLQDELIEISDALLDERVKDNPHVTAENGIRFYAGMPLK
AENGYNIGTVCVVDGKPGKLSDRQKQALKLLTSQAMHLIEARKKNKSLGKELNSILEKRI
ARTERKLELKESENRSLMQAVKNSSGVVEFKPDGTIISINRNFEEISGYTEKELLGSHHK
MFITPADYEANTTLWESLRRCEYKTGRVRRIHKDGSEFYLQASYNPIQDLEGNVVKVVKI
SQDITKEIEAEISLEKAKEMAESLNEQKDNFIANVSHEIRTPIHAVLGFTDLLLENEEDA
HKTSYLKAVKIAGDSLLFIVNDILDLSKMDAGLLQIDKDVFDIRDVVNRVFSILHLKAHQ
KKIGFEPIIETNVPTLLVGDKNRLSQVLINLLGNAIKFTSEGGVKLFLSVTEETSGKTTL
NFKVSDSGIGIPKNKLETVFQRFLQADKNTSQKYGGTGLGLNISRQLIEKQGGTIEVKSE
PGKGTDFIFEIPFEKASQERQLVEDEKDNFEKRYSGRILICEDSELNQRLVKALLKGKGL
EVDIASNGEIALSFLRESTYDLIFMDVQMPVKNGYDTTKFLRKEMGLKTPIVALTANFMA
TERQKCTEVGMDDYLAKPFQKKQLFEKVEKWI
>IFAGANLK_00308 hypothetical protein
MKEKYLIVIIFFLMFGSGEISAQMTHSMPEPLMQDDGGGPIAPPPGLPIDFGISALIAAG
LALGIHHIKNRK
>IFAGANLK_00309 Riboflavin synthase
MFTGIIEEVGEVSRIETEGGNMHFSINAAMTPKLKIDQSVAHNGVCLTVVSISDNEYTVT
AVAETLQKTNLKHLQKGAPVNLERGMKLGDRLDGHIVQGHVDQTAICKKVEEKDGSWEFT
FKYDPTLQNITIEKGSITVNGVSLTVVNSKKNEFSVAIIPYTYRHTTFKNLTEGATVNLE
FDVIGKYVKRLQDLK
>IFAGANLK_00310 4-hydroxythreonine-4-phosphate dehydrogenase 2
MKQAEKVKLGISIGDLNGIGSEIMLKTFDDSRMLDFCTPVIFASTKVLTFLKKHFNLSLN
YQGIDEASKAIDGKINVVNVWKEGVNINFGEEDPKIGEYAFKSLQAATKALKEDEIDVLV
TAPINKHSIQSAEFNFPGHTDYLAKELEGESLMFMITDTLKIGLLTDHVALKDIANTITP
ELIERKLNIIQETLKQDFRIQKPKIAVLGINPHSGDNGVIGKEDEEILKPTLQKLRDKGD
LVFGPFSADSFFGSKNYVNFDAVVASYHDQGLIPFKTLSFGNGVNFTAGLSKVRTSPDHG
TAFEIAGTNSANINSFKEAVFRAIEIHKCREEYKELTKNPLKKQGRKL
>IFAGANLK_00311 hypothetical protein
MHPPKPKRPGQEIDDEMRKLAAYTIPFVGLKLGKHQFEYEIDNEFFEHFEYDDLNSANVK
VDLLLEKKTTMMELTFKASGAINVNCDITNEPYDQPIDGSLFLVIKFGDEFNDENEDLLI
LPHGEFEVNVQQYIYELIVLSIPLKRVHPGVEDGTLESDVLDKLEELSINNNENKNDEDE
IDPRWDKLKNLLNDK
>IFAGANLK_00312 50S ribosomal protein L32
MAHPKRKISKTRRDKRRTHYKASVPKIATDPTTGEAHLYHRAHWHEGKLYYRGQVLIDNT
EEIEA
>IFAGANLK_00313 3-oxoacyl-[acyl-carrier-protein] synthase 3
MNKITAAITAVGAYVPEDVLTNKMLEEMVETNDEWIFSRTGIRERRILKDPDKGTSYLGI
EAAKDLLEKSNLDPKEIDLVILASVTPDLPVAATAVHVATQIGAINAFAYDLQAACSGFL
YAMSTASAYIESGRYKKVLVIGADKMSSIIDYTDRTTCIIFGDGAGAVLMEPNDEGFGLQ
DELLRSDSIGRDSLRIEAGGSLMPPTAETVANKLHYVRQDGKTVFKFAVSNMAEVSANIM
ERNKLTNEDVDWLVAHQANKRIVGATASRMGLEDKKVLMNIERYGNTTSATLPLLLSDFE
KQFKKGDNLVFASFGGGFTWGATYLKWAYNS
>IFAGANLK_00314 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MDLKEIQNLIKFVAKSGASEVKLETGDVKITIKTGSDEKETIVQHVPMGGQMQQMPAQPQ
QQHQQQQAPAPSQESDSQSKEEQKAPAGEDSNYITVKSPIIGTFYRKPSPDKPTFVEVGD
SIKEGDVLCVIEAMKLFNEIESEVSGKIVKVLVDDSSPVEFDQPLFLVDPS
>IFAGANLK_00315 Biotin carboxylase
MFKKILIANRGEIALRILRTCKEMGISTVAVYSTADAESLHVRFADEAVCIGPPPSNLSY
LKISNIIAAAEITNADAIHPGYGFLSENAKFSKICEEHDIKFIGASPDMIAKMGDKATAK
ATMRAAGVPCVPGSEGVMKDFKECQKLAKEIGYPVMLKATAGGGGKGMRAVWKEEDLEDA
WDSARQEAGAAFGNDGMYMEKLIEEPRHIEIQIVGDSTGKACHLSERDCSVQRRHQKLTE
ETPSPFMTDSLRKKMGEAAVKAAEYIKYEGAGTVEFLVDKHRNFYFMEMNTRIQVEHPIT
EQVIDYDLIREQILVAAGVPISGKNYFPQLHSIECRINAEDPYNGFRPSPGRITNLHAPG
GHGVRIDTHVYSGYIIPPNYDSMIAKLITTAQTREEAINKMKRALDEFVIEGIKTTIPFH
RQLMDHPDYIEGNYTTKFMEDFKMKPLEKED
>IFAGANLK_00316 Gamma-glutamylputrescine oxidoreductase
MNLSYWETKTWFSDIDFCIVGSGITGLNCALDLKTRFQKSKILILERGILPNGASTKNAG
FACFGSISEILEDLNSHSEIEVIQLIQKRLKGLKLLRKNLGDQNIGYKEYGGYELFTNED
ATLFEECKSALPQLNKMLKPIFGDDVFSIQKDSFGFKNIQKKLIFNQFEGQIHTGRMMET
LLHKVQKAGIKILNNITVEEFSETKHSVIIKTDKLEFSANKLLIATNGFSQQLGITEVKP
ARAQVVITKPIKNLEIKGTFHLDKGYYYFRNINDRILFGGGRNLDFKTEETSKIDQTEII
LQKLEELLKTTILPETNFEIDQRWSGIMGVGKQKNPVVKQISENVFCGVRLGGMGVAIGS
LVGKELSELIK
>IFAGANLK_00317 Biosynthetic peptidoglycan transglycosylase
MIKKIFKFLLKIAGFLILFSLFMVLLYKWVPVPFTPLMAIRYFENPEEKIQHTWVPREEI
SLHLQLGVIASEDQNFVKHNGFDFEAIEKAIENNQKGKRMRGASTISQQTAKNVFLWPGR
NWLRKGLEVYFTFLIETFWSKERILEVYLNSIEMGTGIYGAEAAAKRWFSKSSANLTVNE
AAAIAAILPNPREYRANPASNYINQRKNWIVRQMQNYGKFSLE
>IFAGANLK_00318 hypothetical protein
MTNPRNCSGSLLKKKEHMNQIKEKLYKACEVYVEERIKRIETALAGLESDLENETKSSAG
DKYETGREMINLEINKLTEQLQQFKNLKNTLIVAKNRMNTSSAQLGTAVKTNIANYFIAI
PANRIIVDGDEYFAIGANSPIAQLLLHKKAGEEITFNGKSATIQEVF
>IFAGANLK_00319 Fe(3+) ions import ATP-binding protein FbpC 2
MLKLKNVSFAYAEEPVLKNIGFTLEKGENLSVIGESGCGKSTLLKLIYGLLHTDGKIFWE
EKELLGPNFNLVPGEPFIKYLAQDFDLMLPLSVADNIGKYLSNQYPQKKRNRIKALLEVV
EMTELADKKAKLLSGGQQQRVALARALANQPELLLLDEPFSHIDHFRKNNLRRRLFAYLK
QNNIACIVATHDSTDALSFADKTIVLKNAKIYAENSPSELYENPPNKYVASLFGDVNEIM
LKNLVEAESSRKKVILYPEEIKLTNKSGIKATVIKSWFKGGTWLIEAELSGKTFYFNHSQ
ALKGEKKINLKVSEKLIESRIK
>IFAGANLK_00320 1,2-phenylacetyl-CoA epoxidase, subunit E
MSQFFPLEIKEVIRETPQAVSLSFNIPENLKEEFKFDAGQYITIKIKLGDEELRRAYSLC
SAPNSGEFKVTVKEVEGGKFSVIANNKLNAGDVLDVHPPEGKFILKPTGEGRNYAAFAAG
SGITPVLSIIKTVLAEEPKSRFVLTYGNKSPEETIFFKELLELQAKFPDRLFIEFVYSRT
REDNSHFGRIETSTVNFVLKNKFKDHAFDAFYLCGPEEMINQVSDVLKQNGITEDKILYE
LFTSEETGAIETNIEGQTELTIMVDDEETTFSMDTKGTVLDAALEHDLDVPYSCQGGICS
SCIARIVEGKAEMRKNQILTDEEIEEGLILTCQAQPLTPKLKVDYDDV
>IFAGANLK_00321 hypothetical protein
MFKRFLWLEWKSFFRSASVGKSIGLKVLLIFLALYFSVAFLSLGIILYPWLQETFPDQDP
LQMVNRFVLLWLVFELGFRFMLQTLPVLDIKPLLNLPIPRRKAVNFVLLKSMYSFFNFLP
LFIIIPFGIFCIYKGDYGTWNILGWMVAMIATTQCVNFLNFIIKKKFTDNLKALIPAILL
VVVLGALEYFEVFEISFWFGKMMDFLVLNPYLAIVPIILVIAFYKWNQLNLEGKFYLDAG
LKEKQKDADTKDFVWTKKFGALAPFLQLDLKLIWRNKRPKTTIYMSLLLLCYGLFVYPSD
MYEHMAIYVFVGIFMTGIFMINFGQFVPSWDASYYPMIMSQNITLKDYLSSKAMLISFSV
IILAILSTPYIYFGWNILLINMVAALYNIGVNVPILLYSGSFNKKRIDLDKSPFMNYQGT
GAAQWIVGLPLMFLPILIFWLLDYFIGFEAGLIGLSGLGILGLLLRSSLMKFIAGVYRKR
KYAMINGFKQTGE
>IFAGANLK_00322 Lipopolysaccharide export system ATP-binding protein LptB
MITATNLSKVYGGTKVLNIDHLDIPTGESFGLVGNNGAGKTTFFSLLLDLIQPTTGNIFN
NEITVSQSEDWKPFTASFIDESFLIGYLTPEEYFYFVGDLRGANKADIDAFLANFEDFFH
GEIIGRRKYLRDLSKGNQKKVGIVAALIGNPKVVILDEPFANLDPTTQIRLKKIIKELTE
NRETTVLISSHDLIHVTEVCERIVVLDKGIPVKDIKTSEATLSELESYFSGEVGTAQAEE
L
>IFAGANLK_00323 hypothetical protein
MLLVGSIAGCSRKNNTFVNRNWHAVTTEYNTLYNGNLGLEQGKEELNQNYADNYWDILPI
ERMQIDENIVLPDSIRNQNFGYAEEKAVKAIQRHSMLIEGKERNPQIDEAYLLLGKARYF
DQRFIPALEAFNYILRRYPASNNIIHARVWREKTHMRLENNRLAVNNLKKVLDLEHLEEQ
DIADASATMAQAYINLRHLDSAVVPLRNAAEFTGNNEEKGRYFYILGQLHNRLGEISEAN
AAFDKVIDLNRRSPRIYMINAYVQKARNFEMGEGNNYKLREMLRVLEEDRENRPFLDKIY
FQIGEYYNRLDSINIAEDYYKKSLREPASDIYLRSINYEILANINFDRTDYLAASKYFDS
TLAEMDPQLREFRTIKKKRDNLEDVIRYEDIAYKNDSILQLSQMMPAEQLDYFKNYTTDL
RAKLEADNDAVAIPVNLPAIESRQPPTSARTFYFYSEARVQQGRQEFLNQWGDRPLADNW
RWAEVSFEREDAVAQETGLSQQVLDNDPRLDPYTYIDQIPTDLAALDTLTRDRDFAYYQL
GIIYKENFKEYKMAQARLEAVLEISSDERLILPSMYNLYQIYQTTDQGFKANDMKQEILE
NYPDSRYAAYILNPESIREDENSPETIYAELYRDFEAQNFNEVIAETNRYISEFAGDPIV
PKLELLKAQTSGRLLGLEAYKNALNHVALTYPQTQEGKKAQEILNKTIPQLRGLKFNTDS
LQENYKLLYRFDVSEQQAASALKEKIETAIAEINYKHLSVSVDVYDPDEVFIVVHGLQDI
NRAKGFAELLKINEDYLVEKESMPISTENYRIVQIQKNLDDFPRPVE
>IFAGANLK_00324 hypothetical protein
MKNKELNKYLGFVNIAFQMGIIIAGGVFLGIWLDGKFPNKYSVFTISLSLLGVFIALYQV
YRSVSKMSEEDEKNEK
>IFAGANLK_00325 hypothetical protein
MKNELLAFLKRLLPFSILLWLIQFLLQQYVFEIEFYYSSFSIYLFHFLATFLIYLSLVVV
YKNFTDKTGFAFIGLSLFKMVAAVIFLLPLVLSEVNAVFVNILAFFIPYFLFLVFETLYA
VKLINKA
>IFAGANLK_00326 ATP synthase subunit a
MQPNLEPIILSRPGTMIAHKSLKIIVTFTLALALLPFNAFAKADPQAEESKEFNPTDMIM
HHIGDSHGWHFFGEGDSSFTLPLPVILFTDNGMVTFMSSEFHHDTEGQYVVEKDGMRFVN
YHEDIYKLDAGAESVEFDEEHNVLNASKPWDFSITKNVAAMLLTVVLMLIFFFGLAGHHK
KNKKAPAGFNNILETLVLFVRDEIARPQIGEKKYMKFMPFLLTVFFFIWITNLLGLLPGA
ANVTGNIAVTVSLGLFTLALILINGNRDFWQHTLWMPGIPTFVKPILAVVEVLGLIIKPV
ALMIRLFANITAGHIIILSLIGLIFILESAGVAGISVPFALFITILELLVAFLQAFIFTM
LSALFIGMAVAEHEHH
>IFAGANLK_00327 ATP synthase subunit c
MELLHVGLAALGAGLAVVGAAIGVGKIGAAAMDAIARQPEASGKIQTAMIIAAALVEGVA
LFGVVAALLGVLTT
>IFAGANLK_00328 ATP synthase subunit b
MDLITPEVGLIFWQTIVFLILMLILAKFAWKPILGAVRTREESINEALVSAEDARKEMQN
LKADNEKLLQEARAERDEMLKEARQLKEKMIAEAEGDAQEKANKIVAKAKESIEMEKRAA
MADIKNQVATLSIEIAEKVIGKELSTEEKQHQMIDKMLNDATLN
>IFAGANLK_00329 ATP synthase subunit delta, sodium ion specific
MKGNRAAQRYAKAILDLAKEKNAAETVFTDMQQISQTIAKSPDLADMLKSPVVNTTVKKA
SLKEIFKDAGEITQGSFDVLIENGRINILDLVARNYIVRYNTLNKSQEAIVTTAVPLTAE
LEEKILAKVKELTGTGANIKNVINKDIIGGFILRVGDLQYDASVSRNLNRLKRELTNNSY
ISSI
>IFAGANLK_00330 ATP synthase subunit alpha
MAEVNPAEVSAILKKQLSGFESGASLDEVGTVLTVGDGIANVYGLANAQYGELVQFDSGL
EGMVLNLEEDNVGVVLLGPSKDVREGSVVKRTERIASIKVGEGIVGRVVDTLGSPIDGKG
AIEGETFEMPLERKAPGVIFRQPVTEPLQTGIKSIDAMVPVGRGQRELVIGDRQTGKTTV
CIDTILNQKEFFDAGEPVYCIYVAIGQKASTVAGIAKVLEDKGAMEYTTIVAANASDPAP
MQVYAPFAGAAIGEYFRDTGRPALIIYDDLSKQAVAYREVSLLLRRPPGREAYPGDVFFL
HSRLLERASKVIDDDTIAKGMNDLPDVLKDKIKGGGSLTALPIIETQAGDVSAYIPTNVI
SITDGQIFLTSDLFNSGVRPAIDVGISVSRVGGSAQIKSMKKVAGTLKLDQAQYRELEAF
AKFGSDLDPTTLRVIQKGKRNVEILKQAENDPYPVEDQIAIIYAGSKNLLKDVPVEKVKE
FERDYLEFLDTKHRDVLDTLKAGKLTDEVTDTLVSVAKELSAKYKK
>IFAGANLK_00331 ATP synthase gamma chain
MANLKELRSRITSVSSTMQITSAMKMVSAAKLSRAQDAIMQMRPYSEKLTQLLQDLSATL
DDDTSSKYAEDREVKNVLVVAISSNKGLAGAFNTNIVKGVRYKAKNDYESKNLSLYTLGK
KANDVLKKDFEVYKNNNEIYDGLTFENVSEIAEELMQLFLDEKYDKIVLVYNQFKNAATQ
IVQHEQFLPIEQFDTEEEKQLDYIFEPSKIEIVKELIPKSLKMQLFKALRDSFASEHGAR
MTAMHKATDNAKELRDDLKLSYNKARQASITNEILEIVGGAEALNG
>IFAGANLK_00332 hypothetical protein
MKKLLFLFSSIFALSFVTGCGSNKELQERAPAQFQDVYYTQGENGLDLHIPVAVIQDNRV
NLESVYFRGMKSPLVRDSEQSNLFIANFRTNGMDIMSSDPAEENKNRIPQKPEEVPFEIE
DDEAILVFTQNDKTKYYKLTGIQEQN
>IFAGANLK_00333 hypothetical protein
MSTFKKLFQHTFVYGLATVLPRMLNVLLIPLYTHVLPKEEYGEVSIIFAYFVFFNVILAY
GMETAFFRFYNKMKNSKEVLSTSGWSIVATSLVFFAAAFLVQDFIAAITNIPVKYIQLVI
WILFLDALVIIPFTWLRAAEKPMRFAVIKLINVCITLGLNIFFLLFLGDLAEESSLFQSI
YVPDFEISYIFISNLIASGATLLIMLPFYFKIDFSFNSKLWKSMMSYAFPVLIAGLAYSV
NEVVDRLMLDYLLPQDIARAEIGAYSACYKLALFMTLFATAFRLGIEPFFFSHADAKNAQ
ETYAIITKYFVVFGSFILVAVIVFIDILKELLIQDSTYWEAMHIVPLILLAQLFLGIYHN
LSVWYKITDRTRFGGYISVVGALSTLALNILLIPIISYTGSAIATLVAYGVMMVLSYFYG
RKYYPIPYNLKKIGGYLVLSVLFSVFSFYVFRGNYFVGISLLIIFLGTVYVSERKQLIKI
LQS
>IFAGANLK_00334 Deoxyuridine 5'-triphosphate nucleotidohydrolase
MQVKIINKSAHKVPHYETEASAGMDLRANISEAFTLKPLERAIVKTGLFIELPVGYEAQV
RPRSGLAAKKGITVLNSPGTIDADYRGEIGVILVNLSNDEFTIENGERVAQMVISKHEHI
SWEEVEVLGETTRGAGGFGSTGNK
>IFAGANLK_00335 UTP--glucose-1-phosphate uridylyltransferase
MKIIVPMAGRGSRLRPHTLTIPKPLIPVAGKPIVHRLVEDIAKVLNQPIEEIAFILGDPA
FFGEDVVASLKDLAKSLNAKASIYRQDQPLGTGHAIMSAKESLSGPAVVAYADTLIKADF
KLDKEADGVIWTKKVENPEAFGVVNLNEKDEIIELVEKPKEFVSDQAVIGIYYFKDIAVL
KGKLEEVLDENLMHGGEYQINDGIKKMMAEDRVFKTGTVDEWMDCGNKDVTVETNGRMLN
FLHQDGEKLISDSVKITNSEITEPCYIGENVELMNAKIGPNVSIGDGTKITDSEIKNSLI
QTFAEVKNAKLDNAMIGNFAKFNGEFTQISIGDYSTLE
>IFAGANLK_00336 Beta-barrel assembly-enhancing protease
MKKIFFITAMLSGALLTFQGSFAQEEEVVLEEVNQDDLGNVTDEFQEQFFEALKQKGIEN
YEKALTALEACQKLEPENPVVYFEMARNYNELENYEEAIANLEKARELAPEREDVLNELY
KSYTRAKQYDSAIKSLVKLQEFDEDYKEKLANIYLLNQQYDEALQTIDELDQKEGPSTYR
NKLRRQIFARTGDTAAQIENLKEGISNNPENEQNYLNLIYIYSDQGENEEAYNTAQELLA
ANPGSTLVHLALYKFHLEREEPEDAVNSMKIVFESEEIDPESKFKVLNDFLLFVDNNPEY
EEDLMQVSKMLSERENAPKLYGQLGQYYLNRGQIEEALNFFEAGLAESTEDFQLVKNTIL
LQIELEKYKEARDLSKEMMEVFPAQPVLFLLQGIALNQLEEYREAIEILTFGLDYLIDNP
KMEVDFYTQLSRAHGELGEKEKSAEFSSKAEALIKETE
>IFAGANLK_00337 hypothetical protein
MYRKILGLVLLSLFVVSCGSRKGVKGIATKNAEAANIIESHYNSETDFKTLSGKLRTVYQ
SEDRTQSVNLSFRMEKDKAIWMSASVLGFPVAKAYITPSRVSYYEKVSQTYFDGDFRLLS
NLLGTPLDFQKLQNLLIGQAIYDLREEEFEFSQTAKGFQFMPSEEGLIKKMFLLDPKNFK
TSAQQLAQTQENKSVTVTYSDYQQVEGKIFPEEINIIANEAGSSTRIELTYRSLEFDGGE
LSFPFDIPAGYEEISL
>IFAGANLK_00338 Murein hydrolase activator EnvC
MKFKKFSEILFCLVVLLLSAGNLSAQTTREALEKKRIELRNEITRINELRSSNKQKERSV
LSQVEDLDQQIRSTENLIKVTNQQANLLTNQISANTNKISRLRDELEQLKEDYARMIEKS
YKSKSTQSRIMFLLSSENFLQAYKRLQYMKQYTNYRKQQGDEIQARTEELQQLNADLADQ
KETKDALIAENRQTRAQLEKNKKAQQDLMQNIRSKEGEFAAQIRQKQQEINKIDAQIEKM
IRESIAKSNEESGSAERDVYELTPAAKALAADFVKNKGRLPWPVRSGVVTSRFGRQPHPV
VKTISINNNGVNIDTDPGGKARAVFNGTVSEVQVLKGANKAVMVRHGDYITIYDNLEKVY
VKRGDVVNTGQELGAVATSRTSGKTTLHFLIYKNMQKMDPADWILEM
>IFAGANLK_00339 hypothetical protein
MRKILLLLSFIVFIGCVKHNVGVVGSKRMLISGNILNAENTPIENISLIASGSEYDRLWA
RPAQMLGETSTNASGKFSFVSLDTHNSFYGVSVNHSNHQDYREEFSTIHFLDSIGSRGNS
FELTNIQLPKVQQFQVKLNNTSARNDTLFFEFSYSSTEIYRKLHEDSFDNPLRFQGESEY
WNRILPGEDEMTISAKTIENSDLLFYYKFSAETDYDTINVEITPENPVYEFSY
>IFAGANLK_00340 hypothetical protein
MSSAIKVFLIAIFFPLLLTAQDTLSEPHRHQYVATDPETVFFVGEFFRGYNVNNSSWENY
SQSGFGLDFNWFVFPFLTIGGQYNFMGGNLKEENINNTGSINRINSHYFGLHLGYYHAFN
KEWNLHSLAGFGRVQNGSRAPDSRFTEDGNSLMLRSELGYRFDKTAAIFIKATLRWDRMD
VDTPRVLDDYFNKHSLLLVGFGVRLHLQNPNG
>IFAGANLK_00341 putative acyl-CoA thioester hydrolase
MQAKHPEESRTTLTDLVLPSETNPLNNLFGGELLARMDRAASIAARRHSRRIVVTASVNH
VAFNKAIPLGSVVTVEAAVSRAFKSSMEIFIDVWVEDRESGNRSKANEAIYTFVAVDETG
APVGVPPLEPETELEKQRYDAALRRKQLSLVLAGKMKPNEATELKALFQD
>IFAGANLK_00342 hypothetical protein
MKIANYIQDLLYRYECVILPGFGAFLSQKEPAYIDKESEVLHPPKKVVSFNSQLKKNDGL
LANYIAATQNVSYSTAVNKITEFVGKLENSFKEEGKVELENIGRFYYAEEKLQFEPVEKV
NYLTDSFGLENVKASAISREVYKKQVEELEEKAPIHFTPERRKSPSYLKYAALGLIALGI
SGFAGLNIYSSQVSQHNIAEQQQAQEQLQEQIQQATFIIDNPLPAVTFNVAKQTGNYHIV
AGAFRVEDNAKTKVAELRKEGFKAHLLGENKYGLHQVVYASHEKRRDAINMLRKVKSSNE
GAWLLVQEL
>IFAGANLK_00343 hypothetical protein
MSAEELQYVLTLQHIPNLGDTFAKKLIRHIGPAKNVLQQKKQTLLKIDGIPEN
>IFAGANLK_00344 hypothetical protein
MPLINFYPKVHHKYVTSIEEKGGFFTDFWSSDTFDRNNFLKRNRIIAGVSEATVVIESAE
KGDSLVTAILRILTTGKFLPYLEDLQIN
>IFAGANLK_00345 Tryptophan--tRNA ligase
MSRILTGVQSTGTPHLGNLLGAILPAIEMANKPDNDSFIFIADMHSLTQIKDAETLRNNT
YSVAATWLACGIDIEKTVFYRQSDIPQTAELSWYLSCFFPFQRLTLAHSFKDKSDRLEDV
NAGLFTYPMLMAADILLYDAEIVPVGKDQLQHLEITRDVASRFHSKMGETFVIPEAKVQE
NTMYVPGTDGAKMSKSKGNTINLFVSDKKLRKQIMAIATDSTPLEEPKNPDTCNVFALYK
LVASEAQITEMRKNYEAGGFGYGHAKQALYEVLLEQFEEPRKKYEYYMNNLAELDKALEV
GAEKARNVANDVINRVRTKVGY
>IFAGANLK_00346 1-acyl-sn-glycerol-3-phosphate acyltransferase
MFPVLVVFSSSERLYPKYYVCARIWAKCILYGMGFYPEITRLEELDPKKNYMLVANHTSM
IDIMMMLVIIKQPFIFVGKRELAKIPIFGFFYRKTNITVDRNCAKSKQDVVTEAQRRLEM
GMSICIFPEGGVPEDRSLVLDTFKDGAFRLAIAHHIPIVPITFYDNKKRFSYKFISGSPG
KLRVKIHEFINTKGMQPADRRDLRNESWQVIYKELTKDLENENPSK
>IFAGANLK_00347 hypothetical protein
MKERKNIDRLYQEKFRDFAPEPRPELWDNIAGKLQEKDKKKPFIIPLWFKVGGVAAVFAL
MLGGYFFSQNNFTNTELVFEVEETAKPQINLPEINKNEQFVNASEILRNINEATYSTSEG
ANTSSANNNSAIASENSNREYTKTSDNSAEKQNSESTEAKLNEQNSAMTGEDHQDSEEDK
NQNQDFINPNSKNEQLPEAIAENSKENNEKEEGISLKDSLEVAEQLAQIEKEKNLDKEEE
LIAEASKKKLRLSTFAAPVFYDNIGSGNAIDRQFSSNKTSSQVSIAYGMNLAYAISEKIK
IRSGISKVAMSYNVEDIVFSASLNPSTISSINYESGGNNVQLDNAAPSGLPGHSDSGNNT
NFSSVNNMALPGEINQQFGFIEIPLEIEYSLLDSKIGLNLIAGGSSLFLDENSIQVNTNN
QNTRIGEANNINKVSFSTNVGVGLDYKLTDSFKLNLEPIFKYQLDTFDDAPGVRPFYFGI
YSGISFSF
>IFAGANLK_00348 ECF RNA polymerase sigma factor SigW
MSLEKLILQCKKQDIRAQEKLYRMYSGKLFGLCLKYSNNYQQAEDNLQDGFMTIFNKIDQ
YEDKGSFEGWMKRIVINTTLQKHRKEKYFEIINENQLEDPVVEIDDDEITTDFLLESIQE
LPERYRQIFNLYALDGFSHKEIADMLNISVGSSKSNLARARNILKEKIENHLNDNKVQSL
>IFAGANLK_00349 hypothetical protein
MKRIALLMILAVSIYSCDTDDDGPNVNYDFAEITEADLPEFFEIGESYDFEVTYELSNAC
NQFVTFDFDQYEDEENDSTFVIEVAALTSYDANLTECTEEGELSETRTIRDLNISSEDYN
NYQFKFLTGVDENEDGEFLIIDVPVGEPEPETPEENTNE
>IFAGANLK_00350 Protein RecA
MSNDKEKEAKLKALKLTLDKMDKTYGKGTVMKMSDQAVADVDAISTGSLGLDLAMGVGGY
PRGRVIEIYGPESSGKTTLTLHAIAEAQQKGGIAAFIDAEHAFDRTYAQNLGVDIENLII
SQPDNGEQALEITDNLIRSGAIDIIVIDSVAALTPKSEIEGEMGDSKMGLHARLMSQALR
KLTSSISKTNCTVIFINQLREKIGVMFGNPETTTGGNALKFYASVRLDIRRSTQIKDSNS
NVMGNKTRVKVVKNKVAPPFKMAEFDIMYGEGISKIGEIIDIGVDYEIVKKSGSWFSYED
TKLGQGRDAVKILLKDNPDLMEELEEKIKNAIKVAKEA
>IFAGANLK_00351 putative adenylyltransferase/sulfurtransferase MoeZ
MQLYNKLSAKEREALIDEAGEDRLTLSFYAYAKIGNPHLFRNHLFIAWDQMDVLGRIYVA
HEGINAQLSVPAKRFDEFKKFIDNIYFLEGVRLNIAIEHDAKAFLKLKVKVRKKIVADGL
NDSTFDVTNKGVHVDAVKFNELINDPKTVLVDMRNHYESEIGHFQGAITPDVDTFRDSLP
IIEENLKDYKEDKNLVMYCTGGIRCEKASAYYKHKGFKNVYQLEGGIIEYARQVEKQKLE
NKFIGKNFVFDHRRAEQISEEVIAHCHQCGKPCDKHVNCANEACHLLFIQCEGCAEKMDN
CCSTACQEIAALPYEDQKALRKGKGNSNRIFKKGRSEVLKYKS
>IFAGANLK_00352 hypothetical protein
MACSSCSTKDGQPKGCKNNGTCGTDSCNKLSVFDWLANMSMPNGIEPFNYVEVRFKNGRK
HFFKNVENLSLSMGDAVAVEASPGHDVGMVSLTGELVRVQMKKKKVKPDSEEVLKIYRKA
TQKDLDVWEEVRSREEAIKKRAREIAIRLNLSMKISDIEFQGDASKATFYYTADDRVDFR
QLIKEFAREFNTRIEMRQIGLRQEAARLGGIGSCGRELCCSTWLTDFRSVSTSAARYQQL
SLNPQKLAGQCGKLKCCLNYELDSYLEALKTFPRTDTKLFTKKGTAVCQKIDIFKGVLWY
AYEGEWMNWHQLTAEQANKIIASNRKKEDVGSLEDFEVQLQLEEKSDFNNVVGQDSLTRF
DKPKGQQKKNKSKKRRKRKGKPSNNA
>IFAGANLK_00353 Gliding motility lipoprotein GldH
MRKAAVFLTFIGVFALLASCDKKRVYDEYKPIHGGWEKDSTLVFNLGELDSLQNYNLFIN
VRNNKDYNYRNLFLITEMRFPQGKVVTDTLEYEMAAPDGSWLGTGFGDVKESKLWYKENV
SFTEPGEYKIAIIQAMRKNDEVEGIENLEGITHIGFRIEENLQ
>IFAGANLK_00354 Penicillin-binding protein 1A
MAATKKKHQKPKTGKRSYIVGFWTIFGIGLLAVVLIFLLAGWGAFGKMPDFEELENPETN
LATEIFSSDGETLGKYYSENRTPIKYEDLPDHLIEALVATEDERFYKHAGIDPKGTLRAA
FYLGTRGGASTITQQLSKLLFTEQVSNNPFARILQKVKEWNIATQLERQYTKEEIITMYF
NKYDFVYQAVGIRSASKIYFGKEAKNLNIEESAVLVAMLKNAALYNPVRRPDLVKQRRNQ
VFVQMNKNGYLSEQEKDSLQKLPLNLDFSPEGHDEGMATYFRVYLQGFMKDWIEKNPKPD
GSEYSLYRDGLKIYTSIDSKMQQYAETAVEKHISHLQKEFDRQNKNNKTAPFRDIDESQV
NGIVRSAMKRTDRWKGMEKQGKSEEEILASFDEETNMRVFSWEGIKDTIMSPKDSIFYYK
GFLQAGLMSMTPQTGEVRAWVGGTNFKHFKYDHVKQGKRQVGSTFKPFVYATAIDQLKLS
PCDVMPKNRFTIEAGKYGNIKDWTPSNANGEYEGMISLKNALAQSINTVTARLIDKTGPG
PVLDLVKKLGVDTENFSDGPAIALGTEDMSLFEMVSAYSTFVNEGVYVKPVIVNRIEDKN
GTVLYQHVPQTRDVLNKEAAYVTVNILEGVTQYGSGVRLRGTYAKEFDHYKRGVTGYPYD
FKNPIAGKTGTTQNQSDGWFMGMVPNLVTGVWVGAEDRAVHFPNLTYGQGATMALPIWGM
YMKDLYADEALDISQDAFPKPDNLSIEINCDEYNQESDSENNSVPDELDF
>IFAGANLK_00355 Succinyl-CoA:3-ketoacid coenzyme A transferase subunit A
MIRKTVANVEDALQGVENGMTFMLGGFGLSGIPENAISELVRLNVKNLTCISNNAGVDDF
GLGLLLQKKQIDKMVSSYVGENDEFERQMLSEELDVELIPQGTLAARCQAAQQGFPAIYT
PAGYGTEVSQFKETREFDGKMYVLEKAFKADFAFVKAWKGDKAGNLIFKGTARNFNPLMC
GAAKVTVVEVEELVEPGELDPNQIHIPGIFVQRIFEGKNYEKRIEKRTVRKK
>IFAGANLK_00356 putative succinyl-CoA:3-ketoacid coenzyme A transferase subunit B
MTKDKFMLDKDGIAKRIAEEVKDGYYVNLGIGIPTLVANFVRNDIEVEFQSENGILGMGP
FPFEGEEDADLINAGKQTITALPGASFFDSAMSFGMIRGQHVDLTILGAMEVAENGDIAN
WKIPGKMVKGMGGAMDLVASAENIIVAMMHTNKAGDSKLLKKCSLPLTGVACVTKIVTNL
AVIEVTKDGFKLLERAPGVSVEEIKKATEGKLLVEGNIPEMKL
>IFAGANLK_00357 hypothetical protein
MYLYIEMWNVTGKWIDLSKEERRELMTNMQDRITGLKENGVENLGWALNDEHTNYRSQYR
YFTVWKMPSLDNVETLEANLKKVGWYDYFSQANTRGKIISQKEAIDFLVNLEAESTSLT
>IFAGANLK_00358 hypothetical protein
MAEFAEIVCISVGFFSFKNGERTFRLTMFKDEEKILLQEFANLLQEHFSKPLHLLCAHNG
KEFDFLFIARRMLIHDLALPFKLNLFGKKPWEIPHLDTLELWKFGDYKHFTSLKILNNVL
KIPSPKNDISGSDVRNVFYKDRDLGRIVSYCEKDVLAIAQVILKLRQEKLLESSEVVSV
>IFAGANLK_00359 6-aminohexanoate-dimer hydrolase
MIRFLKISGTVIFVLLIAVIILIIFDFGYIFRGMQATYFQGEKTAFIDDYPHFENRLIEA
GTEADMWPEHSNYNTVTPTDDLAELNEELETAAFLIIKNDSIWFEEYYQEYGPDSKTNSF
SMAKSIVSALLGKAIQDGYITSLDQPVSDFFPQFKEELKVGDLVSMASGLNWNENYYNPF
GMTARAYFDENIRELILRLQVTDTPGESFKYLSGNTILLGMVIEEATGENLSEYLSKSFW
KPLGMQEDAFWQLDSEESGMEKAYCCIASNARDFARFGKLYKDKGKWNGQQLLDSEFVAR
STEPRFHDSPQYGYGFWLSDYKEKDIFYMRGIRGQYVIVIPEDDLVIVRLGENLIKKDED
EEHAPDFYKYIDETYKMLNDAANN
>IFAGANLK_00360 Methylated-DNA--protein-cysteine methyltransferase
MDEEIPSSKEIPDFLQSAAEQLDDYFKGNLEEFNLKLNPKGTHFQQKIWKALSEIPFGKT
CSYLELSRKLGDEKAIRAVASANGKNPLWVVIPCHRVIGSNGSLTGYAGGLHRKQWLLNH
ENNTSQLSMF
>IFAGANLK_00361 Magnesium and cobalt efflux protein CorC
MGLLILYATLSIFFSFMCSILEAALLSVTPSYIKIKNKEGKAYATTLANFKQDIDKPLIA
ILTVNTIAHTVGAILVGVQAEKIYGDGGNAVGIVSAIMTLAILVLSEIIPKTIGATYWQA
LGNFTAKTLKIMIFPLKYTGILWLMMLTTKLIGKSAHVSSMNREEFAAITDAAEEEGVFD
ESETTVIKNLLVFRSVKAKDVMTPYSVAIIEDEDTSIEEFHRTHKNLKFSRIPVYKNKTN
NVTGFILKDDVLEEMIDDKGPEPLSKLKREIFMSSEDTPIPELFENFVKKRGHISMIVDE
YGNTVGLVTMEDIIETLLGLEIMDESDSIEDMQMLARQNWEKRAKRLGLIQRKDNEDNEE
SPKPDISENTPRDSQN
>IFAGANLK_00362 hypothetical protein
MDTASTLIGLGLLAVFVLPILFLIWQQNTKEKNRLKNLKELSLKNNLNTDTVEISATLLL
GLDSKARKLLVIEPTNNMQHKVLDLCYIKNAKVSSHPFPDKPELIKRISLDLSENKNNKK
LTEIIFYDEDDNANNNASERLIVAQKWNRIISGKISA
>IFAGANLK_00363 hypothetical protein
MKLFFIKLLPSNIIVGGCFMKNRNFYIITLLLGLILNSTGNKVFAFSAPVVDLDSRNYDY
LQADQNQQAVIFFEIISSEHIASEENFSGFSDYVVSAYSSTKEFLIPTEKTSIFSFLDQR
QLILQHIYPFHFFW
>IFAGANLK_00364 Delta-aminolevulinic acid dehydratase
MYPLRRNRRLRTSEAMRSLVRETAITPNDFIAPLFVVEGKNKKEEITSMPDYFRFSLDLL
EKEVKELWSLGIKSILLFVKVPDNLKDNAGTEALNNDGLMQRAIRAVKNVVPEMLVMTDV
ALDPYSAYGHDGIVSGGKIINDDTTAILAEMGLSHAKAGADILAPSDMMDGRIFEMRSLL
EDEGFHETGIMSYSAKYASAFYGPFRDALDSAPVDAENIPKDKKTYQMDPANREEAVKET
LMDIEEGADIVMVKPGLCYLDIVRDLRNEINIPIAVYQVSGEYSMIKAAAEKGWLDHDAV
VIEQLTAIKRAGASMIASYFAKDAVKLIS
>IFAGANLK_00365 Oxygen-dependent coproporphyrinogen-III oxidase
MRDQFYKYIENLQDTICSKLEEIDGSAQFQQDLWEREEGGGGRTRVIENGAVFEKGGVNI
SAVHGPLAPAMQKYFKVGDVDFFACGLSLVIHPKNPMVPTVHANWRYFEMYDKTGTVLDQ
WFGGGQDLTPYYLFEEDAIHFHQVSKNACGKHSPEFYPEYKQKCDEYFWNSHRNEARGIG
GLFFDYLKDSEEKSIENWYDFVIEVGDSFLEAYAPIVEKRKNLEYSQENRTWQEIRRGRY
VEFNLVHDKGTLFGLKTNGRIESILMSLPPHVQWVYDHHPEPGSEEEKLLKVLEKPRNWV
>IFAGANLK_00366 hypothetical protein
MAVWARIKNMNFKELFSVSKVFMKNPRYIFPTYNATIQTIKICDEFYAEEHHNNGKENAF
RHALWNYLICKKCYTISGSAEVVRNWGDHITGLHEKLSPNQKLAKAMDLHNNRIGQQIFT
GEENSTQEIISLLQQKMQQAIKITEEKMPESIQNELVYIED
>IFAGANLK_00367 Uroporphyrinogen decarboxylase
MIKNDLFLKALKGETVERPPVWMMRQAGRYLPDFMKLKEKYDFFTRCRTPELATEITVMP
IHQVGTDAAILFSDILVIPQAMNIEVEMKPGVGPWLPNPIRTAKDVDNVIVPDIDETLGY
VMDAIKLTKQELNNEVPLIGFAGSPWTILCYAVQGQGSKNFDIAKKFCFTNPVAAHQLLQ
KITDTTIAYLKAKVAAGVDAVQIFDSWGGMLSPVDYQEFSWKYIQQIIDALKDEIPVIAF
GKGCWFALHEMANSGASALGVDWTLSARNARYLSGGRITLQGNFDPARLYSPPAEIKKMV
TQMINEFGKDQYIVNLGHGILPDIPVENAKAFVDAVKEYKT
>IFAGANLK_00368 hypothetical protein
MKSILSTKKLSKPQKQLFLNSGLSLVEHNAITIEVTYFKLPSEKIKNAIFTSKNSVNAVS
GKVQIENCFCVGEKTADLANENGFHIQEIADYGKDLAGIIVQNYSEESFIFFCGNKRRDD
IPEILKKNKIEFTEIEVYKTLLNPRSFSQEFDGILFFSPSAVQSFTDKNRLKDSTAFCIG
KTTAAEAKKYTNNIITATQPSIENVIVQVVKYFKK
>IFAGANLK_00369 Porphobilinogen deaminase
MSKVIRIGTRDSELALWQAKTVQNALEKAGHKTELIPVKSTGDLNLDQPLYEMGITGIFT
KTLDVAMIKGNIDIAVHSMKDVPTALPKGIVEAAVLKRANTKDILIHKGLNFLESDGTVA
TGSLRRKAQWLNKYPTHKVVDLRGNVNTRMKKLDDNNWNGAIFAAAGLERIALKPENFLD
LNWMIPAPAQGAMLVVAMEEDEFTQKALALLNHKESEITVHIEREFLKVLEGGCTAPIGA
LATVDKDLIYFKGALFSLDGKEKIVVEKTVFINEIENFGRRCAEEILQNGGAKLMQEIKA
KINTEG
>IFAGANLK_00370 Glutamyl-tRNA reductase
MEDYHIASGKHFYTIGLSYKKADAEIRGHFSLNEEAKNGLLKQAKDEGIDAILVTSTCNR
TEIYGFAQHPFQLIKLLCEHTHGTVEEFEKVAYVHKNKQAISHMFRVGTGLDSQILGDFE
IISQLKVAFTRSKKYGLVNAFLERLVNAVIQASKRIKNETEISTGATSVSFASVQYILDN
VPNVTDKNILLFGTGKIGRNTCENLIKHTQNEHITLINRTKDKAEKIAGKFNLIVKDYAD
LQAEIRNTDILIVATGAQNPTISKELIYSNKDLLVLDLSIPKNVSEDVAHLLNVKLVHLD
QLSKITDQNLERRKQFIPDAEAIIKEVETDFNKWLETRKFAPTIKALKKKLRSMKDAELD
FQRRKISDFNDEQAEIVSDRIIQKIMKHFANHLKGDSTTTDESLELIQKVFQLEEQVK
>IFAGANLK_00371 Regulatory protein PchR
MILEDKNNAVGFTEELKIEDGFYLLKFQNETTEDQKIIRNIDSSFIQFHFNLKGGSKFLF
NNNKYELPLNGESSLLLYNPQQDLPLNLVLEPNSWLISLVISIKKFHSLFSQEAGYITFL
SADNKDKKYYKDAPISPSMAIVLNQVMNFNLTPSIKNLYFKGKAYELLSLYFNRTEDPNV
EQCPFLSDEENIIKIRKAKDIVISRMAEPPSLQELSDEIGLSLKKLKEGFKQIYGDSVYS
FLFDYKMEYARKLLDSGDYNVNEVGLKVGYSTASHFIAAFKKKFGTTPKKYIMSLTSNS
>IFAGANLK_00372 hypothetical protein
MFKKFVAIYILIFFGLNSGYTQETENEDEKDKKEILVFYKTDGFWHESIPTGRTFIEDLG
EDHDFKVTSTKDSDDFHRDDLKGYDLVVFLNTTGNVFDEKEQEGFKNYIENGGNFFGIHA
AADTEEDWPWFVELVGGYFDGHPEVQQAEIKLNMPDHPAVSHLPKVWTRTDEWYNYINLN
PEMEVLLYLDENSYEGGTNGEEHPIAWFRETGHGGVSIYTGLGHTIQSYIEPSFQEHILK
SILFALGEEK
>IFAGANLK_00373 Ferrochelatase
MSKGVLLVNLGSPKSTDPKDVKEYLDEFLMDERVIDVPYWARVLLVRGIVLNTRPKKSAE
AYQKIWWDEGSPLIVLSERLQDKMDKNTSVPIALAMRYGEPNIKSGLQELHDKGVDEVLL
FPLYPQFAMATTETILVLAEELRKKHFPKMQFTTMPPFYNHSDYIRVLAESISEKLKGVD
FQHLLFSYHGVPERHIRKSDVTKSHCKIDGSCCQTASAAHQFCYRHQCFETTRLVAEYLE
LKENSYSVSFQSRLGFDPWLQPYTDRTIERFGKQGMKKLAIVTPAFVSDCLETLEEIAME
GEEIFHEVGGKEFTVVPCLNDRDDWVNVLSRWVDEWAYQKPVKA
>IFAGANLK_00374 Multidrug export protein MepA
MASVNSRNLGEKPIGKLLVQQAAPASVGILVMSLNILIDTIFVGNWIGSTAIAAINVVLP
VSFFIAALGMAIGIGGSSIISRALGADDRKKALKTFGNQISLTLILTVGLVIIGLLFVDS
LIPAFGGKGDIFEPAKVYYTIVLYGVPFLALCMMGNTVIRAEGKPKFAMIAMIIPSVANL
VLDYIFINQMGLGMWGAAWATTASYLFCFAYIFWFFLSKNSELRISLPDFGLNKTILQEI
SSLGFVTLSRQAVVSVIYLLMNNILFDLGGEDAVAIYAIIARMLMFALFPVLGVTQGFLP
IAGFNYGAEKYQRVRKSINTAILYACGLGLLVFSGIMFFSDEIVRIFTKNPTIITETPAA
MRWVFAATPIVAIQLIGAAYFQAVGKAVPALLLTLSRQGFFFIPLILILPYYFGEIGVWI
SFPIADLLSTLLTAYFLNREMRLKLKPKTS
>IFAGANLK_00375 hypothetical protein
MDINALKIELIQKIIACKEIALLKQIEEFLLEVNVKEPGEDYEVESLKNLLSKEQLEELD
RRLEAYKNGTSEAIPWEEAKREIEKK
>IFAGANLK_00376 hypothetical protein
MIEYYQYIKALHLIFVITWFAGLFYIPRLFIYHIEATQKPEPDKSILASQFKLMTKRLWF
IITWPSAILASLFAFLLLHLAPGWLSQDWMLVKLGFVVLLYAYHIKCHLIFKELQNDVVK
WTSNQMRLWNEGSTLILFAVIFLVIVKDAINWIYGVLGIFLLAGMLMLGIKMYKRIRTKN
PDA
>IFAGANLK_00377 Sensor protein ZraS
MKLSKLSLSTRIFISMILLVLGASILIVGITIYQYKLEAENYHRERLDRKEQAIRENIKF
ILASTTYLINTENIDMIFGERNKIHEMAQVHEMQINIYDFQGRLLIKSDQSFFRDTTDNQ
LDKDILRKLERSESKRYIEKTEVNGQKFQSSYTYILDKKFKPLAILYLPYVQDDTVLNRD
LNNFLLRMLEVYLFMLALAIIMSYFLSKYITKSLKIISDKITETRLDKRNQKIDISNASE
EIYTLVAAYNSMIDELEESAVKLAAGEREQAWREMAKQVAHEIKNPLTPMRLSVQSFERN
FDRNDPEIEAKVAEYSTTLINQIDTMSSIAEAFSNFAKMPAQQNEMLNVPKIVKLALDIF
NEDYIQFSSEKDEILAKFDRTQLIRVITNLVKNAIQAMDGQKNPRIMVSIHEEASDVFVI
ISDNGAGISEENIEKVFEPKFTTKSSGMGLGLAMVKNIVETYNGSITFTSKLGKGTTFKL
RFPK
>IFAGANLK_00378 Short-chain-enoyl-CoA hydratase
MEFENILTENNDGISQITINRPKKLNALNRDTIEELHQAFTEAKEDNEVKVIILTGSGEK
AFVAGADISEFADFSPEEGRELAAEGQAKLFDFVANFPKPVIAAVNGFALGGGLELAMAA
HFRIASDTAKMGLPETSLGVIPGYGGTQRLPQLVGKGRAMEMIMTAGMIDANQALQYNLV
NHVCEPEELIEFTEKVAAKIMKNSLVAISAAIRAINSNYEDGVNGFEVEISEFGNSFGTE
DFEEGTSAFLNKRKADFPGN
>IFAGANLK_00379 hypothetical protein
MSNNKDFIYGRGAQLNVHNRFDAHDHEFRDDFLNHCATEGDVVQNSKTVLIDTFPKTIVN
KVNSPDVGMGFSLNPYQGCEHGCIYCYARNSHEYWGYSAGLDFEQKILVKRNAVELLEKK
ISSKKWEASPIVLSGNTDCYQPIEKKLKITRQLLQTFLKYKHPVGIITKNALVQRDIDIL
KDLAADNLIQVNLSVTSLEEETRRILEPRTASIKKRLETIEKLSVAGIPVSVMMAPIIPS
INSHEIMPLVKEISERGALGVGYTIVRLNGAIGGIFTDWIRKAMPDRADKVLHQIESVHG
GSLNDSRFGTRMKGEGEFASQVAQQFKIAKAKYLKGRERPVLNCDLHEQYKDGQMKLF
>IFAGANLK_00380 Formamidopyrimidine-DNA glycosylase
MPELPEVAYQKKYADATILHKKIVNVETGDKKLFQSSKSEFEETLKNNQFTGSERLGKYL
FLNLEKHGVLVVHFGMTGRLEYYQHEELPKYAQLTLTFEDHSRVSFTCPRKFGKLYLAES
LIEFQKRNGLGIDALALQKVEFLEILKSKTGTIKALLMNQKQIAGIGNLYADEILFQVKI
HPATKVNELSEKDKLNIYDKIEEVLEVVKKVREEGQKLPESYITTVRKKGANCPRNEGKI
EQIKVSGRTTYFCPNCQEEKS
>IFAGANLK_00381 hypothetical protein
MNRTQIIENTESFVKRTLKNAEGGHDWFHIQRVWNKAKLIAKNEAADLFIVELGALLHDI
ADSKFHNGDESVGPKVASEFLQEQKLSTEVINHVVKIIENVSFKGGNIKQEFNSIELEIV
QDADRLDALGAIGIARTFNYGGFKGRALYDPTIEPNLSMSKEEYKTSNAPTINHFYEKLL
LLKDKMNTETGREIAQKRHEFMELYLEQFYSEWKGKV
>IFAGANLK_00382 hypothetical protein
MKKILSYPLSVLFYFFFFLNLLVFHPIQWLCLKLGGYHPHKKSVDIFNFFLMRCLNILGT
RFTIENPQDIPIEKPCIFVANHQGMYDIPPIIWYLRKHHPKFVSKKELGKGIPSISFNLR
HGGSVLIDRKNPRESLIKMAKFAKYLNNTNRSAVIFPEGTRSRTGAPKKFAKSGMQMLFK
QMPEALIVPITINNSWKLFKYGNFPMEPGVHIKLKVHEPIAVASDDPEGLVAKVERTIIA
DIK
>IFAGANLK_00383 hypothetical protein
MYPADLVKPMREDLTSIGFEELHSVEDVENAMKKDGTTLVVVNSVCGCAAANARPGARIS
LQNAKKPDNLVTVFAGVDKEATEKARSLMVPFPPSSPSMALFKDGELVHMLERHHIEGRP
AEMIAENLIGAYNEFC
>IFAGANLK_00384 Chaperone protein DnaJ
MFKWIAAVIGYMYFRFPGAILGFIIGTLIDNWTKGSGGAFKQMFGQEEQKVSPGDFELNL
LSLCSLVIKADGQVSQSEMDYVRSYFVQAYGKERANATFRTFNELIKNREISASRISQYL
AAKTKYPARLQIIHFLFGIAQADGRVSEAEARVIQEIAGYLRIGRMDFESLKAMFFKSAD
NAYKILEIEKSATDAEVKKAYRNMVKKYHPDKLGHMDEAYRKGAREKFNKVQEAYDQIQK
ERGL
>IFAGANLK_00385 putative TonB-dependent receptor
MKSLGTIILLIITFQGMAQTGQLAGKIIAEGNSVPFANIYIENLNLGTTADEDGNFLLKN
LPAGNHTIQVSAIGYRKLTREIIIVEEQTKTQLVELEESSSELDEVIIVDTQTGLTRRTP
YNVSSISMQGIENKGNPNGMMGNLREVPGVYGAEFGQGIVKPFIRGLGFSRVVTIYQGNK
LENHQWGADHGLGINDLGIKRVQVIKGPASVLYGSGALGGVLLTQAHEYYKNSTKISGNI
GTTFNSVSNGIRTYASAGKSFENGIFIATDLAFENHADYNNGDDRIIGNSRFNTKTLRLH
TGIEKENFQNKLSFSFNDQNLGIILDEEMQDSQSIVTTRNDREMQLPFQEVKDYLLSYNQ
TTQHENYETSIHLSYHSNNRKEIELDFNLVDLGLQQNHTFFNARISLPNGKIKHSLGAQG
SFVKTKNIKNSQEFLIPDADVFESGIYYLANLDIDSWFFQGALRYDYREVTADASSPELI
TDEFILPGNPENRKLSRNFNGFTGSMGATKKFNERNQLKLNFSTGFRAPDLAELFSNGPH
PGTSRFEKGNDQFGREQSIQFDASYTYRKHRFKGTFSAFSSRVNNYIFFTATDEALPEEN
LEVWSYLQTDANLYGFEFELEHSWLNQQRLETKFSGTIVRAEDLKNNRNLSFIPPDNFNM
EVGYFGLNDRSLYVFSKLRIINDQDRAGLNEETTPGYSLLNLGITKKFNLAGNQLETGMT
VYNSLNKTYVDHMSILRAFNVSSPGRNVMLNVKYNF
>IFAGANLK_00386 Iron-dependent repressor IdeR
MFSFSEENYLKAIFHLERKYQAGVSTNALAEEMETKASSVTDMIKKLSEKDLVIYKKYQG
VKLSELGKKTAIEVIRKHRLWEYFLVEKLNFNWDEVHDVAEQLEHIKSEKLTRELDAFLG
FPKRDPHGDPIPDAEGNFSVANKVLLSELGKEEKGICVGVRDSSSDFLRFLDKNNISLGK
EIKVLEKEAFDGSMLILIEERQLRISQLISNNLYIKKH
>IFAGANLK_00387 Zinc transporter ZupT
MDDLIAYFEELDPVLAALLATIFTWLLTAAGASLVFLFKNMNRKLFDGMLGFTGGVMVAA
SFWSLLAPGIEMSPGEGFEKTVPPLIGFGLGALFLFGLDKILPHLHVNFKMSEKEGIKTP
WHKSVLLTLAITLHNIPEGLAVGVLFGAASAGLEGASIGGAVALAIGIGLQNFPEGFAVA
MPLRGLGMSRWKSFNYGQLSAIVEPFAAVLGAWAVMTFEPILPYALSFAAGAMIFVVVEE
VVPESQKGNFTDIATLGFILGFMVMMTLDVGLG
>IFAGANLK_00388 hypothetical protein
MQEVLCITKGYRIKRYFLLKSALIIATIFLFAMPASAQEEIEEIEHYVKAYLGEAFNFEG
KTIRFKEVVSDSRCPRDVTCVWAGEAKILIEIFKNGKFIGEEIFSTRSQNFSLSKFFQED
FSLHAIALSPYPKTSRKIKASDYQLQFKIIETR
>IFAGANLK_00389 hypothetical protein
MVLLQEILVFITFAIALGYLTTKFIWKPAFLKKKSEKTKACGVSGCGCD
>IFAGANLK_00390 Fe(2+) transporter FeoB
MAKQINIALIGNPNTGKTSVFNQLTGLNQKVGNYPGITVEKKEGICKLPRGLKAHILDLP
GTYSLNASSLDENVVIELLLNKSDKDYPDVAVVVSDVENLKRNLLLFTQIKDLGIPTILV
INMADRMERKGISLDVELLEERLKTKVVLVSARKNTGIDELKEAIINYRHISDEPCVNAS
IIAPEYFDRLRKAFPNQSLYKLWLVITQDVNFGNINRNEVSSSELFETKSHTELKKLQHK
ETILRYQFINGVLKETMKVDASSAKDLRSRLDRVLTHKIWGYAIFFGILLLIFQAIYSWS
SYPMDLIDETFAFLSEWTKTSLPAGAFTNLIAEGIIPGLGGIVIFIPQIAFLFFFISILE
ETGYMSRVVFLMDRIMRKFGLSGKSVVPLVSGTACAIPAVMATRNIENWKERLITILVVP
FTTCSARLPVYLIIIALVIPDRAVWGFNLQGLTLMLLYLLGFGVAIGSAWILNLILNIKT
RSHFVIEMPNYKLPMGKNIAINVVEKTKSFVFGAGKIILAISIILWVLASYGPGENFNQA
EEIVTSEYSQNTEISENELEEEIASFKLRNSYIGIMGRGIEPVVAPLGYDWKIGIAIISS
FAAREVFVGTLATIYSVGSDEEETIKNRMAAEINPILGGPLFTFASGVSLLLFYAFAMQC
MSTLAIVKRETNTWKWPVLQLVVMTLFAYFVALAAFQLLK
>IFAGANLK_00391 Fe(2+) transport protein A
MKRTLADLKRGERGIIKDFSAENIPLKLLEMGCLPGNEVQMLQMAPFRDPMYLNINGSHL
AIRKEIALLIEIDLIS
>IFAGANLK_00392 SCO1 protein 
MRDLFAWLKKFAIVLFILSVIIIYSIYTLLTPEERLPVFQPDMVNAELVDSTVQHIRKYH
TVKDFKLINQNGDTITEDFYEDKIYVADFFFTTCLTICPVMTDHMLEIQEKIKDDPEVLL
LSHTVFPKTDSVPVLKKYALEKGVIDEKWNLVTGDKKHIYELARKSYLASKSNGDGGPYD
MIHTENFVLVDKEKRIRGFYDGTDAEAIEDLLHDIKVLKAEYK
>IFAGANLK_00393 Putative zinc metalloprotease
MCDLKFEALRMDPFIVKAIQLLLSLSLLIVLHELGHFIPAKIFKTRVEKFFLFFDVKFAL
FKKKIGGTVYGIGWLPLGGYVKISGMIDESMDKEQMAKPPEPWEFRSKPAWQRLIIMLGG
VTVNLVLGFLIYMMIMFVWGKNYVGPDEMPEGFAIAEEFKQYGFEDGDRVLQINGEELQN
SDDVNRYLFMRDVNSITVLHQNGEEEVIEVPEDIGEQMWEQGIMIPFIPIQNAVLDSVIP
EQAAGIAGLQKGDSLIALNDQEIGYWHEIKTISLENKEKEMELVFKRGDDIKSVMVAPDE
EGILGFTVKRNFEVKQQEYGFTESIKEGFDYGYWTLHDYVAQFKYVFTQKGATQLGGFGA
IGGLFPDTWNWKGFWHTTALISIILAFMNILPIPALDGGHVMFLLYEMVTGRKPNDKFME
VAQMVGFFILIALVLYANGNDVYRWLFE
>IFAGANLK_00395 Response regulator UvrY
MDKSVSVLIIDDHPIIANAYESALESFVNHNATYNFKITSVYSLDEAQLLLDNTSFIENL
DLVFLDMRLPVSTDGKLVSGEDLGKLIRAKKPDIRIIVSTTFNDNYRLHNILQSLNPEGF
LVKNDINPKELLSAIENVLAGSPYYSKTVLNLLRKQVGSDIYLDEVDRKMLYELSIGAKL
KDLSDLLPLSIAGIEKRRRNLKKMFGISGAEDRELVKIAREKGFL
>IFAGANLK_00396 Signal transduction histidine-protein kinase/phosphatase UhpB
MYFRICLLLFFLVTSCNIDKTSNSSQEYNTAKHFLLDEKEPNIRNRFLNKIPDDSLKNKL
LLDLAYEYYLKEDSARFRYWNSQAQKMAINLDLEANIALTNWDLANFFYREHVIDSSYYH
YNLAFEQYVEAEEELKAGRMLLNMAILQEKVKDYIGSENTTFQALDLIEESTDSQNYVYP
ANNNLGIIYNGLGDYSQALEYHRKALKNAESLEDPVKSARSLNNLGVVYQKLEDHSNSIL
NYTKALQIDSILQKDTNLYAMLTDNLGYSEFKLGNYQVASFLFHKALKIRDSIQHESGIV
INKLHLGEYYLENRDTTQALQYTKKANSLAHATRNNRDLLASYRLLAKIEPRSAPAYLDS
YIKLNDSLLQEERAIRNKFARIRFETDQYIRKTQQLSNEKLWLSLIAVILASVLFLLYLL
SSQRAKNKELKFQKEQQEYNEEIYKLLLKQQTKLEEGRQEERARISGELHDGILGKLFGI
RMNFGLLELKAPNQVSAKYNQLLDKLQLTEEEIRQISHNLIREVSGSHLNFAKLLKQLVA
DYQNLTSAKIEFYFDENIDGELIDENIQINYYRILQEALQNVVKHAEATIVNIKITREQD
VLIMEITDDGKGFDKRKKVKGIGLKNMRDRMEKIDGMFTFETSAMGTHLLFRVNL
>IFAGANLK_00397 hypothetical protein
MKLRATLLGTLFLATFFMSCEPEALPEDQPQMEHEIINIEKTASGDESNPIDDRRNED
>IFAGANLK_00398 hypothetical protein
MKTQKLLLGILATGALLTSCQKEETSTPEETQMEKTTQQTKISKEELKQIDNLHFNTEDA
EAIDFLLPNGETKKSFLIEGDIVLEQEQLESMSSANVTDKQYRTYNLVSSPRNVNVIGFT
GGSEQGLTSKQRTALQRAITNYNSLNIGLNFTLTFGTNYGSYDIVVYQNSNGQAGGVAGF
PSGGDPYKYVQIFSGMENYSTATNEHVITHEIGHSVGLRHTDWYSRQSCGQSGESAGSDG
AVHIPGTPTEFDSNSIMLACFSSSESGNFGYYDEVALEYLY
>IFAGANLK_00399 DNA primase
MKTEKLSCEKARDICIVKYLAKLGHFPSRTSEGEAWFLSPLRSETKASFKVSKTLNRWYD
FGIGKGGSLIDLICHIQNCEVKEALLFLEQDIIYPIYSPPRKQQSKKAKIQITRVEPIDH
PALLYYLKSRKIPINIARLYCYQVWYEWKNKPYYAIGLKNNSGGWEFRNKYFKNSSSPKT
YTVIRNDSEQLVITEGMFDFLSLATMDEELVRNSDNIILNSLAFVDRIEPLIPKYDSVLL
YLDNDSAGKKAAAKFLSLYDHITDCSYTYKDHVDLNENLMKIE
>IFAGANLK_00400 Spermidine/spermine N(1)-acetyltransferase
MKDLELKKNNDWLNYEWNTENNKMQSIKIRKVTTNDINELQDIGRLTFSETFASENSAEN
MERYLEDGFSPKKLKEELTDKNAEFYFAELNQNVIGYLKVNTGQSQTEIKDKNALEIERI
YVLKEFHGKKVGQFLYDKAIELAKEKNVDYVWLGVWEKNQRAIRFYEKNGFVIFDKHIFK
LGNDAQTDILMKLTLS
>IFAGANLK_00401 hypothetical protein
MNTIIRKAVKKDSEKIWELMKELAIFEKYFDTFAITCDIVRKNGFEKNPPDFYCFVAEEG
HNIAGILVYYYLPFTAQNRPAIYMKELYVDENYRGQKIGERLMFALKEEAIKNDCAQIKW
TVASWNKSGQKFYERLGAQKK
>IFAGANLK_00402 hypothetical protein
MNIEQILAKVYPLSEPSRLTLTKKIVKVSFPKYHRILLADRIEKQIYFIKKGIARTFFLI
DGNEITFSFGKEGDTIISMESYIANQKGYENIELLEDCELYKLNIENLQQLFNENIEIAN
WGRKFAELHLLKAEERLMSRQFGTATERYKELLKNYPHLIQRVQLKHIASYLGVTQVSLS
RIRATI
>IFAGANLK_00403 hypothetical protein
MTCFELTKALKLEKVKLSCHSMGTLIGMEFTKQHPDLVTNLVLAGALSPKSNSL
>IFAGANLK_00404 hypothetical protein
MKASIIFILISFQATFLLAQDRNYSEWYLQREDVEIYVKEIGSGKNKLIVIHGGDGANQD
YMMDAIKGLDNKFHFVLYD
>IFAGANLK_00405 hypothetical protein
MHKNISLSLLLVVTVLLSSCQKDDTIPQTDYSIESDTSFEVISQHSNGWIKEAQYNNIHL
EETVPQNEFEYYENGYIKSAKVYSSYPQQHLYMEVNRSEDNKPLGSKYYTPEGDVWFETV
YQSGLPSTKKVYSQKGTAVHSYTDGELATVEFTSADNSATSTTVYNRTAGTKKVTIVQDG
ETVLEEEYSNLENFGNGILTGNRAPMANPFVDTEGYYRQIRSSFFTSTIWENNADPIEYL
KPYRNYYGYHIPGGAEFVPKFATEFAVSSEVYQSIIEQYPVTEDEALVLSYQNTEGSGSF
LPPFEERQALDKEMEENPSLFELKYGNEYIEEIHYGKNIFVIGALRNMPTNDKAATEIKD
IARKHMNGLIDGENQLSNEEAEILDKVWFEVKFFSTLKMHRNGVVINSNADYNKAVQEVM
DAESSIIQLEYIPFDHMISD
>IFAGANLK_00406 hypothetical protein
MYKINGTPLLVIGMMLTALGSTILSDHTFLQYIALFLGLIFSIFSVFLSDKVKKAEMEKA
KIHLTTGKN
>IFAGANLK_00407 Aminopeptidase N
MKHNSIVFILIVFFSFQMLGQDKQFTRADTLRGSITPERAWWDVLRYDIEVTPSFENKYT
SGFNKITYQVVQENHPNLMQIDLQKPLVIDSIIHDKKQALAFTRQGNVYQVKTPSQRMGS
EHEVKIYFSGKPHEAIRPPWDGGWTFTEDEKGRPWMTVTCQGLGASIWYPNKDHQSDEPD
RGASLTMRVPGELMAIANGRMLDKTEHNDGTISYKWGVENPISNYTIIPYIGHYENFAEV
YKGIQGDLDLNYWVLDYNLEKAKSYMPREVHNMLDAFEYWFGPYPFYEDGFKLVETSNTG
MEHQSNISYGNYYSGGYRGNDGSGTGLGLTWDFIIIHESGHEWFGNNITTNDLADMYIHE
SFTNYSETLFMDYVYGEEAANDYNYGTRSGIQNKEPIIPSYGVNAKGSGDMYPKGGNMLH
SIRHSMDDDKLFKNILTGLNMTFHNKTVDGIEIQRYISEKSGYDYSKVFDQYLTTTDIPV
LQLYVDAPNNKMFYRYTNCLEGFNLPLVLKGTQERIKIIPSTEWQSVDVQNRSQYLFTPW
RIEHKYYIDVELVKQMEE
>IFAGANLK_00408 Xaa-Pro aminopeptidase
MFSTTTYTTRREALKKKMKSGILIFPGNKETGMNYKDNWYPFRQDSSFLYYFGINLPDLY
VIIDLDEGKEILFGDDLTPEDMVWVGASEPLANQAEKCGIKEVQPTSKVKDVIQKAKQNG
QTLHYLPPYRSRVTIELSELLGFPVSTIGRNYSIEFVKAVIAQRSIKSSEEIKELHKAVN
ITASMHRHAIKNTKHGVTEKQIAGELQAIAIAGGGNISFPIILTKNGQYLHNHATQARVE
NGDIVLCDCGAETEMGYAGDMTRTFPVAERFTDIQREIYSIVLEAHESAAAALKPGYRFK
DAHLLACTRIVEGLKGLGLMKGDTEEAVNAGAHTLFFQCGLGHFMGLDVHDMENFGEQLV
GYNEDLKKSEEFGLKSLRLGKELEAGNVLTVEPGIYFNPFLIDSWKAKGKYTAFVNYDEV
EKFKTFGGMRVEEDFLITSGGKELLGDPLAKTIEEIEELKNA
>IFAGANLK_00409 Beta-galactosidase
MTHFSSFRYFHFSLLILAFSFSGITQELPEWQRLDILSVNTEEPRASFHYYNSEKEALGG
DYKKSGNYKSLNGTWKFNFAEVPENRPQDFHKTDYNISDWDDIQVPGDWQLQGYDFPLYV
SAGFTFDIDPPFVDNTYNPVGSYKRTFILPSDWRKKDVFIHFGAVNSAFYVWINGEKVGY
KEGTKTPAEFNITDYLQEGENSISVEVYRWSSASYLEDQDFWRLSGIERDVYLFTTPENR
IQDFFVTPTLDKVYDKGILEGYVVIDAEKRKSKLQLDIKLWDGNELISEIKKEVKNAEDD
TLRFEASELNIKHWTAETPNLYHISLSIKEKGETVMATSTKIGFRTSEIKGGQLLVNGKP
ILLKGVNRHEHDQHTGHVISKESMREDIKLFKQYNINAVRNSHYPADPYWYELCDEYGIY
MVDEANLESHGFGYDEDKTPANKPEFEPMHHDRINRMMQTNKNHPSVIIWSMGNEAGDGP
AFIKNYKWLKKNDPSRPVQYERAERGENFKEPHTDIIPWMYASLDFIKNSYLDKYPERPF
IWCEYAHGMGNSTGNLVDLWNFVYEHPQVQGGFIWDWVDQGLLKEDENGNEYWAYGGDFG
PDHYRNDGNFVINGLVNPDRTPHPALYEVKDIYQDIDVSLKESQGIKFTFVVKNRFFFTN
LENYEMSYELFEDGQLIKSGNENFNLGPQQETTNQYELDLENEDSEYFINFYFKTKEAKN
MVPEGHAVARKQIVLQERKEVALDVDSGELKTKKEKSQFVISNDSLEVKFDNETGVLSAY
TFKGKTLIKKGPQPDFWRAPTDNDFGNNFPKRSNAWKSDTQNPKLLKFKVDQTEDGVEVK
TSYQLDSVSSTMNIDYNIYADGTIKVNNQFEFDGDTGKLTSLPKFGNSMILPLDFKNVKW
YGRGPHENYWDRKVSAFLGVYESDVDDLYVPYIRPQENAYRTDNRWIKLIDASGSGIEFI
GIPEVSFSALRNPTSEFDPGVKKAQRHTTDIIPRDQIHLNIDYKQMGVGGDNSWGAETYE
KYQLKPQDYSYSYYIKPVVK
>IFAGANLK_00410 Dipeptidyl aminopeptidase 4
MKNKLTPQLIIFLLFIPFSLVAQQNDSLLSLERIYASGEFKSDYQRPISWIEKGDAFVTI
EKSEAGMDELMKYDSKNYKISLYLSEDELIVNGENLSIEDFSLSPDGSKVMIFTNSSRVW
RSNTKGDFWVYDFDTQKLKQLGKGFPSSTLMFAKFSEDNKFVAYVQDFNIYKENFQTGEV
TQLTKDGTGDIINGTFDWVYEEEFGMRDGFKWSPDGSRIAFWQLDASEIGTFYMINNTDS
VYSEPIPVQYPKAGFDPSSAKVGLINPKTSEVKWIPVPGDPVQHYLPAMQWVNDDLLLIQ
QMNRKQNELTIYTYKPSSSDLNKVYTETEDTWVDLRYPDISSNQWGKNNQLIVENGKSFL
RMTENDGWRHIYKINLETGKKTLLTPGEYDVAAYYHTDGKNLYIVASPDNATQRYLYSVP
LNGGGKLTRISPPEFEGVNTYDVSPNGKFAIHKFTNVNTPNSVSLVNLPKHKTIKELVAN
KHLKVKLKTLVLPETTFFKMTTEEGIEMDGRMTKPMNFDASKKYPVLFHVYGEPWGVVAT
DQWVGLYEIFMAQQGFVVISMDNRGTPTLKGSQWRKSIYQKVGIINTNDQALAAQKVLET
YAFLDKTRVNVWGWSGGGSMTQNLLFRYPEVYQTGVAVAGVANQLFYDNIYQERYMGLPS
EDKEKFIEGSPASYAKNLEGNLLLIHGTGDDNVHYQNMEYLVNELIRNNKQFDMMAYPNR
SHGIYEGENTSLHLYTLITNYFLKHNGLK
>IFAGANLK_00411 hypothetical protein
MRLTKNTLLFFFLYTFVSGCSSDDSFVENDDDKENSEEENNEIDPEGDLKIYIPNEFRDM
DFDDNASTWSYNRSQESEHFIVFWGAEYGDENPGSENIPEQFRVDIDDLLEKSELFYDLN
IVELKFAEVGTGNSKLDEYKMMIFLFHQEEWLATGAGYDDTIGALWVSPNTCQPVGHTIA
HEIGHSFQYQVYSDLQNGHGFRYGFGGNGGNSFWEQTAQWQAFQAYPDQVFTAHDFDVYI
QNYNTHIHHENYRYASYFIHYYWTSLHGKDFIGRLWKEAEEPEDPIEVYMRLTGIRAEQL
NDEIYDAATKLTTWDIDELRELGEEYIGNHKYGYTSLEDGSHMVSPEFAPQTTGYNVIPL
NVPKAGTEITVDFTGLPNQTGFNTVDASIAGWRYGFVALREDGTRVYGEMNQGTTAEVNF
LIPEDCTNLWFVVTGAPTEYSAHAWDDDNSNDDEWPYSVAFSETNILGVVDFPEDAERED
LTLTYDISFPVNTEAYTGGTVNIDANAIANSFLLQPNEITQQIGNDIQFYAVESSGNLNN
NKTANGYGYWFDASGDVINWGDQAVIFSEFDESNFSFNVGQYPGHSITGDSYTIKQALVY
EYEPGNSVQATIILNITLE
>IFAGANLK_00412 HTH-type transcriptional regulator RipA
MKVLPFKIPKPEKEALVYQEDHEIVFYNKLHQHEEIQISYIMEGSGSLIVGDSINEYQPH
DILVIGENIPHVFRSDAKAHPKSVMYTLFFTKKSFGKDFFNITDLTGVQKFFDESEYGMK
IKANEDNYILFNQLKHQNKIERIASLLYLLNGLISSEKNPLSSFVYRKKYTEDEGKRMND
VFQYAMDNFQECISLDDIADIAFMSKNAFCRYFKKRTNKTFFQFLIEIRIEHACKLLYKD
HDLSISVISELCGFQNIANFNRKFKELKGITPSQYRHQTE
>IFAGANLK_00413 4-hydroxy-tetrahydrodipicolinate synthase
MAIKWEGVMPAVTTKFDENDELDLNTFEKNINAQLEAGVSGIILGGTLGEASTLTPKEKE
NLVKKTLEVVNGKVPVIINIAEQSTKDAIQVAQDAFAWGAQGLMLLPPMRYKATDRETVV
YLKEIAKSTSLPIMIYNNPVDYKIEVSLEMFEELLAECDNIEAVKESTRDISNVIRLKNK
FGDRLKVLCGVDTLALESMVSGADGWVAGLVAAYPEETVAIYKLVKAGELKEALKIYSWF
MPLLELDISPQLVQNIKLAEVATGLGTENVRAPRLQLEGAERKRVLTIIDDAMAKRPTLV
DYKSL
>IFAGANLK_00414 Alpha-ketoglutaric semialdehyde dehydrogenase
MITGKNYIGEELSDNGDIKFRTFNPRENKETSPTFFEASKEEVNLAVEKASQAFELYKNK
TNSEVAKFLEAIASALEANGEALKAIYREESGLPEGRSNGEFARTTGQLRAFAEMLKEGS
WVEAIISNPEGKPDIRRMQVPYGPVAVFGASNFPFAFSTAGGDTASALASGSPVVVKSHP
LHAGTGELVSQAIIQAAKKTGMPDGVFSNLNSKGIEVGEWLVKHPKIKAVGFTGSYKAGT
ALSKLAAARPEPIPVFAEMGSVNPVVALPSSLEEKGEEWAEQYAGSITAGCGQFCTNPGL
ILGIESPSLDHFIENLGENLANIAPDVMLSPGIQGQYETSKSGVLSQEGYNPVGKYVGEI
QPNFGRQEVISVTGETFLENTNFHKEVFGPFSVIVKCKNKEQLNEVLQQLEGQLTGTVLN
SDQKELQDYKGVIDSLTATVGRIIYNSVPTGVEVCAAMTHGGPFPATSNAKFTSVGLTAV
QRWVRPISYQDWPDELLPDALKDKNPLGILRNINGKYTTDSL
>IFAGANLK_00415 4-hydroxyproline 2-epimerase
MARKTFFCVDAHTCGNPVRVVAGGGPFIEGKTMSEKRQTFMREYDWIRRGLMFEPRGHDM
MSGSILFPPSDPQNDCGILFIETSGCLPMCGHGTIGTVTVAIEEGLVTPKKPGILRLETP
AGLVKVTYKQEGKKVKSVKIVNIKSYLAKENITVNSCDLGDLIVDVSYGGNFYAIVEVQD
NFKGLEHYQASELITWSRELRNNLNAEHSFVHPEDPTINGLSHIQWTGSVINVNSTARNA
VFYGDKAIDRSPCGTGTSARMAQWYAKGKLKMGDEFIHESIIGSRFIGRIEEETELAGIK
SIIPSIEGWAMVTGYNNIVIDDDDPYAHGFQVL
>IFAGANLK_00416 D-amino acid dehydrogenase 1
MKKVAIIGGGITGLCSAYYLIKEGYNVTIIDKGDITGGASFINAGYVTPSHFIPIAEPGM
ITQGIKWMFNSSSPFYIKPRWDMEFFKWAWYFKKSSTRKNVEKAIPVLVELNLKSRDLYT
EMLETLDFDFHMEKKGLLMVYKTAKNQDHELKLAERGKELGLEVSVLDKEAIKVIEPGLK
EDIIGGVHYLCDTHSTPYIFMKNLKKWLADNGANFILEKNVTGFKTEGNRVEAIVTEAES
IEADEFLIATGSWTSEMTKQLGLHIPIQPGKGYSMDVLRKTNIKLPAILTEAKVAVTPMQ
NFTRFAGTMEFSGNNSNIQANRVETIANAASHFYKDLTITEEEKKLATSGLRPVSPDGLP
FIGKSSKYSNLSVAAGHAMMGWSLGPVTGKLISEIVGNRKTSVSIDPFKLERF
>IFAGANLK_00417 TonB-dependent receptor SusC
MINQLFLIKFIRRKSFLCFFLFFLVSYFAHSQISLTGSVKDENGMPIPGVSVIEKNTGNG
TVTDFDGNFQLNTISENPVLTFSFVGYETQEVNVSEQTNLNIILKEDLSALNEVVVIGYG
TQKRADVTSAVATVKSEEFIQGNVNDAAQLIQGKVAGLSVSTPSGDPTQGAQIMLRGISS
ISGSSQPLILIDGVPGNLQTVAPEDIASIDVLKDGSATAIYGTRGTNGVVIITTKDAGME
IAPTIDYNGYMTLSQINNKMDFLDASELRQKFDEGYTFNGSNVEDFGANTDWLDEITRDA
LSQVHNLIFRGGNKTTNLTASLNYRDNEGIFIKTNNKRYSARIDVNHNMFENKLKSNFNI
ITSEQEFFAGGDGASFNPYVYRQALIRNPTEPVKNEDGTWYERDVYFYDNPVAYLEETDG
KNRYRNLRVTGSLSYEPIEDLVIQGLYTRKGNYNIRGFYQTKNHVSTTKNGLEGYASRGT
DDYIGNYGQITIDYKKNWGDHKFTALGGYNYEDNTYEGFYATNRNFPTDAYTYNNIGIGQ
GLPLGEAGMGSSKSSDKLIAFFSRLTYNYADKYLLMASIRHEGSSRFGAENKWGSFPGIS
AGWRMNEEEFLKDISWIDNIKLRAGFGVTGINAGSSYQSLSSLNYDSYFLYNNRWIRELI
PARNPNPDLRWEKKEEFNAGVDFSFFGGRLGGALDYYNRTTKDALYDYDVPVPPYLYGSI
TANVAQLKNEGFEALINFVPVQTEDFQWSGNMTYSTNRNELLSISNDQFETTNDFFYTGY
VGEPIQISSHIVQVGESIGNFYGLKSVDINEDGVFMIETPDGEIIPATESDASDRQILGN
GLPEHYVSWNNTFNYKNWDLNVNMRGAFGYQILNSQRMFYENPTVGYNVLDTAFDEIYGK
AVLADVQRYVSHYLEDGDFWKIDNITLGYTFNTENIDFLQNLRLYATGLNLITITGYEGI
DPEVNRSGLAPGIDSRDKYPTNRSFTLGVNLTF
>IFAGANLK_00418 Starch-binding protein SusD
MKMLNNINFKIVLFLLFGFTITGCTNLDEEVFSEITEDSFVPAEEDIVALSASAYTPLRY
IMGWQGLFDLQEESADIFVTPTRPNGWDDGGVYKRMHFHTWNETQWQPRNTWITCFNGIN
NINRVISQLESGDLPVSAEQANAVIAEMRGVRALYYSILLDTHGNVPILEDFSDEIPQQR
SRQEVYDFVVSELNSVIPELTETVDQSTYGRLTKWGAYQLLARVYLNAEVYTGTAQWEKS
LEASNQIINSGKYSLDPNYSNIFTTENQNSPEIVFAVPYDYIYATEWSQHMKMLLPSHRD
VFNMQAQPWGGSSANPQFIDSYEEGDLRLENTWLMGDQLDADTGEVLFTLINEIPSIYES
DATDGFRCKKYNIEAGATGSLSNDFPYFRYTDVLMMKAEALLRTGNSAEAAEIVSEVRGR
SFDNPEEATVTGEELEGDTTWEYGTLDENGNIEDPGDQSPVEYGRFLDELGWEFAAESRR
RTDLIRFGVYQTKNWFNHVPQGDHTTLFPIGLEELNTNTNLQQNPGY
>IFAGANLK_00419 Prolyl tripeptidyl peptidase
MRIIKKFYVLLLVFYSLFSFKPLLAQGEVEDYKRANAVDTLFKDKVRNTPDSFHWVNENE
FWYKNNATNGDKYFLVDAKLKSQRQAFDHTRLAGALSEVLEKEVKPTSIKISELNFIEDD
QYLEFQNDSLKFRLNLSDYHLAVTGSVSKKEQEKRYWGDRRKEEKKEPVPSPNGRYKAFI
KNFNLFLVDKNSGEEAQLSFDGSKGFYYSPNIIWSPDSKKILAYKVKPGQEHKIYFVESS
PEDQLQPKLQSRDYLKPGDELDFNSPQLFHVSEKKHIPVPSDLFASQYNLFNYKWFDDSS
AFTFEYNQRGHQVYRILKVNAETGKVQVIIDETSPTFFDYSGKRYRYDVEGKDEIIWASE
RDGYNHLYLYDDDTGKLKNQITSGDWPVRDVLEVDDEKRQIYFTASGLDKDQDPYLIHYF
RIDFDGRNLTRFTSENGNHKVTFSPDYKYYVDQYSRVDLPPVSVLKQTGKKKPIMELQMA
DISALEKNNWKMPEVFTAKGRDGKTDIWGVIVRPTNFDPNKTYPIIEYIYAGPHSSFVPK
EFHSQYSTLQPLAELGFIVVQIDGMGTSNRSKAFHDVCWQNLKDSGFPDRKLWIKAAAEK
YPYMDDERVGIRGTSAGGQSAGAALVFNSDFYDVAVASCGCHDNRMDKIWWNEQWMGYPI
GPHYAASSNIEHAEKLKGNLMLIVGEVDDNVDPTSTMQFADALIKAKKDFELVVLPGESH
TSGGEFGERKRRDFFVEHLLNVKPPSWDKIYED
>IFAGANLK_00420 Non-reducing end beta-L-arabinofuranosidase
MKVANRIPIYLSLILVACSGIIFPTQAQSGDQILDGIGETGLIARYVLDGDVRDWSRNNL
HAELNGQYEFVNDEKFGKVLSLSGEGKAYMAIPGEALTGEESFSITGWVFLRSSEPNQQF
FDFGKSRKNHFSASPTGSKKQEGFQAHVIIGDKKKQSTAAPVVNTNKWVHLAVVVDFPSQ
TLTAYLDGKPIGKKENTTIDLQELFDSKSIKNSLLIGKSLVPGHPYLNASLHDIRLYRIP
LRDGQVSRIYNNSTGEGSSLVNEGEEKEDNLPRFSQTAPQLYNKYLKSVPDLKVETEVGQ
LPRLPRYVDGVYQDGIEGPAVRVLWPAPKDNSSVLKPGKYVVEGRIPGTNLRPKATVTVN
AAKVEAAAAPNRRLEAFGLNQVSLDPDVNGDDSKFIENRDKFVLTLAETNPDSFLYMFRN
AFGQEQPEGAEPLGVWDSQETKLRGHATGHYLTAIAQAYASTGYDESLKDNFAEKMEYMV
NTLYELSQLSGRKTKTSEEFVSDPTAVPTGPGKSEYNSDLSEDGIRTDYWNWGKGYISAY
PPDQFIMLENGASYGGQEDQVWAPYYTLHKILAGLMDIYEVSGNEKALAIARGMSDWVNV
RLSELPIETLINMWNTYIAGEYGGMNEAMARLYRITNESSYLEGAQLFDNIKVFFGDAQH
SHGLAENVDSFRGLHANQHIPQIVGALETYRGSGSPEYFQVADNFWFKAKNDYMYSIGGV
AGARNPVNAECFVSQPATLYENGFSEGGQNETCATYNMLKLSRDLFLYDQRTELMDYYER
GLYNHILASVAEDSPANTYHVPLRPGSIKHFGNPDMKGFTCCNGTAIESSTKLQNSIYFK
NKDNQALYVNLFVPSTLNWTERDIQVEQTTAFPKEDHTQLRIRGHGKFGLNIRVPQWATK
GFFVKINGKKENIAAVPGSYLKLSREWKDGDTVELQMPFAFHLDPVMDQPNIASLFYGPV
LLAAQESEPREEWRKVVLNAKDLSSSIEGDPGKLHFTIDGVVFKPFYETYGRHSVYLDVE
LK
>IFAGANLK_00421 hypothetical protein
MVDIINTFKADKNALRGTYTIKESEEYYQRFFRFYDNWENRIKEIKFKDLTPTEKVDYVL
LKNLIEKEGYLLNQDYKAFEEVASVADFTEILFPFIQERRRGKQPDANVLAQQFKKAEEI
IQTKIKQLENDKFQDWLKAEKAAGIVTSFQQGLKEAYNFYYAYDPDFTWWMESPYKSLDE
DLTKYSDFLKENYSKESIKDDGSGIIGKPVGRKTLIRNLEYEFIPYTPEELIETAEKQFE
WCKQEMIKASQEMGYGNDWKAALEHVKNTYVQPGKQPEAIKDLYDHSVDFIEKRDLITFP
EMAKETWGMIMMTPERQKVNPFFTGGWEISISYPTQGMSHEDKLMSMKGNNPNFSFPTVQ
HELLPGHNLQFYMNARHKPYRSVFGTPFWMEGWALYWEINLWNKDFPRTPEEKMGMLFWR
IHRCARIIFSLKYQLGEWTPQECIDMLVDEVGHENANAKAEVRRSFATSYTPPLYQLAYM
VGGLQFYALRNELLEKGWTEKQFHDRVMQENMMPVSVLRFLLENKEIPEDYKASWKFSTD
FK
>IFAGANLK_00422 Intracellular exo-alpha-(1->5)-L-arabinofuranosidase 1
MKITFKLLIVLACFFSACSEKENNSLLSPREGENIKEKDWQYEEWSPTELFSDTLSENYN
TQILILHSDSLITERWFKTIGVKPFAEYKVSGYIKTVNVAGESKEAGAGFRLGKFDFKGD
TIFKGSTNWTKVEMEFSTEMDDSFILELILGKGGKAKGKVYFDNLRLEELSADDLNPTVK
IEPEKKLEPMSPYIYGQFIEHMGKSIYGGMWAEMLEDRKFYYIPGTPKSPWYASLDPSEV
GIDSSYSYSQGKLPVIQVEKKINLNQDNLSLESGENYVGRVVFKGEGINEVIISLNGNKK
SFVIDQEIGFQKIPFEFSAESDTKTGSLEFNFIGTGELTLAAVSLMPATNIKGYRPEVIN
LMKELNSSIYRWPGGNFVSGYDWKDGIGDPDKRPTRFERAWNGLEYNDVGIHEFMQLCEI
LEAEANIAVNTGLGTAQLAANEVEYINGARHTEMGKWRARNGRPDPYNVKLWAVGNEMFG
DWQLGHMPIEEYVEKHNKVVKAMWDIDPDIELIAVGYPGMWNDMMYENCSENMTYISEHF
YKQDWHAGGLLTHVNQMPEIIKEVAEEHRRARREIPSIKEKNIKIAMDEWNYWYGPHVYG
LLGTRYFLRDALGIAAGLNEFSRQSDIYYMANYAQTVNVIGAIKTTKTEAWLEGTGLVLK
LYRKEFGTQPVELSGNPQPLDVAATITENGEFLTISVVNATHKDQVLEIEEAANTLRNTG
TSYIISGENDMVYNDDDNPERIKITEAEIQISENKLDIPRESAGIYKFSLIENSYEN
>IFAGANLK_00423 hypothetical protein
MKIKKAKILLFLLFIGATGIAQEKSTYWDNIKDRESTLGLEDGFIELKTEEFTLKLVKAS
QTIAKLSPNSDPDFDFTPGERIETRDKDSIYYIGDLNFRIKDKDGKYTSFSTAYNRKKVK
ALPASGTVLAASDLSNTLPEDNPLEIKRYYEEKDGSLLMRFEITNPASTPIEIGALGVPM
AFNNILEGKNLDETHADNVFFDPYIGMDAGYLEVKHLTGEDEALLVLPGENMPFEAYRPL
LDDPSNRSIVFEGVHEWMALSKAYAENEWKGVEQWNQPTSLTLKAGETQDFSLKFVLAPG
IEQIQDKLIEEGRPVAVGIPGYVLPMDVEAKLFLNYPEAVEDIKIEPEGAIEIVEAERKP
GGFTAYNVQGKKWGSARAIITYKDGLKQSINYKVIKPESEVVDDFGNFLMTQQWFDQPDT
LFGRTNSVISYDYETKKQLTQDSRAWVAGLSDEGGAGSWLGAIMKQLIQPEKEEIKKLQK
FIDETMWGGIQYSEGELKYGVKKSIFYYEPEKMPEGTYSDTINYNTWAAWNKKGADDPGR
SYNYPHVAAAHWVMYRLARYQKNLVDNHNWKWYLENAYHTAVAMNRLAPHYAQYGQMEGT
VFLMILKDLQEEGLTDLARDLEAEMKKRADVWKSLNYPFGSEMPWDSTGQEEVYMWSDYF
GYDQKADITLNAILAYMPTMPHWAYNGNARRYWDFLYGGKLSRVERQIHHYGSGLNAIPV
LKAYRDNPDFYLLKVGYAGTLGAIANITQDGFGPAAFHSYPSTLRIDYHSGDYGSGFFGY
AINSATYITKEENYGWLAFGGNLRNKNNEVEVELTTAAKNKVFIASENLWLTLDAGKIEK
VTYNEKNKEVKLQLREKDKFTPIAYLRSNKELELEFKKIRGAYQIELGSKKKEITIKL
>IFAGANLK_00424 hypothetical protein
MKKVLFIILIAFTSFNMQAQKNIEKEAPFSNQIIDVDLDFASSIEITTWDQPTIQVKAVI
KTQDPKYTELFDIKFKDDNHTLFITSNSKDVFKAYQDDHDLPDIGVIYSQGLDHQFNYQL
MVPKDVKLNISSITGDISSDYVNGEISVDLVSGNIQIEEFDGNLNLDTVNGRIELPGNDS
SMVAKTVVGKIQTTPELAVVRKEKFIGQEISLKNENAQNSMRLNTVNGYIVIN
>IFAGANLK_00425 hypothetical protein
MPKFEYTTLAQRYTARFPLLTYVGTQVNFWIMANVLLVIILNLQQRIIDQSLNTSIAVKF
ESILLIAIISGIFYGISLGLSGYYLDRSSFGKLPLGEIIVFKAGGSLILLTILLWLLQIL
LFNSSTASLFYIPGLIFNEGSWRYLIYLLLIYYFFMTLIISFINQVNRKYGPGVLVPLLL
GRYRNPREEERIFMFMDLKSSTTTAERLGHLRYSAFIRDCYGDINEILFPFRAQVYQYVG
DEIVVMWPASEGLKNHFCIRFYFACQDKFRDRRTYYTKTYGFIPEFKAGLHMGKVTAVEI
GEIKKDIAYHGDTLNTAARIQGVCNEYNKDFIVSDCLIERVGENRRMTTEDLGMILLRGK
TEKVRILSVGWCVS
>IFAGANLK_00426 Exoenzyme S synthesis regulatory protein ExsA
MEHTSKYLTPEIKLSCYEDSFFKSDIVFDQHMLIWFISGETKIIQADATHHFKTGDIFLI
PRNIPATIINYPKDGLPHKTVVMLLTTKILRSFYAGTTSKHHAISDPKIRSFSNHPLLES
CLASLIPYFEMKEPFPVNLASLKIVEAISILRAIDNKIDRVLDNFDDPHKVELISFMEKN
YMFNMPIHKYAYLTGRSLTTFKRDFKKTFDTTPRRWLTRKRLELAHYQLTQKKRKPVEVC
YESGFENLSHFSFAFKKHFGYSPKNLMQENLLPSNAPANSLMTGNKNAP
>IFAGANLK_00427 Fatty acyl-CoA reductase
MKKDNYRGAIQKPVGSGFNKSSRASDVIKDIDLTGKIAIVTGGNTGIGLETTKILASAGT
KVIVPARDVDKAKKNLAGVLNVEIEKMDLMEPDSIDAFAEKFLATGRSLHLLVNNAGIMW
VPLRRDNRGFESQLATNYLAQFHLTAKLWPALKKAHGARVINLSSQGHQFAPFCFEDPNF
TQREYETLQAYGQSKTATNLFSVELDKRGKKTNVRSFSVHPGSIAGTELGREASLELFQK
MGFCDDQGNILPEVAANLKTIAQGAATTVWCATSPMLEFLGGVYCEDVDIANLAVDSSPS
GGVKPYSLDKANARQLWTLSEKMTGISFDAN
>IFAGANLK_00428 hypothetical protein
MQKLAGKDYSFRTLQRYNTTKKHLNDIISSNYKSDDFRVKDIDSKFINSFIYYLKTELNL
AHNSALKYLAY
>IFAGANLK_00429 hypothetical protein
MQDLMSVLFYVRKSKDKNATHTTVTLESLTKENELKPVQCEKFFFQNGMRKLTK
>IFAGANLK_00430 Tyrosine recombinase XerC
MSVQLREKKIKNGKSFYLDIYQNGKRTYKFLGIKVITKGPKKDTPLNRREKTRIAEERAA
QEQIKLISKGTSYTPEYLREVSFEDFSNDFLDKYTKRDHRIVQAAVKMFKKMIDARSLYV
SDITPELMERYRDFLLASEDLSGETPHNYFTRFKKLLRSAKIKGLLSEMPTIDIIFKNPN
KEDNLRKEILEIDELRILSKTHCGNPEVKKAFLFCCYTGLGLAEVNDLKWGEIKKDRLVT
KRKKTGSTINNQLSPATLRLLGEPGEKEENVFDINKISHNAVNKNLKHWLKRADIDKKIT
FYCARHSFACLLLMNGANLKSVADAMGHASTKTTLKYLNHVERLKDEAINNLPEIEI
>IFAGANLK_00431 hypothetical protein
MKYNDTYFPKTSMFKKEILERGEEYFRLRYNIIDVTDFINLSFQDEYSYYLKNKEYFAGC
ALKTYKGLYNSRLKTFEENYPYADEFDFIRKELTIIKRIGFHEEYYNFFNDLYRKPYKYN
FRLSSELTREFLFSKVLKDLGGSLELGEKYYEIYLLPDTADELKETAFWNFLPKRPKTDD
ESIQDENVNSRKSNNINLSALETAYLAHYFVESKEYKFINGTPGKGDWEHFSNITSGASS
TNIRKYYSENLKPVNRLKPSRIAKIKKVISYLKAHFPNYQRSLQEAEQELQVMQQELY
>IFAGANLK_00432 hypothetical protein
MNKESKKLAKDLYFLKPVLSFEEACEYTGLSKSWMYKLTHRGDIPHYKPDGKKIYFKTTE
IENWLLRNKVSSNAEIKSKAAIHSLA
>IFAGANLK_00433 hypothetical protein
MSHSIFDYNRAWFNHAFDNPDKVKPVHHAIYYFALEHNNRLGWKDKFGFPSSLAMEGAGI
KSYNTYIKAFREILQWKFFILYKKSENQYQANIIGLSKFDRSLNESLDKSLMNHSTEHCS
STEQITDSIIIQQTDKQKDQKTTRGFSPPSVDEVYNYMSEKGLKDQQADKESEKFINHYE
SKGWKVGKSKMKKWEAAASGWLTRMQNFNNSPQKSQQNGNTSRINRQTPAVVGENLDSSG
YDFN
>IFAGANLK_00434 hypothetical protein
MNLSDAHEKKKFQDGLAVILTKVANLTGLKDPIHPINKRDIAQMIVTLYKTLSLEEIDYA
FRIDRYGYHGEPTKHYQLFNAEFVTTVLIKYEKWKRTTLRSCPPTRFEDKHQAKKVLVNK
CFKEYRETGKLFRSWTKSQIYEAYWYMYSRGFLPSHTELFKEKYRRKVVKRMYKAAEEMG
VFAKRRRIYKLKGIQIGEKLDSYLCIYMTVETFFRKLIAQEKEMQDLL
>IFAGANLK_00435 hypothetical protein
MRSIQYISNRVNCEERLQVLGDAVLSLAKISDKFLRRANAEEVPDEAALRLINYLLSFES
FQELESYWFYYYDPKNLGEWEIILDHVYRRSITAKHLMN
>IFAGANLK_00436 hypothetical protein
MKSNFGITPQTETRIMEKSKEKIRNKGRVEGTLKLIKFLNDYRTIAECANHVDIHRKSVH
RYFNLLTQLGFEIEILVKYRHKYRIINLKEYFQDGNEM
>IFAGANLK_00437 hypothetical protein
MRDSKILIGLLITLGNTYDQHKGKNFTVLYNTHYSDLKNKIKNNSYLWSITQGNILGFSV
N
>IFAGANLK_00438 hypothetical protein
MNHLQTFNYSYEKLEILKILAKFPEDAQKAYELILAGLNEYEIPRIQNILIQFIKDGIWD
FEETEEGKMHSDFKIDFHDYILNYPNPIPENIRSGIDTNSILEKLPCSNLNLFEINYISA
LLKKDAVSQF
>IFAGANLK_00439 hypothetical protein
MKKIIYFLPALLFFFSCSSDSSDDLPGEEEAKTSKFTVEFLQSGDTDKFEQEISFAGSPV
GWENTETGAEVDPELSNSEGQHFSSSFSYSTEDPTTNIRVIYQAIPFDLEEELSLDVTFK
IYKNGELIDTKEISINNDIIKTHYFDWLYFADEQYM
>IFAGANLK_00440 hypothetical protein
MNRIKEVLEEKGITQTLLAEKLGKSYNMVNSYAQNRQQPRLEVLADISKILDVDIKELIV
STKTSPLEN
>IFAGANLK_00441 hypothetical protein
MNLAKQIQKGESKTLELKEKLPKNTNIAKTVLAFSNTAGGKLIIGVNDKREIVGIEDIAL
FEIQDKIASIISDQCSPNIIPEIYSVNIENKLVLVIEVVRGNLKPYFLKNQGKANGTYIR
IGATNRLADLENINELERQKRHISFDEEICYETTFEDLDTSPLFDQFDKIGRPLNPEKLQ
NLKLVKSENNILYPTNSLMILLGKFPHCMVKCARFKGKTMDVFIDKKEYTGDIFSILENT
QHFILNHINLGAEINGLYRKEAYEIPEVAIREALVNAIIHRDYINRGRDIKVGVYDDVVN
IVSPGSLPSNITIEDIFNGRSESRNRVIANIFKELGLIEQWGSGINRIINSCKEYGLPAP
KINEKNDFMDIEIIRSQDNLQTIKAEVQPIATDYDRLRPIATDYDRLSEEEKQLLLYLLD
HQQIVRKEAVHLLKLGETKIKEVFKDLLDKELIERKGKGRATFYTLTNS
>IFAGANLK_00442 Type IIS restriction enzyme Eco57I
MALFQTSVLKSYLAQLDDSAVEKAFKKYQKYFWNTSIQENIKKAKEEQYQATFLNELFVN
ILGYTLFPNPDSNLTTEFKNEKNARKADGAILKEDSAIGVIELKGTNTKDLESIRKQAFD
YKANNNECVYVVTSNFEKLRFYIKDATEFEEFDLFSLTKEKFNLLYLCLQKDKVLNNIPL
KVKEASIAEEEEITKKFYKDYSLFKRELYRDLIKNNSKTVKNKLSQIENIEDHEDVLRLE
KNVRKTLFKKSQKLIDRFLFIFFAEDRMLLPSNSTRQILNKWKDDWDFGDERPLYDLFKQ
YFNFLDGGRKGTEKRAEIYAYNGGLFKTDYILDALEIDNDLLYKHTLNLSNYDFESQVDV
NILGHIFENSLNEIESINAEIEGGDFDKQSTKRKKDGVFYTPKYITKYIVENTIGKLCNE
KKKELGFDEEQYFKGRKNRNKSTIEKLVQILDNYRDWLLQITICDPACGSGAFLNQALDF
LIKEHKYIDELKAKVLGGGLQFPDIENTILENNIYGVDLNEESVEIAKLSLWLRTAQPRR
KLNDLSSNIKCGNSLIENKALAGNKAFTWDQEFTDIFEKGGFDVVIGNPPYVRAELLSDF
IPYFEKNYKVFHPASDLFAYFYELGSNLINENGLMGYISNTFDKTTAGNVLRNYLNTETR
FQEYIDFTEVQIFDGATTYPVIIILDKKDSKSNKFKYIKIPKSSQNSVVNIEVHQSIDVL
QESLNVSSWSFLSAEKGKLFRKLASLKTVKEIFGKSYRGLITGLNEAFIIQEDICNKNHI
KPIFEGKEIKKWSTQEATQNLILFESKWTNEVYPNLETEDDKLKSLKNDYPKIFKNLTPF
IEPAKKRYDKGDYWWELRNCAYYDLFEMPKIIFPNLQNSNKFCLDTKGTYVNAPAVFLPS
DNRTLLCVLNSKVVWEFLKSICVVRSGGYIEVKPQYFEQIPIPEFKNEEYFTEATDKIMS
NVNDLQILKNRFQNYFKSVLHLNRLQRKLENWNDLDFSTFIKELNKAIKSANKIRTKENL
DPITTLTKKDEFEWMELFEENKKKAQDLQAHIYNTEHEIDQMVYGLYGLTEEEIKIVEAS
>IFAGANLK_00443 DNA replication and repair protein RecF
MYLKNLKLWNFRKYGNLAPFNLAEPNLDLDFSKGVNVLIGQNDSGKTAIIDAIKLVLKTH
SYDWLKIANDDFYMESDRLRIELILVDLDPEEAKHFTEWLGWDKKVGEEAKCFLRLIYDV
RRNIADNRIFPSDVKAGVDPVGYQLTAEAREFIKTTYLKPLRNAQSELVPRINSRLTQIL
QEHEAFRGRNNDHLLVGLFNDFNISVEKYFLGFANNGVPLPSVEQKGKELKKEIDGYIRS
FYDEKKESLFGVKGNNLKNILEKLELSIKDEINPGLGTLNRLFMASELLHLRKKNWTGIR
LGLIEELEAHLHPQAQMQIIEALQEDTEIQLVLTTHSPNLGSKIKLENLILCSNNYAFPM
GKEYTQLDNGDYEFLERFLDATKANLFFAKGVIMVEGWSEEILLPAIAQRLKEQNIIQKN
LTEAGVSIVNVASTAFQRYAKVYLRKKNLRNKIEIPVAVITDVDIRAFQETIMTGEDGKP
HKVYTKKDMSSVETESIAEITKLKAKFDKDNVKSFIARHWTLEYALLKSPSLKTIFIEAL
MEVHQKIEPNNIEAELGKKLINKTLYKTELAYKVASKIEKQTVCAIAEDDAGIKYLVDAI
KYVCND
>IFAGANLK_00444 ATP-dependent DNA helicase Rep
MIEVTPDDIAYTESLLLKSGQTFDQERLNFIKNFKTLDLQAVPGSGKTTALLAKLLILER
HLPLEKNRGILILSHTNAAIDEIKNKIGHHCPMLFSHPNFVGTIQSFTDVFLAIPAYVTK
YKQRPVRIDDEIYNETIGRIFYYNKTGFDTQEKKNAIYYNTNFNVLFSIRFVLEDGLFRL
AKSISGDPLVIKTPTPRKEKFNKNELDRIADWLYKTKLKVLEAGVLCYDDAYLLADLILT
EIPSYKNLIQNRFKYVFVDEMQDMEKHQFDLLERIFASENSISFYQRLGDVNQSIYSKSL
DVNEIWNQRSEKVFINGSHRLSAPIAKIVEKFSLTSTQVEGRMTDTNGNQLTIKPKLICY
DIERKTDVIPVFSDLIKELIDDGLIIANEDNKYEAIGWRKHHNDVNKICISDYWENFKTN
GKSKKIDYDTLEDYLKFIENRSYTLGPYRKSILNALNKILYLEGIRDEYSRVFTISKLIK
YFKDLDNEEYDSLKLKLYNWCLGLKTGEISLVLKEIRAYVPEFLNSFDRQLKFSEEFINE
SSTNIDVEIPDEDTQFFEKNGFRVNVSSIHSVKGQTHTATLYLETFFSRGAGSYESERLR
NQILGTPIREYLNNYKGGSVEKIIQSARMAYVGFSRPTHLLCFAIDNSRAELFLKEINEN
DWDVIQIKKQRKQ
>IFAGANLK_00445 hypothetical protein
MTYLEKYVKERGGILSGELARYIEKKQGISNDAARKRVQRLKSPIHKISGLFSDNKVFIY
HSDNYQTRDYFDDLVKAFKTDGKRCYSIINGLKYHHGLVPVDELANYSMSPVNLVKGHMK
FSSVIELMKKHNLIHETRNGEFGLNISIAEHLSPNIRYIKGVQLSKSLVIQQFETWSKNI
GLVSFKKSKNNNVVGNFQFAFTAPTYIDGLVGYIGKTKKPGFLVADILIGNITNEDTVSF
FLKKIASIKASNPTLKLLPVLLVDGITAEGLNSLKSRGVLVASIKELFGKDYSDLLKNLI
NTVTNAGAILKTEPEKYLQLMKKLTKLIDGKTNNLRGDLFELAVGFYFSKYSQSLDIGKR
IPVTDSNRTREIDVLAKSENEICIIECKGYNYPVDIGFVEIYLSEKIKEIRGWLAIAHPE
QRHRFEIWSTGGFTKEAIVLLEATKKKVRKFDFDYLDQNDIKEKANKLNSEKFKEILRDY
YFKEIT
>IFAGANLK_00446 hypothetical protein
MYTKYDQPPEEEIQNPHHGVTFDYYFMGRRQGNQPGSTYVDLILCSAVYDSQNNKYTRKE
HMGMDRSQVKSHIENRIRQHLADLGVDPVMVKGLMRDFEVDLSKCREYDSDEFRPPL
>IFAGANLK_00447 hypothetical protein
MPARPEKIYSQLVIILKDGREEKEKKAIPNIQSAKAENKSLDLSNIDNLAKISANNSVIK
LYKNGLEKALLSLEKTQDQKAVALGKYENQDDNVVLVKKVVTTFSFCNPKLNTRQERTET
FVLSKDGSKVLGVVS
>IFAGANLK_00448 hypothetical protein
MDDQLANVFRGYIELGIQERKEFREMISEFEGADYSKKKEAREIFNKSLGPLMNDVCKCC
GK
>IFAGANLK_00449 hypothetical protein
MNEEILRKESWNKALQSFGKAYIFSQRAEFYKKWIRSLTWLGIIIPLMIGGIAMGYGYNS
SILDIALSITIPVITLQLGISAFALVNNWSDYLSYSLEATNDYNSLSESFKKIAINPPKD
SYEHQKLYDILETKYSLRMQQDSKYGLKDRELRRGMRSGLREFQRECVACRETPLSMQST
SCQICGNFTRNLIQRIFYHG
>IFAGANLK_00450 hypothetical protein
MGNPENWKEVIRDQIKTLMVDISIGSTFIKSSLRFFKVENDHHRETAAFEKEFLELKAKA
>IFAGANLK_00451 hypothetical protein
MKYSKPPRTIKEHLELLEDRGLSIENPERAIKYLTNIGYFRITGYMYHLQESDGSHRFKE
PTTFNDIIQHYHFDKKLRSLILEYLERIEVSLRARLTDYMSLNHGFFWYTEKDLFEDYAI
FTKINEEIVDSFRDPQERFLKAFKANYDNEIPPSNMAMEILSLGRLSRLYKGLKNDEEKL
QIAKDFGLPSTILSSWFIFLNNVRNICAHHGRLWNRGLTADRPTIPSRKKHQFKGEVPEN
FNRSIYGVISLIDRLLHNTNSTNRFTAKIEELVEDFPVVNTYFMGFPDNWKEAAPWKK
>IFAGANLK_00453 Ribose-phosphate pyrophosphokinase
MPNVIPEAKIFSCTQSKALAEKIAAAYGTKLGNVITSTYSDGEFQPSFEESVRGSRVFII
GSTHPGADHLMEMLLMLDAAKRASARHITAVLPYFGWARQDRKDKPRVPIAAKMIASILE
TAGATRIITMDLHADQIQGFFEKPVDHLYASTVFLPHLKELGLDNLTVASPDMGGSKRAY
AYSKALESDVVICYKQRAKANIISHMELIGNVEGKNVVLVDDMVDTAGTLTKAADLMMER
GAKSVRAICTHPVLSGGAYDKIEKSKLMELIVTDSIPLKQESKKIKVVSCANLFADVMNR
VHNNKSISSKFVM
>IFAGANLK_00454 50S ribosomal protein L25
MKSITINGSKRESVGKKATKALRNAGQVPCVLYGGDAKPLHFATEEISFNDLVYTPDVHT
VEIKFGDGEKFNAILQDIQFHPVTDAILHVDFYQISDDKPITMEIPIHTEGVARGVKNGG
VLRYNLRRLKVRGLANELPDYITADVTKLKIGQKLYVTAVADESYEIQHPDNTVICQVRT
SRNIVALEDDEDEDEVPADEVPSTETDDVAAVKEGEDN
>IFAGANLK_00455 Peptidyl-tRNA hydrolase
MLSFFGRILSKKKPQEEEQDPMKKFLIAGLGNPGPKYENTRHNVGFKILDYIAEKEEVSF
STEKLGDVAQFKFKGRTFILLKPSTYMNLSGKAINYWLQKEKIALENLLVITDDLNLAFG
TIRLKTKGSDGGHNGLKDIQNTLNTTRYNRFRFGISDEFSKGQQVDYVLGEWGEEEKKEL
PERFQKSAELVKSFGTAGVSNTMNSFNGK
>IFAGANLK_00456 Riboflavin biosynthesis protein RibF
MALKIHKGANAFKGEKQTVVTIGTFDGVHAGHQKIIKRLVDAAKIENLESVIFTFFPHPR
MVLQKESGLKLINTIEERTEILEKTGIDHLVVHPFTQQFSRLTAQEFVRDILVNRLKAKK
VIIGYDHRFGRNRTADIHTLKQFGEEYGFDVEEITKQEVDQVAVSSTKIRNALLEGRVGK
ANSYMQSPFCLTGNVVKGRGLGKEFNYPTANLSIEEDYKLIPKSGVYVVSSKIDGEHYFG
MMNIGTNPTVGGKDQTIETYFFNLDRDLYGTELKIEMLVRIRDEKKFDSVNALKIAMKQD
EAFSRQYIRDNYAQ
>IFAGANLK_00457 hypothetical protein
MLNKWLFKQVDNSALIAFRIIFGLLITIEAVGAIFTGWIRRTLIEPDFTFNFIGFEFLQP
LPGNGMLYYYGILGLFGIFVMLGFKYRFSIFCYTLMWAGVYLMQKSSYNNHYYLLMLLCG
IMFFLPAHRYFSIDTWKKPSLKKISMPNWVWLFIVLQLWIVYTYASIAKLYPGWLDGTLP
AMLMRGKADYWLVGEFLQQDWVRYAIAYFGILFDLLIIPALLWKRTRLPAFILAIFFHLF
NSFIFHIGIFPYLSLAFCLFFFPSEKINKYILRNKKPYYDKGEIIIPSYKKPLITVLSIW
FVIQIALPLRHWFFQDNVLWTEEGHRLSWRMMLRSRSGKTTFKVVEKGKRDTIYINKARY
LSRKQMRSVSAKPDMMWQFAQRLEKEYAEKNKEVQVFVKSKISINGRPYEPFIDPKVDLA
AEKWQHFKHHDWILPSKLD
>IFAGANLK_00458 Serine--tRNA ligase
MLQVNHIRENKEDFIKGLKKRNFEAENILEEVLQLDENRRATQVKLDDILAESNRLSKEI
GMMFKNGEHQKANLIKEKTGKLKEDSKALSEELSEIVLKLETLLYTIPNLPHDSVPAGTS
EEDNEEIFKEGDVPVLAEGSLPHWELAKKYDIIDFELGNKVTGAGFPVYKGKGARLQRAL
ITYFLDKAIDAGYTEYQLPLMINEASGLGTGQLPDKEGQMYHITADDLYMIPTAEVPMTN
MYRDRLLTDKDFPIACTGYTPCFRREAGSYGAHVRGLNRLHQFDKVELVRIEKPEDSYAA
LDNMVDHIKDILADLKLPYRILRLCGGDLGFTAALTYDFEVFSTAQDRWLEISSVSNFET
FQANRLKLRYKNKAGKKELVHTLNGSALALPRVLAGILENYQTEEGIKVPDVLVPYTGFN
LID
>IFAGANLK_00459 Beta-barrel assembly-enhancing protease
MIHRANPYLYGMRVTFIFLILFCSISGVRGQSEVLARNFFDQGEFEKALKTYEKLVEENP
QNTSYFFGLVESHQQLENFTKAEELLREKLNNSANNPTLLIELGHNYELQQNDEKADQFY
AEALSAVDARPNYAYSIARTFHKYSLLENAAKTYEKAMELNNELNYNLQLARIYGEQGET
EKMFKNYLELIEANPDFFSIANREFGKYISADPSTEANTAFRRLLLTKLQQNPSLLYNEM
LSWLFIQEQEYLKAFSQEKAIYRRSDKSLQSILNLAVMAREAEDFDAAIEIVNYVIEEAP
SENIVLQGNQFLLKMQLENEDEKKYSDIEKRYSELLEEFGTGLNTLNLQLDLANFLAFKQ
EKKEEAIALLKKLSEKANRDFDKAMIKLALADILVLQEKFNEALIYYSQVQNLVKNDQIS
QNARFKVAKTSYFKGDFKWAKQQLDVLKSSTSQLIANDAMELSLLIEDNSIEDSTQTALK
KYARADLLDFQEKNSESIELLGELLNLHKGEKIEDEALLKQARLFEETDQPEKAENNYLA
IIENFNADILADNAHYYLAELYANELQKPEKAKEYYEQIIFNFADSIYFVEARKKYRALR
GDYEENP
>IFAGANLK_00460 hypothetical protein
MYIYNVTINIEEAIHDQWVKWMKEEHIPEMLDTGKFKKALMTRVMVTEAMGGITYSVQYT
AENKAELEKYYEEDAERLRGKSKVFEGKFVAFRTEMQVISEQ
>IFAGANLK_00461 Ribosomal RNA small subunit methyltransferase A
MGKYKKRGKPSQSEDGEVRAKKHLGQHFLTDESVAEQIADTLSYKGYNKVLEIGPGMGVL
TKYLLKQDAEVHVIEIDTESVAYLQEHYPQLEDRIHQFDFLKYDVGTTFRDEAFAIIGNF
PYNISTQIVFKVLELKHQIPEFSGMFQKEVAERICGKEGNKTYGILSVLVQAFFEAEYLF
TVPPSVFNPPPKVESGVLRLIRKEDFSLPCDEKLFFRVVKTAFQQRRKTLRNSLKTFDLP
DNLREDPIFDKRPEQLGYQEFIDLTLKIQPYAVSNQ
>IFAGANLK_00462 Magnesium transporter MgtE
MQFQISSELIEKLQFLVEQENNEELLLHLEDVHHADIAEILTELSLEEATYIVKLLDSQK
TAEALMELEEGVRERILDTLSAKEIAEELEEMDTDDAADIISELSPERQQNVIAELVDEE
HADNIVELLRYDEDSAGGLMAKELVKVNENWSVTGCMTEMREQAENVTRVHSIYVVDDKN
KLKGRLSLKDLLTAPSHANIQDVYIPQVDYVNVHTEGEEVARVMQKYDLEAIPVVDEMGR
LVGRITIDDIVDFIKEEAEKDYQMASGISESVEADDSLWRLTRARLPWLVLGLFGGLGSV
YIMKGFEEALEQFPILFFFTPLIAAMAGNVGVQSSAIIVQGLANDNLRGSLLQRLIKEVS
LSLINGLALGILVILFGYIVGQDQLVSITIAASLLSVIIVAALVGTFVPIILNKQGIDPA
IATGPFITTSNDIFGIFLFFYISKLVLGF
>IFAGANLK_00463 Hydroxypyruvate reductase
MIILHSDTNHPTLIKQLQDAGHQNIEGFTQSREETLENQHLYDGIVIRSRYTIDKEFIDA
APNLKFIARVGAGLENIDVEYAEAHGITLFSAPEGNRNAVGEHTLGMLLSLFNRLNKADR
EVRDGLWHREENRGLELDGKTVGIVGYGNMGKAFAKKLRGFEVDVICYDIKEGVGDENAR
QVSLEEFREKCDVVSLHTPWTPQTDQMVNKEFIDAYKNPFWFINTARGKNVVTADLVDAL
KDGRVLGAGLDVLEYEKASFESLFSNKKNVSLSIENQIPDAMRELMFLNNVILSPHVAGW
TKESHERLASVIAGKIIDKFGRGEEK
>IFAGANLK_00464 hypothetical protein
MMNYRVENLNELLETLKGEGVEVMDEIQKVEEGKFGWIMDLEGNKIELWEPNDKAFL
>IFAGANLK_00465 hypothetical protein
MKTSELFDLLKQHQEKPLLFEYAPNLLIGANYHITEVKHLKIDSVDCGAGTDAWSETIIQ
LWESPEEIGKTEFMQVSKALSILDKVGHMKAYDLEAEVKFEYSNANFHTAHLFVTGFSIK
NGNLLIQLDVNPTDCKAKETCGVAEPSMASSSECAPGGGCC
>IFAGANLK_00466 Glutaredoxin arsenate reductase
MKNVLVLCTGNSCRSQMAQGYLEHFAKERANIYSAGIETHGLNKKAVAIMKEDRLDISHH
TSNHVDEYKEVEFDFIITVCDHANENCPFIPSKNAVRLHQNFKDPSKVEGSEEEIKKAFK
TTRNEIKAWCEKFVNDNL
>IFAGANLK_00467 putative sugar epimerase YhfK
MEKILIAGSTGQTGKRVIEILNNTEHFKPIAMIRKEEQKQIFDDMEVESVMADLEGDIEH
AFKGIDRVIFAAGSGGSTGPDKTTAVDQEGAKKMVDAAKKFNVKKFIMLSAMGTDKPEEG
GDLEHYLRAKKEADDYLVDSGIVYTIVRPGALTDDMGLAKVKLDLKLNERGEISRDDVAF
LLVMCLADPLGKNMAFEALEGEESIKSALIELSQNN
>IFAGANLK_00468 hypothetical protein
MGIVSSREVAKVMNLQKIGLLGTSLGWLILRTTKLSRLNKEYQKRKNLNGIDFIDSILDG
FEIDFEIPEKDLKRIPKSGPFITISNHPLGGIDGMILMKVLLHQRPDYKVIANFLLHRLD
PLIPYIMPVNPFEDHKDAKSSLGGIKEAIYHLKDGHALGMFPAGEVSTYKDEKLIVDKPW
EPAAMKLIQKAKVPVVPIYFHAKNSTFFYRLASMSDILRTAKLPSEMLTQKRRKIKVRIG
NPISVEDQIAHPNLEAFTAFLRRKTYMLANVFEKKKLFDIPKHLKLPKSPKKIAAETAEA
LMEIEVENCRKMDKRLLSSKNYEVFLAKKEVIPHIVAELGRLREITFRAIGEGTNNATDL
DKFDEYYYHLFLWDNEAKKIAGAYRMGMGNEIYAKYGIDGFYLQELFRFEPELHKMMSQS
IEMGRAFIIKDYQQKPMPLFLLWKGIVHCTLRFPEHKYLIGGVSISNKFSNFSKSLMIEF
MKSHYYDPDVARFIKPKKEFKVKLKDADKDFVFDASKADLNKFDKIIDEIEPENMRLPVL
IKKYIKQNAKVVAFNVDPLFNNAVDGLMYIKIEDLPESTVQPVMEEFQKELEEKFNSAH
>IFAGANLK_00469 Lysine-sensitive aspartokinase 3
MKVFKFGGASVKDAAGVKNVRNVLEKTGNGPKVIVISAMGKTTNALEIVIKDYLFGKQIP
ESLQAVEDAHFTIINELFPETQSPVFIKINTLFTELRNFLQHNKSEQYDFVYDQVICYGE
LVSTTIVSEYLNSQDIKNNWLDARQFVKTDSVYRDAGVNWEDTQEAIQQNLNTNEVNITQ
GFIGSDPNNFTTSLGREGSDYTAAIFAYCLNAENVTIWKDVPGVLNADPREFQNPELLQQ
ISYEEAIELAFYGASVIHPKTLQPLQQKEIPLFVKPFLKPESEGTKVGKGQLIFPEIPCF
IVKKDLVLISLSTLDFSFMVEENISEVFRLFHQYQMKVDLIQNSAISFSVCVDNKFNQLE
KLIQHLKARFKVSFVPGVSLFTIRHFNDEAIKSLEKDKEILLKQLTHNTLQIVTRN
>IFAGANLK_00470 hypothetical protein
MEYVIREAKRKDMPAVLELIKELASYEGATDEVEIHVSDLEHEGFDEANFKCFVADVKGK
IEGMALVYFRFSTWKGRTVHLEDLIVRESMRGTGLGGALYKRVVKYGHENSVRRVEWVVS
EGNKNAQEFYENTGADIKKNWYTVHMDETGIQKNID
>IFAGANLK_00471 hypothetical protein
MEFTIRKASQEDMTAVLELIQELAEFEKEPDAVIISAEDLKRDGFGENPSFTCFVAEAAG
KIEGMALCYFRYSTWKGKTVHLEDLVVRENMRGKGLGNALYKRVIQFAKEEGVKRTEWVV
LEWNTHARDFYNRSGATVFTDWCTVQMEEEAMDKFLAKSR
>IFAGANLK_00472 Fructose-1,6-bisphosphatase class 1
MVKKNQTLGEFIIENQEAFPYSSGELSRLIRSLRLAAKVVNHEVNKAGLVDILGLHGDTN
IQGEDQQKLDVYANETFIQTLINREIVCGIASEENDDFITISGKNNDNRNKYVVLMDPLD
GSSNIDVNVSVGTIFSIYRRVTPIGTPVTKEDFLQPGNKQVAAGYIIYGTSTMLVYTTGC
GVNGFTLNPALGSWYLSHPEMKFPEDGKIYSMNEGNYVHFPDGVKKYIKYCQEEKEDRPY
TSRYIGSMVSDIHRNMIKGGIFIYPKSSKASNGKLRLLYECNPMAFIVEQAGGKATDGFN
RIMDIQPTELHQRAPFFCGSKNMVEKAEEFMQKYG
>IFAGANLK_00473 DnaJ-like protein DjlA
MSFSDLFDSGEHLRNINHFASIVNLASSDGAINDKERVLLERFARKLDISEQEYKMVIKR
PADFPINSYNSAEKRLERLHDLFKIIFADNEIDENEENLIKRYAIGLGFSSENAEKIIKR
SIQIFSGQLNFEDYQYLLDK
>IFAGANLK_00474 hypothetical protein
MKPPLLAFNKKGIYCEAADVYLDPWKPVDKAIISHGHADHSRWGNKKYITHHSNVPIIKH
RLGDIEVAGKEWNETFTINGVKFSLHPAGHIIGSSQIRVEYKGEVWVFTGDYKDENDGVA
VPYEPVKCHTFITECTFGLPAFKWQPQAEVFAEINNWWQQNKENGQTSVIFGYSLGKAQR
LLKHLDTSIGKIYTHGAIENMTEVIRPLSEMPESTLITRETKKDEIKGNIVVAPPSAHGS
PWIKKMVPYVTASASGWMTFRGARRRRAIDRGFVLSDHCDWQGLLKSIKATGAEKVICTH
GYTDIFSRYLREIGYDARTEETQYEGEMGEEESKKEVEK
>IFAGANLK_00475 DNA ligase B
MKDFAELIKTLDSTNKTTLKVAALTHYFKNAEEKDKVWTIAILSHRRPPRPVNTTLMREW
ASELANIPLWLFEESYHIVGDLAETIALVIPPAEEPSEKSLNQFLQEIIDLKAKTEAEKK
EYLHQNWLSLNYYERFVFTKLITGSFRIGVSQKLMTRALAKATDIDEDILAYKMMGNWKP
EKTTFKKLILEENEEDYLSKPYPFYLAYALDGKVEELGDVEEWSAEHKWDGIRSQVIVRN
DELFVWSRGEELVTDKYPEFEKFIGNIPNGTVIDGEILPFPEGKIGTFKDLQTRIGRKNI
SKKLLEKTPVILKAYDVLEWKGEDIRIHPFEERRKILEKLYAEVSSEEIHLHLSERISFK
SWTEVAEEREGAREEKSEGLMLKRLDSPYLVGRKKGDWWKWKVDPLTVDAVLTYAMRGHG
RRSNLFTDYTFGLWDDEKKELVTFAKAYSGLTDAEFRKLDNWIKKNTLERFGPVRSVTPH
HVFEIAFEGIAESKRHKSGVATRFPRMVRWRTDKNIHEANTLGELRDLIPD
>IFAGANLK_00476 DEAD-box ATP-dependent RNA helicase CshC
MNKKKLTQIAETWFSNQDWKPFAFQRQTWTAFFQGKNGLLNAPTGSGKTYALWVPIVLDY
LKKNPDYKTTQKKGLKAIWITPLRALSVEIEQAAQRFADEIETGLTVGIRTGDTPQKVRA
AQKKSMPDLLITTPESLQLLLSSKNYEKTFKNLSAVVVDEWHELLGTKRGVQMELGLSRL
KTVSKDLRIWGISATIGNLEQAREVLLGPGSEAFQNSILIRANLKKKITVKSVIPERMEK
FPWRGHLGLHLIDEVVPIINNSRTTLLFTNTRSQCEIWFQKLINKYPEFAGEVAMHHGSI
NKDTRLWVEQAIRNESLKAVVCTSSLDLGVDFAPVETIIQIGGPKGVARFLQRAGRSGHQ
PGKESVIHFLPTHAIELIEASALQKAVKKTAVEDRIPYLLSFDVLVQYLTTLAVSNGFFP
KEIWPEINSTFCFSTMTEDEWIWILNFVTKGSQSLQAYDEYKKIEIEEDGRFKVNNRGIA
MRHRLQIGTIVSDAMLSVKYLKGGYIGTIEEWFISKLTPGDVFTFAGRNLELVRIKSMQV
LVRKSKKKSSKVPSWQGGRMSFSAQMSELLREEMYAASASVSSGAAEKSPELKALRPILE
RQQKESIIPNKNEFLIETFKTREGYHAIFYPFEGRFVHEALGSLLAYRISLLSPISFSIA
FNDYGFELLSDQEIDMQQVLDNDLFSAEFLMDDLYKSLNATEMARRKFRDIAVIAGMVFT
GYPNKLIKSKHLQSSSQLLFGVFKDYEDDNLLYLQSFKETFEHQLEEGRLRLALERIHLQ
NIVWKNCEKPTPFSFPIITDRLREKLSSEKLEDRIRKMLKSLEN
>IFAGANLK_00477 hypothetical protein
MKVQALLNKDSYSKATGRGLLAGVIGGLAGTAVKSLVEHFLPVRKIEQRSAQIKIVDDLS
TKITGSPISVQNEELAEQLVNFPIGASVGAAYGFGKKDNDELNIKDGIILGSSTWITTHE
TSLPLMGLEPKPTDVPIRMQMNELFAHVLFGITTEVVRSTVLQRLNERN
>IFAGANLK_00478 2-oxoglutaramate amidase
MAQKLNTALIQANLKWENPQANRSFFSKEIKALSEEIDLIILPEMFTTGFSMNASKLAEK
TDGLTLNWIREMAKLKNAAVTGSVIITENDNYFNRLFFVFPDGSYKIYDKRHTFTLAKED
QTYTAGKERLIVDYKGWKICPLVCYDLRFPVFARNTEDYDLLIYVANWPSKRVFAWDTLL
KARAIENMSYCIGVNRTGNDGDGYEYNGHTAAYDCLGKNLTELDREEPFVEEITLDKKHL
EETRGKLKFLQDRDEFTLK
>IFAGANLK_00479 hypothetical protein
MLKRIPGILLVAALLLLCVQCAKKGMPEGGPEDEEPPQFIRANPENYNTNFSAEEIRIIF
NEYVKLEDARQQIVISPPIEPRPTIIPMGTARKDVRVQNMDSLQENTTYTINFGKSIVDN
NEGNPLPYFKYVFSTGDYLDSLKISGTIKDANLKAPNEFISIFLYEVDSTFSDSLVYKET
PRYITYTLDSSVNFELENLKEGTYQILAVEDNNDNYNFNPKNEKIGFVENYITLPTDSTY
QITIFKEELEFEPERPKLLKGNQILFGYEGNKGVDSVEINLLTPEPEGFQSRIVKDRKTD
TLYYWYNIRPEYDSLSFEVVSPTRRDTLFTKIAEADRDSLNITTEPSGGIEFEQDFRLKA
NTPITGFNQDLISIRDGDSVIVPFNAEMRRLENEIVISFEKEESTDYRVTALPGAITDLF
EETNDTIQQSLNTKSYADYGSIILTLQNVNRFPLLVQLTDEKGEIQAEKYSDGNTNLHFR
YLKPGKYLIRVIFDDNENQKWDTGNYLKRVQPEEIQYYRDTIDVRSNWDMPETFTLE
>IFAGANLK_00480 hypothetical protein
MHKLPTTSYHLDNENLSKKVFDARLPLKNATSLLYFKKKGMVQNLIHNLMYKKQEDVGTF
LGTWLGEELKSYPGFKEIECVVPVLLYRRKLNQRGFGQELAKKLGAKFIEKLLIKKSSSR
TQTFKNGVDGGTLLMPIL
>IFAGANLK_00481 hypothetical protein
MMTEKKNNTALKILTGVLAVALLALGIYTIKFYNEEKENKAILTKEKEVIEDELNDLIIK
YDEAIDENQVMDQNLVDARNRIERLLDSVEDNEANLVLISRYRREISNLKSEKDRLFRVV
DSLNRQNQMMSQTLDSTNVILEQRTRVSDSLQTTNQDLSNKVDRAAQLKVTNLRGEGVIV
RNSGKLVENDRTRRIDQIRTCFTITANDLAGPGERNMYVQVYNPENELVGDEIVVEHEGG
PMVYSAASKVYYENNELDVCLLANTSENRLQEGTYKVYVYADATLLGTASFNLR
>IFAGANLK_00482 Glycine--tRNA ligase
MAKQEDFFKNVISHAKEYGYIFASSEIYDGLSAVYDYGQNGAELKKNIKEYWWKSMVQLH
QNIVGLDAAILMHPTTWKASGHVDAFNDPLIDNKDSKKRYRADVLVEDYAEKINQKAQKE
IAKAKKRFGDKFDEEEFVSTNPRVIRYKKEEKEILERLAKSLTDENLADVKALIEELEIA
CPETGSRNWTDVKQFNLMFGTKLGASADSATDLYLRPETAQGIFVNFSNVQKTGRMKIPF
GIAQIGKAFRNEIVARQFIFRQREFEQMEMQFFVRPGEELKWFERWKETRQKWHASLGLG
EENYRFHDHEKMAHYANAATDIEFNFPFGFKELEGIHSRTDFDLKAHEEHSGKKLRFYDP
EMKENYVPYVIETSIGLDRMFLAVFSASLKEEELEGGTTRTVLKLPAVLAPTKAAVLPLV
KKDGLPELAHEIIEELKWDFRVQYDEKDAIGRRYRRQDAAGTPLCITVDHDSLEDKKVTV
RYRDTMDQKRVDITELKTLIEQEIDFKTWMKK
>IFAGANLK_00483 hypothetical protein
MKKILFLLILIFGFHSIFLGQDRETAGPVYIDSAKAVTSSAMSKRKLIPPAKEFKIYNPR
NRGINKIVPGKGLPKTRDEALQQKMGEIPVKAPNFTFEAASTQATPTDPTGAAGPNHYVN
GWNSAFSIFDKSGNRIMEPASLASIGGEFTNETLGDPIILYDEFADRFIISQFSDTPESF
LIAVSQGPDPMNDGWYTYRFTTNGVLPDYPKISVWGDGYYITTNKNTRTAATSQVVYALE
RDQMLAGETAQIMSFPLPGIRTNGFYSPAGFSGIGNEIPPRGNSPIVFLQDDSWAGVNED
HLKLWLINVDWNNPLASTISESQELGAAEGVSPFIATFDGGSFSNLSQPGEDTPEMDVLQ
ATMMYMTTYRRFQNYNAVVMNFVVDVDPSAAEHAGIRWYELRQQTDGGPWSVYQEGTYAP
DNSDRFSGSIGLDAEGNIALGYTVLNDNPQNPVFPSLRYTGRYLNDEPGIMTIEEQNIIE
GESPNPNSRYGDYAHLSVDAADGLTFWHNGEYFVGQERKNHVGVFKIAPDFDNDLGVVSL
VSPQDASLGTNEEITVKIRNYGRNGHANFDVSYSINGGPEVTETFEESLAATSSAEFTFS
ETADLSEVGETYDFLFSTNLEGDENIENDTLIASVRHLPPNDVGVTSIDAPQTGESLGNS
EEITVSIENFGGEPQEDIPVFYQVGNNTPVREVFNGTLEVGGLEVYTFNQTADISPSGSY
RITAGTRLENDFDASNDTSVRSVANLDCIPEGSDCSFGDGISFFELEDVLNERIPCGNGY
ADFIGLSATLDRSQGEFTVSVQSLFGDLTDANAEQFSLWIDFNDDAVFGDEERLITSEVI
PTSGEWHSYNFSISEDAPLGQHLLRIRAGDVDFDGDLNNPCEVMAYGTTHDYSVNITDSA
LDIEDFILNEAELVVVSEENKQFRVIMETDYEETLRITVHNILGQKMLENQVENNGTGYV
YELDMSYAARGVYLVRMGTREVGKVKRFIVE
>IFAGANLK_00484 hypothetical protein
MYTQEFTHRLDELTKKFRKTFGELSEREIHWKPDVETWSVAQNLKHLILINESYFPMIDR
LRNKDHRKPFTANLGFLVNFFGKVILKSVQPETSKKTKTFSIWKPSEDNASEDILEKFIE
HQEKLKKKILESEDLLK
>IFAGANLK_00485 Exodeoxyribonuclease
MKIISYNVNGIRAAVRKGFLDWVQQANPDVVCLQEIKATPDQLNLDDFKEAGYPYHYWYP
AQKKGYSGVAILSKHKPLHIEYGTGIDYMDFEGRTIRADFEDFSIVSLYLPSGTNIARLE
HKLQFMDDFQKYVDEVKKDFPNLIICGDYNICHEAIDIHDPVRLKNVSGFLPVEREWIDN
FMKSGFIDSFRHFNEEGDNYSWWSYRANARANNKGWRIDYNLVAEPLQEKLKRAVILPEA
KHSDHCPVLVELESDF
>IFAGANLK_00486 putative lipoprotein YiaD
MKKILVLAFTAVFMLTSCVSSKKYQELVGRHADLKRENRNTQSELEKYQNLDEEFSALKK
DYAEATAERDRLKDELESARKNYATLKNSYDALEENSSAAIAENSRQNRQLLAELEEKEQ
ALVAEQTRLDKLQRDLDARSRRVNELEELIAAKDAKMNALKDAISKALTNFEGKGLTVEQ
RDGKVYVSMENKLLFSSGSWAVNNEGRQAVQQLGQVLAENPDIAVLIEGHTDNVPYGGSG
PLNDNWDLSTKRATSIVQILKENNNIDPQNLTAAGRGEYAPIATNETAEGKAKNRRIEVI
LTPKLDEVTKLLNEE
>IFAGANLK_00487 General stress protein 69
MKYTTLPNTDIKVSKICLGTMTWGEQNTEAEGHEQIEFALENGVNFLDTAEMYSIPGKAE
TQGSTEKIIGSWFKKSGKREDVVLTSKVVGPGNSMEHIRDNLGFSKAAITDALHKSLKRL
QTDYIDLYQLHWPERYTNFFGKLGYEHDENDQWEDNFKEVLETLDGFVKEGKIREVGLSN
ETPYGLSRFLEESRKHNLPKMITVQNPYNLLNRKDEIGLTEILHRENVGLFPYSPLGMGT
LSGKHLDGIQGNSRLGLFPQYKRYSNDQAVKATKAYAEIAKKHHLNFAQMSLAFINTRPF
VTSNIIGATSIKQLKENIGSIDLELSQEVLEEINKIHETYPNPAP
>IFAGANLK_00488 L-Ala--D-Glu endopeptidase
MKQIKILGIFLILIVAGCSQINKASDFITNPTAKEQYKRDFNVSDELFQIWENSAETAFQ
DSVEVSLPYAESGKFYPKSFSVYSYEIELQPGEVLNLEVETDSTKQLVFIELFEKTADSI
TKFEKVESNDFQKKKLNFEAEKTATYKVVIQPEIEAHTPFKFKMEKNPAYLFPVSAGLNA
NVQSYWGDNRDGGSRSHEGIDIFDKRGTPVVAATDGSIGYTGEKGLGGKQVWLRDRKRNQ
SLYYAHLDSIANVSGNVKRGDTLGFVGNTGNARTTPPHLHFGIYKGYRGAINPLPFVYQI
NPLQADPEILDSIPKKLIIKSRTANLRNKPTTSNSKILSTLKAQDTLQFLGKTNEWFHIR
TSANRASFIHQSLVSPI
>IFAGANLK_00489 DNA repair protein RadA
MAKVKSTFYCQNCGSQYAKWQGKCSSCGEWNTIAEEIVEKPDAKDWKSPSEREAKRTAKP
LKIAEIENSPQNRWKTGNNELDRVLGGGLVPGSLTLLGGEPGIGKSTLLLQISLQLNYKV
LYVSGEESQQQIKMRAERINPVAANCYILTETKTQNIFRQIEAIEPEVIIIDSIQTLHSD
YIESAPGSISQIRECTAELIKFAKETNTPVILIGHITKEGSIAGPKVLEHMVDTVLQFEG
DRNHVYRILRAHKNRFGSTHELGIYEMQGSGLREVSNPSEILISKNDEDLSGTAISATLE
GMRPLMIEIQALVSTAVYGTPQRSATGYNVKRLNMLLAVLEKRAGFRLGAKDVFLNITGG
ITVDDPAIDLAVIAAILSSNEDISIPKDICFAAEVGLAGEIRPVTRVEQRIIEAEKLGFA
SILVSKQSKIPKSNFSITIIKVAKIEDVVSHLFG
>IFAGANLK_00490 hypothetical protein
MVKKLLIFVLLVAPLLSSAQTLYETISSEKLGEKREIKIQLPRNYEENTEKTYPVILVLD
GDYLFEPMAGNVDYASYWEDAPEMIVVGVNQSKTRMDDAYYDERNFLPADKGAAFFEFLG
MELMQHLDTKYRTADFRVIAGHDYTANFINYYLLKPDPIFDGYINLSPDLAPPMADRISS
NLAKSETKKWIYLATGTSDIPQLKKGIEDLNSQLAAIENDLVTYKFDNFENATHYSLVGK
AIPSALESMFSVYRPISQKDYNELLLQTSVSSVEFLTDKYASINELFNIQKKIRLEDFMA
VHNAIEKTRRWDDYKELSKLAYDNYPGTMLGTFFEARYEEETGNPKKAMRTYQNAYGQEK
IAFLDTDFMLAKADAIKKDFGY
>IFAGANLK_00491 hypothetical protein
MKKKIIKILKIVLPLLLGVFLIWYSLKSATPQERKELWQNISTANPWFLLLSMFFGGLSH
LSRAYRWKFMLEPLGYKPKLANSFMAVMAGYLANFGIPRSGEVLRAASLSTYEEIPFEKA
FGTIISERIADVIVMLSITAITLFLQTEHLLAYFKANEINPLFSVGILLVLILLGVLGLQ
IIKRSQLSFLVRIKKMAQGLLEGMRSILKMKQKWAFIFHTLFIWLMYILMFYVIVFSIPG
LENTEFSIIMAAFVVGSFAISATNGGIGVYPVAIGAILMLFGISKQSGEAFGWLTWGTQT
VMVLILGGLSFIFLPIFNRQK
>IFAGANLK_00492 Aspartate 1-decarboxylase
MQVHVVKSKIHRVKVTGADLNYIGSITIDEDLMEAANIIEGEKIQIVNNNNGERLETYVI
PGPRNSGEITLNGAAARKVAKGDILILIAYAIMDFEEAKAFKPSLVFPNEQTNLLS
>IFAGANLK_00493 Pantothenate synthetase
MQVFKEKTPLKVAIKAEKSKAKTIGLVPTMGALHHGHLSLVKQALQTCDRVIISIFVNPT
QFDNPADLEKYPRTLEQDIKLLEEASDNLWVFTPTANELYGENISSEQFNFDGLDQVMEG
KYRNGHFDGVGTIVKRFFTIVEPHKAFFGEKDFQQLQIVRKLTEKAGLPVEIIGCPILRE
DNGLARSSRNERLNLEQREKASFIYQTLLKTRELFGTKSADYIENWVKEQFKNHPVLKLE
YFEIANTQTLKKINRKRKGHNYRAFIAAYAGDIRLIDNIALNNEE
>IFAGANLK_00494 Glycogen synthase
MKDKRILYVSSEVIPYLPETEISSTSFEAAKMVNNIGGQIRIFMPRFGNINERRHQLHEV
IRLSGMNLVINDLDMPLIIKVASIPKERMQVYFIDNEDYFKRKATLTDEEGNMFDDNDER
AIFFAKGVIETVKKLNWSPDIIHVHGWLASLLPLYLRRYYGNEPLFSGAKIVTSIYNQDF
EGTLDENMQEKVLYDGMEKEDIKHLKTPNYVNLMKLAADHSDAIITAGEDLPEDLSIYLG
KLNKPILPYKNREEFSQAYQDFYTNEVLSE
>IFAGANLK_00495 hypothetical protein
MMYKTATIFVVVFAFVACDDEYSTVGGEIIENPSNLEREEVEVTAYSKKLNSVQTNNLGN
HLLGVYNHPIYGQTTASILSQISLPTNNPTFGVEPELDSVVLTIPYFSTEGDSDEEGNVE
YALDSVYGNTPIKISLQESNYFLNTLDPEADFQDSQKYYSDQQELFEENLIGDIIYENEN
FIPSPQAIVSYEENDEGEQDTIASGPGLRIKLPVEYFKKKIIDKEGSSVLSNNNNFKNYL
RGMFIKAEATAEDGTMILFNLQGGEAGIELFYTTEVETTNDDGDTETVREPRSYDLNFGS
TIVNTFLGEYPTDVLQAIEESDEDSGAEKLFLNGGEGSMAVIELFENEEQIAAFRENDWL
INEANLTFYVDRDYVAGIDEPARLYVYDLDNNRIIADYSFAMNFVQDGNENNPSTSLTSF
STPLEIDEDENGVRYKLNLTQHVTNIIEDDADNVRLGIAITQNINITNNSAVRNTENVKF
YPAMGIISPKGTVLHGNLSSDEEKRLKLRIYYTEINN
>IFAGANLK_00496 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIVGYIGHRDAYPVVLKGLQRLEYRGYDSAGIALYDGKELKLCKTKGKVADLKEKLEN
TITTNGNVAIGHTRWATHGVPNDVNSHPHYSNSGDIVIIHNGIIENYDALKKELKTRGYT
FKSDTDTEVLVNLIEDVIINEDVKLGKAVQIALNQTVGAYAIAVYNKTKPDEIVVARLGS
PLAIGVGEDEFFIASDASPFIEYTNNAIYLEDGEMAVVRRGKEVKVRKIKDDTLVDPYVQ
ELQLNLEQIEKGGYEHFMLKEIHEQPTAIKDTYRGRMLPDEGLIRMAGVDDNLERIANAK
RILIVACGTSWHAGLVAEYIFEELARIPVEVEYASEFRYRNPIISEKDVIIAISQSGETA
DTMAAIKLAKEKGAFAFGVCNVVGSSISRETHAGAYTHAGPEIGVASTKAFTTQITVLTL
MALKLAKHNGTISNTDFMTYLQEMERIPSKIQKALEGDEHIRMIADIYKDARNCLYLGRG
FNFPVALEGALKLKEISYIHAEGYPAAEMKHGPIALIDEEMPVVVIATKKGHYEKVVSNI
QEIKSRSGKIIAIVTEGDTEVRDLADHVIEVPETLEPLTPLLTTIPLQLLSYHIAVMLGK
NVDQPRNLAKSVTVE
>IFAGANLK_00497 ATP synthase subunit beta
MSKVTGKVAQIIGPVVDVVFDSENAELPKIYDSLEITRKDGSLLILEVQSHIGEETVRTV
SMDSTDGLSRGVEVVATGAPIQMPVGKEVYGRLFNVVGDAIDGLGNLPKAGKAGMSIHRE
APKFEDLSVSTEVLFTGIKVIDLIEPYAKGGKIGLFGGAGVGKTVLIQELINNIAKGHGG
LSVFAGVGERTREGNDLLREMLESGIIKYGDAFSESMEEGGWDLKKVDKTAMLDSKATFV
FGQMNEPPGARARVALSGLTIAEYFRDGAGEGQGKDVLFFVDNIFRFTQAGSEVSALLGR
MPSAVGYQPTLATEMGAMQERITSTKNGSITSVQAVYVPADDLTDPAPATTFAHLDATTV
LSRKIAELGIYPAVDPLESTSRILTADILGDDHYKCAQRVKELLQRYKELQDIIAILGME
ELSEEDKLAVSRARRVQRFLSQPFHVAEQFTGLKGVLVDIKETIKGFNMIMDGELDHLPE
SAFNLKGTIEEAIEAGEKMLAEED
>IFAGANLK_00498 ATP synthase epsilon chain, sodium ion specific
MYLEIVTPEAVVFKADVDAVKVPGHDGEFQMLNNHAPIVSTLVEGEVKIQLAASNKELDD
ELSEEFRKDSANSNILYYTIKGGVLEMKDNKAIILAD
>IFAGANLK_00499 hypothetical protein
MPIIINLDKILAERGMKSNELADKIGITAANLSILKTGKAKAIRFSTLEAICEVLDCQPG
DILEYTQN
>IFAGANLK_00500 hypothetical protein
MKSSEWLKNIFSIAYYLMIIGWIILFGFLLYAIFISPGDILEILRDAEEFKIKSKNALYT
SLAYELSSSGVWIYILYLFKNLMKDLIFRPLFTSLQIASFKLIGQLIILITIVDALSIFV
FKTIFQGRLELSFELFDFWFVIAIGLFLIFLSQIFDQARIIKEENELTV
>IFAGANLK_00501 Na(+)/H(+) antiporter subunit A
MLAAILLGFLFAIFLVFAGKFFRGKLAVLSALVPGGLFAYFASFIPQISSGDIIHKTYQW
VPAFGVDLSFKLDGLSLLFTLMITGIGFLVFAYTASYLKGHKYLDRFYGYLSLFMAAMLG
LVLSDNLISLFVFWELTSISSFFLIGFNNTNPASRKSALTALGITGFGGFFLLAGALLLG
SITGTYSISEMLSIKDTIAGSEYYILAVIFIFVAAFTKSAQFPFHFWLPGAMKAPTPVST
YLHSATMVKAGIYLLMRFTPVLGDSQFWNTTLIIVGGITMVYSAIHALFRTDLKGVLAYS
TISALGILVFLIGLGTKSAFLAAAVFIIVHALYKATLFLVTGIIDHQTGTRDVTKLSGLR
KIMMPVAIAGILAAISSAGIPPSVGFLGKELTYEASSHAETFTIIIVIAIVLTKILLLWA
GFVAGIKPFVGKLPEAHKEVKAPDFLMWGPAIILAVLGIVFGIFPMLIESALVKPVVSSL
GADASEYHLALWHGFNTVLLLSGITIAVGILLYFFLKPSVKLENRIGKLEFISPKSLTEK
GTHYFSVFSAFWTNVFQNGYLRNYVTTIVLFLVVLVGYVMFGNPTVLIDYRQLSEVTAYE
LAVVIILIAGVFYTVFTKSRLAAVAAMGVVGLAICLIFVFYSAPDLAMTQFSIDTLTVIL
FVLVLYRLPKYLTLSDYKMRIRDGVLSVALGTVICLLALQVLAEPTNSEIGDFYAKNAYI
LAHGKNVVNVILVDFRGTDTLMEIAVLSISAIGVFGLLKLRLKSTDRSQ
>IFAGANLK_00502 Na(+)/H(+) antiporter subunit B
MKTLILKTASNYLLPLLLVFSVFILLRGHYLPGGGFVGGLIAAIAFVLHAFANGLDNTKG
LLRFHPGFLMPVGLGLAFVSGLAPVIGLDDPFMTGLWFPEPFPVIGNVGSALFFDIGVYL
VVIGVTLTIIFTISESA
>IFAGANLK_00503 Na(+)/H(+) antiporter subunit C
MEILLAIIIGVLYAAGIYMILRRSLVKLIIGIILLGNGANLLIFLLGRITEGAPPIIPED
SEVFLEAYADPVPQALILTAIVISFGLQSFAIILVKRAHKVVKTDDLDEMNATDEDS
>IFAGANLK_00504 Na(+)/H(+) antiporter subunit D
MTQQLILYPLLLQMLLAIILMFFWRKINAQRIISMFGSLAHLAVSITVFAFIWNNGTQTV
QAGSWEAPFGITFIADTFSATMVLLTSIAGLAVSIFSSGSVIGDRLRFGYFPIFHFLLLG
LTGAFLTGDIFNLYVWFEIIIISSFVLITIGGEKAQLEGAVKYFTLNFLASMIFLTAIAV
LYGLTGSLNMADLANKVAAVENRALVEITAILFLIGFGIKSAIFPLYFWLPASYHTPPSA
VSAIFGGLLTKVGVYALVRVFTLIFVDDVFLDQILLVLAIFTLFSGALGALVQNNIKKVF
SYLIICHIGYMIIGLGMFTEVAIAGTIFYLVHDIIVKTNLFMISGLIYRIKGSNSMRALG
GFYANYPKLSLLMFIPLFSLVGIPPLSGFWPKISLITASFESGSYWSLAAIIFASFITLV
VIAKLWAEVFWKDATEIPVRPKFRYFHAIKNIKRVQIIVPIVFLSLVSLYIGFGAEHIQT
LSARIASELMDNQQYIDAVLNTQTPE
>IFAGANLK_00505 Na(+)/H(+) antiporter subunit E
MKSRFVSNLLLTFVWVALTGDFSFQNYIFGFIVNFFILWVITRGNSDARYFTIIPKLIAF
FFFFLWELFKANLQVAYEVVTPNFGMKPGIVKVPLTIKSNLGITFLANMISLTPGTLSLD
VSNDKKVLYVHAMYVTDKEEFINSIKNGFEKRILEILR
>IFAGANLK_00506 Na(+)/H(+) antiporter subunit F
MTLTDYLYYIILPILAFSVLLIVYRFIKGPSIADKIIALDVLITTGIGIIGVYSIIHGRS
TFLDTAMILALIAFLSTVAFSYYLEKRNRKK
>IFAGANLK_00507 Na(+)/H(+) antiporter subunit G
MSSVIIVILVTLGTLFVLLSAIGLVRMPDTYMRISVNTKAATLGVGLILVGTAVFFNDLS
TTSRALVIILFVFLTAPVSAHLIGRASYFMGVKLWKGSVMDDLRGKYQKNSHVLKSEIDD
TPRNNVDHSRSEDDIVK
>IFAGANLK_00508 hypothetical protein
MELAEFSLSIGLAAMAGLFIGIEREFTGKSAGLKTNALVALGACVFILLSMQFRGEEFVD
ITRVLGQVVTGIGFIGAGTILQHGKNVKGLTTAATIWCSAGAGCLAALQMYAELLIICVI
IVVINIFFGMLEKKLIRGNRKKDDKKE
>IFAGANLK_00509 8-amino-7-oxononanoate synthase
MQLPLKLAKSLEKRKEENALRSLKQNAQLIDFSSNDYLGLASSEEIYQGAHQIVKENNLF
KNGATGSRLLSGNHKLYDLAENFLAEFHQTEAALIFNSGYDANIGFFSSVPKRGDFIFYD
ELVHASIRDGISMSNAKAYKFSHNNIEDLKSRLNRLPKAENSEIYLVTESVFSMDGDMAA
LKELAKILEEFGAFLIIDEAHATGIFGEKGEGLVQELGIQEKVFARLNTFGKAPGCHGAV
ILGNKDLKNYLVNFSRSLIYTTALPPHSVATILAVYQQFKTEIPETQQLKSNIRFFKEEI
IKNDLQKSFLESNSAIQSCIIPGNQQVKNIAESLRKEGFEVKPILSPTVPKGSERLRFCL
HSFNSENDISEVLKNLAKLLPINLHDARVEN
>IFAGANLK_00510 hypothetical protein
MNTFVNIARFQYSSEAQIVKGKLQSEGIEVFLVDQVLIDTDPMVSQAIGGIKLNVRADDE
ERARAILNEIHNYSLDDDGNRVVCPNCDSTHVEVYTHIKDVRSFFAFLFSFLTFALPIHY
KYDYHCENCEEKFTLK
>IFAGANLK_00511 ATP-dependent dethiobiotin synthetase BioD 1
MKHNYFITGIGTEVGKTIVSAIVTEAIEADYWKPIQAGDLDNSDRHKVQKLVSNKNTVFH
KNSFALNMPMSPHAAAEIDEVKITSKKVKRPKTKNNLVIEGAGGLLVPISDKETIADLML
KEDRIILVSRHYLGSINHTLLTVEALKSRGLNCFGIIFSGEENKSTESIIEKMSGLPILG
RIEQEPYFDQNVVKEYAEIFREKLK
>IFAGANLK_00512 Adenosylmethionine-8-amino-7-oxononanoate aminotransferase
MNLTIRDQKHLWHPLTQHKISPEALPIVKAKGSILYAEDGREYIDGIASWYTAMYGHCNE
FITGKVAAQMQNLDQVVFSGFTHEPAVKLSEELIKILPGNQQKLFFNDNGSTATEIGIKM
ALQYHHNRGNNRNVMLAFEEGFHGDTFGAMSVSGLSVYNGAFEEHFIEVLRIPVPLGENN
SEVISQLKKLILENNIAGFIYEPLVQGAAAMKMHDVEGLNEILKVCKENDIVCIADEVMT
GFGKTGSYFASDYMETKPDVMCLSKALTAGLLPMGLTTCSQKIYDAFYDEDISKGLFHGH
TYSANPPACVAAIAGIELLVSKEIQQKIKAIIKSHQIFDKKIRDHPKVTNCRQLGVIYAF
DLNVKMERYGNLRNQLFKHFMDNGVFLRPLGNTIYILAPFTISQTQLNIIYSVIEDLLEK
F
>IFAGANLK_00513 hypothetical protein
MMHPDTELRFINEKVGYGVVATKIIPEGTITWVQDDLDHVFYSAQIERLHPKSLQMLEKY
AFRNRFGDLVLCWDLAKYVNHSFNSNCFSTAYGFEIAVRDIAVGEELTDDYGYLNLDEAF
EAHAENSSRTKVYPDDLVNYHQEWDGILQKSIQKVEKVYQPLIDLVPEGIQLELQKILLG
EKEMDSILNLYYQR
>IFAGANLK_00514 3-oxoacyl-[acyl-carrier-protein] synthase 2
MKSPIFISSLGSISALGQSPAEIWSNYKNQKHFITKKIFGKAEAFAAFLPDNLKAEIESL
RNENTNYRKLDDSVLFAIFSARKAIKDAGWENENNIGINIGSSRGATGLFEKYHKEFIET
GKAVTQASPSTTLGNISSWVSQDLQTEGPEFSHSVTCSTGLHAVVNAIAWMQAGFTDKFL
AGGSEAALTPFTIAQMKAMKIYASEELDFPCRALDMVKKRNSMILGEASGILALQNKDSE
KTIAKITGIGYATETLKHSVSISEKGESLQKAMKMAIGEKELSEIDTVVMHAPGTLKGDL
SEVNAIKAVFGEHTPAMTSNKWKLGHTFAASGILNLELAILMFQYQEFIEVPFSEISKLP
SKLENILVNAVGFGGNAVSILVSRK
>IFAGANLK_00515 Biotin synthase
MATRHNWTKEEILEIYNKPLMELLYEAATIHREHHDPNTVQVSTLLSIKTGGCPEDCGYC
PQAARYHTNVEGNDLMSVNQVKAQALRAKASGSSRVCMGAAWRNVKDGEEFDSVLEMVRT
INKLDMEVCCTLGMITENQAQRLAEAGLYAYNHNLDSSEEYYKEVISTRGYQDRLDTIGN
VRKTNVTVCSGGIIGMGESADDRAGMLVALSTLSPQPESVPINALVPVEGTPMEEQEPVS
IWEMVRMVATARIVMPETQVRLSAGRTQMSREGQAMCFFAGANSIFAGDKLLTTPNPDVS
EDMELFKSLGLNPQKAFEKKEQPKSVSAEESQYQNLGEKPKWSRPGHKIERNLEAQQKRK
AKA
>IFAGANLK_00516 hypothetical protein
MKLNLQDIPRVKALSKEDFLKDYFIPEKPVVFEELSADWPATKKWDFDYFREKAGDVVVP
LYDGTPAKGRQSSHGPAKKIPMREYIDILENGPTDLRMFFFNLLQNCPEFIEDFQYPDLG
VKFFKKLPVLFVGGEGSSVVMHYDMDLANNFHFNFIGEKRVILYPPSESKFLYHVPHSIV
SMEIINMDNPDFEKYPALAGAKGLEAQLKHGEALYIPSKWWHYIKYETASLSMTLRSLPQ
KPGRIAQVLKNLIITRNYDNLMRKIKGQDWIDYKNRKAIENTHRSAGIE
>IFAGANLK_00517 hypothetical protein
MMKNEESLHLEPIPRLKNISKKEFLENYVRPQKPVVIENLTDDWPAKQRWNLDYIKEVAG
EKVVPLYDDRPINSKQKFNEPHTEMKMADYIDLLKSRPTNYRIFLYHLLKEVPSLQKDFK
FPDLGIRFLKQLPTLFFGGENSKVFMHYDIDFANILHFHFHGKKRCIIYPPTQTKYLYKV
PHALISREDIDFNKPDFDKFPVLKKAKGYVTELNHGEALYMPEGYWHQMTYLTPGFSMSL
RATPRTITNFSKAVYNLVVMRNFDNYMRKLKGQKWIDYKNEEAVKRTHKRNKV
>IFAGANLK_00518 Regulatory protein RecX
MKESQQSYTVKEATIKLMQFCAYRDRCHKEVEEKLREMNMIPAAQEQIIMELMQENFLNE
ERFARSFVRGKFRIKKWGKIKIKQELKFKEISAPIIKIALTEIDQQKYTATLYEQAEKKL
RLITETEKFKKKRKLADFLLRKGYESNLVYETTNELLE
>IFAGANLK_00519 Ribonuclease G
MDKELIIRSGTSAVDFALQKDGKLIELNKEEDSNKFNVGDIFIAKIRKAVPGLNAAFVNV
GYEKDGFLHYHDLGPQVSSMLKFIKRVSTGKLKDYSLKNFTFEKDIDKDGVITDVLKSNQ
SLLVQVVKEPISTKGPRISSELSIAGRYIVLVPFSNRISVSQKIESKEEKDRLKRLVKSI
KPKGFGIIVRTVAEGKKVAELDRDLQNLMDRWTGMCKKMYKPHHPSKVLGELNRASSLLR
DIFNDSFTSITVDDETLYTQIKDYVGEIAPSKESIVKLYQSNVPIFEKYGIERQIKTSFG
RTVSMSKGAYLVIEHTEAMHVIDVNSGNRSNKSRNQEDTALEVNMISATEIARQLRLRDM
GGIIVVDFIDMGKAENRKTLFDHLRNEMSDDRAKHKILPPSKFGLIQITRQRVRPEMNIK
TREDNPNGTGEIEAPILLINKIKTDLEKLIKKDHKKITLSAHPFIAAFLTKGFPSPRSQW
FLDHKRWVKILPRDAYTYMEYHFHDKEGNEIL
>IFAGANLK_00520 DNA-binding protein HU
MTKADIVANISEKLGMEKGDVQATIETFMDEVKTSLESGDNVYLRGFGSFVVKTRAEKTG
RNISKNTTIKIPAHNIPAFKPAKIFVEGVKTNVEVK
>IFAGANLK_00521 Adenine DNA glycosylase
MVFSKVLIDWYLKNKRELPWRKTSDPYHIWLSEIMLQQTRIEQGLPYYMHFTSAFPSVFD
LAEASQEKVLKLWQGLGYYSRARNLHETAKYVAEDLNGIFPDSYKELKKLKGIGDYTAAA
IASICYNEPVAVVDGNVYRVLARFFDIETPINSSAGIKEFKALASELLDEKDPSSFNQAS
MEFGALQCKPRNPLCETCPLSLGCLALQKNKIQELPVKLKKAKVKKRYFNYLVVFSEENK
TLLQQRTGKGIWNGLYEFPLIETEEPVSEGAFPSVEKINEILGEQELSLELHNKKPVVHK
LSHQHIYTHFWWVKAEKVGKEGIPVKNVKDYPVPVLIANFLEETALETYSL
>IFAGANLK_00522 Single-stranded DNA-binding protein
MTGTLNKVMLIGHTGDDVKMHYFEGGGAIGRFPLATNETYTNRTTNERVTNTEWHNIVVR
NKAAEICEKYLKKGDKVFIEGRIKTRKWQDDQGNDRYTTEIQCTEFTFLTPKGESEGGGN
MQQQNSPVQNQQNTSKNNNFADQSMAKEEEEDDLPF
>IFAGANLK_00523 Magnesium and cobalt efflux protein CorC
MDSEPPSLLLFWATFDFTQLISYLVLLLLLLCSALISGAEVAFFSLTPADVITEDGKRSK
SQQIVVNLLDKPKKLLATILVANNFINIAIVLLFDSLADRLFGEMNTVLYGINFKFLIEV
GVITFIILLFGEILPKVYASRNNVLFSNFMARPLNFLDTIFTPLSGPMRAVTIFMHSRLG
KQRSFISIDQLSQALELTSEEDTTQEEQKILQGIVSFGNTDTKQVMRPRMDIFALNENQT
YKEIIPEIIDRGYSRIPVYRENIDNVIGILYVKDLLPYIDENSFEWISLLREPYFVPENK
KLDDLLNDFKTKKNHLAIVVDEYGGTSGLISLEDIIEEIVGDISDEFDDEDLVYSKLDEN
TYVFEGKTPLKDFYRIVKIEDPLAFEERKGEADTLAGFLLEISGGFPKKNDVIYFLNYSF
TVEVLDNKRLKQIKMNISPVS
>IFAGANLK_00524 hypothetical protein
MKGFLVIILVLMLVSCGEEDSTPKPRAFLSLNYPEAKYEATNFNCPYNFEINSLAEVKAS
RNNIPCWIDLEYKDLNGTIFITYQEVNNNLDSLLADAQKLPLQHTIKADAIEGDVYTNEI
QNVYGMFYQVSGDAASQAQFYLTDSVNHFVTASAYFRTKPNYDSIIPAADYLKKDMKHMI
ESFRWEN
>IFAGANLK_00525 putative inner membrane transporter YedA
MPLEKLKWVYLILLSIVWGSSFILIKKGLVGLSAIEVGSFRIIFAAVFLILIGFKSIMKI
KKSQWKWMLLVGFLGNFFPVYLFSFAETEIDSAVASILNATTPLMTLIFGAMFFKAVFNQ
NKIIGVAVGLLGTAGLILSGASINPDQNYLYSLLVIIAASCYAMNVNILKTHMSGISPLG
IAAGSFTVLLIPTLMILLFSGFFEKDLSNIVLHHSIGYVAILGVIGTGVAMIIFNKLVQI
SDPVFTTSVTYTIPVVALGWGILDGEVFSAWQLLSAFVILIGVFIVNRSKKVFSKFRKQA
T
>IFAGANLK_00526 hypothetical protein
MKFNILTLFIACFLTTAALAQVDRSKQPEAGPAPKINLGQPDEFTLDNGLKVLVVENHKL
PRVSASLIIDNKPHAEEKPATADLVSSLMGTGSENMSKDDFNEEIDFLGANINFGAERVY
ASSLSKFFPRVMELMAEGALRPKFTQEEFDAEKNKQIESLKSINKDVGSIANRVSSALAY
GANHPYGEFATVENTEKVGLEDIEKFYNSYFKPANAYLVVVGDVETSEVKDLVEKNFGSW
EAGSPNEQDLPEVTNVDETQINLVDMPNAVQSELILQNTIDLEMSDEDYFPVLVANQILG
GSFGSYLNMNLREDKGYTYGARTSTGADKYASRFVAQASVRNAVTDSAIVESLKEIKRIK
TEPVDAEMLENAKSKFAGDFVLRLEQPSTIANYALNIKTNDLDDNFYETFLEKINAVAAE
DIQRVANKYYRTDNMRIVVAGKASEIAENLEKIEFDGKTIPVKYYNKLGEEVEKHQAKEV
DASVTVEKVYSDYIEAIGGRDAVEKVESVVMKAKASVQGMALNLTLKRTTDSKLNQEVSV
GGNVMSKQVFDGESGFVMAQGQKIPYTEDQIKTARIDANPFPELEVGDATLEGIESVEGT
DAYVVALSNNYKAYYNVDSGLKMQTVQTISQAGQTMSIPTGYSDYQEVEGVKFPFKMTQA
AGPQTFEFDITEILVNEGVSAEDFQE
>IFAGANLK_00527 putative zinc protease
MAAFALVCSAAGIAQEVEFTEYDLDNGLHVILHQDNTAPVATVGVMYHVGAKDEEDGRSG
FAHFFEHLLFEGTENIERGKWFDIVAANGGSNNANTTQDRTYYYETFPSNNLELGLWMES
ERMLHPVINDIGVETQNEVVKEEKRSRIDNAPYGKIIYSTGINKYVFDKHPYKNSVIGTM
EDLDAAELDEFKAFFDKYYGPNNATLVVAGDIEIDETKEMIEKYFAEIPEGNEVERVSVE
EDPITETITATEYDSNIQIPAKLFVYRTPSMKEKDAYILDMISSILTDGRSSRMYKKMVD
EEKTALQVLAFPRSQEDYGTYVMGALALGETPLDTLAVSMDEEIDKLQNELISEKEYQKL
QNKFENRFVNSNSSIQGIAASLATYNVLYGDTDLINEEIEIYRDITREDIKRVANEYLNE
NQRLELDYLPESEKE
>IFAGANLK_00528 hypothetical protein
MKNFSVPIKYSLIIAVGLIVYFLILSLFNLHIYPLFSLFNGVIMAIGMWLALKAYRSSKG
AKFKYQKGFMASLLTGFNATILFTIFFALYATELNPDFLNNLINMWRTDYGTDIGIVLFV
VAIMGFATSLVLTLAYMQLFKKSWNTKEGQEHTY
>IFAGANLK_00529 50S ribosomal protein L21
MYAIVEIAGQQFKVAKDQKVFVNRLSGEEGDSVSFDKVLLTGDGDSINLGAPAIDGALVG
AKITRHLKGDKVIVFKKKRRKGYKKKNGHRQSLTEIVIESIDVKGGKKAASTKKEEAPKK
EAKTDSKSEDLNQYTVAELKEMAKEKGLEGYSSMKKAELIEALS
>IFAGANLK_00530 50S ribosomal protein L27
MAHKKGVGSSKNGRESESKRLGVKIFGGQAAVAGNIIVRQRGTAHNPGDNVYAGKDHTLH
AKVDGLVKFSKTKNNKSYVSIEPFEA
>IFAGANLK_00531 hypothetical protein
MKYIDVFRTSDRNEHSIIKNLFDDEKLDYRSYGEATDNATNIGALGNDGLRIEVAESDRE
KATEIIRRSGFLGQSHNISNPKRTKPQVGKWVFVLLAALVVLIAIIFFVWFMSGN
>IFAGANLK_00532 Adenosylhomocysteinase
MSTKTVPYTAYKVKDISLADWGRKEIELAEAEMPGLMSLREEYKNEQPLKGARIAGCLHM
TVQTAVLIETLISLGADVTWSSCNIFSTQDHAAAAIAAAGIPVYAWKGMTEEEFNWCIEQ
TLFFGEEREPLNMILDDGGDLTNMVFDKYPELAEGIRGLSEETTTGVHRLYERMKNGTLV
MPAINVNDSVTKSKFDNKYGCRESAVDAIRRATDVMLAGKRVVVCGYGDVGKGTAASFKG
AGSIVTVTEIDPICALQAAMDGFEVKKLETVLPKADIVITTTGNKDIVRGEHFEAMKDKT
IVCNIGHFDNEIDVAWLNNNHGNSKDEIKPQVDKYTIDGKDIILLAEGRLVNLGCATGHP
SFVMSNSFTNQTLAQIELWKYSEKYENEVYMLPKHLDEKVAKLHLEKIGVELTELKDYQA
KYIGVEVQGPYKPEYYRY
>IFAGANLK_00533 hypothetical protein
MPLYKTITVNPHTKVFIWKVEEPFKKLSEGIELTEHCKNRVNGMKSEIHRRGFMSIRHLM
AEAGYVDQDLFYDDLGKPHLKNGKNISITHSFNFTAIVLSDEKVGIDIEKRRDKILKIAN
KFTPLSEYHTVANEEALIRKLTIVWGAKESIYKMYAEPGLGFLQHINVTDFDFDDAETTA
KVNFKGKESFYEMKFLEFEGFTCVYGWEESRKSEN
>IFAGANLK_00534 Geranylgeranylglyceryl phosphate synthase
MRKFYTEISLAATNGKKQLAILVDPDKFIEAETGFYLKKLPKETTHIFVGGSTVDKSKTE
KTVHAIKVETDLPVILFPGDYSQITEIADALLFLSLISGRNPEYLIEQQVKSVEKLKNSK
LEIIPTAYILIDGGKECAVQRVSGTKPIPQSQVETIVNTALAGEFSGKKLIYLEAGSGAD
FPVSEEIIAEAKKALTIPLIVGGGIRSLEQQNKAYKAGADMIVMGTHFETN
>IFAGANLK_00535 hypothetical protein
MKISVELTLSPLQDDFEPKIIDFIKKLRASGLIVKENPLSTQVYGDYDEVMSILNSEIKE
VFEAIDRGLVYMKIVKSDLSDYAADF
>IFAGANLK_00536 Nicotinamide riboside transporter PnuC
MQPIFDFFFDQYYGYSTLFIILEVIAVIFGFLSVIYSKQNNILVYPTGIISTTIFVYLLW
QWELLGDMMINIYYFSMSIYGWYIWTRKVDEEHYTPITNTTRKENWQSLFIFIATLIFVF
AVYEFFDKWNTWTAYVDTFTTAIFFVGMWQMANRKIENWIFWIIGDVISVPLYFYKGFTL
TAIQYFVFTIIAIYGYKAWQKNLRNDLRPS
>IFAGANLK_00537 Trifunctional NAD biosynthesis/regulator protein NadR
MAEKLAQRPSSVLKVVLFGPESTGKTTLTEMLAKHYNTLWVAEFMRDYLQEKWDKEQKVC
EPKDMIPIAEGQMKRENELIQKANKLLISDTDLLELKVYSEAYYDGFCDPQLLKHALNNL
YDLYFLTYIDVPWTPDDLRDKPEDRIGMFKRFETALKNSKKPYVILKGDLDDRFKTAVKK
IDELLKNK
>IFAGANLK_00538 hypothetical protein
MEFSEIDILQIEEKGLSTQEVERQIQIFERGNIKVDIQKAATVGNGIFAYSVEDQKKYIQ
TFEDQKEHLDLLKFVPASGAATRMFKAFHNFANEFDPGNEGLRDYLDRKEDKSLQLFFEK
MDKLPFYETAFKKANENHPDFSEKSNDERQLILVKTMLYENGLGLSDLPKGLVPFHRYSD
YTATAFEEHLHSAAKYLSVNGVTKLHFTVAEGDKEKFEKEFENIKERVEEAHDTKFDISY
SYQDPKTDTIAVDKENDPFRDEDNRIFFRPGGHGALIENLNKQESDLIFVKNIDNVVVNT
NLPKVVEMKKMLGGKLIALQNQVFEYMQNLDGGNNSEAKLDEIAEFLENELFVKVTSSFN
KFTGEEKTQYLCKKLDRPLRVCGMVMNEGEPGGGPFLIKNEDGEISLQIIEGAQIDKNNS
EQLEILNNSTHFNPVDIVCSLKNHKGESFDLHNYVDKNMSFIADKTKDGKPLKALERPGL
WNGGMAYWNTVFVEVPVETFNPVKTVADLLKPSHQTK
>IFAGANLK_00539 Peptidyl-tRNA hydrolase ArfB
MDEQQITRELSFKAVRSSGAGGQHVNKTSSKVELYFDLEASEGVSEEEKQRLIKKLDSRL
TKENLLILHSEESRSQHKNKELVISKFFDLLRENIKKPKPRKKTKPSKAAKLKRLKAKKI
NAEKKARRNDPLK
>IFAGANLK_00540 hypothetical protein
MKKLGLTLMAVAGMFLFSQNAQAQVEEPEEMEQIEGVEEAQETKDDYKEVDVLALPQAIK
DAVMTDMNGAVAEEAWVKEKEGKKVYKLSLNVDGEKKKAYIDAEGNWIEKEDK
>IFAGANLK_00541 Transcriptional regulatory protein ZraR
MTKILIVEDDVPFGTMLKTFLIKRDYEVELVFSGLEAFKKLKANFFNLILSDVRLPDTSG
LDILKQVKLENAGTQVIIMTSYAEISMAVEAMKNGAFDYVSKPFRPESILQTIKNALTHT
QVQPVAEKRPEKTQKSVSSQGASFVKGVSEAALKLSDYIELVAPTNMSVLIMGESGTGKE
QVAKSIHKQSKRTDAPFIAVDCGAIPRELASSEFFGHLKGSFTGAINDKTGHFEAANGGT
LFLDEIGNLSYELQVQLLRALQERKIKPVGSNNEIHVDIRVITATNEDLAQAVKDGEFRE
DLYHRLNEFSIKVPALKERKEDLMLFAEYFLEEANAELEKNVIGFTESAIEAFKNYNWPG
NLRELKNMVKRAVLLTQEDMIPLKVLPHEIATATQSNTETEYGLFKNKNEEQLILDALEK
AGGNKSKAARLLSIDRKTLYNKLKQYDIKL
>IFAGANLK_00542 Autoinducer 2 sensor kinase/phosphatase LuxQ
MQNTKQSITYKVIGGYLLIAALAAIAVWFVWKQVVAFSEVSENNSSNNEQLFLLSDITTS
LYETENLSRQLIQTGNEADLDKYQLQIDSIQLDIQNLKSSYADNSMKNELDSIAELLSDK
TTNLQELYELREQQRNQNYYSQVLNELRKIDPSFNDYNYQQRFSNLEPHQRRLLISLLEY
SREDNAEQLTNRTADSIIGSVRNVLSQLEVANRRFQNTVDEKEQKFLENDMIINQQLRRL
LGKIEHEEREASIQRAKVSQNMIEESSQIFLIAGIVSFLIILLSLIFIIQDITKSQQYRR
ELEEAKDFAESLLKKREQFMAAITHDLRSPLNTLIGYTDLIEKSSLNTKQSHYMDQVKKS
SNFILHLVNDLLDLSKLEAGKMTIEKLPFNPAKLIKDTVYNSLPATKNENVEVIFEASEE
TDTQVLSDPFRIKQIITNLITNACKFTHQGQIRVGIHLKKEIEDSCCLIISVKDTGIGIS
KEKQEEIFEEFSQENTKIEKAYGGTGLGLTITKSLTELLKGDLKLESEPGEGSEFTVFLP
VRKLPVEAAKAPEVSGIAELPDLTGKTALIVDDEPSQLSLTRELLKSIGMQCDTALNGME
ALKKLGNTNYSLVLTDIQMPEMDGFDLIKNIRKKYKVSQLPVIALSGRTDIDAETYKLAG
FNKSLLKPYKPGKLQQSIAEIFKLNLKQKVNNNLQNSTNNTYDLQDIYDFSAGDQKAVQT
ILEAFIESSRSQIELIAIAREDNDAKEVARLAHKMVPMLKQINALHQAKQFERLEQHEVF
SKEEFKQLKADILNLMEELEQEIKV
>IFAGANLK_00543 Vitamin B12 transporter BtuB
MKSLLFFTGLCLISLQAVAQTHTLQGTVTRGETPVEGVAVYAVEPADGTTTDENGRYSLQ
LEEGDYNLVFSYGNQKTIQVNLDQDKTLDVDLSDVQEVLDEVFLSSVRVSAKSPITYSNL
TNEEIEDRNLGQDIPVLMNYMPNVVTTSDAGAGVGYTGIRVRGSGPTSTNVTINGIPYND
AESLGTFWVNLGDFASSVENLQLQRGVGTSTNGGGAFGASLNILTDGYSEEANAEVANSY
GSFNTHKHTVKFSTGLIDDHWEFAGRASQIKSDGYIDRASSDLKSYFLQGTYVDENTLVK
AITFGGSERTYQAWYGIDSTTLANDRTYNPAGVYTDEEGNTKFYDNQTDNYKQDHYQLLW
NQEYNKNWSSNIAFHYTYGRGYYEEYEEDATLNEFGLENFQAEGEEVTTSDLVGTKWLDN
HFYGSVFSLNYQDQDWDVIVGGGWNRYIGDHFGDVIYTRFARNNDPYEPYYENTGAKTDF
NFYGKATYAVSEKLAAYLDLQVRTIDYETVGMLSEGTEFLVDDSFTFFNPKAGLTYALND
QNQFYFSYARANREPRRSDYENGEPEHEELNDFELGWRHNTPSVQLNTNLYYMGYQNQLV
LTGGIDDVGAFIRENSGNSYRLGLEIDAVIRLSEKVFVRPNLALSRNKNVDFVSTWDGEL
VDFGDTDISFSPSIVGGNRITYLPVEGLELSLLSKYVGEQYMSNIETENSKLDAYFVNDF
NIQYTWRNAPLFKEVVFTGLVNNILGEEYVSNGYYYTFNVENPDNTTGLQTLDGAGYYPQ
ATTNFLAGITLKF
>IFAGANLK_00544 hypothetical protein
MKKTLFLLLFSVIISACSTNDDNDLNNPNLIDLNFRLQLNLDFPEYNDLQFPGNSFVTYN
EGIRGVVVYNINNSQYTAFELSDPNHPPSNCSAMTVEGVTATCNCEDANSYNIITGELLE
GEGEYAMKPYRIERRGNMIEVYN
>IFAGANLK_00545 Transcription elongation factor GreA
MSKVSYYTEEGLKKLRDELNQLRDVERPKASEAIAEARDKGDLSENAEYDAAKEAQGLLE
MKISKLEEVVANARVIDESQLDTSKVLVHSHVRIKNQTSGAEVKYKLVAQSEADLKTGKI
SVDSPIGKGLLGKEVGDTAEIDVPSGKMKFEILEIWRE
>IFAGANLK_00546 putative HIT-like protein
MASLFTKIVQGEVPAYKIAEDSQFLAFLDVNPNSKGHTLCIPKKEVDKIFDLEEEMYQEL
MRFSRKVAIALEKTVDCKRVGMAVVGLEVPHVHVHLIPLNSMSDMDFSKSVKMKDEELKK
LAESIHVNL
>IFAGANLK_00547 Long-chain acyl-CoA thioesterase FadM
MGTEAYKLQLKLRIDWSDLDMYKHVNNISFMRYMQSGRVNFWEASGIYKMYENTNMGTML
VSTHCDFKKSLYYPGKAIVKTKIDFIKNSSFGLKHLILNEANEVCAEGKDVVVCYDFEKD
KTFRIPEDLREQLSKF
>IFAGANLK_00548 Sporulation kinase E
MNFTDERTFNRWFIIISCFIVVGLVLWNTSIFFQRLKQDERAKMNIWAKAQEALDRDPPP
ADADLDLILEILNNNTTIPIIHTDTDGDIAYTTNIDPDKLENEKQAEQLLESLKEENAPI
IINLGNGEQQYIYYGNSPVLNSLKYYPVGLVLIGFLFIGVVYFFYTTTKNSEQNKLWAGM
AKETAHQIGTPLSSLIGWTEILKQENVKESYLVEMEKDINRLETITERFSKIGSSPILEK
TNIIEATQNSFDYLKTRSSRLIEFSIDVPKGYIPVMLNSQLYSWTIENLVKNAIDAMRGK
GKLHIQIKEEQKWAHIFIKDTGKGLDKSKFKLVFEPGHTTKRRGWGLGLSLAKRIIEGYH
HGRIKVAESEIKKGTTFKISLRKV
>IFAGANLK_00549 hypothetical protein
MLTIDPKEVSTGKLHRYLLGAIGPRPIAFASTVDTEGRPNLSPFSFFNVFGSNPPTLIFS
PSRRGRDNTVKHTYTNVKNVDEVVINIVNYDIVQQMSLSSTEYAEGVNEFEKAGFTMLKS
DLIKPFRVAESPVQFECKVKQVIETGQEGGAGNLVICEVLKMHINESILDEDGFIDQHKI
DQVARMGGNWYTRANMGMFEVPKPLSNLGIGIDAIPAEIRESKTLTGNDLGKLGNVEALP
KDEEVASFIDENKDLSELVKLNNKRDIHTRAQLFLEKNNTDAAWKLLLAKTD
>IFAGANLK_00550 hypothetical protein
MEVQGKIKLIGETKTFGNNGFRKREVVVTTEEQYPQHIMIEFVQDKTDLLNNFQVGQPVK
VGINLRGREWVSPQGETKYFNSIQGWRIENLQADPSAGGENVPPPDNFEPANNLNEEDYD
DLPF
>IFAGANLK_00551 Leucyl/phenylalanyl-tRNA--protein transferase
MHYLQHNEKFPPISEADDQGLLAIGGDLSIPRLIYAYNHGIFPWYDDSQPVLWWSPDPRM
VLFPEKLKVSKSMKQLFKKEAFTVTFDEDFEGVIEACAEIRREGQHGTWITPEIIKSYRE
LHEFNIARSVEVWQEDKLVGGLYGIYLKEQQVFCGESMFTTVSNASKYGFITLVDQLKDE
GVKLIDCQVYTKHLESLGAEEISRARFLKYLEVPFED
>IFAGANLK_00552 DNA-3-methyladenine glycosylase 1
MAKLQRCGWCEGDALYEAYHDNEWGVPVYDEETIFEFLILETFQAGLSWITVLRKRENFK
KAFDDFDYKKIAKYSEEKIQELLENPGIIRNKLKVRATVTNAQNFIKIQEEYGTFSKYIW
SFVDGEPIQNEVKNYKKSPATTAISDKLSKDLKKKGFKFVGSTVMYAHMQATGMVNDHEV
TCFRYKEVKKLS
>IFAGANLK_00553 hypothetical protein
MDFFDKHKALIITVLFCSVLILGLYNFSLSQKQKYQQEMLVDLEEYTQTEEEEEEISEEP
ETQTNENSPETHRAFNENQEAREENFNRELDEILEQNSAQQEESSESESATQGTVPTANK
SETKKQSDGDNSSENISTQSGSLRNSSISFSLRGRNAISIPNPIYTCDRAGKIVVNITVN
AEGRVIETGINKASSTSDNECLIENALEYSSDAVFSQLAGRNEQPGTITYNFKP
>IFAGANLK_00554 tRNA pseudouridine synthase B
MTTEIKKFTPEDFKTGQILVFDKPLEWTSFQLVNKVRWLIRKSCGIKKIKVGHAGTLDPL
ATGVLVICTGKFTKKIAELQGTEKEYTGTFTLGATTPSYDMETEVDKTYDTAHIADEDLD
GAALQLTGEIEQTPPVFSALKKDGKRLYEYARKGEDVKLESRPVTIHEFEVEAPRFPEVD
FRIVCSKGTYIRSVANDFGIALGSGAYLSSLKRTRVGEFTIDEALDLQSFEKLLPSA
>IFAGANLK_00555 Undecaprenyl-diphosphatase
MNELDAAILGIIQGLTEFLPVSSSGHLELGKALLGDNSIPSESLLFTVILHAATALSTIV
VFRKDVAEIFNGLFQFKWNDEFKFSLKIILSMIPAAIIGVFFEEQLEGLFGGNIIFVGFM
LIVTALLLWLADKAKNTDKPVSYSNAFVIGVAQAIAILPGISRSGATISTSVLLGNDKTK
AARFSFLMVVPLILGKIAKDLLDGNLMESTTSFSILAIGFIASFLAGLAACTWMISIVKK
SKLSYFAIYCFIAGIVSIAVAYYN
>IFAGANLK_00556 hypothetical protein
MSKKQQPTDHKKYFIFEKKNYQFMFIGLAVIALGFILMAGGGSDDPNTFNPDIYNFQRIR
LAPTLVLLGFAIEVYAILLNPKK
>IFAGANLK_00557 hypothetical protein
MNNNTNPNTTLDEVKNLISYSIYNFDSEENSNYNLMHRAIIKKYFDAKNVKINYKEQTVD
LKIPVGKRKYTGITFECQDLERFLKSCLKKDEKSMDFYQEILNHYNIYHAA
>IFAGANLK_00558 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MKLICISDTHNKHQQIPIPGGDVLIHAGDITEGGTKREVVDFLNWFAAQPHEYKIFIAGN
HDFYFEKFSEEEIQEIIPENIHYLKESEITINGIKFWGSPVTPGDGTWAFNQKPPQEIDA
HWEKIPEDTKVLISHTPPYKIKDVLNNGRHIGCASLFKTIENREIEFHIFGHVHDSYGIT
RVGGTKFINASCLDNKYRYLHPPLELEIN
>IFAGANLK_00559 hypothetical protein
MILKLSIKIVFITVEIFLAVYSFALSDSLLIKFLFFAVTAVIVAFSVTKITNKLLPIDKD
FISSEEEEAEEK
>IFAGANLK_00560 hypothetical protein
MKKKSKLFLSFIVILIVLAIAIIGGNMFIESKMETALEENLKKAEFKYEDLNASLLGRSV
SISNPVYKKNGMQINAEEIKLDGIDIFEYLSNNNIEIRTLKLTKPEVAIYTEAEKEKDTS
EGENSTEIDLLIKSVEVVDGDFKMAKSDSVKEQLLVNIPSLNLKDVSVDQKSLKNGLPFN
YKDLQMTSDSLFFNLNDLHDMYVEKMEMKGSSLVFSNIKMKPLYDKQEFQKHIPYEKDRF
DLSLGELTLQSFNWSFKNDSLSIESENTEITNGDIKIYRDKQVKDDPRQKPMYSKMIREL
PFKLKVDTLKVDNLAIQYEELVKPKRGPGKVTFKNLNASIYNISNVNMDAEDFPRTDIDV
QTQFMGEASLNVNWNFDISNKADVFSISGQMDKISSEGINQFMEPALNVKAEGGIRDMRF
NFTGNNQNSSGDMKLVYKDFKVEVLQSDGEEENKLFSAIANLFINNDATSAEKEQKDIQT
ERTQNKSFWNYLWKNVRNGALKSFL
>IFAGANLK_00561 TRAP-T-associated universal stress protein TeaD
MKKILVPTDFSDTAEYALKIAAQLAKKHNSEIYLLHMLELPLQLIDPVAGGNSQNLPESI
FFMKLAHQRFAKLMERPFLKDIKVHETVMFHQAFDGIMEVSEEYNCDIIIMGSHGASGFK
EMFIGSNTEKVVRSSHIPVLVIKNEHENFEVENFIFATDADASNKHTLEKAYNFAKLLDA
KFHILFINTPNNFITSTEVRERIENFVSGFNIHDYKMHIYNDVSVEKGILNFAMKQKKAL
IGISTHGRKGLAHFFNGSISEDLVNHANMPVVTFKI
>IFAGANLK_00562 Ribosome maturation factor RimP
MLQDKVENLLKEAFQENNSLFLIDLNITNDNKISVVIDGDSGVSVNDCIAVSRKIEHNLD
REEEDFSLEVSSAGVSEPLRLERQYRKNLGRKLQVTTNNEKIEATLTEVDQDGIKLNWKA
REPKPVGKGKHTVEKEAVLPYSEITDAKVMITF
>IFAGANLK_00563 Transcription termination/antitermination protein NusA
MENIALIESFSEFKDDKLIDRVTLMAILEDVFRSALKKKYGEDDNFDIIVNPDKGDLEIW
RNRVVVADGEVEDPNQEISLTEARKIEPDFEVGEDVSEEVKLVDLGRRAILALRQNLISK
IHEHDNTNIFKHFKELEGEIYTAEVHHIRHRAIILLDDEGNEIVLPKDRQIPSDFFRKGD
NVKGIIESVELKGNKPTIILSRTAPVFLEKLFEQEIPEVFDGLITIQKVVRVPGEKAKVA
VDTYDDRIDPVGACVGMKGSRIHSIVRELGNENIDVINFTNNDQLYITRALSPAKITSIK
LDEENKTAEVMLKPEEVSKAIGRGGHNIRLAGQLTGYEIDVFREGVEEDVELKEFSDEIE
DWVIKEFSRVGLDTAKSVLEQELEDLIRLTDLEEETIREVVKVLREEFEE
>IFAGANLK_00564 Translation initiation factor IF-2
MAEAKTMRLNKVLREFNISLDRAVEFLNSKGHDIEARPTTKISSEVYQVLSDEFETDKSK
KVESKEVGEEKRKEKEELRLARERELEEKRKVEEKKEDEKRKEEAVTARAKLAGPKKVGK
IDLDKKPEKKAEKEEEQPAPAESKQPEEAKKPEAEKEKPESQKPAEEAPSKEEKEPEEVS
KKEETPSEKEEEPKDPESMTHKTNYTKLNGPNFTGKKIDLSQFKKPEKKKDEKKAADEKK
EKEKRKKRRRRISKDVKPGASNQGPKKGGAARKRAKPITKEEPSEEEVQKQVRETLEKLQ
GKSGKGKGAKYRRDKRDQHRQRSEDDLAQQETDSKILKVTEFVTVSEVATMMDVPVTKVI
SACMSLGMMVTMNQRLDAETLSIVADEFGYEVDFVTADIEETVEEVPENPEDLEDRAPIV
TVMGHVDHGKTSLLDYIRKENVIAGESGGITQHIGAYSVKLKNGEKMTFLDTPGHEAFTA
MRARGAQVTDIAIIVIAADDDVMPQTKEAISHAQAAGVPIVFAINKSDLPTANPEKIKEK
LAGMNLLVEDWGGKVQSHDISAKTGLGVEELLEKVLLESEILELKANPSKVATGTVVEAF
LDKGRGYIATILVQTGTLKIGDYVLAGRHSGKVKAMHDERGHEVKEAGPATPVSILGLDG
APQAGDKFKVMTDEREAKDIAAKRTQLQREQSVRTQRHITLDEIGRRIALGDFKELNIIL
KGDVDGSVEALTDSFLKLSTEEIQVNIIHKGVGAITESDVLLASASDAVIIGFNVRPAGN
ARQVADKEEIDIRTYSIIYDAINDLKDAMEGMLSPELKEEITGTAEIRETFKISKVGTIA
GCMVTSGKIYRSSGIRLIREGVVVYTGELASLKRFKDDVKEVAKGYDCGIQVKNYNDIKE
GDVIESFREVEVKKKLK
>IFAGANLK_00565 hypothetical protein
MKYILIPTDFSESSKNASEFGIEMAKVLALPVKFLHSIQTPVDWSTLNRQVEDKYPESKS
RINSAKEQLKIWEKKAEEKDVDAEHTLLFNTGMEELNNYVNPKKYELVVMGTHGTKGFEK
IIGSNTQKLIRQSKVPVLAIKYPFKVANLKKILIASDLKEHSQPAFQKVFKILGKLNTEK
NLVYVNTPYNFKEYEEIENSMSNFLKSCGINDIKTQSLSANNEARGIGMALNKLKPDLFI
SITHQRSGLDTIFSPSITEEIINNYDIPVLSINREI
>IFAGANLK_00566 23S rRNA (guanosine-2'-O-)-methyltransferase RlmB
MKVDNLEQGFFGIGIQNGKTPENLGVLWRSAQNMGASYIFTIGNRYAKQACDTHKAVGAM
PYFHYKTFEDFYSNLPKGAMLVGVELTEDAEPLETFNHPRRCVYLLGAEDHGLSNQAIEK
SHFLVKFQSSLSLNVSVAGSIIMYDRNSKLL
>IFAGANLK_00567 hypothetical protein
MRYLSRALLCLAVAGMFSTGAKAQEVVGNNQGDFNEFMDRSGNMYRAASGRPGPEYWQNE
TDYDIDVTLNDKDHIIKGKITLTYTNNSPQELDFIWMHLEQNRFTEDSRGTLTTPIQGNR
YNGDIDGGYTISNLEAKVKRSSSSDYLINDTRMQVFFEDPIPAEGGKATVSMDFEYKIPV
EGMDRMGRLDVEDGTIYALAQWFPKAAVYDDVEGWNIEPYLGAGEFYLDYGDYDYKITAP
ASHIVVASGELQNPRQVLSSTVRDRMERAKESDSTVYLIKPEEVNDMSLRAKQEGTLTWH
FKMENTRDVAFGSSKAFIWDAAKIDLPSGKKAMAQSAYPKESDGQHAWSRSTEYSKASVE
HYSEKWFEYPYPVAVNVAADIGGMEYPGLNFCGWKSEGASLWGVTDHEFGHNWFPMIVGS
NERRYAWMDEGFNTFINYYSTLDFNDGEYPARLNKTRNMTGWFTSEQREGIDTYPDVSNL
RNLGMIAYYKPAIGLLLMREYILGEERFDNAFKSYIETWAYKHPQPADFFNHMENVSGEN
LSWFFKKWFYGTGNIDLGLDGVQQYEGNYVISLTNKGEIPMPVKMKITYEDGSSENVTLP
VEIWQRGDSWNYLHRTDKTIENVELDPDKILPDVSSGNDAWPNSFYED
>IFAGANLK_00568 hypothetical protein
MSIIAEGEKKFEEITSVQNKAMRLNLNENIYGTFAEIGAGQETVRHFFRAGNASGTVAKT
LSAYDKDFSDAIYGIEDDGRYVTEDRLTSMMRYETGLIEERISRLKHPNKLFFSYANTVA
TIDWAKKYKGHGWLGIRFQTKPGEDYSEIVLHVQFHENNASHQQISLGVMGVNLIHGAFY
HYDNPKKLLNHLFDHLNTDKIEIDAINFTGPVFKGVDNRLMSLELVKKGITEAIMFAPDG
NNILPASLLYKKNILTLRGSFRPVTKVNMAMYEKSLELFINERKVEKDNTVVIFEITLSN
LKGEGEIDEQDFLDRADLLGSLGQTVMISNFQEYYKVVEYFGQHTKERMGLTMGVSTLQD
IFDERYYRHLSGGILEAFGKLFFKSLKIYLYPLKDQETGEIITSENLKVHPRMQELYQYF
KDNGRVVDIKDYDPKTLDIHSRQVHQMIREGKTEWEEMLPESTTKMIKEKELFRGK
>IFAGANLK_00569 Bicarbonate transporter BicA
MKKIFNLFDFSQKVDYKNEILAGLTVALALIPEAVAFALIAGLSPLTGLYAAFVMGLVTA
ILGGRPGMISGATGAVAVVIVALAISHGPEYVFATVVLAGLIQVLAGVLKLGKLIRLVPH
SVIFGFVNGLAIIIFMSQLDQFKALNPVTGELEWMTGAPMFTFLGLVIIAILIIWLLPKL
TKIVPATLVAILVVFGIVAAFGIDTKTVGDIASIKGGFPPFHIPMVPFNLDTLMLIFPYA
AIMAGVGLIESLLTLNIIDEITETRGSGNKECVAQGTANVLSGFFSGMGGCAMLGQSLIN
VSSGARARLSGIVAAVSLLIFIMFGSSVIELLPMAALTGLMIMVAVGTFEWASLRTFRRM
PKSDILVMVLVTVVTVILHNLALAVLIGVIISALVFAWDNAKRIRARKRIDQDGVKHYEI
YGPLFFGSVQAFNDKFDVLNDPEEVIIDFSESRVVDMSGIEALNKLTERYHKQGKKLHLR
HLSQDCRRLLSNADAIIDVNILEDPTYKVAVDKA
>IFAGANLK_00570 GTPase Era
MAHKAGFVNIIGNPNVGKSTLMNAFVGEKLSIITSKAQTTRHRILGIVNGEDFQVLLSDT
PGIIKPAYELQESMMGFVKSAFEDADVLVYMVEIGEKELKDEAFFNKIISTDIPVILLLN
KIDKSNQEELESQVQMWTEKVPNAEIFPVSALEGFNVAEVFNRIIELLPESPAFYPKDTL
TDKPERFFVNEIIREKILMHYKKEIPYAVEIDTQEFFEEEKIIRMRSVIMVERETQKGII
IGHKGAALKRVGVEARKDLEKFFGKQVHLELYVKVNKNWRSDQRQLKRFGYNE
>IFAGANLK_00571 GTPase Der
MGNIVAIVGRPNVGKSTFFNRLIQRREAIVDSVSGVTRDRHYGKSDWNGRNFSLIDTGGY
VVGSDDIFEAEIDKQVELAIDEADAIIFMVDVESGVTPMDEDVAQLLRKVDKPVLLAVNK
VDNNKRLENAVEFYSLGLGEYFPIASTNGSGTGDLLDALIEALPETEAEEETELPRFAVV
GRPNAGKSSFINALIGEERYIVTDIAGTTRDSMDTKYNRFGFEFNLVDTAGIRRKSKVKE
DLEFYSVMRSVRAIENCDVCLVILDATRGFDGQVQNIFWLAQRNRKGIVILVNKWDLVED
KETNTMKEFEAMIRREIEPFTDVPIVFMSVLTKQRIFKAIETAVKVYESRSKKIKTRELN
DIMLPIIEQNPPPAYKGKYVKIKFCTQLPTPQPQFAFFCNLPQYVRDPYKRFIENKLRKE
FDLTGVPISVYFRKK
>IFAGANLK_00572 hypothetical protein
MRILLSLALLFLAGNLTAQDFEINGKITGPQGEPLESATVYLEKPADSSLVTYTISDNSG
EFQLSGSTEIQELNLLISYAGFKTYSQQVNINGELNLDVIEMQVADNALDEITITSSRAP
VSIKKDTLEFNAASFKTRKDANLEELLKELPGVEVATDGSITVNGTPVSQIKVNGKEFFG
DDPKIATKNLPKELINKLQVVDSKTKSEEFTGKEGDAENKTINITIDEDKNRGFFSRLTA
GGGTDERYELSGIGNYFKNDMRVSLLASSNNINSSGFSFDEIYDAMGRNAYSITRSRGGN
FSINGSNFGSGNGITKSDNAGFSFVNEWPQETELSSNYFYSRADNRTESRTQRENILPDR
RFFNNSESSGNRVNNNHRFNLGFEIQPDTLTRISVRPNINTNNGRSSNQSFTESVAEDGT
PINTALTDNYSEVHSVNFSNRLNFTRKFGDNGGYYSLGFNNQNNNRSQDNNFFSEREIYN
QEGELVNTDIQDQLISEENKDNNYGVDLSSRFPITEELMLDVSYNFDKADGSNERLVYDA
NETGDYNLLDDELSNDFKSESFTHRPSLGLAYNGEKLRASVSGGFQSIRLKNEDLFTETS
IDNTYENLFADAYFRYNLAQGKAIYFNYNNSWDAPSLTQLQPVTNTINPLNITTGNPDLR
PALRHRFYFNFNNFDFKTRSGFYAYIGGNFTDDQVVTRSTVGEDLVRTTTYTNVDGVYSY
FGGGNIDKTFELEKESSIKIRGGVYGNYNRNVGFTNEQRFTSKTLNLTPNLGVEYNFRDL
VTIEPFYSVEFVDAEYSFNNREENYKNQNISLALTSFWPEKFVVGSDIAYQSIGNASPGF
QNSFYLWNASLGYEVFGDNGTLKIKVFDLLDQNIATRRFTGDDFIQDTQELVLEQYFMLS
FTYKISKFGGKDPNNNRRGR
>IFAGANLK_00573 hypothetical protein
MPHFTKRFNLLFLLFLFFSGFIYAQRDVPPKPEEETSVYDEADILSSSEESQLEQKLINY
ADTTSTQIVIATIESLQGEYEGVYAAEWAQEWGIGQSEEDNGLLILVAENDRKIWITTGY
GLEEYMTDARSKQIIEQVILPEFRSESYYNGLDAGTTAIFQVLDGTFEGTPQRRGQSEGI
PVQLLVMGIILLVIIVSLANKNKGGRNGGRRSAGGTFLDAIILSSLGRGTFGGGSSGGGF
GGGGGFGGGFGGGGFGGGGAGGSW
>IFAGANLK_00574 hypothetical protein
MSKVEEFLSKKDEEEIIEAIRTAESHTSGEVRVHLEKTTGEMDIFDRAMEVFHMLKMDNT
KHDNGVLIYVAVEDHNFVIYGDKGINDVVPDNFWESTKDAIVEKFKKGEFKQGLVNGILT
AGQQLKKHFPYSDETRDELSNEISKG
>IFAGANLK_00575 hypothetical protein
MKKWLIPVIVIVVLGIIVYSLTAGVNNTAVEYEEGVMKNWADVENAYQRRSDLIPNLVNT
VEGSADFERGTLTDVIEARAQATSVNVDAGNLDPQQIQQFQQAQGGLSNALSRLLVSVER
YPDIKSNQNFLQLQSQLEGTENRISVARNRYNEAVRQYNTYIRKFPNNIFAGMFGFERKP
TFEAEEGAENAPDVEFDF
>IFAGANLK_00576 HTH-type transcriptional repressor BluR
MHLNLPDKRYYGIGEVAEAFKVNTSLIRFWEKEFDVIQPKKNAKGNRKFTPEDIKNLELI
YHLVKERGFTLEGAKTHLKEEKHKTLSNFEIIRKLEGVKAKLINLKNQL
>IFAGANLK_00577 Murein DD-endopeptidase MepM
MSKVKYYYDSDTQSYRKIERRKGRRIGIVMLSILGSFLAGFLLLVIYLNIPQIVTPKEKA
LKRELQNMELQYGLLNKKMNQIQNVLANIEDRDNNIYRVYFEANPIPEEQRRAGFGGINR
YKDLEGFDNSKLIIETSKRMDILTKQLVVQSKSLDEIAELAKEKESLLASVPAIQPVKNE
DLSRIASGYGWRTDPFTKVRKFHHGMDFSAPRGTPVYATGNGRVERADNRATGYGNHIRV
DHGYGYTSLYAHLYKYNVRIGQRVQRGDIIGYVGSTGRSQGPHLHYEIFKDDQRINPINF
YYGNLSPEEFDKVLEKAQQENQSLD
>IFAGANLK_00578 Alanine--tRNA ligase
MKSQEIRSQFLEFFKSKSHKIVPSAPMVLKDDPTLMFTNAGMVQFKEYFLGNSEPSSSRI
TDSQKCLRVSGKHNDLEEVGMDTYHHTMFEMLGNWSFGDYFKEEAISWAWELLTEVYKIT
PENLYVSVFEGSKEDKLGLDTEALELWKKIVPEERIVYGDKKDNFWEMGDQGPCGPCSEI
HIDIRSEAEKAKIPGRELVNADHPQVVEIWNLVFMQYNRKADGSLVELPAKHIDTGMGFE
RLCMALQGRDSNYDTDVFRPLISELEKITNSTYGKSEKIDIAIRVIADHVRAVAFSIADG
QLPSNTGAGYVIRRILRRAIRYGFTFLDTKEPFIYKLVDVLSNQMGEAFPELKLQKTLCE
NVIREEEQSFLRTLDQGLILLENIISETKGKTVSGKKAFELYDTFGFPIDLTALILRERG
FDLDQKEFEVQLKEQKDRSRAATQVTAGDWEEINPVNAEAFVGYDHLETATRIARYRKVE
SKKGALYQIVLTQTPFYPEGGGQVGDKGFLKDADGNKVEITDTKKENNLIVHFAKSLPKD
PTAEVKAVVNPKTRAATAANHTATHLLHQALREVLGTHVEQKGSLVKGDYLRFDFSHFSK
VTKEELEQIEKLINQRINKRLPLEEQRSISYKEAVNQGALALFGEKYGDSVRAIRFGKSM
ELCGGIHVQNTSEIWHFKITAEAAVASGIRRIEAITGEAVKEYFANQDEVLQQIKAELKN
AKDPVKAVNTLQEENAILKKKVEALLRDKAKNLKSELKSEISEINGVNFLAKRVDLDAGG
IKDLAFQLGDEFENLFLLFGTEHNGKALLSCYISKNLAREKDLHAGKIVKELGKFIQGGG
GGQPFFATAGGKKPEGINEALQEAASYLS
>IFAGANLK_00579 hypothetical protein
MEFRTKIPIRPAESKIDYESKLFLIGSCFVENICKKLTFYKLEHLQNPFGILFHPLAIAK
FFQKITENYTYTEKDIFQYQERWHCFDAHSFLSNPNAEVLLNNLNSALQDARECLQQSSH
VVITLGTAWSYFHLETEQSVANCHKIPQKFFRKELKSVEEIQCALLLVLKDLKLLNPELE
VIFTLSPVRHIKDGFIENQRSKAHIITAVQQICEENRNTHYFPSYELMMDELRDYRFYAE
DMLHPSQPAIDYIWQRFTETWFSEASFSTLKEVENIQKGLEHRPFNPDSEAHRRFLKNLD
AKASSLKKHYPHIQF
>IFAGANLK_00580 hypothetical protein
MRNFLIGAILVLLVVFGIRYCENKNNERDQLEESTALLQQQIKNVGKLVVTEGTFSQVYS
YNDSKKFYLDIFSARKKALIVVNATATVAYDLSKLQTEIDEENKIVRITYIPEEEISINP
EIKYYDVTQDYLNQFDAADHNKIRSRIEKSIRKKVEASSLKSNAQNRLISELQKIYILTS
SMGWTLQYNDQNFNDSEELQQIKL
>IFAGANLK_00581 Phenylalanine-4-hydroxylase
MLDKIESNAILDRLPAHLQQYIKPQNYDDYTPVNHAVWRYVMRKNVDYLSKVAHESYLDG
LKQTGISIDHIPNMYGMNRILKEIGWAAVAVDGFIPPAAFMEFQAFNVLVIASDIRQLEH
IEYTPAPDIIHEGAGHAPIIANPEYAEYLRRFGEIGCKAISSARDYEIYEAIRHLSIIKE
AEDTPQEEIEAAEKKVDELQNETAELSEMAQIRNLHWWTVEYGLIGTLKNPKIYGAGLLS
SIGESAWCMTDKVKKIPYSIEACKQEFDITKPQPQLYVTPDFAHLSLVLEEFANKMALRK
GGLEGIQKLIDSKNLGTIELSTGLQISGDFSKVIEHEGNPIYIQTSGKTALSHREKELVG
HSIKKHPDGFGSPIGSLKGINLAIEDMSPRDLRAYDIYEGEKIEFEFEGGIKVKGEIITG
TRNLQGKIILISLKDCIVTYGDEILFKPEWGKYDMAIGKEIISAFAGPADNLSFDLITHK
TSSTTIKSKNTPEREELNSLYASVRNIRQGKDASFSLDAALELVQKHHPKDWLLSVEIYE
LVVGKDEKLIKEVLSHLEDVKSRRPDISHLIEGGINLIDAQLVK
>IFAGANLK_00582 hypothetical protein
MKVLKITPVLLLLAVLVTSCSSVRVASDYDREVNFNQYQSYAFFKPGIDKAEISDLDKKR
ILRAIEDEMQRKGFTKSEDPDLLVSIFTKTNENINIYQNNMMGWGYGWGWHPWYWGSGYN
TVNRTSDGTLYIDLIDAEGKELVWQGMGTAALASDVNKKQARINEIVQEILEKYPPKIED
>IFAGANLK_00583 Urocanate hydratase
MDFRARILQGIPSELPSKKEYDTSVNHAPKRKDILNTEEKQLALQNALRYFEEKHHKELL
PEFKEELEKFGRIYMYRFKPEYDLYARNIEEYPGKSVQAKGIMLMIQNNLDPKVAQHPDE
LITYGGNGAVFQNWAQYLLTMQYLAEMENDQTLVMYSGHPMGLFPSHENAPRVVVTNGMM
IPNYSKPDDWEKFNALGVSQYGQMTAGSYMYIGPQGIVHGTTITVLNAGRKISRSGEGLA
GKLFVTSGLGGMSGAQPKAGNIAGCITVCAEVNPKATQTRHSQGWVDEVSDDLEALAKRV
QKAKNNKEVVSIAFQGNIVEVWEYFDKENIYIDLGSDQTSLHNPWAGGYYPVGFSLEEAN
KMMAEEPEKFKEKVQESLKRQTAAINNHTAKGTYFFDYGNAFLLEASRAGADILAENGID
FKYPSYVQDIMGPMCFDYGFGPFRWVCASGKENDLDKTDKIATEVLEELKRNSPEEIQQQ
MADNIQWIKGARENKLVVGSKARILYADAQGRVKIAKAFNDAIGKGDIGPVVLGRDHHDV
SGTDSPYRETSNIYDGSQFTADMAIQNVIGDSFRGATWVSIHNGGGVGWGEVINGGFGMI
LEGNKASEERLKSMLFWDVNNGIARRSWARNKEAVFAAKRAMQMEPKLKVTIPNLVDPAL
FRH
>IFAGANLK_00584 hypothetical protein
MKLFIILLAVFCLFSCKDETKNPELETTEIFKEKETTTPEETFSAKDSLDWAGVYEGFLP
CEDCEGIETKIQIKENRDYALSQQFLGRAANEDNDLNETGKFEWDKQGNTISLGEREKLY
FKVSQNYLLQVFKDESKVIGDSAMKYRLTKINEL
>IFAGANLK_00585 hypothetical protein
MILIVNKYLLGKSFKGVSLWPFVILKNRELKDDFNFINHEKIHLRQQLELLILPFYIWYL
TEYLLRLFYYKDRFLAYKNISFEREAYSQEMKENYLQDRKFWAFLQFV
>IFAGANLK_00586 D-cysteine desulfhydrase
MPKSSNIFTEISSKNQFVAEFYNEISLYLKREDLIHPEVSGNKFRKLKYNIARALEEKQK
TLLTFGGAYSNHIAATAAAGELFGLETIGVIRGEELGKDLETTLAQNPTLKFANSCGMQF
KFISRGDYRKKENRELQEELKKEFGEFYLVPEGGTNELAVKGCQEILTEKDREFQFVAVS
VGTGGTLAGLVNASDINQKILGFPALKGDFLSEEIDKYSFNSNWELKTDYHFGGYAKVDS
ELINFINNFKKKYKIQLDPVYTGKLVFGIFDLIKAGYFPSGSKIMAIHTGGLQGIQGMNT
FLKKKKLPLITF
>IFAGANLK_00587 Autolysin
MRINRFFVLILLAAFAVSCGSKKKVVTTKKDSNRENVFTESSGTQIERVKPLDGKPILPP
VNPRLYTVEDYIRDFAAVAMEEMRLYDVPASITLAQGILESGGGKGDLTMRANNHFGIKC
HDWKGARAYHDDDARGECFRKYKDARYSYRDHSLFLTERKRYAELFDLDKDDYKGWAKGL
RKAGYATDRRYPDKLISLIERYRLYQFDATVLKRPSPSYTHTPESPESVTYRVKKGDTLY
GIAKKHNTTVEELQRFNNLRDTNISVGQMLVIISSE
>IFAGANLK_00588 Glutamate-1-semialdehyde 2,1-aminomutase
MIYKRSSELFASAQKVIPGGVNSPVRAFKAVGGDPIFIKRAEGAYLYDEDGNKLIDYINS
WGPLILGHAHKPVIDAVIDIAKKGTSFGTPTEIETKIAELAVKMVPNIDKIRMVNSGTEA
TMSAVRLARGFTGKEKIIKFAGCYHGHSDSFLIQAGSGAITFGTPNSPGVTQGTAKDTLL
AKYNDLENVKSLIEVNKDEIACIIIEPVPGNMGCIPPDNGFLEGLRELCDDHSILLIFDE
VMSGFRLAPGGVQERMGVNADIACFGKVIGGGLPVGAFAARNEIMDYLAPVGPVYQAGTL
SGNPLAMAAGLAMLTELDNNRSVFKSIDKKTAYLHEGIEKVLLENNVAHTINRVGSMISI
HFGEEPVVDFESAAKSAGNGIFNKFFHGMLENGIYIAPSAFETWFISDALSYEDLDATIE
TVNKVAKTL
>IFAGANLK_00589 Glutamate synthase [NADPH] small chain
MGKIRGFMEYDRKVEETEAVENRVKDYKEFTKELSPEELGVQGARCMDCGIPFCHSGCPL
GNLIPDFNHAVYKNDWKKALSILHGTNNFPEFTGRLCPAPCESACVLGITDPPVAIELIE
KYIVERGFKEGWVTPQPPTSRTGKTAAVVGSGPAGLAAAQQLNRAGHEVTVFERDKKIGG
LLRYGIPDFKMEKHVIDRRVNIMKEEGIKFETGVHVGENYEVEKLKEFDAVVLCGGATKR
RNLPIDGAEGEGVMQAMDFLKNNNEVVDGLKEQTEKFSAEGKNVIVIGGGDTGSDCVGTS
NRHGAKSVINFEIMPMPAEHRDRENPWPYWPFTLKTTSSHEEGVERNWSINTKEFIRDKE
GNLEALKTVNIEWVKGKNGRPQLQEVEGSEKEWPCELVLLALGFTGPEKTLSEQLGLELD
SRTNIKGDEGYQTNIPNIFTAGDMRRGQSLIVWAISEGREAAYHVDKYLMGKSLLPRKGE
GDLPAA
>IFAGANLK_00590 Ferredoxin-dependent glutamate synthase 1
MKLKKQGLYSPEFEHDNCGAGFICNLKGKRTNDIIHKALDILIRLEHRGAVSADGKTGDG
AGILIEIPHDFFKKTCEFKLPDFKEYAVGMVFLPQSENQRKICREIFEEEIIGQGLNLIG
WREVPVNRACLGSIASLSEPNVQQVFIGKGDDVSDESFNAKLFAARKIAEHRIEKSELSE
AEYFYLPSLSTNTIIYKGLLMPQDINTYYRDLNEPDVVTKLALVHQRFSTNTFPTWDLAQ
PFRYMCHNGEINTLRGNLSRMKAREELFESEKFGEDLKEVIPIVPEGKSDSASMDMVLEL
LLQTGRSLPEAIMMMVPEAWEKNPSMIDEKKAFYEYNACIMEPWDGPASIPFTDGKYIGA
LLDRNGLRPSRYTLTKDGYVIMSSETGVLEIKPENVELHGRLEPGRMFLVDMQEGRIVGD
EEVKQKIISERPYRKWLDENLLNLSEVPYTGNKTPVEKIDINTRQKLFGYTQEDIKTIIS
PMALQGKEAIGSMGADIPLAVLSDKSQLLFNYFKQLFAQVTNPPLDGIREEIVTDISLSI
GEDRNLFDIVPEQSKKLRIQNPVISNEDLDKIKYIEHPDFKTASISILYEANKGLNGLET
RLDEIIYEINDAVDKGCNVIILTDRNADPNLAPIPSLLACSFVHHGVKKHNRRSSFGIVI
ESAEPREPHHFALLFGYGASAINPYMVNEIIYSLVEEKEIDVEDPEVAVENFNVAIGKGI
VKIMNKIGISTLHSYRGAQIFEILGLNQKFVDKYFTNTPTRIEGIGLYEVEKEIQKRFEN
AFAPKKTDTDLDLEIGGDYRWRRTGERHMFNPASVAKLQQAVKQNSTKAYEEYSKLINDQ
SERLMTLRGMFKFRDLNPVPIEEVEPWTEIVKRFKTGAMSFGSISKEAHENLAVAMNRMQ
GKSNSGEGGEDPQRFHKDLDGNWRNSAIKQVASGRFGVSINYLSNAKEIQIKMAQGAKPG
EGGQLPGPKVNPDIAKTRNSTPYVGLISPPPHHDIYSIEDLAQLIFDLKNANREARINVK
LVSKVGVGTIAAGVAKAKADVVLISGFDGGTGASPLTSLRHAGLPWELGIAEAQQTLLIN
NLRNRIVVECDGQLKTGRDVAIAALLGAEEFGFSTAPLVASGCIMMRACHLNTCPVGIAT
QDPELRKKFKGTPEDVINFMYFIAQELRQIMADLGFRTINEMVGQSQKLDMNRAIEHYKA
QGLDLSNILYKPKIDEDMPLYNTETQDHNLENVLDFEILNQAHPAIYRKEKMSLDFPISN
INRTTGAILSNEISKIHGAKGLPDGTLTLNFTGSGGQSFGAFATKGLTMNINGNSNDYLG
KGLSGATLSVRKPKEASFKSNENVIIGNVALYGATDGEAYINGMGGERFCVRNSGAKAVI
EGIGDHGCEYMTGGIAVILGKIGRNFAAGMSGGIAYIYNADNTLDNHNFNMEMIGLEDPS
EENKNELKELIENHYRYTESDVAREILENWEENVGKFIKVMPAEYKKALQKMEEEKMLKE
QVELKTA
>IFAGANLK_00591 Acyl-CoA dehydrogenase
MDFKLTEEHIMIRDAARDFAKNELLPGVIERDEKQEFPAEQVKKMGELGFLGMMASPEFG
GGGMDTISYILAMEEISKIDASASVVMSVNNSLVCWGLDTYGNQEQKEKFLSKLTTGEKL
GAFCLSEPEAGSDATSQRTTAIDKGDHYLLNGTKNWITNGNSADYYIVIAQTDREKKHKG
INAFIVEKGVEGFEIGPKEQKMGIRGSDTHSLNFNDVKVPKENRIGEDGFGFKFAMKTLS
GGRIGIAAQALGIASGAYELALDYSKQRKAFGTEICNHQAIAFKLADMYTSIEASRHLVM
KAAWDKDQGGNYDLTGAMAKVYASKTAMDVTTEAVQVHGGNGYVKEYHVERLMRDAKITQ
IYEGTSEIQKIVISRAILKG
>IFAGANLK_00592 Anhydro-N-acetylmuramic acid kinase
MVAKDKVLVCNFQFSLINFTNMKKANYKVIGVMSGTSLDGIDLVYVNFDYKNSWSYKILK
AETVPYPLNWQETLAASINYSEERLEELNKKYTNFLSGIISRFIETHQIKDIDAVCSHGH
TIKHEPENNYTLQIGNLPEIAYLSGQTVICDFRVQDVALGGQGAPLVPIGDQLLFSDYKY
CLNLGGFANISTEKKSERLAYDICAVNTVLNYYAQKLGKEFDEGGKLAASGKVNEELLKK
LNKLAFYNQKPPKSLGIEWVKSEVFPILEEYEENLQDILHTYTVHVAQQISKTLDDDSDS
KVFMTGGGTFNNFLIRLLKKESNCHFTIPSDEIINYKEALIFGLLGILKLRDEVNVLKSV
TGAKKDHSSGVIYEI
>IFAGANLK_00593 NAD-specific glutamate dehydrogenase
MKELLKLYENKEPEIVFNWKDSETEAEGWTVINSLRGGAAGGGTRMRVGLDQNEVLSLAK
TMEVKFTVSGPPIGGAKSGINFDPNDPRKKGVLERWYKAVSPLLKSYYGTGGDLNVDEIN
EVIPITEDCGVWHPQEGVFNGHFKPSEADKINRIGQLRQGVIKVLENTRFSPDVTRKYTV
ADMITGYGVAESVKHYYDIYGGDVTEKKAIVQGFGNVGSAAAYYLSQMGVKIVGIIDRAG
GLINEDGFTFDEITELFLNKEGNTLKHDNLISFEEINEKIWEIDAEIFAPCAASRLITQD
QINSLIKRKLEVITSGANVPFADKEIFFGSIMESTDEKVSLIPDFIANCGMARVFAYFME
RRVQMTDESIFNDTSMTIKNAIQNTYDHNSSKTNISKTAFEVALKQLV
>IFAGANLK_00594 hypothetical protein
MLYFFQQDGVAEAAQEAESVVEEKTLSLFDLMLSGGLGGQIIILILFILLFAAVYIYFER
LFAIKSASQVDKNFMLQIKDNVLNGNIESAKMRCAQSDSPVARLTEKGISRIGSPLEDIN
TAIENAGRLEVYKLEKNVSILATIAGAAPMIGFLGTVIGMVIAFHELATSSGQAQMGALA
EGIYTAMTTTVAGLIVGIIAYIGYNHLVVKTDKVVHQMEATAVDFLDLLNEPA
>IFAGANLK_00595 hypothetical protein
MNLRGRNKISPEFSMSSMTDIVFLLLIFFMLTSPVITPEALDLILPKAKGKTTSVQNVAV
SITKDLQFYVDDERISQSALESTLRTKLSGEETPTIILRAEEGVPIEKAVNVMDIANRNS
YKIVLAVKPE
>IFAGANLK_00596 hypothetical protein
MLETKHEKKSFTITVILHVLLIALLFLLGFKYLDPPPESGIAINFGTSEVGSGEEQPTEP
VKSAPQQTTVPETQTQPEPVVEEEVVTQEIEEAPVIEEKKEPTPVKEQEPEKPVEEPPAE
KPEPKPDQSTTDAMSSILNGPERSGTESGGEGNDNQAGDKGDPDGDPNASSYYGTGSGLD
GDGNYRLGGRRALNKEKFVQDCNESGIVVVRIEVNQNGQVINATPGVKGTTNSASCLTDP
AKRAAMATRFNSDSNAPSRQVGTIIYNFKLSE
>IFAGANLK_00597 Folylpolyglutamate synthase
MFQQLPMFQRVGAQAFKKDLSRTIKLAEHLANPQREFKSVHIAGTNGKGSTSHMLAAVLQ
EAGYKVGLYTSPHLKDFRERIKVNGKFIPKKNVVGFIKEHKDFLTENELSFFEMTVGMAF
DHFAREKVDIAVIEVGLGGRLDSTNIITPEVSVITNIGLDHTAFLGETLPEIASEKAGII
KDNIPVIIGEKQKETTAIFTKKAQQHNSEIYFAEKLKFDKYHTDLKGDYQNKNIKSVLGA
VKVLRQKGWEIPEECLKNGLNSVKLHTSLQGRWDILKEKPKVICDTAHNTEGLTLVFKQL
KKEKFQHLHIVMGVVNDKDLGKILPLFPESAIYYFSKPDVPRGLEAEILQQKAAAYGMEG
RVFNSVSEAYDAAVEAALDEDLIFVGGSTFTVAEII
>IFAGANLK_00600 putative oxidoreductase CzcO
MLDFVIVGGAQAGLSMAYYLSKMGKDYVVVDKEMEVGASWLNRWDSLKLFTPSEFNNLPG
MEFPAEKGYYPTKEDVAHYFKNYVAEFDIKIKLNTLIEQIRKKDDCFILKHQNGEIKSQN
VVIATGPFHIPYTPSFSKKISEEVFQIHSNYYKNPGQLQEGAAMVAGAGDSGFQILDEIS
KTNRTTYFSGTTKVRVLPQEILGKTLWWWFTKIGFLSFSRKSWLGRKLSQSKQPIIGTDV
KNILKRKNVIPVGKTQDAKGEIIITEKREIEDLKNIVWATGYRPNFSWIEGLEFSKDGYP
KHNRGISNIKGLYFIGLPWLHTRGSATLGGIKKDAEYLANYIKTEEKTLA
>IFAGANLK_00601 Putative mycofactocin system creatinine amidohydrolase family protein MftE
MAETNWKHVKAEDFRIAVLPWGATEAHNYHLPYATDNILAEEAAISAARKAWLKNAKAVV
LPTIPFGVNTGQMDVKLCMNLNPSTQYAILKDVAQVLEKHKINKLVILNAHGGNNFKQMI
RELSLEFPEIFACSVNWWQVTDAKPYFEEPGDHAGELETAAVMHLRPELVLPLEEAGDGS
AKTFKIKALKEGWASAQREWTQVTEDTGVGNPKAATAEKGKIFFEKATDMIADFFQDLHE
ADLQDMYQ
>IFAGANLK_00602 Holin-like protein CidA
MLKALAYIFGFLLLGELITYFFELPIAGNILGMFLIFLALRLKIIKLQDVKPASDKLIKY
LVLFFIPYGVGLMVYFEIIANYWLPISVAVIASTVITLYISAIIIEKFGK
>IFAGANLK_00603 Inner membrane protein YohK
MQEFIQLPIFGVFISIIAFAGARELRKKFNYALLTPVLVAIVFIILFLFIFNIDFDTYNR
GGKYISFFLGPSVVALGVFFYEKYEEVKQNLKVFLLSVAIGGITGVLTVIIFLLLLKVPD
FIIESLAAKSVTTPIAIEITKLTGGIPEITAGIVIAVGIFGNAFGPFILKKLGIKSKIAI
GTALGTAAHGIGTARAFEESKLAGVYSGLAMCVNGIITALITPYLIQLSFWGVS
>IFAGANLK_00604 K(+)/H(+) antiporter NhaP
MKEHYWILAGIGFTTLIMAWLPSISKKIKVSGPIILLLIGFLLLGLGLPIGWPDPLWADE
GLMYFSEMIVIISLMGAGLKIGNNYSFKAWKRPFLLVFLTMPLCMVSAYFLGQNFLFFSV
PSSLLLAAVLAPTDPVLAAETQLDDPEREKEYKGKIRFSLTAEAGLNDGLAFPFTYMAVL
VAQAGGWAAFDFTDWMLDKFFLKIIIGTIAGFAIGNAIGFTLDKVHKYAGIKTFDGFLAL
SLTLFSYGATELLHGYGFLAVFFTGLSLRHYEKVSGDYKTKMHDFIHEIERILLVVWIIL
FGGSIMNGMLSLTDWRGIVFAFAFVLIIRPLAGIISMTGIRDSFKNKLAISFLGIKGIGS
VFYLAWAFVEFEDFEYKNELYSITAYIILISIVVHGFTAPSIIEYFKRKTEQNENESGDT
PKG
>IFAGANLK_00605 hypothetical protein
MNNQHKYKMDTSLFLAKFWGWYLLIFFFVLSFNPKRIKQIFEDLKDHKFLILAAFAAIII
GLLNILFHNIWELSWKFIITALGWISLFIGLGLFIFPEPTTRKLTVINLKFVQVVYVLLF
LLGIFLLNMGYGLVLY
>IFAGANLK_00606 Calcium-transporting ATPase 1
MKNVFPKTLPGNSCFTLKVMLKDPHALSSKEILSELKVDPGKGLTAAEVSARFKKHGANR
LKESKSKNIGLIFLEQFLDPIIYILAAAMALAYFFGEWLEGTAVLIVILITALIGFFMEW
QAIRSVEALQKMVETLANVLRDGKEEQIKATGLVPGDIVILESGDVIPADCRMLETESFA
VKEAILTGESNQIEKNAEALPDKVPLANRKNMLYKGTIAVRGKAKAIVISTGIKTEIGRI
GELTSSAKKESTPLEKKLKRLSRWLIWLTLVLAILIVVTGYFQGKDLMLMIKTGIALAVA
AIPEGLPIVATIALARGMLRLSKKNVVIKKLEAVQTLGETGIICTDKTGTLTENKMSVHH
LMLGTLDFPATEASNFKSDPAFEKLVLIGSLCNNSKLKDDKFTGDAVEIALVEFVAEMGS
DYKELQQKYPKIQEVPFDAEIKKMATLHTLENQHLTCVKGALEALLGSCDLILTKDGPKD
FVDKDEWQKQAKLIAAEGMRVLAFAFKQTGTKPAYEDLMKNLTFVGILGFLDPPRKDIKQ
AIETYKNAGIRVVMVTGDHPDTARKIGEEIGLIAEDAPDEMVVHGADLEEIGSLTEDKQR
TLMQAGIFARMVPGQKLDLVKFYQKNKAIVGMLGDGVNDAPALKKADIGIAMGIRGTEAA
KEVADVILMDDKFTSTELAIRQGRTIFENIRQFVIFLLSCNLAEIISVALASLSNLPMPL
LPLQILFLNLVTDVFPALALGVGKGDPNIMKDPPRDPQEPILTKKHWTATVLYGLSITAA
VIGAVAYTHFKMGLSAIVVNNIAFYTLILGQLLNVFNLPGRKISFLKNEVTSNPWVWGAL
IFSVLTMVLVYHIPLMAEALSLVPLSTNHFVVIIVFGFASLALSQILKHLKLAN
>IFAGANLK_00607 hypothetical protein
MESIRKRPKGDFIAEANMEQLYTLTKHWNSDLHFFRDDLIFLHKLLDSYFIWIDKDENYK
VASKMKNELLKLKERCQDLLDKTDKHRQQIGKMILEKMEDSRLFRMEHEHLEDEIASFVK
AFRLNRLELFKITEYIKDNDKLPELS
>IFAGANLK_00608 hypothetical protein
MLINIQFIKTKGSEFLTQNVSKNLNKLSDKYDWLIKAEVYFKEENDPTGRSKICEIELSA
PGPRIFASSTEESFELAIKKTIFELDQQLKKRKAVFVAH
>IFAGANLK_00609 hypothetical protein
MDILLFTLAAICMVLGILGSFLPVLPGVPLSWVGLLLLYLAPSVPINYWVLGIAFVLAAI
IYALQLIIPAMGTKKYGGSKAGMWGATIGLVIGIFVPVPLGIIIGAFAGAFIGEIINKSD
SKSALRAAYGSFIGLLASTFMELVVAVGFLIFFSYKAWELRDLIF
>IFAGANLK_00610 Calcium-transporting ATPase 1
MISEKELSDLRSEAYRLSSKEVVEKLKSDADNGLDKDKIKDRQEKFGKNQLQEKSGKSIL
SIILSQLNNPVIYLLTAAALIAFLFGDIPEAIVILVVLIVNTIIGFWMEYQAQKSMEAIK
KMDKTEITVIRYGKETELDAEEIVPGDILKIDAGDLIPADARLLEANELQIDEAALTGES
VPVNKSTEAIDTEKQVADRNNTIYKGTAVTAGTGKAVVFATAMHTEVGNISAMVQEQDKE
ETPLTTKLNQLTKNLIWVILAMAAAFFLFGWLTDKDLYQLVQTSIAWTIAAIPEGLPIVA
SIALARGMYRLSKQNVLVKKLSAVETLGETTVIFTDKTGTLTKNKLTVKNFSFPQKDDLK
VNWKNEKPEVQDQENSNFQEIFKISVLANDANLEDEGKGNGDPLEIALLKFTKHLDEELY
TENKKKERILHKPFDSDTMTMGVAFKSENGQIYVAAKGSSNAILDKSTHILENDEEKDFS
KEQKEKWQQKNDELSEDGLRVLAFGFRKTENKPEDEDNFIEKLCFVGLIGFIDPPREEIA
SSIETCKKAGIKILMVTGDHPGTAKNVGKTVHLFSEDEENNDVTVHGKNLNDKDIQYEEI
KDSYVFSRVAPGQKLQLIEIYKENGEIVAMTGDGVNDAPALKKADIGIAMGKRGTQVAQE
VADVVLKDDSFDSIINAVAQGRIIFGNIRRFVVYQLSYHLSEILIIAIMSFSLFTLPILP
LQLLFLNLLSDVFPALALGVGEGDKKVLDYPPKDPKEPVLKKKNWRQIISYGLIITASIS
GAYLYSHFILQQSESINNNIAFFSLAFAQFLHVFNLRDGDENMFNNQVTRNKFIWMALLL
CITLVLIAYFVPVFADVLSFEKLSLQSWILIGISSIVPLIIIQLIKEIKKDF
>IFAGANLK_00611 hypothetical protein
MLVYISSMELRLNLIINSSIRAESRICSGLNKRHPEFISEPALILYRGSSTN
>IFAGANLK_00612 Methicillin resistance regulatory protein MecI
MKQLTKAEEEIMQILWKLEKANVASIIEEMPEPKPAYNTVSTIVRILEDKGFVDHEKKGK
GYLYYPLLARETYSNQSINKLMNNYFNGSFKSMVSFFMKKNDMDTKDLEAILKEINKKEK
>IFAGANLK_00613 Regulatory protein BlaR1
MLEYILQVVIFQLGFLLMYELLLKKETFFTINRWYLLVTPLVSLLLPLLKFESLSALVPA
ESISTLSQVWLPEVYIGGQPKNIQQLPAVNVAQEKGLQINWWLVTYISGVVLSLILLLKK
YQNLNHLFRFRRISEDKELRIIEVPNSNIACTFFKTIFLGDKLSEAEKQQILSHELVHVK
QKHSLDLVFFEALKILFWFNPLVYIYQSRIATLHEFIADANVVKTTTKRSYYEQLLNTAF
NTQNISFINQFFNHSLIKKRIIMLQKSRSKTIAKFKYLFVLPLLFMMLTYVSCSDDNSSV
ASAEEDPLSQYSYTIDVSEGMTEENRKVHQKYEEFLMNNPNYVSWATIDSNEKSISYAIH
SRDEEVPEGYIKLYVSDKYDMYINLPNEGKEKDSDKYAEEIEYDSESGVPFALIEDVPVF
EGCEGLNSNEERKDCMSRQITRFVNMNFNTNLGKELNLRGTNRVITQFRIDESGNVVNVK
ARAPHPDLEEEAIRVISELPKMQPGKQDGKEISVMYSLPIVFQVGE
>IFAGANLK_00614 Beta-barrel assembly-enhancing protease
MLAFKAEAQTSALAISDSLYVVGEYSEAIEKLQEINPQTEKTYLKLAKNYAANRQPEIAL
ENYKKVLGQNPDRILTTIDYGELLVKTGKLEAADSLFKVLNQKYPKNAGFKYQQGLIREK
LKDSTAIHFFTYTIMLDTTHQAALYKVAKDKLRNRQYTMAEHYSKRGLRANSNNPSLLSI
LAQTYSSLKLYKEALQPYEKLIELGQDSEFIYNKLGFAYYRLKDYEKAIINYNKALEFED
RNSATHYTLGKLYALTGDLDKSETHLLMSILIKKQPVDAEYLSLGLTYKMQEKYKDALDY
FNKALEENPDNERALYERAVAADNYLEDDSTVIKYYLAYFNKYESIGNDGMLYRAKTRAS
DLKKKMHLAEN
>IFAGANLK_00615 hypothetical protein
MNFKIIIIFISLFLITLSGFAQEAFRVNIFVDADKNIYLEDRNVTIGELSKETKDLIYKQ
PATKYNRLVFNIYGDKNLKHGFIMDINHKLLSLGKGLKSKTNKYLLEYKNINLDDSAWQE
EIKSLQLDAVKD
>IFAGANLK_00616 hypothetical protein
MLKVQVRLPMKKALLDIRDLNALKPVWRFKCCYFYNYFLILFRRSLLALAGFVVFSCNFE
TKKISSEEVLELESQTLNWKEVDEYPAFEDCQNETELIAARDCFEREVAENVYAYLSKQQ
PIVTESIDDTLYLYLEINSAGRPEIDSVKIDSTLNNQLPELRLWLDQSIDSLPKIYPASK
RGVPVSTVFKMPIVIKAE
>IFAGANLK_00617 hypothetical protein
MNYYILSYTTGENYLEERVKYRQEHLNHATEYFNEGYLTLGGAIDSANEAVLVFKAESDK
IVKAFAENDPYVKNGLIKSWMVKKWNVVIGN
>IFAGANLK_00618 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MIFFIIICFCYSVLMLILLYGWKKIPEFSSENSPAEIRFSIIIPFRNEAENLAVLLSSLN
EINYPKTKFEILLVNDESEDNSVEIIKEFQEKHSEFSVKLLENKRVSDSPKKDAITKAIN
SANFEYILTTDADCRVPEKWLKTYNDYILKTGNKLIAGPVALIPFVSKNKQKSKFQNFET
LDVLSLQASTAGAFGIEKAFMCNGANLCYKKEAFVNVSGFSGNDKIASGDDVFLLQKFYQ
KHYKIGFLKSQEAIVNTRAQKNLVNLVSQRIRWASKTPAYKSLFAKFTGLTVLLMNLSLV
IATFLVFFKVLPYQPILIIFLVKFNLDFILIYSSAKFFQRETVLRSYFWSSVFYPFFSTY
VAVKSLFSDFYWKGRQFKR
>IFAGANLK_00619 Crossover junction endodeoxyribonuclease RuvC
MKSERIILGIDPGTTIMGFGLIKVENKEMKFIQLNELQLSKYSDPYVKLKLIFERTIELI
DTYHPDEIAIEAPFFGKNVQSMLKLGRAQGVAMAAGLSRQIPITEYLPKKIKMAITGNGN
ASKEQVAKMLQSLLGLKSLPKNLDSTDGLAAAVCHFYNSGRTEVGKNYTGWAAFVKQNPK
KIK
>IFAGANLK_00620 Oxygen-independent coproporphyrinogen-III oxidase-like protein
MSGIYIHIPFCKQACHYCDFHFSTSLKKKGQLVEMLCKELILRKDEFSSPEIQTIYFGGG
TPSLLEAEELQLIFETIYSNYKISENPEITLEANPDDLTEEKIKVLAASKINRLSIGIQS
FFEEDLKLMNRAHNAEEALKSIKLAKQYFDNISIDLIYGIPGMSVERWKRNLEISLELGV
PHISSYALTVEPNTALQKFIEKGKIKPVDDEAAKKHFEILVETLIKSCFEHYEFSNFGKP
GYFSQNNTAYWLGKSYLGIGPAAHSYDGNSRKWNISNNPLYIKALENGEIPQETEDLSLS
DKYNEYVMTRLRTKFGVDVAEVSDKFGENYKIHFLKLAVPLQNENLLEENNGIFHITSKG
KFLSDGIAADLFFLEE
>IFAGANLK_00621 Kynurenine formamidase
MKASIELNNKTYKVDFSKPLDISIGLRGDSKNPVAWYLDAPKIKPVKDGDFIGKVSGGAS
VNFNNIQFNPHAHGTHTECVGHISREFYSINQTLKTFFFFSKLISVESEKIGEDQVISKA
ILKEKFQSKNTEALIIRTLPNLREKQTRKYSHTNWSYLSEDAAIYLRNCGVKHLLIDLPS
VDKEKDEGKLLAHKAFWNYPKNTRFEATITELIYVPNSILDGEYLLNLQFASFENDASPS
KPVLYKIQ
>IFAGANLK_00622 hypothetical protein
MKITLKLEELSMFLLGVFAFSQLNFAWWWFLVLFFTPDFGMLGYLFGNKTGALFYNIFHH
KGLAILLWFLGFYLQNEVFQLIGVILFSHAAFDRILGYGLKYKKGFKFTHLGEIGN
>IFAGANLK_00623 hypothetical protein
MEFLFIGLAVGAVVAYFIFARFNREKSKLKTNEQSLVIMDKIKSVCKFITVEGDFSEIYH
YENLKEKYLSLLLGKKKAIVLVNAKAHVGFDLSKIRMNSENEKKTIVLTNFPQPELLTVE
TDFKYYDKREGWANPFTTSDLTDINRDAKNYIVEKIPQSGLLDQARKEALDTILLMEKIV
ETIGWKLDYTALTLEDNKQAKIEK
>IFAGANLK_00624 hypothetical protein
MDIETLRNYCISKKGVTEELPFGPDTLVFKVMGKVFALTGLDSVPVSVNLKCDPGKAVEL
REEYEANILPGYHMNKKHWNTVILDGYLKPGFVYELIDHSYNLVKAGLTKKQQQELKDLN
E
>IFAGANLK_00625 DNA mismatch repair protein MutS
MNKPLEFYTKQKEIHQLELSKLSKKLMVSSLIRLLIFLAICFAIYYFFGNMNVIVPVIIG
GIALFLFLVSRHSDLKDKSDKQKEIIKLNELEIDILKTRNFQDLPSGSEFEDPMHAYSQD
IDLFGRGSFFQYSNRTALYEGTKKLVGIFTENSIENIQQKQETVKELAQKPEFRQEFTAL
ARLVKTETPSKTVINWFKNYKNFVPNYIKWLPTVFSVFSLLVIAGYSFDYLKGIHLFLWF
LAGLLFTGIYLKKINLLSGSVSKIQDTFHQYHFLLGLIERENFSSDTLKKNQQLINEEKK
KASAIFKEFSKAIDSLDQRNNMLFGIFANGFLLWDLRQSYKLEKWISNYREHVENWFEVI
EFTDAYNSLGNFVFNHPDYVFPEIINERRGISATKLAHPLLDPKKRIANDFAIGDEEFFI
ITGANMAGKSTFLRTVSLQIVMCNIGLPVCAETCKYSPIKLITSMRTSDSLSDDESYFFS
ELKRLKFIVEEIKTDRYFIILDEILKGTNSSDKAIGSKKFIRKLVNSNSTGIIATHDLSL
CEITSELSQVKNHYFDAEIINDELHFDYKFKDGICQNMNASFLLRKMEIVDD
>IFAGANLK_00626 hypothetical protein
MDSLTQIVLGAAVGEAVLGKKVGNKAMLYGAIAGTIPDLDTFASAFTDTITAIEIHRGFT
HSIAFSILFAPVFGWFISKIEKKSIVTWQNWSWLMFWGFFTHPLLDSHTTWGTQLFWPLE
ARLAYKNIFVIDPLYTLPFLVFLILAMRQKRGTEKRRKYNNLGLIISSIYLLIITPALKL
YTFDKFTDALEKQEITYKKIETKPSPLNAILWSANVEVEDAYLIGNYSIFDSQEIEFVSH
PKNHQLLGDWRNKKNVQRLIDITEGWYTVSKKEGEIYFNDLRFGTLSPIAKADSDFAFSY
KLVEENGEIKAIETEKTRGDAKELLSQLGNRILGN
>IFAGANLK_00627 hypothetical protein
MKHLFTLAFTFLFVSGLSAQQDSRKLDSIISKIVDHTAYDREEFPLGLYTEEYYKEEAEF
AEKRIEELKEINAASLSETEQISLEMLKFKLQETVDHYKYEAFLNPLLSDSGFHLSLAYQ
VRDLNNYAQVKAYLNKLNAIPAYVNQHFVLLREGLKKGNTQPRVIFDGYESTYNDQIVEN
PKESYFYEPFENLPGILSEAQKDSVLTAAEKAISSNVIPQFKRIKEFFETEYLPETRTSL
GVSEIPNGKEYYQNRLDYYTTLDLSAEEIHQIGLEEVARINSEMKKIITEVEFDGSFEEF
IHFLRTDEQFYAKTGEELLKEARDIAKRIDAKLPAYFKTLPRKPYGVAKVPDAIAPKYTT
GRYIGASDETQPGYYWVNTYNLSNRPLYVLPSLTAHEAVPGHHLQNALNAELGDSIPKFR
RNMYLSAYGEGWGLYSEFLAEDMGIYTTPYELFGKLTYEQWRACRLVIDTGIHAMGWSRE
EAVEYFEKNTALSMHNINTEVDRYISWPGQAVSYKIGEIKIRELREKAEEALGANFDIRD
FHEVILEQGVVTLPILEERVNAFIASKNDK
>IFAGANLK_00628 hypothetical protein
MEWYILKSVAILATLLLFYKLLLEKENMHTFKRFYLLFAIIASIGIPLITITTYVEPVSE
SFDPVLFQLSEETSASESNSFEDNLLFILWTIYALGVIFFSIKFIRNLRELLLKIKTNPK
IKKENSTRILLQEKVDPHTFFNYIFLNRREYKEKKIPKEVIIHEEAHAKQKHSLDILIVE
FLQIVFWINPLIIFLKDYIKLNHEFLADREVLKKGIQTAGYQTTLLSFSSGHLHSDLVNP
INYSSIKKRFTVMKTQTSKKTIWAKSLLLLPLLGILIYSCSTKEELEKPNSDPTAQNQPL
EKATPEMIREYNRLASSYNSTGDKSQEINDYDRMSDIYKVMSPEQKKTAESFPEIEIIEV
VEDPKATPEMIAEYNKIIGDLNETGIIKQKDLNQINKILRLMTVEQKKSAVPSKFEILPP
PPPAPPTYKKLLADGATFYYQGKIIEPQKAQELVEDQKKVNMQITYDNKKRPFVELTDKE
N
>IFAGANLK_00629 Methicillin resistance regulatory protein MecI
MNLSKSEEQLMQILWKQERAFMKDLIEAYPDPKPAPTTIATLLKRMQDKNFVDYKQYGRS
REYFPLVKKKDYFSKQFNGIIKNFFNDSASQFASFFTKEANLSKEELEDLKKLIDKEIKN
K
>IFAGANLK_00630 hypothetical protein
MNLERELLKRSDSTCELCGNTENLDLYTYENFPGAESEASFVICSVCKVQFEDPEKVVPN
HWRCLNDSMWSTVPAVQVTAFQMLTRLKNESWPQDLLDMMYMEEELKTFAKSQMVSEENT
TSEIVHKDSNGAVIEAGDTVVLTKDLNVKGSSLTAKRGTAVRRVSLVHDNPEQIEGKVEG
QQIVILTKFVKKV
>IFAGANLK_00631 putative ABC transporter ATP-binding protein YknY
MSKVIEIRQITRDFPLGNETVKVLKGIDLDIDRGEYVAIMGPSGSGKSTLMNLLGCLDTP
TSGHYILNGKDVSQMSDDELAEIRNKEIGFVFQTFNLLPRTTALENVALPMIYAGYSKAD
RIKRAEAVLTEVGLGDRMDHKPNQLSGGQRQRVAVGRALVNKPSIILADEPTGNLDSKTS
LEIMHLFDEIHAAGNTVILVTHEEEVADHAHRVIRLRDGIVESDERKEVVSQ
>IFAGANLK_00632 hypothetical protein
MQLKSYIKFLLKSQNQHGLHSPFVYDLVTNCFYDKKKYKEYKLLKQYRKDLRKNNTTIQV
TDFGAGSKVFTSNRRTVSAIAINVGIPKKRARFLFRLVNYLGCKNNLELGTSLGIGAAAL
AANKKSNLISIEGCPQTANVAREQLKKFGIKNINLIVGEFEEILSKIITEPEEKSKTEGS
KDLQRIEQQTTFDLIYFDGHHTKEATLKYFHQLLPTAHNNSIFVLDDIHWSPGMEAAWEE
IKAHPQVRVTIDTFFLGLVFFRKEQARQHFKIRL
>IFAGANLK_00633 Energy-dependent translational throttle protein EttA
MNYLSVENIAKAYGEHVLFEDISFGINEGQKVGFIAKNGTGKTSLLNILAGSDSPDAGKV
VYRKDITTAFLPQEPNLDPNLTVEETIFSSDNEILNIINRYEKALKNPDDADAYQKAFEE
MDAAQAWDFETQYKQILFKLKLDDLSKEVKYLSGGQKKRLALTVMLLQKPNFIIMDEPTN
HLDLDMIEWLEEYFKKENFTIFMVTHDRYFLERVCNEIVELDHGQLYTYKGNYGYYLDKK
DARMAQEATNTEKAKQLYKKELDWMRRQPKARTTKSKSRIDDFQDIKDRAHKRRQDHEIQ
LELNMERMGSKIVELHNIGKSFEENELLKNFSYNFKRGERIGIIGKNGTGKSTFLNILTG
AIKPDNGKVVIGETIKFGYYTQAGITIKPGQKVIEVIREFGEYIPLKKGRQISAQQLLER
FLFDRKKQYDFVEKLSGGERKRLYLCTVLIQNPNFLILDEPTNDLDIVTLNVLESFLLDF
PGCLVVVSHDRYFMDKIVDHLFVFQGNAEVQDFPGNYSDYREYEESATAEVKEETQSTDQ
KDNKKDWKKTSSGSKLSYNEQKEFGKLEKEIARLEKKKEEIQQKFLQDLSGEKVAENSVE
LKKIEDQIEEKTERWFELGAKAE
>IFAGANLK_00634 hypothetical protein
MLKRYYLILILLAGVLSFSSCISTKKTTYLQDNDEKLDSVIQIQQLKKPYRIQTGDLLSI
RVKALDQELVGMFNPIDEANLSATTEERVFFDGFTVDDHGNIRVPTLGEVNVLGYTEKEI
REKIEGLLLENYFKEEANIFVTVKLAGIRYTTLGEIGTGSQVIYKEKVTIMEAVANAGGI
TEYGDMENVKIIRQYPEGEKVHLIDLTDIDATKSEYYYIQPNDLILVNALPQKALGLGTT
GLEIFRTGVTILSFITTTILLFSRI
>IFAGANLK_00635 Tyrosine-protein kinase YwqD
MAHEDDHISDVGSTFDFKGFVLKVISYWKLILLSVGISLAVAYYNNVRKLPVYNLGNSIS
IKDDQNPFFTSNTSLTFNWGGTSDKVNTAMTILRSRSHNEEVVEKLQFYTQYLKDGEYQR
IDAYGSAPFKVVADTTMSQALNVTMTITFLDSSTYNLKANVPSSLSLQNYKTKEKTYREV
DPKEFSKNYKSGEQVRLPFFSGTILRVEQPLQVGTPFYVSFMNFDSAVGKYRNVNVSPES
QGSSVLKMSQTGGNKGRIVDYLNGTVTVLSDNMLARKNLFATKTIRFIDSSLAVQSEALK
LVEAELNQFRNENAIMDISAESSQLSNRLSTLDLRKEDIRRQLSYYETLRNYLETRNDYS
NVPAPSVAGISEGSIASGVSRIISLAEERSNYQYSLKEDSPVFDDIDRQINSVKSILLEN
ISSSRGLLQDEQRDINQQIARLESEISKLPQEEQDLLKIQRRYSLNEKSYNMFLEKRSEA
GLIKAANVSDVMVIDSAKDTGGGQIGPNTQLNYVMAVLVGGVIPLTFVFLLVFLNTNIHN
AQEVTRLSPIPILGMIGKSKTDSNLVVFNNPKSSISEGFRGLRSSLQFMYKKQGVTGSKT
LLITSSVSGEGKTFCAMNLATVFALSERKTVLVGVDLRKPKIFDDFQLNNDVGVVNYLID
QSSSEEIIQKSKIPYLDVITAGPVPPNPSELLINEQMDKLMEELKQKYDYIILDTPPIGM
VADALNLVKHADATIYLIRQDYTKRGMLESINEKYHKGEIKNISFVLNHFVHRAKYGYGY
GYGYGYGYGYGYGYNRYSKGYVEKSDPTRSLKRWWKKAMRNFE
>IFAGANLK_00636 Asparagine synthetase [glutamine-hydrolyzing] 3
MCGIAGIISAKANKEKLQQMLNLQKHRGPDHTGNYVDSCYCALGHNRLSIIDLSAKANQP
FKDNSGRYHLTFNGEIYNYKELKQELKAYYNFKTASDTEVLLAAFIVWGKSCLNKLNGMF
AFAIWDNKLKKLFAARDRFGVKPFFYSEENKDFYFSSEIKAIRSVLKSNQPNEQVWANYF
TFGSYGMPSDTFYDEIFQLPGGHFLEYQAGNLKVTRWYDFEKNLSKYSKILSFEEAKQSY
YKILIDSISLRFRADVPIGFNISGGVDSSLLLALVNRLNKNKHIKAYTFYAGDENYDELP
WVQKMIETTRNPLTKVKIQPSDVIKKAQFLSNIQDEPYAGLPTLAYAALFENAKKDGIKV
LLDGQGMDEQWAGYDYYQNPGTTATIQGTGKMSPFRVKVLNDDFKELAKKPGYPTPFDND
LQNLQYRDLFYTKIPRALRFNDRISMAYSTELREPFLDYRMVEFAFSQPKTYKIHNGIQK
YLIREILKEIAPQDLSYAPKRPLQTPQREWVGNELKDFTEENIEKLRYSKISYWFNFEEM
QREWNNYKAGDNQSSFHIWQWINAGLLMGN
>IFAGANLK_00637 CMP-N,N'-diacetyllegionaminic acid synthase
MKILGLIPARGGSKGIPGKNIKMLGSKPLLQYTFEAAESSELLNKVILSSDDEDIIHIAK
QLELEVPFKRPDHLAEDSTSSLEVVKHAVNYYLERGIQFDAVCLLQVTTPCRKPGLIDEC
ILKFQDNNFDSLVSVREVPEDFNPHWIFEENNGSLKIATGEEKIISRRQDLPKAYHRDGA
IYLTKTEVLLNENSLFGKKIGFVNTSASPYVNIDTPEDWKKAEEMLSKLKS
>IFAGANLK_00638 UDP-N,N'-diacetylbacillosamine 2-epimerase (hydrolyzing)
MPKRKICVVVTARPSYSRIKTALTAIQDHSDLKLQLVIAGSALLDRYGNAVDFIEKDGFE
IAAKVFMVLEGENPTTMAKTTGLGVMELTNVFYNLKPDAVLTIADRFETIATSIAAAYQN
IPLVHIQGGEVTGSIDEKVRHANTKLADLHLVASEDAKQRVIKLGENPEKVINTGCPSID
LAKEIAEYPFLDFDPIEKYGGVGSKLNWKEGYIVVMQHPVTTEYKQAKAHVTETLKAIKR
LDYPTFWFWPNVDAGSDGTSNAIRSFRELEKPDNIHFFKNMEPTDFLRLLKNSKALVGNS
SAGLRECAYLGVPVVNIGNRQFRRNRATNVTDVNYNLNEILEATENAIKTEHFESSGIYG
NGDSGKKIAEILATSELTYSKTITY
>IFAGANLK_00639 Exopolysaccharide glucosyl ketal-pyruvate-transferase
MKKLKYSSYREKEIPLFYWSEIKFIFREKENYGDLLSKYLVEKISGKPVKFVQPKKQPWY
KMNKTNFLAVGSILHHATKHSIIWGSGIIDHEQEIAEANFRAVRGPQTRDYLLKLGYRCP
EVYGDPALLLPKYYNPQVKKKYKIGVIPHYHDYKTAVAFFGDKPGIKVIDLLTMNVEEVT
RQILSSENIISSSLHGLIVAHAYQIPALWVEFSDKIFGNGIKYVDYFESLKLPIYKAEFI
ENGKTAEELFQLMQSKPLLPEVDQLEKIQKSLLKSCPFS
>IFAGANLK_00640 Ubiquinone biosynthesis O-methyltransferase
MGASNLNQDKNKLHYEKLYANYNIQNILHWINNLDEFLASATTTETSWFALYQRNFREKI
KGNKVLDMGCGDCVNAAVMAALGAEVYANDIADSSGKIVEALNEAYEFEFPIHFVSGDFL
ENNLESNKFDFVVGKAFLHHLELPVEEQFLKETARLLKEDGEARFFEPAVNSKLLDELRW
YVPVKGRPSKFNKTDFAEWKKNDPHPDRSFSSAHFEKAGRKFFAEVETIPVGTLERFSRF
FKWGVTKNNFKKWALKTETKLPRIINKPLTRSQLIIYKKPTIL
>IFAGANLK_00641 Alpha-maltose-1-phosphate synthase
MHLAFLTPEYPHLLSTPSGGLGTSIKNLAEQMVKRDVGISVFIYGQDKNRVFEENGISFY
FIKQLHYNFFGWYRYRKYLEFYINKVIQDEQIDALEAPDWTGITAFIKLKCPLVIRMNGS
DSYFCRLEDRPQKKKNFWFEKLALKNADYLLSVSKFTAERTREIFNLKKEIKVIPNSVDI
EAFKPTGKEPIPDTILYFGSIIRKKGVLELSEIFNLINKQNPKAHLVMAGRDVPDIKTGK
STRALFEELLGDESGEKVTWLGSLPYEEIKAQIAKAAVIVLPSFAEALPMTWLEAMAIEK
ALVTSDIGWAKEVMQDGKTGYTVDSKDHITYAEKTLELLENQELAEKMGKAARQQVVEKF
STEVVVEENIRFYEGILEKKQLD
>IFAGANLK_00642 hypothetical protein
MANLLYLTNKTYHSILHNSKKIFILLPDGVGLRNFAFTSFVKTAEELGWEVIFWNHTPFD
LGELGFQEIKLTGKPRPKTDLLKRAKIEAELDHFTQKFNDPVYQTYKFPASNKGFKDIIK
NTIVRSFIKTHKGPKGLQRLRQKMKVSERKGEFYKNCKAALEKEKPDMVFCTNQRPVNAI
APLTASQDLGIPTSTFIFSWDNLPKATLVVETDKYFVWSEHMKRELLSYYPHIKEKQIFI
TGSPQFEPHYDSSLRQDRETFFKEHGLKLSKKYICFSGDDSTTSPDDPQHLNDLSEVVEE
MNLKGYKLGIIFRRCPVDLSNRYEKILEKYKNLIVPIAPGWKKAGEEWNTILPTKQDIKL
QINTILHSETVVNLASSMVFDFAIFGKPCLYINYEATNKTQTDWSHEKVYNFVHFRSMPN
GDEVYWLNSKEEIKTKLNEALTNPNEKAQKALKWFKKINREPADKASERIWEQLNKITVE
IN
>IFAGANLK_00643 hypothetical protein
MTSSTFKFHGLAIFGAAILFLVISPYKLAFSPDSIVYMEVAENLISGNGITNNEGNLVNH
WPPLFPLFISFVALLFNTDVLNAGLILQIFLFYLFLLVNMKILLQLKVNYRLILLFGLCL
ILSQVTINFLNFLSEGLFLVFLSFSFYFFLRWDQAGKSLNFYLCAIACGLFFLTRYAGIA
FLGCYLIFILFLDRGKVVQRLKNLLKFLLNFALVISPWFIYQVFFDTPPGGRKIAIHLIP
FAKIQDMFITFGYWFLGSKLAIVLFGGVLIIYILRLKLIRFYALKTFKTNRSAVSLILLF
LFLYPLFLIVSISFFDSWTPMTNRMLSPLLGFILILFFLFFQNFWENRNIKLVFVGIAFL
FLSFCSSLFPVVNNHYLYGGGYAKKMWVDSEVISFLKEQSFNNPVYSNGIELGKLHLRKD
FKLLPGKNDRLKLNNLKEKICEGEAYIVFFNKVNWRNYLVNAETLVKTFKKDDIICLEDG
FVIKRIIAE
>IFAGANLK_00644 Undecaprenyl-phosphate mannosyltransferase
MKKLSILVPAFNEEKTIILLLEVIRDVTLDFSLLKEIVVVNDASTDRTRQLIEKFITSNP
ELSIILHNQEFNEGKGTALHKAIKLATGDYIIIQDADLEYDPTEYNHLLKPIMAGKADVV
YGSRFMGGNPHRILFFWHSIGNKLLTFLSNAFTNLNLTDMETCYKLFRADTLKALELKEK
RFGFEPEVTAKTSRIPGIRIYEVGISYYGRTYEEGKKINWKDGLRALWCVFKYNIIQR
>IFAGANLK_00645 Linear gramicidin synthase subunit A
MKIALLTSDNLRHKYIAHCVAKQLDLKLIITEKKSPTITATDSLREEDAEFIKNHFLKRK
NSEKDYFGDYTNFPIKSNLLEIDHGSINSKKVKAEIEKAEVDYILLFGTSIIKKELLNKY
SGLIINLHLGLSPYYRGSATNLFPFYYKEPECIGGTIHLASTEVDRGDILHQFRPAISKG
DTLHDIGNKTIIKGGKLLPKVLEEYSTTKIQIIEQQGEGRLCKIKNLTPEKLRIIYHYIE
QGLIEDYLRDKKSRDEAFKIFQQDLQT
>IFAGANLK_00646 hypothetical protein
MLIVSNYHYIRENFSTPYPSVFGLTPAQFKFQLEQLSNYGAFISQDELLSYKETPLDKNY
FLITFDDGLKEQYELAKPILEEMGIPYIFFINTSNFSEEKVSLVHKIHLLRSYVAPEILL
QKLNTEILTGNEKKAALQHYNYDTEENAILKYFLNFRLSIIEQKEFIDPLFTKYFEEKKV
AEELYFSEEMLHKLYTEGVLASHSHGHLPLGRLKASEIRKEMQNTQDFFLEKFGKKAKAL
SYPYGSRDSCEGIGNLLKNSGFKLGFTMERGANNSLQDDSLLLARYDCNDLPGGKNDLFK
NRNPFESANLRKWHTYENSFTHK
>IFAGANLK_00647 hypothetical protein
MKIKDAIIILGPGKSGTTLLNDILALHQDLFWVSTYLNKYPNHPWLSLLNNFQTIGVIEK
FTRSRQKFPRPAESFPFWAHYIRNFRFNPKNFNEQDILNAQDAVKKINRYQIGERFITKL
TGPSRWRFLEEIFDNPYIIWLDRDPKAVIASFYSYKWKYKNQPEIFKKKEKAELIKEYVT
YYNNLQIDKVNLRRFRYCEVYYEDLVDNPAVFLAKLCNFLELEYSKSFKQKVNTWGILKK
TNSKYQKIFTPQEISLIENLLSK
>IFAGANLK_00648 Putative glycosyltransferase EpsE
MSEICVSIFMLTYNQENFIAQAIEGVLIQETNFSYQLVIGDDCSTDKTMEICSNYASKHP
KKIKLLLNEKNIGIGANYVKTYAECDGKYVAICDGDDYWIDPNKLQKQVDFLEENPDYKI
IYTNNYSLFPSGKKTGPKKDDRPLTTDFQDLVLGNYMASVTVLFKNTPLTYKMKKWIPTS
AYGDWPTYLLVLNRGGKIFFMNEPTAVYRKDFGTSTELRKTKSKMGKINLSILEMLLDDE
TFKKRKEILKAAIYRLKLGLIGSLNKEHNFYDSFLLLIRLSLEKGDWVILRRYISSLKRT
LVLLSRLDKYSLNSK
>IFAGANLK_00649 hypothetical protein
MTDVQNILVATNQLNKIGGSETFAFSLIEELKKREFVVEYFTFLKGAVSQQIEEKLGVQF
MSRKKYDLILANHQTCIELLFTRGYIIQICHGIFPYLEQPSKYADFHIAISQEVQDHLKK
KNFKSRKIYNGIDCERFKPEKKIKPKLTTILSLCQSNSANAIIKEICREHNLSLLVINKF
ETQVWEVEKAINKSDLVIGLGRSIYEAMASGRPVVIYDHRPYSKSFGDGYLDANNIKESI
KNNCSGRRFKFQFSKGDLVTEIFKYDLKTGDFLRNFALKNLNITSMVDEYLEIFLAEQEK
NRGFKRDFRKLMYSMGINKKKKVQALKRQMAKILAYFVRK
>IFAGANLK_00650 31-O-demethyl-FK506 methyltransferase FkbM
MKKIKNFLTSKFLRIYAKLPTPVQRSICSGIKQYCTPSSKIKKLNFQGEFTVKLTKNNHF
KMYNYGGMIEHETFWEGPFETFENDLGWIWIELCQFSEVILDIGANTGIYSLVAKSIKPE
ICVYAFEPSIHTFKRLKSNNKINNFDIKCEQIAVSNFTGKQTFFDLPYPNDNASLSPDKM
KNWQGYKGKIMEYEVETTTIKDYINKNKLEGIDLIKIDIEMHEPEALMGLGEYLNKFKPV
LIIEVLSKEIAQRLNELINFEDFHIFHLKKNRQAEKLDRFIVTELDLKRWEWNYIIFHKD
QTEKIRTNTSLFNTISPV
>IFAGANLK_00651 Teichoic acid translocation permease protein TagG
MQIRIYQKERNLSPVKLLKETFLDIYKSRFLARQLAERDIKAQYRQSYLGILWAFLTPLA
TAAVWIFLNLSGTIQVTDTGIPYPVFAFTGTLLWSIITEAVNSPTQSTNAARGLMSKINF
PKEGLIISGIYKLLFNSSIKIILLIAFVFIFGLGFHWGLLLLPFAILGALLFGITIGLLL
TPLGMLYKDIGKIVTMGFSFLMYITPVVYAVPDSGLMKTIMEINPFTPVILTCRDIITGA
SSDYLVYFLIIMTLCIPLFLVALILYRISIPILIER
>IFAGANLK_00652 Teichoic acids export ATP-binding protein TagH
MPNKDQEVLVKVEGLSKKFCKDLKTSLWYGVQDLLSNLKGNRAERELREKEFWAVKDISF
ELRRGECLGLIGHNGAGKSTLLKILNGLLNPDAGKVTIKGRVGALIELGAGFNPILTGRE
NIYNNGAILGFSRKEINEKLDEIIDFAEIREFIDMPVQNYSSGMKVRLGFAVAAQMEPDV
LIIDEVLAVGDMGFKLKCFKTIDEILPRTAIVFVSHSMPQVSRLCNQVILMEQGKSSFQG
NDIARAIDLYYNRFLNNSSQEIFSDGTFRLEKVELMGATGYEGKVPVLHWNDNLNLFFKF
KVKNVKEVPRFVISIFDKEQRPIAVFEKNDKNAGLEIKDGNLEFFVNHPNLQLTKGLYSL
HVLLLKMNSSGPILRMNDVLSFQIIHKEDVWPPLLLKTNYQNYSIKNLTQ
>IFAGANLK_00653 hypothetical protein
MNKMFVTEIVKNIKLSLIRRVLRKTELILVVSTGRTGTKFFESFLKKIFPKSPVFHEPKP
DLFDISIKKIRFGVSEEKLKNEILFHRTQLFYDNYSFLEIIPLVFFRKSVYVESNPFVFP
ILNEFSSLFKNVKIIYVSRDFKTYSVSAYNMSPQGDGISNFYGMADRRERLTAVDFGEMS
KRQWDFLSRMEKIAWYWNKCNKILYTELPKKNSIHMKFENLFSEDPLVQKSELERIMSFL
EKYNIDVLEFDELMNNKINKSNPSGVDRITNFEEKNSVLVFKLTDEMRKNLNY
>IFAGANLK_00654 hypothetical protein
MDNLFRLYYIQWIRRFIEDKKFKGKWRLGKFLDSVTPELRDNVIVKTKNGFKLKISPLYD
KGIEKKIFENGIYEEGTLWCFQQIIKKGDIIFDLGANIGLTTIHASKLTGKKGRVYAFEP
MPTTFNILNENIRLNRIKNVLALNFGLSDKNKKGEIFPNLHINRGAASIYAANRIEGVEI
DLKTLDSFISNNNIDKVDFIKIDIEGAEVPMLKGANIFFSTYEKPIICIEFSKNVHTEFS
PYFIYDYLNGKLNYDIFKQLKGKESLTPLIKINSKEELPKHDNLYCFQQYHYKRLPKDFF
FKNS
>IFAGANLK_00655 GDP-mannose-dependent alpha-(1-6)-phosphatidylinositol monomannoside mannosyltransferase
MNIAFIVKGFPTLTQTFIENQIVALLKEGHDVDIFAFKKGDLSILHPDIAKYHLLDRVTY
KEEMPPSKKRRVKDLLLWTKKNFFHIHWREFLHALLSEKYNKETFLNLFYKSKWFLSGQK
YDVIHAHFGDNSIPIANLKEKGFLRGVKFVVTFHGYDLTPTLLSHYEHQYKEIFKHAYAF
TVNTAYTKDLLLKVKPHLQNINILPVGLNPVLFQRENKLKNNFRILFCGRLIPLKGPFLL
LEIIAELRSRGFRDVELEIIGDGECREKLEEKVKQIDIERNVFFRGALNQLEIRDSMEKA
FVLLHPGIYDPQTGRAETQGLVIQEAQAMELPVIVSDVGGMKYGLIDGETGFVVKKNDIG
GFADAIEKLILNRELREKMGKLGREFVEKNYDSSFLVKKLLDLYKAN
>IFAGANLK_00656 hypothetical protein
MEFYCAKDFRIQFHHRPKKRRKGANACRNYGFELCKGKYIQWFDSDDLMAPNFLDLKVKA
IEENKVDYVISKSANFKDPNRADIISKNEKYYRFNDFEITNYNYVTQKINWLTYDFLGKR
EVCEKVRFNETLSSGQEYNFFSKLTCFSVNGLIIDSYLTYRRMHSQSIRSNLYRNRKEKE
ELQYNQLETWRELSEISPNSPSVKYLFFSLIKIDSRERMNLKTQTYLLKTLLKKGRLHDV
ALLLCFEYIYKPSGIGYIFRKKLLQSIEK
>IFAGANLK_00657 Putative glycosyltransferase EpsH
MQKLVSIIIPTYNRAHLLGETLDSVSAQSYHNWECLIIDDSSTDYTKKLLEFYCEKDSRF
QYHQRPTVRPKGANACRNYGFEISEGEFINWFDDDDVMLPGYMESSLKAFKEVHLFIVSK
GYYLMNDSAKRIPMKIEIKDSLFKSLVLWESHIITNSVVFRRSFLETKKLFNIKISRGQE
AEFFSRIFFNLPESSYKVIKEPQFLYRQHLESKTHKNRAYVRSFKESQAFISMRNLKYSL
ELKDPDLIVTLYSDIKQLFFMGIEHKHKKNSFYILKNFIPLLWKINKELSIKWLICGSLI
FITGKNSYILGKPIRRSEII
>IFAGANLK_00658 UDP-Glc:alpha-D-GlcNAc-diphosphoundecaprenol beta-1,3-glucosyltransferase WfgD
MKPLVSIIIPTYNRAHLIGETLDSVIAQTYKNWECIVVDDHSTDNTSQVGLEYTIKDERI
TFVKRPKGSLKGAASCRNIGLKNAKGDFVQFLDSDDLLAPDKLEVQFKYARKEILLTGKW
GYFSSRDHLERFKYKQRSYRNFKAPLKLLSCFGKNDEFFPLHTYLIPMEVIKKAGKWRED
LGNNDDAEYISRILRNTRKVKFVKLARVFYRVEGKSTLSGFNTYENALSAVKSLRYLEYN
LSDYPKIKARYVGNLKANISKRIKASYPILYEQNADLWINN
>IFAGANLK_00659 GDP-mannose-dependent alpha-(1-6)-phosphatidylinositol monomannoside mannosyltransferase
MKSILFKIWKFPKLSETFVVNQIVTAIKLGYEVRILTEEFCDISENANKDLFRQYELENK
LILEDYNIPETKRGRAFKGMSLIIKRWDLFKPLLIFYKSSNRKGFFPIFQFFFYASLRNY
EVIHIQFGTNKDPIDILKKNGFLKSRIITSFHGHDLHFPINNQILEDGYYDNLFEVADVL
VCNTTYLKEKLKTLRAPENKIETIPVTVDTDTFRPAAFHRDKNKLKLMTVGRMDQLKGQE
YGIKAVNLLIKKGIDVQYILVGTGIYEERLKKMVDELGLNGNISFKGKTNPKDVAKLLQS
ADIFLMTSVTNKVGMQESQGLVTAEAQACGLPVIAFDTGGVKYTLKDGQTGFLCREKEVN
AMADKIELLINNPKLREEIGKKAREFIEKEYSEIAVMNKWQDIYG
>IFAGANLK_00660 2-O-methyltransferase NoeI
MKNIIKKYTDRPGYKIVRKLSRRLGYDLIPLTIDKIGRDPYLDMKKFIINDHPVFFDVGA
NYGQTIDEITDVFKNHEIHSFEPGPDVFEYLKNKKSHKKNINIWNYGIGSAKSHLLLNQN
TNRNMSSFLEIGNDGWGAIEGQTSVPVTTIDDFCKEQEIERIDVLKIDTQGFELEVFKGS
KQSMQENRIGLLYFEVTFIDMYQNLPSFGELFDFAVENGFELITIYPIKYKNNRAGWTDV
LFRHKNYNLTKN
>IFAGANLK_00661 Chondroitin synthase
MQQEIISIIIPCFNDAEYIEQAINSALVQSWPKKEVIVVDDGSHTDTKIKLKSLEPRINR
LITQENKGVSAARNEGIKVAKGEYILVLDSDDYFEPKFCEKAIDVLLKDTDVKLVTCYSN
WFSKGNNKLFKPSGGQLEDILLKNIAMGSSMFRKSDWKAVGGYDEIMLKGFEDWEFYIRL
LKNGGYAYVIPEMLFNYRNKQNSRNKKANLAMYAIKEYIYNKHAELYKEHFSLFIHEWLK
STKKNEAFKQQVMDSVDYKIGNKLLKPLRALGMFKKK
>IFAGANLK_00662 hypothetical protein
MDNYWFYKTIILKRFESVPKNQKKVFIEIDHITLNRYLYNFIKFFTLNNYTVYIPKNKRV
ISVLNQKKGEFVYGSWILKERVRIGEPENADLVIGKNQLSNNYFRGKVGNSYHVPMSEYP
GIYRHGFFNEVESIQLKRKRSIFMSGNIDAAFYNNISKAGFFEIPSRSQVADFLKKKPYS
LEFNNLLELKSFINEEADYKVVLVDTSKQFRIPLKELKNILQKFNFYLALPGILIPQSHN
LIEAMSVGCIPVIHRTYAELMFPPLKNMETALVYDSWSELDEIILYSFNLEKSILNSLRE
NVLEYFSKYLSPGAVVKKIEENDFSTIYIQAEEESLTLLKKDISE
>IFAGANLK_00663 Putative glycosyltransferase EpsH
MTKELPLISIVMATYNRAHLIKESLIAISEQSYQNWECLIIDDGSKDKTQEIVEKFGNKD
LRFKYSKRGSNHKKGLPGSRNHGISLIKGEYIIFFDDDDIPHPDCLKWSIEEILNYKADY
CRFLRSVFFQDLNKNFNRLRDYAIIQHTPLNVNEMITGDVPFNSCQVLWKSECFNNEIFN
EALMFAEEWELYTRILLKEPKGITIKKPLYFGRKHAVSNTGEFRKADISRVDSKIYAARL
IVAHLSQVSTLSSRMTNFFIRMGFNLKSYNLIKEVLNNSNLNFLEKFKYRLGFAIYPLIK
PILRLKGSVIK
>IFAGANLK_00664 UDP-2,3-diacetamido-2,3-dideoxy-D-glucuronate 2-epimerase
MQLDLIAGTRPNFVKIAAIIYAIENYGQNINYRFIHTGQHYDDSLSENIFKDLELPSPHF
NLGVGSGSQARQSAAIMLAYEKLLLEEKPDLCMVVGDVTSSMVCAITAKKLNIKIAHVEA
GLRSYDWTMPEEVNRVLIDSIADYFFTTTPEASKTLLDAGKDKDHVYFVGNTMIDTLLRF
QSKFKAPNIWKEVNLKPQQYLLLTLHRPGNVDEEKQLEITINSILKNSRNLPVIFPVHPR
TVVIMKDLSFEADNFYLTNPLGYLEFNYLVQNAKAVLTDSGGITEETTVLSVPCLTLREN
TERPETIKLGTNELIGTNPENIAQALHKLFKDNWKQGNIPEYWDGKTGERIIKSLITI
>IFAGANLK_00665 hypothetical protein
MNKKEIKRILVVAESIDVEDSSGTKGRVALIKNLHKAGFELQVFHYTRNDIDLPGIPCFH
IKENRGSFLFFLSRLERYIRYWLKINPNKYIENLFGFSFTLFNDRNSIAAGLKKIRGFEP
DLVLTLSKGGSFRPHHALLKFPKWHPKWMAYIHDPYPMHSYPRPYDYVEPGHQKKRKFFL
SVAAKAKYAAYPSKLLAEWMRSYYGGLKGKTVIIPHQIDEDEMKLPALPEFFQKGAFTIV
HAGALMGARNPKGLISAYKKFLKEVPEAIPESQLIFLGAKSGYTREFEEIKKEIPQFYSS
VDYLPFKQVQAIQKNAAVNVILEAKGPISPFLPGKFPHCIAAEKPILLLGPYYSESRRLL
GEDYPWWSEINEVEKIFMIIKRLYQKWKSDENQLDYNYSELKYYLSAEYLSSQFSEL
>IFAGANLK_00666 hypothetical protein
MLSIFAPHFFNWTEQLNDSGHEVYWLDIFDSNTKVEQIDFAEQIIGWRYRWNHPGRYFLK
KNAIGLTRLINIFNERNLQRQLEKQIKRIEPDVVHSFVMYLGGAPALPVMKKFPDLQWVY
TAWGSDMYYYQKRPEHLEGMRKTLPHMNYMFADCRRDYSIAKDHGFKGEFLGVYPGGGGF
DFESFDPFMMDEEDRNVILIKGYQGLHGQCISVLRGILELKEKLEAYKIVVFGAAPEVFK
FVETSSIKEFKNLEVVGKLPYQKLMELMGQSFIYIGNSSSDGMPNTLLEAIIMEVFPIQS
NPGGATAEIIDHKRNGLLIEDPENFKAIAGLLKKAIDNPELRINAINWNSDRIKPELARE
RIRKRVLEAYQKIEENL
>IFAGANLK_00667 hypothetical protein
MISIIYAHRNRDTERIKISFESLKKQKLQNFEVIFVDYGSEDSLVKELEKLAEVFSFVHF
YHLPVPQVLWNKSKALNYGITKASGEYVFIADIDLVFYPETSVVWEELKNPDKFYLFRLG
FLDKKESQQLSTKYKFENLNPGRFGNVNGMILTSRESLLRVNGLDEFFHFYGAEDEDLFA
RLENAGYQKEQSKKEYFYHNWHPSFSGSEDSLLTGNPRVKNIMRINQRHFQRNRELGIIK
PLRQQGMGSFISIKKAQALKKPDIKLEIPNILARVEHVLREELQSHKGEVVQVKFSEDDY
YTSLKYRLKKSLGKQTQPYISMKEVNDIVLKEILYNYRDHNYSFMLGKDLKSIVFCLEV
>IFAGANLK_00668 hypothetical protein
MSREELVLNTYKNFCNADGNQHIASEYAILKLQKIIERFGIENVLEIGLGIGAIAGSLLS
ANTHIEYSGTENNEFCLDALKKNLGENYRKLEVFSKLCEVPQRKFDLIIIDGKDPELKKI
QKLLTRNGVIAIEGDRMPQQERLRKYFPKHKYVHSISNKKNATYSPFPPAHWQGGLKVIF
VNPNFEQKCWWIKEKLSTKFKYLYRNKN
>IFAGANLK_00669 N,N'-diacetyllegionaminic acid synthase
MFIIAEVGQAHDGSLGMALSYIDTLAETGVDAVKFQVHIAEAESSEHETFRVKFSEQDKT
RFDYWKRMEFSLDQWKLLKQRCDKKGVEFLASPFSNAAVDLLEIVGVKRYKIGSGEVNNF
LLLQKIVKTGKPVIISSGMSSFEELDKTVEFLKERKVEFSILQCTTAYPTKPEDYGLNVI
QQLRERYLVPVGYSDHSARTETSLAATALGAEILEFHVVFDRRNFGPDATSSLEINEIKK
LVEAVKNIKTSLGHPVDKSDNSRFSDLKNIFEKSLAINKDLLTGHKLSFEDLEAKKPKGY
GINALRFEEILGKELKKDMKQWEFLNEEDIL
>IFAGANLK_00670 hypothetical protein
MILVIHQHAKKLVRVRYKGEELEVEETDLCRVFWKLAEEYPEEMIAWCEEEFENNSNLDS
WKNIFHHDLVMASYGIRTAFLSEKIGYIDQLPFINVNREVQYATWQMSTDVGGIRGMVLL
QFEEMFGQIRNFGLLLNSIAKLGQQNGLFCYSVPGLICPELQQDILKRKLKARAGNQELF
SFVQAHYKNIRLWLLFLCFLRYEKSFPIGALIIAFFQKKYFKKNIDLFGIGLQSNRVRNH
GDSIDVIIPTLGRKNYLLQVLEDLKSQTQLPKKIIVVEQNSDTASQSDLPELKTRTWPFE
IVHHFTHQTGACHARNMALGEVDSEWVFFADDDIRFGADLLQKSLDELKRLGADCLNINC
KQEGEKTIFPKIKQWGSFGSGTSIVNSDFSKNIDFDEIFEYGFGEDQDYGMQLRRAGCDI
IYHPNLEILHLKASRGGFREIDLPPWEKDKPKPSPTLMIYAKKYYTPEQLKGFKTELFLR
FYSKQEIKNPFKYLKMMRERWGKSAQWAENLQKNSSEINCKLPVG
>IFAGANLK_00671 hypothetical protein
MMKFLITNRQDLNTLDLPRGCYLYQIGKLSFISEKEIAPENIDQKYLFNDGYLRVLDKDV
SEVTSQIKGVTEAISKGWPLTENITGSFSAVMIAEQEETISLCTDQIGLYPLYYLTGNND
FFFSNSIILTGMISGAKIDPTGVLQRSLGPDFSNQGSRTILKNCKRLLPGECRRYDFKGS
LISVDFDNRLYENLSKPNQDHDLTKEYWKAYKKEVLYCLNDSEKVNIALSGGIDSRVALG
AIPEAKEITCYTFGSSDNYESKIASRLAKLKPAKFKPCYQPDLYFPTPEQLKEYTWHSEG
VELCSWLEITEKADNREKEPLLLGELCEALPARKIAKFSSREFRQNNFIKYYIRNEDYNF
EASSPSKFEKWKQKKLKTYLIFFHEKNLAKFDLDFDYNQVREELISDLEEIFKRIEAHNL
AYTELYDELFSWYTYTRMRLSKQLLVASTKFDAYSPAMSLQMLKRTSSLHPNIRLNYRFI
KKLFSDNKELRRFYRVPTNQAPWIPQNASDLFKFASWGLRSKIDQFLIKRLMKAGDPSKR
YRLFKSINWVKVYQNPNMEKNLNEYFKNDHLGKQYVESIKTQAKNRRDLKQWPFANMNII
NAAALNVELELISSFRKQHEV
>IFAGANLK_00672 hypothetical protein
MKFNLIICTFKRSQAIKRLLKSVALQSRLPDEILVVDASPNDKSRDLIEYRKFPGLKYFK
IGEEDRGLTRQRNFGIRKTGKEIDVISFLDDDIILEPGYFEKLINTYKTYPNAIGVGGYI
CNEVTWKKSPDTPDFDEFKMDGYIRNLGSRNLLRKKLGLLSDQPPGVMPEFSNGLSIGFL
PPSGKTYPVEFFMGGVASYRKSLFKNIQFSEYFAGYGLYEDMDFCLRASKIGQLYVNTAA
QVEHHHEQSGRPDKFIYGKMVIRNGWYVWRLKFPDPDLKARLKWHGTAFLLTLVRMGNVI
TTAKRKEAFTESLGRIFGWWSLLLNKPTHEV
>IFAGANLK_00673 tRNA (mo5U34)-methyltransferase
MKSEERKLVNARQKEFYDTKQKNAVTRLWSYFRNGALNRIKKDIGVERDIYELHKNWFGD
LSQKKVLDLGCYAGNSLSFYLAQNSKEYLAIDLSPKGINNLSRRLEKIPGARAEVMDFLS
EEFREETFDLIYAYGVLHHFKDVDELIAKLQEKLSKEGIIVSHDPLETSLPIKFIRSIYR
PFQSDKAWEWPFSKKTYYKFEKAFEIKERRAVLGKAKWSAVMNFLPIPEGKRVNKAKAWH
REDWKNSLKSDKEMFDCMHLSLLMMKKSQ
>IFAGANLK_00674 Glycosyltransferase Gtf1
MRFSVFTHVIHEEQKGRLHAYSPYIREMNLWFKNVGEVEIIAPLSPKKEELIIEKAYEHN
NIIFTSISAFNLLSISAILKSVVRIPVNFFRILSAMKRADHLHIRCPGNIGLLAVVAQIF
FPRKPKTVKYAGNWDPGAKLPWTYKLQKWILSNTLLSRNIKVLVYGDWEGKSKNIVSFFT
ASFTELEKGIIEKDLTPPYKFIYTGNLVEGKGIFEAITLIDALNKKGVMSELEIYGGGIL
KNQLENFIQKESLQNLMKLKGRRSLEELKEAYKKAHFVILLSKSEGWPKTLAEGMWYGCV
PIATSVSCVPWMLGEGSRGVLIPDLEKREENKKKRSVLVNDESLKNPQFEGLDGSRDVSR
PDSFYETDVEKILRLLENPEKLKEMSSAAQEWSQQYTLEKLEAEIKKLLVLKKP
>IFAGANLK_00675 Putative glycosyltransferase EpsD
MKVLQLIDSLNPGGAERMAINLANSLEGELEASYLCCTREEGMLKEELDENVGYVFLNKN
YSLDLQAFGKLREFVKSEQIDLVHAHGTSWYWGVLLKISGLKIKLVWHDHYGESEQLEER
DVKYLKPLSRYFDGIIAVNGDLKDWAKEKLKCDKIIQLNNFIVPSKIGDSQLRLKGDPKD
FKIICVANLRPQKDHLNLLAAFDMLKIEEISLHLIGSDPGTTYSQTLKMEITKSDKKIFY
YGSSSSVFGLLEQADLGVLSSRSEGLPLTLLEYGLVGLPVVCTEVGQCRELVGDEALLVP
PSNAQALERALRFYFQNPETRENDAYRLHQKLNKNYSKETVLPMLFNFYNNISVT
>IFAGANLK_00676 hypothetical protein
MAAKGRYKYNYIELLLIHLGMAILLYVYEPIAPLLLFGILAYFSFLILTRENKNNEALLA
AAYIAGAEVFFRQTGGMVFYETGKYMVIIFLVIGMFFKGTSNRTVPFWTYLLILIPGIVV
ASMTISYQAEFRKLIAFNLSGPVALGIAALYCYYKKIKQEDFQRVILMLLLPIISQMFYL
YLYTPSMREVSISLSGNYAATGGFGPNQISTVFGFGAFLIATRVFTIKHKLINIIDLVLL
GMMGYRALITFSRGGVFTAIACILAFLIFLYYKKGAREQMNLNFKVILLGGATILIWLFS
MVQTGGLLGNRYSNQDAAGRLKDDITTGRVELVTTELHAFVNYPVTGIGVGKGREYREEN
LGIEINTHNEISRLLSEHGLLGLVSLFILILVPIIFWTKFKNNYYFLAFLAFWFLTINHS
AMRIALPAFVYGLALLYIVDDKKPPVHRKRLTD
>IFAGANLK_00677 Phosphatidyl-myo-inositol mannosyltransferase
MLRKEGYKVKTASTRSNKALRLIEMLGLIVRYHKTTDIVLIDTYGAMNFYYAYLVAKTCQ
AYKVDYIPILHGGNLPERLSANKKYSQSLFGKAKINIAPSEFLYNIFKAEGFHNTKIIPN
AIQMENYPFKKREDFQPKLLWVRRFQKRYNPVMALEVLLLLKKDYPNAKLCMVGPDKDGT
MKTCKKFAAKHQLDIEFPGKLKKKTWAKLSKDYDFFINTTNIDNTPISVIEAMSLGLAVV
STNVGGMPVLIKNNDDGILVPVNNAQDMAAEIDKLIKHPEKAQSLTENARKKVENFAWEK
VKADWNRVLNS
>IFAGANLK_00678 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKNLLYIGNELEDRGGAPTSIDKLSPLLRNEGFEVKTSSSHKNQVLRLSEMLNSIIKNKS
WADYVLIDTYSTRNFWYAVLTAQLCRNLQLDYIVLLHGGELPLRLKKNPQLSDSLFKNAK
LNIAPSRYLFDVFQKAGFTNLKYIPNSIFLKYYPFKSRKVLKPKLLWVRAFAEIYNPMLA
LKVLEELLIEYPEAELCMVGPEKDGSFKECVNYAEKNKLQVKFTGKLTKPEWTALSEEYD
IFLNTTNIDNTPVSLIEAMALGLPIVSTNVGGIPYLLQHEETGILVPPDEESAMLSAIKK
LLIDEDLTEKLSRNARRQSEKFDWEIIKENWKEILLSE
>IFAGANLK_00679 UDP-N-acetylgalactosamine-undecaprenyl-phosphate N-acetylgalactosaminephosphotransferase
MSQRPLVHFEISERKVLLRLLDSLCILTCLSLIGIIFEFDYFRIDSQNWYWTLVLLLYFN
LFASIFELYDLQKASNFDSVLQNSLLSSGATVLFYMLTPFLTPSLPENRLQILFFFLAIL
IPLLLWRLVYITLISSPRFYKRVLVVGNSFDINLISSDLQKSDPNYVVVGYIKTEDRLSS
EIDEDKLIRFEIKDLTEAIKEHHINEIVVASGYKKGLMLPLYNQLSVLLKAGFPIKDYTQ
VYEEITQRIPVQHVDKDFYRYFPFSRSNQNKFYQFFFRIFDIIIALVGLTFLILMLPIIL
IANFLGNRGSLFYRQERIGKYGEIFRILKLRTMVKDAEPNGPQYAEKNDLRTTKFGKFLR
RSRLDEIPQFYNVLKGEMSLIGPRPERPVFVHELSEVIPFYETRHVVKPGLTGWAQVKAD
YGNCHTDSLVKLQYDLYYIKHRGIFLDLNIILKTLSTVIFFRGQ
>IFAGANLK_00680 Apolipoprotein N-acyltransferase
MKNFLYAISSGLLLALAWPTYGFPLLLFFAFVPLLYAEFKVRNSKKKYVKWKVLGLAYLS
FFLWNLITTYWLYFSTAFGGAFAVLVNSLLMALVFLLYHIVAKRTGFSAASAFLISIWMV
FEKLHLAWEFSWPWLNLGNAFSEFQNWVQWYEYTGTFGGTLWVWLANIACFKAVLLYKEF
KDKDFIYRGIFKVGLLILIPIGSSYLLLSQVEEKGETMEVVILQPNINPYTEKYNTNDTR
IGELLLKLSEEKVSDNTKLILAPETVFADGTVLPNFEQSEAAFFSRQLINKYPQTNFLSG
ISFYERFSDPAKVREQSNQLGPYDWYDDYNSAFLMNAEDIPQLYHKSKLVVGVENFPYQE
ILKPILGDVMIDLGGTVAMKTTQEDREVFALNNNATTGPIICYESVYGEYVTGYVENGAD
FLSIITNDAWWGNSQGHKQHLSYAKLRAIETRRDVVRSANTGISAFINQKGEITKSLGYE
KQGSIKADIHLNSEITFYVEYGDYLARVAQFLALFIFLFAIVKYKRNRPS
>IFAGANLK_00681 hypothetical protein
MSIKRHIPNLITLLNLLCGTIAVIFAVQGSLIMAAIFVAGGIFFDFFDGLAARSLNVSSD
IGLQLDSLADVVTSGVVPGIVMYQLLDNALPGNSGVENTGWEVNPGWWDWNFNTIALIGL
LICLASAYRLAKFNVDDRQTDSFIGVPTPANALLILSFPLILTYQPDSFLTGLILNEWFL
IAVTLLSCYLLNAEIKLFALKFKNWGFADNKVRYFFLLLCLVLILVFQFVAVPLIILSYV
ILSVVFPKKEEEVH
>IFAGANLK_00682 Lipopolysaccharide export system ATP-binding protein LptB
MKLRAENLVKAYKGKEVVKGISLEVNQGEIVGLLGPNGAGKTTSFYMIVGLIKPNSGKIV
LDKVNITKYPMYKRAQHGIGYLAQEASVFRKLSIEDNIMSVLELTDLSKKERHDKMETLI
EEFGLGHIRKNRGDLLSGGERRRTEIARALATDPNFILLDEPFAGVDPVAVEDIQRIVAQ
LKDKNIGILITDHNVQETLAITDRTYLMFEGSILKHGQPQELAEDEMVRKVYLGQNFELR
KKKLFK
>IFAGANLK_00683 Alkyl hydroperoxide reductase AhpD
MINKVDEFNAYRQQMNDKILGENNKVLKRIFNLDTNAFTEGAVDKKTKELLGLVASLVLR
CDDCVKYHLESSYKEGLTREQVMETLSIGTLIGGTIVIPHLRRAHEYWEALENAKE
>IFAGANLK_00684 Sec-independent protein translocase protein TatC
MKQIGTPEPEMSFLDHLEDLRWHLIRSVVAIVVAGSIAFLLKGFIFDVLLFGPSRGDFFS
YDILCRITTSLGVDAGFCFDEMPFRIQSRTMGGQFSAHVWTSITAGFIIAFPYVIYQFWL
FVAPAMHDNERKHAKGFIFITSLLFFIGVVFGYYVVTPLSINFLGKYQVSETVFNDFDLG
SYIGLVRASVLASGLIFELPIVIYFLTRVGVVTPQFLQKYRKYALVIVLILSAIITPPDI
VSQIIVAIPVLILYEVSIIISKVIYKQEQRKLNKN
>IFAGANLK_00685 Arabinose 5-phosphate isomerase KdsD
MKLKEKILIAAKETISIEAKAIANLENFIDSEFAEAVEKIYDAKGRVIVTGIGKSAVIAT
KIVATLNSTGTPAIFMHAADAIHGDLGTIQKDDVVICISKSGNSPEIKVLVPYIKDFNNL
LIGITADKESFLGRESDYVLNSYVEKEACPNNLAPTTSTTAQMVMGDALAICLLKLKGFS
RKDFAKYHPGGSLGKKLYLRVSDITAQNMKPQVAPETSVTDAIIEISEKMLGVTAVIENN
KIIGIITDGDIRRMLKNNTEFKNLTARDIMSPNPKTIDQDSLAVDALEMLEENKISQLLA
LDNQTYAGVVHIHNLIREGIL
>IFAGANLK_00686 ATP-dependent DNA helicase RecQ
MSLTEIDLHQQLKKYFGFSQFKGLQEEVITSIVNKNNSFVVMPTGGGKSLCYQLPALIEE
GTAIVVSPLIALMKNQVDAIRSISAEHGVAHVLNSSLNKTEVKQVKEDIANGVTKLLYVA
PESLTKEDHVEFLKHQKISFLAIDEAHCISEWGHDFRPEYRNLRSIIKRIGDNIPIIALT
ATATPKVQEDILKNLGIPDANTFKASFNRPNLYYEVRPKTKNVNADIIRFIKQHRGKSGI
IYCLSRKKVEELAQTLQVNGINAVPYHAGLDAKTRSRHQDQFLMEEIDVVVATIAFGMGI
DKPDVRFVIHHDIPKSIESYYQETGRAGRDGGEGHCLAFYSYKDIEKLEKFMSGKPVAEQ
EIGHALLQEVVAYAETSVSRRKFILHYFGEEFDSETGEGASMDDNVRYPKKQHEAGEEVQ
LLLKTVKETKQLYKSKEVVKTLIGKSNAVILSHKTDTHPLFGKGKDRDGKYWMALIRQVL
VAGLLKKDIETYGVIKLTSKGEEFLQNPTSFMMTDDHIFDSTTEAVPTASQSGGAGIDKT
LVKMLKDLRKKVAVKNEVPPFVVFQDPSLEDMAIKYPVSIEELSNIFGVGENKAKKFGKE
FVELIQRYVDENEIVRPDDLVVKSTGANSALKLYIIQNVDRKLPLDDIASAKGMEMKEFI
KEMEAIVYSGTKLNINYWIDDILDEDQQEEIHEYFLEAETDKIDEAIQEFDGDYDDEELR
LYRIKFISDVAN
>IFAGANLK_00687 hypothetical protein
MSKYKYSLLLLILMFSFSCTSDSDENGDDGISGIDKTANLQGLGDSASHLLSDSEFTSMN
IEIVYVNGFAPTEAALANFKSFLEERTFKPDGINISLRAVSSSGKAPFSIEEIVEIEKDT
RTVYNAGDEIAVYIYFADGKSEKDEENKFTLGSAFRNTSMVIFGGTIEDFASRPNAPTES
DIEAAVLNHEFGHLFGLVDIGTEPQSDHKDDDNEGHCNVPDCLMRASIEFGSGIIDEIEG
GRVPQLGMHCIRDLQAAGGR
>IFAGANLK_00688 Ubiquinone biosynthesis O-methyltransferase
MNQETSAKDIFGKAISAYYHEKDTTDIQVHSPDFDDDVIPVTYLFRNYSEMPPLEQKALQ
LATGKVLDVGCGAGSHSLYLQQEKKLNVTSIDTSQGAIEISRLRGIKDARNIDFFNLKAE
KFDTILMLMNGSGIIGKLNNLDKFFKKTRELLKTGGKLLLDSSDLSYLFDRDEDGGIWVD
SEAAYYGELEFKVSYKGENSDYFNWLYIDFQTLKFAAETNNFSCKRIKEGEHYDYLAELQ
ALKQ
>IFAGANLK_00689 hypothetical protein
MEEILKNLPEKAKDKHKENKKFFAKLRKKPPKDLDRQMQDMHEEEFSRTNCLDCANCCKT
TGPLFTNKDIERISKHLKQKPQQFIEQYLRIDEDNDYVLQQVPCTFLAEDNYCLIYDVRP
KACREFPHTDRKDFHKISNLTIKNTAICPAAFNIVEEMKRRVKG
>IFAGANLK_00690 hypothetical protein
MLKRLFKSTFLFAFIGILSCANQNKKEQSSEEIAINNQNETVTEDIILAANRTEAYLPML
EGKKVGIVGNQTSIMKNKAGEFTHVVDSLLALDVNLVKGFAPEHGFRGTADAGEAVEDGK
DTQTGLPVISLYGDNKKPKAAQLEDLDVLIFDLQDVGTRFYTYISSLHYVMEACAENDVQ
LIVFDRPNPNGHYIDGPILETEFKSFVGMHPIPTVHGLTMGEYAKMINGEKWLKDGIQCD
LEVIEMENYDHSKTYNLPVKPSPNLPNAQAINLYPSLCFFEGTNVNAGRGTDKQFQVFGS
PFLDKEYFDFTYTPESKAGAKNPKHLGKECYGRDLSEIDPVDQINLEWLIETYQNTDKKD
EFFNAFFTKLAGTEELQSQIEKGLSAEEIRKSWQQGLEEFEGKRDTYLIY
>IFAGANLK_00691 Lipoprotein-releasing system transmembrane protein LolE
MNFEFFVVKRLIGGKSHKSSISAPIIKIAIAAIAIGVVMMLVSFATGLGLQEKIRDKIAA
FNGHINISNYDNNSSQVTLTPVDKDQKFYPGFTSVEGISHVQAVATKFGIIRTETDFEGV
VVKGVGTDYNWSYFEDFLVEGNLPDFDKTLNDEVLISAYLANRLQLNVGDKVPTYFLRDG
SDRPLTRGFVVTGIYDSGFMEFDKLYVLADIRHIQRLNRWDENEVGNFEVFLNDFNEIDK
KGQEVYENTGSFLDTQTINQKYYSIFEWLALFDFNIALIIGIMILVAGINMITALLVLIL
ERTPMIGILKALGGNDWSIRKIFLYNAGYLIIKGLFWGNLIGIGILLLQKYFKLIPLNPE
TYYVTEVPVYLNWDYILAVNLGTLILCMLMLIIPSVIISKISPSRAIKFE
>IFAGANLK_00692 Putative cystathionine beta-synthase
MDYVENILGTIGNTPMVKMNKITSEIDALVLAKYETFNPGNSVKDRMAVKMVEEAEANGL
LKPGGTIIEGTSGNTGMGLALAAIVKGYKMVCVLSDKQSKEKIDILKAVGCEVVVCPTDV
APDDPQSYYSTSKRMAEETPNSWYVNQYDNLANTKAHYESTGPEIWEQTDGKVTHFVVGV
GTGGTISGVGKYLKEKNPYIKVWGIDTYGSVFKKYHETGEFDEKEIYPYITEGIGEDILP
KNVDFSVIDGFTKVTDKDAAIYTRKLAEEEGFFLGNSAGAAAKGLLQLKEHFTKDDVVVV
LFHDHGSRYVGKIFNDEWMKKQGFID
>IFAGANLK_00693 Amino-acid carrier protein AlsT
MRNLWLFTSIFLMLTAVTAAQKNTQNNSNLQVEVNLSNPSREINDGTAEVIVTGGKKPYQ
YKWSNQSTALDARRSTGLIEGMEYTIKVTDANNNSVSKSFTIPAESITETFNSNVQPAVD
FLGGILFWDPFASLGLFDPVVYTSNKQIPIPEWDALSNNSYTLKEWLITKNAEVSEGDKI
AIIETNTGEEIEVFAPVKGRLNYLIKEGHVIFDPNRTSDVVKQDAHVFAEVIYAEPQPLL
HPNGDVKMNAIPFIVIWLIIGSVFFTIRLGFINIRGFRHSIDLARGKYDDPNAPGTITHF
QAMATAVSATVGLGNIAGVAVAISLGGAGATFWMFLAGFFAMSLKFVECTLGVKYRFINS
EGRIFGGPMNYLRYGLEKRNMRGLGKFLAGLFAVLGVGASFGGGNMLQSNQAFKIVSEQL
PFLQGHGFWFGIGFAILVGVVIIGGINSIAKVTGKVVPFMAIVYILGCAIVIGTHIENIG
GAFSAIFNGALSADALKGGFIGVLIIGLQRAAFSSEAGVGSAAIAHSASKTNNPIADGFT
SLVEPFIDTMVVCTMTALVLIFTGMHEVNGLGGVELTSDAFGSVISWFPAVLAFAVFLFA
FSTMVSWSYYGMRSWTYLFGKSVKSETVYKVMFLLFVVLGASTSLGAVLSFSDMMILAMS
FPNIIGLYIMSSEVREDMINYLKRLKAGEIYISEKFRKAA
>IFAGANLK_00694 hypothetical protein
MKSLKTVFVIFCLTFVILQTLLLLETPLPDLINFYLADFLCMPIVLSICLFTVQFLKKDK
SLRLNLITVLSVFVMYAIYFEVILPPLHWRYTADILDVLLYLIGSFVFYFLQKLP
>IFAGANLK_00695 hypothetical protein
MESNQENHTNTTSNIASKARQEKEEPKTGIGRFFSKLGYSIWIAVMVVGGIIAFLVSLLV
L
>IFAGANLK_00696 hypothetical protein
MKLYFILFFLSSALFAQETPAESFWKQLQQHCGKAYEGTIPQGMGNDDFDNKKLLMHVRS
CEEDEIKIPFFVGENKSRTWILRLKDDKIQLKHDHRQPDGSEDKITQYGGTSSNTGLANI
QVFPADEETAELIPAAATNVWWISLDDKIFSYNLKRIGSKTNFTVEFDLSKPEKTPTAPW
GWKE
>IFAGANLK_00697 hypothetical protein
MKNFYFIFLAFLAIGCNTSNSVTQNTETDNTSGMDYSYLALGDSYTIGESVPEKERWPVQ
LVAQLNERGYKVAPPKIIAKTGWTSGNLLAAMRSELNYTREFDLVSILIGVNNQYQGQSI
DDYEEELREIFKLALNHSKRREKGVFALSIPDYGVTPFGEENAETIGEEIDEFNAVFRQV
ASEFEVDFYNITPISREAGRDSELVAEDGLHPSGLMYRYWVEEIRDEIPQMLPQ
>IFAGANLK_00698 hypothetical protein
MVHNIRYFFERHGFYVSSRVADKVGMRAKSVRLFFIYASFVTLGSWFVVYLVLAFWLKLK
DLVYTKRTSVFDL
>IFAGANLK_00699 Amino-acid carrier protein AlsT
MRKYLLSMFFLFSILAINAQELDVQAKVGNPSNVINNGFIDLEVEGGVPPYKYQWSDPET
SLESSRAEGLTEGVPYEVTVTDSEGNSVTKSFEIKAEAITEHFNGTFVPIVEGMTAVLFW
DPFTALGIYDPKVYAEERYVPTPEWAADAEDKFILKEWIVEEGAHVDEGDLIAIVDSESS
GELDVLANATGTVSYLAEEGEMIWDYENSSDLIETNAHMLAQIEYDEPQLLTNPNGTPQK
HNIPFIVVWLIFGAAFFTVKMGFINFKGFKHSIDLARGKYDEPNAPGSITHFQALATAVS
ATVGLGNIAGVAVAISLGGAGATFWMIIAGLLGMASKFVECTLGVKYRFINSEGRIFGGP
MNYLRYGLEKRNMRGLGKFLAAFFAVLGIGASFGGGNMFQANQSFEILSGQFSFLIGNGF
WFGLGVAVLVGIVIIGGIQSIAKVTGKVVPFMAIVYVLGALTVIFINIENIGPAFGAIYD
GAFNPTALKGGIIGVLIVGFQRAAFSNEAGVGSAAIAHSAAKTNHPPSEGFVALLEPFID
TVVVCTLTALVLIFTGMHEVQGVGGVQLTSDAFASVVSWFPYVLAMAVFLFAFSTMISWS
YYGMRSWTYLFGKSKKTELAYKILFLVFVVVGASISLGAVLDFSDMMILAMSFPNIIGLY
IMSSEVRRDLNEYSRKLKAGELFKKQREAKAS
>IFAGANLK_00700 Acyl-CoA dehydrogenase
MNTLYFTEEHELFRKSFQDFLQKEVVPHIDKWENTGTIERFIWKKFGEMGYFGLNQPEEY
GGMNLDIFYTVIFLEELQKINSGGFAAAMWAHAYLAMTHVNKEGDDAIKKKYLTPSIDGD
KIGCLCITEPFGGSDVAGMRSTAIKKGDKYILNGSKTFITNGVYSDYLVVAAKTNPDKGN
KGMSIFIVDRETPGISASKLDKLGWRASDTAEIAFDDVEIPAENLMGEEGKGFSYIMQHF
ALERLIMGINAHARAEFALDYTLGYMSEREAFGRTIDKFQALRHSVADMASEIEMNKEFN
YSIAKRLDEGQYVVKEASMSKLLSTKMADKVIYDCLQMLGGYGYMEDYPLARMFRDSRLG
PIGGGTSEILREIIAKMVIDKKEYKPAAK
>IFAGANLK_00701 30S ribosomal protein S21
MLIIPVKDGENIDRALKRFKRKFDKTGTMRQLRSRQHFTKPSVAKRAQHQKAEYIQHLRD
QEDI
>IFAGANLK_00702 Tyrosine recombinase XerD
MSVNSFFMSFSQFLDYLQLEKKYSPNTLTAYKTDLKSFSEFILFEFEEKDLSRVHYSQIR
NWIVALVDQGLSNRSVNRKISSLKAYYRFLQKTGDIEFSPLAKHKALKTASKIQVPFSEA
EITQVLEQIDTSDFEGLRDRLIVELFYTTGMRRIELIEIKLQNVDLSGKYVKVLGKRQKE
RIIPLLPGVISNLQNYISKRADLVKGRETPYLFVTQKGIKLYESLVYRIINNYFSKVSGK
IKRSPHILRHSFATHLLNQGANLNAVKELLGHSSLAATQVYTHNSISELSKVHQMAHPRN
KKTN
>IFAGANLK_00703 Ribosome hibernation promoting factor
MKVNVQSVNFNADQKLIDFIQRKLDRLENYYDKIIYADVFLKVQNTSGKDNKITEVLLSI
PGGDIMVKKTCKKFEECVDECASSLQRQLIKRKEKLSAHV
>IFAGANLK_00708 Elongation factor Tu
MAKETYDRSKPHLNIGTIGHVDHGKTTLTAAITKVMADAGYSEASAFDQIDNAPEEKERG
ITINSSHVEYQTANRHYAHVDCPGHADYVKNMVTGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGIPRIVVFLNKVDLVDDEELLELVEMEVRDLLSFYEYDGDNGPVISGSALGALE
GDEKWSKTVLDLMEAVDSWIELPERDVDKPFLMPIEDVFSITGRGTVATGRIETGVANTG
DPVEIIGMGAEKLTSTITGVEMFRKILDRGEAGDNVGILLRGIEKSQISRGMVITKPGSV
TPHAKFKAEVYILKKEEGGRHTPFHNNYRPQFYVRTTDVTGTINLPDGVEMVMPGDNLTI
TVELIQTIAMNVGLRFAIREGGRTVGAGQVTEILD
>IFAGANLK_00710 Protein translocase subunit SecE
MAGIGNYISESYNELKNHVTWTSWPEAQRLTILVAVFSIIFSLAIWGVDTVFSSAIEEYF
KWIKS
>IFAGANLK_00711 Transcription termination/antitermination protein NusG
MAEGKEKKWYVVRAVSGQENKVKDYIEKEVNHLGMEDYLDQVLVPTEKVIQIRNGKKVNK
ERVYFPGYVMIQASLEGEMPHVIKNINGVIGFLGETKGGDPVPLRKSEVNRMLGKVDELS
VKTDNIAIPFTIGETIKVIDGPFNGFNGTVEKINEEKRKLEVMVKIFGRKTPLELSYMQV
EKV
>IFAGANLK_00712 50S ribosomal protein L11
MAKEVSKVVKLQVRGGAANPSPPVGPALGAAGVNIMEFCKQFNGRTQDKQGKVLPVAITV
YSDKSFDFVIKTPPAAVQLLEASKNKKGSGEPNRKKIASVSWDQVRTIAEDKMQDLNAFT
VESAMKMVAGTARSMGITVKGDAPF
>IFAGANLK_00713 50S ribosomal protein L1
MAKLTKKQKEAQSKIESNKAYSVAEASALIKEVANENFDASVDLAVRLNVDPRKANQMVR
GVVTLPHGTGKDVKVLALVTPDKEEEAKEAGADYVGLDEYLDKIKGGWTDVDVIITMPSV
MGKLGPLGRVLGPRGLMPNPKTGTVTMDVAKAVSDVKAGKIDFKVDKTGIVHAGIGKASF
EAEKIAGNARELLTTLVKLKPQASKGVYIKSIHMSSTMSPSVQVDTKRFTEQ
>IFAGANLK_00714 50S ribosomal protein L10
MTREEKSIVIEDLTAQLTDNSVVYLADISGLDAGTTSNLRRACFKANVKLAVVKNTLLAK
AMEASDKEFGDLPSVLKGNTSIMFSETGNAPAKVIKEFRKKNEKPLLKGAFVEEAVYVGD
EYLDALVNIKSKEEVIGDIVGLLQSPAKNVISALKSGGGKISGILKTLSEKEG
>IFAGANLK_00715 50S ribosomal protein L7/L12
MADLKEFAEQLVNLTVKEVNELADILKEEYGIEPAAAAVAVAGGGAAGGGEEVEEQSEFD
VILKAPGGSKLAVVKLVKELTGLGLKDAKALVDGAPAPVKEGVAKDEAEALKAQLEEAGA
EVELK
>IFAGANLK_00716 DNA-directed RNA polymerase subunit beta
MLAKQTERVSFSSVKNRPDYPDFLDIQIKSFQDFFQLETKSEERGNEGLYNTFLENFPIT
DTRNQFVLEFLDYFVDPPRYSIQECIERGLTYSVPLKARLKLYCTDPEHEDFETIVQDVY
LGTIPYMTPSGTFCINGAERVVVSQLHRSPGVFFGQSFHANGTKLYSARVIPFKGSWIEF
ATDINSVMYAYIDRKKKLPVTTLFRAIGFERDKDILEIFDLAEEVKVSKTGLKKVLGRKL
AARVLNTWYEDFVDEDTGEVVSIERNEIVLDRDTQLEKEHIEEILETGSKTILLHKEDNQ
TGDYAIIHNTLQKDPTNSEKEAVEHIYRQLRNAEPPDEETARGIIDKLFFSDQRYSLGEV
GRYRMNKKLGLDVAMDKQVLTKEDIITIIKYLIELINSKAEIDDIDHLSNRRVRTVGEQL
SQQFGVGLARMARTIRERMNVRDNEVFTPIDLINAKTLSSVINSFFGTNQLSQFMDQTNP
LAEITHKRRLSALGPGGLSRERAGFEVRDVHYTHYGRLCPIETPEGPNIGLISSLSVYAK
VNGMGFIETPYRKVENGKLDFSQEPIYLSAEEEEDKKIAQANIPLKEDGTIDSERVIARM
EGDFPVVDPKEVHYTDVAPNQISSISASLIPFLEHDDANRALMGSNMMRQALPLLQADSP
IVGTGLERQVATDSRVLINAEGEGEVEYVDAKKIIIKYDRTEEERMVSFDSDSKSYDLIK
FRKTNQGSSINLKPIVRVGDRVTKGQVLCQGYATEAGELALGRNMKVAFMPWKGYNFEDA
IVISEKVVREDIFTSIHIDEYSLEVRDTKLGNEELTNDIPNVSEEATKDLDEHGMIRIGA
EVKPGDILIGKITPKGESDPTPEEKLLRAIFGDKAGDVKDASLKASPSLNGVVIEKKLFA
RAIKDKRKRAQDKEDISALEKKYDAKFANLKAELVDKLFTIIGGKTAQGVQNDLGEEVMP
KGKKYTLKMLNAVDDYTHLTHGTWTTDDHLNTLVADLIHNYKIKENDLQGNLRREKFTVS
VGDELPSGILKLAKVYIAKKRKLKVGDKMAGRHGNKGIVARIVRQEDMPFLDDGTPVDIV
LNPLGVPSRMNIGQIYETVLGWAGQKLGNKYATPIFDGATIDQINELTDEAGIPRYGHTY
LYDGGTGDRFDQPATVGVIYMLKLGHMIEDKMHARSIGPYSLITQQPLGGKAQFGGQRFG
EMEVWALEAYGASATLREILTVKSDDVIGRAKTYESIVKGEPMPEPGLPESFNVLMHELK
GLGLDIKLEE
>IFAGANLK_00717 DNA-directed RNA polymerase subunit beta'
MARNNDKNTVKRFDKISIGLASPESILAESRGEVLKPETINYRTHKPERDGLFCERIFGP
VKDYECACGKYKRIRYKGIVCDRCGVEVTEKQVRRDRVGHINLVVPVAHIWYFRSLPNKI
GYLLGLPSKKLDMIIYYERYVVIQAGIAKNEEGEPLKKMDFLTEEEYLNVLDSLPQENMY
LEDSDPNKFIAKMGAECLIEILRRIDLNELSYELRHKANNETSKQRKTEALKRLQVVEAF
RDANNNRENLPEWMIMKVVPVIPPELRPLVPLDGGRFATSDLNDLYRRVIIRNNRLKRLM
EIKAPEVILRNEKRMLQESVDSLFDNTRKSSAVKTDSNRPLKSLSDSLKGKQGRFRQNLL
GKRVDYSARSVIVVGPELKMHECGLPKNMAAELYKPFVIRKLIERGIVKTVKSAKKIIDK
KEPVVWDILENVLKGHPVLLNRAPTLHRLGIQAFQPKLIEGKAIQLHPLACTAFNADFDG
DQMAVHLPLGPEAILEAQLLMLASHNILNPANGSPITVPSQDMILGLYYMTKSRKSTDEV
KVKGEGLTFYSDEEVVIAYNQKRVDLNAEIKIRAKDFNEVGELTYQIIETTVGRVLFNQA
VPEKVGYVNTVLTKKNLRDIIGDVLAKTSVPETGEFLDAIKEMGYGYAFRGGLSFSLGDI
IIPEEKQSMIDEANEQVEGIVGNYNMGLITNNERYNQVIDIWTSTNAGLTELAMKRIRED
KQGFNSVFMMLDSGARGSKEQIRQLTGMRGLMAKPKKSNSGGGEIIENPILSNFKEGLSI
LEYFISTHGARKGLADTALKTADAGYLTRRLVDVSQDVIVNEEDCGTLRGVEVRPLKKNE
EIVESLGERILGRISLHDVVNPSTNELLVASGEEITSEIVTKIENAPIESVEVRSPLTCE
AKKGICVKCYGRNLSTNKLVQRGEAVGVVAAQSIGEPGTQLTLRTFHVGGIAGNISEDNK
LEVKFDGIAEIEDLKVVKGEAPDGSQSEIVISRTAELKVKDKKTGVVLSNNNIPYGSQIF
IDNGAEVSKGDVVCQWDPYNGVIISEFAGKIKYENVEQGVTYQVEIDEQTGFQEKVISES
RNKKLIPTLHILGKKDEVIRSYNLPVGAHLMVDNEEKISVGKILVKIPRKSSKAGDITGG
LPRVTELFEARNPSNPAVVSEIDGVVSFGKIKRGNREIIVESKLGEVKKYLVKLSNQILV
QENDYVRAGMPLSDGSVTPEDILNIKGPNAVQQYLVNEVQEVYRLQGVKINDKHFEVVVR
QMMRKVRIQDPGDTIFLENQLVHKSDFIEENDKVFGMKVVEDAGDSENLKPGQIVSPREL
RDENSLLRREDKNLATARDVTAATATPVLQGITRASLQTKSFISAASFQETTKVLNEAAV
SGKIDKLEGLKENVIVGHRIPAGTGMREYDSIIVGSKEEFDEMMEHKQEVNYN
>IFAGANLK_00718 RNA polymerase-associated protein RapA
MKLSHKPFQTFIQNNTTVKTRSRYTDSLISSLEVSINDIQAEVWGSTHYKVAIAFNRKEV
IAAHCTCPYDQGGYCKHIVNVLVEADRLVHQEVLSSQAHAVNSVELSGVSFKKEGNTFIL
ENQNILELKIPDLQSISITPGNSRWNYLLNLIEAKILPNCLVAKISESYTNFFDLKIIQE
DRNLLLKCSCSNNSDLLCPHLYFVLLKIPESEGLILSFDEKSRFQLIKQKADAQGLGDID
NPDDFYTIYQRYDRIYIEAKHSFLSLTKPDLINLKKELLPDFKLPQSISDDNKIEFILAE
DQQGTRFKFQLMEAALTKSGRIKSPIRPLNLQDKLKTLSQPEEFLFITSLLQQENYNLDF
SVDPHILKNPFNLQFYYFEPDWRKRKITPGKIRPVRFLIEDFDTTVQVEQKNNLYVLKLN
FKINGHNYLSHNILQVGNYFEVDHNFYFIKNEQVNRLLAFFRQKKHEIYLTQAQFLELKK
ELLDPLEQAIKVEYDFIKKVPEKVRKDKFLNQVTEHMIYLSESDDYIIITPVIRYGEIEA
PILSRRNVYAEDEKGKMYVVERNESMEHRFKRNIQVQHLDFEDNPQNEFYYLHKQEFLDK
GWFIDAFEAWREYGYAILGFKQLKNNNLNPNKMKVQASVKSGIDWFDIHTNISFGDQKVG
LKEIRKSIINKNRYVKLGDGSKGILPEEWVEKFSRYFRSGEIKDDAIRTDKSHFGLVDEL
FEKEVLSSEVKMELENYREKLANFHSIRNVKIPKNLKASLRDYQKEGLNWLNFLDEFGFG
GCLADDMGLGKTIQIIAYFLVQIEKGNKNPNLVIVPTSLLHNWEIEIKKFAPKLKYKIIY
GLNRETKNIPFEKYEVLITTYGTMMNDVKILKNISFNVIVLDESQAIKNPASKRYKAARL
LKARQRIVATGTPVENNTFDLFSQLSFAMPGLFGSSKQFAADYSTPIDKFQDESRAKELQ
QKVHPFILRRTKKEVATELPEKTEMIVYCEMGREQRRVYDIYKKEFQQYLNNTTDEELKA
SSMHILQGLTKMRQICNSPALLSDKEYYGNQSAKLDELITQVLNLQSEHKVLIFSQFVGM
LELIKERLDQETIKYAFLSGKTRKRHEQVEIFQEDEQTRVFLISLKAGGTGLNLTAAEYV
FIVDPWWNPAVENQAIDRAYRIGQANKVVAVRMITPNTIEEKIIELQDRKKKLVEELIHT
DSGFFKQLTKNDLLKLVEED
>IFAGANLK_00719 hypothetical protein
MSEEKKKPKKGQINIELDEAVAEGTYSNLAIINHSVSEFVVDFVNIMPGRPKSKVKSRII
LTPQHAKRLLKALNDNIQRFEKAHGEIRDYEKAPMPLNFGPTGQA
>IFAGANLK_00720 hypothetical protein
MDDLGYDYDGNRLMKVSDSGEKTWGFKEPTTSTGNDYEYDVNGNLTSNANKGIAAGGIEY
NHLNMPTKITVSNAGSNNGVIDYVYTADGIKLQKKKTQGEVATTTDYAGDFVYENNTLKQ
FYQPEGYVEPDGSDWQYVYQYRDIWGNTRITYADDDNSGSVTSAEIRREQNYYPFGLEHK
GYNNYSYGAKNNLKTYQGQEFTEDLGLNTHEWKYRMSDPAIGRFWQIDPLAEDYTYNSTY
AFQENKMGLGTELEGKELDPFGVARTVSYYSRKAIAKTVETTKRIDTYLKSEGGGFNFRS
KNGGNGDPGRDGGRNVEMVDADGLLQAAGFAKTGGTMGPKKNPKDYGEVAKNVFTIAANT
LDGMETGGEIVEETENLIEATAKFPTGEVIEGEGNFKIYPVKDSMATFETQIEADNFKKQ
AQTEKKKLIEKTYENQ
>IFAGANLK_00721 hypothetical protein
MKINNNTTKNFMLLFVLVSQIFFSCNVRNDKDFSKIERERDSLKTILNNINQKYVFDNVR
IVTKPSSENVISPGNEYNLEVYFIGYNNDSYFKNYDSINNNSIDSIYPQKGIFHFKTILE
KSGNEFKGLISTNSEYGKNYEAILHNPDLLKQ
>IFAGANLK_00722 Tyrosine recombinase XerC
MNTIFSHLFYLRKSKTKTDSGIIYFRITVNGKRAVTTTGREVPVSLWNPASGKATGNSAQ
AKAVNRFLSKVENDIYNAHQRLVDKGDFFSSKDIIDIYLGKDKKKEDEEKILLEIFQEHN
DRVNRLVGKDFAKGTAERYRTAKKHVEEYIKKEYKTSDIPVMDVNHKFITGFEYYLKTER
NCAHNSAIKYITNFKKIIRIAFTNEWISRDPFQNWKAKLKVVDREFLTEGELQVLISKEI
KNERLSLVKDIFTFNCFTGLCYADVKKLSEKDVVVGFDGKRWIKTNRTKTKSSIPILHTA
EAILEKYSAHPEVSEKHLIPILSNQKMNAYIKEIADICGINKNLTFHLARHTFATTVTLS
NGVPIESVSKMLGHKNLQTTQHYAKILDRKISDDMAILRERLVAKNF
>IFAGANLK_00723 hypothetical protein
MNVLRQLIHWIAYGYLVYAFGYASLFKVFQKPSMMENMEAFGFGKIWTLIIGYGELLGVL
GLILGIWMHHVKNLSTIWLFAFAIGALMVHFSHGDYKYFYTALFCCISCFIVLLTDENFK
LIL
>IFAGANLK_00724 putative HTH-type transcriptional regulator YybR
MRKQSSTNTINKEHIESNCGIAYTNSVLNGRWKLNILAFLLDEEKLRYSELKTRLIGISE
RMLIAQLKELQADGLVHRNSYPEVPPRVEYSLTPKGKSLEKILIQMAEWGTKNNQN
>IFAGANLK_00725 hypothetical protein
MLRDTSEYFIKKGHFVTLLARTNYRMDAIKAEYPDKEKNIFTISQDYTEPEKALNGIKMS
IDTFGPVDIAILWIHTSGEEFSNLIKTFLFSHSPKTTIFQVWGSASVNPKSFTQKNWKEK
YPNRYKEIFLGYKRKNGSVRWLTNSEISEGIIKAVQENDSESIIGR
>IFAGANLK_00726 hypothetical protein
METKLTLKKDFFSSKYTLYSNNESIGGLNDKSFSQTVIGEFRGKKYIFISKGFLAPPTVI
IDKEKDERIV
>IFAGANLK_00727 hypothetical protein
MRELYNNWYFKATITVNNKMFNWKYENIWNTKWRIFNSEKINIEYAGSSSRGEIETGWHC
L
>IFAGANLK_00728 hypothetical protein
MEKIRKKLFVRIVKGEAFNKFVNEINQWWPKDYSWSGDELKEIKIDASKDGLCTEIGPFG
FRCDWGRVTQINVNEKIELKWQIGPNREPIPDPEKASELEIAFIENGNSTTLVELEHRLF
EKHGEMGEDYFKMMDSEQGWEFILDNYKKYCES
>IFAGANLK_00729 hypothetical protein
MRRIVPNIYSNNLEKSKKFYTEFLGMDLVMDMGWILTFASKENKTAQISIFKNKNNKPLD
NSAIFLSIELCDIDQCYEDAKNRAIEIVYPITNESWGVRRFFVKDPNGVTINLVTHL
>IFAGANLK_00730 hypothetical protein
MESIEQINYLKAPITTVYDALTSEEGLGHVWTKNLKVQPEIGFINEFDFEEDYITKFKII
ELKENSKIVWECLASDEEWVGTRVSFELSEKDGITAVILKHYDWRERTDFYRWCSYNWGM
FLFSLKTYCENQKGLPYQERDF
>IFAGANLK_00731 hypothetical protein
MEIKEYIVEEIKVAEVISNEILIQHTDDALDLMGNLYYQGYDKIIIHQKNITPDFFDLKN
KMAGDILQKFSNYRFRLVIVGEFSHITSKSLKAFIYESNKGKQVNFLSSLNEVLKLKK
>IFAGANLK_00732 hypothetical protein
MKDFNPTTVDEFINAAPQESQGIMLRLKKLIEVTVPNAEEGISWNVPIYKYYGILAGFSL
AKKHVSFGIDSLTTEMREILKEKGYKTGKKTIQIKFDQEVPTTEIKELIKEQARQNKL
>IFAGANLK_00733 hypothetical protein
MATIKQKKIIYWIATIWLALGMLSTGIVQLIKMEEEVASMNSLGYPPYLLYILGVWKILG
TIVILIPKAPLVKEWAYAGFFFVMTGAAISHLMVRDEIITLFGPLLLLVLTIISWYFRPP
DRKLIPEIK
>IFAGANLK_00734 hypothetical protein
MEQKTKIKAEEGKQELLITREFNLPVESLYKAYKDKELFAKWMGTNLLDFEFKEYGKYHF
ETRSPTGDLMFSGKGAFHSLIPNKMIVRTFEMDVFSLPPQLEFLNFKAITGEKSILTMHI
IFKSAEIRNELLKKPFTIGFDLAHHRLEAIMNTNK
>IFAGANLK_00735 Transcriptional repressor SdpR
MKLRRDVFQAIADPTRRTIISLVALQAMTPTALAENFDYSRQTISKHIQILTECELLKQE
QNGREIYYHLNSEGMKEIANFIEPFRKMWDDRFDKLENLMKDHQSES
>IFAGANLK_00736 NAD(P)H azoreductase
MNIILGATGQVGSAITDFLLENKLPVKAVIRDQEKAEILKEKGAEVAIADYFDLKALKNA
VKEGEVIFVITPETIKTDDILGDTKRILENYRKAIKGSEIKSIIGLSSGGAHYEKYERHT
GSLLMSNMLEHEFVSLPLNQVFVRPSYYYSNWLMSIDMVKEKDVLPSFFPSDLKIDMNSP
IEVAEFISDIIIKGIDKSEVIELVGPEKYSSRDVANNMAKVLGREVKVQEIPQEEWFPTM
ESIGFSKNAAENFIKMTELVTEGNAKLERKGKNPIRLSTTFEKYLKQTL
>IFAGANLK_00737 hypothetical protein
MGNSIPSLARLTAIFNQLKSKRLTTVKDVAEKQYNTPDIQLSPQLFIFAI
>IFAGANLK_00738 hypothetical protein
MINPIRPTRKNWQRIFNTVLEDLTGLISPRQIIYCEGKDKPGRNGEEKGFDAKVLNSIFD
EKYHDTVFVSSGGNTELDQRSNESLSFELHKITSE
>IFAGANLK_00739 N-ethylmaleimide reductase
MKKKQTLQGQLDEVKNDFESQADASLIRVFNEGVDSVRKGDIVANAKKVGDRAPNFILNN
ALGNSVELQDFLKKGKVVLTWYRGGWCPFCNLTLRQLNKELPNFKAHNATLIALTPEVPD
QSLSTSEKHNLEFEVLSDLRNNIAKEYGIVFKLTDEVAKTYNSAFGLKNYNGDDFNELPL
AATYIINEDGTIAYAFLDPEYRNRAEPTEITTILKSLNKKSPMKNSKLLSAFNSQNLNLK
NHVVMAPMTRSRAINNLPNNIMATYYSQRATAGLIITEATSPSKNGLGYINIPAIYSKEQ
ITGWKKTTQAVHNNNGKIFLQIMHTGRIGHQLNLPKGGEVMAPSAIQAAGEVLTSEGLKP
FPIPLEMTTTDIKQTQKEFVEAAKNAIEAGFDGIEIHAANGYLADQFLNKGTNQRTDNYG
GSVENRTRFLIELTKEIAKEIGNNKTAIRISPYGVFNDMALYKEISETYYYLIEKLNTLD
LAYLHMVSLSEDIPEGFLEDLGKEFSGNVIFNGGFGFDLERAEKVVFENDKNLVSIGFPF
IANPDLVERIERGADYNEPNQDTLYTFGKEGYIDYPILETTK
>IFAGANLK_00740 HTH-type transcriptional repressor ComR
MARKKAYNKEEVIDKAMYLFWQKGYSNTSIQELEKGMGINMFSIYSSFGNKEGVFKECLK
AYKAKTNYIFSNFENSEDGVEDIKKLFRSLFSVWYSNGKQNGCLITNTINEFPNSDDDFI
LKEVKNRKNFKQHIIKKLETDHTKSKATILSEANFLVLSLHALATISRINTKQEIEDFIN
MVFKTI
>IFAGANLK_00741 hypothetical protein
MNLKLNFLSLLMVFSFGFLTSCSEDDDSIDETDDISAGCADFENSYEDVMSVANTYINDP
TEENCEDYRQAVINFYESYKDCSMWTEEYEEEDWDDMENWSCSDSDEAT
>IFAGANLK_00742 hypothetical protein
MKSQVSIAGNNEKTEDKSIGIIAYLTLIGLVAAFIMNKDKNNEFATYHIKQSLGLCLVGF
AIFIVGLIPILGWIISFLGSLFLLVFWIMGLLNAINGKEKPVPALGNKFESWFKNM
>IFAGANLK_00743 hypothetical protein
MKTNLLVAVLFFFAGIYMSSAQQDNRIGVMLNYGTEVEAIGAGANAEFPILENLSISPAF
IYYFPGDQYGGSLNWWEINGNANYYFVNNENLGFYGLGGLNYTHVSFDWGDESFGGIESS
DGRFGLNLGAGANFNIGSNITPFAELKYVIIDGGQLVLGAGVKFSI
>IFAGANLK_00744 Transcriptional regulatory protein YehT
MKVAILDDEVHCVEGLVLHLRKNFPDAEIIYKGTRPEAALEVLPNAKIDLLFLDVEMPGM
NGFELLDQLQETKFDVIFTTAYSQYAAQAFKAKAVNYLLKPIDEIEFREAILDWQEERKK
KNNFSSEKISDLLTYMRREGILKNKIALPVADGYEFIETNEILYAQSQNNYTQLFLSDKR
NLVLSKTLKEFEKLLDKYFFIRIHKSYLINPNYMKKYYKNDGGYLVMQDGKTIPVSKTKK
DLITSLFDAITKTS
>IFAGANLK_00745 Sensor histidine kinase YpdA
MPLPQFRNFSGLFSLICLAILFLPAGLLSQSKIDSLNTEFQQAEKDSLKVVTQIQLSRQI
HREAHDEEEELLHAQEAVQKALQLNDTLLYAHALDNLGLLMRYHQNYDESLPLHTKAYNL
VKDKDINPLNKMIFANNAGVAGRYNQNYDTAISYYMEALKIAEKENDLKNIAIASNGIGN
ALTSIPGRADQALDYFERSLEAEKQRNNSLGVAMNYLSIGDYYIDKGEFTKAREYLNELL
EINREREDQYGLAITNEFLGKAYLVEGKNLERAKEFFNISLVGFQQMGDRQKQAEILSSL
GDIEKKQGQPVNAEKYYQNSLDLASALNLHGLLMENYLRMADLKEETGEPAEALSYYKQG
KAYEDSIKLSQQNVEIAALVRKYDLEKKENRIELLQKDRALQETRLKTQEQLLEERRILM
LLMGIGLLLILIIIFLQYRNAQTKKKTNARVLKEEKEKMKAIYERNLARAEILVTRLQIN
PHFLFNSLNAITYLIQTKENEKAMKYLVVFSRYTRMVLETSQKHIIPLSEEIKLTRYYLT
LEENRFEKDFTYEIKLEESAVEGINIPPLLLQPFIENAIWHGLLPSKCDKKQLLINIIPA
EDEITIIIDDNGVGRKNAGKKTTSGKKHKSMGMQIIQERISLYNKSYSGKITYEIIDKKD
ENCEPKGTRVVLKLQRIKGEHQEDNFYKIDTEISET
>IFAGANLK_00746 hypothetical protein
MSDSNHHGMHSFEGKNVLCSHHSFEEESFGRFGRMFRELSPLYNPPSTLSGLGKKDGPMN
GGNSPKFTNSVPLGMVFFGQFIDHDITFDTSTSFSSINNPNEIENSRSANLDLDSVFGGG
PEDDPFLYKPREEGYYLLTALSNNNIGQNQATEKNDLQRNGKETAIIGDPRNDENRVISQ
MQLAFVRFYNANYKIMKDANPGYSPEHLYEEARKTTTWHYQWIVVNEFLPMMCGKYLVAD
ILGNGRKFYKPVYSAFIPVEFSVAAFRFGHTMIAQKLKLQQDGEMKSIFSKEFGKGFSRL
TSSDQAIEWNAFFDYGTDFQKAEKLDTTLAPILLELPFVPSDDPNDKSLATRNFRRGQSF
LLPSGENVARHMQREDSEIEQVVDFVNNKEKMVDVDLSAGIPLWYYVLAEAEVIGRQDSD
TQFSSGEGLGPVGGRIVAEVLLGLLELDRESFLGNNRDWVPTHGKKRVFTMKDLLEEADK
AYDL
>IFAGANLK_00747 Lipid A 1-phosphatase
MIFQTSTYQQNEPAYVIKKIFLVIFCSIFLLSTDNTYSQFFEKEDSFIEKSGDASVILLP
VSALTTSLILKDHKGCWQFTKSFLLNLAVTGAGKYLINKERPLQGGGYAFPSGHTSVAFQ
GASFFHRRYGFKYSIPAYILAGFTGYSRLNAKRHDGWDVLAGAAIGIGSTFFFTTPYEDQ
QMEVTFSSGDDAYLLGFRYTF
>IFAGANLK_00748 hypothetical protein
MNVLILTDLSDVARNAGSYAVQFLGDIPVNFYMLNIRGFNPEASLEQEKEGTCSKKTAPE
NGGTPGNKYK
>IFAGANLK_00749 hypothetical protein
MEELQEISTNNDHKFFALYSESDLLTATRKYADEKNVDLIVMGAAHKGHSPFTIIGNHTY
EVIKKIRYNILAVAEHCEFKPLKKMIFPIDYSTSLNKDIFTIFNKPKISEGADLTVIEIG
DPTKGVDVEKGRKIFSQIKNRKVKVIPFKDKNIFSDSNLQKIQDRFDMIVMMGKNLGLCD
SFLHTKRGIYSKVSNSIPILVLHGSEK
>IFAGANLK_00750 hypothetical protein
MITNNSIQEGVTMYNSLSPENNFLKQYFENSIVPQLLIDSELFLKDFTPAAGRLFKLNKE
HLDRNICGIKEKMKHKSFIENVRGVLITETVLEKEIKLSDERRFLMCIQPYFSENEEAIT
GLIVTFTQLETPAALIEENKRLKSENQELKEFLYRELTKSRK
>IFAGANLK_00751 hypothetical protein
MAKRGTNLKPSKVDLKARKQEKAARKLEEKKMKGRRKVGG
>IFAGANLK_00752 hypothetical protein
MESFIRKNIERTLGEEISSEMLTHLKELSFEKTYDKKEYLVEAGSACNYQFFILEGGCFS
YYLSEKGDKNVIQLAIEEYWITDASSYFRDTEAVSTIETLEPTRALLINKENFEKLCRMH
PLFDRFFRILLQNSLASLHTRIAKTISEDADHRYKSFSKRNPHFIKRIPQYLIASYLGIK
PQSLSRIRKNLY
>IFAGANLK_00753 hypothetical protein
MKVKIWSDVRCPFCYIGKKKFEAALAKFPQEKEIEVEWKSYQLDPNLKTDPNLSTLEYFV
KAKGVSETRAKEMFSGATNMAAEVGLKFNLETSVTANSFMAHRLIQMGKSKGLGNEIEEA
LFIAHFEEAKNIDNAEVLQGIGISRGLETGEVKNTLESDAFAYEVKQDEMEARNIGVRGV
PFFVIDDKYAISGAQPTDAFLQTLEKAWKEFKPKKNHLEVSEGDSCATYGNCD
>IFAGANLK_00754 Protein YceI
MKQVFSFLFIAFLSTNIFAQTTWKADPAHTQVSFDIVHLGIAEIEGQFGEFQGSITASND
DFSKAEYEMEIDVASINTGVERRDGHLKSADFFDVENHPKLIFKSNSSEKIGDSKYKVTG
DLTFHGVTKPVTLEVWHRGTIENPQSKDMTSGFAITGTIKRSDFNLGADFPEPMLSDEVN
IEVDGEFIKQ
>IFAGANLK_00755 4,5-DOPA dioxygenase extradiol
MSALSDFNKFTANLPRKEQPMPVLFIGHGSPMNGIQDNEFSSGWKKMAEEMPTPKAVLVV
SAHWLTYRTRITSMEFPKTIHDFGAFPQELFQVQYPAPGSPLIAKETRDLVKSTAIVEDH
DWGLDHGAWTLVRHMYPAADIPVLQLSLDHSKDEKYHFELAKELMELRYKGVLIIGSGNM
VHNLKMLAWDKIEEPGYGYDWALEMNDKFKKYISEGDFNRLINYKHLGAEAKLAIPTPEH
YLPLLYTLGLKDKNEEISFFNDKAVAGSLTMTSVKIG
>IFAGANLK_00756 Formate--tetrahydrofolate ligase 1
MMTTTPLTDLEIAQKIGLKPIAEIALKFGLDAQEIEMYGKSKAKLPLIELKEKV
>IFAGANLK_00757 Formate--tetrahydrofolate ligase
MEDINLHFTGDFLAIDKYHNLLATLVDNNIQSKINNLDFDPHTISLKRVMDVNDRSLRNI
VIGLGGTVSGIPRESGFDVTAASEIMSIMCLAENLDDLKGRLGNIFIGYTFGKKTSFCPS
S
>IFAGANLK_00758 Formate--tetrahydrofolate ligase
MQISPRNQLCYRHSNEVSLSDYTVTEAGFGFDLGGEKFLDIKCQSAGLAPKVVVMTTTIR
ALKYPGGADLKTLTIPNVEALIKGLPNLEKHLENAQLYNITTVIAINKCYTDSDEEIQVI
FDLARKLNIKVALSDGWAKGGAGARDLAAKVIEAIEENNSDFKPLYNWEQDVVTKIETIA
KKSTRS
>IFAGANLK_00759 Formate--tetrahydrofolate ligase 1
MLKKVQGAERVEFSPKARRNLKTIIDLGLEELAVCIAKNQKSLSDNPALLGRPTGFTLTV
REIEIATGAGFLIPITGDMMRMPGVPAHPASENITVNLEGNISGLV
>IFAGANLK_00760 Amino-acid carrier protein AlsT
MKKYFLLILLLPLSILNAQELKVDVKAGNISNLINDGFIDLEVSGGEPPYTYKWSDQNTG
LESKSAYGLTEGISYKVKITDSEGTSLTSEFKIKPKAITEHFNGAAVPLVESLGSFLFWD
PFTAFGIYDPVVYAEVAKVPIPNWSPSIEDRYLLKEWKVNEGEKVNEGDLIAIVNSKNQG
DLNIYANTNGSLKHLTKTGDVIYDSNNSDDLIKAGAHNLAEIKYPTPLPVAHPNGDPQTH
NIPLIVIWLIFGAAFFTVKMGFINFKGVRHSIDLARGKYDDPTAPGKITHFQTMATAVSA
TVGLGNIAGVAIAISLGGAGATFWMIIAGLLGMASKFVECTLGIKYRVINKEGKIFGGPM
NYLQHGLERRNMKGFGKVLAVLFAVLCIGATLGGGNMFQANQSFEILASQFKFMEGNGFY
FGLALAGLVGLVILGGIESIGKVTGRIVPLMALIYVVSALVVIGVNFENIGSAFSAIYNG
AFNATALKGGVIGVLIVGFQRAAFSSESGVGSAAIAHSAGKTRHPASEGYVALIEPFIDT
VIICTLTALVLIFTGMHEVEGIGGVQLTSGAFATVMPWFPYVLSVVVFLFAFSTMISWSY
YGLRAWTYIFGKTNRSELVFKSMFLLFVVVGASVGLGAVLDFSDMMILTMSFPNIIGLYI
MSGEVRNDLKEYNRKLKAGELSTKTSE
>IFAGANLK_00761 Putative universal stress protein
MKNILVAVDHKKDAETLISHAVNISKLTSAKIWIIHVTEADPDDFLAREAGPQYVYEKRA
EERKEEKAIIEKWAENLTKEHNVDVEGRLIEGSVIKSIKKLVEECNIDLVVAGHKKRNLV
YGLFTSNKKKDLIDELQIPLLAVPLG
>IFAGANLK_00762 hypothetical protein
MSIVKVIEVIATSTESFDDATRNALAEASKSVKNIESVYVKEMHANVINNKIASYAVNAK
ISFKKES
>IFAGANLK_00763 hypothetical protein
MSNLNICAMNPFYIFLENYKTATSGFHFLAKLFILLILAWIFIAAIFAVWGTLNLIF
>IFAGANLK_00764 Bacteriophytochrome
MGFTAIAKVTEDRWITCAVNDKIKFGLRPGDELKVETTICNEVRQHEQAVFIDNVATSET
YAKHPTPAMYGFSSYISVPLYKKDGSFFGTICAIDKEKAKIDTEEIRGMFELYAELISFH
LEAIEEKENAVAELNEEQHIAELREQFIAILGHDLKNPIATTRMSAEILMKFSKEEIVKR
NASLIKSTSIRMEGLIDNLLDFARGRLGEGIKLNKTTESKKLKEVLKQVINELKITSPEQ
KISSKIQIKNPVNCDPDRIAQLCSNLLGNAVTHGAADKSIELEAVCLNGEFKLEITNKGV
KIPKETREKLFEPFYRIEGKEPKKGLGLGLYIASEIASAHNGQINVSSSDKETVFSFVMP
AQS
>IFAGANLK_00765 Glucose--fructose oxidoreductase
MQDRRTFIKKSGLFVAATTLPIPNFLLQKNKEKLGVALVGLGNYSTGQLAPALQETDYCE
LRGIVTGSPEKIPVWQKKYGIKDQNVYNYDNMDEIANNDDIDVIYIVLPTGLHAEFAIKA
ANAGKHVWCEKPMAKTSEECRQIIEACNDNGVKLSIGYRMQHEKNTQTLMKWAETKPFGK
MKNVKAEAGYYGDPMNPWKLEKEMGGGAMYDMGVYPLNAARYTTGLEPISVSAKHIINRP
EIFDEVDETTVFDLEFPNGIVANCKTSFGESMNNLEIDCEDGWYYLRPFQSYSGVKGKAS
DGTVLPPFGKNQQAVQMDDDALAIINDKKVMVPGEDGLKDIVILEKIYESAANGGERLKL
>IFAGANLK_00766 Putative cysteine protease YraA
MKKILFLTGDFAEDYETMVPFQMLEMLGYTVHTVCPGKKKGDKIKTAIHDFDGDQTYTEK
SGHLFELNYSFDEVFADDYDGFVMAGGRAPEYLRLNQKVIEITKHFFEKDKPVASICHAI
QILTVARVLKGRTLTAYPTIGPEIELVGGTYKEVEPTEAVVDGNLVTSPAWPGHAAFIRE
FVKLLGAKIEI
>IFAGANLK_00767 tRNA dimethylallyltransferase
MKNNYLLNVVGPTAIGKTSLAINLAKKFNTEILSADSRQFYKEMRIGTAVPSTEELRVAK
HHFIQHISIEDNYNVGDFESEAIQKLKEIFQDHDLAIMVGGSGLYTKSVLQGLDYFPDVP
SEIRHNLNLKFEEEGLLPLQQELQKHDPEYYKIADVENPQRVIRSLEVCIASGKPYSSYL
NQPNKQRNFIPISIGLTADREIIYNRINRRVDLMMKEGLLEEAEKLFPQRDLNALNTVGY
KELFSFLEGEISLETAIAEIKKNTRRFAKRQLTWFRKDQDIHWFDFKTPPEEIQEFIEVK
IAE
>IFAGANLK_00768 Cyclic nucleotide-gated potassium channel
MNRTQPKPGWKSKIHEIIYEADTPAGKFFDVALLIVIAISIILVMLESVSTLNLKFYWHF
YIAEWIITIIFTIEYILRVIAIKRPKNYIFSFYGIVDLLSTLPTYLSLILGGHNLLFAVR
ALRLLRVFRILKITRYIGESNRLLLALRNSRPKIIVFLFAVLIICVIMGTVMHLVEGEKG
GFDNIPLSIYWAIVTLTTVGFGDIHPVTPLGRFIASFIMIVGYGIIAVPTGIVTSEITRA
QKKPIPTNTQVCPHCNEAKHMDDAEFCHNCGKKLNEE
>IFAGANLK_00769 putative ATP-dependent helicase DinG 
MYAVVDIETTGGKYNEEGITEIAIYKFDGLKVVDQFISLVNPEKPIQPFVVNLTGINNEM
LRNAPKFYEVAKRIVEITEDCVLVAHNAKFDYRILRTEFKRLGFDFERRSLCTVELSKKL
IPGQDSYSLGKLVRALGIPLSDRHRASGDAQATVKLFKMLLAKDIEKNILKDAVKLEPKR
QIDTRLVYILEDLPVITGVYYFHNEEGEIIYIGKSQNIKKRVTQHFTNEQRKAREMQKEV
SSVSFEATGNELAALLKENQEIKHNKPKFNKVLKKNIFSHALYYSTDEDGYINLKIGRAG
RKNSITTFSSLKRAQNVLEMWTKTYELCSRLCNLEKGDGNCFNYTIEKCNGACIKSESAE
VYNERVRALINQHSYKNQHMLVIDRGRDIDEKSALLVEDGEFKGIGYFNLNHQINNIDII
RSIITPMKNDRDAQHIIQSYLRRNSRLKIVPLAPAD
>IFAGANLK_00770 hypothetical protein
MSIAENIKKYRTELPEDVTLVAISKTKPTEDLLEAYEAGQRHFGENKIQEMTEKWEELPK
DIKWHMVGHVQRNKVKYMAPYVSLIHAVDSLKLLKEINKEADKNERSIDCLLQIKIAEEE
SKYGISTEEAREILDSDKFKSLNHIKVKGLMGMATFTDDESQVKKEFEHLKSVFDDFKET
YSDMNILSMGMSGDYKIALDSGSNMVRIGSDIFGERNY
>IFAGANLK_00771 hypothetical protein
MTKILPFRAVRPQRAKAGLVATKSFEDYTEAEIRSILQYNPYSFLHILNPGYKFQHEITG
GQRFQMVKNRYLEFREENSFIKDEKPAYYLYKIVSRETTCCGIIAAASAEDYENNLIKKH
EDTIARRETLFKDYLKVVGFNTEPVLLTYPDNSKINEVIDQVMQTRAEYEFATVNREIHY
LWKIDQVDLLKQIQEEFEQMPHLYIADGHHRSASSYLLAQESRKANPNHTGKEPYNFFMS
YLISESNLNIHEYSRLITDLNGNTKEEFLIQLDEYFRIENHGMEVYKPQQKHHFNMYLDG
EFYSLYLRKTNYEFGDSLTKLDPYILYKKVLQPILGIEDLRNDKRISYIHGKNDLIELKT
RIDKGEFAVGFGMLPLSIDEIKETADEGLTMPPKSTYIEPKLLNGLTIYEFETN
>IFAGANLK_00772 putative 3-hydroxybutyryl-CoA dehydrogenase
MKNVAVIGAGTMGNGIAHTFAQFGYQVKLIDISEESLDKGMKTISGNLDRMVSKEKISEA
DKEATLNNITTFTDIPTGIKEVDLVVEAATENEGLKLKIFKQLDENCSASTILASNTSSI
SITKIASVVSNPERVIGMHFMNPVPIMKLVEIIRGYSTSDKVTSSIMELSEKLNKVPVEA
NDYPGFVANRILMPMINEAIETYYNGVAGVKEIDTVMKLGMAHPMGPLQLADFIGLDVCH
SILEVMYDGFKNPKYAPCPLLRNMVMAGKLGIKSGEGFYDYSESKKAEKVSAQFS
>IFAGANLK_00773 scyllo-inositol 2-dehydrogenase (NAD(+))
MLKAGVLGAGHLGKIHLKLLNQSEKYELVGFYDADSENAEKVSKEFGYKKFDSIGELIAA
VDVVDVVTPTLSHFEVAKKTITEGKHLFIEKPITNTFAEAEELIGLAKKHGVKGQVGHVE
RFNPAFRAVASRIENPMFIEAHRLAEFNPRGTDVPVVLDLMIHDIDAVLSVVKSKVKNIN
ASGVSVISDTPDIANARIEFENGCVANLTASRISMKNMRKSRFFQRDAYISVDFLEKKCE
VVKMKDAPETPDDYAMVLQNAEGVKKQIYFDNPDVSPNNAILDELETFADAINNNTTPIV
TLEQGAEALRVANRVIANFSK
>IFAGANLK_00774 Protein-L-isoaspartate O-methyltransferase
MIEDNYRHKGKRQQLVKTVKKKGITDKAVLDAIGKIPRHLFMDSSFEDHSYQDKAFPIAA
DQTISQPYTVAFQTEKLEIEKGDKVLEIGTGSGYQTAVLCELGAKVYSIERQRELYKKTK
AFLNKIGYRPKHLSFGDGYKGMPDYAPFDKIIVTAGAPFVPNDLLGQLKVGGKMVIPVGD
DIQIMTLFIRKSPKEFDKTEFGQFRFVPLLGDKN
>IFAGANLK_00775 Membrane protein insertase YidC
MEEKKFDVQSLIGFILIGGILLWMLYTNSPSEAEVEPQQETEQVEVPGNTDSNQPPQQQE
TQTPGADSTALSQARERLGAFGYSASLPSATENTTTISNDVLELKIDNKGGYISEARLTN
FKTFDSIPVYLIKDGNASFNINFTTTDGRTLDTENLYFEPEVTQSGDNQIISMKLKVAEN
EFLEYRYVLKPGEYMLDFSIRSQGLSNVFSSSRDINMDWQLKGYRHAKSISYENQYTELI
YEYDDGDDDYLGGGDSEEQEDENVTYVAFKQHFFTSILLTDTPFTRGKFNSQNLVQDEEV
DTVYTKNFAAQMPLELNGGELNYNMNWYYGPTDYTILNNYDRNLDEIVPLGWGIFGWINK
YVFIPFFSFLSGVLPSYGIAIIVMTIVVRIVLSPVTYKSYLSQAKMKVLRPEINELNEKY
KDNAMKKQQETMKLYSKAGASPMSGCLPALMQIPVFYALFQFFPSAFQLRQKGFLWADDL
SSYDTIAELPFHIPFYGDHVSLFPILASIAIFVYMMMTTGQSMQQAQQPGMPNMKFIMYL
SPLFMLVFFNNFASGLSLYYFTSNLITIGIMLVIKYVIIDEDKIHAKIQENKKKPKKQNK
FTRKMQEMMEQAEQQQKQKKK
>IFAGANLK_00776 CTP synthase
MAETKYIFVTGGVSSSLGKGIIAASLAKLLQARGFRTTIQKLDPYINVDPGTLNPYEHGE
CYVTEDGAETDLDLGHYERFLNVNTSQANNVTTGRIYQSVIEKERRGEFLGKTVQVVPHI
TNEIKDRIQILGQNGDYDIVITEIGGTVGDIESLPYIEAVRQLKWELGDENALIIHLTLV
PYLAAAGELKTKPTQHSVKTLMESGLKADILVCRTEHELSDDIRRKLAIFCNVRQEAVIQ
SIDAATIYDVPNLMLKEGLDTVTLKKLHLPDETTPNLDRWNQFLDRHKNPKAEITIGLIG
KYVELQDSYKSILEAFIHAGAENEVKVNVESIHSEFINENTIDHKFANLDGILVAPGFGE
RGVEGKIDAVKYARQHNLPFLGICLGMQMAVIEFARNVLKLKTANSTEMDPKTKHPVIDL
MEEQKEVTHKGGTMRLGAWDCELTEGSKIHEAYGKTEIKERHRHRYEYNNKYKEELEKSG
MLSTGINPETGLVEVIELKEHPWFVGVQYHPEYKSTVATPHPVFIAFIKAAYDFSKKRKN
ASLAQK
>IFAGANLK_00777 hypothetical protein
MSLKPNHRALLELAHAKMHFGKYKGYYLSDIPEYYLVWYRQKGFPEGKLGQQMSEVFELK
LNGMEQLLRDIRRKFPKP
>IFAGANLK_00778 Cyclic di-GMP phosphodiesterase response regulator RpfG
MRTIILVDDQPIANFITRKLLEIEGYDKDVVDFTNPEEALAYLEERQNTLIFLDLNMPEM
NGWEFLDCLKAKGHQHRIIILTSSTSAVDRNKAKEYPSVIEFIEKPLNKNKFAQLQPLLQ
QS
>IFAGANLK_00779 hypothetical protein
MESLQDRTSRVYRITYETFSKFSNNLNRCKNLEEVSQVSVRFLKYLLNFHLFRICINQAG
SYLVYCQCNSSGEFDLISKENLLAHELRILENNIPVKTEEIPFQLSEKIVSTTLESPSLW
CWTFKKMDVDFTVSLISDKNKAFDVGDIEMLKLISDSFQAKFQEIYLKEELYHKNQSLLQ
ALDVIKNQNKKINQIVENQKQTIADRTKEVVEKNEKLLHISALNAHNVREPLSRIQGIVQ
LFEVFDDKTCREELVPKLKQSSEEMDKVLREVIEMASLELTQLKAKEL
>IFAGANLK_00780 hypothetical protein
MNSTARYPMVSYEEASPEVQEIYDDTKKTLQLPFVLNWFKCQGTNATLLKGNWSKLKNTL
MEGEVPNVLKQLIIYNVSKERGCNYCSHAHGIFADSMSAMISEDEGFKATENINSPSMPA
SFRTAVKIVTHAALNHSEVSDEDFEELEKAGFSQREVQELMAQADLVNMLNTIADVSGIK
IDNELLETPE
>IFAGANLK_00781 Ferredoxin--NADP reductase
MKYQYQIRVSPEEAANQHKLKQAVSRHGGIAKKDITYVNVLKRSIDARQKDIKINLKVDV
YVKEAFTEEKIYLPDYQNIENKEEIIIIGAGPAGLFAALRCIELGFKPIIIERGKDVRTR
RRDLKALNIEHIVNEDSNYCFGEGGAGTYSDGKLYTRSKKRGDVDRILKLLVGFGATSEI
MVESHPHIGTNKLPAIIADIRELILNCGGEVLFDTRMTDILVLNNEVTGIKTLKGETINS
KKIILATGHSARDIFELLHRKNVKIEAKAFALGVRVEHPQELIDQIQYKCDSRGEFLPPS
PYSIVKQIGGRGMYSFCMCPGGIIAPCATAPGEVVTNGWSPSKRDQPTANSGIVVELRLS
DFKNAEGNPLAAMEFQKQIEQKAWLEGGSTQKVPAQRLVDFIRGKVSANLPVTSYKPGVT
STDLGEVFPDFIHKTLQGGFKEFNKSMRGFLTNEAVVHAPESRTSSPVRIPRDPYTFEHV
QIKGLYPCGEGAGYAGGIISAAIDGERCAEKCVESLQQS
>IFAGANLK_00782 hypothetical protein
MPIVGSLIKSLIDLRDTIVSEPEAEEAQKEVLTKLLKKAQDTQFGKHYDFESILKSGDVQ
KTFADKVPYFDYNKLNNEWWYKLHDGEKDVTWPGRPPYFAVSSGTTGTSSKRIPVTDEML
ESIRKAGIKQVSALSNFDLPPDFFEKEIMMLGSSTDLEKEGDHEEGEISGISASNIPFWF
RGYYKPGEEISKIEKWDERVQRIAENAKNWDIGALSGIPSWLELMMKKVIEHNNLDNIHD
IWPNLRVYASGGVAFEPYEKSFNDLLGHPITVIDTYLASEGFLAVQARPDTNAMKLILDN
GIYFEFVPFKAEYINQDGSIVEDAPVISLGEVEEEKDYVLLISTVSGAWRYLIGDTIKFT
DVERKEIRITGRTKFFLNVVGSQLSVNKMNDAVQELEEKFDIKIPEFTLAAVRIDGEFHH
HWYLGTKGSTSEEELTTALDESLKNANKNYKVARSKALKGVKVTKVHPEMFPEWNAANKK
KGGQVKMEKVMDEEKFAKWEKFVKEQKA
>IFAGANLK_00783 hypothetical protein
MKSILKTYFLLITAILFCQWNWSALYAQEKMKQKDTLKFENKIVPDEIWRETYVALSHYP
ELKDTPIEFKFKKKIQKSFMQAQPKVSGLLKNKKNRSYFVMISEHIKIEDEVFDVKNVPS
DVLIGWIGHELGHIMDYRERSAINMVWFGAKYLTSKRYIQEAERAADTYAVNHGLGKYII
ATKDFILNHTHLADAYKARIKKLYLSQEEIMALIDEIDEDDD
>IFAGANLK_00784 hypothetical protein
MIKSKKIAGLLFAFALLGSASVFAQTQQLPQQQQQAVEVDVSDEELSKFADAYQKIRMVN
QQAQQEMAKKVEDSGFDIQRFNEIHQASLDPNTEVDATEEEMTKHKEVVTEIEGMQGEFQ
KEMESAISEEGLDVARYEKIAMALQTDTELQQRLQQLMQG
>IFAGANLK_00785 hypothetical protein
MAANCFVQPFERLKLNHQFRFEQRWKRDYIEDSPFKLSHRFRYKLTAYYPLNNYKLINNT
LFLSFYEEIFVQAGKSITYDYLEDNRMFLGLGYILNENIQVQVGYMWTFRYKEGPNSFEH
RHIPRVSVYHNLDFHRRRIEKQKEKIQVLENEF
>IFAGANLK_00786 hypothetical protein
MKKIFSLFVVCLISFSSLAQEENEPSILNNNYDKEFTHTTGLWTGLYTKYRLNEKLFYYG
EYHFRRRNNFVNDMAQIYLRFGLTYLINPKVELTAGVVTPFYWAPEQNLANQDNVVPQYR
LWQQIVLFSHLKD
>IFAGANLK_00787 hypothetical protein
MKRPVLLLFLINLICTGVSGQNYSYDSIYQPIPGITGKAQFTYKLANEDEKIKDGEFSFL
RENKDSLAETSATYNFWEGKYENNQKVDDWSYEVKHHIVKINEISDVELDYDILTEDEIM
EVTYRDGYPAGDLLMETILYVDGNRVKTLEYLKTQFQNQRMTGKFDYIIANRENDSVSVI
GNMVNGLMDGIWEFNYFTEDIQEIRTYDRGILLSLERNENGRTIEEIKYPLSEGLQAALA
NEQTDVELVNRPLSLTFSDGYPRNSKYIKAQKKGEKLIQNIFKAIFKYDPQIEPMEQLPL
GTNRAFYPLKSEEENALEEWKEIENKYRKNIDSITNLEIENLNLVENADIQKALKWKQKQ
DSLNEYIKPWNDIFYKEQLPFYNREGLLVNYAKELLAQDTLMVQGEKLIYDYRSEEESNN
FLLYVTENFKKRNELADSLIISLTSAIEDLRLDKEIGRLNDEVSRTRRNIEELYSNQLND
EALDEIVKQTKNNFYQDSLPQLVNNFLEDTEDDAIQIERGNSILRQLELLETIWETGERI
TELEGEIDTLYTEYTFDPFTYSDQVPARKKKTLYNEINNTIIEGLKNQARAAYRDPEEVL
KKFNSIQRMQDRLIFMEDKNTKNLERKLRRTDSFNEKLELLRSL
>IFAGANLK_00788 lipid kinase YegS
MLYILHHPDDRETVENDIFPLLENTEKQTIDYPETEFEAGKNDIVITYLSDEFLREFLPK
AAKQNQKVGILPHPENTYTTKGLGIANDPKEVIKEILENEEAHTLDMLYCNDIPIFQSVN
IGNVFIFTEDHQNNNFVREVYTFFKNIRHLSSLSHNSYVISSEGEKIIHTSALGIIVVEH
ALSSVVARRLVSESSLNDGMFTALIISPTNLLQLIWFLLRSLLPGGKQLDKTPPFIGRIK
IANLEIKNSSDIEFTIDGEKEKAKEISLRVEPESLCLAQASKYCTEKDEANLKKSNKTDT
LPTGEKREELTKRTIPILPRATTEEFQELFKVLRENSKSSSIYVVMMILSTLIATFGLFA
DSSPVIIGAMILAPIISPIVSFAMGMVRYDTNMLKRGIITILIGTGVSLLFSSGVTLIIP
IKLITSEIDARLSPTLLDMGIAVASGVAAAYAHAKEGIAKSLAGVAIAVALVPPLAVAGI
GIGWWDWQVFSGAFLLYLTNLAGIIMFAGITFLILGFAPFKRAKLGLVYTLILIGMVMVP
LSLSFNRIKKEASITRELEGSTVNELVIRDVKVRFGDPLRVSLTLVGPENLTGDQIRDIK
KQLEEDIGESINLEVISARGF
>IFAGANLK_00789 Dipeptidyl aminopeptidase BIII
MKYIVYLLAFCSLPVFAQETRQPEDYTIEQFYENTRIGGGYFSPDEDKLLVSSDKSGIFN
LYEIVISSEEMKQITSSEEDSYFAIDYVPDSENILYSADKGGNEISHIYLLEENGTSTDL
TPGENEKAQFAGWDKEKTGFYYLSNKRNPQFFDLYKMDMENKESELIYKNEENLSFEDIS
HHGKLIALTKAITTSENKLYIYNLETEEMTELSEKSAEYSASGFDKNDGYFYYITNEGRE
FKSLIEYNLETKESSNLFETDWDVMYSYLSENDKYRVIGINEDGKNSLIIENNDTGEEVD
LPDMENEDIVAVNISDSEELMRLTIGTAKAPNNLYVYNFSSGELKKLTNTLNPEINPEDL
VSAEIVRYESFDGLEIPAIYYKPHQATENNKVPALVWVHGGPGGQSRVGYSALIQYLVNQ
GYAILAVNNRGSSGYGKTFFKMDDKKHGEEDLKDCIWGKKWLQEQEYIESEKIGIIGGSY
GGYMTMAAMTFTPDEFKAGVNIFGVTNWLRTLKSIPPYWEAFREALYEEMGDPVKDSVAL
YNKSPLFHAEQVKNPVMVLQGANDPRVLQVESDEIVAALKENNVPVEYVVFEDEGHGFIK
KENEIEGYRQIRQFLDKYLKEEE
>IFAGANLK_00790 hypothetical protein
MKNKNLPTIILFSATTASKDFNFRKDHDTIRVKDLKTSVDFYGSILGLEQISNGGLGDHI
KWLQLNNGVQLHLVESEEVVEKNKGVHTAFNTDKLSEFMEFLRFKNIPFENWKGEKNTIT
NRPDGVKQIYFQDPDGYWIEVNDSKI
>IFAGANLK_00791 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YbjI
MIKLIVTDMDGTLLNDQHEIHPDFWEIEELLNDKGIMFAVASGRQFYNLESKFDRIKDRM
MFFAENGTHVVHKGKDLYVNPLDKAAAMDFVRKGRELSHTHLVLCGKNSAYIESKDDSFF
NEINKFYKKIEKVDDLTQVEDTFLKVTFCNFNGVEENTYPNLEEFVNDYKVAIAAHVFID
ITSITANKGNAISGIQEELNISPEETLVFGDYLNDLEMMQNAKYSYAMKNAHPEIIKASK
YLTNFDNNENGVLKTIEELGLLKKEYAVKS
>IFAGANLK_00792 Ferripyoverdine receptor
MFFLFAIQISIAQNTGAIEGNVVNNAANPLSNVNVEVKGLQIGDETNNRGEFILRNIPEG
NYTLQISYVGYETQNLKVSVQSGATTNLPSIVLLGKEEELGTVVVRGNGNGNKFTRNTSV
SVAKMPLKKIENPQVYNNITAELLQEQVITNFDDAIKNASGLTKLWESTGRGNDGAGYFS
LRGFPVQPTLVNGLPALTNGSPDPANMENIEVIKGPSGTLYGSSLVSYGGLINITTKKPY
NYFGGNVSYTLGSFGLNRVTADVNTPLDETGDVALRVNTAYHTENSFQDAGFNKSLFVAP
SLSYKVNDKLSFFVNTEFYDSESTNPLMLFVDRGAPLKATNIAELGYNNELSYTSNDLTV
ENPTFSLQAQMNYELSDSWTSQTAVSTGSAKALGNYSYLYETTQFNQGREEVSGDVTNLD
EGLVFTRYISNQNSTTISNDIQQNFIGDFEIAGMRNRTVVGLDYFNRKVIDNNSGYVGNG
EVYIGNASLQNVNESVYDIYEPENYITSYDSGILSKEGVAGLLENVNRNNNIAEEDIYSA
YISNVLNFTPQLALMTSLRLDQFETETNSQTALSPKFGLVYQPVVDKVALFANYMDGFSN
VGPRQVDNLETGETRTIVFDPERAKQFEVGTKLNLLKNHLSATLSYYDIQVSNMVMQDVE
NPFNLVQDGEQYSRGFEASITASPFEGLNLIAGFSHNDSELTESDQTDFLGRRPESAGPE
TLANFWASYRFVVGDLEGFGIGFGGNYASENMIFNRQTAGVFTLPSYTILNASLFYNVDK
FGINLKLNNLTNEEYYTGWSTINPQRPRNFAASLTYNF
>IFAGANLK_00793 hypothetical protein
MQKKTKNKGIKKWIAKLHLWLGLGSGLIVFIVAVTGCIFVFHDEIKDITRDYRKVTPQAS
AFVAPSKLQNKTKELFPQSQPGMVVYQGKERSAFVYSVIDEVPHHIYFNPYSAEFLQREN
LGDDFFLIVEDLHMHLWLPEKIGKQVVGISTLIFVFMLISGIVLWWPKKRKNLKKRLQIR
WNAKWRRVNYDWHSITGLYISLLALFIAIMGLSFSYEWMNHGLYDLANLWQEKPEDELNI
QFEDAEYSENALDIAVAKTLRQRPEDEMFFVWEQGGRAPITTGSYPEAMDYDHQSNFYFH
PETGELLKNHEYSSKSAGMKLQEMTFGLHTGQYFDLPGKIIAFFLSLFVAALPLSGFMIW
FGRKNKKNKQKA
>IFAGANLK_00794 hypothetical protein
MLQWIVHIVIDALVLLAAANMMPKVKLDGFKTAIIVALIIGVLSFLLSWVLTLLLNVATF
GLFYFLGLGFITRVIAYAIIIEIADQFSDDFKTEGFLPSLWLAVFIAIVGGIVDWILF
>IFAGANLK_00795 hypothetical protein
MKLFRKLILAFALFVIISILIIFGLEAYVQKETSNLIYSEITEIPSAKTGIILGASVHSD
GKLSPILEDRVETAYQLYKLNKIENFLVSGDHRTDDYDEVNAIKNHLVKKGVSPEDIILD
HSGFDTYDSMFRAKSVFDIEDAIVITQKFHLPRSLYIAKNLDAEYKGLEAAPVAYTSSET
IKRREQLANFKAIWEIITNQEPTTLEKQPK
>IFAGANLK_00796 Putative NAD(P)H nitroreductase YfkO
MSNIKALQWRYATKKFDPEKILSIEKINILKEAFNLTATSYGLQPLKMVVVRNKELQEQL
KTASWEQQQLNTASHVLVICIEKKVDKNFIEKYFKRVKHIRETPDDILDPFKRSLVESFE
SKAEEEVHAWAINQAYLTLGTLLTVCATEEIDACPMEGFKPDKYDELLKLSDHNLRSVLV
LPVGYRAEDDMFSEFKKVRRPLDDVIIEVN
>IFAGANLK_00797 Riboflavin biosynthesis protein RibBA
MAQETTTQTPLKLHSIQEAIDDIREGKVIIVVDDEDRENEGDFVAAAEKVTPEMINFMAT
HGRGLICAPITEERCKNLKLEMMVSNNTDPMETGFTISVDLRGKGVTTGISASDRAKTIQ
SLIDPETKPIDLNRPGHIFPLKAKEGGVLRRTGHTEAAIDFARLAGFEPAGVIVEIMNED
GSMARLPELVEVAQKFDLKIVSIEDLVAYRMQHDSLIEKKEDFDLDTRFGKFRLRAYRQT
TNNQVHLALTKGSWKNNEEILVRVNSTLINNDILGTLTNDADKKLDNMFRAINEEGRGAI
VFINPALQSLNLLPRLAELKERQKKGEVKAPPINMDNKDFGIGAQILHDLEIHKIKLLSN
SQQTKRVGMIGYGLEITRYVNY
>IFAGANLK_00798 hypothetical protein
MFIFVLQTIWLYIGELAGKDLDTEIIFKFLLYFSPKLVPLVLPLTILLTSIMTFGNFAEN
YEFAAMKSSGISLQRAMRSLTFFILLVSVTAFFFANNVIPAAEYKSINLRKNIAKLKPAM
AITEGVFNDLGTINIKVDDKSGDNGEYLTDVIIHKKTARSGNFTVMKAKEGELMGSTDSD
VLSLILKDGNYYDEIQPSDYSKRRNKPFAKSYFEEYTINLDLSDFNNVDLEDESYSNTQG
MLNISELKQSIDSFSTSHNEKKRNLSENMYRRTDFDKIEVNLNPSDSIKEIESTILEEYD
IYQAVQIVNLSLGSINGALSHLNIKKSELKNSTKQLNKFEIALHEKYVLAAACIILFFVG
APLGAIIRKGGMGLPMVVAILLFLTYHFIGIFAKNSAEDGSVSPFLATWLSTLIMLPLGI
YLTYRATTDQGLFAFDNITEPIRKALKKAGIIKPKRKID
>IFAGANLK_00799 Outer-membrane lipoprotein carrier protein
MKNLIFITLAVFTISLNAQNSQKAENLLNEVSSKVKSYDNMVIDFKYTLQNNAANVNQET
RGDVSIKGEKYVLNLMGTTQMFDGEKIYTIIPEDEEINISTYVEEEENNITPSKMFTFYE
EGYTYEMDAAQNLNGRKIQYVKLTPKDSDAEVKNILLGIDSQTKHIYNLIQTQDNNTKIT
ITVKSFKTDQELAQNLFTFEEDRYEDFYINRLD
>IFAGANLK_00800 DNA translocase SpoIIIE
MAKKKTRTKTSTGKKSTKFSFKLNRQQKVVLGSFLMLFGLALSVAFISFLFNWQVDQSTL
GEFSNREIETKNWLSKFGAAVSDFFMYQGFGIAAFIFSILVSYTGFHLFLDVKSTKLRES
WFWGILIMLWLAIFFGFFAAENPLLGGRIGFEMNDFLQDYLGFFGTILLMLFLFTAYLTL
RLNLTPELIGGFLKSKKDSLNKEFQSNKEELSATEEETDWKEKSIPKTEKPAEKSSAEIK
LDTTPPKEEKPAPTPKPRPVEPEEVEMEVETAQEEELDEDKISNKIVKDFGEFDPTLELS
NYKFPTLDLLQEYGGGITVDQEELEEHKNRIVDTLKNYKIEIAQIKATVGPTVTLYEIVP
EAGIRISKIKNLEDDIALSLSALGIRIIAPIPGKGTIGIEVPNKNATIVSMRSVIASPKF
QNAEMELPMALGKTISNETFVVDLAKMPHMLMAGATGQGKSVGLNAILTSLLYSKHPAEV
KFVLVDPKKVELTLFNKIERHYLAKLPDSGDAIITDNTKVINTLNSLCIEMDNRYELLKD
AMVRNIKEYNVKFKARKLNPENGHKFLPYIVLVVDEFADLIMTAGKEVETPIARLAQLAR
AIGIHLIIATQRPSVNVITGIIKANFPARIAFRVTSKIDSRTILDGQGADQLIGRGDMLF
TQGNELRRLQCAFVDTPEVDKITEFIGSQKAYPEAHQLPAYEADDSGTGVDIDVSERDKL
FREAAEVIVTAQQGSASLLQRKLKLGYNRAGRIIDQLEAAGIVGPFEGSKARQVLVTDLA
ALDQLLNEE
>IFAGANLK_00801 Undecaprenol kinase
MRDSFLGKRIRGGGYAIKGAWLLLKHEQSIQVQFVLAIIMCITGYFFGITKTEWMFQFVA
IGLVMTAEGLNSGIEAMADFVHPDFHSKIGHIKDIAAGSVFIAAVTAVIIGVFIYFPYIF
>IFAGANLK_00802 Thiol peroxidase
MSQITLKGEKINTYGNLPEKGERAPHFALIKSDLSTATLNDFKGKRVILNIFPSIDTGVC
ATSVRKFNERATELENTVVLCISRDLPFAQKRFVNDEGLENVINLSDFRDRNFGKDYGLE
IMDGPFEALLSRVVIVLDENGNVIHSQQVPEIGEEPDYLAALKTLL
>IFAGANLK_00803 hypothetical protein
MKLPVIKHLARENEVQKLEHTIEVLESYTEHRSVKDEEMDVIGELISNLCGAVEVKHSID
GGTPEKDACNNFMQKVVGSIDR
>IFAGANLK_00804 Putative thioredoxin 2
MIKELEQDNLNEIVSENETVVVQYMAGWCGNCRLMKPKFKKLASENENATFLLVDAEKYP
ESRKLAKVDNLPTFATFKNGSLVNQVQTNKFEPLKDLVNEVTSN
>IFAGANLK_00805 putative peroxiredoxin
MSLVGKKFPNLSVNAMDEMGDTFQLNILEEAQKNKKKVLLFWYPKDFTFVCPTELHAFQK
AAEEFEKRNVMVVGASCDTPEVHFAWLSTPKDNGGIEGVKYPILADSNRNLSSRLGILDI
TGESYDEETGDVTLEGDNVTYRATYLIDEDGKIFHEGVNDMPLGRNVAEFLRLVDAYTHV
QEKGEVCPANWEEGKDAMSADRDGVASYLSLN
>IFAGANLK_00806 Malate-2H(+)/Na(+)-lactate antiporter
MENQNPSQSEQIPTNKELGIWPALIPVFALIAMLAFNVFVFGDDSLNGSNQFVLLLGGAV
AAIVGYFHNVEYDKMIDEVAGNIQSTAGAILILLMVGALAGTWLISGIIPTMIYYGLQIL
NPTIFLAACVIICAVISVATGSSWTTSATVGIALIGIAEALGISVGMTAGAILSGAYFGD
KLSPLSDTTNLAPAMAGTDLFTHIRYMTLTTVPTVTITLIIFVIIGLNLDTSGTTDTSAI
LASIENSFRISPWLFLVPIIVIALIIKKTSPLIALLLGTLLGAAAALFFQPGIVAQIAGT
TNLDFVSGYRGVMQAITVETAVETDNENLNDLFSAGGMAGMLGTIWLIICAMVFGGIMEA
IGALARISRALLNLFHTTFGLFASTVFSCLALNATASDQYLAIVVPGKMFAKAYRDKGLA
PENLSRTLEDSGTVTSVLIPWNTCGAYHSGVLGVPTLSYVGYAFFNYLSPFMTLLFAAFS
IKIKELSDSSKTQTA
>IFAGANLK_00807 hypothetical protein
MKKLLLPLFITFFSLSAFSQTQNEVRLYYGFTNSDLLRGEDLDGAASTDIENSYELGFRY
LLAVTDNLSLETGLNYWRGDVLITSVPMPEQTTRSEELQTTSIPIFANYNFLDYFFVNGG
PVMDFQSSESESVDPQAGIGVGFGLGAQYAFNNFNVYINPNFRRYAVIPFEEKNFHQKLT
TFGIQLGVGYKF
>IFAGANLK_00808 L-methionine gamma-lyase
MKYKPADNIQDLQYFGEFGGVNPSISDSSTYTFLSAKTMFDTFEGNSEGCYLYSRHSSPS
NLYLGEALAAMEGTETANVAASGMGAITSALLQLCKAGDHIISSRTVYGGTYAFMKNFIP
KFNIKTSFVDITNLKSVEAAITKETKVLYCESVSNPLLEVADIEALAKIAKKHQLTFVVD
NTFSPLSISPKEWGADVVIHSLTKFINGSSDTVGGVTCGSQDFINALRSVNDGANMLLGP
TMDSMRAASVLKNLRTLHIRIKQHSHNAMFLAEKFQEDGLRTVYPGLKKHSGHETFKRMM
NEDYGFGGLLTVDVGSLDKANALMELMQEKNLGYLAVSLGFYKTLFSAPGSSTSSEIPIE
EQEEMGLSNGLIRFSIGLDNDIERTYKMMKSCMTEVGILGY
>IFAGANLK_00809 Leucine-responsive regulatory protein
MKLDQKDLQILKHLQQDSKMTNKEISNKLKLSVTAVFERIKRLERERVISRYVALVSPDK
VEKNFMVFCQIKLIQHSRSYLTKFESEVTKLTEVLECYHVSGEYDYILKVIVKDMEAYRE
FMVTKLTNLDHIGSTQSTFIISPVKSTTAVPL
>IFAGANLK_00810 5-aminovalerate aminotransferase DavT
MTEEQTKSQQLLDRRINIVANGVGVFNTATVKKAKGAIITDVDGKEHIDFAGGIGVVNAG
HCPEPVVKAIQEQAEKYLHTSFNVVTYEPYIQLCEELAEILPHGENTKAMLISTGAEAVE
NAIKIARQATKRPAVICFTEAYHGRTLMGMSLTSKVNYKFSSGPFAPEVYRIPFPNFYKY
HGTQSREEFVETELNRLRESAHSMVDINSVAAIIVEPIQGEGGFNPIPQKYLEGLRTFCD
EHGVLLILDEIQSGFCRTGHWASWQHFGVQPDISTYAKSMGSGLPIAAVLGRGEIMDAAQ
PGTIGGTYIGSPVCCAAALATIQLMKDENLNERAVYIGKLITERMENFRKGCPEIGDVRG
LGAMIGIEFIEDNDPGKPHTELCARIVKGCAEDGLILISAGTFKNVLRILCPLVITDDQL
YRALDILENQIRMHT
>IFAGANLK_00811 Aliphatic amidase
MNPFAIAGIQMKVSAVASNVEMMKLKLDITMSLYPWVDMVVFSELCGYGPLTHNAQEIPG
DFEREMQAAAKKHGVWLLPGSIFEKSEDKIYNTATVINPQGEIVTRYRKMFPFYPYEVGV
TPGSNFCVFDVPGIAKFGVSICYDMWFPETVRTLAVMGAEVILHPTMTGTIDRDIELSIV
RAMAAVNQCYFFDVNGLESGGNGRSLVCGPDGRVIYQAEGNEEIFPLELNINRVRRSREL
GVLRLGQPLKSFRDHIGDFNIYQKDTQLPYLNSLGPLIKPTRLDNLAKLKMKEHEYEPPE
NPTGYKGFGA
>IFAGANLK_00812 hypothetical protein
MGGASQKKKKEKQEETVKDFISWFEIPAINFQQAVDFYNRIFKMDMETQFDGNYAMAFFP
AAKGIGGAIVTGPNSIPGIIGPLLYLNAGKDLNRILNRVEGAGGRIVMTKTLINPESGYF
AIFIDSEGNKLALHSKD
>IFAGANLK_00813 Inducible lysine decarboxylase
MPEKKLDSAHYYNIAQLRVESWNTLKSESTKLHSSARGSEDEKNYKKNLQQLFKELEGVE
CFFAFPGLSCIENLREMLRRQEHTALSHKIAEITKNLVSDRYRSNPDFLEDEDPGAELTD
KGEYTEVAKKNYFEVMFVEDISQAEENKLRHDLKEMRLSNEQFAYGIVVQRSFEDALIAL
QFNFNIQAVVIRYAPPYHSKKITPVIKPFIQNILKLKFGSKPPTELGPILGTMVKKFRPE
LDTYYVTDTALGNLKDSTLKTFRRIFYRTEDLQELHLTVIRGISERYETPFFSALKDYSK
KPTGIFHAMPISRGNSVFKSRWINDFGNFYGRNMFLAETSSTTGGLDSLLQPTGSLKKAQ
QKASDAYGSRNTYFVTNGTSTANKIVVQALVKPGDVILIDRDCHKSHHYGLVLAGAYPVY
LDSYPIEEYSMYGAVPLEQIKEKLLQLKKAGRLSLVKMLLLTNCTFDGLVYNVEKVMQEI
LAIKPDMVFLWDEAWFAFAGFTYNYKQRTGMFVAQKLFNKYQSDSYREEYNAHIKNLKKN
EIPGLPNPDEVRIRVYSTQSTHKTLSSFRQGSMIHIWDEDFRKKSENTFMEAYMTHTSTS
PNYQMLASLDVGRRQVQFEGYELVEKSIELAMVLRAKVNDHPKLKKYFDVLTIGNFIPKQ
HRKSGIKEYYNSKEGWNRMETAWEQDEFVLDPTKITLHIGRTGVDGDTFKNRYLMDKFNI
QINKTSRNTVLFMTNIGTTRGSVTYLTNALLKIADELDQEFKTLSQEEGNNRRDRIKSLT
EDFPPLPDFSYFHHSFQAVPGVPGGNIREAFFLAYNEENYEYMALTGCLPAMEENRILVA
SSFIIPYPPGFPVLVPGQVVSKEIIRFLTALDVSEIHGYRADLGLRIFKDNVLNRQKTVS
SMGSMGNNSKKKITNLKN
>IFAGANLK_00814 hypothetical protein
MESKKPKASNKKGATNTKKTTPKKEPVSPERSAKKDRKLKVTEEKPLKGKKSVPLDSTAQ
QGKAPASSTTKKKKATTASGAKKKPAKSKKVVGAKQVKVDKSVAKVPAKSKSKNTLDGVS
DIRRSFHKNEEPLYFISATNFNLLGADEWIKGFKFICHIECFDGLHPNVFSPKTEIPHDD
FEGIEDINNYLLQHPEVQDYLKTRSVDGRAGKAMFLMFNEKTEELAEKLGLEIMFPKAEM
RTFLDNKVNTNRIAEKAGVACVPYVLTKVNNYEHLREVSNHLGNELVIQTPFGDSGHTTF
FISNEEEYEKHSEEIEKEEEVKVMKRIRCRGSAIEACVTRHGTIVAPLMTELVGFKELTP
YEGGWCGNEIYPNAFTPELREKAIEYTQLFGNQLREEGYKGYFELDFLIDQDNGEIYLGE
LNPRVTGASSITNHAVFALADAPLFVFHILEWMDIDYDLDIEAINNRWARQENIDGWSQL
IIKHTEDTIEYVTNAPNSGIYRMYDTGHIQFDRMDTHRRAVENENEAFFLRITRKGDYLY
EGADMGILVSRGRMMTDDFRLNNRAKHWIKAIRGQYTSEIVEDKKKPKLSGTLTK
>IFAGANLK_00815 hypothetical protein
MQLHFNAISEPGKPGSKWQKLYNTHWPAYKSWLNSKGTTNYPDLKTSQEALKKYMPEVWP
TYQRLCKLAKGDKVAARFLTGFQPPAYISGCSQAVTTGEDIQLVRNYDFHPDLMEGTQLL
TSWNGKKVIATSDCLIGVVDGMNEDGLAISLTFGGRKEVGVGFGIPFILRYVLEFCSDVE
EAVAALIRIPSHMSYNVTVVDKTGKFKTVQLAPDKTPLVTDAAFTTNHQGTIDWPENAAF
NKTRERSSFLNKMLSVKGVNSTKVADAFLKAPLYNTKFKEGFGTLFTSVYRPLEGKVELR
WPETSVQQSFENFQEVYKLINYEPAQVATEWWNQDAVEVARTVEDPFEEQYAENVDWQET
VTEIMVNAMAQAHPSTNERELEKLRGKIINKGEVSWQAVAGFWSKMGTGYADSWRS
>IFAGANLK_00816 Succinate semialdehyde dehydrogenase [NAD(P)+] Sad
MEFYSTNPYNGKQVGKYTAQTKEETTVVLNNSGKAFREWKKTPLSYRTELLQKAGQVLRD
NVEEYAKMITQEMGKPISESRAEVNKCAWVCDYYAENADEFLASAEIKTDATHSYVRHDP
IGSVFAIMPWNFPFWQVFRFAAPTLTAGNTGILKHAPNVFGCALKIEEVFEKAGYPKGVF
QNLIVHHDQTEMIIAHDAVQAVTLTGSEAAGSAVAELSGKYIKKSLLELGGNNSFIVWED
ADIDRAVKTAVSARMLNCGQSCIAAKRFILLEGIYDEFISKFKTAVNELKPGDTMDDSTQ
VGALARKDLADQLQRQVKRSLEQGAELLLGGEQNNCFHQPTILGNVKPGMAAFDEETFGT
LAAIIKAQNIEEAFELSEKSTFGLGTTVFTKNIEKAMEMAGSVSDGAYFVNELVKSNPRL
PFGGTKRSGYGRELAKEGMMEFVNKKTVYVKA
>IFAGANLK_00817 Dihydrolipoyl dehydrogenase
MSKYDVAVIGSGPGGYVAAIRCAQLGMKTAIIEKYSTLGGTCLNVGCIPSKALLDSTHHY
HDAVKHFEEHGIEIPGEVKINLEKMMERKSSVVSQTCDGVKFLMDKNKIDVFEGVGSFKD
KTHINIEKNDGETETIEAAKTIIATGSKPANLPFIELDKERIITSTEALKLKEIPKHMIV
IGGGVIGLELGQVYRRLGAEVTVVEFLDRIIPTMDSALSKELQKVLKKQGVKFHTSTKVK
SVERKGDEIIIKADDKKDKEVEFKGDYCLVSVGRKPFTDGLNADAAGVKVTDKGMIEVNE
HLQTNVDNIYAIGDVVRGAMLAHKAEEEGTFVAETISGQKPHIDYNLIPGVVYTWPEVAA
VGKTEEELKEEGVKYKEGKFPMRALGRSRASGDTDGFVKILADEKTDEVLGVHMIGARTA
DLIAEAVVAMEYRASAEDIARMSHAHPTYAEAVKEAALAATDNRALHV
>IFAGANLK_00818 hypothetical protein
MDGLDLLKKDWKKREGNIPQLSYDEIYKMLWKRSSSIVKWIFVISILEFLFWALITIFWA
DHEYWAEMERIHLKEFTVVTYVINYGISFFFIYCFYKNYRRISSTDNVAKLIKNILRTRK
TVKYYIGYILISTALITLIYTYFFMNYHASTTVVEDVEKYSFTPLQWLMFAGIILGGLAV
FLGFIWLFYRVIYGILLRRLNKNYKELKKLEI
>IFAGANLK_00819 ECF RNA polymerase sigma-E factor
MDKELEHQFVKNLEKHQNIAHKICRIYTNDQDSHNDLFQEITIQLWKAYPKFRGEAKFST
WMYRVALNTAITLYRKKKRSIKTQDFDSVDFKIKAEEYDDETEQQLKVMYAAIQELNDIE
KALVFLYLEDKNYRDISETLGITEVNARVKMNRVKTKLKNILNP
>IFAGANLK_00820 NADH dehydrogenase-like protein
MNIPRTNLPRVVIIGGGFAGMAMVRKLIGEDVQTVILDRHNYHTFQPLLYQVSTSGLEPD
SIAYPMRKITRNSKKCIFRMAEVKSINTEKSYIETTIGDLIYDYLVIATGSKTNFFGNES
IEKNGMWMKTVPQALNIRSLILENLEQAVITDDPEKRKALLNFVLVGAGPTGVELSGAIA
ELKNHIVPNDYPDINPNEMNIHLLEGLDRVLPPMSEKASRKAHAFLEELGVKVHLNTMVE
EYDGHLVTTNTDLSLKTETFIWAAGVTGAPVKGLKAEAMVEKANRYEVNAFNQVKGYENI
FAIGDIALMQTEAYPKGHPMVAQPAIQQGKHLAKNIMNILDGKKLEAFKYKDKGTMATVG
RNRAVVDLEQGSFGGFFAWFIWMFVHLWFLIGFRNRLVTFFNWLYNYWNYDKAARLIIRP
FKGYEKQMKVDKEEI
>IFAGANLK_00821 hypothetical protein
MNIFEALRQEHEIQRDLVAKLVETHGDTEERKKIFEQLKHELKIHADAEERHFYIPLIKK
DLTQEKARHSVAEHHEMDELIEELEDTEMDASNWLKIAKELEHKVTHHLDEEEQEVFQMA
GKALTENQKTSLGEDYNKAIKKMR
>IFAGANLK_00822 Sensor histidine kinase YpdA
MKLFLKILKISLVITAMVVFLEILFSEFNLEIFLELETWLLYFSYSFILTFINASYFWWF
GAKISWENATLKKVLLGSFGSVVLTLIGFFFCRLLHHVVYDGVPFQEFLSNERMSFYLFP
LLFTTIISLFFHLIYFYKALQEKKVKEQKIIAGTASAKFDALKNQLDPHFLFNSLNVLSA
LIDENPEQAQKFTSALSKVYRYVLEQKNKELVDLEEELKFAKTYMDLLKMRFEDAIVFNF
PSALKNPESKVVPLSLQLLLENTIKHNTVNSENPLEISIVEEDRNLVVKNNLQPKAILKR
GSGVGLSNIKQRYNLLTDRKVQIDNSNNIFSVKLPLLTKIVKMEEKPPVYAEQDAYLRAK
KQVKAEREFYANLTSYLIIIPVLALFNYLTYRGFVWAIFPAIGWGIGVFFHGLSVFNYNL
LLGKNWEERKIKELMQKDKIN
>IFAGANLK_00823 hypothetical protein
METSEDKYLKARERVKELREFYNHLFSYILVNLFLAGINYYSNQWEYPWFLWVVGGWGIG
LAFDALKAFRLNPMFDKRWEERKIREYMEKEEKQRWE
>IFAGANLK_00824 Sensory transduction protein LytR
MEIVIVEDEKPAARRLQRMLKKLDLEVNTMLHSVKEGIAWFKENPEPNLVFLDIQLSDGI
SFEIFEKVKINSAVIFTTAYDEYALKAFKLNSVDYLLKPIDVEELENAVNKFRENYQKNN
PQIDFNAFRRILETGSKPEYKTRFTIQVGQHLKIISTNEICCFYSENKATYLTTTSGRNY
PVDVSLENLEKDLDPGKFFRINRKSILNIDCIEDIISYTNSRLEVKLKAFTEFQLIVSRE
RVKDFKNWIS
>IFAGANLK_00825 hypothetical protein
MDIQKYISSGILELYVYGALSEKESREVSRVLKEYPEVRTEVEEIEKALLSLSSAAAPNN
AEYLISSIKEKLTKSSSAPTPVATPVRSINWITYSGWAASLLLLIGLFVFFNRTNELREQ
LSAERARNVQMEEQIANARNDAEKAEELLAVIRDRNVERVPLKGQDAAPEAFASVYWNTQ
ENTAYIDAKELPEPPRGKVYQVWSLTMQPLTPTSLGLLDDFETDDNKVFSLENPNQSEAF
GITLEPEGGSETPTMEQLYVLGTVAAP
>IFAGANLK_00826 ECF RNA polymerase sigma factor RpoE
MQQDALILELQKGNERAFERIYHLYSESTYGIIFTIIRDEKVAEEVLQDVFLKIWEKAPS
YNSDKGRFFTWILNIARNASIDKIRSKDFKNDQQNLKTDNFVDILEAKTNFSEAVDSIGL
KKYIDALKPVCKKLIDYLFFKGYTQKETSEELDMPLGTVKTRNRVCIDKLRAMVVT
>IFAGANLK_00827 Superoxide dismutase-like protein YojM
MKRISLSLVFCASLFIIGCKNDKKDNDAENAAETEMNSEMEAQQEEEEVKEITVPLEPKS
GSELGGEVTFTQENGEVTMEATITGLAEGQHAIHIHQEADCSAEDGTSAGGHWNPTNEQH
GKWGDAEGYHKGDIGNFEVDANGEGTVSMTTDEWCIDCDDDNKNIVGKAIIVHDGVDDFT
SQPSGAAGTRVGCGVIKM
>IFAGANLK_00828 hypothetical protein
MKTEKVNFKNKNGDDLSGYLELPFNQDPHNFVLFAHCFTCNKNFFAAKNISRTLAQNGYG
VLRFDFTGLGESEGEFSESNFSGNIQDLLAAATYLEQEFKVPSLLIGHSLGGAAVLFAAK
QLKSVKAVTTIAAPSTTAHVQHLIQNNVEEIEKNGEAQVNIGGRPFKIKKQFLDDIAKHE
LKPYLADLKKSILIMHSPQDTIVSIKNAEELYIAARHPKSFISLDGSEHLLSSKEDAFYA
GNVIASWASRYLEMPKKEIPESEADVVAGLEKEDAFTTQMKAGNHTFLADEPIKAGGKDY
GPTPYQFLSSGLASCTSMTLQMYAKRKKWPLEDVETHVFYSREHSTDCKNCEEKTSKIDT
FRREIKLIGDLDEKQKQRLLEIADRCPVHRSLTSETNITTKLI
>IFAGANLK_00829 hypothetical protein
MKKISLILVSAAVMASACKSDNKSDREAQEAKEAYEADAANDTTAMPNNDENYTELFNGH
NLDGWKAFNADSISNQWQVEDGVLAFTPAEGEREGSENLISEKTYTNFELSLEWKISEGG
NSGVMWGVQESEEFSEPYLTGPEIQVLDNDLHPDAKNGEVRQAGALYDMMPPSEDKTKNA
GEWNKTVLRINHKTNKGSVRLNETLVNEFPVHGEEWSKMVENSKFKDWENFGKDREGHIA
LQDHGDKVWFRNIKIRELE
>IFAGANLK_00830 Inosose dehydratase
MKTVKGPAVYLAQFMDTKAPFNSLDGLCKWAADLGYKGIQIPTWETALIDLTKAGESKDY
CDEIKGKVESYGLEITELCTHLQGQLVAVHSAYDTMFDNFAPDEVKGNPKARTEWAVEQM
KSAARASRNFGLDVHGTFSGSLLWHTAHPWPQRPEGLVEMGFQELAKRWMPILNEFDEQN
VDVCYEVHPGEDLHDGITFERFLEATNNHKRVNLLYDPSHFVLQQLDYISYIDHYHEFIK
MFHVKDAEFNPTGKKGSFGGYGDWIDRAGRYRHPGDGQVDFKTIFSKLTEYGCDVWAVLE
WECCIKSPDQGAREGAPFIQSHIIEATQKKFDDFAGSEIDQQKLKRILGIN
>IFAGANLK_00831 Glucose-6-phosphate 3-dehydrogenase
MGKKIKLGVLGGGGDSLIGVLHRVASSMYDKFEFVGGVFNAELKESQEFAEELGIGTDRV
YKDLDHLIAEEAKLPEEDRIKAVSILTPNFLHFPMAKQLLENGFHVICEKPMTTTYEEAK
ILEETLTKSKTVFAVTYTYTGYPMIRQMKEMIAAGELGEIQKIDVQYYQGWINPIIHNKE
ERNSIWRLDPEKAGISCCIGDIGTHAFDMIEYVTGLELKELLADLNYVYSDNKLDVDGTV
LLRFSEFVKGVLRSSQIATGEENNFAVKIYGKKAGLKWEQENPNYLYKLEDGQPMKVLKP
GHDYNSALSLDGTKLPPGHPEGIFDSMGNIYKGVARAINGEKYHPAEFPTMKDGIRGMNF
IEKVVESHAKGNVWIKIDA
>IFAGANLK_00832 Putative nucleoside transporter YegT
MKSLTRFQLSTMMFLEFFIWGGWFVTLGTFLPQNLDASGAQTAMAFSTQSWGAIVAPFII
GLIADRFFNAERILGVLHLIGALLLYMMFQAEDFSNFYPYVLGYMIIYMPTLALVNSISF
FQMSDPSKQFSSIRVFGTMGWIISGLIISFVFAWDSAEGRSEGMLRYTFLMAAVASAVLG
LFSFSLPKTPPSSKGEKVSISDILGLEAISLLKGKNFLIFFISSILISIPLAFYYQNANP
FLSEIGMEDPTGKMTIGQVSEALFLLLIPYFFKKFGFKITILAGMLAWTVRYLLFAYGDT
GELAFMLIIGIALHGICYDFFFVSGQIYTDSKAGPKIKSAAQGLITLATYGVGMLIGFWV
AGQVSDMYLNADGSHSWEEIWIFPAAFAFVVLILFAIFFKDEKIAKKDIEI
>IFAGANLK_00833 hypothetical protein
MNLRPTKLSYYFLFLFISFGFFSCKDQKAEKDNATTAEVKIEKNAEPFFKLSLAQWSLNE
PIFAGELDPMDFAEKANQMGFEGIEYVSSFYGQRISEANNPEEAMKKMLDTLKAKSEEFN
VENVLIMVDGEGELASPNQAERKKAVENHKKWVDAANFLGAHSIRVNLFGSEEPDEWKAS
AAKGLKELSEYAAEKNINVLVENHGYLSSDAALLVEVIEDVNMENCGTLPDFGNFCLKRE
GGERWEAKCVEEYPKYQGIEEMMPHAKAVSAKSYDFNEEGEETSLDYERILKIVQDAGYT
GFIGVEYEGENLSPEEGIKATKELLIEVGRKLNSNNN
>IFAGANLK_00834 Fructose dehydrogenase large subunit
MSNYYEKDTYDAIVVGTGISGGWAAKELSEKGFKTLVLERGRMVKHIEDYPTMNDDPWDY
KYKGQLTRKEEKRQQKQARTGYTTNKASAHWFVDDVKHPYNEVKRFDWMRGYHVGGRSIM
WGRHSYRLSDLDFTANKEDGYGVDWPIRYKDIAPWYDYVESYIGVSGENLGLSQLPDGKF
LPQMPLNCVEDHLKKSMAENFSDGRVLTAGRVAHITGDKEFEGRSSCQFRNRCIRGCPYG
AYFSSNSSTLPAAERTGNMTLRPNSVVNQVIYDPETKLATGVKVIDTETKEEIEFKANVI
FLCASAIASTSILMQSKSDRFEEGLGNDSGELGHNVMDHHFKAGASGKYDGFEDQYYKGR
KPNGIYLPRFRNINGSDNLGFTRGYGYQGGASRGDWSEGIAEASYGKELKEAIVKPGGWT
MGLMGFGETLPYHENKMTLDYDKTDEWGLPTITFDAEFKENELQMRKDMVDQAVEMLEKG
GFKDVQGYDDIGAPGLGIHEMGTARMGRDPKTSVLNGNNQVHAVPNVYVTDGSFMTSAGC
QNPSLTYMAMTARAADHASKNFKKSNA
>IFAGANLK_00835 hypothetical protein
MNRRQALRNIGLGAGAIIVGPSTLSLLQSCKNDPSYNWEPTFLSASNGFALKQVLEVIIP
TTDTPGAEDLNIAEFIDSYMEEVAPEDRQEKFKQSADAFSRAFKNEFDKDEGEGSAEEYE
QIVAKYLRATPSERDEIAKRNTETQDPQDKDQEVTLDADAGTLAYLEEVRSMGIWAYKTS
EQIGEEVMWYDPIPGEYIPCGPLDELGGGKAMSL
>IFAGANLK_00836 hypothetical protein
MFKKFWLLLVTGLPVLFLLWYFVIKNDDYSIKFEAKALPGEIVYRIDAPIFDQMEVKNSE
IKSDLSQVIQEAELNSENYELNWIIKPQNDSVTHVNVEITNKNNSFEDRFLLLIGQNDFQ
KEMKAEIAYFKKALTTNRELYTLKIEGETVSPENTCACITTDSKVDQKAFEMMKTIDILS
NYILENSLETLGRPRILINSWDKTTKNINFSFCFPIAETKTYPKDLLINIQTIPSEKALK
ASFHGNYMFSHNAWFHLLDYAEKNNIEVKSENMLEVFKNNPQMGGDESLWEAEIYLPIVE
>IFAGANLK_00837 hypothetical protein
MKKYLYFVIATLVLTSCSKEEKPIVVTAENYHQTVDKITDIMVHDIFSPPVASRIYAYSN
LAAYQIMRQENKDLIDFTSKFEELKPIPEADTTANINFKLAALVAKMEIGKKLIFSENVL
TTYRDSLYTKWKKTNEVEFNSSKDYGLAVARHLSAWIDKDNYKETRTMPKYSVYSDDPAR
WQPTPPSYMDGIEPHWPKIRPFTLDSASQFKPAPHPEFSLKKGTAFYDELIEVYEIKNEM
ERKGDESEEMKIAQFWDCNPYVSTQRGHLMFATKKITPGGHWMGICKIASKKAGLDFAQS
SYAYTTTAIALADGFISCWDEKYRSNLVRPETLINKLIDDNWKPVLQTPPFPEYSSGHSV
VSGAASIVLTRIFGDDFHFEDDTEVKYGLPVRTFTSFSHAANEAAISRLYGGIHYRSAVE
NGIIQGRNLGNHVVENLNIKPLTY
>IFAGANLK_00838 hypothetical protein
MRKPFSLIFLFIFLTSCEKEKTSEDFLFENLPAETTGLNFSNDLTETNALNILDYLYFYN
GGGVAVGDINNDSLPDIYLTGNQVKNILFLNKGNMQFEDISEKAGVSGSSDWNTGVVMAD
VNGDGFLDIYVCAVSGINGLNGKNELFINNGDGTFTEKAEEFGLDFQNYSSTAAFFDFDN
DGDLDMYLLNHAVHTVNTYGPAGIRNKRIAESGDKLLRNDDGKFVDVSEEAGIYGGANGY
GLGLATADFNNDGFTDIYVSNDFHEDDFYYLNNGDGTFTETLKSKFGHVSRFSMGNDAAD
VNNDGFIDILTLDMLPQDEKVLKASVSDDPRDLDKLKTEELGYHYQYARNMLQINQRGEY
FQETGLLNGVAATDWSWAPLFADFDQDGFQDLFIATGIPKRPNDLDYIKYVSSNQIQKKI
NNTRLVDNEALDMMPSGKVHNYVFKGSANLDFKDQSGKWMARDSVISTGIAYADLDNDGD
LDVVSNNINSNANIYENQSDSLSAYLKLSFKLDSQNTFGIGTKAIAWQDEKMQTRQLYNS
RGFQSSSEPIIHFGFPKKEKLDSLLIIWPDNTYQKQENLDLDQHLVIRPDQSRDSINYKK
LYSSPKPWFEKIDSLPGITFNHKENRYTDFDRQKLIPYQISDRGPAVAVGDLNGNGLDDI
YFGNSKFEPAEIYFQRENTFEKQDFELLKNDEKTENTSAVIADLNRDNKNGLFVTSGGGE
FYGEADALLDKLFKFENGELKAKDLPQYFENTSVAKLGDLDGDGDLDIFVGGAAVSNDFG
KIPSSYLLINENGKFRLQKNSGLEKVGMTTDAIWTDFDEDGQEDLIVVGEWMSPQFFRNN
KGDLENVSEEILEEKLNGLWQSIIPFDINNDGKMDYLLGNWGLNTKFPASAEFPLKMYYS
DFDQNGNTETIIAYAKNQKYYPSNGLDELVSQLSYLRKKFPQYKDFAGKTIEEVFDKEAL
EKAKLLKVHTMASGYLLNQDGKFIFKHFENALQKAPILTFLKADFNKDKKEEVLVGGNYF
GVTPYHGRFDALAGNMITQNGKILEGFELGLNFTKKSVRSLDLINFKGVVYLMVSLNNSK
PKFYKLKN
>IFAGANLK_00839 hypothetical protein
MLFFIACADDKTENDLPAEKENQEALFSKMPAAETGIYFENKITNTKDFNIFRYRNFYNG
AGVGIGDINNDGLPDIYLTSNLGKNKLYLNKGDFKFEDITESSGTAGTKNWSTGVSMVDI
NHDGLLDIYVSNAGNIEGADRKNELFINNGDNTFTEDAASYNLDENGFTTHAAFFDYDGD
SDLDVYILNNSFIPVSSLSFNNKRDLRSKDWDLPEIFKGGGDKLLRNDNGKFTDVSEEAG
IYGSLIGFGLGVTVGDVNNDQLPDLYISNDFYERDYLYINNGDGTFTEDIKNRVSHLSLS
SMGADMADINNDARPEIFVTDMLPESDKRLKETSDFERYDIYKLKESSDFYHQFMQNTLQ
LNTGNDNFQEIAFHSDVAQTDWSWGALIFDMDNDGLKDIYVSNGIYHDLTNQDFMDFFAN
DILQEMVITGKKKEFDSILNEMPSNPIPNYAFQNNADLTFDNKTQDWGLDEPSFSNGSAY
ADLDNDGDLDLVVNNVNQEVFIYKNRSSEKLENNYLKLNLNGQGKNTFAIGSKALLYLDN
QVLSQELIPTRGFQSSIDYSLTFGLGKAEKIDSLRIIWPDKTTQLVENPQINTTLELNQT
ETSSNYNLKQPKSQPILTEIETDFQEHTENNYIDYDYEGLIPKMLSREGPALAVADVNGD
GNEDFYLGGSKGQSGVLYLQNNSGNFTENKLEIFITAAGFEDTYAVFSDVNGDNKPDLIV
GSGGNEANVDKEVFRNRIYLNQGNADFKLSNSNLPNTGHNTAVIAPFDFDNDGDIDLFIG
SRSVPAIFGINPNHQLLENDGKGYFKDVSDAKAYILNDLGMITDASWEDTNGDGKKDLVL
TGDWMAPKILENNGGSLKLKETKLEEISGAWTSLSVLDINEDENPDFILGNRGTNSFYQT
STEHPVKVYINDFDNNGTIEQIFTRNIDGRDVPIHLRRELAGQISAIKKQNLKFSEYATK
SIQELFPEKIVKNSIVKEITTFKSLLALSGSNGNYHFKELPTEAQLSSIHAIEHLITKDG
NKYFLLAGNDFNLKPQFGRLDASKGLLLKVNGNGEMEIISSEKSGFLVDGEVKHIRKISN
KNGEIFILVAINNQEPKIFKFDEKAL
>IFAGANLK_00840 Starch-binding protein SusD
MKRSILKITLATLGVLSIVSCTDLELEDTDSVSRESSDGGFDGVSNVEGSINNAYNTIQG
HLQTQENLYALQEATSDELLIPTRGTDWGDNGVWRTLHQHTWDATHPYLLNTWNNFNSSV
FSLSEIMETPEASAAQVAEAKVLRAFSMYWIIDLFGQVPFRGVDEGPDVSPMVMSRAEAF
DFAMNDLQEALPELPANGPGADTNRASKALANFLLAKMHLNKHIYLGTGTPAAEDMTEVV
NHVDAIAEDGFALQSGFFEIFEPDVDVSDTEIIFRTNYGADARMWSTLHYNQGTPGQQAG
GWNGFSTLAEFYDLFEGDPEVNVPGSGQEERRGFVPTSGNTAGEGDLDDDDDGMEDGSYI
GYGFLINQQYALDGSELTDRTGNPLVYTKELPGLVGNNERTGIRLLKYHPSDGAYPGNLI
VFRYADAHLMKAEAIHRGGTSDESAIGLVNELRELREATPLESLTDQDLLEERGRELYME
FTRRQDQIRFGTYTDTWEFKDNTEAFRVLFPIPSTALTSNPNLEQNEGY
>IFAGANLK_00841 TonB-dependent receptor SusC
MKQRLLKIGLFLFAIFSFGFVQAQETVTGTVTDGEMPLPGVNVVVKGTSNGTVTDFDGNY
SLDNVPGDGVLVFSFVGFAQQEISVDGRTTVNATMQEDTDALSEVVVIGYGNVERRDATG
AVSTVSSDEFNQGVISSPEELIQGKTAGLQVTTSSGEPGAGVNIRIRGTTSVRGGNNPLF
VVDGVPLAGDEVSAGGDDVGFGSSSSKNPLNFLNPSDIESMSVLKDASATAIYGSRGANG
VVIITTKDGRGDKGRLNYSTNLGIATPANEFDLLNREEFLDAAESYGGNREDLDFGGNTD
WQDEITRSAFSQIHNLSYSDSYTGGNYRVSGNYTNQNGIIENSSMERLTGRLNLTHRLFD
DKLKLNLQSTIARVNDERAPISDNAGAQGDLLGTAYFANPTYPADPEFTPGGDFINPLAL
LKYNQDETETDRVLLNLSADYKILPELSAKVALGYDESNSYRGAALSGDIAGVGSGVPGN
GRGYINEINSTNRLMELTMNYEKQFENSKFTALAGYSFQDFSRSGITVSGYGFSTGDMDA
MIDELQAGRDAIEGTIDGSYQQYGYTGEDIFVNRLFPEIATDNVSNPGNIIASAIAGDKF
DVTDELQSFFTRLNYELAGKYLFTATLRADGSTRFGGNNKYGYFPSGAFAWQMGDEDFIP
DAISTLKLRLGYGVTGNQEIPYNQYEQRERWAGFGINNGGGIDAPGTTLVSFANPNLQWE
ETSQSNIGLDYGFMNDRLSGSLDFYYKNTTDLLIQVFSAQPSPQPFVFQNLDANVINKGV
EFAIDYNIIQQEDLFWNFGFNIAYNDNMVEDFDGVIDTGEISGQGLTGAFAQRLVGGQPL
FSYYLREFAGFDETGQSIYPNGDVQQFVGKSALPTTNLGISTSVEYLNWDLSAFLTGQFG
HYIYNNTENAFFTAGAIGNGRNVTQNVIGNGESNLNAPDVSTRFLEKGDFLRMQNLTLGY
NFDIAEESLFNSLRLSLTGQNLFVITDYTGLDPEVDTNKALNNVPSAGIDYTAYPRPTTV
TFGLNASF
>IFAGANLK_00842 Putative lipid kinase BmrU
MKEIQKVLLVVNPISGDLNKEQIIQTIENELLKINARLITYKTTGENDQDKIKKIVAEDK
FDRVFVAGGDGTIKQVAEALINFLIPIAIFPAGSANGLAVNLGIPNNLKDQLKIAMGNKH
KEMDMLEINGELCLHISDLGLNAELIKNYEHSRIRGKMGYLLQSIPTLWESKYPFEFEIE
LDNENLTRAGILLAFANAQKYGTGANVNPKGKLDDGIFEILLFKNFDILEILKTLRNETD
VNSEFVEIIPVKSARVFCRKPVAFQVDGEYIGEKEEISVKISAKKLPIMTY
>IFAGANLK_00843 hypothetical protein
MKLDLKLYRGYVNDQELNVYGHLFKSWAPDKYRLDRKGIKHAVAIIHMFRISPLKNREIT
LKFRDTKVTTKTLDDGYFRFTIPFSEELKSGWHAYEVSCNIKNFGMIEKGELLKPHPSKY
GIISDIDDTFLISHSNSFFKKLYVMLSKNINKRKIFDDVVDHYKELSRAGQDSDEASNSF
FYVSSSEWNLYEFINEFAKMHQLPKAVIKLKKIKTGISDFLSTGRGSHDHKFEKIKDIIS
FYPNIPYVLLGDDSQKDAHIYERICKIFPMSLKAVYIRQTGRKKKPEITKILKNIESLGV
STCYFKHSNKAIKHSRDEGII
>IFAGANLK_00844 30S ribosomal protein S1
MNVQDYIQSRAQLPSKSIQNTIALLDADATIPFISRYRKEATGNLDEVAVEKISLLLNAF
NELEKRKAAVLKAIKTQNELTETLAEKIEKATTLTEVEDLYLPFKKKRKTKADMAREAGL
EPLAKILMAQNTQNIENSVKQFLSEKVKTKEDAFSGAGHIIAEWINENTYVRNSLRRLYT
RKAQLSTKWVKTAEEHPEASKFTQFEKWEEPLKRIPSHRFLAIYRAEKLGIIKLKIGVEK
SEALNLIEKAIIKNPGFSGGKYLQEAIEDAYTRLLKTSFATEFLNEAKEKADEDAIAVFA
SNLEQLLMEAPLGSKRILALDPGFKSGCKLVCLDEQGNLLHNETIFPHPPQKKTDAASAK
IKSLVNAYKIEAIAIGNGTAARETEQFIKNIYLPKEVSVFTVNEVGASVYSASKIARDEF
PNYDVTVRGAVSIGRRLSDPLAELVKIDPKSIGVGQYQHEVDQTKLKEKLDVVVMRCVNK
IGVNLNTASKELLSYVSGIGPGLAQNILDYRKENKRFTSRKELLKVPRLGEKAFEQSAGF
LRIKNTKNPLDNSAVHPESYFVVEKMAKNNALKPEELIGNIEVLEKIKPEEYVSGSIGLP
SLKDILGELKKPGADPRAKKKPFSFDPTVKTIGDLKPGMKLPGIVNNITNFGCFVDIGIK
ESGLIHISKLANQFISDVNSVIKLNQELEVTVLSVDEEKKRVQLSLVD
>IFAGANLK_00845 hypothetical protein
MMSKDIKSKNLYYLSELKDYKIAGGYPDIRGWVVRDADKRVVGKVDNLLINKNLDRVVYV
DVEVDQTIIDSRHDPYGKPADPEIKEFVNKDGQNHVIVPIGLVELEEDEKYIYTSRITHQ
TFAETKRIERGANPDRHYEKTVLSSYNRPSSAETEEEHLQRRKEEEYADKPISDQREGRI
VDEEDHHKDHRNKDQYSDDEFYDREEFDGANFRRRN
>IFAGANLK_00846 hypothetical protein
MAEIKVEKKKPVWPWILLIAIIILGILFYVFAYDDTNDDVDDIEDTNEIEELNDTSSIYF
KENNKMSFIPNKELIA
>IFAGANLK_00847 hypothetical protein
MASNNNNNRNKDKHLFYLNELSDYKVSSDDPDVRGWKVKDVDQRIIGKVDNLLVNKNTER
VVYLDVEVDKSILEANHDPYRSSASEGVHEFVNKDGEEHLIIPIGLVKLNEDDKFIYTDK
VNHRTFAETKRKRKAANIDREYEEVVLASYNRGAISSEDKPRDDRSQAEFNDDTATKIRE
DRETELRDSDVSHNDPTHKKTGERGEIKDDFNPKNTQKTSFKSNKEKGSSQSTSQSQTDA
ASGRRDHKDDEDFYNKKEFDDKNFRKRK
>IFAGANLK_00848 hypothetical protein
MAEIKIEKKKPIWPWILLGLIILAVIVYFVIADNGDDDDDFNEDENTEQVATPMETEEEE
DTETARWEDDNLSGDESVSKYLTHIGDREKMGIDHEYSSEALIYLINALENRSEEANIDT
EIEIQELKDDVRDIKEDPQELTHANTINDVGGKIVDLMEKMQEEKFPDISRDVQEVRTAL
ESIEPSIPTLDQKDAVNSFYKEAGDVVQNMKMS
>IFAGANLK_00849 Carboxymethylenebutenolidase
MKYFNHVLLLVFFAFLFSSCGNKNDKKESNKEEAQVEIDTTIAQKTEAEELSDSPRHHEW
VTLSHGDREFQAFVVYPETDEATKSVIVIHENRGLNDWARLFADKLAEAGYLVIAPDLIS
NTQEGKRRTTDFENPDAARDAIYALDPEQVTADLDAAFKYIKEDSASTGEVAVAGFCWGG
SQTFRYATNNQDISSAHVFYGTGPEDEEAIANISAPVYGYYGGDDNRVNSTIEASEKMME
KSGKTYKYEIYEDAGHAFMRSGHQTDAEKANKEAHDKAWNRLKDLLK
>IFAGANLK_00850 Bacterial leucyl aminopeptidase
MIKNIPTLALLLFAGLIFQQTNAQTDERIYEIIDSVSADRIEADIRKLAGFGTRNTFSDT
VSDTRGIGAARRWIKSEFDNISNNCDNCLDVFYQKDFVTTEDGERIPHDAWVVNVVAVQK
GTKYPNRYIIMSGDIDSRASNTMDFETDAPGANDNASGMAGAIEAARVLSQYEFESSVVY
VGLSGEEQGLFGGKGLAEYAKENDWEIIGVLNNDMIGNIKGVDGVIDNRTFRIFSEPVPP
NESERERTMRRFYGGEVDGISRQLARYVHKTTETYMPEMNPMMIYRLDRFGRGGHHRPFN
DLGFAGIRIMEAHENYNRQHQDIRTENGIEYGDVVEEVNFDYAKKLTAVNAINMANLAWA
PPAPENVEIGGIVEPSAKLKWDKVEGDIAGYKIYWRETTEAQWQYSRFVGDVNEFTLEGI
VIDNFFFGVAAVGKDGNESVVVFPSGVFR
>IFAGANLK_00851 hypothetical protein
MKSGKMLLGLISGAAAGAALGLLFAPKKGADTRKAISDSSNEAIQGTKGKFNEFSDSLSH
KVDALKNKTKASLSNSKADQKAHEAKAEIHNMKAS
>IFAGANLK_00852 Trehalose-6-phosphate synthase
MSKTIIISNRLPLQINLENNNLEVTPSVGGLATGLKSFHKDGDSIWIGWSGLTKEEIPEN
LLEDVKEKARKEDCVAVNLSEEEIEGFYYGFSNRTIWPLFHYFMEYTEADKDHWEIYKTV
NKKYAEEVLTHYEDGDQIWVHDYQLLLVPNMIREQQPEAIIGFFNHIPFPSYEVFRTLPW
RDEVLKGVLGADLIGFHTYDYERHFLSSVSRILRHQVSFNEITLPERIVKVDSFPMGIDY
NKFEDAALNHFKNTEEQRTELQRRLDHHTSETPEAKLILSIDRLDYTKGIANRIRAFEYF
LDNHPEFIEKVRLVMLAVPSRSNVPQYQRLKREIDELVGRINGKFSTVSWTPIWYFYRSM
PFENLIDLYASCDIALLTPIRDGMNLVAKEFVATRINQTGVLILSEMAGAAHEMNEALII
NPNNFEQISETLIQAIEMPEEEQKQRNKILQKRLKRYSVEKWANDFMKALSDTSQDRDAF
KARRISSKVSDEIIEKFKSAKNRILFLDYDGTLVNFTDKPEKAKPDQELIELVHQLNQSQ
NTDVVLISGRDKDTLGSWWQEIPVELISEHGVWMRQKNSEWELSENVNNDWMSAVRPVIE
TFVDRTPGTFIEDKNYSLAWHYRKADPELGEIRANELSNVLKELISNRGLSVLEGNKVLE
IKSSGVNKGKASNKKLVGKDYDFIFAIGDDWTDEYMFEELPEDSFTVKVGMKKTSARYYV
EDTLKVREILKKFAENS
>IFAGANLK_00853 Trehalase
MENLDYGIIGNCKSAALISKTGSLEWCCLPNFASAAVFAKLLDEKKGGSFEIIVDDSYKI
TQEYLWETNILNTEFTDGENSFQVIDFMPRYPREDGSFYAPPDIIRFIRLISGKPKFKVK
YDPRLDFAREKTYNEFKGNYIKSFTKEGKYDSLFLYSSLDLNDVLEGEEIELTGNAYFLL
GYHEKLITQSLDRSYLKFQRTKTYWMNWSARTTRYTHYENEIMRSALVLKCLSYKKSGAV
LAAATTSLPETIGEERNWDYRFCWIRDASMVIKVMAGLGHIKSAKDFLQFIIDIIPDKDE
KIQIMYGINGEKELTEHILDHLSGYKDSHPVRTGNAAYIQKQNDIYGILMEVIYQQFNQF
ETSLENSEELWTVVRGIVKIVEENWQKPDKGIWELRTEDRHFVFSKLLCWVAIDRAIKIG
EVLRMGINDTHWKSLRAEIYNDIYNNGWNEEVQAYTQYYGSKDLDASTLLMEQYGFIEAK
DPRFVSTVHATERELCKDGLMYRYKNKDDFGEPTSSFTICTFWLIDSLFKIGEKKKAKQM
FDQLLSYSNHLGLFSEDIDFETKRLLGNFPQAYSHLALIETAANFSLGTTSEETWLSEF
>IFAGANLK_00854 Miniconductance mechanosensitive channel MscM
MSLDPLMFRYILAGVISLLVCFLIAFYILKKIGRDPRNILPVNFAQRVWVPLLIFLTALI
LKIALLSKIFRYEYTYDLLQPISTLGIILSATWLIILTLKILKNRMLKRYDVNTSDNLKA
RKIYTQFNILENIIIFIIVILAIGIALMSFESIRSVGVSVLTSAGIAGIIIGFSAQKAIG
TLLAGIQIAFTQPIRLQDAVIVEGEWGWIEEITLTYVVIKIWDKRRLVVPSTYFIETPFQ
NWTKNSADLLGTVFLYTDYTVPVEKIREELDRLLETTPLWDQQVKVVQVTDATDRSMEIR
ILISAKDSPTAFDLRVFIREKLIDFLKENYPESLPKSRVQINKEDDTQAQN
>IFAGANLK_00855 Mechanosensitive channel MscK
MINRIRLLLLSSFCVFLIQSSVFAYQQDSTSTEDELPSEEKIADPTDSNYLPNSLKDYNE
AYYSLTRLNNPLGFPPNKFNLQTPQATLEHFIISCRNKKFKDAAYALNLNLMPNTISEKE
AIDLAQKLYFVMDQRVAIDWHGLPDRPDGQVDIRTTTNQAVAGEPRRSVVFGETNIEDRD
IIFRLQRVKYQEYGAFWLISANTVENTDELYQVYGPTFLDRHMPTWSQAQIGTVPLWKPV
LTILLLIVSYLLGKVVILLIRKIAKSFNKPIILALSKRLGVPAALATGVLFFYITLNNLI
SYSGAFSSTIYALLLAVVIASITWFFMRILDFAMRYVAENKIGDVTSENSHESRQLFTYL
SVARRILTFTVVIVGTAIILSQFRSLEKLGISMLASAGLATIILGIAAQSTLGNIIAGIQ
IALTKPARIGDTVIINDRWGYVEDIRFTYMIVRTWDLRRLIVPLKTVISDTFENLSITSP
HSINEIEFFVDYRVDVDKLRTKFKELVENSEEWDEEHPPMLQVTEMTEKSLKLRAICSAS
TATIAWELHCKLREEMVAYIKELEEGIYFSRSRVELKEPHFNAENLKKSDK
>IFAGANLK_00856 putative acyl-CoA dehydrogenase
MENSIKEDKLLRGGQFLVKETKAEDVFTPEDFTEEQKMMRDSVKEFVDREIWPKKEEFEK
KNYALTEEVMGKAGELGFLGVAVPEEYDGLGMGFVSTMLVCDYISGATGSIATAFGAHTG
IGTLPILLYGNEEQRKKYIPKLATGEWFGAYCLTEPGAGSDANSGKTKAELTDDGKNYKI
NGQKMWISNAGFASVFIVFARIQDDKNITGFIVEYDKENPNGITFGEEEKKLGIHASSTR
QVFFNDTVVSAENMLSERGNGFKIAMNALNVGRIKLAAASLEAQRRVTDVAVKYANDRVQ
FKTPIAKFGAIKSKLAEMATSAWVGEAASYRAAKNIEDRINLRLEAGASHSDAELKTFEE
YAIECSILKVACSEDVQNCSDEGIQVLGGMGFSADTPMESAWRDARIARIYEGTNEINRM
LAVGMLIKKAMKGHVDLLGPAQAVGEELTGIPSMDKPDFNELFAEEKDMIKKLKKVFLMV
AGRAVQKFGQDLEEHQQLLMAASDILIEAYMAESGILRAEKNVKRFGEDSQKEQIAMARL
YLYHAVDIVNQKAKEGIASFAEGDEQRMMLMGLKRFTKYDRMPNVVELRNTIAEKLTSEN
KYCF
>IFAGANLK_00857 3-ketoacyl-CoA thiolase
MNKTAYIVKAYRTAVGKAPRGVFRFKRPDDLAAETIEYMMKQLPDFDKTRIDDVIVGNAM
PEAEQGLNVGRLISLMGLKTEKVPGMTVNRYCASGLETIAIASAKIQSGMADCIIAGGAE
SMSYIPMGGYKPVPNYKTAKEGNEDYYWGMGLTAEAVAEKYKVSREDQDEFAFNSHQKAL
KAQEEDRFQDQIVPIDIEETFVGKDGKKHTKTYTVNKDEGPRADTSKEVLGKLRPVFAEG
GSVTAGNSSQMSDGAAFVMVMSEEMVKEFNLEPIARMVSYAPVGVDPRIMGIGPVHAIPK
ALKQAGLKQDDMQLIELNEAFASQSLAVIRELGLNPETLNPNGGAISMGHPLGCTGAKLS
VQIFDEMRKRNLKDKYAMVTMCVGTGQGAAGVYEFLS
>IFAGANLK_00858 hypothetical protein
MHNLNDLKIWNKAMDFSEKTYLLSANFPTEEKFGLTSQIRRSAVSVPSNIAEGAGRNTKG
EFKNFLGIASGSSYEHYTQLILSYRLNLIEEEKVKPVLSEVIEVQK
>IFAGANLK_00859 putative 3-hydroxyacyl-CoA dehydrogenase
MKRRINKVAVIGSGIMGSGIACHFANIGVEVLLLDIVPRELNEKEKKKGLTLEDKQVRDR
LVNESLQSALKSKPSPIYHKDFANRIETGNMEDDISKVSEVDWIIEVVVERLDIKQQVFE
NLEKYRKKGTLITSNTSGIPIQQMNEGRSEDFQQHFCGTHFFNPPRYLKLFEIIPGPDTK
PEVLEFLNEYGEKFLGKKSVVAKDTPAFIGNRIGIFSIMSLFHMVKDMDMTIEEVDKLTG
PVIGRQKSATFRTVDVVGLDTLVHVANGLHKGVPDDESHDLFALPDFIQTMVDNEWYGSK
SGQGFYKKIKNDDGSSTIKSLDLETLEYRDQKKASFATLEETKSIDNVADRFEVLINGKD
KAGEFYRKNFSALFAYVSNRIPEISDELYKIDDGVKAGFGWEHGPFQIWDAIGVKKGIEM
MKAEGKEPAAWVNEMLENGKDSFYTVKEGNTYYYNIEKKDYKKIPGQDAFIILDNIREAK
EVFSNSGVVVEDLGDGILNVEFRSKMNAIGGDVLDGINKAIDMAEKDYQGLVVANNGKNF
SVGANIGMIFMMAVEQEYEELNMAIKYFQDTMMRMRYSSIPTVAAPHSMTLGGGCELSLH
ADMVVAAAETYIGLVEFGVGVIPGGGGSKEMTVRAADTYEKNDVELNRLREHFLTIGMAK
VSTSAHEAFDLNILQKGKDIVVVNQERQLTIAKKHALLMAENGYTKPIHRTDIKVLGKQA
LGAFLVGTDQMNAGKYISDHDKKIANKLAYVMAGGDLSEPQMVSEQYLLDLEREAFLSLT
GERKTLERLQHMLKKGKPLRN
>IFAGANLK_00860 Multidrug resistance operon repressor
MKEKTIDYVLRATWMAVSKMYNEEAGKAGSTMSTGFALLSIDPENGTPSTSLGPKMGMEA
TSLSRILKTMEDKGLILRKKNPKDGRSVLIYLTDFGQEMREYSKKVVLRFDEAVKENVSE
VDLKTFIEVANTILSLISEKKIYKEEIKIE
>IFAGANLK_00861 Long-chain-fatty-acid--CoA ligase FadD15
MDKPTRLFDFPYFQLEKHALDKALVTKYNGEWKAISTQEYIDQANAISRGLLRLGIKPND
KIAIISTSNRTEWNVMDIGVLQTGAQTVPIYPTISEDDYQYVLDHSEAVFCFVSDKEVLG
KLNSIKHDTKLKEVYTFDEIEGSKNWTEVLELGDDKSNQEEVEQLKKAVKPDDLATLIYT
SGTTGRPKGVMLSHNNLVSNVIDSSKRVPFQRGTYVALSFLPVCHVFERMILYLYQYYSV
SIHFAESIDKISDNLKEVKPHVITAVPRLLEKVYDKIIAKGSTVGGVKQKLFFWAVELGL
EYEPYGANGWWYETRLKLARKLIFSKWKEGLGGNIELIVSGSAALQPRLARVFAAADIPV
MEGYGLTETSPVIAVNDQRDKGFRIGTVGRPIDNVTVKIAEDGEILAKGPNVMLGYYKEP
EKTKEVLNGDQFFHTGDIGELDKDGFLKITDRKKEMFKTSGGKYVAPQILENTMKQSRFI
EQIMVIGDGEKMPAALIQPNFEFVKEWARRKNIDIGDGSEKAIAENTQVKERIQEEVDFY
NEKFGKWERVKVVELTPEVWGIEEGHLTPTMKLKRRNIKDRYKKLYEKIYRPL
>IFAGANLK_00862 Phosphoribosylformylglycinamidine synthase
MILFFGDQATKVFAVETHTNLTAQDITKLNWLFGNTQQINKSALADFFVGPRAAMITPWS
TNAVEITQNMGINGIIRIEEFLRIDRNFHDFDPMLSQKYEGLDQDIFDIHINPEPIIEID
DIEAYNRQEGLALNIEEVSYLQGLADKLGRKLTDSEVFGFSQVNSEHCRHKIFNGTFVID
GEEKPSSLFKMIRKTSEENPNEIVSAYKDNVAFINGPRVQQFAPKRPDVPEFYENKDFDS
VISIKAETHNFPTTVEPFNGAATGSGGEIRDRLAGGKGSLPLAGTAVYMTSYSRLEKDRK
WENGMKERDWLYQTPMDILIKASNGASDFGNKFGQPLISGSVLTFEHSEHERSLGYDKVI
MLAGGIGYGKASQAQKDIPKKGDKIVILGGENYRIGMGGAAVSSADTGELGTGIELNAIQ
RANPEMQKRACNAVRGMVESEENPIVSIHDHGAGGHLNCLSELVEETGGKIDLDKLPVGD
PTLSAKEIIGNESQERMGLVIGGENYEILRRVSERERSPIYQVGDVTGDHRFTFEGSKSG
KKPMDLELSDMFGSSPKTIMTDKSVKRIYADLEYSSEEIKNYLTQVLQLEAVACKDWLTN
KVDRCVTGRVAKQQTAGPLQLPLNNCGVMALDYNGKEGVATSIGHSPVSALVDPVAGSRN
SIGEALSNIIWAPLEKGLKSVSLSANWMWPCNNEGEDARLYEAVRAVSDFAISLGINVPT
GKDSLSMKQRYKDSEVLSPGTVIISAAGHCEDITKVVEPVLQPKHLGGGDIYYINLSQDN
FKLGGSSFAQILNKVGTEVPTIKDHIKFADAFYNIQGLIKQNLILAGHDVASGGLITTLL
EMCFADNNLGADIDLTALNEKDSVRLLFNENCGIVFQAKDKIAEKVLTDNNVEFFKIGKV
TEGNELKIKNGAENLSFSIPEMRDVWYKTSFLLDQKQSGIDKATERFNNYKNQPLEFKFP
YGFTGQLPFQSDLMEKPGQPIKAAIIREKGSNSEREMARAMHLAGFEVKDVHMTDLISGR
ETLEDIKFIAAVGGFSNSDVLGSAKGWAGAFLYNEKAKNALDNFFKREDTLSLGVCNGCQ
LFIELGLINPDHEKKPKMLHNASHKFECNFTSVEIMENKSVMLSTLSGSNLGIWAAHGEG
KFSFPYKKEHYNIVGEYGYDKYPANPNGSNHNTAILTDNTGRHLVMMPHLERSTFPWNWA
YYPKDRKDDKVSPWLEAFVNARKWLEKK
>IFAGANLK_00863 hypothetical protein
MGEVLLEGELAHEETFLIGNESAPFSGTISESNQLKTGTPIYFNGNDPVGLFKDDELIDV
IGHFNNDEDFAKEETKL
>IFAGANLK_00864 Ribosomal RNA small subunit methyltransferase B
MRLHRNLVFATIDALNEIFNNNKYADKVIEQTLKRDKRWGSRDRSFIAETVYDIVRWKRL
YAEIAEVKEPFDRENLFRLFTVWATLRGIALPDWPQFAGTPTRRIKGKFDSLSKIRKYRE
SIPDWMDELGVRELGEKVWDKEISALNQQAPVILRANTLKTTKDNLRSVLKGEEIISEPI
KGYKDALKLEERGNVFRTQAFKDGFFEVQDASSQLVAEFLEVEPGMRVVDTCAGAGGKTL
HLAALMENKGQIIATDIYGNKLKELKRRAKRAGAHNIDPRAIDTTKVIKKLYGTADRVLI
DSPCSGLGVLSRNPDAKWKLQPEFIDNLIKTQAEIIETYSRIVKPGGKMVYATCSVLPSE
NEKQVENFLKNTEEGKKFRILRDQKILSSETGFDGFYMALLEKKA
>IFAGANLK_00865 Ycf48-like protein
MNRIIPLCLLVIFSACKNEEKAEKENSTTTEIDYSSVEIEPILENDSLSIRAIEIIGNNL
AFAANNATFGMYNFDNKTWRTNTQKYDTLNPEFRAVASTDNDFFMLSVGSPALLYKTGDS
GAMELVYKEEHEKAFYDVMAFWNNEEGIAMGDPTDDCISIIITRDGGRTWEKLNCDILPR
VMEGEAAFAASNSNIAMEGESTWILTGGMKSRIYFSPDKGETWEVYNTPLIDGEATTGGY
SIDFYDENSGIIIGGDYTNPEGNTGNKAITQDAGKTWELIADGEEPGYKSSVRFVPNSEG
EKIIATGFSGISISKDSGKSWEELSNEGFYTLRFKNDSVAYAAGKGRIAKLTFR
>IFAGANLK_00866 hypothetical protein
MTQWLMLLEKEELLSSLLDKKNPGRSKPTGMLTNY
>IFAGANLK_00867 hypothetical protein
MKNLLIILLMFSGLWQMQSQHRDESHREKIKELKTAFFTQELNLDKQKAQKFWPIYNEYE
SELHELRKREHRDLPNLECISEDEAEEMLDEYVTIEKQDYVLKQRLFNDLKEIMTAQEII
KLHKLEDEFHKKLIKEYRSRKDRENQEEE
>IFAGANLK_00868 hypothetical protein
MKKEKISYNQKSGFKTPENYFEGLEDELLDMVKFSETLEEKKSAGFTTPNGYFNGLEDEI
LEKATKPEPKVRKLFTKEAFLYAASIAAIVIAFASTFYINPETQTSWEDLELSVMENYID
DNNIDFSTSEISNYIFQQGYIIDDADLNTVNSEAMRSYLDENLEDPLYILDKD
>IFAGANLK_00869 ECF RNA polymerase sigma factor SigW
MHFIDKKNFSDNQELPQILLHTDFKKNKVLTTFGFRYTGFHMKIKTSIPLKTSEDLLIKR
LQDKKTSSEAFKELLSLYKERLYWHIRNMVKDHEDAHDVLQNTFIKIFRNIHNFKGESKL
FSWMYRIATNESISFLNKRAKRNHITSEDLQQQLISNLESDVYFEGDKIQLKLQKAIASL
PAKQQQVFNMKYFQELKYREMSEILETSEGALKASYHHAAKKIEEYLKTN
>IFAGANLK_00870 hypothetical protein
MRNLLIIPIMLLLAFQVEAQNQTEPVRVGDVLVINQTKNQAFKSLDLPKANFIIKKGGIA
NYKSLNGKRVEVTAVETNDAGETTVKLQREDGSKFFRTHTTISANIDEALENGELIL
>IFAGANLK_00871 Putative multidrug export ATP-binding/permease protein
MTYLKKILQFAKPYKRFAILNIISNIFYALFSTLAFISFIPMLRVLFQEEEPISTKPVWD
GEFSGLKDFANDYSNFFLNQQVEQHGQLAALVSICITVIVLFFLKNLFNYLALYFIANLR
NGMLKDIRNRIYDKIVELPVSFFSEKRKGDFISRITSDVQEIQTSFLSMLELFVKEPLTL
IFTLVAMIALSPKLTLFVLVFLPLSGLLISSIGKKLKSQSTQAQQENANFLTIVEESLSS
LKIIKGFNAEEKFKKKFYDSTGRLNRILNTLLHRQNLASPMSEFLGVVVITIILWFGGRM
VLIDNTMDASTFIGFLVLTYNILTPAKAISKATYSIQKGNASAERILEILETESTIQDAK
NAIKKESFENSIEVENINFRYEKENVLKNFSMQVEKGKMVALVGQSGSGKSTIANLITRF
YDVNEGDIKLDGHNIKGITKKSLRNLMGLVTQDSILFNDTVKNNIGLGKDNATEEEIIEA
LKVANAWEFVRELPKGLETNIGDSGNKLSGGQKQRLSIARAVLKNPPIMILDEATSALDT
ESEKLVQKALENMMKNRTSIVIAHRLSTIQNADRIIVLHRGEIVEQGKHLELLAQKGTYQ
KLVEMQSFD
>IFAGANLK_00872 Phosphoglucomutase
MARNKPEILAKAKTWLTDIFDVDTHKEINHLIENNPVELEESFYKNAAFGTGGMRGIMGV
GTNRINKYTLGKNTQGLSNLLKTEFKGEKLKVAIAYDCRNNSKELAQMVAEVFSANEIEV
YLFSELRPTPELSFAVKYLDCHAGIVLTASHNPPEYNGYKVYWQDGGQLVPPQDTKLVDI
INNLEYDEVNFKAKPEFIHTIDTEVDKAFQKASVENGSFNTEASAKDNLNIVFTSLHGTA
CKTNPQILEKAGYKNVFLVEEQKEPNGNFPTVKSPNPEEPEALKMALKLAEEKNADIVIG
TDPDGDRLGVAVRDLNGEMILLNGNQTMLVMTWFLLEQHKKQGKLSANSFVASTIVSTPM
LKNITEDFSTQYHEVLTGFKWIAKLIKDNPDLDFVGGGEESFGFMVGDFVRDKDAATATL
LACEIAAQMKAEGSSFYEQLLKLYTQYGLYREELISLVKKGIEGEAEIKQMLIDLRENPW
QEIDGEKVVLIEDYHTSIANNLQDKIEEEINIPKSNVLIYYTENGTKIAARPSGTEPKIK
FYISVNSDLDKVENFDAENAKLAEKIKRIKNELQLG
>IFAGANLK_00873 Dodecaprenyl-phosphate galacturonate synthase
MQISVVIPLLNEEQSLTELYNWIAKVMRSNSFSHEIIFIDDGSTDDSWKTIEALAENDHA
VKGIKFNRNYGKSQALHAGFLRAQGDVIITMDADLQDNPEEIPELYRMVTNQGYDLVSGW
KKKRYDSVVSKNIPSKIFNAAARKTSGVKLHDFNCGLKAYRQAVVKNIDVYGEMHRYIPV
LAKNSGFTKITEKEVQHQARKYGKTKFGAERFINGFLDLLSIWFLSKFGRRPMHLFGALG
VLMFIFGFLSAGWIGISKLYKLYHGLPNVLVTSNPWFYIALAVMIIGSQLFLAGFLGELI
LRSKREKERYLINKTTPNL
>IFAGANLK_00874 hypothetical protein
MENSTSKVSPGKFGANYGLVLGIILVLISIIMYVTGMALEGKQWPMYIFYFIFLVVIVLA
IKGYKKNNNNFLSLSEALKTGVSAAVISGLIYLVYNILFNYVIEPNFAEDMIEVARDNMN
EMGNLTDDQIEMSLQWIKWVSNPFLGGAIWLGFSAFFGLIYSLIAGLIMKNKNPQDV
>IFAGANLK_00875 50S ribosomal protein L31 type B
MKQGIHPENYRLVAFKDMSNEDVFITKSTANTKETIEVEGTEYPLVKLEISRTSHPYYTG
QTKLVDSAGRIDKFKNKYKKFKK
>IFAGANLK_00877 hypothetical protein
MNLKEEIYNSAAGFSQLELLAKQVVEGYISGIHKSPFHGFSAEFAEHKIYNNGESTKHID
WKLFAKTDKLYTKRYEEETNLRCHFILDNSASMHYPEVKKFSADSLNKVGFSVLSIASIM
QVLKRQRDAVGLSIYSDEFEFYAPEKGSDRHQHMLLDALNKSLERKTDHKETKTYIFLHQ
IAEKLKRRSLVFLFTDMFQADTEEAALFEALRHLKFNRHEVVLFHVMDKKREFDFDFENI
PKRFTDVETGAEIDLYSENIKENYQEAVQKYVKDLRLECAKYKINYVEADINKNFEKILT
TYFIERQKFA
>IFAGANLK_00878 Thioredoxin
MAIEITDANFEEQVLKSDKPVMVDFWAAWCGPCRMVGPIIEEISTEYDGKAVVGKLDVDA
NQEFAAKYGVRNIPTVLIFQNGEVVGRQVGVAPKNTYAEALDELL
>IFAGANLK_00879 DNA polymerase III subunit alpha
MYLIFDTETTGLPKRWDAPLTDSDNWPRCIQIAWQLHDEMGNLIESQDYLVKPEGFNIPY
DAEKVHGISTELAAEEGVSLNEMLERFQEALNKTKFVVGQNVGFDLNIMGAEFHRKGMDN
TLQQLPVLDTCTEVTAQMCKIPGGRGGKFKLPTLTELHEFLFDEPFGEAHNATADVEATT
RCFLELVRQRVFTKEQLDVPVNYFENFSESNPQPIELIGLKHINLKKASEEIRKRFQKQQ
PTSEITTEEIEENLEKLDEVPFTHLHNHSQFSVLQSTISIKDLVNVAAENNMPAVALTDH
ANMMGAFHFVKEIGDYNKAIRAKNEEALANNEPAEARELKGIVGCEFFVCENHADKSRKD
NGYQVVMLAKNKKGYHNLAKMSSKAYTDGFYYVPRIDKEIVKQYKEDIIVLTGNLYGEVP
SKVLNVGENQAEEALLWWKEEFGDDLYIEIMRHNQEDEDRVNTVLVDFAKKHKVNLVATN
NTYYCAKEDANAHDILLCIKDGEKQATPIGRGRGYRYGLPNQEYYFKSGEEMKNLFKDLP
EAISNVQEVVDKIEPFELARDVLLPAFTIPDEFLVEEDKQDGGKRGENAYLKHITFVGAK
KRYGELTPEIEDRLNFELSVIENTGYPGYFLIVEDFIREARNLDVSVGPGRGSAAGSAVA
YCLAITNIDPIKYDLLFERFLNPDRVSMPDIDIDFDDEGRSRVMDYVIQKYGANQVAQII
TYGTMAAKSSIRDTARVLDLPLGDADRISKLIPTMSKLGKIFGMDEKELKKKFRSEDLEK
VNELLNIAEGDDLEAQTVNQARVLEGSVRNTGIHACGVIITPGDITNYVPVSVAKDSDLY
VTQFDNSVVESAGLLKMDFLGLKTLTLIKDTVQIVKGRHNIDLVPDEFPLDDEETYKLFQ
RGETVGIFQYESPGMQKHMKDLKPTVFDDLIAMNALYRPGPMEYIPSFIARKHGSEEIAY
DLPEMEEYLQETYGITVYQEQVMLLSQKLAGFSKGEADVLRKAMGKKIFALLEQLKPKFL
DGGEAKGHPRDVLEKIWKDWEAFAAYAFNKSHSTCYAWIAYQTAYLKAHYPAEYMAAVLS
NNMNDIKQVTFFMEECKRMKLDVLGPDVNESFYKFSVNKDYAVRFGMGAIKGVGSGAVAT
IVENRKTEAGPYKSIFDMAKRIDLRSANKKAFENLALAGGFDGFGDTHRAQYFHDDGDGI
TFLEKVIKYAAKFQENENSSQVSLFGEASEVQIPEPVVPPCEEWGTMEKLRREREVVGIY
ISGHPLDDFRYEMDYFCNSKLAEFNDLEKCVNRDLTFGGVISDVQHRVSKMGKGWAMFSV
EDYTDTYEFRMFGEEYLKFRHFLVPNSFVHIKIFVKEGWTNKETGKKGEPRIQFNNIYLL
HDVMDHFAKKLTIQLDIADLQEEKITWFKDVFRTHRGDHKLNFVVYEMKEQVKLHMPSKK
QKVKISQELLQTLEDEQVMYKLN
>IFAGANLK_00880 Methicillin resistance regulatory protein MecI
MHLSYTEEQLMNLLWKQEKTFMKDLIAAHPDPKPAATTVATLLKRMQDKKFVAYVQKGRS
REYYPLVRKKDYFSKQMNGMIKNFFNNSASQFASFFTKETDLTQKELEDLRKLIDVQLKT
KK
>IFAGANLK_00881 hypothetical protein
MFDYFFKSIFCLLVLWGFYKLALEQQAAHHFKRFYLIGSVLISVALPLITWTYTVEAASS
LPSQVTQLPATLSTMDVPPGTAPDTIHWLPIIMGFIYSLGALLFGYRFIRNLNDLYQKVK
NNEQVRKTSHIVVLLSGKTAPHSFLHYIFLPKQAYKQDKIALELLAHEQAHVSQKHSWDI
LLIEFLQVVFWFNPLLILVKKNMALNHEFLADQAALFQNNNIKAYTNLLFSYSDVAHHNA
LTSQINYSLTSPPFQRAKKRILMLSQPFSAKKIATRLTLFLPILALCIYFFSQDIVAKPI
YSNQDIKEKSQQSVQGIVEEEKPKTSREFLKQIDIFEVKKENLSINGQPVEIEKLEAELK
RRYGKFSQEQLDNQIVIYVQSHNPQADRAKVNIVVGALLKFGINKYVWSASEFANHSKNS
KNKYQHVTSGTAPIELPNVFINPEDYVDKMQEMNTTFFYNSGKISAERAKSILKDNNSVQ
VVSRFSSFYGENPVMQLED
>IFAGANLK_00882 Thiol-disulfide oxidoreductase ResA
MKTKLLFTFCIILFTGCNKKSPEPNFYKNLYTDEILNKKEFENFSKELGPDNPKEPLSIL
FRFSKMIESDDSVIQPFKYDLRVGKEYLMRSNSYDKIGMKIPAQKFELVGGDEIIIGGKA
NKPTLINLWFTSCGGCIQEMPVLNELKVKYAEKVNFIAMTFNEAEEVSEFLEKRKFNFRH
VTDARDFIGTIKSYPYPENIFIDKNGVIKYIEQGASVRHFESIIDELLEPKAVAFTHNK
>IFAGANLK_00883 hypothetical protein
MRTKEEMGSKLNELLEKSYDAREGFNAASKNAKNRKLQEFFKQKSQEREIFIKELRKEIT
GYGQVPKEDGSAKGDMHRTWMKLKSSVESDNDEAMLEESLRGEKAALEDYKDITKEKDLP
PTLSSKLNRQQQHIQSSINNVKVYEQMFD
>IFAGANLK_00884 hypothetical protein
MRYSEKVSKKLNALLEKNYDAEKGYKYASENSQNPQLKAFFSERAQERYDFGHELKTEIR
DFGENPEKGSSLAGDAHRTWMNLKTNFSGNKDEAALEEAIRGEKVAVDEYEDVLKDPEIP
PTTANLLLKQKNGIVAALNKLKSLELEA
>IFAGANLK_00885 30S ribosomal protein S16
MPVKLRLQRHGKKGKPFFWIVAADARSKRDGKFLDKLGIYNPNTNPATIELDVDGAVKWL
ENGAQPTDTARAILSYKGALLKKHLAGGVKKGALTEEEAEKKFEAWLEEKEAKIAAKKDN
LTKEEQEARKKALDAEKEVNAKREAEAKEAEAAAAAEGEGAAVTEEGEPEANVEKEVDQE
TAEEANTEEKKG
>IFAGANLK_00886 Ribosome maturation factor RimM
MTKDECFFLGKIVGKFSFKGEVLIKLDTDVPEMYTEMESVLIEYNENLVPFFIERSSLQK
STLLRVKFEDIETEQDAEDLIGALTYLPLSMLPDLEDDQFYFHEIIGFDVIDATHGNIGK
ITSINDSTAQALFEIQKGEKQILIPMNDEFIDKIDKENNTIYLTTPEGLVELYLG
>IFAGANLK_00887 Leucine--tRNA ligase
MSYNFNEIEAKWQKYWAENQTFRASNSTDKPKYYVLDMFPYPSGAGLHVGHPLGYIASDI
YARYKRHSGFNVLHPQGYDSFGLPAEQYAIQTGQHPALTTAKNIKRYREQLDKIGFSFDW
SREVRTSDPEYYKWTQWIFIQLFESWYDMEAEKSRAISELEEVFASEGNSRVNAACDDDV
EEFSADSWNNFSSEEKQRIFLKYRLTYLAETEVNWCPQLGTVLANDEIVNGVSERGGYPV
VRKKMMQWSMRISAFSERLLQGLDQLDWTESLKESQRNWIGKSVGAMVHFNLYGETLKKV
KDDGSLSEHQKRISVFTTRPDTIFGVSFMTLAPEHDLVKKITTPQQKEEVEAYVAASAKR
SERERMADVKSITGVFTGAYAEHPFTKEPVPIWIGDYVLAGYGTGAVMAVPCGDQRDYDF
AKHFEIPIPNIFENADISEAAFSGKEGTVITNSDFLSGLEYKEALQKVILELEKTGHGYG
KTNYRLRDAVFSRQRYWGEPFPVYYVNGMPQIIDAQHLPLRLPEVEKYLPTETGEPPLGN
ATTWAWDTKSNEVVRNKEIDDKTVFPLELNTMPGWAGSSWYLFRYMDAGNDNEFVSKEAQ
RYWENVDLYIGGSEHATGHLLYSRFWTKFLYDRGQLSVEEPFKKLINQGMILGQSAFVYR
LEGDNVLVSKNLVGKNEVQPIHVDVSLVNHSDELDIKGFKEWRPEFKDAKFLTEKDGSYI
VGREVEKMSKSKYNVVNPDDICEDYGADTLRMYEMFLGPLEQAKPWNTAGITGVHNFLKK
LWKLYHSGEKFEVSEEKASADSLKTLHKTIKKVTEDIEEFSFNTSVSTFMICVNELSAQK
CNSREVLEPLAILIAPYAPHIAEELWSKLGNSESIVTATYPVFEEKYLVESTKNYPISFN
GKMRFTMELPLNMQKVEMEKTVMADERTQKQLEGRTPKKVIVVPGKIVNIVG
>IFAGANLK_00888 Glycogen synthase 1
MNVIHVSAECYPIAKVGGLGDVVGSLPKYQQESEVGAKVIMPFYDNKFSSTHKFKSVYES
ELVLGQDIHAYKILKLKKDVLDIEVLFVDIPKLLFKDFVYSEDDTARFTAFQIAAMDWLL
TLKEKPSIIHCHDHHTGLIPFMAQECFKYESLNQIPVILTIHNAQYQGWFSHDKVHYLPA
FDISNNGLLDWDGMINPLAAGIKCAWRVTTVSPSYMKELQQAANGLEGLLDHEKEKCVGI
LNGIDSEVWNPETDEFIIKNYSAKNIQSGKTANKKWLCKEFGFSASKPLFAFIGRLVYEK
GAELLPEVLEEILPKKECSILILGSGNPEVESALENLKKKHKGVYNVFIGYDEKLSHLIY
SGTDFLLMPSRVEPCGLNQLYSLRYGTIPVVRSIGGLKDTVIDIEDGGFGFSHSEASEND
ILQTITRAIEFYKDVPKFKKTRKYIMSIDHSWDVSAQQYIDLYNSLKSG
>IFAGANLK_00889 Glucose-1-phosphate adenylyltransferase
MLNDKVLSVILGGGQGTRLHPLTESRSKPAVPIAGKYRLVDIPISNCINADLKRMYVLTQ
FNSASLNKHIKNTYHFSFFSSAFVDVLAAEQTPHNKTWYQGTADAVRQGMHHFKKHRFDY
FLILSGDQLYHMDYNLMVQQHIDTGADITIGTVPVNAKEAPSFGIMKTDKDNNITSFIEK
PNSDLLPDWTSPVGPEMEAEGRNYLGSMGIYVFNRKLLEELMDDESTVDFGKEIIPQAIG
HKKVCGYQFEGYWTDIGNIESFFEANIGLTDDIPKFNLYDMENRVYTRARILPTSKISGT
NLKKAVIAEGCIIHAKEIESSVIGVRSRIGKGSVIKNCYMMGTDFYESLKEIEGNNIEIL
AGIGENCNIQNAIIDKNCRVGDNTTINGGPHLEDDETDAYVVKEGIVVLKKEAVLPPGTT
IG
>IFAGANLK_00890 1,4-alpha-glucan branching enzyme GlgB
MTKVITHSLFSEFDINLFKSGKHFRLYEKFGSHPITLNNTNGTYFSVWAPGAKQVSVIGD
FNSWKDGEHLLNVRWDGSGIWEGFIPEVEKGNLYKYKIHSHHNGIIAEKADPYARRCEHP
PNTASVVWEDDYKWQDKPWLEKRKKHNSLNAPFSVYEVHLSSWKKKTEENRSLSYWELAS
DLVSYVKEMGFTHVEFMPIMEYPYDPSWGYQITGYFAPTSRFGYPDEFKYLVDKLHENDI
GVILDWVPSHFPEDSHGLGYFDGTHLYEHPDPKRGYHPDWKSLIFNYNRNEVRAFLISNA
IYWLEQFHIDGIRVDAVASILYLDYSREEGEWEPNQYGGNQNLEAISFLEELNKEVYASF
PDVQTIAEESTAYSGVSKPVFLGGLGFGMKWMMGWMHDTLQYFAKEPIYRKHHQNNITFS
LTYAFTENFMLPLSHDEVVYGKHSILGRMPGDEWQRFANLRLLYAYMFTHPGTKLLFQGC
EFGQSEEWNFQKSLDWHLLEYDTHKGMQELIKALNEFYKSQPALYEKQFVPEGFEWIDYS
DAENSVISFIRKGNEPKDNLIIVCNLTPSPRENYQIGLPEAGELEEIFNSDKKEFHGTGN
YQNPRKPVTSEEWQGKKYSATIKLPPLAMLAFKYTG
>IFAGANLK_00891 Oligosaccharide 4-alpha-D-glucosyltransferase
MITNTELEQKGNAFPSNVVSFRKDVDTLYFTTENDVALQITILRDGLLRFRYSTTGMFSK
DFSYAITKHASIGYNQLDIEEKEGNYSITTTKIICEVSKKGLKVKIFDRADGTLINEDEL
GFHWEESYEFGGDIVKMSKVSHDGESYFGLGDKPGHLNLKGKRFENWVTDSYAYGKDTDP
IYKTIPFYTGLHNKKAYGIFFDNTFRSYFDFAQERRFVTSFWAQGGEMNYYFIYGPKMTD
VVEYYTDLTGKPDLPPLWALGFHQCKWSYYPESKVKEITSKFRELQIPCDAIYLDIDYME
GFRCFTWNKEYFPDPKRMVKELEADGFKTVAIIDPGIKIDKNYWVYKEGLENDYFCKRAD
GPYIKGKVWPGECYFPDFTNPKVREWWSGLFKELIEDIGVKGIWNDMNEPAVMEVPNKTF
PHDVRHDYDANPCSHRKAHNIYGMQMARATYHGVKKFSHPKRPFVITRAAYSGTQRYTST
WTGDNIANWEHLWIANVQVQRLAMSGFSFAGSDIGGFAEQPHGELFTRWIQLATFHPFFR
VHSSGDHGDQEPWTFDEDITDIVRKFIELRYQLLPYLYTAFWDYTEKGIPLIKSLVMFDQ
EDVNTHYRIDEFIFGDSILACPVIEPNAKGRRMYVPRGNWYNYWTDELVKGGKEMWVDAD
IDSMPVFIKEGAIVPKYPIQQYVSEKKIEEITLEVYYKKGKEDSQFFEDAHDGYDYTKGR
FCLRSFKLTGRKNQLIIQQHKEGSFESDCKNFKLKIHGLPFEIKTIQLDNETKSLEHLQV
NGCLTMIINENFSELDFNGENGDN
>IFAGANLK_00892 2-dehydropantoate 2-reductase
MKILIFGIGGVGGYFGGKLARAGYDVTMIARGKHLEAIKKNGLEVESINANFKVKPDLAT
DNLAEVPTPDLVILGVKSWQIQEVAKQLKPIISAETMVLPLQNGANNVEKLQEILPKKNI
LAGLCHIVSFVEKPGKIKHVSFEPRITFGEIDNSNSERIKQLKKVFYKAKITNFIPENIQ
LEIWKKFLFIATISSLGGLTRVSIDKIRESEYLYNLLQKTAQEIKLIANAKGIPLAAEHL
EKAFEIIQNQPPGTTASTQRDIMAGRPSELENFNGFIVKEAEKLGIVTPVNKMIYECLLP
MESEARNN
>IFAGANLK_00893 Cell division protein FtsX
MSTSFEKYQRRRLISSYFSVVISIALVLFLLGMLGLLVLNTKKVADHFKEQIALTVYLKD
TAKEVEIEQLKKSLAMADYTKSTTYVSKEEAAEAHSKEIGEDFMEFLGYNPLQNSIDVYM
NADFVSGEQVDEIAADLTSKNFVDEVIYDKPLIALLNENVKKISFWVLIASGVFTFIAVL
LINSSIRLSVYSKRFIIKTMQMVGATKGFIRRPFIWQSVKLGIIGALIALIGMAGALYYL
NNSFPQLSLTSDVKLLAALFIGVFVMGILITWLSTFFATSRFLNLKTDELYY
>IFAGANLK_00894 hypothetical protein
MKVLKSYQVILTGVFFMLLTAGSMFGQNFRMDNSSEIVVEGTSNIHDWEMKATSKQGGAT
ITTEDGKLTGISELQVSVPAESLESGKGGMDKNAYKALNTDKYKNIEFKLDEVKKIEANG
SNSYKINGLATLKISGVSKQVPVEFTAKLNGNKLEINGEESLNMTNYKIDPPTAMFGTIT
TGEEVTIKFKSTFSK
>IFAGANLK_00895 hypothetical protein
MKNSIKYFGLIAFVLFGLQMQAQDRDLDNFRPLDQRGINMFEAPKDTISTFDGVKVRVGG
ASTIQFQALDHESSGQWSNEDGSVGRLPEIGANFNLPTANLDLDVALYDGVRMHLRTYLS
SRHHPEPYVKDGYIQIDKLEFVRPGFMEDLMNKVTIKIGHMENNYGDAHFRRTDNAQAIY
NPFVGNLIMDAFTTEVGAEVYYRSNGFIGMVGATNGKLNQSVVNPDANGVSWLAKLGYDN
QQFTGADDLRVRLTGSVYHTNRVASSYLYGADRAGSRYYDVMGEGFASGRYNPRFGNEIT
AFMVNPFLKYGGLEFFGTFERSSGKQLSQTEDRSFTQLAGELIYRFGQNENFYVAGRYNT
VNGDHASGDEIDINRVQASAGWFMTKNILAKVEYVNQQYDGYNTSSPLHGGQFNGLMLEA
AISF
>IFAGANLK_00896 hypothetical protein
MKTYFPLLFALIFTLSGVAQTGLETKKIDILPDSHLTIKGTTNINDFECEFNTLRFKNET
FKVHYTENGDILYFKNSVLPLENVYFDCGNRKINKDFHELLKSEEHPEILLKLKKIDMRG
EGNSIVTIGFTIAGVNNDYKFPVEITRDQQLCFDGKLKLNIKDFNLEAPSKIFGLIVLDE
EIEINFNLNVKT
>IFAGANLK_00897 Succinyl-CoA:coenzyme A transferase
MLNHLKILSAQDAVARVKSGDRIFIQGAAMTPVILIDALCDRYKELNDVEIIQIHTEGKA
KYTEEPFAGSFSINTCFVAGNVRNAVNSNKGTYIPIFLSEIHNLFRRDILPLDVAFIQVS
PPDKHGYCSLGVSVDITLPAIQKAKKVIAQINPNVPRTHGDGIIHSSQIDAAIEVNQPIF
AISFTAPTEIEKQIGKHVAELIEDGATLQMGIGGIPNVVLNNLQNHKNLGIHTEMFSDGI
LPLVKSGVITGANKEIKTGKLVTCFAIGSPDLYDFIDDNPIVHFKEAAYTNDTAIIRQNP
KVTAINSAIEIDLTGQVCADTIGKYQFSGVGGQMDFIRGAALSEGGKPIIAMPSITKNGI
SKIVPFLKEGAGVTTTRAHVHYIATEYGVVNLYGKNLKQRAKELISIAHPDHREQLERES
HNQFR
>IFAGANLK_00898 hypothetical protein
MKLYQTLLADFEEMSMGYSAIGIIASSCLGSVAAMLILMNGHTFIDMLQLFIVVVVCMGF
NTVILAQFKSKIVFNALLLSLAISSIFILINIF
>IFAGANLK_00899 Group 3 truncated hemoglobin ctb
MKNDIKTREDVFLLVSGFYKKVRQNPEIGHFFNEVIEDWDTHFEKLTDFWESNLFFKATY
KGNPQKVHVKVDQENNQEISNYHFGIWLKLWFETIEELYEGELANRAKNNARKMSSHLYL
KMFQARK
>IFAGANLK_00900 Carbonic anhydrase 2
MTKDEVLNRLKEGNERFTTDKKEGKLQDKSRREELTKGQEPYAIVLSCADSRVVPELAFD
TGLGELFTVRVAGNIANSSSIASMEYAVANLGTEIIIVMGHESCGAVTAAMSGGDNGYNL
NHLVSHIAPAIAASGKDAPVNDVVKKNAQLTSEELKTRSTIIKDAADSGKVKIVPAYYNL
DSGKVDFL
>IFAGANLK_00901 hypothetical protein
MNILILTDFSPQAYNAARYALNSNSGASKFYVLHASSTGEASTIDEALVDFVDRLKKEPA
ANGHSFSTLPFADNLINATRKAVTEKRIDLLVLGASGKNTSNFQGLGGNTCNVVKKVKCP
VLVVPNCEFKQWERLYLALDLRFPVHTEALQLLHKLPMARDVSIDVWEFNLNNSEAQIDD
FKLPNYKLTRKTLKEESDFFGKFLPEANIKANVIVFFARQLHITEKLLNRLSATETRKQN
LPVLILHG
>IFAGANLK_00902 Phosphate regulon transcriptional regulatory protein PhoB
MKKILLIEDDVTVRENTAELLELSNYEVVTAPDGKKGVDKAKKEIPDIIVCDIMMPELDG
YDVLTRLSEDSQTKGIPFIFLSAKTEHKDVRRGMDLGADDYLTKPFEEEDLLSAIESRLA
KVEILQAQKKDNNDGETIQNLSAFREMMRNREQISFKAGENIYEEGKSSLHFYMVERGVV
KAHKYDSRGKEMITELYKESDFFGNLSFNKNSAYGEYATALEDSVLYVVSKDELREILKS
NSNISMELLQEMGDHLMGVKEQLMEIAYASVRRKTARTILLFAHKIKKNPLHSIRISRAD
LAGVAGIASETLIRTLSDFKKEGLIEIEGRNVKLLNAEKLESIS
>IFAGANLK_00903 Signal transduction histidine-protein kinase BarA
MALEFFRENEQIFNTLFEAASEGVIVVDSQQTIVTANQAALLMFGYEKDELLGEHLNILI
PLRYKSNHHQHFDKFMKDSEKRQMGHGRDLFGVKKNGTQFPVEAGLNPFKVDGERFVMSL
IVDITIRKENQQRIRELNAELEDKIKIRTRELRHTVDNLEKEITKRKEAEKRIKLALKQE
KELNELKTKFLSLVSHEFKTPLSGILTSATLAEKYTQTEQQEKRTKHLATIKNKVHYLNN
ILNDFLSLERLESGNVNYKYTAFSLNKLVNEVIYNANVTLKYGQEIEYDSEMEDITLYQD
EKILELILSNLIGNSIKYSPENSTIYFRIFPAEGKIIFEVEDEGMGIPQKDQKHIFERYF
RAENALLNQGTGIGLNIVKVHLENMGGNIKFESVENKGTKFTVILPNQNR
>IFAGANLK_00904 hypothetical protein
MSWRFFLLFLLLPLLGQAQLVNIETKRLQIDSTRFVLNADFAFNHSNNDGVSVNQINGTL
TTQLKSKNLKRTYLFLGNYRLIDSDAGNLQNSWFLHTRFNYKLSSKLSFESFLQGQYNQL
LVVEQRNLVGAGLRLNWVDRKNFTGYLGNSYMYEVEYSDRAGTTEYNHRNSTYFSVSYLS
KSKKFSVTNTVYYQPLYKNLKDYRLLEQFRLDIPLADWFKVFTIYDYYFDSKTPLNTREY
TSQLQIGIGFSF
>IFAGANLK_00906 hypothetical protein
MTDFSFRKWNKILGWLVFVIALTTYTLTLEPTASFWDAGEYIATSANLEVGHPPGAPFYQ
MLGAFFSTFAPDNSQVALMVNFMSAAASAFAILFMFWSISLLVLKVAGPVEKLKPANKMA
VLGSALVGSLAFTFTDSFWFSAVEAEVYAMAACLMALMFYLGLLWERDMFKPRGNRWLIL
ISLVVGLSFGVHFMGLLTIPAIGFLYFFKNYKKVTVKNFIIANIVVVAVLMFIFKLLLPY
TLTFFAASELFFTNSLGLPFNTGTIIALLVIVAAFYFGINYTRKKNYFQLNTLFLCILFI
LIGFSSWVMLPIRSNAPTVINENSPDNARELLAYYNREQYGETHLFYGPQFSEMYAGLDE
DNPYTDAKPKYEKDEEAGEYIIVNDYKNAKQNLDDSHKAVLPRMWSSQHAANYMDFTGAL
DFTIKPEYQGEERLVSAVNEFQNRFAQGELDNNDYHNFLRQFGEYLNIEKPSFASNIGYL
LEYQIGYMYWRYFMWNFVGRQDDIQGKYTDMHGNWISGIDFIDEMHVGPQDNLPSDVKNN
KARNTYYFLPLILGLIGLVFQFKRDKNNFWVLLVFFLFTGIALKIYLNERPFEPRERDYA
LVGSFYVFAIWIGFGAYALFDWAKKFLKPKIAAPIVIAASILAVPVLLASENWDDHDRSG
RDSTLTMAKMYLDSVDENGIIFTIGDNDTFALWYVQQIERYRTDVRVVNTSLFATDWYID
QMKRKAFESDPIPSQFENEDYNGVNDVVFAKEVTRDTIPIKTWLNYIQNDDARTKAELQS
GQTINTFPTRNISVPVDKQAVLENGIVEERFADQIVDEIVINIESQAIYKNTLLMLDIIA
NNNWERPIYFSGGSFSDEDYLWMKEYLQLEGVAYKLVPIRTPIDQRNPYDMGRINTDKMY
DIVMNWDWGNMGSDDIYHDTETRRNSITYRSNLARLIENLLNEQDTTRAKKVLDLAMENM
PVEHFQYYALLEPYVSGYYEVGEPERARELWEKIAKKYQENLEYYSSWDIDRQYRNFNEI
VSDIERYRALVDLLVVHQDEEILEEKAEEFNEHLEMFRHFYGEEEEIDPQDPQESAIQEG
LNPELNQGNNSLRIDSAVEE
>IFAGANLK_00907 Peptidoglycan-N-acetylglucosamine deacetylase
MNPFFIKYPSILRKLYPNRITRIQGKKSIYLTFDDGPVPEITPWVLEQLKRYNAKATFFC
IGDNIRKNPEIFQQLSKENHSIGNHTFNHLNGWKTKTEVYVENIIKTEKSLLENKKKKEK
REERRAIKNQPQDSRRETQKNPKPATCNSQSETSTQKLFRPPYGKIKNSQASALVTLNYK
IVMWDVISGDFENRISKENCLKNVIDNASVGSTVVFHDSRKAFKNLKYTLPKVLEFYAEK
GFSFKAL
>IFAGANLK_00908 Thioredoxin 1
MSKFGELIDLNIPVLLDFYTEWNEDSKAMSPVLREVAASMGNKAKVIKIDVDKNAQLAEA
LRVKALPTLMIYKSGEMKWRQTGEQDAATLVGILKEYI
>IFAGANLK_00909 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MRWIIFIVFFLLIEIYAYQALKTLTRNYWLIILYFVITAAVLGNFLYQWLTPVVGSVLTG
ARGYAFGFLLSVLLFKLILTLIMFGEDIYRMGVAGYEKLSSSRGNFSLPSRRKFLSQLAM
GLAAIPLASVLYGMYQGKYNFRVLRYTLYFKDLPDAFDGYRLSQISDVHSGSFDNKNKIK
YGLDLLNEQESDMVVFTGDLVNNEASEMEPWKEMFGQIKAKDGVYSILGNHDYGDYKNWN
SSEEKNQNLDTLKETHAKMGWQLLLNEHKIIERNGEKIALVGVENWGAGGFKKEGDLDRA
GEGLSEKDFKILLSHDPSYWQEKIKNDPKHYHLTLSGHTHGMQFGIEIPGWFRWSPVQYR
YQNWAGIYEEFGRYINVNRGFGYLAFPGRVGIWPEISVIELKKGSKPA
>IFAGANLK_00910 N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase
MKRRNFIKAAGIAGAGVGLLPGNLNLNAATFRKEQKPTPICIATWNFHEASKTAGELLYK
GTSALDAVEQGVRIEEANLKNTTVGNGGAPDRDGNVTLDACIMAPSGDCGSVVYLKEIEH
PVSVARKVMEETPHVMLAGEGALQFAIQQGFQRKNLLTEESEKAWKEWLIDKEYKPVINI
ENHDTIGMLCLDDRGDIAGACTTSGLAYKMNGRVGDSPIIGAGLYLDNEIGGAVATGMGE
VILKSVGSFLIVELMRQGKSPQEACEIAVQRIIKQNPNYKDFQAAFIALHKNGEIGSYCI
HEGFSYVKYQDSKNINTTSKSYISQ
>IFAGANLK_00911 Cyanophycin synthetase
MKIREINAMRGPNYWSVRRHKLIVMVLDLEDMEQKPTNKVPGFSERIKAMFPTMYEHRCS
EGCEGGFFMRVDDGTWMGHVIEHIALEIQTLAGMDVGFGRTRGYGEEGVYNVVFNYLEEK
AGRFAAESAVRICEALIAGRTYNLEADLQEMRELRESERLGPSTGSIVEEAASRGIPWIR
LNQYSLCQLGYGANQKKIHATVTSQTSSIGVELACDKEDTKYLLEQAEVLVPKGRIIESA
KELKKTIATIGFPLVTKPIDGNHGRGISVDINSMEAAIKGFKAAKKISNSVIVENFITGD
DYRLLVINHKLVAAAKRTPAHVIGDGKSSLQELIDEVNSDPQRGYGHEKVLTMITVNDLT
KSIIQSYGYTLETIVKKGEQVILKDTANLSTGGTSEDVTDMVHPSSIFMAERISKIIDLD
ICGIDLMTTDISKPLEETNGAVIEVNAAPGFRMHLAPSKGIPRNVAANVVDMLFPPGTSA
LIPIIAVTGTNGKTTTTRLIAHMLKMKGHRVGYTTSDGVYIQNRMLMQGDCTGPSSAEFV
LRDPTIDYAVLECARGGLLRSGLGFHKCNVGIVTNVTGDHLGLKGIHSIEQLARVKGVLP
ETVTKEGYAILNADDDLVFNMSKSVESNVALFSMDENNVHIKALAAKGGLSAIYESGYIT
ICKGEWKLRIIKAVNVPLTFGGKATFMIQNVLPAVLAAYVRGFSVEDIKVSLETFIPSPG
QTPGRLNLFEFQNFQVLIDYAHNPAGLRALKDMLDKMEATIKVGIIAGVGDRRDEDTKEI
GSIAAEIFDEIIIRQDKNLRGKSTTDIREMLKKGIRENHPNKKITNIDSEKEAITSAIEN
AKDGSLIVLCSDMVAESLELVMKLKEKEVKKLYNL
>IFAGANLK_00912 Cyanophycinase
MIKGTLIPIGGNEDKGFHRADRFRLDYISQGILSRVVYESGGNGANILVITTASGIPDEV
GQSYMDAFERLGCNNVSHLYIDSKEEANSEENLNLLKDADCVMFSGGNQYKITRNIKGTL
FHDLLVKRYYEEDFVLAGTSAGAMCMSKEMITGGSSKESFIKGAIKLREGLNLIPELIID
THFIQRGRFGRLSEAVARFPQLIGFGLAEDTGIVIKNGNECDIIGSGMVIIFDPGNLKHN
NIARLKDGTPLTMTNLITHVLSDGDSYYLKERKVKVMASSKSFIE
>IFAGANLK_00913 Isoaspartyl peptidase
MKKIAIAIHGGAGTLLKGIMTPDKEISYKKSLETALNAGYKILENKGNAVDAVTEAVRIL
EDSPLFNAGKGSVFTNAGSHEMDASIMNGENLEAGAVSLISGIKNPILLAKNIMQKSEHV
FLAGTGAMEYANLLGYKLEPEDYFYDDFRYNQWQEIKDSDNFQLDHNVQKDSKFGTVGAV
ACDFEGNVAAATSTGGMTNKKFGRIGDSPMIGAGTYANNNTCAVSCTGTGEFFIRGVVAY
DVSCLMEYKGLSLKDAADEVVQKRLISIGGDGGLIAVDAKGNITTPFNTEGMYRASIDTH
GTQKLDIYK
>IFAGANLK_00914 DNA polymerase I
MAAQKRLFLLDAYALIFRGYYAFIKNPRINSKGFDTSAIMGFMNSLFDVIRREKPDHLAV
CFDKEGSQVRTEMFSEYKANRDATPEPIMQAIPIIQDILNAMHIPVVVLPGCEADDIIGT
LAQQAEKENYQVFMVTPDKDFAQLVTENIFMYRPARMGNGIEIWGIPEVQKKFGVERPEQ
VIDFLGMMGDAVDNIPGLPGVGEKTAKKFLKQFGSMEELLANTDQLKGKMKEKVESHAEQ
GILSKKLAAILTDCDVRFHAEDYELSQPDAEKVQEIFEELEFRRLRDQFIKLFSGEEDQQ
QTQVTNSPSAKKVSKTAGEGQFSLFGGDNSEKIEASTGGRKSLKDTPHVYQSLNTKMGRE
LFLKNLMKQTSVCVDTETTSLNALEAELVGIAFSWETGKGFYLPFPEERENAQELIEELR
PFFEDEKIEKIGQNLKYDIKVLAKYNIEIKGRLFDTMIAHYLINPDMRHNMDVLAETYLN
YSPQPISELIGKKGKNQKSMWDVPLEEQTEYGVEDADVTLQLKKFFEQELKEAETRKLFD
EIEIPLVRVLAAMELEGINLDENFLKSLSDALDSDIKELEQRIYKEAGEEFKISSPKQLG
LILFEKMALVKKPKKTKTGQYSTSEDVLSVLVKEHKIVEDVLMYRALVKLQNTYVDSLPN
QVQKPTGRIHTDYVQTIAATGRLSSNNPNLQNIPIRTERGRQVRKAFIPRDENHILLAAD
YSQIELRIIAALSEEDNMIKAFKEGKDIHASTAAQVFNVNIDEVTREQRSNAKTVNFGII
YGVSAFGLSNQTNLSRSEAKELIETYYKTYPKLTGYIADQVAFARENGYVQTVLGRRRYL
KDINSQNAVVRGAAERNAVNAPIQGSAADIIKLAMINIYRKLNEGKFKTKMLLQVHDELV
FDAHKDEVEEVKKMIQYEMENAYKLEVPLDVELGEGNNWLEAH
>IFAGANLK_00915 hypothetical protein
MSPQIDLAMKNLLIFRNLNAVFGLMLVLVSCEPNEDYAAETEITATNAMATITPEDLEGE
WKLSAMITDTVVDLNSDGVYNSNILLETDCFVDMGVVFYAGGDMTTTNSRLDFRAGVNNN
DFQCLSGRSDTGFWDVENENDQERLVITMTINGETYTHKRILDRTTNTFAFEINKLESQQ
YLNGSPDGTDAENVDVLSLEYTRVN
>IFAGANLK_00916 50S ribosomal protein L13
MDTLSYKTVSANKATVTKEWVHVDAEGQTLGRLSSKVAKLLRGKHKPNFTPHVDCGDNVI
VTNADKINLTGKKWDSKEYIRHTGYPGGQKSLTAAELFEKNPERIIEKSVKGMLPKNKLG
ADLFRNLKVYAGTDHDHTAQKPKTINLNDLK
>IFAGANLK_00917 30S ribosomal protein S9
MEVIHKIGRRKTAVARVYVSEGSGKFSVNKKDLKDYFTTGPLLYKVNQALNLTGNDDNFD
IIANVYGGGITGQAEAIRLALARAMVELDAENRAVLKPEGLMTRDPRMVERKKFGQKKAR
KKFQFSKR
>IFAGANLK_00918 30S ribosomal protein S2
MANKVEVKELLDAGVHFGHLTRRWNPNMAPYIYMERNGIHIINLYKSAAKMQEAGDALAK
IAASGRKILFVATKKQAKEIVAEQAEKANMPYITERWPGGMLTNFVTIRRAVKKMASIDR
MKKDGTFNTLSKKERLQVDRLRAKLEKNLGSISDMSRLPGALFVVDITREHIAIKEAQKL
NIPIFAMVDTNSDPREVEYVIPSNDDASKSINKVVSYVADSIVEGLSERKASKDSKKEKA
ENEEKEPKAPKAAVKQPEAEAPSKDAEDKKAMQEAKKDVKLESKKETLDKASSNEEE
>IFAGANLK_00919 Elongation factor Ts
MAKITAAEVNKLRKSTGAGMMDCKKALVEADGDFDKAIEVLRKKGQKVAAKRADRDSAEG
AAIAKVNDDNTKGVIISLNCETDFVAKNDDFVKMANSFADIALTVSSKEELLKADYNGIS
VEDKLTEQTGVIGEKIEIGAFKTLEAPFVGSYIHAGNKIAVITGLSKQTEGAEEAAKNVS
MQAAAMNPIALNEEGVDQETIDKEVEIAKDTLRQEGKPEDMLDKIAKGKIQRYFKDNTLV
NQAFIKDGKQSVSDYVKSVDSDLKVVAFERVALGE
>IFAGANLK_00920 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MSEKAFQFKEFKIEQDRCAMKIGTDGVLLGAWASLEYQPDSILDIGTGTGLIALMLAQRS
SALLIDALEIDDDAYEQAVDNFEQSNWGDRLFCYHAAFDEFVEEMQDEEKYELIISNPPF
YAEDYTSESASRNKARFAEALPFSELVEGVSKLLHSEGEFNTIIPYKEETNFIALAEEFG
LFPKKITRVRGNETSEIKRSLLSFSFKEIKQEENELIIEISRHFYTEDYKILVKDFYLKL
>IFAGANLK_00921 Acyl-CoA dehydrogenase
MRTDNFQAPDYYNIDELLTDEHKIVRDAAREWVKREVSPIIEDAAQKAEFPKSIIGGLAE
IGAFGPYIPEKYGGAGLDQISYGLIMQEIERGDSGVRSTASVQSSLVMYPIYKYGTEEQR
KKYLPKLASGEFMGCFGLTEPDHGSNPSGMTTNFKDKGDHYLLNGAKMWISNAPFADVAI
VWAKDENGRIHGLIVERGMEGFSTPETHNKWSLRASATGELIFDNVKVPKENLMPNKSGL
GAPLGCLDSARYGIAWGAIGAAMDCYDTALRYAKERVQFDKPIAGTQLQQKKLAEMITEI
TKAQLMAWRLGVLRNEGKATSAQISMAKRNNVEMAINIAREARQVLGGMGITGEYSIMRH
MMNLESVITYEGTHDIHLLITGMDITGIPAFQ
>IFAGANLK_00922 hypothetical protein
MGHKNKINEVNKVLQPKINQLLEHPLYQKIKTPEHLQIFMEHHVFAVWDFMSLLTALQEK
LTKTTNPWVPVGNPETRYLINEIVLAEETDVNYFGKHQSHFEMYLDAMEKSGADTGRIKD
FLLQVTHGTDIFLLIAATKLPHNIKIFIKNTFEVITEGKSHKIASAFTFGREGLIPGMFT
SIIENVQQNFPNEDLSLFKYYFDRHIELDADEHGPMAFKMVEELCGDNEAKWEDVKQIAE
EALDARLILWKGIEDEILENIDSQNLQTI
>IFAGANLK_00923 Rhodocoxin
MSDIKITIIDREGEAHVVDAPTDMNMNLMEVVRSYELAAEGTIGICGGMAMCASCQCYIL
NFEHMLPEQSIEEEDMLDQAFFVEDNSRLSCQIPITEELDGLEVKLAPEAP
>IFAGANLK_00924 Ferredoxin--NADP reductase
MIKTDILIIGAGPSGLFAVFEAGLLKLKCHLIDALPQPGGQCSEIYPKKPIYDIPGFPEV
LAGDLVTNLMEQIKPFEPGFTLGERAQTIDKQEDGSFIVTTNKGTKHHAPVVVIAGGLGS
FEPRKPPIANITDFEDKGVAYIIREPEDYRDKKVVIAGGGDSALDWAIYLADVASEVSLV
HRRNDFRGALDSVEKVEELSKIGKINLITNAEVTDLKGEEGLESVVITHKDSAREKEIKE
TDYFIPLFGLSPKLGPIADWGLQIEKNAIKVDNAYDYQTNIPGVYAIGDVNTYPGKLKLI
LCGFHEAAIMCQSAYQRIFPDKKYVMKYTTVSGVSGFDGSKKEAKKEVVKSIN
>IFAGANLK_00925 Fe/S biogenesis protein NfuA
MTSEEVKLNVEKALAEIRPFLESDGGNISLIAIENDRLVKVRLEGACVDCTVNQMTLKSG
VEMTIKKYVPQIESVINIQR
>IFAGANLK_00926 Iron-sulfur cluster carrier protein
MKLDRKEILKSLETISVAGEGKNMVESGAVQNVMTFGDEVVVDLVLQTPALHIKKRAEVD
VMKAIHEHVEQKAKVKVNIKVESTDKKPEIKGKALPGISNVIAVASGKGGVGKSTVTANL
AVTLSKMGFKVGILDADIYGPSIPMMFDVEASRPLSVNVDGKSKMKPVENYGVKILSIGF
FTQPNQAVIWRGPMASKALNQMIFDAAWGELDFLLVDLPPGTGDIHLSIMQSLPVTGAVI
VSTPQNVALADAKKGVAMFRQESINVPVLGIIENMAYFTPEELPENKYYIFGREGAKNLA
KDIETPFLGEIPLVQSLRESGDIGRPAAMQESTPLETAFQEITRGMVQETVNRNKSLPPT
EAIKITTMAGCSAVNKK
>IFAGANLK_00927 DNA base-flipping protein
MEEKNFFERVYEVVRQIPKGKVTSYGAIARSVGAAKSARMVGYAMNSAKNLDDVPAHRVV
NRNGLLTGKSHFGDHSAMQQMLASEGITVKDNKVQDFKKHFWDPQEDFK
>IFAGANLK_00928 hypothetical protein
MEETKLFLITYFAALLGVIPPGLVNMTVAKTCVEKGKKNGLYVAIGATIVVIIQATLAVL
LSKYIFGNEFVQNILLRAGLVIFILLAVYFFIQAKKRGGIEHQSRKANSNSIFKGMLIAA
LNIFPIPYFVAIAGALNVGVGDSYDWSRIVTFILAASMGSFTTLYLYVLSFIRIEKQAEA
FSRYSNYFMAALMLVLVIVTILRIYYS
>IFAGANLK_00929 tRNA (guanine-N(7)-)-methyltransferase
MGSKNKLRRFRENEAFENVIQPSREELEKNQFPLKGKWNQEFFKNDNPIVLELGCGKGEY
TIGLSKQDSEKNFIGIDIKGARFWRGAKTAIEDKLKNVAFLRTQIELIDRVFAENEVDEI
WITFPDPQIKYKRTKHRLTNAEFLQKYKLILKPEGLVNLKTDSEFMHGYTLGLLHGEGHE
ILYAHHDIYKNEYSPKAVREIQTFYEKQYLDQGKPITYIQFRIK
>IFAGANLK_00930 hypothetical protein
MQKKRILVAVLNWGLGHATRCIPIIKELQQYDFEVFIASDGAALELLKKEFPDIKCLELP
SYNITYTKSPRLLKWKIFAESPRLLKIIQQERKVTRSLVEKYELNGIISDNRPGCRHKHI
KCAFITHQFSVLSGNTTYLSSKLHQKYISKFDKCWIPDAPGNKNLSGIMGHLKEMPKNVK
YIGPLSRFTKSLQQRKYDYAVILSGPEPQRTMLEGKLLAAFQNSDKKIVFIRGIMTGENI
SSPNKNLEIINYLTSKELEVVIPSSEIIICRSGYTSIMDLAKLEKKVFFIPTPGQFEQEY
LAERFMKLGIAPFCKQDDFEILKLDLLEDFSGFQDLNFSVDFREIFALFQGK
>IFAGANLK_00931 Alkaline phosphatase synthesis sensor protein PhoR
MAKKFKRSYKFAIKTSLYITLFLSVVLAGFAYFTSGFLTGPFFAFIFITYLVCFFIIQYR
VEHFIYKRIKKIYDNVSLLDSTTLQPSQVTTDMATLTREVEKFTKDKKLEIETLKVREAY
RKEFMGNVSHELKTPLFTVQGYILTLLDGAMKDKAVRKKYLQRASKGVERLIYIVRDLDM
ITKLEAGDLHLEEEDFNIVELVQGSFDLLEMKAAKKNITLTFDIEYEEPIWVNADRDRIQ
QVLTNLIVNSIKYGKEDGTTEVSIENLIKNKVIVRVTDNGEGIEKENLPRVFERFYRVDK
SGSRKEGGSGLGLSIVKHIIEAHNEKIYVESVFGVGSEFSFTLEKSKDLPEINTEI
>IFAGANLK_00932 Transcriptional regulatory protein SrrA
MKKKDIKILLVDDEPDILEIVGYNLTAEGYQVITTDNGADAVKLAKKKKPQLIILDVMMP
EMDGIEACAQIRKLPELEETIITFLTARGEDYSQMAGFDAGADDYITKPIKPKVLVSKVK
ALLRRFKDDTASSNVVKIKDLIINRDEYKVIKGGEEIILPRKEFELLSLLASKPGKVFKR
EDILDKVWGAEVIVGGRTIDVHIRKLREKIGDECFKTVKGVGYKFVV
>IFAGANLK_00933 TonB-dependent receptor SusC
MLPLICARELNTTMKKYLSILSLLILSVAMQAQSDTTGSIAGKLSDNEVEGQPLPFANVI
IKETNKGTTSDFDGLYSLKNIEPGTYTVEFSFIGYETLQIPNVEVVSGKVTEINTGLGAS
AAALDEVVISTVSRKDSEVALLLEQKNAIQIQQSIGAEELSRKAVTNVEQGVSKVSGITM
VQDRGIFVRGLDDRYNYLMINGLPVASSDPDFKIIPLSYISTNIVSSVDVLKTFSPSLYS
DFAGATFKINTPPAPAKPTTTINFGFNYNTNTTFKDFLTDNSGDSEFLGYTGAGRSLPAE
LDINSLSLSASPEESAGLFNTSWTPESKNAPLDTRFGISHGQRLFANDRENLGFVFSMNY
RNFHRKQNGVERTLNSEGTAGQNFTSTNYNFSTQKSALLSLDYTRFNKLNLSFNTIYLQN
SSNFIREAYGRNDGFTQLNNRDFFIRDMRYTENDQLTLQLTGNLEFEEKKHQIHFGASAG
LGNNEVPDRRVLRAAGVGEDANYITTNGINPFKFYQSLENMNVNSRLEYELGFDQNEEGD
YNTVFKIGHNLDHIEYQFYNRFITAQVNRNNLPNLNTNNPQDFFNQGFNEGFLSYNSTFD
PTAASKIDQTINAGYLTFFRKWDRIILEAGLRAEHALREIIFREPLDRPQTPYQKLAYEP
FDFNPSINLRYELNENSNLRFTSSITNTRPRLREILPTVYQNGDGNQVIGNPDLLNSTNY
NLDIKYEIFPTSSELFAITAFGKYLEDPIERLARSTSVGYRTFFDNFEEAYLYGLEMEAR
VNLGNITKAESLDDLSFGFNGILMNSVATADANNPRFAVVTNKERQLQGASNWGLNADLG
YELIDTEKTESQINLIFNTYGKRIYAVGVEGADEIYEKPMNQLDLSWNTEFNDHIGVKLT
VRNILNEETLFTQDPTQEVRFPDRFSNVVESFDLGTTFGVNVTYKF
>IFAGANLK_00934 hypothetical protein
MKKPILKTLFVLSLLAGFTSCSSDDDGLQPTDDVDDIATDDDNGGGDDGVLQGTVLEGDI
TEDLLVETGDYSLRGAVTVKDGATLTIQQGSTFTVTAEDQEAGVNLVFVEQGGRIVAEGT
ASQPIVFTSENQNSEGGDGDWGGIGIHGRARMNAPGGESQSEAGQLPYGGEDDEDDSGVL
RYVRVEYAGQASSDGQFEFNAFSFFAVGSGTVVENCEAFEGADDGFEFYGGTVNATNISA
VGMEDDSIDWDEGYRGTIDNAVIYQYDGTGDFAFELASRSGENNATPRAKPTVSNVTLRG
HNREGKAAFDLKQGTGGVFDNIVGYNYETMIFVNDQLQEVENGDLEFTNTHFYDYTNLVV
NNVDESDIVEELISMNEEATGADLSEFEGWTRFDAMGGFEE
>IFAGANLK_00935 Beta-agarase D
MKQYYFYSFILAIFLTFSAPNAAYAQDTTSSGNKTEIPIEGLSIYPNPVTNGKVYISTSQ
NKEKEIQIYNVLGKPVQRTKLRGKELDVSALSAGIYILKIKEEEATATRKLVVR
>IFAGANLK_00936 hypothetical protein
MLSERIFNISNQKNFNEIALEVFSYQFQQNKVYREFCELLNRNPGNVATLEEIPFLPIEF
FKKKKVVSGTNSEEIIFTSSGTTGATTSKHYVTNLKVYEQSFLKAFEIFYGKPEEMVVLA
LLPSYLERQGSSLIYMADRLIKLSKHPESGFYLNDLESLQNKLTALDKSEKKTLLLGVSF
ALLDLVENYDFNLKNTTIMETGGMKGRRKEMIREELHQVLSKGFGIEKIHSEYGMTELLS
QAYSKGDGIFNTPPWMKILIRDAEDALSYLPAHKTGGINVIDLANFNSCSFIATQDLGRK
IQENQTEILGRFDNSDIRGCNLLLL
>IFAGANLK_00937 Tyrosine--tRNA ligase 1
MNKNFVEELTWRGMLHDVMPGTEEHLKEGMRAAYVGIDPTADSLHIGHLVSVMMLRHFQL
CGHKPFALVGGATGMIGDPSGKSAERNLLDEKTLRHNQQAIKNQLSKFLEFGKEEENAAE
MVNNYDWMKNFSFLEFIRDVGKHITVNYMMAKDSVKKRLSSDAAEGMSFTEFTYQLVQGY
DFLHLFREKDCSLQMGGSDQWGNITTGTEMIRRIGNGKGYALTCPLITKADGTKFGKTEG
GNVWLDPNRTSPYKFYQYWLNTSDDDAEKYIKIFTLLSKTEIERLIEEHKEAPHKRVLQK
TLAEEITVMVHSREDYENAVKASEVLFGKSTAADLKSLNEATFLDVFEGVPQAEIAKTEI
EEGLDMIAALSAKTNFLQSNGEARRALKENSVSVNKEKIKENYTITSQDLINDKYVIINK
GKKNTYIIRAI
>IFAGANLK_00938 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase
MILVTGGTGLVGSHLLLNLLKAGKEVRALHRKNSDLVAVEHVFNYYTSTEEAKSLFRQIE
WFEADITNIPQLNKAFENIKYVYHCAALVSFDPGDDKKLRKINIEGTANIVNLCVAFKIE
KLCYVSSVAALGRSLNKKEITERVMWNPEEDHSDYAISKYGAEIETWRGSQEDVPTVIVK
PGIIIGPGFWKEGTGQIFSKIDKGMNYHFPKIAGFVGVKDVVNVMQQLMEAEIKNEAYIL
VSENMSFKAVFEQTATELNKPAPKKALKKWMLWVGWIFQKIGGFFGAKRQITKNTVNTLF
QHSKYSNKKIKESLGFEFTPMKKVIAQTAKFFKQDKS
>IFAGANLK_00939 hypothetical protein
MWQSVCSLTDNMLKKLFLLFFICAAFAACQNIEKSERPENLIPEDKMIDVIAEIFLMQSA
RNFNKRMFENTGIRGQEYIFEKYEIDSVQFKRSNDYYADNYEVYQRIYDSVKNRFEKLKV
ELDTLQQQEQQIKDSIAKVRRDSLGVEEDSLNPEEERKIEEISDSLINEKDSLGRRVLDS
LPQPRSRN
>IFAGANLK_00940 Allantoinase
MKKVLIKNAKIVNEGKIKEADVFIEGGIIVEIAESISAKSPDVQIFDAEGTHLLPGVIDD
QVHFREPGLTHKENIEMGSRAAVAGGITSFIEMPNTLPQTTTIEELEKKFELAAERSYAN
YSFMFGGTNDNLEEILKVDPKTTAALKLFLGSSTGNMLVDDEKALEQIFSKSPLLIAVHC
EDEATIKKNLDEYIERYGDDIPIELHPQIRSEEACYKSSARAVALAKKTGARLHVFHVST
AKELSLFSNKKKLKDKKITAEVCIHHLWFNDSDYKKKGTLIKWNPAVKTKQDQDALMKAL
NDDLLDVVATDHAPHTKEEKKNVYTKAPSGGPMVQHSLAAMLQFHHQEKISLEKIVEKMC
HNPAILFDIKDRGFIREGYKADLVLVDLNAPWAVQPDNIQYKCGWSPFEGVTFKSRVTHT
FVNGNLVYKNFKHQPFANVAERLQFDR
>IFAGANLK_00941 Polyprenol monophosphomannose synthase
MVKGIVIVPTFNEIENIERLVRNVFSQHTQFHILVVDDNSPDGTATLVRTLQAEFHEGLF
LEERMGKLGLGTAYIHGFKWALQRDYEYVFEMDADFSHNPNDLIRLYNTCKRNNADVAIG
SRYKTGVNVINWPMSRVLLSWLASKYVRFITGMDIHDTTAGFVCYKRKVLETIDLDSIQF
VGYAFQIEMKFKAYLLKYNLEEVPVIFTDRTRGTSKMSGSIISEAIFGVIIMKIKSLFKQ
IKLK
>IFAGANLK_00942 hypothetical protein
MGAFLLLATVRTAYPQRFEDFLSLLSSNKFMMFRGKKNKAFHPFNILLFFVHLISFSLLF
YLFFSFFWKDTTLNPAFVFIRIATAYGSFVLLKFGLEKIVGNVFDLDPQIDSYLYQKISY
RNFIGLILLIPSLIFVYTFTPTAFALYTLLGILVLSNFFSLLLIYRENQTLITGNWFYFI
LYLCALEIAPYIILYKLITI
>IFAGANLK_00943 hypothetical protein
MKVKTILVSQPEPKVENSPYFELEEKQKVKIDFIPFIHVEGVSSKEVRQQKVDLTKYSAI
ILTSRNAVDHFFRIAEELRFKVPDTLKYFCLSEAVAYYLQKYVVYRKRKIYVGKRTFADL
SPLIKKYKNEKFLLPSSDMLKPDVPKTLDKLGVEWKQATFYKTVVSDLSNLRDVTYDILV
FFSPSGIKSLFENFPDFEQKETKIAVFGNTTIKAAKEHGLTVNIKAPTPDTPSMTMALQK
YIAEANKK
>IFAGANLK_00944 Phosphoenolpyruvate carboxykinase (ATP)
MFANTQTTKTISLESYGIKNATVHYQLSPEELHYDTLEHGLGTETNSGALAINTGAFTGR
SPKDRFIVKDEITCDKVWWGDINIPFDVAKFDKLYDKVAEYLSNKEIYARDAYACAEEKY
RLNIRVVSEYPWSNMFAYNMFLRPEENELENFKEEWLILNAPGFKADPEVDGTRQENFAI
LNFSKKIALIGGTGYTGEIKKGIFSALNFILPVYKNTLPMHCSANVGEDGDTAIFFGLSG
TGKTTLSADPNRKLIGDDEHGWTKENTIFNFEGGCYAKVINLTEENEPDIYRAIKPGAIL
ENVILDDEGNVDFSDTSITQNTRVSYPIHHIDNIQVPSVGENPKNIFFLTADAFGVLPPI
SKLTPGQAAYHFISGYTAKVAGTEAGIDEPVPSFSACFGAPFMPLHPTKYAEMLSAKMKE
AGVNVWLINTGWTGGPYGTGSRMKLKFTRAMISAALNGDLKDAEFNTHNMFGLQMPLNCP
NVPAEVLNPRNTWKDTAAYDRKAGELANSFKKNFEKFEAYANDEIMAGGPTSS
>IFAGANLK_00945 hypothetical protein
MNRKFLITGVIFGLLAVIIGAFGAHGLKPLLDETARESFETGVKYQMYHGLLLLFIGGFK
MHSFRFQKPIFFLLLFGVICFSGSIYLLATNNLTTIDFTGIALVTPLGGTLLIAAWIFLL
VEFVKIKTK
>IFAGANLK_00946 hypothetical protein
MNNILIIGAGKSTSVLIDHLLSKAGTEDLFLRIGDIELENAKNACGSKQHCEAFHLDVFS
AESRENAVKSADIVISMLPARFHIEVAKACVKFKKNMVTASYISKEMKALDEEVKENGLI
FMNEIGVDPGIDHMSAMQVIDRIRDKGGNLLLFESFTGGLVAPESDTNLWNYKFTWNPRN
VVVAGQGGVAEFIQEGKYKYIPYHRLFRRTEFLHIEGYGKFEGYANRNSLDYMSIYGLED
VLTLYRGTIRRVGFSRAWNMFVQLGMTDDSFTMKDSENMSYRDFVNSFLPYSPTDTVELK
LRHNLKIDQDDVMWEKLLELDLFNKDKKIGIKNATPAQALQKILMDKWSLAPDDKDMIVM
YHKFGYELNGEKKQIDATMVHIGKDQTETAMAKTVGLPVAIATLKILKGEITTPGVQLPI
KKEVYEPILKELEKHDIIFKEKETEYLGYNPFGEVGN
>IFAGANLK_00947 Regulatory protein AsnC
MKVVNETVVIDGIDKTILNFLMEDAKKSILEIARNIGITGAAVHQRLRKLEKAGLIEGSK
LMINPRMLGYKTMAFVGVYLDKAVSNPQAVKQLSQIPEVIECHYTTGNWSIFIKILCRDN
EHLMNVLNKDIQAIEGVSRTETFISLNQQIKRQIKI
>IFAGANLK_00948 hypothetical protein
MKVLHQSQFFTSYQCDKQRCFFIEFPHKTIQLGFCQFLAFRQQVKEINLDSHFNGQNHHG
LEMLMLCNRQHFFVFNTLECIDLKEFITGSFAMLELNSLLTTSV
>IFAGANLK_00949 Bacterial non-heme ferritin
MKDLVRQNLSIHVDVMDLLNKQIEKEAHSSSAYLAMASWCDHNALSNSADFFYEQAAEER
EHMMKIFRFINDNGGTAYSPEVSGVNHDFKSLEEIFETALDQEIAITKSIHNIVGKCRKL
NDYTTEYFLQWFIAEQMEEEQTMRRALELFDLMGTEGLGLKLLDERIPQIRNKSTE
>IFAGANLK_00950 hypothetical protein
MLGYYVIAGLIFIVSLYVSNKLKSKFKKYSEVHLQNGMSGKELAEKMLRDNNITDVKVIS
TPGMLTDHYNPQKKTINLSEGVYSQRNAAAAAVATHETGHAIQHANAYSWLTMRSQLVPV
VSVASRFSQWVIFGGLILMATTALGSTILLIGIIMFGMGTLFSFITLPVEYDASKRALAW
LETENMVSGPEHEAAEDSLKWAARTYVVAAVGSLATLLYFLSIYMGRD
>IFAGANLK_00951 Uridylate kinase
MHYKRILLKLSGEALMGQRQYGIDPDRLAEYAEEIKQVIDKGIEVAIVIGGGNIFRGVAG
ASKGMDRVQGDHMGMLATVINGLALQSALEDAGVQTRLQSAIKINEVAEPFIRRKAMRHL
EKGRVVIFGGGTGNPYFTTDSAAVLRAIEIHADVILKGTRVDGIYNADPEKDKKATKFDF
ISFDDVIRKGLKVMDTTAFTLSQENELPIIVFDMNTPGNLLKVVTGERIGTKVNL
>IFAGANLK_00952 Ribosome-recycling factor
MEDEIQFIIDSAKEGMDKAIEHLKKQLQNIRAGKANPAMLGSVMVEYYGAQTPLQQVANV
NTPDARTISVQPFEKKLIPEIEKGIMQANLGFNPMNNGENVIINVPPLTEERRKQLTKQA
KAEAEDAKIGVRNDRKTANNELKKLDISEDLLRDAENEVQELTDAHIIRIDAILENKEKE
IMTI
>IFAGANLK_00953 hypothetical protein
MRSPLLLIFLLFSFSICAQQPLRGRIVNKQTGDPLAYAKITYGDKEDLSKIDGSFSITLT
EEETQLSISYVGFETQNFKVSKNVEFVRIKLTPKIEGLAAVTISSGENKANAIIAKAIAR
KPKNDPEEKLQKFNFKNYNKFIVDNESAALEMASDSTNLEIGTVINSAASYFSEKVSKFY
YSQKEGLKEEVQALKTAGFEKPVYEILSLSVNPFSLYDKDFRIFDTDYAAPLQNSAFRNY
SFKILDTTTTSQPAYVIYFKPKRQRAVAGLEGILYLDTETYAIQQAKAQLLGAIKLEIDQ
DYEYFPEENLWFPKTQKITIRPGNGDQAISVFGGVISAGTLQKKESILNNILAPGKSDPN
LFLNVTSTNFDIQLNSNETLETSAEILVNSTAISREDSFWEENRTEAISSQNKFSRQRAE
RLIKEKEVEEKISFQKSVSTGYIPVGFWDFDLGKFFKFNNYEGIRLGFGGKTNQQLSDIY
SLNGYLVYGTKDEVFKYNLGTAIHLNKATETDLKFNYTRDIVETGSFSYLQGKNDFSIVE
PRFVNINFFYQHRTLSSGLTQRFGSDFKTELQFSKSDISQTRDYSFLLNGQEFSEYTLSE
ATFSFLWRPFAKFLKTPNSTNLIEKGYPKFTGEITKGISGVLGSDFDYTKFGLLVEHEIK
RLNQSRTEIILEGNYATGDVPLTHLYHALPNSPSREGILSRFSVAGRRSFETMFYNEFFS
DKQAMLHIKHQLRPINVHRLIQPELVFISRHAIGDISNPERHSMPFKSLKRGYHEFGIEL
QKILVGFGLGAAYRYGPYSMPNFNENFAFKFTFHLDI
>IFAGANLK_00954 Multidrug resistance protein MdtC
MAKIFSFGFWNSVARLILRNRIIILLLIIATTVFFSTQWKNMRFSYTEANLLPDDHEDNI
AYNEFLDKFGEEGNLVLLGVKDSTLFKPENFEAWKELTKTLEAYPAVDYAISVSNLHKLK
KFEDPSRFEMVPFITEDNPTEEELQQYQDELYNELPFYENLVYSSHSNTLQSAIYLNKEI
VNSKERKTFVIDELQPLIANFEEKTGIDVKVSGMPYIRTLNSQNIIDEIGLFILAALGVT
SLIFFFFFRSIRATIISMITVCIGVMWAFGVIGLFNYEITVLTALIPPLIIVIGIPNCIF
LINKYQQEIKKHGNQAKSLQRVITKVGNATLMTNITTASGFATFILTDSTLLKEFGIVAS
INIVAIFILSLLIIPIIYSYMNLPRRKHLKHLNKRWIGGFVNWMEQMVRHRRISIYITSI
VLLVASIIGIYTIKISGSLLEDMPEEAEFFQDIKFFEEEFDGVMPLEILVDTKRKNGVLK
PATLKRMEELENHLAEIPEFSQPISITRLVKYSKQAFYNGDAQYYQLPSSQEQNFIMPYA
KGFSSNENLLTSYIDSTGRYARITTYMKDVGTDKMEELEEDLWPQINKIFPEERYEISMT
GKAFIFQKGTNYLVKNLIISLSLAILLIALFMAWMFRSFRMILVSLVPNLLPLLVTAGMM
GFLGVPIKPSTILVFSIAFGISVDDTIHFLAKYRQELKANNWKIKRSVYAALRETGVSMF
YTSIVLFFGFSVFMISSFGGTVALGGLVSATLLFAMLANLLLLPSLLLSLEKNIANKEVL
KEPAMKIIETDEDEAEIEKEESKNSER
>IFAGANLK_00955 Asparagine--tRNA ligase
MIQAKIAEILDSNQFLQEFEVNGWVRSFRSNRFIALNDGSTINNLQCVIDFENFDQEELK
RITVGAAVSVKGTLVESQGNQQRVEIEVKKFEILGDANPEEVKLTILSPKRHSLEKLREQ
AHLRVRTNTFGAIMRVRSKLSFAVHSYFQQNNFHYVNTPIITGSDAEGAGEMFRVSALDM
ENPPKNEDGSIDFREDFFGKETNLTVSGQLEGEAYAMGLGQIYTFGPTFRAENSNTSRHL
AEFWMIEPEVAFCDLDGNMDLAEDFIKYVLKYILDHCQDDLEFLDKRFNAEEEAKPKADR
SEMGLLDKLHFVLDNNFKRVSYTEAIEILKNSKPNKKKKFNYIIEEWGADLQSEHERFLV
EKHFKCPVILFDYPANIKAFYMRLNEDGKTVRAMDILFPGIGEIVGGSQREERLDVLQNK
MKELNIDEKELWWYLDTRKFGTCVHSGFGLGFERLVQFVTGMGNIRDVIPFPRFPGNAEF
>IFAGANLK_00956 Ribosomal large subunit pseudouridine synthase C
MKIKETHIVPAVAEKIRLQEYAVSIFTSLPTKSSLKKALKKELILLEGQPAKTSDWIKEG
QKLELLEADTTVKRTFTLKLEVIIEDDYLAVIHKPAGIPTSGNYFKTIENALAFNLKESK
VKDALPAPLPVHRLDNPTSGLLLIAKSKSVQVDLNRLFEEKKIQKSYHALVFGSLSTSVI
LNDKIEEKDAETHSEVLEQFQLKNENFSLVKAFPKTGRTHQIRIHLAGNGNPIVGDQLYG
KTSESIKKGGLFLAATGLEFQHPVTKKMMKLELPLPKKFREIKRFSTNT
>IFAGANLK_00957 RNA polymerase sigma-54 factor
MLKQQLNLKLSQKLSPQQIQLMKLIQLPTQAFEQRIKQELEENPALEDGKVETKDEYEEY
EDDYSDREREDEGTESIEAEIDVDEYLSDDEVPSYRLQANNYSADDDEKSVPYASGTSFT
QYLTTQLSTLRFDETEEQIAAFLVGSVDESGYLRRELQDVVDDLAFTQNIYTDEAAVEKV
LKKVQELDPAGVGARSLQECLLIQLKRKEPTKGVELAEDILERSFDQFSKKHYTKILSRH
DISEDELREAIDVIEHLNPKPGGSYSGNTRMVEHVIPDFTIKIVDGDLELSLNGRNAPQM
HVSRDYSDMLKGYKESKEKTKAQKDAVMFIKQKLDAAKWFIEAIKQRQQTLMVTMSSIMN
YQKEYFLTGDERNLRPMILKDIADEIEMDVSTVSRVANSKYVDTPYGTKLIKEFFSESMK
NDQGEDVSTREIKKILEMSIEEEDKRKPLTDEKLANVLKDKGYPIARRTVAKYREQLDIS
VARLRKEI
>IFAGANLK_00958 hypothetical protein
MKFLLNSASFIFHPLWIPLAGSVLYFLFTPRFFPPGVMQAKLLAIAILTVFIPIVFYFLL
KNLGKAESIFLEDVRERRWPLLFFAILITMVLNQILNAYNYAALYYFFVGILFSTLLAFT
LVMFRLKASLHIMALSGLIIFLIGVSLNFQLNLTYTISFLILALGITASSRIYYKAHTFS
ELLLGLFCGVTPQTLVLYFWL
>IFAGANLK_00959 hypothetical protein
MAQTEEGNRLESIPDSVPAVIDSLYREDQFYVGLTFNLISNKPEAISQSGFSGGVHAGFT
RDFPLNKRRNIAIAAGLGWSLNSYSHNLFIGEDDNGETIFRNLTGEIDYSTNRFSAQLIE
APLEFRWRTSTPETYKFWRIYTGLKFGYIYHFKSNFVQPENEVVQTDVPELDRFRMGATF
TFGYNTFNFHIYYSLNSLFPEARLNEETIDISVFRVGLMFYIL
>IFAGANLK_00960 hypothetical protein
MSKFKKKKSEGQPAISTASLPDIVFMLLFFFMVVTVMRQNTLMVENKLPFADQTEKLDKK
DLVMYIYAGKPSPRYQERFGREARIQLNDKFASVDEVQSFIFSERETKREELVPYLTTAL
KVDEETNMGLVSDIKQELRKAEALKINYTTKEGEALQNMQ
>IFAGANLK_00961 hypothetical protein
MARRSAPEVNAGSMADIAFLLLIFFLVTTTIETDSGISRKLPEWQPEEQDPPIIKERNIF
QVLVNANNQLLVEDEEMEIEELRQAAVEFLDNGGGTGDEACDFCQGAGDPDSSVNPTKAI
ISLVNNRGTEYGTYIAVQNELVAAYNQLRDREAQRLFGTSFTEMQARYDDSRTSEGAKET
LKERIEVIKDMIPQKLSEAEPTS
>IFAGANLK_00962 hypothetical protein
MTLHKILKYVSIALGVIGLILLGRILAEDADAIEASADLQNSLLAPIMYLSYFVLLVVLV
LVAIFVIKGLFKGNIKNTLIAVGAFIAVIVIAYLVTDGSQMTLKDGDILSASASHWVSAG
LVTFYILAGIAILAMVISGIKKLTK
>IFAGANLK_00963 Biopolymer transport protein ExbB
MKRLFSILVIAAVMVLGAGNLNAANNVNTLPGTIVNFVQDEEAAAAADEAEEETLGFHQE
LKKRFIEGGPAFMGIVLLCLILGLAVAIERIIFLNLSTTNTRKLARDVEDALNSGGVESA
KEVCRNTKGPVASIYYQGLDRADESIDAAEKAVVAYGGVQMGQLEKNVSWLSLFIAIAPM
LGFMGTVIGMITAFDRIEAAGDMQPSLVAGGIKVALLTTVFGLIVAIILQIFYNYIIAKI
DSIVNDMEDASITLIDMLVAYKNKKRI
>IFAGANLK_00965 L-asparaginase 1
MKKRAKILLIYTGGTIGMIKDYDSGALKAFNFDELLQNIPELKILEHEIDTLSFDDPIDS
SNMNVECWVKVASTINENFDTYDGFVVLHGSDTMSYTASALSFMFENLTKPIIFTGSQLP
IGDLRTDAKENLITSIQIAGLQKNGKPVISEVGLYFEYKLYRANRTTKINAEHFQAFASL
NHPPLAESGVYLSVNHNALWRPNRRQRTKLHTGFNNEVLILKIFPGINAKTVEYMLSKPG
LKGVVLETYGSGNAPSDDWFLDILKRKISEGLFVVNVTQCIGGSVVMGQYETSVQLKKIG
VVSGKDISTEAAVAKLMYLLGKELSPKVFKTIFETSLRGEMS
>IFAGANLK_00966 hypothetical protein
MKEFEDIRFYKDEEVQPALQEFMRHPMVKTLLQFTFPEKTSEEIAAVLGECHSIRDFQTK
VIYNSVLKVIEKSTEGLTYNGFEKLDTDQAYFYISNHRDIILDTSLLNTSLYEQDLIMTA
SAIGDNLVQKPFLMALSRLNRNFLVKRGLSPREMLKSSMVLSEYIKQLLEGGRSVWMAQR
EGRTKDGSDYTQQGVLKMLAMAKGKKSLAEYFTELKIVPVAISYEFDPTDILKMPELLAK
RMKEEYVKSANEDFNSIMQGALGNKGRIHINAGEVLGKEVFEKIEAEHDSINAQLKAVAT
KIDEHIYKNYKLWPANYIAFDLLKNSETYADKYSDKEKRQFERRLSRRVDVKNALELNSY
LLMYANPVINKEALYEEKS
>IFAGANLK_00967 putative metal-dependent hydrolase YjjV
MILTDTHIHLYSEDYEKDREDLIENAFQQNIERFFLPAIDSETTEAMYELEARYPENVFL
MMGLHPTHVQENYEEELKHVEEQFERRRFYAVGEIGIDLHWDKSTLEIQQKAFRWQIKLA
KKYKLPIVIHCRKAFDEIFDILGEEKSDDLFGIFHCFTGNLEQAKRALSYNLKLGIGGVV
TFKNGKIDKFLNEIPLEEIVLETDGPYLSPTPFRGKRNEPEYLIKVAEKLAGIYEKPLAE
IAEITTRNSKDIFGI
>IFAGANLK_00968 hypothetical protein
MSSLKKFLKEKGFKRIKLKYTKTQHLELVAKINNIEGNFILDTGASSTCVGLEAVEHFKL
LAEDSDIKAAGAGATNMLTQIAQKNRIEIKGWKKKKVDLVLFDLRHVNEALVNHEAEKVH
GIIGADILKKGKAVIDYKAPALYLK
>IFAGANLK_00969 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MALEMKVPSPGESITEVEIAEWLVEDGDYVEKDQPIAEVDSDKATLELPAEASGIITLKA
EEGDAVAVGEVVCLIDTEAEKPGGGDDKKESKEKEESKDDSSDKKEKEDKDKAEAKTQEP
SKSSTPSQKQDSHAKGSPSPAAKKILDEKGVDAKDVEGSGKDGRITKEDAVQSKASMGSP
GKGKRGESKKKMSMLRRKVASRLVSVKNDTAMLTTFNEVDMQPIFNLRKKYKEEFKDKHG
VSLGFMSFFTLAVVRALDQYPGVNSMIDGDHQVSFDYKDISIAVSGPKGLMVPVIRNAEN
LSFRGVEDEVKRLATKARDGKITVDEMTGGTFTITNGGVFGSMLSTPIINPPQSAILGMH
NIVERPVAIDGHVEIRPIMYVALSYDHRIIDGKESVGFLVAIKEAIENPEELLMDNDVKR
ALEL
>IFAGANLK_00970 2-oxoglutarate dehydrogenase E1 component
MDRFSFLNAAHTAYFAELYDQYLQYPDSVEPSWRAFFQGFDFGMQQNGVSAETMEEAPVD
FQDGEIPEHVTKEFKVIRLIDGYRTRGHLFTKTNPVRERRKYRPTLDIDNFGLEESDLDT
KFNAGEMLGIGPSILRDIIKHLEKVYCESIGIEYMFIRKPEEIQWIQDKLNKNENHPNFS
DEEKKKILKKLNQAVSFESFLHRKYVGQKRFSLEGGESLIPALDALIEKAADYGVRDFVM
GMAHRGRLNTLTNIFGKSAKDIFSEFDGKDYEQDIFDGDVKYHLGWTSCRLTDNGKGINI
NIAPNPSHLEAVGPVVEGIARAKQDRHYGGDNMKVLPILVHGDAAIAGQGVVYELVQMAK
LEGYQTGGTIHIVVNNQIGFTTNYLDARSSTYCTDVGKVTLSPVLHVNADDAEAVVHAIL
FALDFRMKFKRDVFIDLLGYRKYGHNEGDEPKFTQPKLYKAIAKHKNAMDMYAEKLKEAN
IIDDDYLKKLEEEYKADLEENLEDSRKEETTKITPFMYDEWEGFNNVREEEMMKEFDTTY
KMKDLDKVAEAISKLPEDKKFMRKVKKIIDLRHQLYFEDNKLDWAMAEHLAYGSLMKEGY
NIRISGQDSERGTFSHRHAIVKVEESEEEIILHNNIEGRDGDFFVYNSPLSEYGVMGFDY
GYAMASPKTLVIWEAQFGDFVNGAQIMIDQYISAAEDKWKLQNGLVLFLPHGYEGQGAEH
SSARMERFLQLCAKDNMYVADVTTPANMFHILRRQMKAGFRKPLVIFTPKSLLRHAKVIS
TKEDFAEGSFQPLLDDLKAKVKDVKSLVFCTGKFYYDLLEYKEENDRDDVALVRVEQLFP
LPSEKMKEAIKKYKNADDVVWAQEEPRNMGAYGHMLLHFDEAKNFRVCSRKFYGSPAAGS
SVRFKKRHDKVIASVFDKNLEE
>IFAGANLK_00971 (2E,6E)-farnesyl diphosphate synthase
MWVDLHYFWGMQDILYYREEFTKYLNSQVTVKEPENLYAPMKYILGLGGKRLRPVLVLMA
TDIFDADYKKALDAALAIEVFHNFSLVHDDIMDDAPLRRGKETVHERWDINTGILSGDAM
LINAYQLFENYEGETFKELARLFTKTAIQVCEGQQYDIDFETRDDVVIEDYIKMIEYKTA
VLVGASLQMGAIVAGTSTQCKEAVYEFGRLLGIAFQLQDDYLDAFGDPETFGKQPGGDII
ENKKTFLYLKALETSGKSEAQQLEHLYTINPAETSGKIEAVKNLFEHSGAAELTRQEIEK
YTNKAFEVLDKIEIADEKKFPLRQFGEMLMNRTV
>IFAGANLK_00972 ECF RNA polymerase sigma factor SigH
MSQQTKENIVEDTISNYNDRLLAFIKPKVKNNEDAEDILQEVWYQFSNLTNFSQIVNIGN
WLYRVTRNKITDNYRKKKTGNLEDYNFEDNDNFSSIKDLLLMDEAKDPELKMYQEEIWRA
LFEALEELPKNQRLVYIENEIENKTLQQISEEQNTNIKTIISRKHYAIKHLRKRLYQLYS
DLKNY
>IFAGANLK_00973 hypothetical protein
MRRKGKFRAKWVLIPVTILLLVTAIVMWLWNAILPEVLEVKTITYWQAMGILVLSKILFG
GFGGCKKGNYTQRKNLREKFKSMSPEEREKFRKMWKQKCKKDSFD
>IFAGANLK_00974 hypothetical protein
MKEDILKNAADLFLRLGFKSVTMDDIAQQMAISKKTIYAHFSTKTKLVKATVEYLIKEIE
QGISLLSAKKLNPIVESYEMKKYAMQMLKNEKSSPQFQLKKYYPEIYYPLRDKQFEIVQR
IVIDNLERGITTGHYKGDIPISFVSRIYFVGMLGIKDKNLFPEDEYSNAKLMDYFLRYHL
NSICTEKGLNTLDELIKSNKQKNEI
>IFAGANLK_00975 Outer membrane protein OprM
MKFRYLLILLISLSSIAQETPEDYSFSLEEAIQFGLENNYSSINAQKDVEIALKQKWEII
AQGLPQVSATGDYQNNLKLPVQLLPAEIAGGERGEFIPVTFGTKHNVNATATWNQLIFDG
SYIVGIQSAKTLLQISENAKTKTDLEIKKAVINAYGNVLLAEENVAILQKNVENVQKNYD
ETNEIYKNGLAEQEDVEQLEITLLNLKNNLSRSRRMRDIAYEMFNLTLGIPVEIPVNLTE
ELDTLAMQYFDLELLQEEIPVEENIDYRIAANTADSREIEVKLEKSKALPSLSGFLNYGV
QGFSQEFTFFDEDQEYFGQSILGVSLNIPIFSSGMRNSRTQQKQIAYEQAMVELEQTENE
VKRQINSAKSDYEFSLENYQAQKKNLELAERIENKNQIKFFEGIASSFELSEAQRQLYQA
QQDFLQSMLDVITAKVELENLLDTRKYNNED
>IFAGANLK_00976 Cobalt-zinc-cadmium resistance protein CzcB
MKIKYTHQISRMKKLAVLLSIPLLLLSCGSNEEEKSVEEIIENEDLTEIRAKKSELSQQQ
SDLTQKLDQLDQAIDRLDKTRRLDLVEIQQIDDTLFKHYAEVQGDVATDENIVIYSEFSG
ILQDLRVEEGQQVNKGQVLAKIDDGGLSSELAQLETQATLAKTTFERQERLWEQNIGSEM
QYLETKTNYESMQNSVNRLKSQLDKTIVRAPFNGIIDEVLTEQGEVVSPGQSQLFRLVSL
KNMYIEAAVPENYLNTVRKGTEVIVEISSLDREFEGEIRRVGNTINPNNRSFSIQVAVPN
ENGMIKPNQIATIRLNDYTAENAIIIPENALLKNSQGESVVFTLQEKEGEDNIGTAKRKI
VETGYSYNNKIEITNGLETGETLIVEGAKNLRDGQEVKIRN
>IFAGANLK_00977 Multidrug/solvent efflux pump membrane transporter MepB
MNLDKEFKLSSWAINNKMTVYVIIAIVMIGGLMSYYNMPRETFPEVVETKIYVSSINPGN
SAEDVEKFITEPLEEEFNDVAGVKEISSSTFQDYSLVIVEFEEDVEVESAKTKVKDKVDM
VKAETTWPTLDNGAKVEPNVFDLNISEEQPILNINLTGDYTVQQLKEYAEYLQERIELLP
QIKEASIRGAEEMEVEIAVDIYKMTASKVSFTDIVNAVSGENRTISGGNVITSGVQKNIR
IVGEIEDPSELKNVVVKTDGGNVFLQDIAQINFREKDATTFAREYGAPVVMLDIKKRAGK
NMIEAVDQIKEIVKIEQEEYLPESLRISLTNDLSTNTRSQVDDLVNNIIFGVILVVLVLM
FFLGFRNALFVGIAIPLSMFLSYIILSSMGYTLNTMVLFALVMGLGMLVDNGIVVVENVY
TLMDEGMPRKQAAKQGLGEIAWPIIASTATTLAAFFPLGLWPGIIGSFMVIFPITLSIVL
GSSLFVALIINSMLTSQFMRTEEEEFTKKKLIKISSILAGFGALLLVVGFVVDAGALRAF
GNILILAAILLWVYKYFISRGVEYFQYTALKKMENAYEKTLKYALRGKKAYLTFFGTLLL
LFVSFVLIGLVQPKVLFFPENEPNQVITYIEYPQGTDIHKTNALTKQVEQRIFDAIKKYE
DEDGYNFMVESAISQVGEGAGNPQTDGGQQNEMPHKAKVTLSMREFTERRGVSSSEVLSE
VREAVQGFPGASIVVEKDAAGPPTGYPINMELKGEDYEQMLMEAENLRSYVNDLSIAGIE
ELKIDVNKSKPELSVNVDRRKAGQLGVSTSQVGQTLRRAIYGEEVSTYKDGDDDYEINMR
FADQYRYDENVLFNQPVTFKDQNTGEIIQVPISSLVTTESASSFSSIKRKDLKRVITLYS
NVLQGYNGNEIVGQLKTALRSYDLPKDITLEFTGEQEEQEENLAFLLKALLIAMGGILLI
LVAQFNSLSKPIIIVMAVVLSLVGVFLGLIVFQMDFIIIMTMMGIISLAGIVVNNAIVLI
DYTQILIDRKKRDLNLDDDDLLTREQYYDCIVRGGKSRLRPVLLTAITTVLGLIPLAVGL
NIDFFSLFTDYDPKVFIGGDNVIFWGPLAWTVIFGLVFATFLTLVVVPVMFYLVNRAKVK
TADKRKERKQRKLEARA
>IFAGANLK_00978 Dimethlysulfonioproprionate lyase DddQ
MKIKKQLIELKSFYFLLMFFLSFGIFAQETSENSIAFSESDSNLEWGPCPDFMPEGCNIA
VLHGNPAEKNADIFFKVPANAYITNHTHTSPERMILVSGEMEVTYEGEQPQILKEGSYAY
GPANKPHSAKCGDSPCVLFIAFEDPVDAMPVEKD
>IFAGANLK_00979 hypothetical protein
MAAIFTFGAAAMAQESPEPKFEKEGDLIKGTFFYEDGSIKQTGTYKDGKLHGKWIAYDVD
GKKQSMATYTEGNKTGKWFFWTSDKLTEVDYDNNQIAGVNTWKSDGTLADN
>IFAGANLK_00980 Aspartate--tRNA ligase
MYRSHTCGELNAASIGQEVKLSGWVQKIRDKGFMVWVDLRDRYGITQLIFDEERSSKELM
QKAQKLGREFVIQVSGKVIERESKNTNIPTGEIEVLVSEVNILNTSLTPPFTIEDETDGG
EDLRMKYRYLDIRRNPVKNKLKFRHKVGMVVRNYLSNQDFIEVETPYLIKSTPEGARDFV
VPSRMNEGQFYALPQSPQTFKQLLMVGGMDKYFQIVKCFRDEDLRADRQPEFTQIDCEMA
FVEQEDILNIFEGLTRHLLKEINGVDVAEFPRMTYADAMKKYGNDKPDIRFGMEFAELNE
LAKNKGFNVFDQQELVVGIAVPGAASFTRKEIDKLISWVKRPQVGANALVWAKYNEDGTL
KSSVDKFYSEEDLKTWAQATNAKLGDLILVMAGDANKTRTQLSALRMHLGNELGLRKADE
FAPLWVVDFPLLEWDEETKRFHAMHHPFTSPKKEDFALLETKPGEVRANAYDLVLNGNEI
GGGSIRIHDKETQAKMFDYLGFTPEEAKAQFGFLMDAFQYGAPPHGGIAFGFDRLVAILG
GQESIRDFIAFPKNNNGRDVMIDAPATLDEAQLKELHLQVNTLEESSKRIPGK
>IFAGANLK_00981 H(+)/Cl(-) exchange transporter ClcA
MSTKATELLTRFSDWSTRNLSHQQFLMVLSSLIGFLAGLVAVGIKNFTHYIQRLLEDEFI
VNYHNAFYFIFPLIGIAITVFLIKYIIKKDIGNGIPTVLHAISKRQGIMRRFQSYASLIT
APLTVGFGGSVGLEAPTVATGASISSNLSRLFKMNQATRTLLIGCAAAGAMSSLFKAPIA
AIIFAIEIFSLDLTLVSMIPLLTASVSAILTSYFFFGNDIILHYQLSDQFDVSEVPFYVL
LGVIAAVCSIYFGKVYFKFAAIFRKIKSGFLRLLAGGLSLGVLIFFIPPLYGEGYDVINN
LLQENYIFALQTNLFDSYLDNIWVVILLLAGLVVFKVIATSLTLGAGGVGGIFAPVLYMG
SAMGHCFALIINNLGILNNPISVSNFTLVGMAGVMAGIMHAPLTAIFLIAELTGGYELFV
PLMITAAISFVVTSRFQPHSVYTMELAQRGELLTHNKDQAVLTLLNIQQIIEKNFVTLNI
DMNLGNVIHEGVIKSSRNLFPVIDENRKFLGIILLDDIRPIMFDQKMYEEVKVSDIMQRA
PEIIDLRKDRPKDIMNKFQETNAWNLPVVEDEKYVGFISKSKLLTAYRQKLIEVTV
>IFAGANLK_00982 hypothetical protein
MNTVLKILAILILIAIGVGFYYRTFEDVVLGDRIIGIAVLASAFILMPIFLYVRWKGKRL
QDYTLTKENMDKMRDKGID
>IFAGANLK_00983 Major cold shock protein CspA
MEGTVKFFNESKGYGFITNDETGRDIFVHITGLDGESLNEGDKVEYVEVEGRKGVNAAEV
RVIE
>IFAGANLK_00984 Regulatory protein PchR
MYIESKLVEVNETLFSEDLSEEKDQNIIKDEINITAYSWLKAKSKIQFSKGLFIVETFFE
NDKNLTDIFSIGGEYIQISYLGKGDSQLVSLKERKPIEMGRINCCYNSNTVTTIEMPANK
PTHYQAIYLSKKYYLELLKNEAWLADSSFYKNIIQSDFQKWGACKFPIDYSLYHILNEIT
KSDWNSDFKKYYLDLRLKELFLSLHFCQQELCSGVVQGISEENLEKIRTAHAYLIENFKN
PPTIKVLARKVLLNELQLKKDFKKMYGKTIRSFIIELRMKKAKSLLGKHTVSEMAGILGY
KSVPHFINTFKKCYGYTPKQGLNQ
>IFAGANLK_00985 Vitamin B12 transporter BtuB
MDINFKISFVLLLFSISISTIYAQQTEPKSFDITGVIEDQNGDPISEATITASTLKHNYK
TQSDSEGFYQLRNLEAGVLLLEIRKGNFIAHHQIAVNSKNFEHNISINTSGNELGEVHLQ
AESFKNKMEKKGFALNVVETAEASIRNIQTNELLNTTVGVKIRQNGGLGSRAEYSLNGLS
GSAVRIFIDGIPISTFGSSYNLNSIPPSMIERIEVYKGVVPGHLADDALGGAINIVLNKQ
SSESINASLSYGSFNTFQANVNGLYRFDNSGFTVKASAFHNYSDNDYEVSGRSVVVTGLG
GQQTPITARRFNDAYRSTGGTVQLGYTDVNWADQFFVGFTGSDDYKEVQHGAFMTIMPYE
GRFLESDATLANLTYQKQDLLTTGLDVNVTGYYGKRNRQVNDTVPWAHSWSGERAIDFRG
NNYKYTWGSQQEGGPTLAKINRNVASMRTGLAYAINNNHKILANHVYSGIDREDSDELQS
VLENTFLGTRDLHKNILSLTYELNAFDDRLKTNLFGKYYQQKSKSVDPEIEINPDGSRQI
VDDVVSSNKKYEGYGFAASYELSPTITLLASAEKAVRLPNETEIFGNDGDNVVANASINP
EQSNNYNLGLKLGTFNFKKHQFNVSTNLFTRNIKDRIGLPIETSLNVDEELIVYVNQGSG
TSKGIDAQLGYNYNNNFGLNFNVSRFDLKIENRGVEIDVPNTPFFTMNGNLRYSFKDLIQ
KNSRLNLFYTLYFTDEFSYLVPQGSNTVGDEFFKVPQQLAQDLGLSYTFPNQNFVMSFDV
KNIFDKPVYDNLSVQKPGRAFYLKLNYSINKF
>IFAGANLK_00986 hypothetical protein
MKREFFSIKTLAAIALATGLLASCSSDDTPIDNGQEPGENEDGRWITVAAARMGENPGDG
NGGTLIYSVSSKDAKDPTVSIEPFDNGFIVPSNRTARLQSSEDGSTIFNISYAGDTGGNY
TKYNVNGGQDFEQTGSEISIAPYVGSAPRWIKLFDGDQTGAAVYVDTENQFDDNDNYLRT
EATMGVVTLDLQNSAILEFQESSLSLSEELETQGYYIGRIDMPTLNAAGDKLYIGARMSK
VDPETGETDRNGEVLGSKTIVLDYPSLENPTIITSEVGKGNTNGYRSINAFLVNGSVYQA
NQGDPNGSHILKIGANNQYDDSYVFNLDEALGLEDAYILAWRPTASGKAVVAYRHAGSAE
GVAGAQGYFALVDLESRTAQKIDEIPYSEDFYLFQYQGFVVDGDEIYVTEAPVGENGNIY
VIDTETGEVTKGAELVNAEGSHFIGLF
>IFAGANLK_00987 hypothetical protein
MKKEKQKKKKYTFRKLLNDLHLWLGLGSGIILFLVCLSGTILTFQTEIKSLFVEELKVNP
GQGEVKDIESLQQSLQSVGTVTGVTLSENGNKAYEFKVKTSPEDRRGTTFYVNQYTGDYQ
QLGENPADEFFFTMFRMHRWLLFDSAIGRPIVGIATIIFLFLSISGVVLWFPKKKIKWKT
LKPGFKIKWSANWKRINHDLHNTLGFYSCLVLVVMTLTGLFWSFDWYKDFGSQVLGTQVF
GGRGGPKIASEASADSKTLELAEIINISNQNLDYAGETSISFPQDEKGIFSIRKYESSNW
SPNTYDMLVIDRDGKILKKELFSDKPANVQVASLIKPIHTGEIFGTFSKIIYFLACLIAT
SLPITGTLIWLNKMKKKKK
>IFAGANLK_00988 putative epimerase/dehydratase
MAGKILIIGACGQIGTELTLKLRELYGNDRVVASDIKEGNKELMSYGPFEVADATDAPLI
ESIIYKHEISEVYLMAAMLSATAEKAPMKAWKLNMDSLFHILNFAKDRKIEKVFWPSSIA
VFGPTTPKNETPQTTIMEPSTVYGISKQTGERWCEYFHDKYGVDVRSLRYPGIISYKTLP
GGGTTDYAIEIFHEALKNKAYTSFLAENTGLPMMYMDDAIKATVDIMEAPSEEIKVRSSY
NLSALSFTPKILAEAIQKEIPEFKIAYEPDFRQEIADSWPSSIDDSEARKDWQWKHNFNL
QGLVKEMLVGVSEQLNTTK
>IFAGANLK_00989 hypothetical protein
MKKTVFIICISLLWACNEKPQTVDNKGRKLDSIALHQPIGTTNEEVILLPEARKHAINWL
AYIAAQNEVDQLKNYNLQQTIESSKPISQVMESLSTSIPDSLSSNAVMARANVLTTKAKV
LEQLSHRRQLDAEAITEVAREIPLEFNNFKIQLNELFLKTLEDFEDELDEFKAERDTISI
DSLPEAQL
>IFAGANLK_00990 hypothetical protein
MKKIIALLFLIFSLNISAQEKSRIDKVLTQWHQAAAEANFDKYFSLITKDGVFIGTDAIE
NWQNTEFREFSKPYFDRGKAWNFTTLERNIYTEENSETAWFDELLNTQMGICRGSGVLQK
TKDGWKIKHYVLSLTVPNENVEEVTQLKKEYDQNLIKQID
>IFAGANLK_00991 Neutral endopeptidase
MKKITNVLFLSILGAATITSCQNDDRERKENEEVHGINLAYMDTTVSAKEDFFRYVNGKW
VDSTEIPSDQTTWGSFMELRERTDEDAMAILEGASANDSLDPSSDQAKAVYLYNTIMDTV
ARNEKGVEPVKPYLAKVDSIENKEDLQEFLTEMQQYGGAGFFSFGVRADAKNSNMNAAYL
YPAGLGLPDRDYYVAEDSDSKEKREKYEAHITRMLQYIDYSEEEAAEAAERILAFETGLA
EPQLDKVERRDARNTYNPKTVAELKNMVSAIDWNSYFEEIGATDLDTIIVSQPKYMESLQ
DVFAENSVEDWKDYLKWSIFNDAASTLSTDIETANWEFYSKTLQGAQEQRPRKERALQTV
NGTLGEALGKLYVDEHFPAEAKEKAQEMIGNLVKAYENRINNLSWMSEDTKKKAKEKLGT
TTIKVGYPDEWKDYSDLEIVNVEDGGSYFQNMMNSSKWRVADNMGDLGQPVDKTEWFMPP
QTVNAYYNPSYNEIVFPAAILQPPFYDYKADAAVNYGGIGAVIGHEISHGFDDSGSRFDA
EGNLNNWWTDEDLKQFETLGKDLADQYSNIEVLDSVFINGQFTLGENIGDLGGVNAAYDG
LQIHLEEHGDPGKIDGYTPEQRFFMSWATVWRTKMRDEALKNRIKTDPHSPGMYRAYVPL
QNIDAFYTAFDIKEGDEMYVAPEDRVKIW
>IFAGANLK_00992 hypothetical protein
MAQHNALGELGEHLALNHLLNKVMKSWLKIMFITKRK
>IFAGANLK_00993 hypothetical protein
MKKLSLIIVVLSLSLTACGSSNSKISKNKFVAENLTGYNAEVLNENYPDANFREDTGMFE
EGTVERAYTVMYPDTPDELHITWKTEEREEIYDIRFSENGKWKSAEGIEIGTPYKALNEI
NGEKISFYGFGWDYGGAVMWNDGKLENSKLRVFLAPEGEVADKFYGDHIIEASEEEIESL
DLKVTSIMLVN
>IFAGANLK_00994 Methionine--tRNA ligase
MSNTPQRYTITAALPYTNGPIHIGHLAGVYVPADIYARYLRMQGNDVAFVCGSDEHGVPI
TIKAKKEGVTPQDIVDKYDGIIRKSFEDFGVSFDNYSRTSAKVHHDTASAFFKKMYEDGK
FIEETTQQLYDEKAGQFLADRFVTGTCPKCGNEEAYGDQCESCGTSLNATDLINPKSAIT
GEIPTLKETRHWFLPLDQYQEWLDEWIVKGHAHDWKSNVHGQVKSWLNDGLRARAVTRDL
DWGIPVPVEGGDGKVLYVWFDAPIGYISSTKEWAEREGKDWEPYWKDEDTKLIHFIGKDN
IVFHCIIFPVMLKAHGEYILPENVPANEFLNLEGKKLSTSKNWAVWLHEYLEEFPNQQDV
LRYVLTANAPEAKDNDFTWKDFQARNNNELVAIFGNFINRVVVLTNKYYSRIVPKPNDYS
EVDEQTIAELKAYPAVIASSIEKYRFREAQGELMNLARLGNKYLADEEPWKLIKTDEERV
KTIMYVALQIASSLATLSEPFLPFSSAKLQKMLNFTDAESKLSGEEYSQWDKIATRDSLL
PAGHQIGKAELLFSKIEDSQMQEQLDKLEATKTANAAENNKVEPQKETATFEDFTKMDLR
VGTIIEAHKMPKTKKLMVIKVDTGLDNRTVVSGIAEHYKAEEIIGKKVTVLANLAPRKLR
GVESEGMILMTENSAGKLVFVNPDEDGVEPGTTIN
>IFAGANLK_00995 Acetoin utilization protein AcuC
MLKIAYHTIYKHPLPEGHRFPMEKYELLPRQLLHEGTCSEDNFFEPELPSEKYILNVHDA
DYFERLSNLKLSAKEVRKSGFPLSEALVKREMIIADGTMKAVHYSLENGISFNIAGGTHH
AYSNRAEAFCLLNDQAIAARYLQQKNLAKKILIVDLDVHQGNGTAEIFQNDPSVFTFSMH
GKGNYPFKKEESDLDIEVPDGSGDIEYLKLLKEMLPDLIEKQKPDFIFYLSGMDILETDK
LGRLSCTVNGCKERDRFVLQSCHDLNIPVQCSMGGGYSKEIRVIIEAHANTYRLAKEIYF
>IFAGANLK_00996 Xyloglucan-specific endo-beta-1,4-glucanase BoGH9A
MRPSTIFLIPVLCFFLNLSAFGQPNEENSGSEKIRINQVGFYPHGQKIAIVVTSEATDFY
ILTADEKNEVFSGKLSDAKEWVHSKETVKQADFSLVENSGKYVLRVPGIGSSHPFEINEN
VHFEPAKASMKAFYFQRASTDLPEEYAGKWAREAGHPDDQVKVHNSAASEDRPTGSTISS
TGGWYDAGDYGKYIVNSGITMGTLFSLYEDFPEYLDTLNLNILESTNNIPDFLDETLYNL
RWMMTMQDEDGGVYHKLTSATFHGAVAPKDATFQRWVVQKSTAATLDFSAVTAQAARIFQ
DYKNELPGLSDSLLVMSEKAYRWAKDNPEVIYHQGELKDPEISTGAYGDQNIKDELQWAA
TELFIATGKEVYYKDADLENSLESDFSIPSWPNVNTLALYSLARHRDKYQGSQIVNIDAI
IGQLTKMADDLVSSSKTSAYAIPMGIEESDFVWGSNSTAANQGILLLNVYKITDDEKYLD
AANDNLDYLLGRNATGFSFLTGYGEKSTRDPHHRPSESDDNEDPVPGLLAGGPNPGQQDK
EDCGDKYTAAHQHPATSYIDDRCSYASNEIAINWNTPFVYLANAIEAIREAK
>IFAGANLK_00997 Single-stranded DNA-binding protein
MSTIRNKVQLIGNVGREPEIVNLESGKKLAKFSVATNENYKNGNGERVTETQWHNIVAWG
KTAELVEKYVNKGIEVGVEGKLTSRNWDDKDGTKRYITEVVCNELLLMGK
>IFAGANLK_00998 hypothetical protein
MERITTICLVFILFIIAGCNEDPLNESTDEAGEAVRNSYGGASGDGAGEPSAENPGNGDP
DSSGLITAGEWKDLENWNFWLELKNTQKFAEKINYWEFYFNNRVSVSLKNMSALPVIDAT
IELNDEQTNTIWTAKTDNKGTAELWINPFERTASSNLANYSLRINGEKINTTLKGIGQGI
NEIQLKNTEVVPNKVEIAFIVDATGSMSDELEFLKDDLKSIIQKVENSNSNLDIFTSAVF
YRDTEDEYLVKQSDFSSDINTTLGFINNQSANGGGDFPEAVHTALNTTLNDLQWSTSALP
V
>IFAGANLK_00999 hypothetical protein
MVYKRPTRLAFLILDAPPHHNQQVISDIQNSVKKSAEKGIKFIPVTASGIDKETEFLMRY
FSMATNSTYVFITNHSGIGNDHIEPSIGEYKVELLNELLIRLITEYSE
>IFAGANLK_01000 hypothetical protein
MSQEEPKVWYACYGSNLLKERFSCYIGGGQPANAKRVYPGCSNKTLPEKSKGVTIHGKLY
FAKSSKTWSGGGAGFIQSDFHKDIKTLGRMYLITRQQFIDLVQQEIKFEGDFNIDLETVI
KNRSLDMKNNSWYGKIIYLGEDENCPIFTFTNEDYLKEEINPPHEFYLKIIIEGLKETYK
MNDAEIKSYLKNKEGIKGFPIEDKIPQLIKS
>IFAGANLK_01001 3-hydroxyanthranilate 3,4-dioxygenase
MNSDKVNLKEKFQLFNQHWTPKIIGELNGQQVKLAKLKGEFVWHDHKEEDEMFLVIKGSL
KIEFRDKKITLNEGEMFIVPRGVEHNPVAPEEAWVLLFEPATIKHTGEVKNKRSVENLDW
I
>IFAGANLK_01002 ATP-dependent RNA helicase DeaD
MSFKKLNTPLKEALERLEIEAPLPFQEQILPKIKSGRDLFIVAPEGSGKTTALVITTIQK
LESAAFEDAPRALIFVQDKEAALALEVEFNKFTKYMDLRIFSAFDAPDIENQKNEIYDGV
DIVIATPKKLFKLFKITGINVSQLKVLAVEDAEFLTKNSDYNDLIRIPQHITKCQYLVFA
STMNPKIERLKDSFMARAETLRIKV
>IFAGANLK_01003 hypothetical protein
MFNSAILFLIFISAMNLNAQDLSKHQWKDRLVLIIAEDENNEKFRKQLTELQKNQTGLKD
RKLITYQFLPEKYHTGFQNNNWKNSTKLFKTYNSEKSDFRIILIGLDGGEKLDQTEVLSV
EKLFNTIDSMPMRQSEMRKNK
>IFAGANLK_01004 hypothetical protein
MEKSCLECGEKIVGRVDKKFCSDYCRNAHHNNLNKDRKNLVRNVNNQLRKNYRILEEFNP
NEKTTISKNKLLTRGFNFEYLTSIYTTKSGKVYYFVYDQGYLPLENGIYALVKRN
>IFAGANLK_01005 Inosine-5'-monophosphate dehydrogenase
MGIKSFQGKRAEPEKPKSAPMLVRDYMTTSLVTFKEDENILDVAEKLTKNKISGGCVVDE
NNKLVGLISEGDCMKQISDSQYYNMPLEDTTVGKRMTCNVETIDGNMNVMDAAKLFIEKR
YRRFPIVEHGKLIGQISQSDVLRAAVRLKSNNWAD
>IFAGANLK_01006 hypothetical protein
MLKNIPRFFSLIFIAVAIWFSFYSSQPKTIEAEDAPETTFSTQRAFNHVEAIAKKPHYVG
TEAHSRVRNYIISELQKMGLQAQTHEDYTFTQNGSLVRPQNILARLEGNGKGEAIVIMTH
YDSNPHSSPGASDAGSGVGTILEGIRAFLAKNKEHQNDIIILFTDAEELGLNGAELFIKD
HPWAKDAKLALNFEARGSDGNSFMFLETNSGNTGLINSFKEANPEFPVTNSLVYSVYKML
PNDTDLTILREQGDIPGYNFAFIDDHYDYHSATDKPKNLDKQSLAHQGSYLMPLLDYFKD
ADLIEVKDEKEVLFFNIPGGEIISYPFSWIFPMLIIAFILFFIILVYGFTQNRLQLKPIL
KSIIPFTVSLAFAGLLVFLLWKFLLFSYAEYSEMEQGFTYNGYYYIAAFISLSLFIAFFT
YYRFRHIENRANLFIVPLFFWLLLCTILSFFLKGAAYFIIPAFFGLLQFFVMMRQENPNT
LLMAFLSLPAVFIMAPFIKMFPVALGLKILFISAILTVLLFQLLLPVFAYFRSNKKIAVT
CFLAFNILLIIAHFKADFTEERPKPNSLVYLADADNNTTNWYSYDNMPDEWTKNYFGEDP
LVAPAEINTLSSKYGSRFTWKTNAPEIDLEEPAIIWQKTDSSETINSYFIKIAPNRNINR
IEIFADREIDFESFKVNNKTADSVYLGQDKFHIHTRRWHERLLTYHASSRDTLRLEFSLK
SDKKPEFTIYESSYDLLENDALNVPPRPETMIPRPFVLNDAVIFKKTIRPE
>IFAGANLK_01007 hypothetical protein
MNISILGAGWLGLPLAKKLAEKHTVKGSVTSQEKMQQLRDAGITPYLIKVFTEGVQGDLT
SFLAHSEILIIDIPPGLRGDPEADFIGKIGRIMDYIEKSPIEKVIFVSSTSVYKDEEDFP
EYTEENEVNGTSEAAKQLISSEKMLLNNEHFQTTVIRFGGLIGPGRHPVKYLANKTGIKN
PQAPVNLIHQKDCIAIINQIIPKEAWNKIFNAAFPQHPTKEDYYTKTARKMNLNLPEFDH
QGISKGKKISSVNLVDVLEYEFQIAI
>IFAGANLK_01008 Transcription-repair-coupling factor
MRGKISAIIFAPMSKTIIAQSFAQSPQQQELRDSLAYSEKNRTKIQLKGLIGSSFSFVTA
NAFKEAEKPFLLIFNDKEEAAYYLNDLEQLVGEKNVLFYPGSYRRPYQIEETDNANVLLR
AEVLNRINSRKKPAIIVTYPDALFEKVVTRKELDRSTLKISVEDELSIDFVNEVLFEYKF
KRVDFVTEPGEFSVRGGIIDVFSFSNDEPYRIEFFGDEVDSIRSFDVETQLSTDKVKKIS
VMPNVENKHLDEIRESFLRYISEKTVVFVKNLDLLTAQADKLFSKAEEAFQKLSEEVKHS
EPNELFCNGQLIKEQLELFSVVELSNQAYLEPEKSIAFQTKPQPSFNKQFDLLIENLIEN
QENGYTNYIFCVSEQQAKRFHDIFDDQEQKVKYQTITLALFQGFIDETGKNVCYTDHQIF
ERYHKFHLKNGYAKKQAITLKELTNLVVGDYVTHIDHGIGKFGGLQKIDVEGKKQEAIKL
FYGERDILYLSIHSLHKISKYNGKDGKEPKIFKLGSNAWKKLKQKTKARVKHIAYNLIEL
YAKRRLQKGFAFGPDSYLQHELEASFIYEDTPDQSTATQAVKEDMENERPMDRLVCGDVG
FGKTEVAIRAAFKAVDNGKQVAVLVPTTILAFQHHQTFTERLKDFPVTVDYLNRFRTAKE
RRETLADLESGKVDIIIGTHQLVNKAVKFKDLGLLIVDEEQKFGVSVKDKLKTIKENVDT
LTLTATPIPRTLQFSLMAARDLSTITTPPPNRYPIETNVIRFSEETIRDAVSYEIQRGGQ
VFFIHNRIENIKEVAGMIQRVVPDAKIGVGHGQMEGKKLERLMLSFINGEFDVLVSTTIV
ESGLDVTNANTIFINNANNFGVSDLHQMRGRVGRSNKKAFCYFITPPFSVMTEDARKRIS
ALEQFSELGSGINIAMKDLEIRGAGDLLGGEQSGFINEIGFDTYQKILNEAIEELKENEF
QGLYNESENIEDKTFVKDTQIDTDFEILFPDDYINSITERLNLYTQLNKITTEAELQKFE
AELVDRFGELPTQAVDLLNSVRIKWIAASIGLEKIILKQGKLIGYFISDQQSRFYQTNTF
TKVLQYVQSHRHKCTLKEKKTRNGLRLLLTFEKIASIESALKVLEPLDFRVKEEVEKAS
>IFAGANLK_01009 Glutathione amide reductase
MPNLLSETIFMAFEHFDVFVIGTGTAGKGVAKDFANEGLKVAIADNREYGGTCPNRGCDP
KKVLVGFTEILDRATKMQGKGITKMPEVNWSHLMAFKETFVDAIPAATEKDLAALNIKLY
HQSPKFLNKNTLSVEGKTVTADKIVIATGSIPMPLRIPGEEHALFSEDFLDLKELPETMI
FIGAGYIGMEFAHIAARFGVKVTMMDFAPRPLFNFDEDMVKYIQQVSEEDLGIKFIFNAE
VNEIEKLQKNYRVKANQDGKEISAKAEIVFNTAGRVPSIEDLDLEQGNVAFSKKGITVNE
FLQNTTNKNVYACGDVSDSEGLPLTPLSSQEAKVVSANLLSKKEPKKAHYPPQPTVVFTL
PKLASVGLSEKEAKEQGYDYSLEHKLVPNWFNAKHINEKIYAYKTLVDKKTGFVLGAHLV
GPEASEIINMFVMAMCGELDCETLKKMIFTYPSWASDIKGMV
>IFAGANLK_01010 hypothetical protein
MEKRLAVLNFISVILIIVVSYISQTGVINGNTMGSISAEYYNLFTPAGYAFAIWGVIFLS
LIAFSGYQLYQAFSAKKNLEFLRKSGYWFLIANLANAVWVFTWLYELTGLSVVLMFLILF
SLIKVILNTNMERWDAPVKIIFLSWWPICLYSGWIAVATIANVSAYLAKIGWTAPFFGEE
LWTVIMIVVAVFLNIAMIWRRNMREFAAVGVWALIAIYFRHFAEIPLIAYSALIGAIAIF
SNIVYHGWLNKETSPVAKVMNKS
>IFAGANLK_01011 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MTINLQNHTFELHPSGAAFWKEEGILLISDVHLGKISHFRKFGSAVPHKAINANFLRLSE
VVGKFQPKIICFLGDLFHSDLNSEWKLFENWLSFIEAEVILIAGNHDIISPLKYEELGVK
IHSEWQLNGFLLTHHPVNREGFFNLCGHIHPGYRLNGKGRQSLKLPCFFRKKDQLISPAF
GEFTGNFMMKLNENENEKAYAITQNEVILIENS
>IFAGANLK_01012 Methionine aminotransferase
MGFKNKAMPDFNNLYSKLPAGKTSIFSVMSGLARKHNAIDLSQGFPNFETDNHLKKLVCK
AMKDGYNQYPPMNGIPELREQIVAKVENLYGKKYNEASEIIFTAGATQALYCAITAFVHP
GDEVIVFKPAYDSYEPDIKLAGGKPVLIELKGKEFKIDWQEVEEKITSKTRMIVINTPHN
PTGIILSKKDMQRLEKLLKDTNIILLSDEVYEHLIFDKEEHQSASKFTGLAERAIVCASF
GKTFHNTGWKMGYCVAPEVLMKEIIKLHQATVFCVNHPMQRAFAEYLKSPEHYLQLGDFY
QEKRDKFLKLMQGSNFKGTPSKGTYFQVMDYSAIIDEHDVDFAKRLITEKGIATIPVSVF
HKDGKDEQQLRFCFAKTDETLEKAAEILHKL
>IFAGANLK_01013 hypothetical protein
MIWCPKYRRKVLIGDIESRLKELLLEKADELGLVIEKMETMPDHVHLLVKAQSTDAPHFI
VGQLKGYTSFNLRNEFAELKSKLPTLWTRSYYIESVGHISEEAVKIYIEDQKNQ
>IFAGANLK_01014 Sensor protein KdpD
MESFKNINENRALQYLIGIGSILFISFICYLFIDVIGYHVVALVLLLVVSILAMFFKILP
VVIAAVLSALIWNFLFIQPELTFKISTPEDALLFLMYFVIAVMNAVFTTKIRKAEAVSRK
RKEREKTIQLYNTLFNSLSHELKTPIAAIIGSVDTLKESTEKLSAENKNELYNEIEIAGN
RLNRQVKNLLNMSRLESDSIHLQLNWYDVNEIVYNVIDNNKIDCNQHQIIYQPQDNLPLF
LFDATLVEQILHNIVHNAIQYTPKSSKIEIKVSHTSENCVFEISDNGKGFPEENMERVFE
KFYRLPNSSTGGTGLGLSIAQGFAEAHNGKIKVQNRSNGGAQFTVTIPAKMTDPKNYQNE
>IFAGANLK_01015 Transcriptional regulatory protein KdpE
MNNAEILVIDDEPQIRKLLKITLESNDYKVVLAETGTEGVHLVANHTPDLVILDLGLPDK
SGHLILKDLREWYDKSIIILSVQDSEADIIKALDNGATDYLTKPFRTGELLARIRASLRI
NQNTDLQPIISTVELEIDLSSRTVSRNNIPVKLTATEYNLVALLAKNQGRVLTHQFLLKE
IWGFGSQNETQYLRVFIAQLRKKLEENPNSPIHIITESGVGYRFV
>IFAGANLK_01016 Ktr system potassium uptake protein B
MLSFFKNILSEIYRERRLSKIAAILSFSGICLLIFDLGFTHIESERNFLKNLYYGIISLG
FLIVLVRSFLPRPETPKKVRLFDWLLTISFGTLLLLRIDFIVANLGFLKFFNQMGWVYLG
LFLFFIREISSFKVNFKKDYLNPAQLFVASFLLIIFLGTFFLLLPKATHSGIGLIDALFT
ATSAVCVTGLIVVDTGSYFTTFGQSVIMVLIQLGGLGIMTFASYFSYFFRGNTSYANQLM
LKDISNSEKIGEVFMVLKKILLLTFSIEAAGALFIYFNLDSAIINSVSDRIFFSVFHSIS
GFCNAGFSTLENSLFEPGFRFNYPLHLIIAALFILGGIGFPILLNLYKYVRYYTLRKLQK
IKDPHKATYMPWVLNLNSRIVLITTFILLVTGTGLFYIFEYNNTLSEHSEFGKIVTAFFG
AATPRTAGFNSIDTSALHFSTLMLVFLLMWIGASPASTGGGIKTSTFALATLNFLSLAKG
KDRIEIYKREVSNISIRRAFGIISLSLIVIGLAIFLMAFLEQDKNIIAITFEAFSAYSTV
GLSMGITAGLSSSSKLIIIATMFVGRVSMLTLLIAILRNIKHLNYRYPSEEILIN
>IFAGANLK_01017 Ktr system potassium uptake protein A
MKYIIIGLGNFGASLAEKLTSMGNEVIGVDNNLDKVEAIKEKITHAISLDATDFNAVSNL
PLEDTDIVIIGIGEDKGANIMATALMKQLHVKRLISRAVSPLQQMVLEAMGVEEIIHPEE
ETAERWSKKLNLEGVVDSFEVTGEYSIVESEIPKEFDGKTLDEIGLKKKYNIIVLTTIKY
TEGKNEIGSAKTLSNVQGVATAKTELHYGDIMVLYGNNQDIKKLLKEIRKP
>IFAGANLK_01018 hypothetical protein
MKALAVFLGIFCLLVSAYPCCMVDDCDSDSEVKIAENEDEQQDDDCGLCSPFISCGSCIG
FIPHTNEVATIPDLPLIPFSNLFGITFKSVEAEYADRVWQPPKQVIIS
>IFAGANLK_01019 Colicin I receptor
MIKLLFKLAIFLVAFNAVGQNSLEAVIKNIEDNTPLLGANAVVSGTDIGATANIDGEITL
NEIPNGSQTIVFSFVGFASEEIKLDFPRTTQDTLEIFLEPGGEEMEEVIIQSTRSRRSIA
DLPTRVEVISGEELTEKGNMKPGDIRMLLNETTGIQTQQTSAISGNSSIRIQGLDGKYTQ
LLKDGYPLYSGFSGGLSLLQIVPLDLQQVEVIKGSSSTLYGGGAIAGLVNLISKTPGEER
ELNFMLNATSALGLDLSGFYSDTYGKLGTTVFASYNLGSPYDPADTGLTAIPEFNRYTIN
PRVFYEFTENTKLDIGVNTTVEERTGGNMAYLEGEEVEDPFFERNNTARTTLQSGFEHSW
NDDNRFNLKNSFSFFDREIQTVDYVFAGNQFASYNEASVVLGTEKMEWIGGLNLWVDSFE
QDVLTDAPVVDYEHLTYGAFVQNNWRANNWFQLESGLRTDYQNEYGWFVLPRISAMFTVS
DAVTTRIGGGMGYKTPSVFTEDAERLQFRNVMPIDVSTTEAENSIGGNFDINYRTELFET
IEFTSNTLFFYTKIDNPIILENTSEGVFEYRQPNGFIESRGIEANLKFGYKDFKLFTGYT
YADVDRTENGNTFEMPLVSKHRLNNVLMYELHEKLKIGLEGYYFSPQKLSDGATGQEYWI
FGLMMEKLWEDFSIFLNFENFTDTRQTRFDSIYSGSISDPQFRDIYAPVDGFVVNGGIKL
FF
>IFAGANLK_01020 hypothetical protein
MTKTNQMHSFHIPVMGTAFTIDSPLRVAKYGISSVISIIDDELIEKMNAFYSKKFDLPYK
EIPKNNPDSRAERITSYLDLVNNIVQDKFEKFKKELAESKTALENYLSILPNHSEIKQGF
QNLLNSGTDAKEKLRNYIENHLSPGSIDVNIMAKIDKDNFVKNEQLPVEFNDAHAALRGF
ANSKLSSSIVLSAGLNPRLYSYFENFKDFFPDVNGNLKKKIILKVSDFRSASIQGNYLAK
KGLWVSEYRIESGLNCGGHAFATDGHLLGPILEEFNQKKDQLIQSAHELMSKALEQKDIP
APEKPLDLKITVQGGVGTAEEHNFLLDHYKVSSVGWGTPFLLVPEATSVDIETRRLLVKA
KEKDLYLSHISPLGIPFNTVRGTTNEQLKEKRIAQNKSGSSCPKKFLALSKEYDEKGICS
ASKKFQDIKLKDLEEKKDSFSQEVLAKKKNKITEKACLCVGLGNASFIENDIRIKGQAQG
VAICPGPNLAYFSKVISLSKMVQHIYGNISVMEMPHRPNMFVKELKIYLDYFKNEIEECM
DEPSAKQKKKLEKFKLNLLDGISYYQDLFSNKTNLFQNGKNQLLGELEELKNSLIGINLE
PKVSV
>IFAGANLK_01021 hypothetical protein
MQKTPNGFKPLGAFLWKIFPKNSFKSNKPEKVTLSLAYS
>IFAGANLK_01022 hypothetical protein
MKKVILSGIFTLCTLGIFAQTSTNNLPATAQEYIQQNFSSVDVKEVKENSKWQIWEDEKF
EVILSNELELDFDENGNILEIESQNDVVIPIAALPSKIAAYVEENYADAQIIGWEKQKKE
QEIELADGTELEFDGEGNFRKID
>IFAGANLK_01023 hypothetical protein
MKIQHLLILSLILFFSISHAQDITENSFGNGIINTVARDSSFSLKFGARFQSLFVSEWRD
SEFEGFESESSNLLIRRARLKFDGFAYSPRLKYKIELGLSNRDMSGASKFTNNTPRYLLD
AVLKWNFYENFVLWAGQTKLPGNRERVVSSGDLQFVDRSLLNSRFNIDRDVGVQLRHKTY
LGNQFVVKEILAFSQGEGRNVVTGNLGGFQYTGRLEVLPFGEFKDYREASLERYETPKLA
MGVTYDFNNDAVKTRSNMGGYMFTENGFHSTNISTFFADLMFKYKGISVLGEFAHRDADN
PIALEEDGTPTGAVVNVGNSINLQGGYLFDNNIEVVGRFTQVKEDIMGSLFPDEKQYTLG
LSKYIFKHKLKVQTDLSFRDSPDPKWNNLMYRLQVDFHL
>IFAGANLK_01024 Cell cycle response regulator CtrA
MKILIIEDEKDMLQNMKDFLLKENFVVETAESVAEARNKIGVYTYDCILLDINLKDGSGF
QLLEELKQNKIEDGVIIVSARNSLDDKLEGLNLGADDYLAKPFHMAELNARVKAVLRRRQ
FNGNNKIKIGNLSIDLDEHEASIDDKPLHLNRKEYEILLFFTSNQNRLVNKSALAEHVWG
DHIDQADSFEFIYSQIKNLRKKLKTAGAEIEIKAVYGIGYKLITQ
>IFAGANLK_01025 Sensor kinase CusS
MKLLNYTTSYFSAILLVLLGIWAVIFYLEMLDEIYDSLDDGLDNQKMLVINRAKQDPEVL
QRSEFKDGSYTIKPIDKSSAISFKDFYRDTLMYMQNEDEYEPVRLLETVFKKDDEFYKLK
IITSMVEEDDLIEDLLFSLILLYVGLILSIVLLNNLILKKIWNPFYTLLQQLKDFRLGKD
QKIETVPSKIEEFNLLNTRVEQMLGKSISSYNSQKQFIENAAHELQTPLAISINKLELLV
EKEDMNDEQIELIASVLYNLEGLTRMNKSLLLLSKIENQQFPEEEIVNFNDLITELKSDF
QDLAGHKEMEISIGSTSELNYKMNKGLARILLSNLLKNAIIHGQKRSEIEIEISARNFII
SNIANNGALDPENVFSRFQKKSPSKNSTGIGLAIAQTIAKKYELQLIYHYKQKHVFQLRF
PY
>IFAGANLK_01026 hypothetical protein
MKKSIFLILAIALGFTACENDDMRNSDIPSVVLNGFTEEFPDAKGVEWEIKADFYEADFD
LANVDYEAVINTDGSLVRYKYEIVYDELPEAVKATITADYDQTKIDDIEVLKISENTYYQ
IEFDEEPTDVKVIFGKTGEVNTEVTTW
>IFAGANLK_01027 hypothetical protein
MVNKIVTLIVLGVLSLAGLILFGYSEFVTKDILQDQPVAYEIINEWQLPKELDEVSGIDW
LGDNKLACIQDEDGMIFIFNLETSKVEKSVEFAGAGDYEDIRIVGTTAFVLRSDGEIFEV
RDFLSGNSKTKTYSNFLTQKQNLESLAWDKNNKRLLLAIKDKEPKDDNYKGVYQFSLTDK
ELQEKPLYRLNMEDSLLRQRETKLNKKLQPSALSIHPGNSNFYILDGRAPQLIIANSKMK
FKKRYALHKDDFEQAEGLTFSENGRLFISNEGKGGKANILEIVFK
>IFAGANLK_01028 TVP38/TMEM64 family inner membrane protein YdjZ
MKELEENTNIKKSKAPLIFSLIVILVLVGGYFFIPSVNEFFNEAWEVLTSNDNQRIKAWV
SNFGWIGPLVLIIAMIAQMFLLVIPSVALMIVSILAYGPVGGSLIVFTAIFCASSVGYFI
GRYFGPVIVQKLLGPKTENKISDFLDDYGFWAVIVTRINPFLSNDAISFVGGILKIGYWK
FIGATLLGIAPLTLFIALIGDSTQQLKDGLLWGSLVSLVLFIGYVYWDKKKR
>IFAGANLK_01029 Pentapeptide repeat protein MfpA
MENQIEEQVFNNKNLQNHTFANSYESCQFTNCNFSTGSLKGILFIDCEFEDCDLSNVNLD
HTSFQNCNFKACKMMGLLFNNCEPFAFSLSVNECILNHSSFFGMKLNKTNFQNSKLQEVD
FSAADLSHSKFLNSELSGAVFQNTNLTKADFSSARDYNIDPENNKLKGAKFSLDQVSGLL
NKYQIKIE
>IFAGANLK_01030 hypothetical protein
MSLLNKLMGNAASISKEELDKKYGRLLTETEEIELGFSLLRDIFMFTNKRLILIDIQGLT
GKKQEYLSLPYRHISRFSLETAGTFDLDAELKIWISSENAPSVSKRFNKSIDIYAVQRYL
AEKVI
>IFAGANLK_01031 hypothetical protein
MISIWYILFFIVLFILIFFWRKRHSNRDSKTDNIKAKKEDFNPEFSSKPETEEEEEGSNK
K
>IFAGANLK_01032 Gamma-glutamylputrescine oxidoreductase
MVSNTIWNSFETVHEFPVLESNHQVDVSIIGGGITGISTAYFLKKAGLKVAVLDAGKIGM
GTTGHSTGNLYHIIAELLSSLDSKYDEETIKKVLKARASALEIIERIIQKESMDCDFTRQ
PMYLFSEDNTGKIQKEISVSSKLGVSHEDLSGENFSFKAAKILKYPAQAQFNPFLYVNQL
ANKIKSEECQIFQDSKVEEVEKLEHDNYNLKTAKGEVSSKYLVHAAHSSKGIDIKFDTTL
GPYREYAVAARLKTENYPQGIFWEYKGKEKYSFRSYKRNGKSYVMAVGKSYKVGQSDNNS
ELMDSLVKYLQGKFPVEKLTHFWGGQNYKPADLLPSIGRKSMNKDEFIATGFSTDGLIYG
SLAGKIITDLITGKVNEYEELFNPLRVNPVKSSKSFIKENLNVAKEFFKDHILGSSTEEI
EKLGAGEGRVVEIEGKKFGVSRDINNRYEIVSASCTHLGCVIHWNDLEKSWDCPCHGSRF
TPSGEVIEGPAMDALPRISDNE
>IFAGANLK_01033 putative zinc-binding alcohol dehydrogenase
MKALVWHGRNDVRIDTVPDPKIKEPTDVILKITSTAICGSDLHIVDGMVPTMEKGDILGH
EFMGEVVEAGREVKKFKVGDRVVVPFTIACGNCEYCDDTLYSLCDNSNPNPEKAKANLGH
SISGIFGYSHMLGGFDGGQAEYVRVPYADVGPIKVPSTLSDDQSLFLSDIFPTGYMAAEN
ADIKRGDTVAIWGCGPVGQFAIQSAFMLGAERVIAIDSVKERLDMAKNHSRVELIRTTDR
DDVYEKLMEMTNGKGPDSCIDAVGAEAHGDTLVGKAVDKTKEVLQLPMSRPYVLQQIMMS
CKKAGTVSIPGVYIGMVNEIPFGAAMNKALTFKMGQTHVQRYLKPLLDKVDEGLIDPSFI
ITHRMKLDEAPKAYDLFKKKEDKCVKVVLTP
>IFAGANLK_01034 hypothetical protein
MAFYKVINWAFAVLGFCVMALFLFKLEQAFSATPTAEAAQQALQNFQISIWCGWLLITGP
AIYFRWKAGNHILFIIDYLIAVTAFIIFGVYVNRGAELELWSLGDSFRGNVTFLVIRNIL
LICGMTAFIHAAIWWFSKRWHRR
>IFAGANLK_01035 hypothetical protein
MKKSSLTENLEYSEKSPAVKVLFETEVSKEIRMAFKKDQGLKEHKTPFPIVVEIFEGAID
FGVNGEKHPLKKGDLITLEGNVPHDLKATENSIVRLSLTKADTTQRVENVAKNS
>IFAGANLK_01036 Lipoate-protein ligase LplJ
MVFIDNEGINDPRINLALEEYALRNFDPANDYLLFYINEPSIIIGRNQNTLEEINFDYVE
ENGLHVVRRVSGGGAVYHDFGNLNFSFITNHDVKSLNNFAKFTEPVIKILRKMGVPAELK
GRNDVLANDKKISGNAQFSTGKRMLHHGTLLLDTNLEEVVKALNVKMTKIQSKGHKSSRS
RVANISEFLTEKIDVEDFRALILKGLYNENEDFETYHLSAAEWKAVHALKDEKYGTWEWN
YGKSPKFNIQRSKRFSVGEIDLRIFVEKGEIINFKIYGDFFGKEPVKQLENLLLGARYDR
QEINKLLEPVIIEDYFGALPKVDFLELIYGNDEVEAS
>IFAGANLK_01037 hypothetical protein
MGRPSTKAKDLRDGYYIEVRNKNQRSGIKIRRDTKEQLLLAIEEYKESKEVVVLGKSENG
KMKEIPDIKVD
>IFAGANLK_01038 hypothetical protein
MSILNPSIKHHIIIGFLIGIWTFIFAFIIRPFDDGTLNFRLWALISIGFSLMTFFSYTLL
AIIQKSVYLKLSSWNIHFEIASLILFYLVYLLGIYVYYKSPILAGGYTFMEFTTIIFLKL
ALISAPVIILARRYLIKLIPVKEDILTIRGDNKLDLLRITKSDLICVSNAQNYIEIFHTE
NGQLKSKLIRYSLKKMQEDFDILVQIHRSHLINLSHFKSWKNSNTIYLTQIELPVSKNYK
DQLLSL
>IFAGANLK_01039 hypothetical protein
MKLKTLCLTGLVLFVISYILFSQGAKWAFAQKPIDFAHWFNLIGAVLLISFNKVFPKNKI
HSLASFLLILGVIAHIGLCTIDFIMWSFGNDEISKAELSNHISNTPSIFYPFIIIGPSLL
FLGLAIHASNFIKTNPISSSMVIIGAPAIGLSFFIIKSGSFMALSCVIFATGLALLLFRE
KYTLKRFKIK
>IFAGANLK_01040 hypothetical protein
MSTKHPSKNTVGTLWHTFISSYAWRWFQYLMVFTIFSLVVNHLASRDSFPDGESYRFPIE
GFLSSIALCILIGIIADLNFKFYKKKHFSRKVEMVTIAGFMASTLGYIIILYIPLNIIIN
IVAGGNTEFYYLLIGLLITLLLSFILVGLLYARDLYNLYKLSLKNAEITIESGAKMTKLT
YENIVCFYIEDKIVYTVQNDGTTISTDFTLNELEEKINDQLFFRANRKTIIHKDAVDQIE
KIENGKLRIRLKTSIENDTIAQIHISRYKRKEFMDWFQ
>IFAGANLK_01041 hypothetical protein
MNNITFRQILVPSITIAIICFIWFGPIRLSYVENIVISILIIIANYIEYNGKPFSALGFQ
RKKFTVKNILVFAPLVALGLFVFYVFALVPGITELTGVPIDYSSFDQLRGNLLACLIALL
LVWATAGFGEEIIFRGYFMRQFVKFFGESKVSIVLNIVLLAAFFGFLHSYQGITGQLVTG
IVGGLLALIFYLRKYDLWFVIAVHGFFDSIAIICIYFGLA
>IFAGANLK_01042 hypothetical protein
MSLIYTVFNTIFHFEDGYAQFSGNEDKVTLSISQWIQENYDYANIIMVIFIAGWGLLLLY
FVTQEWQIK
>IFAGANLK_01043 hypothetical protein
MEELAARAGVALTVIRKIEQNKMNLNLEKVNQVLKMFGHKLVPVSFKDRESNEAG
>IFAGANLK_01044 hypothetical protein
MSKCLYCYKEVSTGGDFHEECSLKFFRTKTAPRIDYSIQEMAKLAQQVVERRISVPGVQP
KLSMSVLEDNRKDQRLTVVGALGGNYIFKPPSEDFSEMPANEHVTMKMANYLILMLFLIL
>IFAGANLK_01045 hypothetical protein
MKLNSLTTGLFILLLQIFVSCQKEKPKNVKVASLTSEYLKNPIGLDTEKPRFRWKLETGD
QEVLQENYEIYVGTDSVEVSNGKGNFWQSGELADGSNLAIYDGEPLKPFTKYYWSVRIGV
ENSKINAISEVASFETGIMNETWKGSWITDGEDMDLKPAPYFRKEIDITKEVKKATAYIT
AAGLFELHINGDKIGNNRLDPTYTRYDKRNLYVTHDVTKQIQEEDEIALGVILGNGWYNH
QSTAVWNFHEAGWRNRPRFLMNLKIQYKDGTSEDIVTDSDWKTATGPIIFNSIYTAEHYN
ANLEDSNWNSPNFEGSAWENAIETEAPSNNIVAQSLHPVRSTEEIKPVSVQKISDTKYIF
DLGRNISGVSKIKLKGEPNTELRITHAEQLDSTGAIDMSNIDVHYRPTDDSDPFQTDIFT
LKGDGEETFMPKFNYKGFQYVEVKSNKPVELNKESLTGMFMHSDVPQVGKIKSSNEIINK
IWEATNASYLSNLFGYPTDCPQREKNGWTGDAHIAIETGLYNYDGITVYEKWMDDHRDEQ
QPNGVLPSIIPTWGWGYDWGNGPDWTSTIAIIPWELYQFYGDSRALEENYDNIKLYVDHI
TEISPSGLTDWGLGDWVPVEDKTPVELTSSIYYYVDANILAKTAKLLGKEEDNRKYSDLA
EKIKLAINEKYLNKETGIYGSGFQTELSAPLYWGIVPTNQKELVAKNLAAKVIEDEKHIN
VGLLGSKTILNALSENGYEDLAYEVASRETYPSWGWWIKNGATTLLENWDIGADSDLSRN
HIMFGEVSAWFFKALGGIFPDHENPGFKNVILKPNFVDDLENFEARHDGPYGEIISKWEK
QEENVVKYEVSIPPNSTATVHLKAKNMQLNGKDVESGEKARFNLKSGKHEILISLQ
>IFAGANLK_01046 hypothetical protein
MKHLTLTIIFSFLTFYSIAKNSRYRIIITDDPSSTITIAWDQISGQNPRVYYGITDGGMY
SSKYSLKKSPDRKVDYKGMNNHFVTLTKLNPDTNYYFIIKDSEGVSKRFWFKTAPKDNIS
MSFISGGDSRNNRVPRIEANKLVAKLKPTAVFFGGDMTNSGSEEEWIEWMDDWQHTIALD
GRMFPILPARGNHERSNSSIYNLFNTPSKAVYYNIVFGKNLFSTYTLNSEIAAGGNQYAW
LKKKIKNDKALWKFIQYHKPMRPHQSHKAEGNDEYNNWAELFYKNGVNLVSESDSHVVKT
TYPIKPCNGGEDCDEGFVRDDQKGTVYVGEGCWGAPLRNNDDDKSWTKNSGSFNQFKWIT
VSRKEIKLQTIIVDKANQVCENSNSTKLVKLPFGVKVWENEGESIVIRNP
>IFAGANLK_01047 hypothetical protein
MSCKKSILSSLLFLAFTTIFSQQNFTEKVNVFLGTSGDYGQMSPAASYPFSMMSISPQTI
PHNHTGYEYYAKKYIGFTHTRIEGVGCTGSGGNILIRPFSGNDYSKNLIKKSQTASPGNY
SVFFENGIKAKINSGLNYGVNSFTFPKNKNGVYIDLGFALAGRFKAEEHQIKNGLIKGWI
DTETTCSRGVYRLYFAIKLPSDYDLKKLTEHKYILSGDSDEIQIPVAFSSVNSEYAAEKI
KNNQSLNLKETTEKKWNELLGRIQVEGENDREKLFYSLLYRGLQAPFQISENDGKFRATN
GSIQTSKNTTYNGWAIWDNYREQLPMLSLMYPDKYADIVKSIANLYRFGKQEWATMHEPS
PTVRTEHALVVLLDAVRKGYDLNLKSIKKSLMEEANNLKYDSPDKALETSYDKWAMAGLL
HQINEKELSYKYLKESQKYKEFWKKDFKDLSRNDVDQMHARGLYQGTIWQYRWFVPFDLN
GLKKLVGGEDKFLDQLDQFFEDYNYNHANQPDLQVPGIYNATKKPWKSQKLFRKILLDTM
VQTYFNNNSKGIDSYIGKIYKNQPRAYLRTMDDDAGTMSSWFVMRSLGLSAANVGSPIYY
LTAPIFREYTITYKNNKEFKVKVNNYNKDWFYIKSAKLNGKTLNRNWLTHQEIVNGGYLE
IELSKEPNKKWGLQDQFATDLERPFSLPSK
>IFAGANLK_01048 hypothetical protein
MPITRTLNLLKFCCVCVFFGRAYEHIFYDPPYRSLLWDEAILSPIIKSVFRMDWADYVTN
TSIDNKIQIGIVSVGFFYFFCGIASVFITRKNYDVLKYIIGTGAGSLIFLAVLQAKSNFY
HFAMFFEHAIQFGSPIALLACFKLKERQFTWILFLKLIIALTFISHGLYAVGRPYPVPGN
FVTMVINILTITEGQAMSFLLIAGCLDFLAAILIFLPKTSNIALVYAVFWGFFTAFARII
SGLTYEFSAIIFHQYLFTTIYRLPHGLIPLLTYYIIKKNNAKSIYYKISMTGFPKIK
>IFAGANLK_01049 TonB-dependent receptor SusC
MKIQMIWDLTLIKCKTGVTTKKFTQLLVFTLIFYIGSDLDALAFQQQEDNTITVTGSVTD
NMGLPLPGVNVLEKSTTNGVMTDFDGNYSIDVAPQNAVLIFSYVGMQTLERAVEGETTIN
VALENDPQALDQVVLVGYGKQKKISVVGAQSTVKAEELELPVANLGTQLAGRVAGLTGVQ
RSGLPGFDGADLWIRGISTFGGSGPLVLVDGIERSLDNIDPRDIDSFTVLKDASATAVYG
VRGANGVILIQTKRGEIGKPEISLDYFEGITYFTQVPELTSGIEYMNLANEARTTRGQVP
LYSQDYIDRTASGEDPLLYPNVNWLDEVFRDFGRNRKALLNVSGGAERARYYVSMGYYDE
TGLFVTDGLENYDSDTRFKRYNFTSNLTLDITKTTQVNVGIQGYLSEGDYPSSGVDAIFG
TALEANPVVYPKIYPGGYVPGRSVNGGLRNPYAEVALRGYRSLTRNKLNTNLDITQELGS
IVKGLSFHGLFGFDTYNEQDINRGKRESTFFVDSNFPYNEDGSLLLNETFTGQNFLGYDR
SNGGNKRTYLQASLNYDREFGKHNVSGLLLANRSDFSDNFAGNFTDAIPYRNQGLAGRAT
YSYDERYFMEVNAGYNGSEKFAPENRYGFFPSFAVGWVLSNEKFFEPISNTINYFKIRYS
DGEVGSDSGAGRFAFLSRVEEGQPGYSYGENPGGIGGIQETFYGADVTWATSRKQDLGIE
FNAFNNDLRVIVDFFKEHTTGAFLNRRDIPNYIGLNSDPSANIGVVNNKGFDGTINYNTT
IGQEFRLGFRGTFSYNRNEIIQSGQPRQPHPWLNDKGYGLLANRGLVADGLFTLEDDING
DGFITTEDGFPTQYGQIQPGDIKYVDLNEDGQIDAFDRKVIGDGDVPALTYGAGITGQFK
GFDLSMFFQGQEFADRYIGGYGVQPFTGDGGEGSTYAIVNDRWTPENNDPNATTPRLSYG
QSAIGQGNNTQLSTYWLRDIAFFRLKSAELGYNLPETLTKYVGVNNFRVYLRATNVFTIT
DFDLWDPELNTSNGSRYPNISVIALGGTIQF
>IFAGANLK_01050 SusD-like protein
MKKIIILCCGLMMLSCSDDYLDQVPDDRLTFDETFSKQNTVRGYLANIYSRFPNEFSQRY
TTSANSGPWTGASDEAEYVWGFHMGNNLNIADWNATTQNVSNLWSNFYRGIRASTTLINS
IDQCQNCSADIKEQYAAEARILRAFYYYNLMRSWGPILLMPETVVPTNANLDELGLERNS
IDAVTNYIVSELDKGAEALDGVNFDGQNAGRMSTPFAMAIKEKTLLFAASPLYNGNSDYS
DLIDSEGNNLVPQSYDQQKWKKAADAAKAFIDKFVPSSFELYKEFNNDGSLNPFLSVKNS
TLEDFNVEIIYAIPRGNNSYQYDVTPLHIGVAGNSPTGAGGLSVTQEMVDAFFTNSGRSI
DDPQSGYRDSGFSDFQAPDDFAPRTTFNPWTNREPRFYAGVTYNNRLWLNRNFGDIVTTT
WYSGNSGIQAGTNDYPPTGYIVRKKAAEDYGARSLPYMRLAEIYLDYAEALNEYDPGNPD
ILKYVNLIRERAGIPEYGDVDLPAPSGQDAVREAIHKERRIELFVENVRYFDARRWKIAE
DAFGGDMHGKDVNARDEQEFYNTVVFEKRVFRPQDYLWPIPQDEINANPKLIQNPGW
>IFAGANLK_01051 hypothetical protein
MKKHTFKILVITIMSGLIYSCTPESTSAIEGLPDAEVNNDPPGAPPRGFVENYQSHDHAV
RRQYFDDYVGVYYDTVVDRSITWPFNFFSSAWNEVTDIYGDFGNESALYVVGHGESSEGI
YTTVFDQQDSHSLIDFTVPADSTGAVLDEPLRLMADVVQMSANGVFKSPAKAVWKDKFSQ
IFIFDLYRKLGMDNEASRVKQEYLNDVDDFPNPGTQWFKDWFLPIYETYNGANTVSNFFE
VLSQNYPIDGSEYSKDMNMGEFIHFWSAATGEDLLPMAEAAFEWNDGYNDELLQARAEFP
NLNYPFEPASELIDLTSEATVSVSKDNDGGAEANEGSLKLIDNDVNSKFLTGGFPQDFWM
QQNFTDAKVANKYTITSGNDAPDRDMKSWELLGSNDGITWEVIDTRTDQSWTERNQTREY
NFDNSNAYLYYRINVLDNNGSSLIQVSEWRLLNLQLLDFGPKDFTENAILSVNQENGSGP
DGPEGSLKLIDNDVNTKFFLGGYTSEFYAQQELPEAKIITKYTLTSGNDSPERDPKNWEI
LGSNNGESWVVLDTREEQTFSERNQTKEFLVDNETAYKYYRFHVTAISSGGAMQLSEWRI
LGIE
>IFAGANLK_01052 hypothetical protein
MNNLKIYLLLSLVCVTFFSCYEKEGGKPSEDKKYENSKAKTAFQTSSEWMPEIDVRADVA
IVYGVHGNPTDGEQEITFEDRVESWRERGYNTHFMTGIAWGSYQEYFLGEWDGENHLGEG
QVQKNGDTIWHGHNVPYIVPTEPFIEYMKEEVIERVIDAGISSLYLEEPEFWARAGYSSA
FKKAWEDYYDEEWKPQHESPENTWLSNKLKYQLYYEAVDKVSSYAKKYGKEKGMDIKVYV
PTHSLVNYSSWQIVSPEASLAALPGIDGYIAQVWTGTSREPTYFNGEEKERTFENAFLEY
GSMVSMTAPTNRKLFFLTDPIEDRKKSWDDYKKNYQATFVAKLLYPMVANYEVMPWPERI
YTRPYSVEGSDEEVLIPEKYATQMQVMINALNHMPESENQVSGSHGIGVLMGNSLMFQRF
PTHDGFEDPKFSNFYGQTLPLLKRGIPVETVHMENLSFDATLENIKVLVMSYSNMKPEGP
EVHERISNWVKSGGVLVYAGRDDDPYQTVREWWNSGNYSFEKPSQHLLEELEIEKSAEEN
MYNVGDGVVHFITQNPKEFVLESNSDVTYLDVVKHAYEKDAFAGKLELKNNLHLKRGNYE
IVAVMDESISRDNFEVEGTYIDLFDPELPVIYNKTIKPGQQALLFNINKVVEQLKPQVLA
SASRVYEEENNDNRYSFICKSPKNTVNSMRILLPQEPKNIQLVDSEGEDINQPESEWDEN
SSTQYLKFENAPDGVKVNISW
>IFAGANLK_01053 hypothetical protein
MNKNLFLISLILISFSLPAQNINPAKELVEYVNTLQGTNSKFELTRGNTYPTTALPFGMN
TWTPQTGVNGDGWKYQYFKDEIRGFQQAHQCSSWSNDYAVFSLMPVVGELKLMEDERSTK
FSHDNETAKPNYYMVKLENGIKTEIAPTERGAHLRFDFPKEKSSYLVLDGYTGLSGVEID
KKNRRITGYVRNGRGMQRFDNFRNYFVIQFDKPFKAYGTWENKNGKKWEGETTREGKGIG
AYLEFKRGIIVQAKVASSYISKEQAQVTLENELGKDRNLEQTKKNAGEIWNKQLGKIEVE
GGTEEQFKTFYSCFFRASLFSRKFYEINEKGEPYYYSPYDGKIHEGYMYTDTGFWDTFRG
QFPLNAILSPKMHGRYVAALLDAYEQCGWLPSWSFPSEAGSMVGNHAISLLADAWAKGLR
TFDPDKALDAYFHEATNKGPWGPANGREGWKEYFTLGYVPYPEVREGTAKTLEYAYDDFC
AYKLAKDSGNEFYEEIFSRHMYNYKNVFDKKTGFMRGRKKNGEWVENFDPYEWGGPFTEG
NAWHYLWSVFQDPKGLIDLMGGDERFTAKMDSVFNVSNKVNVGTYGGKIHEMTEMQMADM
GQYAHGNQPIQHMIYLYNYAGQPWKAQQKAREVMENLYSYTENGYPGDEDQGQTSSWYVL
SALGFYSVAPGTYEYVIGSPIFEKSTINLENGESFVIRAKNNNKENVYIQSASLNGEEFG
KNFLTYDQIFNGGRLEFQMDDSPNKNRGISEESRPFSLSKSED
>IFAGANLK_01054 hypothetical protein
MKIKLILFVLAITIGLFSSCNSGNSSKTVNQEKNTVEANNDTPPETWQEHWFDHEQLLTR
IHYTDDLAVYYDEDVDTTITWPKEYLDKVWVYVKNVYGDFGDDPRLYAIFHTGKYSGGHP
SVYMDESHDYRNVVDCGPYDWKERKPEAGLSMVIHEIGHIVEGATNGVKENPAWEIWKDS
KWAEIFIYDVYKGVGDEEFAQQTYDDMMGTYDDFPQENTQWFKDWFFPIYSNYGESEVLK
SFYDLLYEHFPKKDNDKAFARRMNMGEFIHFWSGAAKTNLQAQAEKAFGWTDEWETQFKK
AQSDFEDVTY
>IFAGANLK_01055 hypothetical protein
MSEVNYISHLNGVLRKFAEDDKISCSHRSLYLVFFELWNHKRFPITIMLNSREVMALAKI
RSRTTYHKLLRDLTNWGYLKYHPSTSPQMGSLVEMFRFDTHPVQKMNRTYPVSEQVPVQK
LVSFKPPGDKSIYFNNLHYSCCQFLFSIRKNCLIEFDYRLLLTALVEKIGLYVFILLI
>IFAGANLK_01056 hypothetical protein
MYISISPQKTGAAFSKSAGDFVSYLEKENEGKSPMEKEYFFNQYDDNIKPYEVIKGIDDN
TAKLKTKEPKYYSITMSPSQYELKHIRNNPEKLKAFVREAMKEYAGSFNREINGRPVGVD
DIKYYAKVEYERTYKSNDVAIRENKPYSKQIAHLKNELRKVQRGEIYGNTRQIENEIQKL
VRDAPYKIRGQVMESGMKKEGLQSHIHIIVSRKDASNTYSLSPGSKYKASEVNMHGKVVM
RGFERDRFFQNSEKAFDKMFRYNRNYVESYAAKKMLSKDPKQYFLGLRNLGINEKKIAFK
MIRQAGLQLPILNLPTSKVGFAYKQLKKVIEAGIKSSSIGY
>IFAGANLK_01057 hypothetical protein
MAKSRLQLKASTAKRFREFSKKNNGNQSETLDLVLDFFEQNNLSPFETLVPSKVSLEQLI
KKRIDAVIAILKNIEKTQTKPSLLMLELLMEGRSVPKLQVAKKEKGSVSDKKSQAQLELE
ISRLQEELKTNKRDLEYLIQNVEIKSSAFGPDYLKLNIPRSELAHYKIVIKQKN
>IFAGANLK_01058 HTH-type transcriptional repressor YvoA
MELKVDHKSPVPLHRQVEDLLRSLIELPEFKNGAFLPQEVELAKRLGVSRNTVRQAANKL
HNEGLIVRKKGVGTKVSTNSITTNLGEWHSFTQEMNSKGIPFKNLKLNVEWVFVDEIIAN
FLNVDTSTKVLKLSRLKGSDKPLVYFESYFQPRIGLTGNEDFQRPLYEILEDDYHSVPAV
SKEKIRAGKASEFAEILEIDKNDPILIRERFVSDPGDRPLEYNIGYYRNDKFTYSIEIRR
>IFAGANLK_01059 N-acetylgalactosamine kinase AgaK
MYSIGVDIGGSHITSCMYEHTNKQLLRKTLVYSKVNTKGSKEEILNSWVYAISKTIEVAK
EKIKGVGIAMPGPFNYFDGISLISNVDKFESLYGVNIREELANRLNINPSQIRFINDATA
FSITEALIGNATNHHRSIAITLGTGLGSSFLINGQPVMQGMNVPQGGFLYDKMYHGMLAD
NIFSTRGIIKKYKDLSGQKANNVRELCDRFEADPEAKRVFQWFGTELGKFLKPYILDFKS
SIIVIGGNIAKAFPYFKNELLLQLPNIEVCVSDFGEDAAIIGSALLLDDIYYDDLKPTLK
LM
>IFAGANLK_01060 hypothetical protein
MGKQKINKIAPVLMSYIVMGFVDIVGVSTGYAQRDFDLSPEVAQLIPSMVFIWFFLLSIP
VGIFQNNFGKRKILLAGIFTTAIGMFIPFVHYTYPTLLLCFLLLGIGNTIIQVSSNPLLQ
DVVNRNKFSSFMSLSQFIKAISSLVGPLIVTFMVASYGDWKLVFLVYGFISIFSGSWLIL
TGIDETQSEFKASFKTSLSLLKNPFVASMVVAIFLIVGLDVGMNTSIQNLLVQKFEVGLE
RASLGISVYFFALMTSRFLGALILAKVDNLKFLYWTTISTIFCIVLLIVAPNSLVALVLI
FLIGLSSGNLFPLVFSLTIGKLPNRANEISGLMIMAVVGGAVIPPLMGLVNRMAGVSISF
IVLLLCAVYVYFTYHLFKKFKN
>IFAGANLK_01061 hypothetical protein
MKRFVFCLTVLGLVCSCGTAIDDQKKDINKKSVLDYVDPNIGTAHSRWFFYTPGAVPFGM
AKLGPSTNGSYGNENGWEAVGYDSRHTSIEGFANLHEFQIGGFLFTATTGELQTIPGTLE
DPESGYRSRFDKEDEHASPGYYKVNLKDYDVTAELTATKRVGFQKYTFPESDNANIILDI
GNQLGESGEVKNASVTFTDDNTIEGWVTTYPEYVKKYQPEGEVNMYFYGEVSKRPKAVGT
FIGDEIFKKQRSITGKGSGLFMEFNTKANESIEIKAGFSYTSVENARLNFESEAENLDFE
EARSAAQITWSEELNKIKVKDSSTQNKKKFYTGLYHALLGRGLASDANGQFPENDGSVGQ
IPLDKNGDPEFGFYNTDSVWGAFWNLTQLWTLAWPDYYNDFVQSHLAVYKNSGWLGDGLA
NSKFVSGVGTNFVGLIIASAYQSGIRDYDIELAFKAAYENEVKYKNRNEGAGKTDLQGFV
ENGYVPYVPGWETSPEGSGFSVSHTLEYSYSSYAVAQFAKALGKDKEYKELMELSDNWKN
LYDESTDFVRPKLVSGKFIEEFDPFAPWEGFQEGNAWQYTFYVPHAPKELVNKMGEEKFV
KRLDSIFTVSEKTKFGGEDIDAFAGLTYLYNQGNQPNLHISWLFNYTDHPWLTQKWTREI
GNKFYGVEEVHGYGYGQDEDQGQLGAWYVMSSMGLFDVKGLTETNPSFQLGSPIFDEVEI
QTGENETLKIKTVNNSPDAYYIQSIKLNGNSYESREIDLKTLRNGAILEIEMGVAPHKTL
LK
>IFAGANLK_01062 TonB-dependent receptor SusC
MINKSILTTILLLICLCSKSFAQESIISGTVTSADDGPLPGASVVEKGTSNGTVTDFDGN
FQLELSNPTNATLVITFMGFATKEVNLAENDNNISITLESDAGQLDDVIVVGYGTKKKVN
LTGSVSEINNEAIQGKPVSNAYQALQGEASGLTIQQGTSEPGSVPQINIRGISTINGNTP
LIVVDGVIGSLNNINPQNIESISVLKDAASASIYGSRAANGVVLVTTKNGEEGKTKFAYN
ATYGVQEATNFPELADSWEYATLRNEALVNSGMSPAFTPEQIMDFRENGPNVSFYESLFQ
DYATQSNHNLSMSGAENGLNYLLSLGYMDQESLFKGPDYGHTRYNFRINLDKKINDKLKV
GGRISFARNDIKGHAWWTEWIIEPSVRTPPIYDIVDENGEYTLVSGSNSNPLAQLEQGGA
RTNQNDEALGNVSISYEPIENLVLKGVLGGNITSNKTHEFRKAIEYVYPGGGNNQNSVAD
NYSRSLYLNPYITATYNNTFFDNHDFDFLLGASSESYKTEFFGVTGLDVPGNEFGVIDNV
SEIQQSGTYGSGNEWSIQSLFGRIGYTFDDKYLFEGNLRYDGSSRFSLDNRWGVFPSVSA
GWILSQENFFDPLDGVISFAKIRASWGQLGNQDINDLYGYQSLVNISSNAYAFGNVGVPG
SYYSVSNQNRTWEISTMKNLGVDLAFFDRKLNLSVEVFDNLTEDILLQLPVPDTYGLGQP
FQNAGSVRNRGWELTLDYRLATGDFNHSFNVNLSDNKNEVVDLRGREFVNGFDVQTILRE
GYPINSYYALKSDGFFNSEEEIQQSATPIFANSVQPGDIKYVDRNGDGEIDYEGDRFILG
NSFPRYTFGATYAVDWKGLDFSVFIQGVGKREQWIRGEITEAFHNNNEGPVFQRHLDRWT
PENTDATYPRLTVGSESVNNAARSDFYIADAKYLRIKNVQLGYTLPQSIMSQIGIESTRF
YLTGLNLLTFSPLLDKGLDPENIDSNGRVYPVSRVISAGLDINF
>IFAGANLK_01063 SusD-like protein
MKKILIIITLIISAGCSSDLDLAPIDATSESTYWQTEEDARVFLNAMYADIMDADMYLFL
SSASDDAYTRGREEYRNIGSGSYGSSNGLVESLWENKYAGIRRANIFFNNIDRVEEISEE
ERISLIAQARFIRAWHYFMLIEIYGDVPFVTEEISIEESLVLERTDRNTILSFIYSELDQ
AIANLPNNYAAEVQGRITSNAAVALKSRIHLYNEEYSEAASLAEDLIGDYTLFENYGDLF
KMDNEYNDEIILSLQYVPTDREHNIQYSLIPPSLGGYANFSPLQSLVESYPTINGLAIDN
SESLYDEENPFQNRDPRLAASIIYDDYTMQDFDGNQVTIDTSPGAAPDGLNYSSNSTPTG
YYVSKFYDREARNQTNSGLNLILIRYAEVLLNYAEAKIELGEFTAEDWDLSIGAIRQRAG
LSEEALEFPGGDQESLRNIVRNERRIELAFEAGHRFFDIRRWRIAEGVLNGWAYGMKTDM
TSEDDGYTRVEHRTFEENKHYLFPIPLSERDINNNLSQNPNW
>IFAGANLK_01064 hypothetical protein
MKTIIKLKYLMLVALMALVSCNEEEYELNPEIVELGALESPSMGENIEIDLESDSRITFT
WSPAKSGDGGLVTYNVLFDEEGGDFQDPLATFPSANSGSSNTLNLRQSDLNEIASESGIG
QLETGNIIWTVEAVSSYNRERFLEISDLSLTRPEGFADFPEYMYVYGPATEAEDIENAVA
FGQIENELPNNDFEPGTFESITKFTSGEFYIVDSNDPDSNPTHYYINDEGKIRAGDEPTN
FEGSEGVYRIRMNLSRTTISYEEMSNVELYVIANGITTGELSYVGNHTFESTNGYFDFLT
PGAPDAPDWLGWEEERYRFRFLIDGEQSYIGSFHNADMNGSLVPGLDAFNARPNEGEPEY
YYNTYFLGPDAEFWQGAWKFADQFNGASFSVRVIFDPKADHYYHEFELN
>IFAGANLK_01065 Cellobiose 2-epimerase
MKRKAMILKLINITFFSFVTALTGCSNDSIEDQMVDNGEDKDTTEVVNLTYKEKAKETYD
LIQELYKEGDLYKENYPAQANDNTYSYLWPYVGMLTAGNLLYELGYDESILEKEFEGLEK
YYDNRSNLPTYQAEPVSEGSTDHYYDDSGIVAMELIDAYRLTDNQFYLDRAITITEFIMS
GEDSRIGGGLYWFEGVSTDCTTDSNCIKAANTSAYAAYVTSELYKITEDPQYLTFAERVY
KWTYDTLRDPSDNLYWNSIHINTEEINTRKWTYNAAMMIMSGINLYEISDEEFYLDQSIA
TARSAHSKFTSVINDRLFYETNDPWFNAELMTSFIELSEYDSKSKDYVEVFIRNADYAWE
NARTSEGQFYEDWSGNNRGRYYWLMHQAALVDVYARASLFKNE
>IFAGANLK_01066 Mannose-6-phosphate isomerase ManA
MNQIKSKVRETSQLELPLKKNKSISEYDIYPAHHIGDNLIQDSYESLAKELASFDYLKID
GYVGILFEEVREKLNEAFGKIGIKSEWVNIQEALKEEREIESLVAPFLGGDDPVFGKIAA
IELKDFFDLKKMSSLVKPKSSNPVIFYGTGAHLIPVEGKTIYFDISKNEIQFRSRAGSIT
NIGTPEPGAAKTMYKRFYFVDWVVLNKHKNQIKNEISYLVDGQRTDDISWVKGDVWRESI
IELTKRPVRVRPWFEPGAWGGQWIKNKIKGLPQDVVNYAWSFELIVPENGIIIESSGVLL
EYSFDFLMFVAGEEILGKDFESYQYDFPIRFNFLDTFDGGNLSVQCHPQKEYVKNNFGEN
FTQEETYYILDKKNNAQVYLGFQDGVTPDNFREALQSSQEENKEMDILRYVRSFDSEKHG
LYLIPPGTIHSSGKDNLVLEISSTKYLYTFKMYDWLRVDIDGKPRPINIERGMENLVFER
SGDRVEKELISKPKVIESNADMELQHLPTHKEHLYDIHRFKINTSVTVKTDGQAHVLSLV
EGEKIELSTKDSTSTFHYAESFVIPAAAEEYTIKNLAKNPVMVVKAFVK
>IFAGANLK_01067 hypothetical protein
MLELGKIYLPTWLSCDPETSMISLDLPEIHSPDYFKNVFYSLQLAFSGSRVAIMYYGEDD
TYLSDVLHFEAWDIAGGNLELESFGKIQERALRALAKYIPDLNREVYDLFNEE
>IFAGANLK_01068 Tyrosine recombinase XerD
MRTDFHTHFHILAKKKNKRGLAPIYLRLTVNGKRKEYSISRRVQPEFWNTKMEKVMGSNP
NEKEINTHINNIRHKLNKIHQVLSETDQPITAAIMIGNLKGENKKPPKLTLEVFREHNSQ
MDRLSGKSISKSTAKRYWTCYNHIEQFINEELKTDDYPMNDINHQFITKFEYFLKTKREC
NHNSALKYVNNFKKIIRIALANEWIDRDPFYNYKVQFDAVEREFLNEEEVQKLIEKDLHL
DRLKLVRDMFVFSCYTGLAYSDVKKLSSADITKGIDGGKWIRIKRTKTKSLSSIPLLPVA
EEILDRYQDYPEVKDGKYVLPVLSNQKSNAFLKEIAALCGITKPLTTHLARHTFATTITL
TNGVPIESVSKMLGHRDLRTTQHYAKIVDRKISDDMKALRKKLEEKAAKDSKKNDSKKKK
>IFAGANLK_01070 hypothetical protein
MIKFALIKEEKTPPDRRVVFSPEKLKELVKKFPEANFKVQSSEIRIFNDQEYRDAGFEVT
EDISDCEVLLGVKEVPLPALIPNKKYFFFSHTIKKQPYNQDLLREILKLNIELYDHEVIV
KENGARLIGFGRYAGLVGAYNGFRGIGLKENLFNIPKVESLPDLDAMLAELDKIEIPLIK
IVLTGNGKVAKGAKEVLDHLGIKKLNVEDYLKFEGEEPVYCNIGVLDYNKKKDFTKGSQQ
EFFKEPEKYEANFLRFARSSDFFISGHFYGDRAPVFFTAEDAKSKDFRIKYIADISCDIK
GPIASTIRPSTIAEPFYGYNPETETEVDFREKDSILVMAVDNLPCELPKDASEGFGEMFL
KHVIPAFFNDDKDGVLDRARMTQNGKLTPKFGYLQDYVERE
>IFAGANLK_01071 hypothetical protein
MKALKRDSRKNYLAGFLFLLIIEILIAFYVKDDFIRPYLGDFLVVILLYCFAMGISRISI
IKGLFSVLIFSFAVEFFQLINIVKVLQYQPPEIVIIMLGSSFSVWDLVAYLLGILCCSLV
EYLRNRIYSLST
>IFAGANLK_01072 hypothetical protein
MKYFVDENSIVREIWGKGDTILFIFAGASAEFALNKAVDWLYFTGRLPKDPLGRLFSTVS
YAREIVFAEKHAALKAIDRINSIHASVEAEREKSIPDWAYRDVLFMLIDYSIRSFEILER
KLKLSEKTEVFYVFWRVGKRMNLKGLPENFEEFEAMRQSHLEEDLIYGAYTKNLYKQYRK
HLGLVRYRLLLETQSLITPLRVRRYLNLRNFSFLKPVLPAYKISRSIKLDGLLKSLILPS
EYKAEIKSLDMKSA
>IFAGANLK_01073 hypothetical protein
MMARLFLSNFVSCVLTAIFLLLGVMNFILVHPVPGIFYILFACIFTPPFNTLLNHKTGWV
IPLWIKIILGLVILWGTLAVGDLAEIYGL
>IFAGANLK_01074 hypothetical protein
MKTNRLLIIVLIVGALLLIPFIAMQFTNEVVWTASDFIIMGILLLVTGLGIDLVLRKFSS
TRNRLIIGGIILAVFFVIWAELAVGIFGSPFAGS
>IFAGANLK_01075 hypothetical protein
MKNIIININKAFDHRVRLGIMSVLMVNEYADFTSLKELLGVTDGNIASHIKALEKKGYVT
VEKSFIDRKPNTRYSATKTGRKDFQKHIDAIESLLNQKNQKL
>IFAGANLK_01076 hypothetical protein
MENEKYLKDISDIKHLMSRSSRFISLSGLAGVFAGCYAILGTVVAEILLAEHNSAIASLR
LSSINAEILMRLFLVAIAVLVLAIVTAVFLTTRKAKKTGEKTWDSTSKRLLINFFAPLTA
GGIFCLVLLQYGLIGLIAPCMLIFYGLALIHASKYTFGDLRSLGYSNLILGLIATQFLSY
GLYFWAIGFGLFHIVYGIWMYNKYDRRNA
>IFAGANLK_01077 hypothetical protein
MIIRIFFACLLFIFTGTTLSSQEVELMSYNIKYANENDGENSWSKRKDHITKQIKFYEPG
IFGVQEALVNQLKHFGSEMKNYKYVGVGRDDGKEAGEFSAIFYDSEEFEVLENDTFWLSE
TPNEISVGWDAAMERVCTYSKFKEKKSGKIFWVFNTHFDHVGEKARENSAKLIWEKISAV
NKENLPVILMGDLNLEPDTSGIQFLMQQLNDSKAVSKLDFGPDGTYNGYNFEEPVTRRID
YIFTSDNIEVKKYAVLSDSKDLKYPSDHLPVWVEVDFK
>IFAGANLK_01078 hypothetical protein
MEKFTNILVALDLSDIDNSVIKYASFLSETLKIHKVYFVHNIKKYEISSLFDEQMKDVNL
DEIIGDELNEKVETHFNSKAEWEVLISEDPYTESLINYIANKYYIDLVVVGNKNRKKGTG
IVSNKLLRLLKCDILSIPRDFHPEIKTIWAGTDFSRESRKIFNIAQMLQEATSAPVTAAH
VYSVPVQFSPYVTIEAMAPKIEKHVREKGDKFLSKLDYQGEVTPLIIPGRDASVASNLLE
CAKKNKVDILIVADKGANNISSLLVGSVTEELFGKNPEVPLWISK
>IFAGANLK_01079 Glycine betaine/proline betaine transporter BetS
MAKKVTRSDEKKSIFGLEVNGPVFFISSFIIIISIALTLIFEKQAETIFADIQTAVANNA
DWFFIMCVNIFLVFLVYLALGQFGNMRIGGHNAKPEFKRLSWFAMLFSAGMGIGLLFFSV
GEPVMHFTAPPTGEPGTAAAAQEAMNFTFLHWGFHAWGVYALVGLALAYFTYTRGLPLTI
RSIFYPFLGDKIYGKIGDAIDIFAVLATLFGLATSLGFGVQQIASGLDHVFNVPSGITTQ
VLLIAGITLIATISVVLGVDKGVKFLSEWNMRVALLLLGLAVILGPTVFIFRSFVENTGS
YLFNFIEISTWSETFTNSSWQNDWTVFYWGWWIGWSPFVGMFIARISKGRTIREFVLGVL
LVPSLVTFFWLSAFGSVSIQEALGGDMSIVDAVNDDIATALFVFFEDYPLSMVINVVAVI
LIAGFFVTSSDSGSLVIDSLTSGGKIDAPKGQRIFWAVTEGTVAAVLLIGGGLQALQTAT
IVTGLPFAVILLIMCYSLYKGLKEDLVEMQDKKEQQEMENYEDIVNDIVKKRNLGKNNNQ
N
>IFAGANLK_01080 hypothetical protein
MHNQPISRGVFSWKSSWAIFCIFIIAPLTAQEEPEVSVGGALRYNYNLSSWKDGQKKRGG
DFGYDIFRVNFNAKYKGVYLNAEYRLYADAFGGGVMKQGWMGYKFNDIDEIQIGLTQVPF
GIQQYNSHNWFFNLTYYMGLEDDHDMGVKYIHAGEKFEYHFAFFKNSEELRFGSDTESST
SRYSYDVVGRNKEVNQFNGKFVYKFGDKAANRLGVSAQYGGLYNLDTQKTGNHYGLAAHY
EITQNRWNLKAQALTASHNPINAEGESREALSFGAYGAPYEVAADFNLYSLAISRNIPVN
LGPVSNLEFYNDFGYMQKQKSSFTDSYMNVTGVLVTAGQVYTYIDYAAGYNHSWLGGNFV
DDFAAGNPDAKWEARFNINIGYYF
>IFAGANLK_01081 2-dehydro-3-deoxyphosphooctonate aldolase
MKLEKIPQLKHINSNNFFLLAGPCAIEGEEMALRIAEKVVEITNKLEIPYVFKGSFKKAN
RSRIDSFTGIGDEKALKILRKVSETFEIPTITDIHEVSDAKMAAEYVDILQIPAFLVRQT
DLVVAAAETGKVVNLKKGQFMSPESMKHAVTKVTDCNNEQVMVTDRGTMFGYQDMIVDFR
GIPTMREFAPTVLDVTHSLQQPNQSSGVTGGRPEMIETIARAGIVNKVDGLFIETHFDPA
NAKSDGANMLDLNYLEKLLSNLVAIRQTVNKL
>IFAGANLK_01082 hypothetical protein
MELQNLLISELQHEVVLTEKFLKRIPADKMDWRPHKKSMSIRQLANHLAEIPSWITATME
MDEMDMAGYKSPDFDSIEEILKILQNNTSEAEAALRKPDEEYQNNWKMIQDGKTLMDMPK
YNVLRMMVLNQLPHHRAQLGVYFRLLDIPVPATYGPSADEN
>IFAGANLK_01083 hypothetical protein
MEGLKEQFSNYYTPKRLLINALIMTAATIFFIYQRPEEPLLGIGFGTIAAIYFGFFVYKR
LKSTS
>IFAGANLK_01084 GTP-binding protein TypA/BipA
MTAIKNIAIIAHVDHGKTTLVDKIMYHCRLFRDNQNTGDLILDNNDQERERGITITSKNV
SVVYKDTKINIIDTPGHADFGGEVERVLNMADGVLLLVDAFEGPMPQTRFVLQKAIDLGL
KPCVVVNKVDKPNCTPDEVHEKVFDLMFELGAEEWQLDFPTVYGSALNNWMSDDPDVKTE
NIEPLLDMVLEHIPSPKVQEGSPQMLITSLDFSSFTGRIAIGRVQRGHLKEGMQVSLVKR
DGSIKKTRIKELFIFEGLGRKKVEEVQPGDICAIVGLEGFEIGDTVADIENPEGLKTIAI
DEPTMSMLFTINDSPFFGKDGKFVTSRHIKERLTKELEKNLALRVKETDSADKFLVYGRG
VMHLSVLIETMRREGYELQIGQPQVIIKEIDGEKCEPVEELTIDLPEEVSGKAVEMVTMR
KGEMLSMETRGERMIIQFMIPSRGIIGLRNQLLTATAGEAIMAHRFKEYQPLKGGIPQRQ
NGSLISMERGKAIPYSIDKLQDRGKFFVDPGEEIYEGQVIGENSRQDDMAVNITKTKKLS
NVRSSGADDKAKIVPALKFSLEEALEYIQKDEYVEVTPRIIRLRKIYLTENERKRNKIV
>IFAGANLK_01085 hypothetical protein
MNEFLGISLTEWIGYLASFFVAISFFMKNIIKLRIVNSLGCILFVIYGILIDSWPVGITN
GIIVAVNLYYLVINKKSHRVKADEVQP
>IFAGANLK_01086 Cell division ATP-binding protein FtsE
MSNTVLELNNAAIYQRESLILSEVDVHVNKGDFVYLIGKTGTGKSSFMKTLYGDLPLTEG
EGTIVDFNLRTLKEKDIPYLRRKLGVVFQDFKLLTDRNIKDNLLFVLKATGWKDQKAMDL
KIDEVLDKVGMKSKGFKFPYQLSGGEQQRVAIARALLNDPELILADEPTGNLDPQTSVEV
MEVLQEISKNGNTILMATHDYALLLKYPSKTLKCDGQRVFEVVQKSV
>IFAGANLK_01087 Outer membrane protein assembly factor BamD
MTPNKILLFVVLILFSFKGISQRSANYTHDLAEFNKALELYNNQQFLAAQNLFDEVKEQT
EDEKIEGDCAYYIANAAVRLNQPGADRLMERFVSRYPTSTKTNSAYLDVADYYFQTGKYS
LARKWYDKVDEKSMSRAEKERYYFNNGYAYFRAKQYDQARTYLERVRDSQEFGSQAKYYI
GYMAYEGDDYEEANQNFEEVSSNDRYSEDLSYFQADMNFKLGNFEEAIKLAKEQLQSSNR
LERSQLNKIIGESYFNLEQYEEALPYLKEYDGERGRWNNTDYYQLGYAYYKQGDYENAIS
EFNKIIDGKNEIAQNAYYHLAQSYLESDQKQQALNAFKNASEMDFNPQIQEDAYMNYAKL
SYEIGNSYESPSQVLINFIEKYPESENREAMESLLIDSFLTSGNFEEAMRLLENNRNFSD
KQAYQKVAYYYGLQLYEEGNYEKAINNFEKALSEPRDQKITAKATFWKAESEYNINRIDD
AIIGYREFSGMNAAQGTDELENLDYNLGYAYFKKNEYSRAIEFFKRYSENGSNDVARRND
ALLRLGDTYFVSSQYWPAIEAYDKALSLSGDNDYAAFQKAMSYGFIDRRDTKISELRSFI
NQYSRSSFRDDAMYELGNTFVSANNTSEALSAYDRLIREVPQSAFVPKAMLRQALIHYNA
DNGNRALERLKKVVNDYPDTPEAMQAVSTARMVYVDLGRTDEYADWVQNIDFVEVTDADL
DNTTYESAENQYFNNEYDRAISGFENYLQRFPNGIHSINANFYLGQMYFRNGNKEKAAAN
YRSVAEKPKNEFTEDALSRLSEILLENENYREAVSYLERLEKEASSEQNVIFAQSNLMKS
YLELDQPEKAANYADKVLANSESDSEARNDARVIVARAAFSSGNMSKAKSAYSEVQKTAK
GELAAEALYYDAYFKNESGNYEASNAAVQILAKDFSSYKRWGAKGLLLMADNFYELDDAY
QATYILENVIKNFSNYPEIVQEAKQELSRIKTEEAKTNSSVEANN
>IFAGANLK_01088 Vitamin B12 transporter BtuB
MQMFSIKRNLFLSLFLISGVLFAQDPIDSETVTVVKPYTPTVKDATKIKQTPTEADSVRT
EKRPVQYSIFSVPVASTFTPAKGRATTVERERPVKVYDNYASLGFGNYGNLLAEFYSNLE
VNRTDNFGVYLDHNSSQGGIDGIALDDKFYDTELNLSYNSKTRNLGWKTEVGAQHQLFNW
YGLPQGANFSNAELNAIDPSQNYFSAYAGAEVELYDSFFDNARGTFRHTGDSYSSAENHF
DARGTFEVNIADELITTNIYTDIVNGQMGEQFLATDTYDYTFMNFGINPSLLILRDDLTL
NLGVAFFYSQDVEDSDGNFYIYPKVTASYRLGGDYFTPYAGLEGGLQQNTYYSFIQENPY
VFPGLEIKPTDNEYNAYVGAKGKLSNSISYNFKTGYESQFNKALFRRNAQANDITTENYA
YGNSFEVVYDDVKTLSVAGELNVDVNRNFRLGINAEYFNYSTDDQVKAWNLPDFKASLNA
DYQINENWYTGANLFYVGERFDQERIASAGDPSMNTISLDSYFDVNAHLGYRFNDRLSIF
AKGSNLLNNDYQRWTNFQVQGLQVLAGATYKFDF
>IFAGANLK_01089 hypothetical protein
MAKGKKFKRSDRSRPYLNILDFMVQEKAFLAIVIVGIIMAGIFTGNKTAAMWLGFFFAAY
ATVANDSIQSLGTFIESNKAKRWWILWLYVGTIFLGVVSFSWFYFDGDVTFQRLLKPDGT
SPYPHPESFSFFQIIAPLVLLILTRLKMPVSTTFLILSVFSADTSGITSVVWKSWTGYIM
AFILSFLVWYLSYNFIKKYFKSRKFNHSWTIVQWIVSGTLWGVWVMQDGANIAVFLPRSL
DTFQFIVFALTIFGGLGLLFYLRGDKIQEVVSEKSRISDIRAATLVDLTYVILLIYKLFI
STVPMSTTWVFLGIIGGREIAISLARTKKGKKHRKKAGKMIFKDFSYAMIGLFVSVALAA
AANKSIRDQIINAIF
>IFAGANLK_01090 N-substituted formamide deformylase
MKKILLLGLFSLMLISCNSIDKEKADLLVFNAEIYTVDDNFSSAEAFVAKDGKFLEIGSA
EALEEKYDIAEKLDAGGKSVFPGFIDGHAHFYRLGLQQQRVDLTGTKSFDEVVQRIVDFQ
NRRDVEFVTGRGWDQNDWENKEFPTKDTLDELFPDTPIAVTRIDGHALLANQAALDKAGI
TTETPFDGGDIEQKDGKLTGIIVDNPMSLITNAQPEPSTQEQVNALLDAQKISFEYGLTT
VVDAGIDRATIELMDRLHKEKSLKIRLYAMISNTEENLDYYLDKDPIKTERLNVRSVKFY
GDGALGSRGAALKEEYSDRAGHYGALLSPVEDFKETAERLAASKFQLNTHAIGDSANYLV
LKTYDELLKDGGDRRWRVEHAQVIDTSDFKYFSKNIIPSIQPTHATSDMYWAEDRLGEER
MQGAYAFKKLLDQAGIVALGTDFPVEEVSPFLTFYAAVARQDTDNFPEDGFMMDQALSRE
ETLKGMTIWAAYANFEEDEKGSIEAGKFADFIILDKDIMEVDASEIPEIKVLETYVNGEK
VY
>IFAGANLK_01091 putative peptidyl-prolyl cis-trans isomerase
MNDGLYAKFYTTKGQILVQLEFEKAPGTVGNFVGLAEGKLENEAFPQGKPYYNDLKFHRV
IPNFMVQGGDPQGTGVGGPGYKFEDEIHPDLKHDAPGKLSMANAGPGTNGSQFFITHTET
PWLDGKHTVFGSVIEGQDVVDSIKQGDKIEKLEIIRSGESAQNFNAVEAFRQFDGAKAER
ETAAKKREEELLGELSQGFKTTESGLRYKIEKKGEGAKPEKGQTVSVHYKGMLTDGSVFD
SSYKRNQPLEFPVGVGHVISGWDEGILLLNVGDQARFVIPSHLAYGEQGAGGVIPPNAAL
VFDVELVAVK
>IFAGANLK_01092 Selenocysteine-containing peroxiredoxin PrxU
MSELKLGDKAPNFDAETSEGKINFYDYLGDSWGILFSHPADYTPVCTTELGTVAKYKDEF
EKRNTKVMALSVDGVESHKGWIDDINETQNTTVNFPIIADEDKKVSNLYGMIHPKADNTL
TVRSVYVIGPDKTIKLMITYPASTGRNFDELLRVIDSLQLTAYQKVATPANWKHGEDVVI
SPSVSNEDAKEMFPKGFKEVKPYLRMTPQPDSK
>IFAGANLK_01093 Thiol-disulfide oxidoreductase ResA
MARTASNMIELGTPAPDFNLVDVITNNRYSLKDVRGNKGTLIMFISNHCPFVKHINEEIV
RLAGDYRVLGFGFAAIMSNDVENYPADHPDNMNEVARRHQYSFPYLFDESQEVARAYKAA
CTPDFYLFDNELKLIYRGQLDDSRPGNGIPVNGRHLRDAMDAILSNKKVSENQKPSIGCS
IKWKYRPES
>IFAGANLK_01094 putative chaperone CsaA
MEISWNDFEKVEMRIGTITEVSDFPEAKNPAYKMLIDFGSEIGQRKTSAQITKRYNKEDL
LHRQIVAVVNFPKKQIANIMSECLVLGAVDKENDIVLLNPGFKVENGLRVG
>IFAGANLK_01095 hypothetical protein
MKNLLFIALFATLAGGCSSTPNSPDLNLDKGEITGKWQLTETLSDPGDGSGTWQPVENGR
TLEFTSNGLVKSSTSFCHEEDINETSYDNVENMISTDCGENTFELKYEVKDGDLYVYPHN
PRCAEACGSKYEKIED
>IFAGANLK_01096 hypothetical protein
MQKLLPFLIFFIFVNSFAQQEDLSLDYYLPQDVSYNEEIPKPQDIIGYIPGEWHVTHDLL
LNYMRELARVSPRISIENRGETYEGRPLILLTITSEENQNNLEEIRQNHLALTQENASSL
DTEEMPIVVNQGFSIHGNEASGSNAALLAAYYLAAAEGEEIQELLDNTIILFDPAFNPDG
LQRFSSWANIHKSENINPDPQDREYDEVWPGGRTNHYWFDMNRDWLPVQLPESQARLETF
HKWSPNILTDHHEMGSNSSFFFQPGIPSRTHPLTPDINQDLTREIGTYHAAAFDELGSFY
YTEENYDDFYYGKGSTFPDINGSIGILFEQGSSRGHAQETDNGVLTFPFTIRNQFTAALS
TLEAAKNMREKILNYQRDFYKNARNSAENGAYVFGSEKDASSAYELAKILKKHKIDIHQI
EEDFKTDGINFKKNSAYVVPKNQRQHRLVKAMFERRTEFEDSLFYDISAWTLPLAFNLDF
AEDVKMNKAGQKIENLEKPEIETVEKSNYAYVMQWHDFYSPKALNMILEKGLRAKVGMQP
FSLENKEYDYGTILIPVQNQELDKEEMHEFLQEVAQKSNVQIDGIGTGLTQGVNLGSNQF
RALEPAKVALIVGEGITPYDAGEIWHLFDQRYDMKITKLDTRNFSRTDLSGYTDIILPNS
WGSALDDGDIEKLKEWVRDGGTLIGYRNAARFFEREDFMDLEIKKDSLVAEDISFEEQRD
FRGAQGIGGAIFEANIDRSHPVNFGYTNDKLPLFRNTTIFVEADKQSYNNPIQYTEEPLL
SGYISAARLDSIAGTVPFKHTGMGRGNVILFTDNTNFRAFWFGTNKLLMNAIFFGEEM
>IFAGANLK_01097 hypothetical protein
MSDKGMMEKEEIFSKVLRAGRRTYFFDVRATRADDYYLTITESKKFTNDDGSFFYKKHKI
YLYKEDFAGFNEILQEMTDFILNEKGEEVISERHQKDFKKEYETSENGEAQGVSPEKFTD
VSFDDI
>IFAGANLK_01098 putative multidrug resistance ABC transporter ATP-binding/permease protein YheI
MKNLKHLNKYFLKYKWKLLIGLVITIVARIFALYYIPLIGDSTDAIEQYINGEISTIDVL
RTELAINIALIIGATLVAAFLTFLMRQTFIVVSRYIEFDLKNEIYKHYQELSLNFYKKNR
TGDLMNRISEDVSKVRMYLGPAIMYTVTTFTSTVVVLIFMVQAAPELTLYTVAPLPVLAF
SIYKISVAIHKRSTVVQQYLSRLNTFTQESFSGIAVIKSYGMETQINHNFVDLANGSRDK
NIDLVKVQAFFFPLMVLLIGISNVLVIYVGGNQYINGEIENIGVIVEFLLYVNMLTWPIA
SIGWVTSLVQQADASQERINEFLDEKPEITNRKEAPDEIHGSIAFNNVSFTYDDTNITAL
KNISFEVGSGETLAIIGKTGAGKSTILELIGRLYDVDQGSISIDGKNIENLNLDSLRNSI
GYVPQDAFLFSDSIKNNIKFGKTDATDEEIFEAAKNASVHNNIVGFSKGYETVLGERGIT
LSGGQKQRVSIARAIIHDPKILLFDDCLSAVDTETEEAILNNLFKISKEKTTIIVSHRIS
SAKNADKIIILEDGAIVQQGTHSQLLNQQGYYKELYAKQLNEKEM
>IFAGANLK_01099 Leucine dehydrogenase
MQVDVLNANELKKSAPVFGQLSFDNHEQVVFCNDKDTGLKAIIGIHNTVLGPALGGTRMW
NYSSEWEALNDVLRLSRGMTFKSAITGLNLGGGKAVIIGDAKTQKTPELMRSFGRFVDSL
SGKYITAEDVGMETADMDTVREVTKYVTGISEDKGGAGNPSPITAYGVFMGIKAAAKHKF
GSDDLEGKSVLVQGIGHVGETLVEHLTQDGAKVFISDINEERLEAVRNKYGAIIYDEADV
YAADVDIYAPCALGATINDDTVNRIKAKVIAGAANNQLADEVTHGTILRERGIVYAPDFL
INAGGIINVYAELENYDKKEIMRKTENIYNTTLEILSKADKEDMTSHFAALKIAQQRIED
RKKQNLK
>IFAGANLK_01100 N utilization substance protein B 
MLTRRHIRVKVMQSLYAFNQSQNDNLGTEERFLLKSMEEMYDLFLVQLSLIAELKGQAEN
FLEKSQQKHLATTEDKDPNKKFVSNAVFEILEHNESLQDALESRKITHWKRDDDYVQIIW
QEIKKSDRYENYMETRDSSFKEDKEFIIAIFKEVIAPNEKLYDYLEDAKLTWVDDLPLVN
TAVLKFLQKLKPNSAENLKIGKLYKNEEDKEFAKELFRKTYLNDDTLANEMLGKTPNWDK
DRIAEIDMILIKMAICEFLKFPSIPVKVTINEYLELAKEYSTPKSSIFINGVLDKLSKEY
KEDNKLNKVGRGLM
>IFAGANLK_01101 hypothetical protein
MKNGILMLAAVGALLFTSCKENNDNASEKVKAENVESAAERDAQATVYPKMEFAESEHDF
GNIAKGENVEHTFTFTNEGQAPLVITNAKSTCGCTVPTWTKEPIQPGESGEMVVKFNGSG
KGQVTKTVTVTANTEAGTERLRIKAFVETEENAS
>IFAGANLK_01102 hypothetical protein
MDQLTQFAPIILMFVVVYFFMIRPQMKKAKQERNFASELKRGDRVVTKSGMHGKIIDFSE
KNNAVIIETGAGKITFDRSSISMEMSKKLNEPAKPEKESKAKAIKEKK
>IFAGANLK_01103 hypothetical protein
MAVQSVDQYIETHPTWKQELLSLREVLQNTELEECIKWGAPVYALDSKNIMGIAAFKNHC
ALWFFNGALLKENTALLYNAQQGKTKALRQIRFEKGNELKLEIIQKYVAEAIQNQREGKE
IKPLKDKKLIFPSELKFELEKDEDLKNSFQQLTKGKQREYADYITEAKREATKQSRLYKI
KPMILNGVGLNDKYKNC
>IFAGANLK_01104 Peptidase T
MINKQRIIDRFISYITIDTQSDPNSTTTPSTDKQWVLARKLADELKEMGMTEVSIDDHAY
VMATLPANVAHKVPVIGFISHFDTSPDFNATDIKPQIIENYDGNDIILNKEKNIILSSEY
FDDLKQYKGQTIITTDGTSLLSADDKAGITEIMTAMKYLLDNPEIPHGKIRVGFTPDEEI
GRGAHKFDVEKFGAEWAYTMDGSQIGELEFENFNAAKAIVKVQGRGVHPGYAKDKMVNSQ
YIAVDFINSLPRLETPEHTEGRQGFFHLSDMQGDVEETILEYIIRDHDLGHFEARKEMMQ
DLASEICSQYESDCISVEITDQYFNMKEKIEPVMHIIEIAENAMKEVDVEPILKPIRGGT
DGAQLSYMGLPCPNIFAGGHNFHGKYEYVPVESMQKATEVIVKIVELTSENYK
>IFAGANLK_01105 Dihydroorotate dehydrogenase (quinone)
MYKSSLRPLLFRFDPEWVHHFTFKTLKKVGKTAAFKSFVRKKFQVEDPRLEREVFGLKFK
NPVGLAAGFDKDAKLFQELSDLGFGFIEIGTVTPKPQPGNEKKRLFRLKEDGAIINRMGF
NNDGVKAAVERLKENKNVLIGGNIGKNKITPNENAVDDYKICFEALYDYVNYFVVNVSSP
NTPNLRELQDKEPLTNLLNTLQGLNAEKPKQKPILLKIAPDLTDAQLLDIIDIVKETKIA
GVIATNTTISREGLQSENKNETGGLSGKPLKNRATEVIRFLSEKSNKAFPIIGVGGIHSA
EDALEKLEAGASLVQLYTGFIYEGPGLIKEINMKLLETENKN
>IFAGANLK_01106 Homoserine/homoserine lactone efflux protein
MLEQLIPFLTASAILTISPGPDIIYVMVQGMANGKKHGFVTALGLATGIIIHTSLVAFGV
SAIIKSSETLFFIIKLFGAVYLLYLAWQVYKSDPEIAYSAKGIKAKPLFSLFKQGFIMNV
LNPKVTIFFLAFFPGFLWVPGGNTVVQFYILGGIFMLVTIMIFGSVALLAGKISTYLKKH
KHSGVVLKWLQIVVFIGIAVFILV
>IFAGANLK_01107 Hydroxymethylglutaryl-CoA lyase YngG
MDKIKLIECPRDAMQGIKTFIPTEKKVQYIQSLLRCGFDTIDFGSFVSPKAIPQMADSAE
VLAKLDLSTTKSKLLAIVANTRGAQDASVHPEINYLGYPFSISENFQMRNTHKTIAESVE
ILSEILEIAEKTDKDVVAYLSMGFGNPYGDPWNVEIVGEWTEKLSGMGVKILSLSDTIGS
STPEIIEYLFSNLIPEYPEIEFGAHLHTIPTKWHEKIDAAYKSGCRRFDGAIQGFGGCPM
AKDELTGNMPSEKMLSYFNSKKADSNIKMTSFESAYNEASKIFSAYH
>IFAGANLK_01108 hypothetical protein
MKKILTTLVLSGLAFTSCTSDDDTIPEDEQIEVPAQYSFERDGESTVSYTGQTQRLSMVK
ELFAEFHNFENATQSSMSNMFSNENDPFTSPELNETSKSIKSKVAASRLYFSTNTVASNE
IKNDFEEFISIQANEVFPNENELAAPGKAGQIAAGSSERYIDEKGLEPDQAFAKGLIGAL
VTDQMLNNYLSVEVLDEGDNLVNNDEENVEEGKSYTTMEHKWDEAYGYLYGDSSIPSENP
NTDLNESDDILLFKYMGSVNNDSDFEGIAEETFEAFKTGRAAIVAGDYDLRDQQVAIIRE
NVSTIIAVRAIYYLQAGKNQLAEGQDGVAFHSLSEGYGFIYSLMFTHNPATGSPYISAEK
VEDYLEQLMAGDGFWDVTPETLDTISEEIAASFDFTVEQASE
>IFAGANLK_01109 hypothetical protein
MIRILRFSTLFLLAAVISCSDTEDTDDGANTDSFDRGEMLQNWADNIIIPSFENFEGITQ
TLEEKTFAFTSDPSETTLNELRSAYEDGYLGFQTVSLFEIGEAEAINYRSNLNTYPLDAA
GVDGKISTDDYNLELPSAYDEQGFPALDYLLNGLAETDTEIVEFYTSHENAEVYKNYLND
VSKRINALTNTVHSGWKDSFRDDFVSNTGSSSTGAVDRITNDYVLYYEKFVRSGKIGIPA
GVFTGNPVPGAVEAYYSPSLSKDLYLKSLQTTQNFFNGRHFNGSQEGPGYDDYLDYLNSI
KNGEDLSKLINSQFDIIRAHAEVLDNSFVSQVENNNNEMLAAYDELQQNVILLKVDMMQA
LSISVDYVDSDGD
>IFAGANLK_01110 hypothetical protein
MNQKITSYFNEKTQAAPLAVFRVFFGFMMLASIIRFWLNGWIEKLYILPEFSFSYYGFEW
VKPLGNFTYIIFLICGLSAFFVGIGYKYRLAIITFFISFTYIELMDKTTYLNHYYFISIL
SFLLIFLPANAYFSLDAKKNTGIAFQKIPRWCIDSIKLLLGIVYFYAGLAKINFDWLLKA
MPLKIWLPSKYDLPFLGDLLQQEWVHYAFSWSGMLYDLLIPFLLLYRPTRLFAFVMVVIF
HVLTRVLFPIGMFPYIMIVSAIIFFDPGIHHKILEKISRLFGIVKARFDNGRALNYLSNK
RKFLLSFLSLFFIVQLLLPWRYLLYPGELFWTEEGFRFSWRVMLMEKAGYAQFKVVDGET
GKRFYVDNSDFLTPFQEKQMSTQPDFILQYAHYLADHFKKDGHENIEIYVESYVALNGRQ
SAPYIDPNVNLLEEKDSFKHKTFTLPFHDQIKGL
>IFAGANLK_01111 Fe(3+) dicitrate transport protein FecA
MTKSRAFSFFCLIFLTFTGSYAQSIKGKVISSEDNSGVPYAEIYNKTTGNLTLADENGDF
AIEALPPATYEFVVYSFEFQIEEREIEVTENTEVIFELEPLAESLSEVVITQRREQLFAL
RRLKEVEGTAIYAGKKSEVVLMDKVTGNLAANNARQIYNHVVGLNIYDNGDAGLQLNIGG
RGLDPNRTQNFNTRQNGYDISADVLGYPESYYTPPPAALSEIQVVRGAASLQYGTQFGGL
INFRFKKPNPVKKFEFINRQSVGSYDLFTSFNSASGTVGKFSYYTYYNYKSGNGFRPNSQ
YESHNAFAHLAWKFSEKTQLSFEYTWLDYLAQQPGGLTDAQFYENPNYSNRSRNWFDVNW
NLFALKFQHEISDRTDFSLNLFGLDASRQALGYRQNRVSQPDDPEEPRELLFDAFNNWGA
EARLLTRYNFLGEESVFLIGSKYYDADNTQRQGPGSAAANPDFSFASSSYPNYPRQSEFQ
FPNKNLAIFGENIFHLTERFSITPGFRFEYIHTQSEGSFKNIFTDLAGNVLQNETIADNR
GFERGFVLLGAGAAYKFTPQTELYGNFSQNYRSVTFNDIRVVNPVFQVDPNITDEEGFTA
DLGLRGRYKDFSYDTGIFGLRYNNRIGEVLRAEERENASGEMVETGRLVRFRGNIGDAFI
YGVEAFGEWNLKNILFGENQDYLSSIFLNAAFTDSEYTSSAQTNVEGNQVEFIPAVNLKA
GMSFGYKNLLGSLQYTYLSEQYTDATNAAQDRRDSQRGIEGEIPAYGIMDLSFSYSYKRF
KLETGINNLLNNSYFTRRATGYPGPGIIPAQPLTWYTTLQFKL
>IFAGANLK_01112 Iron uptake protein A1
MKKLIVAIFSIILLMSCKDSDKKDEAEIKTSEEVNVYTHRHYESDQELFKMFEEETGITV
NVINASADELIQKMRMEGEQSPADVLITVDAGRLERAKSSDLLQAVSSDILEETIPSHLK
DADNHWFGLTKRARVITYAKDRVDESELSTYEDLASDKWNDKLLIRSSGNIYNQSLMASI
MVHNGEEEAKKWAEAVVENMARAPKGNDRDQVKAVVAGEGDLAVVNTYYIGKMLNSEDPE
EVKAGENIELFFPNQDGRGTHINVSGAGVAKHAPNKENAIKFIEFLISEEAQKIFAHSNY
EYPVNEDVAPANLLQEWGEFKEDTLNLSTLGENNKKAVMLFDEAGWK
>IFAGANLK_01113 Spermidine/putrescine transport system permease protein PotB
MKQAGSSDIFSIKSRLRRLKRDTNRWSIFTLAIVLFIALPVIAIAVKLLAGPGETWGHLV
DNLLVDYIGNSFFLIFFCSLLVLIMGVGTAWLVARFEFPFRKQLEWLLILPLTIPSYIVA
YAYAGVFDYGGSLELILRGLNLEFIRIDIMNKFGLAFVLSISLFPYVYVSSRAFFLNQAG
NLLEASTMLGVGEFKSFFRLMLPLARPAIIAGLILVLMEVLNDYGAAQYFGVNTFTTGIF
RAWFSLEEPETAVYLSALLIFIVFALILFEKWQRKNIRFTGNKASGRTHRKLGTKPMQWL
KFLLVLIPVILGFFIPVGQLIYWAFLTAEKVFDLDFIMLSLQSFGIALVTSLVTVLFATL
LIYFAKWSSINGIKSISRLGILGYAIPGAVVAIGIMIPTLAFDKWFINTMDSVFGVETGF
LFNGTLVALVYAYSVRFLAVAYNPIESTALKVSNSIPDSSKMLGVGNFKTFFKIEFPLIK
TGILSAVILVFIDVLKELPLTLILKPFHINTLAVKAFEYASDEMVMEAAIPSLFIIFTAT
IPVIFLNKLLIKE
>IFAGANLK_01114 Fe(3+) ions import ATP-binding protein FbpC 2
MLSVNSISKSFDKGKTFALDEVSFNLEEGDVCAIVGESGSGKTTLVRLIAGLERPDHGSI
ILNNKELSSVKKLVPPEKRKIGLVFQEYALFPHFNLLKNVTYGISKLKNKKERALEMLEL
VGLSGLEKRYPHQLSGGQQQRVALARALAPNPSLLILDEPFSNLDAMLRMQLRSQVFEVI
KKTGVTAIFVTHDTQDALSVADEILILQHGKVIQKDQASNLYIKPNSVYVASLFGNTIQL
NKELQTAFDCPLNPKCSHAIRNENLSINEECEYVTHARVLKKTFMGNGTHLLLKLDNGHQ
ISVVTKDTNVADKIKIGFNSTDVLEFAG
>IFAGANLK_01115 Inosine-5'-monophosphate dehydrogenase
MIAHDSKILGEGLTYDDVLLVPAYSEVLPREVSIRTKFTKNISINVPIISAAMDTVTESR
MAIAMAREGGIGVLHKNMTAEQQALKVRKVKRAESGMIIDPVTLPITASVSDAKANMREH
SIGGIPIVDDDGKLLGIVTNRDLRFEKNNSRPIAEVMTSENLVTVAEGTSLDQAEDILQE
NKIEKLPVVNKDNKLVGLITFRDITKLTQKPNANKDSFGRLRVAAAIGVTADAVDRAEAL
VNAGVDAIIIDTAHGHTRGVVSVLKDVKAKFPDLEVVVGNIATAEAAKYLAEAGADAVKV
GIGPGSICTTRVVAGVGFPQFSAVLEVAAALKGTGVPVIADGGIRYTGDIPKALAAGADC
VMLGSLLAGTKESPGETIIYEGRKFKSYRGMGSVEAMQKGSKDRYFQDVEDDIKKLVPEG
IVGRVPYKGELEESIHQFVGGLKAGMGYCGAKDIPTLKENAKFVKITASGIHESHPHDVT
ITNESPNYSR
>IFAGANLK_01116 hypothetical protein
MTRSSLLIAFLCFSVFVSAQTKVGTIDTDYILSQMPEMEEVNEGLQAYDQQLQQDFQGSV
KKYDTLVKSYQANTETLADEARQQSESEIIELENQIKQFRQRAQVMMQMRRNELTDPLYE
KIDVAMRAVIQEEGFTQILHAGGNSLAFSAEEYDITEKVMNKMGIEIPAPSEVEEEE
>IFAGANLK_01117 hypothetical protein
MLAGCTFFEKEEERKVIVRVNDSYLYEEDINALINENTSIEDSSLIVSNYITRWATQQLL
IDRAQLNLPESQQREFRDLIENYKNELYTSAYKDAVVGRQLDSSLTKEEKKIYFEENIGN
FKLTEDLLKLRYVSLEENNTNIDEIKSYLTRFNEEDKEELDKLSLQFKNYSLNDSVWVKI
KTVYDKIPALSSNNRDNLLNKSNFFQVEDSLGVYLIYVNDVLEHGQDAPFEYAEPTIEKI
LLNKRKRNLIKELEKDITKDAIKNEQFEIYN
>IFAGANLK_01118 Chaperone SurA
MQLKMNNLKSIIKNIGFLLAVLLGFTGYSQDVIVTDSTSIQPEDEIAQNTVTETNNSERR
KVDGIAAVIGDYIILDSDVDMMYKDMQSQGMSTADVTDCQLAGSLMENKLYAHHAIQDSI
IVMDAEVNSYIDQQISEMVRQVGSMEKVLEFYNKEDEAEFRSELFELNKERQLANRMQQK
IVETVEITPEEVRAYYESLPEDELPVFGEEVELSQIVVEPEIPESEKQKVIDRLKDFRAD
VLDNDASFATKAVLYSQDPGSARDGGRISLSRKDNFVKEFKDVAFSLQGGEVSEPFETEF
GYHIIQVDRIRGQKVDLRHILLIPDVTNASVEEAKAKVDSIRKRIDEGVLDFAEAAREFS
DEEETRSDGGKLINPRTGDTRFELSKIDPKLYDEVGDLQEGELSLRMRDQDRTGRPFFKL
IKVNKRIAEHEANYATDFTKIKELALRDKQLEAIEEWQKEKIGDTYIKVNGKFKDCEYSS
NWLKN
>IFAGANLK_01119 hypothetical protein
MSDVALVEKLVVKHRDLKKEIAKIIVGQDVVIDQILLSVFSGGHSLLVGVPGLAKTLMVN
TISQALGLDFKRIQFTPDLMPSDILGAEILDENRTFKFIKGPVFSNIVLADEINRTPPKT
QAALLEAMQERSVTVAGHNYKLANPYFVLATQNPIEQEGTYPLPEAQLDRFMFSILLEYP
SFQEEVDVVKSTTSDKTQKINALFSAAEIVEIQQLIRRIPVADNVVEYAVRLVGKTRPAS
AEAPEFVKNYLDWGAGPRASQNLILAAKSHAAVNGKFSPDIEDVKAVAIGILRHRIIKNY
KAEAEGISEEKIIRDLY
>IFAGANLK_01120 Aconitate hydratase A
MAYDIDMIKKVYSQMAERVNTAREVVGKPLTLSEKILYSHLWDGSAKEAYQRGKDYVEFA
PDRIACQDATAQMALLQFMQAGKKQVAVPTTVHCDHLIQAKMGAAIDLQAANKSSSEVFD
FLESVSNKYGIGFWRPGAGIIHQVVLENYAFPGGMMIGTDSHTVNAGGLGMVAIGVGGAD
AVDVMAGMPWELKFPKLIGVKLTGSLSGWTAAKDVILKVAGILTVKGGTGAIIEYFGEGA
RSMSATGKGTICNMGAEVGATTSTFGYDESMDRYLRATARTEVADAANEIKEHLTGDDEV
YANPEQYFDEVIEINLSELKPHLNGPFTPDLATPISEMGVKAKENDWPINVDWGLIGSCT
NSSYEDLTRAASIAKQAVDKKVKAKSDFGINPGSEQIRFTAERDGLLKIFEDLDATIFTN
ACGPCIGQWDRSDRKGDEKNTIVHSFNRNFSKRADGNPNTHAFVGSPEMVAAIAISGRLD
FDPTRDKLINEDGEEVMLDEPTGIELPSDGFAVEEDGYVPPNEDGSSVVVKVAEDSERLQ
LLTPFEPWDGKNLMGAKLLIKAFGKCTTDHISMAGPWLRYRGHLDNISNNCLIGAINAYN
KKTNFVKNQLNGEYDGVPAVQRAYKKEGVPTVVVGDHNYGEGSSREHAAMEPRHLGVKVV
LVKSFARIHETNLKKQGMLGLTFDNEADYDLIQEDDTFNFIDLEDFAPDKQITVEIVHAD
GSKDTIKTNHTYNQPQIEWYKHGSALNLIKKQNAA
>IFAGANLK_01121 Thiol-disulfide oxidoreductase ResA
MKKLFKNQWTNIIFIVIILVMIIPQTRKPIQIVVNKIFAFSPSVTDEADRKELETYNWTL
ETKDGKRVDFAESKGKVIIVNYWATWCPPCIAEMPSFQELYTDYKDDVEFYFISGEDHET
TNNFLKRKGYNFSSYRMLSEDPKPLDGYTLPSTYVIDKNGTIVVDKKGAADWNSQNFRNL
LSQLLTD
>IFAGANLK_01122 hypothetical protein
MLGPVYFYVIIGGGLAGLQLARQLSRDVFFKGKKIAIIDSDFSLPVKTWCFWEKGAGKWD
HLLTQSWNKGKFITSEENIDLQLSPYSYKMIKAADYHQKLQEEIEESGDIEFITDEIQKI
DPVTMKAKGRKKSYGATHFFDSRIDPSYLESKKHTTIFQHFKGWEVETEKPIFTPDSFTM
MDYRIKYPEATAFTYILPFTEKKALVEYTFFSPFLTEDKVYDEMLQKYFEKVLKTKEFTV
KSTETGVIPMTDFPFNKANTKQITKIGTGGGWVKPSTGYSFKNTEKRINRIIKNIKSGKL
PGENLINEKFRKYDAIFLDVLAQNNQKGEEIFTKFYTKNSPQDFFKYLDEETSVSEDLKI
MFTLYSFDFVKSFFRKTF
>IFAGANLK_01123 hypothetical protein
MDILLWILVFLGTFAGMEGMAWFTHKYIMHGLLWKLHKDHHHKNHSHWWERNDLFFIFYA
LVSIGFFLLWRYEDVWIGLPIGLGILAYGITYFTVHDIFIHQRFKVFRNANNSYAKGIRR
AHKMHHKHLGKDDGECFGMLFVPFKYFKK
>IFAGANLK_01124 15-cis-phytoene synthase
MKAIFDNVSRACSKTVTHQYSTSFSTATRMLAPSIRQDIYNIYGFVRFADEIVDTFHDYD
KEKLFNDFEVDLYKAIEDKISLNPILNAFQETVHRYKIDESLYRAFMKSMRLDLHKSDYL
SVAEYKEYIYGSADVVGLMCLKVFVKGDTKKYESLKQSAMSLGSAFQKVNFLRDLKADFE
DLSRSYFPGTNLEQLDEASKQKIIAEIEEDFKHGLSGISHLPVEAKFGVYTAYIYYRKLL
HKLKKVPSLEIRNSRVRVPDYQKAGLLAKSYISYRLKLI
>IFAGANLK_01125 Dehydrosqualene desaturase
MKKKVAVIGSGFASLAAACYLARDGYNVEIFEKNANIGGRARQLKKDGFCFDIGPTWYWM
PDVFERFFADFGKQPSDYYELKKLSPAYKVFFGKNDSITIEDSLEKICAAFETEEPGSSK
KLKQFIEEAKNNYDIAIKDLVYRPGVSPLELITPTTAGKIGQFFSTISKEVRKEFTNQKL
IQILEFPVLFLGAKASNTPAFYSFMNYADFGLGTWHPKGGMYKVIEAMETLANSLGVKIT
TNAPVSEIFVENNTATGMQVNGERIEADYILSGADYHHTETLLPEYKRQYKESYWQKKTF
APSALLFFAGFNKKLENVTHHTLFFDTDFEKHAKAIYDDAEWPENPLFYASFPSVTDDAA
APEGKEAGIFLIPLAPDVEDTPEIRENYFQKIITRFESLTNQNVTDHLLFKESFCVKDFK
EDYNSYKGNAYGLANTLLQTAFLRPKLKSKKVHKLFFTGQLSVPGPGVPPSLISGKLAAG
LIQKEN
>IFAGANLK_01126 HTH-type transcriptional repressor CarH
MELIKQNFSIKDLENLSGIKAHTIRIWEKRYNILNPDRTSTNIRTYDSSNLQKILNVAFL
NEHGYKISRISKLSDEEIAKMVRSISASTSKENRAQNSFKLSMMNFDEELFNTTYETLRK
DKNFRQIFHQVFLPLLEQIGMLWQTDTIKPIHEHYIVDLIKQKLYFNLAEIKKEIKPTSD
KLYVLFLPENEIHDIGIIYLYYELLYHGNQAIYLGPSLPLTDLGYLLERHDNLSFVSYFT
TAPGDVEDFINQFNEEVCEKKTYELLLFGHKVREIQHKELPAFVKTHTNLNQFIDNL
>IFAGANLK_01127 putative oxidoreductase EphD
MTKISSKLVLITGGASGIGKIMGREVLKQGGKLVIWDVDKLNLQKTLNEFEELGEVYGYT
IDITNSVWVKEMARQVEEEIGGIDILINNAGIVYGGYFHENSSEKIEKTMKVNAIAPMQL
ALTFLPGMLKKKKGHICNITSSAGLVSNPKMAVYAGSKWAATGWSDSLRLEMNQLKTGVG
VTTVTPYYINTGMFHGVKSNIPILDQYKVAKKIIKAIESNKSYLSMPWSMRFVRFSQGLF
PIWFYDWFVGRVIGVYKTMDEFKGRPKKIKL
>IFAGANLK_01128 Nucleoside diphosphate kinase
MAGKRTFTMIKPDAVEAGNVGAILEQITASGFRIVALKMTQMTTADAEEFYAVHNERPFF
GELVEFMTRGPIVSAVLEKDNAVEDFRALIGATNPEDAAEGTIRKKYAKSVGENAVHGSD
SDENAQIEAAFHFSGREMF
>IFAGANLK_01129 Alkaline phosphatase D
MKVILSLFLSFFLFISCGSNSKTPHNEARDAPETFDFIIAFGSCNRQDEAQPLWDAILEE
EPDLFLWGGDNIYADTDDMNELEADYREQKNHPNYKKLWKTIPVLGTWDDHDYGKNDAGK
DWEFKEESQQLFLDFFDVPENDPRREREGVYHSQTFTEDGKSINVIVLDTRYFRSDLEPS
DKPGQRYKINAEGTVLGTQQWKWLENELKNSTADYNVILSSIQILSAEHGFETWGNFPSE
TKKLEELLQASEAKNVIILSGDRHISEFSEQRMEGLNYPLVDFTSSGMTHSYSDFRGEPN
QYRIGEVVSDLSFGLLKFDFDSGEVKMEMRGVGNKLQQEYLVKYIE
>IFAGANLK_01130 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MIEQAILEITAELSQAKNIVIVPHKGPDGDAMGSTLGLMHFLKDKGHKVNVITPNDYPRF
LKWLPGNDEVIIYEKDKANAENLITEADLVFALDFNHLDRSGDMQQILTASEAVFIMIDH
HREPSDFANYTYSDAEMSSTCEMVYHFIDKLRAVPKITPEIATCLYVGIMTDTGSFRFSA
TSAETHRVIADLIDKGAVNHEIHNNIFDTYNEDRLQLLGTALQNLRVKPKFKTAYISLTQ
EELDKHNFQKGDTEGFVNYGLAIENVIFAVIFIENKQEGIIKISFRSKGDFNVNEFARAH
FEGGGHNNAAGGKSELSMEDTITKFSTILPDYKELQQ
>IFAGANLK_01131 hypothetical protein
MNKYLIFITILAFGACKSPEARYPVTQKSGSHISESIAKNQELLEKEIALIETAINRDST
REYQSSQDGFWYTYHKKIEDSTDSITPEFGDIVEFDYSISTINDEVIYAEGEKATRTYAI
DQEELFSGLRQGLKLMKEGETVTFLFPSYKAFGYYGDKNKIGTNWPIKTKVTLNNITEKE
EIQNQQ
>IFAGANLK_01132 putative peptidyl-prolyl cis-trans isomerase
MRTSKFLLICAMVFTMISCNDEYPDLEDGMYAEFKTNYGTFVSELYFEQTPITVASFVSL
AEGNNKMVDSTHKGKKYYDGLTFHRIIDGFVIQGGDPSGTGSGGPGYKFPDEIVDSLSHD
SKGILSMANAGPGTNGSQFFVTLAPTPNLDGRHTVFGKVVEGQDVVDSIGKVETGPQDRP
SKKVTMEEVNIIRKGNDAKDFEAPKVFEEELQAIKDKEDAEAKKRQEAKSAKAEEFESHE
GDAETLDSGLKIHYLNEGDGDRPKTGQMVEVLYEGYFSDGEIFDTNKEELAKEMGLFNEA
RKNQGGYGPMAVVYGPDAPMIPGFKEGIQQLKVGDEVLLYIPSHLGYGERGAGGVIPPNT
DLVFKVELVGIQE
>IFAGANLK_01133 Cytosol non-specific dipeptidase
MNEEIRELEPKILWNKFADLNEVPRPSKKEERVIEFMKNFGNKLNLETLVDETGNVVIKK
PATSGMEDRKPIVLQAHLDMVHQKNNDTDFDFETSGINMYVDGDWVRAKGTTLGADNGLG
VASMMAILESNDIEHPALEALFTIDEETGMTGAKGLDSNLLEGDILLNLDTEEDDEIGIG
CAGGVDITAVRDYEVEHTPDNSVGYQIKVKGLQGGHSGMDIIKGLANANKIMARVLFDSN
RDFGLRVSSILGGGLRNAIPRESEAIVVVDKSNTETFLTEIIQQVRDIKAEFASLEPNMD
IEISETEVPNEVMKVEDQQEVVKAISAAHNGVYRMSPDIKGLVEASNNIASVKVGEGKVK
INCLTRSSVESSKDDLANSLEATFELAKFKVKLSGEYPGWAPNPKSDILKVVDELYQKLH
NEKADVAACHAGLECGIIGNHYPEMDMISFGPTIRGAHSPDERASITSAQKYWKFLREVL
KNIPKK
>IFAGANLK_01134 hypothetical protein
MFLAGYPELVENWYSRLLYPQFSKLMRYGHGFLPFSLGDLLYTLFGILILRWFIRRFKQK
FKNSRFWVVDALAVLSVVYACFHIFWGFNYYRLPLHKALEIENDYTTEELHQLSEILITE
SNKLHNQLSENDSVSVVIPYSKNEIFKKTIEGYTNISKDFPELTYKGESLKRSLYSIPLS
YMGFNGYLNPLTGEAQVNTQIVPYKIPTTASHEIGHQLGFAKENEANFIACLSTMNHPDA
YFRYSGYTFALRYCLNELYRRDPEKFETLKAKLNPGILENYREVEEFWLAHQNPMEPVFQ
AFYNRFLIVNNQADGMKSYSYVVALLVNYFSEEKNRI
>IFAGANLK_01135 Dihydroorotase
MKIRLLLCLVFLVGLQSNAQEYFPKNDGVKNPQTNYTVFKNAKIHVSPQETIENGTFVVK
DGKITAIGKSVSEPQNSIVIDLEGKEVYPSFIDLYSSFGIKEPKEASSGNDQPQYDANRE
GYYWNDHIRPETGAVNYFNYDEKAATSLHKAGFGAVNTHVTDGIIRGTGMLVALNPGGTE
GDRILKDRSAQYLSFDKSKLSRQSYPTSTMGAMALIRQAYLDAEWYGKGKSDNKDLALEA
LNRNKNLTQIFATDNLLDALRAGKIGNEFNVDYVILGNGEEYQRLQEIKETGSTFIVPLN
FPDAYDVENPFLAEHVTLEEMKTWNQAPANLKMLAENEIPFTITAHDLEAEKDFRNNLLK
AVSYGLSKEDALAALTTTPARILGEEERLGTLKEGAWANFLITSGDYFDKETSVFENWIQ
GEKMVINKMNTTDITGTYDLNLEGTTYELKISGKPESQKASVKSGEMKLGAKLSFSDNWM
NLLLSPADTTKTGFTRLVAKTDDSKDDISGTAYLSDGSETDFTATKKTSTETAEAEEDEE
ENGEDKEEDIREIMPVSFPNKAYGFSEMPKEETILFQNATVWTNEEEGILENTDVLVKNG
KISRIGENLNAGNAKIIDATGKHLTSGIIDEHSHIAASAINEAGHNSTAEVTMEDVVDPT
DINIYQNLAGGVTTVQLLHGSANPIGGRSAILRLKWGEDAEDMIFENSPKFIKFALGENV
KQSNWGSRSRFPQTRMGVEQVFTDYFTRAKEYEEAKENDDDFRRDLEMETLLEIINRERF
VSAHSYVQSEINMLMKVAENFDFRINTFTHILEGYKVADKMKEHGAGGSTFSDWWAYKYE
VNDAIPFNAPIMHSQGIVTAINSDDAEMSRRLNQEAAKSVKYGGVSEEDAWKFVSLNPAK
LLHIDDRVGSVKTGKDADLVLWSDNPLSIYAKAEKTLIQGKVFFDIERDEKLREEIQQQR
SELITQMLEAKNKGLKTQPVTKKEEQHIHCNTLEEIH
>IFAGANLK_01136 Imidazolonepropionase
MKMKYLVLLALFTCIGNSFAQQTPASKQTEAITIVGATAHLGNGETIENSLIIFEDGKIT
QVLDATATKMQYRGRIIEAEGKHVYPGFIAPNATLGLVEVDAVRATDDEDEIGSMLPHIR
SIIAYNAESKLVESMRPNGVLMGQIVPRGGTISGTSSIVQFDAWNWEDAVIKEDDGLHIN
WPSSFTRGRWWAGEEPGIKPSEGYQEDLLKLEEFFASAKAYLEGGNDKTNLAYDAMKNVF
NGEKRVFIHVDGKKEILDVIDFKQDHELEHLVIVGGYEAHKAIEELKENNISVLVQRPHD
QPNSEDHDYDFPYKLAGILHNKGVLVALESSGSMERMNTRNLPFYAGTAGAYGLGKEEAL
KLITSNTAKILGIDDMVGTLEKGKTATLFISEGDALDMRGNVLTHAFIQGREVSLETHQT
ELYKRYMDKYDSASK
>IFAGANLK_01137 23S rRNA (uridine(2479)-2'-O)-methyltransferase
MVKQISSTQNKEVKHLLQLQEKSRLRRKEGMFLVEGQREIQLALKGKFELQAVYFCPNLI
SLEEVQKFTSTEIQITEISSEVYEKIAYRSSTEGVLAIFKTKKNSLESIKFETKNPLILV
AEAPEKPGNIGAILRTADAAKVDAVLIANPKTDLYNPNIIRSSVGCVFTNQIATGSTSEI
IDFLKENNISIYAATLQASKPYNDIDFTESTAIVVGTEATGLSEEWRENSTQNIIIPMRG
EIDSMNLSVAAGILIFEAKRQRGF
>IFAGANLK_01138 Protease HtpX
MNPETLFYIIIAIIVIDFIIDKILDTLNAKHFDDPVPPELSDVYDKEEYEKSQRYKKERY
HFGIITSTFSVLLTLGFIIFDGFAWVDGIARSFTDNPILVALIFFGIIMIGSDVLTTPFS
WYSTFVIEEKYGFNKTTKKTFFLDKIKGWFMMGILGGGILALIVWFYQFAGNDFWWYAWI
LVAVFSIILNMFYAKLIVPLFNKQSPLEEGSLRTKIETYTKSVGFTLDNIFIIDGSKRST
KANAYFSGFGKEKRITLFDTLVKDLEEEEIVAVLAHEVGHYKKNHIIVNLVASILTTGFT
LWLLSLFVGSPALSQALGVEEPSFHIGLIAFGILYSPISEITGLLMNYLSRKYEYQADNY
AKNTYGGEPLISSLKKLTKNSLSNLTPHKAYVFMHYSHPTLLQRFRNLKRGL
>IFAGANLK_01139 GTP pyrophosphokinase
MTEAAIEKENKQIARQYKELLRISYRSLSDDDKKQIRKAFDTAVDAHKEQRRKSGEAYIF
HPIAVAKIVASEIGLDATSIIAALLHDVVEDTKYTLKDIEEMFGETVATIVDGLTKISSL
KKDKDVSLQAENFRKMLLTLNDDIRVIIIKIADRLHNMQTMDAMRRDKQEKIASETLYIY
APLAHRIGLYNIKTELEDLGLKYTDPEVYTEIHTKIKESKEEQDAYIREFSKVIEDSLTQ
ENFNYDIKGRPKSIYSIHRKMKAQNVSFDEVYDKFAIRIIYKSDQANEKFLAWKIYSIVT
DHFRPNPTRLRDWISSPKSTGYEALHITVMGPKGRWVEVQIRSQRMNEIAEKGYAAHYKY
KQGDTQDDHGIEEWLNRLQEALENPDVNAVDFVEQFKLNLYSKEIFVFTPQGDLKSLPKG
STPLDFAFSIHTEIGLKTRGARVNNKLVPLSHELKSGDQVEIITSENAQPNVNWLDYATT
ARARAKIKTSLKDEKREIAEEGKAILTRKLRAQKIPFNEKIINELVVHFNLKTSLDLFYR
VGIGKIDNQKLKEFAASRSNALVSYIKRKIKKPVIAEDLNKDEITSKYDQLVFGRDEDET
LEYKLANCCNPIPGDQVFGFVTVNDGIKVHKKNCPNALQLQSNYAYRIIPAKWIDSSQQD
FKAVVKLTGIDNLGLVSEITREISSNLNVNMQKINFESIDGVFSGQITLRVKNNAILTKI
MNRLKKINGIDKVSRE
>IFAGANLK_01140 Ferric uptake regulation protein
MSKKVVNKNDQAVVKNVFTNYLEEKGHRKTPERFAILQEIYNNDDHFDIESLYIKMKNKK
YRVSRATLYNTIELLLECGLVRKHQFGQNQSQYEKSYFDRQHDHVILTDTGEVIEFCDPR
IQSIKKTIEEVFDIEITKHSLYFYGNKKTTN
>IFAGANLK_01141 Adenylosuccinate synthetase
MAVDLLLGLQWGDEGKGKIVDVLTSKYDIIARFQGGPNAGHTLEFDGQKHVLHTIPSGIF
HDETINLVGNGVVIDPVIFKKELDNLSKHNIDYISKLLISRKAHLILPTHRLLDAASEAS
KGKAKIGSTLKGIGPTYMDKTGRNGIRVGDLELSNWKDKYRTLADKHEKMIKFYDVDVQY
DLAELEKEFFNAIQTLKSLTFIDSESYLHEAQKQGKTILAEGAQGSLLDIDFGTYPFVTS
STTTAAGACTGLGVAPNKIGEAYGIFKAYTTRVGSGPFPTELFDEDGETMGRVGNEFGAT
TGRARRCGWLDLVALKYAVQVNGITQLIMMKGDVLSGFKTLKVCTAYNYKGKEIHHLPYN
IEAENVTPVYTEIKGWAADLTGMTKADELPKEFNEYVEFLEKELEIPIKVVSVGPDRTQT
IER
>IFAGANLK_01142 hypothetical protein
MNIIKFLDEFTSEDLTKKASSRREMLGNLGSLGKKAAMVAVPFGLASTSGKAFAQSSGND
AISALQLALTLEYLEAEFYIKALDSGVLPSGGRAEAVYNQISKHESAHVAFLQAGLGDNS
VDSPEFDFTAGGAFDPFNPNNDMAYAQLLALAQAFEDTGVRAYKGQATNLMGTEFLTPAL
QIHSVEARHASEIRRLRADVLGDNTNENALGWITLNNRGPGMPEATQAVYDGEENAVQGG
VNLVDATGFSAEAVSQSYDEPISGELAQQIAGLFIVS
>IFAGANLK_01143 hypothetical protein
MEKPRVKVDAISMQPLKNSKSRRKFLKIGGLAMAGSGLFLYGCSSDDDVNNPEPMPGEVF
DLGSGDVGILNYAYALEQLEAAFYTNVLDGSYWAGANAEEKLILEDLYDHEVIHREFFKA
AISANAETSQVLPELEFDFSSVNFADRDSVLATARVLEDTGVAAYNGAGRLLQTPDFLVI
AGKIVSVEARHAAAIRSIYLENDTAFAGDDIIDSNGLDQAKDPQTILSEVGATGFVVTEF
SANNLPQ
>IFAGANLK_01144 LPS-assembly protein LptD
MKKFILFIVFAFLAFPALTQAQEAKEIDYSADRNIQDEKYPGAFVLSKVENQVYFKHEGI
EVWCDLAIHYKDENFFRAFGNVRMQQGDTVKLNSNYAEYNGNSQFAFASGEVVMKRPQTT
LESDSLFFDRLKQQAYYRSGGKVIDTGGVITSNIGRYFMEDDKYSFVSDVVLTNPEYVIN
SEQLDFYGETGHAYLYGPSTIESETSTVYCERGFYDTRGDTGYFVRNSRIDYENRTVKGD
SMYFNRNTNFASATNNIEVIDTINESVVTGHYAEVFRDKDSVFITKRAVAASVQDSDSLF
IHGDTIMITGKPEKRIIRGFYDVRLYKSDMSGKSDSVHINQETGLTKMINLTSGPVTSVT
KRRSPVLWSGLSQMTGDTIHLQSNTKTEQLDSMRVFNNAFLIQKDTIEGYNQVKGMDLVG
LFENNELRQVDINKNTETLYYSRNSDQELIGINKTLSSSITIMFENQEIEYIDYFTNVEG
NLTPEEDFPENVRELIGFNWRGDERLLTKEDLFKGKPAPELVKIEGIPLPEEDEEFFDER
EAGDDMLLNEKSRLKPEDLQNRAKDSIPQLKEAQQLINAEEEEENAAETEAEELQNRVRD
SIPKLKKSQSLQNAKKKQEEAEEDKPDE
>IFAGANLK_01145 Acetylornithine aminotransferase
MNKDFLKYQAQTTPHPLGLEVESAKGSYIFTTDGKKHLDFVAGVSACSLGHCHPKVVNAI
KEQAEKFLHVMVYGEYAQQPAVELTKLLAEHFLKPLEKTYLTNSGTEAIEGALKLARRYT
GRAEIIAAHQAYHGNTMGSLSLMDYEERQKPFRPLLGGISFIQFNQEKDLQKITKKTAAV
ILESIQGGAGFILPKNNYLKKVKQRCEEVGALLILDEIQPGFGRTGKLFGFQNFDMVPDI
VALGKGMGGGMPIGAFAASAKVMDTLSDNPKMGHITTFGGNPVIAASALATLKEIVSSDL
MAASLEKEKLFRKLLVHPLISEVRGIGLMLAIIIPSEEIANQLILKSKEKNLILFWLLFE
KKAVRITPPLTISEEEIKEGCGIIIDVLEDIMKQQETVN
>IFAGANLK_01146 TPR repeat-containing protein YrrB
MQLSHNDEDNFSLSRFESMLKTNDVLFFDSAEFEDIINYYLENGKFALAKKAVKLGLAQH
PTSTNLKLFKIEILVFEDKLDVAEAMLTDLQQLESSNEEIYIQKAQILSKRDRHAHAIQV
LEMALDITLDPAEVYSLIGMEYLFLEDFENAKFSFMKCLEADEEDYSALYNIMYCFDFLD
QKTEAIQYLNMYLDKNPYCEVAWHQVGKQYFDLKDYDKALSAFDFAIISDDYFIGAYLEK
GKVLEKLGRFHEAIENYRLTLELDDPTSFAYLRIGKCFEKLGLNELALKHYKDCVHEDPL
LDKGWIAITDFYIKKKNYQKALYYINKAINIDEENVLYWKRYAKINNRLKFFEEAERGYK
KSLDLGNYELETWVRRCDILIDLGEFETAIQNLNQALEFYPDTAEIEFRLAGLYFSHNEG
EKAYFHLNKGLKLDAEYYIVIEELFPQIFNRKSVKQIINSFINLS
>IFAGANLK_01147 hypothetical protein
MRKSFKDYFPVTLKGMAMGAADVVPGVSGGTIAFITGIYEELISTISGVNFSLIKTWKEK
GFKAMWHQLNGPFIVALFIGILISVFSLMRIANYLLENHPVLIWSFFFGLVLASIWYVGK
QIPKWNFKIVLALLIGAGVAFYIVSLPPMAANDSNLFIFFSGAIAICAMILPGISGAFIL
VLLGAYKRITEAAHDFDFQTLGIFAVGAVIGLLSFSKILKWLFVHYSSITLAVLTGFIAG
SLNKIWPWKHVLQTEMYGDKEVVLREASVLPWNFDGDPQTLFAVILMLAGFSLILGLEIF
AAKSSTKANATN
>IFAGANLK_01148 hypothetical protein
MQQTRTFTDKVLLVLKGLAMGAANKVPGVSGGVVAFVAGFYEEFIYSLQKINYKAFILLI
NGRFRSLYYYTNGKFLSLLILGMLISYFSVSKVLDYLILHYELYVWAAFFGMIVGSIYYI
SKDFEEWSKRSLVFVLLGIIVGVAISFLEPAKENDNLWFVFFCGIIGVSGMTLPGLSGSF
ILILLGNYVLLLVDSVNALYDTIADLLLWDLSFLADPERLRLLEVLLVFGAGSLAGLVTL
SHLLGFVLKNYKTDTFAAIIGFITGSLGVVWPWKEKIFKVGADGEMILDSQGNAIIDYYD
RYFPAFFSAETWLAIFFIFVGILIVLGLAWYEKKNQKTAKP
>IFAGANLK_01149 Shikimate dehydrogenase (NADP(+))
MKNFGLIGKNISYSFSRTYFTEKFKKENIEAEYQNFDLDNLKEFRDVIKETPNLQGLNVT
IPYKQEIISFLDDLAPEAKEIGAVNTINVNGNKLIGYNTDYIGFSESLKPFLKEHHKKAL
ILGTGGASKAVAYALKNFSIDYKFVSRSSGEGKLGYDDLSEKIMKEYSLIINTTPVGTYP
DVDAHPEIPFKFITSQHLVYDLIYNPRTTKLMARALAKGATVTDGLKMLELQAESAWKIW
TK
>IFAGANLK_01150 hypothetical protein
MAQQENDKNKEEFSNESTNNSEQTQDKKKLTDENKETNAEENSFSQKSETEKTSEEKDAV
IEPAETASEIKSEDDNLEDAMIAEAGDTKNTSEENKASKEQDDDDDPLLEESRKQTKPEQ
QKVQAETGAEAEENSDKSSSEKSEGTDSEEDSDEDEETSEEEEGRTSKHHQEHIDDSVAE
DSEDETKAERHDIPKKDYHAMSKEQLVDEFESLLKKEKVQAIKDHVIEIRAEFNAKFNEE
EEEKKEEFLAEGGNIIDFHYSTPLKKRFNSLYFDYREKRNNYYKQLKQDLNKNLAKRLEI
IEELKGLIDVEENINTTYKHFKELQDRWRVAGPIPREKYNDVWNTYHHHVENFYDFLHLN
REFRDLDFKHNLDQKLKVIDRAEELVQEDDVNRAFRELQMLHKMWKEELGPVAKEFREDI
WERFSSATKQIHDKRQEFFNTMDERYEENWKVKQVIIEKIREIADEEYKSHNKWQQKIKE
IEALREEFFNAGKVPRSKNEETWTDFKQNVRRFNRNKNAFYKNLKKQQYDNLEKKKELIK
IAEDNKDSDDFKTVTPLMKKIQADWKKIGHVPRKDSDKVWKQFKAACNHYFERMHETRDD
ENKEEFEAFDKKKELLEQVKSLELSGDKKEDLPKIKQFIEDWKNLGKVPYNKRFIEGKFN
KALDQLFNKLDVDHTKAEMLKYENKVQALNDADDDKQLRNEHYFLTKKVEETKAEIRQLE
NNLQFFSNVDEDNPLVQDVHKNIADQKEQLEVWKEKLRKIKSLY
>IFAGANLK_01151 hypothetical protein
MKCILCGGSTKEFWKSKKREFVECTNCGGIQLLPEFYISKKAEEDRYLTHNNDVEDARYQ
DFVSPITSRILKEFTPKHKGLDYGCGTGPVVTTELEKEGYFVTLYDPFFHPNTEVLKATY
DFIICCEVMEHFYEPKREFSELARRLNLEGKLYCKTSIYSEEIDFDNWYYKNDPTHVFFY
TANCLEWIKSNLGFSALEIHPTVIVFYK
>IFAGANLK_01152 Nucleoside triphosphate pyrophosphohydrolase
MNSREEQLKAFDRLLTIMDELREQCPWDRKQTMESLRHLTIEETYELGDAILDKDLEEVR
KELGDVLLHLVFYAKIGSETEDFDIADVANGICDKLIARHPHIYGDVEVADEEEVKKNWE
NLKLKEGKTSVLEGVPRSLPAVVKASRIQEKVAGVGFDWEKPEQVFEKLQEELGELQHEI
NTDNKDKIEAEFGDVMFSMINYARFLDINPENALERTNKKFITRFQYLEGKAKGQNKALK
DMTLAEMDVFWNEAKLL
>IFAGANLK_01154 N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 1
MKLDILAIGSHPDDVELSCSGTIAKEVDRGKKVGILDLTRGEMGTRGTAETRDKEANEAA
KILGVSVRENLEFSDAFFEINTAHKLEVIKILRRFRPEIVLCNAVDDRHIDHGKGAKLVS
DACFLSGLRKIETIVDRKSQEAWRPKHVYHYIQWKNLKPDVVVDISGYMDKKMESVLAYK
TQFYDQDSNEPETPISSSNFLDSINYRARDLGRLINTEHAEGFTVERYPAVDSIFDLI
>IFAGANLK_01155 Cystathionine gamma-synthase
MTKKHPGINTICTHSGELEDKQFKGAISPLYMATSYAFEGVEVKRYPRYFNTPNQVALAQ
KMAALEHGEAALIFGSGMAAVSTALMAFAQKGDHVVFQNTLYGGTSNLVTEEFEKFGIEF
TFTKDSKPESFEAEIKENTKVIYIETPSNPLLTVTDIKAIAEMAKKHNLVSMIDNTFASP
VNQNPIDFGIDVVLHSATKYMGGHSDILAGTAIASEEHLDKIFQLAKNFGGSLSDFTVWM
LERSLKTMGLRVKAQNENALELARFLEKHEDISRVYYPGLESHPDHELAKSQMKGFGGMM
SFELRDGLDFDLFQKKLKLIKSSMSLAGVESTILSPSKTSHGLLTPEEREAQGIRDGLMR
FSVGIEEKEDLMEDLEQALKVVRG
>IFAGANLK_01156 Aldehyde reductase YahK
MSEVKAYGAQSSDADLKELNIERREMTADDVQIEIEYCGVCHSDIHQVRNDWKNSKYPVV
PGHEIIGRVTRVGKNVSNFKKGDLVGVGCMVDSCQECDSCKEDLEQFCEKGATLTYNSKD
KHLGGHTFGGYSEQIVVDKEFVLRIPENIDAKATAPLLCAGITTYSPLRHWNVKKGDKVG
VIGLGGLGHMGVKFAAALGAHVVMITTSPSKSEDAKKLGADEVLVSKNEDDMKKQAGSFD
FLLNTVPVGHDINPYIALLKRDATMVLVGAIEPLDPVHGGGLIGGRKRIAGSVIGGIKET
QEMLDFCGEHNIVSDIEMIDIQNINEAYERVVNSDVKYRFVIDMKSLKNQN
>IFAGANLK_01157 Imidazolonepropionase
MKQLFINIKELLQVRDEPVEKLSGAEMKELPSLKNAWLLIENDKISDYGEMNSLPEINAD
KTINAEGKIILPSWCDSHTHIVYAGNREQEFADRINGLSYEEIAKRGGGILNSAKTLQET
SEDEVYEQSAKRLEEVMKLGTGAVEIKSGYGLTEEGELKMLRVIKKLQQNYELPIKATFL
GAHAIPKEYKEKPDAYLNLVIDQILPKVAEEKLAEYIDIFCEKGYFSVDDTHKLLSAATK
FGLKPKIHVNQFNAIGGIQAGIEHDALSVDHLEVMRPEDIESLKGTNTMPVALPSCSLFL
SIPYTPGREMLDAGLPLALATDFNPGSTPSGNMNLVVSLACIKMKMTPEEAINAATINGA
YAMELSETHGSITKGKKANFILTKEIPSYTFLPYAFGTNSIESVFINGKMLE
>IFAGANLK_01158 Arginase
MEGLKIYNYKSVEKLISLRDGETRFGEKISFVGNLEELAKTEAKFVLFGIPEDIGVRANH
GKPGASKAWDTCLNSLLNIQKNEFTAPENIILLGEIDCKSEMQKAANIDEADPNYYLKLG
DLVEKIDEKVSFLVEKIVSAGKTPIIIGGGHNNAYGNIKGTSKAIKKPLNILNIDAHTDL
RKLEHRHSGNGFSFAQRDGFLGKYLMFGIHKNYTPQYIFDEISSLSNIKFHLFEDLILQT
HQGKMAAFNSQLEFLNKQAFGLELDCDAIINFPSSAKSPSGFALNMVRNFLQIASEEKNC
KYLHICEAAPKEENYAQVGKALSFFITDFMKA
>IFAGANLK_01159 hypothetical protein
MTEKVEELIEITALVIEVVGILVMVIGTFLALGRYAFKLQGENIRSFQKIREELGRAILL
GLEILIAADIIATVVYGAEMEQILNLGLIILIRTFLSFTLEVEIEGKLPWKQSKNRTTGQ
K
>IFAGANLK_01160 Periplasmic trehalase
MKKLSINFLFLCSFLLFSACSSAVKTEGNKPEEIQVEEKQLSILPPEELYGKLFFDVQKN
ESLFTDSKTFVDAVPRIAPEEIRKKYAEIKPESNTELKTFLNENFEIPEADSDYKTDSSS
INLHINKLWDVLKRPADEKLSGTLIPLPNPYIVPGGRFREIYYWDSYFTMLGLQEDGETE
TIRNMVDNFAWLIENYGFIPNGNRTYYLSRSQPPFFAKMVELLAQTDGEETYIKYLPALE
KEYDFWMKGSENQEPGAYKRVVRLSNEEILNRYWDDKNTPRPESYREDVETAEKAISKNP
DRTKEEVYRNLRAAAESGWDFSSRWLSINGNGDFNLYSIHTTQIIPVDLNSLLYNLEQTL
ARAYNLKVQPEKAVTFQERAENREAAIQKYLWEEETGFYFDYNFKKEHRTGIYSLAGVYP
LFFEISDEKQAGKISETMEQIFLRPGGLVSTPHNTGQQWDAPNGWAPLQYMSIEGLRNYG
KDLLASEIKQRWLNLNQSVYENTYKLLEKYNVEDLSKESGGGEYPTQDGFGWTNGVYQKL
SKEE
>IFAGANLK_01161 Amino-acid acetyltransferase
MEIISFKSAYAEDFKNLNLAWLEKYFWVEPHDEEVLGRPEKYIIETGGNIFFVKDDKKII
GCVALMKIEDGVFELTKMSVSPEYQGKKIGQKLMEHSLEFAKDQGWDHLIIFSNRKLENA
IYIYKKYGFKEIPIGENNPYSRGDIKMRLDLA
>IFAGANLK_01162 hypothetical protein
MKYLFTLLAVGILFSGCKNEGKNTESEDQINENPYGEENNVLEADSASIDIQPISHATAA
VTWSDATFYLDPVGGAEAFEGIEKPDFILITDIHGDHMSIETLESLSLNGTHIIVPQAVR
DEMPEEMKDKVRVLENGATTRVLEFYIEAIPMYNLPEDPEAYHPKGRGNGYVVERNGQRL
YIAGDTENIPEMKELENIEIALIPMNLPYTMTAEDAADGVLAFAPKKVIPYHFRGEDGFA
DVEKFKELVNEGNKDIEVEMLEWYPDREEE
>IFAGANLK_01163 hypothetical protein
MKILKLVVFALAISAGSLLHAAPGNSPETSASFKKEIHDLLKNIELDIEEEVVANLVVSF
NENNEMQVLYVGTTHTPAGKLIKQHLNHKKIKTVLDPSIKKYKLPIRLKP
>IFAGANLK_01164 Succinate--CoA ligase [ADP-forming] subunit beta
MNIHEYQGKEILSSFGVRIQRGLVAHNAKEAVDAAKELTEQTGTGWHVIKAQVHAGGRGK
GGGVKLAKNLKEVEEIAGNIIGMNLVTPQTSAEGKKVHQVLIAEDVYYPGDNEPEEYYMS
VLLNRATGRNMIMYSTEGGVDIETVAEETPHLIFTEEVDPATGLMPFQARRIAFNLKLSG
AAFKEMTKFVMSLYKAFEKSDSSLFEINPVLKTSDDKILAVDAKVTLDDNALFRHKDYAE
MRDIREENQTEVEAKEVGLNYVDLDGNVGCMVNGAGLAMATMDLIKQAGGEPANFLDVGG
TADAKRVEEAFRLILKDDKVEAILVNIFGGIVRCDRVAQGIVDAYKNLGDTIDVPIIVRL
QGTNADIAKKLIDDSGFKIHSAVQFQEAADKVQEVLK
>IFAGANLK_01165 Inner membrane transport protein YdhP
MNKALVALAIGGFGIGLTEFVIMGILPDVASALDISIPQAGHFISAYALGVVVGAPLLTA
FGGKWPAHKTLLLLMVWFTVFNSLSAFANSYELLLVSRFLSGLPHGAFFGIGAVVAGQLA
KPGKSAQAIAIMFTGLTLANVFGVPLGTFLGHNYSWNVSFMLVGIVGLLAIASVKFWMPV
LPKSSSEGIRKDLNVLKRGELWMVVLLTTIGTGGFFAWYSYIAPLVTDVAGHPEGFVSYV
MILAGVGMVIGNLIGAKLAEKFSPIYAVIMSMVLMVFALITNAYVAENQIAILVMTFLIA
TIAFCLSTPIQMVMINSAKGSESLGSSMNQSAFNMGNASGAYFAGLPIAFGYGFTSASLV
GAVMAGLGVFIALAIILIRKRKESAVATAS
>IFAGANLK_01166 Diaminopimelate decarboxylase
MTNQDLLAVAKEFGSPVYVYDAEKIAFQFNRLKNAFSEIKDLRIHYAVKALSNISILKYL
NSLGSGMDTVSVQEVKLALEAGVAPKDIIYTPNGVSLEEIEQVVRLGVQINIDNLSILEQ
FGAKHPDVPVCIRINPHILAGGNSKISVGHVDSKFGISIHQMPLLLRIVENTGMNINGIH
MHTGSDILDIEVFLRASEILFDSAKNFKNLQFLDFGSGFKVPYRENDIETDIEELGEKLT
ERFKNFCKEYGRELTLVFEPGKFLVSEAGRFLAKVNVIKQTTSTVFAGVDTGFNHLIRPM
FYGSHHDIKNVSNPEGKFRFYSVVGYICETDTFANNRRIAEITEGDILAFSNAGAYSFSM
ASNFNSRYRPAEVLWYKGKGHLIRERETFEDLLRHQKVIDFTPKTAKSSK
>IFAGANLK_01167 hypothetical protein
METVFKNRWFYRLLIIYIFLILIWNTYMVISGNYLGLIAVVIELALLYLLFNKHRLAKMA
IHFWAIIMMVGPGLSIIGKLIKMATGDDLNFMVDSLVQNLLLFTFGLLIYYFNKKTVFIQ
EREVN
>IFAGANLK_01168 RNA 2',3'-cyclic phosphodiesterase
MPLYFLAIIPPENICKRVKSLKEEIAEKYEAKHALKLPAHITLQIPFKIPESEEEKLGEL
LIYFTENQKAFKISLTDFGRFSQKVIFINIQQHKEIIKLHANLQQVLNKNFNFKKHEKFS
KIHPHITLASRDLHYKQFPNAWANFKEREFQASFTAKSLALLKHDGKQWHMHCEFKFE
>IFAGANLK_01169 hypothetical protein
MKKQESTRKYNFTFLEILGIIALIIIAIYFLDFTIEAALDGWNNPM
>IFAGANLK_01170 hypothetical protein
MIIYYKKKRLKYQLISGLAILVFGISILILDTSTGIYSIWILFGLLQIGTWFYQRKYQYL
YIDEESLTKNALSPSSIKFSELKAIWKYKNSFTLETNTTKIKIDKDLMEDESLYKLTDFI
NQIELKSQQA
>IFAGANLK_01171 hypothetical protein
MKKDQLNILKLIGIIFTALMLVIFLDFALKSAIAAL
>IFAGANLK_01172 Thiol-disulfide oxidoreductase ResA
MRLFLTFFLLLFIFPTLQAQESSFSLTGTTSDIKDGNWLYFQDLVNGGTLDSAEVKNNRF
KFDTKLPEPRMWVMLHTKDRSKFVELWLQNKPMQFDASNKDFEEAEITGSISQLLVETVK
AVYEDFDKISKAELRKRQEEFIKNNPNALISVRMLYEVSGKWGQETTGHYFKMFPEEIQD
SALGKRILSILNNDNIPQLGEKYADFELPDRNGKKQKFSALTGKITLLQFWASTCEPSKM
QNRELKKLYRKYKSEGLEIVAISRDTSKTDWIKSIEKDNLKWQHLSGLEGWEGQVFSNYG
IKRTPSNYLINKEGRVVGRNLSDDELKENIKELLKN
>IFAGANLK_01173 hypothetical protein
MIIYYPQKRLKYKLLYGIVSVIIGSFAFIIDSEPIFIYPWVILGFLEIGTWYYEKKYHYL
HIDHNILTKNSLFPKSIDLRQVTAIRKNRNSFVLESEGKNIRIHKGLVASQSLNQLTDLL
DEIQLQPQHV
>IFAGANLK_01174 hypothetical protein
MNKLPWLILIFLIGFIGLIYFSVSGTEKEFETITIKEFKDIENIDFREHDSVLVAASSLY
ETYPLKNIMQGENYREAWATPVKVPVLFLDTLYGGMEIVKEGGGTQTHSLRLKDKEGYLY
SLRSVNKDPSTHVPEFARSLGLENIVIDAISASHPYGAILTAKLSEKANVLHTHPTVVFV
PKQDFLGKKYNEKYGNRLFLLEYETEGKENWTDYENVDEILDTKHLQELKDKHPEKVSVN
KNALVRARLFDLLIGDWDRHAKQWGWAIQEEDDTFRAIPVAGDRDNAFFNLEGIIPGIIS
NKYIEPKVRPFEQEIDYMPGLVYPNDVYFLTDTPKEIFISEAKNLQELMTDEAISDSFKV
WPREIYELDGKEIAEKIKSRRENLEAYAKEFHRNISEKELLDKPLKGSEDAKISPDLIKC
FECGS
>IFAGANLK_01175 hypothetical protein
MKFRFSILSLFCAFLFCFGSLAAQETSVMVRALAKDAKFIGSSIGGAKVIIRNAETGEIL
DLGLTSGSTGDTKLILQTPKERYDKLTDKNTAGFEAKLNIEEPTFINVEAHAPINKKQAK
VVSSTQLWVIPGKDITGDGVVLEVPGFVVDILSPQTHERINASDELSLKANIIMMCGCPV
TEGGVWDANQYEVKAIISAEDKESREITLNSTDKPSTFAANTSLEKGYYTITIYAFDPVT
GNTGVDKTNIIIN
>IFAGANLK_01176 hypothetical protein
MKQQYTTLFLLFSGVILLIFTACNNNAQEPKKEVQPRQLDTISMEPPVFKTSYRLDSIQS
IEHLDSLFNDFSEEEAKLVFTLNRIDEHRVKPGTKLIIPDSLVNDLQAYAPFPKLLEPLD
SIDKTVIISKRIQAFALYENGNLMHWGPVSTGKQSTGTPSGLYYGNYKAKRKISTIDQSW
IMPYYFNFMNFEGIGTHEYTLPGYPASHGCVRMYQEDAKTIYDWANMWQLESDVIVQNGT
PFMVIGEYDFKDIQPWFKLAENQRSNELSKSERDTLRVYAQRYKNDPLNFKFEDLSDQEI
VL
>IFAGANLK_01177 hypothetical protein
MKIVVSPAKSLDYESKLPTTRGTQPAFLETTAKLNRKMSRMTKNEISELMSISDKLADLN
YIRYQEFEEEHNKKNSRPAMYAFAGDVYTGLDAYTIPTEKLDRLQDSLRILSGLYGVLKP
LDLMQPYRLEMGTSVGIERKKSLYEVWQPKVTKLLNEEMEKGELFINLASNEYFKAVDTK
KLNAEVISPVFKDFKNGKLKIISFFAKKARGAMVRYIIDKDINTLEELKGFDYMDYRFSE
EHTEKANEPVFIR
>IFAGANLK_01178 hypothetical protein
MSKLLLFDFSAITDWSAWEVENDVVMGGNSSSKLERSDEGNAIFRGSVSLENNGGFASVQ
YHFPSKNIKGYKKALILLKGDGKSYQFRMKSNLKDRASYIYTFKTTGDWQTVEVPLLKMK
PVFRGNKLDLPNFPAETTQEIRFLIGNEKAEDFRLEIDKIELE
>IFAGANLK_01179 CTP pyrophosphohydrolase
MIKVSCAIIEHNGKVLCAQRSSKMELPSKWEFPGGKVKEETFEECLIREIREE
>IFAGANLK_01180 Putative DNA repair helicase RadD
MSFETGLYEQLITKLVSNKLEDVDLQKFHVSESALDKEEAAQYLSIYLAETIKFALNEIK
DKDRPLKQIELSNKIISLLVEEFKNVEFSDNLIENEGRILQAVFLKLDFPYSNLEARLKE
ITPYTRLSQSELFTGNNVGISLESEIKKEILSADEICWLVSFIKFSGIRIFKKELEEFTR
SGKKLKIITTSYMGATDVKAVEYLSSLPNTEIKVSYNSEHERLHAKAYLFLRNSGFHTGY
IGSSNLSRSALTNGLEWNLKVTTQEIGHIIDKFQKTFETYWEDPEFENYKYQTDRTKLSK
ALNRENTYNTNQISTFFDLKPYPYQKEILSKLQAEREIHNRNRNLLVAATGTGKTVISAF
DFKRFKDKEPNANFLFVAHRKEILQQAQATFQHVLKDANFGELWVDGYEPERYNHLFASV
QTLHSRLENLDLAEGFFDYIIVDEVHHIKANSYRPILHRFKPEILLGLTATPERMDGGDI
ADDFHNKIAAEIRLPEALNRKLLSPFQYFALSDTVDLSNVKWNGKYEIRELTKLYTEDDH
RVADIIKNCEEYLTDINDVQALGFCVSQEHAKFMAEKFTLANLKADYLVSGNSSSRDVIR
NKLLRKEINYLFVVDIFNEGVDIPNIDTVLFLRPTESLTVFLQQLGRGLRLAKNKDCLTV
LDFVGNARPEYDFEHKFRALVGKTHTSITKEIEDEFPHLPLGCSIVLEKKAKEVILKNIR
EATEFRRPQLLQKIKAFKHHSTLPLTLNNFLEFHHLDIRQIYRKGSWKRLCSDAGVIPDF
KEPQEKEFTACMQRKLINCNSLSYFRFIQELIRDDLNLRLLSKEQEMFLLMFHYDLWQES
GTKLKFTDLTISIEILKKNKIMLQELKEYLEHLIEKIEFVEKNIDLKFPFALKLHSRYNR
EEILASLGLSTFQKKSSNREGVAQNKELNIEALFVTLKKTEKEYSPTTMYEDYALNKKLF
HWQSQNSTAPDSPKGESYIKHREKDKKILLFVREQNVDEYGFTMSYTFLGEADFVKSKGA
KPMNVEWRLHEEMPSYILKESQKLAVG
>IFAGANLK_01181 hypothetical protein
MLEELIFKYSNYFKKLNRGFNKKLGRAPHKPILLLSIIQLIAKGKIISNRIFITSEILLA
FKQNWEQLVHTDHSRNFALPCFHMRSEPFWYLVAKPGKRIETTRSKSIKSFNNLNESIAF
AEIDKELFLLLQQPENQLWFEQLLIESYFPDFKVNYLRPDSYYEEDKIENEILNEPSELY
QNHIQQLKETLEENEFEEEIFVRGGLFKRTVPKIYDYTCCISGLKINSAHNIQMVDACHI
YPFSISNDDTVTNGIALSPTLHRAFDRGLITINSDFLVRISPTIKEENSSFPLSAFDGKQ
ILLPEKEEWFPSQEALKWHNKEVFML
>IFAGANLK_01182 hypothetical protein
MKIAEKFELNERQQDRVIAMAWEDRTPFEAIEFQFGLTEKDVIKFMQEQMHPRNWRKWRA
RVQGRKTKHAKLRDNEISRFKSSAQRQITGNRISKKKY
>IFAGANLK_01183 hypothetical protein
MEGSRKHPKLVKAFSGSFLWQNTGGIIIDYNGRLLNSANYQYRTSGGKFIKIRFKKKLNS
AKKLPKFSCDWKMMTNVNCSLN
>IFAGANLK_01184 putative oxidoreductase
MDLNDKVAVVTGASSGIGKSIAEELSKKGCKVTLASRSLDKLKDIGKGLSDSFEVEMDVT
SDKSVTEAFEKIHDRFGQIDILVNSAGVMPLTYLKNRKLEDWLQTIEVNVKGTLRCIHAA
LPMMKKQKSGHIINIASVDGKEIFEGGAVYGASKAAVIELSRAMRMELSPDFNIRVTSIE
PGTVETDLREDITDEELLEDKDYGNGEPKLAPKNIADAVLYATTQPDSVNVNELLIKPTA
KS
>IFAGANLK_01185 hypothetical protein
MQFLEKFSKNELEIISKTDFKKQKAELEKELEAIKKGILI
>IFAGANLK_01186 Ribosomal large subunit pseudouridine synthase D
MKEDEQHEIEEQDETLYEHHKFEAGPGQSPLRVDKFLMNFIENATRNKIQKAAKTGNIYV
NEEQVKQNYKVKAGDVVQVMFEHPPYEFLLTPENIPLDIVYEDDTLLVVNKPAGMVVHPG
HGNYSGTLINALVYHFENLPNNSSDRPGLVHRIDKDTSGLLVVAKTEEAMAHLSKQFFDK
TSEREYVALVWGNVEDDEGRVEGNIGRHPKNRLQNTVYEGDEAEKGKAAVTHYKVLERFG
YVTLVSCKLETGRTHQIRVHMKHIGHTLFNDERYGGEKILKGTTFSKYKQFVDNCFKILP
RQALHAKTLGFIHPKTGESMSFNTEIPEDIQACIEKWRNYAKNQKEVL
>IFAGANLK_01187 hypothetical protein
MGFFKFIFSKTFLIQLVIAAIVIVVLAFLALKWLDYSTNQDQRIAVPDLSKQSLDVVDDQ
LAELDLRFEILDSANFNPDFPRYSVIEQVPEPGQFVKENRKIYLTLNPSGYRKVMIPDLI
RRTRRQAEPTLRSLGFEIGDVSYKPDIAEDAVLELRYKGKKLEPGDELMKTSKIDLVLGD
GSGKYRMEGEEEQDSIIPEEEEIEF
>IFAGANLK_01188 D-alanine--D-alanine ligase
MKKKIAIAMGGFSSEYRISINSGNMVYKHLNRDLYEPYRVHILQKEWFVVADDDTPYPIN
KNDFTVKIAGKTISFDCVFNTIHGTPGENGLLQAYLELVGIPQTTCGYYQAALTFNKRDL
ISVLKPYGIKTAVNYFLNKEDKVNAEEIIAKVGLPCFVKANRAGSSFGITKVKTEEELIP
ATKTAFKEDDEVIIESFLDGTEVSVGVITYKGKVKALPVTEIISENEFFDYEAKYLGKSQ
EITPANISEKKTKQVQEIAKLIYKKLKMRGFTRSEFIFHNGEPHFIEMNTTPGLSQASIL
PQQAEAAGITLTDLYGSAIETALK
>IFAGANLK_01189 hypothetical protein
MKNRLFVLLFFLVISLISAQNKDNIENEILSYTNSQTQIISKGRLLLADSFLEGDLQKVD
EVRNYLLKEVDSENYIALLPGEQWLISYWTGEFYDVIDSVNYYYTKGSTNYEDKIFPTED
RLYYKLVEKSWNELEKLEEKILTSGLNEEEKDFLLLHLNYMISGQPLNTLTQDEINKMAD
LFLEKHPTGKLTDLVKSNIRFRFEASNWGFAFDFFMGYAVQNGALSSQFSNGFALGHGFD
VEYKKFSLYLRNYIGFTKTLEEMEVEAVGWQKDMRLIQYLPEASIGYSVVDNNKLKLSPF
AGIGGVAFSPTESDINNRPELEDSQVGFVTAYTLGANLDFKLGWNTGAIFPNNKTYWFLR
CRYGYTMPQMGSYPGYEGNIHYFNIGIGGVFRAIKRDI
>IFAGANLK_01190 Phosphopantetheine adenylyltransferase
MMRKAVFPGSFDPITLGHTDIIERALPLFDEIILAIGTNSDKKYMFPLEERLHFLKETFK
NEPKISVTTYKGLTVDFCKEQNAAFLLRGLRNAQDLEFEKAIGQTNYKMSGIDTLFFITS
SGKSHISSTVVRDVIRNNGDYEFMVPNVVRK
>IFAGANLK_01191 hypothetical protein
MKQSYFTSPGFTFRLQPFGATTALFLIFFLLNFSFGFGQGPENTTPDYNHENDEDIGSAT
IADTDEIIIAIATDSDGFIYTLSFGSGVEKLNPDGTIAEANFISENELDAPLDIEINSRG
EIHITDYFESGSCGDNGKIKVFNTEGNLLSDRTILTGFYRPLGIAINSDDQIYVAEYNPE
GPGCENEEKSRINIYKSDGSVINTTTNVHAPYRLAVDSNNFIYISHDNNGNSEVAVFDDN
LIKQNSLAVVESPGSIEIDKYGFIHVVDYVGRLEFGQFLNLEDLAPLQLLPIVVGVLDGI
EEQDFIIQIFDSNREYRDFFRDDEVDFPVDIVTSNMTCEQNFFINNSNIFINSIFPIDIN
FDFDIEVYNRIPSYDTENPIAVCENGLELTLANGEVTISAEEIDGGSTDNCEIADLELSR
YTFDEARDYDIELIVTDAAGNTDTCSTSITILPGEEETPPEATCNSFEVVLDNNGEASIT
AGEVYDGEEDLELKIDKSIFTCEDIGENEVTLTATDPDTELTGTCTALITVRDDQNPGVN
CIDPGEEFQLENGSVTIAVSDIELNSSDNCGIVSRSLSQTTFTTSGTKTITLTVEDEAGN
TAICNTTIEILPEESAPFNFQCVEEYKIRLGEDDQISGVTEIPTSEFVTSDISKLDFEIT
NQQFTCDDIGTNSRTINATHRETGEQYSCSVSFTVVDEGAPLIICPAEPITTNLPEGGYA
VPNFFENRVSDNCDNIEDLELVQDIAAGTILDSAETYTINLTATDSNDNEETCQITIILE
ENDPNAPEIDCVNHELFLDENGQATLDPEDIFAGELGNLELSTDIENFDCSNLGENTVIL
TATDPDTGLSDTCVTEVLVLDDIAPEANCVAPGREFRLENGSVTISASAIDLNSEDNCDI
TRTLSVDTFTTPGIKNIILNVEDTAGNTDECSTTIEILPEDTDRVYRCIEEEDIPNIRLD
EDCELNIPDYTRLIETEHFNPAITQTYEELTEETYLITVEIRDADTDEFVGECEFSVGIV
DLIPPTISCPNDQLESFDPDTGFEVPNYENMAGISDNCGEVSFRQEPAAGEIIYNNTTVN
LFVEDEGGLDASCTFELELTESDVLNITCQIDKNVSPDDNCSFWLPDYTGTAEVNFPGAE
ITQTPPAGTILTESTQIQLTASLDGETDDCYFMVNLVDDEAPVANCVSGYVVNLDNNGTA
TINPEDLDDNSTDNCGIVSMALSQTEFTTTDIGDVPVTLTVRDDAGNIDSCETTVEVRGE
ASGEFECRENIEVFLDENGQANLNLQDLYTGDASEINLEASQLNFTCEDVGTAIIQLDYS
GDETGSCMIKVDVRDELPPEINTNLVELTLNPEGFAYLEETDILAEDNCSEELIYRFSKS
VFTCKYVGMNSINVEVEDVNGNRTDQNIQVRISGESCDFPESGGNEYLFLYPNPNNGIFT
IATPEGMFIEQVKVFDSRGRYIMQQEYNANARFYRMTIQGVEESVYTLQIFTNEGVLVKR
AIIKR
>IFAGANLK_01192 Transcriptional regulatory protein WalR
METEDKKILLVEDDPNFGTVLKDYLAMNDYEVTHAKNGMEGFEKFKKDDFDLCILDVMMP
YKDGFTLAKEIREKNEEIPIIFLTAKAMKEDVLKGYKVGADDYLNKPFDSEVLLMKIKAI
MQRKATDSVADSKQFEFEIGGFHLNSKLRFLTYKEEEPQKLSPKENELLRLLALHENDLM
PRELALTKIWRDDNYFTSRSMDVYIAKLRKYLKKDENVEILNIHGEGFRLVVKNNENAEA
>IFAGANLK_01193 Sensor histidine kinase ResE
MSLSLIGIIFVQGYWIKSTVEDKEAQFTYDVKQVLLRVVNEIENQEIEDYWMKFKDADST
NSRLQNATITEYSYVNENKLRNQTLFHSDAILEEDYKVSSGFIESARDSIPFTKLINKKV
TSIVNNRNNIDGSGLSSQQQIERIIRMDEYEKNLLKEYIAEHTSRLPLHQRVNEATIERL
LAQELSNRDINSEFEYGVYSNSISTNLHSENFSLSHPATYGVPLFADDMGNSNYQLLVNF
TEKKKVVLSSITLMAALSIIFTLIIVIAYSSALSQLIKQRQISQIKTDFINNMTHEFKTP
IATINLALDAIKNPKISSDEEKKKRYLKMIRDENRRMHAQVENVLRISKLDKNELDLKKE
RLQLNEIVEDAMTHVELIVEDRGGYIQTHFGALRSSILANQDHFTNVIVNILDNAVKYSP
ETPKIDIYTENVKNYIILKIRDQGSGMSKLVQKKIFEKFYREHTGDIHNVKGHGLGLAYA
KRIIEDHHGQIWVESEKGKGSTFIIKLPLIS
>IFAGANLK_01194 Dephospho-CoA kinase
MVVGLTGGIGSGKTTVAGFFKEKGIPVYIADDAGKRLLETSAEIREKVTALIGKEAYSGK
TPNRKHIASVVFNESDKLEALNGIIHPAVAKDFETWKSKQNSVYVIYEAAILFEAGGYKK
CDINILVTADKEEKIKRLQQRDNSSLEEIEARMAKQWSDERKKKLADFEIENHDLALTKS
RVDELNEIILKRGKN
>IFAGANLK_01195 hypothetical protein
MLFSSLIWFFVQISKEYTQVIDIPVSYENVPLDKTISKERPDNLQLRIQDKGFAIWYYQI
FKPEVELDLGKASEEDGQLVYNFEANREVLEEQVNINFEKARFIQESLSVEFQPKKNKWV
RVTPRIDLGYAVGYSASEPVSLQPDSVQISGPENIIDTLQNLNTVYLKINNISADVSGRV
KIDTTNLGMLSFYNNEVTYSQKVEKFTEGSVQVPVEILNKPEGTNIAIFPKEVLVYYQVN
LKQYEMVKAENFRVVCDFNDIDDGDDFIIARIAEAPLMVRNLRLNERKIQFVIKR
>IFAGANLK_01196 putative glycosyltransferase EpsJ
MTLEYSFIIPVFNRPGEVRELLESMLKLQFDRDFEIVLVEDGSSISSGGIATEFQQQLNI
SYYYKKNTGPGDSRNFGMRKAKGNYFLILDSDVLLPENYLQEVDKFLQQDYCDCFGGPDA
SHPSFSKIQKAIDYSMTSFLTTGGIRGKKSAANDFQPRSFNMGISKKAFEASGGFGKIHP
GEDPDLSLRLKKLGYKLCLIPDAVVFHKRRIDWSKFYTQVQKFGMVRPILNKWHPGSGKI
TYWFPAVFSVGFLLGILLLKLGIWWLFLLYVLYFVIIAIDAAIKNKSLGIGFLAVYATLV
QFFGYGYGFMKSLWHIHILKQDPEHEFPNLFFKNV
>IFAGANLK_01197 putative HTH-type transcriptional regulator YbaQ
MKKLNNIHPGEILKEEFLDPLEISAYRLSKETFIPQTRVSEIIKKNRRITADTALRLSKY
FGTTAKFWLGLQDDYDLEVEKNLKGKEFNNIKPLENNAA
>IFAGANLK_01198 Toxin HigB-1
MIRSFRDKETDKIWKGIQSRKLPANIQNVARRKLRMINNAHTINDLRIPPANHLEKLSGN
FEGMYNIRINKQWRIMFKWENDNAFEVQIIDYH
>IFAGANLK_01199 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI
MSYNLLKGKKGIIFGALDENSIAWKTAERVKEEGGEFVLTNAPIALRMGTLKELAEKTGS
EIIPADATKIEDLENLVEKSMEILGGKIDFVLHAIGMSVNVRKGNHYTEQNYDFTNKGWD
ISAVSFHKTMQVLYKKEAMNEWGSIVALSYMAAQRVFPDYNDMADNKAFLESIARSFGYF
FGKDHKVRVNTISQSPTPTTAGQGVKGFDGFIAYADKMSPLGNATALECADYTVSLFSDL
TKKVTLQNLFHDGGFSNMGVSQEVMESFIKGQEEK
>IFAGANLK_01200 DNA repair protein RecN
MLTALSIKNYALIEDINIKLQEGFTIITGETGAGKSIMLGALGLLLGNRADYGSIRDAEK
KCVIEGSFNISNYKLKDFFVSEDLDYEENTIIRREILASGKSRAFVNDTPVKLTSLNKLG
EYLIDIHSQHETLSLGNNDYQFQVIDTIANSETLLLEYKTELKAYKKLQKRLVELKEEQA
QATKEYDYNLFLLNELEEARLENGMQEELETRYEELSNVEELTENLSSALNLLEQEEIGS
LDSLKQARASLSRIASLSSNYENLHQRIESVIIELDDLSSEVSDALDRVEANPEELEATN
QKLQLIYNLQKKHSAENIEELLKIKDELQEKVSVSENAENALSELENAIVKQETKLGSIA
AKLHEKRKAIVPAFIKEAESLLADLGMPNARLKIELKKAKNFLANGQDELFWYLAANKGG
DFKEIKKAASGGELSRIMLAVKSILAAQSKLPTIIFDEIDTGVSGDIAQKMAGILQRMGN
AMQVIAITHLPQIAGKGNSHFKIFKEDSANATTTKIEELKGGERVEELAMMLGGKNIGDS
ARAHARALLD
>IFAGANLK_01201 hypothetical protein
MRKLLFLILLIAGMPFAAAQELNCEIVINTEQTGQSNLSVFRTLESSLREFVNQTSWTNK
EFEQGERINCSMFITINEFEGESFSGTIQVQSSRPVYGSNMVSPIFNFNDSQFSFNYREY
QPLNYSQNSFSNNLVSVVSFYVYTILGMDADTFAPEGGTDYYQEANRIVNTSQQSGRSGW
SGADGQTSRFRLNSDLLSNMFSEYRTALYQYHRQGLDVMHKDPEAGKIAIADALESLTTM
NSRRANSLLLRSFFDAKADEVTQIFSDGPEINRPELSQTLSGLAPRYSRNWRNLQ
>IFAGANLK_01202 Coenzyme A biosynthesis bifunctional protein CoaBC
MSVLKGKKVLLGISGGIAAYKSAFLVRLFIKAGAQVKVVMTPAAKEFVTPLTLSTLSKNE
VFSSFTEDDEDEQWNNHVELGLWADFMLLAPATANTLSKMATGNSDNFLLATYLSAKCPV
FFAPAMDLDMYKHPSTKKSFESLKSYGNIMIPAGSGELASGLKGEGRMAEPEEIISFIEA
HFSKNLPLEGKKVLITAGPTYEAIDPVRFIGNHSSGKMGFELAKKAASLGAEVILISGPT
HLEIDDPKINLIRVVSARDMYLAAHDYFENVDVAIAAAAVSDYKPKIVAAQKIKKAEENL
NLELTKTQDILLSLGKKKTHQKLIGFALETNNELEHAREKLAKKNLDFIVLNSLNDAGAG
FKKDTNKITLVYKDSEKAFDLKTKAEVASDILNEIVHLLDA
>IFAGANLK_01203 hypothetical protein
MDIKKTDAPINTITFDKNKVDEPTSNIYEAISVVAKRANQINSEIKKELLEKLDEFATYN
DSLDEIFENKEQIEVSKFYEKLPKPHALAIQEWLDGKIYYRNTKDSEEAEA
>IFAGANLK_01204 Outer membrane protein assembly factor BamD
MFLQMMKKAILLVAVLTLTVSCGEYQTLLKSDDAGAKYTYAEELYNEAQEENSKKKYRKA
LRLFEQIVPQYRGKPQGEKLSFLFANTYYQLGDFYLSSYEFERFQQSYPNSDKLEEAAYK
KARSFYELSPRYDLDQTDTHKAIAELQAYLNTYPEGEHAEAANDMAAELRIKLERKEYEI
AKQYHLTGEARAGNYQAAITSFTNFLSNNPGSPFREDAQYYRFDSAYQLAVNSFRELMQE
RLEQALEYSQEYKKYYPEGEYSEAVEASTEDIKSRLQNF
>IFAGANLK_01205 4-hydroxy-tetrahydrodipicolinate synthase
MKSFIGTGVALITPFKEDLSVDVQALENLVENQIENGIDYLVVLGTTAESASLNKEEKQL
VINTVVKQNNKRLSLVLGMGGNNTYALCEELKAADLSAFEAILSVSPFYNKPTQEGIYQH
FKAVAAASPLPIILYNVPGRTASNILPETINRIARDFDNVIGVKEAAGDMVQAMKLISLV
PKDFLVISGDDMLTLPMVLAGGKGVISVIAQGFPAEFSKMVALGLEGKPAEAYELHYKVQ
RSIDLIFSEGNPAGIKALLALKGSIQNNLRLPLVKATPTLQQQIEDFLKNFS
>IFAGANLK_01206 hypothetical protein
MSLFQYILILLVPLLAVNLYAAVAEADWLMQATQLIFVPGLAGIYIKLKKNMGLNAMVFF
IFFFLAQINGFIYNTNNLTLLSFFFYIIAYFGLSREALQNTQMESASKTILVYFFLLLAI
NTYLLFTHVLELKQYMSSELEFGIYIAYYGILLVMGIISLIYYLNSYSKKSIYFITVVLT
FIFSDVFRDSSQFYMKDSAILITANLLWFTGLIFSLLFFLTPERKLRLLNLL
>IFAGANLK_01207 Mannosylglucosyl-3-phosphoglycerate phosphatase
MLSLILLNCKGNQVETAEIKGKRIAIDENIEADPEIEEFVAPYKEHLNKTLDSTLAYNPK
DMVKSDGDLNTAIGNLMADIVMEQVNPIFKSRAGNEIDMVLLNHGGIRSGLNKGNISTRS
AYALMPFENEIVVAELSGEKIKEMLSYLERAKTAHPVSGIQIEMDQNYKVIRAEINGEEI
DENKSYFVATSDYLQQGGDNMNFFKAPINLYKVDYKLRNAIIDYFKKADTLKVEKDNRFI
RK
>IFAGANLK_01208 Trifunctional nucleotide phosphoesterase protein YfkN
MKRRYFIQQTSAATAFIGIGGLSSLSFKPNYKKHITILHTNDVHSHIEPFGPDDSRNPNM
GGVARRATLIQQIRNENPNTLLLDAGDIFQGMPYFNFYGGELEFKLMSKMKYDASTLGNH
DFDNGIDGLYAQLPHAEFDFICSNYDLSDTVMDGHTRKHKVFTKDGVKIGIFGLGIELQG
LVNKGLYKETKYLDPVEIAQDQSRILKEEKNCDLVICLSHLGYDYSHDKISDIKLAKATE
NIDLIIGGHTHTFLDKPSIETNKAGNKVLVNQVGCYGLYLGRIDFYLDDKNNIEANGLKI
EV
>IFAGANLK_01209 DNA ligase
MSTEEKIKQLREELHRHNYLYYIEDKPEISDYDFDMMLKELQELEETNPEFDDPNSPTRR
VGGAVTKNFETVVHDYRMYSLSNSYSKEELEDWEKRIEKSIGGKVQYVCELKYDGASISL
TYENGKLKRAVTRGDGFQGDDVTNNVKTIRSIPLKLKGDFPEKFDIRGEIVLPYEGFAKM
NAERVETGEEPYANPRNTASGSLKLQDSAEVAKRPLDCLLYSLVAEKLPVKSQFEGLEKA
RDWGFKVPPEAELKNSISEVLDYVNYWDKHRHDLPYETDGVVVKVNSFDQQDELGYTAKS
PRWAMAYKFKAEQESTKLNKITYQVGRTGAITPVANLEPVQLAGTTVKRASLHNADQIEK
LDVREGDTVFVEKGGEIIPKIVGVDFTKRDPETPETKYAENCPECESELIRKEGEAQHYC
PNYNGCPPQIIGRIQHFISRKAMDIEGLGGETVALLVNADLITNYADLYILKKKDILPLE
RMAEKSAENLINGIEKSKEIPFERVLFALGIRYVGETVAKKLAKHYKNIDALASASTEDL
TAVDEIGERIAESVTDFFASEENRRIVQRLKDYGLQLEIAAKELENQSDKLEGNTFVISG
VFEKVSRNELKKMIEDNGGKVSGSISGKTDYLVAGENMGPSKLAKAEKLGTKIVSEEEFL
KMIE
>IFAGANLK_01210 hypothetical protein
MKIHKLQIYTDNIKEQLRFYRGKLNFKITDYSDNHFEIETGYSTIRFQHKENATPYHIAF
HIPDNQHNEALEWVKAHVPVLEGNGQEIVDFMAWSAKSLYFYDEDKNIIEFISRESFSKP
NSALFSEKSIVGISEVGLVTENIQEKFHFLNSNYQLEKYDGDFEHFCAIGDDEGLLITID
QQLKDWFPTDDKAYKSEFEIEFTHKGEKHSFIFENDKLKAQH
>IFAGANLK_01211 LOG family protein YvdD
MDNNSKNQLKSIAVFCASSEGNDEKIYTESYRLGKVLAEKNIKLIFGGSKLGLMGQVAAG
TLQNGGEVIGVIPDFLKTKEVVHTELTELITTKDMHERKLKMHDLSNGFIALPGGFGTFE
ELFEIVTWGQLGLHHNPIGLLNINGFYDDLIAMLKTMVRKGLLRKENFDLLIIAEDIEEL
LEKMYNFKPMPVPKWINKDQT
>IFAGANLK_01212 Release factor glutamine methyltransferase
MRLKAQKEIFVKTLEHEYPAEEVLSFFFLLTEAFFGIKRIDLALDPELEINENQVKKIDS
ALVRLKKHEPVQHIMGETEFFGLSFKVDKNVLVPRPETEELVQWILDDFSLENKVLKILD
IGAGSGCIAISLAKNLPVAKISAIDISKNALEIARINAENNKVQIQFFQQDILQTEKFSE
AFDVIVSNPPYVRELEKKEMYRNVLDYDPPTALYVKDENPLIFYDKITKLAKSALKPGGK
LYFEINQYLAKETEEMMKKNGFKTELRKDIFGNFRMLKGELR
>IFAGANLK_01213 hypothetical protein
MSTLKIREIQPEDNQQVAEVVRKVLVEMGVPKVGTAYEDKALDNMFATYQHPRMNYFVVE
DEEKIIGGAGIAPLIGLEEKICELQKMYFLPEARGKGLGTQMMDTCLKFAKSQDFEQCYI
ETLPYMESARKLYGRSGFKSLEKPLGDTGHYNCTMWMIREV
>IFAGANLK_01214 Riboflavin biosynthesis protein RibD
MNIHEKYIKRCNELAKNGLGSTYPNPLVGSVIVHKDKIIGEGWHQKAGAPHAEVNAVNSV
KDKSLLKKSTIYVSLEPCSHFGKTPPCSDLIIAKGIKKVVIGCVDPFAEVAGRGIKKLME
AGCEVQVGLLEKECQKLNKRFFTFHQKKRPYIILKWAQTADGFIAPEIQEKREPVWITNQ
YSKQLVHKWRSEEQAILVGTHTAIADNPQLNTRLWEGKNPVRVVIDKGLKIPKESALLDG
SIKTIVLTEKEPQKAPENENLVFEKLDFQQNLPEQICEVLYRNNLQSVIIEGGAKTLQSF
IDAKLWDEARVFTGIAEFHKGIKAPEFSGKMVSQTSLERDNLKIYRND
>IFAGANLK_01215 Alpha-D-glucose 1-phosphate phosphatase YihX
MIKTIIFDFGDVFVNLDKPAIMREMNKYEIEKLSENLLDINQQYEKGLISSEKFVKSYQS
EHSHLQKEHFKNSWNAILVDFPEYRYQFLKKLSEEKNYLLILLSNTNEIHIDWIKKNVSF
FEDFKACFDAFYLSHEINFRKPDAEIYEFVLEKHDLKPQECLFIDDTRENTDAAEDLGIY
TWNIEPTREDVIDLFTAKKELF
>IFAGANLK_01216 hypothetical protein
MIYLLLSILSSTIIFVVFRLYKKYGVNTLQAIIVNYFIACIVGFFGYIEGVDDLIRIPSE
PWFLGTVFLGAMFITVFNLAAITTQRSGLSVVSVATKMSVAIPVFFGIFIYNESLGLLKI
SGILLALAAVYLSSIKTEKGIKIKKRNLIFPLLVFIGSGIIDTSLNYLENFYVSETDVGL
FSSSIFGIAGIIGISILIGQAVLGKLKITWKNIAGGIALGIPNYFSIYFLVMALRAPGIE
NSVIFTLNHVGIVLASTILGIVLFKEVLLKKNWIGIALAIISIILVASSQ
>IFAGANLK_01217 IMPACT family member YigZ
MKDTYKTITTASPEVLFKDRNSKFFGYAFPVKTEEEANIQLEGLKTKHHKARHWCYAWQL
GKSDFQYRANDDGEPSNSAGMPIYGQIQSFEVTNILVVVVRYFGGVKLGVGGLINAYKTA
AQMALEEANLVTRTIDEVFEISFDYPEMNIVMRLIKENNLNIIEQKLELDCKIYISVRKK
EADQIFEKFDSTYKVEIKRLKE
>IFAGANLK_01218 Putative esterase
MKSHVSYVKVRYAETDQMGVVHHGNYAQYFEIARLDWLSALGISYKSMEENGVMLPVYEL
NTKFLKPAVFDDELKIEVGLKELPAVKITFEYLVFNQREDLITKAYTTLVFMDSNTKKPI
RCPQDILDKLK
>IFAGANLK_01219 Chromosomal replication initiator protein DnaA
MSKTAQSVWNSCLAFIKDNITPQAYKTWFEPIQAVKLTDCALSIQVPSKFFYEWLEEHYV
KLLKVSLTKELGEKAKLVYVIKMENTYGNKMPFTEKIPSTQRSHMASQEVDVPLKNKNPE
LKNPFIIPGIRNVKIESQLNPSYNFENFLEGDSNRLARSAGLAVANKPGGTSFNPLLIFG
GVGLGKTHLAHAIGVEIKDKYPEKTVLYISAEKFTQQYIESVKKNNRNDFIHFYQIIDVL
IVDDIQLLSGKAGTQDVFFHIFNHLHQNGKQVILTSDKAPVDMQDIEQRLLSRFKWGLSA
ELQHPDFETRISIIKSKLYRDGVEMPEEIVEFLANNIKTNIRELEGAIISLIAHSSFNKK
DITLELAKKIVDNYVKNTKREVSIDYIQKVVSDYFQMDVQTLQSKTRKRHIVQARQLAMF
FAKKFTKASLASIGSQIGKRDHATVLHACKTVDNLATTDKQFKKFVEDLNKKLTI
>IFAGANLK_01220 Low molecular weight protein-tyrosine-phosphatase YfkJ
MKTKVLMVCLGNICRSPLAEEILKSKVDQSKVFVDSAGTGDYHIDDAPDPRSVAIAKKNN
LDITYQRGRQFQTEDFDKFDHIYVMDNSNFQDVMALARNDEDRAKVHLILNEIFPSENVD
VPDPYFGGDHGFENVYQMLDEACEKIAAQLKEENKA
>IFAGANLK_01221 Ribosomal RNA small subunit methyltransferase I
MPDFQYSGKLYLIPTTMGAANPMQVLPQQVKEIMESLDIFIAENEKTARRHIKQLVPEKQ
QSTLKFFHLNKFTEASEIPSFLNECKEGKNIGLLSEAGCPGVADPGAEIVKIAHNEGIQV
IPLVGPSSILLAMMGSGMNGQRFTFNGYLPIDKKERKKEIKDLERFSFEKQEAQIFIETP
YRNNKLLEDLFQLLNPTTRLCVACDLTLPTEYIMTKPVSEWKKTKTDLHKRPAIFIFQRE
I
>IFAGANLK_01222 hypothetical protein
MRRKIAKFSILPVLAGCMFFSFSTREAANLEIEGYSTSNLDLNYTVALVEESELVKDQSL
ERALPELGKSYVGFKEAVGFKESRGNYQTINEFGYMGKYQFGIGTLELLGIYNSAEFLNS
PQLQEAAFYTNASRNKWILIRDIARFEGKVINGVEVTESGILAAAHLAGPGSVKKYLRSW
GAQSFSDAFGTSIRNYLKKFGGYDTSFVEPEKNPRVNIKAFRA
>IFAGANLK_01223 Endolytic murein transglycosylase
MYIKKILLAIAILGLIGLSVFSYYIYTSIFSGNTSFSGEEKLVYVPTGANYQIVIDSLQP
YVEDMESFDLVARKKGYASNIRAGRYAIKPGMNNNDLVNALRSGNVPVKLTFNNQERLEN
LAGRIAQQIEADSTTLIEAFKDKEFLAENDFTEAEALAMYIPNQYEFYWNTSAEEFRDRM
KREYDRFWTEEKKQKAEEIGLNPKEVSTLASIVHKETAKVDERPKVAGVYMNRYKNGWKL
DADPTVIYALKNKTQKWDTIIKRVLYKDLELDSPYNTYIYKELPPGPIFMPDISAINAVL
NYEDHEYFYFVADVENFGYHKFAKNLAQHNRNKQEYVRWINNQGVKR
>IFAGANLK_01224 Spermidine N(1)-acetyltransferase
MSSLRGNKVYLRALEPEDLDFVHTVENTEDFWEVSATQTPYSRFLIKQYLENAHRDIYDI
KQLRLVICDFQDNEVGLIDVFDFEPKDQRAALGILIADPSERGKGYGAEALKLLCNYCFT
HLAMHQVYANITEGNENSVKLFENLGFQRVGVKKEWTHSEDGFKDEILYQLIKK
>IFAGANLK_01225 Diaminopimelate epimerase
MKIPFYKYQGTGNDFVMIDNRQQLLSKNNTRIIKKLCDRKFGIGGDGLILLEKPDVDGDD
FKMVYFNADGNESSMCGNGGRCLVAFAKFLGIIENEATFTAIDGPHKATITNHQVSLQMQ
NVADIKQLGNSAFLDTGSPHHVIFTKNVPDLDVKKEGAVIRYSDEYAANGGTNVNFVDMQ
EDNTFLVRTYERGVEDETLSCGTGVTAVALAAHASGKANTNTVKLIVPGGELSVSFNKEN
ETYTNVWLTGPAIQVFKGEIVCQA
>IFAGANLK_01226 Periplasmic pH-dependent serine endoprotease DegQ
MKMKNLSKLLLVSILGGALTLGSYKMFFEEETPAGLPPVSNTSTELIPANYSGNIYGTNA
DFTEAAENTVNGVVHVKNVAVFKGPRSMRDLIQGNHGGGKALQGAGSGVIISPDGYIVTN
NHVIREANEVEVTLNNNKTYTAEIVGADETSDIALLKIDAEGLDYIPFGDSNNVKLGEWV
LAVGNPFNLKSTVTAGIISATARDLNTYDATPQSFIQTDAAINPGNSGGALVNINGELVG
INTAITSQTGSYIGYAFAVPSNNTRKIVEDIMEYGDVQKGILGIKGGSINPRAVEEFGLE
TTQGVMVAEVTEGSGAEKAGLKQGDIIRKLDNVDINKFSDLTGYINSKRPNDEIEVIFLR
DGEEREAKVTLTKFETYTIEPIKIEVSNASKEELQALNVENGVKIYRTLSPRLPAQELVG
TIITAIDNKNVSSVSDVERIFRNKNLAEDIVITIVDRNGEKQRMVWR
>IFAGANLK_01227 Glyceraldehyde-3-phosphate dehydrogenase-like protein
MSFNKVYEKELSFQANRRKATVQFINIISDLWYDKSIELVLFRNQLLNRNVSDILNLHEY
AGEFVEKPISIFDTVEIAKAIQDMDLPPAKLDIGKLTYEYHLEDQGHLNAMAFVSDKLKD
AKKYDKVVPKDVVLYGFGRIGRLVARELMARTGKGSQLRLRAIVTRGAVDKSVLEKRASL
LKNDSVHGDFSGTVSIDEKNSSLIINGTTVKVISADKPEDIDYTKFGINKALIIDNTGAF
RDKEALSRHLKAKGAAKVLLSAPGKGIPNIVHGVNHKEHNPDKISIFSAASCTTNAITPV
LKAVQDTLGVVHGHLETIHAYTNDQNLVDNMHSKYRRGRAAALNMVITETGAGKAVAKAL
PVFEGKLTSNAIRVPVPNGSLAILNLEIEGQTTVEDVNNILKKYALEGELVEQIKYSLDN
ELVSSDIVGSNAPAIYDSKATIVSADRKNVILYIWYDNEYGYSHQLIRLAKYIAKVRRFT
YY
>IFAGANLK_01228 hypothetical protein
MMRNIIFSSLLLIFSVSFLSAQDSLATSNFIEDEFDNLIESSNNYQGYKVVDYDALIELR
DNTKRHVQDLKNELQEEQSTISSQNEEIENLENQLAETQEDLQRVNEEKDAIKFLGMPFS
KGSYMALMWGIVGVLILALLFFIYKFKNSNSTTKEARHRLDETEKEFDLYRAKALEKEQR
LGRMLQDEKNKAKD
>IFAGANLK_01229 tRNA (guanine-N(1)-)-methyltransferase
MRIDIITVVPDLLKSPFEASILKRAIENGHVEIQLHNLRDYVTDNYKQIDDYQFGGGAGM
VMMVEPIDKCISDLKSQRDYDEVIYMSPDGDRFDQKTANTLSLKENLIILCGHYKGVDQR
VRDHFITKEISIGDYVLSGGELGAAVVCDAIIRLIPGVLGNETSALTDSFQDNLLAPPVY
TRPAEYKGWKVPEILTSGNFPKIEAWREEKAWERTKRLRPDLLDETEK
>IFAGANLK_01230 50S ribosomal protein L19
MESLIKYVQDEFVERKDLPEFSAGDTITVYYEIKEGQKTRTQFFKGVVIQKRGSGASQTF
TIRKMSGTVGVERIFPLNLPAIQKIELNKRGKVRRARIYYFRELTGKKARIKEAKR
>IFAGANLK_01231 Isocitrate dehydrogenase [NADP]
MTQIGKIIYTKTDEAPALATYSFYPIVKSYTKAANVGMETKDISLAGRILSQFPQYLSAD
QKVSDDLAELGDLAKKPEANIIKLPNISASIPQLKAAIKELQEKGYKLPDYPDEPSNDEE
KNIQTTYDKVKGSAVNPVLREGNSDRRAPKAVKNFAKKHPHSMGEWSSDSKSHVSTMNGG
DFKANEKSLTLSEETDVKIEFTSKSGDKKVLKDNLHLLKGEVIDATLMSKKALLQFLREQ
VKDAKEKGVLFSLHMKATMMKVSDPIIFGHAVRVFFEDVFTEYGEELKNAGADPNSGLGD
VLNAIEKLPADKKAEIEAKIKADIAEGPDLAMVNSDKGITNLHVPSDVIIDASMPAMIRT
SGQMWNKNNETQDTKAVIPDSSYAPLYQETIEFCQKHGAFDPTTMGTVPNVGLMAQKAEE
YGSHDKTFEISNAGTVRVVDKNGKVLTEHEVEEGDIWRMCQVKDAPVQDWIKLAVNRAKA
TGWPAIFWLDKNRAHDAELIKKVNEYLPNHDTSGVDIKIMSVAEATKYTLERVKAGENTI
SVTGNVLRDYLTDLFPILEVGTSAKMLSVVPLMNGGGLFETGAGGSAPKHVQQFLKEGHL
RWDSLGEFLALAASLEHLGEKYENKKALVLSEALDDATNKFLENSKSPSRKVNELDNRGS
HFYLALYWAQALAAQDKDAELKQHFANVASKLEENEEQINKELIDAQGSSVDIGGYYKPD
EDLTSKAMRPSKLLNDILG
>IFAGANLK_01232 hypothetical protein
MGINAQETYTLKGTITNASSNETLIGVNVIIPEEQKGVVTNEYGFYSIKLPEGTYTLEIS
YLGFQTISETITISEDTTFNTEMTEGSESLDEVVIKSNNEGINIKSPEMSVNKLSINTIQ
KLPVVFGEVDIVKSLLLLPGVSNAGEGASGFNVRGGAVDQNLILLDEATIFNSSHLFGFF
SVFNPDAVKDLKLYKGGIPAKYGGRVSSVLDIYQRDGNSKEFKAQGGIGVISSRLLAEGP
IVKDKGSFLVAGRSSYAHLFLKLADNPNSAYFYDLNTKLTYKLNDENKLLFSGYFGRDVF
DINQNFLNTYGNSVFNLRWNHVVSDDIFTNLSLIYSDYYYGLTLNFVGFNWDSGIKNLNI
KYDFNHYLNDTFQLEYGLHSTYHEFNPGEIAPIDENSGINFFKLTNKYALENAAYFSVEH
NISDKLTAEYGLRFSNFLRLGQESLNEYENDNPIIYNEALDIYEEAQPVDQNSYSRSEVI
KTYSNLEPRLALAYNFSENQSFKASYNRMAQYLHLISNTNSPTPLDVWAPSGPFIKPQIL
DQYALGYFRNINDGKYSLETEVFYKDIQNRIDYVNGANLIANDNIETIILNGRSRAYGLE
LLAKKNEGRFTGWVAYTLSRSEQQTPGRTAVESGINNGKWYATNYDKTHDISLTASYDYN
KKWDFSANFAFQTGLPVTYPMGQYDFNGINVPVYGDRNSNRLPAYHRLDLSATYIPKPNK
KQGFQSSWNFGIYNVYNRKNANSISFRENDDTGRNESAKLSLFGIIPSITYNFNF
>IFAGANLK_01233 hypothetical protein
MKNLYIISLLALLFTFTSCEEVIDLDLEESEPRLVIDASMLWYLGTPGNNQQIKLSETIG
FYEEGVEPVTDAEVIINTGNGEEFIFAHQENGIYLNSNFIPEFDKNYTLEINYNDQLYTA
TSSFVPVAGIDYIEQNNEGGFTREDLEVEVFFTDPAGQDNFYLFSFSNISTSKFTLEIYE
DEFTDGNQVSTNYSNEDLAAENEIHITMEGISEAFYNYLYILRSQGGNSGGGPFQSPPAT
VKGNIVNQTNPENYPFGYFRLSEVDSTTYIVQ
>IFAGANLK_01234 hypothetical protein
MKHTNKKILGKGVKYLAFALPLSLIGPSVLFTAFNNQDHPYYIPVLIVGIIALIAAIFLM
FRGIMTIVKSIFD
>IFAGANLK_01241 hypothetical protein
MKKIFFLFLLCTFIGSCSEGSKYKPIEFDNTYKFSEEILKEAKEGKRFGEHQYAAWEFAF
QGDYKNALSQWDLARQPDFQEFSQQEIDSLHKNYKVVDAKKYLVKKIKSHQIVIINEAHH
NSFHRHFTSSLLEVFYQNDFRYLGLETLENGLKKDPHLNTRNYPIQASGFYTRDPTFGSM
LRKALKMGYNVFPYEDTTGVNHDEREIEQAKNIKKIIDQNPDAKFLIHCGFGHVMEGVFP
SGMKALAERLKEYTGIDPLTIDQVAHSEKSNPNFYSPLSRTYKVRTPSVLVNENGEAVKN
RINDRWTDIAIVQPKTSYDKGRPGWLFEGKAKPVAPAIADIDLSFPLMVLAFKKEEDYQR
AIPVDIIEVKNRQEEMYLALDPGEYIIVLANTEEKQENMK
>IFAGANLK_01242 hypothetical protein
MLILKVTPAGFKPDLRILVLKAVPAIKKIQGNLLGIFNFELIYDILTSRL
>IFAGANLK_01243 hypothetical protein
MVKFKGEGAYSLLNVQTSYYTTVGGDVMRSLYNLDSSSSSEITITEYDAEQNMIKGNFEV
TLLQDWSNPENDITY
>IFAGANLK_01244 hypothetical protein
MRFILLLIFSLILFSCSNEKAEWTNLLDENLSQWDNYLSYHHKDGYNGEEPKDLQGNLIE
PIGANKDQFGVFSVLEENEEQILKVSGEIYGCVSTKTEYENYHFRLKVKWGNNLYPPREK
LLKDSGILYHSIGPNGADYWRSWMLSQEFQIMQGHMGDYWSQANSAIDIRTYPSEGIMSP
VADNNQAFLPIGEGEVLDGYVMRSVNHEKPQGEWNTLELICFEDKSIHIVNGEVVMVLKN
SRYVKEGEKIPLTKGKIQLQSEAAEVFYKDIQIKPLTSLPEIYGKYYN
>IFAGANLK_01245 hypothetical protein
MFFKQGFKMSDKIYPHYLNIFVSFKTHYGRISRLIKIYQAINETKNCVYNHSHTHKKAKK
Y
>IFAGANLK_01246 hypothetical protein
MDTKLTLKLNQEVIEKAKKYASEKKLSLSRIVEFYLQSLTTDSKKDDFEISPFVKSISTG
TSIPADVDYKKEYSDYLMEKYK
>IFAGANLK_01247 hypothetical protein
MKKRLFLDTNIMLDFLGERPPFYEAIAKLATLADKGKIKMVVSPISFATVNYFLAKIETP
EIAKEKLRKFKIISEICKLDGHTIEKGLNSDFKDFEDSLQYFSAVESNCEIIITRNGKDF
KKSLIPIMTAEEYLNSIRKK
>IFAGANLK_01248 hypothetical protein
MPIDRLDHVRDMFVFSSYTEISYTDLIKLTKNNNVLGTDGDQWIIYNRQKTHTAVEVPLL
DTALQILEKYQAHPITKVTETLLPCLTNKKLNVFLKEVGLVGGIKKLTFHMGRHTLATTV
TRNNGLLIETVVLTRN
>IFAGANLK_01249 hypothetical protein
MNIKPAMKNFILFSFLCFSFFLNAQERQAPAYPLVTHDPYLSIWSFTDKINEQPTKHWTG
TDHYLVGYINVDGTIYRFLGNEAKTFNSVLPASEEGFTAQITEEKPEKGWHETGFDDSSW
KSAKAPYGNQSEDATSSWESEDLWLRRKFDLEAADLEKLFLKLRHDDNINVYLNGAKIYE
RNGWTHKFEYHEIPASAFKNLKKEDNILAIHIKNTAGGQWLDFGLAEEIKDKHTTQVAEQ
KSVEFNATQTIYKLTCGGVDIDLTFTSPLLMDDLDILTRPVSYISAKTTPNDGNSHEVQV
YFGASSSIAVNENSQELSSEKSATNGLSFLKAGTKSQPVLEKRGDDLRIDWGYMYIAVPN
NASAHQSVTSVKDAKSNFLEGKSGHSVQSGRNLMLTTVFPKEEIDSEKEHLILLGYDDEY
SINYFGEKLRPYWNKDGNNTIQNELEEAYQDYNNINEECKEFDEELYADGVESGGEAYAN
LLEIAYRQSIAAHKVVESPQGEILFLSKENNSNGSINTVDVTYPSAPLYLIYNPDLMKGM
LNGIFYYSESGMWKKPFPAHDLGTYPIATGQTYGEDMPVEEAGNMIILTAAIAKSEGNAE
YAEKHWESLTTWANYLAEKGLDPENQLSTDDFSGHLARNANLSVKAIMAIASYGYLAEEL
GKDDIAEEYTEMAKTMAKEWMELSDAGNHYALTFNDKNTWSQKYNLVWDKVMELDIFPDE
VIEKELAYYKTKQNEYGLPLDNRSDYSKSDWILWTATLADDMETFQYFANPVYKFGIETV
DRVPMSDWHWTTSGDVRGFKARSVIGGYFIKLLEDHWK
>IFAGANLK_01250 hypothetical protein
MLSKLGVLFVVTGLSISGVLAQQECSQPNVLLIMVDDLKPTLGTYGDTLTISPNIDQLAA
EGMGFAKAYSNQADAGLWTENDFLFTTENA
>IFAGANLK_01251 hypothetical protein
MMNFFKKLSRFSFKIKGKGFWIFTVYFFLPFLAFAQIPVDLNSFDKNGEASVSSKEGFLE
ITWPTGKDEKGKIYVNLEQNQPLFNKIELIKEESISEIATNLDPVFLLSVGERDLEKRDG
WNIFFDQTAYKPYETHLVKLDKRNAQVISEGSRTKILISEVSAGNFNGSLEIILFNGSPL
LNIAAVMATEKDARAIIYDAGLTGSENEWEEVFWADTDDYLQSSKVNLETKSENLAVKYR
TIIGETNGGSLAVFPPPHQYFYPLDNAYNLKFTWYGKQYRKKVPEFGIGIRHELLGDRRH
VPWFNAPPETKQRLNFFILISDEKDGKVLNQVKKFTHGDEYKPLEGFYTMASHFHTEHVM
DVLTHKPLPEIPGHVKALRDAGVNIMHLGEFHLAGNPRDRGPKRLPEFHKMFEECARLST
GDFLMLPGEEPNSHFGGHWMNLFPEPVYWIMSRDEDEPFVEEHPDYGKVYRVGNKEEMLR
LLEEENGLAWTAHARIKGSTGYPDEYKDEEFFKSDRFLGAAWKAMPADLSQKKLGKRVLD
VMDDMANWGHKKHVIAEADLFKIEPDYELYGNMNINYLQLEELPKFEDGWQSVLDVMESG
KFFVSTGEVLLPAFNVDGKGAGETVNLQRNGKAEITLEIDWTFPLNFVEIVSGNGEEVFR
EKIDLTKTKAFGKKEYRFTVDLKDRKWVRLEVWDAAVNGAFTQPVWLEE
>IFAGANLK_01252 hypothetical protein
MRIFLYILVFISLHTYGQEVQGYLYDSNGRIQNNITLENITQQLNSTSDENGFFKITANI
QDTIVFNSILYEEYRLVINRKHLDDNIVIELKNTTLEEVRILNNKKIPIEKLDEKLYYSL
RQDIIKNPTFYEPHKGNIIYLLQAARGLLMRKKEVSKTDAPISKMMNFDDFRILFAKDDI
LNKKFLSENLSIPERYHPLFFEFLVSKKIDSNLLQEKKKLDLIDLVYNAGKEYREINQLS
N
>IFAGANLK_01253 Sporulation kinase E
MSYHKSVFRNLPFPCLLFEKKKNLYVIKEANSLYCKVTNKSEKELIGNTVEEVFPENPTF
SGLKDILDSLNNAYISKEPHRIDVLRYDLFDSQNIIYELKYWEVENIPVFDDVENTWYIL
NIVKDITNQIVEKNRCDLLQVKLDAKTEKHKKFIERNTDGMYILDQDGYFINLNQGLIDI
TETPEEELIKMNFLPFCDPEHRDRIIEKFNNALNGENQKFEAKFVSGKGREMVLDISLIP
FRSNGIIRGAYGIAKDVTKLKESEAALLESERKFKALVQEGSDLIGILDPEGKYKFVSET
SYPVLGFTPEEFIGKTTFDFIHPEDKERVITNFSELKFKNQAIIAPFRFKNAKGEWRWIE
TKATNLVDDPVIEGIVINSHDITDRILSEKALKENEEKYRAFFESSLDGILLTNPYGEIF
AANNAACKLFQRTEQEICEIGRNGLVDLNDPRVEEAIREREKTGKVIAELNMRRKDGSIF
LAALSSAIFEGAKGEKLTSMIIRDISESKRAEEELKASELEYRKLFQNNPLPNIIYDKDS
LKILDVNKATLDHYGFSRKELMNVSLLDFIPEGEITNFKKKIFTFSSNEGEVAHHRNITL
EKNGRRVIVETFGYGLQYQHKDCRLIILLDVTEKEIALQKLKDKTEKLITAQKIAKMGYW
THNLENNKFFWSDEVFNIWDRDKENFQPSVDTFKKTIHPEDLENFINKNKLALEGNMQLD
FEHRIILPSGKIKWVHEKGKVIKNLEGNTVFEGTVQDVTERRNSLEKLMQSEARQRGILQ
SQTNYLTRINMQGNYSYVNDKFIKDFEWVYTNNEIVNQSALSTVKPHYHEKVTTTFKKCV
ANPNVVFQLEIDKLKEDGGERITLWDFICIPDVDGNPVEVQGVGIDITDRVKAERELKES
NTRYELVSKATSDAIYDWDINSNFLLWGKAFYAIFGYSQDKFPPTIEAFFDKIHPDQRDT
ITESLTHGIKGKDNRWKEEYRFKKADGTYAFVIEKGFILRDKNGKAYRMVGAMQDVTERK
KLEALLDEATKLARIGSFEIDCEKETLYWSAVTKEIHGVPLDYEPTLEKGIYFYKEGESR
TAMNNAYRRAIEENIPYDIELQLITTEGEERWVRKIGQPTFINGKCVRINGSFQDITNLK
MSEMQALKASEEKEKILESIGDAFWMVDNDWIVTYWNKHAEDVLNCPRDQIMGRNLWEVF
SDALGTDFETYYFKAVEEQTIENFEAYFERVEKWLEVAAYPSPNGLSVFFRDITERKESE
LQIRELNKNLKIYTEELVEANKGLEQFSFIVSHNLRSPVANIIGLADLINQKDYPEEVRN
KFLQALFDNVKRLDTVISDLNTILQVKVEMDAKKEPVVLNNLVAGIKSSIQNLIEKEKVQ
IKTYFEISTLHTVQSYLHSIFYNLISNSIKYRKLDIPPQIKISSKIKEGIIFITFEDNGL
GIDLEKKGDQVFGLYRKFHNHVEGKGMGLFLVKTQVELLGGKISIESEVNGGTKFIITFK
EKTYNYISEYV
>IFAGANLK_01254 hypothetical protein
MYNQRYMVVDDDSTNNMICEFTIKRFDKEGDIKIFSVPEEALSFIAEEYRLENRKQPTLL
FLDVNMPTMSGWEFLDKFLKFEESLKNQFTIYILSSSIEDFQEKAEIYSTIKGFISKPLK
MNNLEEIKNGL
>IFAGANLK_01255 Alkaline phosphatase synthesis sensor protein PhoR
MPYNITGSESSISKMSLEQNAREFKFVIDLMPHMVWATKPDGYHDFYNQRWYDFTGLTYE
ETKDKGWSLVLHPDDYDRAWKIWQHSLDTGNPYEIEYRMRRFDGTYNWFLARAQPLKDDK
GKILKWFGTCTDIQGQKEILEERERTKEELRISNQDLNKSYEELSRINLELDNFVYSASH
DLKTPLNNLEGLIALLKQAENTKEDQQEILGLIDKSVKHFKEVVNDMTLIAKTAKGNNTM
HNINFSVLLEEIKNDLGHLIKSTGIIIKSDLQVRNIQYPRKEIRSILFNLISNAIKYGRP
GRPPVIVVRTKLTSEEILLEVEDNSSGIEDEHLPDLFNKYFRINRAVEGSGLGLFIVKQM
VENRGGRIEVTSKVGKGSIFSVFLKPQK
>IFAGANLK_01256 hypothetical protein
MLDFFYYNEISPQERLGPTGRTIEASLKKRIHAVIALMRDIEKTQTKPTVVMIQSLFEME
EPQKKPLILEKNQVEERERVGFREKSNSQNKI
>IFAGANLK_01257 hypothetical protein
MYITITPQKLGKNFAQSASDFVEYLEKENEAKVQEKMEHFFNQYHEGIPAEEVVKGIDGN
TAKLKKTEPKFYSITVNPSKYELNKLQNNSKDLKRYTRELMKDYVRSFNREIKGRPVNID
DIKYYAIIEHTRTYKGTDWQVKENQPYAAKILNLKNEVRKIEQKQIQGNIAHIKEKIAQQ
ERQVPHQQNGKRIVQGTPKAGNQSHIHIIVSRKDASNSFSLSPGSKYKASEVTMNGTLVK
RGFNRDQFFEKAEKTFDKTFGYRRNFVDTYKGRKEFIKDPKSYFANLNKLPTPERIFAFK
MRKETGFSVPIIPINKAQLALKIFKGLRKGVDIARKSSSIEI
>IFAGANLK_01258 hypothetical protein
MQPDKLYIILLIVVLCSMVGYGLYRITRYAFLLNLFLLGLILYFLSSSYSLVFLVLILGC
PLMLINIVGYVFMHDPDQGRPKNPQYTVHFATSSGDFKLDNIKRGASVIGSAGSGKTESV
VYGFLKHFEKKGFCGIIHDYKDFELTEMAYPIFKGKEIPFKIVSFDSIIHRVNPIAPRYL
ENEESVNEVSRVLVENLLELRESGSFGTSKFFNDAAEGLIGGLIWKLKTSYPEYCSLPHL
IAIYQYLDTNSLIEFLKTNTTSRAMADAFISGKDAERQTAGVKSTLANALKRISTRRIFM
ALSADEVPLNINNKENPAVISVVNNPKYESSYSPVIATIIHTITKQMSVRNSKASFLLME
EAPTLRLLNMHRIPATLRSYNIATVYVMQDKIQNDMMYGDKASRAILSNLSYQFFGKVND
PDTAKYYERFFEIVKKPTKSVSSSYSLNFDTRVTTGEKEIPKLRSDVFFRLKQGEFITYA
DGIDKRLQFKLQKIQRHLPEAKDQKPYSKADLQENFDRVYKEARSIFDQ
>IFAGANLK_01259 hypothetical protein
MSETNRIEYKRELSDGLEKEVVAFLNYREGGIIYIGIDKEGKTFGVKDPDSVQLKIKDRL
KNNIRPSALGLFDIVTEKRDGKDILKIIVASGSEKPYHLKKFGMSEKGCFIRLGSAAEPM
SQKLIEELFATRTRNSIGKIKAHRQDLRFEQLHIYYQEKQKPLNKQFRKNLELTTTGGDL
NYAAYLLADENNVSVKFAKYKGITRVHLVESNEYGYCSLIKAAKRVLEKMNLENRTITQI
THSERKEHRLWNAIALREAIINAFVHNDYTREIAPKFEIFSDRIEITSAGSLPDGLSEDE
FFEGFSIPRNKELMRIYKDLDLVEQLGSGIPRILESYSKDSFRFS
>IFAGANLK_01260 hypothetical protein
MTFPSAEDVYRETKQVPSKYQASATQVTTQVEELLKVFTGEHTRQDLQEKLRLANRENFR
KNYLQPALESKVIEMTIPEKPQSSKQRYRLTSRGVQAKKI
>IFAGANLK_01261 hypothetical protein
MADAFISGKDAERQTAGVKSTLANALKRISTRRIFMALSADEVPLNINSEENPAVISVVN
NPKYESSYSPVIATIIHTITKQMSVRNSKASFLLMEEAPTLRLLNMHRIPATLRSYNIAT
VYVMQDKIQNDMMYGDKASRAILSNLSYQFFGKVNDPDTAKYYERFFEIVKKPTKSVSSS
YSLNFDTRVTTGEKEIPKLRSDVFFRLKQGEFITYADGIDKRLQFKLQKISRYLPPGQEQ
YSQADLEDNFKRIYEEAKSIFGQ
>IFAGANLK_01262 Dihydroxyacetone kinase
MKFFINDAQDVVNEGIDGLLTDPNLTRLDNFPEVKVVLQKELDKNKVAVISGGGSGHEPA
HAGFVGKGMLTAAVCGDIFASPSVDAVLSAIIATAGEKGCLLIIKNYTGDRLNFGLAAEQ
ARELGYKVETVIVGDDIALGQEVEQRGLAGTVFVHKVAGHLAEKGKSLDEIAKTAQKVAN
NIFSIGLSLEEGKKFQNPESSRLSSSEAELGLGIHGEPGVKTIDMEKADDLMSKAVEKLK
EYLPKKNNEKFVLLMNNLGRVTPIEMNILLNSFQKLEIARQVEYIIGPSQLMTSLNMSGF
SISLLKLNEGLRDSLTSEVEPVSWSIRKFGENSSIESPDLPDTMPFKPSENMQFKNAIKA
VAEELISLENDLNAIDEKVGDGDAGSTFATAGKKLLEVADKLPYANTAELLITIGRILAR
EIGGSSGVLLSIMFTGAGNSYKEESNIGKALMSGLQKMKDYGGAKEGDRTMIDALQPAFS
ALENGKKIDVVAKKARQGADSTKEISSTKFGRSSYLSEESLKGIPDPGAEAVAIVFEKLA
SL
>IFAGANLK_01263 hypothetical protein
MISKKTILLPKHRKIFEQIGENIKLARKRRKLTTEQVSERAGIHRATLYRIEKGDPGVAI
GLYFNVFRVFNLQDDFLKLAVDDEFGRKLQDLDLL
>IFAGANLK_01264 hypothetical protein
MAGEKFDIYVFADWIALKKPTLIGILSAHFAKGKKAFSFEYDKNWLKTDAHRLLDPDIAF
YSGPQYPPNKENFGIFLDSMPDTWGKTLMKRRAAQNARTKDEKIKKLYEIDYLLGVYDES
RMGALRFKTDFDGPFLNNDNQNPTPPWSSLGELQEAVNQLENDDQSDAIRRWIAVLIAPG
SSLGGARPKANILDAQQNLWIAKFPSKTDTIDKAAWEFLAYKLALASGIEMAESKIEKIT
GHYHTFLTKRFDRDNGNRIHFASAMTMTGNTEEIIKDDSPSYLEIIEFIENYGVDVETNL
HQLWRRIVFNIAVSNTDDHLRNHGFILKEKGWILSPAYDLNPSVEKDGLSLNIDMEDNAL
DFDLARSIGKFCRLDEEGMETILKEVLTVVKDWKSMASKLGIANKEIEIMSPAFRYL
>IFAGANLK_01265 hypothetical protein
MKNYILTTAALLAFVFTRAQTEEKLDTIFANELKNVALFFPSPISQGITGNDNFVFTYNR
ERQQHFGLLQAKPGEESNLLVIDAVGSVYSYIIKYKKALSRLNYFIRESESIGPQKTLAI
DSAKTIKPEKELRNNSHYYQRYSRYLLSKKERIGRISKKQQGIELSLENIVFDRKELYFV
IVIENKSSLDYDLNYLNLSIHTRQKGKKKSSQRILKEPIFQFEVPAKIRKGRTTKLVYVF
PKFSLSRDRRAVLELNEKDGERNLKLKISHRFINNPN
>IFAGANLK_01266 hypothetical protein
MKIEKSKIVFVSVLVVIVTFLITYTIMITGDDPENHFLKETEVPELEEDDQRVYESKLDA
INDLKEVREKSAPSIYEEKLIDSLGYYDPNLPEKEKERLIDSIYLLGQSRQEQIRAATKP
IEIPETIKEKALVASETPEDEKIKVKEMGLEHQLFFASAPKKTEPAIVSTTAKQINVVVD
GNQVVKANSRLRMRLSEPSLIGGIPVPKNTPIFGFISFQPNRVLIEIENIMHYPTSLKAF
DLEDGSEGIYLENNFRSEVTTEVLDDIIGDINIPSVPQVSGISKVFRRNNRNVKVTILNN
YRLILKADKPEPKWEIDNQ
>IFAGANLK_01267 hypothetical protein
MKTPYQNIYKVLKLNRFIVLSVVICSFLTSILALWTAFSTSRKALNSAFAINTDGSIIPL
TLVTQKENFRVEALAHLELFHSYFYDIDASNYEKNLEKALWLGNSSVDNLYRQKKADGVY
NRLLQYSLVQEVLEIDSQLEEQEDVYYFRTKVIFEINRGSIIDTYELISTGKLLPVDRHF
PNNPHGLLITDYFENSLRKLAE
>IFAGANLK_01268 hypothetical protein
MNATIILALGLEYMDSVFQTIQDSEFSRYTIVGIKALAVLFFLVNILKKYNEGVADRDGY
TWGLSPGELAKNFVVVLLVIFSTQILGFFDGVLVAIENQYRETAPMLLPLQMQEIPIEEE
VSAMDAMRKAMALLYEALVTPLYGLKTLAFLISLFLWMLDLFIYPLFLAERYFLLGIMQA
FFPLVLSLAVFEKFRSMAYSFFRLYAAVYMLVPAFFLVNVFINAIYTEINTNFWQNLFGT
EYGSSFFAPVVELGSIAFIVFLKFKLYRRAITFTLRLFTN
>IFAGANLK_01269 hypothetical protein
MQPIRIIRHRTLIITTALALLLPAGATCQGMPVYDNTNFVSLVKSLVESAKQTANLVKTV
NFLKAQKENIEKVNSVVRDLQAVREIGRNNERLIAVMQNDLRDILDSPYIKPGEVTKVTE
SFNSVVGNSLATLDFIDEILSSDHLKMSDAERAEVLKQKELESKEMVTDVRLKTKRYREI
ISFRKMQDKINNRETTY
>IFAGANLK_01270 hypothetical protein
MNKIKLSSHWPIGDIQDNSIFANNGNVVMCYEMILPEIYSLSEKDFEDLHTVWHQALKSL
PVGTVVHKQDIYTKQAYNSEVLPRDTFLEKTTHDYFKGRQYLEHRSYLFFCLTKNKALNH
VKYVNPFRKISSGAIRECDTNLQGFMQSVSDSVSFLDNSRKFSLKKLSAAGIIKLTQNYF
NGFNEGFDTDILLENKNVTIGGNHFDALAINSELCFGERVQSSKTNEKFTSDDFVFHQGF
IDGIGLTLNENHIVNQVLYLDDKHKWRKLLDKKIEELSKSSNFGSQNKVVLGKIQEILEK
INKDDNARIIRGHLNIIYWDNELSNLESIRSKIKSEFKELDITPYYPRGEERKNYILNSY
CCFSSNFSNEDLYVTDLKHALCLLINNTNYKSDKTGIIFNDREHNIPVVKDVWDEHRKRI
KARNFAIFAPTGEGKSFLANNILRQYFESGVRLVIIDLGGSYTKLAKLYPEAYTVLRYES
GKNLGINPFYSSNSEELSPEHLEDLSVFLFELLASDLKISKAQSVSIKKILRHYYKSTVE
NHSLESFYNFIEQHQKTLLETLKIHPDYFNITNFLHVLSEYVGDGLYSFLFEGNQDQSFK
IEDKRLIIFELDEVKDNKEILSVMLKLIKSAIQRSIWKNRAEKGIILFDEFAKQLKFENV
LESVEFYYQAIRKQNGAIGIILQSINQLPGNTTSASILENTQVIYSLNNEKGYDELVRRL
HLSSHDLNQLKSIKNKLSGPRKYTEIFIKIGKESNIFRLEVPPEVYAAYLTDGAENAVIM
DNFKLTGDMEEAIKGFVSAKMKQDAAN
>IFAGANLK_01271 hypothetical protein
MKKYEPYRNIRKGAVIFGLSLPLFALMMMCVIASLLVIIFSFSLGVILSGLVFNVALYIG
LLRLSRLIEFFQMTGVFSKIISNKRNSNINYEQD
>IFAGANLK_01272 hypothetical protein
MKKSTFLATSFLLLSTNLFAQIGGIEDSVAEISDTIRNIFPIVLGIIFLVGFLFNIGHFF
GENSDMKKGLTRVLIFVLISGTVVGIFSYLITIVV
>IFAGANLK_01273 hypothetical protein
MESKDFRELIERNSKKLQLEKYKTTYYTESADSIVFLVLIKSNYSKNYYLRLKTEIKPLE
KDFNKEDFIKHDISDILVSLDSESPEIFDLENHLTDFERGEKMNKFFANNVEQWIKAMLS
KESIIEKSNKEDLVLLPYTKSKLGLK
>IFAGANLK_01274 hypothetical protein
MDTQSTASIPKLYVGIDIHKRSWKIHCSTDLFAGKSFTMPPVPEQLFQYVNKHFQGYEVS
TAYEAGCCGYYAHRSFKSYGWKSLVVNPADIHRKGKERYTKTDKIDAQLISRELKDDRLE
SIVVPDKKREELRSLFRRRNDLVKDMRRIKSMIKMQLLYFGIKEPEEFDNDHWSHNFRDW
LDNLSFEFDTARETLNSRMRSFRFIDQELRQVTNELRAYCRKHYKKDYYLLKSIPGIGGI
VAVGILSELGDLRRFNSLKHLAGYVGLAPGMHQSGANSKAMGMNPRSNRLIRSYFVEASW
QAIRTDPVMQAYYRTHIGKDVKKIIVKIAHKLLSRTLAVIKTETPYEIGVIE
>IFAGANLK_01275 Thiol-disulfide oxidoreductase ResA
MKQSLTLILLIILTSCKENSNKESDPTESYTISGNLRDKYNGYIYLMYGDVIDSSRVTDG
TFEFQGKVEDTVSAFLSLESGKSGANFYIENSQIKLKCAIKQTPDSNRISGQNLEIKNIQ
GSYSEEIRKDYSLFYQNNKDKDSFPNLLYQKLSALIEENRSHPFSGGILAGNAVMNPVFS
KEQLVDLFSKLDTTRMENSDLSLIKRSIVNLSAYRVGKPFLDFKLYDQKKKEVDINTTYA
AFTLVDFWASWCVPCRKANPELVKLKNELQNNDFEIVSVSIDENKEKWLKAIEKDSLNWT
NLIDPNQNVYKELDIVGIPYSFLINQNGVILKLNPTITEISNIVKGKASR
>IFAGANLK_01276 hypothetical protein
MDTKSTALIPKLYVGIDIHKRSWKIHCSTDLFAGKSFTMPPVPEQLSQYVNKHFHGYEVS
AAYEAGCCSYYAHRSFESYGWKSLVVNPADIHRKRKERHTKTDKIDASLSAGNLRMIAWK
AL
>IFAGANLK_01277 Methionine aminopeptidase 2
MSITKESELKGMKKISEVVGTTLKLMREYAKMGMSTKELDNYGGEILKGYGAKSAPCKTY
GFPGYTCISVNNEVAHGIPSNSKILKEGDLINIDVSAELNGFWSDNGGSFIIRKDINNHQ
PLVDASKTILQKAIHHIKGGVKIADVGYLIETEAKKSGFKVIKNLAGHGVGRSLHEKPGN
ILNYRVKSNRERFKKNTTVAIETFISTASTIAMESNDKWTLIGNKGGHVTQHEQTILVTD
NIPVILTQSNEIWN
>IFAGANLK_01278 hypothetical protein
MNLSTRLLSMMLLITLANSCKGQETEKKDNKKVNSSQSNIEKHQPFIYRSSKQHSTLNGA
VSEFVWQIYQDKKGNYWFGTNHDGILIYDNNSLIHYTSKDGIGGNAIRAITEDKTGDIWF
GTSNGLTKYNGKEFTNYTIDDGLIDNEIWAIEVDNTGRIWIGTVGGVSIFDGNNFETLEV
PKPNVPNPEPMLSKNRVSDILIDKKGHFWFVNDSYGITKFNGNQYEFFTTENGLTDNNVA
ELFEDSQGNIWIGTFYGGVSKFDGKTFTNFTKEGIINGLETYNFCEDKAGNIWFSAENYG
VYSYNGKDFTQFTVEDGLATNTIQTIYEDKKGQIWFSTWEGISLYDGKEITNVYDKESWT
K
>IFAGANLK_01279 hypothetical protein
MELDRTYNANVEIFGERAQSPSYAEVDFYVNIKNSSKWVN
>IFAGANLK_01280 hypothetical protein
MGKLTIKTDPKVETVFASYPDIVRDKMQYLRELVIETAEETEGISVLEETLKWGEPSFVT
KNGSTLRMDWKEKTPDQYAMYFQCTSRLVDTFRLVFDHKFQYEGKRAIVFQLNQKIPELE
LKECIKASLIYHKVKEQITLGI
>IFAGANLK_01281 hypothetical protein
MSTPITRDDLQDFKMELLRDIKQLLKQQKSARIKKYLRSSEVMDYLQISPGTLQNLRLNG
TLPYIKIGRIIYYDPGEVQKVMEKNRILNLGL
>IFAGANLK_01282 hypothetical protein
MTDEDLPSTNSLNKPNLKIAQQRFYLFSFTTSMFEKDMETFSENLERLIHSGKTELKMAD
DGIRLCIQTLSKLQKQVDKEDFEDTQTEIEFFKNIKPIPMSYLIYFTEVRSCELMLPKAG
DSHKVRYLEKEIKKINKFFSANHSFVNYMEQNKNYLDFEFFSRKGGMDFSFSPVINYYQN
PEFSTTHDMLWSKVQALYRYIHYIREKLELIQPGSNSNFRKRQPNLLVWSGCKISLAEVI
YALYHAGDINHGTADLKTLFSVFEDVFNIKFDNFYKTYREMKARKDPRAKYLLEIAINLE
AKMRREDK
>IFAGANLK_01283 hypothetical protein
MKFTSSLLECISISELYLLYLSGISWFFQVFAYKSLLNENPPFDV
>IFAGANLK_01284 hypothetical protein
MFEGKYGKYCIVDGILFVDYKEDLIFTLKVAKRIVQERMGFQHNKEYPVCCKLSGRIDSQ
SEARHYLAQEGALFIKALAFHATSPVTIRLTEFYIQTLNHQIPIRVFKDRNQAIQFLKPY
SQRSIN
>IFAGANLK_01285 Regulatory protein PchR
MERVFNRTNLRGIYRMLTEMAKGNFAYQIKRTHHRDELEGLNAYVNQTAEELRRKRHQFL
LLNRQTEIMMIRTATFLLNENLKVVDYSYKHPDNIEIAPSTIINNPFYELLIKKSQDRWT
KKITEFLEGNEQSFNITLEYHFDELLKIDLHTVVSRLTGMRNEKYIVTSYLMDTTKDFFL
ELPENSEIKTYSRWDQKLFHEIHIYIMHHLEEPPKTLDQLAGLFNTNKYKIKTGFKEIFG
CTPTQYYNKQRIRKCKILIENTDLSLTEISIKMGFSSYPHFSKSFTKATHLTPRFYKKIT
RNS
>IFAGANLK_01286 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MMTSNFNYSSAASAKDFKINSTSLQAENLAATEEDSVNYRKATFTKRHLFILASTFLLLI
GGAFSFYLLQAEFKAVNMNRMNTLGGIILLIISGFLLVFRLGFLTYIARLFFKYKPVNSV
TDTELPSCTVIVPAYNEGKLVYSTLESLVNSKYPAQKLQVIAIDDGSKDDTWEWMKKAKE
QWGDRIAIYQQPKNQGKRHALYRGFNLGTGEVFVTVDSDSIVEKDTLRNLVSPFVTNEDC
GAVAGNVRVLNNEKAIIPRMLNVSFVFSFEFIRSAQSALGSVLCTPGALAAYRATAVKNC
LPEWINQTFMGKPTDIGEDRAMTNMILKQGFHVLFQRNAYVLTNIPEKFSSLHKMFTRWE
RSNVRENLMMSKFAFKTFRAGSKSGPRILLLNQWMKMLTTYPLLLIMLILLVAHPVLFIT
SALLSILIFSTLPAFFYAKKYNIAESFWIYSYSIFYTFGLFWITPYAMATASKRGWLTRE
LPQKK
>IFAGANLK_01287 hypothetical protein
MKILSLLLFLLIGITSVSAQEIEAEKVFLGYKFTMNNKTLDFKGMQKLMIADEQATRLIK
KARKNNTISTILGSIGGSFVGIPIGAAVAGGDAPWVLAGVGAAFIGVAIPISIRANNQAH
QAAERINQVNSSQPNPLVPVTFKFIGNQQGLGLALSF
>IFAGANLK_01288 hypothetical protein
MVVASLLTLYSVFIIYFMLFSPAEKRFNVAAHLQGSFLSQNLFEILKFQDPENDEIYFEQ
SVAFNKRGEYKKGFELLDQAVDLNPKVHLGYRGYMKLRFLRDFNGALKDFTRLDPLTPNF
VDAPWGEDINFLRGESYFGLKDYEKAKAYFEKSIETQGADWVDIQAYVYAGICEYKMNKP
AEAIAFYQKALEQSKYTVEAQLGLAKIYLEKQDLKNAEIHADLAQKYYSYKRNDGYNEYL
NEVYKEDIELLQKRFK
>IFAGANLK_01289 hypothetical protein
MKSKTNLFLFASLVIALILTGWLYYLSGKRVGDLAVDEQQDGDFQVCDEDKIFQYYNLDT
DYKGGKKAIKKEILNELESLNFKNQGLVTARFIVNCNGDAGRFRYKSTDLDLKEMKVNSE
NIERIKSAVLLLQNWNSPKENKVFDSYYVLNFKIRNNKIVDIF
>IFAGANLK_01290 hypothetical protein
MLAGIIKSIRKFTDLSEQEISEFIEMARIESYKPKSHFIRAGQIPTKFGIVISGLFRYVY
ISQEGKEFTKVFMPEGSFISSYSAMIAQTASHFFIEAIEESEVLVISYPNWQKLKSQNPQ
WNLLLLKLLEKGYSVKEKREREFLLLDAESRYRIFLEEYPELEKRVKQHMIASYLGITPI
ALSRIRKNMGA
>IFAGANLK_01291 hypothetical protein
MKKLIPPFLFLICIIFMVVLRNVIVIQEIMPQPYNYLGIILILLGLIMTIKVRKLFNKIE
TEIHTFKKPRKLVTNGLFKFSRNPIYLGFLISLLGVWVLLGTLIPILGCLLFILVTNYWY
ISFEEREMEKQFGTKYRAYKSKVNRWI
>IFAGANLK_01292 hypothetical protein
MKKHQYELSVEWTGNQGNGTLNYKSYNRDHSISAEGKYTEIMASAEPAFLGDKTKYNPED
LFLSSIAACHMLWYLHLCSKHKIVVIAYLDNATGVMEEAANGSGKFTKVCLNPKVKVAEQ
SMITKATELHKEAGKMCFIANSCNFDIEHNPTTTTD
>IFAGANLK_01293 Extracellular exo-alpha-(1->5)-L-arabinofuranosidase
MRYSFMPILKVLGVLNLIFIMCSCGSSKTGNEEIKSLQFDNPLAEQRADPFVTKAEDGYY
YFIATVPEYDRIEIRKSKTINGIKEAEPVIVWRKHDKGVMGNHIWAPELHRIDGKWYVYF
AAGSAEEKWKIRMYALSNPSADPTKGEWKEEGQVVSNRDDFSLDATSFELDGQRYMIWTD
RASDTIMNTGLYIAEMTSPTTLADKQVVISQPTHDWEIQGHRVNEAPAVLVRHGKVFVTF
SASATDANYSIGLMWADTDADLIDPNSWHKLPEPVFYSNPGLERFGPGHNSFTKASDGET
DVMIYHARNYKEIEGEPLYDPNRHTRARVLKWKDGMPYFGQELSDKEMSMTIEN
>IFAGANLK_01294 hypothetical protein
MKTTPKHNERMAKMTFASVYPHYLTKVEKKARSEEELQQVIEWLTGYDEKKQKKLIEEKV
SFETFFERANLNPNAHLITGVICGYRVEEIDNPLTQKVRYLDKLVDELAKGKQMEKILRS
N
>IFAGANLK_01295 Transcription antitermination protein RfaH
MAWYVLYTKPRMEKRVADDLEQIGIEIYCPLITEVKQWSDRKKKIKTPLFKSYVFIKLEE
KKRNRVFEVPGVVRYLFWLGKPAIVRDEEIKVIREWLEEDKVEDAKVEHLSAGDKITIKN
GAFKQHEAIIRDIGKRKMRLVLPHLGFTVEVQTKEVI
>IFAGANLK_01296 hypothetical protein
MNFLWGKKGYCFIFSFLIFSWFNGSAREYEGLTIEEIDSIRSVRLTGNSIWENDMETSML
WNFKLLEASTELGYKKGITYVYFDIGNLLCNIGQFNEALEYISLLEKSDYYNNCTCKLLN
AEISNLKGRIFIGLGYHSFALENLNEGIEHLKSDTTQSSMIGKLYLNKAAAYSGMGEIDS
LFFSQKRALKYSPITMNYVLMGRWYLTYDKKIDSAKYFLEIAQNKLDESVSRYQESIYLR
NVAYYNKVIGDFEEALCYYNKALDISLEINRNKEVLKTYRNLAGIYSDIGDAEKSNSYYN
KFLTLSDSVTNSKNKIRDIAARKFIHQQEETYNKKKYQWLTISLCAGIFLVGGSVLSRKY
IRSKYKKSVKENNDKLQEINSLVNQKKLEEVELKAKSENNLRELCELAKRNDESFLPEFR
KHYPNLSNKIQVLNPKITKSDFILLALIWLNFSSKDIARYTFVQHKTVQIKKYRLRKKLD
LSKGTDLYQWLQDLNQK
>IFAGANLK_01297 hypothetical protein
MPIRNWDIILNQFFTIYRKNQTLKSLTPVILTLHTLQDSVKVELWAILINFESRIPLDYF
QF
>IFAGANLK_01298 hypothetical protein
MILVILYLYYYTFLSLIFNFLEMLNISNTLVLYVAEKEWVVFRIVFCSTYVISLLAVFYD
LFIDFREN
>IFAGANLK_01299 hypothetical protein
MKKLLLLSLIFIGFSVNAQVGIGTDMPNPSSQLEIVANDRGILIPQVSLLSITDQTTITN
GNVESLLVFNTSTTEALTPGYYYWYNGSWKRISSSNNSNPNIPENIVIWNSENEEFVYLN
EEGDNVRIDLGEIANENITTLVDNIDGTYTYTSEDNTVTTINVPADVIGNINNNGNIYER
IIDLIKANTFNTKITDNGNGTFTHTAVDGTEVIFDANTTNLLDNGDGTYDLTNADGNTIN
INTNADSNAYDNTNSGLTAGNVQDALDEIQDNLDNTSDILVDNTDGTYTHTAVDGTEVII
DANTTSVSEVDGVYTFTDGNGDAITSIDTNADAINFDNSTNGFTSDNVQAALEEVQASLD
DTDTGLENIDLTDNGDGTFTYSDAAGTAIDFDANTTSYAQDGAGNYTFTNHNGESMTVTV
IDDVVANIQNEGAIYNEIINILGDETDAFVDNRNGTFTHTAVDGTEVIFDANTTNLLDNG
DGTYDLTNADGNTININTNADSNAYDNTNSGLTAGNVQDALDEIQDNLDNTSDILVDNTD
GTYTHTAVDGTEVIIDANTTSVTENADGSYTFTDATGTEITTIETAADTNLYDNTNSGLT
AGNVQDALDEIQDNLDNTSDILVDNTDGTYTHTAVDGTEVIIDANTTSVTENADGSYTFT
DATGTEITTIETAADTNLYDNTNSGLTSDNVQDALDEIQGNLDGASDGAILSDDLTVTDG
ENSIFKDVTLEIAPGAVGTDELANDAVTNIKLANNSVSNSKVQDGAITSAKIQNGEVNEV
DINTDAVSTDKIQAGAVSAEKLGSDGVPAGQVPIADGAGNVTYGNVSSSSVDGEDFTSND
LTITNGTGATLTAVTAEISDGAVDTDALGADAVTNEKLSDDAVDTENIVDGGVGTSDLAG
NSVTADKLNSGSATSGQVGIADGAGNVTYGNVSSTSVDGEDLSVSDGIEFTGGTDGVGKL
LAETGIGIADGGITTDKLATNAVTNEKLSDDSVNTENIVDGGVGTSDLAGNSVTADKLNS
GSATSGQVGIADGSGNVTYGNISSENVDGADLTAGDGSITVVDGTGATLVDANVSVAADG
ITNDKLADDAVSTENILDGGVGTSDLAGISVTADKLNSGSATSGQVPIADGAGNVTYGNI
SSSRVDGEDFTSNDLTITNGIGATLTAVTAEISDGAVDTDALGADAVTNDKLSDDAVDTE
NIVDGGVGTSDLAGNSVTADKLNSGSATSGQVGIADGSGNVTYGNISSENVDGADLTAGD
GSITVVDGTGATLVEANLRVAADGITNDKLADNAVNTENIVDGAIEASDINSNVAGDGLT
QNTTTGALEVSANNGVTATTDNIQLGGDLIQPTAITTDATNTLAVEGLQDGSATDNIVVA
DPNTGELKQLKAAMPKFFYMPSVVFDTSTQDTGITRNLHQDYVDQFGSPVVSSSGASGAI
PTLDANDLEYYITYYDDTVFENVSIDAVGNLTYDVISSTNSAASFMNIVFVVK
>IFAGANLK_01300 hypothetical protein
MKNIIHILITSIVLLLAPFKVSAQFTITDDFRGSGSQDVILGDQAYLTSGVVDPINAGWL
RLTEDTGNQKGYAYVNRSFPSTLGVIVDFEYKMWRENGIDPGADGVGVFLFDANYGPGNF
ELGAYGGSLGYANGNDADYGVTGGYIGIGLDSYGNFANPTEGRNGGPGEKPNALVLRGPT
TNNTITTNEYLDGVTLRDPDQVLSINTNTGNRNENQIDYNTGTAIRPSDDLFYRRVQIQI
TPTGGGFFDIDVRWSKDLGGSFTELISYTTTEAPPELLKLGFAASTGGSYNYHEIRNLLV
TTPGNLRVGKLVDKSTLRSVPGSGNENEVTYIIEVTNDTPVALTAIDVEDQLTDGEGNSI
PNGMLNITDISHSGFTSASLPSPTAGTPITSGNFNGTVGLSANSTGKITVKGTLTDIPEG
NLLQNRVNIENNEITDSDLANNTATVSTPVIAEGVDLTIEKDANQQCLDVTNGNEFTITV
SNMGTDDLNYSNTNAVVVTDELPAGATLINNSTGWTHNGNGTIHTFTLDGIGTLGSGLSA
PPITFSIDAGTSSGYTNTAEVEFNGSGSNIEPPENLGNNSSSVNIASQPPVPSVPVAGYI
EVCQGETIPTGDIADPGYTLTWYLNEGGSPVIPNTSTPGYDTYYVSQSEGGCESELTEIL
VLVKDSSLPESMGGCATGWCEEDVAGERFDLSDGESVTFNQPATDYGFQFDIYTLDNSFN
LEINGTQLAVDELEFQSSGTSGINIRFADGDEYETDTEGAVWEMTGNASAPLIRVVISPT
GSVALYASKASGGPLFPLVLTNGNIFNSIPWNTSGSNTITATQNVVGATTMTGYGSGKNQ
TPCLIMTNPMLPSKAKTP
>IFAGANLK_01301 hypothetical protein
MKYLYENNIKLFLLLFLISGAGIAQTTNSGKLYVSEGTQISVVKDFQNEGSGEFYNDGEA
FIYSNFSNDGIINFYGNTGLTRFIGQNIQELSGSKESYLYDVEFYNSSDEVPFHLYSTLT
IEGESNFFQGIVDNDNYGGSIFYGENASHVNTSNESHVDGKVGHFGKEDFIFPIGDGGYY
RYAGTADLINDASIVEAKYFLENSDVLYSHELRPDFVQLINNKEYWTIEHIGGAEEAFIT
LSWSEETTPAAILQEPREESIHIVRWDESENRWVDEGGIVDNTNQTVSTLVEKYGIFTMA
RMDDSGILPCEISVYNAVSPNGDGVNDYFKINTGSSNSCTENLQVEVYNRWGVKVFETNN
YGEEGDLFDGFSRGRLNVNGDEQLPSGTYFYILKFDYEVGGDQLETFKKAGYLYLNGN
>IFAGANLK_01302 hypothetical protein
MSIHLKKIFFFLLVSMGLFYQDLNAQQDSQYSQYMYNTVSINPGYAGSRGMLSTFGMYRN
QWVGLEGAPETLNFSLNTPIGLRRVGLGLNFVSDRIGPSSEDILTADFSYSIPVFNAETK
LSFGLKAGLNMFNLDMNKLDIENPNDINLVSRNLTSPVVGLGFYLHSTKWYFGLSTPNML
ETEHYDEIAVSTASEKMHMYAIGGYVFDLNQDVKLKPAFLLKAVSGAPLAVDISANLQLY
DQFTLGAAYRLDAAVSALAAFNLSDQIMVGYAYDYDTTPLTRYHSGTHEIFLRFELGTKI
RNSVNPRFF
>IFAGANLK_01303 Photosystem I P700 chlorophyll a apoprotein A2
MNKNYQYLYLLLLFFSISSIEAQEAKLDMAEKKYENYGYINAREIYLKVAEKGFESEELF
QRLGNSYYFNAAYSDALVWYTKLFSLNEDQEEKYLRRYAQSLQATGNSKKAESYYNLFQE
KDGLTAEDYLYLIERNSGRYSIQKLKGINTNGREFGHSFKNGKLIYASTQDTGVFVKRKN
SWDGLSFLNLYEVELKQDSLLGKPKKLKSISGKYHESSATLSENGKTLYFTRSNNNKNQN
QYLKIYRAELNNGKWKNLEDLSINIQGYSTAHPTLDKEEEYLYFASDRPGGFGESDIYRA
AIHKDGSLSEPENLGPEINTKGKETFPFISNNSELYFSSDGHFGLGGLDVFYVKMEGSEV
SNILNIGRPINSYADDFSFGVNQKTKQGFFSSNRKENGTFGYDNIYTLKEKENIQNAYKA
IILGKVLEEDTGEPLVNASVKLYTDGKLYDSIATDGAGNYSIAVNYFSKYRLQADKEDYD
SKEKFNKPREEEQEINFSLRRNTLALVPGTDISSLLNIKNILFDFDMANIRSDAQIELEK
LLMVMQDYPDLKLEIRSHTDSRGSDSYNKALSERRAQSTKRYLIEKGISEQRLKAKGFGE
ERLLNDCGNGSACSSAEHQRNRRSEFIVLE
>IFAGANLK_01304 hypothetical protein
MKNGKAVIEAHRLLKNSISIKPYFLLTESVFNANIGKFKGTCYYSGSQLCEVYGNLKKIG
YAYFDHEEDKEAGTISSVDDYLENKSRLSFV
>IFAGANLK_01305 hypothetical protein
MFVRKKPNKSGLISIQIIDKSSGKYVVLETVGSSDDPQEIEHLVKKGKQRIVKLAGQVSM
SFDRDKELEFVDAFMNSLDTFYLVGPELLLGKLFDEIGFNTIEEELFRHLVITRLIYPVS
KLRTVDYLFKYKGVEISVYSVYRYLDKLHKEQMEQIKEISLKHTLSLYDNALSVVFYDVT
TLYFEASKEDELRITGFSKDGKHQNPQIVLGLLVSDGGYPIDYHIFEGNKYEGDTLLPVV
DHFSTKYRSQHLTVVADSGLLSKRNIELLTQKNYKYILGARIKNEPESIKKQILALDLKD
KEYAEVQKEQQRLIINFKEQRAHKDAHNRKRGLERLEKRLKSGKLNKTHINNKGFNKYLK
IEGKVDILIDYQKFEDDAKWDGLKGFTTNTDLPSKQVIDQYRELWTIEKTFRIAKSDLKI
RPIYHRLRRRIEAHICVSFAACKVYKELERQLKTKESSLSPEKAIDILKTIYQVSIQSPY
SSAKHNRLVLKNEEQKDLVNLFDLDRNLS
>IFAGANLK_01306 hypothetical protein
MNYNNLKFKPVQNSVNGETTEETIFEYKQIENILTSEYKGGQIIKGHLIGLVDKNGNVEM
RYHQINKKGELMTGICYSKPEFNENGKLRLYESWKWTSGDKSSGNSILEEL
>IFAGANLK_01307 hypothetical protein
MGKDLINHDDIKTFTVNTSDIGMDGEIKIMGVNTRL
>IFAGANLK_01308 hypothetical protein
MERRNFIKSIAALSTTTVLPVSAFSMFGAAKYKVGLQLYTIHDDMVKDAIATLTAVKKIG
YQDFETFGFNHEKGTFYGYNSSEFRKIIDDLQLTASSGHFGFSAYLNETEDKLKRFVDQC
INGAHTLGMKYITWPWLDPDQRSIDHFKLLAEKLNVIGEWVTSAGLGFAYHNHGFEFIDH
NGENGFDIILNETNPSLVKLDMDMYWVVRSSKHSPKELVSNQPGRYVMWHIKDMDKITWD
YTELGNGSIDYTQILPDPKESGLEFYYLEQGGNYAHSPMKSVTDSATFFKKQLQAYL
>IFAGANLK_01309 hypothetical protein
MEDAYIGELRAFAGNFQPRNWMFCHGQLLSIADNNALFSIIGTIYGGDGRTTFALPKGKG
SN
>IFAGANLK_01310 hypothetical protein
MEETEEQHLLSLRGRVAISSGAGPGLNNHDLGDKSGTQTNTLGQLNLPPHNHTANGTIYA
SMENGSTNDPSSAIPAKSVYPKDRSTNEAVNSYAQKANTKMAANGIEISVNNTGGGQPVN
NMQPYLAINWIICVNGIYPSRG
>IFAGANLK_01311 hypothetical protein
MVPNYQTEDKVLLAVDCIIFGFDEEDLKILLIKRNFEPEKGKWSLMGGFLKRHENLNMAA
NRILYQLTGIEQIYMEQLYAFSEVDRDPAERTISVAYFALINIKEHDKALIDKHSAHWFS
VTELPDLIFDHSEMIIKAIRRLRYKTSKKPIGFELLPEKFTMRQLQKLYESILGEKLDKR
NFINKINALDILIKLEEKDMNSSRKGSFLYQFDAEKYQQKVEEGFSFKL
>IFAGANLK_01312 TonB-dependent receptor SusC
MNNANSYYDKLSLLRKRFMLTFLVLLFSGTALMAQENITVTGIVTSKGENLPLPGVNVIQ
EGTSNGVVTDMEGRYSISVPEDAVLNFSYIGFESEIISVDGQANIDIVLAEDYASLDDVV
VVGYGTQRRQDVTGSVASIDAEEVQKQSNNDVSRMLQGRTAGVTVTSNGEPGAGGNVRIR
GVATFGDNQPLYIVDGVPVGTSIRDFNPNDIESIEVLKDASAGAIYGSRAANGVVIITTK
SGKKNTPLQIKYSGYYGIDEVAQDIPVLGREDYQMISNEKRTNAGLPLIPGNDPSSDLFV
DNIDTDWQEVGLQSGSRQNHNLNFSGGGDNITYNASLDYFNNEGVFVGKGPDYERYSGRI
NTTMEKGIFKISPSLYYTHSFENSLTFRDDVLTGGRPPLINDLVNAIPTLGIYDENNEGG
YAGTSSEIHQEIILNVPGINSLFTNTVEVDRIFAIVNPELKLLDTDGHELTYKLNTSYDK
THVRSFSFVPEFEMGYFFGSGRSLLDDNSSIYTVALIENTLNYKKEFGKHGVDVLLGQTY
QENSTVLRQAHSESLPKPYYPVLSNGSNQTVGGEEIYSSLASYFGRLNYNFDDRYLLTAT
VRRDGSSRFAPENRYGTFPSLALGWRLSNEDFFNVPEVDQLKFRASYGELGNQNIGDYLY
QAVINRNIPYNFGGNRVLGGLQTSIIAEDIKWETTTSLNLGMDVSLFNNKIDLTLEYYDK
ETNDVLVGVPIPASTGSINTAPTINAGSLKNSGFDAQITYHYNNEEDFSFDISANASTIK
NEVLALGGSDEPIAGVGSRTQVGGEVGEHFGFVYDGIFQSAEEVEGHAFQNAATSAGDVK
FADINEDGVIDANDRTFLGSAIPSVTYGLNFTAQYKNFDLTMFASGAAGYYINSRLYRSL
MLSTGFINAHEDILDRWTPQNTETNIPRVVANDPNNNARDSNRPGWLQKGDHLRINTLSL
GYSLPQGLFEDALNSARIYATVQNLYTFQYYDGFNPDFNSGVFEPGFDNGTYPKPRTFML
GVDLSF
>IFAGANLK_01313 SusD-like protein
MKTKNILIIFLLGILFSGCDEELELNNPNSMTAVEYWADEEQAIAGINAAYNSLLIDGYY
MRMTPALNDGRGDDFRGDTPWPDLMQISNFTILPTSGPIQWMWSAYYQQVFRVNQILERV
PEIEMDEAVKERVIGQAYFLRGLAYFNLKNNFERVPLIISVAQSEEEYYPPTASEEAIWS
QIISDFQEAQSRLPVDYANISGIDQGQVGRATKGAATGFLGKAYLYSEQWNLAATEFQKL
IDGPEVNIYRLEDNYKHNFGPFNENNDESLFEVQFAGTDEVGGTVMNYGGEPSAAWMQVS
SVGHTYAMDGYGYSDFLPTRWIYDKYKSEETVDGGIDPRLLVSIASYEPEANSTTVYNGT
PWPHAEDAIYPRKYTHDGFGFDTESQGGVERSEINYRVMRYADILLMYAEALNEMGQTED
AYDYIQEVRDRANLPDLRETKPGLTQEQMREQIAHERALEFAIEGMRIHDIIRWGWLYDD
AKLAELRAHDSEFDTWSPGKEYLPIPQSELDVNPNLEPNSAN
>IFAGANLK_01314 Intracellular exo-alpha-L-arabinofuranosidase 2
MKKFSLFTVLVGIFCLPNLFYGQTSISIEETEDAPTISKHIYGHFAEHLGRSIYDGLYVG
EDSEIPNKDGVRTDIIQALKDIQIPNLRWPGGCFADTYHWKDGIGPKEDRPSIVNAWWGG
VTEDNSFGTHDFLNLCEELGAEPYLAANLGSGTVEEFTDWIQYVNHAEGSPMADLRKENG
KEEPWNVKYWGVGNEMWGCGGNMTPEFYANLYRQYATFMTSWENDNDLYRIASGANQDDY
HWTEVLMRDIPKHLIEGVALHSYSFVEWQDKGSATDFNEEQYFSTMKTALWMQELIDKHT
DIMDKYDPEKEIDLIVDEWGGWYEVEEGTNPGFLYQQNTMRDAMIAGVTLNIFNNESDRV
KMGNLAQTVNVLQAVALTDGADMILTPTYHVLKMYTVHHDTKLLPVEFDSPDYTYEGESL
PAISVSASRNDAGNVNISLVNIDAEKENKVEIDVDALDVDNMTAEILKSDELQDHNSFDD
PEKIAVKEFKDFKLKRGTLEVTLPPFSVVVLKEK
>IFAGANLK_01315 Extracellular endo-alpha-(1->5)-L-arabinanase
MKRKAMFLRFVIFFFTFSAGIALVGCSEDDTDFTDDVTEDDDDVDPGKKDDFPGPTYADD
YSGIASWQDRAQWNLANVHDPTVEKDGEYFYMYNTDASYGNAHEGNGHFPVRRSTDLVDW
EFMGTVFPEAPAWIKDSLNSIRAQMDPPLAPIEDPNYGFWAPHIQKTGDTYRLYYSVVVT
NPIVGSDPNTSWTERAFMGLAESTDLSSNNWEDKGVVISSVPDGVESYERDGGDDWSGYF
KFNAIDPSFIETPNGEHWLIYGSWHSGIAAVQLNTETGKPNQLNELEDYGKRIAGRGNVD
NNRWQGLEAPEIIFNEDTGFYYLFLAYDELSVAYNTRVARSENIEGPYVGIDGANVTEGA
EAWPMLTHPYAFDGHPGWVGISHPSVFQDPESDQWFYSSQGRLPEGVSGINASNAIMMGH
VRKIEWTSDGWPVVSPQRFADVPQTEITSEDINGTWEVITLEYEYQGIQESSDVVFHEDN
TVTGAINGSWSFDESSGILTVNDHELIVDEAWDWEASPRRTTITFTGLNEAGRSLWGKKV
N
>IFAGANLK_01316 Non-reducing end beta-L-arabinofuranosidase
MKTVIKPYYSAILGIFSLVSGHCVFAQNSEIELFHLEDVQLSESMFKEAMHIDLNYILEL
NPDKLLAPFLAEAGLEPRAQSYTNWENTGLDGHTAGHYLTALAQMYASAESEEAHQALEY
ALSELKRVQEANGNGYLGGVPGGEKTWKEIAKGNIDAGNFSLNDKWVPLYNIHKTYAGLR
DAYLIAGNELALEMLVDFTDWMMDTTAQLSDEQMQEILISEHGGLNEVFADLARITGETK
YLDLAKRFSHKKLLNPLAKNIDVLNGMHANTQIPKVIGFQTIAALDDNNDFHNSATYFWE
NVVNHRTVAIGGNSVREHFHSKNDFSEMISSVQGPETCNTYNMLRLSEKLFVAEPNEKYI
DYYETALYNHILSSQHPEKGGFVYFTPMRPGHYRVYSQPETSFWCCVGSGMENHGKYNQF
IYAHSSNALFVNLFISSVLNWKEKNLKIVQKTDFPNAESANFSIETEKAQEFELRLRYPD
WITEGEFEIFINDELYEHSNKPGSYVSINRVWENGDEIHIKLPMKIGFEKLPDDSGFFAL
KYGPIVLGTKLGDENLDGQFADDSRGGHIAEGEKIALSNLPIFLAENDEDWVKKIKRVDG
ENLKFSAKEIIFPEKFKDLKFVPFYDIHEGRYAIYLPIETPESFENIQKARVEREKIERE
LAELTIDQVATGEQQPESDHFIKSENSNAGVNLGEHWRDASGWFSYELEDKENEAKKIRL
TYFGKDVNRKFKIFVNNVEIAEEHFETELNKQFYTKDYQLPKKIKEQNLKHIAIRIEAVN
GSRTAGVYNIKLMK
>IFAGANLK_01317 Arabinoxylan arabinofuranohydrolase
MKKNTLLLFSLSIFSLGTLLGQSEEKFNNPIITEKYTADPATIVHKDSVYLYAGHDEAPK
DFHFYKMDEWLVYSSADLINWQEHPVPLKPTDFTWAKGDAWAAEVIEKDGKFYWYVTVEH
DDSHPGKAIGVAVADSPVGPFKDAIGKALITNDMTTEHTDISWDDIDPTVFIDDDGQAYM
YWGNTVCYYVKLKDNMLEMDGDIQTVDLPNFVEAPWIHKKGDWYYLTYAYGFPEKTAYAM
SKSVTGPWEYKGLLNEVAGNSNTNHQAILEFKGKDYFVYHNGSIQPDGSSFRRSVCIDRL
YYNDDGTLQRIQMTSEGIQEPVK
>IFAGANLK_01318 Extracellular exo-alpha-(1->5)-L-arabinofuranosidase ArbA
MKKSNLFIFLFLLAISLVEAQEIIVHDPVAAEQDGVFYLFNTGRGISVHSSTDLENWKRE
EPVFSEKPDWTDDVVEDFENHIWAPDIFHKNGTYYLYYSVSSFAKNTSAIGVATNETLNP
GDDNFEWVDHGIVVQSVPNRDMWNAIDPNMIEDEEGTVWMSFGSFWNGLKLVKMDEDLKS
IAKPEEWHTIARRERSFDIPSEDPGDAALEAPFIFKKDGYYYQFLSWDLCCRGEESTYKV
VVGRSKEVTGPYLDKKGKPLNEGGGTLVIQGNENWYGAGHNSVYTFNGKDYMFFHAYDAQ
DGAKPKLKIKELSWDKGWPTIAPLE
>IFAGANLK_01319 Extracellular exo-alpha-(1->5)-L-arabinofuranosidase
MKAKSLINLVLIAFFLMGCANSSQVNAQDHAAADKDTTKSNDPIVLQRADPFIYKHTDGY
YYFTGSVPTYDAIEIRRAKTIEGLQNAEPFTVWEKHESGPMSRHIWAPEIHYLDGKWYVY
FAASEEDDIWALRPYVLELKGQDPLKDEWVELGMMQAADDDPKSFTDFSLDGTVFEHNGK
RYFCWAEKTGGQFAASNLYLAEMESPIKLKTVQFMLTTPDYDWERIDFWVNEGAAVIKNE
GKIYITFSASATGASYAMGMMEADENADLLDRNSWIKSRYPVLETNEEKDIYGPGHNSFT
VDENGDPIMIYHARDYEKAVGDPKMVPATDKRPLEEIKADPLYDPNRHARMMEVKFDNDG
RPVFEFY
>IFAGANLK_01320 Ribulokinase
MKNYVIGLDYGTDSVRAVLVDTGSGEELATDTFYYPQWRDKKYCNAATNQFRQHPADHIE
GLEKTIKGVLAKTNIDGTAVKGICIDTTGSSPIAVTKEGAPLAFEAGFKDNPNAMMVLWK
DHTAIDEANEINELARNWGGEDYTKYEGGIYSSEWFWAKIAHIIREDEAVKNAAYSWIEH
CDLMTFMLIENQDLATFKRSRCAAGHKAMWHESWGGLPSKEFLNQLDPYLGDLRDRLYTE
TYTSDEVAGNLSAEWAQKLGLSTDCVIAVGTFDAHSGAVGAKIDKHTLVRVMGTSTCDII
VSEQENVGDKTVRGICGQVNGSVIPKMIGLEAGQSAFGDVLAWFKDVLNWPLENLVFNSD
IISEEQKAELRDEIDKDFIKKLSEAAEAIPLSESIPIALDWINGRRTPDANQELKSAITK
LSLGSKAPHIFKALINAICFGSKQIVDRFEEEGVKINSVIGIGGVARKSPFIMQTLANVL
NMPIKVASSDEAPALGAAVYAAVAAGLYPNVIEASKKLGSDFEAEYHPEAEALETYAGLM
EEYKELGAFVENNINRKSTVNEL
>IFAGANLK_01321 L-ribulose-5-phosphate 4-epimerase UlaF
MSSKYKALKQECYEANMELDALNLVIYTFGNVSAVDRKKKVFAIKPSGVPYEDLKPEDIV
ILDFENNVIEGEMRPSSDTKTHAFLYKNWENIGGIAHTHATYSVAWAQSQLDIPIFGTTH
ADHLTADIPCAPPMRDELIEGNYEHNTGIQILDCFKDKKLSYEEVPMVLIGNHGPFTWGK
DAAKAVYNSKVLEEVAKMALLTKQINPEAPRMKDSLIKKHYERKHGKNAYYGQN
>IFAGANLK_01322 L-arabinose isomerase
MINIEAKEIWFVTGSQHLYGDETLNQVAADSKAIVNGLNDSKHLPLKIVWKDTVKTADEI
TDICQEANSNKKCIGIVAWMHTFSPAKMWIKGLSLLKKPLCHLHTQFNAEIPWGKIDMDY
MNLHQSAHGDREFGFMMSRMRKKRKVIVGHWKTDRVQQKLGIWSRVVLGWDELQHLKVAR
IGDNMRNVAVTEGDKVAAEMKFGMAVNGYDSSEVVAHIDKISKEKVNDLLKKYDADYNLS
EELKEGGLQRESLVDAAKIELGLRSFLDEGGFKAFTDTFENLGKLKQLPGIAVQRLMADG
YGFGAEGDWKTAALLRAMKVMAVGLEEGTSFMEDYTYHFTPQKSYVLGSHMLEICPSIAD
DKPTCEVHPLGIGGKEDPVRLVFNAPKGDALNASLIDMGNRFRLIVNEVEAVAPEADLPN
LPVARVLWDAKPNLEVAATSWILAGGAHHTVYTQALTTEFLEDFADIAGIELLVIDEKTS
IREFKDKINANEAYYHMFQHGM
>IFAGANLK_01323 Aldose 1-epimerase
MKISTNNLFGFGIVFLSLFFIQCKNGDKKAETKEKEMNIEQSPKTKIKKEEYGTTSDGEK
VAQYTLINENGMEVKIITYGGRITSLKAPDKNDEFENVVLGFDSLEQYTKDNPFFGALIG
RFGNRIANGKFTLDGEEYTLAQNDGENHLHGGEKGFDKVVWDAEEAGENSLKLIYISEDM
EEGYPGTLETTVVYTLTDDNALEVDYKATTDKTTVVNLTQHAYFNLSADFSETILDHKFE
INADEFLPVNETLIPTGELKDVAGTPFDFREAKTVEQHIEEKNEQLERGQGYDHCWVLNE
QDSGMRFAASAYHEESGRMLEVHTNEPGIQFYSGNFLDGTLPQADGDGNYGHRSGFCLET
QHYPDSPNQEDFPSVVLEPGKTYSSKTSFKFSVK
>IFAGANLK_01324 Sodium/glucose cotransporter
MKALDIYDWFAIAGYFLILAGIVVWVIRKKQSNTEDYFLAGRNVGWFVVGASIFASNIGS
EHVVGLAGAGAGDKLPMLIYEIQAWVVLILGWVFLPFYARSGVFTMPEFLEKRFDARSRW
VLSVFSIIAYVLTKISVTIYAGGIVVSALLGINFWTGALSTVILTGIYTVLGGMRAVVYT
ETLQAIILVIGAAALTFIGLGEVGGWASMKETVTPEYLNMWRSASDPDFPWPSLLITSTI
VGIWYWCTDQYIVQRALTAKNIKEGRRGTIFGALLKLLPVFLFLIPGIIALTLKMRGELH
WDSPDEAFPVLMSNLLPSGLRGLVAAGLLAALMSSLASVFNSCSTLFTVDIYKKLRPNTP
EKKLVRTGQIATVIIVIIGIIWIPIMANISGVLYEYLQKVQSYIAPPITAVFLLGIFYKR
INAHGAFVTLVVGFIVGALRIILELFKDSLDPGGFLFLVGDINFLTFAAWFFLFCVVLIT
VVSFLTSIPSKIKTDNLTFQTISEEEKQNNKNSYNWVDIAVSILVVILVAGVMIFFNGR
>IFAGANLK_01325 hypothetical protein
MSNSPITLVKSAIWSILFFFTASGMAQDGTIYPLETPDEPEAIPLETGGVEDQPAPETWF
RQWGDPMARNISTATLTPFLPNPDKANGTTVIVAPGGGFRWLSLGNEGWEVAEALADKGI
TAFVLKYRLHPTPESLDDFKTSMERPATPPAESSDDTPETRPERPRSNLSNQLEDAEAAY
AMIVERAEEWGVDTTNIGMMGFSAGAGLTMHSTLNSKTMDLAFIAPIYGGLNEVEVPEDA
PAMFNVIAADDFLFFGEFGLIEAWHKAGKPVEFHLYQNGGHGFGLGNPDRTSNRWFDAFI
HWLEVNKFLVSNSEE
>IFAGANLK_01326 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase
MKIPQEFQITNLLHQENYLSNGELIKWTGQTDEVYSTISSTENYKPTLLGTIPHMDKDAA
LEVLDSACKAYAKGQGDWPTMKVSERISCMQNFVAEMQINREEVVKYLMWEIGKSLPDSR
KEFDRTVEYINDTIEDYKQLDRDSAKFFKRDGIHAHIRRGPLGVVLCLGPYNYPLNETFA
LLIPALIMGNTVIFKPAKNGVLLISPLLEAFKNSFPRGVVNVIYGRGREVAAPIMAAGKI
DVLALIGNSKSAIALQDQHPYKNRLRLVLGLEAKNPAIILPDADLDLAIEECISGSLSFN
GQRCTALKIIYVHEDVREEFNKRFAKKVDALKFGNPWEDGVKLTPLPETDKPDYIKELID
DAREKGAEILNEKGGEISENYIYPAVLFPVNKKMRVYQEEQFGPVVPIKPFTDIQEILDE
MAESSYGQQVSLFGKDIQEIAPLIDTLVNLVCRVNLNSSCQRGPDVFPFTGRKDSAVSTL
SVHDALRSFSIRTFVASKDNDYNNEILQELLNSKTSNFVSTDYIL
>IFAGANLK_01327 General stress protein 69
MNYRKLGKTGFEISEISLGTWQIGGKWGSDFSDKTAEETINTAIDKGINFIDTADVYEAG
LSEAAVGRVVRSRSERVFVATKCGRQINPHTAENYTPEALTGYVEESLKRTGFEALDLIQ
LHCPPTNVYYRPEIFETFQKLKDQGKILHFGVSVEKVEEALKAIEYDNVETVQIIFNLFR
QRPSELFFEQAKKKDIGIIARVPLASGLLTGKFDKNASFDKEDHRNFNRNGEAFDKGETF
SGIDFERGLKAVEELKKLFPEVQNLAPIALQWILKFPEVSCTIPGASKEEQLLSNLSIYD
RRELSKEKIKEMNKIYDEYLKHDIHHRW
>IFAGANLK_01328 Gluconolactonase
MTINDIAGRIYTLKVNTMKLNFSPFLLLVFILNSCNSQKELIKEGQELKRISNEFEFTEG
PASDAEGNVYFTDQPNNRIHKWSVGDGSVSVFMEEAGRANGLYFDDDGNLLTAADENSEI
WKINPEKEVEVLVESYQGNRLNGPNDLWIASDGGFYFTDPYYQRDYWERTKKEIEEERVY
YVNPQGEISIVVDDLVQPNGIIGTPDGKTLYIADIGDNKTYSYKINPDGSLSDKKLFTEL
GSDGMTIDNQGNLYLTGNGVTVFDKSGKKIQHIPIDKDWTANVTFGGKDNQTLFITAQQA
AYTLEMNVKGVRW
>IFAGANLK_01329 Inositol 2-dehydrogenase
MSKLPRRKFLQQTTLAAAGLSLSGSLLANPISIFSANDRVNFGVIGCKGMGWANMQAHLK
LPNINCVALADIDQRVLDERSAQVKEISGKAPKQYKDYRKMLENKDIDAVIIGTPDHWHC
LNMVDALQADKHVYVEKPLANSIEECNVMLKAGKRYDKLVQVGQWQRSGKHYDDAINYVQ
SGELGQIRLVKCWAYQGWMNPVLVKPNSTPPEGVDYQMWLGPAPDRPFNENRFHFNFRWF
WDYAGGLMTDWGVHEIDIALYAMGAKAPKSILASGGKFAYPNDASETPDTLQTVYEFEDF
NLLWEHATGIDGGNYGRNEGIAFIGNNGTLVVNRDGWEVIPEGENKNDDWVPKTKRIDLT
TPQGNALENHAENFVSAIRANDSSKLTCGVETGSIAAITAHMGNIAYKTGKKLYWNAESG
SFEDAEADELVKANYHNGWKLPQV
>IFAGANLK_01330 hypothetical protein
MPQPSITNFQKVCSLFLCLGFFQIASAQDSYVSQQKSENTFPLNSVTLFLDLEDHEGVHL
VAEDLQTDFKKVTGNEPEISSEEISGDYPVIIGTIGKSKLIDELISRAKLDVSQIEGKWE
NFLIDVVESPSPGVEKALVIAGSDKRGTIFGMYDLSEKMGVSPWHWWADVPVEKAEELYI
NPGSYTSGTPKVKYRGIFINDEEPGLGNWAREKFGGINSQMYEQVFKLILRLKGNYLWPA
MWGKAFNEDDPKNPVLADKYGIVMGTSHHEPMVRAQKEWGTHREDYGNGEWDYQTNAEGL
RDFWRDGFERNQDYENLVTIGMRGDGDEPMTEGTAIELLETIVADQRQIIEEVTGKPARE
TPQVWALYKEVQDYYDQGMRVPDDVTLLLADDNWGNIRKLPNPEDEPREGGYGIYYHFDY
VGGPRNYKWLNTTQIERVWEQMNLAYQYDATELWVVNVGDLKPMEFPISFFLDFAWDPES
IDAGGLEEYATDWVEKQFGSEYASKISEILNKYTKYNSRRKPEMLSPETYSLINYNEAEN
VVKDYNQLVEKAEGINKKLPDEYKDAYFQLVLFPVKASANLNELYVATAKNRLYAEQGRA
IANSYTEKVKELYKKDSELTEEYHNIADRKWNHMMSQTHIGYTYWQQPEEQVMPEVSTIE
VAEKPEMGIAMEGSKESWPASNKEARLPEFNSLADQKYYVEVFNKGKGDFNFKVKKKDKW
IKVSEEKGSVSDQKKLHVSIDWDKASKGKKTGSFSIKQGRNSVEIEVPIHNISSENIKGF
VESNNYISMEAANYSKKGNDEQGWTLVPNLGKTGSTMTSFTETPTHGVFSEDNPYLKYDF
HNFSTGEMKIEFLLSPTLDFHNTGGLRFAFSIDDAEPKIINVHQDTHDDWETSVGNNITR
VISEINLEEKGNHTLKVWALDSGIALQKIIIRKGDVRESYLGPPESKAAE
>IFAGANLK_01331 Endo-1,4-beta-xylanase A
MKSIKILQKSVFILAIAAAFTACKSSTDSEEKEAKSQTEDSSEMGLKDYYEDYFPMGVAV
APNSVKGKSAELIKKEYNSITPENVMKMGPIHPEKDKFYWEDADLLAEFAKENNLKMRGH
ALVWHQQTGGWIFKNENGGKVSKEELLKRMKNHIDSVVPRYSDIIYAWDVVNEAVADDST
KVYRESEWLEIAGKDFLVKAFEYAREADPNVKLFYNDYNAIIPEKRDRIIELLKYLQQNN
APIDGVGIQAHWSIHSPSEEELREALDLYSELGLEIQITELDVSLYPWEKERRELKEGES
DEFTPELEQKQIEAYDMFFRVFRDYKDVITGVTFWNISDRYSWLDTYPVAGRKNYPLLFD
ENFERKKAYEKVVEFETQPETKTP
>IFAGANLK_01332 Mannonate dehydratase
MRWYGPNDVLLLKDLKQAGITGIVTALHEIPVGDIWTEEAILERKNLIESYGLEWSVIES
LPVHEDIKKASGNYKQYIENYKISLQNIGKCGIRVVAYNFMPILDWVRTDHYHENEEGAL
VLKYDPLKFAYFDLFLLKRKNVEKDYTEEQITAAKKVGDNLSSEEKEELFKNILLGLPGS
TENFTAEIIKDLLDSYSHINDEKLRENLVNFLSEVTPTAEESNVNLAIHPDDPPFSVLGL
PRVVSNHEDLKFIFENVKSKANGLCYCTGSLGANPAHDLLEIYDEFEERIHFLHLRNVNK
KITGVFMESDHLDGDVPMVEVVKRILKTMRKRNQSIPMRPDHGYLHTLEADKNYYAGYSF
IGRLKGLAELRGLELGLQESLN
>IFAGANLK_01333 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MTKPLTAIVTGANAGLGFATAKKFCEKGIKTYVNGRNKEKTEQACKDLGENAIPFILDLN
DLDKIPAAVEKIGQEAESIDILVNNAGINMKKEFLEVTNEEFQNILHTNVLGLFAISREV
AKIMKKQNSGSIINISSMAAQYGIPKVIAYSASKTAVDGMTRAMAVDLAEFGIRVNAVAP
GFIETNMSRKALDNDPERKNRVLSRTPMGKLGQPSDIADAVYYFATTESSFVTGTILPVD
GGNSIGF
>IFAGANLK_01334 Extracellular xylan exo-alpha-(1->2)-glucuronosidase
MNLKKFISLALFSLFAVNIQAQEGYELWLDYKEVQDRTIEKNYAAFLNNVDIIGNSSTIQ
AIKEELQLAREGFGFDDSETGGDSKLIIGVQSKLPSSLRNQAKTENLEEEGYNITSLKNG
KTILISANSEVALLYGTFGLLREMQQQNDISNLKIEEKPKIQKRVLNHWDNLDRTVERGY
AGFSIWDWHLLPELIKPEYKDYARANAAIGINGTVLTNVNSNALILTPHYIEKVKALAEV
FRPYGIQVYLTARFSAPIELGDLDTADPLNEDVKQWWKNIADEIYAEIPDFGGFLVKADS
EGQPGPFQYDRTHVDGANMLAEAVAPHDGIIMWRAFVYSEEDPDDRAKQAYDQFIPYDGN
FADNVLVQVKNGAIDFQPREPFHPMFGAMPDTPLMMEFQITQEYLGFSSHLVFLPKLFEE
VLDEDTYADGKNSTVAKVIDGTNSNKKLTGIAGVANIGTEKNWTGNPFGQANWYGFGRLA
WDPYMDSEEIAQEWLRINFSNEEDFVKTMTDLLIESREAVVNYMTPLGLHHIMATSHHYG
PGPWVDDLGRPEWNPVYYHKADKNGIGFDRTSSGSNALAQYAKPLEEKYSNPETTPEKYL
LWFHHLSWDYEMDNGKKLWDNIALHYQKGVEQVEEMQATWNKMEQYVNEREFKKTSMLLE
IQLKEAKWWRDACLSYFQQFSEMELPAGVPEPEHNLEHYKSIDRPYAPGINPSW
>IFAGANLK_01335 Xylan 1,4-beta-xylosidase
MNYKVLGTFLLVLILVNCGSINAQEKAEDYGFRNESLSIDGRVTDLINRLTLEEKAMQMM
HDSPGIERLGIPEYNWWNEALHGIGRSGVATVFPQAIGMGATFDENLIFEVSSAISDEAR
GNHNTAVENGYRRQYSGLTFWTPNINIFRDPRWGRGQETYGEDPFLTAKLGVAFVKGLQG
DDDIYLKTAAAAKHYAVHSGPEKLRHEFNAVASQKDLWETYLPAFEALVDAGVETIMCAY
NATNGEPCCANEYLLTDVLRGKWGFKGHIVSDCWALEDFYGGHDVVETPEEAAALGIKSG
VNLNCGSVYPSLVEAVNQGLVTEEDIDEQLAVLMKTKFKLGLFDSPANNPYSKLSAKAIN
TSEHRALARETAQKSIVMLKNDNVLPLKNDLAKYFITGPNATSVEILLGNYHGVNPNLVT
IIEGIAGAIEPQSQLQYRQGTLLDRPNANPQDWASPNAENSDATIAVLGISGVLEGEEGE
SIASETFGDRLDYNLPENQLDYLRKLNEAAGDNPVIAVITGGSPMNLEEVHELADAVLMV
WYPGQEGGNAVADIIFGGVSPSGRLPITFPKSLDDLPPYEDYTMKGRTYKYMDAEPMYPF
GYGLSYSEFQFSDIKLSKEKIRKGQNLEASIEISNVGDREAEEVVQLYVSDMETSVNAPK
YQLYGIKRINLEAGNSEEIKFEITPEMMELVNNEGESVIEKGEFKIYIGSSSPSTRSLEL
GAVQFKEAVFTLR
>IFAGANLK_01336 Uronate isomerase
MTNFIEEDFLLKNRYSKELYERYAKDMPIIDYHCHLPVKDIAEDRQFKNLTEIWIAGDHY
KWRAMRALGIEEKYITGNSSDEEKFQKWAETVPYTMRNPLYHWTHLELQRYFGITDLLNE
KNAKKIYNQCNSLLATQAYSTRNLLKKMNVKVVCTTDDPADDLRHHKKIAEDRFEVKVLP
TFRPDALLNIESDGFSAYLDKIGNQTQVDIKDFDSLVKAVADRIEYFHQHGCRLSDHGLE
RMLAEDFSKEEIDNLLGKKLSGDNLTTEESEKYQSALLLKLGSLYAEKNWTMQLHLGPVR
DTNSKLLNQIGKDAGVDSIGDLNQAKPLAKFLDTLNKNEDLPKTILYNVNPSDNEVMATM
AGNFVSDSPKGKIQHGSAWWFLDQKDGMEKQLNSLSNMGLISCFVGMLTDSRSFLSVPRH
EYFRRVLCNLFGKDIENKELPEDMEWIGKIIQDICYYNAESYFQFPE
>IFAGANLK_01337 2-dehydro-3-deoxygluconokinase
MEKLVSLGELLMRLSCEDALRFTQVNNFKVVYGGSEANVLITATNFGLKTEFLSVLPEND
LGKSALNDLRNNNVGLNHIKFQGKRLGLYFLETGAINRAGKIIYDRENSAFSKVEPDWFD
WDEIFKDCNWFHWSGITPAISVKAAKVCLHAVKVAKSKGIKISGDLNFRGNLWQYKDANP
KETMTKLVEQSDVLLAGSYACNQFFDIKDIQSNSELSKALTKKFPSLEKIAITNREELNA
SHHKWSADLFTGSGLLSSKEYDIYPIVDRVGAGDSFMGALIYGLQHFEDQKTLDFATAAS
CLKHSIVGDFNKVSKEEVLELIEGDGSGRIKR
>IFAGANLK_01338 Putative KHG/KDPG aldolase
MDQEELKDKIMKKLSRPEITIKMKESGLVPLFYHQNREVVKEILTAVYKGGARFFEFTHR
GEFAHEVFSDLVKFSRKECPEMILGVGSVVDAGTASLYMNLGAEFVVSPVIREDVVKICN
RRKVLYLPGCGSLTEISQAEELGCEIVKLFPAAVLGPGFVKAIKGPQPWTSIMPSGGVSL
EKENIKEWFNTGVTCVGMGSALIPKDLVENSDFESIKNNVAKVLKIISEIRSE
>IFAGANLK_01339 Solute-binding protein
MRSVFILFISSIFFISCGEKEEAKSLKLAHSLSLDHPVHQALAFFAERVEEKSKEKLIIE
VYPGGQLGSERQSLELLQLGGLAMTKVSSAVMENFSPKLRVFGYPYIFKDREHRYKLYDS
ELGNELLLDGEQYWLRGLTYFDAGSRSFYTKDTPIETPADLKGLKIRVMQSPTAINLIKA
LGGSPTPVSWGELYTSLQQGVVEGAENNLPSFYTSRHYEICKNFSLDEHSAIPDILVIST
QIYNKLSSEEKKWIQEAAQEASVKQRELWEIAEKEALEAIKKEGVKVTYPDKELFKEKSN
HIIKVLEKTEPELYNTIQEIKNLANE
>IFAGANLK_01340 Sialic acid TRAP transporter small permease protein SiaQ
MSRKLNWFLEWLVVCLVTVMLFSVLWGVCSRYLLADQSSWTDELARFMLIWVSLFGAVYI
SGRNTHITIDLLPKSFSVKTKLKLDLLVQFIIMLFTASIFVIGGGRYVYVSFKLEQTSAA
LGLPMGFVYLVLPISGLMIIYFKWMQMQRTLQELKANR
>IFAGANLK_01341 C4-dicarboxylate TRAP transporter large permease protein DctM
MEIFVLIFSFIVLVGIRVPIAWSIGIASVLTLLFSVDTIPAFTTISQRVATGLDSFSLLA
IPFFILAGHIMNSGGIAKRLIEFAKSLVGALPGGLAHVNIVAAMMFGAIAGSAGAAAAAI
GSFMSERMEKEGYTKEYGVAVNVTSATTGLLIPPSNIFIIYSLASGGVSIGALFLAGYIP
GILTGLILMAIALVWAKKKGFPTGKRSSFKHIMKSFFDALPSLLLLIIIIGGIVGGIFTA
TEASSVAVVYCLILAFLYKELNFSKLKTVLVESVGTISLVMLLIAMSIAMSWVMSYENIP
QEVTSALLGFSDNPFVVIILINLILLFVGIFMDMTPAVLIFTPIFLPVAVAMGMDPVHFG
VIMILNLCIGLCTPPVGAVLFIGVGVANTTIQKVVKPLLPLFVGMLVSLILVIIFPFLSL
WLPELFGF
>IFAGANLK_01342 HTH-type transcriptional regulator DegA
MFRNIVAQPYFSVYLMKKKEVTIYDLAKELNYSPSTISRALNNHKSIGKKTIKKIQKTAE
EFNYRPNALAASLRNNTSRSIGITIPKINHPFQASLITGIEKAARKAGYNVIITQSDDKY
KNEVDNVKALYDARVGGLIVSLGIETRDTSHFDQYVKQNIPIVFVDRVPENFNSYRVIID
NHAAGYRATKHLIEQGCKRIAHFAGAQHVNVYNLRKKGYVDALRESGLQVDEELILDMKT
LSFEEGKKATEMLLKLDNPPDGIFSANDTAAVSAILYAKGKGIKIPEELAVIGFNNDPIS
QIVEPTLSTVSHPAQKMGEISTKRILEHSTRKLDTAVSEITMLDTEIIIRDSSKRK
>IFAGANLK_01343 Non-reducing end alpha-L-arabinofuranosidase BoGH43A
MRKLLFSSLFLFIAFGSAAQENYLNPILAGWYPDPAITDDGEGNFYMVHSTFAFYPGIPI
FHSTDLVNWKQVGNVIHRPEQVDLHGFGTSRAVFAPDISFDDGTYYLTCTIVDGKGNFVM
TAEDPAGPWSDPVWLPEVSGIDPGLFFDDNGKSYMVYNSEPPNNEAKYDGHRTIRIIEFD
KENLKTIDDNRILVDGGVDISTEPVWAEGPRIYKLNGYYYLMTAEGGTAVNHSEMIYRNT
SIDDEFIPFEENPILTQRHLDPNRENPITSAGHADIVQHPNGDWYGVFLAVRPYEGDLYN
TGRETFLTPVKWENDWPIFDLDGEEIKYSYPLPEGVDLKEDLFPLNGNFSFEEKFAKNEL
PLSWMMLRNPKTTWYDLKDGAEGISFKTRPETVEGKANPSYLGHRQQHIIGEVSISVEFD
AETENEKAGLLAFQKETHYYYAALSKENEKPVVQLYKSDELIKSVSLDNSVSEVEFKLEF
EEDEYTFFYKTGNDWQQLGETQDGKFLSTQVAGGFVGVNLGLYTTSNGKPSNNKALFNWF
RYSGNDEVYRD
>IFAGANLK_01344 Xylosidase/arabinosidase
MKLKQSLPILLPALIAFGCKDNNKQEEKDEVAEDSLAQQDTIRYHSEPLITDHYTADPSA
HVFEDKIFIYPSHDWDSGKPEDDTGNHFNMKDYHVYSMEDPNGEVTDHGEVLTVEDVAWA
ERQMWAPDAAEKDGKYYLFFPAKDKDDIFRIGVATSNNPEGPFTPEEEPIEGSYSIDPAV
YKDTDGEYYMYFGGIWGGQLQRWQTGEFAEEDEYPADDEPALRPKIAKMSDDLLSFAEEP
KDVEILDENGEPITTGDNDRRFFEAAWVHQYNDKYYFSYSTGDTHNIAYAIGDSPYGPFT
YQGVILEPVVGWTNHHSIVEYEGKWYLFYHDSSLSEGKTYLRSMKMMEIEYDEDGKIKTM
QSYTELD
>IFAGANLK_01345 Transcriptional regulatory protein RcsB
MFKRVLVAEDMDSINQAVSIILKDLGITEVFHSQYCDQAWLRAKKAIKDNHPFDLLICDL
SFKQDYRDEKIPSGQELISILKNEDPNLKVIVNSIEDHPQTVRDLWNSGNIDAYVCKDRT
GLKDLKEAIKTVSNNKQYNSPSIQKALKQKNLLSLNEFEINIVKYLSNGYTQDEIERELK
KKNIKPSSRSAIEKRLKELREEFKANTNPHLIGIMKDLKLI
>IFAGANLK_01346 Sensor histidine kinase LiaS
MVSAFGPRAFYIFEHMKHYYCLFFSLGILLWGCQKKEVNTEEDKKSIDSVSYYYEKAKAN
DSIPHKISFLNKGLEKIQQESDTLLPILLDYKIYYHNRLKEYDSSLVFADSLKRVANFQK
DTNWIALSFYRKAVINRYLDNQETVFKNAFESRKRYLQLRDSTKAARRSLEMAIAQSRMQ
DYTGSQESATEALRYLNEEKDTQYLCSAYNIIAIAYRNQGFYKDAIKEYQNALHYAQDLE
DSLTYHNNIGLVYQAQKNYKKADSVFKEILSKVSEQDYKARARYLDNLAFNKWLQDAEKN
ISVELLKALQWRKEHGDKTGIKASYAHLSQYYENRDKEKAIDYAEKWLKTGEATNTLLAQ
TAALKRLIKLNAGETGETNYVSEYIRLSDSLNKVSLQAKNTFAKIKFDEERKQQQISGLE
TSSALQALENQEIKTRNYILFFFVILIIGFTVFITYYNRQKHKKEKIKEIYNTETRISKV
IHDELANDVYNVMSSIEAIAPTETMDKLEQIYSRTRNISRENRDITTGPGYSNHLMTSLS
SICPDNTRLIVSGEKNITWTKIKAEKKLVIYRVLQEIMVNMKKHSNARFVALIFNEEGKH
LKIDYSDNGEGSSMQAIKTGNGLQNVENRIFSINGKLTFETEKGKGLKITILVPL
>IFAGANLK_01348 Type III pantothenate kinase
MNLIIDVGNSAVKSAVFQDAKLLRSYVFSFEKFSEKFQQIKKEHPKITFSMLSSVIKDTS
EIEKMLKKETELFVLGENTKLPFKNKYASPQTLGKDRLALVAAGAKEYKNKNLLIIDAGT
CITFDFKNDKDEYLGGAISPGLHMRLKALHNFTAKLPLVELEENVALIGNSTQESILSGV
LNGVLAELDGIIDRYRADYKYLTIILTGGDTQILSKRVKNGIFANPNFLLKGLNYILEFN
KTQ
>IFAGANLK_01349 hypothetical protein
MIKRFIVIVAVFFTVVATAQENVSSPYSYYGIGLNTFKGTVENRSMGGLSMFSDSIHLNL
RNPAGYGRLRRTTYALGGSHERLTLNSDAAEDNAKVSSLDYLAIGVPVGGNLGFAFGVLP
YTSVGYQILDIREDVASRLEGRGGMNKVFLSAGYQVIPSLSLGIDVNYNFGNLQNHRTLI
RDEVQLGSRDISRSDLLGFSYNFGADFQQRLENGLKLHAAATYSPTTNIDAENSRQLATI
AFSPNGGESVVEERDISVADSELTLPAKYTIGLGLGRPNKWFFGGEYVSTDDNSFLSVSG
AGGANANFANASQYKFGGYFIPQYNSITNYFNRIVYRAGFRFEETGLNINNQDINEFGIT
FGVGLPVGPGFSNINLGFEYGQRGTTDSGLIQEDFFRLSVGLSLTEARRWFERRKFN
>IFAGANLK_01350 Photosystem I assembly protein Ycf3
MKARFIALITGAVLGSSVLSAQSNDCATMAALAYDDAKAKDYEAAYEPLMKVREECPKYS
LATFQYGERALEYKIENAEGAEKEQYIEELISLWEERLELFPNKTSKGKIYADIAQVRFD
NKTGTTEELYNAFDKAYTEDRDNFTSPKGLYAYFQLMVDMQDAGERELQDVFDNYDKVMA
KIEEEENDAAENLAPLLEKQEAGEELNAKEKKQIQYAEINLKNYNSVKNALNAKLGARAD
CDNLIPLYKKDFEEKKSDVDWLQNANARLSAKDCTEDPLFFQVSEALHQLEPSANSAYSL
GQLAEADGDRTKALEYYNEAAELEEDPNDKARIYYRIASNYKERGSFSQARNYYRRALEA
KPSLGNAYLQIANMIAQSANDCGETTFDKRAVYWLAADYAARAARVDPSIASNANETATA
YKGRAPQKSDVFQGGRSAGEAIQIGCWIGETVRIPQM
>IFAGANLK_01351 Lipopolysaccharide export system protein LptC
MLFSCQGNLNEIRALEIEGDAPQAIAQGINLKYTDSGRMVANLKSPKMMDFTNKEFPYRE
FPEGLELEIFDENNEKSTVTSDYGIIYDGTNLIDLQGNVVIHTADSMRLEASQLFWDQNI
SWVFTDKPNTIKDPNGGVNESEGFDANQNFGNFRSRTNVGIQIIKDNKSDE
>IFAGANLK_01352 Hemolysin C
MEVEIIIIVLSLILSAFFSGMEIAYISSNKIFIEIEKRQNDFLATVLKRLTKKPSKFIAT
MLVGNNIALVVYGFFMGDLLMVWLEGFQPVNNAFLKYLIVDLNLFTQTVISTLVILLTAE
FLPKVFFQIYANTMLKFFAVPAYIFYLVFSFISSFVIWISDVILKRFFKTEGDEVQLAFS
KVELGNFINEQMETVEDDDEVDSEIQIFQNALQFSDIRAREVMVPRTEIIAVDQHQAPKD
LVNTFTETGLSKLLIYNETIDDVIGYVHSFELFKKPESIKSILLPVVFVPETMWVKDVLN
NLTKKRKSIAVVIDEYGGTSGMITVEDIVEELFGEIEDEHDPVVLTEEELGENHYKFSAR
LEVDYLNENYKFNIPEGENYETLGGYIVNHTEEIPQQNEELEVDNFLFKILEVSNTKIEL
VELKIKPAD
>IFAGANLK_01353 Foldase protein PrsA 1
MAVLNKIRQRSVFLIIIIALALFSFVLADVIRNGGFSSQKDQNTIATINDEEVSREDFAR
QVEAYQRNMGSNASTAQAVNQVWEQTLRETILKEEMEKLGIRAGKAQIREVMRTQMGNNP
AFRNEAGMFDENRVREYIASIRSTQPEAYQQWLQMESNMGDMARQNMYFSMVTAGIGATL
TEAKQAHQFENNSVDLRFVQLPYSSIPDDEVDVSKDEIRDYIKENPSQFETEASRNIRYV
YFEEEASEEDVQEAEEALTGLLESRVEYNAVTSSNDTLAGFNTTNDYEDFVEANSDLPYE
DRFMFKNELPSEFADELFNLEEGETFGPYQHNGYFKLSKLVETKQIPDSTKASHILVAYQ
GQQFAPDVTRSKEEAEALADSLVNVVRGDKDKFDELAAEFSSDRSNSEDGGDLGYFGPGT
MVPEFDSYVFDNNPGDVGVVETDFGYHVIHIEEQTEREKAVKIATIARELEASERSRNNL
FNETTKFEIAAGEGDFDEVAKEGDYNVRTVNNVKALDENIPGVGNQRRIVQWAFEDDASV
GDIRRFDIPSGYVVAQLTAKNKDGLMTAENASSKVIPILTKEKKAEILKGKINSKDLQEI
ASANNTMVQTANSVNLSSPTLPGAGREPEVVGSVFALEPGTVSNPIAGEKGVYVVELESK
NEAPEMNSYSGIAEQETTKRRQNASERLFEALREKADIEDNRARFY
>IFAGANLK_01354 hypothetical protein
MKEFYSNGKLLITGEYAVLDGAKALAVPTKFGQSLENKASDAKNIQWNSFDENEKLWFQG
EFEFKNGKIELISGEESTGRKLQQILNEAHRLNPELFSEEKGGIEVNTQLNFNKNWGLGT
SSTLINNIAGWFEIDAYKLLKNTFGGSGYDIAAAQNNQPITYQVTENGPSVLKANFYPEF
SGNIFFVYLNEKKNSREAIAHYKALPAANKKGLTEKISSLTEQFNNCNSLKEFELLINIH
ETLLSKALQTPKVKHERFSDFPGAVKSLGGWGGDFVMVTGEKDEVFKYFGKKGFSTIFAF
EDIVL
>IFAGANLK_01355 3-hydroxy-3-methylglutaryl-coenzyme A reductase
MIKPISGFSKLTKKEKIDWLAETYLKDRPEDVAILRQYWNEDSGLQQLHDEFTENTLSNF
YLPFGLAPNFLVNGDLLAIPMAIEESSVIAAASKAAKFWRTRGGFKATVIDTKKIGQVHF
NFFGNKEKLKQFFEATKPKLLEAVKPITHNMEKRGGGVLDIKLRDKTAEITNYYQLHCEF
ETKDSMGANFINSCLEKFAEVFENEAQQYADFSSEEKNIEIIMSILSNYVPECLVRAEVS
CPVEELNENKDLNGEDFANKFIQAVNIAEVEPYRAVTHNKGIMNGIDAVVLATGNDFRAV
EAGIHAYAARNGKYTSLTHASLENGIFKFWIEIPLALGTVGGLTSLHPLVKLALDILQQP
TARELMKVVAVAGLAQNFAAINSLTTTGIQQGHMKMHLMNILNQHKATEAEKTILIQYFT
NNTVTHSSAVEELQKLRNS
>IFAGANLK_01356 Dipeptidyl aminopeptidase 4
MKFSKILVGLLIAATSTIYAQDKEISLEEIYDGTFRQERLQSLQSLDNGKEYLVLNRDRN
ANTTSIDVYSYKSGEKVRSLLNSEDLSEISGFQGFELSEDEDKILLSTELEQIYRRSSRG
IYYFYDVEDKSLTKLSDNKVQEPTFSPDASKVAYVFENNIYTYDIASGEETQVTTDGEKN
TIINGVTDWVYEEEFAFVRAFDWNKSGTHLAYLKFDETEVPEFSMDIFGQDLYPSQQVFK
YPKAGEVNSEVSLYTYELATEESEKVDLGDYEDFYIPRIKWTQDAEILSVQVLNRHQNNL
DLIFVDAEDNEAEVVMNETDEAYIDITNNLTFLEDNSFIWTSEKDGWNHIYLYDEDGDLE
NQVTEGAWEVTNYYGYDEDSKRIFYQSTENGSVNRDVYSIKINGKSKKRLTEKEGTNSAD
FSADYTYFINSYTSIENPYEFTLHNAKNGKLVRKIKDNSALLEKEAAYNFAPKDLTTIEI
NGNELNMSMIKPTDFDKNKEYPLLMFQYSGPGSQSVSNSYFGTNDYWYQLLANEGYIIVT
VDGRGTGFKGADFKKVTQNELGKYEVEDQIAAAQKLGARDYIDENRIGIWGWSYGGFMSS
NAILKGNDTFSMAIAVAPVISWRFYDTIYTERYMTTPQENPSGYDENSPINHVEKLKGDY
LLIHGGGDDNVHLQNTMRMVEALVQANKQFDWAIYPDRNHGIYGGNTRLHLYTMMTDFIK
EKL
>IFAGANLK_01357 Di-/tripeptide transporter
MATVTNRVPQKELFGHPIGLYILFFTEMWERFSYYGMRAILVLYLVSATTGGNAGLGWTG
GEAIALYGWYTMLVYVASIPGGIIADKLLGQKKTVLWGGIILVAGHGILAVEEMWAFYSG
LGLIIVGVGMLKPNISTMVGGLYKAGDIRRDKGFTIFYIGINLGAFLSSLIVGYVGENIG
WHYGFGLAGIAMAFGLIVYLWGQKYLVNVGNLLSKVERNEGASLSKMFSELLKSPIQLTI
TSILMVGSIYFLIAESIPFGLLFIFLTLVIALMLMVYKDLTTQVMKDRYVVMILSFLLVV
VFWGAFEQAGGLMNIYAADKTDRTLSVTLPLIGNEVPATWFQSLNAMFIIIFGVIVANFW
AKRKLKNKEASSIFKMATGVIIMGLGFVFMAIASQEYSAFESKSAMYWLVLAYLLHTIGE
LCSSPVALSFITKLAPVKYASLMMGVYFAATGLGNKMAGLIGEFSQGEPATVQLSTEADD
VANRLQLNDTIIQNKNDFTFNGFVYLENNEIAVTNMESGEPVMELMNFENDDRKSEIIAN
LKKEGATAQDPYHVMLNFRQEEDKVGYYGDFVIEEVQTKLEFRTFIGITIFTTVFGLIVI
FMLKPLKRLTHGAEDNEREMLEQEQYEIADTERDRK
>IFAGANLK_01358 Disulfide bond reductase DsbH
MRFMIRIITIIFLLVGINAQAQEIKWMSMNEALEAQKEEPKKIFMDAYTVWCGPCKMLDK
NTFTNADVIEYVNEHYYPVKFNAEGEEEIDFKGQIFENPQYDPEKKKRRNSSHQLARALK
ITGYPSLVFFDEEANLIAPIPGYRTPQQLELYLKLFAKDEYKKMTSKEAFADYQEKFKGS
FD
>IFAGANLK_01359 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MKKAFKLLFLSFFALSIISCGSSRSKVITTKSEDNRSERVSHSRNTEIEPVDNKVYNIIS
KAKSFEGTRYKYGGTTKRGMDCSGLIYTAFLEEEIAVPRTSRAMSLEGERLYMKQVTPGD
LLFFETDKNRKVINHVGLVVERERENIYFIHSSTSRGVIISSLSEPYWNGAFVMARRIL
>IFAGANLK_01360 Lipid-A-disaccharide synthase
MKYYIIAGEASGDLHASNLMRALKQTDPEAEFRFWGGDLMQAQGGELVKHYRELAFMGFA
EVLFNLKTILKNISFCKEDISSFNPDAIIFIDYPGFNLRIAKWAKKEGYQTHFYISPQIW
AWKENRIQAIKRDIDHMYVILPFEKEFYEEKHNFPVHFVGHPLIDAIGQKDLPDVPAVKN
EYQLDERPIIAVLPGSRKQEISKMLEVMLSITPDFPEYQFVIGGAPSQDAEFYAPFIKQK
NIKLIMNRTYDLLSLSHAALVTSGTATLETALFKIPEVVCYKGNYISYQIARRIVNLDYI
SLVNLIMKREVVKELIQDDFNTKMLKKEFKKILEKENRTRIFKDYFELERKLGGKGASEK
TAQLIVEAIKN
>IFAGANLK_01361 hypothetical protein
MIKQNIFIGFLTGISANIGGILLYILLFSEMGIDETLDNAIAEGYFGKLIALGAILNFLP
FFVFLRKKQIYHARGVLMASIIAAISIFISKII
>IFAGANLK_01362 5'-nucleotidase SurE
MTKKKPLILVTNDDGITAPGIRTLIEVMKELGDVVVVAPDSPQSGMGHAITISDTLFCEQ
VTIKENYKHKEYSCSGTPADCVKIATQEILHRKPDLCVSGINHGSNSSINVIYSGTMSAA
VEAGVEGIPAIGFSLLDYSLNADFEPARKYVKAITKNVIKNGLPKGVVLNVNIPKLKASE
IKGMKVCRQANAQWEEEFDKRTNPQGREYYWLTGKFVNKDKGEDTDEWALEKGYVSVVPV
QFDLTAHHFLDDLNNWELND
>IFAGANLK_01363 Tail-specific protease
MLFMKRNFKILVVVLLMAATSCSFTTKKFDDPNKDKLLIDLITYVLNEGHYDAREINDEF
SEGVYDKYLGGLDGSKRFFYASDIEEFNEYRDKIDDQINEKEIGFFDLTYNRLQKRSEEA
RKIYKEILKEPFDFSEAEDINTDFSEAEYVSSKKELKERWRKQLKFSTLITYHDKVEDEE
MKKEEDPDYEMKSKEELEKDAREVTLSSLDEYYDFTDDLDRKDYFSVYLNAIVESFDPHT
LYLAPQDKDRFDIAMSGKLEGIGARLQKKSDNITVTEVISGGPAWRSEELSEGDEILKVQ
QEDEEDPVSIVGMRLEDAVDLIKGPKDSKVTLTVRKKLMGNIEEITLTRDIVEIEETYAK
TAMVEQEGKNFGVINLPKFYFNMEDYEERNAASDIKKDIIRLKEKDMDGLVLDLRNNGGG
SLKTVVDIAGLFIEEGPIVQVKSNGQRKDVLSDEDPSVLWDGPLVILVNELSASASEILA
AAMQDYKRAIIIGSKQTYGKGTVQNVIDLNRWLRSNEFGDVGALKLTTQKFYRVNGGSTQ
LEGVKSDVVVPDRYSFVDIGEKDQDNPLPWDKIDPAKYEVWDGYVDFEKTISESKERMNS
NEQLKRIEQHAKWIKDQSENSAHSLNFEEYAATAERNQEMAKSFDSINDYKTNLTFTSLP
YEEEMFENDTILKEKRDRWHSNLSRDVYVEEAIHVLSDMRKNNIREDKLAKVRD
>IFAGANLK_01364 hypothetical protein
MKRIIVDYKKLTPEILGLLVEKYPDGYDDDQIIAFKNAKNETVEAVEVKTEDTIYLVKVS
TRLENTMANFDEDDYDDSDFNEPIVEIPEKDEEEDDKD
>IFAGANLK_01365 3-dehydroquinate synthase
MSNMAAKGPVYYQEDGFLKINSYIKEAKPSKVFILVDNNTHRDCLAAFLQKIDTSENFEI
LEIEAGEINKNLETCTGVWNALSELDADRKSLIINVGGGVVTDLGGFVASTFKRGISYIN
IPTSLLAMVDASVGGKTGVDLGNLKNQIGVINHAEMVIIDPSFLATLPQTEMRSGLAEIL
KHALISSETYWNKVTNLSELTLDDLDDIIKESVEIKSKVVTEDPEENGLRKTLNYGHTLG
HAIESYFLTHSEKTTLLHGEAIAVGMVLATYLSKELQSFPEDKLKEITRKILDIYERVEF
LDGDIQQIIDLMKYDKKNSHGNINFVLLKDIGNTVIDCKVPNELIWNAFEYYRKA
>IFAGANLK_01366 hypothetical protein
MINRKIFNDTKTAFKLKSDLELDRAIFLFSMMKNKQLVDAGSWLTKISLKLHLPVEALIK
KTIFEQFCGGVTEDDCKPITKEMYAEKLHGILDYSVEGKETEEQFDAALDKKMKLIKFAA
ESDELPFSLFKPTGIGRFAIWEKITERINLSDEEKQEWERVKERVDTLCKCAYDNNVRLY
ADAEESWMQLAADELMEEMMKKYNKDKILIYNTFQCYRWDRLEYVKNLHERAKEEGFKIG
AKIVRGAYMEKENARAKKYNYTTPICENKEATDVNFNSVMSYCLANLNDIHLFIGTHNEV
SNYLALQSMEDKGLPLNDDRIWFSQLYGMSDHISYNLAKKGYNSAKLVPFGPVREVVPYL
LRRAQENTSVKGQTGRELSLLEEEKKRRKGQPTKHDRGEH
>IFAGANLK_01367 putative transcriptional regulatory protein
MKRWSAMAKAFTRIGKDIVMAVKEGGPDPDTNAKLRAVIQNAKSVNMPKDNIERAIKRAS
DKNQGDYKIVLFEGYAPHGIAVLVETATDNNNRTVANVRSHFNKCDGNLGTSGSVEFMFD
HTCNFRLNSEGLDVEELELEFIDFGAEEVFEDEDGIHIYAPFEYFGAIQKELENREIEIL
SSGFERIPQVTKPLSAEEASDVEKLLERLEEDDDVQNVYHTMEETED
>IFAGANLK_01368 Putative pterin-4-alpha-carbinolamine dehydratase
MKKLSEDEINKKLENLEGWVYKDNAIHTSFQFADFKDAFTVMTRIAFEAEAQEHHPNWGN
VYNELEISLSTHDADGVTEKDFKLAKAIEEIVEASA
>IFAGANLK_01369 hypothetical protein
MERILILGASGFIGNALYKELCSFFDTHGTYHTPNRILEENHQFHHFDMETENIEILLQN
VKPTIIISAVRGNFDAQIIAHFEVINYILTHKCKLLFISSANVFDAFTNFPSYEYDKTLS
QSIYGRFKIKIENALLRLPNDKYNILRLPMVFGHNSPRLKQIKTLIDLGEAIEVFPNVVI
NVTEIEKVTQQIHYIINRKKQGVFHLGSSDLVHQKDFIEEVCEVLGYKNLVFKNIYDSNF
DRFLAVLPKENILPKNLQVSVQQVTKASVKN
>IFAGANLK_01370 Aminomethyltransferase
MKEVALAARHKELNAKMVSFAGYNMPVSYEGVNIEHQNVREKLGVFDVSHMGEFLITGDK
AQELIQKITTNDASKLIDGKAQYTVMPNETGGIVDDLIIYRINSEKYLLVVNASNIDKDW
NWIAQHNTMDATMRDMSDEFSLLAIQGPKAAEAMQSLTEVDLSNMKFYTFEVAEFAGIDK
VIISATGYTGSGGFEIYFKNEDAEEIWDRVMEAGKDYGIKPIGLAARDTLRLEMGFCLYG
NDIDETTSPIEAKLGWITKFTKDFINSEAIKKEKEEGPKRKLIAFELEERGIPRQGYEIE
DEDGKVIGEVTSGTMSPSLEKGIGLGYVPAEVAKFGNKIFIKVRKKSIPAVQVKLPFYKG
>IFAGANLK_01371 hypothetical protein
MKNRENNRVRLSLIALTLFELNFYWQIYLKFKFRLNFSNEAFRL
>IFAGANLK_01372 Bifunctional NAD(P)H-hydrate repair enzyme Nnr
MKILSAEQLKEADEVTLKTEGISSTRLMERAASLVFNEIHTRLEGADINIKIFCGIGNNG
GDGLVVARLLHKYGYKVEVYVVNYSDKRSDDFLVNYDRYKKESHTWPALIKRVEDFPEIS
PGDFVVDAIFGIGLNRPAEGWLAKLLLHINGSGAFCLAVDMPSGLFPDKVPSEDTAVIKA
NYTLTFQTPKMVFFLPQTMKYSGEVQVLDIGLDRGYLKEVKAMAQLIGKREARQLYKPRD
KNSHKGDYGHTLVIGGSYGKIGSMVLSAQSTLRAGAGLCSVFVPKCGYEILQSSFPEAMV
ITDEDANELTDIKTDLEPDVICFGMGAGKSSKTVKAFKGLLEQTENPMLIDADGLNMLSE
NNELLALLPKNSVLTPHPKELERLIGKWDDDFKKIDKIEKFTKKYKVVLVLKGAHSFVFS
GKHTYINNSGNPGMATAGSGDVLSGIIAGLMSQKYEPLVAAILGVYLHGLAGDIVAEENG
YESLISGDICDNLGKAYLALMNDKKKV
>IFAGANLK_01373 Histidine ammonia-lyase
MQSHHYISSAILDLETIEDIMVNKKKLALSEEAESNIQKSRKYLNKKITESDTPVYGINT
GFGALCNVKISPGKLTELQENLVKSHACGTGDKVNKEIIKLMLLLKIQSLSYGNSGIALE
TVLRLIDFYNLDILPLVYEQGSLGASGDLAPLAHLALPLIGEGEVYFEDEVISGEELLKR
QDWDALKLQSKEGLALLNGTQFMSAHAVYALIKSYKLSYLADLIGSVSIDAFDCNLSPFD
ELVHLARPHRGQIKTAERMRRFLEDSQIAKSEKENVQDPYSFRCIPQVHGASKDTLSFVR
KTIKTEINSVTDNPNIFIEEDKIISGGNFHGQPLALAVDYLAIALAELANISERRTYQLV
SGLRGLPAFLVENPGLNSGFMIPQYTAASIVSQNKQLAVPASVDSIVSSNGQEDHVSMGA
NGATKLLKVVENLNSVLAIELFNASQAMHFREPAKTSVMLSEVLGEFREVVPILHNDVTM
APHIQAAKTYLNNFSFKENIFD
>IFAGANLK_01374 hypothetical protein
MTTDIMELEFGQVRIFQNILIAELNEGVLFTSENNKELLAIGKEAFKGGPYGYISFRKNS
YAVDPMVYRESALAENLKAIAVVSENELIRLNAHKVERQFYKTQNSFEVFDNLDQAINWI
RYKI
>IFAGANLK_01375 Negative regulator of genetic competence ClpC/MecB
MDDNFSPRVKDVIAYSKEEALRLGHDFIGTEHLMLGLLRDGDGKAIDILNALDIDLSHLR
RKVEILSPANPESTAVSNEKRNLHLTRQAERALKTTFLEAKLFQSSNINTAHLLLCILRN
ENDPTTKLLNKLKIDYDGVKDQFKYMIASDETDFQDSPTAESFSDDDSNTDDATKDNPFS
GGGSGPGKTSKKSKTPVLDNFGRDLTAMAENDKLDPVVGREKEIERVSQILSRRKKNNPL
LIGEPGVGKSAIAEGLALRIIQRKVSRILFDKRVVTLDLASLVAGTKYRGQFEERMKAVM
NELEKNDDIILFIDEIHTIVGAGGATGSLDASNMFKPALARGEIQCIGATTLDEYRQYIE
KDGALERRFQKVIVEPTTVEETIEILNNIKDKYEDHHNVSYTDDAIEACVNLTNRYLTDR
FLPDKAIDALDEAGARVHITNIDVPKQILDLERKLEEVREKKNSVVKKQKYEEAAKLRDD
EKNLEKELQIAQEKWEEESKKHKETVDEDSVADVVSMMTGVPVNRIAQTESNKLVELPKK
IKGKVIGQDDAVSKVVKAIQRNRAGLKDPNKPIGSFIFLGQTGVGKTQLAKVLARELFDN
DDSLIRIDMSEYMEKFAISRLVGAPPGYVGYEEGGQLTEKVRRKPYAVILLDEVEKAHPD
VFNMLLQVLDDGYLTDSLGRKIDFRNTIIIMTSNIGARKLKDFGQGVGFGTASQRSQVDE
NARSVIENALKKAFAPEFLNRIDDVVIFNSLEREDIHKIIDIELVKLFSRIGSLGYNLTL
SGKAKDFIAEKGFDKQYGARPLNRAIQKYIEDALAEEIITSKLAEGDKIFMDLDEEKNEL
TIKIDKAVKETES
>IFAGANLK_01376 DNA gyrase subunit A
MAEGEKLIPINIEDEMKSAYIDYSMSVIVSRALPDVRDGLKPVHRRVLYGMYELGVLSNR
SYKKSARIVGEVLGKYHPHGDSSVYDTMVRMAQHWSMRYMLVDGQGNFGSVDGDSPAAMR
YTEARMRKISEDMLADIDKETVDTQLNFDDSLNEPVVMPTRIPNLLVNGASGIAVGMATN
MAPHNISEVIDGTVAYIENNDIEIEELMEHIKAPDFPTGGTIYGYDGVREAFKTGRGRIM
MRAKSQIEEINGKEFLVVTEIPYQVNKADMIKKTADLVNEKKIEGISLIRDESDRNGMRI
VYQLKRDAIPNIVLNTLYKHTALQTSFSVNNIALVKGRPEMLNLKDIIYHFVEHRHEVVV
RRTEFELRKAEDRAHILEGLIIASDNIDEVIALIRSSSNAEEARNKLIERFELSELQAKA
IVEMRLRQLTGLEQDKLRAEYEEIMETIEDLKDILARKERRMQVIKDELLEIKEKYGDER
RSTIEYAGGDLSIEDMIPDERVVITISHAGYIKRTSLTEYKTQNRGGVGQKGSNTRNEDF
LEYLFSGTNHQYMLFFTQKGKCFWMRVYEIPEGSKASKGRAIQNLINIDPDDRVKAFICT
QDLKDEEYINKHYVIMATKKGQVKKTSLEQYSRPRTNGINAITIREDDELLEAKLTNGDS
QVMLAVRSGKAIRFEEGKTRPMGRNASGVRGITLADDKDEVVGMISVEDFNSDILVVSEN
GYGKRSSLEDYRITNRGGKGVKTISITEKTGSLVAIKNVSDEEDIMIINKSGIVIRMEVA
NLRVMGRATQGVRLINLKGNDAIAAVAKVLHDEDDVELMEDPEKAEETEENPNGTTIVDD
SEE
>IFAGANLK_01377 Photosystem I assembly protein Ycf3
MKTNIFTVALSLLSVAAVAQKSEIRSAGKAVDDGNYAEAKTELQTAESMLSEANDKWTER
FYLYKGQAYLGNGENASMEDLEVAAEAFQKAQDMGNDDEAVQGFDQVRNALVQSAINDQN
TENYESASDKLHYSYQLNKQDTLYLYYAAGNSLNAQDYTTALEYYEDLKELGFDGSGVEY
LATNVETGEQEVMPKEQRDLMIKTGEYEDPQDRKIPTKKGEIAKNIALIYIQEGEDEKAI
EAIQDAKAENPDNIALIQAEADVHYRMGNKEKYNELMQEIVKKNPNDPNVYYNLGVTAAD
LGNNEQAIEYYEKALEIDPDMTNARMNIVVAILAKERDLIDEMNELGMSEEDNKRYEELE
EERIEIYEEAVPYLEEVIERNPENVEAIRTTINIYNQLGEEEKAAELKARLE
>IFAGANLK_01378 Group II intron-encoded protein LtrA
MRKWYSLIDKVYALPRLEQAYREVRKNKGSRAQGVDNQSIADFNSALEENLCQLSMELKE
GRYKPQPVRRVNIDKPDGSKRGLGIPTIRDRIVQQSLLNVLQPIFDPEFHPSSYGYRLKR
SAKTYSTSI
>IFAGANLK_01379 hypothetical protein
MKNSGIRMVRFAGDVLLFAPTKAQAGKYMAKATSYLEKELRLEVNKNKSSLTPIEEGIQY
LGVVISPME
>IFAGANLK_01380 K(+)/H(+) antiporter NhaP2
MLLIFTISALIILSGTFYKKLENHYITDPLIALIFGVVLGPDLFNLISLENSKSLDILKK
ATEFTMAVALMATALRIPPNYFRKHFKTQSMIIVLGILAMFLSSSVLLFWLLPLSLPESC
LIGAIITPTDPVVASTIVSGENAKKFLAARIRNTISFESGVNDGLVYPLILLILASITTG
QNFQNWVLKDLLFATVLCGFLAFGLGKLLGKLMHKAHVKGWMTTKAVLPFSLALAFLLLS
GFNAIGMNGIFSVFIGGFAFSSEISENETIQEEHVQESMDRIFTIPVFFIFGLLLPWKEW
IDLGIWTSLAIILAIILFRRIPGFLLILRAAPQFKSKFKDQLLIGWFGPIGVAALYYSIL
TLEKTKDENAWIVTSLVVMASTVIHGLSSLAFSKWYAKSVNKSNAE
>IFAGANLK_01381 Transcriptional regulatory protein QseB
MFKNKSYHFLLIEDNDGDYYLISDYLKEKLPEHSLTRYSRFSDFKENELNVKYDAILLDL
NLPDNKGNDLVTKICHLFAEIPIIVLTGEVFEEFALHAISLGASDYLIKDNLNPDILYKS
IIYSIERKANLQLLKKSQQLYYDLFEFNPQPTWVYDLETLRFLDVNEKAINHYGYSKEEF
LNMTIKDIRPKEDIPIMEASLKDFKAEKKLEGKRIFTHLKQNGSEIQVKIDSKIITYMNR
RAAIIVATDITEEIEHQQIIEKQNEELKNITWIQSHLVRAPVAKILSIVKETTWHELNGE
ERNFLFKGLNDSATELDGITRQIIGKSEAILQL
>IFAGANLK_01382 Uroporphyrinogen-III C-methyltransferase
MQTLIQNPKCTIVGAGPGDPDLLTLKAVKTLSIAAVVLYDALVNPQILEHASNAEKIFVG
KRKGCHAYAQDQINELIVKFAREKGPVVRLKGGDPFVFGRGSEEKKYACAHGVKVEIIPG
ISSAISVPASAGIPVTKRHTAESFWVITGTTSGHKLSKDVALAAKTSATVVILMGMSKLA
EIVALYKNEAKGELPIAIIQNGTWEDQKLIAGNIHNIENLVKKYKIGTPAIIIIGEVVKE
CEAYNNGVNNSEVDEFVLQNLNYLNLHQTA
>IFAGANLK_01383 Rubredoxin
MEKSFSRIIIKGGVLSPAELKEIVELAETSGSDSISLGSRQDILITKEIEVDNFSAENKY
QIIPPKTDGSENIVSSYVAADIFPGTHWLTGDRYLYVLEQFRNPSNLKVNITDPKQRLVP
LFTGDLNFIASEHEDYWYLYIRLPEWKKMQVYPALIYTWDVGEIVYGIEELLQEEPEEVE
MIFNLLSDALESNNRTVDKALEIGYHPFPYYEGMNKIGMDSYWLGLYWRNNKYYTSFLKE
MCDLCAESKIGKISITPWKSLIIKGIPTNSKLEWEKFLGKSGINVRHSMLELNWHIPVDN
EEALNLKKYLVSNFDQNDISTYGLTFGIFDSTKRSNYFTAVVIEKNQAPEILNEIGVRDT
YNLLYAQNFDPNTRDYVIHVQEVDKVELPGLLIELSKMYFNQLGEKEEKPRKKPEPEPRK
EKSSKEIWQCNACLSIYDAEFGDITQEIPPGTSFTQLPGNYECPLCEATKSEFEKRIQEK
VG
>IFAGANLK_01384 Nitrate reductase
MKKIQQEEFKTTCSYCGVGCGIVAQKSSDNKITVKGDKNHPVNRGMLCSKGMNLDYVAND
LSDRILYPEMRWSKSHPRERVSWHKGLDRAARVFKTLIQKYGPDSVGFYVSGQCLTEEYY
IANKLTKGFLGTNNIDTNSRLCMSSAVVAYKKTFGEDSVPVSYDDIELADCFLIAGANPA
WCHPILFRRLEKHKEENPEEVKVIVVDPRRTDSARFADLHLQLIPGTDIILFNAIGRRLI
ERGYIDKRFIKEHTENFQDYKKQAYSLSLKKAAKGCGLPVDEIKEAAEMIGRSKGFISMW
AMGLNQSSVGTDKNFALLNLSLITGRVGKPGNGPFSLTGQPNAMGGREVGGMANLLAVHK
NLNNPQHRQEVADFWGVDKISEKPGYTATEMFDALESGELKAVWIACTNPMVSLPDVRKA
EAALKKAKFVVVQEISHKSDTLECADLVLPAAGWMEKEGTMTNSERRISYLPQELSPPGE
ARADVEIFCDFAQRMGFSEFNYNSTEEIYAEYCEMTKGTNIDISHLNYDRLKNEGSIQWP
VPEYRHPGTTRLFEDHQFYTPSKKAIFNIPASINNTSTLPDEEFPLILTTGRVRDQWHSM
TKTGKVSRLRTHYSSPVLEINPVDGIKYFIKNGEVVEVKSENGNVRLRAKITKDVRPGVL
FLPMHWGKQLSSDLNRANNLTFNRVDPQSKEPDFKFTRVSVSKFKKPVEKIIIIGAGAAA
FRFVQNYRDHNVDDELHVFSEEEHPFYNRVLLPEYVTEELSWEKLLKIKETELGKLNLQL
HKGGAISKIDEKEKSVTDHLGKKHHFDKLIIATGSRAFVPKDAQLDLPGRFTMRSKLDAD
EFKTYLQNTGLPAEEQHVVIVGGGLLGLELAAALQKENVNITIVQRSSRLMERQLDILSS
RLLASDVQERGINIYFDNEVSTVFDDQENPGELDISLKSGKILNAHAIAYAIGTRPNIEI
AKESGLNCGRGVKINEHLQTSNPNIFAIGEIAEYKGQLFGITSAAEEQAEVLSNFLAGDV
GSIYRGSVLMNILKFKNLDLCSVGDINVPDNDPSYEEIVFTDVSKRYYKKCIVKDDLLVG
AILMGDKNEFAQFKTLIESKMELADQRDTLLRGSGSSKPVKGKLVCSCSQVGAGNLQEAI
KNGNKDFTTLCKETGAGLGCGSCKTEVRELLAVG
>IFAGANLK_01385 putative nitrate transporter NarT
MKDVITGKATKLDLRNLRSIPIRTFWISAIAFFICFFSWFGIVPFMPQVEKDLGLSPSQK
WNAIILAVSGTVFARLLIGKLCDKYGPRLCYTWLLMLGAIPTILCGLVQTPLQFQLCRLF
MGFIGASFVITQVHTSLMFASNVVGTANATSAGWGNLGGGANRLGMPLIAAALVAFGVAE
AEVWRYAMVVAGLVCFSMGFVYYFFTQDTPEGNFSDLKKSGKRIPVKKDQNGFLTAIKDY
RVWILFVVYGVCFGIELTVYGTMDSYLQNTFNLERVTAGNIILGFALMNLFARTLGGYFG
DKSGEKGGLRGRVFFLTLILIAEGVILSLFSMAGSLIIAIILLTAFSLAVQMAEGATFAV
VPFINKKAIGSISGIVGAGGNVGAFLAALFLKIKSVAAEEAAIAANEGRSSEIIESARAS
ASSAAISDAFLWIGFSILAAGLVSLAIRFSQEDEKEAALELNHQNA
>IFAGANLK_01386 Oxygen regulatory protein NreC
MGQTKILLADDHELVRDGIIALLENEENLTVVNEAANGKEALEIIEKDTPDLLIVDIRMP
ELNGIEVVKKVKKDFPNLKTLVLSMHDSTEYVVQCVEAGADGYLLKGSSKEEFLKAINKI
AGGGKYFSGDISAIIVSNFVNGNSEKRVDTNSQKQDAALNILTKREKQILELILEGKNNQ
EIGDELKISKRTAEAHRFNLMKKLEVKNLMELTHKSRELKLI
>IFAGANLK_01387 Signal transduction histidine-protein kinase/phosphatase DegS
MAPNSSLDQHTFIKLRKLYILALTAIALSVIISQLFIGKFLEEQEGDSKLINISGRQRML
SQKLTKECLLLLKTENINERQDIAQNLEESLTRWTHSHEVLQNGSDSLNIVSEQTEEIEE
KFSEIQPYFEKIREASQSIVLKIKENPGRPIENFSAEIAIINENEAAFLGIMDAIVNQYD
EEAHTRVERLQNLELFLTIFTLSILLLEFFFIFLPTAKGVKTNIKNLIHAESRAVKMARN
ADAISEAREKSVKELRALGQAMDQILLFARITPNGDILHIGDQFSKLFQYKKFNIETKFS
EVLSPKENEQLNIEKLISAHKRSGWQGEVKATTKDNKDIWLELSIVPFQPEKDKTELTII
GVDITKNKEAQLKIEELTRRSYEEKMRQQGLIAKKIIENQENEQNRIAKDIHDGIGQMLT
GLKYNLESIDFKYPEKAESKIESLKELSTRIIQGVRAATFNLTPPELTDHGIVPALQKLT
EELSKLTGKNIILFNKTGFSRRLGNIIEINLYRITQEAVNNAIKYADSTHIIVSVSHSKE
ILSISIEDNGKGFNPEGISTEKNGNRGMGLTFMKERVKFIDSRLFINSSPGEGTRITLNL
PL
>IFAGANLK_01388 hypothetical protein
MSKFQEATKRIDAKNAEDPNLEMSDGKEAPKELLYSERMTDKLLDFHPQASEELQIAVRA
QHICRWKVPRDSYPKNRVGYLKWREGLKKTHAEITDEILKEVGYDKDFRDRVSFLIRKKH
IKKDEGSQVMEDVVCLVFLEHYFDDFATKHNEEKIIDIVKKTWAKMSPEGHEAALKLPLS
NRSETLIQEALK
>IFAGANLK_01389 Nitrite reductase (NADH) small subunit
MQELLAQYQSVAAPEVIKWVNVGKAIDFPENGGACIKYKNKQIAVFNFTRESHWYACQNL
CPHKLEMVLSRGMIGDKEGIPKVACPMHKKTFSLKDGNNLNGEDYKIAVYPVKIESENVY
IGFID
>IFAGANLK_01390 Nitrite reductase [NAD(P)H]
MRKIVVVGNGMVGYKFCEKLMASPDRENFQVQVFGEEPSPAYDRVHLSEYFSEKGKNELL
LAPRSWYEDNGIELRTSSLISEINTEKKEVVTYKGEKVSYEYLVIATGSSAFVPPIKGSE
KTGVFVYRTTEDLDAIKTYAKKLQKKYKSKATVLGGGLLGLEAANAAKELGLETSVVEFA
PRLMPRQLDEAGSNTLIGKIESLGIKILTNKATSKISGEEEIDALTFSDGSRHETDMLII
SAGIRPRDELAKSSGLKTGERGGIFVNNKMETSAKDVYAIGEAALYNNAIYGLVAPGYNM
AEVAVSQICGGDKTMAAHIDMSTQLKLIGTDVASFGDPFIENEEISAITYENKQSGIYKR
INVSRDGKKLLGGILVGDASDYQNLFQIYINGMKLPENPEDLILGSRGGENTAMGSVTDL
PDTAQICSCEAISKGDICKPLESGECCSMDDVVTKTKASTGCGGCKPMVTDLFNATMKSL
GKEVKEVICEHFDFNRQEIFDLVKINKVQDFDEALNLFGKGHGCEKCKPVLASIFASITM
ETANKQVTIQDSNDKFLANIQRNGTYSIVPRIPGGEITPDKLMTIGAVAKKFDLYTKITG
GQRIDLFGAELHQLPEIWKELIDAGFESGHAYGKSLRTVKSCVGSTWCRFGMHESVSFAI
QIEERYRGLRSPHKLKGGVSGCIRECAEARGKDFGIIAVESGWNLYVCGNGGATPKHAIL
LAEGLDDETTIKYLDRFLMYYIRTAAPLMRTAPWLEKLDGGIEHLKKVVIEDSLGIAEDL
EKEMQGLITNYECEWKQAIEDPEMMKRFKHFVNSDEGDDNISYVPLRDQKMPRAWT
>IFAGANLK_01391 hypothetical protein
MKYSANFKTLLPLFLLIIVPLLSLAQEQEYYELKVYEFENDEQIEKTENYLQQALMPGFE
ELGVKNIGVFKPKADSLNKLYVLIPYTSLEEFGSKNKAFQNSEILQQKGGEYISGSNDNP
PYKRMSTILLKAFKDMPVMKPSVIEGPKKDRVYELRSYQSSTEALLKNKIKMFNEGGEIE
LFDELDFNAVFYGKVIAGPDMPNLMYLTTFSDRKSRDEHWESFGNSPVWKKMEIIPEYQG
NVSQIDIHFLYPTEYSDY
>IFAGANLK_01392 hypothetical protein
MTVEQVNLLLKTMPLDLTYVDENDKVIFYNRGEERVFPRSAGIIGREVKFCHPPKSVGTV
LKILEEFRKGTKSESSFWINFKSRLIYIRYFAVRDAQKKYKGVIEMSQDITDIKNIEGEK
RLLDWD
>IFAGANLK_01393 hypothetical protein
MNETIDTSKLVAGHPVSVYFKEKELIKLLTEELKDTDPSSEYQKFYNIFNQLQSVERRFE
RKENQLFPFLEKRGWNNPSQGMWSFHDTLREQFRLLRKKIEAREIEEIDQDIQYLISGIF
RLLLIEETTLFQTL
>IFAGANLK_01394 Quinolinate synthase A
MSVLTENNISLQNEISILKKAKNAVILAHYYQEPEIQEIADFVGDSLELAKKAATTNADI
IVFAGVHFMAETAKILNPSKKVLLPDINAGCSLAESCPPEAFQELKEQYPNHAVVTYINC
SAEIKAMSDVVCTSSNAERVINSIALDKSIIFAPDKNLGRYLIEKTGREMLLWDGACIVH
EAFSIDKLLELYAKYPLAKIIAHPESEEHILKISNYIGSTSGMLNFVKSSQQDTFIVATE
AGILHQMQMDVPNKTLIPVPAKEDNSCACSECAFMKMNTLQKLKACLKDESPEIILKERL
MKAAHRPIKRMMEL
>IFAGANLK_01395 L-aspartate oxidase
MKTDVLVIGSGIAGLSFAIKVATAKPEATIHVLTKSNNDVGNTIKAQGGIAVVVDKIRDS
FEQHIEDTMKAGKGINDPEIVKMVISQAPERLYELINWGTSFDANELGELELGLEGGHSQ
KRIVHHQDLTGKEMETKLLQKAASYSNIIFYDHYFVTDIILKKQESSTTCIGVRAIERKM
AEEVSISSRITFLATGGSGRIFENTTNPLVATGDGIAMAHRAGAKISNMNFIQFHPTALY
TKNQHSLFLISEAVRGFGAHLVDSTGNRFLFKYDTHGELATRDIVSEAIMRELQRSGKKS
VFLDCRHLNPEAFKNHFPTIVQHCLDEGINYENDLIPIVPAAHYQCGGIQVDKFARTSIN
QLYASGECAHTGLHGANRLASNSLLEALVFSHQAAGKVVEKLDSILVEKLQQEAALQIDQ
SKEENDILNKFEKELNHLMSYNLLYTSEENEKKKALVKLNFLDEKLEKLCKNKYLEFFEL
KNMIQTAIIILEHAIKSKFFNKKKTYKFSN
>IFAGANLK_01396 putative amino acid permease YhdG
MGEKKLKRSLGLWDILMFGIGGIVGAGIYAIIGEAAALGGNMLWLSFIIAATVALLTGLS
YAEFVSRFPDSGGSFEYIKQSLGKKPAFFMSIFMVFTGVVAAAAIAISFASYLNRLWDLP
AWIIVIGIVALMALFNIFGAKYSSYYNSVATVITLAGLAAVIAVCIPEFGSTDLTKLNDS
GWNGVIAGSALIFFSYIGFEDLVKMAEETKNPEKNMPKGVLLSGLAVLVLYVLIAISSVS
VLDWQKLSESEGPLAAVIETKLGTAGATGLVVVALFATSKTILSNILGTSRLLYDVARDS
EVNWLKKFTTISGIGNAPNYAIIAIALMAIGFGLLGDLKMVASISNIFIFIVFGMVNFSL
LIFRYKNRMNNKKAPFHIPLNVNNIPIPTVIALLTILILFGYNLYNLTQGNM
>IFAGANLK_01397 Haloalkane dehalogenase 2
MSGKNSIESVIEKHEASGKYFNVKGLQCFALDQGKGEAVLCLHGVPTSSFLYRNIVPVLA
DKGYRGVAIDFPGLGFSDRPEDFDYSFSSLAKFCAEAAKSLGLVKYHLLIHDIGGPIGFT
LAAENRDKILSITVLNTWIDGVNFKKPWPMRPFEKPALGEIELATIQYPTWQIMFNKMGV
NDSSAIPENEINAYVDILKRSDGGDAFLKIMRSFDNSEEFRSLCYKAVQNVPYPIQAVWG
ADDPFLTLDHHGQEIKEAAGLSNIHQLSSRHFLQEEKPMKIVAKLEEIIQESKQILPR
>IFAGANLK_01399 Tyrosine recombinase XerD
MRLAEDLVWIEKNLTKRFKLRFDQVDMIYLSQEELQKIKNQKFKRDTHKINRDIFLFCCY
TGLPYGDVKDLKKKHIQIGVDGKTLIYTRRIKTNKMLRIPLLEEAERILEKYQDHPKVHS
SDILFRVHSNQKTNQYLREVTKAVKINKELSFHSARHTFATTVILANGVPIETLSKLLGH
TKLSTTQIYAMVVDSKISHDLYILRNGLK
>IFAGANLK_01400 hypothetical protein
MSLIPTKAQNILDLYLPQKSTTRNLVFPELRGTNLDDQIEVRKREKTITRNFNRRLVRIA
KYLGIVKKLTMNIARLSFGNVSGDKISVQLLQQLYRHCSITTTMMYLSNFINTQTDEALN
NVVDFLN
>IFAGANLK_01401 GDP-mannose 4,6-dehydratase
MGLTTAKPCNLIYIISHKRYYKFTKKISMKTALITGITGQDGAYLSEFLLDKGYLVHGIK
RRSSQFNTDRIDHLYQDPHVNNRNFILHYGDMTDSTNLIRLIQLIQPDEIYNLAAMSHVH
VSFEIPEYTGNTDGLGTLRILDAVRLLGLEKKTRIYQASSSELYGKVQEVPQSETTPFYP
RSPYAVAKLYAYWITVNYREAYNMFACNGILFNHESPVRGETFVTRKITRAVARIALGLQ
EKIFLGNLDAQRDWGHAKDYVRMMWMILQADEPEDWVIATGKTTSVRDFVRLAFAEVGIE
LKFVGKGINEKGVVTYCHNPDFKITTGTEVLSIDPRYFRPTEVELLVGDASKAKNKLGWV
PEFELNDLIKEMVESDLNLMRKEQCLKDVGFTVMNYYE
>IFAGANLK_01402 GDP-L-fucose synthase
MKKNAKIYIAGHTGLVGCAILKQLEFKGFSQIITRTHKELELMDCIAVEEFFREEKPEYV
FLAAAKVGGIIANNNYRAEFLYENSMIQNNIIHHSYLNNVKKLMFLGSTCIYPKNCKQPI
KEEYLLTGPLEYTNEPYAVAKIAGIKLCESYNLQYGTNFISAMPTNLYGPADNFNLETAH
VLPALIRKIYLGKALEEDDWFKIKEDLNSRPIEGINGNAKKTEILSVLEKFGVRIKRAKY
QIDNSKKVVSIEIWGTGTPYREFMWSEEMAEACIFLMENRNFQDIVSIQEDNESAIQEVR
NTHINIGTGKEVSIAQLAEMTKRIIGFKGEFFFNTEKPDGTYRKLTDISKLEALGWKAQV
ELDEGIESLYSWYKYSIYKKMESKLKA
>IFAGANLK_01403 hypothetical protein
MKDLLQSISIKIESGSFITKGQIRLISSFLVGQGVVQFVQLFTGFLLIRWLTVEQYAQYS
VAFAFQSTAQVLVELGFSGSVIALVGSRIYDKEVLGGYIKAGKFFRNRLFAVVGATCLVG
FPVITAHHNWPFYITLLLLIAILSNLYLSGNSAFYATPLIIHAKLKNFYRIQLKSALFRL
SFLGILALFSIINAWLAALGTSFLIWYNGKHYKNRSQEYIAEPSSSPSETKKEMLQYVKP
VMPGIIYSAFSAQIALFLISIFGNTQNIAEVGALGRVGQIFFILNAASSTLIVPFLARQP
NEGLSKKYFSIISGALAIAALLSIIAFLFPQPFLWIMGSKYDHLDREVGLLVLNSAIIFL
NVVMWDMNCSRKWLWYWIPIVSISSNILLQIFLIFKMDLSTTYNVLIYAIILSVFNLSNK
VLVGFIGLKKTKDEVNLLSEGS
>IFAGANLK_01404 Exopolysaccharide glucosyl ketal-pyruvate-transferase
MKLIYFQKVPNFGDALNPLILNRFFPGFFDANKDEIFLGIGSILHLEFPPETRKIVFSTG
YAYYGDLPKIDKSYEISCVRGPLTAKVLGLDSKLGITDGAALLREMYFPNEIKIFDYSFM
PHHASIHFNDWKRICKEAGYNYIDPAGDIQVILKQISQSKVVIAEAMHGAIVADTLRVPW
IPVKLYPTINEFKWRDWTESLALEYRPNNLPSIYSSQMIIQKITAKFKAKEKDLHVRGMS
KIYETYQDNFLNRNVVKQFVGLKSKQQFLSSERLLDRKIEQLLEKIEMIKSTYGFLQKSK
>IFAGANLK_01405 Chondroitin synthase
MSNLKFSVIIPTCHRNELLAECLERLSKQYYSLGEIEIIVTDDGEISTAESMIELNFPFV
KWTKGAGRGPAANRNNGARVAKGKWLIFTDDDCLPDPNWIKEYDKAEQSNPGIMVFEGRT
YPDKLKMAFNEVAPINETGGQMPSCNFMVSRELYWKLGGFDENFKFYFEDMDFSYRIKSL
GFSSLFLPKAAVCHPWRKVDSLNFWKTRKFYKESYWKFIIKDEDLFKAHSPFFFLKQLIK
DIVLDTLANFYKFKGRGILFNLSHRAIHLDLLIRTLFVTQEELQKIRKEYSPNHTSQV
>IFAGANLK_01406 hypothetical protein
MNLFLTSAYPYHHSQNFAVSWLKESARLDTFKEHSVSDDPDAADIILFTEHHPPEDPYFF
KVLKNDLYKQYPHKSILYTDIDKPLPLLPSILPSIESRYYRKRLVRSGPYIAKQYKNESV
LFREESTEREFLFSFIGAARTHTIRQRILDLNYSNSFVKDSSAINLWELDSNTKKIVEKE
YADVSLNSHFILCPRGEGVNSYRLYEAMEMGITPVIISDDWVPMRGPDWDEFSLRVAEKD
IQEIPDILLEKKGEARKMGRLARKNWEMWFSKEVCFHHIACMCEDLMKSRESGINKKVYT
YSQFLRPFHTRNLLRFYKNSLL
>IFAGANLK_01407 hypothetical protein
MNILFICGCLEGGKDGVGDYVQILAKELLLQQHEVAILAINDPFLSVNEEEKIETILSLR
LSNKKSWGSRVIKSREWIDEIKPDHIMWHFVIYGYHPRGFSFRPIHIINKLLKNYSQVSI
MFHELWIGAAKEDSIKNKIIGEIHKLIIKYLVWDLKPVKVFTSNSTYMGLLSKEGIPSFL
LPIFSNIPYIPGAEILFEDILNARGIVNTEESLKLGIFGTIPFVWQKEKFISQLKKTKSS
ITLFIAGRSNQYTAAELKDDLKKEIPSLNIIILEEQPPAIISGFLQYIDMGITLTAPQLL
EKSGVYAAYVEHGLPILFAGLDKNFNCGNKDLVDDNHHLKWELDGFPEQVKMEKFTPRNI
KEKIARNILEIIGEAQSKVSIPLIKM
>IFAGANLK_01408 Chondroitin synthase
MKKLTVAICIPTYNQAEYLKRSIQSALDQTFPEISVYVCDDRSTDNTKLICEKFNAEYSN
FYYQQNDENLGIAKNVNKLLRWPKTDFIVRLDSDDLLHPNYVKTLLSLFEKYPEAGVGHV
NVQQIDEHHHFTRKRLLARQKEFYSAEKSLRESIYGYKVAANICMFRRNVLEELNFTSGR
PEYTEDYDLWVRIADANWGNVFSSKILAYYRVWVDKNNYRISLQRKEAELIGYQRLFDEC
VEPAYKRRNWSENIIKTQREKFALEHAFALKSSYFTKSEKDIITQRVLNIYDSKKVRSRI
SSYLNPGSLGAKYYSFKRKLIVKIKDLIKGSQFFLRKSKAA
>IFAGANLK_01409 Glycogen synthase
MKIIVSHPNSNQFNRSALQGFLEKDMLSEFHTGIALFPNGLLDRLASFPTFSEIRRRSFS
PDLKNYTHNWPVLETGRLIAGKIGATFLTRHEKGIFCIDSVYNSLDHRTSLRLKEAKKRG
AKGVYAYEDGALKTFREAHNLGLSCFYDLPIGYWRTARELLELEKERWPEWSATLTGLKD
SEEKLIRKDEELALADRIFVASSFTAHTLKNYPGNLAPIEIIPYGFPPPISTRKYEGINN
LKPLKLLFVGGLSQRKGIADVFAVVDKLQPHVTLTVVGYKASDNCRVLDENLSKHKWIPS
LPHSEILKLMRDHDVLLFPSLFEGFGMVITEAMSQGTPVITTERTAGPDVIIHNENGWLI
KAGSTIALEECLDYLLQNPKSISEVGKAARETAKQRPWSVYGKELATAISEHVGKANASK
LRI
>IFAGANLK_01410 hypothetical protein
MRIILARLVDENDPYRLLKLGIWGYFFLLLFEGALRKWFLPGLAAPLLIVRDPVALFLLF
HAWRRNLLPPSIYLVGMLGIGMFAFVTALIFGHGNLAIGIFGARILMLQFPVIFVIGKVF
SHEDVIKVGKIMLWIAIPMIVLISLQFYSPQSAWVNRGVGGDMEGSGFSGAMGYFRPSGT
FSFTTGNTMFFSLLSCFVFYFWIGGIKVNRLLLIAATIALFIAIPLSISRSLLFQVIIGV
TFAVLASIRNPKYAGRIIGAGIAGFVILSVLNNVEIFQTSTEVFTSRFETASKVEGGLQG
TLVDRYFGNLISAVSGSSAERIPFWGYGIGLGTNVASFLLTGGRNFLVAEDEWLRLMGEM
GFLMGFGVILIRLGICLQMALASYQRLKTGDFLPWMLLSFCLLIVPQGQWAQPTTLGFAI
LIGGLLLASLNVEDEKITHHF
>IFAGANLK_01411 D-inositol-3-phosphate glycosyltransferase
MNIVFFSHPSFIAHKSMPRFTRLLDEGMRERGHTTRVWSPRGRFYYLPMVEKFKKWLGYL
DQYLLFPLEVYFKVKKESADTLFVFTDHALGPWVPLVFNRPHAIHCHDFLAQRAALDEIS
ENITGWTGKKYQAMIRRGYSRGRNYISVSKNTKRDLHRFTSSTAGVSEVVYNGLNNSFKP
MNVFKVRIDLKEKTGIDVCHGYILHVGGNQWYKNRRGVIEIYNAWRIKFKKDLPLLLVGE
KPDELIRNEWQSSSFKKDIHMLDSFSDEWLKKVYAGASVFLFPSLAEGFGWPIAEAMASG
CPVITTREAPMTEVAKKAALYVPRKPSSSLEVMKWSENAAEVLEKIISSSSTELEMIKER
GIQNARRFNSKDALDKIEKIYLDILKSENN
>IFAGANLK_01412 Alpha-D-kanosaminyltransferase
MRLLHAIDNMNPERGGVCQAVRTVISGLSEYEVANEVVCVNSPDEDFILKSDFKVYALGP
SDKFWSYSAKLMPWLRKNFSEYDAIIVHGLWQYPSYAFEKIRKELEGRGDFRQNLPKLHV
MPHGMLDPYFQTAPDRKLKAIRNKIYWELIERKIVNNADAILFTCETECLMARIPFKPYH
PKEEIVVGLGVEAPPEFIPEMKVSFKEQCKGIENNDYVLFLSRIHEKKGVDILVEAYADL
LNNGGKAKISASKIPKLVIAGPGLASEYGKKVQNIINHNPALKENVFLPGMLSGDAKWGA
FYGCEAFILPSHQENFGIAIVEAMACRKPVLITNKVNIWREILNSDAGFVEDDTLIGVSN
LLERWWALDKERKDDMAKNAKINFEEKFAISKASSRLFEVLSKSLTNMEGVDF
>IFAGANLK_01413 Galactoside O-acetyltransferase
MVMDAKAISKVKLNEFDASIGLDRGASRIKEVTWYLFKMLFFLTAFPFPSSLKVSLLRLF
GAKVGKNVILKPRVNIHFPWKLEMGNNVWIGEEVFILNFEKINIGDNVCISQRAFLCGGN
HDYRKPSMPFRNGPINLENGCWIGACCFIGPNVTIGIDSVITVGSVITSDVKNNLICKRT
GSDFEKERWKNTEEVVNLF
>IFAGANLK_01414 UDP-glucose 4-epimerase
MKRILITGGAGFIGSHLCERLLKEGNEVICLDNYFTGSKKNIIHLMKNPLFEVIRHDITT
PFFIEVDEIYNLACPASPVHYQYNAIKTTKTSVIGAINMLGLAKRIKAKILQASTSEVYG
DPQIHPQPESYWGNVNPIGPRSCYDEGKRCAETLFMDYHQQNDVCIKIIRIFNTYGPNMN
PNDGRVVSNFIMQALKGEDITIFGDGSQTRSFQYVDDLVEGMIRMMNTEDAFTGPVNIGN
QKEYTMMELAENILELTGSDSKLIFKSLPQDDPQRRQPDIHLATAKLNGWKPEIQLKEGL
SKTIQYFEAIYHGTPLKERNLSLHLVK
>IFAGANLK_01415 hypothetical protein
MKTSSLTLSFAAFMHLIVIDSICFFLSSEIAMNLNIIAGYNILWVILIVLIGAQAYNHER
A
>IFAGANLK_01416 PGL/p-HBAD biosynthesis glycosyltransferase
MRISIITIVYNRQYCIAECIESVLNQSYDDIEHLVIDGGSNDGTQLEVEKYQDKLGYYIS
EKDEGIFDALNKGIKNATGDLIGILNSDDFFYEADTIKKVVEAFKISNADLVYAKGLFVD
QKNPEKVKRMYSSKPFNKRFLFFGWIPLHTTIFVRKEVFQIYGMYNSGYTIASDYEISLR
WFQNDDIKKYFLNEWVVKMRLGGLSTSMKLQIKKSKEDLRIIRLNRLSGFFTLFCKIGRK
VPQYLIPQFRSLTSIFPKA
>IFAGANLK_01417 UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase
MKWSPFIMPFSLLAHLVIINVFLHLLNPEFYSNILAIIGFNLAWILSALCLNFYVVERKE
RFRTKFNKFLRHYLLFCLAYFSVFAFLKLELVIEYQVFTLVFLLLILTFYRWFFFSVRRL
YRLEGGNYQNVVIVGNDKNMGIIRKVFDEPDFGYRYKGFFHNKSSDNKDYLGNVESCYDF
ILKNNIDEIYCIVSQLSNEQLNRLISFADNNLKHLKLIPDNKEIFTRSMNVELFGTVPVL
NLRKSPLEKNYAKYGKRIFDVLFSIFVIVFILSWLIPLVFILMKIESKGPLFFKQLRHGY
NKKPFWCYKFRSMAVNKLANERMCSRNDPRVTKLGRILRKTSIDELPQFINVLKGEMSVV
GPRPHMETHTLEYAGTVDKYLVRHFTKPGITGLAQIKGYRGEISCKSDIINRTRFDIFYL
EKWTPLMDFKIIYQTIYNAVLGDEKAF
>IFAGANLK_01418 hypothetical protein
MKFNSTLKRLLLSGILCILLYSCVSRKEMVYFQEIEQLRKNEAKRSGNNLEIQPDDVLTI
RVSAPEQEAALPFNLTKSITSQDRIMGEVELETYLVSDEGTIVFPVIGELEVEGYTNIQL
AKKIQDLIAEYVKDPIVNVRILNFQITVLGEVKNPGTFFIDDDHISITKALGMAGDLTIF
GQRKNILVMGEDGDHKTYAYLDLTDAGVVNNPHYYLRQNDVIYVEPRGTRRQSAGSTGLA
STYLSIISVIASLIILITK
>IFAGANLK_01419 Tyrosine-protein kinase ptk
MENNINKAHMDKINMRKEITKYLKKWPWFILCIIICGAAGYTYLRYTTPQYLAKTQIILK
DDSSKNSESVIFKDLGIMSTAGTKSIENDLGILRSRRLMNEVVRSLNLYIQYYIEGEFND
IELYENVPFSIHVMGFDENLLKQNGGGRFEVWRSSNKIYKIKNLQTGRIKEEEPGNTIDL
GFAQIIIRPRENNRDYEGKTIVQFSEINKIAANYRNKINFTQADENSLLIGIELTDPVKE
KARDILDQLIMEFNRSAIEDKNLIAGNTFDFINERLAIINEELDSVETGKKIFKQQNQLT
DIHAESQMFIQNASDYNKKRQEIGTQLELSNAMLEYISSNSDGNLLPSNLGLSEGGVNDQ
IDEYNSLILDRNRLLAGSSEKNPMVIKLNSQIDQIKANVVQSLNRARSNLLISQEDIQRQ
ASSIGSKIYSVPTKELQYRGIERQQSIKETLYLFLLQKREENSLAMAITEPKAKIVDRAY
FSDYPISPNSRSVYMGTFILGLFIPFSLIYITGLLDNKIRKRVDIESMASNIPLVGEIPK
MKQKLKLIKSNDRSVLAEAFRILTTNLQYLLITKKNKNSGITFLVTSTIKGEGKTFTSIN
LSITLANTSKKVLLIGGDLRNSKLQPFVINKSQKLGLCDYLADDTLTLDCLIQKSSLNAH
LDILLSGNYPPNPYELLKTEKMGVLIEYMQKDYDYIVIDTAPSLLVADTFLLTKFADIVL
YIVKAGFTDKELLEFPQRAKEQEKFSKIAFILNHVSKAHLGYGNNYGYGYGEAKERSWSK
GYKSTVFDI
>IFAGANLK_01420 hypothetical protein
MNRYFLMIIISIFCVSFTQAQEYSFGVKGGGNYVMGGELTGLDSGEGFNSDTFNAEAQFG
FHAGIFFELNFGKFFVRPEVIYNSMETEFPFPDQNSTYAVEKLSIPLLFGYNVWGPVDVY
AGPAYQNIMNATLEGTEPINQTIVAQNTPLAAQAGIKVGFGRFEIDFRYDRSLASAETQS
IDINNGDYGVNRAEFTDTRLNQFLVSLSFKIGDSESNTGRRRGGGCYF
>IFAGANLK_01421 hypothetical protein
MKDLYSIKPKKRKRLILLLSAFFALLLITEIIEKRSLKSIDQDISSLYQDRLLPASQIYE
LSEILHEKRMLFEDIKDNGEYNAAFNLMEIKAYNSQVDQVLKDYGKTYLVEREEVYFQDF
QKHYEEYLVLENTILENLKEEDFTTAIYLINKNATDYFKILNVDLHNIASIQPEIGEQLM
AHYKTSSGITSLLYYFKIALTILIGIFVLRLLGLEKLLRQPKQQFELN
>IFAGANLK_01422 Catalase-peroxidase
MEKNDHRNHPDNHKVWEVNESSRCPFMGGALDKTAGSGTSNRDWWPNQLNLSILRQHSNL
STPMDEDFNYAEEFKSLDLKAVKKDIFELMEDSQEWWPADYGHYGPFFIRMAWHSAGTYR
IGDGRGGASSGSQRFAPLNSWPDNANLDKARLLLWPIKQKYGRKISWADLMILTGNCALE
SMGLETFGFGGGREDIWEPEEDIYWGSEGEWLGNKERYSENNELESPLGASHMGLIYVNP
EGPNGNPDPVAAAKDIRETFGRMAMNDYETVALIAGGHTFGKTHGAGDAEQYVGAEPAGS
AIEEMGLGWKNSMGKGNAGDTITSGIEGAWTNTPTKWSNSFFDNLFKYDWECIKGPGGAY
QWKPKGDAGAGTIPDAHDPSKSHAPFMLTTDLSLKEDPAYEKISRNFYENPEEFAEAFSK
AWYKLTHRDMGPLSRYLGPEVPSEELIWQDPVPKVDHEIINDKDVAQLKKKILDSGLTVS
QLVSTAWGSASTFRNSDKRGGANGARIRLEPQRHWEVNNPPQLQQVITKLENIQKEFNDA
QTGNKKVSLADLIVLGGCVAIKKAAADAGFDIGVPFTPGRTDATAEKTDVEAFEPLEPNA
DGFRNYARNRDNISASAEEMLVDKAQLLSLTPPEMTVLVGGMRVLNTNFDGSKHGVFTDR
PGQLTNDFFKNILDMRTTWKATSDAQTEFEGSDRTTNSVKWTGTRVDLIFGSNSELRALA
EVYGCEDSQEKFVKDFVKAWDKVMNLDRFDV
>IFAGANLK_01423 hypothetical protein
MKALTNNFYKPVFVIVLLLFASCGSMQNTEDDLRSDATDARNEIRQNHTNAAEMLDNSAG
YAIFPNVGKGAYVIGGASGNGVVYQGNNIIGYADLKQVDIGLQAGGKAFIEVLFFETDAD
LERFKEGDYELSANASAVILDKGASRDIDFQDGVAVVTIPKGGAMAGVSVGGQRFSFQPR
>IFAGANLK_01424 Sensor protein ZraS
MAPESISVEEKLQERIKELSCLYQVSSAIREFEGSYEVTLESIVQILKSAWRFPELATVE
IRCESYHLSSNPIPKEGYSQKSIIKISKNEIGFIKVHYPAADLSKAHFLVEEQRLLDKIA
DEIALFFERQNIKVQEEHLKQTAARNDRLAILGEITAGIAHELNTPLGNILGFAEFIEEK
TAEKQTKRDAQKILNSAIYSREVVKKLMFFSCDMPQDIKKIKVKPIITQALSLLKPNFKK
ANIRFKFNIQDPVLKAQVDPIQLTQVFFNLVINAIYYSPENSQIVISIYSNESHYTIEIA
DEGKGIDHKVKDKIFEPFYTTKPLGEGSGLGLSVVHGIIKSHKGEISIASNIPKGTIFKI
KLPLNF
>IFAGANLK_01425 Transcriptional regulatory protein ZraR
MSIRKENLLIVDDDYDMLEVLDRHLKQENYHNYKAGSVMEAIDILKHSSIDLLITDLQMP
GMNGMELVKYVDDHYPEIPKLVITGYPSIDNALTAIKSGALDYLPKPFTKSELLTSVKKS
LVNRPSTQKSTATKEIRTNYGGMVGSSAKFEELVDIIERVKNNRATILIRGESGTGKELV
ARAIHYKGSFAQNPFIAVNCGAIPENLLESELFGSTKGAYTGASETREGYFQAANGGTIF
LDEIGTASLAVQVRLLRVLQEKEIRKLGGRNSEKIQVRVIAATNSDLREMVEKGTFREDL
YYRLNVVDILTPPLRERKEDILPLAKTFLDKYQRDYGKTGLKLSEKTLEILKRYNWPGNI
RELENVIQRAIIMSEDEILPQDLPASVKYQVPAVDDELVALKEVEKKHILKVLAAVDQNK
SKAAEILQIDRKTLREKIK
>IFAGANLK_01426 hypothetical protein
MNIVEMERPAVVEETEKELEQAGSELFKTLCFNCDLRHHCSWKDNRKMYCEHFQ
>IFAGANLK_01427 Glutamate dehydrogenase
MIATKSMPKQSMYDTVIKQFNKTADIIDLNPNIKKILEITNNEIVVHFPVKMDNGKVEIF
TGYRVQHNNALGPYKGGLRYHPTVDVDAAKALAMWMTWKTSLAGLPYGGAKGGIQIDPRN
YSDGELERITRRFTYALGENIGPEHDIPAPDVNTNAQTMAWIADTYMSTISTSERSQNQH
VVTGKPVGSGGLEGRDRATGFGVYLTTKELVKSRGESLKDKTFIVQGFGNVGYWASKFLI
ADGAKMLAVQDAHATLYNEEGISVEKLFEHSSPRKGSIQGFTDAEEMNPEDFFGLECDIL
IPAALGNQITGENAFKIKASIVAEGANGPTNEEGEAILLEKGITIIPDILCNSGGVIGSY
FEWLQNRNGELWELDEVMQKLEKKLLQVFKKVEKEVEERKTDWRTAAYILAISRIETAYN
QRGIFP
>IFAGANLK_01428 Regulator of nucleoside diphosphate kinase
MKYDVIIIEKVEYELLKRIVSMAQYYKDSTYRASIEKLKNELDFAKIVSEKNMPEDVVRF
NSKVEISTPFGVNRTYQIVTPDHSNIKENKISILAPMGLALFGYAQGDKVEWEFPTGKNA
VNIIKVEQMAREMKMQK
>IFAGANLK_01429 hypothetical protein
MMEKFQEHHNDEEIQILSIQSESEDWEEHLIYISEEINFFSNILKSGLKETIEVEINRED
ASYLKKQLDLLNKANEFHLTTFFDYKNKLEGLKECDDVQCENFYLKDHLVFKNTLRKHFK
DFRQLKILIFKFLKVSFN
>IFAGANLK_01430 hypothetical protein
MKLIVRIGLALALVFSFAACGDSEKEEKENLRLDDYSSKPQEKETETTEDEGDSEDDLSN
KGIGPIKSMDLPESIDSDMAANGASIFKNMCSACHKMDKKFVGPAIEGVTERRSPEWIMN
MILNPEEMIKKDPIAKRLMVESNMAIMADQGLEEDQARAIVEYFRQYDAEN
>IFAGANLK_01431 Nitrous-oxide reductase
MKKITNFIAVFALAAIFTSCNQNDEGEKSGAMASSAAEKVYVSPGEHDEYYAFLSGGYSG
NLTVYGLPSGRMLKEIPVFSQFPTNGYGYSEETKDMLKTSFGMVPWGDSHHPDISQTNGE
IDGRWIFINENNTPRIARISLETFETEEIIEIPHSAGNHSSSYVTENTEYVVAGTRFSVP
YPQRDMPIDEMKGNFKGPLTFIAVDDDGHMEIDFQVDMPGFNYDLSHPGRGESHGWFFFT
TYNTEESHTMQEVNASQNDKDFIAAVNWKKISEYVENGGGEIMDAEYVHNVFDHDTQTTI
STTKNEVLKVDPRDIPGAVFFMPTPKSPHGCDVDPSGEYIIGNGKLSSDLTVHSFSKMLD
AIDNEEFDGDAYGIPVLKFESTLAGTVKDAGLGPLHTEFDDKGNAYTTFFISSEVVKWKV
GSWEVLDRQPSYYSVGHLMISGGNSRKPDGKYMISLNKITKDRYLPTGPELEHSAQLFDI
SGDKMELLLDFPTHGEPHYAAAIKADKIKENSKKIYRLDENNHKYAALNEGETKMVREGN
EVHVYMTTVRSHFAPDNLEGIHVGDKVYFHVTNLEQDFDVPHGFAVIGANTSELLIMPGQ
TKTITWEPKKPGVWPFYCTDFCSALHQEMQGYIRVSAEGANTPMKWGLDDEYTSN
>IFAGANLK_01432 hypothetical protein
MKRSAILMILGSLLLLGLFYFPLWNIQLGAPQYPDPMGMNIFISGIEGEEEFDIQNIDGV
NHYIGMKKIPTPAEMWEFQVFPIVIGGMAALGMVIGVLGFFRKIHPSWFLGWFILMLVLG
LLGMYDFNNWLLDYGTDLDPKAIIKLTDPEGNPINYKPPLFGTQKILNFTAHSYPRTGAY
LMFVGMTLTLGAWWIRKKALKTIK
>IFAGANLK_01433 hypothetical protein
MKFSFYILAIVFVFSACNFEPEPINYGEDNCHFCQMTIVEQAYSAQMVTDKGKQYKYDAI
ECLVNDMNQREYQTSFLLVSNYDKPGKMLPVSEAEFVQNDSLRSPMGANLAAVKKESRDS
DELQDWEELKNNFK
>IFAGANLK_01434 hypothetical protein
MKAVLFIFLSFVSFSFYATEITVCETCEIKSIKKAVEVAESGDTIRVKPGIYKENDIVIK
DKSITIIGDDFPVIDAEMQGTAISISAEAFKIEGFKIINIGRSHTSDFSAILVSNSTNFE
IKNNRFDNIFFGILIERSNNGRIIGNRVTGKAKSQAHSGNAIHLWKTEEMHIENNYLEGV
RDGIYLEFTDDTEIINNVCKNNLRYGLHFMFSDGNTYSGNLFENNGAGVAVMYSKEILMY
RNTFKNNWGSASYGLLLKDITDSELKQNTFEENTVGISADNTNRINYIENDFKSNGYAVK
IRGGCYNNVFERNNFLYNSFDLTYNGHSNENTFNGNYWSNYSGYDLDKDNFGDIPYRPVS
LFSYLVDKTPESIVMLRSLFIDLIEFSEKVSPIFTPANVLDEQPYIRKIQW
>IFAGANLK_01435 L-cystine import ATP-binding protein TcyN
MVTVTNLHKRFGSQKVLNGLNLETHLPGIIAVLGPNGSGKTTLIKSLLGMVIPQKGEIAV
NGKEIRRQSDYRKEIDYLPQIANFPGNLTVKELIGMIKDLRGKPARDKELIAFFGIESFL
DKKLSKLSGGTRQKVNIVLCFMFDSPLIILDEPTSGLDPASLIKLRELLQKEKAAGKTII
ITSHIMNFVEETADRILFLLEGVIYFNGSITELKTQTGQDDLEHAIAQILT
>IFAGANLK_01436 hypothetical protein
MFKILKYSFFDLFRSRWSFVYFFFYLLLGLVLLFLNNDLSNAIITLMNVIIVLVPLIGTI
FGIMYFYNSREFTELLLAQPIARKHIFLGQYLGVAISLALSLVLGLGIPFIIYGLFESSA
IWDFFSLLVVGSFLTFIFTALSFGIALRFENKIKGFGMAILMWLFLAIIYDGIFLLLLMY
FQEYPLEDFALAASVLNPIDLSRTLILLKLDISALLGYTGAVFKSFFGTTKGSIISFGVL
LAWVILPIWGMLRLASKKDF
>IFAGANLK_01437 cAMP-activated global transcriptional regulator CRP
MVAENILLEFGASRETYHKGDQLFREGEIALNFFQIISGEIKMNNYNADGKEFIQGMFSD
GQTFGEPPLLADVKYPANAEAIKTSEVLKLPKLNFLELLTKHPETHLKLTRTLAERLFYK
AIMVSEISSQDPEHRIIRILDYLKRYVHQIEGQFKFKVNLTRQQIADLTGLRVETVIRAM
KGLEKKGELKIRSGKVYR
>IFAGANLK_01438 hypothetical protein
MLRLDLKTHHNIALAYFLLAALLGIFLRLFYVTPLPGNYKYILHAHSHIALLGWVYLALT
GIIYGLYFHKTKLSKKYIYIFLATNISLLGMLFSFPFQGYAIISIIFSTLFLFCSYFYAA
FVLRNIPHKHSKTLSFKLIKASLWYMVFSSIGPWALGGIMSTLGNTSIWYKLSVYFYLHF
QYNAWFLVALLGILFYLFQKLNLDFGRKEFKRFFLLLNSGVILSFFLSTYWTNPPLVFYL
LGGLGVILLLIAFYQLFAFILRNKNLLKSVLSTFNYRILLISGVLLVGKILMQSLSAIPF
FADLAFNNLDFVIGYLHWVFLGFVSLALFAFLNWLKLIRIPKNAFYLYLSGFLISEILIF
YKGLVLWLGLPFFSNYFLLLVLVSALMPIAVGWIVGVNYLGASSRGIH
>IFAGANLK_01439 Iron-sulfur cluster repair protein YtfE
MNTETVKTVADYVTENIKNAHLFKKHGIDFCCGGGISLAQAAEKANVSLEVLEKELEDTA
SVTSPGYDFKAWKLDFLTDHIINVHHQYVEENIPLLIQYAARVAKVHGHERPELKRIQQL
FTEVAQELSAHLKKEELILFPFIKKLVRAQEEGTPVPQPQFGKIDNPIKMMETEHDDAGA
IFKEISELSDNYNYPEWACNTYRAFYAKLEEFETDLHHHVHLENNILFPKAIELERRLNG
>IFAGANLK_01440 putative ATP-dependent helicase DinG 
MKDVKFAITDIETTGGGIKGNKITEICVLVVQNGEVIDEYSSLVNPGTEIPLYIETLTNI
TDNMVADAPKFAEIAPEIDKITKDCVFVAHNVNFDYNIIKAEFNNLELSFQRKRLCTVRL
AKRLIPGLFSYSLGNICTSINIPHVDRHRARGDCEATVTLFQRCLDLDPEYEVFKAFLNQ
RTAASYLPPNFKNSDFEKLPASTGVYFFKDKDGIPLYIGKAKNIKSRIKSHFQEKSNRKY
KLMQATYSIDYELTGSELLALLRESALILKHFPEFNKAQKKVSRPYTLTSYHNQKGIEQF
VIHKNKVSPVSWMKFYTREEAIKFLENICTEFDLCPRYCGLQTGVSHCSHYKIVNCSGMC
KGEINKEEYNRRVSEAVEYIQQYENSCLLVEKGRTKAEKSFIYLKKGRYAGYGFVENSDD
FNGPGQFEDYLVPQTNSSYADRIVNRYLNTKKNITRLNLNTGEEVEERETEEWFG
>IFAGANLK_01441 hypothetical protein
MSRKKSLSKDREEEIIQMLKTRFEQHKTYFKQVEWPEIEEKLKANPKKLQVLNEMKETGG
EPNLLSYDAKTNEFTFCDFSKESPKGRRSLCYDREALESRKKFKPRNNALDLASEIGIEI
LDEEQYRELQQLGEFDTKTSSWLKTPEEIRELGGAIFGDFRFGRVFIYHNGAESYYGARG
FRGFLKV
>IFAGANLK_01442 hypothetical protein
MRIALIILIGIHGIIHLFGFFKGFGIAEFSAISQPISKTYGIFWFLTFLLFALTVILVLV
HSNYWWVSGFLAVLLSQVLIFNYWSDARYGTIVNLIILLAAMIAFSNFNFKNLIKGERIA
LFENSQLKTREIVTEEALQDLPQIAQKWLTNSGMIGKPLISNVHLVQELQLKLKPEQTSW
NNGTAEQYFTIQPPAFNWNINTKMNSMLSVVGRDKFEDGKGEMTIKLLSLIPVVNAKNDE
KVDQATLERYLAEIVWFPSAALSPYIEWEPINEYSARATMEYKGTKGSGEFHFEEQGVFK
KFVAMRYQNANDTKPTKWTVTATKTEEMNGIKIPVECEASWELESGPWTWLKLKIKEIQY
NVKEMPVATNGNKQSGLGSEDDTNKIGIQTND
>IFAGANLK_01443 hypothetical protein
MIWFNLKKLERLLIQNKITEAISYQYLLVLLVLLTLSSNVPVKYFSHTGWEISYIILDLL
ITIVGTYLLFKVNSNGDNRDFLKRYFSLAFVNALRLIIFYLVLRLIFKIIMFVIPLDLWY
TINDFLGEDAGEFFFDIIFSLIFYWLLMSSFKRVNSGRSEEKVAVQSDVKKA
>IFAGANLK_01444 hypothetical protein
MPHDIIGWIHTIAAIIALITGSMILAKAKGTFQHKITGRIYGVSMLIVCITAFMIYRVHH
TFGVLHVFAVVSTITLVLGMLPMYLKVYKKPRIVHLSWMYWSVIGLYCAFAAEIFTRLPL
IFDLPNTYGFFYMLVGLSAGAVGMIGSYFFKRKQKVWETRFGT
>IFAGANLK_01445 hypothetical protein
MSYLLIPLGIFILVIALIDIFKTILYINGGGRLSSFTARKIWWVYFKIARGKGKAPILNF
AGGTILMALVAMWIFLIWVGYSLIYLSDPNSVVETSTGENANFIGNIYYVGYTLTSLGNG
DLRAGSDFWRIISNIMGMNSMIFISLGISYLLPVLQAVVDKRTLAVYIYQLGRSPKEIIN
KGFNGEDFSPLYSRLQNLETMLLKHGEHHLAYPILHYFHTHKRSHNIRLNLAILDEALNI
QEAYHLDKSANAFTWRVLRGAMDNLAVRLHESYTSLADDPPVFDYFNDLPDELKANFEED
PGIPKDEDFNKRRGKLLGYIKKDGWEWEDVVEEK
>IFAGANLK_01446 hypothetical protein
MKIEAATVEEYIAKVPEDKKPAIIELRNVILKNIPEGFTETLNYGMIGYVIPHTIYPAGY
HANPKLPLPFINIAMQKNFIALYHMGLYADPELLQWFKEEYAKLPLNKLDMGKSCIRFKN
SEKIPFQLIGELVSKMSVQEWVDLYECTQR
>IFAGANLK_01447 hypothetical protein
MEKKILIPTNFTKHAWNTLVYALNLYKNIPCTFYILNAYEVPVRISLKRNHSAELEAAKA
ESENGLQKILQGLNFRKENQKHKFETISRNKDLVEALQEAVNTHNIDLILMVSRGENVSI
NAAFENEISEVTEKVQDCPFLILPEKMQELPASKREIVFPTNYKFPFKNKEVAALIDMAR
NLKASIRILYIDSDGRPLSKEQEQNKEALKTYFSDVDFSFHKLTQTTETTGIHLFIESRD
SNFLALYKRKQGFFSKLFSQRFKEEIDFNPKVPVLILKELE
>IFAGANLK_01448 Succinyl-diaminopimelate desuccinylase
MKDIKSYVEENKDRFLTELIDLLKIPSISADSNYKDSMLQTAEAIKKNLLEAGCDAAEIC
ETPGHPVVYGEKITDKNLPTVLVYGHYDVQPPDPLDLWNSPPFEPVIKETEIHPEGAIFA
RGACDDKGQMFMHVKALEYMTKNNELPCNVKFMIEGEEEVGSEHLGWFIEKNKEKLANDV
ILISDTGMIAKDTPSITTGLRGLSYIEVEVTGPNRDLHSGLYGGAVANPINILSKMIASL
TDENNHITIPGFYDKVEELSKEERAKMAEAPYSEEAYKKKLDIKDVYGEAGFSTLERASI
RPTLDVNGIWGGYIGEGAKTVLPGKAYAKISMRLVPNQDWREITQLFKKHFESIAPDAVK
VEVKPHHGGQAYVTPIDNIGYRAASKAYEASFGKTPIPQRSGGSIPIVTLFEKELKSKII
LMGFGFDTDAIHSPNEHFGIWNYLKGIETIPWFYKYFTEMKQE
>IFAGANLK_01450 hypothetical protein
MPLPEIWFPFNKDSDVDNVVHFLEELPANIKSITDPDNSNFYEVCLYKAELGIDRILYEA
SLKEATEEFLSSLDESKENWSEQNLRRIGFSGESLILKAKILDGLWKKMRDLMKDVWKEY
IDFTNDTVVKWLREFLAFLNSILGSLKTLIPGIDSIKESKEIMETFISITEK
>IFAGANLK_01451 hypothetical protein
MSDKSESLIRNDLYYAVSNGDVVSLRHKFYLIIPPRYSHSGKLPIELYLDKLFGFQNRNY
YLGLYSAAKYFGTSHQQIQKEYILHDKSPLPSVSKGAVKLDFFTVSNWPEKIF
>IFAGANLK_01452 hypothetical protein
MCITAEVGLPYRVKYNPFDVRTNSTGWTWIRAAYLFIAIFVIVQSAFEGEWIGILLGAWP
AVMGLFGLACPEKNCDDGNCNV
>IFAGANLK_01453 Thiosulfate sulfurtransferase PspE
MINKLKELLGIKPPPDYSQLIKEGGIIIDVRTKAEYAGGHIKGSKNIPLQTLNANTNILK
DKNKPVITCCASGMRSASAKSILKSSGFNNVYNGGSWASLQSKI
>IFAGANLK_01454 Thiosulfate sulfurtransferase GlpE
MKAEDLIKNNKGTIVDVRTVPEFQGGSVARAINIPLNEIPLRLDELKELESPLILCCASG
NRSGQAANYLGNKGYDCVNGGSWLDVNYLTSKETEYDK
>IFAGANLK_01455 hypothetical protein
MSYYFSKVLDDSFDEAIDKVTKELKEEGFGILTEIDVKETFKKKLDVDFRKYRILGACNP
KMAHQAISAESKIGTMLPCNLIVQETEDGKTEVSAVDPVASMTAIENDELGSIAQEVRSK
LKTVIERLS
>IFAGANLK_01456 hypothetical protein
MKNRVVRGIAGTFVLVSLLLAVYVNINWLWFTAFVGANLLQSSLTHWCLMDKILERLGVT
DEIRPDQKC
>IFAGANLK_01457 hypothetical protein
MKLLIVTSVAEFQKEILNIFKKANIEAFSRTEIDGYKSSNSVIATMSWFPGEKGGNESLM
FFSFTEKEKIDLLFELVSEFNKNLETNNPIRVAVVNIENYI
>IFAGANLK_01458 Swarming motility protein SwrC
MREGLAGKIAKGFMDSKLTVLLMIVFMVIGVYSSFLIPREEEPQIDVPMADIFVGYPGAS
PTELESRVIRPLEKMVSNIPGVEYIYSTSMKEKGMVTVQFLVGEDIERSYVKLYNELMKH
MDQMPQGSTMPLVKTRAIDDVPVLGLTLWSETYDDYQLRQIANELTHEIEKVPDVSITNK
IGGRSRQVRVVLDKEKMAASGVDFLGVSKMIQASNQQLSSGSFNQNDTEFFVNTGSFLES
AEDVENLIIGSQQQQPVYLYQIAEVIEGPELPKEYVSFGYGKGSAVGSDFSSEYPAVTIS
VAKIKGADAMKIADVILDKVEHLKTNLIPDDVHVEVTRNYGETASHKVSELLLHLIGAII
AVTLVVMLAMGWRGGLVVFLSVPVTFALTLLSYYLLDYTLNRITLFALVFVTGIVVDDSI
IIAENMHRHFKMKRLPFKQAALYAINEVGNPTILATFTVIASVLPMAFVSGLMGPYMSPM
PIGASIAMILSLFVALTITPYLGLIFLREKSKGKETVEEESTEQIEDTRIYKIYNKLERP
LIDNKRTRWIFLGTTMLLLLGSVALFFTKSVAVKMLPFDNKNEFQVVIDMPEGTTLERTA
TVSREISQYLSKRPEVVNYQSYAGTSAPITFNGLVRHYDLRGASNTADIQVNLKDKSERS
EQSHDIAKLLRPDIQKIATKFDANVKIVEVPPGPPVMSTIVAEVYGPDYDKQMEIADKIQ
GILRKTPDVVDVDWMVEADQIEYHFEIDKEKAMRYGIAPQQIVHTMNAALGERAVAHLYD
EDATQRVEIILALAEQEKSTPVDISQIKMVSQTGQMVSVADLVQIEEQVRENSIFRKNQK
RVVYVMADMAGELESPVYAILGMEDKLKEIELPAGYELDELYIQQPELEDDYTVKWDGEW
QITLEVFRDLGIAFLGVIFIIYILIVGWFQNYRAPIVMMVAIPLSLIGIVLGHWIMGAFF
TATSFIGMIALAGIMVRNSVLLIDFVNLRLEDGVPLKQAVIEAGAVRTTPILLTAGTVVI
GAFVILFDPIFQGLAISLMGGTIVSTILTLLVVPLVYYMIERKKYEARDEKPVVVEEKEP
VEVK
>IFAGANLK_01459 Multidrug resistance protein MdtA
MKTKLYILSLLGATTLLFSCGDSPEQNTAENAPAVEVTVKTPSRSDQSFLTFSGKIEAVE
NATLSTRNMGYVTRVNAKVGDEVKKGELLIEINNADLQAKRAQVNAGITEATAAFNNAEK
DFERYKSLFEDNSATQKEMDDITARYEMAKARLEGATQQKNEINAQFAYSNIVAPFNGVV
TAKNVEVGDMANPGMPLLNLEVPGKFEVKASVPESEIASVKQGTEVDVLVKSSGETLKGI
VSEISTSARNSGGQYVVKVALEETDASIYSGMYASVQFPTTARENSEVVLIPASALVTRG
DLHGIYTPSQQNTAILRWVRLGRTVGDEVEILSGLNAGESYISTAEGKLYNGTRLEIR
>IFAGANLK_01460 hypothetical protein
MKNKYIIMILALLPGLWLQAQETKPISRSEAIQLVKENNRKIKISQQEFLESRGDYRQTN
SIFLPNVAVSHTGMTTTNPLMAFGSKLNQGIVTQEDFNPDFLNNPERIDNFATKIEVEQP
LINVNGIYQRKAAKKKMDATALQTDRTVDYMVLEVEKAYMQLQLAQQAVTVLESAQKAAL
ANKKLANDSYKQGYLQRSDVLSVEIRVSEVNNQLQYAKSNVINASDYLAYLLNEPVNTIF
EPTDPLEVSVPVQGNLETVSPDRADIRAMELATEAYGEMLQAVKMSFLPRLNAFGSYELY
DDEVFAGDASGYLAGIQLKWDVFEGYKRFGKLQKSRATYEKARLEYDSYVSRSEMEKNRA
SRAVKDAENNLNLTRLALEQAEESLRIRSNRFEQGLEKTSDLLTAEAQFSQKQLEYAQTI
FEYNYAQAQLEFLNK
>IFAGANLK_01461 Sulfide-quinone reductase
MKTILVLGAGQGGIVTARELSRHSGNEEDINLVKILVFEKEETNVYSPSLPWVMVGKSKQ
EEITERIHRLDASGLEVIKGEIENIDPKNIAVTVKGKQYKGDHMVVSLGVAQTDAFDLRK
YGFNFFTLKGAQDFYTQLKKFAGGEIAILVSSLPFKSPAAPYEAAMLIEDYVGKNNLLKN
TTVSLYTPEAGPMEFAGAEASQELRELLEKKGIKYYPNYELKIVSGNSLEFSNGEIYSYD
LLAYTPKHLLPEVIKTSDLAGKSGWVDVDNKTLETKFSNVYAIGDITHVTAKNGSVLPKI
GVFARQQAAVVAHNIDRKLANQKPDQTFVPEGKYFIEVGKGKASETGGRFSVTGKNDVKM
KTPAQWGHFSKWWDEKSWFFKNF
>IFAGANLK_01462 hypothetical protein
MMNKLHQYFKKSLIVIMEALVFTLQPTPIEPKALLIRVHNINLKNNQS
>IFAGANLK_01463 Subtilisin NAT
MNLKNFKSFAVTAIAAAFFVSCSQDEAREQSMDEELVAPSSADIIEGQYIVVFNEDVTGN
ASSKYPESYTKAQEEVANTTKRVLSEANIPDTELLAVYSKTINGAALKLSLEQVEALRGK
KEIAFIEENRIVQFAPPCGTPNGGPCDEDPGDGDDGGGDSSQDVPYGITRVNGVASYTGS
NVAWVIDSGIDTDHPDLNVDASRGFNAFTSGKDGKSTDDGNGHGTHVAGTIAALNNDFGV
VGVAPGALVIPVKVLDSRGSGSYSGVIAGVDHVAAYGSAGDVANMSLGGPTSDALDNAVL
SASENGIIFALAAGNESSDANTSSPARVNGTNIVTISAMDSNDNWASFSNYGNPPVDYAA
PGVAVNSTWKGGGYNSISGTSMASPHAAGVLLLGSASTDGTVNGDPDGTADAIIVH
>IFAGANLK_01464 hypothetical protein
MNNKILKSVAFLSVFLFMVSCGESSDVVESGTYQGTIEEVEPSKDEIYVKIDDNKTLELY
FNDNTQLTRDGNTVEFSELEKGQKVEVKVEKTEKGLDPISVKIME
>IFAGANLK_01465 hypothetical protein
MRFVHYFTILFFICSSAIAQTDSLSYTEFLDIVISEHPVVSQAGLVRNIGDAEVQSARGA
FDPRFEVDYKEKEYKGTEYYDLLDAQLQVPMWYGIKLKGGFQQNQGTYVNPQNKVPEAGL
FQAGVVLSVGEGLWINSRMAGLRKAQAYREQSRAEQQLIINDILLDASFVYFDWLRAHQK
LQIFEDFLENANERYRGIRRGAQTGEVAGIDTVEASLNIQKRRLQANQALVELRKKRLEL
STYLWNQDQPLILEEQVSPVSTEEVFRTLISEIPEANLDTHPQLEFYRRKIEALQIEKRY
RINQLLPKIDLEYNFLSEEPDNFETFNASAYKAGVKFSMPLFLRRERGDLKIAEYELQDA
RLELNLKDNQLQAKINALEQQLQAFLEQIEMTEQMVVDSNVLLQAEVRKFNFGESSIFLI
NTRETRFIEARLEQLDLQVKYLKTQAEYLQALGGNPVQ
>IFAGANLK_01466 hypothetical protein
MLNISEEKLNERIDLSDSRSGKFVFNRKHYTIFNKVLIGMFLLFIIILFLPWTQNIRSSG
NVTTLSPEHRPQTIQSPIPGKIEQWYIDEGDFVNRGDTILRISEVSSDYFDPLLINRTSS
QIDAKSQSADSYDQKINALRQQLDAQQQERELKRSMATNKLAQAGLKVRSDSIKLEAAKT
EVEIARTQFERMQTLQEEGLKSLTDLEARRLRLQEAQAQLIAQENQLLASRNEVINAEIE
INRISAEYADKISKTRQEIFTTQSNQFGTLAEVDKLQIQLSNYEQRSSLYYILAPQDGYV
NKALRAGLGETFSQGEQLVGIMPSNYQMAVETYVRPLDLPLIHVGEDVRIQFDGWPSIIF
SGWPNLSYGTYGAEVVAVENYISKNGKYRVLLAPDPEDNPWPEQIGIGSGAQTIALLENV
PIWYELWRNLNGFPPNYYEPETGGNTENQAAKNNNKK
>IFAGANLK_01467 Alpha-hemolysin translocation ATP-binding protein HlyB
MSKTKPGTPVKRLWNLLKLDKRDVSHILFYALFAGLINLAVPLGIQAIVNLIQGGKVSTS
WVILVILVTLAVGLVGVFELLQLRLAENIQQKIFTRSSFEFSYRFPKIKSEALQNIYPPE
LANRFFDTIKVQNGVSKILLDLPAATVQVVFGVILLSLYHPFFILYGLLLVLLLYIVFKF
TAEKGLKTSLDESKNKYQVAHWIQEVARNLNSFKISGRSRLALDKNDRLTEKYLREREEH
FGVLKIQYIKLIVFKVLVAGGLLAIGGMLVLNQQMNIGQFVAAEIIILLIISSVEKMIRG
LEDIYDTLTSLEKLGQVVDKPLEPAENQNSVNPVNGIKLEFKDVAFEPEGYSVLKGINFT
INPGKYLVITGPPGNGRTSLLKLIAGIFSPTKGKIYINDLARHTLVLNEYRQYLGTLLPD
EIPFEGSLWENITFGDESISDQDIDWALEHSGLKEFVREQNNGIYTQIHPEGRYLSTLIS
QRIILARAIVKKPAILILKEPFTKFEPQEKKRILKFLTDPQHKWSLIVASNDDLWKDICD
ERLELEDGKIVKSL
>IFAGANLK_01468 N-acetylneuraminate epimerase
MKKYLLLSIFCFSVLSLNSQSWKTLPANEEAQERHENAFVQAGKRFILIGGRGNKPIDIY
DTENQKWKKGAQPPLEIHHTQAVSLDGLVYILGAFTGGWPDEDPIPHIYIYDPLEDLWIK
GPEIPADRRRGAAGVVVKDKKIYLINGITNGHTSGWVNWFDEYDVYNNKWKKLLNSPNER
DHFQAVITGDILFVAGGRKSGSVEGNGFAGTVKATDVYDFEAEEWKTISEIPTPRGGTAV
GLLDHNPVILGGESDAQEEAHNEAEIFDFAEGKWDSLPPLKEGRHGTQAITINKQIIIGA
GSGNRGGGPELNSFEVFAQDNSLNFSTDAILAGELRASEDNLDFSKEETKSLRISHKGGN
QAIVITKINISDNFNIVNKKSLPFILAPRSEFELKIKGNQNTGELIIKRAGKKEDLKVTL
NRKNDK
>IFAGANLK_01469 hypothetical protein
MKLKALFLNCTLKKSPKTSNTEAFIEEAEKVFKDLDVYTEIVRVVDHDVKFGVTSDEENG
DEWPKILKKVKTADILILATPIWRGDRGAVAKMVAERFDGIMEEGSEENGQFPTYNKVAG
VMVDGNEDGAKKAISSMVFDLSEHGFTVPVNGFCYYVGEAGPGPSYIEAGGNKHEFTNNM
MLLMAHNLVHLAKTLKENPYPTDVKKLEEKAKEMSK
>IFAGANLK_01470 hypothetical protein
MEHTQELRSGHLNLDDRVNQPTMKKKIFKALSKLNKKFLPSYTKKELDLRKASKVQMAII
GWKSWVTRNSLD
>IFAGANLK_01471 hypothetical protein
MYKITLKCILVLSIFFISIKSFAQLGVSFHQSNLPFVGISYEINNKFLPELRIGADNYIE
DTSLEFAVNYIFKRNEIVNIYAGVGGRIGSLEGIVVPVGLNIYPFEKKNFGFQIELAPIL
RESSVLRGSGGIRYRF
>IFAGANLK_01472 Vitamin B12 transporter BtuB
MEAFLNYLLKSAGLLCIFYLAYIILLKKETNFQVNRRFLLGGILTSAVLPAIYFTRKVTV
EASSFSFNDVPVTTHVSSEDIISTTGTWEILGVIYLLGTLFFLVKISVQLFNIQKLIRRS
QIHKADGFSFLKTEATVSPFSFFQFIVYNPAAHSEKDLQMILQHEKIHAAQWHSTDILIA
NLTTALLWFNPLSWLYKKSVEQNLEFIADRETVAISGAKKSYQQALVKVSIANLQPALTN
HFYHSFIKKRILMLNKKPSKNSGLWKISLVFPFVLAFMLTFNVKTEARITPSDDKKFQNI
NIEEDQKLLEAHFSENTSKEDLQNYQDAFAEKNVKLQWKDIQYSDNKLKNIHITYTLETG
DSRQFQSETNDDGNLLAFKIGARFHDNSKIAFISISNKKLGEPVNSQLIAQEVPPIKHKK
LPENLVYKIDGEIVSIADAERLNPEEIAEMQVLKGEEAIDDVGKKGENGVILITTKTSKN
LQEIPGNPIYILNGEKSKKDIIELIDKSLIKSVNVLKGESAISLYGEEAKEGAVIITTKT
LDKGNNKTLNGTGSINVQEKENRFQKKSDYKIMTGNSFSLSDSDDLNAFQKYEKNKKSGQ
VTGYGVKANVFTYERKQPSPLVIIDGKKKSAEFMKEELQPENIENINVLKGKAALEKYGE
DAEDGVIEIITKSPSDTKQN
>IFAGANLK_01473 Methicillin resistance regulatory protein MecI
MKRLTNKEEEVMRILWQLEKAFVKEIIPLIQDKKYHYNTVSTIVRHLEDKGFVAHKAYGN
THQYYPIISKEKYRKHIMSLTSKRFFDNSYKSMVSFFAKEEKISAKELREILEIIEKDKK
E
>IFAGANLK_01474 hypothetical protein
MFNNLNKIIPACILLIVGICQGQTQLSGFVYSAEDSTALFGTSVYFDGTSIGVSTNEEGF
YKIASSKESSSPLIISSLGFQKVTVSNYSGLNKIPDIYLKEKADNLDAVFVETDPWSRKK
KLEIFQKEFLGKTSSASKCKILNEEVLELNYRPSTKTLTAQANQDLIIKNRYLSYNIKYN
LTNFEVKFRTGTSGLSLVHSVYYEGSSYFEELRKNPRKKIFKNRKNSYSGSGLHFMRALA
TKKLVENNFRIFHEKFQVSPYKFFEINNTGNFTKVKLLTSKISILYKDLEQSAFQTIGSF
IIDEMGNHSPPNSIIFSGEIAHKRMAETLPLNYRIEN
>IFAGANLK_01475 Inner membrane protein YrbG
MSIVFILIGLALLVVGGEFLVRASVAISFKFNISRMVIGLTVVSFATSAPELLVSLQAAL
SGFSDISLGNVIGSNIANLGLVLGITAIITSISVDREFYRFNWPTMMLFSIVLYYFLYTG
GHISRLEGLLLFIGLIVFLILLIRRSRRKTEIAVEGIDDSLKDTSNFKMIMWLLIGGVAL
WGGSELLVDGAVDLATMLGVSERVISVTMIAVGTSVPELAASVIAALKKEKALSLGNLIG
SNIFNIASVLGITAMIQPIYIQSDQILTNDIFWMIGISFAIAPLAFVPKRFLFTRYKGVI
LFVSYVIFTGLAFLG
>IFAGANLK_01476 Glutamine synthetase
MSTLRFEALKETFNRKPVKIKEPARRSELFGTNVFNEASMKQYLTKEAYENVMEAIKTGK
KIDRRVSDHISTGMKEWAIAKGATHYTHWFQPLTGATAEKHDAFFETQADGSAIEKFGGG
ALVQQEPDASSFPSGGIRNTFEARGYTAWDPTSPAFLWGTTLCIPTIFVSYTGEALDYKT
PLLRALQAVDQAATSVAKYFDKNVTKVTATLGWEQEYFLIDSALAATRPDLSLAGRTLLG
HSPAKGQQLDDHYFGSIPSRVLAYMRDLEIECMKLGIPVKTRHNEVAPNQFELAPIFEEG
NLAVDHNSLIMDIMSKIAEKHHFKVILHEKPFAGINGSGKHNNWSLATDTGTNLLAPGST
PMKNLQFLTFFINIIKAVHDNEELLRAAIASASNDHRLGANEAPPAIISAFIGSQLTEVL
DELEKVTDGKLSPQEKTELKLNVVGKIPEILLDNTDRNRTSSFAFTGNKFEFRAVGSTAN
CANPMTVINTIMAKQLNDFKAEVDELIKGKKMKKDDAIFNVLREYIKKSKNIRFEGDGYG
EAWEKEAKKRGLSNNRTTPQALKAQISEKTIALYEEMKVMNKVELEARHEIELEDYAMRI
QIEGRILGDIARNHVIPTAVRYQNILIENVEGLKHIYNEDFKKHSNEQLELIEEISEHIA
KINSGVKAMIEARKVANKIEDSEKRAFAYCDDVKPYFDEIRYHCDKLELLVDDELWPLTK
YRELLFTR
>IFAGANLK_01477 Minor curlin subunit
MKKVIFCASALMFGAIGFAQNNESTVGQTGNANDAQVNQIGSNMSSVAQETTANVAEVNQ
VGENTSTVQQRGDVNDNVAASGENNRAYVHQYGEENDSDIDQNGDRNFASAWQYGSDNDS
DIMQGTGGAEDNKAFVTQMGDGNTSNVEQHNDNNQAYVKQDGQDNSVWLYQNAHGGSTDG
NFSFLVQHGNDNEIETTQRTDSRNNGYISNRESVVQAGNDNYSLLNQWGDGNLSSLYQAG
NDNSSKVSQGNPTSEGPYNDNTSYVTQIGDDNDAFTRQWGNDNWSATKQFGENNDSKVRQ
EGDDNFSLVNQYGNDHVSDVTQNGSAHMSMVKQWGGNGNAATVLQNDMNHNSSIMQNGSG
NTATVTQSGFVAQ
>IFAGANLK_01478 Minor curlin subunit
MKKVIFCLGTLLIGSLGFAQNNSSVSQVGNNNDASVVHSGIQNVSTVIQGIDGDEAYSNK
AIITQSSHRNESTVKQFDGREGENENNLATVTQTGYDHVSMVEQLDDDNIAEVSQRGRRS
NSDIYQNGSSNFSYIDQVGSLHTSVINQSGDAGEIEPNNETYVYQSGKANNSIVYQDNTL
NFADVYQRGVVNESEVQQATINPTGGTENHAEIYQWGDFNTTRVIQAGQYPQGRLGLGSY
YNESFQTQIGDYNEALVRQEGSGHLVVQEQFGNGNRVDDFQKGASQESQVLQDGDYNVSE
TLQNGWDHYSDVGQLGSGNDSNVYQTGGENHSTVIQDGMSNASIVSQMGNSNANTVSQTG
NGNSSMVTQ
>IFAGANLK_01479 hypothetical protein
MKFSMKDYLSIPTIFLMFFCVSTSFSQDHKEQNIEAKIKLDNKDRFLNISGEAINNTSED
YQLRYKLSVVTGGEQHSNSSQNNQSGSFLLPSSDTKILSRTSISQNPGNRAEIHLHIMDK
DKVVARDSITFQF
>IFAGANLK_01480 hypothetical protein
MKKVILGAAALMIGAISFAQSNGSTVGQKGDNNAAQVDQVGYSHISTVETKGFENAIDVD
QYGGNQNNSDVLQGASNAEYNSAVVEQVGDYNDSDIEQHNDYNC
>IFAGANLK_01481 hypothetical protein
MEISLSLTQVGDRNYSQVVQGVKLNVGPYNDHTSNVEQIGDDNRSFIKQWGENNRSSVVQ
TGDDNDSKTFSAVW
>IFAGANLK_01482 Minor curlin subunit
MIQKHFQQFGNDNVSEVIQTGNENISSVTQEGSRHWSMVDQLGNGNKATVNQFGNDHSST
IMQNGSGNTATVNQWFSFSILSGYLLA
>IFAGANLK_01483 hypothetical protein
MKKVILGTAALLCGAVTFAQNNDSDVNQNGTNHGAVVNQTGTSNRNDVDQDGHANNAEVG
QEGISNTSSVIQTDGDPDENSNHEAYVDQYGIDNDSYVLQAGDDQIARIDQIGNNNESDT
YQYGSSNLTEVWQDGNGNNALVFQMGDAGATEPNNRAFVTQLGNNNTTIQKQFGTENLAT
SMQEAKGSDVFQLQIGANNEAEATQTGGVPGQSGRGIHAVVQTQLGNDNIAVSNQMKNNQ
EAWQTQTGDGNESYVTQTEQHNDSYQTQVGYGNQSSVDQRHALMPINGDRSRNVSVTLQI
GEMNNVTHMQNGLRNEATTEQFGAFHSSNVNQTGAYNTATVTQSGLGL
>IFAGANLK_01484 Minor curlin subunit
MKKVILGTAAILCGAVTFAQNNDSDVDQNGNANSAIVNQVGSINLSEITQEGGDSDETAN
HEATVNQTGTDNWSFLTQIDDDNIAFINQTGDINTSDVYQEGSSNLANVDQTGIFNNVLT
VQIGDAGTIEPNNVIDIDQIGGLNDASVYQEGALNSSVVLQEGDLNSALVEQIGSGNSGD
IRQWGDGNSAFQFQGNPLVDLGTDNTAIIRQGEALSGWQSAQNSVAQQEQYGEDNYAEIT
QRGDTQRAIQAQLGDDNVVTAYQGNDNNFSRQYQEGDGNDANTQQYFSGNISFQEQVGND
NIAHTVQTGPGAGLNFSILTQSGNDNLAMHTQNGFFNDASTTQVGDMHISNINQLGSNNQ
TTVTQSSPGAISVPASYQPQMVGGL
>IFAGANLK_01485 Minor curlin subunit
MKKVILCLGALTFSAAMFAQSNESDVDQDGDLNAAIVTQVGMDNEAVTNQSGTSNSSDID
QEGLANEAVVLQVGTSNDAIATQAGEINDARIDQAGEGHSAIQDQSGDDNRANTFQRGWD
NTSMQVQDGTANQGVVVQNQGDNLAVQFQSGSGNFGQLNQNHFGAGGSNEGYQVQVGDNN
GAFIYQASQYGNGTNNSTAVQFQLGEDNHAEIEQQGNNHMAVQLQYGNGNEAYDLQKGAS
EESLVLQSGMDHFSTVEQNGWGHDSVVSQYGNSHESDVFQTGGQNSSVVTQYNGMTAN
>IFAGANLK_01486 hypothetical protein
MVNMPPFFNIFIMKMKITILNIIFFFCTLGVFSQIENIPSTSLWEMQMLSENMKPESASA
AKSLNENNVFIRQVGEGNNVTANISANNTAVSYTQEGNFNHIGVDVNVEDYQSTINQNGN
NNNFFDQMYNSDTGASMELNQTGDNLHFERFGSNSIGDKLQFNMTGESRSIIVRNFN
>IFAGANLK_01487 hypothetical protein
MKIFVFVMCLCIPTILFSQNFNSRVEAIINTNDNKDDILEVTGIAQNKTDVSYGLRYELS
VITSNPEFSNNSSKNSQSGFFTLGSYETTELSTTSVFIDPQMQTIILLLIYDEDDELVGT
ARKVYEASSVSRAAKNEKLSYKKENEGIQLYGLVTETTKTKPGKDFYDFFYQKYQLSQNP
ENKIIEIDEMISFGRTTRIMVKIENQIIFQFFSRPKLDYLEEMAENALQRVNRYFQDLRK
QKQQIMQY
>IFAGANLK_01488 hypothetical protein
MKLTFTLLCIFGCFYASSAQDLVYQPTNPAFGGNPYNYQWLLSSAEAQNSFEDPDASLGR
QQESELERFTSSLNSQLLGQVTRRLFTDQFGQGALEEGTYSFGSLAVDIYPSNEGLVINI
LDTETGEQTQVVIPN
>IFAGANLK_01489 Curli production assembly/transport component CsgG
MRFYNFTIIVAIASILTSCGSYLSQPVDFEAPRTGEISETTKRLRSLPEPEEKVVVGVYN
FRDLTGQYKPSEVGSTFSTAVTQGATSILVKALEDSGWFTAIERENIGNLLNERNIIRST
RQEYQGGNSSEPQLPPLLYAGILLEGGIVSYDTNIMTGGLGARYLGVGASTQYRQDRVTI
YLRAISTSSGKILKNVYISKTILSQALDASLFKYVSFQRLLEAETGFTRNEPVQIAVKEA
IEKAVEGLVVEGIEDKIWTPKGGDTIASQLVNDYSLDKEEEELTGLYNRKYIERKYNSAL
GVSLGASLLSADFSKNYLAPQLTIDYKNHIYRGLALQLSGSVFELNGGAAFTETFGSLGA
GLNYTVLPNDKLTPFVQAGAGVLSRLSEIEISDAKSNFFKLQYGLGMEYLITDNLGLKGF
ATHNITLSDELDYTINGTRDDHYFNFGIGVNFYLGKSNNNN
>IFAGANLK_01490 Protein TolB
MKSIKFIYTLFLAILVSSCSEETIDNVQVGTITGTVVTEGNFEPVQNARISTNPATSTVF
TDENGEFILKNIPAQEYSVQARKDSLLTQFQGVEITADGEVNVVFEMKPETADNLAPKAP
ELVSPENNTEGLSRDVTFTWTSEDVDGDDLNYQLEIRNDRNNDVQTYSNISDTTYTVDNL
NYGYKYFWQVRVSDSINEDVLSEVNTFSTLEFPKSRIAYVKKINGNNVIFSRDLNENEYQ
LTSANHNSFRPRKNHRTDKIAFLRTIGSQTHLFTMNLDGSGERQITSNIPVNGFKLDKVD
FSWANDGASLVYPNFDKLYRVNATGDGTTQIYSEPDGKFITEVDVSNDNSRMALSVNDAD
GYNASIYLINNEGQRTNTIISNIQGALGGINLSVDNNKVLYARDVSGFESEDYRQLNSQL
FVYNINTQETMNVSDNKPDGTNDLDPRFSPNEAEVIFVNTSNDGISQNNIYSTEINPGTT
EENRALLYEDASMPDWE
>IFAGANLK_01491 Phosphoribosylformylglycinamidine cyclo-ligase
MSQEVSKRYAQRGVSAGKEDVHNAIKNVDKGLFPKAFCKIVPDYLTGDANHCLIMHADGA
GTKSSLAYMYWKETGDLSVWKGIAQDALIMNIDDLLCVGAVDNIMLSSTIGRNKNKIPGD
VISAIINGTEELIAELKEFGVEIHSTGGETADVGDLVRTIIVDSTVTARMEKAKVIDNAN
IKPGNVIVGLSSSGQASYEKEYNGGMGSNGLTSARHDVFSNDLAEKYPESFDNDIPEELI
YSGTKSLTDSVENSPLDAGKLVLSPTRTYAPIIKEILSKFSNNEINGMVHCSGGAQTKIL
HFIDNLHIIKDNMFEAPPLFKLIQQESKTDWKEMYQVFNMGHRMELYVNPEIAEEIIAIS
KSFNVEAQIIGKVEGSEEKKLTIKSEFGEFSY
>IFAGANLK_01492 hypothetical protein
MANKLNIYNSKFVFASTVFWVILNLLSLYFFTEEASRWLRLAASTYFVIWSLSFQALNSR
IQYVLLAFWMCDISVLFYENQFFNFLTFITRSLTFFLLISIVYPKIHGVKFRLSELLVGI
AIIAINIYLLWELFYMVPEAHLYDYFVPAYLGFTILTMVLVGVAITCNNRYSSKASLYLL
LATLFMALSDINFFIAFYLDISIFYYPDRFLHIFSLGLILLFWINPLETSMHNLGNREI
>IFAGANLK_01493 Lipopolysaccharide export system ATP-binding protein LptB
MIFEIDNIELYFAEKQILNGVYLKTETGKITGILGANGCGKSSLLNIFFGSLQPRHKLIR
INKKPYLKPLFKYGIVTYLPQQNFIPPKMNLKSAFQLFKINLKEFLYDFPEFKAGKNNRM
RELSGGQRRLIEIYICLNSNAKLILLDEPFSHLSPLYVEKIKKLLQKLKKEKAIIITDHM
YRHILESSDEIYLLKNGSTQLIKEEKALEDYQYLRAGTI
>IFAGANLK_01494 Peptide chain release factor 1
MIEKLNIVKQRFDEVNDLIIQPDVISDQKRYIELNKEYKDLKALMDVREKYLELTNNIEE
AKEIISDGSDAEMTEMAKMQLEEAEKEVPKLEEKIRMMLVPKDPDDAKNVVMEIRAGTGG
DEASIFAGDLYRMYTKYVESKGWKHNIVDYSEGTSGGFKEMIFEITGEDVYGTMKFEAGV
HRVQRVPQTETQGRVHTSAATVMVLPEAEEFDVEIDPKEVRIDYFCSSGPGGQSVNTTYS
AVRLTHEPTGLVAQCQDQKSQHKNKEKAFRVLRSRLYEMELAKKQEADAAKRNSMVSSGD
RSAKIRTYNYSQGRVTDHRINLTLYDLSNIINGDIQKILDELRLVENTEKLKENSDIF
>IFAGANLK_01495 Orotidine 5'-phosphate decarboxylase
MSTKELTEQILKKKSFLSVGLDVDIDRIPTYLLSEDDPIFEFNKAIIDATHKFCVAYKPN
IAFYEANGVEGWQALEKTINYLHHEYPEIYTIADAKRGDIGNTSRMYAKTFLKDLGFDSV
TVAPYMGKDSVEPFLEFDNRQAILLALTSNEGAFDFQTQQIDGEELYKKVLKTSKTWKNS
ENLMYVVGATKAEFLKEIREIIPENFLLVPGVGAQGGKLEDVCKYGMTKNVGLLVNSSRK
IIYASESSNFAEIAGAKAEVLQQQMADELKQL
>IFAGANLK_01496 Vitamin B12-binding protein
MEVKDQLQRKINLPDVPKRIISLVPSQTELLIDLGLEENLVGVTKFCVHPKYLRKIKTIV
GGTKQVKIEKIKVLEPDIILCNKEENTKEMVEELEEIAPVHVSDIVKLEDAFELMLQYGD
IFDKEALAETIVSSVEKKIALFQEQIKDKPKKKVAYFIWKKPLMVAGKDTFIDELLKLNK
FENVFKESRYPETSFEELKAKNPDLLLLSSEPYPFKEKHKEYFSELNIEIQLVDGEYFSW
YGSRLAGAIDYFKKLRS
>IFAGANLK_01497 hypothetical protein
MNINADLAILCGPGSYLCIKDENRLMFKIFETKSTEECLCDKYTHLMHKAYKLALTDKEE
SDRLNARAKSILRELRRMKYDKIDY
>IFAGANLK_01498 hypothetical protein
MKKITLILSIFIFSSCAELQTIAENYPQTGVSNTEIATGLRQALDMGIEKQVTKLTEENG
FYSNELVRITLPAELQKVDKTLRDVGLDALADQGLKVLNRAAEEAVKEATPIFVNAVREI
TFNDARNILLGQDNAATMYLTGKTEEPLYSKFNPVVTSSLEKVGATEVWTNIINRYNSLP
LTNNVNPDLADYVTQEALQGVYTMIAVEEKEIREKTSARTTNLLKRVFALQDNQY
>IFAGANLK_01499 Formyltetrahydrofolate deformylase
MSKITLLIYCPDTSGIIAHVTSFFYKKQGNIIYIDQYVDVENTVFFMRLECEFNAETNIS
ATKDEFKETVAEKYNMSWEMYSANTTPRMAVFVSKYDHCLYDILSRYKSNELKVIIPLII
SNHKDLEQVAQNFGIPFHHIPVTAQTKEKAAEFQLELLQKEKVDFIVLARYMQIIPKSLI
TAFPNRIINIHHSFLPAFAGAKPYHLAYKRGVKIIGATSHYVTEELDGGPIIEQDITRIS
HSHSIKDLIFKGRDLEKIVLAKGVKYHIERKTLVFNNKTIVFT
>IFAGANLK_01500 hypothetical protein
MATYLNTNEIRVSLKQLVKQYVEECVTCQELPDEFISLIKHNFLAKYVYYNKQKKQIEIG
IDESESPDTYPEIKVYKIPVNKAAKWLDKSFRDQQNDLEFYGKLLNRNEIFNSSDVVLMS
R
>IFAGANLK_01501 Alkanal monooxygenase alpha chain
MFINISEIPYSILELATVAKDSSVKETFDQSLDLAQNAEKMGYTRFWLAEHHNMVSIASS
ATAVLIGHIAGGTKTLKVGSGGIMLPNHSPLIVAEQFGTLGTLYPNRIDLGLGRAPGTDQ
VTAQAIRSDRMKSVFKFPEEVKEIQKYFSIENAQAQVRAAVAEGVEVPIYILGSSTDSAH
LAAEQGLPYVFASHFAPTQLHQALSIYHNNFKPSKFLDKPYTIAGVNIIAADTTAKAEKI
STSLIKMMLGVMSGNIDYMQPPVEFTNEHREILAHPGFQRMLQYAFIGDPETIKTKTEAF
LKETGVNEIMAVSHIYDHTDRLRSFEIFSEIMKGKI
>IFAGANLK_01502 Cyclic pyranopterin monophosphate synthase 2
MVNITHKNNTLRKAIAQAVVKVSSADTIKAVEEKTVPKGDVFEMAKTAGLFAAKRTSDMI
PDCHPLPVEYTNITYNIEDLEIYINVEVHTIYKTGVEVEAMHAASVVALTMYDMLKPIDK
GISIEKIKLLEKKGGKTDYRKVVEENQISATVIVCSDSISAGEKQDKAGKVIMEKLKAYQ
VAVEDYQVIPDEKETIQTLVKEKCAKKVNLVILTGGTGLSPRDVTPEAIQPLLERPIPGI
EEAIRAYGQDRTPYSMLSRSVSGLIGNTLVLALPGSTKGAEESMDAVFPAIMHIFRVMAA
FKHD
>IFAGANLK_01503 Molybdopterin synthase catalytic subunit
MTRKPKNIFVEGPISSEKIAKSIQNHSSKTNIGAHSIFLGQVRADEKEGSVVRAIEYTAY
EEMALQKAFEIREAIFEKYNLTCMHIYHSLGEVKTGEICLFVFTSSKHRKMAIDACEELV
ERIKNELPVWGKELLENSDENWKVNT
>IFAGANLK_01504 putative adenylyltransferase/sulfurtransferase MoeZ
MSRFSRQTILPEFGQEGQEKLSRARVLVVGAGGLGCPVLLHLAAAGVGTIGIVDGDTISE
SNLNRQTLFGHQHTGRPKASTAAEVLKEKYPDLNFEVFSDFLNTNNALEIISSFDVIVDG
TDNFGTRYLVNDACVLLNKPLVMGAIYKYEGQLMIFNYGSVALNYRDVYPNPPSENQIPN
CAETGVLGVLPGIIGTLQASEVLKILSGVGKVLSEKILFFNLKNSSFYEVGIQPNTKGRE
NLPESEMDFKDRNYNINCGIAERINWETALDWALNMTNSILVDIRETGEKPLFEKEYLSR
IPMGDIRENPESLSAYENILLCCASGQRSSQLAKELKQQFPEKKIFSVEGGILNPASPLN
SNEYDT
>IFAGANLK_01505 hypothetical protein
MEGLTVKAFGMIAEKLPEQEFKFPKKENTEELLASLYNEYPNLKDLDFSLAVNQQLIQQN
TPLEGDEEIALLPPFSGG
>IFAGANLK_01506 Molybdenum cofactor guanylyltransferase
MGRDKGLVSLNEEPMILHVLRELETLKISTKIIANNSAYRRFKLPVYSDVIPEKGPMGGL
LTAMENTGAEMVLLIACDMPFITASAIERLLKKADKKQIIASMSNQKINPLFSVYPVILK
EKIKKSIAAGELKMTDFILKNQHVLLPFEYEQSGKIFKNINTEEERIEAEKKWKD
>IFAGANLK_01507 hypothetical protein
MQSEFLPYLFLLLPLAAFFYSSVGHGGASSYLMILALTGFAPEEIRPTALLLNMAVSFIA
FTNHRRSCEFPNKLFLQLVVFSVPAAFIGGLVVVESSIYKNILGVLLLFPVLNFLGVFPK
NDKTILRDKIWMPPFIGILIGFFSGLIGIGGGILLSPLLLMLGWTNVRQTAALSALFIFV
NSVAGYLGTTGFNLIENKSLWILIPPAVLGGILGSYFGALRFNVKLVKHLLTFVLAGAAL
KLIFF
>IFAGANLK_01508 Molybdopterin molybdenumtransferase
MISVEQAKKILAENSERGEITEKSLGECLGLTLAENIYSLIDVPSFDNSAMDGYAMNFDE
SNRTWEVSNIIQAGDTSEINIAPGKAARIFTGAKIPKGTNTVIPQELIAISEEGQISYDG
DKISTGSNVRLKGSQSKKNSLILEKGQVLGAGQIGLLASVGVALVKVFSPPKVGFIVTGN
ELKEPGTPLKEGEIYNSNGPMLEALLKESGVKQIQSYRAADDKESLQKIIDQALTENDIL
LLSGGISVGDYDFVKECLNTAKVKELFYKIKQRPGKPMFAGKKERKLIFALPGNPASVHS
CFIQYVRPSIKHWLGGTAVWEADHTLEIIEDIPKKPGFTHFMKGKKNGNQVELLKGQQSF
NLQAFATAECLLELPAENSVVTAGTKVKVYDL
>IFAGANLK_01509 GTP 3',8-cyclase 1
MLVDNHKRIHDYLRISLTDSCNFRCQYCMPDENIQCLPNKHLMQVDEIEKIATNFVNLGV
NKIRLTGGEPLVRKEFREILSRLSKLPVEISLTTNAVLVHKFIDDFKAAGIRAVNVSLDT
LDAETFKRITKRDQFDLVWRNIQLLLKEGFRVKINAVAIEGVIEKEILDFVEITRDLPLH
VRMIEFMPFEGNHWNSKKVITATQMLKWAEAEYDMVKLKDKPHATAKKYKAIGHEGTFAF
ITTMTEHFCGDCNRMRITADGKMKNCLFGKDEMDLLGTLRKGEDIEPLIRLSVLKKHAVM
GGQFNKSYKDTETTQLENRSMIRIGG
>IFAGANLK_01510 Chloride/fluoride channel protein
MKIRTRRKLIRSLDVLDRPLKFNPFVFSRNFFLWALLGIMGGIISGVYWIVLEIVMHGMA
FFDGWQVIPTMALAGLLAGLIIHLIGDPGEIQLIVNNIRFNKGKLDPKNNLSMVLSSLLC
VGSGGSLGPEAPLVQVTGSTGSWLGKVLRLKGEELRSLSIAGMASGFTALFGAPLGGSLF
SLEILHHKHAAAYYKAIIPAFVASCFSYIIFALIIHLGIGPIWDLPSYIMEDKFDFAYAV
LFAVVATLFGWVFIFCTKFLKSAFYKLNFPIYYKTFIGGIILGIIAFYFPITRYFGHHEI
NDLLLNDFNLEFLVAILFVKILAISVTVTSGWRGGFIIPLFFVGATLGLIIHQLFPSTNL
SLAVITCMAAINACVTRTPMSTTILLATLTGFGYFIPILFASLTGYFLAPRIPFISSQMG
EERNDDN
>IFAGANLK_01511 hypothetical protein
MSTSVKSSAKNPSELKPVLEEHHHALQVCSRIREGLENDVELERIRAYMNWFQKNYLEPH
FEIEEKYIFPKLGYNVRVKKALANHRRIRKLLSCGCADEKVLNLLEEELSAHIRFEERIL
FKEINNKKELAEIEKQHHTISFSGEDWEDQFWA
>IFAGANLK_01512 hypothetical protein
MKKPIKRHEALKPLSREHHHGLLLCWKIRQGVRKEVEVSRIKAYTEWFKIHYLDPHFEAE
EQYIFPVLGNDNKLVKRALKEHRRLKRLFSQDTDIEIALNNIEEELDSHIRFEERILFNE
IQEVASAEQLANIEKHHNGIQFSDDHWQDHFWEN
>IFAGANLK_01513 hypothetical protein
MKHYIWMLGLALCFLLSCNSDDSCENYRIATISLEDEYACNDTRYSLDISTTEEFELITN
LAEYKDKVTGTCDPTLIDFTNFDLIIGKVRLGSGNDSIDYSLIESCTEGRNLYVTFIQND
AMIAPVITYHVLVPKDEANKTIEVRIFKQTRA
>IFAGANLK_01514 hypothetical protein
MNKEELIEKYFSNQLSENEFQQLEQLLQEDAELRENFYNELEIKQAITQEKHVSLKERLQ
KLEKKPTNKKSWYLYAAAVTILIVIGSLFYNLKTNDQLYAENFEAYPNVISLSTRSEVSI
ENKESEAFKLYDAEKFNKAAIAFQDLYEKNEKDYLRFYHGVSLLAKNNTIEGIEVLEGYD
WQEQQSDFTIPAFWYVGLAYLKLEKTSEARNYLKKVALSDSQLRSQAQRLLKQLD
>IFAGANLK_01515 hypothetical protein
MVKDQYLVDKLKQNDLKTLDRIYLTYKEEFFLFAHTFFIPSEDISDIYQETIISLYENVQ
DQKLEQLTSSLKTYLFAIGKFKIYKQLNKNKKIYHGEGIIHVSEEMKVFEAEIDDQRQIA
LKRSWTSLGEKCQEILELYYYKGMTLNEIQEALKYSSKDVLKSQKSRCLKQLKQLVRGKY
E
>IFAGANLK_01516 hypothetical protein
MKKTLFSIILMLGFLSTTQAQEETRIGGFLAYGTEIENLGIGVNAEFPVMEKLSISPSVI
YYFPKEEYGFKMNWLEFNANANYYFLNNSDLGVYALGGLNYSSIKVSYDDSWGMGGNFSA
SDGRFGLNLGGGLNFDIGSSILPFAEIKYVILDSGQLVASAGVKFKL
>IFAGANLK_01517 hypothetical protein
MKNYFKPTSYLSLLICSILLLASCSSDDEDIEPVEELLPPIVLECDYFSEDRVLENDTNR
PVDYIISCWTNVEGSLRIEAGVVIEFENHAGLRVNLDNKVFEIKGTATDPVILTGTSKQK
GYWRGIFLTEAHNPNNLIEHTVIEYAGSQNLTSSSPVYEGSLALRGVSGTPPQALTLNHV
EIINGGSVGLDYHGISKNASISTSNLIIAGNEDVPVKVSAEMAHFFDNTSSYTGNASDFF
NITGSYYEIEDQTVSWQKLDVPYLVDSRVSIGDDGHLSIEEGVEMQFKAGAYLQAYGFLP
PYNLSLKILGTEADPVHLKAHNGTNWGGIQFGFTQENNIISHTVIEHAKGDFPVGNIQNS
GAIYMHARPKLTVENTIFRNLENCAFYGYSSNPFENLTTTNLTFDNVSEEWCEE
>IFAGANLK_01518 hypothetical protein
MKGSMLHIILLLTLNCWLTSYTSFSQTLDKETILGTWDIQGNLMGENGKGWLIPHKQSNA
DCLPDHTVFTKNHMAREVKYNKSCQERENTFNWTLNEGIITLSKGERSIKWHIEDMKNGK
MTIGVPIHPGAEKKLYLLYKKRN
>IFAGANLK_01519 hypothetical protein
MKRTIIQSATYIIALCLFMACSNDNEKKENKNTSSNVHTYHIDIANGKTYQGNISKVSGG
VYNPVSIVEYSQAIDSKVMAGTLMDTGEFQIGIGIALDENNKPSLKGSGPGIVFGQWGVE
DKYSPSGIIDITLNNYEEHNISIYGQDGKVASCILNFSGKFKLGADGEEVNVTGEIVVDA
P
>IFAGANLK_01520 hypothetical protein
MNITTLSRPIIIICILVLAIGTTAQTNNEHQVSFVVSGAISGKKTGNAKVLFSEGQNRHF
FTIQITDENTNTPEYRLRFRAESWEELGLPEPGEYAIIDRGNPDLGYEAGFEVTYTHYLE
YNDSYYQNVAIEYKAQPAWKIAPKGKIIIESVDGTSLTGSFEFELPENTSINKAPLTGKG
INIVSGKFNVETKK
>IFAGANLK_01521 hypothetical protein
MKTIYSSTLMLLCVWLSVSSCSKEQNPAPPQDEEEQQLSLTINQAMIMVSSTVTFEVTAD
GEPVTDADIFINGQKTDAYQHQFNQAQTATAIAKKDGYKDSEPLTITVNVMQSDVDIYVL
GEGYHEQLQGIWPMYWKNGEPMPLLLAPNHMEDPVIYHSIAVSGHDVYITGERIFSSSRA
SAFFWKNNTYHELTQPSGYAKGLDISLADDDVYVAGVQKNANNLIDIAYWKNGGELPVRL
DSGTIGQTGESFIKVIGDDVHVAGILDAEPTYWKNGVATPLEGTGVVTGIAVSDHGDVYI
SGYGSNGNRTIAKYWKNGQEVILGTGELESESSSIFVEDDDVYVAGYEKVLHKSGQGRVN
VARYWKNGEAVDLTDRSYPAEASGIFVLDGNVYVSGIESLPDQKVSATYWHNSQPVRLSN
KDHNGQAGDIFVVKKNP
>IFAGANLK_01522 hypothetical protein
MNFIKITFLFLLIAWQSTAQDAIDPGNIDLGFSPEFIDFSPDDRYLVAENDSHYQVWDLE
TQTRILNGKHTFKPGRAIKSKVLPTGSGYFLFGTEQVFMTVDYQHNKTHVKAFSLKDGKM
IWETDQLHMEVSLAETILRLHGEGIVTAEIVGKQVNPRHSFNSFFTPDKVLDRLINYLPE
RNTLFFNGKKGLQSVDINNGNINWTQKSVTGGIGEILFNPQAGQLYLIKVPNSEGSVDLL
TAKPEVQALDVNTGKLLWSVPYTGDFTPGYASIVGHTLVLPYLDLTFIDVKNAVERNGDI
KSRLGAARTSTKVLGGIMAIDKAINGGNSQAKTDSKYNRLIPRQLYFDANGKLCYFTIFN
KKGKLGVGGKKGYLNIDIHKDKVEVEKYNILGDQWTVIQDQLEDGIFYIKSSGTLNRTMI
TAINPENGEILFQTDKARNSADRAKAFNPFLISNARIIDFVSKGIYTLDARTGQKIAYTT
SRDLGVGTIKSSRFFEKGIYIFGTKGIGIMDFDGKIILNVEARNVKDVVANSNEVWILEN
NKFTRVNLQLAKITENITFKSRETMVFSPSGKYLLKVNKKGDKIKMYN
>IFAGANLK_01523 hypothetical protein
MNKMKSITHLLTIMLVISLTVSCSKDNSEEIGNDLTGVNATYNMMVDYNDKGSQIPELTE
SNYLFESDLYTFYLKTEINKLETKINNWAEIAPKNPKYEEVQADIKKAKESLIGLYENLE
NIKPLIGIKPPRKPRPCLGKDNDAIPCINPKRFSLLVTTDDVEILSLSLSDSKNNTIAVN
NSKETHQPLPEYKNLLYYTSVQLKEIQPMVEATLSIQKQVKGKTFIYKVPVMVRQD
>IFAGANLK_01524 hypothetical protein
MKKTIITRIGLILFFTTSIQAQNDTLEYHYSQLHQYVYTDQDSTYYHADKIIPVASRHKA
YDYLFYTLTMVNYSAGYFHNLSKLRESTHLADSLFTTHHTGLQNLGLRDYTDITVQKQFD
KGLYYYLVGHYKKARSSFNSMLETLSSLPDSFQTANDYASISSAYNYLAKMYTNEGKYEL
AKLYYKKDLQFLKEKLPIQQENISHVYRLLGEVYMKEGQYQEANRYILASLNHDLKDFTT
EESNSIAAGTGYMVENYLALSKVDSAKHYLSIMRRALTDNSSYAPNYYLNKAAVLDKEKE
KKGALTAYLKALELAKAKWNNSPHSNIAQIHDKIASFYQREGQTTLALEEYNKGIAQVYG
NSIERSTLNLITLVNLLKNKANALSTFQTTEARNNILQTVDLGIRTLDSLKPTFENHGDK
YQLIENAYQLFETGIAASFALYQLDNDPGYIDKAFYYLEKSKSILLMEALLSAKATRFGS
VPQSLLEEESSLRKEISLLEKQQHTAKKTSNKIKKRLFLLKDEYHKLMATIEKNHPEYYN
LKYNTKVVNLNEIKTLLDSDQAFISYFYGSENLYAITAGNKKNGFYRLDTSKNLNEQITT
YYHTLSTPGILNSKLITASAELYAQLLEPMQNDFSAKERLLIVADGALNYIPFESMVVSK
ETDKINFLAEKKSIGYVNSATLYKELSGKKEQNHSVLAFAPSFMGSKNDKLQSLKSNKDE
VAAILGHFKGNGFIDSEATLANFVKEPNLFGILHLATHATVNDTLPELSYLSFEPVEGQE
STLHVSDLYNLKLNANLVTLSACETGIGNLMRSEGFISLSRGFYYSGASSIAGTLWKISD
ESAAELMDYFYKNLAEGKTKDAALAQAKRDFIVYNPLKAHPYFWAGFIVNGDVSPVTAQK
NNIVWWVLCFLILGGVVFFVLKRRKSQV
>IFAGANLK_01525 hypothetical protein
MKKLFFLSFISLLSFSSYAQWNFEGSVNLNGYLHEGSLQKLPFWMVHNQRGRVSDETNLS
GWISGRTFNEFRNGNSLEIGAGILYQDGISDEIFLDEVYAAYNNNWLEAVLGRRQEKELY
KGLSATNENMLWSLNARPLPGISFSTNRTIFFTPESAYGFEASWSEYLLGDDRFVKGARL
HHKSINLVYQPNPDFQLKVGVRHFAQWAGDSPESGPQPDGFSDYVKVISGREGGDNAVGG
DQANVLGNHLGTYELEITKRINPELELSFIYNHMFEDGSGSRYANFPDGRYGIFLDFEDD
QRLVNGILYEFFYTRNQSVNAGSPHGADNYMNNFLTYHSGFTYERRIIGLPFFTYNEELD
QVVNSKFSAHHLGLSGNFSNYFVSYPWKLLLSFSHNEGRYGRFYTPNRDILAGLFDINVL
QSFVQLNVQLGVEVSNISEPLYGVGLNLSKQF
>IFAGANLK_01526 Tyrosine-protein kinase ptk
MSQQHHTPIRSQEEEINLREELDKYLKYWPWFVFGVILCVLIGFVYLKYTTAQYSTTASI
IIKDEESKGPSSEMAGFADLGLLSGMGASSIENEIGILRSKTLMTKTVKALDLNIIYYDE
AGVKSKELYNKSPFNVQVLQLDEEKLSEIIKEELGHRFLIEPQSENDFILINTESDKNFE
GRFGNPVNIGFADITLERTGIEPEEEEDLEVSVQFSPVESIVGKYREGVQVNLTDKNSSL
LELSLVDPVTEKAQDILDQLILEYNRQAIEDKNLVATNTASFIDERLSIINQELDSVEVG
KEEFKESNQLTNIEAESELFIENASDYKKRQQEVGTQLELANAMLDHLKGNTSDLLPANL
GIQEEGVNDMIKEYNTLVLERNRILSASTEENPVVLRLNSQIDQMRGNVLQSLERMRSNL
LIAQEDLDRQAAVIGSQISAVPAKERQYRGIERQQNIKEALYLFLLEKREENSLSLAVTA
PKAKIVDSAYSNTKPVSPKAKIILLAALILGLLIPFLIIYVKNLLNNKITDRTDIENATK
EIPIVGEIPRIARKESDLISVNDRSVLSEAFRIMVTNLQYLLVGAGDKEKGIKLFVTSTV
KGEGKTFIAFNLAITLANMGKKVVIVGADLRNPQLQRYETDARTYVGVSDYLYNTETGIK
EIIAKAKAHEKLDIIASGHIPPNPSELLRSERMARLLNELEGIYDYIIVDTAPSMLVADT
FLINKYADLTLYVARAGYTEKKLLGFAVDAKNEGKLHDVSFVLNDVELANFGYGNKYGYA
YGEEKKSFFKRLKEKAAIF
>IFAGANLK_01527 hypothetical protein
MKYPHFLRLPALGLFCIFLATSCVSRQEIVYFQGLEEAEAKMEEQSNKSLKIKPNDLLTI
SVAAAQQDAALPFNLPVIGVPMGGDQIGLSVNGRQQLQTYLVGKDGNIDFPFLGKTKAEG
FSQEEFAQNLKSQIKRYVQDPIVNVRVVNFQVSVLGEVTRPGTFNVQDDYFTLPQALGMA
GDMTIYGKRDNVLVMREENGRTTHAYLDLGDADIINSPYYHLQQNDVIYVEPNGPQRQSA
NYNRNAGVYISIASVLVSVAVLLTR
>IFAGANLK_01528 putative undecaprenyl-phosphate N-acetylglucosaminyl 1-phosphate transferase
MNILDQNILLDLFHQHYLFFAIGVFLLAFCLTWYFTPKVLWVSREKNLMKEVNARSSHKT
AIPPFGGVAFFLVLVLIISLLQALRTSPTGNHLIIGLTFLFMAGLKDDLVISSARLKFVS
QLFAAGFIIFSPELSLTSFHGFLGIHEIPEILGYAFNVLIVVALINAYNLIDGIDGLAGI
VGIVISLTYALVFYTTGHPYFVLLSLCTAGILGAFLRFNFSRGRRKIFMGDGGSLVMGFM
IAFLSLKILVMQPYQPLMREGYVPENTLLFALAVLFLPIFDTIRVIVIRLRNGKTPFEAD
RSHMHHVLLDNGLSHKKASFVLGGLSLAVIVLFIILSRDLRSVGMCLAMLGVFIIVAIAF
EVLKKKALRRNLRKQSEGMDRSRKDKVAMAGE
>IFAGANLK_01529 UDP-2,3-diacetamido-2,3-dideoxy-D-glucuronate 2-epimerase
MLKINIIAGARPNFMKIAPIIKAIKKARSVGEKIDFRLVHTGQHYDKKMSGSFFEQLGIP
EPHANLEAGGGSQAEQTANIMVRFEKELQENPADVVLVVGDVTSTMACSITAKKLNVEVV
HVEAGIRSGDLSMPEEINRMVTDSISDHFFTTSEIANENLRKAGIAEERIHFVGNTMIDT
LLSNMKNFIDPQIKVDGKALEDKNYFVLTLHRPANVDEEEKLKEMMQAIIDGTGNLPVIF
PVHPRTAKILKNLGIEHHDLHYVEPLSYLEFNYLVQNAKAVITDSGGITEETTVMGVPCM
TLRDNTERPETITMGTNELVGTEPEKLKPYLEKLMVGEWKQGGKIPLWDGKTSERIIERL
IDIYQTIEVRLDA
>IFAGANLK_01530 Putative teichuronic acid biosynthesis glycosyltransferase TuaH
MKILFITDNFPPEVNAPANRTHEHCKEWLKTGVNITVITCAPNFPKGKVFPGYKNKLYQT
ENIDGIKVIRVWSYITANEGFVKRILDYISFAMMAFFAGLFVKTDLIVATSPQFFTAVSG
RLLSFFKGKRWVFEVRDLWPESIIAVGAMERNRTIRFFEWLEKKLYQSADHIIVVTDTFK
KKIIARGINGEKISVFKNGANLELFKPQGKKIELEQKLKLQNKTVFAYIGTHGMAHGLSF
ILNAIKPLAESHPELAFLFIGDGAEKKNLLKQAKELNLQNAVFVDSVGKKEVVDYLSLMD
IALVNLRRSDTFLTVIPSKIFEAAAMEKPILLGLEGETKGIIENYNAGVCFRPEDQHSFY
EAINSITSKEKYQENLEGSKKLIKDFDRSKIAARMLECLQRVKRD
>IFAGANLK_01531 hypothetical protein
MKILMIIKTSSITYDERLKKEIDSLLTLGVEQITVFAIEDIKSSYSKSNVKVLNPDFRIR
KTNSGLGKALTLLELVFKLNKEIRIKNFDKVWVHDPILMFIIPFLRLKTKKSLIWDLHEL
PPSSFVKNKGLNYLFTKIGKKANTIIVANGERGAYMTNKGMITKYNVLHNYPSMEGKNQS
LDKDFFDSEFEEWIKNKNFAYCQSATHPSRNFDSLVLACINTKQYLLVVGEQNETYKKVR
TKYSEFDSFIKVLGKKPSNSLGYYMRKARFSFIFYTDENKNNYLCAPNRMYHSLKQGIPV
IVGANPTMKNIVSKYNCGVTLNSFGELVEDIEVGIYEMKKNYDGYRTNTTKIVNKFTWED
QDIVIKKIINT
>IFAGANLK_01532 Heparin-sulfate lyase
MRRKFSFVGFSLFEGFLVKFSNILNDYHRHHKTLKFFKPVEVLLNQNIENRNTETKLLEK
VYKEDNFRQFILSTKNLERNEAFRWNAFYPLYSLLEENNDREDVLEVCKDYISNWIELFL
KKGKSNPFCWYDMADSFRLILLYRIVQTESLNFSKSESKRFDYAIKLHEFFLKKDYLLQK
GNHQIFQRVARLLIFQRLENFVKLKKEKESVVELFGKQFSKEGVHQEHSPEYHLWATFVF
EELRIIFDINELKDKILKCKEISSFFITPNNEIPLIGDSGLDHKVSYSKMFKNSSRDFHG
NLYLKDYLLSISNQTGWYFSSILSTNSRIHKHKDTTSFELFLQGNKIITDAGKFTYSKSE
FNKNIRSEQSHNLAFVVSKPDYFSLSTYKIEKIMQVKDFQMVKISSELQKKIHERLFIFN
QKDHLIIVDLFSDNRIACNINLVDSKTYFVKKDIHGELRLYSNLLETEVSFLNISKISQK
KNYISYEYQERHIEHSYEVFSETNYIITSILKGTKGFDFSIIGNNIYILKVGVHNIQITL
KDNKIFFQ
>IFAGANLK_01533 hypothetical protein
MILLPFIFLSLLTVYKKSPFVALISGYYLLIILLVLAIFSLEHTFRGIDYFISDEAVYFY
NLDISEAAKQDRILWFNIVQTVKSTDFEFGFFSKIIHLVIIPFLIFVLWRLTNSRKSLFI
PLFFPYILFLSQTALRDIWLFTFSLIFIYAFFNFKGKYRILILVLSVFFIVGMRPFYLGL
LLFALLGVYILEIILKKKEGNFFKKFLKYVVLSALSISGIFVVFKNKINSYLFSIEVLLE
DGFSKAQDTAIEASLTGEYFIYSFVRFVFTPIPTSMFQEIYSNGASEFGYTNDLLRLLSQ
ISLYLSFFYIIFNIRKLKGVILEYFFKEKELLAYLLFTLGTISIYGLYHGGGGHSRVKLP
LYVLAGITVILIKKYKLRRNA
>IFAGANLK_01534 Asparagine synthetase [glutamine-hydrolyzing] 1
MPGFNILFEKNNFLKNKETEPYLINNFITGESFSIQRFTTNKFLNDKVFYEDENCIILIE
GVILNKKSLISSQKKKEWAKYIWSLYLERGNDFFKIFRGSFSGLVYDKKTLKWIIFTDHL
GTKHIYYDSNFKIISSVITDIYHYWKKNKLKPKLDINAAYMLLSFGYMLDDNTLCANIKK
LEPGHYILIEDNISKVVKYYQLPLSKVDGEFTDNDLETLDDLFRKAVSLQFDKDKEYGLN
HFVALSGGLDSRMTSWVGNELGYNNQINFTFSQTDYLDETIPKKIAAELNHEWIFKALDN
GNFLTDIDQINLMSGGNVLFYGLAHANSLYKIINFENLGIIHSGQLGDIVIGSFVKELSE
KSFKELSGAYSKRLVDKIEFKPIEIDNFQNLEKSLVYRRGLNGANNGLLSAQQYTETMSP
FYDIDFFEFCLSIPIKYRMNHKVYKNWIIRKYPDAANYVWAATESKITDKQVKFRNKYVP
VKKIPAIVRRKILGSPDRKATKNHMNPLDFWYNNNKSLQAFQDSFFDENISRLDDLGDLK
ADCISLYNNGSGVEKNQVLTLLSAVKLFF
>IFAGANLK_01535 Serine acetyltransferase
MKTIFIFFKPFTILYVWLFYKNIWKVKAKLNQQFSPFLLSIYEEYMDRKFNSWIAYNSIV
KGQPFFPHGPRGVFISGGASIGKNSIIYQQVTIGSNTLYKHRNFGSPTIGDNVYIGSGAK
IIGKITIGDNCRVGANAVVYEDMPCNSIAVSAPTRIIKKKIPMDNRFFSERGGKWYYYEN
GHWIEDIKY
>IFAGANLK_01536 Teichuronic acid biosynthesis protein TuaB
MTKKKKVIKGTKWTTLGAIVTSVVQLLQITILTRFLNKDDFGLMALALFIIGFSRIFVDM
GLSNTIIFKQNVHKSQLSSLFWLNVFFGILIYFILIISAPFIGIFYESNELTSVIIVIAT
TFLVIPWGQQYEALLKKELNFKALAIRDIIGKVTGLITAVILAYLNYGVFSLVIASLTTA
VISTFLVILYGIREYKPQFMFSYKSLKDQGFFSFGFYQVGEKLINYFNGNFDTILIGKLL
GMEALGLYNIAKSLAIKPFQILNPVLTKVAFPFFASIKGEPVRLKNAYIKVVILLTSANA
PVYILSIILSEPIISFAFGAQWIEAAPIFEILCIMILSVSVGNPVGSLQLAKGRADWGFY
WNLGLFFLMPATIWLGSSFGLLGIAISLAILRTSTIIYPIWYLFLKPLCDINYTEYFQSF
AIPIGISLISGIIPLFLYSFISNLFLATISTAIIYTLIYLMISRKLNLALIHEVKELNIF
RKIKGV
>IFAGANLK_01537 TDP-N-acetylfucosamine:lipid II N-acetylfucosaminyltransferase
MKKIIHIASDEKFINSAYWQFNEVFPNRNLFYLLVDNPYEKLKYVNQNQDFLLVEKKIKT
LKVLAKNLSYDKIVIFHGLDYYSAFLLNKISKDCQIVWFLWGWEVYNNPLIVDPRNIIGP
ITYSKFLKKTGFKVLKSSIKNILRPVYYQLFFQTNTPSETILTAIRNVKFCGILFKEEVD
FIHQKISQDVDFLKFSYYPIELMVKNEKARVNATNILVGNSASENNNHLEIFELLQRLPL
MGKKIIVPLSYGKKNYADSIISKGREIFPENFEPLIDFLPLHQYNEYLQQCGIVIMNHYR
QQAIGNVLSMLWLGSKIYLDERNSIFHFLKRKGIHVFSIEKDLRRENLEVFDLLSFQEQN
RNREILKKEVGEKQLLKELKNNFEEYFR
>IFAGANLK_01538 dTDP-4-amino-4,6-dideoxygalactose transaminase
MKIPFNKPYMTGKEAHYMYDAVHTGKISGNGKYTKKCQKYLKELFGFGKCLLTTSCTDAL
EMAAILIDIKPGDEVIMPSYTFVSTSNAFILRGAKIIFADSRKDHPGMDEDSLEDLITER
TKAIVPVHYAGVACHMDKIMDLADRYNLFVIEDAAQAIDSYYTGRNGIKKALGSIGHLAA
FSFHETKNIISGEGGMLAINDLHFAERAEIIWEKGTNRSAFFRGEVDKYGWVDIGSSFLP
SDIIAAFLYAQVENIENIQCKRKELWNNYNNSFCGILDKVNKVQLPFVPEYASNNAHMYY
LICSNAREREKLIDHLKTDGILAVFHYLSLHKSKFYEDKYEGEKLEVSESYSDYLVRLPL
FYELTEMEQDKIIKSVLEFYNTYSIEEDNTHSLRRKVYK
>IFAGANLK_01539 Methionyl-tRNA formyltransferase
MKVTLFLLNKKGYQSLKSVLIENKLKQLIELVVIARDEGNKEDYYEEIKNLCEANSIPYI
DRKDFAKVNTLYSIAIGWKWLLFNIPNLIVFHDSLLPKYRGFAPLPNMLINGENQLAATS
LFASERMDEGNIIFQKVIEVDYPLKIKDAINLIAGLYSEIILEILTYVNQAKKLPSSLQD
HSKATYSIWRDDEDYFIDWTMGAHFIERFVNAVGFPYDGAKTNLDDEIIRISDVEVIRNF
KLELIHPGKILMFNNKRPIVVCGQDAIMIKQAYHMDGKPYQFNKLRKRLK
>IFAGANLK_01540 Glucose-1-phosphate thymidylyltransferase
MKGIILAGGSGTRLHPLTKVVSKQLLPVYDKPMIYYPLSVLMLAGIKDILIISTPSDLPN
FKNLFGNGSHLGLNFQYAEQPFPDGLAQAFIIGEDFIGNDDVCLVLGDNIFYGAGLQKLL
SDSVETVKEEKKAVVFGYYVEDPERYGVAEFDEKKNVLSIEEKPERPKSNHAVIGLYFYP
NSVIEIARKVKPSLRGELEITSVNQDYLKKEELKVQIMSRGYAWLDTGTHEALTEATEFV
KAVEKRTGLKIACIEEIAYRMKFIDRNQIEKLANEDAKSSYHQYLNRIF
>IFAGANLK_01541 dTDP-glucose 4,6-dehydratase
MEFQNRKILITGGAGFIGSHVVRLFVKKYPEYQIYNLDALTYAGNLENLKDIETASNYTF
IKGDIIDANFINTLFIEYDFDSVIHLAAESHVDRSITDPLAFVKTNVLGTMNLLNAAKEN
WKKNFQNKLFYHISTDEVYGSLGASGLFTEETSYDPNSPYSASKASSDHFVRAYGESYGL
PFIISNCSNNYGSNQFPEKLIPLFINNILKEKSLPVYGDGNYTRDWLFVQDHAEAIELIF
QRGRRFETYNIGGFNEWKNIDLVKLLCLQMDEKLGRDKGTSEELITYVKDRPGHDLRYAI
DATKINSELEWKPSVTFEEGLSRTIDWYLANQEWLSNVTSGSYQDYYIKQYQKSI
>IFAGANLK_01542 UDP-N-acetyl-D-glucosamine 6-dehydrogenase
MNENIKIAVIGLGYVGLPLARLFATKFPVVGFDINAARVEELKKGHDSTLEVEDEILKAI
LVNSIYEFKKQPTLELTGEVDKVDVTPSAVEESGLFVTRDLGDISDCNYYIITVPTPIDK
NNRPDLTPLYKSSESVAKVLKKGDIVIYESTVYPGVTEDECVPVLEKHSGLKFNEDFFVG
YSPERINPGDKEHTVEKILKVTAGSTPEIGKKVDKLYKEVITAGTHLAPTIKVAEAAKVI
ENSQRDINIAFVNELAKIFNKMNIDTQDVLEAAGTKWNFLPFKPGLVGGHCIGVDPYYLA
QKAQELGYHPEIILAGRRMNDSMGKYVAGEVIKLMLQNDLKVKGADILVMGITFKENCPD
VRNTKVVDVVKELQSYGTNITIYDPLANPEEVKHEYGLQNTRQLPKQKFSAVVLTVAHKE
FLEMDLEQFKAEKAVVYDVKGVLEEKASSKL
>IFAGANLK_01543 hypothetical protein
MKIGENIKEVREKERKLNKDFVAKALGITTKAYSNIESNKSDITLTRLFEIADILECSPE
YLLNYQDKQTFSNHFNNYEGNRGVNIMYQGCTSDHVKNLENALKDSKRKHQDLEASIRTK
NN
>IFAGANLK_01544 hypothetical protein
MKVGDNIREIREVERNYKRSFVAKSLQISTRAYGNIENNITDLTLDRLEEIAKILECSPI
YILNYKDYKKKFYDHFREEIIRKTSLINQQVYQNPPSQKIIILQEELLKSERNRIALLEA
LLRNYKIKF
>IFAGANLK_01545 hypothetical protein
MKIGKNITQVRESKGYSAQFVADGINMKLEDYLKIEQDILDITLNQLNHLAAILSCSPIY
LLEYKESGGSIYNHFDNAGNNGTNIQIQGVDQKEIRTAYKELYREELERIPKLERLLRDH
NIEFDI
>IFAGANLK_01546 TonB-dependent receptor SusC
MKNNYSRLKWVALIILGGMLMFLSMVATAAIPTPLPLLQQEVSGIVEDQNGLPIPGVTIT
IKNTNRGTVTNLDGQYSITAPSNGVLVFSFIGYSTIEIEIDGQKEIDIKLEEDIAALGEV
QINAGYYNTTERERTGSISRVSSEDIEMQPIVSPLEALQGRMAGVEIEQPSGIRGVASSI
RIRGRNSLRLGGDQPLFIVDGVPINANSISSIGLFTQNSGMDPLSTLNLSNIESIEVLKD
ADATAIYGSRGANGVVLISTKRNKGGRSQVEAKIYSGFSQVSNRMDLMNTAEYLEVRRTA
FENDGVTPTESNAPDLVLWDQNRETDWQEELLGGTSPITDITMSVSGGNEQTSFRLGGSY
RKEGSVFPGTFEYNKATANFSLNHRSKDNKFALDFTANYGVDNNQLFFGSNYVRLAVILP
PNAPELYNDDGSLNWAENRWINPLNGLFKPQDIETNNLLSNLSLKYNLGKGLEFKTNFGY
SNLISGQVTKNLINSFNPVTWGYTRLSSYHSDTRRKSWIIEPQMTYNKQFGGFNVNAITG
LTFQENQNSLLTMDGTGYGDDSLVGNLSAADQVRVNSDQKINYRYAAIFGRLGLDWKKKY
YFNITGRKDGSSRFGPNKRIANFGAIGAAWIFSEETFIQQNLSFLSFGKFRGSYGTTGSD
QIPDYGFMDTYETTNGPGGLYPTKLYNPNFSWEINKKLEAALQLGFIEDRINLEVNWYRN
RSSNQLTGYPLPAITGFSSVQANLPATIENSGWEIALNTLNTKGENFFWQTSLNFTIPRN
KLVEFDNLDLTPYRQTYRVGEPLSIALVYKYDGINPDTGRYEVKDINEDGRLDFSDRTGI
AFLGRKYYGGIQNTVKVRNFNLGFLFEYINQDKHSYLRDTGRTPGYYGNNSTQILDAWTQ
AGDHTNIQQLSTSSSSSFLNALESDRMITDASFLRLKTLSLSYQFSKTFVERMGVKELDL
YLHAQNLFTLTNYLGLDPQAGLAVPPMRTITSGLRITI
>IFAGANLK_01547 SusD-like protein
MKYIKILILALACLLQLSCEDFVEIEIPDDRLINKSVFSSDKTANSAVKGIYNELYQANF
SSGLQVSLTVLSALSADNLKATVTTENLLEFEANEIFIRNSYNLGIWSSAYNIIYMANAV
LEGLTGNNNISQDLNEKLSGEARFIRAFTYYYLVNLYGEVPLVLATDYEENSRKSRNSTS
EIYAQIVQDLEIATEQLGNTYNNGERLHANRFTAMALLARVFLHLGEWELAEDYSTEVID
ASQTYELLAHDEVFLANSKEAIWQISPREGGSSRTNTREGALFILVNNLRQVALTEDLID
SFESNDTRLEQWIGHFKTENESYFFPYKYKIHTDTEEISEYSMVMRLAEQYLIRAEARAE
QGKLAESISDLNKIRQRSDLIPVDLDDPGITSDMVINLILQERRKELFTEWGHRWIDLKR
KGEAGAVLSSKKPLWDNTDVYYPIPEDELLKNPNLTQNPGY
>IFAGANLK_01548 hypothetical protein
MKIKIKKRIFLSLIANLIVSISLANTSISNDSIPLDASIRYGELPNGLTYYIKPIDNPGA
GLNLRLIVKAGIRQEKNGELEFAHITEHLGFVSGKNISRKKSTHLFDEAGVRLSQLNGST
AGNYTNYSVQVSDDNEKGITLALNFFKDILWGLELNEKNIRLERITVFDEANGGVFHPGI
HSFHLEQQITGWGAEAPEDFEKHIKTFEHKKLIDFYEKWYRPDLMAIVIVGNIDNIDNLE
KELKEKFGTKKRPGIPPNPDVDQINYLEKAPQFYKKELQSDSEHLIYKPLHLSLYFRQFE
SKKHQNKQELKNQLIRNLFIELLNKKYLQVLQEYNTFTSIRAKFLDPPAALRLEIIPKEG
LKQKHLSTALTTLREIKEFGFSANEFNQGKAEYLNSIRETDTLSQFQWKNKIIQHFLYGE
ALPGNKEQLQVGILQNLNQEEFHREIKNYIKEEPEDISLVAHKDDPALENSEKKVRFWIK
EVNNLPVEASAPPKRNLVLMDSSVATALNETPVKDLETEISGAKSYEMENGLRVILKSTL
SQTSDAVSDQNSIRFQGFSPHGINCFPKEDYFSALNSTEILRNSGVGKLNKFELDRILNR
KRFKGFVSPYIESDAAGIRANITLKDLETALQLVYLYFTSPDFNTTAFEDWKTRQKIYIA
YKNNPAQNFETAIREFLPDNDYKPKGQKFIEGLDQTDLDRAREIYNQIFNDAGNFTFLFT
GKFNEEVVLTLCQKYLGNLPAATENSSCITKKDSLVLPIESKTFYSVAPLNSTIIKMVYV
KESNSSSMDWQEEIKLILLNRIIKESLMRRLRFESEEGGTYSVTPALNIVNSHNYIETPI
GFNANPKDVERLILEVQNFIEELKSSPVEISLFEKLKKARLNKKMRNGLTLMEMLKHSKD
NSPWLDNDERSAFINTLQPKDIQETARKYLSNEPIIFKMLPKENKE
>IFAGANLK_01549 hypothetical protein
MKLKKFLLPMMAFIFAIGMAFATVNMEPEPEIPESDNYATMYVHINGEWYDIQVDCEIGT
SDCIVEFDEDPTLGATYEVYNSDDFNDPAEGGGIIKSLEGFPPTDDN
>IFAGANLK_01550 Transcriptional activator FeaR
MLTPNQIYDHRFMQLVKALLKMASGNFLYRIPISDARDWKDTLGMLINKTNIRLNTMFNE
IKKTRVYTHPQIILLINSKKELLTHTDENHQIISKELIPKTLNDLLSVKGRKIFSKHWYK
WDKKTLSCYDMGILDFRGETELLVPLHIQVRQSRALLEDSWYYIFGFDPQQPVPPLRTKE
QDTLKTFPGKKAKNNSKTIGDFLLAQRVHDALLKHQTSSIPSLEVIASEAGASISAMQKA
FKDRYGKAVLKYDMEKRLEASTFLLKESDIEIKEVSKNYGFKTDSHYISRFREKYGITPL
QFRKKAFFNKHN
>IFAGANLK_01551 hypothetical protein
MQEESKYATMWVSEGILYFTFKAIAELDLKKAEILVASRLKFQDKTPYPVLCNIYNLKTV
SEEAADYLATEGIALIPAIALLCNSYYHRVLAEVFIKFHNLAKPIQIFSNKQEALDYLQK
FIQKKS
>IFAGANLK_01552 hypothetical protein
MRRAFSSYLLQVEFKAVHIHRMDGLDATILLIFSGTLIALMLGVLSYIDKLYFKYKPANS
DTELTSCLTSSKRIL
>IFAGANLK_01553 hypothetical protein
MVLFIFLNSFTDAVDKDLKFEVINFIVFSLKPFIRFLVKGKPK
>IFAGANLK_01554 TonB-dependent receptor SusC
MKQFYLILIIFNLSWGMQAQEEISGLVTDPDGLPLAGVAVSVNAGAVGTVTDFNGRFSAS
VKKGDTMSFSYLGFLSKVVPVADQTEISITLEPNTESLDQVVVTALGITKAEKKIGYATQ
EIETDNLDNLPIANVGNLFSGKVAGLQVSSPPGMFQSPTFLLRGKTPLIVIDGIPVETDF
FDISQNNIGSINVLKGTTASALYGSRGRNGAILISTKNATENGLSVGVSQNVMVTAGYAI
FPETQHEYGNGSNGQYEFWDGADGGIADGDMIWGPKFDSDLLIPQWNSPIVDNETGEIIP
WWGSVTGTQYDDRSRYSRQALPWVGHDNLDDFLRTGVISSTNFNIGHKNENGFYRLNGNF
SHNRDRVPNSSLSQGGLSFKSLTNITDNLSLSSKLTYNKVYSPNSPNYGYNPSGHMYTLL
IWMGEDVNGRDLRDHQWVPTLEGYRQANWNYAWYNNPWFGAEHYQKEYDADLINAQMRLS
YSLGEKFQFQLRGSGVLRNNFEDLESPKSYFNYSAPREGSYQTWNKSRLNIDYDFLATYN
EELTEDIGLVVYAGASTFYRKYQQEFSATDGLTVPGVYNMGNSTGPVRAENYFEEKAINS
VYGTLELDFYDTYFLTAAARNDWSSTLPKENRSYFYPSLSGSILLSNIFDLPKKVNYMKL
FSSWARVSSDLNPYELSAYYNSSGNFANNQRLNYPSDIVNPNIEPETSTSYEIGLNTSFL
DNKLALDATYYHTVDTDQIIDQPISLASGFSFRKINGNEYTTNGFELSLSFKPVQNENFN
WSGILNWSKRVTRLSEITGESQKFGNLSLDDRVDSYYDTQWRKSPDGQVILDEGTGMPTR
DTYVSYLGHFDPDWTFGFVNDFQYKNWHLNVALDGIWGGVFRSEVVEKMWWGGKHPKSVQ
YRDEEYAAGQPVYVPQGVNVVSGELVRDVNGNVTSDNRVFQQHTTPISWQAWSQNYPYRA
RVTEDESETFANVFDRTYLKLRSISLSYNLTEILGSKTIKDASVSFNGYNLFVLTKGDYH
TDPDYKTQNENNIQDPSSRYLGLGLNFKF
>IFAGANLK_01555 hypothetical protein
MKSIKKYFYLLIVVVLLQACQDLDEINENPNYVNQTHPQLLLTQVASSAFQVQGTSPLYA
SRMLIQTGEENDYQYFKWGNGSYNTYNDLRQVTIMIEEAQRIGSSNYEAIGKFFRAHYFY
KLSLMFGDIPYTDALGGESGSFQPRYDSQEEVFAGIITELDEAASLINEETTIDGDIIYG
GDPSRWLRLINSFELKVLLTLSGKERVGEINTAAKFNEVYTRGPLISSLSENGQLVFVDQ
QDSRYTEFNSSSYGSSMFMSATFIDLLQELADPRLFIIAEQTPGAASEGKPINDPESYNG
GDPTANYSLINETLVADGNISKVNARYYTDPTTEPHNILSYWELEFILAEAAVRGWINSD
APMHYENGIRANFEFYRNYAEPYSDFLSEDFVEQYTNQEQVVLPTGDQGLSIEYIITQKY
LSSFLQGGWTQYYDYLRTGYPDFAFPSGATPPTRFVYPNDEYNNNTTNLEEAINNQFNGN
DGIRELPWWLK
>IFAGANLK_01556 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MKKIFLLLTIVCFCTGMVKAQQKEKVIIISLDGLRWQELYGGADSLFINDSDFVSNPKSL
NTEFWAKTKEERREKLMPFFWSHVSKQGVMLGNRWKGNKVNLTNKMLFSYPGYNEILTGK
ADDEHINSNNKAHNPNITILEKANFSEAYKNKVEAFGSWDVFPFILNEQRSKIPVNAGYR
AAITSYPTEKELYLDLIQEQTPRRWEGVRFDVFTHNYALESLKNRKPDVLYIAYGETDDF
AHDGRYDQYLKSAKRTDQMIRELWEFVSNDSYYKGKTSVFITTDHGRGTGTAKDNDWRHH
GSSIPVSDQTWIIAFGNHIVPSGEQEDKKQYYTTQFTPTIAEILNIEMEQKGSLLPVLEE
>IFAGANLK_01557 hypothetical protein
MNMEINNTKAANRSGILKLALVLALISASTPALAQSNNEVSFYLQGSFSELGYEALGQKS
KLENGFGLGAKYAYYFSENWSLGTGAEFQYMEGSIFVPAIQGAFMTQDAEADAFEFRYQA
DNFSENQKVYFLNIPLQIQYESLGLTRFYAAAGVKVGLGLASEYNTYATSLETSGYYPQY
DVELTDPEFAGFGEFGAVNNAKSELDLKTNFVAHLESGVKFMLENRQSLYMGIFLDYGLN
DIKPDTSGQRLVDYNAQNPTEFAFGSVLFSRNDMNSEPYVDEVRTLAIGLKVQYAFQF
>IFAGANLK_01558 hypothetical protein
MGSLSAGVNYTIDYTGADFTIGTKVLSVTADTDQSKIYGETDPEFTYTATGFENEDDASI
LSGSLTREVGEAVGIYSIGLGSLSAGANYTIDYTGADFAINAKVLMVTADPGQSKIYGDA
DQIFTYTATGFENGDDASILNGSLTREPGEAVGIYSIDLGSLSAGANYTIDFTGADFAIN
AKVLMVTADPGQNRVYGDADPIFTYTATGFENGDDASILNGSLTREPGEAVGLYAIQQGM
LNAGTDYTIDFSSADFEITPAIITGVAFEDVNEIYDGTAKSIEVSGLPDGASVNYANNEK
TNAGTYEVTATVRQENYNDLVLTAELTIEKAAAVIAADAVQAFTYNNEVKNVVASLNHTE
TGLTYMPQQGYADAGTYVIEISSEETANYLSASREVTLVIENTEIDGVTLEGASYVYDGT
SKSLKVSGLPDGAAVSYANNGQINAGSYTVTATIRLDNYDDKVLTAQLDIEKAEQEINFN
EIEDRNQQTDEHFQLEAISSSGLPVIYSYTYETENPAATVGPRGLVRILGGGEVWITATQ
EGNRNYEAATPVVRTLTIVGGTARLNSVIINGTPYSNPGEEIYYLIDCGNAENEVHIELE
QNEGSSIDQGDSFTMSTPGAGIYRETVTVTSEDGNTTKTYNITVEKNFNFEDIVIQKFNN
VMLINNNPETNGGYKFVSYRWYKDGSVIGNEQYFSAGKNADDLLDAESSYYVVLETAEGE
ILKTCTSEIQLRSSFNISLAPNPVSSGGTMELLADFPKDELETMQLSIHNLNGTLIKHLK
SNRKITSITLPYTLQMGVYVLKIRTENFNKSVKFIIK
>IFAGANLK_01559 Exopolyphosphatase
MAKNTSNSKPKKRIAAIDLGTNSFHAVLVDIYPDGSFRTVNKLKEMVILAEKGLEDKLSR
DAMDRGLEALKRIKFLCDSHKVENILAFATSAIREAKNGGDFIKEVGENVGIRVRAISGK
MEAEMIGLAIRHSIVLGEEMVLMADIGGGSVEFIIGNEKEFIYYNSLKLGVARMAAAFVD
SDPIEEKDIKKLQKHFAKELAEVLKLAKKHKVKTIIGSSGTMENIGEMVANRNSITAKRS
LNELELNADDFKDLYKDFIKLNKKDRLKEKGLEEKRVDIINPGMVLLKFLIDKFKIENIK
ISEGALREGMILNYINNQKEQLNLDLVANFKDPRRRSIYELLRKCNWPEKHSRHVSNFAL
QLFDEFKEELKLKESDRELLEYASLMHDIGYYISYRKHHKHALYLIRYSDLLGFKEDEIN
IMANVARYHRKSTPHKRHEPYKQLNKKSRKRVKKLSALLRVADGLDRSHYQNVEKLEINN
KKNKIQLIITTHSDPELEIWGTLRKGDLLEKLTDKKLEVFHVVENEKK
>IFAGANLK_01560 Amino-acid carrier protein AlsT
MNQLDEFVSQFASAVWGLPLVILLIGGGLYLLILSNFLPFRYLGHSLDLLRGKYNNPNDP
GEINHFQSLSTALSSTVGMGNIAGVAVAIALGGPGAIFWLWVSAVVGMATKFFTNTLAVM
YRGIDTQGNIQGGVMYFIEEGLGKKWKFMAIFFSVAGLIGALPVFNVNQLTQAINFILLE
PNNIPTGFGTNLIIGIILVILTSVVILGGLQRISKTVSKLVPAMVALYFVSVIIILIVNY
DVVPYYFSTIFTDAFAAENYKGEPMLGGVLGGLIILGVRRGAFSNEAGIGTATMAHGASK
TSEPVREGLVAMLGPAIDTLVVCTLTALCILVTGIWQTSDVNGVSLTAAAFEDSIPYVGD
YLLLLCIAAFSISSLFSFSYYGTKCLSYLAGAENKHYYNYFYIISILLGATTSLSMMINL
IDGFFALMAIPTMISTLILAPRVMKAARIYFKKYKD
>IFAGANLK_01561 Peptide chain release factor 3
MKSFQKELKRRRTFGIISHPDAGKTTLTEKLLLFGGAIQEAGAVKSNKIKKGATSDFMEI
ERQRGISVATSVLAFEYKDIKINILDTPGHKDFAEDTFRTLTAVDSVIVVIDVAKGVEEQ
TEKLVEVCRMRNIPMIVFINKMDREGKDAFELLDEIEQKLNLTVTPLSYPIGMGYDFKGI
YNIWEKNVNLFTGDPKKDIEDTIEISDLTSNELDELIGSKAADNLREELELAQGVYPEFD
EEAYLEGRLQPVFFGSALNNFGVRELLDCFINIAPTPRPKQSEERLVKPDEDKFTGFVFK
IHANMDPKHRDRLAFIKIVSGKFERNKAYLHVRHNKNLKFSSPNAFFAEKKEIVDVSYPG
DIVGLHDTGNFKIGDTLTEGENLNYRGIPSFSPEHFRYINNADPMKSKQLAKGVDQLMDE
GVAQLFTLELNGRKIIGTVGALQFEVIQYRLEHEYGAKCTYENLNVYKATWVEAEDEKSE
EFKDFKRLKAKFLAKDKKGQLVFLADSQFSLQMTQDKYRSIKFHFTSEF
>IFAGANLK_01562 Outer membrane porin F
MGQYFRRSIVILSFLFTGYNCFGQRNEQVIAPGAYVINMGSNPQTAENSLQVYGLIYNLL
KNERIEVKWIINPRKEKDGTDFTYKDIDFKGSAFVIPVSYITEDIKNLILAWEEKGIVGL
FLEEAIDVPVFTSLSVAPRWTLDRENGYIALPFFKAAAIPEEAYGGNTSKNWKAPEDLGV
CDDIFVMPHADPSFSTHKNLYKWNNKYKGAIWAGCHAVSKLENLSGNIKLQDEDSTAFIQ
LNFLSSGFPGAQSAGLIHYKDHRHGTPPYLNLLPADPVAQYIGRPDEAHLNGSERIFLPK
KINRWRRETNKIVIDEDAPDIPEIAEDTAVVTAYGHAFGNPENGLVMYQAGHSIYGKKPS
NIAALRPFFNWSFYAAEIKRRKNVLEFGNLEGRPVLDAKVGDDLAGILRLKPIHFDLDKA
EIRKNDKPALDSIVTFMKTHPELLLDIRSHTDSRANDTYNLQLSERRVEATIKYLTESGI
SEGRITGRGYGETELLNNCGNYSICTEAGHEENRRSEFILAIDCDIYAKNEF
>IFAGANLK_01563 Isopentenyl-diphosphate Delta-isomerase
MGTDKVILVNEKDEQIGVMEKIEAHEKALLHRAFSVFVFNDKGELMIQQRAHAKYHSPGL
WTNTCCSHQREGESNVAAGKRRLQEEMGFSTDLKEIMSFIYKAPFDNGLTEHEFDYIMIG
NYEDDPNPNPDEVANWKWMSLDAIKSDMEVNPGVYTEWFKIIFDKYYSSIQK
>IFAGANLK_01564 6-carboxy-5,6,7,8-tetrahydropterin synthase
MRLSVHRKAHFNAAHRLYRKDWSDEKNLQVFGKCSNPHYHGHNYDLIVKVTGEIDPETGF
VMDLKRLKDLIYEEVEVPFDHKNLNEEVPPFNELNPTAENIAVVIWNKIREKLKPELDLE
ITLYETPRNYVTYKGE
>IFAGANLK_01565 Putative peroxiredoxin
MKDQDGENYHFSRVEDKALVIFFYPKDFTPGCTKEACSFRDHYEEFQDLGAEVIGISTDN
ENSHKKFATKHQLPFVLLSDKEKRARKAFGVKPGLMGLLPGRETFIFDKNKKLIHRFNSM
GASQHIPEALNSLKKIQEK
>IFAGANLK_01566 hypothetical protein
MASKRLLKRDVNYVMGDIIDAAYIHQMANPDDASKTEAIVDEAIADFDELITKINQKDVE
NKKQHFKAVSKELEAKAEALIAKINAL
>IFAGANLK_01568 putative malate:quinone oxidoreductase 1
MNQKVLKENNYDLICVGGGIMSATLALMLKLIDPEIKIIIFEKLREVSKESSGAWNNAGT
GHSALCELNYTPENSDGSIDISKAIEIFSQFETSKQFWAYLVGQKLIKDPQNFIHSVPHH
SWVQGEDNIQFLKKRFEALSQTSLFEEMKFSENPNKLKEWIPLIAQGRENEKMAATRMEI
GTEVNFEELTQQYFKVLEEQFDVPVLRNTDVLDVDPDETLEWTVEAQNLDSGKVTYYDAE
HVFIGAGGGALPLLQKVEIEEKDGYGGFPVDGQWLVCKNREIIEQHWAKVYSKAGPDAPP
MSTPHLDTRYINGKKELLFGPFAGFTTKFLKEGSKMDLPKSINKENIPSMWGVFWHNLPL
TKYLMKQVTMDHSDRMEDLRVFIKDARPEDWELKVAGKRVQIIKKDEEQGGILEFGTDVV
HSKDGTITALLGASPGASVAVSIMLKVINIAFPGRIKSKEWQEKLSKMIPLWDKKIEENI
PEFKEVQANSSEKLELDVLH
>IFAGANLK_01569 putative MFS-type transporter YhjX
MSAPNKNRWLIAASAVFIHISIGAAYAYSVYTQPLVETKGWSMASVTTAFTIMMVLGGGS
AALFGKFVERSGPKKSAMLAAVLFGLGQAGSGFAISMDSLTGFLLSYGLLSGLGLGIGYI
APVSTLVKWFPDKRGLATGMAVLGFGTGALVTAPVAASLIESIGISTTFYILGASYFVLM
MIGASYIAPPPKNWMPAGMEAAVKAGTKKIKKDLTQATSGEAVKTKHFWMLWTMMLINTS
AGIMMISVASPMAQNIVGLSAGAAATMVGIMGIFNGGGRLGWAAASDYISRPKVFIIFFI
IQLVAFISLPIITSAIIFQIFIFLVVSCYGGGFSNLPAFIGDLFGTKELGAIHGYLLTTW
SLGGLIGPTLVSQIYTRTGSYIPVFYVFTALIIVALIISLLLNRSVKKVRTEHKEFEYKT
SASD
>IFAGANLK_01570 hypothetical protein
MKKLSILFLAIIALTSCNNKESNLIVNASIDGLKKGTVYLQKIDDTLMVDMDSVVVNGDA
NISLEAFIESPQVLYLYLKKVDNSQYDDRIDFFAEEGEVTINTTLENFVTDAEITGAKNQ
EKLEEYRTMMQRFNDKNLELIQMNFEAQRDENEEQLIDVNKQYESLLKRKYLYTVNFAIN
NKDLEVAPYLALSEVFDANIKYLDTIYKSLEPKVKKSMYGKELKDFLKERRDEEEASDNV
KPVETEENAEDIS
>IFAGANLK_01571 hypothetical protein
MEDTPVFTNDAIVFGLLMLALGFVFYTSSKEGGFWKKFYGIVPALLMCYLIPAIFNSLGL
IDDGTSQLYFVASRFLLPAALVLMTLSIDLKAIFNLGPKALIMFFAGTVGIIVGGPLALI
IVSAISPETVGGVGPDAIWRGLSTIAGSWIGGGANQAAMLEIYEYNPELYGGMVLVDIVV
ANLLMAGLLMGIGKTEKIDKWLKADNSAITELKNKVSNYAESVTRNPHLPDYMIMLALAF
VTVGIAHWGADEISVYLSSNFEVFNDSKSALSSFSSSFFWMITIATAIGIGLSFTRFKTY
EGAGASKLGSIFIYILVATIGMKMDLGMVFDNPGLIGIGLIWMSIHVIFLFGTAKLIKAP
YFFLAVGSQANVGGAASAPVVAAAFHPSLATVGVLLAVFGYVVGTYGAILTTILMQIAAG
S
>IFAGANLK_01572 Putative phosphatase
MQYKIVFSDIDGTLLNHDRELSPTTISTIKNLKDKLPFVLISARMPAAMRHLQADLEINE
QPIICYNGGLILVDGEAISSTEIPLNTLENLADFNKNMNCHLSLYNSDEWYVPQYDQWAA
REENNTKVKPELRSNREVISDWKKDNKGAHKIMAMGDEAHIDKIKDYLSENFPGQLHLYR
SKPTYLEIANKEISKLTAIKLLLKNHFNLTPEQSIAFGDNYNDVEMIKGVGMGVAVRNAR
KEVLEVANIVTESGKEDGVANSLKELFKI
>IFAGANLK_01573 hypothetical protein
MSNKKAFALRVDEKMLKAIEKWAADEFRSTNGQIEWMLNKALKEAERHPKNKKEEE
>IFAGANLK_01574 Esterase EstD
MRNLILSLFLIFFGSFIAFPQEQTFTEEEIAVDKFTDGTIVIPSSLENPPLLILIQGSGP
TNRDGNSPAGMNNKSDFAKKIAYELADEGIASFRFDKRSIKAKELNLDSISFNDLVMDVE
NILIHFKEKRNFSHLIIAGHSQGSLIGILAAKDNADAFISIAGAGESIDHILAAQLSVQL
PQSEDEIKQSFKEIKETGSTDKYPQILGSLFTPENQAFLASWIKYDPSEEIANLQIPVLI
INGTNDVQIKEEQAEMLHKAAKNSELVLLKDMNHVIREVSSNDLTKNYQTYNNPELALHP
EIIPVLTDFIKNLENK
>IFAGANLK_01575 hypothetical protein
MTQEKDLNASNGYIMLFVFLLLFFGSIIGFIILSNAWFILGIIISLFILPGLILVNPNGS
RVLLLFGDYKGTVKKNGLFWVNPFYTKKKISLRARNFDSERLKVNDKLGNPVMISTILVW
RVRDTYKASFDVDNYENFVVVQTDAAVRKLASLYPYDNFADEGLDEDITLRSSVNEVSDA
LEKELEERLHIAGIEVLEARIGYLAYANEIASAMLKRQQATAIVAARHKIVQGAVGMVEM
ALHQLSEKNLVDLDAERRAAMVSNLMVVLCSDKDATPVVNAGTLNH
>IFAGANLK_01576 hypothetical protein
MKKLLLFALVVLIGNTGFSNDNDWGKTGHRATGEIAENYLNKKAKKAIDKILNGQGLAFV
ANYADDIKSDPDFRQYGPWHYVNLAEGQTQYDTETANPKGDLYQAILKCKEVLKDENASK
EDRQFYLKMLVHFVGDLHQPFHVGRASDKGGNDVQVRWYNQGSNIHRVWDSQMIDSYQMS
YTELAANTKQLSRAQIKAIEDGEVIDWVYESGAMANELYDSVETGEKLGYEYMYHHLPTV
LEQLQKGGIRLAKILNEIYG
>IFAGANLK_01577 hypothetical protein
MKSEIFSLPDAELHYFPDFLNTEKADFLVGKLLKEIPWQQQNIKLFGREIPQPRLTAFFA
EKGISYTYSGLQLEPEIFSAEILELKQKTEELSGFEFNTCLANLYRDGNDSMGWHADNEK
VLGKNPVIASISLGGVRSFQFKHKTNKNLKEKIELQHGSLIMMKGCMQHFWKHQLPKTKK
KVSPRINLTFRKIQ
>IFAGANLK_01578 hypothetical protein
MQYPWHLYLMGAMYIVAGIIHFIKPKMYMRIMPRYLPAHKPLVLLSGLAEIFLGFLLFFP
ETKALAIYGIILMLVIFLLVHFYMLSSKKAGAGIPKWALILRIPLQFFLMYWAWFYLQF
>IFAGANLK_01579 Aerobic respiration control sensor protein ArcB
MRIKNVTVLLIFLVSSLAFSQSKESKSSDSIKELLDLSTDAMYSYEYTKAIDYSLNLIEL
AEEEKDYYHLYHGYNNLGITYDELYDTIRAKESYENALKYAKIVKNDTLLWWAFNNLGNM
YTSNKETIDQGFAYYDQAIKAASNLDDPDSRATPLINKGWTHLYMEEYDEAYPYLIEVQK
LIEDFEDPYILSQIASLFGNYHSGKNNYEKSKEYYEKAIEIAEKDSLYYEAVTAYDGYAE
TLFKNEEFEEAYNALDKYIEYDAELYEKEKLEQMETAQARFETKRYRENLEIAKREQKYK
DEVIAKSQQNSIIMIISLIVMLFFIILLVKNNSTRKKLISQLKNKNSELITAKDEAERLS
MLKSQFFSTVSHELRTPLYGVVGLTSLLLDDKSLKKHESDLKSLKFSADYLLALINDVLQ
MNKMESKQVKLENVSFNIKELILSIVNTFEFTRLQNKNKVHYNIDEKIPENLIGDPVRLS
QILMNLVGNAVKFTENGNIHINVELQTKVEDRAVIYFEVKDDGIGIPKSKQKLIFEEFSQ
LKPSNYNYQGTGLGLPIVKRLLQLYESQIHLKSKEGEGSVFCFSLSLKEDKSSTKKAGFA
HEVYLDNLKEKQRILIVDDNRINQVVTRRILEKQNFECVVVGNGVEAIERVTAENFDLIL
MDLNMPGINGMETTKRIREISKNVPVVALTAVEIEEVRNEIYAAGMNDIIVKPYDVERFY
QTIKRNLSSNLETSSKD
>IFAGANLK_01580 Chaperone protein HtpG
MATGKINVSVENIFPLIKKFLYSDHEIFLRELISNATDATLKLKHLTDIGETDVKYGNPV
IEVKVDKEGKKLHVIDQGVGMTKEEVEKYINEVAFSGAEEFLEKYKDSAKDSGIIGHFGL
GFYSAFMVANKVEIITKSYKDEPAAHWVCEGTTEFTLGDSDKQERGTEIILHINEEDEEF
LEENRIQELLVKYNKFMPIPIKFGTKEETLPLPEDAPEDAEAETKTVDNIINNPEPAWTK
QPTDLEDKDYKSFYRELYPMQFEEPLFHIHLNVDYPFNLTGILYFPKMTQDMNIQKDKIQ
LYQNQVYVTDNVEGIVPEFLTMLRGVIDSPDIPLNVSRSYLQADGAVKKISSYITRKVAD
KLKSLFNNNREDFEQKWNDIKIVIEYGMLSEDKFYEKAQKFALYPTVENEYFTFEELQEK
IKDNQTDKDGNLVVLYASNKDEQHSYIEAAKAKAYKVLLLDSPIISHLLQKMEGEKEKIT
FVRVDSDQVDNLIKKDEEKISKLSEEEKEKLKEDFEKVIPKEKYTVQLEAMDSDAAPLLI
TQPEFMRRMKEMQQTGGGGMFGMGNMPEMYNLVVNTNHPLISDILNTKTEKKQERLIKHS
LDLARLSQNLLKGEELTNFVKRSFDMVK
>IFAGANLK_01581 hypothetical protein
MATTSKKTTTKKVLDKDKLIAMYMDYVLEQEHRPKTVYKFCKENKIKEEEFYNFYGSFEG
LQKGIWERFYEHTMNAINKSPEFESFSNREKMLTFYYTFFEMLTANRSYVLFSLKEHESQ
LKNLQQLKGVRKNVKSFATELIQDGNSDKAISALQQSEKVFSEATWVQLMFLMKFWMDDN
SPQFESTDVAIEKSVNTVFDVFDNTPLERVIDLGKFLWKEKMA
>IFAGANLK_01582 putative protein kinase UbiB
MKTIDNIPTGKIGRTSKLVQTGVKLGGNYLKYYSKRAFDSELTRDELDQSNADDIYDGLK
SLKGSALKVAQMLSMEKSLLPNAYVEKFSLAQFSVPPLSAPLVRKTFKKYNGAYPEELYD
KFASESVNAASIGQVHRAEKDGKKLAVKIQYPGVADSISSDLAMVKPIATRMFNLQGKDS
AKYFKEVEGKLLEETDYILEVKQSKEISEACAHIPNLKFPRYYEDLSSERIITMDWMDGK
HLSEFAKENKDQEKANKVGQALWDFYMYQMHGLKEVHADPHPGNFLIDKNANLIAIDFGC
IKQVPEDFYVPYFELAKKENINNPEFFNEKLFELEILRKDDSEREIKYFSELFYQMLNLF
TSPFHEETFDFADETFWNSITALSEKYSKDTELRKMNGNRGSKHFLYINRTFFGLYNLLH
DLEAKIEVNKFRDYMS
>IFAGANLK_01583 Dipeptidyl-peptidase 5
MRKIILSIFSLFSLLLSFPALFAQENLTYQKPPQEILDLVDVPLAPSTILDSDGEMMIFL
YRDQYKSIAELSEQELRLGGLRINPVTNISSRATYFNNLEVKPIDAETPMQVTGLPENPR
LSNFSWSPDESKIAFTHTTNTGVELWVLEVENAQARKLTEANLNANMRNVVNWFKDNASV
LVKMLPEDRKDLIDTETAVPTGPTISVSDGKEAQNRTYQDLLKNPNDEYNFEQLARSELV
KVNLDGTSEKWMDAKMYSSVSFSPNGEYVMVNHIKKPFSYLVPYYRFPSETNIYTLSGEL
VNQVNDEPLLEDLPQGFMSTQTGRRSVQWRNDKPATLVYVKALDEGDPEIEVDYRDEVYI
LEAPFEGEGKSMFKTKDRFSGITWGNDEIALVDDYWWNTRNTRTYVFNPSDASEEPEVIF
DRNYQDRYSDPGRFVTTKNEYGQNVLKLDGEDAFLLGAGYTEEGQFPFADKIDLEDGETE
RLYRSEYNDKKETLVEALDIEDGEILVRIESATEYPNYYIRDIDDNEDLTQITSFENPFK
SLENVSKEVITYEREDGLELNGTLYLPAGFDKENPEEHPMIVWAYPREYKDKNSASQNTS
NANDFTYPYYGSPIYWVNRGYVVLDDASFPIIGEGEEEPNDSFRKQLVANGKAAIDAVAE
KGYVDRDRVAVGGHSYGAFMTANLLSHSDLFAAGIARSGAYNRTLTPFGFQSEERNYWEA
PEVYYNMSPFMHAEKMKTPLLLIHGEADNNSGTYPMQSERYFNALKGLGATARLVMLPKE
SHGYSAKESVLHVLWEQDQWLEKYVKNKEESGDIETSAELKD
>IFAGANLK_01584 3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 1
MYQSKIAGVGSYVPENVVTNDDLAQRMDTNDEWIQERTGIKERRHIKKGDGNSTAIMGVK
AARIAIERAKIDKDDIDLIVFATLSPDYYFPGCGVQVQEMLDIETCPALDVRNQCSGFIY
ALSTADQFIKTGMYKNVLVIGSENHSGGLDFTTRGRSVSVIFGDGAGAVVLTRSDHNGEG
ILSTHLHSEGKHALELSLKGPSTEHWVPEIIAENPQGDDIPYYPYMNGQFVFKNAIQRFS
EVIMEGLKANGLEVKDIDMLIPHQANLRISQYVQQKFKLSDEQVHNNIQKYGNTTAASIP
IALCEAWEQGKIKNEDIVVLAAFGSGFTWASAVISW
>IFAGANLK_01585 hypothetical protein
MSNLKEGGRRNKWYLILGILFLVYGVYRLYSHLTAEETDNFGSVLAVGFIVFGLYDLFRY
FRKV
>IFAGANLK_01586 hypothetical protein
MSSDESYERVYTGSEPNVQYLQELFDKANISSRVRNDFDSGLRAGFGGGLRGQVQLFVVK
NHYDEALKIAKTTFPKDFKDE
>IFAGANLK_01587 hypothetical protein
MLKKKKMKLKLALRRTNLEEQLYKSRKQRISSENVLQQVQEIFEQEAVKADKILEEIHSG
SAGNNNFNLDLLESNRIFHLSDIEKLCIDYRLRFLDSGYFKGEIPYEAVSRIKAIEKEQQ
ISLKGFKIVAPSKLFKLENADDPLLFAPMGNDYFYLIHKWGNDLHPLRKLLMWPFRHLEN
FIGSLLVLSFILALLIPDGLFSPQQTTTQFFMIFFFVFKWVAGLAIFYGFKKGKNFSSAI
WRSKYYNA
>IFAGANLK_01588 Immunogenic protein MPB70
MRKLKHLGILCFLFIGGTLMAQNGSTMVGGAEMSPRKNIVENASQSSDHTTLVAAVKAAG
LVETLQGDGPFTVFAPTNAAFEKLPAGTVEALLKPENKEKLQAVLTYHVIAGNFSADDVV
AAIKEADGKATFETVSGGKLYAMMEDGKVKLKDASGNVATVTIANVNQSNGVIHVIDTVV
LPGK
>IFAGANLK_01589 hypothetical protein
MKKLKLFITTITAAAFLMSCGSGSNISKDSARKLKNYDTYSYLPNQDTILNRDYDNDRVH
EVIISTINNNMSSEDFAIDNRQPDVLIYVHTMFDEKVDVNANPVYTNFSYYRPGLYIGPY
YEDYTYENYFTIQRIGADDAVKQLPYKEKSIVIDFIDRRTNQILWRGTADEEIGSRRLER
DLRNYVDEIFKKFP
>IFAGANLK_01590 Phenylalanine--tRNA ligase beta subunit
MKISYNWLKQFIKLPEDAEKTGELLTDLGLEIEGLQPFQSIKGGLEGIVVGHVLECKSHP
NADKLQLTNVDLGNGEQVQIVCGAPNIAAGQKVPVATIGTTLYDEKGEAWPIKKGKIRGE
ASYGMICSEKELGLGQSHEGIMVMQDDLIPGTPVAEIFDVENDQVFEIGLTPNRADAMSH
WGVARDLKAGYTQQGKNLELITPSVSSFHVDNRSLKIQIQVEDSALAPRYCGVTISGLKV
EESPKWLQNRLKAIGLGPKNNVVDATNYVMHELGQPLHAFDAGKIAGNEINVKTLEKGTK
FTTLDEVERELHEEDLMICDAEKPLCIAGVFGGATSGVTQATTQIFLESAYFNPVSVRKT
AKRHALNTDASFRFERGIDPNITEYALKRAALLITEIAGGEVTSDIDDLYPKKIEDFQVF
LTFDKVNKLIGENLEEETIKSILASLEIRVNNVTETGMGLTIPSYRVDVQREADVIEEIL
RVYGYNNIKFGEKLNASVANSSKYEDYKLQNIIANQLVGQGFYETMANSLTTPAYSELSE
QIKESQNVKMLNPLSQDLSVLRQSMLYSGLESVSYNINRKRSDLKLFEFGKTYHDFNGSR
VENKHLSIFISGNRNAERWNSVSAKTDFFLLKGVIQSIFQRFGIENLKPSAVKSDVFSEG
LIFSSAKNNLISFGVIRKKVLKHFDIEQEVLYADINWDALLEVVKTRKTNFSTIPKYPAV
RRDFALLLDNNISYDQIEEIALKTEKKLLKEVDLFDVYQGKNLPEGKKSYAVSFKFQDEN
KTLTDKQVDKMMKKLQQKFEDELQAELR
>IFAGANLK_01591 ATP-dependent DNA helicase RecG
MNANILQTPIDYLKGVGPNRADLLRKELGIYTYQDLLNFFPNRYLDKTRFYKINELQRNS
AEVQVVGKITHIRSVDQKRGKRLVADFIDDTGKMELVWFRGQKWIRENLKINTPYVIFGK
TNWFNGLFSMPHPEMEPVEEYKKQLRTAMQPVYPSTEKLAKSGITNRVINKLMQQLFIET
KEKFYETLSEEITTELKLIPKPEAVFNIHFPQSQDLLTKAQFRLKFEELFYIQLQLLIKN
MLQKQKIKGFVFEEIGQNFSEFYSNHLPFELTGAQKRVIKEIRADLGSGAQMNRLLQGDV
GSGKTIVALMSMFIALDNGFQACLMAPTEILAIQHYNGLVELCKNLDTNIFLLTGSSKTK
ARREIHEKLENGEIDILIGTHALLEDKVQFKNLGLAVIDEQHRFGVAQRAKLWRKNQVPP
HILVMTATPIPRTLAMSLYGDLDISVIDELPPGRKPIKTVHRYDSNRLKVFAFIKDEIKK
GRQVYVVYPLIQESEKMDYKDLMDGYESIAREFPDMQISILHGQMKSDAKDYEMDRFVSG
ETQIMVATTVIEVGVNVPNASVMIIESAERFGLSQLHQLRGRVGRGAEQSFCILMTGHKL
SNDSKTRLETMTATNDGFEIAEVDLKLRGPGDIMGTQQSGVLNLKIADIVKDNQILKSAR
YHAMKILKEDPNLSMKKNKVLRFTYGQVAKHKNIWNYIS
>IFAGANLK_01592 Aminopeptidase N
MKYSFITLLFCCSWNFYSQAPIADSLNQVENIDFIKADAEVFVNPANKEVWGEIDYEFKI
LKSIDSFYVDARNMHFDEVLLNGEPKNFRNSRARIWIKNEINHSENNSLQLKYSVEPKEA
VYFINWDITDSIKAPKQIWTQGQGKYTSNWLPSFDDQREKVEFNITYHFPKDLELMANGK
LTGTSINDSLRVWNFDMQQPMSSYLLAFAAGNYAVDENKSATGVSLQYFMPVSEKEKMEP
TYRHTKKIFDFLEDEIGVAYPWQNYKQAPVRDFLYSGMENTTATIFDHAFITDSIGFTDR
NYVSVNAHELAHQWFGNLVTAETNNDHWLHEGFSTYYALLAEREVFGDDYYYWQLYESGE
KLKEISDNGKGEPVTKAGATSLTYYQKGAWVLHILRERVGDEVFKKAVKNYLERYKFKTA
TTENFIAEVESAANVSLSDFMAKWLNQTAFQGFAALNSLKNSEFIQNHLNILALRETALE
KKEELLSAELDFPVSDYTGQEVVYQLEGETSARAINLYNKAFETNNMYVRQAIATSMERI
PQELKSKFESLLNDESYVTKEAALLKLWMNFPQEVSTYLDQTKGIEGFTNKNVRMLWLTL
NLVTPNYEPEKQQETYNELSGYTAVHFPIAVRENAFGYLYQINSFTNQNLLDLMQGTQHP
TYRFSNYSRQLLNELLKNEEYQQKFLALEDSLSQKELDYLQTKLN
>IFAGANLK_01593 hypothetical protein
MRALVISGGGSKGAFAGGVAQYLIEELQRDYELYLGTSTGSLLISHLALNKCEKIKEIYT
TVNQSSIFSNRPFLIKRRHGYDQISINHLNVLLNFLKGKKTFGESKNLKKLIEATLTKEE
FLSLQAAKKDIVVTVSNISLNTVEYKSIKDFEYEEFCEWIWISCNYTPFMSLVQKNGCEY
ADGGLGTMVPIEEAIKRGATHIDAIILQTEATFYNRMPSKNVFGLITNLFRFMLDRIESQ
NIKIGKFAAANKNVTINFYYTPTVLTTNSLIFDEKQMKSWWKSGYKFAEEKSEEINQIEP
>IFAGANLK_01594 hypothetical protein
MRALVISGGGSKGAFAGGVAQYLIQEEGKKYDLFLGTSTGSLLIPHLAMGNIDKVYEIYT
NVNQRKIFSINPFVVKRKEGREYVTINYFNMFWQFVRKKRTFGESQNLRKHIKRNFSEED
FDKLKNQVEDVIVTVSNLSKNRVEYKSINDFSYEDFCDWIWISCNYIPFMSLANKDGFEY
ADGGLGCVVPIREAIKRGATEVDAIILEAENMEYNKVLGKNPFSLMINLFGFLLDQVEYH
DIVEGKLAALNKKVKLNTYYTPTKLTENSLVFNKKLMGEWWQQGYDHAKEKHMQFLATKR
KSFFGLF
>IFAGANLK_01595 hypothetical protein
MNQIELSQILLAILPALIVGVVAFYFFSSYNKNEENRRRFLLHRENQKTSLPLRLQAYER
MTLFLERISPGKLLFRVKPNSNDKEAYERALINTIEQEFEHNLAQQIYLSVECWDYIKTA
KNATIGIIRKANQQESVTDSDKLREIILKNLMEKQSPTEAAIAYLKNEVKRFI
>IFAGANLK_01596 Ferredoxin-dependent glutamate synthase 1
MESILDFLASIPWWGWILIVIVLIAIRDIFFNREHTIKHNFPVVGHLRYFLEGIGPELRQ
YIVASNREELPFNRVERGWIYASAKNENNYEGFGTDQDIFSTHYIFINNAMIPYKLDEKH
PNRIDPNFIACAKVMGEFNKRKRPFRPASIINVSAMSFGSLSARAIESLNAGCKEAGAYH
NTGEGGLSQYHQKGADVVFHFGTGYFGVRDEKGNFSMDRMVALVKENPQIRAIEIKLSQG
AKPGKGGVLPASKITKEISEIRHVPMGQDILSPPNHSAFDNIPELVDFIEDIAEATGLPV
GIKSAVGRLNQWEELATLMAETKRGPDFITIDGGEGGTGAAPPSFADHVSLPWIYAFTDV
YKIFLNEGITDRIVFIGSGKLGFPAKAAMAFALGADCINVAREAMMSIGCIQAQACHNNT
CPTGVATQNKWLQAGINVKDKARRVNYYFTKFRKELLEITHACGYEHPSQFTMDDVEINL
SDKNLAKTLAITFAYHKEKVPFGGIQTHMDSPHLGGIHKQKEVTTKEAETEETAPHNKNE
>IFAGANLK_01597 putative hydrolase YxeP
MREINQNDTIYKPVNLLCFKQTQISFEQLFKFLISLKFCNPIEREIKLTMKKIIFSLLGL
FSFNLAAQEIYPEINSAAEEIEEQVISWRRDFHQNPELSNRETETAKKIAAHLKSLGIET
TTGIAKTGVVGILKGGNEGKTVALRADIDALPVTERNDLPFKSEVRTEFLGSETGVMHAC
GHDTHIAIMMGVAEILSKNKDKINGTVKFIFQPAEEGPPPGEEGGASLMIKEGVLKNPDV
DAIFGLHINSETPVGTIKYKPEGTMAAVERFVINVKGKQTHGSAPWSGTDPILISAKIID
GLQTIISRESKLVDAAAVISVGKITSGIRFNIIPESAEMIGTIRTLDPDMKALILKRMND
MVPAIAKAYGGEATVEIQNNTAITYNDPELTSKMLPTLQKVAGKENVVLAKATTGGEDFS
FFQEEIPGFYYFLGGKPLDSNEPAPHHTPDFFIDESGMLVGVKTMSQLAIDYLNQ
>IFAGANLK_01598 ATP-dependent DNA helicase PcrA
MEAYLAELNDAQRAPVLQKDGAMIVIAGAGSGKTRVLTYRIAYLMSQGVDPFNILSLTFT
NKAAREMKTRIAKIVGNSEAKNLWMGTFHSIFAKILRFEADKLGYPSNFTIYDTQDSQSV
IRAIIKDMRLDKDVYKYKQVYSRISSYKNSLITVKAYFQNPELKEADAMSKKPRLGEIYQ
EYVERCFKAGAMDFDDLLLKTNELLNRFPEVLHKYQNRFRYILVDEYQDTNHSQYLIVKA
LSDKFQNICVVGDDAQSIYAFRGANINNILNFQKDYDNVQMYRLEQNYRSTKNIVKAANS
IIEKNKTKLEKIVWTANDEGPKIVVNRLLTDGEEGRFVASSIFENRMQNQMSNGDFAILY
RTNAQSRAMEDALRKKEIPYRIYGGLSFYQRKEIKDVLSYLRLLINPKDEEALKRIINYP
ARGIGQTTMDRLSIAGNQYGKTIFEIIENIDHLDLKINKSTQTKLNNFVNMIKSFTILAE
NADAFTVADTVAKKTGLVQELKKDGTPEGIARIENIEELLNGIKDFVEGQKELADADGSL
AEFLEDVALATDMDKDTGDDDRVALMTIHLAKGLEFPYVYIVGLEEDLFPSGMSMNTRSE
LEEERRLFYVALTRAEKQAYLTYTQSRYRWGKLVDAEPSRFIEEVDEQYMDYMIPQDDYK
YKPLIDTDIFGDDIDKSKLRQSKPKKGTPPPAHKPSESQLRKLRKLKPASPEPQKATNAI
KLEVGNEVEHMRFGKGKVLAIDGVGQDKKAEIDFENGGIKKLLLRFAKLKLIS
>IFAGANLK_01599 hypothetical protein
MIREGSTVSWEWGNGKAEGKVTETYTKEINKTIAGIEITRKGEEGNKALFIEQEDGSKVL
KLESEVSKLD
>IFAGANLK_01600 Threonylcarbamoyl-AMP synthase
MAELLKIYDENPSQKHINKVVEVLRKGGLIIYPTDTVYGLGCDITNTSALEKIAQIKGVK
LEKANFSFICEDLSNLSDYVKQIDSATFKVLKRNLPGPYTFILPGNNNLPNVFKKKKTVG
IRVPDNAICKSIVATLGNPIVSTSIYDEDEVIEYTTDPELIKEKWDHLVDLVIDGGYGDN
IPSTVIDLTNSEPEVIREGKGSIEIM
>IFAGANLK_01601 Arylesterase
MNYIETKNEEKGNKIKLFYEDYGEGQPVILIHGWPLSHRMWEYQVEKIVDAGFRCISYDR
RGFGDSDKPWKGYDYDTLASDLNDVITVLGLSKTILVGFSMGGGEVARFIGKYGTANIEK
AALVSAVPPFMLKTDDNPDGVNKEVFEGFKEEIRKDRAGFLAGFGDKFYNFNKNKDRISE
DQKHYDWSIACKASAKATLDCVDSFGLTDFREDLKEFDVPTLIVHGDDDEIVPIELAGKK
SKELIKNSTYEVIKGAPHGLVMTHKKEFNEILLRFLKS
>IFAGANLK_01602 Outer membrane protein Omp38
MKRIMLLSATAVLLFSSCVSNKKYAELEEKQQQTQDELNTATIKLNACLEDKQNLNQQIS
RLNNTNAALLNNVGDLATLSKKEAENLERSLESIKEKDMAITRMRDAINKKDSVTLALVT
SLKGALGNMADEDIEINVEKGVVYVSISDKLLFDSGRYNVTNRAKEVLGKVATVVKNKPD
IEFMVEGHTDDKAIKTSMFEDNWDLSVKRATSVVRILQDEFGVEPARMTAAGRSYYVPVA
SNDTEEGRAKNRRTRIVVLPKLDQFYGMIEEGMEAAE
>IFAGANLK_01603 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MTTAVVILNWNGRHLLQQFLPSIISFSEDANIYVADNASTDDSVVFVKENFPQVKIIQNK
ENGGFAKGYNDALHGLSEDIFVLLNSDVKVTENWLKPILAIFENETKTAAVQPKILDFKK
KDHFEYAGAAGGYIDKYGYPFCRGRIFETLEEDYGQYNDDVPVFWGSGACLAIRNTVYWE
AGALDEDFFAHQEEIDLCWRIHNLGYQIKSSGISSVYHVGGATLDSMNPRKTFFNFRNSL
YMLLKNVPAPNVYWILIIRMILDGIAGIRLLANGKFSHLYAILQAHTSFYRNFQKIFRKR
TGVPKNPGYYQVKSIIWSYFCLSKKEFSKLK
>IFAGANLK_01604 hypothetical protein
MLALNFPKYNFRFKNSENKIAVFDELRKKFVVLTPEEWVRQHVVKFLTLDKNYPKNHINV
EKQLKLGKLTKRYDAVVFYPDGEIKVVVECKAPHIKITQDVFDQIARYNLSLKADFLMLT
NGLQHYYCKLDYEKERYDFLTEIPDYISTKTSENL
>IFAGANLK_01605 hypothetical protein
MEEAKEIVNNIQKGSVSPLYFLMGEEPYYIDRISDFIAQNLLAEEEKGFNQIIMYGRDTS
VDEIISNAKRYPMMAERQVIIVKEAQDLSRTIENLVAYAENPQPTTTLVFCYKYKSLDKR
KKLSKVLKKNGILFESKRLYENQVADWIMKTLKARNYTISPKAAQMLVEFLGIDLGKIDN
ELNKLQLITPEGTQITPELIEQNIGISKDFNNFELRKAIGMRDSLKAHRIVNYFAQNPKD
NPMVVTISLLFSYFSQIMQYHGLPDKSKANVAKQLKVHPYFVGDYIAAAKNYPMKKVSQV
IGLLHESDVKGKGVGAVNISHGDLLKELMVKILN
>IFAGANLK_01606 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MGKINSWISAARLRTLPLSVSGIIVGTTIAVEQGFFNISIFSLALATTLGLQVLSNFAND
YGDGIKGTDNEDRVGPQRAIQSGLISQKEMFQGIVITAIVTLLFAILLIYASFGKEKLGY
ALFFFLLGVGAIAAAIKYTVGKSAYGYRGLGDVFVFIFFGLVAVYGSYFLYANHWNWLVL
LPAFSIGFLSMGVLNLNNMRDRISDEKAGKNTLVVKLGSKNAKNYHYALILGAILCLVIF
TVLTLESINDFLYIPALIPLILHLKRVVENENATLLDPELKILALSTFATAVLFGLGQIW
>IFAGANLK_01607 hypothetical protein
MKITYYGQSCFGIKIADINVLVDPFITGNELAKDKINIKNIKADYILLTHAHQDHTLDAE
EIAKNTGSVIISNFEIANHYEEKGIEVHPMNHGGSWDFEFGKVKYVNAIHTSSFPDGKYG
GQPGGFVIEGEHKNIYIAGDTALTMDMKLIPQRTTLDLAILPIGDNFTMGVEDAIVASDF
VECDKVLGCHYDTFGYIEIDHEEAKRKFFDEGKDLMLLEIGESLEL
>IFAGANLK_01608 L-Ala-D/L-Glu epimerase
MQADYKKYILNFKRPSGTSRGVLTTKETWFLKITDGDKVGYGECGILRSLSVDDRPDYEE
KLQWVCNNINLGETMLWAELKEFPSIQIGVEMAFRSLKAENPFEIFPSEFTKGKASVPIN
GLIWMGEKSFMKSQIQEKIEAGFDCIKMKIGAIDFETELELLKYIRSEFSSGEIELRVDA
NGAFKPNEALEKLKRLSAFQLHSIEQPIKQGQWEQMANLCHKTPLPIALDEELIGVFDVT
KKQEVLQTIEPQYIILKPSLIGGFKGTQEWIDLAEENNIGWWITSALESNVGLNAISQFT
YTKNNKMPQGLGTGNLYTNNIQSPLEVEKGNIQYNPAKSWEFNF
>IFAGANLK_01609 hypothetical protein
MYIAQAFRYHHELWRYIIGVVLIMIAVFIAQIPFVVALFLEGGIDAAMDETAVLKVFDSN
ITLFFLLLPFAAGLVAVLFNVKYLHSQPLKTLTTTRKKIDWSRFFFAFTLVAIFTILTTL
GYYFFYPEDYQLNFEPTSFLILVGIAVIFIPLQTSFEEYMFRGYLMQGLGVFAKNRWVPL
FLTSIIFGGLHYFNPEVGQLGDIIMIHYIGTGFMLGIMTLMDEGLELALGFHAANNLVAA
LLVTADWTAFQTESIFKDVSAPIAGFWDVAIPVFIIYPLFLFIMAKKYGWSNWKNKLFGK
VENPETLKLSEES
>IFAGANLK_01610 2-succinylbenzoate--CoA ligase
MADKYKVPETHPDFRLNKRHYTNAELHLVAYNFIKEGEAFEEKIGSFLLDWIKPSKYVEV
KTSGSTGKPKIIRIKKEQMINSAIATSRFFDLPEKTTALLCLPATYIAGKMMLVRAMVLG
WQLDMVPPSSNPLDQVFKRYDFCAMTPFQLDNSVGRLHLIKKLIVGGGAVSPRLQKMVKE
VSTKVYETYGMTETVTHIAAKRLNPSKNKKKSRPFKVLPNINISQDDRGCLVIKAPKLSD
ENITTNDVVEILTYKKFIWKGRIDNVINSGGVKLHPEQIEKKLSKIIDQRLFVTAMPDDS
FGEKLVLFVENEFSEVFLQKLQKEISELKSLEKFERPKKIYFIEKFEETHTGKIHRENTF
KSKVN
>IFAGANLK_01611 hypothetical protein
MYKLFLLVGLLSVLNSSAQILPERERATFVNEILNDKFENILPDLMDRAEVDMWIVISRE
YNEDPVLRTMLPATWLNARRRTILVFSRNKEIDTLERLAVARYEVGESIDAAWFPEKEPE
QWKALIEIIEERDPQKIALNSSKNYGLADGLVKTDSEEFLDHLPPTYKNRLVSGEDLAVG
WIETRSQMEMEIYPQLVQITKNIIRKAFSKKVIIPGETTTEDLVWWMRQKVTDLGLETWF
HPTVSIQRDEEALEDHVSAFSSNNEGKVIYTGDLLHCDFGITYLRLNTDCQQMAYVLKLG
ETEAPEFLQKTFEKGNQLQDILTENLKTGKTGNQILSESLDQATEAGLKPMIYTHPLGLY
GHSAGTTIGMWDSQEGVPGSGEYPLNENTVYAIELNTSVFLEEWDQEIRIMLEEAGFWGE
NGFRYVNGRQEELILIPSE
>IFAGANLK_01612 hypothetical protein
MLAVFLATSNISCAQVLSNKEGNYTEADSLRGSLRLERTFDVQKYHLKLKVEPEKQFISG
SNTISFIAEEDLSIIQIDLFENMKVDSVLQNGKTLAYERKHNAIFIDLKETVKSDKKGEI
QFYYSGEPIVAKNAPWDGGFVWDQDENGDPWIGVAVQGTGASLWYPNKDHQSDEPEEVQL
DIAVPNGLMNVSNGQFLGEKDLGNGFTEWSWKTVNPINNYNVMINIANYEHFSDSYGDLE
LDYFVLPYNLEKAKEQFKEVKPMMDCFYEKLGEYPFVEDGFKLIETPYLGMEHQSAVAYG
NEYKMGYLGNDLSGTGIGLKWDYIIIHESGHEWYGNSITAKDIADMWIHEGFTSYTEAVY
VECRWGKEKALEYLKGTRRGLGNNAPIIGDYGVNSEGSGDMYFKGANLLNTIRSIYDDDE
LWWKTLKDYTETYKHQIIDTETTENFFNEATDVNLDPIFEQYLRQADLPKLEFRKRDGKT
QTRWVTDVENFKMPVDILVEGKEIRIHPTNDWQNLKHDIELDEIKVNELEFYIASAYMR
>IFAGANLK_01613 hypothetical protein
MKKSFKQYLSLLFFFIIGALYSQDTIVSHYISISHYKEDGNKLTRKDTANFQFYNGDTLV
AISPDYKSPLDKNKVKVAYEPKDSIFLNLYKNVVYNTDKSQKEKLYMRYWKDSIKVFFEA
GVSDQHAKELMQFAYKISKDIDSLNIKRVFRSKDANYRVYYLNSEYKTDFEPRITGKSGY
YVHWNAKNQIYKGDLKINSDLIENGLSVELLKFHFFRSLGYFKGSKNLSCESYLSGCNNL
RQLTQPDLELLKYHYSYGVCKGVNLEDFEKLHAHMIKSKEQNPNVPLYVMHRE
>IFAGANLK_01614 putative propionyl-CoA carboxylase beta chain 5
MNMKFNKNEDHNKLLVSSLNHKLKRIKLGGGEKRIEKHHAKGKMTARERIDFLLDEKSNA
IEIGAFAGEGMYEEHGGCPSGGVVVKMGYVSGKQCIVVANDATVKAGAWFPITGKKNLRA
QEIAIENRLPIIYLVDSAGVYLPMQDEIFPDKEHFGRIFRNNAVMSSMGITQIAAVMGSC
VAGGAYLPIMSDEALIVEKTGSIFLAGSYLVKAAIGETVDNETLGGATTHSEISGVTDYK
ARDDKDALTRIQNIMDKMGDFDKAGFSHKKAVKPKEKQEDIYGILPKKRSDQYDVREIIS
RLVDGSEFEEYKEGYGQTIITGYARIDGWAVGIVTNQRKIVKTKKGEMQFGGVIYSDSAD
KATRFIANCNQKKIPLVFLQDVTGFMVGSKSEHGGIIKDGAKMVSAVSNSVVPKFTIIMG
NSYGAGNYAMCGKAYDPRLIAAWPSAELAVMGGTQAAKVLAQIETAAMEKKGEKVDEEKE
KEVFEAIKSRYDEQTSPYYAAARLWTDAVIDPLDTRKWISMGIEAANHAPIEKDFNLGVI
QT
>IFAGANLK_01615 hypothetical protein
MYKILSMGMNKNTIFAWASFALFIIGAAIILLGVLKYRDYAIGFSVTGIGFFAISWAFNA
LKGRI
>IFAGANLK_01616 hypothetical protein
MSNSGSKEKLIKHLEGGEAFMALEDFIDKIPFEKLGEKPHNLPYSFYELFFHIVFAQKDI
LEYSNSKNYKTSKWPDDYWPKESAPITEEAWDELKKEYFEDRERFKKFILDADTELNLPV
KNSENHSLLREIMLVIEHTAYHTGQMLILLRLLGLYK
>IFAGANLK_01617 Energy-dependent translational throttle protein EttA
MADDKKVIFSMSGVTKTYKNANTPVLKNIYLSFFYGAKIGILGLNGSGKSTLLRIIAGDD
KNYQGDVVFSPGYSVGYLEQEPKVDEDKTVLEVVKEGVAETVAILDEYNKINDQFGLPEV
YEDADKMQKLMDKQAALQDKIDSSNAWELDTKLEIAMDALRTPEADKKISVLSGGERRRV
ALCRLLLQEPDILLLDEPTNHLDAESVHWLEHHLAQYKGTVIAVTHDRYFLDNVAGWILE
LDRGEGIPWKGNYSSWLDQKSKRMAQEQKQASKRQKTLERELEWSKMNPKGRQAKQKARL
NNYDKLLSQDQKQMDEQLEIYIPNGPRLGTNVIEANGVSKAFGDKLLYEDLNFKLPQAGI
VGVIGPNGAGKTTIFKMIMGEEQPDKGSFEVGETAKIAYVDQAHSNIDPEKTIWQNFSDE
QELIMMGGRQVNSRAYLSRFNFSGSEQNKKVNMLSGGERNRLHLAMTLKEEGNVLLLDEP
TNDLDVNTLRALEEGLDNFAGCAVVISHDRWFLDRICTHILAFEGDSQVYFFEGSFSDYE
ENKKKRLGGDIMPKRIKYKKLVR
>IFAGANLK_01618 hypothetical protein
MGLTNNDIFKKLRVAHKLRDDDIVKICALVDFKVTKSELGAIFRAEDHPKYVECGDQFLR
NFLNGLIIHLRGPMPPKKEKKPEKE
>IFAGANLK_01619 hypothetical protein
MKYFFNRIYILLSNLQSKIAFYPSVFAIFGFLIAFLLIYIENQGVSRYLLDHIPMLVVDN
GNTALSILTACITGLISMMVFSFSMVMVLLNQAASNYSPRLLPGLISDKNHQLILGIYLA
TILYCIFVAVSIQPEGDSYQTPGFSVLLGIIFTVICIGAFIYFIHNISQSIQINNILDRI
FRQAKTRLNFLLKTEEKENQDFPDTKEWYEYHSEKSGYFQNLSSDNLLDICKEKETQFEI
LPVKGIFILQGIPLFKSKEKLDDDTFKKVLSNFSLARGELVNTNYVLAFKQITEVIVKAM
SPGINDPGTALNALDYLAELLALRMQKQDLQFLKADKKVLIKMRSVDFEELLYQVLAPIR
AYCKHDIIIIQKLGLLFYYLKSQKAVNEKYYEVLDIEAKNLIADAKSAIKNEADIKKINA
IEKQLNLKS
>IFAGANLK_01620 18 kDa heat shock protein
MSLIKRNEANWLPSVFDDMFKTDWLGGTTNVNSIGTSIPAVNIQETEDNFSVEVAAPGKT
KEDFNIELDNDVLTISSEEKKENETSEKNGRYTRKEFSYSTFKRAFSLPDSVDSEKISAS
YKDGVLNIELPKREEAKVQAKRMIDIS
>IFAGANLK_01621 hypothetical protein
MRQVSLFVFLKPKFVRMNYILFDGSARNRLLPFTFTRPVADIRVGILTIREKWEFLLKST
TSTVTEDYLAGKWPMVELEENIMINASFLPNPEFLQQLQNLKPNQAIFHKEDIVAFHAYK
DQEVALGDYEQKELADGVIQINNSWDIFSKNGEAIEADFEIITKDRQSQPIHDSNYVKNP
ERIFIEEGAEVENCSLNASSGPIYIGKDAKVLEGSLIKGALAVCEGALVKMGAKIYGPTT
LGPGCRGGGEINNAVLFANSNKGHDGYLGNSVLGEWCNLGADTNNSNLKNNYAEVRIWDY
ETEGFAKTGLQFCGLMMGDHSKCGINTMFNTGTVVGVSANIFGAGFPRNFVPSFSWGGSA
GMTVYKTQKAFEVAEIVLNRRNVEFSEDDKKILEHVFEETSKWRRG
>IFAGANLK_01622 hypothetical protein
MGFGGSSSGANVIFKNNRRERKSKTDKFQKSTGSGIKGIKSEEVNSAEILEIRRKIRLEN
KRRQRKLLIFSTVSILIFIIIFWKVMF
>IFAGANLK_01623 hypothetical protein
MKSILAVILLFFSTAILAQAQLPQDYFQKPLEVPLVLSGTFGELRSNHFHSGLDIKTQQR
QGLNVVASAKGYVSRINIQHYGYGKALYIQHPNGYTTVYAHLKEFSPEIEAFVKKRQYAN
ETYEIELFPEAGELQVEANELIAFSGNTGGSGGPHLHFEIRDGSQRPMNPKMFGFNIKDN
RAPIIDGVYAYPLDEEAHVNNSRERQKINLTPLEDGTYIANEIDACGNIGFGVSSVDQQD
GAPNRNGVYHIEAKLNGDRVFTLPFKRFSFAETRHLNQLIDYEYYSKNRKRIQKLFVEDG
NPLSLYEDVVNKGELHIQDSLNYNYTIKVSDFAGNQRVIRIPIQGMQRNDIPPKKEDKTD
YFAQANQPFAAEANGMDIYIPKGSLYNDTYLDIEFRENKVKVHHDHTPLHKNITVGFDVS
EYTAEEKEKLFIARLGYGNRPTYSSTYKKANRFTTGTRNFGEYTLASDVTPPKIWPTNFS
DGQWISSNNTLQVKISDDLSGIKSYRATVNGKFILMEYEYKNNTLTHDFSDAVVTDTENQ
LKIIATDNVGNSNTYEATFFRKTS
>IFAGANLK_01624 hypothetical protein
MSELTEIVDSLENRISKLLHKYENLKQNHRSLEEEMSAVKEENLRLTQKIEGSNQEIQNL
KAANAMLGSTEFKTETKLKLNSLIREIDQCIVQLSE
>IFAGANLK_01625 hypothetical protein
MADKLKIKLSIADRVYPLTINPQQEEGLRKAAKKIEAMIKQFEQSYAVRDKQDVLAMCAL
QFAAQTEQKDIERSTDSLKAEDKLKSLNDLLQKHLVS
>IFAGANLK_01626 Ribonuclease Y
MEILLNIVIGVVGIAIGFAIAKQLERKRASQTIKNAKKTAANILKEAKSEGESIKKDKIL
QAKEKFIELKSEHEKVILNRDKKMNDAEKRIRDKESQVSGELSKNKKLNKDYEDKLADYN
QRVEYLEKKQDEIDKLRNSQIQQLEVISGLSADEAKAQLSEALKDSARTDAMALIQDTIE
EAKLTAQQEAKKIIINTIQRIGTEEAIENCVSVFNLESDDVKGRIIGREGRNIRALEAAT
GVEIIVDDTPEAIILSCFDSVRREVARLSLHKLVTDGRIHPARIEEIVKKTRKQIDEEII
DIGKRTVIDLGIHGLNPELIKLVGRMKYRSSYGQNLLQHSREVAKLCGVMASELGINPKL
AKRAGLLHDIGKVPETETEVPHAILGMQWAEKHGEKPEVCNAIGAHHDEIEMNSLLSPIV
QVCDAISGARPGARRQVLDSYIQRLKDLEEIAFGFGGVKKAYAIQAGRELRVIVESEKVN
DEKASNLSFEISQKIQTDMTYPGQVKVTVIRETRAVNIAK
>IFAGANLK_01627 Aldo/keto reductase
MKTLKFKNGDEMPAIGLGTWKSGKDEVKNAVKIALNNGYRHIDCAATYGNEDAVGEAFAE
VSSEGKIKREEVWITSKLWNNAHKKEDVIPALKKTLKDLQLDYLDLYLIHWPVAFKPEVD
FPQNDDQYLSLEEVPLIETWKMMLEAKKQGLVKHVGVSNFSTMNLEGLMEETSDYPEINQ
VELHPYLQQNELLQFCSKHNIHLTAFSPLGSGDRPDGMKAKDEPSLLENPVIKKIAKKHG
ASAGQVLIKWNEMRGTAVIPKSTNEERIIENLASAGLNLNEEDLEKIAALDEHYRYVTGE
FFVTKGNSYENIYDDDDYKA
>IFAGANLK_01628 Tyrosine recombinase XerD
MKWASALQDYCNYLRIERGLSDNSITNYRLDVVKLINFLSVKNIEVSPIQISEEILQQFI
YEIAGDVNARSQSRIISGLRGFFNYLVFEDYRKDNPLDLIESPKIGRKLPDTISTEEIDL
LIATIDLSKAEGERNRAILETLYGCGLRVSELTELKISDLFFKEGFIKVTGKGNKQRFVP
VSEYTQKYINIYKDEVRIHQKINKDASDTLFLNRRGNPLTRAMIFTIIKRLAEKAGIQKK
ISPHTFRHSFATHLLENGADLRAIQQMLGHESITTTEVYMHVDRKHLREVMEQFHPRR
>IFAGANLK_01629 hypothetical protein
MKKSILIALITVFGFTTAASAQEFVYFGAKGGVNFTNMSSDGFEDEKSRTGFHLGLLSEI
PLSERFSLQPEVLYATQGLEANRTFAGQNFNGEYQLDYIQVPVLAKIYLIDGLSIEAGPS
FNFLVEEEYDFESSMGDAEFDTEAGSTFEFGGAIGASYKFNNGFFLSARYTQGFTDVFDS
DNWDDDAIKNNGIQAGIGLMF
>IFAGANLK_01630 hypothetical protein
MKRLVLVICFALLGATVMQAQSGLRIGANVGLPVGDIEEVSNFQAGADLAYLLGVADMLY
IGPKIGYTQFFMEEDNFGGFEVDDPAFLPISASGRISLVRGFFFGTDLGYAVGLNDGNDG
GFYYRPQVGYNFGIIGLVGSYTGISADDGSFGAINLGIEFGL
>IFAGANLK_01631 3-dehydroquinate dehydratase
MIINGPNLNLLGTREPDTYGNKSFDTYFSELQFKFQKTELSYYQNNVEGELINKLHEADK
DFDGIVLNAAAYTHTSVGLGDAVKGIKTPVVEVHISNTHSREEFRHKSYIAPNAKGVILG
FGLLGYDLAIQSFLNKK
>IFAGANLK_01632 hypothetical protein
MKRAYLNWSSGKDAALALYKIQQEGEYSVQKLVTTVNTEFNRISMHGVRIELLLKQAEYL
NLPLQQIELHGEVSMEDYNEVMKIETNKLLDEGFTHSIFGDIFLEDLKDYREKQLEEIGV
KAVFPLWKQNTKALLKEFIANGFKAIVVCVNTDKLDKSFCGRIIDPSFLNDLPPNVDQCG
ENGEFHTFVFDGPIFKKPIEFEKGEMVEKSYKPVDESDNNCFSEDQKSWDTSFVYCDLLL
K
>IFAGANLK_01633 Dihydrolipoyl dehydrogenase
MSKYDIIVLGSGPGGYVTAIRASQLGFKTAIIEKESLGGVCLNWGCIPTKALLKSAEVFD
YLKHAEDYGLSLEKADKDFSKVIKRSRDVAAGMSKGVQFLMKKNKIDVIEGFGKLKSGKK
VAVTDKDDKTKEYQADNIIVATGARSRELPNLKQDGKKVIGYREAMSLEKQPESMIVVGS
GAIGVEFAHFYNAMGTEVTVVEFLPNVVPLEDEEISKQFERSMKKAGIKVMTNSSVESVD
TSGKKVKAKVKTKKGEETLEADIVLSAVGIKTNIENIGLEDLKIKTDKDKIVVDDFYKTN
VDGIYAIGDVVHGPALAHVASAEGILCVEKIKGMDVEPLDYGNIPGCTYATPEIASVGMT
EKQAKEAGYELKVGKFPFSASGKAKAAGKSEGFVKVIFDAKYGEWLGCHMIGAGVTDMIA
EAVLGRKLETTGHEVLKAVHPHPTMSEAVMEAVAAAYDEVIHI
>IFAGANLK_01634 hypothetical protein
MKKLFSILFMTTFLFAACEGDQGPQGPPGPPGENGVDIVGISYEYDVEFQYVEDDNIYFS
LLEFPTTEKPSDAILVYRLETIEGVETWNLIPKSYFFNEGILQISSNHTDQDVELLIEAD
FDLENLDASFTSNQYYRVVVVPSDFEQSTGVDTSDINAVMNALDLKESDVKKVGSLK
>IFAGANLK_01635 Peptide methionine sulfoxide reductase MsrB
MKKYSIEKPETEWKEQLSEEQFRVLREKGTEAPHTGKYNMHFEDGEYFCAGCGEKLFDSE
AKFESGCGWPSFDKAIEGKVEYVQDKTFGMIRTEILCASCGGHLGHVFDDGPTETGQRYC
VNSASINFNK
>IFAGANLK_01636 Peptide methionine sulfoxide reductase MsrB
MKKIIPILLAVFVMSCQGNAQKDQEKDQQKKEEFEVSKTDEQWKAELSDAEYKVLRKAAT
EPSFSSPLNDIEEQGTFVCAACGNELYKTEHKFMSGTGWPSFDRPIKGGVAYGTDSKLGY
QRNEVHCARCGGHLGHVFEDGPKETTGKRHCINGIAMDFEPEEK
>IFAGANLK_01637 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MNKKQKDQIPVQRLLVPNYIRYTGNVLSKLSPFVASRFAGQLFLTPFKYKLPEREKNMDE
LSKQYRAEIPKTSREIVVYEYGESKKKILLVHGWSGRGTQLAKIAETLKAEGYSTISFDA
PAHGKAPGRKSMMLDFIDSIQFLDEKYGPFEAVIGHSLGGMATLRAVKEGLNTKKLVIIG
TANSITHITREFAQNLKMNRKVADKMKAHFDKKFDIDMDSYSGAISAKEVKIPTLVVHDE
NDVDVEISSAYDIHEALENSELFITKGLGHRRILGDSKVINKITTFIAV
>IFAGANLK_01638 Beta-barrel assembly-enhancing protease
MKLKKTISVIAVLLLVIACKTNPFTGEKNLNFVSNDQLFPAAFQQYDQFLSENEVVTGTA
EAQMIKRTGSKIETAAERYLNANGYQGFLEDFKWEYNLVKDDAVNAFAMPGGKIVFFTGI
LPVAETETGVAVVMAHEIAHALADHGAQRMSAAQLQQLGAVAGSVAVSGRSQETQQIFAQ
AYGLGTQVGVMLPFSRSHETEADRIGLTLMAIAGYDPYEAADLWRRMAAQSDGQAPPEFL
STHPANQTRINNLEKWAPEAEAEAKKYGVTSFQ
>IFAGANLK_01639 hypothetical protein
MNKLPKGHKKLLHAWAFYDWANSVYSLVISSAIFPIFYGALTIVKDEDGTILDDTVDFLG
FSINNDSLISYVTAAAFLVVSVLSPFLSGIADYVGNKKNFLKFFCYLGALSCIGLFWFSL
EFLWFGLLCYFLALIGFWASLVFYNSYLPDIAFPNQQDKVSAKGFSLGYIGSVILLVICL
LMILNFETFGFESEALPTRLSFVLTGVWWIGFSQYTYAYLPKGNKKAAFTKNVLFNGFRE
LRGIWITLKHNIQLKRYLAAFFVYSMAVQTIMLVATYFGIEELEWGEQDATTGLIISILL
IQLVAVVGATLTSRLAIKFGNIKVLIFINLIWIAICGYAFFIVSPQQFYVAAASVGLVMG
GIQSLSRSTYSKMLPENAIDTASYFSFYDVAEKIGIVIGMFLYGIVAQITGSVRNSILFL
VIFFIGGVILLLRVPIKNPVSKDRI
>IFAGANLK_01640 hypothetical protein
MKKLILILSVLFIASSPVQAQWWGSNETIKGNGEMTSEKRNTGDYDEITLVGSMDVELVS
GSEGNLTVEAESNLQEYITTEVNGGTLKISIEKGYNLRPSRNKGIKVTVPFQDLDAVEVT
GSGDLWNSATITARNFSTKLTGSGDIKLDLEVENLEGAVTGSGDIQLRGKARDFDCKVTG
SGDFKAYDLRAENVEATVMGSGDIQISANKKLKAKVMGSGDIKYKGNPENQDFKTSGSGS
ISSN
>IFAGANLK_01641 hypothetical protein
MKTIFKILMVTMLVPALSYCHGDLNGRHTKEKKVTKSYNVSATDMLTIDNSYGNVDISTW
DQNKVVIEVNIKTNGDDEEKVQQKLDEISIEFNQSASGVSAKTHFTREDRSWWSSLFNSS
GNVNMQINYTIKAPERHSVDIENDYGGIYIDRLLGNAKISCDYGKIDIGELRGNSNLLNF
DYTRNSHIGFVKNAEIKADYSGYEIEEAERLNISADYTDSRIKKVAQLDFNCDYGSINIE
KAKRIVGNGDYLSTKIGRVFESLDLNLDYGSATIDKILKGVSKVEINTDYAGIKLGYDRE
HPFNFTVKSSYGNAKGLDEMQIRKRHDENTSKLFEGYHLEENSGNSIFINTSYGNVTFNK
Q
>IFAGANLK_01642 hypothetical protein
MKNDNTYELFKELDFDNKEPASGHKTRFLKKLEEQNNQTKPLGSRPHKRSLWAPMLSVAA
ILAIAFMVFTGFFNENTRGNSGELASVSPEMKETQQFYTQLIKTELATLETEDTPGTEAI
VKDALTQLEKLENEYTKLKKDLQNSGKDKRVIYAMISNFQQRIDLLNEVLEQIENIKTLK
KQSDENYI
>IFAGANLK_01643 ECF RNA polymerase sigma factor SigW
MTPTITHINDLVARCRKNDQRAQMEVYERYYKAMYNTSLRIVNDTAEAEDIMQEAFLKAF
AKIDSFQGTSTFGAWLKRIVVNLSINAFNKKVKLNEVAYNDELKNEIDESEGIILEEDSK
NEKVNKILKTLNSLKENYRVALTLHLIEGYDYEEIGEILNLSYANSRTMISRAKESLRKK
LLKDETGMRPDPKTGKEPGKNN
>IFAGANLK_01644 Lon protease 2
MAKTKLTSFDSLSLQDIDQDADLIPLMTPEDEEEINREELPSTLPILPLRNTVLFPGVVI
PITAGRDTSIKLINEANNDSKIIGVVAQKDEEVENPSAKDIYTTGVVARILRVLKMPDGN
TTVIIQGKKRFEIDEIVKEEPYLTAKIKEVPEARPELDNKEFPAIIDSIKELALQIIKGS
PNIPSEASFAIKNIESSSFLINFVSSNMNLAVEDKQKLLETNDLKDRALATLRHMNMEFQ
KLELKNDIQSKVQSDMSQQQREYFLHQQMKTIQEELGGVSHEDEIEEMKLRAKKKKWDEK
VQKHFDKEISKMQRMNPQVAEYSIQRNYLDLFLDLPWNEFSKDKFDLKRAKKILDRDHYG
LDDVKRRIIEYLAVLKLRNDMKSPILCLYGPPGVGKTSLGKSMAEALGREYVRVSLGGLR
DEAEIRGHRKTYIGAMPGRIIQSLKKAGTSNPVFVLDEIDKLSMGHAGDPSSALLEVLDP
EQNSEFHDNFLEMGFDLSKVMFVATANTLSTIQPALRDRMEIINVTGYTIEEKVEIAKQH
LLPKQLKEHGLTKEHIKIAKPQLEKIVEGYTRESGVRGLEKQIAKMVRHAAKNIAMEEEY
NVKVTNEDVIEVLGSPRLERDKYENNEVAGVVTGLAWTQVGGDILFIESILSKGKGNLNI
TGNLGKVMKESATIAMEYMKSNAEELGLDPTIFEKYNVHIHVPEGATPKDGPSAGITMLT
SLVSLFTQRKVRKSVAMTGEITLRGKVLPVGGIKEKILAAKRARIKEIILCKENERDIKE
IKADYLKGLTFHYVNEMSEVIDLAITDEKVKNAKTL
>IFAGANLK_01645 Cytidylate kinase
MSKKITIAIDGYSSTGKSTVAKQLAAELGYVYVDTGAMYRAVTLYLMRKMIVTDSNFDKE
TILRQLPFINISFVFNKEVGYGEVHLNGENVEKEIRLMEVSQQVSKVAAVPDVRKMLVDI
QQEIGKNKAVVMDGRDIGTVVFPDADLKLFMTASTEKRAERRYNELKERGNDVKYEDVLE
NVKERDYLDTTREDSPLVKADDAIEIDNSDMNLEEQFKKVLKLAKDKIEE
>IFAGANLK_01646 30S ribosomal protein S1
MAEDKTNQDVQDENLEVQPVAGMATSSQPAPTEQQENPEKFLEEFNWHNYEEGIDPIDDK
KLEEFEKLVAENFVDTLNDEVVTGKVINITDRDAIIDINAKSEGVISLNEFRYNPDLKVG
DEVEVLIDVREDSTGQLILSHRKARVIQAWDRVNKAHDESLIVNGFVKCRTKGGMIVDVF
GIEAFLPGSQIDVKPIRDYDAYVGKTMEFKVVKINHEFKNVVVSHKALIEADIEEQKKEI
IGQLEKGQVLEGTVKNITSYGVFVDLGGVDGLVHITDLSWSRINHPNEIVELDQKLNVVI
LDFDEAKTRIQLGLKQLSKHPWEALDENLKVGDKVKGKVVVIADYGAFIEVADGVEGLIH
VSEMSWSTHLRSAQDFVNVGDEVEAQILTLDREDRKMSLGIKQLTPDPWTDITTKYPVGS
KHKGIVRNFTNFGVFVELEEGIDGLIYISDLSWTKKIKHPSEFTNVGDELEVVVLELDVE
GRKLSLGHKQVEDNPWDKYETEFAVGTKHTAEIAEIVDKGATIDFNEDITAFVPTRHLEK
EDGNKLTKGESAEFQIIEFNKEFKRVVASHMAIHKEEEQQIVKQAAKKAASQSNDKTTIG
DVNADLQALKDKMEGK
>IFAGANLK_01647 hypothetical protein
MKIISTNIGKPTKIIWNSKEILTGIYKTATDEPIYLAKNNVMNDEVSDRKHHGGFYKACY
IFSSEQYPYWKNLYPNLDWNWGMFGENLTVTDFDERKVFLGDVYKVGDAVVQVSDYREPC
YKLGYKFGDQKILKQFIKRGFAGTYLSVLEEGFVANNDKFTLIERPDKSLSVSDLFHLVY
AKEKNRDYLQIAANNKALDPKKRALLEKYIW
>IFAGANLK_01648 Quercetin 2,3-dioxygenase
MRSIKKIHTAVSSPIADLITYRALPTNSIDHIDPFLFLNHHGYQEYPENNNGLPFGPHPH
RGFETVTFILKGDLTHKDSGGFESVIKAGGVQWMTAGKGLIHAEVSSEEFKKNGGELEIL
QLWVNLPAKYKMTEPNYVGLQKEDIPQLTLNDGEVKLAAVSGNWEEKKGAFNPLNDIQMA
TLEFAEGGKYSVEIPSKRNIFFYVVKGKVNVNGEEAKMHNLVEFANDGEKLEIEALEEST
LLLGHAEPFNEPIVAQGPFVMNSQQEIQQAFQNYQNGEFGNWNG
>IFAGANLK_01649 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MHKKEIYTAGKELREAEKVLVLIHGRGGSAKEFLSLANQLNTSDFAILAPQATDFTWYPN
SFLAPLAQNEPEYSSALEVLEELLEEIKETGIASENIYFAGFSQGACLTLEFVTRNAQKF
GGVAAFTGGLIGDKIYTENYSGDFNGTPIFIGTGDPDPHVPVERVEDSAEILREMNANVE
VKIYQNRPHTISEYELKIANNFIFN
>IFAGANLK_01650 hypothetical protein
MKIGLKSILLILALSLSFVSCREEEEKSEIEQLAGEEDAKVKVKDDKIKVKTDDKKIKIK
EDDGEVTKKVKIDNDDN
>IFAGANLK_01651 hypothetical protein
MKKILLLLSIFMAFSCGAKKIKGSRNVTTEKTRLTDFHSVDIAGDFEVTLKQGSTAMMEV
EADDNLHRIIRGEVVDQVLYLKPTKKIGRSKSQEISLTYPENLQKITVSGNTELEADEDL
YSEELKITTADDAEVYLTVTATKFDLFNEGKADVELNLTAEDVYFQLNESSYIKSLVNAP
RFKVDIYEKASARIEGEVDDLQLRSEHSTKFDGRRLSARTAVVIAEGKSKNELEVLENLT
LTAKNRSEMELYGNPKVDLVEFSEKAVLAKKD
>IFAGANLK_01652 hypothetical protein
MIQLILHLLMLLFGLGEPAEENDPLVEDYIECNEVLTEHCTIAFNEC
>IFAGANLK_01653 hypothetical protein
MAVSGAPLWLLWLIAFLLAGIPLFFLFILGLKILVGRLKSIGTPAKLVLLGLWLLALIGA
AVIGIQQATHRAFDGEQVITETLSISANDTLYLAMQANPNYSSSIYRSSDFKIKYDDNDE
KVLYSSDVRLIVKPTKDSLAKLEVVKSAEGKDYKEARERAQNIVYNTNFSRNELLLNSFF
TSATKYKYRDQEVKVTLYLPEGASLVADDNTSSFHRNTDYWGDILISGDEEKVLKITEDA
AICEDCPVEEWETESEDEWDEDGDFNARINSGDEEVNIQINRRGVTVDKKPVDKEQENLE
NEEL
>IFAGANLK_01654 hypothetical protein
MNKTVNINLAGIFFHIDEDAYAKLQHYLDAIKRSFANTQGKDEIIADIEARIAELFNEKK
KDDRQVIGIKEVEEVITIMGQPEDYMVDEEIFEDEPVHTKTTKSPGKQLFRDTEHSYVGG
VSSGLGHYLGIDFIWVRLLWILLTIFSSGAFILIYIALWIFVPEAKTTADKLAMRGEEVT
ISNIEKKIREGFDNVTGKVKDVDYQKYGNQAKSGATSAATAIGDVIAFILKVFVKLIGII
LILLAGASLIGLFIGLVTVGTFGLIDAP
>IFAGANLK_01655 hypothetical protein
MKIENTKAQMRKGVLEYCILSVLKDEDAYVAEILDTLKDAKLLVVEGTIYPLLTRLKNAG
LLSYRWEESSSGPPRKYYGLTDTGKLFLKELTGTWDELQTAVNVVTNQKNKNHE
>IFAGANLK_01656 hypothetical protein
MNSKIAKEEKTLATILHLSVFSKFIIPFGNFIFPLILWLTKKEKPFIDDHGRKAINFQIS
LFLYTILILAVGISIILFQAIRLGGDVPFAIGPDHFYIDEMGQAISIVITISVFAILLSL
LFFIEIFAVISASIKASNGENYSFPLSINFIGKSSDNHHNNNHQQSKKEQFNNPQNETL
>IFAGANLK_01657 hypothetical protein
MTLSKNKLNKFLMLKLPSAWFCGVRVSEIEENTCKVNVKHNWINQNPFNSMYFAVQAMAA
ELSTGALVMGKIKQSNRKISMLVAQNRATFTKKATGKITFYCYDGHLIDEAIEKTLATGE
GQTLWMKSTGINDTGEQVAVFEFEWTIKAK
>IFAGANLK_01658 hypothetical protein
MNAHEIDYQIFGEEMQYVELELDPHEAVIAEAGNFMMMDDGIRMDTIFGDGSKENEGFLG
KVLGAGKRLLTGESLFMTIFSNEIQGKKRISFASPYPGKIIPIDLTRYGNKFICQKDAFL
CAAKGVSVGIEFSKKLGRGFFGGEGFIMQKLEGDGMAFVHAGGTMARKELSAGEKLKIDT
GCIIGFTQDINYDIEFVGGIKNTFFGGEGLFFATLTGPGTVYVQSLPFSRLANRIWQAAP
QGGGKDKGEGSILGGIGDVISGDRRF
>IFAGANLK_01659 hypothetical protein
MARAMFEYTKTVLDKVSFDPILFCREVKKALQRLLPHEIEELRIWIIALTRKNPELNQCL
TYLNT
>IFAGANLK_01660 Hydrogen peroxide-inducible genes activator
MTITQLHYVLAVAEHKNFTKAAQKVFVTQPTLSMQIQKLEEELDVQIFDRTKKPIQLTET
GQKIVQQARNIVNESDRIKDIVDQQKGFVGGIFKLGVIPTVMPTLLPMFINNFIKKYPKV
KLKIEELNTEAIIERLREGHLDAAIAATPLELQGIKENVLYYEPFVGYIPNTHRLHKKEK
IEVNDLDIDDMLLLEDGHCFKDGILNLCKSSRNYDDDHFQLESGSFETLIKLANEGLGMT
LLPYLHTLDIKDSEKKNLRMFKEPVPAREVSLIYNRSELKMQIIEAIQSTIAGVVKGAIA
FHNVNIISPVNKKKEYGE
>IFAGANLK_01661 hypothetical protein
MKTIAILFSLFLCNLALAQTEKSGNISVSVDNLSTEEGKVYFALFNEDNFLKKAPVKGEV
SEIKDGVAQVTFKEVPSGTYAITAYHDENGNQQMDFEPNGMPKEDYGVSNNEMNLYGPPV
WDDAKFDFDGESKEFKLRF
>IFAGANLK_01662 hypothetical protein
MLKFFKSLYLNQRFFYAIFAIALLFLFSYFFDFLYGFTWVLSLIFLLLFLADLVSLYKTN
RINAERILPQKFSNSDENEVEIILDNNYNFSVYTEIIDEIPVQFQKRDFLKQLKIGAGAS
EKFSYYLRPVARGEYYFGKLNIYVFTKMGLAKRRSVFGNKQMLKVYPSFIQMKKMDFLAI
DNRLSQPGLKKIRRIGHTMEFEQIKEYVSGDDVRTINWKATAKHGDLMVNQFQDEKAQPI
YSIIDTGRVMKMPFNGLSLLDYAINSSLAFSNIALKKKDKVGLISFSSKIENILKANAKL
SQLQQIMERLYNINTQFPDSDFNMLYSNLRQRITHRSLLMLYTNFEHISALKRQLPYLKA
INKKHVLVVIFFENTELDKIIGSNPDNTTDMAHQVIAESFAHDKKLMAAELRQHRINTLL
TKPEDLSINTINKYLEIKARGIL
>IFAGANLK_01663 Holliday junction ATP-dependent DNA helicase RuvB
MENQENKENESIDFDSRIPLDDLKEAVSSLKNQMAKVIVGQNDFVELLIAGLLSNGHVLI
EGVPGVAKTLTAKLFAKSLDTNFSRIQFTPDLMPSDVLGTSVLNAQKGEFEFKPGPIFSN
IILIDEINRAPAKTQAALFEVMEERQITIDGFQHDLEAPFMVLATQNPIEQEGTYALPEA
QLDRFLFKIQVDYPNLEDEVDILKSHHNRKGVLPVSQIEAVLNPKNLNELKNQIQEIIVE
EKLMLYIASIVGKTRNHSHIYLGASPRASIAVMNASKAFAAINGRDFVIPEDIKKALNPV
LAHRLIISPDREMEGITAKEVIEMISQSVEIPR
>IFAGANLK_01664 hypothetical protein
MGKTSKLFFGAFLLLVIFLTYLEATEPEPVNWTPSYMSDDKIPLGSFVFYESWVNTEKWE
FEEIGVPPFEKLSDSLENGTYFFLNNAVNFDPDELDKILDWVSNGNELFISARGISSALL
DTLHLETKVFIPKNDLSSKPQLNFKNSALKTETDFQFKNEFSSLFFHQKDSAKIEILGEI
NIQGDEKSSQPNFIKSDFGKGKIYLHNTPEAFGNYFLLTNQNYEYAESILAYVNNKNPVF
LDNYYKAGKTFYSSPLYILLSDNRLKWAYYFLLAGCVLFIIFEGKRKQRAIPIMNPLQNQ
SYEYSKTVGDLYLEEKEYAELITKKINLFFEYIRLQYKISTKTIDEEFHTLLAAKSGNSI
ASGKALFAKIEKFSNNTNAGKSEFQELSEAINNFKLHSNGKPGK
>IFAGANLK_01665 hypothetical protein
MFKILILFSFIFFGNLIPQEEAVTDSTEMIQNSSEETLEEVGFDTEKIENYKADKAFDYL
EKIEEDSWWTRLKRWINLKWNAFLQWLFGDYETNTFWGAVLSAVPYILLILVLGLITWLF
IRLNPGNAVMAEPITGKVNLKKEEDIVKSADISSLIDVAIRDENYRLAVRYLYLKSLRIL
DQKEHIQYRFQKTNEDYITEINAPEIKNQFTKITHLYDFIWYGDFELSKPRFEKVNREFT
KMENNLKTGNNG
>IFAGANLK_01666 hypothetical protein
MKQDYIDFKQQRELGDIISYTFKFLRENYKAYFTSVIKISWPAFLLLIAAVAYYSYTTVG
NSLMFNQDGGFFIGFGLLMIGLLLYFSVMNVAAFHFIKSYVNNDGEASHQDVKQGVKKDL
GKMFGLGAVTWILIFAGLIIFLLPGIYLSVPLSIAAAVLVIKSDSIGGSISEGFHLVKDN
WWMSFISLFLIWLIVYIISLIFQLPVLIYTFVKMFTLMEENSASTTNVAEMFDWVYLTLS
IIASAIQYLLYAITPIGVAFVYYNLNEIKYFTGAYESIENLGKND
>IFAGANLK_01667 hypothetical protein
MREAAFVKQNKDKWLKFESLLQNKNNLRPEQLSNIYIEISDHLSYSRTFYPKSNTTTYLN
QLAASAHQKIYKNKKESQNRFITFFTKEFPIFFYKFQKQLLLSFLIFALFSAAGAFSAAS
DHTFVRSILGDAYVNMTLQNIAEGDPMAVYKKMSETDMFLGITINNIRVSLMAFSMGILA
GIGTVFILMQNAVMLGSFQYFFYDQGLLWESARTIWIHGTIEISVIIIAGCAGLVVGKSI
LFPGTFTRLTSFVKGVKNGLKIVISTIPFFIIAGFLEGFVTRLTQMPDWLAILIIGSSLA
LILFYYIFYPIYLYKQQQIHETGLH
>IFAGANLK_01668 hypothetical protein
MDNFQIETAQNISINQNVASVGDRILAFIVDAFIIGLYMVISSLAIAGTGLDASGQWIYY
LVLGLPSLLYYLLWESLYNGQTPGKAALQIRVVKLDGSRPTFAEYIIRWLLRFIDISISS
GAIAVVTILLNGKGQRLGDLAAKTTVISEKPRTNLNRSLAVDVPEGYEPKYPQVSVLKDA
DVQNIKNLYQTARRSHNHRLILSLSEKLSELLETQPKESPMEFIQQVITDYNYYTQRA
>IFAGANLK_01669 Peptidyl-prolyl cis-trans isomerase A
MKNSLAFVYLFLILFFASCEDKESSSKNTSEKPLDKEEVTQKTSKLDSLKAKYSKAEESS
YQSDSIQSNEEFPIGQEELIPFLTQYGKENPENRVRIITSFGNIEVELFRDTPLHRANFI
MLVKEGYFNSTFFHRVAPGFVIQGGNSDNAATPRKRSQIGDYLIPSEFEAGHKHTYGAFS
AAKYSEQNVSKASSPFEFFIVIKENGTPHLNNDHTVYGRVTKGMDVAEKISQVETGQSEW
PIDNVKMDIEIIN
>IFAGANLK_01670 putative Nudix hydrolase NudL
MAVFYPNNFGKAHLVLILRKTYKGVHSNQIGFPGGRVEPEDENLAQTALRETEEEVGIPR
SNIEVIRELTRLYIPPSNFWVQPYMGMVDETPVLIPQESEVERILEVDLDHFLDHSNFVK
QELSTSYMNNMIVPAFRLNEQIVWGATGMMLSEIREIFRKSF
>IFAGANLK_01671 hypothetical protein
MGLFKKNPFGHYLFIKKWLIRIFGLLSHRRYRGYNELSIEGSDIIKNLPDTNVLFVSNHQ
TYFADVTAMFHVFNASLSGRVDSIKNIGYIWQPKLNIYYVAAKETMNAGLIYRIMAYAGA
VSVERTWRAKGEEVERKVNPDDTKNIGMALDDGWVITFPQGTTKPFKPIRKGTAHIIKQY
KPIVIPIVIDGFRRSFDKKGIRIKKRGILQTMQIKEPLEIDYENDSIEDIVNKLEYAIEQ
HPSFLKVIPSEAIKEMEELNKKRAY
>IFAGANLK_01672 tRNA pseudouridine synthase A
MQPKRYFYLIKVQYLGYRLHGWQKQPDVKTVEELITKTLRYVMPAEKFKILGTSRTDAMV
SAQESAFELFLDYKPLLDLDKFLKEFNLNLPQDIRALSIAEVDSKFNIIQHPKLKEYAYL
FSFGEKNHPFCAPLMANFQLDLDIQLMKKGAKLFEGKHQFRNYCVRVSENSTFEREITKS
ELVENTEINASFFPVKSYIFHIHSAGFLRHQVRLMMGALLQLGKGEFSLEDIENSLKPGV
EMQMDYIVPASGLLLNKIGLEDY
>IFAGANLK_01673 ATP-dependent DNA helicase RecQ
MENTRVLHTLKEYFGFDSFRPLQKKIIDSVFAGKDNLVIMPTGGGKSICYQLPAILFPEI
TLVISPLIALMKDQVDGLTANGVPAAFLNSSQTESQQQEIFKKIDSKELKLLYVAPESLQ
FVDRFMSDGKISLIAVDEAHCISSWGHDFRPAYTQLGYLKNRFPTTPMIALTATADKATR
EDICKQLNIPNAEKHIASFDRKNLSLDVRSGIKRFEQITNFAKNRKKESGIIYCLSRKNT
EEIAEKLQRKGFEAEAYHAGLPAEKRIEIQDNFINDNSKIICATIAFGMGIDKSNIRWVI
HYNMPKNLEGYYQEIGRAGRDGLPSDTILFHSYADVVQLQKFASNSGNEEVQLAKLDRMK
QYSEALSCRRKILLSYFGELKQEDCGNCDICKNPPKFFDGTVIAQKALSCIFRLKENEPI
TVVIDVLRGSQNESVFSKNYQVIKTFGIGKDISWHHWQQYIIQLINLGFVEIAFHRGNNL
QLTALAKNVLFEGEKVQLAEVPDRKKLKRREETEVSEKASDNSLFEKLRQLRLKIAREEE
IPAYLIFNDATLKEMEKSRPMTDDEFLQINGVGKQKMLDYGYEFIKEIIAFSKEKRTTKK
RKKANTYKATLGLLNEGLNLEEIAKKRELAITTIYSHIAKLYAENENVDPMKYISKADFK
AIEKAKAELENPEGLKPYFEFFDEAIDYGTLRLALAILEKEEAKIN
>IFAGANLK_01674 hypothetical protein
MKKIQILLLALSLSLAGCYTDRDDLDNDGSNPEVPEIPQETENQFVSEDGEVYSTGLECT
GNGTYNVNTENLLEGLMVPDTLPEAFDLSENLPPVGDQGELGSCVSWATSYYLKSFQEKI
ESGLQYSEANIFSPSYTYNQLTTDDCGGTSIPETLALIEEQGVAPLEFFPYTATECESQP
DEAVIAAAAEARISDFKGLSGENMLAEMKALIIHQQPIVIGAVLSPEFGKTDSFGLSAYR
THTVDYDDVTCHAMLVVGFDDEVNAFKIVNSWGEGWGDDGFVWIDYQAFENISDEDAPFK
VINQAYVAYDL
>IFAGANLK_01675 Ribosome-binding ATPase YchF
MKAGIVGLPNVGKSTLFNCLSNAKAQSANFPFCTIEPNVGVVNVPDPRIQRLESLVNPEK
VQPATVEIVDIAGLVKGASKGEGLGNQFLGNIRETDAILHVLRCFENDNIVHVDGSIDPI
RDKETIDMELQLKDLETAEKKLEKVKRAARTGNKEAQKEETALNKVKQGLEAGKSVRAID
LTEEERKDFITPLQFITDKPVMYVCNVDEDAAVEGNAHVDRVKEAVKEENAEVLVLAVGT
EADITELDDFEERQMFLQDIGLEEPGSAKLIRGAYELLNLQTYFTAGVKEVRAWTIPVGA
TAPQAAGVIHTDFEKGFIRAEVISYADFDSFGSEAKVKEAGKMRVEGKEYIVQDGDVMHF
RFNV
>IFAGANLK_01676 hypothetical protein
MKLRKNFKSTLKTPAFIKKTGLIVMASGLLFACNDGNKKADDAEIEIEQTMEVEEDTMSN
YAYERNAVADYLTYVDGDDEYEEMQEEIDPETALQKFAAAVSERSRDFGMQADQKLEVIG
DSLSKPVDNMDAQLQTAIASLEKLQENAYDELSEEVDELKAELQEIDMQADDAKEKLRNF
FHNAADVMEEMDAPTSEEGTMSANPGAVDEADYSQEPDTVEVDQ
>IFAGANLK_01677 putative methyltransferase
MLFMKDNFSTHSSAYAKFRPTYPQKLYEFLQAKLTDTETAWDCGTGNGQVAGELAEFFQK
VKATDISKQQLKNAVKKNNIQYSLQGAEKTNFQDNTFDLITVAQAIHWFNFKDFYKEAKR
VLKPNGIIAVIGYSLFNTTPETDEVIRKFYNDIIGPFWDEERRYLDEKYKNIPFPFHEIE
TPEFQQEYQWSFEHLIGYLETWSAVKHHEKETGENPVNLIKNELKTAFGSQNKIVFPILF
RLGKFKD
>IFAGANLK_01678 hypothetical protein
MNKLGFIFLLVAGMFFQNISAQSFADDQTVTQQVLQELNRERSLLSQNLEFRIKEIDSKI
SNLDESIQNTNSSSEKVEKLLERVKFLEERQEEIDKNTISVYKYNYSSAVLNLASMEREI
KPLNLFNASREFYATLDQVSNPMHYEGYQEWFGEFRKFVEDEKKNDARLSALSHILNVTG
DLAQGTPFTGMFAGTVFDGIGSFINSLGWGDKKLKQQSTEMLKLTTTVAQFTHDKDLIET
EWESINKNLDELKELQEKAMQENLVKILGIDPNEFDRNFTNETDAKKRTQYILDISKIAE
NKIAEEKAKNPENWKQDYHDQMIAVQNLKIRFGTITFRILENLKKYDSLIQKYENDEYLK
TKIADLKTKLNVVRNSFESTFNPQEYIKASNEMYVVE
>IFAGANLK_01679 Putative ring-cleaving dioxygenase MhqO
MEDKILGLHHITAIAGNAQRNYDFYTKVLGLRMVKKTVNFDDPQTYHFYFGDKVGSPGSI
LTFFPWTRVKQGKNGVGMATEIGYSVPQGSLDFWQKRFEKHGVEFGKIREQFGEQYLPFR
DPDGLNLKLIVTKHKDNREAWETDEVKNDVALKGFHSVTLTLFNVGPTASILTDIFDYEL
QEKAGEFYRYKTKAVENAAIIDIHEDPTAERGINAGGTNHHIAFRVKDEETQMRFREKII
QKGLQITEKIDRDYFFSLYFREPGGVLFEIATDNPGFTRDESLEELGTSLKLPDQYEGSR
DRIEKLLPELKH
>IFAGANLK_01680 hypothetical protein
MLVQRHDYETVSQAMNGLATRGYTTDFKLEPEKDKIVDPQRSLELSPDDFEIDEIYRFEG
MTDPGDEMIVYAISSHNHKVKGILVNAFGTYSDSNTYDIVKRLHKHL
>IFAGANLK_01681 Bifunctional protein pyrR
MGQRTLLNSVEINIILHRLACQLVENHTDFKNTVIIGIQPRGVFLAGRIIKILEEEYQIE
NLKYGHLDITFYRDDFRRSDKPLEANKTKIDFIVEDKKVVFIDDVLYTGRSIRAALTAVQ
SFGRPAEIELLSFIDRRFSRHLPIQPDYNGRQVDAINEEKVIVNWKENDGEDVVYLVSK
>IFAGANLK_01682 Aspartate carbamoyltransferase
MSELSVNHLLGIKYLTKEDIELIFKTANHFKEVINRPIKKVPSLRDITIANLFFENSTRT
RLSFELAEKRLSADVVNFSAASSSVKKGETLIDTVNNILSMKVDMVVMRHPNPGAGIFLS
RHVKASIINAGDGAHEHPTQALLDSYSIKERLGEVKGKKVVIVGDILHSRVALSNIFALK
LQGAEVKVCGPKTLLPKHIESLGVGVETNLKKALEWCDVANMLRVQNERMDISYFPSTRE
YAQQFQLNKKMLESLNKEIVIMHPGPINRGVEITSDVADAENAIILDQVQNGVAVRMAVI
YLLASKINH
>IFAGANLK_01683 hypothetical protein
MKISEKENYILIEPLEAPVVEFVSLLTQRHTEFENNNVAVNLLAYHQLQKEEVMGFLEIA
TTHQMNNKSFVLISNAVTIDELPEEIVVVPSLREAEDLIQMDEIQRDLGV
>IFAGANLK_01684 Ribonuclease Z
MKLNILGCYAATPRSFTNPTSQVLEMKNELFLIDCGEGTQVQLRRNKIKFSRIKHIFISH
LHGDHSYGLVGLISTFRLLNRETELHVYGPKGIKEIIILQLKLSNSWTNYPLYFHELSSK
EPQLIFENEKLSVETIPLIHRIYTNGFLFKEKPGDRKLLINKAVEYNIDVSLYKSLKKGK
DVTSENGELIPNHLVTAPPEPTKSYAYCSDTAFNQKMIPQISGATVLYHESTFLEDKAEL
AFPTKHSTAKEAAQIAKEAGVKKLILGHYSTRYSNINLFREEAEGIFPEVDLADDGKVFV
FE
>IFAGANLK_01685 hypothetical protein
MRKATLRFAILLLLSISTISCAKESIEEEVNSYNHTAEEKVNFDYSEIENNILELVNAHR
KSLELEPLKPIAEVSLEAESHNYYMLEVGKVSHDNFGERYENLVAAVGAKSVSENVGFGY
RTAEAVVNAWLNSDGHKKNIEGNHSHFGVSVVDDEVGRNYFTNIFIRK
>IFAGANLK_01686 Outer membrane lipoprotein Omp16
MKKQYYLILLFLVFSISLQAQYGKQKKADKLYSNFAYTEAVDLYKELIENKYNLKENRLK
LADTYMKLRSPENAVFYYEDLLKDSTNISTEVYYEYAQALRGAKRYDESREWLQKYLKSH
AGASAEANKMLNQENSEIQTTYRLIKSDFNSEFSDFGALKYKGETYLVSARNSENSEKEY
SWNEEPFLDIYKLNSGGEVSPISGEINTKLHDGPISFSPDGETLYFTRNNYFNNKEGKRD
KEATNHLKIYSAQKSGNNWVNIQELPFNSDDYSVGHPTVSKDGKTLFFASDMPGGEGGTD
LYKIIINKNDTFETPENLGSKINTAEDETFPFIDEDNVLYFSSTGHGGYGLADIFKSDLK
AENIEIQNLGETINSNLDDFSFFRETLTNAGFIASNRDGSDNVYGFNQLLPLILKGKVTD
VINGNPIAQATIRLFNKNNQEIAFLESDEDGNYQTAVNRNVDIPLEAKQIEYKNFNDTLD
TRNMDGSEEMIYDIELQPVADVEYLAEINNIYFDFDKSNIRPDAAEELDKLAEIMKKEYP
DLVIEIGSHTDKRGSDNYNEALAERRAEATRDYLIAEGISGERIQKRAFGERKPAIDCDR
CSSEQHQLNRRSMFNVVKMN
>IFAGANLK_01687 hypothetical protein
MKNIYLLIFCLMFSVSALAQQLPQFTQYMYNTISINPAYAGSRDGFSITALNRNQWAGVS
GAPNTQTLSVHSPLTNDKVGLGLSVINDKTGYENYTYAYGDFAYRLDFNNNISLAMGLKA
GMSYYNLDEELFNDQQVLNDPFFEDQFNKWTPNFGIGFYLSAQNWYIGASAPKLINNNNH
EYNEFLAMEQIHYYLTGGYVFDLNENLKFRPTTLLKMTSGAPLSVDFSGTMIFHEKFYMG
ANWRIEDALGAFLDVELFDGFRAGYAYEYSISDIRPYTSGSHEILLIYEFRFQKTRYKSP
RFF
>IFAGANLK_01688 hypothetical protein
MIEETPGSPAEPQAVVSQQPTCDDVTGTIAATTVQGISYTLLDENQNELANSIENGEFSD
LGAGTYFVQASNNDCESISEALVIEENLGSPAQPQAVVSQQPTCEDTTGTISINTVQEIT
YTLFDENQNTVNSTIENGEFIELPVGTYFVQASNEDCESVSEALVIEENLGSPAQPEANV
SQQPTCEDSTGTISVNTVQGITYTLLDENQNAINNTIDNGDFTNLNDGTYFVQASNKDCE
SVSKAIVIEENEGQPEAPVVMSVTNTSCNENNGIIEFKLIDGLSYILKDSEENKYSHSSG
IISNLAAGTYHLVAQNNDCETSAEVVVEKDLDEEAPVIISCPADLTNVLVDEAMCSAFNI
ELGDLVAEDNCNAELSITNDAPEVFELGETIVTWTVTDLAGNEVTCKQTITVKDNEAPVI
VEVESVHTTTDADTCGAMIEITAPEVNDNCSVESVIGTRDDNQGLNTQYPVGTTTITWNA
TDENGNEAEAVVQTVTVIDDQEPIIAEVEPINTTTDADSCGAMIEITTPPVTDNCSVENT
VGTRDDNQALDAEYTVGTTTITWNATDENGNEAEPVVQTITITDDQAPVIAEVESINTSN
YIDSCGSMIEITAPAVTDNCSVENAVGTRDDNEDLNAEYPVGTTTITWTATDEKGNGAEP
VVQTITVTDNQAPVIECPKNMIFNTENGVDFATVNFENPVATDNCEVRVEQTGGPASGSQ
FPIGTTTVTFTATDNSGNISECSFEIIVEDAEDPSLECPSPVTTGIDAGICGAVVEFTIP
QGFDNSGEVNVSQTEGPASGEVFPVGTTTISFRATDSTGNTVNCSFEIIVIDDLAPVIED
KDDITVNTDPELCGAVVNYDIPSTSDDCRLESVELTEGLTSGSEFPLGETTVTYTATDIN
GNSATSSFTVSVIDNEAPVIDCPDDITIKVEFGTETVVVNYDAITASDNCSETSIELIEG
YASGEEFPVGETKVTYKVTDPAGNSVTCSFIVIVEEIPEETPPAPDAPIVELIQPDCITP
TGVILINFENGLTYSIDGENYYAVDEFTELEPGTYSVTARDEFDQVSEATLVTLEEPVAN
EIETSTISLCTEDITFDLFELLQGDYNAAGVWVDTENTGALNQGIIDPALLEVGTYIFEY
QINNGVCSSTTEAMVSINDDCVVLPCSLEDIQSSISKAVTPNSDNHNDYFSINFASECGF
TYDVKIFNRWGSKVYEAINYQNDWDGYSTNSVTSSNQLPSGTYFYILEIRNSGFAPIQGY
IYLGTK
>IFAGANLK_01689 Adenosine monophosphate-protein transferase SoFic
MDFNETEAVRYHYGKFPPKNISYNNFITEIIKATAALARFDQMLKNLHNNEILLAPLRNQ
EAVISSRIEGTISTMDEILQYEADDDGGNLNARSEVIETILYQRALKNAQKALEDGYELS
TSYIKQMHQQLLHFGRGATKSPGEFKTEQNYLADKIKKKIQFIPISPEKLDEGLDELFNY
LKNSDDPALIKTALMHLEFEALHPFQDGNGRIGRMLITLFLWKEGILSQPHFYISGYMEE
NKDQYIDTMRKVSEKNDWEAWIKFFLTAVEKQAIWNLEIAENIRTLYEKMKIEFSDILSS
KWSMNTLDFVFTFPVFRNNKFISTSGIPSATAAGITKKLLENGYLLQKEEASGRRPALYS
FEPLMRIVRV
>IFAGANLK_01690 hypothetical protein
MVRATRNLKQGSGLVKESLESNKMKLVWSGLKEVSNTLHFATRTDLKYKKEIELIKQIFI
MKMGPKNGGCKINSV
>IFAGANLK_01691 hypothetical protein
MTTKEQQEFEKKVLDQFMSGKSLFGADGAFAPMLKNVIEKALEAEMNSHLNSDERSKGNK
RNGKGNKKLKSGFGSFDIETLKTVKAASNRNWSKNDRRF
>IFAGANLK_01692 hypothetical protein
MSYRDISGHIKEMYDTDISHTVLSQITDQIIPDIKAWQSRPLEPLYCIVWLDAMHYKIKV
DGKITHKALYNILGITKEGKKEILGMYISESEDANFWLQVLTDLQNRGLQDILIACTDNL
KGFTQVILSVYPKAQVQLCIVHQIRNSLKYLASKDQKEFMKDLKKVYRAVTKDVAEDELI
NLEEKWESKYPVVIESWQRNWEQLSQYFEYTEDIYTTNAVEGFYRQIRKVTKTKGAFTND
MSLLKLVYLATRNIEKKWTAPLHNWSLTIQQFYIKFGDRIPLAINANSSEASLRGIEISD
RV
>IFAGANLK_01693 hypothetical protein
MKISITVALYGNWIHYQGIYVGGILASIIKFIEE
>IFAGANLK_01694 hypothetical protein
MKSLKTQLSILTIILCFSACKENNASNDDFSTKERLIRIAELEIYPEYLEEYKVILKEEA
EASVRVEPGVVSIFPMYQKEEPNQIRILEIYADEKAYEAHLETPHFKYYKNNTQKMVKSL
RLIDMNAIDEESMPEIFKKIQGLD
>IFAGANLK_01695 hypothetical protein
MSESIENRVKKKIGNYKRGKIFSPSDFTNLGSSTAIRQALNRLEEDGFLTRLAHVIYLYP
KEHPILGELIPTTEEIALAIAKRDRARIIPTGNQALNKLGLSTQVPMNIVYLTDGSSRSI
KINNGSAQKHNLPGVGRSLIAVFNLNSNIKVLINHHITLMIISRDT
>IFAGANLK_01696 hypothetical protein
MLNVEKLKNEVVGQKWIFTSRNKTKAKVKIPFLDKALEILEKYDEHPMTEITQITISNVE
FVLMGRKERY
>IFAGANLK_01697 Intracellular endo-alpha-(1->5)-L-arabinanase
MRQVFYILIFLFAGGVHAQVKNYKNPLVDFNFPDPTVIKAEDGNYYAYATNTERKGEVIN
IQVLKSDNLVLWEELGDALPENPNWASSDFWAPHVVYNKKNRKYYLYYSGESNDKTIGKC
LGIAISNSPEGPYIDKGEPLLCGDNFVNIDPMVYQDEKSGKNYLYWGSAHESIKMRELSR
DLLNFKKGSEVKEIIHPVENSEIENYENLIEGVWLSKHKDFFYLYYSGDNCCGDEAHYAV
MVARSKSPEGPFKKFKNPKGNSVILSRNKDWIAPGHNSLITDEEGTDWIMYHAIDPKDRS
KGRVFLMDSINYKNGWPIIKSGSPSRKWLPAPQTN
>IFAGANLK_01698 Aldose 1-epimerase
MIISCLSTVFYSCKDETKSTKGLTSKESQTMKNNPEELLKAENFDTIIDNKKVRLYWLEN
DSIKAAFTNYGGRLVGLWVPNRKGEMTDVVVGMNSVKGFVESTEPYFGATIGRVGNRIAD
GKFQLEDKEYNIPKNNGENSLHGGNKGFQYVVWNATQPEKNKLVLEYQSPDMEEGFPGNL
DVKVTYSLTDDQEIVMEYEATTDKATPVNLTNHAFFNLNGEGSGEILDHQLQLNADRFTP
VDSGLIPTGELREVQGTPFDFREFHRIGERIEENNKQLNYGKGYDHNFVLYQGESKFQDL
THAASVIGDQSGIKMDVFTEEPGIQFYSGNFMEGKNNFKSGASDDFRTAFALETQHFPDA
PNQDNFPSIILEPGEKYQTLSKYKFSVIEQEN
>IFAGANLK_01699 Arabinoxylan arabinofuranohydrolase
MKKKFKCQYLLFISLAFLAFSCKQEEKKSDNKKKDLAQVKTYSNPLDVEFGDPYILNDGD
GKFFMYGTGGGVKNGFATYSSNDLVNWEFEGQVYKGNDEDSWAIGSFWAPEVYKFNNKYY
MFFSAQWRKNPSDELENFKIGVAVADQPTGPFKEVSDEPLFDPGYPVIDANVFQDDDGKF
YLYYSRVAYKHPVETEISEWAREKGWFDEIEESWVYGIELKPDFSGVIGEPQLLLRPPKK
MDEDNAEWESLSVTTREVNRRWTEGSFTFKHNGIYYMMYSANFYGGPNYAVGYATAPSPL
GPYQKADHNPILAKNIEKGGNVTGTGHNSLVFSKDSTKIYAVYHGRTKSTGDERVVFIDR
LRILENGKLQAEGPTTTDQPLPFLTNETE
>IFAGANLK_01700 Extracellular exo-alpha-(1->5)-L-arabinofuranosidase
MNYKPLLLLFVLYVTFGCNQSDNEPSSNDDNDSSVVAEENTFKNPLLSSGADPWVIKRNG
TYYYTHTTGNKLQIWETKNMEDLSSASPKTIWTPPSGEEYSTQIWAPELHYINEAWYMYF
AATSNNSDKDRRMFVLENTAESPMEGEWEFKGKIADETDQWAIDGTVVEIADEKYFVWSG
WRTENPEVNSGRQQLYIARMENPWSLEGSRVMISEPDYEWEKNGLVNEGPVAWKNPNGEL
FMFYSGSGCWTDDYKIGVLSFEEGDPLDPASWKKHQEPVFEKSEINNVYGPGHNSFFKSP
DGSEDWILYHANDHSSDGCTDKRKPRVQQVHWDEQGFPDFGIPAGRNDQLTPPSS
>IFAGANLK_01701 Non-reducing end alpha-L-arabinofuranosidase BoGH43A
MKKYILKVLMFIVVILNISCTDGKGNSRSENDISPDTENETKSEQIELADPTIFYHNDTY
YLYGTSQGSLAEKGLGFLVFTSDDMENWEGPVGKSNGFALAETEAYGNQGFWAPQVFEYK
DTFYMAYTANENIAIATSDSPLGPFVNAGEALYAETKQIDPFVFFDNGKAYLYHVRLEDG
NRIFVAEMEEDLESIKPETLKECLSATQPWENTASAAWPVAEGPTVLKHNELYYLIYSAN
DFRNPDYAVGYATADSPVGPWEKSGDNPIINREMVGENGSGHGDIVIGENEEMHYVLHTH
FSNASVHPRKTAIIKLNFNEDAEGNVSLTAEEESFKFLKSN
>IFAGANLK_01702 hypothetical protein
MKKNILTTLLVIISLGSLNAQERWSREKAQDWYNQHDWITGANFNPSTAINQLEMWQEET
FDPETIDRELGYAAQIGFNTMRVYLHSLAYKADQEGFKSRMEEYLKIADSHDIKTMFVIF
DDVWDANPKTGKQPEPKPGTHNSGWVQDPGYPESVEMADSKELEAYVKDILNTFGEDKRV
LLWDLYNEPGNNDKGNESMPLLKNVFKWAREANPSQPLSVGLWKWNLKDLNTFQALNSDI
ITYHSYDEPEKHRRIIELLKTHGRPMICTEYMARTRNNTFNNTLPMLNEENIGAINWGLV
SGKSNTIYAWNTPIESGEEPVEWFHDIFRKDGTPYRQDEVDLIKKLNAETP
>IFAGANLK_01703 Extracellular exo-alpha-(1->5)-L-arabinofuranosidase
MNTEHQYIIGLLFILMFANCFSQSKTFTNPLLPSGADPYSTYYNGYYYYTHTLQDKLVLW
KTKNLANIAAAESKIIWTPPEGTMYSKDIWAPEFHIIDNKWYVYFAADDGNNENHRMYVL
ENDNEDPFQGEWDFKGKVAAWPDRWAIDGNVFTYEDERYMIWSGWEGHTNGQQNIYIAKM
KNPWTIEGKRVLISEPTYVWEKQGDLDDEENPPHVNVNEGPQYLEHNGEIFIVYSANGCW
TDYYSLGLLSFKGEDILDPGSWIKHNKPIFKKSEENSVYAPGHNSFFKSPDDSEDWILYH
ANSRPGEGCGTRRSPRMQKIKWNEDGTPNLGTPVSAKTILEIPTLK
>IFAGANLK_01704 hypothetical protein
MKFLIKLFLAALVIVMISCSTDEAQPKNDEIDDDPVSGIESRTPVAGVRIAWDFNTKTLV
SQENDTGYSGYPRLIQLEDESLLVVYESKGNVLVKKSNDSGENWSEPITVVKGDQGVNMA
TPDVLQLQNGAILVMYNPRPGETADPTKKFLIKTILSNDNGMSWQNDQVVYEGDTEFENG
VWEPTALQLPEGEIQLFFSNESIYPNSNEQNISLLRSKDHGLTWSEPEIVSFRAGSRDGM
PAPLYLDNQNEIMLSIEDNGEHNQFKPYIIRNSVSENWSHTIGGSSEQRNYALLEELENS
EYAGAPYLAQLQTGETLLSYQGTDARNGNDLNNADMKVALGNENGEDFNRISTPFLIPEG
KSALWNSIAVLNDNTVIALTTTNAFSSANASEVWMIKGQVIPELKAEHTSLEIDGETTEG
IWKDHFPIFIGHTSSTRLQANVSFDNQNLYIISKVSDVTVSTDNQNIANNDGMVIYLDPS
NKSFETPGPGTYKIIISASNQVLAYEGNDSQWREIELTEMDTEVINNEEGYAQEIALAWN
AIGGKPTSNTIGLNVELIERGDSNYIETISATQTDAPYTWLSLKL
>IFAGANLK_01705 hypothetical protein
MKHFKFIFILLGLSNVLAQQPDPPGQVNSGEKAVNEAYLFAHMTHKDYGRLYYSVSKDGL
HWQNLNEGERVFDNYQGHPDIVKGPKGNYYIAGNTSDSSPDINIWSSDDLITWEKHAIYT
PDLTATPGYENALQRIGAPKLFYDKASSQFIMTWHTPHKEGTKEDPERYWASQRTLFVLS
DDLKEFKGPPKMLFDWNIGTIDVIIRKVDSSYYAIIKDETYPTLYWPTGKTIRIARANSL
LGPYSLPQEPVSPNFREAPSLIPSPTGEVWYLYYEQYPGVSYGLSIADNLNGPWYQASGY
TFFSDWDKYSLPEKVRHGSMITISGKEYDTLVNEFGISLETKGEK
>IFAGANLK_01706 hypothetical protein
MKKTYFLLLLLMSSVLFSCKETQNKEENIAANNSEERALETRTIWSKEKAEEWYSKQPWL
VGANFNPSTAINQLEMWQEETFDSETIDKELGWAEDIGMNTMRVYLHDLLHKNDPEGLYK
RMDEFLKIADKHRMKTLFVLFDSCWDPFPEAGEQRAPKPHVHNSGWVQSPGQQVLQDSSQ
YDRLEKYVKETIGEFRNDDRILGWDVWNEPDNMTGPSYEDVEIPNKVELVLPLLKDAFGW
ARAANPTQPLTSGVWIGDWSDPEKMEPMHKMQLEQSDIITFHNYDSPEDFEKKIKDLQRY
GKPILCTEYMARPNGSTFQGFLPIAKEYNVGMYNWGFVDGKTQTKYPWDSWTKTYTSEPE
VWFHEVFRNNGEPYDEEETELIKELSAEVNTP
>IFAGANLK_01707 SusD-like protein
MKKLLLIFTVFCSLLALVSCQEEELDLKNPNALTTDQFWVTPNDAELGVNSIYAMFYKDG
LWARWMYFRLDLTSDEGFSTSPWIELADWTRFNYINYNFWEGNAVTWRDSYKAIFRANQV
LANVPEIEFEDEARKQSIIAEAKFLRALHYYYAGLLWENIPMVLEPSTPDALPQQVSQEE
VFAQVEQDLNDAFTDLPMQWDAENVGRPTKGAVKAMLAKVYMQQHRWPEAKTALDFLVIG
EGANYSLVDNYKDNFTDINENNSESVFEIQFGDQRRGGTGEGQDASVSSTRAQFFAPRGI
GWSDGQARFWLVDTFKEEQTVAGEIDPRLQHSLFYPSLFEDFGDRTYGREWEWGEDEAWF
RKGARDYKRDNEDYFSGVNWRLIRYADILLRYAEVLNELEMTSEAYQYVDMVRERANMAP
LADTYPEIGNDQDRFLDRLKIERVLELSGESVRWEDLKRWGDLEDQASVDEIAERDPDFN
NFEIGKNIRMPIPQSEVENNPNLEQNPQY
>IFAGANLK_01708 TonB-dependent receptor SusC
MRTILPFKLMFIVGFLLFPFLCSEAQNASQVTGKVTNQNGEAIPFVNVVIKGTSVGTSAD
IDGNYTIEASPDQTLVFSYIGFDSREVAVGDQSVINIQLQEDIAALDEIVVVGYGTQERK
DLTSAISVVSSDQIQKRQTTTVAESLQGLAAGVNVRGGGQPGQEARIEIRGLKNLQSANP
LYVIDGMVTTANRDFNPNDIESIQILKDAAAAAIYGSRAANGVVIITTKKGKKGPLQVNV
SSKLSITEVPRYDLAGQEEFVRLNNMAYDNAGIPRQDLNLDVNTDWQEEVFRTGMIQDQN
VSFSGGGENSSYFMSGNYFGNKGTVIDTKFDRVSFRVNSSGSKGIFSVGENLAISNSKNN
EIGGPEALRGNPFIDVVRMFPTIPVRDESNPGGYGYGKSGVANTFGANPIAISNLIDQTI
ENLRIRGNVWAELDPFSWLKYRVSYGYETSFDDFKYLRREGSWTLNQPQDPSFTDQNRAQ
SQTHLLENTLTFDKEFGKHDISLVVGTTYQKDSYEQINGLKRNLLVNPNTGEYFDVLDLG
DQAQVGGFRNESTLLSYLGRLEYNFDDRYIVNAVFRRDGSSRFSDENKWSNFPSLSAAWR
LSNESFFDINNISDLKLRASYGELGSGNIGNYEYQGFINTFGAIVLGNGQNLYPSATQVR
LANSRLRWETLKQTNLGVDLSMFKNKLQFTADYFVARTEDVLFGFPILLSTGNDGGNPIS
NAATVENKGFEFNVSYNKVVNNDLSFNASVNFTKLNNKLVRLGNGLNESIQGNTITRAGG
PVGMWYVLQTDGLFQSQEEINNYTNSEGEIIQPDALPGDIRFLDINDDGEITNEDKEVVG
SPWPDFEMGLNAGLNYRNFDFSMNWIGSFGATVYNGYRSTVDRFDDDTNYRSGIQPWTPE
NPNTDFPRVVKGTTLNSRGDSDRWLEDGSFARLKYIGLGYNIPANTLEKIGFSRARISLS
AQNILTITDYQGLDPEFSNNNIFQRGVDLGSFPNVQTYSLGVEFGF
>IFAGANLK_01709 Sensor histidine kinase TodS
MRSFRIFLILVFSFYISEAQNLSFKQLKVEDGLSHNSVISMLQDDNGFLWFGTKDGLNRY
DGYNFKIFRNESENENSLGSNFIRCLYQFDGHIWVGTDTGLFKYNDKTESFKLILSTKDK
PILDIEGDSKGNLWFIASGTLHKLDLTTDKTKEESFDQFYTSFITTNEEGDVYVSSSDLF
YQYVPENNSFKRIELEGTAIENGVSDLIITTINAHSKDSIFIGTKNKGALLYNRIKNTLT
PLLKEDENPLFVRDFLMKNNKELWIASESGIFIYNLEKGTYQNSTKSYNNPYSLSDNAIY
SLVLDREGGVWIGTYFGGVNYYPKQYTPIDRYFPKVGENSISGNAIREIKKDSFGNIWVG
TEDAGLNKLETDTGRFKNYFSVRSGGILSHYNIHGLLPRNDELWIGTFEHGLDIMDIKTG
KVKHHFGTASYEGGLRSDFILYIYETRNKDVYVLTSSGIHRYKPESNSFELVEGFPEIYH
YTTFIEDHRGVLWAGTYWDGLFYYDPKTKDKGFYRFNSNDKSSLSSNVINGLFEDSSNNL
WVTTENGLNLFNQKEDNFYRYTTENGFPSNVAYSILEDDDSNLWISTSNGLVEFSMKEQE
LKVFTKSNGLLSDQFNYNSAFKDENGKMYFGSVNGLISFNPDKFIQNNYQPPIYITNIQI
NNQDVSVKKNNSPLETSITFSENIELNNQQSTFSLEFASLSYTAPEMTKYWYKLEGLNEN
WIPIGKNHKVSFNELPAGDYTFKVKAFNSHGVWSNENSSLKIEVLPPFLSSNLAYVFYAA
LLILIIFFLLRYYHRYNRDKNNLRIQQLENDKEKEIYQAKIEFFTNIAHEIRTPLTLIKS
PLEKLLSLKYNSLEIPKNLGIMERNTSRLLNLVNELLDFRKTEMKHVKLSFVEVNISQLL
EETYIRFSQLIKDKNIHFDITKKEKDIYAFVDEEATRKILSNLFSNAIKYCEYHVQVQLE
KTEDHFRIIVQNDGEKIPLELKQRIFEPFFRVPGETKKSGTGIGLSLAHSLAELHHGKLF
INSNNLSLNEFVLQIPLHQDNEFRAFKNQPKEVKESDEIIRKFDNDSALILVAEDNPELA
DFILNELSEKYNIIVASNGKEAWKAICTYEVDIVISDVMMPFKSGIELCKEIKEDIDKSH
IPVILLTAKSALNAKIEGLESGADAYISKPFSLNHLQVQISNLLQNRKSIIGHYNSSPLA
HLKSLSLATSDKSFISKLDQKIDDNLKDTNLNVEMLARHMNMSRSTLYRKIKDISNLSPN
ELINESRLKKAAYLLKTSNLKIYEISEKVGFKSQSSFGRSFQKHFSMTPSEFIDQDHNI
>IFAGANLK_01710 hypothetical protein
MKYLKFLIIGIIFGIVMFKSEAASWFRIYEMFQFQSFHMYGIMGSALTLGVLGTWLIKKY
KLKSIDGEPIKFTPKNKSFSRYMYGGILFGLGWALAGSCPGPIYTLIGAGYISILVVLVG
ALVGTFLYGLLREKLPH
>IFAGANLK_01711 hypothetical protein
MEWILEPWPWYVAGPLIAGIMFLLLFGGRTFGMSSNLRTMCTIGGAGKKADFFAFDWKAQ
RWNLVVVAGAILGGFIAANFLSTDISVEINPDTVTTLENLGFASAGEAYLPNELFATNAL
TDPKSLVILLIGGLLIGFGARYAGGCTSGHAISGLSNLQLPSLIAVVGFFVGGLVMVHLL
FPLIF
>IFAGANLK_01712 hypothetical protein
MHKWLPILSFLIINAFKVPYLHIRLVLSFFPAGLKEVNLRELKEEGFGILTEIDIKETFK
KKLDLDFRKYRILGACNPKMAYQAISAESKIGTMLPCNVIVQETEDGKIEVSAVDPVASM
TAIENDELGGIAQEVQSKLKTVIERLS
>IFAGANLK_01713 Thiosulfate sulfurtransferase PspE
MNTEEIIKNNAGTIVDVRTPGEFMGGSVSGAVNIPLNEIQQRIDELKEMKTPIIFCCASG
NRSGQATNYVSRQGVDCVNGGSWLDVNYLTSQEA
>IFAGANLK_01714 Thiosulfate sulfurtransferase PspE
MLGFSPVPDYNQLLKEGGIIVDVRSKAEYAGGHIKGSKNIPLPNLNSNPGIPKNKNKSII
TCCASGMRSASARSLLKSQGYNNVHNGGSWSSLNNKIG
>IFAGANLK_01715 hypothetical protein
MINRIFINWTWMRAVYLIIGVWVIVQSAVEGHWIGVLLGAWPAAMGLFAFGCASGNCATG
TCEFKPDTDHKQ
>IFAGANLK_01716 hypothetical protein
MEAHKYHVDLEWKMDRKGEISSPVLDQKVEVATPPEFPKGMPGIWSPEHLFTAAVSSCFM
TTFLAIAEYSNLEFESLTCPAEGILDKKGGKFAMTEIILKPVVTIPNEAEREKAEKIMIK
AERACLISNSITSKVHLKTKVFISEKHTA
>IFAGANLK_01717 hypothetical protein
MKVLNHLLVVFLTAAIFTSCGEDRKSDTEVPGRDESTKTNVLETGSNLIQTKAPFDPMEV
YLVGFHPMKQDPGHQMEAHHFCTQINEDFAQCVLFDGNTEDARLTGIEYIISERLFETLP
EEEKQYWHPHNYEILSGQLVAPGLPDIAETELMDSKMNSYGKTWHTWSTDKGDELPFGDP
MLAWSFNRDGEANPELVRRRNEAMDIDPNEKREQRKELISKANPQEGVDAIKDEFPGPTE
LIPGVESKKGRDSVQ
>IFAGANLK_01718 hypothetical protein
MEEQHQEHEERVRSSSSSKKNRKIDRETIANIRKYENKSPQEIQNRIEELEKEWDIERLL
ETNMSTLALIGIALTILVHEYWIILPLVVLLFFLQHALQGWCPPLPIFRSMGKMTRAELD
REKYALKVLRGDFKNVPRPGAPGNPEMIFKATTKD
>IFAGANLK_01719 Hydroxyacylglutathione hydrolase GloC
MTIKQFKDDPLAHYSYAIVSKGEMALVDPSRNPKQYYKFAEEHNANIVAVLETHPHADFV
SGHLQIHNETGATIYVSEKVGVNYPHKPFDEGQSVKIGKINIRPLHTPGHSPDSLAFVAE
ENGETALFTGDTLFIGNVGRPDLREKAGNMKSKRVELAKAMYNTMQTKFNDLPDNSIVYP
AHGAGSLCGKNMSASPSSTLGDERIGNWAFKDQTEEEFVEEILKDQPFIPSYFGFNVDLN
RNGAGNVQQEKYRVPLRVGVNDVEEGITVVDVRDGDSYKAGHLPYSINIMSRTEGDKYET
WLGAIIEPKEPFYLAVNSVENIDELLERTAKIGYEKQMKGVVTLSEKVSRTSSDLDLQNF
KDNKDNYTIVDIRNESELAEGKIFDSAIGIPLNELRNRADELPKDKPFVVHCAGGYRSAA
GSSILENKFKDQKVFDLSEAIEDFK
>IFAGANLK_01720 Inner membrane transport protein YnfM
MRTEDIKLGLKENWKQFTLLVLVNAFVGGMVGLERSILPEIAEKEFGMAATSAILSFIVV
FGIVKAISNYYAGALANKFGRKNLLVLGWIFAIPIPFILMYAENWNWIIGANVLLGINQG
LAWSSTVVMKIDLVGEKQRGFAMGLNEFAGYLAVAVVAFLTGWIAGEYGLRPYPFYLGIL
LMILGLVMSIFFIKDTRGHAKKEEGSSTVSLLKNIFWDTTWKDKNLGSVTQAGLINNLND
GMAWGLFPILLAAKNFSLEQIGIVVAIYPAVWGLGQLFTGKMADKFSKKDMLFYGMLLQS
LVLITLVWAESLWHFIVLMSLLGWGTAMVYPTFLATIADNTHPRDRAKSIGIFRLWRDLG
YAVGAILTGVISDLISIEAAIMTVGLITFVSSCIIFFRMKNKDVAPSLVSIFRHSS
>IFAGANLK_01721 hypothetical protein
MESFVANPNLPMKAIFIILLFFFQFTLFSQEYIPKNDHRENRLGDIIREGTVHGHIRNFF
MTTVNSEDLTNYYTNATGGAVGFTTGNYKGFEIGVKGIFTFKTFGSDLGLEDPITGANAK
WEYELYDVLNQGNFKDLDRLEELFIRYSFGNSYISYGKLETEYTPLLNHSDGRMKPFAHR
GFWGYLNLNPQNTINIGLLDGVSPRSTTEWFDLEEGIGLFFNGFQPNGERANYHEIYPVN
GIGVFNYNYKIKNFNFAIYDVFIDKLHNTVWTEANYVYDGFNLGLQYVYQTPMNFSEGLA
YENRYIQPDENGQVISSQLGWGNNRFNFGFAYTHAFDTGRFLFPKELGRDRFFTSIPRSR
LEGLGAANVYTIKGEFLLPRPDLHFGVELQQVKGTTPGDFQLNKYNVDESFQVNTHLTFA
VNGFFDGLSFDLLWVYRENKNTRDAESIFNKSNFNQFNFVTNFIF
>IFAGANLK_01722 hypothetical protein
MDSKFLVVLLDTDEIVYVNPFCEKQNAKQNAKIDGDTSPATFTVDSNQLSISMDTFCNTS
FKFEIFNWENPIVLDESRAYAYHSPSLPDSNRDRFYPPPKA
>IFAGANLK_01723 hypothetical protein
MTTHISVSRRSIQVLRIMLSGIFLIASVNHLMNVEQTANRIDQASFKGIAYFFGNPELLV
ILSGIVMLIAGISFLIGFKTRWTAIVLLAVLIPITLTVQVGQINTLGPLFKNIAIIGGLL
FFILNDLNKESVTETNPAQTELSVKNK
>IFAGANLK_01724 hypothetical protein
MKMYFLSSIVLLLALISSPANAQVQDEQQNYVVLTKKIPQLQPIFLTAETLAEEDGNNFG
KFEVIICGQTVKELTDKEMMQKYINKAKEQDVELVACGFSLNKFGVDRKDISPEFRVVEN
GILYNLQLQKKGYTSISL
>IFAGANLK_01725 hypothetical protein
MKRSLGIFMLLIMLGITGNAQTNPQGDLNNYVVSTTKIPQLQPIILTAEALREEDGDKYG
DFQIVMYGSNVKGLTNKEEMETYTGKAKAAGVSIFVCKISLDRQGIDQSELHKYIQVVDH
AYTHLFQLQKNKNYYSLQL
>IFAGANLK_01726 Trifunctional nucleotide phosphoesterase protein YfkN
MKFNLKTSLCILAVLGIVSLTSCNQAAGGNSEEKNTKTDTLSITVLQTADIHGQLDPHPE
LFWENEEIVFKERGGLANIKTLFREEREKNPGRTVIVDGGDLIQGSGYAALSEGRIFPEL
ISEMGYDVIIPGNWEVVYGKERMMDIMTNYDTPVIAQNMFHEEDGKELFPPFWTKKIEGV
KIGFIGINDPDVPVRQNPIFSEGITFRGIEDKVKDLISSVKQEEEVDVLFLVTHMGVFKQ
VDLANQEMSKDVDYILGNDTHERVRELIQGKYAKVSEPGAFGSFVGKLTLHFVDGKLVGD
EYELIDVDPEVYPADPELQQLVDNAKEPYEEHLETVVGHTATPIYRYLTVENPMDNMITD
AARWKTGADISISNGFRFGNPIVPEDGKPAPITRANLWNLLPVNEKVKTGKVTGQQVKDW
LEREMHNAFAQVPTERFGGWLVRFSGMQVDFNSQGNKGERVQSITIKGEEMQMDEYYTIS
ACVRPGDPIDNLCRIPDVEDVEVKDYTIHDVVEEYLQKNSPVSPELDGRAYCEYLGEYSF
STVPGTEYIFQ
>IFAGANLK_01727 hypothetical protein
MRLDKTVKTLSMVVVFAVFTAYGKGTPTPAHEAQQDQTFTILHTNDIHGNYMPFLTTTVS
ATS
>IFAGANLK_01728 Mannosylglucosyl-3-phosphoglycerate phosphatase
MVLPTSQLYIKTKAFFGNPYILKEVEGTKIALLSLGYHNTNLTGNSKNMNDLEFRRGNEV
LNEILHELKEQADIIVLLSHQGTAVDRLIAEEFSEIDMILGGHSHDLISGPERIINTFMV
QAMADAAALGEIELKIRDRKLTGVKALHHFLWLSDYEKDPEMGSLIEELRAPHRGPPGGE
HSNGNRGDPQAIQK
>IFAGANLK_01729 hypothetical protein
MLLEEYDVDISFLPGVGYGISLQGDITRKNLSRLIPHPSKVATLTLTREQVKTTLEQTTT
NQKPRDKYEMVGGLL
>IFAGANLK_01730 hypothetical protein
MPIIKLQTSIKANRNIVFDLSRSIDLQSRFVTGSNEKAVAGRTSGLISIGETVTYRGKHL
GVWQNLTSRITDFDRPYFFADEMEKGAFKTLRHEHHFFATEEGTMMKDIFNFESPLGILG
KLANTLFLKSYMTNFLKNRNEIIKEFAENGRWKELLAEKNVEYKD
>IFAGANLK_01731 Thiol:disulfide interchange protein DsbD
MKLSNPIFFLVLLLFGASSAVGQMMEAPQWEVNLNNPDAEPGEKVTIHFEAEIPDDWYMY
SNDFDPDIGPLLTEFTFEESEEYELLGDIQPIGQKKKYDEIWEGEISYFNETANFSQEVL
IKKDSPEFTGNIFFQICTDVTGQCIPFDTDFAFDSTGNTLISTGNEGSEIENSGISDIFS
AQGNTTTKGNENVSAGENGEILEPFQNSFKTESDEDDQTWAGLLTFFFISFGAGLAALLT
PCVFPMIPMTVTFFTKGSGGKKGKMNALLYGLFIIAIYTIVGTLFAVLFGAGFANFLSTH
WLPNLLFFAIFLLFALSFFGMFEIRLPNKLVNRVDKQADRGGLVGIFFMAFTLVLVSFSC
TGPIAGTILLQAASGEAIMPLIGMLGFSLAFAIPFTLFAFFPGWLSSLPKSGGWLNTVKV
VLGFLELAFALKFLSMVDQVYHWNILDRDIYLALWIVIFALLGFYLLGKLVFPHEKKIES
VSVPRLMSAILVFSFVVYLIPGLFGAPLKALSGYLPPMGSQDFNMVTASAGPELESSSNS
CGTPLYSEFLELPHGIQGFFDYEQAVACAREQNKPLFIDFTGHGCVNCREMEANVWSDPE
VLRSLKSDYVVVALYVDEKTVLPKDKWYTSSYDGKLKKTIGAQNMDFMIQKLNANAQPYY
TLLGEEGELLAAPKGYDLDIAAFISFLDKGKEAFYKGSIEIKQD
>IFAGANLK_01732 Thiol-disulfide oxidoreductase ResA
MKKKTKKNLIEYGIIFAIFAGLYITGLHTEVLGFLQRGVLATGLMDPDLDKNADLAVNDT
NSKADFSMSLINSKGENVAMEELKGKVIFMNLWATWCPPCVAEMPGINKLYKDIDKDKVA
FVMLSIDQDFQKAIDFNEKKGYDFEIYRSNGPIPQMYSSQSIPTTYVIDARGNLVLTHMG
MGDYDTKDFKEFLKKQY
>IFAGANLK_01733 hypothetical protein
MKTTIAVQNLKCGGCVNTITTKLSEIENIQNVQVEKASSSVTFSYREPEDAFKVKEKLRK
LGYPAVDAKNSLASKAISVISCATGKM
>IFAGANLK_01734 hypothetical protein
MELIDILGYFGALVIGITLGLIGGGGSILTVPVLVYLLSINPVTATAYSLFVVGASTLVG
AINNMKKKLVDLRTATVFAIPAFIAVYGTRKYLVPAIPDHIFTLWGFEVTKDIGIMLFFA
IIMVVASISMIKGNGKEELQEVKVKYNYPLIIVEGVVVGILTGIVGAGGGFLIIPALVLL
AKLPMKKAVATSLLIIAVKSLIGFIGDVENLEIDWVFLMIFTGLSIAGIFLGGYLNKFID
GGKLKKGFGWFVLVMGIYIIGKELL
>IFAGANLK_01735 Global nitrogen regulator
MLQELKDAYGFIFEEELIREIEETGVLKVSHAGEIIMDINDYITSMPLLLDGAIKILRED
EDGNELLLYFLERGDTCALTLSCCLGQTRSEIRAVAERDTKYIMVPVSKIEEWTTRYKSW
RNFVFESYQSRLSEMLETIDTLAFMNMDQRLLRYLQDKAKINQSEELQVTHQQIAYDLNT
SRVVISRLLKKLEMEGKILLQRNQILVQDL
>IFAGANLK_01736 Single-stranded DNA-binding protein
MKTLRNTVQLIGNVGEDPKTHRFENGMLVCRFSLATNEQFFKDGEKIQETQWHQLVAWSK
QAELVSKYISKGKEIAIKGKLTYRSYNNEAREKQYITEILVDEILLLGNSKQDSN
>IFAGANLK_01737 hypothetical protein
METKVNEIAISYSGSIKTKFLPKISSSRDAANLLFEHWDKQNIELFESFKMLLLNNSNQV
KGIYTLSTGGITGTLVDIRIVFAVVLKSVTTSIILAHNHPSGTLHPSQPDKLLTEKIKKA
GELFDIKVLDHLILTPDGDYFSFADDGIL
>IFAGANLK_01738 hypothetical protein
MDKEYKKEKFETLKIKTSVAKKFRRFSRSLSKSQSMTLLSMVDFFEMNSISPNELMGPKM
ETLENLVKKRINAVIAILKDIEKNKVNPTLGILESLMEAADPKNNYENRIRDYEEDDTHP
DFYK
>IFAGANLK_01739 hypothetical protein
MYITITPQKLGANYSQSAADYVDYLEKENQIAGIEEKDQELFFNQEEDGISPEMVVKEID
ANTAKLEKMEPKFYSITVNPSQYELKKLQNSSEALKQYTRAIMKDYASSFNREINGRPIN
VSDIKYFAKIENHRAFKGTDYQIKENQPYATKIQVIKNEIRKIEGGEMQGSIRSREQQIT
NLEREAPHQQNGQRIVQGMLKEGNQSHIHIIVSRKDVSNSHSLSPGSKYKASEVELNGKL
VKRGFNRDDFFKKAEKTFDKQFQYQRNFVETYQARKDFINSPKIYFSAIMGLPASEKALA
MKMLRETGIPLPPVIPLSKAQLSVKLIKTIQKGILTASRSASIGI
>IFAGANLK_01740 hypothetical protein
MEVNFLNIILCIAIGTGIFFRMYKITSFAFPKNLLVCGLFLWALLPNDPSLKEIANIALY
LGCPLILSNTVLYVFIPKKEIPNIETKYQVQFKTESGSFKINNIKRGVSVIGAAGSGKTE
SVVYNLLEHFSRNSFCGLIHDYKDFEITEMAYPLFKNRNLEFYILSFDKIIHRVNPIAPR
YMENEEDINEVSRVLIENLLEQKESGAVGVGKFFNDAAQGLISGLIWKLKVSFPEYCTLP
HLIAIYQYLGTDELIGFLKSNQTSRAFADAFISGKDSEKQTAGVKSTLSTALMKISSKRI
FMALAADDIPLNINNKDNPAVISLVNNPKYDSSYSPVIATVMHTIVKQMSVRHSKSSFLL
IEEAPTIRLLNMHRIPATLRSYDIATVYVMQDKIQNDMMYGDKASKAILSNLSYQFFGKV
NDPDTARFYERFFEIIKDETKTVMRGTGLDFDTKISTGEKEIYKVRANVFFSLKQGEFIT
YADGKDKKVQFKQQLIERELPEVGQFFSDEEINENYIKIYREVRNICKVFKGKKKSTKPD
EAASKS
>IFAGANLK_01741 Putative SOS response-associated peptidase YedK
MEWGLFHSQPGIDIIDFRKDYNTLNARGESLLQSKLFKEPARKRRCLILADGFFEPHYPN
DNFKAKPVPKYCYLENRKLFCFAGIYNEFDDEYWNVSLVTTEANDFFGKIHNKKKRMPLV
LDPTFEAEWLREDLSDKGILDLVKHGFIKEEFKAHSVANIYKREINTNTPEFLEPVDDGA
GEQGKLF
>IFAGANLK_01742 hypothetical protein
MSTSNTFSILFLVNPKKISGDLVTIYVRITVNQRRSTISLKRKIPLKCWDSAKKRARGTS
AETKQLNHYLDKVQARLFQCYQDLLFKGKKITAQLIKATYLGEDENSKSLQDLIDYHSRK
IEHTLASGTIKNFKITEGYIFKFLKKEKKTTDVYIKELNYKFLCDLQDFLSSYYPKGHPK
AMGHKFYITEPMNHIIIFQAILIQTFFAYQLKIFHIFIQWSGAYFIVSLG
>IFAGANLK_01744 hypothetical protein
MKLKKLLLAVFSVSLLCVSCEQEDIENTTPEAEAEVISQDKVSKAVLAKLEALNLNTEDV
EISEFVLPDGTKKQTFIIEGDIAIDAEQLDAMQPGNITSKQYRTYNLVSAPRTLNVVGWT
GGSQSLTQKQRDALQAALDNYNEIEIGLSFTLEFSTNQAAADIVVFQNPNGAAGGVAGFP
SAGNPYGFVQIYSGMEAFSLGTNTHVMAHEIGHTLGLRHTDWFTRQSCGRPSFGELANPS
GAVHIPGTPFRLDPESIMLSCFSTNEDGEFGANDVVALEYLY
>IFAGANLK_01745 ATP-dependent Clp protease adapter protein ClpS
MTMSTKEEVLEEVKTTTQKENEIVLYNDDYNTFDHVIETLIYACEHTPVQAEQCAILVHY
KGKCTVKTGSFDDLKPRCSKLLEEGLSAEII
>IFAGANLK_01746 Ribosomal protein L11 methyltransferase
MSSNYLEFKFKIEPLQPASEILVAELGYLGFESFVEEEDGLTAYIPAEEYEDDLLAGVHI
LQSEEFQITYSKGEIEQVNWNEEWEKNFSPILVDDICSVRAPFHPEPDTEFDIVIEPKMS
FGTGHHATTHMMIQHILKNDWNDKAVLDMGCGTGVLAILASIKGAKFVDAIDIDNWCYQN
TLENVERNECDNINVEEGGAELLQGRKYNMILANINRNILLRDLPIYKDCLKKGGNLFLS
GFYEEDIPVIKKACLELGLNYIEHIERSNWVAVKFSA
>IFAGANLK_01747 Triosephosphate isomerase
MRKKIVAGNWKMNNDLAETQELLSHLKMQLVKEPQAEVMVAPAFTNLYSAFQGLKDTPVQ
VVAQNMHQAENGAYTGEVSAKMLKSIGVDTVILGHSERRAHFGETNDILAEKVNAALKNE
MRIIFCFGEELADRKSDKHFDLVAKQLLESLYQITDSDWKNVVLAYEPVWAIGTGETASP
EQAQEMHAFIRKNISEKFNDEIAQNVSILYGGSVKPANAKEIFAKEDVDGGLIGGASLKA
VDFVEIINAF
>IFAGANLK_01748 hypothetical protein
MKLLVGISRVLVGVLFIFSGFIKLNDPLGFSYKLQEYFSPEVLGLEFLVPYSLVIAIILV
VFELVVGIMILIGYLPKFTVWSLLLMIVFFTFLTFYSAYFNKVTDCGCFGDAIPLTPWQS
FIKDVILLIFILILFFNRKLITPVLNPISHRWIIFLSFMLSFWFCYHVLMHLPVFDFRAY
KIGSNIQEQMEVPEDAQKGVYEYEWTFLHNGEKVTVTTDGSYPNQEGEFVEVETTMVEEG
YVPPIQDFEIEKDGEVFTNEILDTEKLFMVVAYDLSHTEQEGFKAIEKLAAEADDKGYKV
VGLTASNDADQQKIISKFKLDFDFYQVDKKVLQTIVRSNPGLLVLESGTITQKKHWFDAE
DIKL
>IFAGANLK_01749 hypothetical protein
MQNTSEQYDAVVATCRSLFINKMKDYGSAWRILRLPSLTDQIFIKAQRIRKLQENEVRKV
DEDEKSEFIGIINYSVMALIQLEKGVVAQPDLGVEEAKELYDEKIAETKALMMNKNHDYG
EAWRDMRVSSLTDLIIQKLLRVKQIEDNKGKTLVSEGIDANYQDMINYSIFAMVLMTENE
D
>IFAGANLK_01750 Dihydropteroate synthase
MTINCKGELIDLSSPKVMGIINTTPNSFYAESRKISKIDILKQVEQMLKDGADFIDVGGY
STPPGATKVEEAEELQRVLPAVENILKNFPETLISVDTFRTKVAEESIEAGAAIINDISA
GNLDPKMMKTVAKHQVPYIMMHMRGTPQTMKDLNQYEDLVQDILFYFSEKINTARTLGIN
DLIIDPGFGFAKNISQNFELLSKMELFKTLELPILAGLSRKSLIYKTLNTSAQEALNGTT
FLNTIALSKGASILRVHDVKEAVECTKLYAELNK
>IFAGANLK_01751 Cyclic di-AMP synthase CdaA
MDIINLRFLDVLDIVFVALLLYYLYKLVKGTVAVNIFIGIVIIYLMGSLTQLLQMELLSS
VLGEFIGVGMFALIVVFQQEIRKFLLMIGSTNFTQKGKFFTQLRFLKGDLETSTNVEDII
SACEVMGQSFTGALIIIQKNTNLDFVKNSGDDMNIELNQPIIESIFYKNSPLHDGAMIIE
DNKITATRVILPVSNDRSIPLRFGLRHRAAVGITEKTDALALVVSEETGQISYIRDGEFV
MFESNEELIERIKEDLL
>IFAGANLK_01752 putative ABC transporter ATP-binding protein
MASKTGSAFDFDLFKRLLKYTNPYKGTFYFVAIAAILLSFFAVLRPYLLKVTVDDAITPQ
DYSNLVFYVGLMAGVLLLEVIFQFLFVYFANWLGQEVVRDLRVNLFKHMLGFKMTYFDKS
AVGRLVTRAVSDIETIASIFSQGLFMIISDILKMLVVIGFMFYQSWQLTLLVLTVLPLIM
YATRVFQKKMKVAFEEVRTQVANLNTFVQERITGMKIVQLFTREKAEYNNFKEINGKHRD
AWVKTVWYNSIFFPIAEMATSITIGLIVWYGGLRAVADDGITLGVIIAFIELSQLLFRPL
RQIADKFNTLQMGMVAANRVFGILDTESSISNTGKIEVSDLKGEIEFKDVRFSYTDDEEV
LKGVSFKANPGETIAIVGATGAGKSTVINLLNRFYEINSGQILVDGIDIKDITLESLRSE
IAVVLQNVFLFADTILSNINLNDPDITEEEVINAAKQIGIHEFINTLPNGYHYNVKERGA
MLSSGQRQLISFLRAYMSNPSILVLDEATSSVDTYSEILIQEATDKITKGRTSIVIAHRL
ATIKKADKIMVMDAGKIVEIGTHTELLQKKDGYYKNLYEVQFMAEESL
>IFAGANLK_01753 tRNA pseudouridine synthase A
MRYFLELAYFGKAYHGWQNQPNAISVQEEIEKALAIIFQRKTDIVGAGRTDAGVHAKQIF
AHFEVEAELDKESFLFKLNSLLPADIALKDVFKVKPDAHARFDAYSRSYEYHIVQHKDPF
LEDRSYFLKNKLDVEKMNQAAEILKDYTNFKCFSKSKTDVKTYNCKISEAIWKTENEVLV
FHISADRFLRNMVRAIVGTLLEIGFGKQPVENMHEIIKSKDRSKAGTSVPAKALYLTRVT
YPEIALK
>IFAGANLK_01754 hypothetical protein
MKKILLLSDTHSHIDERILHYAGEADEIWHAGDIGTTDVSDELQKIKPLRAVYGNIDDAE
IRKEFPLHQRFKCEGVNVWITHIGGYPGKYSPAIREQIKQDPPKLFISGHSHILKVMNDK
NLGLLHMNPGAAGKQGFHKKRTMLRFKIEGENISDLEVIELKS
>IFAGANLK_01755 Peptidoglycan glycosyltransferase MrdB
MSKSVAGFDWITILIYLLLVGFGWANIYSASLGSGTPIDFFNMDAPYSRQALFIVLSIFL
IILILSIEAKFYQRFSSVIYTISLLSLAGLFVFGSTIAGQTAWYQIGPVSIQPAEFAKAA
TALAVAKYLSGIQTNIKDFKHQLRVFLIIALPMILVLLQPDAGSAMVYFSFAFALYREGL
HFAYLLLGFFAAILFVATLAFGPLWVIGGVLLIAIIVYLKNRKRRPNILKYLFFAAVAVG
FSLSVNYVFENVFKQHHRDRFNIVLGKEVDSRGIGYNTNQSEIAIGSGGLFGKGWTEGTQ
TKGHFVPEQHTDYIFSTVGEEWGFLGSTFILALFVLLMLRLLYMAERQRSTFNRVYGYGV
IGIIFMHFLVNIGMVIGIFPTVGIPLPLLSYGGSGLWAFTILLFIFIKLDSDRMSF
>IFAGANLK_01756 Peptidoglycan D,D-transpeptidase MrdA
MRKLLLYIIILTTGIIFLARLFYLQIMDDSFTVRSQDNAIEVVYDYPQRGYISDRNGKLM
VSNQPSYDVMAIPRNLKPFDTTEFCEILSIEPEELGRRLDKAKIYSPILPSVIIPQLTKS
EYAYLQEKMRKYEGFYIQKRSLRDYQVDHSANVLGYITQVNQKKVNDDPYYISGDLIGRS
GVESVYEELLRGEKGVKYIQKDRFNRDIGPYKDGIYDTLPTKGKDINITLDAELQAYGEK
LMENKRGGIVAIEPESGEILSLVTAPNYDPALLVGRKRSPNYTKLYYDSIANPLYDRGLL
AEYPPGSPFKTLTGLIALQEGVIDTEDRFSCNNGYNYGARRPLGCHAHPSPLDLVPGIAH
SCNSYFAQVYRKTIEKYPTPQEGMDTWNKHLQSFGLGQFMGNDLSTGRPGKIPDADYYNR
IYNYPTYKWYSTATISNAIGQGEVLMTPIQLANMTATIANRGWYYTPHILKAVEGDPIKE
EQFTVKNITTVDPKHFDPVVEGMHQVYKSGTARTLQIPGIEIAGKTGTAENFAKIDGKRT
QLTDHSIFVAFAPVDNPKIAIAVFVENGYWGSRYAGRIASLMVEKYIKKEITRTDMEDWI
LSHSLEEEYAKPLSGEPFIINR
>IFAGANLK_01757 hypothetical protein
MNNSILKNIIRFVGLVFIQVLILNNINFLGYINPYLYILFILLYPFNGNQSLFLILSFLL
GFSIDLFEDSGGVHAAACVVIAFIRPNLLRFSFGISYDHQNLRLSTTPFGARLSYIFISV
IIHHFILFFLEMFSLSHIIIVLQKTLFSGIFSVVMIILSLIVFSKKYR
>IFAGANLK_01758 Cell shape-determining protein MreC
MQQIFNFLIRNKNNILFLFLLALAVFFTIQTHSFHKSSFISSANVLTGGIYSWANDFDKY
MHLDEYNERLMEENKQLRNILTNLNDTISVENYTDTTSFESTYYFRTARVINNNYAKPNN
FLTLNQGKEAGIKTEFGVITSKGVIGIVDRVNDRFSRVISILNSDSQINAQLNKTNHFGS
LIWDGKNPNIVQLIDVPRQAPVKEGDTIVTGGKSLIFPEGIPIGSIEDFKLDQSESYYNI
NVRLFNDMTNIGYVYIIENLDREEILELEREDEQ
>IFAGANLK_01759 Rod shape-determining protein MreB
MGFFDFLIEEIAIDLGTANTLIIHNDKVVVDSPSIVARDRTTGKITAVGKEAAMMQGKTH
ENIKTIRPLKDGVIADFDASEKMLTMFIKEIPALKKKMFTPALRMVICIPSGITEVEMRA
VKESAERVNGKEVYLIHEPMAAAIGIGVDIMQPKGNMIVDIGGGTTEIAVIALGGIVCDK
SVKIAGDVFTNDIVYYMRTQHNLYVGERTAEKIKIQIGAATEDLEVPPEEMSVQGRDLLT
GKPKQVNISYREIAKALDKSILRIEDAVMETLSQTPPELAADIYNTGIYLAGGGSMLRGL
DKRLSQKTDLPVYIAEDPLRAVVRGTGICLKTLNRYKGILIK
>IFAGANLK_01760 Bifunctional purine biosynthesis protein PurH
MSDLKKAKSALISVFSKDGLEPIVKKLNELGITIYSTGGTEKFIKDLGIDVVPVEDVTSY
PSILGGRVKTLHPKVFGGILNRQDNESDVKELAEYEIPQIDIVIVDLYPFEKTVASGASE
QDIIEKIDIGGISLIRAAAKNFKDVLCVSSVEDYKDFENLLEEKNGETSLADRKLFAGKA
FNISSHYDTAIFNYFNEDGGVKAYKESIQTGKELRYGENPHQQGTFYGDFDAMFEKLHGK
ELSYNNLLDVDAAVNLINEFKGEAPTFAILKHNNACGLAQRDTVHQAYVDALAGDPVSAF
GGVLISNVEIDRATAEEIHKLFCEVVIAPSFSSEAEEILKGKKNRILLIQKETELPQKQV
RTCLNGVLVQDKDNKTDTLEDLKEATNNKPTDGELSDLLFASKICKHTKSNTIVLVKNKQ
LCASGTGQTSRVDALTHSIEKARSFKFDLNGAVMASDAFFPFPDCVEIAGNEGISAVIQP
GGSIKDQLSIDYCNENNIAMVMTGTRHFKH
>IFAGANLK_01761 Macrolide export ATP-binding/permease protein MacB
MLIYLRVLRESFNFAINALKNNKLRTFLSLLGVTIGIFSIIGVLAAVDSLEREIKGSLSA
LDNSTIIVMRFSFGPTDIPQWKRQQFPDVSYDEYQFLKRNLPNTESISFTIGVPDESIKY
QDVTSTGVGVGAITHEYYDIEALELEEGRFFNESESVSGSPVIVLGHEIANNLFGGLNPL
GKEVRLYGRKLTVIGVLKKQGASLFGGSRDGQVFIPANIARRVYGDNNKGVFPQLILKPE
DDVDNAEYMAVLEQRLRNYRGIKPGDINNFFVNQLQGFADLIDNITGQLNFIGLIISGFS
LLVGGFGIANIMFVSVKERTNLIGIQKSLGAKNKFILFQFLFEAIILAVIGGLVGLGLVW
LGSIAASQFTGDFEFVLSSWNMFIGTAVSAVIGLISGIIPAISASKLDPVEAIRTGM
>IFAGANLK_01762 Free methionine-R-sulfoxide reductase
MPFQKLKPEIKTILEDENLSIDHRLSQVCEVLKENIPYYDWVGFYFKNGDKDELKLRSFA
GEPTDHTIIPFGKGICGQVAVSNKNFVVPDVKAQNNYIACSIHVKAEIVVPLFLKGENIG
QIDIDSHTPDPFSREDEEFLEWVNEKVAEVLKA
>IFAGANLK_01763 hypothetical protein
MFLGSYLVFTLIYSVYLEFFRSQVYFPDYITHLVAKQSEALISSFGYNAQILPHQSELSM
KLIVNEVYLARIVEGCNAISIIILFLAFVLSFFGRLKLTLLYLLAGTVIIYAMNIIRIAI
LTIGIYEYPQHTEFLHSIIFPLIIYGTVFLLWIIWVRIYSQKQKV
>IFAGANLK_01764 hypothetical protein
MKQFIRLSEIGVLVLLLVSVRHFEYQLFYDPLIDFYRYGGHLAMEVPEINFPKLLMNISL
RYWLNTAISLVILFVSFRDKNIVKFAALLFALLFGIGLVTFSVLYFNLNAENVMGLFYVR
RFLIHPIFILILLPAFYYYRLKKRENL
>IFAGANLK_01765 hypothetical protein
MKKAFQHSISIAMAFLVLFSTFSFTVDKHFCGSFLVDKAIFSEAKTCGMEMEASTEDSCC
SNEKVAVEGQDELKHQFDSLNLDQQVFLSGFAYSYIYIFEDFSKEIIPFKDYSPPLLVKD
IQLEDQVFLI
>IFAGANLK_01766 Cation efflux system protein CusA
MFNKIIKYFLYNRLVSILLLVFLIGWGLVTAPFNWNTGFLPSDPVPVDAIPDIGENQQIV
FTDWPGRSPQDIEDQITYPLTSSLLGIPGVKSIRSSSMFGFSSIYIIFEEDVEFYWSRSR
VLEKLNSLPSGLLPDDAQPALGPDATGLGQVFWYTIEGRDKDGNVTGGWDLHELRKVQDY
YVKLGLSGAKGVSEVASIGGFVQEYQIDVNPDALKAYGIGINQVMMAVKNSNRDAGAKTL
EVNKVEYLVRGLGYIESIEDIENTVVAESDNTPVLIKDLGRVSLGPAERRGVLDKGGAEV
VGGVVVARYGSNPLAVIQNTKDKIQEISSGLPSKTLSDGTESQLTIVPFYDRTQLINETI
NTLERALSHEVLISIIVIIVLVLNLRASILISSLLPVAVLMTFIAMRYFGVDANVVALSG
IAIAIGVMVDVGIVFVENTIRWLEMPENKDLRGNKLAGVIYKATAEVAPAVTTALATTIV
SFIPVFFMENAEGKLFRPLAFTKTFALVAAFLIGVFVLPMLSYFFFNIKINKKKTQQIWN
IVLIVSGIALTIIFSFWLPLALTLIGIVKIVEDRNPQFFGKYTNLVIPGLILTVTVFFLA
EEWMPLGFQKSAFSNYIFVILLLSITLAVLMMVVKFYEPILNWCLTNKGKFLTLPIITIF
CGTMIWFGFPKLFGFVASGFDKVGWNVRTTQVWSGMAHTFPGVGKEFMPSLSEGSFLLMP
TTMPHAGMEETTETLKQLDMAVTSIPEVEIAVGKLGRAETALDPAPISMFENIINYKPEY
IHAEDGSMQRFKVDDENRFILKSGDTLTNTEAIQRDVIASNLIEDEDGRFYRNWREHINS
PDDIWNEITKRTKLPGVTSAPKLQPIETRLVMLQTGMRAPMGIKVYGPDLRTIQDFGMEL
EELLKEVPSVKSEAVFADRVVGKPYLEIDIDRNAIARYGLSIEDVQQTIETAIGGMEITS
TVEGRERFPVRVRYPRELRDDPESIKNILIPTSDGAQIPLGELAELKYERGPQMIKSEET
FLTGYVLFDKRDGYAEVNVVNDAQQHIQEKIDAGELQVPQGVSYKFSGNYENQVRAVERL
TILIPICLIIIFLLLYFQFKTIIASTIHFSGVFVAFAGGFVMIWLYGQGWFMDFDMFGTN
MRNLFQMQEVNLSVAVWVGFIALFGIATDDGVLMGTYIHQVFERKNPQTVSEVRDAVMEA
GLKRVRPAMMTTAVTIIALFPVLTSTGKGSDIMVPMAIPIVGGMLIQIMTIFVVPVLQAI
WRENASSNFTEENGEEPTTIEA
>IFAGANLK_01767 hypothetical protein
MKINTKKIFISLLLIPLWGGVGIAQELEDYLQIAAENNPKLQSAYTQFEAALQQSPQVAS
LPDPTLTLSAFGRMIETRLGAQEARFSLMQMFPWFGTLKTKREAADLLAEARFQEYLAMR
ADLFFEIKKAYAELFAIEKTISLKEENLDILDSYRELSLSKFRSGSSKMVNVVRVDIKRD
ESLTEIELEEEQLESLKKQFNILLNRDREAEVSIEDTLIFNSGIQNEIIDTEAAFSTHPE
LTKFDKEREAYEHRAETAQKSGLPNFGIGVDYSVISKRTDANPPMNGQDAIMPMFSVSLP
IFRKKYKAAEKEAELMQQAAIQNKEARENQLQSEFEQTVYDLNKAAKLLKLYERQIESSG
QANRLLVSAFSNNDGDFEEVLRMNQDILMLKTQQIKALKTGFTAQAKMDYLSAKTENYDE
TN
>IFAGANLK_01768 Cation efflux system protein CusB
MKRINNIWKAAGILILGLLLGYLLFGGGNDAEEAEDHNHSEMSEDQIWTCSMHPSVRQNE
PGDCPICGMDLIPVSEDEKELDSDMFVMSDNALKLANVETMLVGAGETSKEIRLSGKVEV
DERNTYTQSTHIPGRIEQLRVNFTGEKVNRGQVLASVYSPDLVTAQEELLQAAEIRESQP
ELFEAAKQKLRNWKISEAQINSMLSRGEAIDRFPITADVGGVVTDLMAEQGDYLERGMPI
YEIANLDKLWVLFDVYESNMALIEEGSKIKYSIQSLPGETFEGEVDFIDPLLNNNTRVAT
ARVEIDNENRRIKPGMFVTGIIENSLNAENEEIVIPQSAVLWTGKRSVVYVKEDVESGAG
FKHREVVLGSSLGDSYVVKEGLNKGEEIVVNGTFTVDAAVQLAGKPSMMNPPGNGAGNIN
EIELSEAEKSEILAVFTSYLALKDALVEDDFEEAKNQLTAVENEIEAVDNSGFDASAVEA
MVNYKTELQEQLNVLKASEDISVLRTGFMDFSAEMIRMAKSLKPFNEQIYIQHCPMANND
EGADWLSLSEEIRNPYYGSAMLNCGEVTSVIEQ
>IFAGANLK_01769 hypothetical protein
MKKNLRNLMMLSLIAGAISMTSCRDAEEKKDEPAEPMQNEMHQSEDQATMETYEGESLEA
EFKDENTAEVYNLYVEIKDAFVNTDAETASDKAAELAEKAGENEEIASAATQIAESEDVN
TQREDFSKLTAAMEPVLQDALESGEIYKQYCPMAFEGKGDYWYSNSKDIFNPYYGDKMLK
CGRVEATLN
>IFAGANLK_01770 Cellobiose 2-epimerase
MKLSSVTGILLTFFLTISCVDESKNNSSSENQLDKEPAEHEFTNMLVNESSPYLLQHAHN
PVNWYPWSEETLNKAKEENKLLVISIGYAACHWCHVMEEESFEDPEVAELMNENFISVKV
DREERPDVDNLYMNAAQLMTGSGGWPLNVLALPDGKPFYAGTYYPKEDWLKILKHFVKLN
KDDPNAIVEQAEKITDGIQSLEHMSIVDKEKAFSLDELETLYAQLKSKIDFEKGGKVETQ
KFPVPVLWKFLLHYNYLTNDPSALEAVDITLENMAYGGVYDQLGGGFARYSTDEDWFAPH
FEKMLYDNAQLIELYSQAWQKTRKPLYKEVVYESLEFVGQELTAENGAFYSSLDADTDGE
EGKFYVWTADEIDTHLGGNSSLFKEYYNVEEEGNWEDGKNILHREKSDKAFADENSLSRK
ELKEILSEGKNKLLKERQKRTLPALDDKVLTSWNALMIKAYLNAYKAFDEKRFLEAALKN
ASFLNENVIAENGAVTRNYKNGKTSIPGFLDDYAFVISAFIDLYQATFDEKWLFQAQDLA
NYTKEHFFDSTSGMFFYTHDNHSGLITRQKEILDNVIPSSNSEMAKNLLILGHYFYDNEN
KDLAEQMLLNVQKDLKEYPDFYANWAIVEALLVKPPFEVAIVGENHNSVKKELNDDYLPN
VILMGGEEEGNLELLKGKFIEGQTTIYVCKDHVCKFPVTTAGEALGQINESEGFW
>IFAGANLK_01771 Endoglucanase D
MKNITRAPYLAHNNLCQKLLVKAIYMSTFLMVGSLFGQSSQLTLNEEEYFEKPGVNILVF
SNWYDGLFSDSKISGIEVIHHGVRTVTNGDVRLHATPEQWDAIPTFVRREVDREKIRIDT
YEKYPDHDFEYMIRAERDGDKVILSVHLEEPVPEELKGRAGFNLEFIPSAYSEKTYYMDG
EGGNFPLYPHSSMDKDTTGYTAPKPFAEGKTLVVAPGDPERKITIVSDEANLMLHDGRDK
AQNGWFVVRSLLPEGETGKVLQWRLDVNSTPGWTRKPVIGHSQVGYHPTQEKVAVIELDK
NDSPAAQATLYKLNEIGEKVEKHTAALSNWGQYTRYEYLYFDFSDVKEEGLYVISYKEET
TAPFKINEDVYEKAWHPTNDVFFPVQMDHMLVNEAYRVWHGASHLDDALQAPVNHEHFDL
YAQGPTTDTDYEPGEHIPGLNIGGWYDAGDYDIRTQTQYYVVSNLAHAYEDFNLERDQTL
VDYDSKYVDLHNPDGKPDMLQQIEHGTLGLIAQHRALGRAIPGIIVPDISQYTHLGDGLT
MTDNLIYDKEMEPLESDGYRSGKFDDRWAFTSKSTPLNYGSIAALAAASRVLKGYNDELA
EECINTAINVWKEEHSKEPDLFHHGNTTGGTLEDEELKAAVELLLSTKDEMYATRIKEMW
PIIDKNFNLHAGRVIKILPFMDEDFKQKLKSRVEAYRDEIAAHSEENPYGVPIGRGGWAG
NGQIVAYAINNYHLHKAFPDLIEKEEVFKGLNYLYGTHPDSDISFVSGVGTKSKKVAYGM
NRADFSFIAGGVVPGVLILKPDFPENKEDWPFLWGENEYVVSVGASYIYLVNAVRDLLN
>IFAGANLK_01772 SusD-like protein
MKKIRIILMVFVTLFVVNGCEEEDFELTNPSGLSPETYFRTEAQVQSAVNAVYANTQTIG
LYTRTMFFAMDIMSREALGNPQLEADKRVYQDWSFDASHPPIAWYWDSCFRGINKANFVI
DNADRINEIPSSLLSDEKKARFIGEAKYMRAFYYFLLVTRFGDVPLITEVPEDGSGFPRT
PADQVYDQIIADLNDASQSLWDKGRTENGRATQGAAFALLGKTHLYLEEYEEALAAFDNI
YGEYSLEEDYFANFREEEEFGPESIFEIQYDDDMGNSAVWNSNAAGEDANEVTFRGQEYG
FNDWFNVYPNPVLVDEYEDGDIRRDETFYFPGDTFAGGEIEELPLERNAAWRKYQNYYKD
VNEDQASGINMKVIRYADVLLMMAEAENAMGAGDKSQAIDYINEVRERAELAPLSDDLSQ
DEVFDAIVHERMVELAGEQVRFPDLVRWGLAADYLSEFGFQAGKHEIWPIPNDEISANEG
ISAEDQNPGY
>IFAGANLK_01773 TonB-dependent receptor SusC
MKNNYLKRGLFIVTFLCFGFMTAQQTVTGTVSDESGPIPGVNVIERGTSNGTTTDFDGNY
SIEVGEDAVLVFSYISYQTQEIAVNDQNVIDVNLVAGSESLDDVIVVGYGTQSRAEVTGA
ISSIDTEEINSLPVSTAEQALQGRASGVTVINSGSPGNSPAVRIRGLASPNNNDPLYVID
GVIAGGLGSLNPNDIENIQVLKDASTTAVYGSRGANGVVLVTTKSGTASQKAQLSLDTYT
GVQFNSNRYDLLNRDQYIQYAREVTDTDPERITNPEYADFIDNNTDWQDEIFRTGVMKSI
NLGLSGGNENSNYRFSGGYLNQEGAVVETEFERFNFRSNSNFNFGRLSFGQTLNVAFTLQ
NPEREDGGRSIIEHAIKSAPYLSVYNPDNRGGFQGPNSALDGQDAANPVRVQTIGSAENK
GLTILGSLFAEYEIIDGLTFKSQAGIDYYKYNNNNFIPSYNDDSNGGTHQFDFAQITKNS
GTNQSLTLTNSLNYKFEVADLHNFEILVLAEDQTIDSESLNASSQNPITDDVEELSLNQA
GLESASSEYRRFGYLGRLNYNFDQKYLLSGSYRRDASSRFGANNRWGTFWSVSAGWNVAK
ESFMQDTDFNNFKIRGSWGTTGNDQIGNYRYASTLVTSFIYPIGGAALQGTTAEGLPNQN
LKWEEVTMKNIGLDLGMFNNALTLSLEYYSNQSDDLLYELPLPLSLGYNVPTIASNVGSV
ETTGFEADLGYNDYEGEFTWSANLNLGTSRNEVLSIGSLDQVQGGFFENEYLTRIAPGEP
LFHFYGLKTDGIYQNQAEVDEVFTANPDQTTVQPGDIRFVDINGDGDITAADKTVIGNPY
PTLTMGLNLSAQYKSFDISLFIQGAYGHEVYNTNLYDLQGMPRLFNSGVAVLNRWTGEGT
SNTIPRALGAPQNLNASDRFIEDGSYTRLKNLNIGYTFDEDIFGESLANLRIYISGQNLI
TLTDYSGLDPEIGVDNVLQQGTGAIGIDRGLYPQPTSLTFGLQLGF
>IFAGANLK_01774 hypothetical protein
MKILFKSFFLILFSLIISCKDSDPEKELAKKESTENTKIFSTVSAARSGIDFSNDLTEND
SLNYFTYSYIYMGGGVSTGDINNDGLPDVYFTGNQVPNKLYLNKGNMEFEDITESAGVAG
DERWYTGVTMADVNADGFLDIYLSVGGKFQPKNNQLFINNGDGTFSEKAKEYSLDDPGNS
VQATFFDYDKDGDLDVYIANYPPTRFDAPNFVYEYQMKSVTDLQTDHLMRNDGGKFTDVT
NEAGVRSFGLTLSATVGDLNNDGWPDLYISNDFSSPDFMYINNGEGSFREVVKDATSHTS
FYGMGVDIADYNNDGLLDIYQVDMSAKDNRRKKANMASMNPDLFWSTVEAGFHYQYMQNV
LQTNTGVFNNDTPFFADQSRIAGAASTDWSWGPLFADFDNDGHKDLFVTNGTRREINNND
YFNELKDKSLSKEDRLEKSLNIPSEKIDNFIFENNGDLTFNIANEKWGIKYEGFSNGVVY
VDLDNDGDLEIITNNIDDKASVFENQSSKNNNYVQIKLEGPEKNKFGIGSRAYITANDSE
QMQELTLSRGFQSSVAPQLHFGLAQADLIDEIRIEWPDGKVEIKENVEANQFLSFNYKNA
SEIKTPKELKPETLFTTITDSTSFPAHKHIENEYDDFKDEVLLPHRTSTFGPSIAVGDLN
GDGKEDFIVGGAATYEAGLYYWTENGFEKQNSSAFEKDKAYEDLDALIFDANGNGHNDIY
VVSGGNEFDPDSEMLQDRLYINDGKGNFTRDLNALPKMHDSGSKVYKADFDKDGKEELLV
LGRLVPGNYPSPANSYILKNNSKNGKVSFKDITQSVAPFLTSLGMATSAEIVDIDNDGWQ
DIIIVGEWMPIKIFRNNKTAFKDVSKKMGITDDTAGWWWSIKKGDFDNDGDQDFVLGNLG
ENYKYTASEDETFDIYFKDFDDNNHSDIVLSYYNKGEKFPLRGRECSSQQIPGIKEKFPD
YESFSTATLEEVYSEKELENSLHYQVKSFSSIYLENAEGKFKIHKLPNVAQISSINQILV
KDYNNDGHLDALIAGNLFWSEVETTRSDAGYGMFLRGDGTGNFEGVVPAESGFFLPGDVK
DMTTIQVEGREIIIAAKNNNPVQYIHLKNQNR
>IFAGANLK_01775 hypothetical protein
MWGFIALLFFNLQGGMEVTKTSPSTTEDKIEVITPKENLGENNLAYKWGKLALVATAKDT
DRFKPRPTISSRFLGLIFTAVFDAWSRYDEKAVPVYMHDIERRPLDEQNLSNKQIAISYA
AFRAMNEYYFTDEAIFREFMVELGLDPDDTSLDSTTPVGIGNLAAKAVIEARYNDGANQY
GEEEGSNGEAYYDYMGYEPVNSADENIDLNRWQSKYFSDGKGGQFAPECLTPYWHKVEPI
GLQSSDQFRPGPPPMVGSTQLEEEVEEVVQLQANLTDKQRALVEFMRDGPQSVQQAGHWL
KFAQEISVRDQHNLDKDVKMYFYNQITAMDAFIACWDSKMYYDYARPYALVHEFFKDEEI
YGWGGPEKGMIKMKGQDWRPYSPSTFLCPPFPGYVSGHSAISGACGEALKLFTGSDEFGS
EVKLIPGILTEPDRLGEEVTIEFPTFSEAAEMAGLSRVLGGYHIQADNIAGLELGRQVAR
ENWIFFKKHLGEPVISDHNSLSNN
>IFAGANLK_01776 Bifunctional transcriptional activator/DNA repair enzyme AdaA
MNNNILHIKNMVCDRCLMSVENTLQQQKLRYVHISLGRIEFEKELSLAQFQLFEEALKAN
GFEIVAERHDRIVTDIKSIIIEWVYERKDFKNKKLSEVLSEELHYDYSHLTSIFSKVDGQ
SIQSFQNKIKAERIKELLEYDELNISEIADKMGFGSAAYLSTFFKKETGLNPSQYKLHHQ
ERKSLDKL
>IFAGANLK_01777 putative cysteine-rich protein YhjQ
MRNEKLLSTLGNCINHCNYCADACLDEDNVKMMKDCIRTDRVCAEVCSTLNQVLVTGYKN
VEGLVKYCIEICNACADECGKHDHQHCEDCAKACRECAKACEAYLA
>IFAGANLK_01778 Silver exporting P-type ATPase
MKHTYQISGMTCMGCRAHVENTLKNVEGVTDARVDLQKASAEIEMQKHIEIEEFQKALED
SNYQIHPKNEIVQTYPVSGMTCKGCRSHLEKTLSKVEGVKTAEVNLEQQEAKIVAEKNVS
LEKLQKALKEDGGNYEIHEPGKKVESKNKKSSKSGQGTGVYYCPMHCEGEKTYDEPGDCP
VCGMDLVEEASLKPQATKYTCPMHPEVVQDGPGSCPKCGMDLVPKQPEESSESKSYKKLL
KKFKIAVAFTLPIFIIAMSEMIPGNPLYDILDMEYWNWVQLGLSIPVVFYATWMFFERAW
RSIKTWNLNMFTLIGIGAGVAWLFSVFGLLFPDFFPPQFKTEMGTVHVYFEAATVILTLV
LLGQVLEARAHSKTNSAIKELLKLAPNKAIKVVDGKEKEVSIDEIEKGDILRVKPGDKIP
VDGIIENGNSSIDESMITGEPIPVDKAEGDKVSSGTINGNRSFTMKAEKVGEETLLSQII
KMVNDASRSQAPIQKLADRISAYFVPVVVLIAVITYIVWAVYGPEPQYVYALVNAIAVLI
IACPCALGLATPMSVMVGVGKGAQNGVLIKNARALEQMDDVDTLIIDKTGTITEGKPKVE
KVEVISEENKDEIIKLIASVNSQSEHPLAKATVDFANEKEQKFTETSDFNSVTGKGVTGM
VNNKKIAIGNDKLMQAENVEIPSEITRRVTAEQEKGKTVSYVSVDGKVAGYFTITDPIKK
TSREALKSLMDDGVEVYMFTGDNEKTAKSVAEELGLTGFKAGMLPEDKQNEVKKLQKEGK
KVAMAGDGINDAPALAQADIGIAMGTGTDVAIESAEITLVKGDLKAVKKAKMLSKKVMKN
IKQNLFFALIYNTLGVPIAAGVLYPVFGLLLSPMIAALAMSFSSVSVIANALRLKSAKLD
>IFAGANLK_01779 Putative permease
MQDFLSKWGEAAYTSAGFFWMALWAFILGYVISSCIQIFVTETRMERTMGKDESKSILLG
TFFGFVSSSCSFSALASTKSLFKKGASFSSSIAFLLASTNLVIELGILIAIFLGWQFVVG
EYVGGILLILISWILIRLINPKKLIKKARERLDEKDEDDEDSEKSWKKKIKSETSWAKVS
KQYAMEWKMVWKDVTLGFTIAGVVAAFVPDSFFQTLFINTGDGNIDFGFFTILEHIIVGP
IAAFLTFIGSMGNIPLAALLFGKGVSFAGVMAFIFSDLVVFPVLRINAKYYGWKMSLFIL
FLLFTALIGTSLLLHYGFNLFNLLPDPTSVKITDAEHFKIDYTFWLNMLFLAISGVLIYL
GFFKRKDVMHMKEMAPKSQLLETSLKYIAFVCYLWLAGGLIAKFFI
>IFAGANLK_01780 hypothetical protein
MTKRFTHKLFLVVLSVSVSSCAVFQPNKSSADASKEEASKKNGDFEPYAKVITKDAKSDE
GLFTVHRVEDKYFYEIPDRLFNREMLTVTRIAKTATGIGFGGGKQNTQVHRWQKKDGHVL
LRVVSHEIYAADSLPVHEAVVNSNFEPVLQRFPIKTVGKDSVSKTTVIEVTDLYTKDVQA
LGLRDGARKQYKVSRLDDSRSYIDTIRSYPENIEVRHVKTYNAGEPPSNESTGSISLEFS
NSMILLPKEPMKRRYFDQRVGWFARGQTDYGLDAQKSKEVKFLDRWRLEVKEEDKEKFEN
GELVEPKEPIVYYVDRATPDQWIPYIKQGIEDWQVAFEAAGFKNAIIAKDPPSKEEDPDW
SPEDVRYSVVRYLASPIPNANGPHVSDPRSGEILESDINWYHNVMTLLRNWFFVQTAAIN
EDARSVEFEDEVMGRLIRFVSSHEVGHTLGLPHNMGSSVAYAVEDLRDPEFTAEYGTAPS
IMDYARFNYIAQPEDGDVALMPDIGPYDKYAIEWGYRPILDKSAEEEKEILDEWILEKAD
DPLYRFGSQQSGGVIDPSSQTEDLGDDAVLASEYGIKNLKRIMPNLIEWTAEDGKNYDDL
DDLYGQVLSQFNRYMGHVTANIGGVYEYYKTYDQEGAVYSHVDAERQKEAMNFLHEQLFE
TPEWMIDQEIFNKIEFDGQVERIRNMQERSLNNLLDFGRMARLMENEEINGEEAYALIDM
MTDVRTGIWSELSSGQNIDRYRRNLQRAYIERMEHLMTEEQSEIPSRYRSWISRSNIDVA
QSDIRPVVRGELKTLQNQIRRAANRGDRLTRYHLQDALERIDLILNPIK
>IFAGANLK_01781 Lysine--tRNA ligase, heat inducible
MQLSEQEIVRREKLSALRKAGINPYPADLFPVEDTSKGIKENFEDGKKVVLAGRLMSRRI
QGKASFAEIQDSKGKIQVYFNRDEICTGEDKSKYNDVYKKLLDIGDFIGIEGELFKTQVG
EMTVMVKDFTLLSKSIRPLPLPKTDKDGNTYDGFTDPEHRYRQRYADLAVNPKVKEIFVK
RTKLFNAMRNFFNEREYFEVETPILQSIPGGAAARPFVTHHNALDIPLYLRIANELYLKR
LIVGGFDGVYEFSKNFRNEGMDRTHNPEFTAMEIYVAYKDYNWMMEFTETLLEHCAIAVN
NTTEAVFGQHRIDFKAPYKRVTMTDSIKEFTGFDITGKSEAEIRKAAEDMGIEVDETMGK
GKLIDEIFGEKCEGNYIQPTFITDYPKEMSPLCKEHRENPELTERFELMVCGKEIANAYS
ELNDPIDQRERFEEQLKLAKKGDDEATEFIDQDFLRALEYGMPPTSGLGIGMDRLIMFLT
NNQSIQEVLFFPQMKPERKAVELSEDEKAVFQLLKSDEIQELETIKTTSGLSNKKWDKTL
KSLRKYKMIDVFKDDETMKIKAV
>IFAGANLK_01782 hypothetical protein
MSVWRVILSVLFPPLAVYDRGCGSILIVLILTILGWIPGVIAALIILNNPRKGV
>IFAGANLK_01783 Octanoyltransferase
MNKQINLQNLGYRDYKETWDYQESLFKEILELKIKNRRQNLNEITPNYLLMVEHPHVYTL
GKSGNIKNLLISEAELEKRQAKYYKINRGGDITYHGPGQLVGYPILDLDNFFTDIHKYLR
FLEECIILTLTEYGLKAERSPGETGVWLDVGTPFARKICAMGVRASRWVTMHGFALNVNA
DLGYFDHIIPCGIEGKAVTSLNVELGKKEILLAEVQEKVLKHFGELFEAELN
>IFAGANLK_01784 hypothetical protein
MKKIPFKILLVFFFISCQNQEKFVDPSAFISEDAAVIIQTPNLKDLQQDLENFSFFNKNK
LTAENHIKNVLGFLKKTDTLTEAIISISTSENDKLVYSLLFKDQPKFQLDSIKNKSVESI
KAEGHAYQKMVLEENTFFISTENALIIASNSEEKLIQLLNEEKLLKNEDFKRVYLAIDPN
KTSVIFNHQNFKDFQQKLFPNLELQNVENYADWSAIDLDISQEDVSFNGLSIAQNSSNLH
KILQNPGTVSQEFASITPVNALGFTAIGYRNPEIFLRNLKKFRGDSVSNAIDEIILKTQE
AGIIYTEENPLFGIKTLVNIEATDLISDYAELEENYRDFPIYKVSQPRIFEKLFSPILIS
KKNNFAAAIDEYLIFASSIPQLRELIADYVNQNILAHQSYYKNSQQKLARESSILIVGKP
EALKSRLAKAVANELSEEMNNLDFGEHKLAILQLVEEGDFAHIHGTFVAQNNKNNSNTKT
EEILSVSLEAELLNEPVLVKNHLNNQMDIAVQDINNTLYLISNKGMIFWKKKLSGPILGE
IKQVDLFKNGRFQLAFATPYSIEVLDRNGNTVELFPLEFKDEITQPLSLFDYDNNRKYRF
LITQNDEVFMYDKNRKSVKGFDFRKTNSEILQAPKHLRIQNKDYIVFPEKSGKLNILSRQ
GDHRVSVKESIDFSDNQWYEFENDFVSTNAEGHLVKVTQSGQVTTQNTNFSENHKISARP
NLLVSLSENILKIRDKELNLDYGLYTEPEIHYVNDKYYISLTDFQTQKVYIFDSNAELLA
GFPVYGTSKINLNNADIDNRPEFVVKGGEKEVLLYKL
>IFAGANLK_01785 TonB-dependent receptor SusC
MNGKKLHGILALFAVLMMQFSFAQEKTVSGKVTDDNGFPLLGVNVIEKGTNNGTQTDFDG
EFSLSVEPGDVLVFSYVGFIAREVQVGADDVYNVALDTDTGSLEEVVVVAYGTTTKEAFT
GSAEVIKSEQMEQRSLTSPISAIEGNATGVQITTSSGQPGSSPGIVIRGVGTLNGSTDPL
YIVDGVQFEGDLNAINQNDIESITVLKDAASTSLYGSRAANGVVLITTKDGKKAGGLRVD
VNSQYGVIDKAIDEYDFVGPGQYYELMWEGYKNSLDVDNPAAEASATIYNRLGYNPFDVP
NDQIVGTDGQLNPNANVIFQGLDWYDALERQGSRESHNLSVSGGGDNHTVFFSASNLHER
GYVVESSFRRTTSRLNANFTPTDWLTLGGNLNLSLSNTTGPSSRGTSIANPFSFAKDMGS
IYPVYVVDPATGEYVRDVEGNLQYDRGEGYPDLGIRSRPNNVGRHAIEEAILNSDVTKTN
NYGFRYNAGFKIIDGLELTLRYGQDVNDYLNKEYENNLVGDGAPAGRYSELRYRRTVENF
NQIITYAKSFGNHNFDLTLGHESFDRHYSEVDGFKNTQTAVGIYEFDNFSTIADLSGYSS
NKTLEGYFSRLNYNFDEKYYLSASARRDGSSVFNEDVRWGNFYSVGGAWRIDQEAFMDNV
DFVNNLKLRASYGEVGNDDLNDYFISQPRYSLFPNAGEPGIFWSDLGNEELTWETVESWD
VALEFGFFDYRLSGSIEFYRRNSTDLLYNVPLPISMGLSEGPANIGDMYNQGWELGLEGL
IVDTEDFSWELGLQASTLKNEITFLPDPFVDGSKRWIEGRSRYDYFIHHYAGVDPENGDA
LYYAYEEDETGENVPVLNDDGTHQTVNDQNDANRAYVDATSIPDLIGSIRNDFTYKNFNL
NFLFTYQLGGEILDYGYANMMHEGSYGDSFHPDILNAWKNPGDITDVPRLETGNNTLAPT
LSSRWLTDASFLSLRNVNLSYDLGESALDQIGMDRLRLFVSAENLFILTERTGLDPQYNL
SGTPSGNDYNPNRVISVGVNVAF
>IFAGANLK_01786 hypothetical protein
MMKKNIIKLKSLIVIAVVTVISIGCTEDFLDTAPTDAISADAALSSPENMMLVLNGLHRI
MYAQNPLPGGESSRSGESHFIPALDAQGGSIIHSSPGNGWMTADLQWLNHTNPNTTTVYN
FWYQRYHFIASANSIINTIEEGDFAETPELNNILGQAYAYRAWAYHRLVTTFAKGYLIGN
PSSDPGVPLVFSTEPPYESAPRSSVEEVYNQIETDINTSIDYLADASAPANKSHISINAA
HGIKARVALSKGDWEVAATSAEAAREGYPLLSESEWLSGFNTYDLSEVIWGGRVIDSETN
YFQSYFYYISPTFNGSQNRSNPKIISSELYDQIPETDYRSEAWLPLAPNTNPSASNDQGG
GFESDPNYDSEDEFWNAWEEIIATYGMTSGHNTHPYMTVKFLQQNPGTIDPDDVIYMRAS
EMVLIEAEARAMMNDIEGAQEALAILGNARDSAFDVSEFSTQEELMEEIKFQRRVELWGE
GFSFHDHIRWDEPLDHTNSGAARVLYQDGFTQDRPSENDDWIWKIPQAEINANPYITESD
QN
>IFAGANLK_01787 Ribonuclease HII
MFNLPCQIAGTDEAGRGCLAGPVTAAAVILPKNFKNKLLNDSKQTKLSDRNKLKEIILNE
AITFGIAHVYMEEIDEINILNASILAMHRAIDQLNCEPEHIIVDGNKFKPYRNIAYDCII
KGDGKFLSIAAASILAKTARDEFMQEVHNEFPMYNWHQNKGYPTKEHRRAIMEFGSTPYH
RKSFKLLPEQLKLSF
>IFAGANLK_01788 hypothetical protein
MAVFNELKLYEDFNTKKAITSVSYRFAQFFRSTLYIIYEEKEAIVLYLAGNLTIFALPC
>IFAGANLK_01789 TonB-dependent receptor SusC
MKNKLHGILTLLLAFVVQFTFAQEKLVTGTVVDEDGLPLPGVNVIEKGTNNGSQTNFDGQ
YSLSVDVGDIIVFSYVGFRTQEITVGEADVYDVTLGTDAAALDEVVVVGYGTATRQSFTG
TATTIDGENLEGKNFSNVTQALAGEVAGVNVINNSGQPGTTSTVRVRGFGSINGNRAPLY
VIDGVPLSSGDPNSDAQAAIVESTLNSINPADIESTTVLKDATATAIYGSRGANGVILIN
TKSGRSGESYIEVDVKTGVNNQWIPRYDVISSPEQYIGAVWEGIYNRGVLEDSENPVQFA
NERLFSNDYVAPGYNMWNVEDGGELINPDTRMVRDGVTRRYTPERYEDAAFQKGALRKEA
NVRFGGGSDKTTYFASVGYLDEEGTAINTGYERYSTRLNLKSDVKDWLEVSANMGYAYSE
RIANGQTDGAENLFEFSDKMAPIFPVFLRDDAGNLVADPIFGGNQYDYGSASTGAGTQNP
GITARPRPNANNLNPIGSALYDFDGTDRHEMNGNFALNFILTENLTFETRFGAQYFMSRN
KDFRNPFYGGGNATGGDLITRDYESLTTNWLKLLRYENQWGDHSIEALVAHENNEFDISY
SSQYKGTSVSPDIYELNNFVDNLSPPTGFVEGRALDSYFGQINYNYLGKYYFSGSLRRDG
SSRFVNDKWGTFGSAGVSWVASNEDFLANNDLITFLKLKTSYGITGDEAGVGYYAGYDTF
SLGTLGGGISITQRDNGNPNLTWETSKMYQAGVEFSLGRFLDATVDYYIKDTEDQIFERR
VGPSQGIAIIDVNDGDLRNSGLEFNLTGHLVTTEDFSLDLNINGEVLSNKITAMPIEPST
GEPRVLDTSPTYFAYSDGGSIFDFYMREWAGVNSENGAPQWYRYFDDVNGNGTFDEGDGA
ITDLPVYLDDNPGADIEREITETYSQATNKFIGKSAIPDVRGAIRLGGRYKSFDFSTQLL
YSLGGHAYDAQYGELMSDRFGAVGNNYHTDIAQRWQEPGDVTNVPRLSDAFDVNSTATSS
RFLTSTDYVALNNARIGYTISEELLGDTGINFINIFFSGDNLWAKTARDGFLPFTRETGN
SGRALYAPLTTITAGVRVKF
>IFAGANLK_01790 hypothetical protein
MKNIFKLTGVAALLMFSVGCSEEFLDKQPSEFLTTEQVGAAAEKNPDVTIGTMNGIYFQT
FQTQTGGTTGHTDFGHKGYDIYGDMLSGDVALSVSTYGWYRADITEFQAPLDFTRNSNYQ
PWRYYYRIIRSTNTVIDALGGNDVVPENEENLYIMGQAKAMRAHSYFYLAQYFQKTYDPS
EEILPIYTSLEDENGPKVPASEIYAQIDSDLNDAIAHLDGFNRTGKNQINQSVAQGIKAY
VEGVKGNWQEVYDLTNDVITNGGYTLMSAEEVVRMSHDGPDTDPYGGGFGDLSTPGWMWG
VDLTSDQELALVSWWGQMDLFTYSYAWAGDAKAIDEDLYNKIPEGDVRKAQFLAPTGIYE
DLMPINKFYAPNRVVGGQDPVETDYVYMRVAEMYLLHAEAAAQLGNEAEAISTLKTLLDE
RMDDTSYVDGLSGQALLDEIYLQTRIELWGEGKSYLALKRNKATVVRGPNHLSFVGEPIP
FDDERLTFEIPEQEIQANPAINTQNN
>IFAGANLK_01791 hypothetical protein
MKKIFFVLLLIPICGLSQNRLSGAGGNQNTEEGTTQEDTIKPPISDYKIISVENDTTFLD
TTLTIEKDYKFNYRRKDNFELLPFSNTGQTYNRLGVDFDAKKLYPEFGAQARHYNLLDIE
DIYYYHVPTPVTEAYFKTVPEQGQQLDVLFTINTSERLNFSVAYKGVRALGRYQNALTST
GIFRFGLTYKTLDRKYHLRTHFVSHDLMNQENGGLSDLALQQYINKEEEFEDRSLLAMNF
ENAESTLYGKRFYLDHFYHVTRPDTLSSNALKVGHIFNHDYKKFDFLQANAVNDIFGPSF
QRNNLRDRVRLTEFYNEAYVQWSNKTLGEVKAKAAVKNFEYGYKTFYIRESDTINNKLTG
SNYAIGGEYRKSIGGFDVEADVMLNLAGDFTGSYFSAHAGYSLDEENRLEFGVNQNSHMP
NYNFLLYQSNYINYNWQNEFDNVNTQSIYGKLRSQKLLNVEGRLTQIQNYTYFAEGEDTL
VKPFQSGDQVRYLKLKASKDFDFGLFAIDNTLMYQNVLDGASVLNLPEFVTRNSIYYKDE
WFDKALYLQTGFTFKYFTNYNMNAYDPVLAEFYVQNSAEFGNYPVVDFFFNAKVDQTRIF
LKLENVNSLLEANNNFVAPRYPYRDFLLRFGVVWNFFL
>IFAGANLK_01792 hypothetical protein
MRSVDDKVTEQVNDNKPGAILFIEDFLGLGSNGAVHTALHRLVKAKKISRLARGIYAKPT
FSKLLNQDVLPDAEEVAIAIAKRDKARLLPTGAQAQNALGLSTQVPLRIVYLTDGSPRTI
QIGKRTIQFKKTTPKNLALKGEISKLVVQALKDIGKDKATPQELEKIQSLLLKEDKQNLK
HDIWLAPQWIAEIMAKAL
>IFAGANLK_01793 hypothetical protein
MAAQEFYKLKDAEKAEIFTAVAQQKGLPVYALEKDWWVVQTLDIIFSQLEFAEHLLFKGG
TSLSKAWQLINRFSEDIDLALNREYLGFAGGLISKSQVKKLREKSFEFVTTTFYEALQKA
FAEKGYTNVTFDFENLGDSDQDPVSILIYYPAVTEHSEYVLPRVKVELGSRALKDPFTNC
KIISFVGEQFPSRPFADSPITVLCVNPERTYLEKLFLLHEEFKKPNYKIRVERLSRHLYD
ITKIYNSEHKDKAYGQELIVSIIEHRERFNGMRGVDYNTLYPPNLNIIPPDDFIKAWEDD
YKTMQTNMIPEDSPSFTDLLETVKQAIQEYNALKFE
>IFAGANLK_01794 hypothetical protein
MRDGLRLLENEESKVIALRNAIQEGIDSEIDHDFDPKKNLEELKAKCKKNG
>IFAGANLK_01795 hypothetical protein
MDMTAQIKNTLISRIKDSKDLNFLKALQTIFDASEQELFQLSSEQKDAITIGRKQIKNGQ
FSSNESVINEMKEWLTKNNLVRYSQIEVSRYS
>IFAGANLK_01796 Ferredoxin--NADP reductase
MQTPKNTYDVIIIGGGPIGIACALEAEKKNLSYLILEKGCLVNSLYHYPTNMTFFSTSEK
LELNGIPFISNNPKPRKAEALEYYRRIATSNELNINLFEKVTGVESKDNFHKVSTTKNNY
TAKNVVVATGFYDIPNYLNIPGEDLPKVAHYYGDPHYYATLKTIVVGASNSAVDAALEIY
RKGGEVTMIVRKEEIGRRVKYWVRPDIDNRIKEGNIKALFNAKLKEIRETEVVIETPDGE
QTLENDFVLMLTGYRPNFEFLKKMGIKLSDDGRKIPQYDQETMETNVQGIYLAGVICGGV
ETHKWFIENSRVHAKMIMGDLAKKFEA
>IFAGANLK_01797 Ribulose-phosphate 3-epimerase
MTTKLIAPSILAADFGNLQRDIEMVNKSEADWFHIDIMDGVFVPNISYGMPVLQAITKHA
EKTIDVHLMIVDPDRYIKEFAKLGADNLTVHYEACTHLHRTLQAIKAEGMQAGVAINPHT
SVDLLKDVIQDIDIVCIMSVNPGFGGQSFIENTYHKIQRLKELIVTHNASTLIEIDGGVT
NENASQLIKAGADVLVAGSYVFKAEDQLETIKDLRQLANS
>IFAGANLK_01798 Blue light- and temperature-regulated antirepressor BluF
MRYAISYVSTANPALSETEIQEALDFSKDWNNNHNITGILLYSQGNFFQVLEGEEQLLKD
LIDRIKTDERHQNVITIFQKSIPNTQFDGYQADFISLNDRYNDENFDTYLAQISLLNPSI
QSSVKYILNKFTEGIK
>IFAGANLK_01799 Phytoene desaturase (neurosporene-forming)
MSLSYDAIIIGSGSNGISAAIYLQQKGLKTAIFEQAANPGGSTRTQELTLPGFKHDVGSA
ILPMGFGSPFLRSLPLEEHGLEWIFPEIPYAHPFSDGSAHACYTDIRKTAVQLGDDEASY
FNLFEPLVKDWEKLENDLLGPLGIPQHPLDFMKFGLKALPSAKLLAKHYFKNEKSRIFFY
GSAAHSTLPLNSLASASFGLVLSTMAHKYNWPFPKGGAQNFINSMLSYYTSIGGELHLEK
NITQLDELPESKTYLFDLTPKQLLKIKGTDFPGLYRKRMDSFKYGAGVFKVDWALSEPIP
FTNEKCRKAGTVHIGFSEEEMENSEQSIHQKNMTQTPYVLVAQHSIFDNTRAPEGQHTAW
AYCHVPNANTEDFSKIIEDQIERAAPGFKDCILKKSTMNSAQLNAFNPNIIGGDINGGKQ
DITQLFTRPIAKMSPYSTPNPRIYICSSSTPPGGGVHGMCGFNAARAVEKDHF
>IFAGANLK_01800 NAD(P)H azoreductase
MKDEGKTLIAGASGALGTEIINLLTTEGKDIRALTRSDKGVSKLSKYTDDVWKGDAAKDQ
EGIRGITKNITTVISALGKSVSLFTPSQESFMESDFRANRNLLKDAVKNGVKRFIYVSIM
GADSSKDFSIARAHKMFEKELKSSGIAYTIVRPAGFYSGLNDLAIMAKRKVIPLIGSGEA
QTNSIHHKDLAKVVVSFLNDGPEIAEVGGPNIHTRREMAEMIKEIVGGEIIEIPEPMAKI
SASLGLPKIFSEGINDKLDYFTFITTNDMIGESNGKISFREYLGNLDLKKIT
>IFAGANLK_01801 hypothetical protein
MKLIYKLLILVTVLSACETDDVIERKSGSVPRMDCIDIEEERGIIAEYKNENSFILAPDE
NCPIYRIDDFLWACNLPKEFQKDSLKVSFSGYLYESLENADVCAETFELTEIEIRQ
>IFAGANLK_01802 RNA polymerase sigma factor SigA
MRQLKITKQVTNRETASLDKYLQEIGKVDLITADEEVELAQRIKAGDDRALEKLTKANLR
FVVSVAKQYQNQGLTLPDLINEGNLGLIKAAKRFDETRGFKFISYAVWWIRQSILQALAE
QSRIVRLPLNKIGSINKINKTFAFLEQSHERPPSAEEIAKELDMTINDVKESMKNSGRHV
SMDAPLVEGEDSNLYDVLRSGESPNPDKELLHESLRTEIERALETLTPREADVIRLYFGL
GDQHPMTLEEIGETFDLTRERVRQIKEKAIRRLKHTSRSKILKTYLG
>IFAGANLK_01803 hypothetical protein
MQTLTIKLVFLIGGILLLVSCSKDDDSQAIPMEFTELQYQKDYELLPGDTLNISPSLSNV
AEDVNYLWTLNGIDIGSTQNLSYTAQEPGTFSLEFKAMAYNHSLIRTYRVSVIDPYDLYS
RPKTQSSSEFISEIIEYKPAPGQYINKNFGSTEAAESIIGGKTNILSLGAWGGYVEFSFD
HTIENREEDKDFVIYGNAMNGHSEPGIVQVSFDENGNGLPDDTWYELAGSAHQEEETLLD
YEVTYNNPGTHANVPWTDNRETQDSILVNSFNTQNYYPLFIQEEKAVSFNGTRVYPVINQ
EGFVSVDALEWGYVDNFDENYDTYGGNAMEIDWAVDDQMNAVKLRGIDFVRVYTGALGNA
GWLGEISTEIKGASDLSMVE
>IFAGANLK_01804 Transcriptional repressor SdpR
MKLRRDVFQAIADPTRRTIISLVALQALTPTAIAENFDYSRQTISKHIQILTECELLKRE
QNGREIYYHLNPEGMKEIAEFIEPFRKMWDDRFDKLENLMKNHQSES
>IFAGANLK_01805 hypothetical protein
MEQKTKIKAEEGKQELIITREFSLPVESLFTAYKDKELFEKWMGTNLIDFEFKEYGKYHF
ETRSPTGDLMFSGKGAFHSLIPNEMIVRTFEMDVFSLPPQLEFLNFNAITGEKSILTMHI
IFKSAEIRNELLKKPFAIGLEMAHSRLEDVLNKIN
>IFAGANLK_01806 hypothetical protein
MTATKQSKIIYWIATIWLALGMLSTGIVQLIKMEEEVASMNSLGYPAYLLYILGVWKILG
TIVILIPKAPLIKEWAYAGFFFVMTGAAISHLMVGDEIITFFGPILLLVLTIISWYFRPL
GRKLIQQ
>IFAGANLK_01807 hypothetical protein
MKDFKPTTVHEFINAATEESQRIMLRLKKLIETTVPDAEGGISWNVPIYKYHGILAGFSL
AKKHVSFGIDTLTTEMREILKEKGYKTGKKTIQIKFDQNIPSAEIKKLVKEQARLNEK
>IFAGANLK_01808 hypothetical protein
MKKSYLFKSSRLGFRNWVDTDLKEFTELNADREVMEHFPKPLTEKESTDFLCRLKEHFEK
NGYCYFATEVLETREFIGFIGLALQEYKSDFTPAVDIGWRLKRSTWGKGYATEGAKKCID
WAFNTLKIERLIATCTKNNTRSENVMKKIGMVKKGNFKHPKLKQYPKLQECIYYEIVKKD
SLIVGSYWLLKSVQ
>IFAGANLK_01809 Transcriptional repressor SdpR
MRRDIFQAVADPTRRAIIALIAVQALTPNAIAEHFDTSRQAVSKHLRILQECEVVKKEHQ
GREIYYELEVEKMKEIDQWLEQFRKIWETRFNQLDDVLATLKMKENE
>IFAGANLK_01810 hypothetical protein
MNKNASLEFTVNKANNSIHIKREFDANLKQVWQAWTDPELLDKWWAPKPYHIETKSLNFE
EGGRWLYAMVSPTNEKDWCKADYKKIAHLKSISWLDAFCDEEGNDTYGKPNSSWTNIFSE
ENGTTTVDITLQHESKADLEMVIQMGFKEGFSMALENLDKVLSNLNTP
>IFAGANLK_01811 hypothetical protein
MRGKILNILSVLLGLLFLNGGLNKFFNYMPVPEDLPQPISRDNEALMEIIWLMPLIASAE
ILGAILILFPKTRALGALVIFPVMVGILLTHIFVAPEGLVMAILIWAVFLWILYENKQKY
FALMQ
>IFAGANLK_01812 hypothetical protein
MKKLHFEFIVDKKNNAITVEREFAANRQLVWDCYTKSELLDQWFSPKPLTTKTKSMDFKE
GGHWIYAMVEPNGTEYWSRMDYLQISPIDFYRALDGFCDSTGKLNPEMPRSEWQVNFKDF
EENALEETLIKYNSLKDLETVE
>IFAGANLK_01813 Polyribonucleotide nucleotidyltransferase
MIPQTFKEVIDLGDGREISLETGKLAKQAHGSVVVQMGNAMLLCTVVSSYKESTMDFFPL
TVDYREKFAAAGRYPGGFFKREARPSDGEVLTMRIVDRVLRPLFPSDYRTETQVMIQLMS
HDEEVMPDALAGLAASAAIQLSDIPFETAISEARVGRVNGEFIINPSRSQLAESDIDMII
GASSDSVMMVEGEMKEISEEEMADAIQFAHEHIKKQVEAQLRLAEAFGKKPVREYAVTPE
NEDFEKRVHDAAYDKIYEIAKGGHSKKERSEAFSAVKEEVLALFSEEELEESEKQIKKYY
SKTEKEAVRELTLAEGIRLDGRKTDEIRPIWCETDYLPSVHGSAIFTRGETQALATVTLG
TSREANTIDMPTHQGEETFYLHYNFPPFCTGEAYPIRGTSRREIGHGNLAQRALKGMIPE
NNPYTVRIVSEVLESNGSSSMATVCAGTMAMMDAGIKMKKPVSGIAMGLISDGERHAVLS
DILGDEDHLGDMDFKVTGTADGITACQMDIKVKGLPYEILVKALKQARAGRLHILEKLTE
TISEPNENVKAHAPKIITRRIPNEFIGALIGPGGKVIQELQKTTGTEIVINEDPVTEEGI
VEILGTKQEGIDKVLAKIESITFKPEKGSVYEVKVIKVLDFGAVVEYLDAPGNEVLLHIS
ELAWERTDNVTDILNVGDVIDVKYFGVDPKTRKEKVSRKALLDKPEGYQARPPRDNDRND
RGRDNRGSRDNRGRDDRGRDDRRGRDNRDRKDND
>IFAGANLK_01814 30S ribosomal protein S15
MYLAKERKEEIFEKHGKSKTDTGSAEGQIALFTYRISHLSDHLKKNRKDYNSERSLVMLV
GKRRSLLDYLMKKDIMRYRAIVKELGLRK
>IFAGANLK_01815 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MAWFKRTQKGIQTPTEHKKDVPKGLWYKSPTGKIVDAEQLESNFYVSPEDGYHVRIGSKE
YFKILFDDNEFKELDKDMTSKDPLDFKDTKKYSDRLKAAQEKTDLKDAVRTAVGKSKGKE
LVIACMDFRFIGGSMGSVVGEKIARAADYAIKNQLPLMVISKSGGARMQEAALSLMQLAK
TSVRLAQLAEARLPYISLATDPTTGGTTASFAMLGDINISEPGALIGFAGPRVVKDTTGK
DLPKDFQTSEFLKEKGFLDFITQRSELKNKVNLYLDLIQNQPVRA
>IFAGANLK_01816 Fructose-bisphosphate aldolase class 2
MSHNIKPGVATGKEVQEIFNYAKEKGFALPAVNIIGSSSANAVMETAAELNSPVIIQFSN
GGAQFNAGKGLSNDGEKAAVAGAVAGAKHIHELAEAYGAVVILHTDHCAKKLLPWIDGML
DASEKHYEQFGKPLYSSHMIDLSEEPLEENIEICKKYLERMSKMGMTLEIELGVTGGEED
GVDNTDIDSSKLYTQPEEVAYAYEELSKVSDQFTIAAAFGNVHGVYKPGNVKLTPVILKN
SQEHITKKYGVEENHIDFVFHGGSGSTVEEIREGIGYGVIKMNIDTDLQYAYLEGIRDYM
GSKKDYLAAQIGNPEGDDVPNKKHYDPRKWLREGELTFKARLKKAFEDLNNVNTL
>IFAGANLK_01817 Outer membrane protein assembly factor BamA
MNRHFAKISLFFLSLLFLISCNAVKRVEGNDKLLTENEIFVNDEKIKEARIYNQLYQEPN
TSFLGIPLRLHFYNLARPDIDSILSEKYLENESKKNTLVDILSYKQFEKFLHSRKSFNEW
IKRTGEEPVIVSEEETRKSVNRLNSWYWNNGWFNVETDYEIIPSENKKKRARVEYEVSTG
EAYHLDSITTNIASRVIDSLYELHKNESVIQEGVQYRTLDINEERDRLTSLFRNNGIYNF
DQEYISFDADTINTGGKVNTTVIIKNRFASEEDTTSRVPFKIHEISKVNIFTDYKYANRN
QPLTDSVTTDEGYMLYSFDELRYKPEAITDAVFIRPGNTYSDLSRSRTYNRLNSLRVFKY
PNVQFTPDPADSTRTDLVANIFLTPQPKYSLGFDFDVSQSNIQKFGIGFGGSLLIRNVFR
GAENFEISGRGSIGSSTDAAISGNDDRFFDISEVGADLKLTFPRIFLPINTDKFIPKYMQ
PFTSLSLGVSTQNNIGLDKRNLSGIMNYRWNPSRQLSNRVDLLNIQYVRNLNIDNYFNVY
RNSYNDLNEIIQSGSIVTDPDYLNEEGLLRIPTGAESFIRDVSNNTGGTTGLDEDQIQLV
NNIGERKTRLTENNLIFASNYTYLWNTKKNLYDQEFTRFRFKVETAGNVLSAVSSLAGFE
KNENGNYDVLGVNFSQYIKTELDFIKHWDMGQSNILAFRAFGGVAIPYGNANSIPFVRSF
FGGGPNDNRAWRAYDLGPGSSGGRNEFNEANMKLAFNLEYRYNLFGALNSAVFVDVGNIW
NVLDIVEDEDATFESFSDLKNIAVGSGFGLRYDFNFFVLRFDIGFKTYDPAQPDDKRWFR
NYNFNHAVYNVGINYPF
>IFAGANLK_01818 23S rRNA (guanosine-2'-O-)-methyltransferase RlmB
MVSKSQIKLITSLAQKKYRYKHGLFVAEGFKLINELINSNFKLNRLFTLDADFGLKPDEI
QKIEERELKKISFLKTPQTALALFEIPEEKISRENILTLALDGVRDPGNLGTIIRLCDWF
GITNLVCSQDSVDCFNPKVVQATMGSLARVNISYCDLKTFLENSELPVYGAFMEGENIYK
SKTEEKAILVMGNEANGISAEIEELIQKKISIPRFGELKETESLNVATATAILLSEFKRK
DFTR
>IFAGANLK_01819 hypothetical protein
MKKFFVIVLLFCVQFGYAQIFGGDKIINNENFDKQRWSWGYYLGFNTYDFKFKYNDEITS
NGNDLIIEKTMGFNVGLVGNLRLNNNLDLRLEPGVTFNTRNFRPPYSQDIEEVNSTYVHI
PLLLKFSADRHNNFKPFVVGGLSTSINLSSNENNPDVDTRLKTNNYHYEVGLGIDLYLYY
FKFSPSIRGVFTINNEMVETQYQVVDAMRSQAVFLNFTFQ
>IFAGANLK_01820 Demethylmenaquinone methyltransferase
MSKKVTPYQDSGLNKKKQVEQMFDKISGNYDGLNRVISMGTDVKWRKKVIALVKAQQPKS
VLDIATGTGDLAIQMADINAEKIVGLDLSEGMLKVGRKKIAAKQLTDKIEMVQGDSEALP
FENNSFDAITVAFGVRNFENLEKGLSEIQRVLKPGGIFVVLETSVPTRFPFKQGYKLYSG
YMLPLIGRVFSKDREAYSYLSKSAAAFPYGETFNNILKKTGFIDVEDKPQTFGVATIYTA
SK
>IFAGANLK_01821 Trk system potassium uptake protein TrkA
MKIIIAGAGEVGFHLAKLLSFESQDITLIDTSRDNLTYADTHLDIRTIKGDATSISILKD
AQVKHVDMLISVTSSEATNITCCVLAKQLGAKRTIARISNTEFLENKEEIGFTSFGIDEL
ISPEALAAREIALLLNQSAFNDSYEFENGALTMIGLSLSRNALFVGKTVKEAANIFPDLN
FVPIAIQRYGTQYTLIPRGDTQFKEGDQVNFITLKSGVENLYKLTGKTKHAIKNVMILGG
SKIGKKTARDLCRNNFHVKLVESDKEKAYDLADELPNALIIHGDGRNVELLEEENVHDMD
AFIAVTGNSETNIMSCLVAKSKSVKKTISLVENMDYYQLSHSIGIDTLINKKLLAANNIF
RYVRKGEVVAMTKINNMNAELLEFIVKPNSQVCNKKIKNLDFPRSAIIGGIIRDGEGIIA
LGDFTITRGDRIVVCCLPRSIKKVEKLFL
>IFAGANLK_01822 Trk system potassium uptake protein TrkH
MPRLNHQIILHVMGLLLLCNGGFMLLAVLVSWFYEDGVTVHILAAAFTTLFLGVLLMFTT
RGHRKEVKKREGYIIVTFGWIFMALSGTLPYVLSESIPAFTDAFFETMSGYTTTGASVLN
DIESIPKGILFWRSLTHWIGGMGIIVLAIAILPLLGIGGMQLFAAEAPGPSADKLKPRIT
DTAKRLWLIYVSYTVAETILLKVAGMSFFDAINHSLSTLSTGGFSTKNISVAYWNDRPII
QYIIMLFMFLAGTNFVLSYYSFKGRVQKVLHDDEFKWYFFFIAIFTVVASAFIYFEADVA
LSQIDHPMVWGDAESAFRHALFQVLAIITTTGFVTADYTMWTPFLTILFFGMFFLGGSAG
STSGGVKVMRHIIMIRNGGIEFKRALHPNAILPVRFNGKSIGKGVTFNILGFFILYMLSF
IIGSVVLGGLGLDFETAIGGAASSLGNIGPAFGALGPVNNFDILPPIGKWWCAFLMLIGR
LELFTVLILLTPFFWRNR
>IFAGANLK_01823 hypothetical protein
MNKILLILFFLISAFSYSQSNIKGKVIDAETKSELPYANIGIQGTNIGTVSDKKGDFNLN
LKKNLRPYDTLQFSFLGYKTNLIQISSLLNKENVVEMIPQSDQLTEVIIPSKKPKEKTIG
RSHIGTGTLWFNFYSAGEVQDDKLGTEAGMKFNLNGDYRLKSLNFYVGSNQYNSVKFRLN
IYRLANNEPTELLNREDIIFDVGDIQSDWFKVDLDTYNIYLKEELGSFAVTIQWLESIKK
APDSKFFAIPLGINPLDTKYFREKGMSTWESSNHNLSFYLEVDRY
>IFAGANLK_01824 Putative ribosomal N-acetyltransferase YdaF
MNKSKYILKEIEQSDINNIHKGLSNSEITEFYDVHFSTLEETEEQMEWYQNLKKEGTGIW
WGIYDKKDNEFCGAGGFNGLDKNHQKAEIGLWLLKEYWGKEIFKEVMPQLFEQGFKNLNL
NRIEGYVVSKNTKCKSALEKINFQYEGTMRECEIKNGEKISVDFYSVLKSEWE
>IFAGANLK_01825 hypothetical protein
MNNNLLKVGDQYIVTDWKGNVKTIIETMEVEKVLYKKITAEFAEMEGKADKSLNYWKKST
KLTTKEKWNLTEGFSMKYDYSLVILPIYLNNE
>IFAGANLK_01826 hypothetical protein
MKNSKFSKIFVGLFLSIGIASCSNDDEVSTIQPSTSLIEMEAEGGETAISFTNGDWQIAE
VINHNSNYSIQGNIYSQDGEVIRVNSVLSLEDQGKIEALWDIKGFVITRDTPSSLEIMLK
ENSSSEEFGFTVVLNSGEEVKEIDVFQKKSQGYRFDSIAYTLKEDDGDSLFVRKGTTYTF
NVLESQEISISPYGGVDIHNQSHFKSPQDDAFIWLKNDSLMVEVPTDIYQNEIYFNGDER
LYSEYSSINPHGFEEMKSVSIPAGESEFFVKQEWRKRKVSYRLSLINNRTGEEKIIEGSW
IEIAPTGGYSIHWED
>IFAGANLK_01827 hypothetical protein
MKYFLFIAAMLLSVFGVKAQNEQINPYQKNNEIKIDVIQPLLSGSVEAVYERNFNHKSSL
GISGVYLFTEKIDDDMNYSLTPYYRRYFGKKYAAGFFLEGFGMFSSIDGKKVYDTEERLT
FTEGSDVYDLSLGIGLGSKWITKSGFIVEANFGFGKQLFNAEKTDHNQVIRYGIKLGYRF
>IFAGANLK_01828 Aspartate aminotransferase
MQEQLSNRINNLATSQTLAMAAKARELRAEGKDIIGLSLGEPDFNTPDFIKEAAIQAIND
NYNSYTPVDGYVELKDAIIKKFKRDNNLTYNHSQIVVSTGAKQSLANVAMVLLNPGDEVI
LPCPYWVSYAEIVKLAEGVPVEVPTSVETDFKMTPEQLEAAITPKTKMIWYSSPCNPSGM
VYSKEELRGLADVLKKHPDIIIVSDEIYEHINFVGGHASMAQFEDMYDRVVTVNGVSKAF
AMTGWRIGYIGAPAWIARATNKMQGQITSGANCIAQRAVITALEAPVSKISYMVDTFKSR
RKLIIDLLNGIEGFVTTEPEGAFYVFPNISHFFGKTIKGHKIENATDFSMFLLEEALVAT
VTGDAFGNPDCIRISYAASEDQIEEAMKRIKSALSEA
>IFAGANLK_01829 NADPH-dependent stearoyl-CoA 9-desaturase
MENIQNHIKFSRKDSTKFFRILNKRVNSYFKDNNIKKTGNWKLHLKAVAMFSLFLTPYFL
ILTLDISQWWMLLLTVVMGAGMAGVGMNIMHDGNHGSYSSKKWVNKFMGGTIYVLAGNVY
NWQVQHNVLHHTYTNIHGHDEDLDAGRIIRFSEHAKWYSFHRFQHYYSVFLYGLLTFNWA
LTTDFKQTRNYLKRKLSYGKMPNPVKQWSIIAITKLIYVSIWIVIPMLILSVSWWKILIG
FFVMHYTAGLILSIVFQLAHVVKETEMPLPDDTGSMKNTWAIHQLFTTVNFSTKNKIVNW
FTGGLNHQVEHHIFPNISHIHYTKIAKIVKETAAECNLPYHEYKTTRAAIIAHFKHLKEM
GAKPAIS
>IFAGANLK_01830 Ribosomal RNA small subunit methyltransferase G
MEIVKTLDLIKKYFPDLTDDQYAKFAQMESLYKDWNLKINVVSRKDIDEIYLRHVLHSLG
IAKIQQFNPGANILDVGTGGGFPGIPLAILFPETNFHLVDSIGKKMKVVNEVVEGLQLTN
VKTTNARVEEISGNYDFIVSRAVAAMPTFVHWTKGKIAKKSQHELKNGILYLKGGDLTVE
LRDYPKARIYELRDYFDEEFYDTKKVVYLPLKYKP
>IFAGANLK_01831 hypothetical protein
MGKITPRFFLIALISGWFLLSGNSLLANISYGPEKPVLKEKQQKNLFFVGFLLELAPSIT
LSKNTPATCSNAQDGALNIDVSGGVSPYSYSWSGPNNFSSTSQGITGLASGSYTVTVTDS
NKDTATKSFTVEFEDSEAPTVNFRNITVELALSGSVSIQASDINNGSSDNCGIDQISINK
TNFSCTDVGDNTVTLSVTDVNGNTATGNATVTVQDNIAPNVSTQNITVQLDENGTANITP
DQIDNGSTDACGIQSTSLDISTFDCTNIGANTVTLSVTDNNNNTSTKTATVTVEDNIAPQ
VITQNITVQLDENGTTSITPDQIDNGSTDACGIQSTSLDISTFDCSNIGANTVTLSVIDN
NNNTATKTASVTVEDNVAPQVVTQNITVQLDENGTASITAAQIDNGSTDACGIDSSSLDV
STFDCSHIGANTITLSVTDIHNNTASNTATITVEDKIKPVLPTVNDITWGCEYTVETPVA
LDNCGGEITAEANRSTIFAESGTIIWTFTDTSGNTDSIEQNVTINQIELNVKVDDILCNG
FASGEAQAIVTGGVGEIIYDWGELGNGAAKDGLSPGTYSVTATDVNGCSATKEFTITEPE
SFIETTSININEGCFEENNASITVEAQGGTGQLTYNWSNGQTGAAINNVNNTSASNNLIL
TITDENGCSIEETITVYPPEELVITNIVDTETNTFGSATGTATAIIEGGTANFEFLWSDG
QTGQTAKNLAAGTYSVIVTDANGCTDEETITIIDPLEASMIPTSKCLSDAGGLRTSTFEL
DSVQGGIAPYNYKWDFAGETVEFGDTNNQTEGPGVHVVNYLEGGVYPVSLTVTDSAGNEY
TEIFNHYVGECFEPCGQTGNLDFELDTFYIGKEDSSPLTGAECQSYTGKRYIYLRIEQNA
NAYNPSVEFIYSISQGGEFISEERITGCIDIGDEKIPELLRIGEVQNWSCGNAITLESFY
MDWTNNHKKACGDVRQRMCVSTNENDEIHFPLSARIEKINNFCHGDEKGAIEIIPTGGVG
TYHYEIQNTLTGDIYGPKDTRKFEGLPAGTYKAMVHDDNESYTVNNIIITQPENPLLLEE
IDQTPLVCFGGSNATATVEASGGTAPYTIVWDHISQTSTETTGTANNLSAGAYTVNVVDA
NGCEFTTEVTIAQPEELIANAGSDQVLECGVNQVNLGGVFEGYINPRTEEEEFGTWRIIN
GPSGAVISDPNNPESLFTITTTGTYTLEWTIPCGSTDRVKIIFSNCSTIDFDGVDDYIDF
GNNLNLPSGFTLEAWVKQDPSAGTTRKTILSKRDNNNPAAGGYDLIIENNTPTFRWNNET
ISSTHQIDSDRWYHIAVIQGGNDAGIYIDGIKTGETAPGIPTSTDNRFLIGAMHDSTLEP
LPTHFFHGWIEEVRVWNTSLDQAQLQFMMNQRITDNNATNVKGEIVPLNVPNNLEWANLT
GYYRLITSEATNGITKNKIPNGIDGRLKNIQSTQQNTAPLPYIATGGDWWNINSWKQPQV
WDTPNSTGVNGEKINWNIARLDGKTLTNAATTDNSNSITLLGLLDDGGSLIMDGTNQTSG
NELHISHYLELNGHIDLNGESQLVQPENSQIIGSGSLERDQQGTASSFNYNYWSSPVISD
PANTTYKVNRVMKDGSTLGTNKFQNINFKWPHTHADGPKANPIKISDYWINAFRARQANE
YSQWEQIGSYTALKPGEGYTMKGTENIDIAEGKLQNYTFNGFPNNGIIEVSEIKSGQNYL
LGNPYPSAISVEEFILDNIREGEGRNDKNLLNGAVYFWDHFAGKTHYLSQYVGGYAVRNL
IDGVPAISNDSRINASGAESNKRPGAYIPVAQGFFVNTTQDSQAGSFGSFDTGNIIFKNS
QRYYKTEIEREISFFLQARDNSKSKQETEGKSEDGRYKIRLLFRSPTGYHRELLVGADAR
SSQGFDLGFDAPLIDKGPEDMYWVVGEGKYVIQGVPHFNLDQVLPLGFKIAEEKEFSIEI
GELENLPEITEIYLRDNSDSTYHDLRKEAYKATLPAGEYQELYEIVFQDITSTREDKEPG
EGPIDYFYSMEEREFVISNPELYEIEHINIYNIAGQLVDQHFGIPDIKEIHILQKKSLSS
GVYIVKVYTSAGDYAKKVIIRKD
>IFAGANLK_01832 hypothetical protein
MEWTCATTITDYPTTTDNCDTEITGTTSDPLELDSYGEYTIIWTFTDSSENSVTAEQIIS
IPEPTVEIPVINGNEYCNTEQVPGITFTGNNLPNKKYEWFYETDNNANIGLASSGTDEIP
EFTATNNTSSPIEVKFTVIPFGRNCEGEENYFFITINPTPTITTPNDIEICEGETVNTID
LSGFSVTGSTVEWSNDNPNIGLGTSGTGNINSFTANNNTNEPQIATISLVPSANNCVGEV
QTFTIEVKPKPELENPVIPELCNGEPTQEIELTGDVPGLTFDISGGSSVGLSNRTNVTEI
PIFTPVNNSDILVNTTITITPKADGCIGVPVQIPVTVKPSPLVDASFSNQICSGETTDIS
LSSPVANTGFTWTVDAPPGIEGAANGSLQGEGTIEHELINTTSQPQKVTYRITPEADECT
GSTIPVAITVNPMPDFEITDPEPGCSPIEIDLTASEITAGSSSGLTFTYWNNEAATDEFE
NPTSAGAGTYYIKATTNNSCSVVKSVTVVENQTPELTSPLQAPGFCSETAFEYEFSSTVP
DTEFNWTRENIAGISTSGNSDSGSINEVLVNETTNPIEVVYEVTLISPEGCSNQQEITTI
VTPTPLLTSTLTPEGICSGINFNYNPTSETGGTVFSWTRERVDGISNPPANGTGPINEIL
ENTTTQPIGVTYTYTLASNNCENPDEYNVNVVVTPSPDTQVQVSTAGENNKQNEIEICSG
TNVDLFSTTSFVDNTSLPFELFRSNFNNGNQGWETNPSGGSSRWQLTNSGTEAYTYECEW
WEEYFYGCQDERIDFQSNSNDQFFLVNSHDSNDDFNNISLTSPVFNTQGYNTLNLSFWHH
YRDGGASRWNQRDIGLLEYRYENSNGSWTNWQNIDTYTSTEGNADNFVQRNYNIDNLINR
NAVQIRFRYDNASDDWYWAIDNVLVTGDGISTSPEVEWTSDVSDWTSNEVNPTNVSTAQT
TTYTATYINPETGCPGSASVKVTVREPLQPRIIADYCLFAESNRIRLSSDQEFDSYRWES
AGERLSSNSSIDISLARTYTLYVTKDGCEASTSITPNENLVPNGDFDNPDYPLPYSESTN
YGERDILSNGDVLFSTLYDFKVNPNDNQNTWGALGPEGTMAVGDNANDYHSNFNGRGHGG
QGNFLIVNGDRSIGNIVWESHTFEITPDTDYYFSAWTSNVNPASPARLRLQVLVPGNNTP
EVESTLGDLTNEPVGNWINFYNPELWNSGNNTEVVLRIINENPTAGGNDFGIDDISFSAF
RSFDFEFTPENNGAICENETLELAANLDGGRFPITFNWTGPNGFSRSKTISEESERVAAD
TIRIPNATAEMAGEYSLQITDFYGCNLESKTTSVEVIEKAVVFAGDDVEICSNNPVIDLS
SASITHPSIDSGFWSTAEGDNSGFTDPNTLNTTYHPSEEEIAAGEIELILTSNEDAGAVC
ETVTDTINIIFNISPELELVAQDVNCFEGDNGKIEVNIIENTGTAPFTFEWSDGQTGRIA
ENLVAGEYYADITDAKGCTVRTETYTIRQPEELIVGSPIGLEEASCFDEFGAVVSIPVSG
GLFAEETIEPENIPYVLEILDADGNQINLAQEQINYDIATERFIISGLQGGKGYTFLVSS
SENCAAEVKTFTTLTPPEINAGEVPEISECGIKTLWLAASPIDPEIGTGSWSYNNGETVL
LGDPDNPNTSFTGQPGQTYTLSWSVSSVTNESCSVTDEIEITFPPSCSQLNFDGIDDFVD
LGDHYNINSSFSIEAWVKPHSTSRTKTILSKRSATNLNSGYDLFLNNGSPTFQVNNTSVV
ARSKINTDRWYHIAAVYSQGSALKIYVDGIEIQTNTTNIPQSVGATDTPTLIGATYAPDE
SIESKDHFEGYIEEVRLWNTAIPIDQIRFFMNQRLEKDGTNVSGTVLTNNLNLPNAPETI
EWSSLVGYYQLLAQNDLISDGFTDNLGSTGGTANGLLKNIQEMQENTAPLPYILYTSGQE
WFNKTTWKLPAQIDGQNIRERDVWDAPSSPGINNSPINWNIVKLSKDIENPATQNNHNNI
SLLGLISENGTLNMKGENNMGGSQTGFGTGNALTITHYLELDGYIDLNGESQLIQTEGSE
ISGSGSLERDQQGTASSYNYNYWSSPVVPTSNSPNYKVNQVMKDGSTVGTKDFQNINFKW
PHTHADGQKANPIKISDYWINAFRARKANEYSQWEQIGSYTALKPGEGYTMKGTTGEARI
IDLQNYTFTGFPNNGTIEVSEIKAGQNYLLGNPYPSAISVEEFILDNIKDSGGRNNKNLL
NGAVYFWDHFGGQTHYLSQYVGGYAVRNLIDGVSAISNDSRINDSGAQSTKKAGPYIPVG
QGFFVNTTLDAQAEDIDEFGSGTIVFKNSQRSFVMERGQSSSFFLKPSDNTKNNKNVEEK
SEDGRYKIRLKFNSPTGYHREILVGADARTSQDFDLGFDAPLIDKGKEDMYWVIGERNYV
IQGVPHFNLDQKLPLGIKIAEEKEFSIEIGELHNLPDIIEIYLHNNIDSTYHDLRKEAFK
ATLPVGEYKDLYEIVFQDITTIRKDKEPGEGPVDFYYSMENREFVINNPEFHKIEHINVY
NIAGQLVDQHFGIPDIKEIHIPQEKSLSSAVYIVKIFTSAGDYAKKVIIRKD
>IFAGANLK_01833 HTH-type transcriptional activator RhaR
MIIILLIAAIFGFVLSTTLFFKKSTNTLATRILGSFYFILSVYALQAFIIDGGYLEHFTW
FFLWPLLPYHLIFIPIYYYFKVILTDQFKWDKAELILLIPFLLGLIDVGYVYLQPEHFYN
SILSEAISTPEKRLNVQYWLLSLDQHLLMRHFWQFGVLIVLLPEIKFFIKNGGDDELKKI
LNKWLIIFWGILMVMAVLAIIYALEKMKLLNIFDSLIIIGENGGIITFFLYIALFLIGII
PIYFPSILYGYPQKLTKSSNFISIEQPEDLKFGLEKEEVLAKLKRLKENDCHLDKKFNLT
ECARKLEMPSHHISYFLKQYYGLSFATYKNTLRTKHAKRLIEEGYLQNNTIDALAEKCGY
ANRTSFSKSFKSLVEISPSEYAAEFK
>IFAGANLK_01834 L-fucose-proton symporter
MTKETNKSIIIIGVLFFIFGFVTWLNSVLIPYLKIANELNNFQSYLVAFASYISYLVMAI
PSAWVLKKIGFKKGMSLGLVVMAIGALVFVPAALVRNYTFFLFGLFVQGTGLALLQSAAN
PYITILGPIESAAKRISIMGICNKIAGALAPIVFGAILLKNMDKLETKLINLNPVEKAAE
LDALSARVITPYIIMAVILSGLAVLIYYSTLPEIETDGEDEEVAVANKNKTSVMQFPNLL
LGTLAMFLYVGVEVIAGDTVISYARDGQDIATGTAKFFTSYTLVAMIIGYLIGTVTIPRF
ISQEKALQISGILGIILGLAAIFGDGYFSVLCISLLGLANALVFPAIWPLALKGLGRFTK
MGSSFLIMALAGGAILPLVYGYLADQFDPQQAYWIIIPCYLYILFFGTKGYKMK
>IFAGANLK_01835 hypothetical protein
MVNLIQMIGVKYIIGAVLMAASFISCEESGNKTTTADENKAENEMIVDRTLRVMSYNIHH
ANPPAEEDKIDIAAIVKVIKAEDPDLVALQEVDFSTERSGEGNQAELIAKALDMEYYFAK
AIDYDNGEYGNAILSKFPIKEGEILDLPNHPEDNTENRVVALGLIEINEDQNILFGSTHL
DYKKDSKSRILQVKKLIESANERNEALILGGDFNDDPDSETIQLLDSELERTCKTCPPTI
PVKNPQRAIDFIYYKHPQTKFQVKSHKVIPEEYASDHRPVFAEIDIVK
>IFAGANLK_01836 SusD-like protein
MKKIVVFSVILSMFCLVGCEKDFLDRAPNDELTDETFWENEEHLRLAANALYANVKAKNT
VDQENMGDNTLWPSTTQYQRIGSGNYNSDLNTLNTEWTTQYRGIRQANSFLANYQKAEVD
DPLVAERYAAEVRVIRALMYLYITEFWGDMPLVTEPLNIDELMIPRDPKEEVVDFVLNDL
EDAAQYLPEEIPSGENLGRMNKGAALALKARMALYNERYDVAEDAAKRVMDMGVYELYST
GNPESDYYDLFTYEGKLANGNNKETIIARLSLEDEAMHNLSREIHVPDQVIRWNPTKSLV
DSYLMADGLPIDKSPLYSVETYEDVFENRDPRMTQTILEPGSEWGGRYDGRENNENPEIF
EVPKFQSDGRGAVTLTGYYFTKYAEPTAVPTYNRDFNDIHLLRYAEVLLTYAEARFEQGV
LSQEDLDISINLLRERVGMQPMVLADLESNGMDIREEIRRERRVELALEGQRYFDVKRWR
QGELLAADVKGTNVEWLPNPEMADNLRTDENGFIIALTDQVFDPERHYLWPVPLPQLERN
PDLVQNPGW
>IFAGANLK_01837 TonB-dependent receptor SusC
MTKNIKKVLIVLCTLFSWVGFAQEREVSGRVLDEDALPIPGVTVSEDGTSNGTVTDMEGE
FEFSVTDDENTTLIFSFLGFQTQEIILNGQTEFEIVLEESSEGLNEVVVVGYGTQKKANL
TGAVSQVDSETLEDRPITNVSSGLQGSMAGVTVTGASGAPGNNSGDIRIRGIGTWGNASP
LIVIDGVPGGNLDILNPSDIESISVLKDAASSSIYGVRGANGVIVVTTKSGKGGEPTLSY
NTYYGMQRPTAIPEKLGSPEYMELLNESQINVGRNPTYSEEEIQIARDGSDPNYYANTNW
VNEVYKDYAPQESHNLSVNGGEENLNYYLSYGLLKEGGLVVGDKFEAKRHNMRAKVSTTL
LDRIELNTNLGYIDRNYTGSSQGFAPLYQALTVRPLVPVRNTNGGWGYIGGSSNPVATAY
EAGTNDFTSEEFTANVDAAIRIFEGFKIRGRYGLVKYNSRRNVFDRTVNYYDADTGNLVW
QINNPSQITTSSYKGTYQTFVGTAEFDRTFAEDHSVQALLGVSQEETINDDLSASRTDVA
STSVGHINLGTDNQRNSGSNAQNALQSVFGRLNYAFKDKYLAEANFRYDGSSRFAKDVRW
NLFSSASLGWVFTEEEFIENDILDFGKIRASYGTQGNDRIADWAFMDVLGPVNTMPIGNA
VTIGYRQTAVGNELLTWESAEKLNVGLDLSFLDNRLNITADYFENNTNNILLRLPIPDVF
GGPAYPYQNAGSVENTGWELELGWRDQIKEFNYDLNFNISDVRNEVTDLGGTEPTIDDRI
RRVGDPLDAFYGLVADRIAQESDFTYDAGSDTYTPNFPYIQGDPVQPGDLIYKDLNGDGE
VDLVNDRKVIGSHIPRYTYGFRGDFDYKNFDLSVFIQGVGKVNGLLTGTARHALISESAI
PQAVHLDRWTPENTNASYPRLTYQQSYNQRLSTYWLEDASYIRLKNVQVGYTLPENFTSR
FRVDRLRAYVSGENLLTFTDYFDGYDPESPVSSGSFYPQIRTFTVGLNINLK
>IFAGANLK_01838 hypothetical protein
MYRSSLAVVFFLFVSMVNAQESLFNGHDLTGWEIYGTEKWYVDNAVLVAESGPDEAYGYL
ATKKNYKNFELELEFLQEANGNSGVFFRSSLEGTKISGWQVEVAPPDLHTGGVYESYGRG
WLVKPKPRKEKILKFGKWNQLKIRVKDGEVTTWLNGRKMINFLDEKIEQANGKIALQIHD
GGGIKVLWRNINLRHL
>IFAGANLK_01839 hypothetical protein
MKKLIVSVLTVASLMACKNDGKNPDKEAEIKEKDNAESITGNEKDEEWQYLFDGESAEGW
RGYNEKNADALPEGWIVEDGTLKSLGEGGDIGGDIVYGEEEFDNFELYLEWKISPEGNSG
VFYHVIEDEAYDSPYFAAPEYQIIDQKGFPQELQAWQSIGADYGMYDPEYDEDDLKEVGE
WNTTRIRFTEDKVTYWLNGEKTVEFEPWSEEWKQKKKEGKWKDFPDYGKAKSGLIGLQDH
GSYTWFRNIKIKKL
>IFAGANLK_01840 Inositol 2-dehydrogenase
MENNRRSFIKKLGVAGATAAIIPSVFASEGKPLNFLNRIETKRNSKPIAIALIGAGGMGV
ADTKTALEHDNINLLAVCDLYDGRLEESKKRWGNNLFLTKKYEDILKRGDIDAVIIGTPD
HWHKKISLDALKAGKHVYCEKPMIHSVEEGHEIVKAWKKSGKVYMVGSQGLSSLGNEKAK
QLLEEGAIGEINYAEGFWARNSPLGAWQYPIPNDASPQTVDWKKFVEPTTKRPFDEDRFF
RWRNYTDYGTGMSGDLFVHLFSSLHFITNSLGPTKVAATGGLRYWHDGREVPDVLLGMFD
YPDTESHSAFNLSLRCNFVDGTSGSTYLKIVGSKGSMEVTWDDVLLKQNTASNDNDPFTE
EKASEESMTRSDRKKILPPSDTFYEAERGYKGAHYDHFANFFHAIRTGGTVVEDPVFGFR
AAAPALLCNDSYRQNKFIQWDPEQMKIV
>IFAGANLK_01841 hypothetical protein
MKRFFILVAILWSVCSLGQNKHPDSLWLSKSESSDLSGDLKKGYNAFFIESLPDFENKFD
SLNPLLPSGKQVLFIPNFNPKGLKNIFPDSLKISSKLFENSKKIKLFNVEKKRFNHIIYQ
PDSLRDLRLCKEFNLVNTDSLKSKKEIDFFLQNLLYTKGVVPDLIVSPFVSDITYLKKQY
YKEPVYRAEVSYNNEELKNVRWKEFPHLETCGIFRTSDSTLSPQKRGFMFSPDIYNFTDK
NTRISGPKTFRAIKYELEERLRYSLPLEDEIVNLVNQADKSTPTDIEFVKDIYRDKSVSI
FNGTSSYIDIRSKPEEWLEEISISAWVKPDEVDGSFSLIGKGEAFSAKIYFGRLQFTTTG
IKDHTTSKRVIEKGEWSHVAFVYVPKQKLYFYVDGNLVEEIAASDIRQTDHALLIGTNLW
GQYYSGLMSDLKIWDRALSDDEIKSVFIDKPNEGHDVFSSGKWLYFTGLIMILAISAFFI
YQRKPKKPKEAPTPVETLQPSVIKENVKQNGINLLNGFKIWNKKGEDITSKLPPKRRELL
ILVLLFTLRDGGITSKKLSDILWPGFPSENKKNNRSTQIKELRKTLGEQLDAEIVFEDKK
WQLQISETGRVDLFILNTILPDFWSSEKKILSELQAIEFAGIVSKGPLLPQVEVEWLDAI
KAEYNSRVLDLLTPFLENKDLNSTQKIEIIEAILVVDPLFEPAVRKKVSCLLQQEKYGSA
KKTVENYKKLYESYYNETIDPEFMKLVK
>IFAGANLK_01842 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MKKINFITFLLIVIPGFVIAQNATGTIFEDKNGNGRQDSNESGIPNVAVTNGEDVVLTDQ
KGEYQLPKSDAFIISVIKPSGYKYPVDENNLPLFYYNHKPKGSPDLKYTGVEVTGDLPRE
LNFPLLKNNEEKENFSALIFGDPQVYNEDQVSYFQKGMVSRVKKNKDILFGISLGDLVGN
DLALFDPYIQVMKDLKLPWYNVLGNHDLNFDVDKDKYSDETFEKYFGPPNYAFNYGKVHF
IVLDDILYPDPRDNKGYWGGFREDQLNFIENDLKHVPKDHLIVLSFHIPLSEPNGDAFRD
EDRQRLFEILKDFPNTLSLSAHTHIQKQDFFKKEDGWLGEQPHHHFNVGTTSGDWYSGRL
NETGIPISTMRDGTPKGYAVLNFEDNNYTIDYQVVGESEDYRMQIFSPKVVAKDQNTKAG
IYVNYFMGSEEDKVEYRIDEGSWSTMKYVEDYDPSYVAMVYEWDLTEELFSGRRPSNPIK
SKHLWRANIPTKLAEGVHTIEVRVEDMFGRIFTDTHEYRIVSPDQ
>IFAGANLK_01843 Glycerol-3-phosphate dehydrogenase 2
MKKINSRENSENDSFKRDHILTKLDPSEIWDVIIIGGGATGLGTALDASSRGLKTLLLEQ
ADFANGTSSRSTKLVHGGVRYLAQGNLGLVMDALKERGLLINNAPHLVKMLPFIIPSYKA
WDKYYYGIGLKIYDWMAKNLRFQKTKFLNKEETLSHLPNIKTKNLNGGVLYYDGQFDDTR
LAINLAQSAAEQGAHLLNYFEVTELCKDENKKITGVKAKDIESGNLHNFKSKVVINATGV
FVDNILKLNDSSKIPLVKASQGIHLVLDKSFMKSDHALMIPSTSDGRVLFALPWHEHLLV
GTTDTPVEQHLLEPSALDSEIDFILNNLEEYLTRKPSKKDILSVFAGLRPLVQPNKDKDK
GTKEISRDHKLTVSRSNLITITGGKWTTYRKMAEDTVDFAIETGNLSKSPSKTDHLKIHG
ATEKVTGNHLDIYGSDANLIMKLAEEEPRLQEQLHPEFPILKAEVVWAAKNEMARTIEDF
LARRTRLLFLNARAAIDAAEDTAKIMADVLGKDSNWQDLQIKKFIKMAQKYIPEPYNPVT
RKSEEIESK
>IFAGANLK_01844 Glycerol kinase
MEKYILSFDQGTTSSRAIIFNKNGNPVSVAQKEFKQIFPKPGWVEHDPGEIWSSQISVAA
EVVSKAKLKSDDIQAIGITNQRETTVVWDRETGEPIYNAIVWQDRRTSDYCDFLKKEGHE
EMIREKTGLVLDAYFLATKVRWILENVLGAKEKAKAGKLALGTIDSWLVWNLSNGKDHIT
DVTNASRTLLFNIHTLEWDKELLELFKIPESMLPRVCDSSGELSMTSGEIFSKKIPITGI
AGDQHAALFGQMCTDKGMAKNTYGTGCFLLMNIGDQPIISKNKLITTIAWKIGDEVNYAF
EGSIFIAGAVVQWLRDGMGLISSASEIETLAAKVESTDGLYLVPAFAGLGAPHWNQHARG
TIVGITRGSNQSHIARAALESIAYQTYDVVKAMEADSGINIKELRVDGGATVNSLLMQIQ
ADILNTRILRPEITETTALGAAYLAGLGAGIWKDIDEIKSKWKVMESFNPNDKIPVQEML
EGWQRAINTTNCWSKN
>IFAGANLK_01845 putative glycerol uptake facilitator protein
MNEFTAEFIGTMFLILMGNGVVANVVLKGTKGNNGGWIVITTGWALAVFTGVVIAAPYSG
AHINPAVTLGLSIAGEFPWTKVPIFIGAQMLGAMAGSFLVWAIYREHFNCTTNSALHLAA
FSTAPAIRNKFSNLLSEIIGTFTLIFVIFYVTNPVMGNESETPIGMGSLGAIPVAFLVWA
IGLSLGGTTGYAINPARDLGPRIIHSLVPIKNKCKSDWSYSWVPIAGPLIGATIAAVIYL
LLNN
>IFAGANLK_01846 Calcium-transporting ATPase
MNAKYLLIFCLLFFSNNYAQQQQDQQKPKLVVGIVVDQMRYDYLTRFWDRFEDDGFKRLV
NEGFNFRNHHFNYVPTYTGPGHASVWTGTTPMNHGIIGNNWFDKVKGESVYCTDDDSVSP
IGTESAAGKMSPVLLKTTTITDQNRLHTQMKGKTIGVALKDRGSILPAGHTANAAYWFHG
GTEGKFITSSFYRDDLPKWVQDFNDSGKVESYLKEWNTLYDIGTYTASGIDENNFEGGFE
GKEKTTFPYDLNALSSLNGNFGIISSTPYGNDLTTDFALAALKGEKLGQDNITDFLTLSF
SSTDYVGHNFGVNSKEVEDTYLRLDKNIAELLEFLDNYVGKGDYTIFLTADHGAVDVPSY
LQSVKIPGGYFDDIQFTKALEEYVLNEFSAEDLIQNISNNQIFFNYDKLREANISIKELE
NSVAFYCIQQTQVDKVITRSQLNSANFNSGIRELIQNGFNQKRSGDVVFVLNPATIVYSK
TGSTHGSGLTYDTHAPLIFFGAGVKPGSTTERSEIPDITPTVASLLNIAFPNGASGAPLH
MMLDQ
>IFAGANLK_01847 Arylesterase
MKPTNFLLAILLITTTSLVSQSIEVDSLHRPRNYHIQVNQFQGYPDSKQDIIFLGNSITA
GTNWNELLGLPNARNRGISGDTTFGILERLDEVIEGDPSKVFILIGINDIARNYPDELII
SNYEKIIRRIKKGCPNTEVFIQSILPVNNTFTRYKNHYNKDEHILAINKELKNLSKTNNV
NFIDIHPHFLDEENRLSRKFTEEGLHLNALAYQTWAELLKPYLK
>IFAGANLK_01848 Glycerophosphodiester phosphodiesterase
MKVIRLLLCSILIASFSCKNNAENNQDHSPEKDNPATGKVQVQGHRGDRGNLPENSIPAF
LSAVEKGADVLELDVVVSQDKKIVVSHEPVMLALYMLTPDGDSIAKENEKDYNLYKMDYD
SIRKFDSGSRKNRLFPDQKSQKTYKPLLSEVIDTVENYIQVNDLDEVKYNIEIKSSERNY
GIFQPEPDEFVDLVMNIVVEKGIKDKVNLQSFDVHILQILNEKYPDTEVAYLVSKEGIDK
NLEKLEFVPDIYSPNYKLLKSKEVVDSIKERNMVLIPWTVNEEEDINRMLELEVDGIITD
YPERVLNKI
>IFAGANLK_01849 Arylsulfatase
MTIFKKILLLLIGITGPSFGQERPPNIIVIFVDDLGYGDLSSFGHPTIQTPYIDQMAQEG
AKLSQFYVGASICTPSRAALLTGRLPIRSGMAGSKNSGNVLYPRSTGGLPQSEKTIAEAV
KEQGYTTAIVGKWHLGHLPEFLPLNHGFDYYFGIPYSNDMLPPRYKKAPKLPLYENKEII
ENDPNQKLLTKRYTEKVVDFIKANKDNPFFLYYPNNFPHTPLHVSDDFENRSKRGLYGDV
VEEIDWSVGEILKTLKELNIDENTLVVFTSDNGPWLKRGKNGGSAGLLYEGKASTYEGGF
RVPAVVRWPGKIPANQTFDAITNAMDLYPTILKLVGSPLPEDRTLDGVDLMPLLSGEEKK
ANDVVYYYLRDELYAIRKGSWKAHFITKPSYSKEKPKVHKTPKLFNIDVDPSEKYEIGEH
HPEIIEEIKDIYKEHQKTIEPVKSQLDLGY
>IFAGANLK_01850 hypothetical protein
MKKIDIQKKMIRVSSLVALSLLLISCDADILDQPPGDAVTSDEFFNTGADLEAYTNDLYD
VLPTTSVYMDDSDSDNILGVSAGDRLRGTRRVPTDRGSGGWSWGYLRRINYFLENYNRVD
DVEATAKYSGIAKFFRAYFYFEKVQRFGDVPWYGEVINQDDEELLSKARDSRELVMDSIM
ADIDYAIENIPAEKELNRITKYTALILKARIALFEGTYRKYHGLDDYERFLEEAISAAEQ
LMDSGAYELYTSGGEDQAYQELFAMEDQNMTETILAVDFEFGLRTHDLAYRMTAPTQGRW
GLSKDLVNSYLMTDGTPFTDQSGYETMEFYEEMQNRDPRLTQTTAGPNFSTYGSDEPEPV
NLDITRTGYRVIKALPPKGPQWGSGGSFNDVILFRYAEALLIYAEAKAELGTLTQGDLDI
SINKLRDRVGLPHLNMAEANANPDPYQGSLYEKVEGPNKGVILEIRRERRVEMVNEGLRW
DDLMRWKEGQIIEDPIEGIYFSELGAHDFDNDGNYDVYVHDGDASGAPDEVTTTINISER
QLTNGTSGNLLLFEGGNFDETRDYLYPLPLEDLELNENLEQNPGW
>IFAGANLK_01851 TonB-dependent receptor SusC
MKKILQRLMLLTFVLGGWVIHAQERQVSGVVADEIGMPIPGVTVQEKGTSNGTVTDFDGE
FLLSVSDSNNTVLVFSFLGYESKEVTIASQTTFNITLEEDSESLDEVVVVGYGTQREENL
VGSVSTADLGNIEARPSADIASSLQGAVPGLNIRSASGGDPSTTPEINIRGFNSINGGSP
LIIIDGIEGDLANINPNDIESVTVLKDAGAAAIYGARGSFGVVLITTKSGKEGEFNVEYS
NNIGFTTNTTRTDFVTNPYTYAKWVDEAIGSYHSGCYVCYEDEDWEIAQQVGNGEREPFY
EQQPDGTYKFFGNTDFYDVLFKDRRSHQINNISVSGGSEKLRGVISGRTYEREKIQNIQD
AEMKRYNLQLKLTANPYEWLELNALSRFSSRYDEQYAGTKNGWGDEFGVSKWRDLFPNHP
AFVDGYGVSVGRTGNGYVGRLGALKEGAAHRQWTYENQTNTLGAEIKPLKGLVLNMNYNY
SIDRTDRTFSYKPFSYLSGNKLELLENEGLNRHNEYRWKDYYTAINIYGTYTTEIADKHN
FKVMLGFNQEEFDRDRVGMRIEDLLTRDKANIAFGTEMLDMEGSTLEWAIQGYFGRFNYD
YDGKYLLEINARYDGSSRFPEENRWGLFPSIAGGWIIDKEDFWTPSLESVISSLKLKASY
GKLGNQSVGVNTFRQLIGMGRTNWLFDGEQSNYARVPSPLPANIGWEKITSTNVGLNMGF
FEDKLTTSLEVYERNTRDMYLPGQPLPAVFGASEPRRNYAAMRNRGFEVTLGYNDEFMVL
GSELSFSAQANVSNNRAEITKFDNPNGLLSTFYEGQQVGEIWGYRIDGQFQSDEEAAAFQ
SEYGRDNLFRVYRGILDYGSNSDWNLLRGGDLRYVDVDGDGSIDNGNNTLEDHGDLVPIG
NALPQFPFGFNISATWKNIDLSVIGQGVAKQDWYPNGPLYWATFHRPYTSFIRKDLLDQV
WDPAHPNDPNRIYPQRQRAYNALSNGRMSYNYNDHFLTNIGYLRIKNLTLGYTIPPTFTK
KVNIKRLRVFLSGENIFTWSFGGLTKYLDPEEVGAHVSYSNPNSVSGRSATDTQLYPMGK
TFSAGLQINL
>IFAGANLK_01852 hypothetical protein
MEHLPGAIINEGIGINFQIGYLLDNNYEFVGRTTHIDRKFEFPNHIENQYTLGLSKYFKK
HKLKIQTDISLNDMENSLTDRTLYRLQIDFNL
>IFAGANLK_01853 Glucitol operon repressor
MGTVDRHQIIIEKINKDGQVKVQDLCDEFDVSSVTVRKDLKFLEEKGLLYRMHGGATHTN
PYTTDRHVNEKEKIHLPEKMGIGEIAAKMVTANDSILIASGTTVLSLAKNIKPLENLTVI
TPALNVALELNQHKEIEVIQLGGILRKRSSSVTGLYAENNLSDFSCSKLFLGVDGIDLEF
GLTTANMMEARLNREMIKVSQKTIVLADSTKFGKRGFGRICGFDSIDEIITDTGISKFTR
EALEEHGIKITIV
>IFAGANLK_01854 hypothetical protein
MVREAIALIYVRFRLYEDANKQSEKTLEFAQNNSLPELEMRSLSLLEDLQQAVTTDKRLL
YDSKLLELAEVNND
>IFAGANLK_01855 hypothetical protein
MKIILFLTLFTIFFVSNLVAQEEIPHLQQVGNKYQLVVDGKPYILVAGELGNSTASTMKS
MEPVWPRLKELNLNTVLLPIYWELFEPEEGKFDYKLIEDLILEARKNDLKLVVLWFGSYK
NSMSSHVPSWVKLNQKRFPRAVSKEGQSQEILSAFSENNIKADLNAYQHLLRYIKKIDGS
HHTVILMQPENEIGMLPSARDYHPLANQKFKEEVPKELMDYIINNEQNLNPEFSKIWKDN
GAKEQGSWEEVFGKGLHTDEIFMAYYFSRFADEVAEAGKKEYPLPAYVNAALNRPDVKPG
DYPSGGPLPHILDVWKAGSPNIDFYSPDFYNPRFKHWNDLYERQGNPLFIPEHDFDNTVA
AKALYAIGHYEALGFAPFSIEQLSEEPLTPKEQKLAEVYEIIHQIKPILDANRGQNQIEG
VLLDKEVNEKTFTLGDYEFTAEHTFNLGWEPNSGGDIWEPSAAIIVQTAENEFYYAGYGV
SLKMTNLKKPNSQVGILKTDRGYFRDGKWNVFQHLNGDQTHQGRHIRSFIDDVSIQRFTL
YEYN
>IFAGANLK_01856 hypothetical protein
MRFYKGLLFIISLLFSVVLSAQDLNQGLIGRWDLAAGSAIDISGNGNNGIIYNTTGTLDR
FGTVNEALDFSGNGQISFGNVLDMGLGDFSMGAWFKINPANTGVYAIATKKTYGIGVDNK
RIRVYFEGAGTLDVRMGVISDDSWHYVAVTFDRDGFLKIYLDGEAIGSRDISSSSNTNVQ
STHPFFIGRYNSPSYSYRGSIDDVRIYNRVLSEEEVIQLSLFNDSNCTELITNNEENIGI
GGLPNQNYGLTVEGNIYTDQVKVMDVDTWPDYVFFEGYDLLDLEDVASYIEEQGHLPGLP
SAEEVLSDGISLTQMDKTNLKKLEELSLYLLDQHDRMERLRAPKTQKAPVLAYRTDKERP
YNFVFEQSGIAEGKGQLKTMSTDSLSTGNIYCDGDNVGIGVAQASGYRLAVLGGILSEGV
KVSSVSNWPDYVFSDDYALLSLEGLRAYIRANKHLPGLPSAKTIAREGYSLSEMDRLLME
KVEELTLYVIQQEEELQSLSGALGVILPLRGDEVVSDKTVYKSHNVDIETHLKAPTQKEE
RTFRDMASPRSIEASTEALCDVISCDGEGVGIGADPVEGYRLAVSGGILTHDIQVASVAN
WPDYVFEADYKLRDLLSLSAYIEREGHLPGVPKAEILEQEGYRLEVMDGLLLEKIEELTL
YLIQQERQLTFLESRKQ
>IFAGANLK_01857 hypothetical protein
MECNPFLSNQFIIFQLTFQITRPKGLLIQTNMLYVKKNWTYFLVVLFLISIIFYGILKER
NYSNYIGDDRTEKRYTVGEIDHFQGGAKTSPFFEYSYNVGSKSYSDKFYINGELRKKKSS
ELKKYLNKRFYVLYVLEDPSYSKLLIEKPVIDSLLQIQTGGKKFLFKVLLLIFGIIVRI
>IFAGANLK_01858 hypothetical protein
MKLKSEKVFGYIIAGIIVLVFSYMVTKNFIKKSYFDNSKFEKRITIGEINKIVPGAKSPP
FFEYEFIVNDDSYGGAYIIESDLRRLSTKELKKFVGKKFYVKYVEKDPNYNKLLFNEFIK
DTTLSIPSSGWSEIPE
>IFAGANLK_01859 hypothetical protein
MPSRNIDGQYRYAYQGQEKDDETGMEAFELRLWDSRIGRWLTVDPYSQHFSPYLGMGNSP
IVSIDPNGGANCGGPNQPPCQVPEINLFSVNNNNFPSNTNWNGTGHQNYLQALLMRQRAD
DFARDFERFKANFDAGWNNWDKDGIGNFWMNATAGAVVGFLGATMAAPYVLGEASLTYGA
AKFTASSVAQLAINKQINFAGAATDAFLVPGVGDMVGSSFELGYNLKNNSFY
>IFAGANLK_01860 hypothetical protein
MGWQYFRVIGGFILWVLLQKKNLKTYIDHKYSIFIGFGFIVLCIIILFIYDRFAV
>IFAGANLK_01861 hypothetical protein
MRIFKNVLFSLIIILLGEKCLAQQTPELRNSLETITYRLDGDITSRSKEYYNELGKKTQM
QSVDILSNKTWAMQVLYDAFGRPALQSLSAPIGNSGFLYNEDFIKKPGGGAYSASDFDTD
QENPAAVGTQQNSLGWYYSGNNSNEPNQDVTSFPFSRTIYSTLNPGQALKSIGGNKINGE
WKNGYSFSMKASQELSQSAAFGETKYNSIKTTKTVVKDVHGVENVVFADTDGNTLAAARS
GGGSARNMSLSIGEQGYVDIHVPNGGNANGLTINSSGGVETEVFNLITENPVSGSTEGLG
NGFYRVSITNLESYDPDVNPVTVNYKENYYDYSLNLYNKAGMLIATRQPLNQLETTFKYD
AMGQLNKTTSPDEGTAEFKYRKDGQIRYSQNGKQEVEGEFSYTNYDEKGRPVESGVLQNN
DFPNANPDTALPSGSRSEQNFTLYDVPDNTGLHTALTNSSIPVANYESQAFTAGNVAKTF
TENPETTTSWYSYDVYGRVQWVVQDIPGLGAKTIDYEYDPATSNVTKVYFQKHNTQELFL
HRYSYNDVGELVKVETSDDDSNFTEQAAYTYYETGALKRTELADNLQGIDYIYNLNGALK
SINNPVLQDDPGNDVNDVFGMAINYHHNDYQRQNTPITVPTSTTGQDQFNGNIKGITWNN
NYGEEVPPVQYEYNYNRNNWLTEANFYGDSLNNIEQDIVLDTLMNNNNQTIQAANSVNLQ
PGFEVTATDSSRFVIELIEADSLSNGDFRVYDIAYDANGNLQSLSRNKHTENGSNEMDKL
SYNYYNGGNRLEYVQDSVTAETNAPDIKNQNPGNYVYNSIGQLVYNGQDELTYSYNTAGL
VTRIEKSEQTLVEFVYNDKGQRVEKKTYNQGSQVATTHYVRDVAGNVLAVYSNGQLEELN
VYGNDRIGVFYKQLNTNYYEIKDHLGNVRTVIAKNGENALAIQAKTDYYPFGMAMPSRNI
DGQYRYAYQGQEKDDETGMEAFELRLWDARIGRWLTVDPYGQFNSPYLGMGNNPISMVDP
DGGYKNWFQAVAGWIGGGFKGNIFKSNDPATPLHKYGIDKTNSENGILVDFGNIKGDLLD
AGYSWRSDGQGAIHSSGNIGNTNLFAEMDFWRSSPSQDLADFGSKILVDMTYGTVENISF
SITGRTFSGNVPQGQNAFEKRFDSFLTLASGGYTQAAKTVKSVKSSGKLWNTYQKSTKGL
YDHKGKHANSVKSQFYKENIKLHNSAVKNIQKSSGIFNDAGIIFGPIESASENN
>IFAGANLK_01862 hypothetical protein
MVKYYNKPKTGKILKQKRWHRSGAVFLIINILTTFLPFNLFANNGGPTAIEATSFEPIDA
TDMVNLATGDFTYVLPLLNVPSPEGGYPIALAYHAGIAMDQEASWTGLGWNLNAGAINRS
VNGYPDDYNRSSLTEFFYDEGGKEVMHSLSLGYSSPEGMGSVGLNLSWGSNRSLGGSVSI
GAGTGLDGGGSIGGNLTAGTDGVGMGLGVTTGGLSLGANISSNGAYGGDIGVGNNDAGFN
VGMNSNGTVNLGVRSGTGNDNQAHLGVSLSSNSIGINAGITNLTGNNVNGGIGTGIQFAL
NNSIKMGDYTVSSSGFFIPVIVPTQIGIFSMSYGRQEFRYFLGEFHDNSVSGPLHFKTGY
WRVNCTTSSPRTGCGGEVFESYEDAENFVEDFEEESDCRCSINQANFGDAFMDIYELPID
SDFIRNSKIENNNPSFPNYDNYNVQAQGLSGGMSSRLFENGVLFGLSGKENAEDYSLEHP
LSGASASLNAETRFDNRPEFYFENEISSYSPVGDADFNNSLSNSEILDHFQNNVMKGGIN
RRANSTFVEYFKNEEIINGQAEIIKPEVDGFNRSLKPKDGIGAFKITAVDGKTYHYSLPV
YNHETITRTFGVISSSPNEEQSYFEKRQLEPFATHWLLTAVTGPDYIDNNSNGILDKGDF
GYWVSFDYGKWSDGYVWKAPYKKDYITDPEDNSVKTWIRGRKEIYYLDKVKTRTHSALFV
KEERQDGNSDYWSYKSVVHAEYLDQNSGDFEERFSIPSQNLLRLKEILLVKNDSSLKNSG
MNNSQPFEINYHTDISSDRRGFYPIGHSRGEPVEISMNLYENVLEDSDNLNSIHTNALKV
ISLDYNNNLSNGKSTLARVNFKGKGGRQLLPPYKFDYENDTSYNFDIDDRDAFGYLENNN
SIWSLNQITTPQGGEIQVEYENHNIKPVVGSSFEFTTNGEEYSIEKLNSLNYKISSTNNL
GIHIGDELQFKYDIYCTYEEPGNCGGPCGYEIFDCDYEKQAIVTSDLGNGEYQITIDAHN
CPYPPDMSYCDSGGRERISAIYSQTDPINGLGGIRTSKITTTDGLNSYTAEYKYGENENG
IGYISYLPFAPDIARELPYSAELPAPKVMYSEVSEQSSANGEPSPVRTIYKFNVLTEKSE
DKIKFSDFYEIDIQKENFTNNSGKEVDISKYVIKDNLASLGQLLEVATYNREGQLINKTI
NNYYKPGTTPDSLGMTKEAYQSYKIVDYNDTSKKDKWLINSSARITYPNLIKSTKQIGNG
FEYNTVFKNLDTITGKAKDLITESSAGDQIRFKSILAYEKYPAMGSKVLQPWTNPTISGK
ANMLNQVAANYSQVKDQNGDWKNLSVNFNTWIPQTYQYTYQIGQYPDQTDITEVKDVWRK
HQNYIWNGDFDNQTGMYIGFNGQDDGFDWSPGQGVSQPSQWKKMQEVTKYNNFSKPLETE
DVNENKVSRKLDVNQNNIYLTGDSAYDEIFYSGGEDALDEGDVKTDTDYVSRTNTRSHTG
EYSIEVPANRTGFSVTPGSNKPYRVSVWVQKDNYENTRVINGADQINYSEAETVIAGDWV
QLNFNVDLTSSSDSKIDLTTISGTAYFDDFRVYPLNASVNSYVYNEWDELTHILGSNNLA
SKFEYDDVGRLIREYKEVGDAGNLTGGFKLVKEHKYTYKGVVEIDDDGDGVIDPGEGYPD
TSLTLEVDDSSFPEVKVTAQASGGSGNYEYRWAVGYDPAMTYGSWGSLNSTWASVYCPDG
FVFFKCEIKDLVSGETVEEIGNYFTECPDDPNGQFPDEN
>IFAGANLK_01863 hypothetical protein
MVCSCSPPFLEDREDMLKFLQNEDNGYTKRKVINNIDFKLMYKPTDLLVDQHLENNFSIQ
EVDSLRAALKDFMYFNLAISSDNREVLNTLAQDRAEFGKMVSTLSFNFQDKVSMVTSNKD
TIQMVDFSYPRMYGLSRATSLLLVFPVEAGLRNSATIDVIVEDIGFQTGQVKFRYDVSLI
TNQPEINFSSIPKD
>IFAGANLK_01864 hypothetical protein
MNKLSIPLSFIAIVISLSAFFYLSPKEELVYVDVNRLLNGYDRTAIEKQKFEIKTNKLKS
DMDSLNVSWQQDLQAYEKDRISLSEKELEMKKEALTSKQQQVNNYQRAVQQQLQEEDKKM
TQTVLNDINDFVKGYGEEHGYQLIFGATGSGNVMYAHGSSDLTEEVLEALNKDFEKRN
>IFAGANLK_01865 hypothetical protein
MKAQKLPSFNLQEMLIVLAILGILLLIALPNFMPLISKTKAQEAKIQLKYISNLQKQYQY
LNSKYTADFEALDFEAPRTVLEEGEANYRYEVIETSLDNFKVRATAVVDFDGDGVFNVWE
IDRNGSPKEVIKD
>IFAGANLK_01866 hypothetical protein
MVWWFLFPVFAITAGYLHFIHAVEIVFILNLAINFLIVMICMSVGFLYARLKLKVSFLRE
AFGLGDLLFFIGLAGAFPTVSFIIVFAALLLSSLLTHFIIAKSSELDSVPLAGYASFFLT
LTYITNWTGEFLNIYKI
>IFAGANLK_01867 putative type II secretion system protein HxcR
MSPNYSIPVNLKQIITANQAFHHRIVPIGKEQDITIFKTDSSHQQELKEELEILLGFPIQ
LEYEDTSIIQSYLSHNYRQRTNSASQKLDFKTNFLSQLLQTAKDYNSSDIHLEPQEETCR
VRFRLDGKLKEQFLIEPSEYPQIINQVKIQAGLDISQKRLSQDGRITVKSISNEFDIRVS
TLPTLHGEKIVLRILKRDAEEVKLTDLGFTKDEFALYMEGIRKPNGIILISGPTGSGKTT
TLYGTLKILNTEESNILTIEDPIEYTLQGINQVQLKEDIGFDFPAALRTFLRQDPDIIMV
GEIRDEKTATMAIKAALTGHLVLSTIHTNSAWATISRLIDMGIPPYLIASTLNLSIAQRL
VRKLCGLCKKKVPVNANLFPDGFEAPDSLNFCYEAVGCPNCYHTGYLGRQAIYEILPIEK
ELEVAIKENRQHIEEYVQTKGLKTLKNNAIRLLMEGETSIEEVYSLLK
>IFAGANLK_01868 Type IV pilus biogenesis and competence protein PilQ
MSIRHFVLFLIILFLGFKGFGQEQTRLSSLQNRLEVLAIEYPELDEKVNVNISNTTLSNF
LLAISEVHQININVDPDLNSVEIINNFNDVSIQNLLFFLAKEYNLKLDITGNIISISRYV
LPVAEPEEKQLVVKYNPIGNTISLNLNDNPLSKVFRKITDESGKNLVYAPGMDELELSIY
LSEVNIDTALEKLALANNLKMAKSKDGFYLFNTPISGGESNGVERAINKNDNFYYRVVDS
LNRIIEVDFNNVPAEDVIYTIAEDLNLNYFTASSLNNMGEVSVTSESINFDKLLEKIFES
LKSQDFEKIINDQNRNRPQTQAQNISERAGAVFTYKKENNIYYFGTENQLALKQTEVVQL
MHRSIEMLSNPSSNRRQNRSNRNNFMTGSSNYISGNNSTFGNNGMNNNNQSDFNRNIDRR
TTGEEELNTEAIKKLIPEDILNGININIDSELNSFIVSGPSTNIERFKKFITYIDKPVPV
VLIEVMIMEVNKSATIETGVSFGIGEERVSTEGQAFPTTSMRLGAETINRVIGGFDGFGS
LNMGKVLPNFYMDLKAMESNGSIKILSTPKLSTLNGHKAYLSSGETTYYAVTNQNFFGSQ
IPQTSETTNYYPIDAELALDIMPFVSGDGEITLDINVIQSSFNGQRIAENAPPGMNSREF
SSIIRMRDQDVAILGGIEERTKDDSGSGVPLLARIPVIKWLFSERRREDSKRKLNILIKP
TVIY
>IFAGANLK_01869 hypothetical protein
MSSLSHYWNYGKEYTAIDWCQLAADTTEYYLLTSTKKKGELELKELLHLNNLETLISKLK
KNQHTYLNISGNQVLIKTTAKTSGNHNSIVESAFPNLDLKEFYFQVISNETESIVTICRR
NYVEGIIDTLAKEGVVILGISLGFTPLLNITSLLGELEIETHSHSLVINKNTIVNFNKND
KILEEQQYDIDGIPIGGSFLISLSCIFYYFKNDKDVFSNIAEKNYLLKTKFRQKQFFKQT
LIIGLSFILICLLINFFIFTNMHREYQSRQNQFEIEVSQREIQENKIKEVQRKKELVAEI
MRNSNSNSTLYLNRISSQIPTSITLNNLIYQPLEKRIKENSPVELSYNDIILQGESKDKE
SFSSWIQYLEDIPWIKELAIENFGFISQNTSEFTLNIELKDESEK
>IFAGANLK_01870 hypothetical protein
MNQKNKNIALIIGLLLIGFLSYEFSISNTLEVVDNLKELDKTINKNTSQPEEISKINKEE
IYLDSIIQAKRLGDVSLQNNLLNVLNKYAENVGYKIISFQKPHLLKDGNTTITTFGFTLE
GDYKSIEKILYILENQYIFGEMTHVNFLKEKDYGKKEEYLQCRVLIQHLQ
>IFAGANLK_01871 Response regulator UvrY
MKRLVKVLMVDDHQLIVEGYKNILLETQNEEFKIIFEEANSCKTAYDKLQESLRTGNFFD
LIFMDINLPEYTQKKIYSGEDLGLFAKMLSSETKLIFLTMHEDNYRLYNIVKNVNPEGLL
IKSDVGSNELVKAFQEVLDGKISYSHTVNTFIRKQITNDIALDQLDRQIIYYLSKGIQTK
KLPERVPLSLAAIEKRKRNLKDLFGLEKEGDLVLIEKAKSMGFV
>IFAGANLK_01872 Oxygen sensor histidine kinase NreB
MSESKEGVKIGDDYNSLVTSVEIQSLSRDSLLRIGNEIVMDSLRSKFFFQVSYHYLIEND
SINFRDWNDRTIQFSFQQKDTSGVAEAYWDLADFYVKQDKLDSAYYYFNASSKLYKEIGK
EFYFGRMLLNQALVQTKASDFLGSEITSFQAIRLLKPMGKTKQLYLAYNNLGVIHNNLEN
FQKSVEYHRLAQEYNKSLDNDYYSVITLNNLGVAYKNMKAFDSAIECFKNALDINDSENI
RMQAMLLDNIGHAKMFNGDLDEGYKCMSEALKLRTEIGHIDGISVNNLHLGDYFRLIKDD
ERAISLYKVSRDLSEKNHNHSDLLASLTSLASIDSANSSNYLTRHIELTDSLRKEERNIQ
NQFVRIRFETDQFKEDADQLSRQKIGIIVGAGIAILFLILIYIIQVQKSKNKKLFLEKKQ
QEANEKIYDLLLSSQQKFEEGSSKEKKRISRDLHDSVLSKFFGIRLNLEVLNNKTGKESE
IQRAVYIGDLRKIEADIRTISHQLKSDSLLKETGFMSVIKELLNEVENDEDFKISLVADG
GIDWKSVKNGVKINLYRILQEGLQNIRKYADAKNIYIKFDMNEMWLKFEIADDGVGFDLE
KNETGIGLSNIEDRISEMKGKLKIKSSSRGTILLIKIPKKRL
>IFAGANLK_01873 hypothetical protein
MKSLTRNLLFIFVFSFFAACEPEPLPENNDLEVFSDVMEQGDEEVPIDSKKNKD
>IFAGANLK_01874 Transcriptional regulatory protein YehT
MGFTYSIISDDAELISKLLELPIDFKEFTCVGYTGNGERACDIILQSKPQFVFIDLDNPR
INDPFSFVNQFYQFLEVLPSFIAISASKNYAYEVIKNDFIDYLLKPLPLFELRKSLMRFK
KKMTDSGQICLKSYSDYHFLKLKHILYLKADNNTTDFYLTSGDRVVAFKSLKIYQQLLPV
EFVRVHKSYIVNSNLIRRINFAKNRISLEELVSVTEIPFSKKYQDNVTRLRDSFFKTNLS
FD
>IFAGANLK_01875 hypothetical protein
MNTKVNEINISYCGNIKVSELPKIHSSATAAIVFFENWNKDQIELHESFKILLLNNNNRI
KSIYTLSIGGITGTLVDIRILFAIVLKSLTTAVI
>IFAGANLK_01876 hypothetical protein
MITTRKIFFCLSANEISLDLNNPKNPCVVTIVNNPKNETAYSPVIAMIIHTVLRQMSVRN
LERAFVLMEEAPTIRLLLNMHRVPSTFRSYDIATLYILQGKG
>IFAGANLK_01877 hypothetical protein
MILLPFTFYREKASKAILSNLSYQFFGKANDPVTAGYYEKFFELVKREILSLSKGEGLNL
DTRITKTKREVSKLRADLFFGLKTGGFVVYADGKDKRIEFKYQHLEKALPENFQHYSCDE
INNSFSGIYNDVESLLKTL
>IFAGANLK_01878 hypothetical protein
MQKVLFFLVFFHCGFSLNSQNLTDGLIGHWPLDGDAIDLTINGNDGEVHGAIGVSNRFGE
ESKAMYFDGNDYIEISNIPTMGTGDFSMSAWFKYDSGAKGELAILSKAKGQNVTGRYAFG
IEDSRIRAFIDFGPEVDFRSPTILESNGWSLATVTYDRDGQLRIYANGVLDGSRDISASA
SIDFHRDFSFLIGQYIKGMWAFKGALDDIRIYNRVLTPTEVEALYTLSSESSECTGLITE
VDGNVGVGVNVENSCGYGLAVGGSIYTDEMKVMGVSNWPDYVFSEAYKLMDLGVVTSYIK
KYGHLPGLPSAKKVFSDGLSLIGADKANLRKMEELTLYLLDQRDRLDRLRSSKVLESSGL
MYSSVKESDPNFVLHRNQFFFAVKPNDSLSSGLSCQGENVGINTSNTGDYRLGVTRGILS
QGVKIESVSNWPDYVFSSDYSLRSLDELEEYIEANRHLPGIPSVKTIEIEGYSLSEMDRL
LMEKIEELTLYIIDQGRHLMELSKKLGVDFSNKSYKWQGTSEKSLADAFGSHSKDNTKKE
VKNYSGQILAGVSGTPEESICDVIICNGEEVGIGTDPVEGYRLAVDGGILTDDIQVASVS
NWPDYVFGADYKLRSLSNLSAYIEREGHLPGVPKAEFIEEEGYHLEAMDALLLEKIEELT
LYLIGHERQLAFLESRQ
>IFAGANLK_01879 hypothetical protein
MKYIWIIFFLFGSLTNAQDLENGLIGHWPLDGDALDLSFDTNNGQIFGAVPVSNRFGQEN
KAMYFDGNSYISFGNVLKMGLGDYSISAWFKIQEGAQLGRESAIVAKSYSTGAIDRFAIG
IADGNKVGVVLQNSKYIANELIGEEEWHLLTATFDRSSFLSIYLDNFKVKEVDISNSQNV
DIDEPWPLHIGDYSGDGREFIGNIDDVRIYNRVLTAGEIEMIYTMDPEEDDCTGLITEND
EGIGIGIENPGDYGLAVGGGIYTDAVKVMDVAMWPDYVFSETYDLLDLEDVASYIKEQGH
LPGLPSAEEVLADGISLTQMDKANLKKLEELSLYLLDQHARMERLRAPKVEKASAITYSE
GKERPYNFVLEQSGIEEGQGPLKTLSTDSLSTGTMYCDGDNVGIGIGQTSGYRLAVAGGI
LSEGVKVSSVSNWPDYVFSDDYAMLSLDDLRAYISTNKHLPGFPSAKTIAREGYSLSKMD
KLLMEKVEELTLYVIDQESELESLSGELGVILPVADEEIASGKTVYKSYNVDIAPPLIAH
TQKAAPHFEGGVSTSLKASPKALCDVIICNGEEVGIGTDPVEGYRLAGDGGILTDDIQVA
SVSNWPDYVFGADYKLRSLSSLSAYIEREGHLPGVPKAEFIEEEGYHLEAIDALLLEKIE
ELTLYLIGQERQLTFLESQSHRQ
>IFAGANLK_01880 Tyrosine recombinase XerD
MSKTRKGQYSFEDAITYFKRNTRLEFREMNESFLNKYKAFCSTYLGHKTRTITNQLIFIR
TLFNIAIKDGIVSQKYYPFVGEKEKIRIGSGNKIGLTAEEVTKIENLAVESHSSIWHTRN
VWLVSFYFAGIRISDVVALKWTDIKDGRLYYVMNKNEKPLSFKVPDKAKTVFNLYLMDKT
ENNGYIFPFLKDADQQDPKSVFLKMRNATKVLNKFLKRIADECEIDKNLSNHIARHTFGN
ITGDKIHPLMLQKLYRHSDLKTTLNYQANFIHRDADDALDSVINF
>IFAGANLK_01881 hypothetical protein
MLQSNPTKKGTGIELWGDYGDLASLYETIHKIGERLNEFKKEEKGQSDIIMGFAYEVRKA
FQHSRLNEKFVFDSENKVEYLGFRYLWTDLLYLISVLRYNAGYVVLDALDQANLYILEYN
CKKALFDYDPQGAQQIQLFIAQKINIHNDLVFLVLQGINIEYLSKTPGKRRFRGIPDLLI
AYSQFSPAYKMWKADIEIRAKELGCRVDQLNYDDYPEIVW
>IFAGANLK_01882 hypothetical protein
MEEQGAFKEVPFHDEFRKEVIDKLLELHRQLVLLEHLERGSRMPFLRKIAILRDFFGIQI
LKNIYTIMKVLYIYNNLERLMEKT
>IFAGANLK_01883 hypothetical protein
MQIYGIDLSKSKFDVNFLDANGKSVNMTVKNDLKSISKFLSKVPKDTVLCAENTGTYGDL
LVFLCNQYEIKIALVPGYNVKHSLGLVKGKTDPIDAARLREYGERFYDKLSLKVYQSESM
SELRQLYSLRSQLVKARKLLTTGVHARQQMPMQSIMTNNILKATLDSLDKQIKEAEVEII
LIIRDDAELQENYELSVSVLGIGPVIATNLIIKTGNFEIIDTARRAASYAGVCPFPNASG
NMVGKSKTSPFGDKELKTLLYLGARAAVKHNKEYKLYYQKKQQEGKHHFLIMNNVMNKLL
RTIYSVIKNKTPYDRNMLFFLFSQFMR
>IFAGANLK_01884 hypothetical protein
MKLNTKEVENVSKLKPFKRYKYFIKKIADFEEFWTIVDEKGDLALSEIDENTLVSFWTAE
DFIKSNLDSGWGNCVPFKITLDDFEDTIAPLIADNSYLINVFPVNGKSGFVVDLNEFIRD
LNEELEQYE
>IFAGANLK_01885 hypothetical protein
MDYLDYDYDGNKLLRVSEIEDGEAGYGFKDGNTTGDDYGYDVNGNLTSDANKGILAGGIK
YNHLNLPTEVMFNNSSSQVIKYTYDATGVKLRKEIPGKITDYAGNFIYEGGTLKFFNHPE
GYVSYDGGQFNYVYNYVDHLGNIRLSYTDANQNNTNPVSLQIIQEKNYYPFGLTHQGYNT
NGSPLGNDAAKRYGFGGKELQDENISGSILDWYDVSARNYDPALGRWMNLDPLAEKMRRH
SPYNFGFNNPIYFQDYDGMAPSGPGNPIKKLIKKAVKKLGRLGRQNRLRQVVNDPKASKA
DKGWIKSEMNQMKNGKRKSIRNPPGKDLAHERGREAAKGYDYKHSNLQDRDLHRTQHKYD
NNGRKNKERPVKEATATAVATGTMANEEVNASTEESTSITGNETADAVLDISMTYVETMD
NLGTVIFGDNDFGKAVNEFNPFPGFSEFFSILKDDNDKSNTNTK
>IFAGANLK_01886 hypothetical protein
MVWTAYKKVRANKGSAGVDSVSMQEFDANRSRHLYKLWNRLASGSYFPPPVKEVEIPKKD
GKSANLEFPPSAKE
>IFAGANLK_01887 Group II intron-encoded protein LtrA
MVIKDYLEPRFEKIFSSNSYGYRPNKSAHQALETVRENCRRQNWDIDLDIKDFFNTIDHQ
KLMLAVRKHVPENWACLYLERWLEAPVLKTSGELQSKQGKGTPQGGVASPLLANLFLHYA
LDKWLEHTDVTVKYARYADDCILHCQSKTHAEHILEAVNKRLESCGLELHPDKTKIVYCK
DGRRREDYPVVKFDFLGYSFQPRATKSRKTGKLFLGYDCAISISSRKRIADKLEALKFER
VSFKSIIGIAYYLNPMIRGWVNYYGRFRRSELSKVFRLLRIRLIRWARKRYKRYRTRLKH
AYQWLDRVRKQFPYLFYHWKLGFSC
>IFAGANLK_01888 hypothetical protein
MMREYHVRICERLGVKLPLSTRRGTLVRINKNNVRNKLLALVILMYVLSLNAAKNPLTIE
KTGTNFLPHQSEFKI
>IFAGANLK_01889 hypothetical protein
MEYYGFEIYPGYDITNDTLNSDKVSRTFFETEIKIISE
>IFAGANLK_01890 Adenosine monophosphate-protein transferase SoFic
MKPPYDITSTILKSITAISEKIGAINANYLNKPSPKLRKENKIKTIHSSLKIEGNSLTEE
QITALLEHKRIIGPKKDVKEVINAIEIYEHLENYNAFDEKSFLKCHKHLMKNLIEDAGKY
RNQGVGIMKGSEVEHFAPPHQNVPFLMKDLFDYLKKSEEIELIKSCVFHYEMEFIHPFLD
GNGRMGRLWQTLILMEKYPIFEYIPFETLISKDQEKYYAALSKSDKAGNSTSFIEYMLDV
IEKSLNELLGFNQRTFTEKDRLEYFVSLNKREFTRKDYMDIFKDISGATASRDLKKGVEL
NLFQKTGEKNKTKYKL
>IFAGANLK_01891 hypothetical protein
MKSYRIHKKKAELKKSKKKNALVTISKSVKINYKPLNLLVIKTLRNTVQLIRNVGEDPKS
PKFENGMLI
>IFAGANLK_01892 hypothetical protein
MKNHLSLITCLLLIFSSCTIEDEFTELTSHEDILVETRIFFKDTLVDYDIGFEYYKTDGY
NNLISRYISFSGSTNNGRETFSQVFKEYRKAGIKVEAAENVDFITITFTEVNWDSQPYFY
YRHDSPGEFTFMYDFESDTYEVTED
>IFAGANLK_01893 hypothetical protein
MPKKLHFLLIIFFLAFFNFSGIAQENDFQHGLMNVGMGGVIGGIGAVINKAPDQTLGKTL
LKGFAQGAIGGYFVFESKRLVRRFAREKKYNYIWPSKLVNAAGNSIIENAAANRNFWERM
HLNLAFNRIEIDFKNRFKLKYRIMPFALSRAAYLFTQARLDVDRSMVFGTLVFSQRIPEI
LGEKGSNGKAMLSSILLRRGSGQRTEAHEIIHTYQFENFSGINTIFDRPRSRLEQESKFV
RIYNKIFHTDFNALFSQGLYSLETEIKGYRENSFEKEARHFSE
>IFAGANLK_01894 mRNA interferase HigB
MVTLLYICSKLFNVKIFSRGTIRDFWEKHGDCELQLKTWYRETEKSNWSSINELKNEYPS
ASILKYNRIVFNIKGNDYRLIVKFNFEYQLAWIRFIGTHVEYDKINANEI
>IFAGANLK_01895 Antitoxin HigA
MKIKPIRNEADYHKALERLEVIFDAKRGTDEGDELEILAIIIDNYENENFPIGMPDPISA
INFRMEQMGLKQKDLVEMIGFKSRVSEIMNKKRKLTLEMIRKLNAKLHIPTEVLIQDY
>IFAGANLK_01896 hypothetical protein
MNKSFLLLLLLLLMISTSCQKSFQGNDKVRILDNFNEVSSLEELINLPEFKNKILYINLF
SFYCKHSVDEFTYIEELQSNSHKNLKVGEDVAFIHLSTPKWAFESFWKSNVEDYDLAGYH
FLMNEKFLNNFWSHFPEAQKGTPFFIQVTMDKKISKTFRPSTMIQKAPLDAALNDFVLQT
FKFVRANLDSVLSGHPEKYDLLFKFDKSSEEKISFFTYSKNDPDNSNEVDVWKNLNVFAE
RSFDSIPDKDGLSGYSFAIPLNVKTLDSIIPE
>IFAGANLK_01897 hypothetical protein
METSIIKIGNSRGLRLSKTILEKYHIKDKVELILEKGQIILRPIESPRKNWEEKFKEMAD
NNDDGLLMNDVFEDENFDEWN
>IFAGANLK_01898 Endoribonuclease EndoA
MELKQYFIILVNLDPTVESEIKKTRPCVIISPNEMNKFLKTIVVAPLTTNLKKYPTRISI
KSNDKKGMIAIDQIRTIDKQRIIKIFDSLSKSEVRKCKEVLKETFVD
>IFAGANLK_01899 hypothetical protein
MPTAKNNAKTILDLKVGARLDSGLSCSQSRTPARTFLWGTLVRIKKNNVRNKLLPLVILM
YIGSVMIREIIRMKNNGFANIGISQS
>IFAGANLK_01900 Release factor glutamine methyltransferase
MLILEYPNPETETLVNWVKEKFSRLQQEKNARTLSLLDIGTGCGLLPITLGKELPIETTA
VDLSERALEVAQENAKLNNAEVDFIQGDVLKWTSLPKQFDIIVSNPPYILEKSRKDVPRN
FLDYEPPVALYVKDEDPMLFNRKIAELAKES
>IFAGANLK_01901 Antitoxin YefM
MLITTVSDFRKNIKTYLDRVVKNFETLIINRGKDSGIVVMSLQEYNSLMATNHELSSRKN
ELRLDSAIDKLKSGTTFDKDLIEY
>IFAGANLK_01902 Toxin YoeB
MRYIFVDESWEDYLFWQKTDKKKLKKINELLKDIARNPYDGIGKPEPLKHKYAGFWSRRI
DSEHRLIYQYKEGEILVAKCRFHYD
>IFAGANLK_01903 Ferrichrome-iron receptor
MKRFLFLSLLLFTSYTYSQQVKLSGKLIDQKDDPIPYANVVLENTNYGTTTNQDGEFEVK
ARPGTYILVVSSLGYGRFSQKVVLDKTSNDLGTIILTNQTQSLNEVAINSHHINRFSDKR
TDYVARMPLENLENPQVYSVISKELMQEQVVTDIGQTVRNATGVVPIIYPSGGLATTFRG
FNVGINARNGMETTSGRSGIDIANVERIEILKGPSGTLFGGNVSSFGGVVNLVTKKPMEA
RKNEISYTTGSYNLNRITADINNPLNKEKTVLFRLNTALNKEKSFLDYGFYDAYLIAPSF
LFKASDRLTFTLDTELLNVNSTRNLYNRYAPESGITSPEDLKLDYNKALFHNDADAQTAS
TKIFAEAKYQLAENWTSSTLFSFVGEDVDHSYQYYATWLSPTVAQRESGNWNSIYNNYTN
LQENINGEFSTGNIKHKVLIGASYRSFQSRSEASRTGTIDTIDVSTDFHALRKEDIDPHL
VSNYWPGWNAVNSYTLSGYATDVIDWTDRLSTMLSLRIDHFDREAKAGAEGFQQTALSPK
LGLVYQVVKDHVSVFGNYMNGFQNQAPRTQPDGSQFVLDPVYAEQSEGGIKAEVFDKKLS
ATASFYHIAINNAIRTNTDGFAAQDGEQVSKGIDVEVIANPFPGLNIISGYAYNDNRIIK
SSDESIEGNKAVDSPENVANFWASYTFQNKLKGLGFGVGGNHVGQSYMFSDNVFSIPAYT
VYNASLFYNQPSWRIGLKINNLTDEKYWTFWGVRQVPANFAANLTFRF
>IFAGANLK_01904 hypothetical protein
MNKRIYNILFHTHTISGILISVGLYIIFFAGSFSFFREEINSWERNEPVMEKGFGNANLN
ILMDSINKNHDTFGRDISFNKHVEDRRLRVNLSASKDTTAQQEGVKREFFYIDADTQSAF
DYESNYSIGEFLYRLHFFAQLNLYGTIGYLLAGIISFFFLFAIITGLIVHWNKIVSNFYV
FRPRARLKTIWTDAHTALGVIGLPFQFIYAVTGIFFIIATALVSPPVLSIIYDDDLEKMY
EDFGFGQRDFPLAMEEAEVPVDLNKFIRKTESHWPDFNIKTLSLYNYGDKNMHVGLQGTP
KYEKQFIGQGELIFNAATGKIVLEKNPFENTSYVEGARGVMSRLHFGDYGGLGLKIVYFI
LGIISCFVIISGILIWLVARDKKHIAEKKRKFNAWVGWGFLSICLSLYPATAFTFVAVKL
FLPDFDPERMTHIYHIFFYSWLVLIILFTLKKDNFFTNKYTLISGAVLGFLIPIANGIVS
GNWFWKTYAKAHYDIFFIDVFWMVLAATTLIIALRLKRIKPNSKNKQKSIATNKK
>IFAGANLK_01905 hypothetical protein
MPANKKHLTKSKSQRFAKISAGMLGGYMVTESLHIALAFWVNHLVVLMTLRFGGFILWVG
LLILAFLAKNGWKVWGLYLLLTLFSCLMIYLGKIYNPII
>IFAGANLK_01906 hypothetical protein
MLTLVITITFLGFFILYNTSEKAVLTQSLFLEKWVQNNHLPSKFLGYTLLLIAFIISIPL
FGIGAGISLYLTILMTVASVVILLAPLHYITYKTLSAIFIISFIVELIFC
>IFAGANLK_01907 hypothetical protein
MQYTNLPWIIALCCILTGSVFFHNDNEVIGFLIGILGIPLSGTACLLKEFLKEIIIKAKG
EFSFNSKGYFKSSTIETSLLYYGTHSQFLQNSKIEEISVKIFPKEFPVNSPP
>IFAGANLK_01908 ECF RNA polymerase sigma-E factor
MAHGIINNSLFINRLKKGEHTAYETLFRLYFDRLFYFAKSYLEDEDEAKEITQNVFFKFW
KSRNSLSIDSNLNAYLFRMTKNECLDYFKHQKVRANYQDNIKKERAALNQSSLQDHPDLL
LIETELEAKVSQILDELPPRCKQIFIKSRFEGLKYKEIANEMNISIKTVEHQIAKALRLF
RRELQEYMGLF
>IFAGANLK_01909 hypothetical protein
MRKEDLIQFIKGSGNKRFQQSVIDWVKTSPENRRYYNRVKADYVSKFQVDHHIDIDKEFD
RFLVRKQQGHNQRIFFKVASVIVLALLAGGGWFLTKADLSSTTPLAVYEAQPSLMEEITL
PDGSKVSLNSGSIIEIADDFNKSNREVYLEGEAFFEVERDEARPFVVSTSSDLKVRVLGT
SFNVKSYKTDQTIETTLVSGKVELLQNNRKKSGIALFPNQKATFDKVEDRINIEKVSTFN
ITSWKDGVLIFDNEPIQNVLNSLERWYDVEIKIKDSVISTYTFSGKVKRKTDIEEVLELL
EASSPIKYHLNEKQKTFILSKNN
>IFAGANLK_01910 TonB-dependent receptor SusC
MKKKLNGPLPSCNSDDFSKKLIRIMKIYSLILCLTIVKISASSLTVYGQNIELNYQDTEL
RAILYDLEEQTDYNFFYNNKLVNEKVKINIRFSSENVQEVMSQILKSTNINFKIINNNIV
LYRDDFSETSEYKSNHPSGRSLSAQRLIDPSGFQQVVKGKVMDDNGLPLPGVNVIIQNTN
TGTQTDFDGVFSIEAGEGDVLEFSYVGMESLTYRITDLESPIEVVMLQDADQLSEVLVVA
YGKQSRASFTGAAVDVDVSKIDESPLASFQESLQGNVAGLQMSTESGQPGAAPNIRIRGI
GSINASSDPLYVVDGIPVISGNISQIATSSNTIAGINPKDIENITVLKDASATSIYGSRG
ANGVILITTKQGKEGKTTFDVSAQRGVSQMLIPDRNKPLNTAQHLELLIESRVNAGDTQQ
EAEDYIYSNVDRTIDTDWVDVITRTGNYEQYNISANGGSEKTQFFASLGLYEQEGVIIGI
GYNKLNARLNVNHQATDKLKIDFGVAANNQKLNTNSDAGSAHNPVRALARVVPWEPVYNE
DGSYNTDILLTYNPVGLVEENIRETKIYGILGNLSLTYDFTENLSFQTKGNVDFNLADEF
RFDNPVFGEGRNDGGRGRAYNNKIINYNITNLLKYNWRINDDNNLDFTLGQEAQKIERSS
VYAYVSNYGAPGLTTLDNASVFLNATNSRTASSISSYFINASYAFGNKYYLNATGRRDGS
SRFGSDVRYANFWSVGGAWNIAAEDFMENAEVVKELKLRSSYGVNGNQEIGDFASRGLYS
TGADYNGQPGYVYSQQSNPGLTWEKNKPFNVGLDFNFNHLITGTIEYYNRTTTDLLFRVP
ISATNGITNFLANIGEMKNSGWEFALNTVNIDNPDGFSWTSNFNFTSNENEITKLQDDEA
IVDGYYKREVGEDFYTFFMPGFAGADPENGDALWYTDGSETNTTNQYSEAEPYKQGSALP
DFYSGLTNTLTYKNLSFSFMLYLNYGNKVYDYWGRYTNSDGSARLNDRGNMTQNIYENRW
QNPGDITDVPKVVWGNSQSGLSSQHSTRFLYDGTYLRLRDVTLSYNLPESLIERIRVNNL
RLYLKGNNLLTWVKDDKIEMDPEVGITGQSDLRIPISRQLLVGLDLSF
>IFAGANLK_01911 SusD-like protein
MKKSIKFILVSFWTFLSISCSEDFLEIDPEQNVAAENAVVDLSTLQTAVNGVYSNLQSNG
YYGRNVYVMPELMADNLYLSLRNTGRYLDFNNFVVSEEDSYVESTWNSIYEVAVNATRVI
EGGENLLEQFPGQEAQIKQLLGEAYALRSLAHFDLVRLFAQPYNFTAGASHPGIPLIIEI
NENEVSPSRNSVNEVYQHINSDLSTAVSFMTEANQDGRFSLNAAYALAARVALYEEENEK
AITYSTNVIESNVFSLIPNERYMELWSLDFNEETLMEVINTIADNAGTNGLGHFFDVTGY
ADALVTEDLVATYDENDVRLQAILEGSKPGAEEEAYFVNKFPNGTLHDDNIKILRLAEQY
LIRAEAYAKTGQNELAQQDLQVVMSRANPGAEEIAEVGNELIDRILLERRKELAFEGHRL
FDLNRNKKGVSIDQGEGNVIEASYPNEKFILPIPLSELNANPQIGPQNPGF
>IFAGANLK_01912 Penicillin-binding protein 4*
MTRNLLSLMLLLGLLGILSCGTKPRPVSQNSDEITTDKTLDRFFQELEEKEMFNGAVAVK
KNGEILLKKGYGKANFQFDKDFKANTPMEVASVSKQFTAAAIVLLEQQGKLNIEDKVQDY
LDDFPYSEITIKHLLTHTSGLVNYATHFRKNWDTTKVAYNKDIISYFKSEKPDLESAPGE
KYSYSNSGYVVLAEIVARLSGETLDEFLEKNIFRPTEMESSAFYERDTIWRMKNYAPAYM
LNPKTCEYTKPENLPGKNYYTFLSGRLGPGRLSSSINDLVKWDSILNTNAIFSEKSKDKI
FQVYKPEKDSSDYGFGWHIYNDNSLGKVVYHTGSWAGNLTSIKRYIDDKSLIVVLNNRYN
TAYLKEIRKQVEGYLKGQTLEVPKQKIEHLLQKEICNLNKENLYSWYESIADEAEISLEA
LADLEKEYREIDEPQKASLAKNLSFFITNSN
>IFAGANLK_01913 N-acyl-D-glutamate deacylase
MKFRLIIPLSFLLLLGQYTKAQDYDLIIRNATVYNGLGDEPRVQDIAIILDKIVTIGDLK
DKTAARSINANFKAVAPGFIDTHAHIENIRELPAAESAMRQGVSLLIGGADGGGPEDFPA
YLDQVRELKLGVNVGYQVGHNSVRERVLGTENRHPSEEELLEMQELVAQAMNHGAFGLST
GLTYVPGTYSETEEVIALAKVAAAHGGFYSSHIRDESLGLIEAVSETIEIAEKADITVVL
SHHKALGAGMWGASDRTLKMVDSANAAGLDVRLDQYPYTASSTGISALIPSWALAGGSDR
FKKRLEDKTLRDSIEKGILYNIIHVRVGDELERLQFRKFDWKPELQGKTMEDWLEMEGLE
STPVNAVNLIIEAQKNGGAQMIYHVMHGDDVNRIMKHAKTMIASDGKLSQPGKNHPHPRS
YGSFPRVLGVYARDKRVLSLSEAIKKMTSMPADLLGLNNRGRILEGCIADLVIFDSEKIK
DMATFEEPHQYPQGIETVIINGQISLEDNKLTEAASGKLLTSQTTKP
>IFAGANLK_01914 Glutamate racemase
MRLYKFILIVFLPSILWGQEAITNSILKDKDSFYYINTKDYPEGEKKLPIGVFDSGIGGL
TVLDAIVNFDGFNNESLDPGADGEIDFIMEEFIYLADQANMPYGNYSAENKDELLLEHIL
KDVQFILGNKYYPSSEAQTFKTDKLPIKALVIACNTATAYGKENIETFLKHAELDIKVIG
VIDAGVRGALEKLALDEDATIAVMATAGTVSSKGYVNTINEQKNKLEYTSNIEVFQQGGV
GIAEAVDEDSDYYDKDLTKPRENYKGPNLKGNLRIDKALMDIYNFDYEDFKMLCDSQGSD
DCSILQINDAENYVRYHLVSLLEKIRKANVQQPLKSIILGCTHYPYLTREIDLVLKELYN
YQEEDGSYRYRQFMAKDIDLIDPAVNTALELFQHLKGEKLFNENGNIHNSEFYISVPNQD
NPNIITNEKGNFPYEYKYGRSEGEIQEYVKVVPFSRRSISEDIFSRLEFQLPFTYNLIEK
FIGDSTKIDR
>IFAGANLK_01915 hypothetical protein
MQGNYAKFGLMMLVSFIVMYGIMFLNADKFEYVMLSTMRTYMTLLMITAMAVIMLLFMLG
MYKNKTLNAIILVVSLVGFGSVYYMMRTQTGISDVQYMKGMIPHHASAILTSQEADLKDP
ETKELAKEIIAAQKREIAQMKKIIYRLENEEK
>IFAGANLK_01916 hypothetical protein
MKYTRKYWLLPLLFFVFTSCIDKKQEQSVEVKTEEEVKEKKEVIPDIADSSFKDGMTGTV
YHYYLKVRTALFNDDLEASKDASQNIANSFDEDFAELKSLSEEMAKAEDIEKLRSTFSDF
SVEVESLFKQNLSEGTIYKQHCPMAFNNKGAFWFAEVEEIKNPYKGEEMPKCGSVKETIK
PKK
>IFAGANLK_01917 hypothetical protein
MSGILLFIGIVLLLIAIHDFFFTTLSGSGTGFVSRNISILSDKIIQFCVKIFGRKTYNYN
GLFVNLMILFFWLLLIWGGLFLVFSSNPEAITNSSGKAANFWERLYFTSYTLSTLGMGNF
EPTTAIFELLTGAFSFFGFIFFTSSMTYFLSVSSALVNKRTLSKSIYHLGKSPQEIANNI
LNFDSSFSYQQISELRTLIDKHSVNHYAYPVVHFYRQSKKRDSFSINIARLDEALSILLY
SEEENKYREELNILRSSLSDFLEDMENNFASNLLIGDNAGDSYNFPSLNSKEDEKELQKR
RNIVEGLFRSENYTWEDIFAKS
>IFAGANLK_01918 hypothetical protein
MEKNKPGKKFRKYIRTLHLYLGLATGLVVFIVSITGCLWVFQEEITALTSKVPEVVPQTN
PEIYPLEAKNIAQSVFPEKYIHGTLYGGGKKPIEVIFYEEEPEFYQSVFLHPWTGEILHT
EDHLTGFFHFVLDGHMHLWLPKELGSEIVAWSTFIFFLMLVSGIILWWPKNKKVRKQRTW
FKWKPSTKWKRKNYDLHQIIGFYASFIAVIFIFTGLVMTFETFAKVFYNGIGGEKEVVFA
VPENPSGSFKNSPKKNEPIRELMPFLKEKFPDAKDFEIHYPHDENHSIYVEVSNSDGIYY
DSDYRFYDQNDLSEVPSKTIYAVYEEAGVAEKILRMNYDIHVGAIAGLPGKTLAFLISLL
CSSLPVTGFLLWYGRKVKAKAPQRQEKQVLATSN
>IFAGANLK_01919 Inner membrane protein YedI
MASGFFALLDDIAALMDDVAVMGKVAGKKTAGLLGDDLAVNAEKASGFMSARELPVLWAI
TKGSFLNKLIILPAAFLLSGFLPSAITVILIIGGLYLAYEGAEKVHEYLFPHLHKKEKPK
LEELSEEEVLSREKEKIKSAILTDFILSVEIVIIALGTVGQEPLLTQILVVTLIAIIATV
GVYGIVALIVRMDEFGAKLINLNEEENSFSDKIGRFLVSALPKVIKSLSIIGTIALLLVS
GGIFVHNLDFFHGLFENIPGIIVEFLTGLVVGFVVFGLIKLGIIIWKKFKN
>IFAGANLK_01920 hypothetical protein
MSVTWFECKVKYKKTHETGEQKMTTDTYLLDAVSYTEAEARISEEMTAYTSEDFRIMNIK
VANFSEVHPFENSDRWFKSKVSLVALDEESGKEKKTNIYLLVQANDVKEAFENTTKAMEE
TMGDYSIPSITESPILDVFPYFTGEEKQLEKFNLLDADEPSEAETEEEAEEVV
>IFAGANLK_01921 Fused isobutyryl-CoA mutase
MEQQKPYTPKNKIRIVTAASLFDGHDAAINIMRRIIQSTGVEVIHLGHDRSVDEVVNCAI
QEDAQAIAMTSYQGGHTEYFKYMYDLLQEKNAGHIAIFGGGGGVILPEEIKELMDYGITR
IYAPDDGREMGLQGMINDMVKRVDTETRDLVQEKSVADDLKDKNVNTISRLISLAENKHD
SFLKHFEPIRRETENSKIPVLGITGTGGSGKSSLVDELVRRFLTDFSEKNIGIISVDPSK
RKTGGALLGDRIRMNAINNEHVYMRSLATRQSNLALSKHVAEAVEILKAAEFDLIILETS
GIGQSDTEIMDHSDVALYVMTPEFGAATQLEKIDMLDFADLVAINKFDKRGAQDALRDVK
KQYQRNHQLWHEDPDKLPVFGTIASQFNDPGMNTLYRQIMDTIADKTKADLNSTFEISAE
MSEKIFVIPPKRTRYLSEIAENNRSYDEKAATQAEVAQKLYGVFKTIESVSGLDMTNNQS
QYLEKHGVNQDEINDFTEDSRKDFLKLLFAEFDRVKMDLDPYNWEVIQSWQEKVTRYVEP
VYSFKVRDKEIKIDTYTESLSHSQIPKVSLPKYKAWGDILKWCLQENVPGEFPYTAGLYP
FKRQGEDPTRMFAGEGGPERTNRRFHYVSMGLPAKRLSTAFDSVTLYGNDPDERPDIYGK
IGNSGVSICCLDDAKKLYSGFDLADAMTSVSMTINGPAPMLLGFFMNAAIDQQCEKYIKK
NGLENKVEAKYKELYDDNGLDRPVYRGDQPEGNNGLGLMLLGLTGDQVLPAEVYKEIKDQ
TISVVRGTVQADILKEDQAQNTCIFSTEFALRLMGDVQEYFIKEKVRNFYSVSISGYHIA
EAGANAITQLAFTLANGFTYVEYYLSRGMDINKFGPNLSFFFSNGIDPEYAVIGRVARKI
WSKALKYKYGANPRAQMLKYHIQTSGRSLHAQEIDFNDIRTTLQALYAIYDNCNSLHTNA
YDEAITTPTEASVRRAMAIQLIINKELGLAKNENPIQGSFIIEELTDLVEEAVLTEFDRI
TERGGVLGAMETMYQRGKIQEESLHYETLKHNGDYPIIGVNTFLSSTGSPTVTPGEVIRA
TEEEKQHQLKTLNTLHKAKEDSAEEALEKIREASIKNENIFKELMEATKVCSLGQITKAM
FEVGGQYRRNM
>IFAGANLK_01922 hypothetical protein
MGKNFDKWNYIIDRWGLFNPPGIDYDDKDTDDDIPFDNPLGEDELNNLGKVGFAFYILLI
NKNPDETSSSGVREPVNISLLKKTCISRRSQYRCAHRDKRFAHFPKQKALKSGSLLTYSS
YTAHLPQTSLWLFGQENKLW
>IFAGANLK_01923 hypothetical protein
MELDKYRELPLYQKAEEILNMVHRIIELIPKENEMLKSTGDFMMADALKLPSKIAGAEGA
DLYDIRMENATIIRKSERDIFVSCNHFFAEDFKETEYLDLLRDTIEEFRVLFAEWVKTLT
SGITS
>IFAGANLK_01924 hypothetical protein
MENIWLYAIGAFTAFFAINNPVGNIPIFLSLTKQADGKRKRFISKKATFTAFVIVTGFIL
LGKYIFQLFGLTIPAFKITGGILVFFVGFEMIRAQQSSIDNQTEIDFNEGISISPLAIPI
LAGPGTIVTAMNYTTTASYIDMAIIVAMFGLIMVLNHLAFISSDYLVRFIGQNKIIVIEK
IMGLIIAIIGTNMLIEGIKIAFF
>IFAGANLK_01925 hypothetical protein
MSQAFPNNTYQMPIYRKALEIFKLSRAMAVHFTQDKHVVEMGFSACPKDRYAGDLVSESL
QLAPGIASVATAKSSGSRLERIRNIKKASKSLKLLCKNLEFSGAKEHEFLNLLKKEIHIF
DKMITDWIQQIRKV
>IFAGANLK_01926 HTH-type transcriptional regulator LrpC
MQVDELNWAILLRLQENARYSFAEIGREVGLSSPAVAERVKKMEDAGIIKGYKTQISYHK
AGYQLKAIITLRAFMGRLKPFLEKVKEFKEVNNCYRITGNENIIMEVVLRDQVHLEEFID
KLITYGETKTHIVLSQVVDFAAINKSRVK
>IFAGANLK_01927 hypothetical protein
MRKYSTLYLIVAALTGAIGFSGLNFAGIEVVRVLFLIFADLLVVSLVARLLFRNDNLRLQ
RIKK
>IFAGANLK_01928 hypothetical protein
MMKRIPFLILLFTFIFQFSNAQEIELPLGKIVDSIPTADTTASSFALYLPKNFNEKEKWP
VIFVFDHEGRGRATTQLFRTVAEEQSYIIASSNLNLKDDSLKNNLNKIGPFINQVDGMLP
IDREQVYVAGLSAGGQLATALPFLYNNISGVLAVENAWINTEYLNTNNKFIFSAVACDSN
NSMFVLEEIENYLDSKKFPTELNFYTCEEVVEWPDADIVRNAVAGFTLNAMNEGKRTKDI
ELVKELFDAEVEYAEVLRRTRNYYQAFEKLKQIEDKYDDFEIDVDLRYQIRNIRRNKAFK
QQRRDYRNVAASEEAKQEEYLYYMETDVVTSNFENVGWWASQVEELKENEEKFSGPKQKM
ASRLQGFLDNLSKNYYDSYVDSQATPRSKVFVSVLRTIFDREDPAAYLNIIKIAGHDGDH
ETALLYLEDLLKTGFDDMEALYDIEGILDLKVSEAYNEKIREYLGEAKYYKAEG
>IFAGANLK_01929 hypothetical protein
MKKFTIANIQKLFLIGICFGLSSSLKAQEAETTEVESFMSNFSISGSVDTYFRTNFNGLN
KYEYNDAGEIIAAPQAPASSFANDPGFAIGMANVILGYEGEKVGFVADLVFGPRGEDAVF
ASAAPSNIVNQLYVYWNVSDAVTLTMGNFNTFLGYEVISPAANFNYSTSYMFSYGPFSHT
GIRADFTIDDNWSAMLAVMNPTDWTEFNPYGKYSFGGQLGYSTGEGSAFLNLIYGEQMPL
SDEATFQIDLTTGWDFSDAFYLGFNTTYNTTDGEGFYGAALYPQIQTSDSFAIGLRAEYF
KELEDGGPVYGADAEAIDFTLTGSYNVGSLTIKPELRLDKVSNTASPVFVNSDLEGTDNL
SSFVLAAIYAF
>IFAGANLK_01930 Ammonia channel
MELLTTNNVWMMVCTALVFFMHLGFSLLEVGLTRQKNAINILFKNVFIICAGLLTYAIIG
FNLMYPGSFIAGIIPDYFFDLFGLSAPVADGSLDLAYNEGYTYWTDFLFQGMFAATAATI
VSGAVAERIKLGSFMLFSVIYITIVYPIVGSWKWGGGFLDGLGFYDFAGSTLVHSVGGWA
ALIAIYLLGARLGKFGKDGQSHAIPGHNIPLATAGVFILWLGWFGFNGGSVLSADPSLTS
ITLVTTCLAAAAGGISAFVVSTIAYKNYDLTMFLNGILGGLVGITAGADLMSPLDAVLIG
LVAGGVIVLGVALVEKLKLDDPVGAVAVHLACGIWGTLAVGIFGSLAGFNQLLIQLAGVG
IIGAFCCITAFGILSIIKATMGLRMEEKEETEGLDAHEHGMDAYAEFGTVQER
>IFAGANLK_01931 Nitrogen regulatory protein P-II
MKKIEAIIRKSTFDEVKKALHETEVNFFSYWDVTGVGNEKQGHVYRGVSYSTSDIQRRKI
SLVVSDENVDSTVATILKAAHTGSVGDGKIFVSPVEEAYRIRTKEKGTDSLS
>IFAGANLK_01932 Putative fluoride ion transporter CrcB
MLKQLLLIFLGGGLGSVLRYLISKSLNLETAFIPFGTFTVNILGSLLLGIILGIAAKSDF
FSSNIVLFLAVGFCGGFTTFSSFAFENQALLRSGDYLNFFFYTFGSIILGILAVFLGLFL
SKFT
>IFAGANLK_01933 hypothetical protein
MKILKYLFFLLLIVIIAGSIYIATKDGDYQVEENQVITAPVEMVFQEVNEFQNWENWEPW
SAEADDMIIEYGEKTSGDNASYSWKSEGAGDGEIRTISAKPYSEIEQEISFKTPFGTTTS
DVYWEFKEIENGTEVTWGIKGNQSFMEKLAFTFQDESITEMMRPKFQTGLNNMESVVLNK
MDKYAINVDGVIQHGGGYYMYTTTASKISQVDEKMSSMFSEVSTYMDENGIEKSGNPFVL
YNEWNENSGNVIFSAGIFTPSEVITPAESEILTGFLPNQKVLKTTLKGDYKNLKEAWDTA
YNYIEEYDLEIAEEAKNFEVHLTSPEKVANPAKWITHLYIPVK
>IFAGANLK_01934 hypothetical protein
MFSTGQLIFAGLFVVVFIIIIAFSYKKDTVLHRKQYKGSFWVLVAFLAFIGLLFILKGFL
NP
>IFAGANLK_01935 hypothetical protein
MKISLLSILLLLGTFGCKNNPETAETSRDPKQLDTTKTTNEVQKYVDSTWNFALEYPSNF
KVSEGELPGNSSVINVYPKNTEITEPLSIHEEPDIAYIAFLPKGFGVDGPSGRQKSINEW
ESNLDLSFNINKNDSRVYLLENGKAWAYFLKFYQPPEKWDKYGGIYLHYQIENFKATCIS
SEGESKPMQECDPLAEDEVRLSGEINEETKMQLDKIMSSLYFFRENAEERTELSDLINVE
KPSAHELINSPLKISGKARGNWFFEAEAPVKLVDGNYKILTKTSIKANGEWMTSDFVPFS
TELSFEKIPEDEKGYLIFEKSNASGKPELDRKLTLPVRFREE
>IFAGANLK_01936 Branched-chain-amino-acid aminotransferase 2
MKYDTDQLEINKVQKSKIEEVNFDKLVFGEIFTDHMFVCDYVNGQWQNPKITPYGPIQLD
PSAKVFHYGQAVFEGMKAYKDENDQIWLFRPEENHKRINKSSARLAIPEFPKEFFFNGLE
ELLKLEKDWIKKGYGNSLYIRPFVIATEECVSANPSTKYKFMIICSPAQAYYSGEVRVQF
SEKYSRAADGGVGAAKAAGNYAAQFYPTNLAKEAGFQQIIWTDANTHDYLEEAGTMNIFF
RIGDKLITAPTSDRILDGVTRKSVIDLAKDMNIEVEIRRVPVSEIVEAAREGELKEIFGS
GTATVINPIAGFGYKNEKFELPKMENSYGKSFKDRLMKIQYNQAEDKHGWRYQVK
>IFAGANLK_01937 hypothetical protein
MRKITAILVLSLIFIACKNEKSNEEAEVFAEVKTDSYNSFGTEIDSENAISSAQALEKFN
SLKLGDTLDLKFTSNINSVCKKKGCWMILELPEEEDVRVTFKDYGFFVPKDSENTEVIVQ
GKAFINEMSVEDQKHYAEDEGKSETEIAAITSLEISRAFIANGVLLKE
>IFAGANLK_01938 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MERKIIKTGDGSVTIHLSEWDEQYHSKHGAIQEAQHVFIKMGLEYWVGLNKEKNPAILEI
GFGTGLNAFITFLEAKKLQLKINYTGVEAYPVSAAEIKELNYAEMLSAENQLDSFQKMHE
IPWNEKVAISENFQLEKQQKRFEEIEDANQYDLVFFDAFGARVQPELWTEDIFAKMFAAM
KSNSVLVTYSAKGSVRRAMQTAGFIVERLPGPPGKREMLRALKK
>IFAGANLK_01939 Epimerase family protein
MRVLITGATGLIGSKISRLCREKGIQVHYLSTSKEKLENKPDYKGFYWNPDENEIDSKAI
EGVDAIINLVGASVAERWTPEQKEKILKSRTETANLLYTCLQENEHQVKNLVSASAIGIY
PSSLEKLYTEEAQGVDDSFIGEVVVKWEEAVDNFTDLGIEVAKIRIGLVLAENGGMLQKL
KEPVNFNVGSPLGNGKQWQSWIHIDDISGIFMFAVENKLTGVYNAVAPNPVTNKELVNEV
ASQLGKPVWLPNVPKVALKLVLGEMSHLVLSSQLVSSDKIEQEGYSFKYVNLSKALEDLI
>IFAGANLK_01940 Protein YceI
MRKSILSTFVIAAFLTAVVGCKNDKNKAETSEAKDAATAQAEAMEFTVDTSASTIEWRGS
KPTGEHTGTIKLTEGTFSANDSIIESGNFVINMQSITVTDLEGDDKKDLEAHLMGTVEGK
EGDFFNATKYPEATFEVTEITEENGQKMLSGNLTIKEETKNVSFPVNINQSDDSIEITSE
EFTIDRTNWNVNFGSKSVFDGLGDNFVSDDITLKVNLKATKA
>IFAGANLK_01941 Protein GrpE
MSNKKKDIREEQQDQPVKDQIEDAIDEAIDEVEGERENEDSNEDSPEFTEEEKLKEDLQK
EKDKFLRLFAEFENYKRRTSKERLELFKTANQEVMAAMLPVLDDFDRALKEIRKSGDKNL
VHGVELIHNKFKETLTSKGLEPMDVKEGDDFDSEIHEAITQIPAPKDKLKGKIVDVVERG
YKLGERIIRFPKVVTGK
>IFAGANLK_01942 Chaperone protein DnaJ
MKEDYYDILGISKGASTAEIKKAYRKMAIKYHPDKNPGDAEAEEKFKKSAEAYEVLSNED
KRARYDRFGHQAFEGGGGGGGFGGMDMDDIFSQFGDIFGGGFSGGGGFSGFGGGFGGGQR
RAKGSNLRIRVSLTLEEIANGAEKKIKVKRKVQAPGTTYKTCTTCKGTGQVTRVTNTILG
RMQTASPCTACSGSGQIIDQKPPEADAHGLVQKEETVSIKIPSGVEDGMQLKVAGKGNDA
PGNGVPGDLLVAIEEKEHHSLQREGDNLHYDLYISLSEAVLGSSREIDTVTGKVRIKVEE
GVQSGKILRLRGKGIGNLNGYGKGDLLVHVNVWTPKNLNNEQRDFFERMAEDENFQPNPE
KSDKSFFEKVKDMFS
>IFAGANLK_01943 ABC transporter ATP-binding protein NatA
MENLLVAENIYKQFGNFTALNNVSIAIPRGSIFGLLGPNGAGKTTLLRIINQITMPDKGR
VYLDGKPLHPNDIAHIGYLPEERGLYKSMKVGEQALYLARLKGLSKAEAKERLEYWFKKL
QIEGWWDKKIQELSKGMAQKVQFIITVLHRPKLLIFDEPFSGFDPVNAGLIKNEILQLKE
EGATILFSTHRMESVEELCDYMALIHLSNKLLDGKVSEIKREYKSNTYEVGLESENDTAL
LAELKEKFVIGNTNFKSINDDLKLTIQLKEGETPNQLLDYLLGKARINHFVEVIPSVNDI
FIKTVTQHA
>IFAGANLK_01944 hypothetical protein
MRNLKLIIQREYLARVRNKTFIIMTFLSPLILVGMFALIAYLSMLNSSEQRIIGLFDETE
MFASEFKDQEQVQYLDLSGKTFEEAKQMVNEQDYYGLIYIPENINNDLEGVQFFGKESPG
LGTIQAIEKTIADRLTREELIERGIDVNQLNEAKTEVRIEIQNFSGERTSKMSNYIKMFF
GGAAGYLLMMFIIIYGNMVMRSVIEEKTNRIIEIIVSSVKPIQLMMGKVLGTSLAGITQF
TIWVVLAGVLAMTSFYVLGIDIFTVQKSQLETVEQIAQPEIAQLVMDVLNLPILKLIIFF
LIYFIGGYFLYSSIYAAIGAAVDSETDTQQFMFPVILPLMLGIYVGFFSVIENPHGTVST
IFSMVPLTSPIVMLMRIPFGVPWWELAISVALLIITNFIVIWIAAKIYRVGILMYGKKAS
YKELFKWLKY
>IFAGANLK_01945 Mechanosensitive channel MscK
MQEQENSETTEAIKDVVQQDIWGAIVDIWNFVLIPIETGENTVKITVGLILLVISAFVVT
SIVLRLIRSFITSKLAQGDKHKFISVFKFIKYFVYLVVILITLSSAGINITILLTASAAL
FVGIGLALQELFQDIIGGVFIILDKSLLVGDVIEMEGRVGRVFEIKLRTTRALTRDDKVM
IIPNHKFISDVIYNYTQNHATTREGVQVGVAYGSDTQKVKETLLKCALENDSIVKSPEPF
VLFDDFGESSLVFSLHFYVTDSFVDPKIKSALRFKIDEEFRKNNITIPFPQRDVHFYPTQ
NLTQNLSKNE
>IFAGANLK_01946 hypothetical protein
MNKTFKIIVFLLLGAVTFPATAQSTDLARIEYTYFPQSDSDNSFRRFRTFVNLPIKLNGK
GAYLIPGVEYRNVNFKYKNSEAFTTNNLDRFQSFTGKIGYTFKMNELWRFGAETGVKIAS
NFATSELVKDDFIYTGSVYFIKIKEDERYIEPWRLILGLSYSTTTGFPFPLPVINYYKRF
DENWSYGLGIPKTNLKYYFNDKHEVQGFVTLDGFFANIQQNFNPYPQTNPGANRLAESMS
MTIVLSGLGYQYNISDHIAFYAYAGYTVMNDIRLRDNERENLYTIDDKNTFYARSGLKFS
IL
>IFAGANLK_01947 Transcriptional regulatory protein ZraR
MARILLIEDEAAIRRVLVKILTEENDNYEVEEAVDGLEGIEKIKDEDFDLVLCDIKMPKM
DGVEVLEAIMKIKPEIPVVMISGHGDLETAVNTMKVGAFDYIAKPPDLNRLLNTVRNALD
RKELVVENTRLKKKVSKNFEMVGESEGIQRIKELIEKVAPTDARVLITGQNGTGKELVAH
WIHQKSDRSKGPMVEVNCAAIPSELIESELFGHVKGAFTSANKDRAGKFEVANGGTIFLD
EIGDMSLSAQAKVLRALQENKISRVGSGKDIKVDVRVVAATNKDLKKEIEDKKFREDLYH
RLAVILIEVPSLNERREDVPLLIDYFSEKISAEHGSGKKEFTEDALNTLKDYDWRGNIRE
LRNVVERLIILGGDKITEEDVKLFGSKF
>IFAGANLK_01948 hypothetical protein
MNKAEKEEIITKVTSLLKEIPSSMDIVKKGGNRHKRFEYLATHMVEKAIEKDALIISENR
MGIAILFKTSKKDDNFLKDISSQIGLVLNVTGIKNAYRIVKNQNYIKKQRPQTGEYLYCW
FWGILAESRGADTQVGKEMKDEFYRQATEYQIPLYAETRMRKNALVYQRFGFELFHEWQH
PSGDTMYFLRYNPPPKKID
>IFAGANLK_01949 Bacterial leucyl aminopeptidase
MKKYIFAIFGLFLTINLNAQAPEAKEDSLKIREIYSAALVHGQAYDWLDHLSNKIGGRLS
GSLNAQKAVEYTKAQLEELGLNKVWLQPVMVPKWTRGGREHAYIQTGPGMTTEVNITALG
GSVATTTGGLKANVIEVQGIEDLENYKDEIKGKIVFYNRPMNPELIQTFSAYGGCVDQRY
SGAEAAAKYGAAGVIVRSLSHKIDENPHTGSMSYGDLPDSKRIPAAAISTKDAEYLSGML
KLKKDLEFYYKLSSENHGEVQSYNVIGEITGSEFPEEIMVVGGHLDSWDLGDGSHDDGAG
VVQSMEVLRLFKETGYKPKRTIRVVLFMNEENGLRGGNKYAEVAENKNEHHIFALESDAG
GFTPRGFSFEADDAQFAQIESWKPLFEPYLIHYFGRGGSGADIGPLKKGDIVLAGLRPDS
QRYFDHHHAATDTFEHVNKRELELGAATMTSLIYLVDKYGMKRINLEKDQKL
>IFAGANLK_01950 Multidrug resistance protein NorM
MQLSAYTQEFSKNLNIAFPVMLGQLGHVLVGLVDNLMIGQLGPAPLAAVSLGNSLVFIAL
SLGIGFSFAITPLIAEADGVQDINKGRSYFHHGVILCTINGVFLFLILLIAKPVLYYLDQ
PPEVVELAIPYLNIVAFSMIPLMIFQAFKQFADGLSQTKYAMYATILANVVNVIFNYLLI
YGIWIFPRLELEGAAVGTLISRFFMLWFVWEILRRKKKFAEYFKWGKKESLNSDVFKRLL
NLGFPTALQMLFEVGIFTATVFLAGLLGTNPQAANQIALNLASMTFMIAVGLGVTATIRV
GNQKGLANFKDLRRIAFSTFLLVFLIEAVFALGFILLKDWLPTFYIDNAEVILLAAQLLV
VAALFQLSDGLQVVILGALRGLQDVKIPTVICFISYWIIGFPVSWYFGKAENLGSMGIWL
GLLAGLSVSALMLYIRFNYLTKKLILQESSLVQSKI
>IFAGANLK_01951 hypothetical protein
MDFPKFLLGDNTDYPTAIFVVHTEFPRFIINLENDEVEWLEEFDQHDEEELENETEGLIK
EASEFYDREIERYEDD
>IFAGANLK_01952 hypothetical protein
MDKLIELDHKLFIWLNNLGNESWDWLWLLITDKWTAIPLYALLLFLIFKKFGWKSSLVTV
VFITLLITATDQLGNVFKDAFERLRPCRQEGIMEYARFVAVRCGSYGFFSAHASNSMGVA
IFLGLLFRKVFPKMIFWLIAWALLVAYSRVYLGVHYPGDILVGMLIGGLIGFIFYKLHEW
AQQKIFKKD
>IFAGANLK_01953 GTPase ArgK
MSKKNQASALSESGSKPTSANVNPNSAQRIRASRKNKFEERDLLQQLLDGNKTALGRAIT
LVESNQFSHRKKAQQLLEGALPYSQKSIRIGITGVPGVGKSTFIESFGSYLIQQGKKVAV
LAVDPSSSVSHGSILGDKTRMENLVKEESAFIRPSASGSSLGGVAKKTRESIILCEAAGF
DVVLIETVGVGQSETTVHSMTDFFLLLKLAGAGDELQGIKRGIIEMADAIVINKADGDNI
KAAREAKLEFNRALQLYPTKESGWKPKVALSSALKQTGIDNVWDFISEFEKMVEANGHFQ
KNRKEQDKFWLLQTINEHLKNRFYQNVMMKKELEVQLKAIEDNKITAFAAADLLIEKFEK
LN
>IFAGANLK_01954 Organic hydroperoxide resistance protein OhrB
MKNLYKTTVTTKGARKGHAKSDDGILDVQLSMPKSMGGEGGDYTNPEQLFAAGYSACFGG
ALQLAAKNHGIELDENVSVSAVVKLGLTDDEELQLSVVLDCFLPGVEVEAGEKIVNEAHE
ICPYSRATRDNIDVTLNLLVDED
>IFAGANLK_01955 hypothetical protein
MKKPVKTFLKIGGVIILLAAVLVFIMRYSTKAHSPEDTVSYTQVDLKLEVFYNRPYKKDR
VIFGKLVPYNEVWRTGANEATTFETNKDIMVDGSLLEAGKYTLWTIPMENSWKVIFNKNM
YPWGIDMEEKAYRDPEFDALVLEVPTKDLKRTMEQFTIAFNEKNEFVFLNLAWDETLVSL
PIKPEKV
>IFAGANLK_01956 ECF RNA polymerase sigma factor SigR
MIQHQLIEACKNNDRRAQLKLYNQYCQGMHYVALRFLKDPFEAEDAMQEAFIKAFAKLQQ
FTGEVTFGAWLKRIVINKCIDKLKAKKLELVAINEQVLSTAEENDNWQVDDGIGMEEIKQ
SMEKLPEKYKYPLMLFLMEGYDHEEISEILKISPVASRTLVHRGKKKLQEELKTKKNGTG
Y
>IFAGANLK_01957 hypothetical protein
MAQDIREMFRNDKEPKPNTLPKGHQKRFEDRLEKEIPSEKKNNTFFFLKIAAVLVVALGV
GFFFLNSGGDNFNDGPSVADTPRETSEEKEDKLPTENNFQLSEVSPEFKKIEDYYMANLN
IELSKINITPENKALIDSFMNQMAELDKEYQRLNTEIKEAGPNEQTLEAMIANLQLRLDL
LYKLKNKLKEIKQSKDNEYENYEV
>IFAGANLK_01958 hypothetical protein
MKTMRYNLIVALLLCLPVTLGAQTKKLDKTYKTSGDVEVKIDASHTNIIVDYWDRNEVKI
EATLETDELEKSEVKDVLAAWKLSTSGNASEVTISSGGGMQWSGDIDLSGLEKPLASLPQ
MLEPLMNNLVTPLMQSMGESMGAPLPPEFSEKMGNIKFDYEAYKKDGDKYIAKFEKEIEA
NFGEDFEKDMEKWASQFEKNAEKWEKNFEMKMEINSEELEKSMEKWAESFGKDMEAWGES
FGAQMEARFGDVEGEETKVIGLNNSKAKKTIKLKIPRNGILNLDVRHGDVNLSGTTHNLR
ADLSHSKLTADRINGKSTNVEAAYTPVNINYWSYGIMDAKYVKNFKIKKVKSIKLSSNSS
NVNIDELEDTGILSGNFGELNIASVGANFKNLDINLENSDLELGLPSSAFNFIYSGTQSD
IKHPNALKLTSSESYDNKKLTGFHKTKDSGGNISIKANFSDILLN
>IFAGANLK_01959 hypothetical protein
MGTTNFSEFLSQLTPGFTQVLDVNLKAEDYIVIDLSENNVELGKVDISSSRAFSDYIAEY
LNAFGKKVAFGGYSEVRKLYNRSELFTALEDEDSNRNIHLGLDFWADAHTDVLAVLDGRI
HSFNDNSSFGDYGPTIILEHDFEEKKFYSLYGHLSKASLEGLAPGRPVKKGEKIAELGTP
EENGDYAPHLHFQIIEDLSEKIGDFPGVTSRRELDFYLQNCPDPNYLLKLRNS
>IFAGANLK_01960 hypothetical protein
MRNYQIEIKWGVIFFAASLLWMYFEKLMGWHDVLIDKHPIYSNLFGIVAIAIYLFAIHDK
RKNFFRGKMSWKQGFVSGVILSIVIALLSPIGQVITHYLISPGFFENAIESSVERNAMKR
EDAEAYFNLSSYIVQSIAGALMMGVVTSAIVALILRKK
>IFAGANLK_01961 Protein translocase subunit SecA
MSFLNSVLKVFVGDKSKKDVKEIQPIVEKIKALEGEFEALSIDELRAKTASFKAKIAEAL
KDINKQIEELEAEADASDDITRKEDIYAEIDALKAKSYEISEGVLNDILPEAFATVKETA
KRFFHNEQIKVTASEFDREISAEKDYVNLEGDHAIWNNSWDAAGKPVTWDMIHYDVQLIG
GVAMHQGKIAEMQTGEGKTLVATLPMYLNALTGNGVHLVTVNDYLAKRDSAWMAPIFEFH
GLSVDCIDYHRPNSASRRKAYNADITYGTNNEFGFDYLRDNMSHAPNDLVQRPHNFAIVD
EVDSVLIDDARTPLIISGPIPKGDVHEFNELKPAISNIVELQRKHLTKVLAEAKKLIKEG
NTKDGAFLLLRVYRGLPKNKALIKFLSEEGIKQLLQKTENHYMQDNNREMPKVDADLYFT
IEEKSNQIDLTDKGIEFLSADGDTDFFVMPEMGMEIAKIEKEGLPKEEEAEKKEELFRDY
SVKSERIHTLRQLLKAYTLFEKDDEYVVIDNKVKIVDEQTGRIMDGRRYSDGLHQAIEAK
ENVKIEDATQTFATVTLQNYFRMYGKLSGMTGTAVTEAGEFWEIYKLDVVEIPTNRPIAR
NDKDDLVYKTKREKYNAVIDHVTDLSNAGRPVLIGTTSVEISELLSRMLKLRNVPHNVLN
AKLHKREADIVAEAGKSGIVTIATNMAGRGTDIKLSKEVKEAGGLAIVGTERHDSRRVDR
QLRGRAGRQGDPGSSQFYVSLEDNLMRLFGSERIAKLMDKMGLEEGEVIQHSMISKSIER
AQKKVEENNFGIRKRLLEYDDVMNAQREVIYKRRYHALFGDRLKVDIANMIFDTSEAITE
NNKIAQDYKNFEFELIRYFSMSAPVSEEDFEKMGVQKISGIVYKEAYQHYQEKMKHSASR
AFPVIKQVYEDESNNFERISVPFSDGQKTLQVVTNLEKAYETEGVQLVKDFEKNISLAII
DDAWKTHLRKMDELKQSVQLAVHEQKDPLLIYKFEAFELFKSMLDQVNRDVISFLFKGEI
PEGNVSNIQEARQRRKEKVETQKEEIPNIDERAAQSRAAGNTQQQRRPQVTETITRDQPK
IGRNDKVTIKNVMSGENKTLKYKQAIPLIEKGDWVVVNQ
>IFAGANLK_01962 hypothetical protein
MYWTLELASYLSDAPWPATKDELIDYAIRTGAPLEVVENLQAIEDEGDSYDSIEEIWPDY
PTDEDYLWNEDEY
>IFAGANLK_01963 Cob(I)yrinic acid a,c-diamide adenosyltransferase
MKIYTKTGDKGTTALFGGTRVPKHHIRIESYGTVDELNSHIGLVRDQDTGEHSRKVLSRI
QDRLFTIGSTLATDPEKQKLKNGKERLNIPKISAEDIEMLEKEIDKMNEDLPPMTHFVLP
GGHQSVSFCHIARCVCRRAERLATALHEIEAFDDKVLQYLNRLSDYLFVLARMLSKKLEA
EEVKWIPEKS
>IFAGANLK_01964 hypothetical protein
MKKIFIIMSVLFIAGGAQAQNITDAYRYSSEELNGTARFQALSGAFGALGGDLSAITVNP
ASSAVFLNSFGTMTFSHRSTNKNVDYFGTGTTNENSDFNFNQAGGVLVFDTRSESPWRKF
SLGLNYSQTNNFDDTFLATGTSQTSIDQYFLNYANGIPLDLLQTREDESISDLYSYLGEN
EGFRAQQAFLGYQGYVIDQAEDSPDNTEYNSFISPGNFNQEYRSVATGLNGKFSFNFGTQ
FKDFLYLGANLNTHFLNYDRTTRFRENNSNSGSGTNQVIFNNNLSTTGDGFSFQLGAIAK
VSNRFRVGASYHSPTWFNIVEEATQYLETNNDANERVIVDPNVLNLYPDYNLKTPSKLTG
SLAVLFGTKGLISFDYSYKDYSATEFRPTDDPEFDFQNSLISEELQAASTFRLGGEYRIN
NWSLRGGYRFEQSPYADESTVGDLTGYSGGIGYDFGSMKLDLAYTNANYEENARLYETGL
TNTANIDRDLSKVILSVSFGL
>IFAGANLK_01965 hypothetical protein
MIRNYDLHKKAILFVAPMFLLLLASCGSYQYSGYEDGIYGDSNQQQSTAEEPSQYANNNQ
DQGNSYYKNLFSEKSEFYGQMADNIIFTDVESYSSAEGGEDEIYYEDQQAYVGGRAPWGE
DPDQYTINIYNTGFHGGFYNPWRWNRFGYGYGFGGYYDPFMWDPFYGPGYWGAGFGPWGG
GFAYGPGWGWGNRFGYGFGYGGFGGFYNGHWGRGFVNNPYYGHRNNYRDVAYNSGRRASY
SDYGTNSRDNVSRLRSNESSYSRSIRNIRSNENASRTRSYTRSNSDNSNIYSRSNRRSEP
ARVNTSSTRRNSAINRSNRSSRSNSTYNRSSNSSSRSSGTVRSSSSSSRSSGTRSSGGGR
SSSSRGGGRG
>IFAGANLK_01966 Proline--tRNA ligase
MSKKLTKRSEDYSKWYNELVVKADLAENSAVRGCMVIKPYGFAIWEKMQAQLDKMFKETG
HQNAYFPLFVPKHLFEAEEKNAEGFAKECAVVTHYRLKTDPNDKSKLIVDPDAKLEEELV
VRPTSEAIIWNTYKNWIQSYRDLPIKINQWANVVRWEMRTRLFLRTSEFLWQEGHTAHAT
KQEALEETELMNNIYAEFAEKFMAMPVIKGSKTESERFAGAVETYCIEAMMQDGKALQAG
TSHFLGQNFAKAFDVKFTSKEGKLENVWATSWGVSTRLMGALIMTHSDDNGLVLPPNLAP
TQVVIVPIYKGEEQLEEISKVANKLADDLKEAGISVKYDDRDTQKPGWKFAQYELQGVPV
RLAIGPKDIEKGSVELARRDTLTKEFISQAEVVEKVKHLMVEMQETLYEIAFNFRNDHIT
EVDSFDEFKKVLKEKGGFISAHWDGTPETENKIKGLTKATIRCIPFNSEKESGSCVLTGK
PSEQRVLFAKAY
>IFAGANLK_01969 30S ribosomal protein S20
MANHKSALKRIRSNETKRLRNRYQHKTTRNAIKKLKESEKKEAEALLPSVISMVDKLAKK
NIIHDNKAANLKSQLAKHVAAL
>IFAGANLK_01970 Thermolabile glutaminase
MDYQSILNTINDELSYRDVTGKVASYIPELAKIDPRKFGMHVYCGDRQHFSFGDSEELFS
IQSISKVFSLSMAMRIMGEDLWDRVDVEPSGDPFNSLSQLEYESGVPRNPFINAGALVIS
DILVDQLEDPKQELLDFVRKITEDNSINFDPKIAASERSTGYRNVALVNYMKALGNIKCE
VEPIVDFYFHLCSLAMSCKQLAQAFMIFANKGKILSTDEEILTPTSVKRINSLMQTCGFY
DEAGEFSFEVGLPGKSGVGGGIVAIHPDQYSVAVWSPILNEKGNSELGMKALERLTSLTG
LSVF
>IFAGANLK_01971 Peptidase E
MSKALLASTSTLHGQEYLEYLIPELKTFFSNTEEVIFIPFARPGGISHDKYTKKASEAFN
KAGITLRGIHEFDNMREAITSAKGIFTGGGNTFLLVSELYRNKLIQPLKESIQNGAAYMG
TSAGTNIAGLTMQTTNDMPIVYPPSFKTLGVVPFNINPHYLDPDTNSTHKGETRETRIKE
FHTINTQPVIGLREGSWILVSDNKIELKGSLSARIFKSEKLPFEIETNSDLSELN
>IFAGANLK_01972 hypothetical protein
MLKNTFFIIFILFSSILIAQEKERTLVNGKIIVPEEDTPEGMTIFNQNTSRGTIANPDGE
FKLSVGLNDTVVFSSIQFEEFRVVVEEGVVNSGEMNVFLTESVTELPEVLLSDNQLSGDI
RVDVARIEVSDPDVPRYSAADLEAMNVRRQPDSLMGPGRNAALAAGNTRLVNGLNFVNIF
KFLVGAELENNPFTKQELDEKLRDLYDDEFFRTNLDIEKDKINDFIYYVTDHGLDNDLLE
DGNELSLIEFLIEKSEEYKAFHERE
>IFAGANLK_01973 hypothetical protein
MKYFLSVLSFCCVLAVNAQEKKQLSGKIKADSIEAPIHIINLTKEKGSVTDKKGNFEIEV
SENDLLLISSVQFQRKEIKITSKILKEEALIIELLPAITELEQVRIHNLSGNLGEDIANI
KVIAMPVISVPPSPSNVLPRGTPNAAFNASQTQAPAGMNILGLVGLISGKPNFGSLGGKS
VPPVKREREVVNSLRNKFDDYFFTNHLKIDSTHIMNFLTYIFENGFQEKLLKEERALELV
VFLEKKSEAYRKFINE
>IFAGANLK_01974 hypothetical protein
MKSSFFLICTLIFSSHLFSQQRILLKGEILADSIEAPIHIINITAEKGTVTEASGEFSVE
VKQNDLLLFSSVQFQKKEILITAEILSSEVLKVELQKDLTELDEVRLHQLSGNLANDIND
IKTFDPGIIGYALSDKEPLSVEERKLFAITRPDDPVGTLYGIISGQKKMYEKAIKNNRLS
ALVYKAREFIPDEYFTETLLLPQHKIMDFLYYCSLKPDFKELVNKNDPLVLIEYLKGMII
EYNEFIEE
>IFAGANLK_01975 hypothetical protein
MSLSRNKWVFLVVLGMITVSVFSQEKEVLSGQIITDETLSSPVHIINVTRRKGGVSELSG
YFSVEVNIGDSLVFSSVQYKKETLVVTRQTLQDNNFTIKLKEDLTELDEVKLHKLSGNLA
NDISGIKTFNKFDLNAPMRRKPPPSQVERQLYTATTGPGGTRLSVLGVLTGTIPLDPVIN
AISGRTARLKKIKAKNEFKFIIEKAIYLIPENTLIEDFEIEETEVMIFVYYCAENYDLEI
LLDNPLELYEFFKSKSIEFNALGALD
>IFAGANLK_01976 hypothetical protein
MKKISLILASFFLLSAFKSGAHEFYLSVTEIEYNNEEQSLQIITRVFIDDFQKVLNERYD
ADIQLSEEAEEGAVTEYISKYLNQKLRLKTNGEELQLNYLGKEYDADQLVLYIEVENVAS
FNQIEVTNEILTDLFDDQKNVVHVKVNNKTKSLLLMRQQETEKLTFP
>IFAGANLK_01977 hypothetical protein
MNKLRLLSFAFVMLFVSGVQAQESEAEEQQPKQEGHENNNKFKQLYETFATPNQYRTGAG
APGEAYYQNQADYKMDIVLDDKNTRLDGEAEVTYYNNSPDKLEYLWVQLDQNVRKKDAPA
LERNPSGMSPVTTPQRFVNQHMEESFDGGFNIVGLTHNGDKLNYTINQTMLRIDLEKALE
PGESFQFEMKWWYNINNHITDRARSGYEHFPKDGNNAYVIAQFFPRMAVYNDVEGWQNMQ
FWGSGEFALPFGDYEVDITVPADHIMEATGELQNRKDVYTKEMMSRYEQAKKSYDEPVIV
RTQAEAEEAEKSFSNKTKTWKYKAEMVRDFGFSTSRKFILDMMATDVGGKDVMAVSLYPK
EGNPLWEEWSTKAVASTLKSYSDQTFQYPYHKAVSVHARNQGMEYPMICWNYGRPDEDGT
YSDRVKFGMISVIIHEIGHNFFPMIVNSDERQWGWMDEGLNTFSQYLAEQDFGKKYPEAI
VPLEQYPSRRGIPAKIVPYMKGNQKYIAPIMSNPENVYQLGNNAYGKPATALNILRETVM
GHDLFDHAYKTFAHRWMFKHPTPEDFFRTIEDASAVDLDWFWRGWFYTTHNVDMGIKEVQ
KLYITDNATKEGKEFLERYGADPEEIDAIYVVEEESEEFDENLKGKPVLENSPTLKEYVM
DNFPEEERAKLKDPKYFYQVTFEKPGGIPMPLIVEFTYADGSTEMKRYPVQLWRMNDEMA
TKAIATSKEIVKMVVDPNLETADVDVSNNTWPKEETTSKFEEFKESLGN
>IFAGANLK_01978 Sec-independent protein translocase protein TatA
MNIIPLFISGAEIAFILFILVMVFGADKIPDIARGMGKGMKMLRNASNDIKTEIQKSAEK
QGIDTDISKDVRGEIDKVKEDIDEITGSVKRRF
>IFAGANLK_01979 hypothetical protein
MLEQLKQWDRELFVYLNGLGIETYDNFWITVTTIQNWIPLYVTFFIIYFLAFHWKKALFT
SLFILATALSTYGFTNVVKNFFLRLRPNNEPEIADIIRILQTPDNYSFFSGHSAVSMAAA
LFLILSLKDKYPWIWAVLIWPLLFMLSRIYVGVHYPGDVLVGAAVGVIFAIIFFLLYQRS
GKRFI
>IFAGANLK_01980 Putative O-methyltransferase
MHFLPEAIDQYILEHSVKEPEFLAKLNRETNQKVLQPRMLSGNYQGRILSLISKIIAPKS
ILEIGTYTGYSALCLAEGLTKDGILHTIDINEELYDFQQKYFQASEYKNQIKQYIGDARE
IIPEIDAKFDLVFIDADKPNYPAYFDLIIGKMIPGGVILSDNVLWSGKVVEPVKPEDEST
RALLKYNKMLAEDERVETVILPIRDGLTLTRVK
>IFAGANLK_01981 Kynureninase
MQFQNTLEYARELDFQDKISSYRDQFIFPQHEGKNVIYFTGNSLGLQPKTAKKYVDEIMT
DWANLAVEGHFYAEKPWWDYHERFSAKLAKVVGAKTTEVTVMNTLTVNLHLLMVSFYRPK
GKRYKIICEEKAFPSDQYMISSQVRFHGYDPKNAIVEIKRREGENNFRTEDIIAKVNEVG
DECALVLIGGVNYYTGQVLEMEKITKEGRKIGAFVGWDLAHAAGNIELKLSDWNVDFAAW
CSYKYMNSGPGNASGCFINEKYHNQKDIPRFEGWWGHNKERRFLMEPEFQPEKGADAWQI
SNAPVLALAPYLASLEMFDEVGMPALIEKRNKIVAYLEFVLHEIDKEVDSSFEIITPSNQ
EERGTQLSVFLHGEGRELFNYLMENGVVTDWREPNVIRLAPAPFYCSFEDMYQFGQVLKR
GILE
>IFAGANLK_01982 Carbapenem-hydrolyzing beta-lactamase Sme-1
MKKLISTIFMTVLCVALSRAQEVEIDTKLEQKLKELTESFKGDVGVYVKHLKTGKEATIN
ADTIFPTASIVKVPILLKIFDKIENGELSYKDSLVYSEDRIYGGSGLMQFYKDSTTTDLR
TLVALMISYSDNVTSLWNQELAGGGKAINELMAEIGLEHTRVNSRTVGRDKDWEKYGWGQ
TTPREMASILEKIRNRELVSAAASGEMYRLLGNSFYQDYALSQVPPYVQAAAKQGMVNKS
RSELFMVNAPSGDYVCYIATKNNEDDSWDENNEAWQLQKEISALLWNYFEPSSKWKPAEG
AEEILSGLKY
>IFAGANLK_01983 hypothetical protein
MKKLLLFTFLFSAFISCKNNETKIGQEVETEAEKSIAQQIAEAHGLNNFDEVEEIQFTFN
VRVEDSLRTSREWTWKPQTDEIRLTEGDISRNYTRTDNIAEDDKDIDQKFINDSYWFLFP
FQMVWSDAEISEEKTGIAPISKEEMKYLEVSYKDEGGYTPGDTYVVYYNDDYLLEEWIYK
SADGQREMPTTWEDFEDFQGLKISKSHKSPDGSFELFFTDIEVK
>IFAGANLK_01984 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MWNLNNKYALVTGGTKGIGKATVLEYLRLGAEVLFTSRTQKDIDLVLEELKEYDKKFYGL
VADVSVAEDRQKVHDFIENQWGRLDILVNNAGINIRKKANDYSEEEFRKVMEINLSAPFE
LSRKLHALLQQSGNAKIVNVASSAAMQDVGTGTPYAMSKAGLLQQTRSLAVEWAADGIRV
NAVSPWFTVTPLTKGLLSESDRMDPIIKRTPLKRVAEAQEMASIVAFLAMDKSSYITGQN
IVADGGMSINAI
>IFAGANLK_01985 hypothetical protein
MRDLIWLIVVLLVIGWLVGYFAFPDLGSIIHILIVIAVILILYKLLTGRRL
>IFAGANLK_01986 hypothetical protein
MRDLIWLIVVILIIGWLIGYFGFGEAVGNLIHILLVLAIIGILYRLATGRRL
>IFAGANLK_01987 hypothetical protein
MQHITSEEIAEMEKLFRLNLINSVTGYKSANLIATKSEKKGVNVAVFSSVTHLGSNPALL
GFITRPTKEVARNTYKNIKENKYFTVNHIQKNMIESAHQTAAKYDEEISEFQQTGLEEEY
LDNFYAPYVKQSKVKLGCEYVNEYYIKENNTVMLIGAIKHIYFDEGIQAPDGWLRLDDAE
TVAINGLDGYTLPSLLDRFHYARPGQEIKSFFKKED
>IFAGANLK_01988 hypothetical protein
MDESKIEQMRSTLNKLEDIKNSQESIIDKINHVITDLFQHPDKELEKAMNDAHQKSSDNV
DAVREAMEEYEMRINKLENQD
>IFAGANLK_01989 N-ethylmaleimide reductase
MNNTQALLKSVNIGDFELKNRVIMAPMTRNRAANKDNAPTELHAEYYAQRAGAGLIISEG
SQISDAAVGYINTPGIYTENQVKGWGKVTEAVHENDGKIFLQLWHCGRISHPKFHDGEKP
LAPSAVNPNTQAYTPDGFEDTVEPQAMSVADIKQTVLDFKHAAENAKRAGFDGVEIHGSN
GYLIHQFLNKNANIRTDDYGGSIENRARFFFDILEAISEVWPENRIGVRLNPSLNDAFGI
KASEESIATFDHVIEKLNAYDLAYLHLSEPFTDVSEIDYLEPNIAKHYRPIYKGKLIINA
GFDQESGNKVIEEGNADMVSFAKLFISNPDLPVRFAIDAPIAEWDEDTFYTPGPKGYTDY
PSYDAEKSK
>IFAGANLK_01990 Kynurenine 3-monooxygenase
MQTPKKIAIVGSGLVGSLLAIFLRKAGHEVEVFDRRKDIRNVEFSGRSINLAMSNRGWKS
LRAAGIEDEIKKLALPLDKRAMHVNDKPVYFQKYGKEEEAIYSISRGVLNRKMITLAEDA
GTTFRFEEKVWDIDLAEAKLYTGESEKGEWKEYQFDLIFGADGAFSRVRHKMQRQSRFNY
SQHFINVGYKELSIAPNPDGSHKLDNASFHIWPRGEFMLIAMPNLDGSFTCTLFMPFEGE
NSFESIKTETDADLFFQKHFPDINQEIENLKKDFFKNPTSSMVTIKCYPWSYWEKVTLVG
DSAHAIVPFYGQGMNAGFEDILVLSQKMKKHGDDWESIFEEYQKARKPNTDAIAELSYRN
FIEMSSKTADTDFLLRKKIENWFSTKHPETWVPLYSRVTFSDKPYAEALAIGDYQRKIMD
EVMEIPGIERKWDSLEVENKILKLLDNKPAFSV
>IFAGANLK_01991 K(+)/H(+) antiporter NhaP
MSITIENILLIGSLLLFISILAGKTSYRFGVPTLVLFLAVGILSGSEGIGGIYFNDPQLA
QFIGIVALNFILFSGGLDTSWKTIKPVMWQGISLSILGVLFTAVSVGVFVWYITDFTIYE
GLLLGAIVSSTDAAAVFSILRAKNLALKSNLRPTLELESGSNDPMAYFLTIAFLGLVVNQ
DQSIYSIIPLFLQQILIGAALGFIFGKLSKLVINRIKLDFEGLYPVLAIALMFIVFSATD
ALGGNGFLAVYLSGVYLGNHNIIHKKTIMRMFDGLAWLMQIVLFLTLGLLVYPSHIVPVI
GVGIFISVFLIFIARPLGVFLSLIFFKMKMRRRWYISWVGLRGAVPIVFATYPLLAGIEK
ADMIFNIVFFVSLTSVLIQGTTLSVVARWLHVALPMKAKQKSPVDAFMADGAKSFLREIN
IPEQNHSVGKRIVELQFPKKAIIAMISRDDQFITPNGNTVIEADDMLVVLTEDHRTMEGV
YESLNIEPEFDEKLD
>IFAGANLK_01992 Peptide methionine sulfoxide reductase MsrA 2
MKRFFFSTFIFLLISCGNNAQQKTVTKPEIANADPVVVPAENGYKKAYFASGCFWCVEAV
YESIEGVKEAVSGYSGGHTKNPTYESSNTGKTGHAEAVEVIYNPEVVNFETLVEVYFGSQ
DPTQVNGQGPDIGSQYRSIVFYQNKEQKNIINKVKNEVAQDYEEPIAAEILPFQKFWVAE
DYHQNYEKNNPNNPYIQKVSIPRLNRFKEKFPEILKDNSH
>IFAGANLK_01993 hypothetical protein
MRYYASLLCLILVLVSCKNEDKNQEREPDFETEQTENKNTPEKNTEKSTSENSDYNEKET
LEAPDSENNETETSSSKITPGTTYVKVDERDANCSCYCLELDMNKNTELCLSEDEMYINA
RYAKTGNSVNIFYVSPSNKNTNEDLPWEDFDTNNPIAVLRPGENGNMELDWKGFYIDGVL
AVDYAIYGKKTLEGTYKKQ
>IFAGANLK_01994 hypothetical protein
MKKITKSLLGIFLLAVTLHSCSTESEENPAASQELEQELALENGGVLKIQSATYIFKNTG
ETAKFISQDRDFNFKFVNELSFEANQQNKHAVEGLKITNPETEEYLIFSHFEELKNGFVK
FDAELSTGEVLRSVMYKTGNSNASSNKWHDEPVIGVTTPVIGAMIEFSQEEQLRNCRAAL
QVCANTNGVPTVALTNGKGWFTSIESCALECHD
>IFAGANLK_01995 hypothetical protein
MAKKNDVTVEDKLRALYDLQLVDSRIDEIRNVRGELPLEVEDLEDEVAGLSKRLDKMDAD
IEVIENDIKSKKNLIDESKVTMKKYAEQQKNVRNNREFNALSKEVEFQELEIELAEKHIK
EYRAQIEQKKEVIEQTKERLDERKKHLEHKKSELNEILAETEKEEQALIKKSAEFEKNIE
DRLVNAYKRIRSNVKNGLAIVPVERGASGGSYFTIPPQVIMEIAGRKKIITDEHSGRILV
DEELAKEEQEKMQNLFAKV
>IFAGANLK_01996 GTP cyclohydrolase 1 type 2 
MLVKEVIDIIEEFAPHTYAEDFDNVGLLVGDKNATVTAALITLDTLETVVDEAIEKNCNL
IISFHPIIFSGLKKLTGKDYVEKTVIKAIKNDIAIYAIHTALDNQFKGVNDMICEKIGLK
KRKILIPRKGSIKKLTTFVPNKQAAGVRKALFEAGGGSIGNYDNCSFNLKGEGSFKPNEE
ANPVIGKRGKIHLEEETQISLIYPSDIEKKLLHALFSSHLYEEVAYEVSALENENQHLGM
GMIGELETPEDEKSFLKRIKTEFNCGCIKHSELRGKPIRKVAVLGGSGGFAINNAKAAGA
DIYLTADLKYHDFYKGNNSFILADIGHYESEQYTKDLLHSYLTKKISNFALILAETNTNP
IKYI
>IFAGANLK_01997 Tetraacyldisaccharide 4'-kinase
MKILRKMLLPFALLYGFVTWSRNLFYNSGILKSKSYNVPVICVGNLNTGGTGKSPMIEYL
LKLLLPDFKVATLSRGYKRTSKGYKLLNGNETAAEVGDEPLQFKRKFKNALIAVDVDRQN
GTVKLQQESAEIILLDDAFQHRKVKAGLNILLTAYGDLYVNDFMLPTGNLREPTLGAERA
KIVVVTKCPPNLTKAEMELAKGKLKLQNYQQLYFSFIEYDEEIFSEATTAKLSSLKDKKF
TLITGIANPKPLINYLEGNGLDFEHLAFKDHHNFTTTEITRLQKETLLLTTEKDYVRLRE
NFKDGQLFYLPVKTAFLNNEEAFKQKILSFVHKK
>IFAGANLK_01998 Autoinducer 2 sensor kinase/phosphatase LuxQ
MKNFTLILFLACWCSLTYAIQQDETEDSQITNERIQQLLNDAEVSVNMLDFDNAIAQLNS
SLELSKSINDKRAIALSSSILAKLYYLRHDFDKAITELQRAISIQRDIDDQNGLAYSYVN
FAKILMAQLEKPRANRYLNLAEEIYLKLDNEVYLGIVDLNRAIIILNTENEPRKALNLLQ
QARTRLSDTNKVYELSRLYYYIARAHLDLKNYQLAEENIKRVLDIAYAQNFGGMIMSANK
LMSKLYEETGDFESSLAYLQKSFARKDSIIAMNNAVLAEQVNARYGVDALQSSLNELSLQ
NAEQERNLKVNKLTTILSVALITILSLLTLSLYKNNNLRARANELLQKKNAELTKAKENA
EKASLAKAQFLSTITHELRTPLYAVTGLTHLLLEESPTENQKEHLNSLKFSGEYLLSLIN
NILDLNKLEANKVEIMEASFDLKKRISDVLVALKNSADEKNTKIHFNYDDSIPQELKGDP
LKISQILINLIGNSIKFTEDGDIWINVSMNSREGNFVLLDFEIKDNGEGISKEKQQAIFE
NFTQGSTQINRKFGGTGLGLSIVKNLLTLLGSEIKLDSELGKGSKFAFQLKFEAKEVENK
LNNSPRIEVEPLEDKLEGKHILIVEDNKINQMITRKILEKQGVTCEVADNGTIAIEKTKE
KEFDIILMDIHMPGISGIEATKEIRKFNPEIPIVALTAVTLDENLDEFFLNGFSDIIPKP
YKTEEFFLKINRQLAIRESAV
>IFAGANLK_01999 Glyceraldehyde-3-phosphate dehydrogenase
MNKSINVAINGFGRIGRNLFRLLIDNKSINVVAINDLADAKTLAHILKYDSIHGVSQAEI
SSEGNNIVVNGKSIPLLNFAHPKEIDWNKFNIDTVIEATGKFKTYKDLQHHIENGAKKVI
LSVPPEDDQIKMVVLGVNEHILDGTEKVISNASCTTNNAAPMLKLIHENFKVEQAYITTI
HSYTSDQSLHDKPHRDLRRSRAATQSIIPTTTGAAKALTGIFPDISNVIGGCGIRVPVPN
GSLTDMTINVSKETNIEEINTIFKKASETSLKGILSYTEDPIVSIDINNNPHSCIFDALM
TSVIGGKLIKIIGWYDNEIGYSSRLVDLISIVNDK
>IFAGANLK_02000 Lipoyl synthase
MSTDTISPVKEKPKAKPKWLRVKLPTGKKYTELRSLVDKYDLHTICTSGSCPNMGECWSE
GTATFMILGNVCTRSCGFCGVKTGRPETVDWDEPEKVARSIKIMGIKHAVVTSVDRDDLK
DMGSIIWAETVKAIRRMNPETTLETLVPDFQGNERNIDRIVEVMPEVVSHNMETVKRLTR
EVRIQAKYDRSLEVLRYLKQQGINRTKSGIMLGLGEKEDEVIQTLHDLRSVDVDVVTIGQ
YLQPSKKHLPVKQFITPDQFKKYEAIGLDLGFRHVESSALVRSSYKAHKHID
>IFAGANLK_02001 ECF RNA polymerase sigma factor SigW
MEINHELLLTKIKAAKKGSQSAFNYLLDTFWDNVYGFQLKKTGNAYESEDITIQTFSKAF
NKIHTFDEDYSFSTWLIAISKNIHVDMLRKQKSSIRSRTTSDENDKVYRIADETPSIEDK
LISEQHLAQLLTDIKQLKPHYQEVINLRYFQEKSYKEIAQSLDEPMNNVKVKLLRAKKLL
AEIIEARKSV
>IFAGANLK_02002 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MATLLLGFFLLFSLIILAYYLAFFAFANDKTKNPGKLNLPVSVIVCAKNEAENLKNFLPP
ILDQDYPDFEVIVINDASQDETLEVIENFQALDGRVKLVDVQNNEAFWANKKYALTLGIK
KAKNPYLIFTDADCAPQSRNWISHMAAGFQEEKAIVLGYGGYFKNSKSLLNKLIRFETLL
TAIQYFSYAKLGNPYMGVGRNLAYTSRQFYEQKGFANHLHLRSGDDDLFVNEGGNEDNTF
ICHHPEASTRSVPKTDLKSWFQQKRRHASVAGFYKTKDKVLLGLFYASRFFFWILLAALL
IIQFQWELVLGVAGFIFMVQAVVYAKSAQKLQETDVVWLFPFLEVFLIFTQFGIFIANSV
SKPTHWK
>IFAGANLK_02003 hypothetical protein
MQLFLITIVLLGLAFAGIAIKIWGKKDGKFAGTCASQSPFLNKDGEACSFCGKLPDEMSD
CSGEEKKAAN
>IFAGANLK_02004 Cell surface glycolipoprotein MPB83
MKTKILITLLAALAFSFTSCEDTKKKEEENAKMEQQEAERQAEMAAEEERMEMESNSIAA
KAMETDSLSTLVSALQNADLADTFTEDEGPYTVFAPTNSAFEKVDQATMDELMKSENKDQ
LATVLKYHVVDDEITASDLSQMIEDGEGEASFSTMDGAELKVMMEGDNIVLQDENGNKAT
IIATDIEASNGMVHLIDGVVMRKKDS
>IFAGANLK_02005 UDP-N-acetylenolpyruvoylglucosamine reductase
MQVAENFSLKEHNTFGVDVNARKFVSVHSTEELRDVLQQTYASEIFVLGGGSNMLLTQNI
DKTVIHIGIKGIELISESRDEVILKVGAGENWHQFVLYCIEKDYGGLENLSLIPGNVGTA
PVQNIGAYGVELKDTFESCEAMRIQTLEIKTFSREQCEFDYRNSVFKNKLKGEYIITSVN
FRLNKKDHQLSTEYGAIQAELDKNQIKKPGIKDVSDAVISIRQQKLPDPRELGNSGSFFK
NPVIKESEFKNLQKKFPEIPFYALQANNIKIPAGWLIDQAGLKGYRQGDAGVHKNQALVL
VNYGNATGEEILALSKEIQDKIYKKYKIKLEPEVNVF
>IFAGANLK_02006 Aspartate aminotransferase
MPSISNKGRNMPESPIRKLVPFAEAAIKKGKIIYQLNIGQPDIETPKAALDAVKNNNIDV
LSYSHSAGFESYRTKLAKYYRKNDIPVDAEDIIITTGGSEALLFAMGSITDPGDEVIIPE
PFYANYNGFATASGVQIIPIKGSIDDNFSLPAISEFENLITDKTKAILICNPGNPTGYLY
TREEIQQLADLAIKHDLFIVADEVYREFAYDGVKHHSIMSIPDLEQNAIMVDSVSKRYSM
CGARIGCLVTKNKEVMAAAMKFAQARLSPPTFAQIAAEAALDTPDQYFEEVNKEYTERRN
LLIEGLEKIPGVKVAKPKGAFYCIAELPIENADKFAQWLLEDFQHNGETVMVAPANGFYS
TPNTGMNQVRIAYVLKKENLEKAIEILKIALEEYNK
>IFAGANLK_02007 hypothetical protein
MKKLIAIAIFVVAGLGTAMAQETAKIEFKSETIDYGEIKKGSDGVRVFEFTNTGNAPLVI
ANVTSSCGCTIPKKPEEPIQPGETGEIQVKYNTKLVGPIRKTVTVYSNAEEATKSLKIKG
RVIEDDSSR
>IFAGANLK_02008 Valine--tRNA ligase
MMYTQNFNQINFFYNPSVIITFALFFKNQTNMAIASQYDSKKVEDKWYNYWMENKFFHSE
VDEREPYTIVIPPPNVTGVLHMGHMLNNTIQDVLVRRARLKGFNACWVPGTDHASIATEA
KVVAKLKAEGIDKNDLSREEFLQHAWDWTHKHGGIILEQLKKLGASCDWDRTKFTMDDNM
SASVIKVFVDLYEKGLIYRGYRMVNWDPVAKTTLSDEEVIHLEKQGNLYYLNYKVEGTED
VLTIATTRPETILGDTAICINPNDERFTHLKGKKAIVPICNRVIPIIEDEYVDVEFGTGC
LKVTPAHDENDKMLGDKHNLEVIDILNDDASLNAYGMHYEGKDRFQARIEIVEELKEMGV
LTKVEEHTNKVGTSERTGAVIEPKLSDQWFLKMKDMAKPAIDAVVGDEINLVPDKFLNTY
KHWMENVRDWNISRQLLWGQQIPAYFYGSGKEDFVVAETSEEALEKARKKSGNASLKAEE
LIQDKDALDTWFSSWLWPMSVFNGILEPENEEINYYYPTNDLVTAPEILFFWVARMIMAG
YEYRGERPFRNVYLTGIVRDKQRRKMSKSLGNSPDPLGLIEQYGADGVRVGMLLSSPAGN
DLMFEEDLCKQGSAFSNKIWNAFRLVKGWEISEEKEQDETSKIALDWYTARFRKTLAEIE
DHYSKYRMSDALMSTYKLIWDDYCSWFLEMVKPPYGQPIDAKTYKAVIEILEDNLKILHP
FMPFVTEEIWQEITERTPSEALIIAKWPELKEFNDEIISEFGLASEVIAGIRKIRKEKNI
SFKNTIDLMVMNNENVSELFDPVILKMGNINEFGYVDKQVEGALSFRVKSNEYFIPIAGS
IDVEAEVKKLEEELKYNQGFLNSVEKKLSNERFVNNAPEKVVAIEKAKKADAEAKIEAIK
ASLKSLK
>IFAGANLK_02009 hypothetical protein
MPETTDEKFLKAYDMASKTNQKFAPDVMLHFYAYYKKATQVNGFYIPPTNEGDLRNAFKI
NALLQVKNLSKQEAREKYVELVEEHIGEVTP
>IFAGANLK_02010 Phosphatidylserine decarboxylase proenzyme
MFHKEGYKIMGWAALLLITINVVSYSLINTYWIKFAILVATIILFFLIIQFFRNPKRNTV
LNDAHVVAPVDGKVVAIEEVEEKEYFKDKRLQVSIFMSPINVHVTRHPIGGKVKYSKYHP
GKFLVAWHPKSSEENERTTVVVANEKAGEVLYRQIAGAMAKRIVNYAEVGNEVIQGSDSG
FIKFGSRVDVFLPLNTPISVKLNQKVKGGLSVIAKIDE
>IFAGANLK_02011 Phosphatidate cytidylyltransferase
MREAIIRTISGLLYVSILVASILSSELIFISLFYLLGLVCLVEMQKLLHLKSYALYAVQA
LLFYLFSYLKFNQDATILLLFITIFVNLFLVKDLLVVRKIPVFEKKKYIIIIFYLISSVI
FLTLIPTIEGVFIPKLVVGIFILIWTNDTFAYIVGKNFGSRKLFERISPNKTVEGFLGGV
IFSGVASFFIFYYTQFLTFPIWLGMAIILSVFGTLGDLIQSKFKRQAGVKDSGTLMPGHG
GLFDRLDSIIFSSPFVYAYLYILDYVS
>IFAGANLK_02012 hypothetical protein
MSLFRRFLNPKSKSDKKQDSPEKAERGKYMPEVKLPTDERFMLNFKNNGGKFLYCEDTKE
MQEAFDNILLENDWYEKECFCLDPNLQDKFKGFNLNFTRSGTAPFFLSTCEYLVANDGSI
LISSNQIKECKLNDLPDNFVIISSTSQLIDTIGEGLRGIKFRNKQRIPSNITTIKNFETQ
KEGDFMSYGSSTKNLYLLLLEDL
>IFAGANLK_02013 ATP-dependent zinc metalloprotease FtsH 3
MAKQQPKKNTDPKKPKFNAYWIYAAIIIIFIGINFFSGGGFSEPAQTNPAEFLTYLRDGD
VKKVEIVNRKQAKVYLTEDAAQKDIHKQANDPELFNTGGETPAYSFEFGDLQNLEDDIKE
IKAENNLDTTVVYDTQSNVMSEIFWALLPFILIIGVWIFIMKKMSSGAGGGAGGQIFNIG
KSKAKLFDQNTDVKTSFKDVAGLEGAKEEVQEIVDFLKHPDKYTSLGGKIPKGALLVGPP
GTGKTLLAKAVAGEAKVPFFSLSGSDFVEMFVGVGASRVRDLFKQAKEKSPSIIFIDEID
AIGRARGKSNFSGSNDERENTLNQLLTEMDGFGTNTNVIVVAATNRADVLDKALMRAGRF
DRQIYVDLPDLNERKEIFEVHLKPLKKVAEELDTEFLAKQTPGFSGADIANVCNEAALIA
ARKGNKAVGKQDFLDAVDRIVGGLEKKNKIITPDEKKAIAYHEAGHATVSWMLEHAAPLV
KVTIVPRGQSLGAAWYLPEERLIVRPEQMLDEMCAALGGRAAEKVVFDKISTGALSDLEK
VTKQAKAMVTIYGLNDKVGNLTYYDSSGQSEYNFTKPYSESTSELIDKEISNLIETQYKR
AIDLLTEHKDKLGQLADILLDKEVIFKDDLETIFGKRPYDKDQEKTEVLGKKETPKIQEK
AAETKEQNPAPGSDSEENTITEDNSVNK
>IFAGANLK_02014 Ribosomal silencing factor RsfS
MAKKEANNDQLIAHIIKGIEEVKGNDIDILDLRQIENTVCDYFIICNGTSNTQVNAIVNS
IQKTVSKALKDKPWHVEGGENAEWVLLDYVNVVVHVFQKHIREFYDIESLWGDAKITSIE
TNY
>IFAGANLK_02015 Bifunctional ligase/repressor BirA
MRIIKVNATNSTNEFARELYRGKTSFEPICVVAYEQTKGRGQRGSGWVSNSGENLTFSVL
YPKIKVGVNHQFLMSATVSLAIIEVLNKFNVPALKVKWPNDIMSARYKISGILIENILKN
NEIAASIIGVGLNVNQTEFPDLPQASSLKLVTGVHFNLDEILKRITDELEEKLTQINAEV
ETSILEKYAKNMFRRDAVSTFQLPDETYLTGIIRGVTTSGRLNLEIEDSVFKTFDLKEIK
LMY
>IFAGANLK_02016 hypothetical protein
MNIESPKVTADKSQQEMFNFLTKVENYEQLMPESKEVFEVRDEKTFVFGLKGMPVIKLEI
QETIEPELVVLGSTSDKFDFKLKAHISASSENQSEVQMEFNGAFNAMMAMMVKKPLTKFI
NTLAENIGKL
>IFAGANLK_02017 Orotate phosphoribosyltransferase
MILNKETARTTAELLLQIKAIKLDAQEPFTWASGWKSPIYCDNRIVLSYPPIRNHIREQF
ARQIEELYGKPDVIAAVATGAIGIGMLVAEILSLPFIYVRPEAKSHGRKNQIEGNLSEGQ
TVVVIEDLISTGNSSLNAVKALKEAKANVKGMLAIFTYGFKTADENFEKEGIELHTLSDY
DFLLETAQRTNYINATEAGMLREWRQDPANWKK
>IFAGANLK_02018 Diadenosine hexaphosphate hydrolase
MYKVFVNDIPLILSTKKDFGENYVSLPIKKVRIKRIIKKISKGELLYVNLYHEKEEKLLK
HLFKKLRVVTAAGGMVLNDKDEILFIYRKKRWDLPKGKTEKNETIEASAIREVEEETGVE
GLQVTKFLQKTYHIFKRKGRYRLKVTHWYEMRTSYEGELRPETKEGIEKAKWKDLKKSQK
ALQKSYANIKLLFSEKYLARQSEDRVA
>IFAGANLK_02019 hypothetical protein
MKKILVLSVGLLSLISCDLEKYQLVTDYDLETRFEKSDGKETGTYEEVIDFYTQLAESSG
KISLEEFGKTDSGEPLHLAIYSPNEDFDFEELREENSIILINNGIHPGESDGIDATMMLF
RDLAGDSIKTPTNTVLATIPVYNIGGALNRNSTSRTNQNGPAEYGFRGNARNYDLNRDFI
KADTRNTRSFYEIFHHVKPDIFIDNHVSNGADYQYTLTHLFTQHNKLGGELGSYLNEQIM
PALEDSLAKKDWDITPYVNVFNEVPEEGFSQFNDHPRYSTGYTTLWNTIGMMVETHMLKP
YPKRVRGTYELMRSMIDIAENDRERMKDIRNRASRKYLTERWYPINFKPDMENPSRRNFK
GYEGEKIKSEITGGDRLQYDSSKPFNKEIDYYNNFIAEDTIEIPRAYIVPQGWWQLTDLL
KLNKIKLEPLQSDTTLYVETYKIENFKTRNQAYEGHYMHSETKVSKKMDSVRFRKGDFVV
KTFQDGARYLIETLEPEAPDSFFNWNFFDTVLQQKEGFSPYVFEDVAKKMLEENPELKEQ
FEEKKRTDAQFSNSPYNQLAWLHKQSKHYETAHLRYPIFRLPR
>IFAGANLK_02020 Aldose sugar dehydrogenase YliI
MKKLTTIIGLSLSCCLAIPAQAQVNTDLSEEKKKELSQQSADVVETAIGELRLVPPFSSE
SVTKESEVIGWGDKKPQAPAGFKVTMFAENLKHPRRTYIAPNGDFFVVESNTKNSADRII
LIRDKDSDGNPDYQDIFLDDLNQPYGMLVLDNYFYVANTDGLYRYPYTEGDMKIEAEGEK
ILSLPAGGYNNHWTRNLLANEDGSKIYVSVGSASNVGEYGMDKEERRAAILEINTDGSGE
KIYASGLRNPVGMDWNPVTGELWAAVNERDKIGNNLVPDYITSVKEGGWYGWPYSYFGQI
QDPRWADDPHMELVEKTIVPDVPVGPHTASLGLAFYTKDKFPEKYKNGAFVGQHGSWNRA
VFSGYKIIFVPFDENGKPGQPEDFLTGFIADEAESKVHGRPVGVTVTPDGALLVNDDDAN
VIWKVSAE
>IFAGANLK_02021 Colicin I receptor
MEKKLLALLCLLWIGNLFSQENQFKILNANNNEPIEDVSIYKASSLVAVTDKDGNFSFTS
GELPGDFQISVLGFETLEVELTSSTPQEIYLSPTSETLSEVVVRSTVIPKSLREVPASVN
LVTQTDFNRTDATNVLETFNNVPGMFVNQGALNTNKINIRGIGARSQYSTNRIQAYFDGI
PLTTAEGELTLDDFDQESLDRIEVIKGPTSSIYGAGLGGSINLYSKQSGKEEARLGLKTQ
YGSFNTRKQVYQASNTTANSALFATFSNLTSDGYRDNGNYDRKSALVNGSLKTSENGSLS
YLANFTRLKAFIPSSINEDDFLNNPETAAFTWGQSQGYESYDRGMLGGSYTHSLFDNLKN
TTSIFLSFRNAYEPRPFDILKEERVSAGVRTKFNLDTRVFELPSEISFGAEYYNEWYETG
TFENLYEDFPGEGSVLGERESNNEQDRNYANFFAQINFEFTEKWNLEAGFNLNTTNYSLT
DLYNQDELDQTGDYGFDPVFSPRIGTSYEIGTGKNIFASVSHGFSTPTVAETLTPEGQIN
TNLKPETGINYEAGFKGNWLRNKLYTEVSVFSIQIENLLVAQRVAEDQYVGINAGKTNHN
GIEFLTNYRFLIGPDISIKPYVNGAINFFEFDEFVNNDEDFSGNQLPGVPKYTMNLGVDI
QSESGFEFYGNFRNVGEIPLDDANSGYTDQYSLLNFKAGYTFNIFQELNLNLYGGVNNAL
DEHYAASVLSNAVGFGGAAPRYYYPGNPRNYFGGVQLNYIF
>IFAGANLK_02022 2-oxoglutarate carboxylase small subunit
MKIQKVLVANRGEIAIRIFRACTEIGIRTVGIFTFEDRYSLHRYKADESYQIGPDKEPLK
PYLDINAIINLAKKVGADAIHPGYGFLSENANLAQACKDNDIIFVGPEVSVLKSLGDKVT
AKTVAVKNNVPVIQSNEKELESLDIAIEEANRIGYPIMLKAASGGGGRGMRVLREEAELK
KAFSESKREALNAFGDDTVFIEKFIENPKHIEIQIVGDNHGNMVHLFERDCSVQRRYQKV
IEFAPSYNLDQTTKEKLYEYAVNICKAVNYNNIGTVEFLVDQDGIIYFIEVNPRIQVEHT
VTEVVTGIDLVKAQLFIAGGYKLSDEQIKIKDQESLSTNGFALQCRITTEDPANDFQPDY
GTITTYRSASGFGIRLDAGSLYQGVTISPFFDSMLVKVSASGRTLDGACRKMRRALAEFR
IRGVKTNIPFLDNILQHEKFRDGSVTVNFIADNPDLFKLKETRNRATRMVEFLGDVVVNG
NPDVKDVKDKPKLIKADVPAFDPHAAYPKGTKDLLTELGPEKFAEWLKNEKKIHFTDTTF
RDAHQSLLATRMRSIDMLKVAEGFAKNHPETFSMEVWGGATFDVCLRFLKENPWERLQLL
RKAMPNILLQMLMRGSNGVGYTAYPDNLIEKFVAEAWENGVDIFRIFDSLNWMKSIAPCI
EYVRKNTSGLAEASICYTGDLLDKNSKYNMEYYLQLAKDIENAGAHILAIKDMAGLLKPY
AAGELISALKSEINIPVHLHTHDTSSIQSATYLKAMEAGVDVVDVALGGLSGLTSQPNFN
SLVEMTQSSERKADFNMDKLNEYSHYWEAVRKYYFPFESGLKAGNADVYKHEIPGGQYSN
LKPQAESLGLASRFHEITAMYSKVNKLFGDIIKVTPSSKVVGDMAQYLVSNNLSIEDVME
KGEDLSFPQSVVNFFKGDLGQPYGGFPAEVQKIILKDQKPYTDRPNAHLEPIDFEKEFGE
FCDIFSEGMGRKLEMTDFLSYKLYPKVFTEYFNHYRKFGEVMNIPTPNFFYGMQPGEEIT
VEMDKGKTLLIEFLSVGTADEDGLVDAFFKVNGQTRTVKIQDKSVKVEKVVHQKINKSND
KEVGAPIQGSISSILVEKGQKVNKNEPLFVIEAMKMETTITATKDGEIDEIIHTESTMVF
ADDLVIKLK
>IFAGANLK_02023 hypothetical protein
MFHHTHPYKPYIPENATKLIVGTLPPPRFTKRQLKEGDVDFCYGSRDGLLWIVLDNIFGL
DLKFENTDDAVNQRKEFLEERGIGICDMVESSRRKKIDASDLGMQEVELRNMIDILKENP
KIDTLLFTGGNSKNGPEYFFRKHLKEIDSEIRLKVISNEVPRVHQFILDGRLIKTVSLTA
PSGSANRAIGSMELYKQLKHKDKDFNTIDFRILQYKEWF
>IFAGANLK_02024 hypothetical protein
MGRGDKKTKRGKIAIGTHGKLRPKRKKFKVKPTTMAQQEKKELQ
>IFAGANLK_02025 hypothetical protein
MAGKIEENKRKRNKDQENPTNPTGDTKKRTNEVDFDEKTIKDQQNKK
>IFAGANLK_02026 Tryptophan synthase alpha chain
MNRINKKLKEEQKLLSIYFTAGYPETGDTVSIIQDLEKNGVDFIEIGLPFSDPLADGPTI
QESSTKALKSGMTTNKLFEQLKGIRDSVEIPLIIMGYFNPILQYGVEKFCKKCAETGIDG
LIIPDLPVDVYNEEYKSIFEENGLQNIFLITPQTSEERIRFIDSVSNGFIYMVSSASVTG
STSGFGDETKKYFQRVNDMQLKNPQVVGFGISDSESFQQATQHAKGAIIGSAFIKHLNKN
GKNNTADFVKSIRPV
>IFAGANLK_02027 Tryptophan synthase beta chain
MSYQANEKGYYGDFGGAFIPEMLYPNVEELRSQYLDIMKEESFQKEFKDLLRDYVGRPTP
LYYAERFSKKYDTKIYLKREDLCHTGAHKVNNTVGQILMAKRLGKDRIIAETGAGQHGVA
TATVCALMGIECIVYMGEIDIERQAPNVARMKMLGAKVVPAKSGSRTLKDATNEAIRDWI
NNPLDTHYIIGSVVGPHPYPDMVARFQAVISEEIKVQLKEKEDRENPDYVVACVGGGSNA
AGAYFHYLDNPEVGIIAVEAAGKGIQSGESAATSALGKEGIIHGSKTLLMQTEDGQITEP
YSISAGLDYPGVGPMHANLFRSGRGEFISITDKAAMDAGLELAKLEGIIPAIETSHALAI
FEDRKFEKDDVVVINLSGRGDKDLSTYIDYFDL
>IFAGANLK_02028 N-(5'-phosphoribosyl)anthranilate isomerase
MKDPENISEVAKLPPDYMGFIFYENTPRNFDAEIPEIPSEIKKTGVFVNEKINVILDRTK
KYDLNALQLHGDESAAFCAELKTLLMETSVEIIKVFSVNDDFNFKRLKEYETVVDYFLFD
TKGKNKGGNGITFNWEILKEYPSEIPFFLSGGIGPHEIEEIKKLKAYFKQNGNENLLYAI
DVNSKFEEQPGFKDVVKLEKFVKQI
>IFAGANLK_02029 Indole-3-glycerol phosphate synthase
MNILDKIIADKHKELVLKKLVIPISQLEQAALFERETISLAEELKTSKTGIIAEHKRRSP
SKSVINQDLNVEDVARGYEDAGISGMSVLTDGKYFGGSLDDLLYARAAVKMPLLRKEFII
DEYQLLEAKAHGADVILLIAAVLEREQIKSLSEFAKSIGLEVLLEVHNEEELQKSIMPSL
DMLGVNNRNLKTFEVSIEISKTLSEKIPEDFVKVSESGISSVKAIKDLQQYGYKGFLIGE
NFMKTNNPGKAAVEFVRELSTSP
>IFAGANLK_02030 Anthranilate phosphoribosyltransferase
MKKLLNRLINHETISKDEAKQALFSISNGEYNESQIAAFLTVYMMRSITIEELEGFRDAL
LELCVAIDLNDYNPIDLCGTGGDGKNTFNISTTSSFVTAGAEVNVAKHGNYGVSSVSGSS
NVMESLGIKFSNDAGFLEKCIAEAGICVLHAPLFHPAMKNVAPIRKSLAVKTFFNMLGPM
VNPAFPKNQLVGVFNLELARMYGYLYQNTDKNFTILHALDGYDEISLTGNTKTISNNSEG
MLSPEDFGVETLKQEEIAGGGSIESSAEIFVNILKGKGTKAQNNVVCANAGMAIATAKQI
SVKEGFEAAKESINSRKALNALEKLQELSK
>IFAGANLK_02031 Aminodeoxychorismate synthase component 2
MKKILVIDNYDSFVYNLVHYLEEFDCEVTVIRNDQLELEDVQKYDKILLSPGPGIPSEAG
LLKPIIEKYASTKSILGVCLGQQAIGEVFGGKLGNLESVYHGIATTMDLCVDDEPLFKDL
PKTMNVGRYHSWVVLKGLPDSLEATSYDENGQIMSLRHREFDVRGVQFHPESVLTPDGKK
MIQNWVNS
>IFAGANLK_02032 Anthranilate synthase component 1
MYKLKTTHKKLLADTITPVSVYLKVRDKYPNSLLLESSDYHANDNSFSYICCNPIASIKI
QNERITEVFPDGSKKTTEITPEVNVPLRIQEFSKQFKTEDSDFKFINNGLFGYIAYDGVR
YFEDLEIKKRNGDLKLPDIYYAVYQNIIAINHFNNEAYIFDHSYDTGSKIPEIEQLIKVK
NFATYNFERQQEPISNLTDEEFKANVRLGKKHCYRGDVFQIVLSRRFSQKFKGDEFNVYR
ALRSVNPSPYLFYFDYGNFKIFGSSPEAQLVVQDGQAEIHPIAGTFKRTGNDEEDAELAK
KLAADEKENAEHVMLVDLARNDLSRHGNNVKVEKYREIQFFSHVIHLVSKVTGTKDPETP
TMQVVADTFPAGTLSGAPKHSAMKLIEKYENVNRDAYGGAIGFMDFHGNFNHAIIIRSFV
SKDHQLHYQAGAGVVSESVEENELQEVYNKLGALTKALDIAEDI
>IFAGANLK_02033 Protein YceI
MEKQVNAQASNIAWKGKKVLGSHSGTIDLKDGKFQFENEEIVGGEFVMDMTTITVTDLKG
DDKAGLEGHLNSDDFFGVDNHPTSKLVITSVAKKDDGTYGVVGDLTIKENTHPVTFDLDW
SNNTATTKLSIDRSKYDVKYNSGSFFSGLGDQTIYDNFDLNIELKF
>IFAGANLK_02034 Protein YceI
MKKNLLKTVFASAFLVSFLSFSTVNAQDKKIDVKESNINWEGEKVTGSHYGTIDLQNGHF
TMQNGELTGGEFVINMSSITVTDLTGEDKGKLEGHLKSDDFFGVNNHPTSKLVITSVAKK
SNGTYGVVADLTIKDKTNPVTFDLDWEENSASTELTIDRSKYDVRYGSGSFFDNLGDKTI
YDNFELDVELKF
>IFAGANLK_02035 Putative NAD(P)H nitroreductase YfkO
MENYIENLNWRYATKKFDVAKPLSQEDLEKLQKSIQLSASSYGLQPYEVFVISDKETKKK
LKAAAWNQSQLTDASHVFVFVGLKKLNEAYIDAYLKNISKIRKVQFQDLGGLKDMLTSNI
LGQTEDQQTIWAQKQAYIALGNLLSAAANLKIDTCPMEGFDAQKFDEILGISGTNLTTAV
IATAGYRSDEDQLQHAKKVRKQEEELFHLI
>IFAGANLK_02036 HTH-type transcriptional regulator MhqR
MYIQMLFRQMNIEDQLKTNNLPPARKLSLSILVTANLIDENVAAALKPFDISVQQFNVLR
ILRGQKGKPANLSTIQERMVSKMSNTTRLVDKLITKGLTERVICEANRRKVEISITEKGL
DLLKEIDPKVDAVEKELIQDITEEEIEIVTNCLNKIRK
>IFAGANLK_02037 putative adenylyltransferase/sulfurtransferase MoeZ
MKELSQEEWQSQLQKDEKAVILDVRTEEEVEDGYIPKAKNLDIYKGQEFVNEVEKLDKDK
NYYIYCRSGKRSAQACTILDQMGFANTYNLEGGFMEWKGDRAED
>IFAGANLK_02038 UvrABC system protein B
MKFQIESDYKPTGDQPKAIEQLVTGINNNDQYQTLLGVTGSGKTFSVANVIQEVQKPTLV
LAHNKTLAAQLYSEFKQFFPNNAVEYFVSYYDYYQPEAFIPSSGTYIEKDLSINEEIEKL
RLSTTSSLLSGRRDVIVVASVSCLYGIGNPVEFRKNVVSIERDMQISRTKFLHQLVQSLY
SRTEAEFSHGNFRIKGDTVDVYPSYADNAFRIHFFGDEIEEIEAFDPGTNDIIEKYERLN
IYPANMFVTSPDVMQNAIHHIQDDLVKQVDYFRDIGKHLEAKRLDERTNFDLEMIRELGY
CSGIENYSRYLDGRQPGTRPFCLLDYFPDDFLMVVDESHVTIPQVHAMYGGDRSRKETLV
EYGFRLPAAMDNRPLKFEEFEALQNQVIYVSATPADYELQKSEGVYVEQVIRPTGLLDPV
IEVRPSLNQIDDLIEEIHTRNEKDQRTLVTTLTKRMAEELTKYLTRINIRCRYIHSDVDT
LERVEIMQDLRRGLFDVLIGVNLLREGLDLPEVSLVAVIDADKEGFLRSNRSLTQTIGRA
ARHVEGKAILYADKITDSMQKTMDQTEYRRNKQINYNKENNIRPTALVKRLENSTLIKEK
LDVYDAEKPLTTKAAEAEVAYMSKADLEKRIRQKRKAMEKAAKDLDFMAAAKHRDEIKML
QNKIKETQG
>IFAGANLK_02039 hypothetical protein
MLRLLEIEYHKLRYSRSAKILVFTYFILITFIALIASIEFNLGSINFRVADQGIFNFPYI
WHFNSYIAALLKLFLAIVIVSMMSNEYSNRTLKQNLIDGLSKKEFIASKFLTVTVFSLIS
TLFLFIVSLILGLSFSDFTEASIIFSDMEYMIAYFVKLTGFFAFCMFLGILIKRSAFALG
FLFIWWILESIVYGVLKWQIFRDSEIADNIARFFPLESMSNLIKEPFSRLSAVQTAATQL
GSEFDKDYGIHWDQLLIVIFWTTIFVFLSYRLLKKRDL
>IFAGANLK_02040 putative ABC transporter ATP-binding protein YxlF
METILSLKDLTKKYGSLTAVDNLSFTIEKGNVYGILGPNGSGKSTTLGMVLNVVNKTSGE
FAWFSGNTDTHDALKKVGAIIEHPNFYPYMTAAQNLALVCKIKDVPKDKINEKLEIVGLL
DRKDSKFRTFSLGMKQRLAIASALLNDPKILILDEPTNGLDPQGIHQIREIIRKIAAGGT
TILLASHLLDEVEKVCSHVVIIRNGKKLYSGPVDAINASHGFFELQAKNMQLLQELLIAH
PGIENVSEKENIVTAILKEPMDAETINEYLFEKGLSLSYLVKRKESLEEQFLQLTNQTTA
V
>IFAGANLK_02041 hypothetical protein
MEEKLMSKKKPSFAVNERLNRYLAKHNRNTKIPVFYDDLLRFSGSVVVYDQHEEDTFWVR
CYYPDFEREEIDNSLKQVYTIMHSDGSDDSLEFLNVDAIDYCTFGNSKPFRIKVRNILND
SFTYFYVKKADASRIYGLEFEHLLSPHRINFLVYKDTLIEEHIAGIPGDVFIEDHLPSCD
NRAQTQIAKQFVKFNERCTVRLLGDMRSYNYVVIPTHDFDHVEYQIRAIDFDQQCFEGNL
KVYRPQFFKENLKMVELVQDKLQESSIEQYRKEERSLLAKRIINTRPRYKELLRCMINDH
VSTQANVKTLRSDLYKYTKDIKFKRASTMGQILRTALDFVRRNYEDVNMKRLLESS
>IFAGANLK_02042 hypothetical protein
MINLFNAQIESLSIHRVGNKSRNENIFLSAAPYQLNDEITPLIKEYFLKPFREKEENYFN
FSHETDLEFNELYNLANAVFDDPANIHEASKKITTLLFEQSSHPHIKSGEVYVVYFENLQ
MDNEKVSGIGIFKSELKHDFLQFEENGSILEMIVQQGINLNKLDKGALIFNKNREEGYKI
LSVDSNKYDTKYWLENFLGVDVMRDENYNTKSYLNFCKNFAKDVVLPAEDKKEEVMFMNR
SMDYFAKNDDFEESNFLNSVIDNPELLPEFQHYKTEKAPKYKIEDLTNFPIANKAVTDAR
KKIKSVINLDTHIQIKMDFVNAESADKFVEKGWDEEKQMYYYLVYFNKEEKS
>IFAGANLK_02043 hypothetical protein
MVYRFRVILDAEEDVFRDIEILQEDTLEDLHNTILQSFGFDGTEMASFYLSDDDWQQGEE
FSQFDMGGEVRLMNETSLESILDEENRKVIYIYDFLKMWTFLIELAQVGEVEAGRDYPNL
MFVHGQLPDEAPDKDFVGEDDEDAGGGDMFDQGFNTNDYDDLSFDENWN
>IFAGANLK_02044 Heme A synthase
MYRKSVKISLILVYLVIVAGAVVRMTGSGMGCPDWPKCFGYYIPPTEVSELEFQANREYE
KGQVIIVDETLKVAATDFTSKENYSEENWDTYIKHDYAIFNPTHTWVEYINRLAGALAGF
AVLIMAFLSFKKWKKRKRITILSWLSVFLMGFQAWLGATVVYSVLSPVRITIHMVMALVI
VALLLYLLFIAEEKVKNKVPNRTFRNLMILAVGLTLIQVVLGTQVRQLVDEQVKMLGYDA
KELWLANPNLNFYVHRSFSILVFLVNAVLWWKNRKLQLQFGKINWVMLFLLLEIATGIAM
YNFDFPFLSQPFHLVIASVLFGFQFYLLLECFAAGRKLKTL
>IFAGANLK_02045 Multifunctional CCA protein
MKNYKGALTHNIFRVITQASEDLKLESYVIGGFVRDHILQRGEPKDIDIVAVGSGIELAR
KVATILPHKPKVQVFKNYGTAMLRAYDMEIEFVGARKESYQKDSRKPVVEDGSLVDDQNR
RDFTINALALGLNEDNFGNLLDPFDGIEDLNSKIIRTPLDPDITYSDDPLRMLRAIRFAT
QLNFKIEKESLKAITRNKKRIKIISNERITDELHKIMLAEKPSKGFSLLHKTGLLHIIIP
ELTALEGIDEIEGQKHKDNFWHTLEVVDNISENTDDLWLRWAALLHDIGKAPTKKFHKKI
GWTFHGHEFVGAKMVFKLFKRLRLPLNEKMKYVQKLVLMSSRPIAIVDNDVTDSAVRRLI
FDAGEDIEDLMTLCEADITTKNPKRYKQYHNNFKVVRTKMKEVEERDHVRQFQPPVSGEE
IMETFNIKPSREIGIIKETIKEAILEGEIPNEHEAARELMLKKGRELGLSVGSDHSQ
>IFAGANLK_02046 Threonylcarbamoyl-AMP synthase
MEDLKTEMQNALATLKRGGLILYPTDTVWGIGCDATNAEAVEKVYKLKKRHESQALICLV
SDYKMLNQFVEDVPEVAYDILKFARKPTTIIYDDPIRVAENLIADDNSLAIRVSKDKFSN
DLAKRFRKPIVSTSANISGEKTPESFAEISPEILEGVDYVVNLQKNKKSAKPSAIIKLSN
DGKVKVIRK
>IFAGANLK_02047 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MNILHLSAVRNWGGGEKHIENLCLELAESNPEVNNFILCKKGDLFEKSLQKNNLPYAATP
ILTNFDFRYVIKLMTLVKERKIKIIHIHDPTALAFAVIADKFTALPPFIFSKKTSFPIRD
RKRTLYKYNYPKIKKILCVSEKSKSIIAAHIKEPSKLIKIYHGFRAEREQFKTTREKLLT
ELDIPEGKTVVGNIANHIWPKDLETFLKVAHHLVYTKNRKDLYFVQIGFYFRETPHLLKR
LKGLKLEGHVKCYGFKDNASRFFKIFDYFLLTSRVEGLPNVIYEAFYHKVPVIATNVGGI
PEIVNHLENGLLADAFNAEKLAEHILFLEKNQELIPRFTENAHKKLVENFTTKQMAQQTL
QEYKNVLYGRS
>IFAGANLK_02048 hypothetical protein
MAQVFKEKIRGFFENIFGKEPKNFKQIPIIINNYNRVTTLKKLISDLEKRGYHNIHIIDN
KSTYPPLLDYYQTCPYKVYRLKKNIGFKALWRSGLWYRFFQEYYCYTDSDLSLVEDCPDD
FMETFYKLLKKYPEVHKVGFSLKIDDLPDVYHRKQEVIDWESKFYKTPKEKNVFIAPIDT
TFALYRPFSKRGKRDGSMEMLRSGWPYQCHHLPWYVNSAKPSSEEEYYIKSLEAPVHWGA
KDQNSGEK
>IFAGANLK_02049 hypothetical protein
MKVAVVIPVYKQKMSETEEISFKQCLKTLSDFPIIIACPEGFNKESFKNFRITFEEFETH
YFKDISGYNSLMLDSHFYERFLAFEYILIHQLDAFIFKNELEDWCKKDYDYIGAPWLATN
NLTSKILKPFQSKKKKKRAPIFYKVGNGGLSLRKTQSFHHISKELAPVIEKQLEKKDEIY
AIEDVFWSLKVPEHYPDFNIPDYTIAAEFALDRKPKIGLKLNAGELPFGCHGFNKRKVID
FWMPIIKEEFQKK
>IFAGANLK_02050 hypothetical protein
MKIITSENYRHLQAEIGNLIQNFNETGIMLVDGKRNKLKLFKLKGLKINVKSFKIPNAVN
KIAYRFFRKSKAERSFKYAEYLLSKNVGTPQPIAYVEETIAFSFLRSFYLSEQLSYDLTF
RDIDLSKPGHEAILRAFTRFIFELHDKEIEFLDNSPGNTLIRLNDGNPQFFLVDLNRMNF
KTLNFSERMKNFSRLTQDKEVVRIMANEYAKHIDKKEEEVFEKMWFYIKKFQEGFVRKKA
FKKKFKL
>IFAGANLK_02051 hypothetical protein
MFQHYILTRFNLRAEDWTTTKNNEKVLTEEWLEERFDLFENFCFTSVKNQTNQNFKWLVF
FDINTPDVYKQKVEEYRKTYDNFLPFFIDGMNNFLPEIINNINKLDSREYIITSRLDNDD
CIHENYTEVVQNYFSKQDHQALDIIDGYTLETGQNTRLGVLTKLNNPFISLIEKKEDFKT
VWFRNRHGSWKYEKNMIRIENQRLWLSIIHSKNKVNRFSGYGNVDPKKLYEFHISKERTA
EIIDRLMSFNSWRFLSFKNRVKFTFKRYYKDLKTSLGLYKKRK
>IFAGANLK_02052 hypothetical protein
MKYRFLIYISYPYAFPIGAPLQEEILKRGYEVKWFCDVEETKEYFTENGELIPEVNDAVS
YNPHIVLTITDSVADFIPGIKVQIFHGFPANKRKGTDQFKIRGFFDLYCTQGPSSTIPFQ
KKQQKHRNFEVIETGWSKLDPLFPLEPTTNEKPVVLIASTFTKQYSLALNVAVVAEIERL
SKTNQWYFMAVLHPKLSNEVYSKFKALENENFRFYDTTDLVPLFKKADIMFADTTSALIE
FLIQEKPVVTFKNNMPGPYLIDISQVSEIEPALEKAISKPAYLMKEIKTFADYSHPYKDG
NSSERVLDACIEFLNRDNSHLKKKPLNLIRKYKMRKKLGYFKF
>IFAGANLK_02053 Lipopolysaccharide core heptosyltransferase RfaQ
MIGDVLTSSILFEALRKNYPDAELHYLIYPHTRPVIENNPVIDKVIEYDHTSNKSPVNFI
SFLQKLRKENYTVVIDVYSKISTGILSFLSTADMRIGYKKPYTHFFYSHVFNQNIQEKSS
AGIAIEKRLQLLSPLKGNFSSEFKPQIYLTENEKLKAKKQLTNAGLLEGKPLFMISVLGS
SIEKTYPPEYLAVLLDHIVEFTNGNLIFNYIPSQEEKALNIYRLCAPVTQKAIHLNILGE
SLREFMALTSYCTALIGNEGGAVNMAKALNIPTFAIFSPSVKKQNWSVYDDGISQVSVHL
EDFMPEDFKQCSKKEIRKKTSFLYEKFKPQYIIPGLNKFLKRLK
>IFAGANLK_02054 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase
MEQLKNTIEAAWENRELLKDTETIKAIREVVSLLDAGKLRTAEPTENGWQVNEWVKKGVV
LYFPIQKMETLEAGIFEYHDKIPLKRGYKEKGIRVVPNAVARHGAYISSGVIMMPSYVNI
GAYVDEGTMVDTWATVGSCAQIGKNVHLSGGVGIGGVLEPLQASPVIIEDNAFLGSRSIV
VEGVKVEKEAVLGANVVLTASTKIIDVTGDEPKEMKGIVPARSVVIPGSFAKKFPAGEYN
VPCALIIGKRKESTNKKTSLNDALREYNVAV
>IFAGANLK_02055 hypothetical protein
MKKNYPEKIFTGIMVCILILLVLNILSYLDFYYNNLDQRDYFFRKTNFNLERNAPTIFSS
SLHFTASILLAIVAYSKLSIKKIKSFWVFLSILILFIGLDELLVIHEKVGRAFGENVETS
GIFFFAWVVPYGIALILIGLALLKSLLKLPKKTRLNFIMAGAIFVSGAMGIEMFTGWYVE
YNQLQNENLLRVPDTFILSTFEELFEMIGIGYFVYSILDFIREYRIKK
>IFAGANLK_02056 Putative pre-16S rRNA nuclease
MGRVLALDFGTKRTGIAVSDELKMIASGLTTVKTPELLGFLENYFKEENVELVLVGEPKQ
KDDSASESEVYIQEFLKVFTNKFPEMPLKRVDERFTSKMAFQSMIDSGLKKKKRRDKALI
DEISATIILQTYLYE
>IFAGANLK_02057 Peptide deformylase
MILPIVAYGDPVLRKKCKEIPEDYPKLDELIENMWETMYNAFGVGLAAPQVGRPIRLFLV
DSSPFAEDEELELQEREELKKLKKVFINPKIVEEEGEEWAFNEGCLSIPEIREDVFRKPK
ITIEYQDQDFKSHRDTFTGLAARVIQHEYDHIEGILFTDKLSSLKKRLLKGKLAGISKGK
IKIEYKMRFPEMKKGR
>IFAGANLK_02058 hypothetical protein
MGLDKILAISGKPGLYELTAQSRGGFIVKSIPEGKKMAVNIRHNVSLLSEIAIYTYTEEV
PLAEIFQKMKEKENGGEAISHKSNKAELENYFAEILPDYDVDRVYASDMKKIFQWYNLLI
KNGITDFATTEEEKPADKDNSGEEE
>IFAGANLK_02059 Macrolide export ATP-binding/permease protein MacB
MSNNKTSKPGFNWLFKMAWRDGKASGKKLTLFMASIVLGIAAVVSIQSFGENLKDNISLQ
SKALMGADFKIDSDDAPNERVMQIMDSLGGAEAREIKFASMAAFPQNEATKLMQVRGIEG
GFPFYGELETQPVSAANTYQEDGAALLDATVMLQLGIKPGDSIKIGKVILPIAGALNSVP
GSTAIFSSVAPPVLIPYRFIEESGLVQTGSRIDYEFYFTADPKTDMEKLDEALDPILDAE
DADLDTHTSTSDRLGRRYENFGKFLNLVAFIALLLGCVGIASAIHIYIKEKLRAVAVLKC
LGASKKQTFLIYLIQVAFMGLIGGIIGTAVGLVLQQLFPLLLEGLLPVDVQITFSLQVIV
MGILLGVLMSVLFALYPLIGTLYISPLQALRVVNEESKKSRKAIILVSIGIFLFIFLFSL
WLLEDWEYSLAFVCGILVTFSILAGIAYLFMQAIRKYFPHSWGFVARQSLLNLFRPQNQT
LTLVLAIGVGTFLISTLYFSKDLLLAQASIESQADSPNMILLDVQSEQREAVAQTIKTND
LPVLDDLPIVTMRVQSIEGKSVNEIRNDTTSQINGWVLNHEFRVTYRDSLSASEYIESGS
WTAEGGDISPVPVSISDNFAEDAKVEVGDELVFNVQGVLLDAVVGSVRTVDWSRMQMNFS
LVFPNGVLEKAPQFHVLTTKVPGEEKSAELQQELVRKFPNVSIIDLRQVLNVIEMLLGRI
SWIINFMAFFSILTGIIVLLGAIRTSKYQRIRESVLLRTLGAKGKQILNITALEYIYLGV
LGGLSGVLLSLISSQLLAWLVFESSFTPSLIPFLVLFPGIVLLVLIIGLSNSLSVIRKPP
LEVLRKEMT
>IFAGANLK_02060 putative ABC transporter ATP-binding protein
MAKILNVTNLEKSYSSGSKKLKVLQDINFNVEEGKTFAIVGPSGSGKTTLLGLCAGLDRP
DTGSINLCGSELSNLSEDERALLRNKHIGFVFQDFQLLPTLTALENVAVPLELQGNKDAS
KIGKELLEKVGLGDRIHHYPSQLSGGEQQRVALARAFSTRPSILFADEPTGNLDAETGEK
VEALLFDLNKEAGTTLIIVTHDIELAEKTQHILRLKGGRIVENQQKHV
>IFAGANLK_02061 Esterase TesA
MRNLMRYCMILSIFMIFSCGENAEKKSEETTAEETETKKETEVSEKNVILFFGNSLTAGM
GLEPSEAFPALVQNRLDSLGYNYEVVNAGLSGETTASGKNRINWVLDQDVDIFVLELGAN
DGLRGIPLEETRKNLQDIIDTVKEENPGTRIVLAGMQIPPNMGEKYTSEFRNIFPDLAEK
NDVELIPFLLEDVAGDPELNQQDGIHPTAEGYKIVTENVWDVLEGVLEKE
>IFAGANLK_02062 Metalloprotease TldD
MGAGALMVPSYLMGSNISAEALLHPGMDILTKRKLADVALNTAKSLGSTYADARIGRYLN
QYVFTREDKVQNVVNTESFGIGIRVIANGTWGFASTNSVTEDGIKKATQQAVAIAKANSK
IQREPVKLAPVQSHGEVSWKTPIEKDFKEVPVSEKVDLLLSANAAAMDNGANFVNSALFM
VNEQKYFASTEGSYIDQDVHRIWPTFGVTAIDREAGKFKSRDAMSAPMGMGYEYMDGLES
EKLEGPSGLRLYRNSYDIVEDATLAAKQAKEMLSAKSVEPGKYDLVLEPNHLGLTIHESV
GHPLELDRVLGYEANYAGTSFATLDKWKSGDFQYGSDIVNLVADKTQVGSLGAVGYDDEG
VKTKKWDLVRNGILTNYQAIRDQVHMIDQNESHGCCYAESWNDVQFQRMPNVSLEPGKDK
YSINDMIKDVEKGIYIAGRGSYSIDQQRYNFQFGGTVFYEIKNGEIVGMLDDVAYQSNTQ
EFWNSCTKICDKSDYRMFGSFFDGKGQPSQVSAVSHGSSTSRFDGVNVINTGRSV
>IFAGANLK_02063 Metalloprotease PmbA
MAIYTKEEARQIMEKALSFSTADACVINMGGSESGNIRYARNTVSTSGHRSNQTLAVEAS
FGKKSGTATVDEFDDESLESVVKRAEELAKLAPENPEFMAPLGPQTYDESISFVDATANI
KPEYRAEVAAKSINPASEKDVTAAGFLNDSSGFSAMLNSSGLFAYNKSTDVDFTVTMRTN
DGTGSGWVTRDYNDVTKFDPAEAAKVAIDKAVMSREARAIEPGKYTVILEPAASVDLLRN
MSGAFNARTADEGRSFMSKDDGTKMGEKIVDERVNIWSDPLHPDVPTSTWNGEGMPLKKM
KWIENGVVKNLAYSRYWAEQQGVDPVPFPSNFIMEGGDASREELIKNTKRGILVTRLWYI
RSVDPQTLLYTGLTRDGTFYIENGEIRYPVKNFRFNESPIIMLNNLETLGEQVRINGNLI
PYMKVRDFTFTSLSDAV
>IFAGANLK_02064 hypothetical protein
MNSFFFTRLQYESGDWDVDQRMPSNLLNSLVEYTTLEVDTKENIVPLSSDEIFKCPFCYI
SGHKLVQFTTKERENFEKYIRNGGFVFADDCNHDIDGLFAKSFERQMEEIFGPGELAKIP
NDHEIYNIFFEFEDGPPTTSQELNGWGDDLVHEYLKAIVVNGRIGVLYSNKDYGCEWDYD
FRNKRFYKIDNTRFGVNIVMYALTS
>IFAGANLK_02065 hypothetical protein
MDQQLADLNQEVKTLTGKLKDLKTEIAKVIIGQEETVDQLLITFLAGGHALLEGVPGLAK
TLMIRSLSQAIDLKFKRIQFTPDLMPSDIIGTEILEEDHTTGKKFFEFNKGPIFANIILA
DEINRTPPKTQAALLEAMQEFEVTYSGTTYQLERPFFILATQNPIEQSGTFPLPEAQQDR
FLFYIKIGYPTEIEENQILKHTTGSKKATIKPVLTGSEILRLQELVREVPISDELISYVN
KLIRATRPETSNNEFVKEWVSWGAGPRAGQALILTAKARALQQGRLAVTPEDLEHCAYPV
LRHRVIVNFKAEAEGITSDEVTTGLMKSIFPAEKARNK
>IFAGANLK_02066 hypothetical protein
MKQDYRQLLKPEVINSVSGLSLIARVIVDGYLSGLNHSRRLGPGMEFSQYRGYEPGDDMR
LLDWKMLARSGRYYIKQSEVETNISVKFILDASNSMQHREDGISKIEYTRVLVASLAWLA
QNQGDAVGLFALNDRELHALFPRVQKKHFNRLLQELINIKTEGKWPKDPKAAEKLHDRGH
KELIFFISDLHEETSELTNVITKLKTPRNEVVVLHLLGKNEVEFNHKGSLTFEDLETGAR
MEVDAKEARSKYLEALEKSIKTTKEIMLANAISYQLLRLDEPIGEALQLLLKKRNNLM
>IFAGANLK_02067 hypothetical protein
MFFVNPSFLWALIGLAVPVAIHLWSKKEGKTIKVGSIKFLQESDSQKSRSIKLNELWLLL
LRMLIITIVGLILAEPHLNYKAENSPITYLVESSLLSSLEVKSLTDSLNNTAELRFLQSG
FPEYQPEIENNFSETPSYWQLAVEMQTLKTDSIVVFTNAFLSGIKGKRPEISKNINWINL
NPGETEKNRVGAIKKGDSLELISAISDAESFRFQKEKQHTSSGNQESELKNVPVLEVDPL
QITIYSDEEFQAERRYLEASFLAVGKYLEQPIEIRSFEEDNFKPDSDEFLVWLSEKPVPK
TEGKILNFRRGTLANSLIETGNSKNEYYLTNELNSENVVEEHLGEQLIQMLDLYSEIENV
ANKYDRRIMNVGILKPNFETGLAPIKNKEGRDIVKYLWILLIIFILSERILARVRKQ
>IFAGANLK_02068 hypothetical protein
MSKTGKNILKRYQKRWQFLLWLEVFLYAIGAAFFTWFLSFSLLLSIFAALLVFLIVMVLE
RPWEIDIKRVSRFIDRKSDKLEYSSGLLLQPSGDLSGLAKLQQQKVAKEVEAESKRIQPK
NNLKTAAITSVGMIGIGFCAFYFGLTETYLLKDKNIPTDEIINFKPTDSSGIKIETPVLN
DQQLTISYPAYTGVPATTTSKMDIKAVEGSRVSWKLGFEGGVNSVSIESMGKRRTLKKDN
GEYSGSTVLENSGFYNFRFTDTAGSAYVSDLFAIEVIKDKAPMILLEDLQQFTTFNYDDR
KLINFSASITDDFGVADAYIIATVSKGTGESVKFREEQLSFDNSVARGERKLNLTKNIDL
DQMEMEPGDELYFYVEARDLKQPQANIARSETHFAVIKDTVDYGPGVEGGLGVDLMPDYF
RSQRQLIIDTEKLISERRKLSKEEFNDTSNDLGFDQKALRLKYGQFMGDEAEGGMESGGE
TLEENNEDPLADYTHDHDGDNGHNLVEEEHDHDNGEENEEGEDPLAEYLHDHGDPESSTL
FTDNLKSKLRQALNIMWDAELYLRLYEPEKSLPFQYEALDLIQEIKNSARIYVHRIGFDP
PPIKEDARLSGELEEVGNFSKKEELENPDEYLFMRNSILRLEELKDSNSEISETDRELFE
KAGNELAEKAIAEPGKYLNTLQQLKQLAEVQQTEQDLISEVQKGLMQALPKVSPEPGKRN
GFSDKLNDLLLKELELNGQ
>IFAGANLK_02069 hypothetical protein
MDNNITFLNSTWFWPVLMCWLLLMLVFVWKEVSQSGKKRLILKVFLIFLAVSSLALIAIK
PAILKEIKEESYLILTENFKQKQLDSLKNKYRKIEVIDYRKNKVLPTLGNSKEIFVLGSG
IRDYDRWQFEDLPVTYLPGETPSGIVKLNFKQQKQVGDKLELRGEFLAPKPGTQLVLKDA
GGISVDSIVFTLEENTNFKLSTDLKAAGDYVFNIVEKDSLGEILNRNPFTVKVDKKENLR
ILILNSYPTFEIKYLKNFLAESGHELVVKNRITTGRFKFEFFNTKRGNLGRLQQSNLEDF
ELLILDSGALRNLSSAERNALQNLVREAGLGVLILGEANILNSLGDFSVFALQRVSATEA
VLDDFPEIAIGKQPYQLKPKFGLEEIHRSNSSILSAYKRFGQGRIGTTLLESTWQLQLEG
KQESYQQIWSELVEQISKRESVIASWHQETGFAFKDEPFQFQLRTSVENPRVRDKNNYLI
PLKQDLNNSELWTGKTYPRETGWEQLKMEQDSASVFNYYVYKDNDWQAIKSYQTLQENNR
FFPQKISKDSVEKTPVAINPLWFFGLFLIGMGGLWLEPKL
>IFAGANLK_02070 hypothetical protein
MEIIILFLTGIISALLTYVVNNKYKQGAVRASAGLSLLVGLFFYLFPDILTPYLTKNIPI
VFIGATFIGMVSSKILPSYLLVGFSGFIFSIIYLNASPFFKGYGGALGTTAAISVLVSLS
LAVVSKSEKIKKIKNYRTSRKNK
>IFAGANLK_02071 hypothetical protein
MQFAFLFAIFFDKMNAPLVLLFLGIISVLISLAYFKAPREEESYFIKDLYLIFFAVTGAL
STFFINTGLKFGPVIAAGFIGTLASFVPSINRKSNLLKEAPPAIYCGAFVGMTSASVAPN
LKFILLAGIIAGSILILSKNIFNGFGGKLGTIAFGSIAITSAILYTLF
>IFAGANLK_02072 DNA polymerase IV
MKNKSILHLDLDAFFVSVERKQNSELENKPLIVGGMGDRGVVAACSYETRKFGVHSGMAM
KVARQLCPQATVIKGNASTYTKHSHEVTEIIKSQVPSFEKASVDEFYADLSGMDKFFGIN
QFARELRQTIIKESGLPISFGLSQNKVVSKIATGEAKPNAEIVIPHGNEKVFLAPLSVNK
IPMVGNKTFQKLLNLGVREIKTIQEMPVEMLESVLGKSGRTIWKRANGLDDSPIIPYHER
KSISTERTFGRDTIDMVRLHATLVAMAESLAYQLRRGSKLTSVVSVKIRYSDYQTHSKQV
KISYTSADHILIPKVEMLFKQLYSRRLLIRLIGVKFSGLVGGNYQINLFDDSEEMLNLYN
SIDKIKERYGEHSVMRAVTLGTKTIGRMANPFNGEPPIVLAHRKQ
>IFAGANLK_02073 DNA polymerase III subunit alpha
MIYLNCHTWYSLRYGTFSVEKLCELARKFNVESLALTDINNTSGCLNFIKIASAYGINPI
TGIDFRNGAKQQYIGIAKNNEGFRQLNEHLSQQLHSKKEFKSEAPGLPDCFIIYPFEKVV
ANKKFSFKENEFIGISVESLRKLKFSKYLEFKDKLVLLQSVSFRNKRDYNAHRLLRAIDN
NTLLSKLPESEQGSFAHQMIPSEIIAAEFEDYLHILENTRELVKDCRVDFEFGKEQNRNL
LVSGESPEADVARLRKLCDENLLKRYPKAEAKVLERMEKELRAIIKLGFVSYFLINYDIV
SYARSRNFPFIGRGSGANSIIAYIIGITNVDPVELDLYFERFINESRSSPPDFDIDFSWK
DRNEVTRFIFEKYKFTALMGTYVTFKRRAVARELGKVFGLPKENIDKLSAGFFNINELDK
LEKLVLRYSALIEGFPNYLSVHSGGILILNNSVYNYAATFLPPKGFETIQIDMNIAEDVG
IHKFDILAQRGLSKITDTIEIIKENQPEAEIEDIDNIDVFKEDPEINELLKTGDCMGVFY
VESPAMRGLLTKLQTDNYLNLVAASSIIRPGISSGGMKEEYIKRHRDPSRRKQGHPVMLR
IMEDTYGVMVYQEDVMKVAHKFAGLSFEDADVLRRGMSGKKTSKGQMERIEAKFRDNCRQ
RNYSEKIIDEVWEQISSFAGYAFPKGHSASYAVESYQSLYLKKYFPLEFMVAALNNGGGF
YDVETYIQEIRKCGGKVHPPCINNSDHPNKIYGKDIYLGLGYIKELETKTVQQILENRQF
FGVFKSFDDFIDRVNISIEQLSILLKIDAFRFTKIDKHHLLWKAHFKLNATKPAVKQEKL
FATPHRDFELPRFQYSALIEAFDQLELLGFPLCSHFKLLKNPIEESVMAKKLKDYVGKEV
LIYGALITAKKTGTSNGKYMYFGTFFDGEGDVFDTVQFPATAEKYPLRSKGIYKCYGTVN
NELDYISISIKWLQRQDTLTDPRLIGYQFS
>IFAGANLK_02074 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MNTIIKTDFNFPGQTDVYKGKVRDVYTLKNNKLVIVATDRLSAFDVVMPKGIPYKGQILN
QIATKMMEATRDLVPNWLEATPDPNVAVGQACEPFKIEMVIRGYLAGHAAREYKAGKRML
CGVEMPNGMKENDKFPEPIITPATKAEQGDHDEDISKEEILKRAIVSKEDYEILEKYTRN
LFKRGTEIAAKRGLILVDTKYEFGKNADGEILLIDEIHTPDSSRYFYADGYRERQDKGEP
QKQLSKEFVRQWLIENNFQGKEGQILPEMSDEYIQSVSDRYMELYEKITGETFIKSDISN
IEPRIEKNVLEYLK
>IFAGANLK_02075 PhoH-like protein
MNEIVIELSEINPREFFGQQNENIELLKKYFPKLKIVARGNKIKVFGDEEMLEEFDERIT
MLMEHFGKYNKLDENVIERVLTSEKSSDYQTSDESGEVLVHGVGGRLVKAQTANQRKLVE
LMRKNDMVFAIGPAGTGKTYTGVALAVKALKEKQVRRIILTRPAVEAGENLGFLPGDLKE
KLDPYMQPLYDALRDMIPQERLDSFIEKGVIQIAPLAFMRGRTLDNAFVILDEAQNTTHA
QMKMFLTRMGKSAKFMITGDPGQIDLPRRVISGLKEALLILKEVKGVGIIYLDDKDVIRH
RLVKKIISAYKEIEHTE
>IFAGANLK_02076 Adenosyl-chloride synthase
MAIITLTTDFGEKDYFVGAVKGAIYSELKDGRIVDISHSVSPFHISEAAYIIKNAYNSFP
NGSIHIIGIDSEFTPENKHLAVLLDDHYFICANNGILSLLASEIKPEKIVEINIHDTIET
NFPVLDVFVKVACHLARGGTLEVIGKNISEIKYLKQFEPAINSEKNQIVGHVLYIDNYGN
VVTNISRKLFDQVGKGRNYLISARMVTFPKIYEAYSDWINFEVEKENRGEEDGKKLALFN
SAGYIELAIYKSNPSTVGSASTLFGLEHRDTVTIKFEEK
>IFAGANLK_02077 hypothetical protein
MIHRIVKMEFDPEKVEEFLSNFEKNKKKIRTFGGCYKLQLLQDQDNTNIFFTYSYWVDDP
SLERYRNSELFKDVWAKTKVLFNAKPEAWSTNIISSQ
>IFAGANLK_02078 hypothetical protein
MLAILNKEINSFFSSPIGYLVIGIFLVVCGLFLFVFTGDYNILDNGFADVKPFFNLVPWI
FIFLIPAITMKSFSEEKRQGTMELLLTRPIGFTQLILGKYFGALILVILAILPSILYVIT
IHQLGKPVGNFDLGATLGSYLGLIFLAGCYTAIGIFASSFSQNQIIAFIIAVFLCFLSFF
AFEGLGNLDLFGSTNYGVEYLGISFHYQSISRGVIDTRDIIYFLSFIVLFLKLTQIRLIS
IQKKS
>IFAGANLK_02079 hypothetical protein
MKYQNTYKAVFLLLIAILAINFLAANFFERIDLTRDGRYTLSPAAREIVSDADSPIVIEV
FLEGNFPSEFRRLRNETRQMLEEFSAYNSNIKFIFTDPLEESNDAEATAQKFYEDGMPPA
RVSVQESGKSSEVLIFPWAVARLGYKKVQIPLLKNKLGATDEERVSGSVQQLEYAIANAL
NKLVYPRDKKIAVMRGNGELPDAQIADFIKTLQEYYFMAPFTLDSAAVNPQKTLQQLKEY
DLIIEAKPTQAFTENEKYVLDQYTMSGGKSLWLTEAVAMETDSLMNPSGKTFALPRDLNL
GDFFFSYGIRINPVLINDIYSAPIILASGQGKNTRFNPYPWFYSPLTTSPNDHPIINNIE
AVKFEYANQIDTLQNNIDKTILLSSSPQTRLEGTPREISLEMVSREPDLASYNDGEQPLA
VLLEGEFTSAYNNRIKPFEIENPRDESPETGMLVISDGDVIKNDVQRGEPLELGFERYTG
NTYGNKEFLLNAVNYMLDDSGLIDIRSKEINIAFLNDQKAAEEREKWQVINLVLPLIFLG
IFAFGFNYFRKRKYLK
>IFAGANLK_02080 DNA polymerase III subunit beta
MKFIVSSSYLLKQLQILGGVINNTNTLPILDNFLFDLKQDELTVSASDLETTMSAKLKVE
SDSEGKIAVPAKLLLDTLKTFPEQPLTFVAEDNNTIELSSNHGKYALAYADGEEFPNPVE
LEDPSSTVLEGDILATAISKTIFASGNDDLRPVMSGVFFQFTTEGLTFVATDAHKLVKYQ
REDVSASQASDFIMPKKPLNLLKGILAGSESEVLIEYNDSNAKFTFDDTQLVCRLIDGKY
PNYEAVIPKENPNKLTIERNQFLSSVRRVSIFSNKTTHQVRLKIAGAELNISAEDVDYSN
KAEERLTCSYQGDDMQIGFNSRFLTEMLNNLTSDEVQLEMSLPNRAGILTPVDGLDPGEK
ITMLVMPVMLNN
>IFAGANLK_02081 hypothetical protein
MREDNQMLVITHLSQLLDLVTGIGGFIVPLILWLTQKDKVAGMDFHGKMIINFQISMFIY
GLICVPLIFLFGLGFIGLIGIAIIMLVLPIVNAIKVSNGEIPNYPLTIEIIK
>IFAGANLK_02082 tRNA modification GTPase MnmE
MKLNDTIIALATPSGAGAISIIRVSGPEALAIVSPLFRAKSKKKLEEQPTHTLHLGNLMD
GDRTLDEVLISVFRAPKSYTGEETIEISCHGSPYIQQEIIQLMIRKGCRSAEAGEFTMRA
FLNGKMDLSQAEAVADLISSENQASHQMAMQQMRGGFSNEIHRLRQELLDFASLIELELD
FSEEDVEFANRDQFKELVARIQQVLKRLIDSFATGNVLKNGIPVAIVGEPNVGKSTLLNS
LLNEERAIVSEVAGTTRDSIEDEMSIGGVGFRFIDTAGIRETEDVVESIGIKRTFEKISQ
AQVVVYLLNAEKFKAESSKFKVEIKKIHNQFPQKPLVVIANKVDQLTEKEKESLSKNLNE
LEGASLQLISAKTGEGVEELKSKLLEFVNTGALRNNNTIVTNSRHYNALLKALEEINKVE
EGLNNDLSGDLLAIDIREALEYFGEITGQVTNDELLGNIFSNFCIGK
>IFAGANLK_02083 hypothetical protein
MLAPVSKALVNIKYLKMKYFFPFLFIIVLSGSILCAQNTFQDQKPKTEASEVTSIFLKVR
YLDKPTLLEKERIQDALNKLKAREIRNISITDGMTTVTYNFSPESGKVIIESSKKSQPSN
SRENDV
>IFAGANLK_02084 hypothetical protein
MKKIFFFWLVISMSTSCDIGTEICEKGKAAKLYYTPDCATINGHIILEGGNKTYVFQHEI
DEQFQGTGIDVCVQYEIEPEPIPLTAECTQADVITIIHLKER
>IFAGANLK_02085 Sensor protein FixL
MGVLQDSNLKVEADAYLLEQVLINLVLNAMEACENTPNPKVKVYAVKKFDGQVIISVTDN
GPGIPEEIKDQIFIPFFTTKKEGSGIGLSLSKQIMTLHGGKIQVNSMENKGTLISLIFKE
NTASTKTSIL
>IFAGANLK_02086 hypothetical protein
MRLMDEHYTDHPFKGAKRMHTWLSMDKGYKVNKKRIERLYSKVMGLQAIMPGKHTSRRHK
KHKVYPYLLRNLKVERPNQVWATDITYIPMRKGFMYLIAVIDLHSRYVLNWSVSNSMDAH
WCKETVEEAIRLHGKPEIFNTDQGSQFTSEIFTGSIRSRDIKLSMDGKGRAIDNVFIERL
WRSVKYENIYLNPPESGVGLYRQLRDYFDFYNHRRRHQGIENEIPINRYLQQERNAA
>IFAGANLK_02087 hypothetical protein
MTRRKFTSKFKTKVVLEALKERQTVKELAQKFEITPQQIGTWKRDFLNEADTVFSKGEKS
KKSEAEEKKDQLLKVIGELKVENDFLKNALR
>IFAGANLK_02088 hypothetical protein
MQLTNIISKRSQYSSNLIIAGDFNTSSFSNHFKILLSNNLKDSRVGFGLLPTWPANYGIL
QTTLDHFLVSDDLQVIDRSTGPNIGSDLLPINMIIGIE
>IFAGANLK_02089 Imidazolonepropionase
MVSIKSYCLLLFVFLTTIIKAQENEKFILAGSFYDSEQNILLKDRIIHIDGNEIIDVGKN
IKIPSDAKIIDLSNYTVLPGLIDAHTHVLFDQEPQDDFAEHSITTLVLKNQALRTLRGVK
RAESYLDVGITSIKDLGNSGEFLDVALRNAINEGSIEGPRIFAAGQIMSGPGGQIYGVQK
KYQEIIDEEYRIIKSPEDAINAVREHINQGVDLIKICADNLPNNTRLTVPEMRAIVQTAH
SNGLTVTAHSITNHSAWNAIKAGVDGIEHGFFLADSTLNLMADKNVFLVPTENSRDYMEA
YYQLQGKDPEEIPWLDRYMNDMQDRLMKAIEKDVMIVAGSDNYSDIQVPRGVSSQDMYKA
YYESGMKPLNILQSATYLAAKSLNKQDEIGVLKSKSYADIIALKGDINKDFLSSIENIVF
VMKDGKIDVDKSN
>IFAGANLK_02090 hypothetical protein
MEVDYKKYFDLFMEQFPELSPEAKNFTRASLSLEKYSKKEFLFKSGQVQKELGYVCEGLL
RKYYISEKGNKITTSFLSERGYATDYPALLRQQPSKYNIECLEPSIIIKLPYIKLQEAYF
KHKESEMYGRLMAEKVLTREIDRVESFLFENAEERYLNFIENNKHIINRISLTHLASYLG
IERQSLSRIRSKLAKP
>IFAGANLK_02091 putative hydrolase YxeP
MTSIQQNIKFLFLVIMLSNFGYSQEKQVIPSIHQSIQSQTDNIFESLVEIRRDLHKYPEI
SGEEKRTAGKINEYLLSLGLEVKKGIGGNGVVGILKGAKKGRHIAWRADIDAMSSDIPDV
VEFKSENPGIRHICGHDVHTTIAMGIANVLNSQRENLKGTVYFIFQPAEETYRGAKAMIN
DGLFEIINPEEIYGLHITPSPAGVVSTKENNVYAHRTKIEVVYQSTNQNTAALDYTKGLI
SNLQTYGKESEFWEDKNLMDPDLGLANRNTIYSNYIAVKSDYYIKETEDKLKISAIVDAS
EKDLLEKFKTTIKNVINESKFSENLLAVKFNFSKEMPIKDTPMNDKELATATMNSLAEIY
GENVIVPVYGVTSGQMADDFAYFQEEVPGVYFFLGGSKYEKGIIAMPHTPNFAVDEESMR
AGVKYFSSMIVERLLD
>IFAGANLK_02092 Ferri-bacillibactin esterase BesA
MKFKFLIGLILFSYSSYSQIPIPIGETETIHSEILKEDRILEIHLPESYGESDKTYPVLY
LLDSFYNFSHAVGTVEYLQLNRLIPDMIIVGIRNTNRNRDLSPNSPELSKEERERMGRPG
GADNFIAFLEEELIPYVEKTYKAAPYRIIFGHSLGGLFNVYTFYKNPELFDAYLTVSPSL
WYPNELISRDFKDVFKNPSKLRAAFYMSLADENKGNMRGNVLKLSGEFNNYINTHKDAGL
RFKYEPMPEESHGTVGLPSIFSGLPFIFEPIQYEIPRTKEEILAQGGPEAAIKNTVAYFD
ELSEKYKFEVSKKNALTDLGYAFLRLEEYKEFSVNAFKVNVETQPDSYEAYSSLGMAYEE
IGELQKAKNNYEKALNLVMKTDDPEWEFYKADLDNLKSKMEAKPGK
>IFAGANLK_02093 UvrABC system protein A
MRIINAHQNNLKNINLEIPENQLIVVTGLSGSGKSSLAMDVIANEGYRYFLESLPAYNQQ
NAQLIPTAEVDDIESLPPVIKVEQSKRFQSINTTFGTLSEIASVFRILFARYSADDTMSK
SLFSFNHRKGACEHCYGLGEAEYIDLNKLVGDENKTLREGAITTTLPNGYIVYSQITVDE
LNKVCRAHGFSVDIPWKELTAEQKEVVLNGSDRTKVFFGKHTLESRLRWEGLKAKPREEG
FYKGMLPIMKNILRLDRNPNILKFASSKTCPSCKGARIKAEHLKYKWKGRNFQQWMELPL
NDLYNKLKSQDLADGEQVLVDKISIQLFDLIWLGMEEYRLGTPSTEISSGDAQRIKLIKQ
VNSSLQGILYVFDEPSIGLSEDYQKYLRHILKRLIKRGNTVMVVEHDLSFIKSADWIIEL
GPAAGAYGGEIIFNGTIQEFLNAKDLSSPTLTELQKEFSNPDSEIKKISADSFQPKPGEL
TVVSRKTPQLLKKLSKHSEKEDLKLLTVSDQPIGKTPRSNPATYTGLADKIRDLLAKSPE
AKALKLAKGAFSFNNKRGRCEACEGAGVITLSMNVLGTINQVCPTCNGKRFKPEVLQVEW
NNKNIAEIYDLSLAEAFDFFSGEKKITKILALMLQLGLGYIKLGQPSNTLSGGEAQRIKL
TKHFAKQSKKTLLLLDEPSIGLHQQNVRQLLKALHQLKEQTAGIICFENHRLFQSSCDLL
VEDNSKSSPLEFEESPDHSRNTISVKGARTHYLKDLEVDFPKNQLTVITGISGSGKSSFV
IDTLHGYGLQEMTKQFSSYQQSRVGVNFQFEVDHIEGLTPTICVTRKEKSFTDRSDIAKQ
TGIDKILRFAFSRKAQYVGKELSASHFSNNHELGKCAVCDGMGQELLPDLDKIVLDKNKS
IADGLFEHSTALAYYGQASSQYIAVVREVGAKNGFNLETPFNELTNEQKDILFNGAGETV
WKANWKFKTKTREGIQEVSMKWEGLFHYLKEEYYKTRKNKNIEKLKALFSLEECSHCAGS
GLKPERLDFHIGGKSIHEIRTMDFKALENYLSSDSKIEKIDQKLISNIHPHLLNTIKRAK
QLHINHLQLNRKSNTLSGGENQRVALIKQLNSPLKGITYLLDEPSAGLSNDNIPDLINIL
KELIAKGNTVIVIEHNKEIILKADKLVEVGPKAGKLGGYITFEGNPKNYLKKKDSHSFLK
EPSKAINLKDAKDSVSIRRISKHTLVKDHLKVPVGGITAISGKSGIGKTTLVKDILIPSI
ETGKPVNCEGIKFPKKYSEAHYFETKKLRTHANTLLVSYLNLLKDISKIFATETKLKPRD
FSYKTKTSQCPNCKGKGYLETSLDVAANAIEKCAVCKGQRYQPDILKHTVNSKDIADVLA
LNLMELKEWFAGTKVSDKIIPFLNQLEEIGLAHLRLDQPVQSLSSGEKQRLLLLNWLQNT
TNNTLYILDEPSTGLHYADIDLLFEILKKLSKNNDLLIIDHNPYLLGKIGVGVVLE
>IFAGANLK_02094 hypothetical protein
MNKLVVSRRSEWTNRARKIGLYLNDQKIDTIGNGESKEFDLEPGNYKLKAKIDWCGSQGH
HVEIKDNEVTKVEITGFTQNKWVLPVFIIHY
>IFAGANLK_02095 hypothetical protein
MNKVRITGFVLLAIGIGLFSLIDGDLADISAGLLTGLGVGLLLTGRLRFQK
>IFAGANLK_02096 hypothetical protein
MKNKLKVLRAENNYTQEDLADIIGVSRQTINAIEKEKFDPSLPTAFRISKLFKLPIEAIF
SFEEN
>IFAGANLK_02097 hypothetical protein
MKAERKKNLYILAIWTWTWVATLALASFGPKYIWDEHSVLTTLAVSVNFVHGILMIIANR
RMFNNFDELERKIHLESLALTLGLAVVVGLTYSLLDATNLIAYNAEISNLVIFIGLTYLV
LVTVNTKRYA
>IFAGANLK_02098 hypothetical protein
MKRIFQVLIILLTTVTIGQTSEQTKEEKIKDLIENSFQKIFSDMEPKALDTYCTPDFLLL
ETGEVWDMDKMRNYIKEGGEQKSGVKRINSFDFIEIKIEGKMGWVAYHNKAEFLSGDEVV
REINWLESASAILTDEGWKLQLLHSTIAREE
>IFAGANLK_02099 hypothetical protein
MPITANDPNRKTWLETSENTDFPIQNIPFGVFLTRDDVITIGSRIGDFAIDLGALHQLGY
FEGIPLTDDIFLQDTLNDFISDGKKTWRLVRNRIADIFDAKNDKLRDNEEHRSRVLFTLD
EIEMQMPVQVGDYTDFYSSKEHATNVGTMFRDPENALLPNWLHIPVGYHGRSSSIIPSGI
PVHRPQGQTKPKDSDTPIFGPSKRVDFEVEMAFITTDANVLGEPIPIDEAEDYIFGMVLF
NDWSARDIQVWEYVPLGPFLAKNFASSISPWIVTLDALEPFRTESPKPEVELFPYLRSTG
KKSFDINLEVSLKPENSEETPLAKTNFKHMYWNMSQQLAHHTINGCPVNSGDMMASGTIS
GKTPDSYGSMLELSWKGEKPVKLKDGSERKFIEDHDTVIMRGYCQSKGRRIGFGEVSSQL
LPVFEPKKK
>IFAGANLK_02100 Serine hydroxymethyltransferase
MQRDTEIFNLIAEEKERQLNGLELIASENFVSEQVLEAAGSVLTNKYAEGYPGKRYYGGC
EVVDKVEQLAIDRLKELFNAEYANVQPHSGSQANTAVFHTCLNPGDKFLGFDLSHGGHLT
HGSPVNFSGKLYNPVFYGVDKETGLIDYDQVAEIAKKEKPKMIIAGASAYSREIDYKRFR
EIADSVGAILFADIAHPAGLIAKGLIGDPMPHCHIVTSTTHKTLRGPRGGIIMMGKDFDN
PFGQNLKNGKPKKMSTLLNSGIFPGNQGGPLEHIIAAKAVAFGEALTDEFLHYTVQVKKN
AAKLADIFVEKGYEVISGGTDNHCMLIDLRNKNVSGKEAEEALSKAEITVNKNMVPFDDK
SPFVTSGIRIGTAAVTTRGLIEADMPKIVDFIERVITNIDNDSELEAVKQEVKAMMKGKP
LFKM
>IFAGANLK_02101 hypothetical protein
MAETPEIFEQSFLVEERHLDEQNHVNNVQYVQWVQDVAKAHWEARATKKQNEKFFWIVVT
HEISYKQQAFLGDKILLQTYVGETSHVKSVRHVIIKNAETEKVLVEAKTTWALMDQEKKR
PTKISEELKKVFQQ
>IFAGANLK_02102 hypothetical protein
MNKFKLLGLLLLGFIIFSCGSNSDKKTSYFKLKIAENKTEFKLGETIEGSIESLKDREID
SIQLYFQQKYLQTLKTETSFSVALENTKLGRQKLEAIVFSEGETDTISDNLKILNNQSPK
AYTYKVIKEYPHDNEAYTQGLEFYQDTLYESTGQYGSSSLRKLNLETGEVLNKINLEDTY
FGEGLTILDNKLFLLTWREKEGLIYNLDDFEQTGTFSYNQSKEGWGLCNDGEKLYKSDGT
EKIWILDSGTLAEKDFIQVATNTKIYSKFNELEWVDGKIYANTYQFPSVTIINPENGAIE
GVIDFRGLRERLSNLEDLDSQNHVLNGIAYNQNTNQLYVTGKNWDKVFEVEIIEK
>IFAGANLK_02103 Cyclopentanol dehydrogenase
MKTNTSPQKVVLITGASSGIGKSIGEYLSKQNFKVYGTSRNPSKISHPPFTMVALDVTKK
ETIATAIEQIIAEEGKIDVLINNAGVGITGPIEETPDEEIAKAFETNYFGPIKVIKAVLP
GMRKQNSGLIINITSIAGYMGLPYRGIYSASKGALELTTEAFRMELKDFSIKMTNVAPGD
FATNIAAGRYHAPVLDDSPYKEPYGNTLKLMNEDVDAGKDPLLMAKVVHKIIQEKDPRGH
YKVGEALQKFSVGLKRILPDKVYEKMLLKHYKL
>IFAGANLK_02104 Transaldolase
MKFFIDTANLDQIREAQALGVLDGVTTNPSLMAKEGISGKDNIYKHYREICEIVDGDVSA
EVIATDFDGIVREGEELAELHEQIIVKVPMIKEGIKAIKYFSDNGIKTNCTLVFSAGQAL
LAAKAGATYVSPFIGRLDDISTDGLNLIADIRLIYDNYGFETEILAASVRHSMHILECAK
LGADVMTGPLSSIEGLLKHPLTDIGLEKFLSDYKKGNQ
>IFAGANLK_02105 hypothetical protein
MKYYLLFFLIGVILFTGCNDSQKDQKGTFVGGQIMNPYNPYFILSKDNETIDTLFLDQNN
QFGKNFKDLEAGIYSFNHPPENQIMYLEPGDSVLVWLNTMQFDESLNFSGPGAAKSSFLL
DMFLNNERNNNLMLSYYKINPSEFAGITDSIKNTRKNKLKDLNEKKKFSESFLELANNSI
DYDFYHLRERYTFLVKKYYNELAQQIPDDFHDYREDLNFNDTQLKEYYGYLNFIEDYLRT
RSIERCLEEYDTNSDCFELHSVDNIQYRISLADSLIKKEEIKNIFINRLAIQGLVFSNNA
EKIDSILGILEDIKFSGKNLPDLKQMAGIQKSLLPGNNIGNLSLTSFQEDTVSLKEISDK
PIVTYHWSMEAPEHYKWQHSIIATLREKYPELEFVGINIDKDSHQSWKNTIEIYGMNRER
EYKLNPAKIKVNLLKNYLNKLIFLDTNGNIVNGEAQLNTPNFERQILEFLNN
>IFAGANLK_02106 putative ABC transporter ATP-binding protein YbiT
MLSVSNLSVQFGKRVLFDEVNTTFTQGNCYGIIGANGAGKSTFLNILSGKSEPTSGRVHL
EPGKRMSVLEQNHNLYDDTPVLDTVILGNKPLAKIKKEMDEIYMKEDFSDADGERVGVLQ
VEFEEMNGWNAESDAASLLSNLGIKEQHHATLMKDLDGTQKVRVLLAQALFGNPDVLIMD
EPTNDLDYETISWLENFLANYDNTVIVVSHDRHFLDAVCTHISDIDFGKINHFSGNYTFW
YESSQLAARQRAQQNKKSEEKKKELQEFIQRFSANVAKSKQATSRKKMIDKLNIEDIKPS
SRRYPAIIFEREREAGDQILNIEKLEASIEGETLFKNVNINLAKGDKVVVYSRDSRATTA
FYEIINGNQQAVSGKYSWGVTTNQSYLPLDNSEFFDNDLTLVDWLRQWAKTDEEREEVYI
RGFLGKMLFSGEEALKTSKVLSGGEKVRCMLSRMMMMRANVVMLDEPTNHLDLESITAFN
NSLKNFKGTVMFTTHDHEFAQTVANRVIELTPGGAIDRYATFDEYMSDKKIKEQRDKMYA
IEA
>IFAGANLK_02107 hypothetical protein
MKQLFLILALCISSFTAMANEPVGKISGSVIDGDLEEPIPYATISITDMEGNLVSGNTSS
ADGTFYIEKIPNGTYTFKVQFMGYKTFSKQIEITKDQSTHNFGPIKLEPDVAMLDGVTVV
AERTTIEQRIDRKVINVGKDLTTTGASASEIMNNVPSVNVDQDGNIALRGNSNVRILIDG
KPTNMDPAQLLKQIPSTSIKTIELITNPSAKYNPEGMSGIINIVLHKNAHDGFNGNLNTG
VTIGENTRYNGSLDMNYRKGKFNFYGNFGAQFGDRNNLGRINFTEDNYRQAFDITNRRES
YLYKVGVDFYLNDKNTFSFYTNQNHYDGGPLGALRIIYPTNPDLDLAQNLDANFNNINST
YNFAYDRKFEKEGHKILFEVDYNTFDEDENSVFGFEGNTNGFNDYREHVKETRENIIANV
DYENPLSENSKLEIGAEARLLDTDNDYTTTSDFLNDATYQYKRDIYSFYTTYGQNFEKWS
YQVGARLENFSVDAIYNDENVFSDDYFNIYPSGFLNYTPNEINSYQLSYSRRVDRPGFGQ
VSPIREVSTPRLTVSGNPELDPQFTNSLEFNYTRKFTKKGSLTAGVFFRNINDEISQVFI
EDPNEEGSLLLKFDNFEDNNAYGLELGTNYKFTNWWSTNTNFEVYSQKLKGVVGTEYLET
DNTAWTFRTNHSFKATDKLTFQLFGFYRSKAKNLQMDMDPMYFMNLGGRYTFLNDKATLS
LNFNDVFDTQEFSFTNGRPLPQTGRFKGETQNVYIGFAYRFGGGKNRALKRKQRDDNEAE
GGGVF
>IFAGANLK_02108 hypothetical protein
MEKKTLVLGASLNRSRYSNIAIERLVRYNQPTVAIGLRKGEVAGVNIETEKVPFQDIDTV
TLYLGPPRQEEYYDYIVSLNPVRVIFNPGTENPEFYQILRKNNIEVEIACTLVMLGTNQY
>IFAGANLK_02109 Sodium/glucose cotransporter
MQPYQILILIAAYFGLLFLVSFFSSRAGSNAEFFRANRESPWYIVAFGMIGASLSGVTFI
SLPGTVATDSFSYFQVVLGYTVGYAVIGLILLPLYYRLNLTSIYSYLETRFGKYSYKTGA
SFFLLSRIVGSSFRLFLVANVLQLILFDELGVPYYATVSATIFLIWLYTFRSGIKTVVWT
DTLQTFFMLLSLGVTLVVVSDELGITAGGMINHLSESGLTKIFFFEDWKSSDHFIKQFVS
GAFIAIVMTGLDQDMMQKNLTCRNLKDAQKNMFSFTIVLTIVNMMFLVLGVLLTQYADLS
GIDAIKDELFPAIATGGELGIGVAILFILGLIAAAYSSADGTLTALTTSFSIDILNIEKR
YAEAKQMRIRKQIHIVISILFIVVMLIFKYAIADKSVINKLFEFAGYTYGPLLGLYTLGL
FTNIKVKDKLVPIVAILAPVLSYIISINSLVWFGFEFGFFILILNGFLTLLGLILIRAKH
H
>IFAGANLK_02110 Recombination protein RecR
MDFSSKLLEQAVDEMSQLPGIGKRTALRLVLHMLKQPESQTKQLADALTKLRTEIKLCKN
CYNISDTDLCAICANPSRNSEIVCVVEDIRDVMAIENTDQYRGHYHVLGGKISPMDGIGP
SQLSIKPLIEKVQAGKVEEIIFALSSTLEGDTTNFYIYRQLEGTGIKTSTIARGISVGDE
LEYADEVTLGRSITNRVPFESSTKS
>IFAGANLK_02111 hypothetical protein
MASKREVIWAPTAVKELDQFLEYIENEWSKSISEDFFISCSTQ
>IFAGANLK_02112 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MGESVAEATITNWLKEVGDTIEADEPVLEIATDKVDSEVPSEVEGKLVEKLFEADDVVQV
GQTIAIIEIEGEIPAGAGDDELDLDLDGREEEDQYAEEVAESVEAAKETAGSKDFSEASR
FYSPLVKNIAKEEGISLDELESVEGTGKDGRVTKDDILAYVENREKGTSQQQAPKTATAP
SAVTGKMAEAKAKSEAVIPSGEDEIIEMSRMGKMIAHHMVESAQTSAHVQSFIEVDVTNI
WNWRNKHKNDFQKKEGEKLTFTPIFMEAVAKAIRDFPLINISVDGDKIIKKKNINLGMAA
ALPDGNLIVPVIRNADQLNLVGLAKKVNDLANRARQNKLKPDDIQGGTYTVTNVGTFGSI
MGTPIINQPQVAILALGAIRKVPAVIETPDGDFIGIRYKMFLSHSYDHRVVNGALGGQFV
QRVAQYLEGFDKNREI
>IFAGANLK_02113 hypothetical protein
MDSGFSKKRDFSDWSMAFEKLQNDEASEILGYKNLEAENLFDDDNRLLEQPALSLLHNYV
KNL
>IFAGANLK_02114 hypothetical protein
MFKYLAYVSRQSHLITDNNLKELLSKSQSRNSEIGVTGM
>IFAGANLK_02115 putative ATP-dependent helicase DinG 
MELNLTRPICFFDLETTGTNVAKDRIVEIAILKVFPNGNKESKTWLVNPEMPIPKEVVAI
HGISDEKVANEPTFKELASQVHEMIKGCDLGGYNSNRFDIPLLVEELLRAGIDFEMKNVV
AVDVQTIFHKKEQRTLAAAYQFYCGKDLIDAHSAEADTTATYEVLKSQLDRYEDLQNDMK
YLADYSARNKFADFAGFIAYDKKGNEVFAFGKYRGKNVEKVLEEEPGYFGWIQNADFPLY
TKKVLTAIKLRKLNNKLS
>IFAGANLK_02116 hypothetical protein
MKQCLFVVCLLCFAVASAQENRVIGQVVDALTSQPLPYVNIVLEEQHKGTSAGAQGRFLF
VLKGADTSAILKFSFVGFKTEYINLGKLNNSRVVKMQPDVSALSEVQLYSILNNNSEKIN
DFRGKESIGLGNFSGGQFPSMVARYYARPENFKAGCFLEEVEVRFFATDLNMNKKSKFRL
RILEVGQNGKPAGDLLTSNLIIERRSNSFKTKIPLLQYRIPIPKEGFFVAVEHLFIKENE
YIEKKDYKIYRENDTLLYDNFRVVKYLPVFKGVLEKKKHDFNSYFKDTNGWKKMNSLDNS
HQVFKGEYPAPAFKITLTD
>IFAGANLK_02117 Fumarylpyruvate hydrolase
MKIICIGRNYTDHISELQNEKPEDPVIFLKPDTSILLKKQPFFIPDFSNDVHYEVEVLVK
IKKVGKHIQEKFAHKYYDEIGLGIDFTARDLQQKLKDKGLPWEKAKAFDGAAVIGEKWLA
KDAVGDINMLNFSLEKNGETVQKSNTRLMLWKIDELIAYVSQFFTLKIGDVIFTGTPAGV
GKVTAENKLTGFIEDKQIFSIQIK
>IFAGANLK_02118 hypothetical protein
MSNYDLSEVKEMAGGDEDFMKIVVQTFLEEIPPDVEAMNEAISNDNPDLAYQFAHKMKPN
LQLFGLELMDEVKVIEAWAKAGKKKDEVPTAASKITKKVNVASIALKRDFELE
>IFAGANLK_02119 Nicotinamide-nucleotide amidohydrolase PncC
MKAEIITIGDEILIGQIIDTNSAFIAKELNKIGISVKQISTVEDEKSHILEALYEAKNRA
DIIIITGGLGPTKDDITKDCLCEFFEDKLVKNEEVLKHIEFLFDKYIDTPISDLNRKQAM
LPSKAVALKNKYGTAAGMWFESEGKAYISLPGVPFEMKALIEGEVVPKLQQTFKRPVILH
KTVLTYGMGESAIADKIEDWENNLPPYIKLAYLPNLGRVRLRLTAKGENEEHLQNSIESL
ITDLHGIIGDIIVGYEDDEPIEIQISRLLRKINASIATAESCTGGKLASLFATPPGASNY
YKGSVVSYATSVKEDILKIDKKLIEEHSVVSKEVAIAMAKNIRDLFKTDYAISTTGNAGP
AKGDSDAEIGTVFIGIATPDKVYAKKFIFGNHRDKVIGKAVNKSMEMIREELFQQIKTYP
>IFAGANLK_02120 50S ribosomal protein L28
MSRVCELTGKRAMVGNNVSHAMNKTKRRFNANLVKKRFFIPEEDKWVTLKVSTSALKDIN
KKGISAVIKEAREKGFLKK
>IFAGANLK_02121 50S ribosomal protein L33 2
MAKKGNRVQVILECTEHKATGQPGTSRYITTKNKKNTPDRLEIKKFNPILKKMTVHKEIK
>IFAGANLK_02122 hypothetical protein
MAKKSVASIQTGSKRLTKAIKMVKSPKSGAYTFVEQIMAPEDVNDFLKKK
>IFAGANLK_02123 Signal recognition particle receptor FtsY
MSLFKKIFSKDKKENLDKGLEKTKTSFMSKMSKAVAGKTKVDEEVLDDLENVLVSSDVGV
ATTIKIINRIEERVARDKYLGTEELNKILREEIAGLLSESETGEAANIQLPDVKPYVIMV
VGVNGVGKTTTIGKLAHQFRSAGNKVVLGAADTFRAAAIDQLQIWADRTDVPIVRQKMGS
DPASVAFDTVQSAVKQNADVVLIDTAGRLHNKVNLMNELTKVKRVMQKVIPNAPHEVLLV
LDGSTGQNAFEQAKQFTAATEVTSLAVTKLDGTAKGGVVIGISDQFKIPVKYIGVGEGVE
DLQVFNKYEFVDSFFKQ
>IFAGANLK_02124 Mandelamide hydrolase
MKKLLPDNRDFNASSPASIFNFFFPSKCFVNFRGILLLLLLPVMFSCADDKNSEDENIDS
RDSLKTEKEEEFKVLDSKNITQDSLWAPFESDLAKFSEDKYEAIKPHIFDKNIPEIQEAV
KNGELTYEELSLFYLYRIKRIDRENEFSLNSVISLNPNLLEEAREKDEQLNNSEEKHLIT
GIPVLLKDNINTQNMATTAGAIALQDNQTEDAFIVQKLKENGALILGKSNLSEWAYFFCG
ECPSGYSAIGGQTLNPYGRKIFDTGGSSSGSAVAVAANLAPVAIGSETSGSILSPSSQNS
VVGLKPTIGNLSRGGIVPISSYLDTPGPITKSVIDNAILYSAMTGKDVEDAFSIEVENTD
FNFENTTLDGKRFGAFKQLMQEDSLYKRAVNDLKSTGVEIVEFEAEEIELENFLRLLSLD
MKKDLPDYLEKYGGETGFTSVDDIVKFNIEDSINRMPYGQALFDGILHESGDTTDLDSIK
SDLSEKGKKYFDTPMQEHNLDGILSINNYHAGFAAVAHYPAITVPMGYSEEGAPKGLTFF
AKSSEENKLYQWAFAYEQASKRRETPKNYE
>IFAGANLK_02125 hypothetical protein
MKQRNLKPLISKIILFYSIFYGAMKIIAVLFQDAWPLPNLIMTIPFVIFAIIGGILLKRD
TYSWVYVAAGVIVISIVRYYEMQWLQQLHQHFN
>IFAGANLK_02126 D-alanine aminotransferase
MKPKKKYPSEVYLNGKWVKPDEAFVSVFDRAFMFGDGIYEVTPFYNGKAFKLKEHLKRLQ
YCLNEIQVAIDAFSLEKLMYEAIDRTGLNKADAAVYIQVSRGVAARSHFVPEKIETTVLL
YAFPVTLEGFEKKTWEVIATEDKRWHRCDIKSTALLANVMANEEAIAAGFAENLLVRKGY
FTEGSHSSLFFVKYGVVHTHPEGHKILSGITRAEVIDICTDLNIKVVEKAVHIDELVEVE
EIFVTGTTTQIIPISSITHKDKKVYTAQKDSLTKKIQEVFIKKSRG
>IFAGANLK_02127 hypothetical protein
MLSSGDYKFIKDADYDDSLITAKDFFDHTESTAFINEALSKAVRCKIFNAWIHANSITVD
HIQRKAEGGIENFENAQLAHPYCNSTYKN
>IFAGANLK_02128 hypothetical protein
MKQLLLITCFFLIAITEGKSQSLEVGFGLGSGSAYTFENMDSNIDIDYSLPFSSYLSLKY
AKPDSYFGIKLKFQYLNAGIKGRNWKNLNEPINGDVTSLTSLILLEHLKDNNKWNLGYNF
GFGYTHQNFRQDLTNSSSGMEINFMSANISGIISSKLSNNLALQLEPSLLWTDPVGSLRD
SDKWQIAGEDLHLLIQLGFTYKIN
>IFAGANLK_02129 hypothetical protein
MKKILPVLISIFFVACSKDDDSKNIPITEENIVISQNEIYEYDLEFPGDEDGFSITRQAV
NCEISKIEQDSITGNFIYTYKPEAGFTGTDTVEITHNAYSISRDEAYNVRIIRINIEARK
>IFAGANLK_02130 hypothetical protein
MIKLYLISLLLLIPVLGFSQQKDSLGEPIIPSDKIELLKNINFTFDMRLGFQAYTFRGGD
NYYNGIQFLNGFTALGISGKLHEKVNFTFRNRFNKNSDVQTLDRLGSNIELAFIDIKASP
KLDIRLGKMNPFYGGYEYEYSPLYVLEYNDVYNNVLAFVTGAGITYQALENHKFGFQVLN
SRTMHYDDLYGDIVAENIQEPDWPVAYVGNWRGSFFDGKLQTIYSLSHSYEVKKRGTTFF
TLGHKYQNRNLSLMYDFHYSYEEVDTKGILTSIVNDQSIAEDVLYIENWIRAEYRFNPKF
TGLLTLMTSSAYDNVKTSNDHIRRSYGMIPTIYYSPFKNLDLRFFLAYIGRYFDYSEFAS
QNFGASSYNKNEVRVGFIAPLLLL
>IFAGANLK_02131 hypothetical protein
MSEPINICLSCGLCCDGTLIGFVQLDNEELSPLRQLMDIEETDENGMFFLPCDKFDCNGC
NIYSQRPKACSNFECGVLKSFEKKELSFDKAIQVIDVVKQKKISIEKQVATLQIELQSKS
FHFKMLELKKLLRQNKSELSLSQNHQELLLEVRELDKLLSDSFGVSF
>IFAGANLK_02132 hypothetical protein
MRLKIIFILIFIGFQTSYAQTAYGIKGGFNLSKYHSDLTDNYSFKPGFYLGGTGKFELNN
TFNLKPEVFFSFQGSDMNANIILYDLNDPQAERREISKIRVNEYAFNIPVLIDFSLSDNF
HLEAGPQAGFIFKNSSKIVEGRGDYGNFQEEDDNDLRISLAISFGINYKVTKDIYLGARY
SRDIKRHDSTLKNSIISTGLEFYL
>IFAGANLK_02133 Beta-peptidyl aminopeptidase BapA
MKKYLLFPMLLFLLLNTLSAQQRVSELPLKIGVMERGELNAITDVEGVNVGHTTLVKGDS
VQTGVTAILPHGGNIFQQKVPAAVFVGNGFGKLAGSTQINELGNLETPVILTNTLNVPTA
MDAVIKYTLNLPGNENVRSVNAVVGETNDGYLNDIRGQHVKKEDVISAIENAKSGKVTEG
NVGAGTGTIAFGYKGGIGTSSRKLPESLGGYTLGVLVQSNFGGVLQIAGVPVGQKLGKYS
FKDDLLNNVDGSCMIVVATDAPLNNRNLERLAKRAFLGLAKTGGIASNGSGDYVIAFSTA
EGVRIPYKIETATLEQEVVTNDLMSPLFMAAIEATEEAILNSLFMAKTTTGFKNRNIKAL
PITDVLEHLKKAGVIEEH
>IFAGANLK_02134 hypothetical protein
MAIYEIIKSIFFNGLLLVNPFSQNMCTKPRDSGWSIFSIDHPQGFVHGF
>IFAGANLK_02135 Ribosomal protein S12 methylthiotransferase RimO
MRTKSIKKNRINVVTLGCSKNVYDSEVLMGQLKGNNKDVVHEQDGNIVVINTCGFIDNAK
EESVNTILEFVEQKQQGEVDKVFVTGCLSERYKPDLQKEIPDVDQYFGTTELPGLLKALE
ADYKHELLGERLTTTPKNYAYLKIAEGCDRPCSFCAIPLMRGGHKSTPIEDLVKEAKNLA
ANGVKELILIAQDLTYYGLDLYKKRNLAELLENLAKVDGIEWIRLHYAFPTGFPMDVLDV
MKREPKICNYIDIPLQHINTELLKSMRRGTTHEKTTKLLKDFRKFVPEMAIRTTLIVGYP
GETEEQFQELKDWVEEMRFERLGCFTYSHEENTHAYNLEDDVPQEVKQDRANQIMEIQSQ
ISWELNQQKIGQVFKVVIDRKEGNYFVGRTEFDSPDVDNEVLIDATSIYLKTGEFYEVKV
TDAADFDLYAEPVHAAPKPQRKELKVKSV
>IFAGANLK_02136 hypothetical protein
MSIDKIQKPEVEKFYHRLENSADLDPLLEKIGDAKYVLLGEASHGTHEYYTWRAQISKRL
INEKGFSFIAVEGDWPDCYKINKWIKSYKNSGENIQDVLKEFNRWPTWMWANWEIAAFAN
WLKDFNLNKKQEEKIGFYGLDVYSLWESMDSIVNYLQKEDPATAELAKDALNCFEPFKAK
DSYASIFSTSKGDCKNEVVQLLKEVREKAHSYDSAEEAGLNAELNALVMANAEKYYKAMA
GFGDDSWNVRDRHMVETLNRLMAHHHEEAKVIIWEHNTHIGDARATDMAASGLVNVGQLI
REQHSKEDIVLVGFGSYSGSVMAGRNWGAPMQKMKVSEAIQDSVEHRLHKSDPENKLIIF
DENQELNDAFSEKMKHRAIGVVYHPDRERGNYVPSRMSERYDAFIHLDKTTALHPLNLQP
KTELTPETYPFGI
>IFAGANLK_02137 TVP38/TMEM64 family inner membrane protein YdjZ
MKNSVSKYSSFFLSGVILLLLLAAYFSLPSFREFVDTTIRVLTNGNTDITRAYFKDFGVW
GPVAIILFIILQMFLIIFPSWIPIIVAVMAYGFWWGSLISLTGVVLASYIGYFIGEKLKG
VFLTKIFGEDKLKKMDFWIGNYGFGSVILFRISPFLSNDSISFIAGMLGMELKKFIYATL
CGMVPLTLAIAYFSEDPSKLKEGLYWIGGVGLVAYAIYILIDYKKRRKNSNSKA
>IFAGANLK_02138 hypothetical protein
MKQGFRYFIKFILILLAPPVIYLVVALIGSIIPVNSKHETKKSDIEIYLYKQDMHTDILL
PVRSYIINWDSIFKPEHTLANPKNSEIIGFGWGDLNFYRNTPQWEDLKLNVAFKALFLKS
QSALHTRFYQKVPVSENLVKISVTEDQYKKLSKYILEKSNIQKSVEIQPVQDLHYYRDDA
FYLAKTSFSLFKTCNTWTNSALKYAGLKACLWTPFPQGIFYQYR
>IFAGANLK_02139 hypothetical protein
MRVSYIYIQEGADKIYYTGVTSNLEKRIVEHHSGAHPDSYTAKRPPLKLLFFPNLQTLIM
LFYETNKLRNGLKLKRKL
>IFAGANLK_02140 hypothetical protein
MKKILLLPVLALLLSCANEAEKEKTNLRIDNLEADLNDLKIEKDSLQKELRLLKSRNPVV
FTEDFDTMQNPETFIVESLERNSQLIPEESVLGGTMRFLDTEILNERFIWAYYEDGHVAG
EAIFQYKLNEADSIDFTLVSEIRD
>IFAGANLK_02141 Inner membrane protein YrbG
MIIPALLLVLGLVILIFGANYMVEGASALAKKFNISNLAIGLTIVAFGTSAPELVVNTFA
AADGYSDIVFGNVIGSNNFNLFIILGITGLITPLAVQSSTAWKEVPISLIAVVILFFIVN
DQFFSANKTGILGTLDGFILLFCFLAFLFYVYKQLKNDDVVEEDDIKLLSPLKTTLFIIG
GLAGLVLGGQLVVNNAIEIAESMGISQKIIGLTVVAAGTSLPELATSIVAAAKKNADIAV
GNIIGSNIFNIFLILSAASLINPINFNLNFNQDLYILAGGTLFLLLAMFTGKRRRLDRWE
ALILLIAYLAYTTYLVMQEL
>IFAGANLK_02142 putative zinc protease
MKFRIILLLLYSFAISQNIQSQVSTDFNVDFETYTLENGLNVIFHVDKSDPVVAVALTAH
VGSAREKEGRTGFAHLFEHLLFLESENLGKGGLDKLSARIGGSGANGSTSRDRTNYFQTV
PKDALEKMIWAEADKLGYFINTVTEPVLAKEKQVVKNEKRQGVDNRPYGHTMYVIDKNLY
PENHPYNWQVIGSLEDLQNATLEDVKEFFNNWYVPNNVTLSIAGDFDKEQAKEWIHKYFD
EIPRGPKIEREEKQLVELSETKKLYYVDNFARLPQLTIAWPAVYSYHEDTYGLEVLAKYL
SEGKNAPLYQHLVAEKELTDRVRMYNYTSELAGQLMLQVTAYNEVDLDKVESAIFETFEE
FESEGIPERDLKRIKAQQETNFYNSLASVLGKGFQLAQYQIFANDPNYINKDVEKILAVT
AEDVKGVYEKYIKGKHFVATSFVPKGQTELALENAKEAEVVEEKIVENAEEEVNVSTDAS
YEKTPSSFDRSAEPPYSSAPELAVPEIWEKILPSGLKVYGITNTEVPLVKFSLEMQGGLL
LENPNKVGVSNLLANLMTKGTKNKTSEELEEAIQLLGADISINAEDEKIVLTGSTLAKNY
AKTIDLVQEILLEPRWDSTEFKLLKQQALSRIQQQEADPNSIANNEFRKLLYGENHILGQ
NSLGSESSVNNITLEDLKNYYSENLSPKRSVFHVAGSIEKEEAIKGVRGLSVAWPPKSVK
MPEIAQPELPEKSQIFFYDVPGAKQSVLRFGTPALAATDEDFYAAEVMNYRLGGGGFASQ
LTQELREGKGYTYGIRSGFNAGKNKGPFLISSGVRSNITYDAVKLIKEIIENYPHNFDGE
DMEVTRGFMVKSNARKFETLNSKLDMLNEISTFGREYDYIKQREKMVNELTVLDIRELAE
KYINPKKMYFLIVGDAETQMEKLEELGLGKPVLLNETKE
>IFAGANLK_02143 hypothetical protein
MKSTLLSFVFLFVGLHISAQLQSPEEFLGYEIGQQFSRHADVVNYFEHAAENSPLVNYHT
YGKTNERRPLTYAVISMEENLRNLEEIRNKHLGNTGISETVGEADKAIVWLSYNVHGNEA
SATEAAMKTLFELITAKEDWLENTVVIIDPSVNPDGRDRYVNWYNQVKAEPYDPMQAAAE
HHEPWPGGRPNHYLFDLNRDWAWATQVETQQRLKIYNQWMPHIHVDFHEQGINEPYYFAP
AAEPFHEIITPFQREFQTEIGKNHAKYFDEEGWLFFTRERFDLLYPSYGDTYPTYMGAIG
MTYEQAGHGRAGLGINTDEGYELTLKDRVAHHHTTGLSTVEIATKNIEALNTEFKKYFDN
SELEYKSYAVKGNPDKIASLKELLEKHEIQYQKAASGRVNGFNYTEGKTGRFNADKNTLV
INTNQPKGKMVNVLFEPKTTLTDSLTYDITAWSLPYAYGLEAVASTREVDAEANLEVPEI
KNSANPSGAGYVVKWNALQDAQFLAELLNENIKVRFTEIPFKSEGKDFDRGSLIITKSDN
RTHGNFDKTVIEIANKHQRELVAANTSFAAIGPDFGSPEVKLINPPKVAVLKGEGTSSLN
YGEIWHFFEQDLNYPLTSINTDYFKNVDLSQFDVLIMPEGFYSNVLYEETLKMVKDWVNN
GGKLIAIGSAVGTFAKNEGFNLKENKSETKDTTTVGNLIPYTQRERESAKDMITGSIVKT
KLDNTHPMAFGYDDTYFSLKLSNSSYKLLEDGYNVSYIQQPEIVAGFAGSSAVKNLENSL
VFGEERMGSGSIIYMVDNPLFRAFWENGKMFFTNSIFFVNNNKFRL
>IFAGANLK_02144 Putative cysteine ligase BshC
MPTECIPYKETNYFTDLTLDYLAEKEELKSFYNRFPNLENFKAQIEEKSSFPQENRKVLV
NALQEQYSGLEISEATQKNIKALENEETFTVVTGHQLNLFTGPLYFLYKIVSTINLTQKL
KEKYPENNFVPIYWMATEDHDFEEINFFNLNGKKFQWANAPENAERDAVGNLSTHGLEDV
FKLFSAEIGGGKDAEFLKELFKKAYLEHDNLAEATLFVANELFKEEGLVILDAQQKSLKE
LFIPYAKNELLEQISHKTTTKTAEKLNDLGYNVQVNPREINLFYLNNGLRERIIERDGEY
FVHETEIKFTKAEILEELQHFPERFSPNVMLRPLYQEVILPNLCYIGGSGEIAYWLELKE
YFAAENVIFPVLLLRNSAMIQSEKLDEKRRKLNISNKELFLKQHELINRKVRQISNIDID
FSKQKEHLVKQFQQMYDLAEQTDKSFIGAVKAQEVKQLKGLNNLEKRLLKAQKRKLEDEV
SRIAELQNELFPNKALQERQTNFSEIYAEYGPELISVLLKELDPLQAEFKILTFGKE
>IFAGANLK_02145 L-2,4-diaminobutyrate decarboxylase
MHTIDMDLVEMTLDVMKYTIDRISNITPEMGAPKKEEELFKIVGETVTPEGIGGENAFQL
FRDVLVKATVPIDHPRHLAFVPAAPTRAAIMFDLVTSASSIHGAYWMEGAGGIFCENQAM
KWLVSLTGLPEGAFGVFTSGGTAANLSAMVAAREEWRARDSQNVGKKALLLTSHGAHSSI
QAMAKVIDADVVMIDCEEENLTGRELQNGINELEEKDRSRLFAVVATGGTTNAGIIDQLD
TIADVCEKEKVWFHVDCAYGGGALAAPSVRHLFNGIERADSITIDPHKWLFSPYDCGAVI
YKDLELAKNAHSQKGAYLEIFKDEGAEGFNPADYQIQLTRRIRGMPLWFSLAMHGTNKYR
QAIETGISLAQIAAKKIEKRENLELVRPASLSVVLFRRKDWTPEQYRDWTYKNHRDGFAL
VTPTTWKKETVVRFCFINPDTTEKDIDMILDTLE
>IFAGANLK_02146 hypothetical protein
MKYISAIIFAIAIVLAAWFLGESYVSRANPDGVISVTGSGSENFTSDLIVWEGSFSRMSP
NLEQAYKDLNSDKETVRNYLIEKGINEENIVFNSVQTSEQRENQYQNGNYVGSIFQGYQL
TQNVKIEANDVENVEAVAREITELLNKGVQFNSTPPRYYYTKIADLKIEMISKATEDARL
RAERIAENSGGSLGELKNANMGVFQITGQNSGEDYSWSGAYNTADKRKTASITMRLDYEI
E
>IFAGANLK_02147 GMP synthase [glutamine-hydrolyzing]
MQKNVLILDFGSQYTQLIARRVRELNIYCEIYPYNKIPDDISSFKAVILSGSPFSVRGED
APHPDLSKIRGKLPILAVCYGAQYFAHFHGGKVEASETREYGRANLSVIKDAEPLFEGIM
ENSQVWMSHSDTIKELPTNSVRIASTTDVLNAAYRIEGEQTFGIQFHPEVYHSTDGKQVL
ENFLVKIAGVAQTWTPGKFVDLTVSELKEKIGKDKVVLGLSGGVDSSVAAVLLHKAIGKN
LYCIFVNNGLLRKGEFESVLDQYKDMGLNVKGVDASARFLDALAGISDPEEKRKAIGNAF
IEVFDDEAHQITDVTYLAQGTIYPDVIESVSVNGGPSATIKSHHNVGGLPDFMKLKIVEP
LKMLFKDEVRRVGAEMGIDKELLGRHPFPGPGLAIRILGDITAEKVRILQEVDHIFIQGL
RDWMLYDKVWQAGAILLPVSSVGVMGDERTYEKVVALRAVESTDGMTADWVNLPYEFLQK
TSNTIINRVKGVNRVVYDISSKPPATIEWE
>IFAGANLK_02148 D-gamma-glutamyl-meso-diaminopimelic acid endopeptidase CwlS
MKYLLIVCFLFQLSSLSASAQEFKYHTVEAGETVYSIAKSYDISEEAIYKYNPDAKGNLE
VSSKLVIPLREEKVVSEEDEDIQFITHTVKRKETLYRLSKDYNVEIDEIKRFNKHLYSEE
LRRGEEILIPQRKKGSANSEIASSEDLNIPATDKPQTSDTREHVVLPKETKYGIARKYGL
TVKELEELNPKVDVLQPGVMIRVGTDVLDEPVILTDEVFEFYEVKPKETLFGLSRKFDVP
QDSLISLNPALEDGLKIGMVLKVPNTGEGEGSLEKGETEELAGEYDSEDANKRLDLSNKL
SNFDTKELVVLLPYSLNNIEGDSTSNYKDAILNDRVLRISLDFYSGVRKAVEDAKKLGIS
TQLRTYDTRRSVQEVTNIINTNNFSNVDAVIGPLLQNTIEATASKLNQYNVPVISPLSDR
EMRPYQNLFQSRPTTEIMKNAMFDYLGRNAIGKNVIIIADGAKNQVKNELTQLLPNSRVI
LPSDNYVSVEKIKAQLSENQENWVILESSNIGLLSSATSALNRLARDHEIKLFTTERNSG
FEDDNVDNEHLGRLNFHYPSVDKEFDVASSEEFIEAYQEEFDMIPNQYVIRGYDLTMDVL
LRLASAEDLYDSFEKYTGFTEYHENKFHYSSKRNGGFYNDAVYIMSLDEELNLKVANDQQ
SNIYREFKD
>IFAGANLK_02149 hypothetical protein
MTSKVIYTGSLRTEAEHLKSGAKIITDAPTDNHGKGEAFSPTDSVATALASCMLTVMGIK
AEDLKVSLKGTTAEVTKTMAANPRRISKVEITITFPETYSEKLQKILEHSARTCPVLESL
HPDMEKVITFNYL
>IFAGANLK_02150 hypothetical protein
MRFLIFLLILIFTVPVLAQENEKLSWTEDRILTWEDFKASPKKHLPYKANTNSGLSFSWN
ATESSGGIKLNYEVGSNFYPNRSWVKEIEEVDYLLAHEQLHFDITELHARKLRKALQNYE
PGGKIKKELDSIYSETEKQRRQMQMQFDKETNHSIYKEAEFKWRVFIKKELDKLSEFSS
>IFAGANLK_02151 Nitronate monooxygenase
MPNNKITELFNIQYPIIQAGMVWASGWKLASAVSNAGGLGIIGAGSMYPEILKEHIEKCT
KATDKPFAVNVPLLYPDIDKIMEIIIQEKVEIVFTSAGNPKTWTKHLQEHGVKVVHVVSG
VKFALKSQEAGVDAVVAEGFEAGGHNGRDETTTFTLIPMVKEKITIPLIAAGGIATGRGM
LAAMVLGADAVQVGSRFVATPEASSHQNFKEMVVKAQEGDTKLTLKELAPVRLLKNKFFE
DVQKLYAENPSKERLIELLGRARAKKGMFEGDLEEGELEIGQISGLIHEIKPAAEIVKEM
MHEFEAAKKEVSNL
>IFAGANLK_02152 tRNA-specific 2-thiouridylase MnmA
MKKKVVVGLSGGVDSSVSAYLLQQQGYEVIGLFMKNWHDDSVTISDECPWLDDSNDAMMV
ADKLGIPFQTVDLSEQYKERIVDYMFNEYERGRTPNPDVLCNREIKFDVFMKIALSLGAD
HVATGHYCRKGEIQQNGETVYQLISGKDNNKDQSYFLCQLTQEQLSKTLFPIGELQKSEV
RKIASEQKLVTADKKDSQGLCFIGKVRLPDFLQQKLQPKEGQIIEIEAERDLFSTEIPKF
NNKKEELDFLAKKYEYSTAEGKVVGKHQGAHYFTKGQRKGLAVGGTPEPLFVIDTDVEEN
VIYTGQGKNHPGIYRKALFINEDEVHWVRKDLAISADETLKVKARIRYRQPLQDATLHQT
ENGMYVVFEEQQASITEGQFIAWYDGEELLGSGVIS
>IFAGANLK_02153 hypothetical protein
MKKLFLMLFSMALLVSCSEDDDANGEDDILGTWYAVEINNSPIPGLELSECNQNSNIIFN
SDFSTYSEYYSEIDGECEIEDTTESTWSKSNEIYTFTIPFEGLGQVNGTARFEGETFIFT
PIGSPDTNIVFEK
>IFAGANLK_02154 Cell surface glycolipoprotein MPB83
MKTIKFTKLAVLAFLAFSLFSCSDDDDGGDVIMPTNTIADFVAENDDYSSLQAALEVTGL
DATLDGSADYTVFAPNNAAFNSFLSANGFGSLDEVPTDVLTEILLNHVQEGEITSGALST
GYIESMATGMASDLPLSLYINTDEGVMINGVSSVTTADVEVDNGVIHAVDAVIGLPDVTT
FATADPDFDILVQALTADESFTFVETLMMTDDPAPFTVFAPTNTAFANVLEELELAGLGD
IPADLLSSILTYHVVAGANVRAGDLSEDMMVETLETGGFTINLGDNVTITDENGRTATII
ATDIQANNGVIHALDTVLLPENDAIEIETNTIADFVAGNENYSSLLAALEETGLTSTFTG
TDEYTVFAPDNDAFEAFLNENGFDSLEEVPVDLLAQVLLNHVQAGAIMSGDLSTGYIPSL
AVWGTSEEPLSMYINTNDGVMINGMSSVTAANIEADNGVIHAVDAVIGLPDVTTFATADP
MFDVLVQALTREDSFTFVETLMMTEDPAPFTVFAPTNDAFVALLDELGAESLADIDAATL
EAVLSYHVVAGANVRSGNLSDEMMVETLQGGEFTVNLGDNVVITDERGRTSTVIAADVQA
TNGVIHALDTVLLPAE
>IFAGANLK_02155 Aminopeptidase S
MLLVGLTAGMVACGTQKNVENANPMEYAETITTSELRDNLTTFASDEYEGRNTGEPGQKK
AAEFIVNEYQQMGMDAPEGYSNYYQEIPTEFFDGKLKDSENVLGYIQGSEKPEEILVITS
HYDHVGVDDEGNIFNGADDGGSGPMAILEVAEAFKEAQKDGYTPKRSILFIHLTAEEKGL
LGSKYYVENPVFPLANTVANLNMDMIGRIDKDHEGNDNYIYLIGSDKLSTDLHELSENVN
SEFMNMELDYTYNDENDPNRFYYRSDHYNFAKNNIPVIFYFNGVHPDYHKPTDTAEKIEY
EALKKRAQLVFLTAWEIANRDERLVVDKAEE
>IFAGANLK_02156 hypothetical protein
MKKVILISVVILLSNFLFAQTEYRELMEQDWANLKKYKTENDKIIHTKNYPDVVFMGNSI
TEGWINAQPEFFEENNYAGRGIGGQTTPQMLVRFMPDVVKLHPKAVVILAGTNDIAGNTG
FSSVEMITNNIKAMAQLSKANDIKVILASILPVYDYPWRPGLEPVQKIAKINTWLEKYAE
ENNHTYLDLFTPLKDEKQGLPKQYSEDGVHPNLAGYKVMAPLTKEEIEKTLKQ
>IFAGANLK_02157 hypothetical protein
MKKLRSSIHLLAFIILLPFSNLEAQEQSETLNNPELSSSNFYTSRYQAQNAFNGLGYYKL
YNQTFNYETDKLLITLGAGFLEQNTIFNNMAPGIHGSISANFEYKFNQRFSFYLFGRYLT
PSLNEEGRINTPHMELLYPQSEVSAGLRGNFNNVNIDVGASTLFGNQPELNTLLRTKVSI
GF
>IFAGANLK_02159 Tyrosine recombinase XerD
MENHFSYTLFVRPIRTKPEFGAIYLRVNSNGQRAACSLHRRIRVIDWDNNLSQLLPGTPD
SQVLNNYLTKVKADILRIHQRFLFGDKQFSAQDIIDSYSGKEKLKTIKNQKMVLQIFQDH
NDKVDRLVGKDFAAGTAERYRTAKKHVEEYIKKEYKTSDIPVKDVNHKFITGFEYYLKTE
RNCAHNSAIKYITNFKKIIRIAFTNEWISRDPFQNWKGKLKVVDREFLTEGELQALISKE
IKNERLSLVKDIFTFSCFTGLCYADVKKLSEKEVVVGFDGKRWIKTNRTKTKTRSSIPIL
PTAEAILEKYSEHPEVSEKQLIPILSNQKMNAYIKEIADICGINKNLTFHLARHTFATTV
TLSNGVPIESVSKMLGHKNLQTTQHYAKILDRKISDDMAILRERLSAKNF
>IFAGANLK_02160 hypothetical protein
MARHSLGTTVTLSNGEPIKTVSKMLGYIKLSPTQIYARVLEH
>IFAGANLK_02161 hypothetical protein
MKNIESIQEMPVQEEFSKEIIDNLLELHRQLILLEQLDGGSKIPFLRKIVILRDYFWDLD
IEEYLYDHEDLGYIYDNLERLMEEIKIYVPFPKRTS
>IFAGANLK_02162 hypothetical protein
MNNETFGITFQYAICKEYNLSNQIAPKRISEDILLKIEESGIIKELFKKATPVEFLTYSK
KYTSEFVKKCPHNFLLSDGQTFSIRTFGKKNKKFAPKVVGQAGDITFNHFFGDLAGETID
RENFKAFCLSKVHEILPILIDYALISDETAWIYVDGNENLTFKMIPREDLPELTFERKDF
SFTKDTVAAWNETTTAKYKGKTIIEFQLHSNRSGYKIRLDRENFPSLLMVEKILNNAVIG
DSAELAICENFLLDPGVDNDRLKNNSNSVVVRLFKKHYKTNEEKFFPYKPVKYGGTAARV
RGGNSKSGIDFILEAGKSLSLKTNKNKNAKVCPPEVGQPSPKTFDYYFSAKGWYEGNMDG
IKFREIVLDRVILADLLSEYLKHLNECDYLLWSVYNEGSNINSQLVEKKFFKDWYFSPKE
LEYSNNFQDKNSVTIRYGKISLGEFQIHSARNSLKFRFHFGNLVSIIDPERK
>IFAGANLK_02163 Modification methylase FokI
MNYIGSKNKLIPFIVENVQDVVGTDLSGFTFCDLFAGTGIVGRNFKPLVKKVISNDLEYY
SYVLNRNYIGNHLSISGHSDLLKELNEIEPLEGFIYKNYCSGDKAERQYFSDINGKKIDA
IRMQIETWRNKEQIDESTYFFLLASLLESADKVANTASVYGAYLKKLKKSAQKEMVLLPA
NFQLNGNEHEVYNEDSNNLISHIEGDILYLDPPYNARQYGANYHLLNTIARYDNFIPKGK
TGLREYIKSDYCSKVKVEKAFEDLIKKSNFRYIFLSYNNEGLMPQKNIEKIMQKYGHYQL
ASKSYQRFKADKTENRNHKFDKTTEYLHILEKFF
>IFAGANLK_02164 hypothetical protein
MHNETDVQWHIIYKRLATLLFDFANANSQGVGFELFKILTKNARFKELNPWISNLYSESF
KSFDPIQVFASFNGSRMKDETRLQRINILFSILEDKTDFQEFKNIDFKGCPAPLSIKLIS
PRTHKDQREIWELFRGIFENSSKSLRASTFNDVKNWYGVDVVSLTQFLFWIDSDSYLPLD
KNTVQFLKKLNKIDSLPDNVEEYNDLIVQGKPGLFREITELAYERKLERIHFSTNSKAFQ
EFFIENFKYENSQDLQSFKFIGIRPLKEMPSSLKKVLLEDHLYIFYNHYQFSNEDKKVVY
DNRYENIYNIKDGPIINISAMVGKNGVGKSSLTELLYMSIYNLSIAKGLISNQFIEDLHI
ELFFRTDTLYKLTVNGEKISIYSYSHVEGGFQNPEKKNLDDFHLNRFFYTIAVNYSHYGL
NSKKYKLDWITPLSHKNDGYQSPVVINPMRTEGNINVNREESLLNARMLANILEPVEEGA
EETLRTIYGHKKATHLIISENEKKGDPKKGEELNYTTIERRTRNEIIRELYSVFQLETQH
ELKYKVLAEKYFVKKLFSVCHTYSKYHTHLPQKKSGNLTLEDVRGLLKKIKADQSHMVFK
LKQTINYLKYGHIDAFVTGDKIALEDLSAEINRIKSKDQDVQTILLIPPPIFNCKILLED
GSDFAKISSGESQLISIASTVAYHLNNLDSVQDETGFYRYGNILVMMDEAELYFHPDLQR
RFIQFLLDYLSKIDLSRIEGINFCFITHSPFLLSDIIRSNVLPMGDESSKLDLKTFGANV
YDILANSFFFNDGFVGELAKRRIKEVVDWINGKKKLPEYVDAEYCKKIIQLIDEPIVQKK
LAEMYDKKVNGNVREKILHRQIQELQAELAYIKK
>IFAGANLK_02165 hypothetical protein
MLYVDPHSSKIQKAKYNFLKKIKPRVISKIEDLPEGELKDYFDDNLTPKLDDILVGLPSV
IYPLNEELKNDIDAIPGLKDAIIDVLDYDDFIIKRKEKYCAYHLAEEINIRSCVYCNLNY
AVTIREKGENLIRPDFDHFLDKGTNPLLRLSFFNLIPSCGTCNQKLKNTIHFEYGVQQHP
YEDDLLDDFHFSYRYNNRSADGLEIILNQEEPDGKIGKSFEDLKMIKIYNGYTQELYDLL
KIRQTFSDKYLANLGSQVLHGLKISDEELYRLAFGTYLSKEDYINRPFSKFKRDILGELG
IIKE
>IFAGANLK_02166 GTPase Era
MSLKIANQKIKEARRTKSTYLNLSGLGLSKLPQDISDMTYLLDLDLSYNNLTNFPESICY
LYNLRTLDLSYNNLIDFYLLSGKTYCLKEIDISNNNLNFVPQELLELDFNPIIRFENNFF
TENLPPEIIFHEDLSYIAFYLESLEKKLITPRLFETKIIIVGKGEVGKTTLLKTLNDEKF
KFKLGKENSTHGIDIQSSGFQVIFPAKKPYYNRFEDFENLLLYDNDYDHDENYSQVIDQY
DPLSELNFDEELQLDLRVQDQPFDFFYHNLFFQKEVKLNFWDFGGQEILYSTHQFFLTQR
SVYLFVWEPRSDTESENFDYWLNTIEKLGENSPIIVVMNKADIRLKQIDEKAYSNKFKNI
VSFHQVSCLTRKGIDHLKEKIAEEVRRLPHIGDLLPGTWNKTRRKLKKLDSNYITYSDFK
SICNYKENKEVNFISSYLNDLGDIIHFPSDIRLRDIVIINPEWLTHAIYELIHSLDIQRN
FGRFKMEKLEELLDESIYPRDKHLDIIAFMEKFEICFKIIGSANEFIIPALLPAQSNTKG
FEDDYSVKEASKIEIRYSFLPSGIIERLICRMNSYIDKDNFWKFGVVFKHQHAYATVQLQ
SLDKKLTFNVTENIGMELFHIIQHNLDEIHNSLNLNDSDFQKYFGCNCTDCSTSENPYMF
EKETLKRFLLKGKNSIDCQKSTESINIKSILAGFKIKPTSFSLLRSFIDAASILQTRIST
IQKADENQRNLYLLDLWRPSLMKYNYIPKEQAQRGLSATGKNSGELDIVIEDDIGTIKTI
FEGFNLPSINRAVIEAHINKLVDNYDRNGLKEKFIGIYSESNDFKSLSQKYFKQLENSEK
LKQIEDISENYGIGEELKIFKSELNKYVNPTFLYHVLINLKN
>IFAGANLK_02167 Modification methylase MboII
MEDIFKVHHEDARNIDKIIKNKIVDVTITSPPYFDLKDYGSDNQIGYGQDYEAYLDDLKI
VFQKVFNVTKESGTLWVIIDAYRREGEVVPLPFDFSHKLREVGWKLKEVIIWGKDRTVPW
AHKGQMRNLFEYILVFSKSDDFNFYIDEVRDFETLKKWWVKYPERYNPKGKTPDAIWNFD
IPTQGSWGNGYIRHFCPLPEEMIEQMLKLTTKEDDVVLDCFSGSGSVLSKALNMKRRYIG
FELNQEYIDMFHNYIKETNEEKSSKYCISKKNRIGQAKFEKLVNDLRALKYARLLYKKLQ
TEGFKNVLKIYVKRTYTLSNGDRKYLKVKYLFLLEDRSRKNEIAKKVEDWTKKAPFSKFG
IAPTYLYTHKVTSFIEILTNEKKDLYIYDFKATHRFVKKIKIEELNRSGKNNVIISSIQV
DLNESDYA
>IFAGANLK_02168 hypothetical protein
MAKKTKRRKKVSPEELEKRNHRKDVRAVFRNAGFTKVLSVSDKEFTFNGHTSDFDDVFVY
QNVILFLEYTTTKSSKIRDHLKPKKLIYDEILSNSASFIEFFENKFSKFKETRDQYYDPI
QCQIRILYCSKNSVSPKYKEQISTISYFDYPLVKYFKNVAEAVKKSARFEIFSFLGLSNN
EVGKDSINSSNGSEDYQGSILPHSYSNFDYGYKVISFYIDPLSLLHRSYVLRRDGWKDQA
GVYQRMISKGKINNIRKYLNSKERVFINNIIVTLPSDTKLLNKNGNTLNPNTLTKTEPVT
IQIPKRYNVIGLIDGQHRVFSYHEGGLYDEKIGKLREKQNLLVTGIIYPDTILDQDKTKF
EANLFLEINSNQSNAKSDIKQAIGLILKPFSSESIAKALINKLNNNGPLEDNFERHFYDK
KKIKTTSIVSYGLKPLIKLGGDDSLYKIWSHPQKLEIKDESDEKLLEAYLEFCTSQVNDF
IAAAKDNLSSNKWTRSKEEKNKVLTTTAINGFIICLRQIIENNHKTDYAYYKNKLKHLNS
FDFSEYKSSQYGRMGRDIYNKYFTNNR
>IFAGANLK_02169 hypothetical protein
MKNLTNFLSLFFLLLIFQSCITYNLPDGELKGKEVCGYNKCKPGYIGTVFHYDDNPYSPD
ISDESDSKSIAYSVLGHTLPLSDKTGGEIGTCSYNAKTPFSKTDITNIRYSNGHNLEYER
SEKLELDVQAAVEADMNKLKNLITDQSLLNDLEGKITAAYNNVNDKELKISAKYSEWGLK
NNAIDRFRKNVDFEDCKKYMKEQNHRLITAIGLVYYEIEYSQNSLSKIASEVQAELEQEG
VNFNFGANFKREVSKNLTATTPGGYQVLVLRQATAEKLSL
>IFAGANLK_02170 hypothetical protein
MFKLIIFLLFPVIIHGQTFKSSATAHIIESYEIEFMERTIEISENEIIIISQGKKYKDIQ
TLNVVEIEEKEFGKFGVCSWYYCNTKDIPGSEKLIILPMQENPKQLSIFEPSKDGASTKE
FKIMLD
>IFAGANLK_02171 hypothetical protein
MTLYEFKLLPEQVQYRILFNEGDFISYRLEPTTRFSLYALDKFFVKVEYNPKSNKIVNKV
SFISGEKLNLYSNFKDNEFY
>IFAGANLK_02172 hypothetical protein
MTEKEKIGKQVLKLRERLPSKEYDKEKISQQELADTNFGLTKHLIGTVERGDANPTLEKM
MLLAKALKVRKIQLYEIEIDVNKFIDEINSENN
>IFAGANLK_02173 TonB-dependent receptor SusC
MKNNYSRLKWVALIILGGILFFLSKAATAATSNTAFFQQQLISGIVSDQNGLSIPGVTIT
VKNSTRGVVTNLDGEYEITAPANGTLVFSYMGFKTFEVTIDGRSEINIQLEEDIASLGEV
KINAGYYNTTERERTGNIAKVSGEEIERQPIINPLEALQGRMAGVEIEQRSGISGNAPTI
RIRGQNSLRTGSSNNGNLPLYIIDGVPVNSSPLVGSDLSGGTGIDPLNTLNLSNIESIEV
LKDADATAIYGSRGANGVVLISTKTGKSFEQKTQVEARLYSGVGEVSNKIKLLNTPQYLQ
LRNQAFENDGVVPDQTNAYDLLLWDNDRYTDWQEELLGGTAAITDLNLAVSGGNETTSFR
IGGSYHEEGTVFPGDFKYHKVTGGLSLNHKSKDEKLNLNLSMNYGVDNNNLFGSDSYISE
ALSLPPNAPQLYNDDGSLNWADLTWDNPLSNLQNSSINQVNNLISSLSISYEFLNGLTFK
TNAGYTNLYRNQKSITKKESYRPDIRDRREHLSSERINKRKSWIIEPQLTYSVHIGRGNL
DALIGMTFQESENDNLRISGEGYVSESLIGNLEAAEAVDVNEYLNIRYKYTALFARLAYN
WDQKYFLNLTGRRDGSSRFGPNKRFANFGALGAAWIFSEEPIFRDHISFLSFGKLRGSYG
TTGSDQIPDYGYLDAYEATPGPGGLYPTQLTNPNFSWEENKKLEASLQLGFLEDRINLGV
SWYRNRSSNQLVGFPLPSTTGFSSIQANLPAMVQNTGWEVEFSSLNISTKDFSWRTSFNF
TLPETKLVEFDNISQTSYQNVYRVGYPLSIALLYNYNGIDPETGLYQVQDINGDGNFSYE
DRTVIEELGRQYYGGISNNLSYKNFSLQFLWQFVKQNGYKGYFAPPGNVSNQPQNVISGI
ENGTLQQASQNFTAFNSYFFASTSEHFISDASFLRLKTLGFSYDLTEKILQNWKLDGFRF
FLNAQNLITITDYEGINPENPGVETLPSLRTITGGLQINF
>IFAGANLK_02174 SusD-like protein
MLRNTYFKQLFILLVILINTSCEDYLEVDTPKHKIVSATVFEEDETAISTMTGIYNELLN
ADFSGGWNYSVSVLGGLSSDVLEPVNPNSVSYAEFNQNEISPDSEFNFYLWSSTFNIIYM
TNALLEGLSQSEGVSEEISKQLEGEARFIRAFTYFYLVNLYGDVPLILSTDYEQNSLIAR
EGQEQIYELIIDDLQASIELLENTTSETRTRADKFVVTAMLARVYLYLGNWEQAEFLSSQ
VIAESSKYELLENLDEIFLPESKEAIWQISPVGRGNILTSTNEGLAYVGSSFSSFKISDE
FVNSFNSEDKRLTSWIGFYTNATRSFHFPYKYKDGSSISNITEYSMVLRLAEQFLIRAEA
RAQTGYFSGAINDLDKIRTRSNLESISGSDLEINQENLISLILEERKRELFSEWGHRWLD
LKRTNRASSVLGHLSDSWEDTDILYPIPEMDRMKNPNLTQNDGY
>IFAGANLK_02175 hypothetical protein
MMVIKNLKLIKDRGYYLLVFLFLGFNTAICQQKPKTPDSELLGLDPSVRYGKLENGFTYY
LQKSDSLTNTIDLHLVVKGGTYHEDKDQLEYAHLIEHMGYKSTKNFPDLPAYFNTKGLYV
HAGTRNLHTFYFTRIPSGDKSVLDSGLLVLRDWSHDIRFDQQSIDVEREAILGEMRVDNP
YNDWFWNVLTKNLIKNTGAHFRDQNAAEKSILDFDKNAFLRYYKDWYRPDLEAAIIVGDI
NVDSVEAQIQRLFSDLKTPEKRSNVNKKLAKWKVDFNVENQYISVLDTLKPGFRLYIASK
RMDEKNPKNVSDYKAMLLRQLYEIILKPRIKQLKQQLKPPFSEFFMTNNPVNGQLAYDLM
KVDLESDEPRKVKNGLVRALSARKQIHKGVTDLELDRAKKEVLQHYSGKQRSNSELVSKY
ENHFVSGTAAPDPKNEYKLISKILNQIDLNKMQSVFNDYGNFMNKTDFLFFRAKDQVAPD
SDTLAKWLDEIDSMTVDPLKPLPPAIESLSEVAGIQEIDEYDVELETEHIIGVTEIKLKN
GIKLFFKPLKPISERNAKTISIHAFRPNNIPIRRRKEYLAAKVVPEVLKFTGAGSFDKFQ
LENFKKSTGLRLSFELGRNYQKIYATSKERDIDELLNLLYLRLKKPLLDKESFSAWKSDQ
KGVLNEDSFGRGNPNFFMDDIRAIWYPDIPNLKLQDLEDLTMKKVSEAHQEWYSNLNGYT
FIISGDFDREDLTKRLVKKMSAFPVTTKQVSNDQTIDFPFYKMDKVIRLSNLEQSYISLY
FPVNAPRDIKTQVELKLLSKALHKRIWDRLREGCYAPGAWGEWMDINNGIYSLNVRFNSE
LGNESELTQMAIEEFRKLKKFGVDRTWLENAVVDLKENYGKGIDYLSTFSSFWPEYFQDK
INTGEDIENEVLQYEAVLDHFTSLEDINAAADKYLSEENMQKFLVLPKDYVQNE
>IFAGANLK_02176 hypothetical protein
MLAFICSVGMAFATVGTNYAAATGFIETDEGWKPVTVNCEEGSFDCRVYLESDTETPYTV
YPVANSQSEPLESSSPLPIMISD
>IFAGANLK_02177 hypothetical protein
MFFTYHQKYRLSEIIRFFLAILFIYTGATKLFDYSSFYDNLYNNPLINSRLLTNFLSIGV
PILELIVGSLLLYPKKKLLGMIAAMGLLNLFTIYILGILFLSPYTPCSCGGIISLLSWHQ
HLYFNLGCIAIGLLGLYLMKNNKLKNQAEITDKI
>IFAGANLK_02178 Regulatory protein SoxS
MYFPNDKLFDQITHLITALANDEYDKRIKINKLRSKLSTIGVLLNMLAGVLKLKVPSKIP
EYDLSYLNHIILIVEENYQIKDYNTGSNGLFDNQLHNLESILDEESLKKVQEIMDSTSFD
RSIKLNYRLRDDLFLTMDSRITKFENNNSEVFILSAVKTISKNEWTKEKLLKKALHPKRQ
FDISKNKKIIDRLYHYLMDNLDSPLKPIPEIARELETNSTVLIRGFKAIHGKTIASFHRE
KRLEKARDLVLDTDTKLSNIATLCGFGSLSHFSRAFKKHFGVNPSDSR
>IFAGANLK_02179 hypothetical protein
MIKRAQNNFAEVWIENDILYFVYAPLENLSLKIAKNLLKLRLSIQNNKGYPILCDLREVI
QADKEAMDYLAKEGSVQATAVALLVQYPHTKSTAQFYLSTSIPKVDTEVFEDKLKALEFL
SNYPVKN
>IFAGANLK_02180 Putative pyridoxal phosphate-dependent acyltransferase
MAKVKHNNFLDTVDEVITNATDAGVIHLHAEGRKLNGRKITINGKSSYHFGTTGYLGLEQ
DERLKAAAIDAIRQYGTQFPLSKTYISHPLYAPLEEKIFQMYQHPILITKNSTLGHLAVI
PTAVRDNDAVILDHQVHWSVQSATEILKSRGIPVRMIRHSNMDMLEHYIKEYRNKADKIW
YMADGVYSMYGDYAPLNDLIALARKYPQLHLYIDDVHGMSWKGKHGSGYVMSELKELPQN
ILLFGTLSKTFGASGAVLVCPDEKLHKKIKNFGGPLTFSAQLEPASVAAATASADIHLSS
EIYELQADLEGKIRYFNQLLESSDLPLIHRNSSPVFYIGTGLPATGYNFVNKMMNAGFFV
NLGLFPAVPVKNTGVRITISRHNELEDIKALVDAMDYHFPKALEQTHTDLPSIYKAFGMP
KPGLPNEKFAEKTNTNLHLTYTKSIKELDKESWDKCFLGKGTFDWDGLSFLEHVFINNNL
PEHNWNFHYILIKDNRDKIILAAHMTSALLKNDMLSNAATSKAIEDIRKQDPYYMTDIVL
SMGSVFSEGDHLYIDSGHSQLVNTMRLFLKQLEVIKQQVKAKLIILRDFNKNNDLNSFFN
EQGFVAIDMPDSCEISSLHWSNEEQYVSTLSKRSRKHFRKDVKAFENYFKTRIVCLPTSE
EIDKYYELFEEVWSHNLGINTFKFPKKLFSEMIISPKWDFLVLYLKPNRINASEKVVGVM
FVTRSGNTLIPSLVGMDYDYNEEFNIYRQLLYQTIKTAGILKFKKINFGFSASFEKKKLG
ATLTPKIAYIQADDNFSLEALDWLRKE
>IFAGANLK_02181 hypothetical protein
MKIAQQRHYLLSLNTKLMFEKAMSIFTDEVERIINSQEDTLKKAELGIRLSNRTLSELQR
MVEKEDFEDPAEEINFFRNIKPIPMSYLIYFTEVRTCELSIPKLGTQPKIWFLEKEAKKI
NKFFSKNKDFANYMEQSRRYMDPEFFTRNKLDNFPFAPTINYYQYPEFSTSHDMLWAMIQ
AMYKFIHYVREKLHTLQPGNKALFLERKPKLLKWTGSKTALVELLYALHADGALNHGNLE
ISTIISAFEDFFNTKLDQGYKTYYEIKARKGDKAKYLNQLILSLLNKMRRDDEL
>IFAGANLK_02182 Cytochrome c551 peroxidase
MKNNYKLFHCCLFIILAFSGFKVYQEYDIDELRKRYSSGDPSMWPAPDIDEEVKNNFEDI
GHLPPPNFPKDNSYNKEKKELGKTLFFDPRLSSSGQIACASCHDSEIGWGDGRRVSYGHN
RQQGRRNSMTLLNVGYVDSLFWDGRAESLEDQVGFPINDTLEMNFHVNLATERISAIKGY
KALFESAFGNEQISEKNIRKAIATYERTIVSESTKFDRFIDGEADIYSDREVLGLHLFRT
KARCINCHNTGYFSDNKFHNTGLTYYGRKYEDLGLFEVTGKPEDVGKFRTATLREVSRTE
PYMHNGLFPHLEGVVNMYNAGMPRPKRKPHEVNDTLFPTTSPILEKLNLTNEEKAALVAF
IKTLESRNRRVNPPNLPN
>IFAGANLK_02183 hypothetical protein
MKRFGLLVLLCLSFRGTAQDSLNSPVSNQFFTEVLKNYSKNPVNMACVPLKDYTASTLYY
HFEEGALKQGGEPQGVQDFGLKTQGIYRTGMGITFFGDLLVKKTYYRDLAWNLSYMMPKK
GMMPDPHYFGVSKPGNWSNQHYELNGGVVIPVNQGWNLALETNYNLFNKYRVNLDPRPKI
TYNKLTLGANLSYNITKNHRFNMGYAFEQAAIINNINFSNNNQNEAVNYDIYIKWIAGYG
SLMNVFEEDIKRKNKAQNFSLGYTFQNSSHQLLVTANLKRGENITFKEDVDDRVDNENSY
FATFEPEAFQLDIMGLKYKGKGKLIKAEYTYHRNLGENFLTAKGGKTYSNSLDEHMLSYS
HIQQDAQGSTKNEYGLKFQYWESSQQDALAVTRSDFKNGEIHFYGQKVVFETKKIKLRPQ
LRTSIIFNIEENLENGNSQYLENIDEYDYMGFSLRDYYNQVIMPDLQLVSSTRINLEAGA
YLDFISRQNLQSILNLKIGYLSSLESDNYHANNQRLYTSLSLILNY
>IFAGANLK_02184 hypothetical protein
MRKLSFLALIATLIIGCSKDDDGDFIAPVTHEIHVAYDENYENENAAGAVISLENIEDGR
SYEATTNAEGRAVVEVVPGSYQINISKTMTAEEYFDFSGQEVETEVSFNGSAENISISEN
GSSTSLEIVTGTIGNLLIKQIYYNGSDVRLGAVFRDQFVEIHNNSNEIQYLDGLYLAQVY
GNGSTPSTNESYHQASGQYDWSQSLGQDKENPNSDYIYADEVLKVPGSGEEYPLAPGESA
IIAATAINHKQPLVIEDEDGETQTYEVAEPERTVDLSQVRFEAYFRPYMESTGGNFLDYD
IDNPNVTNVEVIFKSSGGRDFILDTHGREALAIFYSDDENISSWGEYPAPDQNEIDEETS
LYLQIPNEVILDGVELQYNNPAKQKPKRLTSQIDAGETTTPNGAFSSQSVIRKVAGEIDG
RIYYQDTNNSSNDFEFLDRPQVKTN
>IFAGANLK_02185 Vitamin B12 transporter BtuB
MKLLIYFISFLSGFSAMGQVSGRVLDFDTKKPLEQVLIINKSGNEWTVSNEIGAFSLDLK
ASNFILEFQLLGKQDFIIESKNIENSDNLQIYLKDDDLRLDKVMVTAVPKKSKIGSTVTL
GEYAINQVQAYSLADILKQLPGQEVTPPSLNRPNSISLRTANPNDNNAFGVSYMLDGMQL
SNDENMQSYSPGFDLTAYDNTNTGIDLRTIPASNIEEVEVISGIPDAKYGNLTSGVIDIK
RKAGISPYHINANIRQGNTSLSLQKGYGLGKQLGNLSVSLDYLNANADPRNSLESYNRVT
ALLIWSLTNKNKTLRNSFSLTAHNNLDDEKFDKDNDDGGRDSAFRKDRGIRFNNRLNWKP
AVSLIDNINLNTGFSYAYQHSYRQEFRNDGGRIVPLNLETGISKGTYTPVAYLMKRETFG
QPLNISANISGDKAFNAGNTSHSLTFGFDFSYSDNKGRGKEYDPEHAHTQVSFSGGSSGL
EEGIRQVNFKRSVLGQFRFGAHLQDNITHTFSNNRKVFANLGFRYDSQNGFSSYSPRVNL
AYELTNRLSVRGGFGFASKAPSLAQTFPGDKYFDRVLADYRTSNYSYNLIYTHKVPIEKN
ELEPSKSWKYELGGNFNAAFAQISFSAFYNESFDGFTSDNIIQSVYLPQLEFSFPNSETP
PTYEIVGPATMILNYSLPTNASTVIDKGIEFFINFKKIEAINTSFNVNGTYTYSNSASIL
PTIRKNPDPLNEEYLYGIYNRTSNKQDMWRLRGTITHHISAIGLLMSFTAEHFIRSAVYA
SFADIYPIGYIDASANQYSIPSSERTNPEYASLFLDPDSTEDRITPFYNNFHFRLTKEMR
NNISISLYANNFLNYRPTIEVNDAIRRKNEAISFGANLKYEF
>IFAGANLK_02186 RNA polymerase sigma factor CarQ
MSKVSDDNLDCMRFLYERYYQWIYNFFMQMIRDKDASEDLMQTTFYKAIKYRKSYKGGKF
DSWIFRIARNLSADYFREQKQTYSNERFENITEVIAETEAGGDVQKLNLVMLKLSPEERE
ILVLSRFQEMRYLQIAKLLGSTENAVKVKAHRALKKLKKLFFESVEI
>IFAGANLK_02187 hypothetical protein
MKCKEIEVRIFYYLEGQLSKKESGEFEKHLEQCNGCRKELKENKKLLATMDTVEPENPGT
GHKQSFEKMLEREKQGLVKSDSSKVQPLFWKTAFQIAASILLVLCGYLYGEHRGTQDAQL
QIAQLTQQSQELKTDMTLAMMDNRSASKRIQAVNYSEEIHMPENKVLEAIIGRLHNDDNV
NVRLAAAASLSRFQENRLVKDAFIKALETEGNPDVQIAVIQFLAYVKEERSVTPMKKLLN
KPDVPDYVKLQVNEGLAQIL
>IFAGANLK_02188 hypothetical protein
MKRTSILCLAFMLIGVLASAQEEFKKSLSGISRIEIETGTSVSLKKGTTNQLIIKEGCSN
CGNEDEPVTGWEASNEITDEKAKGLTPIYAGGEDNTGTGMYLEQDGEVLRLTDLKSFYKR
MGLTITIPASVSLKINCGNLGNASVEGLTNELEINTNVGYIKLNNVTGPVTAHSATGNID
AIFTSVNQTAPISISSSTGMIDVSLPTNTKASVALSSTMGSVYSNFDLVGPREDGLKAIG
GNKSISGNINSGGVKIALKASIGNIYLRKK
>IFAGANLK_02189 hypothetical protein
MKNLILFNFIVLFVSASYGQRNVEENFKISGDQQISFNFKFAGDIKFIQWDKQEVKINAR
VLVDNGEGNDAYSLKSEASSGEISIYSDFGDYFEQKNNTVINNCNRKTEISYVVYVPTNC
KLKVKSITGNVLSDSFSGKLETDLIAGNVELKKYDGELMLKTISGNLDVTLDKAEIDAKT
LTGTIYSDLDITSLHNNNEKSVASRVKGTVNNGGKRTKLETISGNIYMRKG
>IFAGANLK_02190 hypothetical protein
MGYILPKSRLGIFFSVVNLEQDVIKMENQIYDRGIIPDLTIPQSYENFLKQEDTQMKETL
KLIRAE
>IFAGANLK_02191 hypothetical protein
MIPFSQNVKFSRNYVCHCEIKSEDPFKFVITKVKPVAPIFKKIVKGGGFTQNVITMEISI
ITTEDLSLFKKDLLNEIRELMQQQDSSPVKKYLKSSEVIKLLKISPGTLHNLRENGTLPY
SKLGGLIFYEADKIARVLEEGKVSN
>IFAGANLK_02192 hypothetical protein
MNYIRLLTEVTEKFKNDDRLNATHISIYYALFQYWNLFRFRKQFFVQREEIMQASKVGSL
TTYHRCIRELSKWNYITYLPSKNPLKGSQVMMSIFWSSSKQVMDELKTSDNRPVNKFKPC
NEQVEDKSGTSPGQALVYETNNSKPTKETKYTRDRPKGADEVVSFFKEQRWSVQEALKFY
HHYEANGWKVGGNNPVQNWKSLANSWVLKAEEFKKSTRKETDHLKTTKNKDYGQPL
>IFAGANLK_02193 hypothetical protein
MVNPCEIIEGGVSYHIGKIKGKKACYDFQKMLEYLEIKGKLLFMEFKIYPEDEALLFKLC
NYIIADTEQCEKFKIDPRKGLLLSGPVGCGKTSVLKLLRHLVPHQKAYQVIPSRNIVFSF
NHLGYKTIEDYGNAGYLCMDDLGVEPMGRYYGRDCNVVGEILLSRYELFLNHKVRTHAST
NLNAEELEERYGNRVRSRMRKLFNLVAFDKNSADKRK
>IFAGANLK_02194 hypothetical protein
MRIASYNIQNLFFRDEALFGTGHSKNFMDWLDEFEAILRKGLRLNEDYRRLRELSFLMGL
SKEHPQKYLVLRNHGGVLHGKIVASPRTLEKDFKAGHSWIKMTSQMIPRESVIHKARVIS
EINPDVLLLQEVEDRASLISFRDKYLADFNYRDCYYFEGNSNQGLGFGIFLRKGYSLSVC
RSYCNKEDSEGKPLFDTGLQILWLRDPKNQLFRILQTNLSGLGKGEKVDQKRRDQLGFIS
KVWEEQLDMFHDLLIFCGSLGRPSYCESLSKLMSKKEIRNILKSGCFKADRDYGKAASYF
SLGAYQKGINLRETQYLLYNNTPSAELLSCGLNRRGIWSGRTHNWYCYPGINSEVSQAGM
HPLLWADFLLTPGNK
>IFAGANLK_02195 hypothetical protein
MKNAFYPSLFLSLFSLPMFAQIGGIEQSVADISDTIRAVFPIILGVIFLVGFLFNAGHFF
GENADLKKGITRVLVFVLIAGAVVGIFTYLIGIVV
>IFAGANLK_02196 hypothetical protein
MNINLQDYYPIIDQQEHLIFLANGNIALGYELELPEIFSLSEKAYEKLHSTWFQALKTLP
VGSVVHKQDIYLKKEFESKGIAGNTFLSKATKKHFQGRALLEHQSYIFFTWPFQKSFSRP
RMANPFVKVPKKLPGEMNTETRQFMAAVSDSVGYLNNTANISLKPISKEKAISITNQYFN
GFCAGSDTDIRLKNGELRIGNQRLGILAINHESCFGQGVQTSKPHSRFTSDEISFHKGFL
DDFGLELNEDHIVNQVLFLDERSRWIAILNNKREELLKSVNFGTQNKIFLSQIDETLETI
GKDEQSRIVRGQVNILFSGKDQKELSQISSRIKSGFKELDIKPYEPAGSLLYQYFLNSYF
GHSPAFSNEDLYVTDLRHALCLWINNTGYRSDKKGILFNERLFNTPVIKDVWDSDKKRIK
ARNFAIFAPTGEGKSFLANNILRQFFEGGTRLVIIDLGGSYSKFAKLYPKDHIILRYEHG
KNLGINPFYIAKPDDLSPERIEDLCGFLMELYASGLKVAKEGQVAIKKILRFYYEQESGP
YSLEGFYRFVSTNQETFESSLGIGKDYFDAVQFLHIMSEYVGSGMYGFLFESREDQAYKL
EDKRLIIFELDEVRNSREILSVMLKLIKSAVQRTIWKNPGERGIILFDEFAKQLKFDNVL
ESVEFYYQAIRKQEGAIGIVLQSINQLPENATAASILENTQVIYSLHNEKGYKDLVRRLN
LSVHDLNQLHSIRNDLKGKRKYTEIFIKIGRESNIFRLEVPPEVYAAYLTDGRENQAIME
IYERTKNMEVAILEFLTTKTEKS
>IFAGANLK_02197 hypothetical protein
MNRKKFKILIIALGFTFFSSGHIVAQGMPVYDNTNFLALGQSLIESAKQTSELLKTARFL
KEQKERIEKVNALIKQLRTVREIVENNQSLYETVRSDLRAIISSPYISPEEVARISESFN
SLMENALEDLDFMQQLLTSDMLNMDDAQRLEVLESQRMRSREVIREIGLKKQRYEILIEF
RRIKEEINRRQAQY
>IFAGANLK_02198 hypothetical protein
MDLGLEYVDAVFTTIKEAEFSQYTITGMKALAVFLFLVNIIKKYHEGAVARDGYTWGLSP
SELIKNFMVVLLVIFSDQILAVFDGILVGIESDFRDTAPALIPLQLQDIEIDRDVGLLEA
GTKALSLLFEYLVTPFYALKMIAFILGLFLWIMDLFIYPLFLAERFFILGLMQVFFPLVI
SLSVFEKFREMGYRFFKLYAAVYMIVPAFFLVNIFINQLYQAINTEFWPGLIGNNGEDSI
LSPVIQLGSVAFILLLKFKLYHRAISFTFRIFST
>IFAGANLK_02199 hypothetical protein
MKTPYTHIYKVLRLNRFIVLSVLLMAFCSSMISLYQVRQVQQDFLNKAFAISPDGGVLPL
ELVSQKDQIEVEVKSHLDQFHRYFYGLNTSNYKENIAKALWLGNSSVDQVYRQKKADGVY
NRLLQYSLVQRVTKIESTVKLAEVPYSFEATTWFEINRGSSTEKYKLVTSGELLRVDRSF
PNNPHGLLITNFFENQLIKQPDEH
>IFAGANLK_02200 hypothetical protein
MNIDRKKAVFVGVVVLLTCFIVAYGFWGMETNEKLGDEKISNPGIPELSGESEEYQSRLE
AVEGLREERDRVPPSLYPDKNLESSGEYDPYLEEEEKNRLMDSILKSGPEPDEYYFEPEA
TPVKEKDTTGISLVNKSTNPPDHIPGQGHLEFFFVSKAQESQPLEKSLESFRVSVNGDQV
IRKDERLELRIIDPIKIGKDSLASNSLIYARAGFRANRLLLEITGNFIPGGKLVAYDLTD
GLEGIYIENSFRSQVTTEVLDDVIQDINISGVPQVRGLKSIFQRDNRNVKVKVLHQHQLI
LKPAL
>IFAGANLK_02201 hypothetical protein
MKNPVLLYLLSMLPGLLIAQSKMIYCNDFQNTVVLSPEPIIQAVTGSDHFVFTYDKTKPD
ILGLLQGSPGHQSNLILRTSGGDIYTYTLEYRDSLSDYSFQIKRADRIRLNDSIVMESKP
FSKKRIEVKDRKETYYQKLSAYFASKAKKRLAVKRKEGMRIEVLAVHHHRDEVFITYRIK
NRSRISFEIGDLALFRVQGKKARRSSFQKIRLEPVYREKVPKAVAVGEERKFSVVYSKFS
LGEHQELHLELNEARGSRFFKLFF
>IFAGANLK_02202 hypothetical protein
MKRNRLVVPILWVIALALLGALLSNFFHQEEPIDLRKQSLHGKIDKSSFHRGFIKVNDNI
WISQNTPEVSIVDGQKTGRLIDEIYPPYRLKKQAGDSIILLEKDEDSLYFRVLGEDSIND
PTFSQLYRRWFKH
>IFAGANLK_02203 hypothetical protein
MILYFFISYTIIAGGFALLDRLKQLSFFQCFGILVVSNYALFMVYSKAGYIIIMCASLPL
IFILLLIYGFESNNTIASKYRVKFALDSGSFSIQNLKRGVSITGAAGSGKTESVVYNFLK
HLSRNNFCGIIHDYKNFELTELAYPLFKNSDLPFKIISFDPVYHKVNPIAPQYLPDEESV
NEIARVLMENLLEQKEQYASGTTRFFNDAVEGILCGMIWNLKTHHPKLCTLPHLIALYQR
MNSDQLIEFLSSDITSRAMADAFISGIDSERQTAAVKSTLANAFKKITTRKIFFCLSGHD
ISLDLNNPKNPAVVTIVNNPKNESAYSPVIAMILHTVIKQMSVRDRKSAFILMEEAPTIR
LLHMHRIPATLRSYDIATLYILQDKVQNDLLYGEKASKAILANLSYQFFGKVNDPVTAAY
YEKFFELVKRDTVSISKGEGLNFDTRVTRTKREVSKLRADLFFRLKPGEFVAYADGKEKK
VRFKYPKIQKALPGKFKHFSKDELDARFASIYTEVEELLKATKK
>IFAGANLK_02204 hypothetical protein
MYITISPQKIGPAFSSSVADFVDYLEKENTDRLPEAQEYFFNQTQEKITRDQVIKEIDGN
TAKLKTTEPRYYSLTINPSQKELQHIKNDPEKLKAYTREVMKDYAASFNREINGRPVQVS
DIKYYGKIEFSRTFKERDKEVRENAPYNNKIAQLKNKLRKVQRGEIPGHPHNIRKEILRL
QRDAPHKIEGKLIDEGTPKQGNQTHLHLIVSRKDQSNTVSLSPGSKYKASEVSLHGKIVK
RGFDRDRFFEKAEKTFDQKFNYKRNFVEQYKARKTYLQSPQKYYSMILKLPTNERKAAMG
ILNTGVSKIPDARIRFAVKQFQKAIELGLKSSSIGY
>IFAGANLK_02205 hypothetical protein
MKKQTKKETFKNLSIKASVAKRFRKFTKDLGLRQSASLDLMLDFFETNRLSPTQHLGPNM
KSLEHHLEKRINSSIAIVRAIESTQTKPTQAMLAALFESLPEKTKKKLPPSFEQALQNTL
AQKPIIQQLPEAPPEKKDLEAVLKNIELVKPTFGNPYLKVNMEYDELKSLKYKYHVYHD
>IFAGANLK_02206 hypothetical protein
MKSINILSVAQANSKLPDELLKTYLSASGIKMKKKELEDLTKLVRKLSSKNKDAPALYDT
FFIGYKIPQISREFDLLRFGKNYIVNIELKQESTEEKIKEQLIRNEYYLSFLDQNTIHLT
YVSKSNKLFRLDNDEELIEISFSDFARILKNQKTQDILNIDSQFNPSNYLVSPFNSTTKF
LSGNYFLTNHQEHIKDIIVTQIENEETTFIKISAKAGTGKTLLTYDVAKFYHNQNSKKVL
IIHCGKLNRGHEVLRDEHRWNIIPIKDYKKKDYSKYDVVIIDECQRIQTFQLEDILKEIK
KNSSNCIFSLDPKQCLRGVEISRNINELLENSVSPINFTLTEKIRTNKEISYFIKGIFDK
NYNNRKANFNNIEITYFCETDSALNHIQLLKSLDWKIINLTESTRDVLPYDVLTIPGEDN
AHEVIGQEFDKVVVIVDKHFYYQENGMLSTKGYKKRPYYHPTKMLFQIMTRTQRKLNFII
IGNNEILSRAIKITDQY
>IFAGANLK_02207 hypothetical protein
MEDHSNNEEFLLSIAKRFKDLRELIKLTQENVYNDTSVHISRIESGKTNITLLTLKNLCD
YFKITIPEFFRSC
>IFAGANLK_02208 Single-stranded DNA-binding protein
MSNLRNQVQLIGNVGNAPEIKNFESGKKVSSFSLATNEYYHKDGEKIQQTDWHNVVAWGK
RAELVEKYVDKGKEVAIRGKLTSRSYETQSGEKRYVTEILINEILFLGNNEKSK
>IFAGANLK_02209 hypothetical protein
MKFYVIWFVLLLVSPLNFSYSQTCPEVNNPIQNFCDSNVSTVADLLPSDAIWYTSNDPGA
IALSPNDELINEGIYFAGNLNGNCDNRLQVSVNIYQTPDAGSDKQAYLCGTSSGALFNNF
TEVRNYFTNMLDEGVPKDGTFDPTLREINEEYWSSPVEGSKDLNTTYTVGEFGCEDAVEL
TVTVYEYVNAGEDGEVILEDSSPIDLFQYLDGNPSEGGTWSGLEDGIFDPLSDEDGAYTY
SVGNNLCSVSSTLMVSYTGGNDLLDCNNLFVDNENVGIGTANPGSYSLAVGGGIYTDEVK
VMNVDTWPDYVFSESYNLMDLEEVASYIEEEGHLPGLPSAEEVLSDGISLTEIDKSNLKK
VEELSLYLLDQHGRMESLRNGKVQKSSVLAYRADNERPYNFILDQSGIAEGQAELKTMST
DSLSTGNMYCDGDNVGIGIGQTFGYRLAVAGGILSAGVKVSSVSNWPDYVFSDDYAMLSL
DDLRAYISTNKHLPGLPSAKTIAREGYSLSEMDKLLLEKVEELTLYVIEQEAELESLSGE
LGVILPVRDEEFVSNKTVYKSHNVDIESYLTAPVQREGRTFRDASLRSMEGSTEALCDVI
SCDGEGVGIGTEPVAGYRLAVSGGILTDDIQVASVANWPDYVFEADYKLRDLSSLSAYIE
REGHLPGIPKAELVEQEGYHLEVMDGLLLEKIEELTLYLIRQERQLTFLESRQ
>IFAGANLK_02210 hypothetical protein
MKSLFITCVFYVLAQPFFSLSGIFNAENDRSGLLTYSTNNDLYIERISNSVGRETSSLCP
TTDSPYQEICEATEGDFPKIKHLDANDNGDGVAWYPDNVSTEALDEETYLEDEKIYYLGA
ESGGCVGSRIEVTVSLALAPNAGRTTSINIASDSEPVDLRDLINTTYLRPEPDDGGFMVP
ALNSGSTIFDPSIDANFTGGKQFRHWVYSTNNICDDDSTIVYITIDPAPNTSHLLYYLGT
DEEESKNFLEQSPPSTSEEGIRTNIWIDQPLVKNSIYKIIVNDQAKYYYVNNLYAEPDTA
PAMTLTQANEITLIESSEGSNCTELITNNEENIGIGGLPNQNYGLTVEGGIYTDQVKVMD
VDTWPDYVFSEGYGLLELDEVASYIKEEGHLPGLPSAEEVLSDGISLTQMDKANLKKLEE
LSLYLLDQHDRMERLRAPKTQKAPVLAYRTDKERPYNFVLDQSGIEEGQGQLKRMSTDSL
STGTMYCDGDNVGIGIGQTSGYRLAVAGGILSEGVKVSDVSNWPDYVFSDAYALLSLEDL
RAYIETNSHLPGIPDATTIAREGYSLSKMDKLFMEKVEELTLYVIHQEAELQSLSGELGI
VLPVREEEFVSDKTVYQSPEEEIETHLNTPTQKEGGTFPDMASPRSLEASPAALCDVISC
DGEGVGIGTEPVAGYRLAVSGGILTEDIQVASVANWPDYVFEADYKLRDLLSLSAYIERE
GHLPGVPKAEILGQEGYRLEVMDGLLLEKIEELTLYLIQQERQLTFLESRKQ
>IFAGANLK_02211 hypothetical protein
MLQRIQTVYLLIAAIISGGLIFVFSLWENSEGVAMFAEDYLMVFIAFLASALLSLVSIFM
FKNRKLQFVLGRLNILLNFFLLGVFVYWSLSLPGEMDISEKGIGMFLPIISIVFLVLANK
AIKKDEDLVKSVDRLR
>IFAGANLK_02212 Transcription termination factor Rho
MFEISELKAKKLPELQDIAKTLNVPKFRTLKKLDLVYQILDYQAANPKKAKEALTDDTKK
EETPKSDERNKTAEKPQPKKGGKVGSNKKPPRAAATAETKEPRPAPARKENSSPKKEDTP
AKAREPKKQEQKPREDNSNSSHASKNNPRDQKKDTRSNSSNKSNGGRDVGNRDGRNRYRE
PDYEFDAIIESEGVLDIMQDNYGFLRSSDYNYLTSPDDIYVSQSQIRLFGLKTGDTVLGQ
IRPPKEGEKYFPLIKINKINGLDPQVVRDRVSFEHLTPLFPKEKFNIAEKQSSMSTRIMD
LFSPIGKGQRGMIVSQPKTGKTMLLKDIANAIAANHPEVYQIVLLIDERPEEVTDMQRNV
RGEVVASTFDKEAHEHVRVANIVLEKAKRLVECGHDVVILLDSITRLARAYNTVQPASGK
VLSGGVDANALHKPKRFFGAARNIENGGSLSIIATALTDTGSKMDEVIFEEFKGTGNMEL
QLDRKIANRRIFPAIDLTSSSTRRDDLLLDEAALQRMWVLRKYLADMNPIEAMEFINDRI
KQTKNNEEFLISMNG
>IFAGANLK_02213 hypothetical protein
MRTSTIDKLCCPFDKNDLELTSISKDIEGKIIEGFLSCKKCKRIYPIIKGIPIMNPDEYR
ELKLEAPLIEKWNKHLKGKKVENFRLVDTGVNNLEE
>IFAGANLK_02214 Thiamine-phosphate synthase
MIKKPQIKEGVYLVVDPQMEKTVLISKLKQIVDISEIAAVQVWDNFKNIENQISLINEIC
KIFKNYQVPVLLNNNGNLLNQTEANGVHFDEIPSNFKEIKKNISSNALMGLTCNNNLETV
KWAAINKLDYISFCSIFPSSTANSCDLVDFEIIKEARKITEMPIFLAGGIKPSNMHLLKE
LDFEGVAVISGIMNAENPSISAENYNSEFKKIKNENFHNR
>IFAGANLK_02215 Hydrogenase isoenzymes formation protein HypE
MGEKLGKIAEAELEGFILENCGHTRKEVSTKPGFGVDVSLVDLPDNLALISTSDPLSLIP
TLGLEESAWLSVHLMANDMATTGFAPQYAQMVLNLPASLSREDFKTYWNYIHQFCKEIGV
AITGGHTGFVEGQNSTISGGGTFFSVAPKKEIILSNGAEENDVILVTKTCALSSSALLTM
SFPETIKNKLGPQTYETGCEMFWQTSSLKDGLAAVGAGDKFPEIHAMHDVTEGGVLGAVY
EMVKASGKGALIYDEALPVTSWQKEVCKLFKLDYREIIGAGSMIISCEKGKEEQVISRLK
AENINCTAVGVIKAQEEGVKIAKADKIKSLEYKTEDPYWKAFFTAIKSGWK
>IFAGANLK_02216 Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE
MEIEKSSRFELLPVNHQNWQNREEWFFNRKHTDTYEQWYEGRYKRAEVWQKKVMEQLVSK
DIRVKTLLEFGCGTTRFTRWWKEIGIEATGGDISPLMLSQAVHLFEGDLVMADSHYMPFK
DHTFDSLAFITTFEYYKDPVKVIREAARVGKYGIALGMMNRNSTKVVRRRVQEIFGANPF
YLTATFYTPKKLTKIIEEALQGREYSIEWSCTGLPKWFPVQQWGLPYGDFFGLYVEFKDV
K
>IFAGANLK_02218 ATP-dependent Clp protease proteolytic subunit
MSNKPGKTQDLIDAKFLKERKIFLWGEVNDKSAKHIIDRLLYLDMEGDKEIQFFINSPGG
YVTDGFAIYDTMQSLNSPVSTICSGLAASMGSILLSGGTKGKRFIQPHGKVMIHQPMGGA
RGQASNIEIQANEILKTRELSAKILAENCGQTQEKVLKDFNRDYWMDAQESQDYGIVDGI
FKK
>IFAGANLK_02219 hypothetical protein
MDIKHRENDSRGMFFVEDEKGIYAELTYTKKPDDVLTIDHTEVRPELEGQGIATKLLAHS
VDFAREHNYKIDPLCPFAEVQFDRNESYKDVRA
>IFAGANLK_02220 hypothetical protein
MNLLFPMKFFKFLMLFVFVFFISCGDDKNREPGIETTKEEEAEVIEKLASADLIAKKFPG
ISNSVGNIDLQHANLLDSIYSKRDYTPIWTERALREDLYRSIERATEDGLEPEDYHLTYL
QNSLANLSQLDDEELSLTEIILTDAFFGLASDYNSGKLNPKEIYSIWGVENNIIDLPGLL
NYGVQQNNIIAAIDSVVPKHEVYKGLKRSLKEYRKLAENGENPTIISEEGESIKADEKDD
RIPNIKRRLKELGYWDKEIVDTATVYDEPLQEAVKQYQEKYGIETDGVIGGGTIKTLNKT
YQDRLEQILVNLERWRWYPKDLGDQHIVVNIANYRLHFVRNGDTVATHRTMVGTEARKTP
VFSDEVEHIVYNPTWTIPPTIKSRDVIPSAKNDSDYISRKNYSIFNRSGQRLSAREVDWS
SSEVKSYTFRQEAGPANPLGLVKIIYPNKYMIYLHDTPSKSLFNKNLRAQSSGCVRVQDV
LELAKMLLSDQPEYDDEKIKKILDSGKTTTIKITQKVKVHHLYWTAWNENGSTRFAEDIY
KRDAAIYKLLTAN
>IFAGANLK_02221 hypothetical protein
MIYRILTVFAVLTFSFAFTTTDNLDSNLENSEIAAVTSPVFEDNTKTSFETKVADLYSEF
STNNSSIPAKPVFEKAMKGYDQLEEKGKVGKKILTVIDFGLSSTQKRMWIMNMETKEVLF
NTYVSHGKNTGGEFATKFSNTVNSLQSSLGFYVTAETYYGKNGLSLFIDGMEKGFNSNAR
KRYVVIHGADYAEPNFIDRLGRLGRSYGCPAVPNTIAKDVIDTIKEESVVYIHKNDNNYL
NNSSLLN
>IFAGANLK_02222 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MILDGWGITQNPDVSAIAKAKTPFMDSILEKYPHAELRTDGMQVGLPEGQMGNSEVGHMN
LGAGRIVYQDLVKINMAVEKNTLKDEPVLEEAFNYAIKNNKPIHFMGLLSDGGVHSHINH
LKGLLSAAEEFGVKEKYVHAFTDGRDVDPHSGKGFIEEIEEHLAKTNGKLASVIGRYFAM
DRDKRWERVKKAYDLIVKGEGAKSTNAAETIAKSYKNKVSDEFIEPIVMTNEAGEPVATL
KEKEVVIFFNFRTDRGRQLTQALTQDDFPEYNMKKLPLYYVTVTKYDDSFEGINVVFKKD
NIKSTLGEVLEYMGKKQIRIAETEKYPHVTFFFSGGREKPFKGEKRLMCSSPKVATYDLQ
PEMSAFEIRDKIIPELKEESADFICLNFANPDMVGHTGVFDAAVKAVETVDSCAKDVAEA
ALENDYSVLIIADHGNSEIMINEDGSPNTAHTTSPVPLILLDKDVKSIKSGKLGNIAPTI
LKLMGIDQPEMMTEDPLI
>IFAGANLK_02223 Thioredoxin-like protein YtpP
MVNKVLLLFLGFSVISGEVSDEKSIIENKNSAEILIGEFTQADLEKAPHSRWFTPGYENY
KPKKEALVSIKKNIHDYEILLFMGTWCGDSRYEIPKFFRLLDEVDFNRKNLKNIAVNRAK
KAPGDLDEEYKVHRVPTIIFLKDGKEVNRFVEYSIESLEEDIAKIVEGKEYTDPYSE
>IFAGANLK_02224 hypothetical protein
MPHTLTIAVDFDGTIVENKFPEIGKPRLFAFETLKKLQEDGHRLILWTYRAEDKLEEAVK
FCEKRGIHFYAVNKSYPEEVFEENISRKILADIFIDDRNIGGMWGWGEIYQRLKDRAIIR
ENKKQKKKFGFFGRF
>IFAGANLK_02225 Methionine aminopeptidase 1
MIITKNPEEIELMRESALIVSKTLGMLAPHIKPGVTTLELDKMAEEFIRDHGAEPGFLGM
YDFPNSLCMSPNAQVVHGIPNDKPLEEGDIISIDCGALKNGFYGDHAYTFEVGEVKAEVK
DLLKATKESLYVGIREFKIGNRVGDVGYAIQKYTEDRGYGVVRELVGHGLGAKMHEDPEM
PNYGKRGRGKKFIEGMVVAIEPMINLGTRRIKQLPDGWTILTADNKPSAHFEHDVALIDG
KPQLLSTFGYIYEALGIVSEEEDEFKAQVYGKEI
>IFAGANLK_02226 hypothetical protein
MVKKFRGEIWKRLHKEEWQDRFVYDVSNYGRIISYVQNPEGELINGGRTNGYTSFSPRLQ
NGKHKAYYVHRIVAELFLDKKEDDKFVIHKNFKKDDNRLENLAWTTQEEWVKHQHNSPGV
KENKRKRKLRRVVTYSKLTYAQAVILKKKLLDPKRKTRIKVLAKQFGVSEMQLYRIKSGE
NWGDIKV
>IFAGANLK_02227 Demethylrebeccamycin-D-glucose O-methyltransferase
MSKLFKVVLNTLPRPLLIRLSYWVKPFFKYALRGNKYSDPIDGRSFSKFLPYGYINQREN
VLSPSTLSLERHRLLWLYLKNETEFFSKNLKVLHFAPEQAFYKRFKKLKNLAYTTTDLNS
PLADVKADICDLPFEANKFDFILCNHVLEHIPDDTKAIQELYRILKPGGTAILQIPQDLN
REQTFEDDSITDRKERERIFGQYDHVRIYGRDYFEKLRSVGFKVEEVNYTENLSPEEINK
YRLAKGEVIPVCYK
>IFAGANLK_02228 hypothetical protein
MVEGKFTGRFKIVKSTADHLILNPGGIVDYRFKRTKELPETCRRRNTKKEKSFETNFKAF
WETFDKNYAFFEERNLNWQKVYNNYLPKVKKLKTKREFALVLQEIIGKFKDGHINLEIPD
SILENQSKSKSVESSITKDHIVSAIDSIYLKEINSYNNGVIKWGSVQDSNIGYIRISDMN
DFANYVPKEYQNTAKFDSIYNLSKYSAEPLEQFQDEINGINRIMKKVLIDLKDNDSVVVD
LRFNGGGYETVALRLLSYFVSEEKEIIKIKARIENGFTPAQKISLKPETKNPKKIYLLIS
PVTASAAEIFALGSLRYSNIEILGTKSAGIFSEILWKKLPIGWEYSLSNEVYMDREGRPY
EKEGVPVDYELNYPTERFKFYKSFYSNNKFSDLAIEKVLKGDFSD
>IFAGANLK_02229 hypothetical protein
MKQLLLLIFLIPILTNAQAKSIENSDVVNVSIQNGLEDSDLQTLFDFENINYSEFSFQGK
SIEGKYFVIRMKEFSNGDLINTTTLFDERGNDYFKIDSTQTSFKFLSKIGNEDLKTWIRG
NSFGSKQLYFPINDKNGNYVAKDFFGAKTVLEENMNHPFYILAIITPNRNPDGSASYCRV
AQSEIDPDNFGKEFNIPHYYLVEIEFTN
>IFAGANLK_02230 FAD:protein FMN transferase
MKRISVLFLLVFLSISCKNNGPHSYTKTGKALGTTYQIKYFSSENLNTEKALDSIFEVIN
TSMSTYQDDSDISRINTGNEDIEVDIHFQKVFQLSKQIFKESNGYFDPTVGSLVNAYGFG
PDKPLNEPDEAVLDSIKQLVGFEKVKLTEANTIQKENPDIYIDFNAIAKGYTIDVIAQYL
DSKNVENYLIELGGELVAKGENLERESNWNVAIDNPQQTEDERTLQTVLALKNRAMATSG
NYRKFRVDTTTGKRFVHTINPLTGEAEKSDLLSASVLAENCTLADAYATAFMALGYEKSL
KMLENLENIDVYFIYADDEESIRVFTSTGFEQALR
>IFAGANLK_02231 hypothetical protein
MAKLNDQELHNLAMNIVGKELEAQGYEFLGVNSELKKDPQFVALKDKKLHFVIVRAIEYP
HNPKDYDLTFLRSIKDHATKFKARTFYAGVGLANSSDYEKPVMHDEEYVVNYEGWQEI
>IFAGANLK_02232 Na(+)-translocating NADH-quinone reductase subunit F
MTVIIASIVVFLALILILVSVLLGAKAKLAPSGPVTINVNGERDMEVGSGGTLLSTLGDN
KLFLPSACGGGGTCVQCKCIVKEGGGAILPTEEPHFTRKEIAQGWRLGCQVKVKEDMKIT
IPEEVFGIKKWEATVVRNYNVASFIKEFVVEIPEDMDYKAGGYIQIEIPKCEVKFSDMDI
TAHPEEHDVPDMFEAEWDKFKLRPLVMKNPETVERAYSMASYPAEGREIMLNVRVATPPW
DRSKDTWMDVNPGIASSYIFSRKKGDKVTISGPYGEFFINHSEAEMLYVGGGAGMAPMRS
HLYHLFRTLKTGRKVTYWYGGRSKRELFYIEHFRALERDFPNFKFYLALSEPMEEDNWKV
KESLDDEGDGFVGFIHQVVIDNYLSHHEEPEDIELYFCGPPLMNKAVQKMGEDFGMPPEN
IRFDDFGG
>IFAGANLK_02233 Na(+)-translocating NADH-quinone reductase subunit E
MDFINLFVRSIFIENMIFAYFLGMCSYLAVSKTVKTAVGLGAAVIFVLTITVPINYLLDN
YLLRPGALSWLGAEFADVDLSFLSFIMFIAVIASMVQLVEMIVEKFAPALYGALGIFLPL
IAVNCAILGGALFMQQKDFGVITEAITYGFGSGIGWFLAILGIAAIREKIAYSNVPAPLK
GLGITFIITGLMALGFMSFMGIKL
>IFAGANLK_02234 Na(+)-translocating NADH-quinone reductase subunit D
MATEKKNISEEKEAKKKEMILFLSSSEEKEHFLSKGNRKLLSDPLDDNNPITVQVLGICS
ALAITVQLEPAVVMAIAVVFVMAFSNIIVSMLRNLIPSRIRIIVQLVVVASLVALVDQVL
KAYAYDVSKQLSVFIGLIITNCIVMGRLEAFALGNGVYKSFLDGIGNAAGYGLILIIVAF
FRELLGSGKLFGFEVLGHKAATVADSTGLYALGYENNGLMLLSPMALIVVGLLIWVQRAR
NRKLIEEN
>IFAGANLK_02235 Na(+)-translocating NADH-quinone reductase subunit C
MEEKSVNKTNSNGYTFLFAVIMVIVVASVLAFTATSLQPIQRENVRQEKMQSILATIGVE
TDRAGAEELYNRYITEAVTLDYQGEEREGVDAFTVDLAKEIKREDEEQNFPLYIAEYEGE
TYYIVPLRGNGLWNAIFGYISLEDDVNTIKGATFDHLGETPGLGAEITKEWFKESFAEEK
IFDESGNLVGVSVVKGDIDPSDKDDNQVDAISGATITGDGVSDMISERLQRYLPYFKKQT
DIKVATK
>IFAGANLK_02236 Na(+)-translocating NADH-quinone reductase subunit B
MEWIRQRLDKIKEPFAPGKKYEKYAPAVNAIDTFLFTPNHTTQKGAHIRDAVDLKRTMIT
VVLALVPALLFGMWNAGYQHFSQLGEAFTFWEALGHGALKFIPMIVVSYAVGLGIEFAFA
IFRGHEVNEGYLVTGLLIPMIMPIDLPLWMLALSVVFAVLIGKEAFGGTGMNILNPALTA
RAFAFFAYPTYMSGNQVWVSEASNVDAISGETILGSLAAGDNVSYGMMDMFYGIIPGSVS
ETSTLLILVGALLLILTKVGSWRIMLSAFIGAAAMALIFNALPAMGVTGNDLTNFPWYGH
LIIGGLAFGIVFMATDPVSAAQTLKGKWIYGFLIGFLSVMIRVFNPAYPEGVMLAILLMN
VFAPTIDHYVIQSNIKRRKKRIQSATAQVKTTV
>IFAGANLK_02237 Na(+)-translocating NADH-quinone reductase subunit A
MSKDIRIKRGLSLKLEGEAEKELVKAPRSKTYAIKPPDFHALVPKMVLKEGAKVLAGDEL
FFSKYTDELRFTSPVSGTLKEIKRGEKRKIMEVIIEADPEDTYRDFGKMDAASSDAEAVK
QRVLESGCGAFINQRPYDIVADPKDTPKAIFISAVSTAPLAPDWGFILKDKVAAFQEGVD
ALKKLTPGKVHLAVDASSAQYLKDIKGVELHNVKGPHPAGNVGVQIHKIDPINQGDRVWT
VNPEDVTIIGNLFLTGKFIADKTVAVTGSEATNRKYFSITIGAEVADIINKVDEDVRIIS
GNVLTGLKLAYDQHISFFSNEVTLIPEGNNYRAFGWLPFTYNNIHSNSRTSLSFLFPNKK
FKPTTNLNGEERALVVTGEMEEVLPMDVYPMQLIKACMAGDIEKMENLGIYEVSPEDFAL
VEYVNTSKIEIQEVIRLGLDLMITEVG
>IFAGANLK_02238 hypothetical protein
MKNYFLFFLLSISSLNLVAQVEETPPPNYIRSVQLSGNTQSNKGNPILQMGEQLTLNFDD
IIGDEADYYYTIEHYNYDWTPNQLAKSEYLIGFDDIRIFNYSNSYNTLQPFSHYELKIPN
EDTGGFKLSGNYMINIFNGEKELVFSRKFMIYENIARVKLNLRRSRDLNFIDEKQVVNFT
IESPDLILKNPDNTVNVLITQNHNLKSAIKNIKPQYTVGNDLVYRYDSETAFWGGNEYIQ
FDNKELRASSADISSVSLNELYHHYLFADRTRANEPYTYNPDINGQFVIRSLPAANPSIE
AEYVWVHFKLQNYSELNGGEVHIYGCFNNFTLDNSTQLTYNKNTDLYEGARLFKQGFYNY
KYVLKRPDGTIDEGFFSGNFDETENSYQVLVYYRSPGARYDRLIGVGSGNSTRITN
>IFAGANLK_02239 hypothetical protein
MAGSRYDLKYRGTRCLNCEHPLDKSDKYCPSCGQLNSTKKLKFDDFFSEFFSGIFAYDSR
FHRTVRVLLFSPGKISKDYIQGKRMRYANPFKFYLSASIIFFLIWGFGNSFENVEPIVDD
EEIEKLVQDSITGPNMIPTPGGKEINLDSLIVNQQRNAKRSYRELYKPNEELDTMSYLDA
GNVKFDLYSRFYKETTIRNAETAMDSLSYPQTSYNHWLYKKAVDWNTLKENPGLFLNYFI
NKLPFIIFFYLPVFALFIWLLYIRRPFNYIEHLIFTFHVQTTFFILLSLALFVDYLFPGN
WAFLLFNFIFAFYLYKALRGFYAQGRVKTVVKFVLLNFIFFILAGIASIISILASFAIY
>IFAGANLK_02240 Protein ApaG
MIQQVTRGIKISVHTNFEGTFLKNLGSRFAFSYHITIENQSNDSVQLTSRFWKIKDALNH
TEIVQGEGVIGQKPVLKPGESHTYQSGCLLSSPFGSMSGYYNMISFTSTRKFRVKIPTFK
LSAPFALN
>IFAGANLK_02241 hypothetical protein
MCTISLTPHLKNSNGFILTSNRDEATERETYPPDFKIEKNTLLLFPEDAVAGGSWIGVSE
KQRVLCLMNGGFEAHKREDSYRKSRGVVLKDWLIAEDIKTEIENYNLKNIEPFTVVIADW
SSELFFAEFVWDGAQKHFKELPVQPQIWSSSPLYTSAMKKLREEWFSTFQKEKNLSAENL
WEFHHSAGKGDKEIDLIIDRGFLKTKSISQIEFLPGKLNFKYEDLEQGKISEKEFPRL
>IFAGANLK_02242 1-pyrroline-5-carboxylate dehydrogenase 2
MGKGFFHVPQAVNEPVKTYAPGTPEREEVLLTYKDLYNSNMEVPLYIGSEEIKTGDTADI
RPPHDHKHKVGTYHRAEKKHVQQAIDEALKAREKWAKLEWEQRAAIFLKAADLIAGPYRS
RINAATMIGQSKNIYQAEIDSACELCDFLRFNVEYMSDMYNEQPESSDGNWNRVEYRPLE
GFVYAITPFNFTAISGNLPSSAALMGNVAVWKPSDSQIFSAQVIMEVFQEAGLPDGVINM
VMGDPEMITNTVLDSPDFSGIHFTGSTDVFKGIWGKIGNNINKYKTYPRIVGETGGKDFI
VVHPTSNAKEVATAISRGAFEYQGQKCSAASRVYLPESLWPEIKEFVKTDLESFKMGSPE
DMSNFINAVIHEGAFDKLAGYIDRAKKDKNAEVVIGGNYDKSEGYFIEPTVILTSDPHYT
TMETELFGPVVTIYVYDDKNYSEEKWRDLLKTVDNTSIYGLTGAVFSGDRYMAALATDLL
QNAAGNFYINDKPTGAVVGQQPFGGARGSGTNDKAGSKMNLLRWASVRLIKETFVPAKDY
RYPFLGE
>IFAGANLK_02243 hypothetical protein
MKKNLKIISVLFLFLFSSLIQGQNEDITTPNFTPPSPTAYELGKYGEFPIGMFTGTVNFS
TPLLEFKTKEITIPLSINYSSSGIKVDQLASTVGLGWSLNSGGVITRVVNQNPDELRDYA
PPTNTNDGYFSFEWVDYYNDLSYQVQGISQPLEIDGEPDIFSYNFLGRTGRFTFKNNNQR
EIVLLDNIGLEVVYNPEQSGGFLIRDENGFKYYFLDVENTKMETIGGSQQYNQLGRWMPT
SWYITRIETPTGESVFFDYENVVYNYTTTQSQYATIPANATGIDSGPSCFQPYEQPNESP
VIDHPLYVQGKQLRRISSSNPIHGEISLSYDFEHPQVPNYYLVSSIDKIYDINSIPEADD
LVETINMNYLTVNQRVFLENVQFQDPDKIYSYEYIDVNNLPQRLSFSKDHWGYFNGKGNT
KLYPDLSGVNNVYGNRFASVFASGANKEIDETKAKKGLLKKVVYPTKGYTEIEYESNTEY
TSEESSSEANVLIEVETTDISNHTNSETVVLNDVEEAGIYPLDINFSLNYQSSCSTQGPT
PDPADRKLFITIENLTNPSQTNIIHRMAGNVGVPISIGNSVSVTEEQSYNDEYFFNLAAN
DQYEVTVSLFYECLMGRLSFNYPNSSSTLTYTNKKTGGLRVAKTTNYDYDNEYLSAKKYY
YASKDNLDRSSGVKGFDPSYYSYYTSVGACDVGGTTNPFCANWKIDYVRLNSGALNALYR
TSIATTRYEYVTVSNDAGDLSNGGTEYKYKIASPSMSYNINGIFSPIFSEGQKSWGDGYE
LQKTLFKVDGSAYKNTYKEINDYIRDVRINDTVTGFKVSRKYNLPCRDFNTNDPEEQQVI
IARDELNVTRFYLTSNWAYLKSKTKLTFDENGSNPSTEITSYYYDNEEHAQISRTETVNS
KNDLLEEKIYYPDDFDSNLIIEGGNLTTAELNIIDRLKSENQHRTATPIQTVTKKNGSTI
YIKRNNYDDFHGQTLQSSLETQKGSGDMEERITYSDYDISGNPQEVSKTNGPNVIYIWGY
EREYPVAKIENAFLTDVLNLVDINLLNDPSTSELIMKEELEKIRTGLPQSMVTTYTYKPL
VGLTSITDPSGLVTTYNYDDFNRLRFIKDDDWKILKEYDYHYKNTN
>IFAGANLK_02244 hypothetical protein
MYCDGDNVGIAIGQTSGYRLAVAGGILSEGVKVSSVSNWPDYVFSDDYAMLSLEGLRAYI
RANKHLPGLPSATTIAREGYSLSEMDKLLMEKVEELTLYIIDQESELQSLSGELGVILPV
ADEEIASGKTVYKSHNVDIETHLKAPTQKEERTFRDMASPRSLEASPAALCDVISCDGEG
VGIGADPVEGYRLAVSGGILTDDIQVASVANWPDYVFEADYKLRNLSSLSAYIAREGHLP
GIPQAQLVEQKGYRLEVMDGLLLEKIEELTLYLIQQERQLTFLESRQ
>IFAGANLK_02245 hypothetical protein
MISTTKNRLVIYYLLILFSLAANAQELENGLIGHWPLDGNGDDVSVNSYNGIAYNTTAVI
DRNGNSNSALSFDQNGYVALGKVLNIGYEDFSFSAWFRVDPYNTETGMFAILSKSHYGPE
PQYAIGIHNNKLRTRFIYNSGIDIIGDKVIDDNEWHSFIVTINRNGNIEMYLDGILDTSA
SIADSPDFNVTNNFSLSIGQYEYKSYRFEGDLDEIRVYKRVLSGEEIALLSETEFTEEIK
CENLITGADESVGIGADNPGGYGLAVDGGIYTDEVKVMNVDSWPDYVFSESYNLMELEAL
SYYIRERGHLPGVPSAREVFSGGISLTQMDKTNLKKVEELS
>IFAGANLK_02246 Putative type II secretion system protein F
MGIKIDHTGSGNILKERNSLENLLKKEITLFGNTFSGRKKEQFYSELSVLLKSGVDLKNS
LELIAESQNKIKDRESIAKINDFIISGNSFAVALECNPNFSPYECKAIKLGEETGEMAFI
TRDLADYYQKKNDQKRQIISALTYPAIVLCTALVVVFFMLKYVVPMFEDIFEQNNVSLPF
LTQLIVSGSHILESYGLLFFFLLVLLIVGWRLVRKKIWYKKITGIFILKIPLFGNYVRKI
YITRFIHTMTLLTRAKVPISNGLGMVCEMLDFYPLRMCLQEIEKDILKGEQLSASFKKHP
IFDKKIIALLKVAEATNQTEFVFGKLYIQYSQELEYESKSITNIVNPLLTLFVGLIVAVI
LIAMYLPMFRLSSVIG
>IFAGANLK_02247 hypothetical protein
MLIVLVISSLVIGITFSVLDLVQKTFVMIQDNYAQSIVTVQLKERLSIDFNRYHEITYNS
EFEELVLKNPLDSVLYEFNQSLVIRNEDTLMLNIQKPKCYFLGKEVSHGMIDAIKIQLNE
ELGSGFIFVDRVNDVKIMLDSWE
>IFAGANLK_02248 hypothetical protein
MALLKRLKGASLMETLTASVIVVIVFMIANLSFSNIFLSTIKSNSFELENRKQELKYLIR
NGKLELPYFGEGAYWNESIQQSAQGKYVILEIINDRNNKIWTDTLVFNN
>IFAGANLK_02249 hypothetical protein
MKKIAEVFFLKKVKASAMYFVILVAIIVGLILSSFLLLTHTFVSYHSKSTEIFEDIDHIE
NGIDSVLTKTENTPMGANPHFFSTKEYWGSFELLVFNSENEFSKAVLLGGEINDLSSNIY
LADNKLPLVVAGNAKLEGIGYFPKNLIKPGSIDGNYFNKGKLFYGESFASKNDLPQVSTS
WRNYIENIVRSTPDKLGELMELSNASNSFFHTTGVIYSPDALLISHRLQGNIIVKSEKTI
RVSSLSELNQIILIAPEVVIESGFRGNIHIISNEIEIKSNSLLEYPSSVIVTENQSQEFR
KPRIQVLKNSTIKGNIIAFERVKKNKLKNDIIIAANVNIEGSIYCEGYLDLRGRVHGNVF
SQFFATHQNGSIYINHLYDGEILKHIEDLGGVLLEDNNKIRAKWLY
>IFAGANLK_02250 hypothetical protein
MKSKKNLYFLFPSVVLIWGALLYQFMGSFPKETTSNVLASKEFISDFEYKQEQEFSLNSI
DRDPFLGKSYLKASPPNPKIKKSSPSIPWPKIHYLGSVSDKEGLNGIEIIIIDGHQNLFK
IGEIKSDITLISTQDNSVTLKYKGQIKKFSM
>IFAGANLK_02251 hypothetical protein
MHLIKFKKLAVRYFLKLILSISCLGMLISCEEILFEENLTHSKVDILAPSDGSRLQATSI
NFRWSPVNGATAYQIQIASPSFEQAGQILLDEEVEETSFSEELPRKDYEWRVRAVNSGYK
SPYTTAKFKIESNEDFSSNTIQLLSPADNYLTNQTMLNFEWRVLQDAISYRVQLRKDGEL
IEEMSLTDVSVEMELPEGESAWRVRGEKDGEYTLYSERKIIVDTVPPTPKKLLSPQDEMI
LTNSAVEFRWENDAVVNDEIDSVFIYRDEGLTNLVEKGQGIDSYNANLEDNETYYWLVNT
YDKAGNRSEPRDIYSFSINEL
>IFAGANLK_02252 hypothetical protein
MKWTCKNGPLSVFWEPYFYYGFSLVEINFRGLIFQTICECTVFMKGKLLLTFGSILFFFA
CSSGFLENDSIKPLSTSPVIGNVGVYSGSLLTNRFVESGIVILDSKVRLSVQKRKFDKGT
LKKYNDKVIDKKDYLKIVDSIDVKPTYYRVKLSDEIGFIESMNAKQNKALINYLRVTKNN
VLLSELFIYFSEEHSSKIDNAKEVYLLNSREGAYSLEVLGYENTREIIEFSQGVNFGFDF
KEFCWKENYKKEPVIASFKKLNGSCPGSTKSDPEKVKSKDAFDKI
>IFAGANLK_02253 hypothetical protein
MKKIFIIIFYIYSFNCVIAQEDLNEFIKYQPTQPETTEIQKIGDFSPPNAFGAQPINLQI
TNVDIGNLSIPITLSYTSSSGIKVDEKESVIGLGWDLSILNNYIEIVEQGASLDFNQSHS
AYASYQEINNRYQVQNLDSMFVLNDQLKSNALNTPFVNKDYISDQINYNFLGKTGTILKD
SLGNFIDFTSSKNELEIVQHSINNYEVIDGDGNHYIFDKVVSYNLDSSSKNIKKRFYLSE
IELYDGQVVEFLYSDGQDEGVTVSDSYSSSSIMVTRMFEEALQNPSQNMTISDFTPIFEQ
NNNSITYATPNILKEMVFPNGKVSFDYLSETNQLNKIEVWDNISIIEKFVFKNSDFFLDS
SGAPVAARLEAIDRIGGDETQEKLYRFSYNETPIPQRATTKGDYWGFHNGRETDVPDFSY
YYNSQEYDYFGSNRRPVFNYTKAGILEEIIYATGGKSKFYYEPNYYKTEKVITDPSEGGN
KKINLAAIGQNPAVSYQTPIDSTSFYIEHGSISSTGGITVTYAASRFTQNSSQLPYYKIT
DPQNTVYTKIFNREDEKLSGTFNITNLPTGWYKVIAYVGDASLFPNDSEPSIFNTASVEL
TLSWKEYSGDEEMDYEDVLVTGGGLRIKSIENYDSLEDNVAAETKSFEYGNSSLNGYGVG
EFLGVSNQVYPISDINADLDGENHILSNFLINKNITDLRFWGGVSGGGVFYAQYTGKGIQ
LSSDPLFPISYKGNSVFYPKVTIYNSGEKGDLGYIENIYSPPSRIEVRDVMGDISTSSSA
HLELNKYSDYSGVHLIKEVKFNSLNDTVFLKNYNYTKKIISEFPRLAIKPSEYTLHYSGS
PIIVPPSDIRAMSKKNIKHFYYKEKLYQEKLVSTSIRNFYENGNIETIQDLEYVANKSFR
ISEKTTYGSDGKINLQRLIYPDQIISSNSLGFDPIAESELNNYNSLASTGVNRINRPVQI
ENYKKLADGTIFSSEVQRTYYNTFNTKLFASSIWTGRLGVPLYKEIEFLDYDYNGNYTII
RKVNGPPVIYLWGYNGEYLIAKVQNSNLEELKVALGVQDLTEIDEQDIPSIDALRAELPN
SMISTYTYKPLIGLLTIRNPNGKIITYNYDSFNRLHFKMDDDQNLLEEFNYHYKSFSE
>IFAGANLK_02254 hypothetical protein
MEDDKLERVAKALDVSTEAIKSFSEEKLIYNIQNNYEGSNPGATSVSVANFNCNFNPVDK
LVEAYEENKKLYERLVQAEKDKVSYLEDFIKNN
>IFAGANLK_02255 hypothetical protein
MNLREWFLEFFREKEYYSINKESFKNELSNTFKVITNHDLVQIKKVITSWEDVVKIEDLS
KGLLLQDSEIFYDIDNLISRVKEIISEDYKDSYFRSQKEKWDFQYSFNSLNDHYKGTLFI
SNSMTYPNDQNFGDVIYHLLAIRKKDNIFYLWDLLDKDF
>IFAGANLK_02256 hypothetical protein
MWGSSILIYTRVLGTSSWITTTTGYDAKGRVIWVSSANEYLETTDVEEYELDFTGRIKRS
KSTHSKNGASPIVVEDTYEYDHMSRQLKHTQCIDGDCVVEEDLVLDQVVTQSSSVKASNS
ITLEPGFEVMAGDSLTFSARIGIGGELIASNTYDGLGHLIKKGVGGVDSLSLQEVDYAYN
IRGWLKQINDPEDLGDDLFGFGINYNDPTGGALPLFNGNISETHWNSQSENTSGNPVSNY
YGYNYDAMNRITGASDNTANYNLSGITYDKMGNILSLQRQGYLDNSVTPFGKMDNLDYDY
DGNKLLRVSEIEDGEAAYGFKDGNTTGDDYGYDVNGNLTSDANKGIAAGGIEYNHLNMPT
KITLSNAGSNNGVIDYVYTAEGIKLQKKKTQAGVTTTTDYAGDFVYENNTLKQFYQPEGY
IEPDGSDWQYVYQHKDIWDNVRVTYADDDNSGSVTSAEIRREQNYYPFGLEHKGYNINSY
GSKNNLKTYQGQEFTEDLGLNTHEWKYRMSDPAIGRFWQIDPLAEDYTYNSTYAFQENKM
GMGVELEGLELGLNKWFKKGVKWVARNSKGQLKPISRKSADRILKNRGSVTQTQIRGGNK
KAKNLMQSTTDKKVVRHDGHELKSGKTGRNHYQKKSGDGSHVFTESVKDGAIVTAGINTD
KVDEVTSKALEMGSEMTDAVENFGTNVFGDNAFGNFVDDMNPLNLGINELFNTFNEVLNP
ESNSASNDSNSSNTENSNNISVDNCEGEGCQ
>IFAGANLK_02257 Insertion sequence IS5376 putative ATP-binding protein
MQGYKVLFTTAHKILTQIRESHSQGNLKVIEARFEKYDLVICNEFGYVSFDKEGSELLFN
HLSLRAGRKSTIITTNLGFERWEEIFGDPVLTAALVDRLTHKVHLINMNGESYRLKETKQ
IMNK
>IFAGANLK_02258 hypothetical protein
MSNRKVYHVTQNPNGTWKWKAQGGQRASVVTNTKAEAVSKTTGMAKNQGNSQVIIHKTDG
KFQEERTYGNDPYPPGG
>IFAGANLK_02259 hypothetical protein
MRLLTYFFILISTLGCAQDNWVTLEKEDFSISYPSSLNIDDSGKEGTQFILTTDKDGEDD
NFIENVNLSTQKVGAVTFDEYIKKMEREVSGIAKIIEKKKLEINGNKCYSLKMKATQNGV
DAIFLQHFYIENQKAYVLTFSSEAKVYDDYYDEMNRVLRSFEIK
>IFAGANLK_02260 hypothetical protein
MSLIYLLFFAILNFLIFVFLAKKVKLNTKVRTILFSLLLLLLVFHFLVFSNRGVSGSHFL
HLLIASAILIVLHYLAILPILALIRINKKNASHIALKGFNYIRFYMIYILIYLYQCMSIL
SDSAREHFNSIDIII
>IFAGANLK_02261 hypothetical protein
MVTGTYDEGSLYKVVTYDENHDSGKNHSVEEYTDKQGRVILKRAYADEEAQSGVTHDTYY
VYDDYGNLTYVLPPKLVEDAAPLTTITNNLPDLGYQYVYDGRNRLIEKQLPGKGREYMIY
NSLDQVVLTQDAMQRAKSPKEWLFTKYDAFGRVVETGLYEDTSGLDREAMTTAVKDYYDT
SQARVYEHKSGQGYSNQSFPVSGTQLLTQNFYDSYTFDLNGLSVPASSYEIPLASALKGL
PTGSRVRVLDTQDWITRVIGYDERGRVIWSGEKNTYLETTELEEIKLDFTGNILATRLTH
QRGLDDAIHIVDSYTYDHMGRLLEHTQCIDGDCVEEEDLVLNQVVAQSSSVMASGSITLA
PGFEVMASESLTFSARIGIGGELIASNTYDELGQLIRKGLGGNLMDDLEAGSSIDFVDLV
GVAVDADGEITNITTSNSWGDSGLATAESFNGDGYIQARVTSDNIRVMMGLSPTNTSAHY
NTISYALYTQNDGILNVYENGNKKGEFGPYENGDILRVEREGELIHYKRNGETVYTSAVP
ATSSLLGDISIYRVGSSVSGLKFSTGNNKDFLQEIDYAYNIRGWLKQINDPENLGDDLFG
FGINYNDPTGGALPLYNGNISETHWNTQSENISGNPVSNSYGYSYDALNRITGATDNTGN
YNLSGIAYDKMGNILSLQRQGQTDAGATLFGTMDNLDYDYDGNRLMKVSDSGEKTWGFKE
PTTSTGNDYGYDVNGNLTSDLNKGITAITYNYLNLPVDVEFNGSSSQKIHYTYDATGVKL
RKEIPGKTTDYAGNFVYEDLSGTMELQFFSTPEGYVSYDGGQFNYVYNYVDHLGNVRLSY
TDGNGDGSIDPATEIIQEKNYYPFGLTHQGYNGGGGGSAYGNTVAKRYGFGGKELQDETF
SGNTLDWYDITARNYDPALGRWMNIDPLAELMRRHSPYNFAFDNPIFFIDPDGMIPFGND
DDPPTVYSGSSVAVGNNVNNQLDEVVITVNGNGTVATGTAQGAHFVTTETGKRFNGYKAE
GQVEGDNGKVNGSVSGFSAGYDGYTESGGAHGSASVYGVSADGSARLGSKDNNVAIQGEG
SAFKAEVSGDATLSGEGGKYVAELGGEAGVYALEGNVTPSLSIGGIQIGFTIGGSVGSAH
IGGRVAGATNTEAREFEVTGNYHIGLGAGLKLGFSLSNTSQEVNPRRR
>IFAGANLK_02262 Putative aminopeptidase YsdC
MSKDSILDKESIDFLEKYLNNAAPTGYESEGQKLWMDYLNPYVDEFFTDSYGTAVGVINP
EAEYKVVIEGHADEISWYVNYITDEGFIYVVRNGGSDHQIAPSKRVNIHTKKGIVKGVFG
WPAIHTRDKDEEQSPKIDNISIDVGCTSKDEVEDLGVHVGCVITYPDEFFILNENKFVCR
ALDNRMGGFMIAQVAKLLKENGKKLPFGLYITNSVQEEIGLRGAEMITHRIKPNVAIVTD
VTHDTNTPMINKKKTGDTKIGHGPVIAHAPAVQNKLRELLIDTAQEKEIPFQRMANSRFT
GTDTDAFAYSNGGVPSALISLPLRYMHTTVEMVHRTDVENVIKLIYESILKIKDGDSFSY
FD
>IFAGANLK_02263 hypothetical protein
MTISPEEINNFISDPYQAIDFANLIYVSEEHLSISRKKVGRGFSYFYKGERVKDKKTLER
IKRLVIPPGWKEVRITHLKNGHLQVVGRDEKNRKQYIYHPTWSKLRNETKFFKMTGFGEN
LPKIRKQVDKDLDLPEMSRKKVLALILRLMEETHIRIGNHYYARKNKTYGLSTFRTRHVK
TYKNRIKFEFIGKKGKEHAVTVKNRKLIKLVNQCEEIPGWELFKFYDENGDKHAIDSGMI
NEYIHEISGDLFSAKDFRTWSATKIFFETLRELGYTEEEKQNKKNLIQAFDASAEGLGNT
RAVCRSYYVHPKIVNSYETGEIVPYFDQIKAEEKQDYISLSETEKVILNMIKDYEVNI
>IFAGANLK_02264 Inosine-5'-monophosphate dehydrogenase
MKNTIASRIADFLKNYPPFNLLKKEDLLMISKQVKVKYLEKGKLLFAEGDIGHKRFYVVN
KGAISLERDNEGKRETIDKCDEGDIFGLRPLFAKENYLINAIAEEETILYAIPIKKFKPL
TEENKEVGNFLIQSFASNTRNPYAEAHKGKLISEKEPVENQYQPNNNLFELQPAPVTRKV
VMTSPETTIKAAAQLMSKKKVGSVLVVEENIPKGIVTDEDFRDMVATGAFGIETEVSKIM
ASPVICYPQGLTIAQAQLTMMKHHINHICITEDGTPNTKVVGILSEHDIMVSEGHNPSVL
MKAIQRSSSTNELKKIRHKITLLLRGFLAVNIPLNHISKIIFELNDATIKRIIERCIKKL
PTPPPCDFTWISLGSQGRKEQLLQTDQDNALIFEDVPEEKLEETRTYFLELARKVNKRLN
IIGYEFCPAEMMAKNPKYCLSLNEWKDQFTNWIIDPGNDEILLCSIFFDFDISYGNVNLS
NALADHIFSLTKENRKFYAVMGATTLRNPSPLGFFRQFLLEENGENKDFFDIKKRGITPL
TDAGRLLILYHQVKNISNTAERFEKLAQLEPNNKELFLACAYASKVLLKFRTQHGLENRN
SGRFIDLENLSKEEKIKLKRCFKSIRQVQELIKYRFEVTPYI
>IFAGANLK_02265 DNA polymerase III PolC-type
MLNLFKKKQDNLPDFWKEYETKFQEKLPKEIAETRFVVFDTETTGFDIKKDRMLSIGAVA
IKNKSINIADGFEEYISQETFNPKTVKIHGIIQNERIETLSEEEAVKTFLKYIGNSVLVA
HHAGFDVGMINEALSRMGLPKLKNKVLDTVNLYRGTRIISNLINREKSYSLDEIAETYNI
DTKDRHTAAGDAFITAIAFLTILGKLNNDGKINLKKLFRV
>IFAGANLK_02266 Acetyl-coenzyme A synthetase
MSNYHIKNLEEYFQVYRKSVRDPQNFWEEIAEEHFSWQKKWDNVLSWDFNKPEVKWFENA
KLNITENCIDRYLFNRSDKTAIIWEPNDPDEEAQHISYGELHKKVNKFANVLKSKGIKKG
DRVCIYLPMIPELAVAMLACARIGAIHSVVFAGFSSKALATRTNDADCKMMITSDGSYRG
NKTIDLKGIVDKALEDCPGVENVLVAKRLDSDIEMKEGRDEWLQPLLDEASDVCEAETMD
AEDPLFILYTSGSTGKPKGMLHTTAGYMVYTAYTFKNVFQYKEGDVYWCTADIGWITGHS
YILYGPLANGATTVMFEGVPSYPDAGRFWDVVDKHKVNQFYTAPTAIRSLAKRNIEFVES
HDLSSLKVLGTVGEPINEEAWHWYNDNVGKNKSPIVDTWWQTETGGIMITPIPYVTPVKP
TYATLPFPGVQPAIMDENGNELKGNQVDGRLCIKFPWPGMARTVWRDHERYKTTYFSTFE
NMYFTGDGALRDEVGYYRITGRVDDVIIVSGHNLGTAPIEDAIDEHPAVAESAVVGFPHE
VKGNALYAFVTLKEVGESRNQDNLRKEILQQIGDKVGPIAKPEKIQFVSGLPKTRSGKIM
RRILRKIASNQTEDLGDTSTLLNPEVVEKIMKNSL
>IFAGANLK_02267 hypothetical protein
MRLVNLQHTDDAYVAKAEITLKAFGVALGQKSKIYIRKESENAWREKKTNKKVSPREAAH
LNKWLSDHQKFVEH
>IFAGANLK_02268 Ribonucleoside-diphosphate reductase subunit beta
MSIFQKRVNYKPFEYPEILKFTEAINRSFWVHSEVDFTADVQDFHSHLSENEKQVIKKSL
LAIAQIEVAVKSFWGDLYQHLPKPEFNGLGSTFAECEFRHSEAYSRLLEVLGYNNEFEKL
IETPVIKKRVAYLSDALSNTKSSDEKKYVFSLILFSILIENVSLFSQFAIILSFSRFKGV
MKNVSNIIAWTSVDEQIHANAGIYIVNQIKNEYPEFFNEDTKTEIRKIIAHSMEVESEIL
DWIFADGNLEQCKKDDLLNFMKYRVDDSLEKIGLEKIYFVSEYDYKAMLWFEEEVFANSL
DDFFAKRPVDYTKHDKSITADDLF
>IFAGANLK_02269 Vitamin B12-dependent ribonucleoside-diphosphate reductase
MPETIIKETQQERLWWLNEESQQILNRGYLLKGETAKSAIERVANAAAKRLYKPELAEAF
IEMIERGWMSLSSPIWANMGTERGLPISCFNVYVPDNIEGITHKLGEVIMQTKIGGGTSG
YFGELRGRGSAVTDNGKSSGATSFMKLFDTAMDTISQGGVRRGAFAAYLDIDHPDIKEFL
EIKNIGNPIQNLFYAVSVPDYWMQEMVDGDREKREIWAKVLESRQQKGLPYIFFKDNINR
FKPQVYKDKNYTIHSSNLCSEIALPSTEDESFICCLSSMNLELYDEWKDTEAVKLAIYFL
DAVLQEFIAKTEDNYYLSSANKFAKRHRALGLGVMGWHSYLQKNRIPFEGLKAKGLTNSI
FKDISEKATKASKELANIYGEPEVLKDYGLRNTTLMAVAPTTSSSAILGQASPGIEPFSS
NYYKAGLAKGNFMRKNKYLKELLQEKGLDTEETWRSIMLNHGSVQHLKELTDEERLVFKT
FKEISQLEIIQQASVRQKYIDQAQSLNLNIPSDLPVREVNKLMIEAWQLGVKTLYYQRSQ
SVSKEFIANMVNCSSCEA
>IFAGANLK_02270 hypothetical protein
MKKIFLFLCTAGIMSTAHAQVQAPQPSPFTKIEQKVGLTDIILEYSRPGVRDREIFGALV
PYGEVWRTGANENTKITFSDDITIQGNELKAGTYAIYTIPKENEWEVMFYTDASNWGNPA
EWNEEKVALKATAEVMELPFKMETFTIMIDELKHDSAALNFIWANTVASLRFEVPTEEKA
MASIEKVMNGPGAADYFAAATYYHDVDKDLEQAYEWVNKSLEMGNPNAFWILRRKSLIAA
DLGKKEEAIEAAKKSLAEAEKAGNKDYVKMNKDSLEEWGAM
>IFAGANLK_02271 hypothetical protein
MKIYTLKSVQKLPISLEKAWEFLSSPGNLKTITPDYMGFNIVSGADRPMYPGQIIQYIVT
PIAGIKTSWVTEITHVRDKEYFVDEQRFGPYALWHHKHFLKEIPGGVEMEDIVDYKLPFG
ILGQMFHPILVASKLKEIFDYRQKKLVELFGEFDEPRTKNPTLKQDILA
>IFAGANLK_02272 3-oxoacyl-[acyl-carrier-protein] reductase FabG1
MKRNILLIGGSTGIGLEIAHQLVKENKVIVASRNKGELNDDIDHLEFNVLKDKIEDLELP
EEIHGLVYCPGSINLKPFKMLKSKDFEEEMNLNFLSLVKVVQALMPKLKKAENTSLVFFS
TVAVKVGMPFHTSVAAAKGAIEGFAKSLAAEYAPKIRVNVIAPSLTDTPLAEKLLSNDSK
KEKMSERHPLKRVGNTKDIANAATFLLSEENSWITGQIIGVDGGLSTLNIS
>IFAGANLK_02273 Deoxyribodipyrimidine photo-lyase
MKEEVNIFWFRRDLRLDDNVGFLQSLKSDKPVLPIFIFDSEILGKLPKDDGRVTFIHEQL
QEMRKELQDDYESSIAMYHGKPKEIFQQLIKDYKIAEVFTNHDYEPYAKKRDKKIAGLLS
KNNIEFHTFKDQVIFEKDEVVKKDGDPYVVYTPYMRVWKEQFKSHDLKIHYTSQYLENLV
KNTRLPNLSLNDIGFTTSEIKVPEYDVTPILIQQYENTRNIPGKEGTSRLGAHLRFGTVS
VRKMVKKANAESNKTFLEELIWREFFMQVLYHNPDTITDSFKKKYDRIEWRNNEDEFEKW
KTGQTGYPLVDAGMRQLNESGFMHNRVRMLVGSFLCKHLLIDWRWGEAYFAEKLLDYEMS
SNVGNWQWVAGSGVDAVPYFRIFNPTTQINKFDKDEKYIKEWVKEFGTNEYPEKMVDHKE
ARERALKIYKAAVS
>IFAGANLK_02274 3-deoxy-manno-octulosonate cytidylyltransferase
MISMNNPLKIIAMIPARYEASRFPGKLLKDLNGKTVITRTYEAAKSTGLFDEVYVVTDSD
KIYAEINKNGGNAIKSKKKHECGSDRIAEAVENMDVDIVVNVQGDEPFIDKDSLAKLLVV
FREDDASAIDLASLKTALSESEDITNANNVKVITNKNDFAMYFSRFPIPYPRNTDAHVTY
FKHIGIYAFRKQALIDFYNLPMLSLESAEKIEAIRFLEYGKNIKMVETEMQTIGIDTAED
LEKARKIWNN
>IFAGANLK_02275 ATP-dependent RecD-like DNA helicase
MENLDASKFYKLLLSDLGFTAKAGQDLALQQLSRFVLNNNKDELFILKGFAGTGKTTIIS
TLVKNLWQIKKSGVLLAPTGRAAKVISNYSKKEAFTIHKKIYFPKKSGGSGVQFVLQPNK
HKNSIFIVDEASMISDTPTNSKLMENGSLLDDLIQFVYSGHNCQLILIGDTAQLPPVKME
ISPALEAEKLQFSYNKEVHHIELDEVVRQAEESDILLNATKIRQSLQDGFYDSFQFELTP
KADVIRLQDGYEIMNAIEECYNELGNEETSFIVRSNKRANLYNQQIRSRILFQEEEISAG
DYLMVVKNNYFWIKPSSEAGFIANGDIVKVLEIFGIKELYGFRFAEVQVQMVDYPKMRPF
ETVVMLDTLTSNTPSLSYEESNQLYQEVMKDYEDETSKYKKFMKVKNNKFFNALQIKFSY
AMTCHKSQGGQWNTVFIEQPYLPEGVGKEYLRWLYTAVTRATDKLYLIGFKDDFFVNK
>IFAGANLK_02276 hypothetical protein
MRLAIQLLLWVVIIGLAYLTFNAVYEPIQFNKIKEKRYAKVVENLKDIRDAELAHKEIIG
TFEDDFDKLVGFLDTAEFAITQRRDTTVLDEEYRKQYGVDEYIEKVIIDTLGFVPVKDSL
FKGNKERYTNMINVPVEDVDAKFELDAGTITKGNSEIPVFRARVAKSVVLQGLDKELILQ
QNQVQSVDDINGRYINVGSLEEVNTKGNWPTQYGDE
>IFAGANLK_02277 hypothetical protein
MATNNSTKQITLELSIQVSLDGLSFCTLNSTENKVVQYKKIRFSQQIDPLKLLEEIQKIY
AEEKSIAEATQVKLIFDNALYSLVPEPLFKEENASDYLKFNTKILKTDFIAHEEIGITGI
INVYIPYTNIINFFFEKFGEFEYQHLSTVLVENLLKLPKAERPQMFAHIKNKQFELVVIE
NCELLLCNSFSFTEKEDFLYYILFTAEQLNLDPEKFRLILLGAISKASPLFKIAFDYIKH
VELLETSFSLNLEEELTGLNQLEEYVLLKSFK
>IFAGANLK_02278 Ribosomal RNA small subunit methyltransferase D
MAPKKLPVRPTTDMSKEALFNILNNNFQFSQLSILDLFSGTGNIAYEFASRGSKEVTAVD
ANFDCVKFIKKTAQELGLNITPIKSDVFKFLEKAFVKADIIFADPPYDFEKEKFLKIPEL
VFEKNLLNPNGQLIIEHSKHTDLSDLPNFIEGRRYGGSVFSFFENAE
>IFAGANLK_02279 hypothetical protein
MTDRIKRIELIDVILSFYEGMVISEVKDDVVFEIEHVEQILKICNEVYEGADFVYVSDRK
NNYNVNPTIYFELKDVKNLLGIAIVSQRYEALQVANFEKQFSPVPFDIFSHMDEARAWAK
TLL
>IFAGANLK_02280 DNA polymerase III subunit tau
MEHFIVSARKYRPQTFKDVVGQQAITNTLKNAIEHNHLAQALLFTGPRGVGKTTCARILA
KMINHDGTQSPDEDFAFNIFELDAASNNSVDDIRNLIDQVRIPPQVGKYKVYIIDEVHML
SQSAFNAFLKTLEEPPQHAIFILATTEKHKIIPTILSRCQIFDFKRITVSDAKNYLVYIA
QQEGVNAEEDALNIIAQKADGAMRDALSIYDRVVSFSGKDLTRQAVTENLNVLDYDTYIK
VTDLILSNNIPQLLLSYNDILSSGFDGHHFISGLASHFRDLLVCKDQKTIQLLEVGEQTK
ARYFEQASQTNHQFLIKAIDLANECDLKYKTSQNQRLLVELSLMQLASITFDGEKKKFEQ
SIIPASVFEKQPATLSSEEKSMVRENEHGELATEAPKESQLPSGENKTPNSNCADDKEDN
YHSDKTMVPGAKEQQEEPEPTPPVPAPKPVIDPEVKKEKVSGLSLKSIQKKREIEARQQE
AAPTKDVVLNNEFSETQLQATWNDYVKRIKKQGSKILASILETDLPKLKEENRIVIELPN
ETMKINLEREQNKLMSYLKQKLQNTEIRLVINVNEQSAKKYAFTPIEKYNKLKEKNPLID
KLRSTFDLDV
>IFAGANLK_02281 hypothetical protein
MLGLKLPTDPRWANIAEKNIEDILVDHAYCEQKAASTAISLIVSFPEYTELVDEMIALSR
EEMGHFKMVHEQLLKRGYVLGRDRKDEYVIQLLSFFPKGGSRTTQLVHRLLIAGLIEARS
CERFRLLSEELKDEELAEFYHKLMISEANHYTMFLKFARKYGERAEVDKKWEELLNFEAE
IMKDLSKDKTIHG
>IFAGANLK_02282 hypothetical protein
MNLKYLFKTGILMLSMGLLVSCSDDDDDVDTGEPQPDTYNTEVYLTDAPIDNAEVEGVFI
TVTGVSVNGNTIEGFEKTTVNLSSLQNGETELLGDVELESGTTSEISLTLDNETDASEEA
PANYVLTSGGEKNALATSSGEISITDQVEIQENDDNEIILDFDLRKSIVTNSAGEYQFVN
DSELAHSIRAVNSLEAGTITGTVSDFGTTESETIVVFAYEDGAYSEDETLANGEGVLFAN
ATASSKVNDSSGEFEIHFVEEGEYELRFVSFSDENADGELELEGEIEATTTSEIDLLGFS
VGANSEVDFDILLVGLLDL
>IFAGANLK_02283 Phosphate acetyltransferase
MNKGIYIATLESHSGKSMISLGLMRTLLGKMVKVGYFRPIINDVPKGEKDNHIDTVLSYF
DLKIPYEDTFAFTRSEVIQKTNDGKSGEIIDTIITKYKKLEDEFDFILVEGSDFSGEGSV
FEFDVNVVIAKNLGIPVIIVVSGQFKSWEELLGNQQMAYRAFRDKEVQVIAMVSNKIQEE
NLEPATTNMRGFLPQEVDVFAIPLIDTLNNPTLKEIVKALDGTVLFGHDFLDNQTGNFGV
GAMQLRNYLTTLKNESLVITPGDRADIILGALQANISSNYPRISGIILTGGLRPEESILK
LIEGLSDIVPIISVQEGTFAVTNKVGAIKSNIYADSIQKIQTTISIFERYVSFDPLVEKL
TNYKPQGRTPRMFQYDLVKRARQSKKHIVLPEGTDERILAAAKRLIDMDLVELTLLGDFD
TIQKTVAKIALDLDFSKINIVDPVNSPNFQDYAETFYELRKHKGVNMDMAKDRMSDVSYY
GTMMIYKGHADGMVSGAAHTTQHTILPALQFIKTKPNVSVVSSIFFMCLEDRVSVFGDCA
INPNPTAEELAEITISSAESAAAFGIEPKIAMLSYSSGTSGKGEDVDRVREATAIVKERR
PDLKIEGPIQYDAAVDISVGKSKLPGSEVAGQANVLIFPDLNTGNNTYKAVQRETGALAI
GPMLQGLNKPVNDLSRGCTVADVYNTVILTAIQAQGI
>IFAGANLK_02284 Acetate kinase
MKNILIINSGSSSLKFQLIQMPSEEVLASGMVERIGLEGSKLHYKTKNESVSEELSAKDH
AIALKAITDLLMDSEKGVIKNAEEIPAIGHRVVHGGDSFSKTIVIDEKVKAKIKEYFSLA
PLHNPPNLKGIEVAEKLFPNATQVAVFDTAFHRSIPNEASQYAIPIELSEKHHIQLYGFH
GTSHKYVTERAIEYLQKENSKIISIHLGNGCSITAVKDGKSMDHSLGFGPVNGLIMGTRS
GDIDQSVIFYLVEQLGYSAQQVSDILHNKSGMYGLTGYSDLRDIEEQAEKGNKQCQLALN
MNAYRIKKYVGAYTAAMNGVDALVFTAGIGENSDVIRKLVCSDMEFFGIKLDEEKNKQRL
KELRTINAEDSKVQVLVIPTNEELEIAQQTYNLGI
>IFAGANLK_02285 hypothetical protein
MLRKPSEVDHLEKYYIANYTAAIYYKHCILTTKKIFLKKLFKSLYNHKKALKDDLDRHIL
EARDQEYLDQLLLKCKKEVLKMQQNLSKNTNPKSGQICTEMERRFFNQLHQTLQVLTDGS
LRNTLLSHKHKSKALQERLLLVSKYLI
>IFAGANLK_02286 hypothetical protein
MGNSLTYYNDMPQMLQKMLNETNSNIKIDQITFPGISLSKHLDNIIEESSEDHIRTRLKQ
EGDTTATEKKIQEKKWDIIIKQTGTVAVLIPESRKYKTDPAIKQIKKLNDNDNSRYILFN
TWTGKVEYPEQYCYSGFMLGDSFNRDERYCSPELVNELQYLTLINENYAALAKENSLELS
KHGDIFYKVSENNPKIKILEDDIHPSKLGAFLSACIFYAMITNEDASNLEYNADLDTQLA
NVLKASVE
>IFAGANLK_02287 hypothetical protein
MLATLFCCIHVNCQEEEQYDLRIFFTNYKNYKIAYQKSEKNTQIIIHKEISRTNISNSDY
LKMKKIVTEEENDGLRKLIQIGENYREYETDTLIIKNGSSIVEIVDNFVENWERNKSHQE
SYPENRLILDGYGLIIFLKKNNITYESISVRTPTAQSHPEIFELYSKIESFYKKNAKKPV
IE
>IFAGANLK_02288 hypothetical protein
MAEFYSPTLSNMFSKAESKKLRQQFWTSFGIVFRRKWLLYNTGIKELELKFTFNRKFAQV
SLDVIDEDPLIRAYYFEKLLSLKKILTSEYLADVKFEEEYELPEEKIISRVCVQLENVSI
HSRNQWPEAMKFLNDNMEQMEAFFVEYKDLFR
>IFAGANLK_02289 hypothetical protein
MIYILPLLSVFAGYLIAIFLKPSSSVGFKLLLSFSGAYLLAVTIFELLPEVYLNGTEEVG
IFIMLGLLLQIILEFVSKGVEHGHLHHQEGMKKFPILLLISLSIHAFLEGFPMDEGDHIL
HGVVIHKIPVATILSVFLIHSNLSKIKIGLFLAVFALMTPLGSFFKSQFSLLQDISIYIN
ALVIGIFLHVSTTILFEASKNHKFNLSKLAVIVGGILLAYFI
>IFAGANLK_02290 Ribosomal RNA large subunit methyltransferase L
MENNFKMIAKTMYGFEPVLAKELMALGAMDVKEGTRNVSFVGDKGFMYKANLCLRTAIKI
LKPYQSFKIFSEEDLYKKIYELPWEDFMDVDDTLAIDATVHSETFTHSQYISLKTKDAIV
DRFRDKFDKRPNVDLDFPTLRINIHIEKNFCNVSFDSSGQSLHKRGYKTATNIAPINEVL
AAGMLLLSGWDGQCDFLDPMCGSGTILIEAAMIACNIPPNLNRKEFAFERWKDWDEDLFE
KIEESVLKKVREFHFTIQGYDTAPSAVHKAIDNVENANLTEFIKVKRQDFFASEKEGERH
LHMLFNPPYGERLEIDMPKFYKEIGDTLKQAYPGTDAWFITSNLEAIKHVGLRPSRKIKL
YNGALESKLLKYQIYQGSKKAKFQE
>IFAGANLK_02291 hypothetical protein
MIQNHISAYFFSILFLLLAAPLLSQETTVQEKTVQDSLANREKFGLRAGVDISKLLRTAF
QDDYSGFEILGDYRVYKNYYAAAELGNESIGYSEDNISLTSRGSYVKLGVDYNAYENWTG
MENLIFVGARYGFSTFTQDVEEYRIYTTNPFFEPDIRSETIEYSGLTANWVELIAGIKVE
VLNNLFLSFNVQLKRRLFQSTPDNFDNLAIPGFNRTYDDSNIGVGYGYTISYLIPFYKK
>IFAGANLK_02292 hypothetical protein
MSKSYLKILAASVVFLMLIMGCQRDDICPESTQTTPMLILSFYDVDDRESYKRPTNLSVR
SMVADSVKTLYRRINPDTIQIPLRTDQNTTTYTFTLYDAEEDEEDPEFTPDTDTLTFTYG
TEEVYVNRACAYKVIYNSLKLTIEGGEEDEWIDSYIIDEPNIEDDTESHISIFF
>IFAGANLK_02293 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MFVGIFKNTGNKSSQLFYFCAMGRRNKNKVFEAVEVTGAGGKGKGIGKSPDGRVIFIDNV
VPGDVADIKTTKQRKSYYQGTAVNYHQFSDKRVEPVCQHFGTCGGCKWQNMGYEYQLEYK
QDEVLNNLVRVGKVELPEVTPILGSKEIYFYRNKMEFSFSDSRWLTPEEINSGKDFDDKN
ALGFHIPGMWDKILDIKKCHLQEDPSNAIRNFIKEFATSNGLSFFNARKQEGLLRTLMIR
TSSTGEIMVLIQFFYENKEKQELLLDAVIEMFPEITSLQYVINEKGNDTIYDQEVICYKG
RDHIFEQMEGLQFKINAKSFYQTNSAQAYELYKITRDFADLKGDEIVYDLYTGTGTIAQF
VAKKAKRVIGVEVVPEAILDAKENAERNQINNAEFFVGDMKKVFSEEFINNHGQPDVIIT
DPPRDGMHKDVIAQIIGILPERIVYVSCNSATQARDLSMLDEYYKVTRVQPVDMFPQTHH
VENVVCLERK
>IFAGANLK_02294 Ornithine aminotransferase
MSLPKITSSKEAIELEDQYGAHNYHPLPVVLSRGEGVHVWDVEGNKYYDFLSAYSAVNQG
HCHPKIVDALCNQAATLTLTSRAFHNDVLGPYEKFATDYFKFDKLLPMNTGAEAVETAIK
IARKWAYERKGVKETEAQIIVCENNFHGRTTTIISFSNDEGARKNFGPYTPGFIKIPYDD
IDALEKVLKENDNIAGFMVEPIQGEAGVYVPSEGYLKRARELCKENNALFIADEVQTGIA
RTGKLLAVDHEEVKPDMLILGKAISGGVYPVSAVLADNEVMEVIQPGQHGSTFGGNPLAG
AVATAALEVIRDENLAENAEKLGNLFRRLLNDFIRDSNIVELVRGKGLLNAIVINDSEDS
STAWDICMALKENGLLAKPTHGNIIRFAPPLVMNEEQIRDCVNIITTTLKQFEK
>IFAGANLK_02295 hypothetical protein
MERQQLPNSTLILIFGILSIIGCCCYGVLGIIFGIITLVMAKRATEIYNAQPELYTGYQN
VKTGKILAIIGLILSAISLISTIVTFIMYGGIEGVYEMQEEILREIEQNQ
>IFAGANLK_02296 hypothetical protein
MEDFMLPCLNKSLFGVDCFGCGGQRALLLVFKAEFTQAFLMFPAIYPILFLLAFLILNLF
VKFKYDFLIKITLIIMSGAVMLISYLIKMNQLIQLTQ
>IFAGANLK_02297 hypothetical protein
MRQIYFLAFIFSFYYGNAQLHILPSNSGDSYIYLSDRFLYVEDDINLEKNNTPDTEASIY
LRKESQLLQGEKSTNLNSGNGLIPVFQEGTSHAFDYNYWVLPVKDNISQKQFGAIFFQPK
SITNSNPTRVTGSLEGTSNPFGISRRWIYKYSGREYNYWQHVGVNFDVAPGEGFTMKGVN
GTYNRIINGVENNPDNKQRYDFRGLPNDGEIKVSINNDQNVLVGKPFPSALHLQSFLMEN
PASTGIAYFWDSRENGDSHHLKDYEGGYASYSPGANAYVPAVLKIYNGAGEETGNSGETG
GEIAREYSPIAQGFMLNGRNDGYIHFRSSQRRFQQENSQTSEFKNQQRSEFPLLKLNIIV
NNLYTRPLLLAFREDSSKDYDWAMDAKVYGVSQNDVGWNIEEALYNFQVRPFRKNDKIPL
LINLAEDAELSFQLDDFREFENEDVYIFDAEVESYFRLNNDKFSIDLPKGNYSNRFFISF
IEEKEDDLQFELPKEELDFIIPEVLIVQNNLKAQLEIQMLETDIRQILLYDLNGQMIYNK
TIPMETANYTLPTSGLQDAIYVLKLISSKNMEFTSKISIKN
>IFAGANLK_02298 hypothetical protein
MNNSQVINSILIVVGGALLIYAIAAEDAHAYFKIGGLIVIMLGLYRATNFWVATKDDHKE
DENNE
>IFAGANLK_02299 hypothetical protein
MKINPTLKLVILVLFANAFISNAQQNYTITDFDRLIGQESTQTRNQQNFDYQEVENLKNL
VFELNPLIVVQENEHAKMGDGPAKLVIVPSNYLSNISSLKTELQSLELILIKHSSDNSAA
TLDLNSLKSSALKYVLIECDFECSVANIQDMLKNTSNVKVLYRTTTEQ
>IFAGANLK_02300 hypothetical protein
MNFSKNFLQFKNHIVTKIFIAILAVSLGSCTAGMTNPDSYTRNHVVYAVDFNPHNLNELQ
ISKMDEGKWIDHETSKNGKSARYTIEIENGFLTVISNKNKMDVPTYQTWIDYARQELGYT
VQDEYDIFTTIEDGFIYEIDLEEHPLIEGEEHRILMYEQN
>IFAGANLK_02301 Pyridoxine/pyridoxamine 5'-phosphate oxidase
MQKSLDDYRKSYGKSELLEDNIPSFPLPLFTAWFEEAEQHPEIAEVNAMNLATCGIEGFP
KSRIVLLKSFGEIGFSFYTNYNSEKGRDIEENPRVCLSFFWPALERQVIIKGVAMKTSEE
ESSAYFGSRPRGSQLGAWASNQSNVLSSREELDGQLKEIEERYQNKDVDKPPHWGGYLVT
PRSFEFWQGRNNRLHDRIIYEFIEQDTWERNRLAP
>IFAGANLK_02302 hypothetical protein
MKRLILVRHGKSSWENNLPDDKRPLKKRAYNDAEVVLKTFKEFQSGNLTLWSSPAVRANT
TANLFKDELQIPDDRFTVKKELYTFDENQLLSVINTCPNNVEKLMVFGHNPAMTGLVNRL
GDKPIDNLPTTGLCVIDFDLDSWKDIKTGKTLLQLFPKNLR
>IFAGANLK_02303 Polyphosphate kinase
MPQKKYLNRELSWLQFNARVLQEAEDETVPLIERLRFLGIFSNNLDEFFKVRYATVKRID
LAGKAGKSVLGGIKASKLLEEITQIVIEQQAESLKILDDIQHQLKDYKIHIINEKQVSAS
QQKFIKNFFLSKVSPALVTIILNDLPEIPSLKDSAAYLAVKMVMKEEKPQKGISKVLDKT
EKDRKYVLIEIPRSIERFVVLPEENGNQYIILLDDLIRYNLGTIFNIFEYESISAHMIKI
TRDAELDIDSDLSKSFIEKISSSVKDRIKGEPVRFVYDMNIADDTLSYLMNKMGIESTDS
IIPGGRYHNRRDYMNFPSLGREDLLYKPIEPLPIPGLILQTSLFGSIAKKDFLLYAPYQS
FAYTVKFLREAALDPKVKTIKITIYRLAKISHIASSLINAVKNGKKVIVQIELRARFDEV
ANIRYAEQMQAEGVQLIFGVPGLKVHCKACVIEREEEGKMKRYGFISTGNFNESTSRIYT
DYTLFTAHPEILKEVNKVFDFFEINYKVNKYKHLIVSPHYSRNTFVGLIQKEIENAREGK
PSGIALKLNSLSDYPMIDKLYQASQAGVKIKLIVRGVCCLIPGVEGLSDNIEVISIVDKF
LEHPRVFIFKNCGNSKVYISSADWMTRNLDLRVEISCPIYDEEIKQEIIETFDISWNDNV
KARMITAKQDNAYRNSSSKKLRSQFELYDYYSNKLPGSKSEQHIKNENR
>IFAGANLK_02304 Guanosine-5'-triphosphate,3'-diphosphate pyrophosphatase
MITQKNYAAIDIGSNAVRLLVSTITEQKGREETDFRKTSLVRVPIRLGEDVFKESFISEK
NIERMVDTMQAFNLLMKSHGIVKYKACATSAMREAKNGAEVVEKIKAKTGVEIEIIDGNH
EAAIIAATDLHELIKNDCNYLYVDVGGGSTEYTLYSGGKTVASRSFKVGTVRLLNNLVED
GAWEEMEKWVRETTKPYKDIDLIGSGGNINNIFKTSGKKEGKPLSLAYIKKYNELLNSLS
YEERVMDLQLKSDRADVIIPASRIYLNSMKWARADNIFVPKIGLADGIIKSLYNGKKK
>IFAGANLK_02305 Queuine tRNA-ribosyltransferase
MKFDLLSTDAGSKARAGTITTDHGKIETPIFMPVGTVASVKGVHQRELKEDINPDIILGN
TYHLYLRPKTEILKKAGGLHKFMNWDRNILTDSGGYQVYSLSARRKIKEEGVKFKSHIDG
SYHVFTPENVMEIQRTIGADIIMAFDECTPYPCDYKYAKRSMHMTHRWLDRCVNHLKKVD
PLYGFDQTLFPIVQGSTYKDLRKQSAEYIASVGAEGNAIGGLSVGEPAEEMYAMTEVVTE
ILPEDKPRYLMGVGTPINILENIALGVDMFDCVMPTRNARNGMLFTAHGTINIKNKKWED
DFSPLDEMGTTFADKDYSKAYVRHLFSVNELLGKQIATIHNLGFYMWLVREARKHILAGD
FTSWKNMMVKQMDKRL
>IFAGANLK_02306 Lipopolysaccharide export system permease protein LptG
MKILDWYILKRYLGTFFLMLLLFIPIGITVNLAEKIGKILDNEVPFIEVALYYVDFTIYF
ANLLFPLFLFLSVIWFTSKLANNTEIIAFLSSGVSFWRFLRPYLIGATIVCILALILGMF
LAPKASKGFNEFKYEYLKKGSETRETRDVYRQINDNEFIYASHFQPLGKSARNFTLEHFE
GNKLEYKISASSLRFNPEDTTYSLTNVNKRIVGVDEDSIIHQNKLDTILPFEFDELTPET
YIAETLNYNELNEFIEQERRRGSGNINRYLVVAYKRWSIPVSAFILTIIAVAVSSMKRRG
GMGVNLAVGITLAFIFIFFDKVFGTMAEQSTFSPLIAVWFPNISFGILAIFLLYRAKR
>IFAGANLK_02307 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MEYLEFELPIKELEEQYAKACNIGEESDVDVTATCRQIEKKLKETRKDIYKNLTAWQRVQ
LSRHPNRPYTLDYINAICGDTFLELHGDRNVKDDKAMIGGLGKIEDQSFMFIGQQKGYNT
KTRQYRNFGMANPEGYRKALRLMKSAEKFGLPVVTFVDTPGAYPGLEAEERGQGEAIARN
ILEMTRLKVPIIVVIIGEGASGGALGIGVGDKVMMLENTWYSVISPESCSSILWRSWEYK
EQAADALKLTAKDMKKQKLIDEIVKEPIGGAHSNREETFNTVKNAILGAYSEFKNLSPTD
LVNKRMDKYLDMGVFKS
>IFAGANLK_02308 Replicative DNA helicase
MEKITAPQQFSAKKSNVISLEKGKLPPQAVDLEEVVLGAMMIDKKGVDEIIDILSPDAFY
KNSHKLIFEAIHKLFENTEAIDLLTVSNQLKKDGNFEKTGGDYYLIQLTQKVSSSAHIEF
HARIILQKYIQRSLIKISNEIIEEAYDESTDVFDLLDSAEAKLYEVTQGNIQKSTETAQS
LVIQAKNRIEEISNKEGLSGVPSGFDKLDKLTSGWQPSDLIIVAARPGMGKTALTLSMAR
NISVGQNMPVAFFSLEMSAVQLITRLISSETGLSSEKLRTGNLEKHEWEQLNVKVKDLEN
APLFIDDTPSLSIFDLRAKARRLASQHGIKLIVIDYLQLMTAGGSQKGGGNREQEISTIS
RNLKALAKELNIPVIALSQLSRAVETRGGSKRPLLSDLRESGAIEQDADIVSFIYRPEYY
KIEEWDDEERTPTDGQGEFIVAKHRNGGLENIRLKFIGHLGKFDNLEEFDSPFEYHSKMN
TGENDENEFNSPNLPNPSANEAFGSSMNSGFNNDDDDEVPF
>IFAGANLK_02309 hypothetical protein
MTKCRFKISNKIKENSLNNNFLKDQKSGKTTVFLVFFVSLLLSCFQVSASQLLIPMDEDS
QKNHLKAYGITYFALEEELEVRWLLNYRGGSFLISDTEELRKECQIRGVSFEVISDEKTQ
SILEEISSPSQNKESVELEKAPKIAVYSPQGNKPWDDAVTMALTYAEIPYETIYDEAVLN
DALVLYDWLHLHHEDFTGQYGKFYRTFRATPWYIQEKEESEALAKKLGYDKVSEEKLAVA
LKIRDYVVGGGFMFAMCSATDSFDIALAAEGVDIAETMFDGDPSEPGYQSKIDFNKTFAF
TDFTLERSPMVYEFSSIDMTAKRSIPKETDYFTLMDFSAKWDVVPTMLIQNHTRLVKGFM
GQTTAYNPDNIKANVLVMGESKLNNEARYIHGIKGKGFFTFYGGHDPEDYQHRVGDPKTE
LELHPTSPGYRLILNNVLFPAAKKKPRKT
>IFAGANLK_02310 hypothetical protein
MKFFQKEVKLKARSRGFHIVTDEVEGQLPELKEINSGMLNVFIKHTSAGITINENADPTV
RDDFESHFNEMVPENMPYYKHTLEGSDDMPAHIKASLLGNSLQIPVTNGRLNLGTWQGIY
LAEHRDNGGSRKLVLSLYGV
>IFAGANLK_02311 50S ribosomal protein L20
MPRSVNSVAKRARRKKVLKQAKGYFGRRKNVWTVAKNAVEKAMLYSYRDRKVKKRNFRSL
WILRINAAAREHGMSYSQFMGAAKANGIGLNRKVLADLAMNHPEAFKAVVDKVK
>IFAGANLK_02312 50S ribosomal protein L35
MPKMKTKSSAKKRFKLTGTGKIKRKHAFKSHILTKKSKKRKLALTHSTLVHDADKSNVKL
MLRLK
>IFAGANLK_02313 Translation initiation factor IF-3
MGVYPTKEALTIAEDLGLDLVEISPDAKPPVVKAMDYKKFLYEQKKREKAMKAKASKVVV
KEIRFGPNTDDHDYEFKKRNAEKFLKDGAKLKAFVFFKGRSIVFKDKGEILLLRLAQDLE
ELGKVEQMPKLEGKRMTMFLSPRKAK
>IFAGANLK_02314 Threonine--tRNA ligase
MIKVSLPDGSIKEFEKGSTPMDVANSISSGLARNVISAKFNNNIVEVSTPLTTDGSLTLF
TWKDDEGKKAFWHSTSHVMAQAIEEMYPGSKLTIGPAIENGFYYDVDFGEHKISENDFKK
IEDRMLEIAREKHDFKLREVSKADALSYYKEQNNQFKVELIENLEDGEITFCDHANFTDL
CRGGHIPNTGFIKAVKLMSVAGAYWRGDEKNPQLTRVYGISFPKQKELKEYLELLEEAKK
RDHRKLGKELELFTFSQKVGQGLPLWLPKGAALRERLEDFLKKAQKKAGYEMVVSPHIGQ
KELYVTSGHYAKYGEDSFQPIKTPNEGEEFLLKPMNCPHHCEIYNATSWSYRDLPKRFAE
FGTVYRYEQSGELHGLTRVRGFTQDDAHIFCTPDQLDEEFKKVIDLTLYVFDSLGFENFT
AQVSLRDPQNKEKYIGSDDVWEKAETAIINAAKEKGLNYVVETGEAAFYGPKLDFMVKDA
LGRSWQLGTIQVDYNLPERFELSYKGSDNETHRPVMIHRAPFGSMERFIAILLEHTAGNF
PLWLMPEQAMVLSISEKYEKYAQKVLTLLENNEIRALADNRNETIGKKIREAEMNKFPYM
LIIGEQEEQDGTVSVRKRGEGDIGTMPVEDFAAIINNEIKKTLKTFEV
>IFAGANLK_02315 Membrane-bound lytic murein transglycosylase D
MKILKSALIIVGLFTIVFVSIQAAQQSPVSENEDTAEATTTNQKDRPVKDYNIYALPMPE
NINFAGEEVPINDPDIYERMDRELLVNTYWQSNALLLIKRANQFFPIIEPILKEEGVPDD
FKYLAVIESGLTQAVSPAGAKGFWQIMEGTGKDYGLEINGNVDERYHIEKSTRVAADYLK
KSKEKFGSWTMAAAAYNAGNRGVQRQLDRQKVDDYYELLLGEETGRYMFRILAIKEILSN
PEEYGFNFDEKHLYKHIPTRTVKVDTVVKDFADFAHQFDINYKILKIHNPWLREAHLNNA
SRKEYEIKIPEKNTYTAVK
>IFAGANLK_02316 hypothetical protein
MTEENQLIHVYFMPGMAANSSIFEFIKLPENRFKMHFLEWIIPKKDESLKDYAGRMNKYI
EHDNAVLIGVSFGGIIVQEMAKSLNLKRLIVISSVKCREELPRRMRYAASTGLFKLIPTS
LLDYVDHFEKIAVGDFIKKRAKLYRQYLSVRNQRYLDWAIENMVLWNCPKAQKGIVHIHG
DKDEIFPIKYIPECITVKGGTHIMILNRYRWFNKYLPEIILSGKIEEKNKKLN
>IFAGANLK_02317 hypothetical protein
MMNAEEIIITDNEFLRQFETTINQQLATIEYAQQERKIFLTKVFMPEALKEEGYMDIFIE
AVLEEIKERNTRVMPTSPDVAKFIRKNRRKYKDLLPVGINI
>IFAGANLK_02318 Threonylcarbamoyladenosine tRNA methylthiotransferase MtaB
MNNKKVAFYTLGCKLNFSETSTIARSFREEGFERVEFTEEADIYVINTCSVTDNADKRFK
TIVKQAQKVNEDAFVIAVGCYAQLKPEELADVNGVDLVLGATEKFKITNYLNDLTKNDLG
EVHSCEIDEADFYVGAYSIGDRTRAFLKVQDGCDYKCTYCTIPLARGISRSDKLENVLNN
AAEISAKGIKEIVLTGVNIGDYGKGEFGNKKHEHTFLDLVKALDEVDGIERLRISSIEPN
LLKNETIDFVAESNTFVPHFHIPLQSGSDDLLKLMKRRYMSGLYSDRVGQIKEVMPNACI
GVDVIVGFPGETEERFLETYNYLNELDISYLHVFTYSERDNTPAADMEGVVPTKVRKKRS
KMLRGLSAKKRRAFYESQLGNTYTVLFEGENKEGYIHGFTENYVKVKAPWDPGLVNTLHQ
IELTSIDEDGLVRFEFASEKVAV
>IFAGANLK_02319 hypothetical protein
MAEKHEYQVDLTWVEDRKGEVSSPELTDTIETATPPDFPKGMPNIWSPEHFLVAAVESCL
MTTFLAIAENSKLDFISFKSKAIGKLDKVEGKFQMTEIILKPVLKIADESNAERAKRILE
KSEKACLISNSIKSKIILEAEVVIVSQEKV
>IFAGANLK_02320 Cysteine desulfurase IscS
MKNVYLDSAATTQMRDEVINRMTSVMKEVYGNPSSTHSFGRSAKSLVEQARKTVAGYLNV
KASEIVFTSGGTEADNLALNSAVRDLGVKRIITSKIEHHAVLYTVEQLQDCFDVQVDYVE
LDSCGNIKELHLEELLKSSDKKTLVSLMHVNNEIGNKLDIKKVGKLCKEHDALFHSDCVQ
SVGHYNLDFSEIPVDFTAVSAHKFHGPKGVGFAFIRKNSGLKPLIFGGEQERGHRAGTEG
VHNIVGLEEALKLSLDNLEKEKAYIADLKDHFISKLRAEIPGVKFNGDCSDFTKSTYTLI
NVCLPVPADKALMLLFQLDLKGIACSKGSACQSGSDKGSHVLNAFLEEEDLKKPSVRFSF
SRFNTKEELDYVVNTLKEFIES
>IFAGANLK_02324 Shikimate kinase
MKIFLTGYMGSGKSMVGEKLAKKLNYKYVDLDDQIEVIQGKSINDIFEDRGELYFRKLEA
QILDDILENNSDMVISLGGGTPCYGDNFDRICAQKDAKTIYLKASIPTLTERLFLEKVHR
PVISHLETREALEEFIRKHLFERAYYYSQSDITVNVDEKEPETIADQIIEKL
>IFAGANLK_02325 Bifunctional protein PyrR
MKERVLILNHEQIQHKIKRIAYQVYESNIDEKEIILAGIAKKGYQLASHLKEALETISPL
KIQLCEVYVNKKNPLEEITTSLEPGVYQDKSVILVDDVLNSGTTLIYGVRHFLNVPLKQF
KTAVLVDRNHKKYPVKADFKGISLSTSLNEMVEVSFKIKNFKAELL
>IFAGANLK_02326 Thiopurine S-methyltransferase
MKKTKKHSFSSEFWSQRYEQNQTGWDIGEVSTPLKHYIDQLEDKELKILIPGAGNAYEAE
YLFKQEFKNVYVADISKKPLHNLKTRFPDFPEEQLLHIDFFEIEDSFDLILEQTFFCALP
IASRQEYAKKSADLLNENGLISGLLFKFPLTEQGPPFGGNKEEYLTYFSPYFEIEILETC
YNSIKPRQGNELFFKFRKKSA
>IFAGANLK_02327 Heat shock protein 15
MRVDKFLWCVRYFKTRSIATNACKQGKVKVDGANVKPSKEIFPNDKLTVRKNQIDYQIEV
LDLPPSRVGAKLVNLYIIDVTPKEAFEKLELLKYSKDYYRKKGTGRPTKKDRRDIDDWFE
NTDPNPDEKDKEA
>IFAGANLK_02328 FKBP-type peptidyl-prolyl cis-trans isomerase FkpA
MRLNKFFILSLISASTLISCDDDDNRNTPEIEERDPEEQALTDADSINNFLDTHFYNYEE
FENPSDDFDYMVRLDTIAGENADKTPLSEEENLIMKTVVNNDVEYSMYVLKVREGEGQQP
KFTDSTLVSYRGELLNLTAFDNANTPVWFDLTTLIKGFTEGIVEFKGASGYKVNPDNTVE
FNDDYGVGALIFPSGLGYFSSSQTSIPPYSPLVFNVQLFRVNETDHDRDGIPSWMEDLNE
NNNILDDDTDGDETPNFADADDDGDGKPTREEIIINEDGSLEFPDSNGNGTPDYLDPDTF
E
>IFAGANLK_02329 hypothetical protein
MRYQNLTIKQSTMKKLMFIAVFLFSSIGLMAQEADFGIKGGFNYGATGDLKMENASNDLG
NIIEGKEKSGYHIGLFSRFEIVGIFLQPELMYTRLNTEYETFNYKIDKIDAPILLGVNVF
GPLNIKAGPSFQYILNNELEDTQLKIGDVEKDITVGYQLGAGLNLGRLGFDVRYEGAFTD
NTAFSEEASDNFSIDSRPSQWILSLSYAF
>IFAGANLK_02330 1-deoxy-D-xylulose-5-phosphate synthase
MTLGEDGATHQILEDIGLMKMLPGMTVINTCDFNQTKAATLAIAEHDGPVYLRFGRPKVA
NFTAEDQKFEIGKAVQLYEGEDVTIIATGHLVWEAIQAAQKLSEKGISADVINIHTIKPL
DAKAIIKSVKKTGCVVTAEEHNFLGGLGESVARTLAENNPAPQEFVATQDTFGESGTPEQ
LFEKYGLNAEAIIKATEKVLKRK
>IFAGANLK_02331 Transketolase
MEHKPEFNMDGKDEDLFFLSNGHISPVFYSVLARSGYFPVDELNTFRLIDSRLQGHPTTH
EGLPGIRVASGSLGQGMSVALGAAQAKKLNKDNHLVFSLHGDGELQEGQNWEAIMYAAGN
KVDNIISTVDLNGQQIDGSTETVLPMGNLKAKFEAFGWDVMEIENGNDMQQVIDGLTEAK
SRTGKGKPVCILMTTMMGNGVDFMMHTHAWHGKAPDDEQLEKALSQNPETLGDY
>IFAGANLK_02332 hypothetical protein
MRKLSINKILLSCFLSGFSFLNLTAQEGQININEDDKLSKLLALKSEMSQDNEIGDRYKI
QLFYGNNGEANDVIKDYRSKFEYPSLIAYEAPNYKVWVGNFRNRLEADRALLKIKESFPS
AFIPKPRNR
>IFAGANLK_02333 Menaquinone reductase, multiheme cytochrome c subunit
MKKVKYRHSTSRLLLLSVAFFISFSVLGIAQEEVSQDAAEEGQEQTDESSGESSEAEAAA
ASDLGDPANGKSLFNSLCAACHKPYSAGIGPALHGVTEKREMDWLYRWIKNSQDLISSGD
DQAVAIYEEYNQTAMPAFPQLSDADIDDILAYVEQPKPEPQAAQAGGESGGGDSSGGGVS
VNVILAILVFVLVMLLAVLFLVNKTLRNFAQASGVVIPEKTKRKPIWKSFVENQFLVLVS
AVFGLLVIGYFAYGFFMQVGVDQGYEPIQPIHYSHRIHAGDNQIDCKYCHSSARTSKQAG
IPSLNVCMNCHKSISEVAPETATDEYSKEFYDGEIAKLYDAVGWDPAEQDYTGEEKPVKW
VRIHNLPDFAYFNHSQHVSVAGVQCQKCHGPIEEMEVVYQDAPLTMGWCINCHRDTKVRM
EGNEYYEKIHEELSKKYGVEELTVAQMGGLECAKCHY
>IFAGANLK_02334 Menaquinone reductase, iron-sulfur cluster-binding subunit
MSSNKKYWKSVEELNENSSVVETLQQKEFAEEIPVNEFLGDKESLESSKTSRRDFLKYVG
FSTAAASLAACEGPVIKSIPYVVQPERIVPGVANYYASTMADGFDFASVLVKTREGRPIK
IENNELSKSKSGVNSRVHASVLSMYDANRVKRPMIEGRNVSWEEFDREVGSALDSVSGDI
VLMTQTFASPSTTKLINEFSEKYPNVRHVVYDAVSEDAALNAFQSKFGQRALPNYDFSKA
ETIVSIGADFLGDWQGGGYDAGYAKGRVPQNGKMSRHIQFESNMSLTGANADKRYPVTPS
QQKAVLAALYGYVAGGSSTSDLPAKIDDAVVKAARQLRKGGSGAVVVSGIPDDNAQALVL
AINEALGSGVMDTSNPRMIRQGNSQAVMQAVEDMKSGSVGAMLMAGVNPAYSLPNGAEFA
EALANVEVSLAFSMSPDETAKLCKYVAATPHYLESWGDIQYTTSNFSLMQPAIRPLFDTR
QFQDCLLKWTDNNQSYHDYIKETWSGSISSWNTALHDGIFEAASPVNVETAEGSGSVNVS
TAASELARSAEGEGLELTLYTKLSMGDGQQANNPWLQEMPDPLTRASWDNYLTVSKSDAE
SLGLENDNDSNGGLNGSYVNVTVDGTTVENVPVIIQPGQAKGSVGLALGYGKKEGLQKEM
QVGVNAYPLYKNLNAVQSVTIEKASGMHEFACVQLHNTLMGRGDIIKETTLEIFNTRNAS
EWNSVPNVSLDHVEKPVTSPEVDMWDGFDRSIGHHFNLSIDLNACTGCGACVIACHAENN
VPVVGKSEVRRSRDMHWLRIDRYYSSEDTFINDLDKKENISGLGSSLSEFGELEEPADNP
QVVFQPVMCQHCNHAPCETVCPVAATSHGRQGQNQMIYNRCVGTRYCANNCPYKVRRFNW
FNYAQNEEFDYHMNNDLGRMVINPDVTVRSRGVMEKCSMCIQKTQKTILDAKREGREIED
GEFQTACSAACDKGAMTFGDINKEGAVIRDRKEDDRMYHLLEYVGTKPNVMYQTKVRNTT
EA
>IFAGANLK_02335 50S ribosomal protein L21
MSHYEAPIRKPLVTGDKSYHDVTVDVAAPVEGRANKSWWIVFSIALVAFLWGVGCIIYTI
STGIGTWGLNKTVGWAWDITNFVWWVGIGHAGTLISAVLLLFRQKWRMAINRSAEAMTIF
SVMQAGLFPLIHMGRPWLAYWVLPIPNQFGSLWVNFNSPLLWDVFAISTYLSVSLVFWWT
GLLPDFAMIRDRAITPFNKKIYGILSFGWSGRAKDWQRFEEVSLVLAGLATPLVLSVHTI
VSFDFATSVIPGWHTTIFPPYFVAGAVFSGFAMVNTLLIIMRKVSNLEHYITIQHIELMN
IVIMITGSIVGVAYITELVIAWYSGVEYEQYAFLNRATGPYAWAYWAMMTCNVFSPQFMW
FKKLRTSIMFSFFISIVVNIGMWFERFVIIVTSLHRDYLPSSWSMFSPTFVDIGIFIGTL
GFFFVLFLLYARSFPVIAQAEVKTILKSSGSKYKKLRAEHGDDVKHYTPVNIGEPKQNIA
NKVDKKMGDEDAYREGDRDGHNETVNADALTLSEVQKDRIDEMLERTGSFNPENQTADEL
QKLKAVGPFLEQRLHQVGLYTYVQVSKLAQDDFELLDEVIENFPNTAQREDWVAQANELK
NK
>IFAGANLK_02336 hypothetical protein
MASKVIHAIYNDDDLLLQAVKQVREARYHIGEIYTPMPVHGLDKAMGLAPTRLAITSFLY
GVVGFAVAVAMMDFIMIEDWPQDIGGKPSFSFIENMPAFVPIMFELTVFFAAHLMVITFY
MRSKLWPFKEAENPDLRTTDDMFLMEIDAANHNVDELTKFLYDTGAAEIKLIDNK
>IFAGANLK_02337 hypothetical protein
MRNLFYKAIILFLVGGFVMSCADNDKPNYQFMPDMYEPIGYEAYGEYDVFQNGQEAKLPA
EGSIPRGWMPYDYENTPDGMANAKANLNNPLPYTEDNLNEGKQLYTIYCAVCHGDNGDGQ
GILAEREKILGVPSYDDAGRAITEGSVYHVIYYGLNTMGSYAAQTSEEERWKITHYVMNL
KNELEGGEEIPFEEGKEASIAEANPVEVERAQENAEEVQGEGAVTGEEEEQNNN
>IFAGANLK_02338 hypothetical protein
MIVGAIGLVIGFLQAPSNLDDVREMMAAEEHHGEASHSEEGEANFAEAEHGMLLDDEPGR
NAEAEHAEEAGAHDTEHLEHKLHQLQNKPWAAIYVAAFFFFMISLGVLAFYALQYASQAG
WSPVLFRVMEAISAYIVPGGIIMFVLLALSGFHMNHLFVWMDPEVVAHDEIIQNKTAYLN
VPFFLIRAAIFLAGWFLFRHFLVRNSRRLDEATDNYYFKKNFKLAAGFLVFFLISESIMS
WDWIMSLDPHWFSTLFGWYVFSSMFVSGITVIALVSIYLKSRGYLPFVNNSHIHDLAKYM
FGISIFWTYLWFSQFMLIWYSNIPEEVVYFISRIENYGLPFFGMVVLNFLFPLLVLMNSD
YKRVNWFVVMTGIVILIGHYLDVFNMVMPATVGESWFIGIPEISAVLFFGGLFTFVVFSA
LTKAPLLAKRNPFIKESEHFHY
>IFAGANLK_02339 Alternative cytochrome c oxidase subunit 2
MTVFLVIIVLALLAVTGWQMSKIFQLSKGPGAESSEIANDNDNRQQAKLMLWFMIFIYVG
MAYSFWQWSKLYLPEAASEHGNQVDTLMFISIGLIMVVQVITQALLHWFAYKYQGKKGQR
ALFFADNDKLEFIWTIIPVITLAGLIIYGLFTWSDIMNISEENDPIVIEIYAKQFSWQAR
YAGEDNTLGEANVRFIEGINTVGVNENDPYADDDKITTELHLPVGKEVLFKFRSQDVLHS
AYFPHFRAQMNVVPGMVTQFAFTPDITTEEMRNSEYMVDKVKTINEIRKDNSEALMAEGD
APLDSYEFDYFLLCNKICGDAHYNMQMKIIVESEEDYNEWLSEQDTFASTLESQE
>IFAGANLK_02340 Alternative cytochrome c oxidase subunit 1
MSAIATAPAHDHHDDHGHHHKQTFITKYIFSTDHKMIAKQYLITGILMGIVGIMMSVLFR
MQLAWPEESFMLFEWLLGDKWAPDGVMTPSIYLALVTIHGTIMVFFVLTAGLSGTFSNLL
IPLQIGARDMASGFMNMLSYWLFFISCVIMLSSLFIESGPASAGWTIYPPLSALPQAIGG
SGMGMTLWLISMAIFIASSLLGSLNYIVTVLNLRTKGMSMMRLPLTIWAFFVTAIIGVVS
FPVLLSAALLLIMDRSFGTSFFLSDIYLEGEVLSHQGGSPVLFEHLFWFLGHPEVYIVIL
PAMGIVSEVLATNSRKPIFGYRAMVASILAIAFLSTIVWGHHMFVSGMNPFLGSVFTFTT
LLIAIPSAVKAFNWITTLWKGNLQMNPAMLFSIGFVSTFITGGLTGIILGDSTLDINVHD
TYFVIAHFHLVMGISAIYGLLAGVYHWFPKMFGRMMNKNLGYVHFWITAVGAYGVFFPMH
FIGLAGLPRRYYTNTAFPYFDDLADVNVIITIFALITAGVQVVFLYNFFSSIFFGQKATQ
NPWNSTTLEWTTPVEHIHGNWPGTIPSVYRWSYDYSKMNLEATDYVLPGQDFVPQNVPLQ
DHEEELNH
>IFAGANLK_02341 Holliday junction ATP-dependent DNA helicase RuvB
MNENLDPSGENFSPEEFDIERALRPLSFDDFAGQDQVLDNLKVFVEAANQRGEALDHTLF
HGPPGLGKTTLAHILANELEVGIKVTSGPVLDKPGDLAGLLTNLEERDILFIDEIHRLSP
VVEEYLYSAMEDYRIDIMIESGPNARTVQINLNPFTLIGATTRSGLLTAPMRARFGISSR
LQYYSTELLSDIVQRSSEILRVPISLDAAIEIAGRSRGTPRIANALLRRVRDFAQIKGNG
KIDMEIAKYGLKALNVDAHGLDEMDNKILETIIDKFKGGPVGLTTLSTAVSESAETIEEV
YEPFLIQQGFIYRTPRGREVTEAAYKHLGRVKGSTQGGLF
>IFAGANLK_02342 Pentalenene oxygenase
MAEKYIPTVSMFRFVKNAGRILKNPLPFHRENFEKYGDVFQIHIGPGQKVIFSRDAAFAE
YVLQKNQKNYQKSTIQTRDLAKYVGKGLLTASGEHWAKQRKLIQPAFHKSHLTGLLESVQ
QAINIEIEKIQPNKKFDVFPVFNDLAFQTVVKSLFSSAANQKQINRLQYITEAAQKMLVK
ELRQPFKLWWFHLSGEIKKHINLTREARAILEDIVEERKKSETRYDDLLDMLLDARYEDG
QPMDKEQLIDEILILFTAGHETTSNALTFTCELLARNPEAQEKIFKEVETAKSETHDLMG
FVRSCVYTQQVIEESMRMYPPAYFIDRVNIEEDNFNGFKLPKGSSILFSCFEIHRHTKQW
ENPEKFDPERFLDSKAHSSHYFPFGAGPRKCIGNNFAMFEMIMAIAEVISRYKIVPKTSE
MEIKPLITLKPKNAILEFSPR
>IFAGANLK_02343 Epoxyqueuosine reductase
MYENKSKYTQLIKTEASRLGFLSCGISKAEFLEAEAPRLEEFLKKNRHGEMRWMENNFDK
RLDPTKLVEGSKSVISLLLNYYPKETQREDSYKISKYAYGRDYHFVIKDKLKQLLQVMQD
EIGEINGRAFVDSAPVMDKAWAAKSGLGWIGKHSNLLSKQTGSFYFIAELIVDLDLEYDA
PVTDHCGSCTACIDACPTDAIVEPYKVDGSKCISYFTIELKDELPNSYKNQFEDWMFGCD
ICQDVCPWNRFSKPHNEPLFNPHPELLEKDKKGWEELTKETFNEIFRKSAVKRTKFEGLK
RNIEFLQK
>IFAGANLK_02344 hypothetical protein
MKLVKKKNLPGQAYVQFVINETGEVKQVKVRTRNKYLEKEAIRLFADLKIKQPASINSKN
VSLKHTIPITFNLLEFDSYEEFGRKFKSKN
>IFAGANLK_02345 NADP-dependent malic enzyme
MSNNPRKRREALVYHAKPKPGKIEVVPTKKYATQRDLSLAYSPGVAEPCLEIEKDKENAY
KYTTKGNLVAVISNGTAVLGLGDIGPEASKPVMEGKGLLFKIFADIDVFDIEVDTKDVDK
FIETVKNIAPTFGGINLEDIKAPEAFEIERRLKEELDIPVMHDDQHGTAIISAAALLNAL
ELAKKKMEKVKIVISGAGAAAVSCTKLYKAFGAKAENIIMTDSKGVIRKDRPNLSEEKIE
FATSRKIDTLEEAMKDADVFVGLSIADIVSPEMLKSMAKRPIVFAMANPNPEIDYQLAMD
TRKDIIMATGRSDHPNQVNNVLGFPFIFRGALDVRATKINEEMKMAAVKALAEMAKEPVP
EQVNIAYGETRLNFGSDYIIPKPFDPRLIAKVPPAVARAAMESGVARQPIQDWDRYEEEL
LERMGSDNKITRLLLNRAKMNPKRIVFAEADHLDVLKAAQIVHDEGIAIPILLGRRKVIE
ELMAEIDFHEEVAIIDPKSDEEEEHRKAYAQVYWKTRNRSGVTLYDAEKLMRERNYFAAM
MVNEGDADGLLSGYSRAYPAVVKPMLELIGMAPGVTRVAATNLMNTSRGPLFISDTSINI
DPPAKDLAKIAQMTARTVQLFGLEPVVAMMSYANFGSSKDPRATKVKEAVSYLHRNHPEL
NVDGELQADFALNREMLQNKFPFSKLAGKKVNTLIYPNLDSANSTYKLIKELNKVDSIGP
IMMGMRRPVHILQLGASVEEIVNMTAVTVVDAQEKEKKQKK
>IFAGANLK_02346 Holliday junction ATP-dependent DNA helicase RuvA
MIHHLKGQLIEKNPTYLVIACNGVGYMVNISLHTFSLIPDSENISVYTHLHVKEDSHTLY
GFYQKSERDIFRLLISVSGVGTSTARTMLSSLEPNQVKDAIANGDVPTIQSVKGIGAKTA
QRVILDLKDKILKVYGEDEVFVPQDNTIKEEALSALETLGFARKQATRVVDKIMKDSASP
TVESIIKMALKNL
>IFAGANLK_02347 hypothetical protein
MRHNYWKLSTSVKLSLLLSLIISLSSTAQETPQDTTETGYALGEITLPDSELISSFYEYD
AILDRYIYREQLSDIDLSIPLILTPEEYENLVLDEEMRNYFKQKVDAQAGRKEGAEEIQR
DLLPDFYVNNNFFESIFGGSEINIVPQGTVEMDLGLLYTKQDNPAFSPRNRQNLTFDFDQ
RISLSLLGQIGERLQITANYDTESTFDFQNQLKLEYTPTEDDIVRKIEVGNVNMPLNNAL
MQGAQSLFGFKTELQFGKTRITGVFSEQKSERRTVNVEGGSTVEEFEKFALDYDQDRHFF
LSHYFRDNYDDALKDYPFINTNIQIKRVQVWVTNRTNNVQNLTDTRNIVAIQDLGESNVP
GNVGLDNPPAGFFNQPGGSFPDNENNDFNPFGIDGSAESVLTPSIRDVATVDNGFGGVHV
SEGLDYVKLENARQLQPNEYSLNTQLGYISLNQRLSNDEILAIAFQYTVNGEVYQVGEFA
NDGVNATGDNNPAQNPTQDPDEPVTNQRINQNLVVKMLKSTITNVNEPVWDLMMKNIYSL
GAYQLEREDFRMNILYTDPQPLNYIKPAGDGSVALPEDISETPLLRVFNLDKLNNNNDPI
NGGDGFFDYVPGLTIDPENGNIIFTSVEPFGRHLFEELDNSPNTGTEDYDNPETWNANQQ
KYVFRSLYRTTKTQAEQEDADKNKFQLKGRYKSGEVEGIPIGFNLPPGSVTVTAGGRILQ
EGVDYVVNYELGRVQILDEALLASDIPIQVNTENNALFGQQTKRFTGLNVEHQFNENFLI
GATFLNLKERPLTQKANYSYEPINNSIFGFNVNYSTEVPLLTRLVNKLPNIDTDVPSNFS
VTGEFAYLQPGAPSINDFQGEATTYIDDFEAAQTTIDISAPLSWELSSVPLGYGGERANG
DIKVGDKRAKMSWYTIDPVFYSSNRPDGITDNDISTYATRRVTLSEIFPNTDVVQGQPQV
VYTMDVAYFPEERGPYNFNPAATDGTLPNPSESFGGIMRGINTTNFEQSNVEFIEFWVMD
PYIYSENSGNSAGTINFNLGNISEDVLKDGRKQYENGLPASGGAENTIETQVAKVPADQS
LIYAFDSEGEERTNQDVGYDGLSDAQESLKFPEFSNLPDPAADNYEYFLNTDGDIVNRYR
NYNGPDGNSPPEVGDTNRGNTTLPTTEDVNRDNTMNTIDSYFEYEIPFFPGMGVENNQYI
TDEKELTTTLRNGNELPVRWLQFKIPIYEPTDSKGGIADYRSIRFMRMFLSGFEEETLLR
FGTMELVRGDYRRYNRGLRDRNILPENQNTLFEVSAVNIEENENRQPVPYVLPPGVIREE
LFENNTNIRQNEQSLSLRVCDLEPQDARAVYKNFQIDMRQYKNLEMFLHAESLPNQTPLK
DGQLVAFVRMGTDFTDNYYQIEIPLSPTAFGAMTAEEIWPQVNRMNLPLELLQRVKTGVL
GDPSLNSGELNFFTENLELIDEEDSYEMDQLRLGIKGNPSFGNVRVLMLGLKNGTPTNGV
QDLCGEVWFNELRLSDLDNEGGWATIVNMDTNFSDFATVAATGRKSTVGFGTIEQGPNQR
SRENSQQYDVVTNINAGQLLPEKWGVKIPFNYSRGEELITPKYDQEFLDLELETRLSDIV
DPVERDRVKKQSQSYTRRQSVNIIGLRKERTGEAKPMPYDIENFAFTTSYNQVDHRDFEI
EESLNQNVRAGATYEFNFEPKEIEPFKNISALDSSDYYSLVRDFNVNLLPSNINASSTIL
RQYNEQKFRSLELSDDDLGIPTLYQRNYMFNWEYGINYNLTNSLNFSFNASNNRIVRNYI
DEDGFADNNIRVWDNFFSIGTPDLHFQNLQVNYEIPFDKIPVLEFINATYSYTGDFQWQR
GSRIYENLEGIPDIGNSVQNSSSHQINASLDMENLYSYLGLEKKEGRGGQTIKQRSGGVP
TLDGSPQDAERTQNAEVVEKTSKSFNTFVDFVTILSRLQVNYRQNEGTFLPGYTPSVGFM
GTLQPSTAFTFGWQDEVRYTAARRGWLTLFQNFNQQYSTLKNEQLDVQASLDIVPDLTVD
ISANRNYSENFSENYRVNPTTLEYISLTPYNYGNFNISTILIKTAFNQSDEQSSETFESF
RENRLNIARRIARERGLDPNNVDEDGYPVGIGKTNQAVLLPAFVSAYAGKDPEDMKLGAF
RDMPLPNWNLKYTGLMRIGWFKDKFRRISINHGYQSNYTINQFQTNLDYDPENEFDTNQA
GDFKNPMLYSNIVLTELFTPLFRLDLETQNAIQLLAEVRKDRMLSLSFDNNLLTETTGNE
YILGAGYRISDLRIATGLGGTNRILSSDLNFKADVSFRRNKSIIRYLDLETSQVIAGQDI
WRINFSTDYAISSNLTAIFYYEHNFSEYAVSTAFPQTTIRSGITLRYNFGN
>IFAGANLK_02348 Glycine cleavage system H protein
MNIPQDLKYTKDHEWIKVEGDTATIGITDFAQGELGDIVYVEVETVDETLDREEVFGTVE
AVKTVSDLYLPLSGEIIEFNESLEDEPEKVNSDPYGEGWMIKIKFSDESQLKDLLSADAY
KEVLGS
>IFAGANLK_02349 hypothetical protein
MPIKKFLVAKIILFVASFYTILLTVSSLVKLGKISVGSFNPTDKLLHLGAYFGLVVLWKV
YFMQKNKPRTTYKINLFKIAGLSILFGMLIEVLQGVVTSYREPDWYDILANTAGILLAVI
IFLLFEKSLKRLNSKINLIF
>IFAGANLK_02350 hypothetical protein
MEPKKNPKADLTRRSVFFLQLGLILVLLITWRAIEWKTYDKDAIDTGQLNMDDLDDEEIP
ITEMQNTPPPPPPPPPAPEVIEVVEDEEEVEEDEIESTETNMDDIVEVEEVVEAPVEEEV
EDVPFAVIEDVPIFPGCENLNNNEERKQCMSQKISQFVNREFDTDLGAELGLSGVNRVIV
QFKIDEKGNITNVQSRAPHPRLEREAARVINKLPSMQPGKQRGKAVGVMYSLPIVFQIQD
>IFAGANLK_02351 hypothetical protein
MKNYLFLLFLLSAIISKSQAQDNSQRFPEFLQCTEVDFANKEACFKNTLTEFVLNNYEIP
LEVTRENYSGEIIVIFEVDKTGNFNIVYTDAVYAELKDEMQRVFNLLPQIKPATYNSRPI
FVQFKMPVKIPLELNTEELSATSQVKPDISEVNLQQPEEDDVTHEYDKILSGEFTRPRYE
SQINIPLSHEYYGRFDAQFNRIGVNTHSASKPLLFSEVSKYYDFKAEEDKMLRDANSWFD
RKLWNEHLVQYQTEDYWFTLDFALDLQLGKDFQQTDFDFTYNNTRALIFQGGLGKNFNFY
TVAYENQGRFADYYNRFAESIRPDGGDPAIIPGRGIAKPFMDEGYDYPVAEGYLSYTPNK
FFNLQFGHGKNFIGDGYRSLLMSDNASPYPYFKLNTTFWKLKYTNTWMSLRDVRPAVTEN
GSFRTKYMANHYLSYNVTKRLNIGLFESVVWENDNNRGFDLNYLNPVIFYRSIEFSTGAR
GGNAIIGLTSKYKFSDEINVYGQMIIDEFSTSDVFGGQQSWKNKLGYQLGLKYFDAFNIP
GLFFQAEYNQVRPYTYSHNTGVLNYGHNNQSMAHLWGSNFREILAIARYKNDRWYGNAKV
IYGKRGFDYNMAANQAAYGGNIYTSERQRPFETDVEIGQGNTTISFFSSIEAGYIVNPAT
NLKLYGSFIYRSFNPEVKTPQNFDNTTSWVNFGLRTDIFNWYYDY
>IFAGANLK_02352 Protoheme IX farnesyltransferase 1
MSSTGVHISSASILTDFKEITKVRLAVSVVFSSVAGYFLGADSIDFVTVFLLAIGGYFMV
GASNAYNQIIERDLDALMDRTKNRPIPDGRMSVSTAFAIASIFTIAGLIVLYIINPKTAM
FGAISIFLYVSVYTPLKTKTPLSVFVGAIPGAIPFMLGWVAATGEFSIEPGTLFMIQFFW
QFPHFWAIGWWLFDDYKKGGFFMLPTGKRDKGTAIQVILYTVWTILVSLIPVFGVTGKLF
LSPVAGALILILGLGMLYYALKLYKEKTAQAAKKLMFASVSYITLLQIVYVFDKFIREWI
>IFAGANLK_02353 Cytochrome c oxidase subunit 3
MDLTQGAEKHKYDRAKKMMLWFGIISMIMTFGGLTSAYVVSKTRPDWLTEFDLPNAFMWS
TLVIVLSSFTFIMAKQSILAGNRRNASALLIGTLVLAVLFVALQFNGFTEIIGEGYYFTG
SESSITTSFIYVLVLVHMAHLLAGIITLLVVIYNHFKQRYKKGQMLGIELGATFWHFVDL
MWIYLFVFLYFFR
>IFAGANLK_02354 Cytochrome bo(3) ubiquinol oxidase subunit 3
MEATVVRTGTEGKTWGGGNEPLKSSYGKMMMWFFIVSDALTFSAFLAAYGFSRFKFMDSW
PIADEVFNHFPFLHGVDAPMYYVALMTFILIFSSVTMVLAVDAGHQLNKAKVTFYMFLTI
IGGVIFLGSQAWEWKNFINGTYGAVYTTGGNVLQFIDGDGHRVALADIAVPGASDRVEHE
AKNGIWFEAEKALPSYSIEEVKAGFAANPDLLIRTQIMNEEGEKTILSREESLAKLDSEA
IGVVEGANLTRNEYGPPLFGDFFFFITGFHGFHVFTGVLINIIIFFNVILGTYERRKNYE
MVEKVGLYWHFVDLVWVFVFTFFYLV
>IFAGANLK_02355 hypothetical protein
MAHGTAHHHESNTKRIWTVFVILSIVTLIEVVLGILKPEFLTDTSFLSMSLLNWIFIILT
IYKAYYIAWSFMHLEGETKGLRRAIVWTAVFLISYLIFILLTEGDYIYEVFKSNHVAWDF
>IFAGANLK_02356 hypothetical protein
MKKFLVLLVLFALPIIAYMFFASGQNNFAKLPVLTKGVNDVSEFESLDGEPISLEDKISI
VAFFGKDLDNLKGNTFNLDQKILEKYYEFKDFQFVVVLPEEAREEAEKFKKEFSGISETE
KWEFIFGTSAEVEETFKSFDTPHQLENTYTPYVFIVDKDLNLRGRDEDEDFGKVYGYDSR
SVAELSDKMNDDVKVILAEYRLALKKNNAERKNN
>IFAGANLK_02357 SCO1 protein 
MKKKYSYIGLSLIILIFGIIVIPKIVDTISSDEVVKSDRLNIKGADKELDTDKALSYIEI
NGRKKKAPEFQLINQDGDTVSSKDYRGKVYVAEFFFTTCPTICPIMNQNLVEVQKEFKNE
EDFGIASFTIDPKHDTPEVLNSYADNYGIDHPNWNLLTGEKDSIYSLANGGYNIYAGENS
EVPGGFAHQGLFALVDKEGYIRSRLDNFGNPIIYYRGSVERNKSVAEGEEEPQIDILIED
IKKLL
>IFAGANLK_02358 hypothetical protein
MRKTLTKSDRIAVPVIIALSILVPVLVLILMYLPERYNIFGAQTGTFPFFHAVLNGSTAI
LLMLGYFFMSIKEYKLHRNVMITAFVLSAIFLVSYVISKISNDPVPYGGEGILRPVYFFI
LITHIVLSAIIVPLVLFTMYRGLTGEYQKHAKIARWTFPIWSYVAITGVLVYIFMFPYY
>IFAGANLK_02359 hypothetical protein
MHLEIAAMKIRFLFIFFFLLLFPELAEAQCSMCRAVLESDTDTSAAEGINNGILYLMAFP
YLLVGGLGYFIYRSRKKAKKSGEV
>IFAGANLK_02360 putative ABC transporter ATP-binding protein YknY
MIEIKDLHKSYKMGSNSLHVLKGINFSVAEGELVSIMGSSGSGKSTLLNILGMLDEADEG
SYTLDGVPIKNLNEKIAARYRNKFLGFIFQSFNLISYKNALDNVALPLYYQGIKRGERID
KAMSYLEKVGLKDWAGHLPNELSGGQKQRVAIARALASDPKVLLADEPTGALDSKTSYEV
MNLIQEINDEGRTILVVTHEPDIAAMTKRIVNLKDGRIIQDTPVNQVRALQNV
>IFAGANLK_02361 Macrolide export ATP-binding/permease protein MacB
MFDLERWEEIFETIRKNKLRTFLTGLSVASGIFILVVLLGIGEGMRNGISQEFQNDAANI
MYVYTGVTSKEYKGLNPGRRIQMKNEDFNYTALKYQDDLEYRSSIYRIWNGIVNFGKESG
SYRVEGVYPDYQFLENSGMLEGRFVNYKDHDNFEKVVVVGNKVRNDLFKDSKDPIGEYVQ
ISGVNFKVIGVFTDPGGEREESRVFMPLSTAQRVFGGGNNIANMAFTLEPEENFEAALAA
STRFSDAIEDQLKETHTIAPDDESAISINNSLENAKRFFDLMDMIKFFFWGVGICTIIAG
IVGVSNIMLIIVKERTREIGIRKALGAEPLSIVGMVLHESIFVTAIAGFIGLIASLLLLE
FVGPLIETQYISNPAVNFNVALTTVFILVLAGAIAGFFPAWRAARIKPIVALRDE
>IFAGANLK_02362 Macrolide export ATP-binding/permease protein MacB
MFNRDKWSEIIEALSANWFRTLLTAFGVMWGIFILVILLAAGKGLENGVKQGFGGIATNT
MFMWTQTASKPYKGLPKGRRYDFKTSDVEALRENVPGLRFISPRNQLGGFGGNNNVVRGL
QTGAFNVYGDYPEIIQQEPMDVTSGRFINYLDIQGKRKVAIIGEGVRRELYEKEEEVLGS
YLKINGVNFMVIGTYKKKGGGGGNAEEAQKEIYVPFTAFSQAFNMGDTVGWMAITAKDEN
SITSLKSSVLDLIKSRHSIHPEDERAVGNFDLYEEFNKINGLFVALNAVAYFVGILVLLS
GIIGISNIMLIVVKERTNEIGVRRALGATPWSIRGQILMESIFLTIISGMTGIIFATGII
AGINYALSGMDTSEMMFANPSVDLGVVLTALMILIFSGLVAGLIPAQNAIKIKPVDALRT
E
>IFAGANLK_02363 Multidrug resistance protein MdtE
MKKTVTISILVLIAVVFVGALYYLFQKNQEDPTVYETEQASVETIVKKTVATGNIVPKEE
VLIKPNISGIIDEIYIEAGEKVKAGDLIAKIRVIPNVNSLQSAKDAVATARINLENEKKT
FERQKALFEKGVISQNDFDNAEANYKRMQQNFRSAEQNFEIVQTGTTSGIGSAANTLIRS
TVDGMVLDVPVRVGNQVIESNNFNDGTTLATLADVNEMIFEGKVDESEVGKIKEDLPLEV
TVGAIENKTFNAILDYIAPKGVDENGAIQFEIKGTLDKADTTFIRAGLSANASIILDRAD
EVLAIKEALVQFDPDSQEPFVEVQTGDQEFERRDLELGISDGIQVQVINGISKDDKIKVW
NIVKPSPEFAGN
>IFAGANLK_02364 Outer membrane protein TolC
MKKYSLLTIFLFSAFFVKAQEDNEWTLQECVNYALENNIQVKQSELDVELAELGRRDAIG
NFLPNINASATNSWNTGLTQNVTTGVLQTQTTRNFSAGVTASLNLFDGLRNFKQLQRAKI
SELASQYALDRMKDDITLFVADSYLQVLFNKQNLEILRLQNEVTQEQMERTRELVDAGSL
PQGDLLEIEATNADEQQRIIVAQNNIRISLISLAQTLLIKDYENFDIVERDYNILGTEIL
DNPVEDIVEQAKEERSEIKIAEANRELAQKDVEIARGAYYPSVGAFFNYNTRESGQGRIV
GAEIDPNDPTREIGIVEETGDVVVAPNTLTTIGSPLPFFEQLQRNDGVTYGVQVSVPIFS
GFATRNQVRRSQVNARRAEYELEQAELDLEANVYQAYVDAEGAFEAYEAALVAANAQEQA
FDYSTQRFDVGISNAFEFSQAKLRYENAQSEVLRTKYDYIFKLKVLELYFGVPVTDLKF
>IFAGANLK_02365 Macrolide export protein MacA
MKKKTLFIIIGIALALIVLLIVGKKAGWFGKSGNFKEVEITKIEPIDIIETVSATGKIQP
EIEVKLSSEVSGEIIELPVVEGQAVEKGDLLVRVNPDIYQSSVNRAQAGLETSRANYSQA
EASLKQAEANYNRNKSLFEKGVISKAEWDRIVSEYEVAQANKESAYYNMQSTAATVKEAT
DNLGRTNIYAPMSGTISKLDAELGERVVGTQQMAGTEILRVANLSNMEVEVDVNENDIVK
VQVGDSTIVEVDAYLGKEFNGVVTEISNSADAALTTDQVTNFKVKVRILEESYKELLAGE
DENYSPFRPGMTATVDIITNRKVNIIGVPISAIVIKNDTTAGKSEDQKYEAVFLKEGEKA
ELRKVTTGIQDDSNIEITEGLTEGETVITGPYNTVTKSLKEGDDVEVINK
>IFAGANLK_02366 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MALILCLETATTNCSVALSKDGVQLALKEDKSNNYSHAEKLHIFIDEILKENNLAVTDLD
AIAVSKGPGSYTGLRIGVSTAKGLCFSLDIPLISIATLASLATQVELDKGFIIAMLDARR
MEVYSAVFDEKLNSIRETKAEVLDENSFIDFLEKDKTVFIGNGVEKFEAICKHSNAEFIS
DKLPSAREVCSLAEAKYKISDTEDVAYFEPYYLKDFIAG
>IFAGANLK_02367 Small-conductance mechanosensitive channel
MDKLNDWGAIAKEYAEKLIDYLPTLLGALALLIIGLWVIGLIVKYLDKLFKKKDFDETLE
IFTINAVKWGLRIILFVLFITQLGVESASLVAAIGAAGLAIGLAMQGSLSNLAGGVLLII
LKPFKVGDWIEVQGVSGSVVEISLFYTKLDTFGNQRAVIPNGELSNDNIINYSHNGTRRE
TLSFGISYDDDLKKAKQVLRDLVEEQEDVLKDPPPQIIVAELGADSVNFSVRYFAENSKF
WDLHWYMIEEGKIRLEEAGMTIPYPQRDVYLYDQTKMNGTIEKKSVKKQDNNNSNIAE
>IFAGANLK_02368 hypothetical protein
MATPKFTNSLINETSPYLLQHAHNPVNWEAWNSSTLKKAREEDKLLLISVGYSACHWCHV
MEHESFEDESIAEIMNEHFINIKVDREERPDIDQVYMNAVQVMTGAGGWPMNIVALPDGR
PVWGGTYFRKEQWKDALKQLSGLYQTKPDEMKAYASRLDEGLQQLQLIKTPEEETPFSKD
FLNEILEKWQKGFDIKNGGSRGAPKFMLPVNQEFLLRSGMQLENKELLEHSLHSLNKISY
GGVFDHIGGGFSRYSVDERWHVPHFEKMLYDNAQLVSLYSKAYSFTKYNWYKEVVFKILD
FIEEELTDKSGAFYSALDADSADEIGNKTEGAYYVWKKDNLQELLKEDYSIFEAYYNINS
HGKWEENNYVLIRSKNDKTIAEEFDLSLSELQSKKENWTKILKKERDKRTKPGLDDKSLT
SWNALMLNGYVDAYKAFGNQEFLRKALKNTEFLQEYQLKKDYRLWHNYKNGKSSINAYLE
DYVFCTEAFINLYEATFDEKWLEIAEKLTEVCFEDFQDEKTGLFYFTSSKDEALITRNYE
LNDNVMPASNSVMAKNLFKISKISGNRDYYDLAEKMLKTIQFQIETQPQSYANWLDLMLN
FTENFYEVAITSKNALGIRKELQGEYFPHTVFAGSVNESEVAILKSRFKENKDLIYICSD
GKCDLPLNSVEESIKKIKQF
>IFAGANLK_02369 Calcium dodecin
MSIVKVIEILANSTESWEDATKKAVKHAAKTVKNIKSVYVKEQSALVNGENITEFRVNVK
ISFEVN
>IFAGANLK_02370 hypothetical protein
MQDVYLIILGLLFILAITDLVVGVSNDAINFLNSAIGSKAVSLRSILIIASLGVAVGAIF
SSGLMEVARKGIFLPQEFYFEEIMVIFMAVMLTDVLLLDFFNSMGLPTSTTVSIMFELLG
AAVSIALIKIFTTTNDISHLVDFINVEKASEVIFGILIAIVIAFITGAVVQYFSRLVFSF
KYERRLKYTGAIFGGVSLAAIFYFILIKGLNSMAFISDHFVEDVNDNRIQIIIFSLLGFT
ILSKVLISFFKINILKIIVVVGTFALALAFAGNDLVNFIGVPIAAWQSYEIWSASEVPAS
ELLMSDLAGSVPTPEIILIFAGGVMVLTLWFSGKAQAVVDTGVKLSRQHEGSERFGSNYL
SRTIVRYSIMFGAAVSDVFPKKVRKQINNQFEAPKTKSQSREIAPPAFDLVRASVNLVVA
SILISMGTNLQLPLSTTYVTFMVAMGTSLADRAWNQESAVYRVAGVLNVIGGWFVTAFVA
FLGAAIFAVIIYYGGLIAIAILVCITAFFIVRNTMAHAKKAKADKRQKKYKRTDIITINE
ITAESSVNISQVISGISKRYTKTVDNLGYHDLGKLKKNNKKVGELESEVDDLKGNIYYFI
KSLDEDSVEASRFYIHLLDYLQEMVNSTRYITRNSFEHVNNNHKNLKFNQIRDLKKIDRK
LQELFKEIKHTFDEHDFERLDDILAEKQQLLDTVSEMIEKQITRIRTSESSPKNTKLYFG
LLLESKDLISSTLNLIQLFREFYEEAKSTL
>IFAGANLK_02371 Fe/S biogenesis protein NfuA
MSNFTINIQATNKPEIIKFETNKFLTRHENYEFKNIDEAAQSPIAQQLFYLPFVKTVYIA
QNFIAIEKYDIVDWGDVQEEVASQIEEFLNKGGVVVKEDTKDAKNVPVTVYAESTPNPGV
MKFVANKKLVLKTAEFKNIDEAKDAPLAQQLFHFPFVKAVFIDSNYVSIHKYDVAQWEEI
TLELREFITNYLQEGKEVLKAEASVPQQTEASSHPANPEVSQEIRDLDDTSKQVIAILDE
YIKPAVASDGGNILFDSYNADSKTVKVILQGACSGCPSSTMTLKSGIETMLRDMLRGKVD
YVEAVNG
>IFAGANLK_02372 hypothetical protein
MGIRTLFIGDYNVFFRANQVSLTIKFIFLILFIFLTGFSVKSQEVIPIYSDYLTDNLFLI
HPSMAGAANRNQIRLTARQQWFDVDNAPSLQTLAVNGRVGDKLGVGGIVFNDQNGNFSKI
GAYGTVAYHLLFSRSELDLNQLSFGISAGIVQHRLDQSGFTDFDPIVSGSNVSDIFGNMD
LGMSYYYMDFYAHLAAKNLISVRRELFYSDAVPSNQRKYLFSTGYVFDNNSDWSYEPSIL
YQLRQATNEMNIDLNMKVYRNVDFGQVWGGLSYRNSFEGAEYTTEGDEVESQQLRYITPF
VGLDYKNFMFGYTFSYQFNSVVLSNNGFHQITIGYDFGKSRGRWDCKCPAIN
>IFAGANLK_02373 Glutamate racemase
MSTSQPIGIFDSGIGGTSIWREIHELLPNEKTIYLADSKNAPYGEKPIEEIKNLSRKNTE
KLLDMGAKIIVVACNTATTNAIKELRNEYAIPFIGIEPAIKPAALNTKTKTIGILATRGT
LTSTLFSKTSDFYARNINVVEVEGRGLVELIEAGDLNSAQMKSHLLRLLEPFLVNKKDYL
VLGCSHYPYLIPILKELLPKDVIIIDSGEAVARQTKSILSDNNLLMTKEPSQKPIPEFFS
NTDPKVLESLIEAEKNGYKVSYLDF
>IFAGANLK_02374 hypothetical protein
MKQFRTLFIALALTIGATAFTNAQSKVAHVATQELVETMPAYKDAMSQLEKLEKTYDAEI
KDMLTEAQNTMQRYQSEAETVTEEENAKRASELQATERRIQEHSQRARQELQKKENDLIR
PVIERAREAIQKVAREQGFDYVLDSTTGTGVILADGKDLMADVKAELGM
>IFAGANLK_02375 hypothetical protein
MLKRTFLFTLFILIGFGASAQKPINIGFVDMEYILENVPEYQQASSQLDQRVNEWRNEIE
QKRKEISEMKTSLQNERALLTPELIEEREEEIAYQQEQATNYEQKRFGPKGDYMIQKRQL
IKPIQDQVFNALQEIGENRDFDFIFDRNAESGMLFAKKRFDLSDQVLRSINRASNRKQIE
TKQEEKELEMAEARTAEEDEELSQREQAIQDRKSEREALIEERKRKQDSIKEARQKAFEE
RRERILKERQQKRDSIEAARNRKDTIN
>IFAGANLK_02376 Outer membrane protein assembly factor BamA
MTKKVFSLFAVACSLIFSISSQAQGLPLADGKKYIIGDIKVTGTVSFNEQTVIAYTGLKK
GEEIFIPGDKISSVINKLWDIDQFSDINFYITNVSDGNVADLEIEIQEVPKLNKVQVTGL
KKREKEEIIKENKLRTGAKVSENLITTTKNYIESKYRKEGYFNANAKISTSEVTDTTANT
NLVNMLININQGDRVKIADINFSGNEKFSDAKLKRAMKNTKQKNFIRFWKRSKFVRADYQ
EDKENLIDKYKESGYRDARIVTDSLVEIDDETIALNLKVEEGDQYYIGNIDYLGNSVYTD
AQLQRALGINKGDVYNGVLLDERIADETKPDGEDLSNLYKNNGYLFSTINLVETNVYNDT
IDFEIRIVEGKEAYFNNISVTGNDRTKDHVIYRELRTKPGQKYSQEDVVNTVRELGQLGF
FDAEQLEPKFVDPDPQAGTLDLEYSVVEAGASQIELQGGYGGGGFIGTLGLSFNNFSLSG
IFDKEAYKPVPMGDGQTLSLRAQASTFYQTYSLSFQEPWLGGKKPVSLQTSFSYTRQFLF
DYINREADRSRSFDILGINVGLAKRLTVPDPYMTVSHSVGFQRYNLNNYNTGLFTFGDGH
SNNFTYTFGLTRDNTYVNPIFPMGGSKFKLTAKFTPPYSLWNGVDYANLADQREFQLEDD
NGNLIDQQGNRVTPENAVGDQRLIDQKKFNWLEFYKVKFSGEWFTQIYDKLVLRTNAEYG
FLGAYNSDRGVPPFERFFLGGDGLGAFSLDGRETVQLRGYPNQSVVPLDRPAGVNDDGAT
IYNKYSLELRYPITLKPSASIYALTFLEAGASYDNFRDFNPFQVNRSAGAGLRIFMPAFG
LLGIDFGYGFDPIGGQPGPNGWETHFIIGQQF
>IFAGANLK_02377 Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)
MDYKEKIDLKKLPKHIAIIMDGNGRWARQKGFLRAAGHEEGTTAVRDVVEASAEIGIEYL
TLYAFSTENWKRPKLEVDTLMRLLVSSLRKEIKTLQDNNIRLNAIGNLHTLPKKVFRELH
EVIEKTKTNDRMVLNLALSYGSREELSSAIREISLKVKNNEISADAIDESVINQHLYTRN
FPEVDLLIRTSGEQRISNFLLWQIAYAELYFTKILWPDFRKENLFEAIYNYQNRERRFGK
TSEQLS
>IFAGANLK_02378 hypothetical protein
MRYLLVFVIMLVFAPKTNSQTFEVGPYIGGANYIGDVGRTNFVLPSGLVGGALLKWNRSP
RHAFRFSLLYAEISADDANSNDPRRLNRGYSFNNTIAEASLGIEYNFWSFDLHEGHPQST
PYLYTGITYFRADHVLLDADFPNGQLENQGANWDFAIPVVFGYKESITTHIVGALELGVR
YTFTDNIDGSWPEEVVGTRMPKREFGNRNTNDWYVFTGVNFTFSWGREPCYSRF
>IFAGANLK_02379 NAD kinase
MKVGIYGQFYHTNAGIYIGQLLELLKRENIKVVIEENFLDLIHLNKTIDEKYSHFTTFEE
LDNSFDLFFCIGGDGTILKSINYIRNLDIPIVGINTGRLGFLATIQKEEIKECLQSILEK
KFSISRRTVLNIKTNPTSHDPVFRNIALNEVAVSRKNTTSMITVDTWLNDQYLNSYWADG
LIVSTPTGSTGYSLSCGGPVITPDAGSLIITPIAPHNLNARPLVIKDDTKITLRVSGREE
SHLVSMDSRIATLENDTEIIIEKAPYAINLVELKGDSFLHTLRKKLMWGEDKRN
>IFAGANLK_02380 hypothetical protein
MHMEDFIINDVSIRHFSDKIGEVQDLFNQLTYSHLPVENNGIYMGCISENDIRCFEAEKS
LEDYQYALEGFFVRNTDFWLDILERFAQNNTNILPVLDEESTYLGYVELNEIIALFNETP
FLSEAGNIIVIQKGIKDYSFSEITQITESNNANILGIFISKIEHDVAQITVKLSPSGINE
IIQSFRRYGYKIVSEHREDNFNKNLRDRSKYLDKYMNI
>IFAGANLK_02381 Pyridoxine 5'-phosphate synthase
MTKLSVNINKIATLRNARGGNIPNVVEAAKKIESFGGQGITVHPRPDERHITYQDVRDLS
SNVKTEFNIEGNPVAKFINLVLEAKPAQVTLVPDAEDAITSNAGWNTIKNKEFLQEVIQE
FKNNGIRTSIFVDPDEKMMDGAAETGTDRIELYTEAFAVKYAEGDKTGVEPYKRCATMAH
QLGLGVNAGHDLSLDNIKYFKDNVPYLDEVSIGHALIAEALYMGLENTIEKYLELLK
>IFAGANLK_02382 Esterase YbfF
MKLNSIILGEGKPLLILHGFLGMSDNWKTIGNKLAEEKAFQIHLIDQRNHGKSPHTDEHS
YELMAEDIKEYCEQHSLSNIILMGHSMGGKTAMLAAGEYPNLVEKLIVVDIAPKYYEPHH
QQILKGLTALEEADLESRQEADKLLSEFISEKPIRLFLLKNLNRKSEGTYCLKVNLETLK
NNIEEVGKSLPQDKTFKGPTLFIKGGDSNYIKEEDKPAIKKQFPEVKFEEIANAGHWVHA
EKMNDFYKVVADFL
>IFAGANLK_02383 Putative outer membrane protein
MKKLLFLGLFGLMAAVTYAGGYRVSLQGQRSLAMGHTGVAVVNNAELAFFNPAGLVYLED
KINLAAGASAVFSNVKYQNSEFGISSETDSPVGTPFYAYGSYRVNDWLTLGLAAYTPYGS
TVEWPTDWAGSHLVNNIDLQAIYIQALASVKISDKLSVGGGPIYVNGSVNFNRNLNRTLT
DVDGNRSNVTVDASGVSAFGWSASAMYNATEDLRFGINYRSEIMVEAEGGDATFRNVPNS
PLTPFQNTEFDAALPMPAELSVGLSYQLLDKWLFAFDYNMTYWDVYESLDIDFANATPDS
NNPRNYKNSSSYRFGLQYFANETVTLRVGYYFDESPVQSGYFAPETPRNDAHGFTGGLSL
HVSNRFSIDAAFLYNRYEEIDESYNYYTENGETVPFEGTYKTSAFIPGLGVTYKL
>IFAGANLK_02384 hypothetical protein
MKQYFKYIAILALGIVSCEPEFDNPVDEAGAYSNGEADFSRYVALGNSLTAGYADNALYI
TGQENSYPNILAQQFDKTQDIEEFTIPFMSDNAGGLLAGGNQITNNRLVLSVVDGDTLPR
VYTGMQPTTEVGNVQQGPFSNMGVPGAKSYHLGAQGYGNIQGVAVGTANPYFARFASEPN
ASVMEDALAQDPTFFSLWIGNNDVLGYARSGGTGEYQLNNLEPSTYGENDITDPNVFASV
YSEMVQALAANASGGVLINIPDVASVPFFTRVPVNAIPLDAQTAGALNQQFSAYNTQVLP
GLVQAGFITAEEAQNRQINFAEGQNYVTLQDESLTDISQAIQGAPFNLDPQTAGLLSQLR
QATPTDLIPLTSSGFLGTPVGDNPNMINGVSVPLGDEHVLTNAEQELIRDATDRYNQVIS
GLAQANGLAFVDANAMLNTLATDGISYDGGFVTSEFVTGGAFSLDGIHLTPRGNAIVSNR
IIDAINDTYNADVPEVNVGSYGTVTYSNEVQ
>IFAGANLK_02385 hypothetical protein
MNFILRILLTAVAVVILAKFLPGVEVEGYLTAVIVAIVLAILNLLVKPILVIFTLPVTIL
TLGLFLLVINAIIILLADAFVSGFGVSGFFIALLFSLLLSLFQSLLFSLLGKD
>IFAGANLK_02386 Trigger factor
MNITRENIDELNAVVKVDIAKEDYAGKVDKILKDYRKNANIPGFRKGHVPMGMVKKQYGQ
AVLVDEVNKLLQDSLNKYLTEEKLDVLGNPIPKEQENFDWNKEEYSFEFELGLAPEFDVK
LDLERPVTHYNIVADEKMVNNQIESMRKQYGKLTTKDEAEEGDIVAGIFKNEEEGIEKET
SIELDKIKGKRNLNKFVGAKVGDVVTLKTKSLFEDDHDLIQHLGIEHDKAHDLDIEVEFT
VKEINHRELAELNQELFDKLFGEGKVTSEDELKEKIKEDAAKQFKQQSDQQLMNDVTKQL
IEQTNFELPKEFLQKWIQTVGEKPMTEEEAKEEYEKSEEGLRYQLIEGKIVNENNLTVEF
EDLKSFAKEKIKEQMAQFGQMNPGDEELDDIAARILSNQDEVKRLSEQLMNEKLLDFYKE
KMSFEEKEVTYDEFVKEIYE
>IFAGANLK_02387 ATP-dependent Clp protease proteolytic subunit
MDYGKEFEKYATKHHGINSNYYQKIVSSVTPTGMTPNIIEERQMNAVAMDVFSRLMMDRI
IFMGTAINDQVANIIQAQMLFLESTDASKDIQIYINSPGGSVYAGLGIYDTMQFIKPDVA
TICTGMAASMGAVLLCAGEKGKRSGLPHSRVMIHQPLGGAQGQASDIEITAREILTLKKE
LYDIIAKHSGQSYEKIEEDSDRDYWMKAEKAKEYGMIDEILTREG
>IFAGANLK_02388 ATP-dependent Clp protease ATP-binding subunit ClpX
MAKEELECSFCGRKKPETNLLIAGLDAHICDKCIEQAHGIVMEELKQGEAKELSSDLMLS
KPKVIKEFLDQYVIGQEATKKVMSVAVYNHYKRLLQPASDDDVEIQKSNIIMVGETGTGK
TLIAKTIAKMLNVPLAIVDATVLTEAGYVGEDVEGILTRLLQAADYNVEKAQRGIVFIDE
IDKIARKSDNPSITRDVSGEGVQQALLKLLEGTTVNVPPKGGRKHPDQKFVEVDTENILF
IAGGAFDGIERNISKRLNMQAVGFSASKSDDTIERTNLLKYIIPKDLKDFGLIPEIIGRL
PALTYMNPLDKSTLRSILTEPKNAIVKQYQKLFEMDDIEFEMTEDALDYIVEKAVEYKLG
ARGLRSLCEAILTDAMFEMPESGHSKLKVSREYAEDKLNKSTINKLKAVS
>IFAGANLK_02389 hypothetical protein
MQVIKKQSGAAFKLKKGQKLKVIDPEGEQVSDMVLFNAKDRREKLSSGKTLDFEESILIS
TGNFLWSNRSNKMMELLEDTNGRNDFLLAPCSPETFEVMYDYEGYHPSCFENLYTNLEKF
EIEPDDIPTAFNIFMNVQFDEKGKLSVDPPLSKAGDYVLFEAKIDLIVALTACAAEDSNN
GSFKPIHYEILD
>IFAGANLK_02390 Protease synthase and sporulation protein PAI 2
MEMPFSSRKEITMYQPKKYKKDDAEFIFKFIQQHPFANFIINGDRLLATHIPVLTHGTAK
DFILFAHIANHNEQFKHLEDGKEALLIFQGAHGYVSSSWYKEKDISTWDYSAVHVNVKLK
IQSREELEESLQELVATFEKPQKNPLYYKDLPKEMRENHLPHITGFWCEVENIQAIAKLH
QGFDKDDIESVTSHLEKRQNNLSSTLSENIKREHKCK
>IFAGANLK_02391 hypothetical protein
MISTREKSKVKQIKASTDQAIELAFNDFVLTQDHPCIMAQTVFNQEHIDLHTYDEFPSRK
TAKLIYKDLEKYIENYDFESNEFHTFMAVFKDQESFSETQFETALWKQLEFLHDVDNKDW
DPTVSNNPKDDNFSFSIAGKAFYMVGLHPNSSRKARQSPYPAMAFNLHWQFEKLREMGAY
YTVRDKIRERDTELQGNINPMLEDFGNKSEARQYSGRKVGDEWKCPFHHGKK
>IFAGANLK_02392 Sugar transporter SemiSWEET
MTLEWTDILGLAAGICTTVAVIPQIKKAWKTKKVEDVSPGMFSILILGVFLWVIYGITQK
DLPIIATNGVSLGLNSVMLYLMIRYRKKE
>IFAGANLK_02393 hypothetical protein
MEKWFEASWTSVLAIFLTATGIYLAIIIFTRIAGKRSFSKMSSFDFAMTVAVGSILATTI
LSASVSLLHGIAGLAAVYILQISAAILRRFSWFQEAIDNSPLLLMDGNTILHNNLKKARV
TEGDLRSKLREANVLNLLQVRAVVFETTGDISVLHSSDENEALEDWLTKDVLK
>IFAGANLK_02394 General stress protein 39
MNEPEKFPDQQQEQPGKEYKMNPEPEIIRKNYKGSGKLEGKNALITGGDSGIGRSVAVHF
AREGANIAIIYLEENEDARETKKLVEKEGKKCLIIEGDLKKEDFCKKALQKSSKELGKLN
ILVNNAAIQFPKESIDDISTEQIHQTFETNIYPYFYIVKEALQQLQEGDVVINTTSVTAY
RGSEHLLDYSSTKGAIVSFTRSLSKMLADKKIRVNGVAPGPIWTPLIPATFDDVTEFGQD
TPMGRAGQPSEVAPAYVFLASEDSSYITGQIIHVNGGEIIGG
>IFAGANLK_02395 Glycerophosphodiester phosphodiesterase
MLIEYLCQMNLLKIGHRGAKGHLAENTLESIQKALDFGVDAIEIDVHRCKTGELVVIHDF
TLDRTTNGSGEIAKKSLDELKSFKVEDKFEIPLLIEVLDLIEGKYTINVELKGLNTAAAT
SEIIKQYISERNWKYEDFIVSSFQKNELFQMRKLDKNVPLGILSKASVTEAIELGKLLNA
SAIHPSLGIITRDNVKASHEAGFKVNVWTVNEPDDIARIRDFGVDGIISDFPDRLF
>IFAGANLK_02396 hypothetical protein
MQHFDIIIIGGGAAGFFTAINAAELNPKLKIAILERGKEVLTKVKVSGGGRCNVTHAEFL
PKELSTNYPRGEKELLGPFHSFMTVETMQWFEERGIELKIEEDGRIFPVSDDSQSIIDCF
LLETERLNIQVLKSHAVQNFQQEEGLWQIKTSKGDISAKKMMLATGSNPKMWNLLKNLGH
RIIEPVPSLFTFNIKDERIKDLAGIATEAEVKINSKKVNLESKGPLLITHWGMSGPGILK
LSAWGARDLEKLNYQFEIKVDWLPGKTSEEILSQLKDLKTKFAKQQVLKNAQFDLPKRLW
RNLIVAAGITDGTTWADLNKNQLQNLSSQLTEGIFKVDRKSTFKEEFVTAGGVDLKEVNF
KTFESKFHKNLFLAGEILNIDAITGGFNFQNAWTGGFLAAKAMSED
>IFAGANLK_02397 Tryptophan-rich protein TspO
MTKKLFFRSSVAIGICLLFGFMGSIATQTGFDGWYPELNKPWFDPPDSMFGPILFLMYVL
MGIAAGIVWSKGFYHKWVKTALYHFGFQLLLTGSWSLLFFGLQKPLLALLNIIALFILLL
FTIKWFKVVNNIAAYLLIPYAIWVLFAIALNFEIWRLN
>IFAGANLK_02398 hypothetical protein
MPEKDFISKQFSNNIEKGEVTWQSPSNIALVKYWGKREGQIPANPSVSFTLNNCKTTTKL
EFEKKVEKSVFFDFELYFEGEKKEDFKPKIQQFFERIEIYCPFLKDYHFKIYTENSFPHS
SGIASSASGMSALALCMMSLEKELGAIQTNNEEYFFKKASFLARLGSGSACRSLQGELIE
WGEHKNIPGSSDLFGIKYPFEINEVFKTFQDTILLVDKGQKQVSSSLGHNLMHGHPFAEN
RFAQAHSNLDKLKKVFASGNLDQFIAIVESEALTLHAMMMSSNPYFILMKPNTLEIINKI
WEFREATKTPVCFTLDAGANVHILYPEANKAKVLEFIKNELVVYCEKGQYICDVVGKGAE
KVVPQQ
>IFAGANLK_02399 hypothetical protein
MAKQVDFKKFELLDWLKDLEDENVLNEIRLLRTGTRNSTLTRNGRMVLTVEEVKALSKKR
KSEWWGKKK
>IFAGANLK_02400 hypothetical protein
MVGEEKIIISRVIVYLDKLVQTVYLKDYFSFLESELCWGYL
>IFAGANLK_02401 hypothetical protein
MKGPLFYSKILLFGEYGIIKDSKGLSIPYNFYNGALKVDEDPSEAAIASNKSLRRFADYL
SELEQNNPELVQFDMAALNSDIKKGMYFDSTIPQGYGVGSSGALVAAIYDKYATGKITVL
ENLTRDKLLKLKKIFGEMESFFHGKSSGLDPLNSYLSIPILINSKDNIEPAGIPSQTENG
QGAVFLLDSGSTGETGPMVGIFMENMKQEGFRQMLKDQFVKHTDACVDDFLKGDVKSLFT
NVKRLSHVVLDNFKPMIPAQFHKLWKHGIDTNDYYLKLCGSGGGGYILGFTEDIEKAKKA
LKDYKLEVVYNF
>IFAGANLK_02402 hypothetical protein
MASTSNKRLLLKMLSLFSVVRGYNILVLIVAQYLTSAFILAPELPLREILFDDNLFFLIL
SSATVIASGYIINNFYDSEKDLINRPKKTMLDRFVSQRTKLSVYFILNLLAIFFASYVSF
RAVVFFSIYIFAIWLYSHRLKRILFLGNLVASILTITPFFVVFVYYKNFETVIFIHATFL
YLMIVMRELVKDLENMKGDLIQNYQTIPVVYGERLSKLFLSVLCILAIVPILLLITRYDT
GYMNYYFYVSLLLLVFFLLFLYFSKAKWQYLLLHNILKLIIVVGVFSILLIDIQEVFNRV
F
>IFAGANLK_02403 Guanine deaminase
MEKDHNYFLKRAIQLAEEGIDKGQGGPFGAVIVKDGEIIAEANNKVTASNDPTAHAEVVA
IRKACEKLQDFQLENCILYTSCEPCPMCLGAIYWARPKMVYYALTREDAAKIGFDDQFIY
DEIALKMDDRRIPFENLMRAEGLPVFQKWEAKGDRVDY
>IFAGANLK_02404 Ribosomal large subunit pseudouridine synthase B
MSRNDKSKGGKVSGRQGGGSSKKSMARGNAPIKKQQSAPKTPSKTDGIRLNKYIANAGIC
SRRDADIFISAGNVTVNGNVVTEMGFKVAPTDEVKFDGRSVNPDKPEYFVLNKPKGVYVT
GSTEKGGKTVMDIMAKATKAKLDPVGKLDTQAMGLLVFTNDGTLAKRLGKPRNGIRQIYQ
VNLTKPLSVEHLEKIRNGVILEDGKVNIQDISYIAERPKNEVGIETNSTKNHIIQRLFKS
QGYEVEKLDRVVFGGLTKKDLPRGRFRRLTDQEVINLGML
>IFAGANLK_02405 Biosynthetic arginine decarboxylase
MNTKYSDLIDQTYYFPQEEFTLKGTELKFHDIDLMELVKQYGTPLKFTYLPKISDNIGRA
KKWFADAMAKHDYKGSYNYCYCTKSSHFQHVLNEALKNDIHIETSSAFDINIVEQLKKSG
KITDDTYVLCNGFKRDQYVENISRLLNNGHKNCIPIIDNYEEIDLLTGKIEGKFPIGIRI
ASEEEPKFEFYTSRLGIGYKNIVPFYNKQIKENDQVSLKMLHFFINTGIRDTAYYWNELQ
KCLRVYINLKKVCPELDSLNIGGGFPVKNSLHFEYDYAYMVDEIINQITLYCEEAEVDVP
NIFTEFGSFTVGESGGAIYEILYQKQQNDREKWNMINSSFITTLPDTWAISKKFVMLPVN
RWNDEYERVLLGGLTCDSDDYYNSEQNVNAIYLPKYKKEKPLYIGFFNTGAYQETIGGHG
GLHHCLIPQPKHILIDKDAAGNIETSLFSPEQNADDMLKILGYKENN
>IFAGANLK_02406 N(1)-aminopropylagmatine ureohydrolase
MNKKNYAGISDKYSRIDEAKVVLIPVPYDGTSSWQKGADKGPEAFLEASENMELYDIETK
SEVYKKGIYLAPPVTEDSSPEKMVDTVYKTVKNYIKQEKFVTIFGGEHSVSIGTIRAFNE
SFEDLTIVQLDAHADLRPEYEGSSCNHACAVHEASKKANLVQVGIRSMDVSEVEHMDENR
VYFAHDLYEDWQEDAIGQMTPNVFITIDLDAFDPSILPSTGTPEPGGLFWYETLEFLKMM
FKKKNVVGFDIVELCPNKNEKSSDFLAAKLYYKMLSYKFKYQNYNEEDEDE
>IFAGANLK_02407 Deoxyhypusine synthase-like protein
MSKGAISQFIEKYYLHFNSAALVDAAKDYEKQLEGGSKMLVSLAGAMSTAEIGKIFAEMI
RKDKVHIVSCTGANLEEDVMNLVAHSHYKRVPHYRDLTAQDEWDLLEKGLNRVTDTCIPE
EEAFRRIQKHIEKIWKDAEANGERYFPHEFLYKLLLSGVLEEHYEIDLKDSWMYAAAEKN
LPMVVPGWEDSTLGNIFASYVLKGELKASTMKSGIEYMTFLADWYTNNSKEGIGFFQIGG
GIAGDFPICVVPMLYQDMERTDTPFWSYFCQISDSTTSYGSYSGAVPNEKITWGKLDINT
PKHIIESDATIVAPLIFAYLLDM
>IFAGANLK_02408 hypothetical protein
MSSSWIVYAIGFLAQLLFSARLIMQWIKSEKTQKIEIPTLFWKLSLQGAVLLFIYGYLRD
DIAIMLGQFLVYGGYFRNLQLQGEWGKSGIMFKIYVIGLPILIALYIIFLGQLNWEDLIK
GENNSTWLIILGVVGQLIYTTRFVYQWIHAERNHESDLPLKFWIISLVGSILIFAYGIFR
DDPVLIAAHFFGGIVYIRNLFIIRKSAE
>IFAGANLK_02409 Alpha-(1->6)-mannopyranosyltransferase A
MTNHISLKKNVANFLKNHKFSLLLVLTGIAFYWSFGYDLERSDFIKLISLYAGLFFISFK
LIQLEKNNFWLLAAITVLFRLIFIVATPNLSQDFYRFIWDGNLILEGLNPYLSVPNEFST
NAGLKDALNQGMGSLSAGNFTSYPPVNQLLFAFSVLLGGKSILGSVVVMRLLISLADLGI
LYFGRKLLLTLDLPTYQIFWFILNPFIIIEFTGNLHFEGVMLFFLIWSIYLLHKKKWIWS
AILLGVSVSVKLLPLLFLPLLWNYFLKKRSFKNLPKNALIKNKIRQARELNFQKLLIYYL
IVGITVLISFLPFISSELIYNFSASIALWFQKFEFNASVYYVIRWIGFQLKGYNIIETAG
KILPFIVILILAGLAFFRKNDSTEKLLTTMLLGISAYFFLATTVHPWYIGTPLLLSVFTK
FRFALVWSLLVILSYSAYANTEFQENFWLITIEYVVVIGVFILEFFQPKLLRRLPYYK
>IFAGANLK_02410 Beta-monoglucosyldiacylglycerol synthase
MDLTIIIIYTLALLLIFFYSISQLQLLVNYLKAKKEIDSSEKFDLENPAEIPFVTIQLPL
YNELYVVERLLKNIAKINYPREKLEIQVLDDSTDKSVEKIKTLVVELQKDGLDILHITRK
DRSGYKAGALKEGLKIAKGEFIAIFDSDFLPQEDWLLQTVPYFKNSEIGMVQTRWGHINR
DYSLLTKIQAFALDFHFILEQTGRNFGGHFINFNGTAGLWRKECILDAGNWSGDTLTEDL
DLSYRAQLKKWKFKYIEDVETPAELPVAISAARSQQFRWNKGAAENFRKNFKKLLKDKSV
PFSTKFHAFFHLLNSSMFLVILVLAVLSIPVLFIKNNNPQFGWYFNLVAFFLLSTVIFFL
CYYVAYAKIHGNSFKSFLTFIGMFFTFFSVAMGFSVHNSLAVLEGHFGKKSAFIRTPKFN
VNSLRDSWKNNIYIQQKFSLSIAVEFALWLYFGFGLYSAFMLNDFSLAIFHLMLFIGFGF
VVFRSVRI
>IFAGANLK_02411 putative glycosyltransferase
MSPKIRVIIPAYNEEESIAKVITEIPEIVQEIIVVSNNSTDATEENAKNAGATVLQEPRK
GYGYACLKGMDYISYQSTKTDIIVFLDGDYSDFPSELTKIVAPIIEKDKELVIGSRVKKW
REKGSMTFPQIFGNWLATSLMKLFFNARFTDLGPFRAIKYNKLLELEMQDKTYGWTVEMQ
LKALKKGFSYTEVPVHYKNRIGTSKVSGTVKGAIFAGIKILGWIFKYSFK
>IFAGANLK_02412 Putative electron transport protein YccM
MSKLEHNMSLTAEAPAKLSKTQRLASGIGLVGLFILVLAIANVNFPNKVLFLSISLGLIT
LGTIIFANDLYLGKHEGIKNDGVWFKSLTGRGFWAWVLGISLTLFYVVLYWFPQYLGLNE
NAANTGIIALFDPLSRLISGNPASQWFVYGTLYTVAILIFGYKFILKYRHNRYEIIRTFS
VMFFQLGFAFLLPEILIRLNQPYYNPANIWPLNYDLFTDYKINEFLSAGNIGVLMLAFGL
ISVFVITPILTYKYGKRWYCSWVCGCGGLAETAGDPYRHLSNKSQYAWKIERWVIHSVLV
FVTVMSIAVLYSFLGENSEEFWLTRDMFLGGSAGFLTLLFAVIMIFKRKELAKDAKYGAI
GYLVVILAIIGINYFSGNGNIFFFAGYQLREWYGFLIGAVFSGVIGVGFYPIFGSRVWCR
YGCPMAAILGMQQRLFSKFRITTNGGQCISCGNCSTYCEMGIDVRAYAQKGENIVRSSCV
GCGICSAVCPRGVLKLENDDLDGRINSEEVLLGNDVDLMNLVNQKSK
>IFAGANLK_02413 hypothetical protein
MKYEPIAADSITTYITLAIISNQYSSRKKIIIISSALLKNILIPVANIYAYCLIKIHFQI
LVKTKTYLPDLKIPKAFSNLFNAYAKAINKTHNCSGSLFQDRFKRKIIKNEEYLKTLIPY
IDLNPKNHKIIDNFVNYKHPSYSRIILSENSFLSENEVIELFNDKSNFSYVHSQRQAEIL
KLDKNIFLE
>IFAGANLK_02414 Rhodocoxin reductase
MEHIVIIGNGIAGITCARHIRKNSDAKITVISAESDYFFSRTALMYVYMGHMKWNHLKPY
ENWFWEKNRIELKKAWVDKINFEEKTLHFSSVETMDYDKLVLATGSVYNKFGWEGQDLKG
VQGLISKQDLELLEENTQNCKKAVIIGGGLIGVELAEMLKTRNIEVTFLIREEAFWHNML
PIQDAQLISEHIKSHGVDLRHQTELDKIMSDENGRVKAVTTKSGEEIECQLVGLCTGVRP
SIDFLKNSELETDRGILVDNFLQTSFKDVYAIGDCAQLKQPPAHRKPIEAVWYAGRMMGE
TLAQTLTGNAMKYKPGHWFNSAKFFDIEYQTYGQVSAKPGEKEMHFYWQHKDNTKGITIA
FNRNSNKFLGINTFGIRMRHPVFDRWLTEDRKIDYVLANLKQANFDPEFYTRHEKEVFKS
FKENLQEF
>IFAGANLK_02415 Purine nucleoside phosphorylase 1
MIKDIQETTKYLKDKGFENPEIGIILGTGLGQLLDEIQIKVEVSYNHIPHFPAATVEFHK
GKLIFGELAGKKVMVMQGRFHMYEGYSMQDVTFPVRIMHQLGIKKLLVSNASGSVNLKYK
KGELMLIDDHINLLGDSPLAFKGVSQLGERFVDMSAPYDAEMNILFEEIAKKQEIKLHKG
VYAALLGPQLETRAEYRMLQVLGADAVGMSTVPEIIVANHLKLPVSAISVITDEGDPDNL
KPVNIDEIIAMAAKAEPNMIALFKEVIKAV
>IFAGANLK_02416 2-phospho-L-lactate guanylyltransferase
MSLNSADNLLIIFTRNPEPGKVKTRLAKDVGDKTAFIIYNFLLQHTVSVTENLKVCKEIY
YSETIAEDDIWNPYIYSKKSQQGKGLGERMKNAFKDGFRNGYKNIIIIGSDLYDLQQHDL
ENAFKILAEKEAVIGPATDGGYYLLGMNKLIPEVFEEKDWGTAFVLEETLKDLKNRDFAL
LEARNDVDYYSDIQDHKDFQQFFNR
>IFAGANLK_02417 Putative mycofactocin radical SAM maturase MftC
MALLKSLSARKNDLSKPENQLAFLSNGIFREGKLPLFKDKIAESGNFPLKPKKLEVLQLN
LGYMCNQVCSHCHVDAGPDRKEIMTKETMQQCLEVIKTTKAHTLDLTGGAPEMNPNFRWF
VEEASKAGIKDFIVRSNLTIILANKKYHDLPEFFKKYNVHVASSLPFYKREKTDKQRGSG
VFDKSIKALQMLNEVGYAQQGSGLKLDLVYNPAGAFLPAKQGELEKDFKEALKEDFNIDF
NNLFAITNLPISRFLEYLIASENYQDYMYALVDAYNPAAVESVMCTNTISVSWDGWLYDC
DFNQMLELKVKSKVQHISEYNEDLLNDREIRISQHCYGCTAGAGSSCQGTVA
>IFAGANLK_02418 Alkyl hydroperoxide reductase AhpD
MSKTYYNPDDLRKFGEITEWSEELGNKFFDYYGKVFEEGALSAREKSLIALAVSHVVKCP
YCIDAYTKDGLQRGITKEEMMEAVHAGAAIESGATLVHGVQMMNKYDKLSI
>IFAGANLK_02419 Regulatory protein PchR
MRINVKTLPVDEIIQDISENLNAPVQNGSGEYTIELPKEVGEGFIRGISFDSGMGFISYN
CKFYEDVEIHFALNTVHPLKFIFCSAGSIGHSFQDSEKINEIKAYQNIIVSSSGYNGHVL
FFKANEATHISSLEIIRSVFAHRRNYDFQDLEPTLKELFQDAVAERQFFYQGNYSIKAAD
IMNEINTKEFSGFLRLLYLEAKTFQMLVIQIAQYEDDEDGDKLPQILRQSDIEKVDYVVK
RIQGDLGSNLTVESLAKEAGTNVNKLQEGFKYVYDLTVNKYMQHKKLEAAKEMLMTSEKN
ISEIVTAIGLNNRSYFSKIFKEKYGVNPKYFLKTRKKEVD
>IFAGANLK_02420 hypothetical protein
MNTQKISVWRLPKILRPNFHESLIMEISGSGVYFYKKIYNSNVFSKVGNRH
>IFAGANLK_02421 TonB-dependent receptor SusC
MGKKLLFLLGLMFFSFNQNLIAQEQTVTGTVTDSENGMPLPGVTVLEKGTSNGTSTDFDG
NYSLEVPEDATLVFSMVGFMSQEIPVSGQNLINLELSPDTEALDEVVVTSLGLTREKKSL
GYAVTELDSEEVNTVKDYNVASSLVGKVAGLVVNQASGVGSGSRITIRGNNTLTGNNQAL
IVVDGIPIDASGNESGGSIYNSTVTGGGITDINPSDIESISVLKGPNAAALYGSRAASGV
ILITTKKGTRGAGLGISLNSNISVEETMFLPDFQNEYGQGTNGAVYADLENFGSNSWGPR
LDGSQQLYYTGEERAYNAQPENVENFFENGIKSINTIAMDQGGENHSVRFSYTNNQTTSV
IPNSELHSHNLNLRGVIDLADKLTLDSKATYFTQELENRVNVGTEGVLAYVYSMPRNVAI
DDLKRYKPSLWSNPDMFPDEYGAISYAGQNKSIGNPYWMLNQDTNDERRDRFLGFSKLNY
EFNDWLSAFIRIGGDVTNVRTESIQDFGHHFFYDGRLNFANRKNVEINSDFLITANKDLT
ETLNLVANVGGSLSKRTFEGMSVSGNQFRLPSRAFLNNTNVQTSTHTPLGVKKINSLYGS
FSFSYDDFMYLDLTARNDWSSTLSEDNRSFFYPSVSYSLLVNRFIDPDRNFLDMLKLRAS
WAEVGNDTDVYQLYQTFSVPQQGYLGLTVLEGPSVKLNPDLRPESVKSTEFGVEFNMFKN
RFYGDFSIYEIVTNDMIFNVPVPFATGFSFFKENVGEVKNNGFEIMLGGVPIQNENFRWD
ISANMSRNKNELVELIDGLDYTVLNSLGDLSVRAEVGGGIGDIYGTTWKTDDNGERVVNA
EGFPVASNEREKLGNAQPDFIGGLTNTFTYKNWNLRFLVDGRFGGEIYSATSSYLDAAGV
SERSLEFRDDGITIDAINEGTGEQNDIQISGQQYWSNYSDITSNYVYDQTNVRLREFALT
YRLPGESIDNIGLTSASVGLIGRNLFFIYRAAEDIDPDASIGTGLSGQGISLNNAPTIRS
LGLNINIKF
>IFAGANLK_02422 hypothetical protein
MKGILKTISATLLLVFVLAGCSDFEEINTKPDAFGSDEVSAKYFLTGIQIELYAPNRFPY
WRAQLIHADRYAGQFTFGFNGAWWTGALGYDYDSAYTDAAYDWIAGYVSNLSVYQNFVKE
GGDLENQNFYAIGLVMKGLYYQMYTDTFGMVPYSEALDPDIITPKLDSQSEIYRGVIGDL
DEAMDIIGDQTVTGDGIELLAENDLFFNGDLQQWKKLANTLKLRMALRAQGAPGADFAET
AISEAFQAPLLTSEMDNALMEKDTEIDQFGNAAYGDVWHNFAGIGSHWNVSKTLIDYLRE
NNDPRLSRYAKPIIGGEFTFTRPAEGSGASLFDKHVDFVLDELDNAEVPYTRNGSGDEFT
ISVPQDQNYYVGQPSRLNPEIYPHVKNDLFSEPADWIINPKNEGLEIFPEIVFTAAEGNF
LQAEAIIKGLGTGDAQELYQEGIRQAMKIWRVEESEIETFISNEEMAQLNGTDEENLEKI
AIQRWIVSYTDGFEAWAVVRDTGYPSELASGVSDFDIYAAGTLNGEYPQRMRYGNQEYNT
NGANVEAAIQEQGPDEQGTELWWAQN
>IFAGANLK_02423 Sodium-dependent dicarboxylate transporter SdcS
MNKLIRTLILIAGPLLFLILQIIGAPQSMPPAAFDIFCITIWMALWWVTEVIPISVTALI
PIVMFPLTGALDIETTTAAFGHKYVFLYLGGFVLAVAIEKWDLHRRIALNIINLIGSKIK
FIILGFMIATAFLSMWISNTATSVMMLPIGTAIISQLKNNPFSNENEPAVFGKALMLAIA
YSASIGGIATLIGTPPNLVFAGIVEELYGIEISFLKWAFLGIPISILLIFICWKYLTVVA
FNFDKAEFPGGKAEITTLLKSLGKISKQEKRVLIIFACTAFFWITRSFLIQPFLPFIDDT
IIAIIAAIALFIVPSGKETKPLLNWEEAVKIPWGIILLFGGGMALAKGFSDTGLAVWIGE
QLTYLQNLPLFLLILILVAAVNFLTEVTSNLATTAMLLPILAPMALAMGLHPYLLLISAT
LAASCAFMLPVATPPNAVVFGSGYLKIPDMIKTGLWMNLVSILLISVLVYFFLPVIWDFK
VNEIPQIFR
>IFAGANLK_02424 hypothetical protein
MKTLEIKTALQIAKPKTEIYQAIIDTEHMKNYFIAEGLGMMEEGKSISWKFPEFDEYVPV
NVLKLIPNELISFEWEGAKGKNLEVKIILTEMPNNSTLVKITEGKMEVDEMGIQWFGGNT
EGWANFLACLKAYLEYGINLRKGGFDFMKV
>IFAGANLK_02425 60 kDa chaperonin
MAKDIKFDIQARDGIKRGVDALANAVKVTLGPKGRNVVISKSFGAPTVTKDGVTVAKEIE
LEDALENMGAQMVKEVASKTNDLAGDGTTTATVLAQAIVKEGLKNVAAGASPMDLKRGID
KAVIAITKDLEKQTKEVGDSSEKIKQVASISANNDEHIGDLIAQAFGKVGKEGVITVEEA
KGTETHVEVVEGMQFDRGYLSPYFVTNSEKMTADLEDPYILLFDKKISSMKDLLPVLEPV
AQSGKPLLIIAEDVDGEALATLVVNKLRGSLKIAAVKAPGFGDRRKAMLEDIAILTGGTV
ISEERGFSLENATIDMLGTAEKVAIDKDNTTIVNGAGDNKQIEERVNQIKAQIETTTSDY
DKEKLQERLAKLAGGVAVLYVGAASEVEMKEKKDRVDDALHATRAAVEEGIVAGGGVALV
RAQAVLSKIKTENDDEATGVQIVYRAIESPLRTIVENAGGEASVVINKVLEGKKEFGYDA
KTDTFVDMMKAGIIDPKKVTRVALENAASVAGMILTTECALVDLPEDDKGGGMPGGMGGG
MPGMM
>IFAGANLK_02426 10 kDa chaperonin
MGLNIKPLSDRVLIEPEAAETKTASGIYIPETAKEKPQRGKVVAVGKGNKDHDMTVKVGD
TVLYGKYSGTELKLEGTDYLMMREDDILAIV
>IFAGANLK_02427 hypothetical protein
MSTFTIFLALIVIVAFLLVVVIMVQNPKGGGLSSSFGGSGQQVGGVKKTGDFLDKSTWTL
ATLLLVLILLSNVTIMDDSGYGESRVFDEDAMPENTATPPAQMPGQQPESDNDQ
>IFAGANLK_02428 hypothetical protein
MEATEFIQLLQKPAGITAGQTSALEKLIQKAPYFQAARAVRLKGLKEHQEFSYNSALKKT
AAYTTNRSVLFDFITSEEFNQNKIARQIQEQEEQLRNITVFEPEEVFAKRSMAIDEAIKM
RQSESEQVMDPELFSEKSSEAGEQTEENSSEDKLKWGEPLEFDASESHSFSEWLRLTSAK
PITREESEEENPKDDVQHKKFELIDRFISKSPKIKPGKPANKSNLAEVSTTPPESLMTET
LARVYLEQKNYKKAIQAYKILILKNPEKSGFFADQIRAIEKLQENNTKQE
>IFAGANLK_02429 hypothetical protein
MKKSAFLLCFVLILSTQSCGIYSFTGADTGDAESFQVNFFQNQADLVEPGIDRTFTLELQ
DLIQNQTSLSLANNNADLIFEGEIIDFYVAPITSTAENTAAQNRLTIAVNVRYYNTLEPE
KDFERRFSFYYDYPANAQLVGDVLATALDEIYSRLTQDIFNAALTDW
>IFAGANLK_02430 Nif-specific regulatory protein
MESIQAVKQRFGIIGDDQRLNRSIEKAIQVAPTDISVLVTGESGVGKESIPKIIHSLSHR
KHGKYIAVNCGAIPEGTIDSELFGHEKGAFTGATQTRNGYFEVADGGTIFLDEVGELPLP
TQVRLLRVLENGEFIKVGSSKVQKSDVRIIAATNINMQESIKKERFREDLYYRLSTVEIN
LPPLRERKDDIHLLFRKFASDFALKYKMPTIKLQDDAVGLLQKYRWGGNIRQLRNIAEQI
SVLEQERIIGPERLKEYLPDIGSNLPAVIADKKKESDFSNEREILYKVLFDMKSDLTDLK
KLTLKLMESGNSKKVQDENESLIQKLYGDDDGEDVDAEELEALNDERLEVLQIPQNSPKS
EHSREKDKYYFAEEIQEEETLSLQDKELELIKKSLERHSGKRKAAAEELGISERTLYRKI
KQYNL
>IFAGANLK_02431 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MEKTIDEKQQGNTLVMEPQQGNSRKLFIESYGCAMNFSDSEIVASILAKEGFNPTQNLEE
ADLVLVNTCSIRDKAEQTVRKRLQKYNAVKRINPGMKVGVLGCMAERLKEKFLEEEKIVD
LVVGPDAYKDLPNLINEVEAGRDAINVLLSKEETYGDISPVRLQSNGVSAFVSITRGCDN
MCTFCVVPFTRGRERSRDPQSIVEEVNDLWDRGFKEITLLGQNVDSYLWYGGGLKKDFKN
ASEIQKATATDFSALLRLVAKAQPKMRIRFSTSNPQDMTLEVIEVVAAYPNICKHIHLPV
QSGSDRILKEMNRLHTREEYFKLIDYIRELIPECSISQDLIVGFPTETEQDHRDTLSLME
YVKYDFGYMYAYSERPGTMAARKLEDDVPAEVKQRRLAEIVQVQREHNHFRTQGYLGKTV
EVLIEKESKKSSEQWSGRTTQNTVVVFPKESYNIGEFVNVKINDCTSATLIGEAVGYSEN
N
>IFAGANLK_02432 hypothetical protein
MRFFYSLITLLLLALMALFTSCEKDATQEEFYNVAVPVVQPIEEFRAMVKVSEPRAISEA
GKIYSYEDYVFINDDQKGVHVIDNSDHRNPVKIKFLEIPQNTDIAVKDDMLFANSAMDLV
IFDISDMNNIKEEERMKNVFPNHNSRIPASASFVDSDNFNAETEVVIGYVMETRRIEMAS
NTEWLTNDGASFSESGNASGGSGTGGSLARFNIHDDYLYIVDQNQLSVFNIEGLSTPELL
KTEWVGRDIETIFYKENHLYLGSSTGMYIYSVENPATPEYKSMFRHILGCDPVVVKGDIA
YVTIRGGNVCGQEWSQLDVIDVADKSNPQLLQSYPMKNPYGLGVKDDWLFVCDGYAGLKI
YNTENTPNLKLIDHFPEINTYDVIPLEDVLLMVGDNTLFQYTYKGNEINLLSTFSLN
>IFAGANLK_02433 DNA topoisomerase 1
MAKNLVIVESPAKAKTIEKFLGKDYKVASSFGHIADLPTKELGVDTEGNFKPKYIVSKDK
KDVVRKLKGFAKDADMVWLASDEDREGEAIAWHLAEELDLTSEKTKRIVFHEITKSAILK
AIDNPRDINYNLVNAQQARRVLDRLVGYELSPVLWRKVKGGLSAGRVQSVAVRLIVERER
EIQNFTAEASFRIDAEFTTEDGKSFKAKIPKNFDTRKEAEEFLQQNLQSDFKVAELSTKP
AKKSPAPPFTTSTLQQEAARKLYFSVSKTMTMAQRLYEAGHITYMRTDSVNLSEDARKGA
NKEILKAYGDKYAKSRQFKGKTKGAQEAHEAIRPTNFASHSVRADRDEQRLYELIWKRAI
ASQMSEAQLERTNVKIDASKHDKQFTANGEVLKFDGFLKVYLESTDDDEDAEEQNGMLPA
LKENQPLNNKYITATERFTRPPYRYTEASLVKKLEELGIGRPSTYAPTISTIQNRNYIEK
GSVDGTEREYLQFVLKGENIKENKLTENVGSDKGKLVPTAVGMVVNDFLVNHFSNILDYN
FTARVEQSFDDIAEGNEEWTHMMKEFYEDFHPQVEDVAKNADREVGERILGKDPETGKPV
SVRLGKFGPMVQIGSVEDDEKPKFASLGPDQTLDSVTYEEAMDLFQLPKELGEYKDEKVE
VNNGRFGPYVRFGKKYVSLEKGEDPLNVDFDRAMELIKEKEKADAPIHHYEDMPVQKGVG
RFGPFLKWNGIFINVNKKYDFDNLSIEDIETLIEDKKRKEREKLIHNWEEEGIRVEKARW
GRFNIIKGKTKIELPKTTDAENLSLEEVKEILEEKSKKKKKTTKKKAPAKKTTAKKSTAK
KKTATKKKK
>IFAGANLK_02434 Formimidoylglutamase
MDLDFLSPLAEDLLREITGFGEHSLGNSVKKHTASHGLPDLDGVQMAVVGIKENRLGEEI
DFLDFVDVRKAFYSLFPGNWHIKIADLGDIEKGETVEDTYFAIQTLVAQLVKKDVIPVLL
GGSQDLVYAQYRAYDTLDQMVNLVNIDSRFDLGDAENPISNRSYVGKIVVNQPYNLFNYS
NIGYQTYFNSQDEIELMERLFFDAYRLGEVSNNIKLVEPVMRDANMVAIDLASVSAPSSG
SRDIASPNGFDGKEICALSRYAGISDKVSSFGIYEYDNLKFGNLGAMLMAQMLWYFAEGV
NYRTNENTISAKKEFIKYQVPIDDEVLVFFKSPVSGRWWIEIPFLEHVDTKLKRSTLLPC
SEEDYLEACNQVIPERWYKAKRKNEV
>IFAGANLK_02435 Serine/threonine-protein kinase pkn1
MKKFISLIAVLALLSSCGRGDRGQLVGAKGEKWNPEKPLGMTLIPGGSFIMGKSDDDIAG
QRNAPPKTVTVRSFYMDETEITNAEYRQFVNDVKDSIVRTELAIMAENMGEAEGSGGIGD
YAFMDADEGDMTPYEEYMLNTYGQGGPSDTYENRRLNKDIDIIWDTEDYPDVYYAEVMDM
MYIPMEEVYNGQRTIDVEKLKFTYTWMDVQGAAKKQGNRSDYINREEIEVYPDTTVWIRD
FNYSYNEPMHNDYFWHSAFDDYPVVGVTWKQARAFTQWRTLYHNYYRREKGEHNVPSYRL
PTEGEWEYAARGGLEGATYPWGGPYAKNDRGCFMANFKPLRGDYAADQALYTVEAQSYDP
NDYGLYNMAGNVAEWVDSSYDPASYDYMSSMNPTVNNPDDMRKVVRGGSWKDVAYFLQVS
SRDYEYADSARSYIGFRTVQDYLGTDVTLNQPTNN
>IFAGANLK_02436 hypothetical protein
MAKSNSTKRITNMVYGLGASVVILGALFKIMHWPFANPMLIAGLVVEAFVFAYSAFEPTD
DDLDWSLVYPELAGGQGTRRTATVIEEEKETQGQLSKKLDEMLKEAKIDASLMSSLGDSI
RNFEGAAKGIAPTVDAMASQKKYSEELTTAATQMETLNNIYKAQVESASRQAEINQEVAE
NAGKLNQEMGSLAANLSSLNGVYGGMLTAMNGTRSGVPTN
>IFAGANLK_02437 hypothetical protein
MASGKQTPRQKMINLMYLVFIAMMALNMSKEVLTAFGQMNEDLEESNATTSQRNDMAMAG
LAAKAEEQPAKYEELKAKAEQIGTLSDNLYATVGNLKEELLADFEAEDRGNYEAMDRSDK
LDNLFFASGRVTPRGEEFVAAIDNYRNEVLSILGDGFPQIRSEIAKDFSTEEVTNNENVT
KPWLMYNYQGFPLIASLTKLTQIQTDVRKTENDILSSMLEGQLQSDVSLTNYQAIVVPDK
TAFFSGENFKGKVVLGRVDPTLKFENVTINGNEVESTQAGQVMLDFPAGNVGEKEINGEL
QFKEGDSIVRIPINSSYAVIPKPNSAVISADKMNVLYRGVQNPMTISIPGVGSISAQAPG
LSQAGGAGQYVMNVTSLQAREVAINVSGKLPGGETVSDSKTFRIKDIPRPAGTVRGEDGS
VQMQRNSLEVSTIGATLPDFDFNLDLNVTGFSFKVPGQPTIQVNGSRLDDRAKAALRRAG
RGESVQIFDIQAGISGNSGYKLKKVSPVVIELTN
>IFAGANLK_02438 hypothetical protein
MNWRGFLLNALVFSFTIASFGQANILNAKDPEDIGKRTEAQIQSDINDKPLEYGYIEDRD
VLWSKNVWEKIDLDERVNFPLYYPIDTNNIGSNRRALYDVLVSAIKSGEIENIYADSYFN
EKRTLRDIEATLSKVDTTDLGIEQYNAGEQVDEQFIDRRDLSAADIAQYHIRGMWYFDKR
QAELKYRILGIAPVAPDVNFIDSGQTDLVELFWVWFPDAREVLHENKAFTGSSSAQTVTF
DHLLNSRRFDAMIYKEDNVYGDREVDEYIVDNAFMELLEAQRIKEQIRNFELDMWNY
>IFAGANLK_02439 Glycine oxidase
MLDYIIVGLGLSGIAISQRLEERNKKFVVFEDNSQKSSLVAGGLFNPVILKRFTLAWNAN
KQVEIALPFYREMETKLQAKIVYPLEIYRKFFSAEEQNNWFEAADKPILAEYLDTKLVKE
INPNISSEFSFGRVRQTGVIDTDVLIKEYRNYLKNKDEIQFKSFGYNALQINNDSVSYNG
ISARQIIFCEGFGMLHNPFFNYLPLRGNKGEYITIYSEELRLKEIVKSSVFIIPLGNDLY
KVGATYNSRELDPQPSETAREDLENKIKKLVTCKFEIVDQSAGIRPASKDRKPMLGRHPE
YKNLYCCNGFGSRGVLISPMVSEQLINFIENDIQLPQEIDLQRFNKKHYEA
>IFAGANLK_02440 hypothetical protein
MEFLKGTKLYSILTGTCPVCHEESMYVESNPYKLGRIFEMHEHCSNCGTKYKIEPSFFFG
AMYVSYAVGIAFSVAAFVIAYFFFGGGLMTSFWAIIGTLVVFMPIIIRLSRNIWINLFLN
YKPSAGKR
>IFAGANLK_02441 putative ABC transporter ATP-binding protein YheS
MLNIHNLSVSFGGEYLFEEITFRLGAGDRVGLIGKNGAGKSTMLKILAGEQEYDGGQIAR
DKELNIGFLKQDIDFEQGRSVLEEAQQAFVEIKKLEKQIDEINHQLATRTDYESESYTQL
IQDLSEITHTYEIIGGYNYEGDTEKVLLGLGFQREQFDKLTETFSGGWRMRIELAKLLLQ
NNDILLLDEPTNHLDIESIIWLENFLNNYSGCVIIVSHDKMFLDNVTNRTIEISLGQIYD
FNKPYSKYLVLREELREQQLAAQKNQQREIEQTEKLIDKFRAKASKASMAQSLIKKLDKI
DRIEVDEDDNAVMNVSFPISVQPGKVVIEAEGIGKAYGNNQVLKNIDLLIERGSKIAFVG
QNGQGKTTLAKIIIDEIPYEGNLKLGHNVQLGYFAQNQADYLDGEKTVLDIMIDSANEKN
RSKVRDMLGSFLFRGDEVSKKVKVLSGGERNRLALCKLMLQPFNVLIMDEPTNHLDIKSK
NVLKEALNRFEGTLIIVSHDRDFLQGLSNKVYEFKDTKIKEYLGDINYFLEQRKLEDMRS
VEKRDKAAKVQKDAAGSNNKKAYKDQKKVKSLKNRLSNTESKITKLEKDLEARDMELATN
YDEVAAKPGYLDKYKTKKKELNSLMKEWEEIQESLDGLA
>IFAGANLK_02442 Efflux pump periplasmic linker BepD
MDKRKIILSILGVLLIVLAVFGAKAIIDSNVKEVPETTKVVKNVFVETVENRRVPIIVPA
NGNVTALKKMELFSEVEGIFQYSSKNFRPGQHYNKGQVLLSINSEEYSASVRSAKSELFN
NITSIMPDLRMDYPDSFQKWQDYLNNFDVNSPAKPLPEPDSDKEKYFITGRGIQSAYYEI
KNLEERLRKFNIVAPFNGVLTEAAVNPGTLIRPGQKLGEFIDPSVYELEVAVGKKFSDLL
QIGEDVALQDLDGNQTYTGTVSRINARVDRASQTIQVFIRIEDSEIREGMYLEAKLDARD
EENAIEIARELLVDRSKVYVVKDSVLVLEEINPVYSSSNKVVIKGLKDGDKLVSAPVPGA
HPGMKVQIQKQEDTAKAEEF
>IFAGANLK_02443 Multidrug resistance protein MdtB
MRKLISYFIKYEVAVNVVILAFVIFGLVGVFSLNSSFFPLEESRIININVNYPGSAPEEI
EEGIILKIEDNLKGLVGIERVTSTARESGGSITVEIEQDEDIDVMLTEVKNAVDRVPTFP
GGMEPLVVSKEERVRPSISFAISGDDVPLVTLKRISEQIENDLRQLDGISQIEISGFPEE
EIEIAVSQDDLLAYNLTFEEVARTVGAANILSTGGTIKTEAEDYLIRANSRSYYADALND
LVIRSTATGQTTRLSDVAEVRDQFGETSNSSYFNGNIAVNVAISNTNNEDLLSAAKKVKE
YVKDYNAKSSNIRLDVVSDSSITLGQRTQLLLENGAMGIFLVLLFLSIFLNTRLAFWVAF
GLPIAFLGMFMFAGQFGVTINVLSLFGMIIVIGILVDDGIVIGENIYQHYEMGKTPVQAA
LDGTMEVIPPIISAILTTVLAFSTFLFLDSRIGEFFGEVSTVVILTLVVSLVEALIILPA
HIAHSKALQARNIEEDNKKTGLAKFFVKMRVVNRTGDRIMSYLRDKSYSPVLKFVLKQQM
LSLGILVAVLILTIGAIGGNWIRITLFPSIASDRVSIDLLMAEGVNPEKTDSIISMVEEA
AWRVNEDFSSRQSGNKQVVENTIKRVGPGNNKASLQVNLLPGEERDIGSPEITNAIRDEV
GPVFGVENLTFGSGGNFGGDPVSVSLLGNNLQELEAAKEELKENFENNALLKDVKDNDPQ
GIKEININLKESAYALGLDLSEVMRQVRNGFFGTPVQRFQRGQDEIRVWVRYDLENRSSI
NDLDDMRLTTPDGDRVPFDEIANYEIVRGTESISHLDGLREIRVSADMEDPNGSSTEILA
DIRSNVMPDLLTKYPSLSVSYEGQNREANKLTDSAKGVLPVVLFLIYAVIAFTFRSYSQP
LLLMIMIPFSIIGVAWGHWIHDFPVNVLSALGIIALVGIMVNDGLVLISKFNGNLRDGMK
FNDALYEAGRARFRAIFLTSLTTIAGMAPLLLEKSRQAQFLKPMAISISYGIAIATVLTL
LLLPLLLSISNNIKVGGKWLASGNKVTHEEVERAIKEQKEEKAHGEIG
>IFAGANLK_02444 Outer membrane protein TolC
MGRSVNLILVVAIFCMGSIVAQEEDVLTKEEAIALALERNYGIEMANNDVEIAENNQGIL
NSGYLPSVTGRAGAGYDLNDRLTEPEEGEPLNQEGIESNSYNASINVDYTLFDGLGRFYN
YKSLKEQYDLSKLQARETIENTMLQLLTVYYEIARLTENVEVLKDVLETSKDRVTRAQYQ
FDYGQSNNLAVLNARVDVNNDSVNLLQTRQQLDNTKRDLNVLVDRQMTEKDFEVDTTVNF
IPKLQLEAYIEEAEANNVSLLQLDRNLAITEYDIKISKSGYLPTIDLNGSYGWNFNRSAA
TAFFPGSRQTTDGISGGVSLTWDLFDGGTTSVQIQNAKITHENQELQKKQVALGIKRDIA
NALGNYENRLYILRVQEENVATNRDNFERSREQFNLGRITSIEFRQAQVNLLDARTSLNL
AKYDAKIAELELLQLTGQLLNIEL
>IFAGANLK_02445 hypothetical protein
MEKTFEFADNVVGFLIKEEIDQKKMKEILSKIKERIEKVSPICIYIEDESDEGISLGGLL
KAVKFHFSHSEDLKKIAIVTDDKMFKKSMDIKDVIVPADVKSFEKKDRMKAMNWVMI
>IFAGANLK_02447 hypothetical protein
MNYRNNKEPKFLPDFNLQHVNHMMNFYHVQKMYLAYFGKVPSYYTFSNRDIEKFHQRFSE
TFATNILGKHFRRCYDKDEHKAEIIYILKQEIMLEQDPDEINVYFQDENSALLDNLLEFI
KGFKKEKPDQAHINLIIMQPHGLDNKKIDFTKPDLDLSKSYNDDFPGYHDKMLKIVQENN
KSGLHLLYGKPGTGKSTYIRYLCGLVKKEIVFLPGQMAQNLDNIAMTKYLMDNPNSVLVI
EDAEELIVSRDNQRNSNLAMILNITDGILGESLGIQIIATFNTDVQHIDPALKRKGRLKS
AYEFKALSVEKANHLLIDQSLNYSTQDDMTLAEIYNISEEEQYKYPARKAVGFR
>IFAGANLK_02448 hypothetical protein
MMKKLFLDDLRTVDMVYDYIQISEFEVVRSYDEFVAYIQKNGLPDFISFDNDLGLNELGE
VAPDGYAAAKWLVYESGLDLRELQFKVHSANPVAADQIRGLLNNYIKFLKE
>IFAGANLK_02449 hypothetical protein
MKSPRYLTKSRFKLALDCPTKLYYTRKPEYENSADTDSFLEQLAQGGFQVEELARMEHPR
SIALIGDDYDYQKLADETRKLLTQDEVKIFEPAFLFNGLFIRVDILVKKGNKVRLLEVKA
KSVSRERHESYLNSKGNKLQGGIDHYLYDVAFQKYVMQSCYPELEISSFLKLVNKDAVTS
VDGLHQSFKVVADSNLRTGIEKREGLTKEDLGDSILCEVNIDAEVDLILNQNPIDEALSF
EEMLNLFRSHYREDRKLFIGIGGHCKGCEFKSEPASKKKSGFHECWAEELKLPVSAIDEP
KIYDVWYNPAKKLIEEGKYFMKEISEEDFTVKPEAGKLSRSERQWLQIEKTVQDDNSPYF
DLENLRAELASWKFPLNFIDFETTAVALPFFKDMRPYEQLAFQFSHHIVHEDGRVEHFNE
YLNTEPGEYPNFDFIRALKKSLTSNDGNVFRYHNHENTIVNVIYDQLRNSAEPDKEELLQ
FIETISHNTSRNAKSWKGERDMIDLQKTVVKYYYDPGTGGSNSIKAVLPAVLHSSSYLLE
KYQKPLSEIDVSSKNFDPDHIFLRMENGKAVSPYKALPPVFENWDSDKLEEITESIPEIA
DGGAALFAYQKLQFPDLSAPEREAINLALLRYCELDTLAMVMIYEYFREVCYF
>IFAGANLK_02450 tRNA (cmo5U34)-methyltransferase
MTNNKKITKPWPTKDAMAQIYEKNLWGGKRSEFYSGLGSHRPEIVNPYIAVISDFLKNFE
TPPVVCDLGCGDFNIGKELVKYSKKYIAIDIVTDLIAHNKKEFKADNLEFHSLDIAEDEL
PAADCVILRQVLQHLSNAEIKSVLGKLYEFKYVVLTEHLPEEDFEPNKDIISGQGIRLKK
QSGVNLLEPPFNFIGKEEKQLLCVKSPGFKGVLVTTLYKVF
>IFAGANLK_02451 hypothetical protein
MIKLSKDPVIAKEYARRILTDKGNYISPKTKLENWIKSASNGGDKRTMEYVLENLEYILI
SEPKILQEIKDHMTSSGLFTHIYDTNGSTLTPLGKKIDDFFGYDRFRKSAKAVWLSKKLN
IKSCVYCNTQYGLTVDHNGKTKLLFHIDHYFPQKIYPFLSLSFYNLIPCCASCNMSKTAN
EYNLSDNIHPYEEDVHTIAKYKVDKGTLTRYLMNLDEDDIKIKLELRGKYLGNKLLEKKL
NHFKSEFKLESQYRQFTDIAAEIFLKSVYYNSSRKKEIINFFKTTHSINIDEELIHRFII
GNYTENKDLLKRPLAKLMKDLGEQVHII
>IFAGANLK_02452 hypothetical protein
MEIKFVWIQDYRNIKNIGFNFNNSNGDQFEYDGQNLRISQNLDTTPKGFFRENISSITAI
VGKNGAGKTNLSEFLYYNLVHVRNGALARFPTGKGILILEKKIFIQETLKLVNEKKLQEE
GYEVERYEFNPLDKKGNRDWFKMEANRYIYYNPLLDMRFKDWVSGNDNIQDISTTYLLTS
DIYNSSKHYNNSQPYRVQKRTERLLAYSRNEKLRESDLILNYSEIAEFLPNHSDIISFSV
DTIRNNQLLNLEYYGREEASRDKNKQNSNEIYHFLDDLEKNISYQLEEYHKKENEYTSLY
TVPLEVKKELFKKIFYITFFRAYWKIHASTLTAKLLDDFFTKGNSEFGDDNLDTKLKAIV
INLDQILVDSGFTVKSNVIVHDQTDDEKWEDTFAAIFNKFELSLNKKQKQFKRIISNSKS
LLKDNLHFHYQFENNYSSGEQKLLNFYARLFYAKNEIKFREKNNYNTQSKRIVLFIDEGE
VGMHPEWQRLFFSKAIEFISRLFDEYIIQIIFTTHSPFILSELPNSNVIFLNKNKFGNTE
LVQHKTQHTFGGNIYSLFADSFFMDNGTIGAFSKKKIEWVLTLLESEQDLSHEESKTIEF
IISRIGEPIIKMELEELFKRKEGTAEIDELKNKIKNLEKELRNKTNDQTE
>IFAGANLK_02453 Type-1 restriction enzyme R protein
MPSQTNEQALEAAIQETLSGITIEKIKEQDPNANIAEKSEQYLFGNGYYIGNPNDFDAKY
AIDKRRFWSFLEETQKEELEKLQRHGDWKLKILERLDRMIKKYGVLQLLKKGLAVDDAHF
TLFYQAPLASSSDRVKKLFKDNQFSATRQLRYSVENPREEIDIVIFINGLPVITAELKNH
WTGQNAKVHAQKQYKYDRDIKQTLLNFGRCLVHFAVDTDEVYMTTKLNGGNTFFLPFNKG
DDNGKGNPVNPNGHKTAYLWEEVLIKKSLANLIQHFVRLDGKAKDPLHSKTLFFPRYHQM
DVVRKTIDHAGQNGVGQTYLIQHSAGSGKSNSITWAAFQLIETYPELEGIHGSQGMEKPL
FDSVIVVTDRRLLDKQIRDNIKDFSEVKNIVAPAYSSKELRDSLESGKKIIITTIQKFPF
IIDGISDLSDKRFAVVIDEAHSSQSGSAHDKMNQSMGQQAQEEDEEDVQDKIIKAMQARK
MRGNASYLAFTATPKNNTLEKFGVKQSDGSFKPFHLYSMKQAIEEGFILDVLANYTTYKS
YYEIEKSIEDNPLFDSQKAQKKLKAYVESHQQTIDTKAEVILDHFIPNIVNKKKLKGKAK
AMVVTQSIVSAIRYYKALSRILEQRGSPFKILIAFSGSKTVDGIEYTEADMNGFGEKDTK
ENFDKDEYRILVVANKYLTGFDQPKLTAMYVDKKLQGVLAVQALSRLNRSADKLGKKTED
IFILDFFNSTDDIRNSFDPFYTATSLSAATDINVLHEIKETLDETGIYEQQEVELFCEKF
FMKEDAQKLSPIIDQAAYRFNTELELEDEDKADFKIKAKQFVKIYGQMAAIMPYEMLTWE
KLFWFLKFLIPKLIVKDKDADNLDELLESVDLSTYGLERTKLNDSIGLDATETSVDPQNP
NPRGAHGEKEEDILENIIKNFNERWFQGWEATPDEQRMKFIQLSKHIQEHQDFQAKVANN
TDKQNSDLALKRIIEDVMRKQRKNELDLYRLYAKDDAFYQAFFDTMKRMVSMRENRN
>IFAGANLK_02454 hypothetical protein
MNIKASVKEILETRLNDLKNPKSLVSMYGIEKQTNQGYNGRQLLELFQNCEDEGATDVRI
FLDTENCVLKISNNGNRPFSIKGYNSIFYPGLSAKVSSGYIGNKGLGFRSIINWADEISI
ISNDFKVVFSEAFKKDILINELEYTDESLQRIREERKFNKNVLPLPFLNSCEIKDLDFPH
QYTTTIAIKYKKAFEEDVIKQLRSISEKTLLFLRNINTIRIEGNVIQNTISIGRKAIDDH
HTEINYNGHKYFVLSNDGEIDKNLLEDIESTEPKRYSVKIAYNNDLSFRDEVMYNYFKTQ
IPFELPFVVHASLELDQNRNHSTESKVNSFVLEKLFELHLRFIEVLKTKLSMSWLPFQAI
NNKDFDVYKPYSEMIDEFWDEYKVYPTLSGKYGASGQVVNLGNKISKFLKKNSLEEYCKS
QIMSSENIIRPLQYVSKPENYTEIIEFIAKGLNIQQRATFIKLLLDSYPNNRFCVLIDEY
ENLIKAEDYVYTDKTGENKDLKVPSFSNIRFIHSSLYRALIEELDLSSEPNKSRTLKDKL
ESISDVHSFEPQTVIKKIISETDNYLKKNNPKATEVIIEFFQKLYYNYKLRPDIPKLDYD
SKIPCLNRSGQVRDIRELVLSEEFEIGKANRTIFNFTYPDEFVISRIEDIGLKDQDLDEI
EVFLKWLGVNSFFSLKLESSNIPNEYLSYIRNRYGRSIDVYQLFYLESFEEIINDKGIDI
NSIIAWLSIDEQIKGIFSNYSIIFSDKEKLIYHHYGQKKLSPFKNFIYFLISTRFQIENY
LITSKRNEWFNPFKVDYEYLNNINPDLEKMEVDRILSFFGAKKDFNELDIEYLKQKTQEL
ANKRKPKGAQVFYKNLVGHYKQNQKKLLNVDLYAREGNNIVVKDSTEIYYSDRIQLPDSL
TNDFPILYYPSRSGGTTAIEMFGLKNLNDLDLDVKSLKINESLSEGFQQFIQEIKPFILA
FRLDKITKEEEKKRQVQRLNKLKIICCEELICELEIKPFKIEPFDYVFSNSQYYINIPSG
IDIFQLRQIKKFRDNLSDVFLKVFDTLDEKKTFESLILQSTQDNIYDINNELAEGILEES
KILLGEISVRLSIWKSIFALKKIEVQEHLDENNLEEIIYRFFPDLDKELLFVSDDNMDHL
QRIKKVFDVLGLDLIDYNNSSEYKISFDKIYNKEFKEYYNSIKKNLKDQIWYYLSSKEIA
IQKQFLKELYKIEHLFDTHLFVENASRYNFDKIIISELKKEYPLINFDLNSDQYPNYDLT
HKKNILPLSEDEELELRKNEVLNSLSYFHGQMEFIKSELGKLTVNNEQTKTDDYNWDITG
TGDLVHDFEIELGVQAEGIKNKNGPWLGDKKELSPNQKKKLGNKVEKIVEEYLLSRPDLY
TQVEHIAKTNEGEHYDLSYYDSAEEKTKYVECKFYNGSSFLISREEKRFADDNEDQFELW
LVNKDSKIFCVKNIILLGELQPVNYRVNIKLNEYAISN
>IFAGANLK_02455 hypothetical protein
MKLIIEKYIGKEAFEEKFQKISGNKEFEEVFTFFLVNFLTELEEDNAIEEDDTPATLLDI
PNDYIDCYIENRKNGFSKVWSKTQAELKIMRDLNNTVIRCYEEVASSDKHEALKDLQVFC
KLKNGDKRYTDFLIDYVINNGYSERPVEEIAADFSRTYRKQLEKGKSEIYADKYASLIAE
DYYHEIYCEDYAFIYDQALTKGKSEEYAKRYAEKYASELVDVKRRAGIADDEESLEFAKA
KAKAYINGWEYATTNSIQEKSGFIDCYSNCYLNTFFSDNINEWSSIEQCEEIVLRKTLEK
FESAC
>IFAGANLK_02456 hypothetical protein
MAKDNIQAELKFEDLPDYSSVLGKLNKRKDPKHLIMGNGFSMAYDHKIFSYNALYDFIEK
LEDPVLSKLFKVINTKNFELVMQQLDYFIEIAEAFDTDKKLTQKLKGANSKLRSSLINAI
TDLHPEHVFEIAEEKSEKCAAFLNEFLEKDGKVFTTNYDLLMYWVLMRNNATKGIDGFGK
EVLNPKEVKRGEEPELSDLYWGKNKDDQTVFFVHGTLPIFNTGIEIIKEVYDSEHYLLQN
VKERLDKKEYPIFVTAGNGEEKLKHIRHNRYLSFCYEELTKMEGSLISFGFNFGNYDEHI
IDAINKAAKQGGIPKDGRRLWSVYIGVYSEKDLDHIKEIQGKFKCKVNVYNARTAPIWN
>IFAGANLK_02457 hypothetical protein
MEAVKEKPQLQKYPAYKDSGVEWLEEVPEHWELRRLGSRFEERKTKVSDKDFPPLSVTKN
GIFPQLDNAAKSNDGDNRKLVKKGDFVINSRSDRKGSSGISDLDGSVSLINIVMKPYNLY
GPFSNYLLKSTAFVEENYRIGHGIVADLWTTRFDELKNIKAAFPPFDEQTAIAHFLDEKC
GKIDTAITQKQQLIELLKKRKQIIIQNAVTKGLDPNVKMKESDVEWIGQIPVHWEVKKLK
HSAALRSDKTVSKFSTMNYLGLENIESWTGNLIETDSETEGQANCFKVGDVLFGKLRPYL
AKVLLAKKDGICSGEILAFNANEEVYNSYLHKVMLSYRFIDLIDSSTYGAKMPRANPTFI
KHQIIPIPGFDEQQEIVKYINDQVQKSDKTIDFQRQQIEKLKEYKSSLIDAAVTGKIKVS
>IFAGANLK_02458 hypothetical protein
MAKYSVHQQPVETLLSWIKSGEIAIPEIQRPFVWKNTKVRDLIDSLYKGYPVGYIITWRN
PDVKLKNGELSAGKKVLIDGQQRITGLTAAIVGQRVLNKNYKEISIRIAFNPITEKFDVL
NKAHERSPQWINNINPIINDEISISKAIRKFKNENPEVDEDLIEERIENLKKIKNKQVGI
IELDHSLDIDTVTEIFIRINQKGVVLSNADFVMSKIAADEQHEGNKMRKLIDYFCRLIVD
KDFNKHIQDNDPEFAKHEFYRAIKWMANGNDNLYVPDYIDVLRTAFTYKFSRGKFSDLVA
LLSGRNFENRSYEDEIAEKSYKILAEGLTDFVNQTNYQRFLMIIQSAGFIDQKLISSKTS
LNFSYSLYLKLRSEGMPEARIQHFVKRWLVMSLLIGRYSGSAESMIDEDIKQINEKGVEA
YLQQMEQSNLGDGFWDFGLVDSLETSSVNNNAYNVYLAAQCYFNAPAFLAKTMKISSLIE
QRGDVHHLFPKKYLMNNSFPQKAYNQVANYVHTEQATNIKIGMAAPTEYMLKVIAEVNNG
SRTLTTLDSETVLWENLKENDIPLLINDCDHTSYTEFLRRRRQLMSKKIKTYYESL
>IFAGANLK_02459 Type I restriction enzyme EcoKI M protein
MTQQTHNKLVSFIWSIADDCLRDVYVRGKYRDVILPMVVLRRLDALLEPTKDEVLEEMRF
QKEEMDFTEWDTRGLEAASGYVFYNTSKWTLQKLHDTATNSQQILQANFEDYLNGFSPNV
KEIIEKFKLKSQVRHMASKDVLLDVLEKFTSPYINLTPFEKEDPEGRKMPALSNLGMGYV
FEELIRKFNEENNEEAGEHFTPREVIDLMTHLVFDPIKDQLPPVMTIYDPACGSGGMLTE
AQNFIKDEEGLIRATGDVYLYGKEINDETYAICKSDMMIKGNNPENIRVGSTLSTDEFAG
TTFDFMLSNPPYGKSWSSEQKYIKDGKDVIDPRFKITLKNYWGVEEDADAIPRSSDGQLL
FLMEMVNKMKPKHQSTSGSRIASVHNGSSLFTGDAGGGESNIRRYIIENDLLEAIIQMPN
NLFYNTGITTYIWLLSNNKAKNRTGKVQLIDGGQLFRKLRKNLGNKNCEFAPGHIDEIVK
VYAEMQAESRKIDKETNAEVPGIAAQVFDNQDFGYYKVTIERPKRLKAQFSPERIEELRY
DKQLKEPMQWAWETFGKEVYTKLKDHEKEILAWTEENDLNLSSKNRKKLLSPKVWEKHQK
LVNNAYKLESLFFGDTLYNDFNLFRKEVLDFLKNRKELTSSDKNAILSAVSWYDAKAEKV
IKKKEKLSGEKLSTLLAHLSCTEEQLPDFGYFPTGKAGEYVIFETESDLRDYENVPLKEQ
IYGYFLEEVKPHVPEAWINLDAPKIGYEISFNKYFYRHTPLRSIDTIAKEILELEEKNEG
LIMDILGIS
>IFAGANLK_02460 hypothetical protein
MKYEVNYFKGLSQIEGLEKLLEISFLKEALLRCVLKNEGSSWFRVENQDGNCLTLSNEKY
LVILLIEVNEFIINEIKEAIPNIDKYIPIVVKLEIDTYNYDFPREVDLKVDDICETAKRD
GIGHKNLFLIFLRILFDKKPY
>IFAGANLK_02461 hypothetical protein
MNIKQALNTLFLCCLINSTINAQGIKDENKYGEQLYLIDGNLLKEKNKYGKDLFYWNGQE
IKLKNKYGSSIYFLDGNTVKLENKYGDRLYEFDGYYIRYRDKYGPKIWYLDGRVLKRKDK
YGEPVFYFEGIPDRWVLVALLDLSK
>IFAGANLK_02462 hypothetical protein
MSVRQTIKRHYKIISLLRLRPMSYEEVQDMMADNPDAVEEDLFSSQRTFQRDIKDIETIH
KIEIKCNRSTKKYAIVEDVEETHSQRLRENFDLLNAIRLSKSFGNQLIFEERKPLGTHHL
AGLLHASQNFLEVAFEYHKFWDTSVSTRKVKPIALKEARNRWYLIADDTKDDIIKNFSLD
RIQKLEITKEKFKPIEYQAYEEFKDSFGIINGTNEDPVKVILSFTPREGRYVESLPLHHS
QELILNNEKEIRFSYFIRPTYDFRMEILSYGDQVKVVEPKALQTQIKKELQCSISNYK
>IFAGANLK_02463 hypothetical protein
MNILYLHGLKSKLKEPKRKILEKYGQVFAPDIDYSEIHFQPELILKQFPTTEFNVVMGSS
MGALNAYAVSEIIGRPALLFNPPLSKYQSLKPKNKFTPGISTKQILIGGSDEIVNPAETL
NFLSKNLQQSELDIQILPQLGHRIPIDIFTTQVEKFFKDVCA
>IFAGANLK_02464 hypothetical protein
MSRSKRKTPILPNCTATSEKAEKQKANRKLRRIVKEKLAITDENFPHIKEISDSWNWEKD
GKSYRTDLSNKEKSK
>IFAGANLK_02465 hypothetical protein
MRKLEITLTEEQYQHIQEEIKYGGRTMLEEETFGGYEITLHVGVPNIYTYIEMSYINKID
LGEVEWSFSKNFQSLKN
>IFAGANLK_02466 hypothetical protein
MLNSKEVMALAKIRSGTTYHKLLCYLKAWGYLQYHPTTNPQMGSLIEMFRFDILPDQKMN
RTYPVSEQVPVQKLVSFNKHKSKHIINSFKTTCSENEQVVIEFFRAEKRSVLEAKKFYNF
YESIGWKLMVKIQLQIGRPVPEVGC
>IFAGANLK_02467 hypothetical protein
MLPGEGCRYLKHLVNIPIPKVSLYNSVRGTESLVDKNPSDLNYHYFLLSIYLRDTRYKDK
FKKIKDNILKNFKTDEEERMKFEVLNYEE
>IFAGANLK_02468 hypothetical protein
MNKYLYIIVFSFVFVKSFSQSNTLTNSPYSLYGLGEKNLLNTGKTNGLGGTGIALPSSTM
MNNLNPASYGAIPQNHFFFDVGINYQINNLSEAGNEDRKTNGNFSNIAFALPINEKSGVG
LSLLPYTDVGYNFTSLQNNIEGSSEAYYTSIDGYGGINELAINYGISLGKKLRLGISGEV
LFGKITEYETNYIGNNTLELIEQNYYSGFKAVFGVQYDASENISFGAVVNSPTNLGASQN
QTVYQYQQNTQVASSSDENNIPDFSLPLDIGLGISSKLSEELTVSADYTREFWTATNQSD
NLGTYVDRDFIGLGLEFLPQGNPLRYTNHIQYRLGMNYDSGNLEVSGIKTHNYSINVGLG
LPLNTRSSSMFNLMYSYGKKGIVSDGLIQENYHTLSLNISLQDIWFVKRKFN
>IFAGANLK_02469 hypothetical protein
MKFHIQRNPIIISILFISAFLLFSCSEDSDISEVADNWINSNTKVYFIDTLTVNSSTFKF
DSLSVSGSNRLLIGAYTDEDFGYIESKVFAPIYPSTYTIDSEAELDSVALILNYDGYAYN
DTLQNQVFNVYEILEKVDNDGEDFYNTTSFKVAENAIGVKNFKPYPTLNDSLHITIDYNF
GEGIFEKIKNKDLTNTEDFMREYRGINIVPDRENTGVLGFSRESSLRLYYSISAEVDSEE
KTLDLNFNESDSFNHISSNNAGSLLDSLSQNSYLSSLDSDNQTFIQGGTGIATRIDFPNM
EALNNIQGEGTIMDANLKIYLKTRDNKLSSPSNSLQFYIINQHSDIIGNLYDYNQATVTG
EIHQESQEFNIISYSVPLKYYLDSKASDPNGNNWYLIMYGQDFSSSVDSYIFYGEKAPGD
RRMKLELTYALYDE
>IFAGANLK_02470 hypothetical protein
MLKRLVMMLILIKGTTFYSQIFENKIVANYTLVPSGEEMGSSRSNISYILGLNAGNFNIN
NKLGIGVNNLSYPMDASFNTTGLETFYRFHNYTAIGYRFSRYWKLEVDSDISLASNLKGE
LTSEKFLLNGGFAITRDFGTVELPAYVKFGLGYYTFLGVPKILPRVLFYKKFNKTLALGL
GFPKTEITYQLDRNNSLQGNLEFKGMYANVHHSSRLTSSISNMVWSSNTTSLKFQHRIDN
TWSFDLNLGYGFSDEYKFIDHLGNETYTINNESFFLGTGIILNLNNK
>IFAGANLK_02471 N-acetylneuraminate epimerase
MIKMQRKIKYLITAALLGLILTGCSDDDDDFERGNWVSRSVFDGVPRSNAIGFTIDQKGY
MGTGYDGDDYMNDFWEYNIDGNYWVQKADFPGTPRTAAVGFATAGKGYLGVGYDGIDELD
DFWQYDPATNTWNQKADFMGGSRREAIGFGAEGTGYVGTGYDGKNDRKDFYKYDPGTDKW
SEVVGFGGDKRRGATSFSIDGLVYLGTGESNGIYQTDFWVFDPSTEVFSPLNDLDEEDDY
YVTRSYAVGFEMEGLGYIATGYSGGALSTIWEYDPLDDTWEEITQLEGTARQDATYFSTG
DRAYISMGRSGSLYLDDIYELYPQQEYDDED
>IFAGANLK_02472 hypothetical protein
MSRKNSKHKYHAPPVSCFGFFFNFLYMKLDKISTVFASICMVGLSVYFLNSGNLTDLTSN
NFSIAVHRVNSGYGYTISEGAHLLIKQDFIPAIQNEIPFPNYDIARSSARLVVKKITRGQ
QPALTLEELQEIGLDLNRNETGITSGLPIQSLCP
>IFAGANLK_02473 Macrolide export ATP-binding/permease protein MacB
MKILNLLRIAWKAIILNKMRTFLTMLGVIIGVAAVITMLAIGEGSTQSIKEEISGMGSNM
ITISPGAGMQGGVRTDPGQMQSLKLSDYHAIKEKSSLITHISPQVSGNGQAINGAENWPT
SIYGVTPEYLNIRVLELEDGSMFTDAEVKASSKVAVIGQTVRENLFSTEEDPIGKMIRFN
KIPFRIIGVLSPKGENTFGQDQDDVILAPYTTVQKRILGINYVQSIVASAISEEKAPEAV
NETYSILRKEHNILTGEEDDFNVFSMDELISMFNSTSEIMTALLVAIAGIALLIGGIGIM
NIMYVSVKERTREIGLRLAVGGQSMDILVQFLIEAILISVTGGLIGVSLGITATLLIEHF
LNWPTSITATSIIISFTVCAFTGIFFGWYPAKKASGLDPIVALRYE
>IFAGANLK_02474 putative ABC transporter ATP-binding protein YknY
MGQETVEALRDVSFSIAEGEFVTIMGSSGSGKSTLLNILGCLDQPTSGSYEIDGLNVKDQ
KPNGLAKIRNEKIGFIFQSYNLLPRTSAIENVELPLLYNSAISKDIRRRRAIDALIRVGL
EERLHHTPAQLSGGQQQRVAIARSLVNDPVVILADEATGNLDTRTSYEIMALFQELNISG
KTIVFVTHEQDIANFSARTIELKDGNIIRNVQNHDIMLAAEELESLPKENI
>IFAGANLK_02475 Macrolide export protein MacA
MKTKKAKILLSVSLIIILLISAYYILNTDNESSFSVETVPVKRGEINTLVTATGTIEPLT
KVAVGTQVSGEVEKIYADYNSEVKKGQLLAELDKTNLKAALGQAQASYENALNEKEYYGN
IFKRQQGLYEEEVISRADFEEATYNYNLAKTQVTQSLSNLQEAKTNLGFADIYSPIDGVV
LSKEVDEGQTVAASFETPTLFTIAKDLRQMQVEASVDEADIGNVKEGQRVTFTVDAYQGE
TFEGIVTQVRLSPIEQESVITYTVVIKAQNPDLKLKPGLTATVVIYTLELDEVLTIEAKA
LNFKPNPNQLIKYNEQYLTGEKQPREIPETSQEDMVIVWKHTEDNRILPEKIEVGASDGI
NTEVVSGLSEGDKLVYNLKTNANRGVRKESSSPFMPTPPGNNKNKPGEDE
>IFAGANLK_02476 Outer membrane protein TolC
MKWYLTICVLVSNLVAMGQQDLEWIQKTMTEAPPQKKIWSLEECLEYARTRNLTVLNAHL
DKSSAEVNYRQSELERLPNLSANASESFTNGYSIDPITSAYVNEQIFATSANLNSEIVVF
NGFQLNNEIKKSKLLVDQNSFFVQEAENNISLNITNAYLQALYYREEIYVTENTLDNSEI
ALDIATARFEAGAIAKKDYSDALSQAASDRYLLIEARNNYNSQILILKQLLELGPETNFS
IEEPDTNYNGVTIIDNKLNIYERALESLPEIKAGELNIAINEKELDIAQGGYLPSLSLSG
NLGTGYTSVQDIGFYDQLNLNFNPRVSLSLNVPIFSRGQNRAQEQNARIDIEKARINLKS
TEKEVYEKVETAWRNAIAAQNQIIAAEAARDAASDSYQLAQKQYEVGSINTMDLLVSKNS
YSNAEQNYIQAKYLSILYSQLLQFYQGNKIKI
>IFAGANLK_02477 Transcriptional regulatory protein YehT
MKCIIIDDEPLAIDVLESYIEKIGSLEIVSKCTNPIEAINIINKEEVDLVFLDIEMPNLT
GIELVKSIDKLPQFIFTTAYPQYALQGFDLNATDYLVKPIPFHRFLKAISRANERHENKR
TQPETQPGSVSNNHPPVYEEDFIFIKADYENVKVYLKDICYIEGLKDYIKIHLNTGSKPL
LTLSNFKGILDKLPSGKFLRVHRSYVVNIEYITALQKSRLILNNTKIPIGNTYRKEVLKR
LKL
>IFAGANLK_02478 Sensor histidine kinase YpdA
MPGISAYITRKKPLLIHVIVWLILMVILLYQAYNNNGKIDNRFLLFHIFSIVVFYINYLY
LVPKFLLQKKTSQYLIYSGILVFVPLLQSLFFEPPPRPSRAIIEQFGREPSLPEPFFFLG
PILINVCFLVIGSSIKIYIEWNKNEIKKKEIETQKSKAELNFLKNQLSPHFLFNSLNSLY
SLSVKKSDAAPEAIITLSELMRYMLYQTDNDYVALKEELEYIENYLKLQRLRLANDEFVS
FEIRGTITNQKIRPLLLISFIENAFKYGTDAQGKTRVVINIIVGQKTLEFMCTNITQNKI
KTGNNTGIGLKNTRSRLNLLYPGKHHLEVSNHSNQYKVNLKLDLSV
>IFAGANLK_02479 hypothetical protein
MIKYGLVVLGLLLSFSAYSQEKIMMEGKLQGEFFDKTSIHIINQRNENGVNSDFEGNFNI
EVMLGDTLIVSSVQFEKVNRVITPEIFKLEKIIIDLKPQVNELDEVRLSNISLSGSLMLD
FKDIEVIDKSEFGLSYVEERTRTEKKLQAANRNLFATIFNSFSGKTNQLESIKNIEDKRN
LIDRAIHAVPKALFKDLNLPDNLIKDFIYFCAENPNFHLLVAKERHLELVEYYQMKAPKF
LARRK
>IFAGANLK_02480 hypothetical protein
MEVRSNFIYREVLFIDGIFEGTMKTKKLYYFIFSRKRKFPKKWE
>IFAGANLK_02481 hypothetical protein
MEEQKGIGKKGSVAVANSYFKNRWHLSEKLHPLFHLLLDRKAPFPYTVTIQKWIGINGRF
PNESPEHLIHKKEWSLLLILF
>IFAGANLK_02482 Outer membrane protein assembly factor BamA
MEKPVSNSVSAFMTKKVFSLLAVACSLIFSNASQAQGLPLADGKKYIIGDIKVTGTVSFN
EQTVIAYTGLKKGEEIYIPGDKISSVIHKLWDIDHFSDINFYITHVSEDNVADLEIEIQE
VPKLNKVQVTGLKKRENEELIKENKLRSGAKVSENLITTTKNYIENKYRKEGYFNAQAKI
GTSKVTDTTENVNLVNMLIDINKGDRVKIADINFIGNEKFSNARLKRAMKNTKQKNIIRF
WKRSKFVRADYQEDKENLIDKYKESGYRDARIVTDSLVEIDEETVALSLKVEEGDQYYIG
NIDYLGNSVYTDAQLQSVLGINKGDVYNGVLFDERIADETRPDGEDLSNLYKNNGYLFST
INLVETNVYNDTIDFEIRIVEGKEAYFNNIKVTGNDKTKDHVIYRELRTKPGQKYSQEDV
VNTVRELGQLGFFDAEQLEPKFVDPDPQSGTLDLEYSVVEAGASQIELQGGYSGDGFIGT
LGLSFNNFSLSGIFDKEAYKPVPMGDGQTLSLRAQASTTYQTYSLSFQEPWLGGKKPVSL
QTSFSYTRQFLYDNTTGEADRSRSFDIFGINVGLAKRLTIPDPYMTVSHSVGLQRYDLNN
YNTGLFTFGDGFSNNINYTFGLTRDNTYVNPIFPMGGSKFKLTAKFTPPYSLWNGVDYAN
LDEQREFQLEDENGNLVDESGERVTPENAVGDPEEIDQKKYNWLEFYKVKFSGEWFTQIY
DKLVLRTNAEYGFLGAYNSDRGIPPFERFFLGGDGLGTYSLDGRETVQLRGYPNQSVVPV
DRPAGASDDGATIYNKYSLELRYPISLKPSASIYALSFLEAGASYDNFRDFNPFQLNRSA
GAGLRIFMPAFGLLGIDFGYGFDSIGGQPGANGWETHFIIGQQF
>IFAGANLK_02483 Outer membrane protein assembly factor BamD
MKKIIILISMVIVSASCSEYQKVLKSTEAGEKYVLAEKLYNEAQKENSKSKYRKALRLFE
QIVPHYRGKPQGEKLGFLFADTYYQLGDYYLSSYEFERFQQSYPNSERVEEVVYKKARSF
YELSPGYDVDQTDTHKGIAELQAYLNVYPDGEYTDRANDMASELRIKLERKDYEIAKQYH
LTGEARAGNYQAAITSFNNFLANNPGSPFREEAHYYRFDSAYQLAINSFRELMEERLEEA
LEYYQDYKKYYSEGKYSEAIEASVEDIKSHLQNF
>IFAGANLK_02484 Single-stranded DNA-binding protein
MSNLKNQVQLIGNVGNTPETKNFESGKKVCSFSLATNEFYHKDGEKVQQTDWHNLVAWGK
QAELIENYVEKGKEIAVRGKLTSRSYETQTGEKRYVTEILVNEILFLGNKEITD
>IFAGANLK_02485 hypothetical protein
MKSKVNEIAVSYNGSLKTSLLPKINSSSCAAALAFDQWNKNNIELQETFKILLLNNANRV
KGIYEVSNGGITGTLVDVRILFAVVLKSLTTAIILLHNHPSGTLKPSEADKNLTSKIKNA
ASFFDVKVLDHIILTPDGNYYSFADEGML
>IFAGANLK_02486 hypothetical protein
MDSFIGIRFKKETAKRFQEFSRKHFKSHTEAMVTMLDFFFYNEISPKEKLGPTGRTIEQT
FKKRISAVIAIMRDMEKTQTKPTVAMIQSLFEMEEPKKKPLLLEKKQVEEKQVQFREKKN
YNNL
>IFAGANLK_02487 hypothetical protein
MYITITAQKIGGNYSKSAAGFVAYLEKENQELAPDEMEHFFNQYEDNISADKVTREIDGN
TAKLEKTEPRFYSITVSPSKYELKQLQNNSEDLKKYTRELMKDYVASFNREVNGRPISID
DVKYFAKIEHTRSFKGSDKQVQENQAFASEILNLKNEIRKINRGEFQGDVASREKRISQL
EKQAPHKQNGERIVQGMKKEGAQSHIHIIVSRKDASNRFSLSPGSKYKASSVELNGKVVR
RGFDRDAFFKNSEKTFDKTFGYQRNFVETYKARKSFIKNPRGYFDSLLKLPAPEKAIAFK
MMKESGIPMLPSIPTNKAQLALKVFNRLRKGIDIAVKSSSIGI
>IFAGANLK_02488 hypothetical protein
MLITENRGEAQSVQTSISFKANLKYVDDDQELKEVADEVKKYSWKLEDLKWEKRKAKKV
>IFAGANLK_02489 Leucine efflux protein
MTGIENLFAYMVTALFFIMTPGIDTIFVLNKSIAQGRKSGIYATLGVNAGVLTHTLFAAL
GLSVIIANSAYAFTIIKYVGAFYLIYLGILKFKNRKDFLPTDDGKQVQKKGNNDFWSGFL
TNTLNPKVALFFLAFFPQFINPTQMENPVPFVLLGFAYALIGIVWFLILTVFASVFSQKI
KNNPNAGLWLNKLSAFVFILMGIKIALNKN
>IFAGANLK_02490 HTH-type transcriptional regulator BenM
MTIQQIKYFLELAKELHFWKTAEKVFISQSSLSRQIQALEDEVGIQLFERDKRNVKLTDA
GKFLQEHWTEKINEFEQILRQAKKIDAGNSGTVSITYPGSITFEFLPNFLKILNTNLPEL
KLELTEPTDENHEKLLLDYRTDIAFSRDKIENANIDSLKLYSEPICLVVPNNHWIKEKSL
HSIAELKNEKFIISGLHQTTFFASMLRSLFDKYGFEPITTVESDFGGMILNLVAKEIGIS
ILPLSFKTAKVENLRFIKLDEKIDLYVNWRKDELNKTIRKVVEYAKFTERK
>IFAGANLK_02491 hypothetical protein
MDNPSKITEGGVEYSLGKFDGKCVHYDFPKIIVYLNAKGKLLFGKKFKIYQEDKPVLLKL
CSYFIRDKENCKKHGIDIDKGILLSGPVGCGKTTLMKLLRHLVPNQRPYEMIPSRNVTFS
FNHLGYKTIEDYGSTKFFCFDDLGVEPPGRFYGKDLNVMGEVLLSRYELFLETKGKLKTH
ATTNLNAEELEERYGNRVRSRMRELFNLIAFSERSVDKRK
>IFAGANLK_02492 hypothetical protein
MNYIKQLNAAFEKFYFDDRLNPTHISLYMALFQEWNSSRFANDFFVNRRDLMKVAKIGSK
STYHRCVTDLDTWKYLSYFPSNNPYKGSKIKMTIIGTGDEPDEGHYDPKLEQLAERYHSI
QEPVVHRYPPNNEQAMYSQRPLNGLALVSTINNTKLIKHNKQPNSLEVVLNFFKDKDLDP
DYAKTFFEYYQDRDWLTSDGLEVRDWRALALYWAEKKSLARQKKKLNKHEVSRFRDNLRT
TKNKDYGQPL
>IFAGANLK_02493 hypothetical protein
MPTSIITTDDLQDFKMELLEDIKQLLNQQESGKIKKYLRSSEVMDYLQISPGTLQNLRIN
GTLPYTKIGGIIYYDAQEIQKVMEENRVLNLEL
>IFAGANLK_02494 hypothetical protein
MKIAQQRHYLFSLNTNLMFEKTMSIFSENVESLIQSGKPDLKKAEDGINLCIKILSKLQK
QVDKDDFENTQAEIEFFKNIKPLPMSYLIYFTEVRSCELKLPKVGNSHKVRYLEKEIKKI
NRFFSENNSFVNYMEQNHNYLDPQFFSRSGKMDFSFSPTINYYQNPEFSTSHDMLWSKVQ
ALYRYIHYIREKLELIQPGSIGNFRERQPNLLRWSGSKTSLVEVIYSLYLKGDINHGTAD
LKTLISAFEDFFNIKLDNYHKTYSEMRARKDPRAKYLYQIAGNLEAKMRQDDEK
>IFAGANLK_02495 8-amino-7-oxononanoate synthase
MAKIKHNNFLDTVDEVVTNATNAGIIHLHAEGRELNGRRITINGKPSYHFGTTGYLGLEQ
DKRLKLAAINAIEKYGTQFPLSKTYISHPLYAPLEEKIFQMYQHPILITKNSTLGHLAVI
PTAVRAGDAVILDHQVHWSVQSATEVLKSKGVTVRMIRHSNMDMLEHYIKDLRNKANKIW
YMADGVYSMYGDFAPLHDLMELSKKYAQLHLYIDDVHGMSWKGKNGSGYVMSVLKDLPQN
ILLFGTLSKTFGASGAILVCPDKKLHKKIKNFGGPLTFSAQLEPASVAAATASADIHLSP
EIYDLQSDLERKINYFNHLLELSDLPLVHKNASPVFYIGTGLPATGYNFVSKMMNAGFFV
NLGLFPAVPVKNTGVRITISRHNELKDIQALVDSMSYYFPLAMEETHTDLTRIYKSFGIQ
ETEKNNTIGTQVEELNLESTETIQQINKTEWDTCFSGKGIFDWDGLNFLEKVFTSNNLKE
HNWGFHYITIKDKNGKIVLAASLTSALLKNDMLSDANTSRVIEEMREEDPYYMTDVVLSL
GSVFSEGAHLFLDDDHPLHIRSMRLFLKKLDEIKTKMGAKLIILRDFEKSNTLNTFFHEQ
GFISIDMPDSCEIANFNWRNEEHYLSTLSKRSRKHFNKDIKAFENYFQTRIVISPTPEEI
DKFYTLFEEVWSNNLGINIFKFPKKLFSKMVKSPKWDFLTLYLKAESPNISDKIVGVMFI
TRSGKTFIPAFVGMDYGYNEKFNIYRQLLYQTIKTAGTLKFEKIKFGFSASFEKKKLGAT
LIPKIAYVQADDNFSLEALDWLQKD
>IFAGANLK_02496 hypothetical protein
MVVDGTYAKMWISNGILYFVYKEIYEINRSMAKQIVSQRLQLQNENSYPIFCDLRAVTIA
QKQARDYLAIEGAYMTTALALLVEDEHAMVITQLFIKTNSPAYPTRVFTDKEEALSFLQD
YKK
>IFAGANLK_02497 HTH-type transcriptional activator RhaR
MKKEISNEEKMRFNSLYQQIIEIACGNFMFRQEPSGRRDPLDTVAVLLNMMSEEIYNSCF
KPQQRGEHPEFHFSIFLDKNYHITSYTYETPKILKWDEKKIDRPVSEILSNNSVTILKEE
LESNGEKPYQRLISLDFITENKSLYRAPCTIQKMTGINSDCSYVITAFRFGNKEEEDEKD
SNTARSSKSEKKESAATKILLKQVRLYILRNLHTELPSLKELGLIHRTNKTKLKEEFKKM
YGTTIPRFHMKKRLEKGALLIRSTELPISIIMQKCGFKDHSHFSKNFKLQYGQTPSQYRI
KNAWSIQ
>IFAGANLK_02498 hypothetical protein
MKFTIVNDSSHKLILLSIFSNALEYLHHKRNVTNLFAQKVGDAENPSKSRCILKLFIMKY
LKVILPMLAIIFAIGLTFASVNSEPKPDVQTTDFIYLGNDNWQSIPEQECQGTEENCRVQ
IGAGGPVYDVYDEMDLGTVKLSPADQEPTVINLD
>IFAGANLK_02499 hypothetical protein
MNSLKTLVVWSLIFLWILPVLAQTAYHNSEDSLTLDKSIRTGVLDNGLTYFIKPLQNSNQ
QITMNFLVKVGSQDEQQHELNFAHHIEHLSFRPSDNFPDGLKNNSKILSQFGMKMYDIYG
RTGAGVTRYFYNVPYENEKAINTGLLWFKDIASGLDLTKKSIDRERGVLLQEYRGGVASR
AQTTAYNDVHSTLFSVVNSKKSFSSHNRNFPHQDLQKFYNTWYQPQRMAVIIAGNIENTE
QLEENIKSIFQELKSSENKVEPKGKEQSNPKSEKNFTSVVRNSNGNSAYEFKAVNMYLFY
KHKVDKKKDEGLGRLQRQIQGEIVTDILKTRFNESSKIDDRTTIYSSYTPVWNIPRDMLT
ITINTELQYEKVALENTLYILRQFVEYGITEEEFKNAKDNILETLESYDTSKNRYWVNEI
EDYFVNGQALPTNKKEIIINWLSKLSKEEINRLIKEIIKPSPDKMGLIFPEDSESPLSSK
EKTQEIIKKKAMEKVFPYKPKSEIKRLLSQNQMDSLPIGKKLNAKPGKLDTEIYSLKNGS
KLILKPMKSTNSNALTIRGFSPFGASYFPKEEYNSTMFATSIIRSSGVGSYEKKDLKKIY
ENTQSIKLGFNPYIFSNESGFESEVSIKELDKFLQLLYLYFTKPRKDQAAFENWKKGYLQ
DARYIINPSKDLIDALKKVTRDSTRLPIASDLVKASQRVNLNVAHRNYQELFGNIGNFTF
IVTGDFDSDAVLTAFQKYVGNIPSNSKTICTDKNKAIEIPDGPKYYELSASDLYETENSF
YGIRFVHNPPDKKVWQEELKIRVLGQMLNSLIYDLRDKEELSLYTISAGAYFDRRTQRFE
VQFRFSCLPEQLPIIREKTNKIIENLKEADISEKVFENQKNRIRSIYTPQALNQPSYIAR
KLYRYYRFEEPPIPSSAIENYLKDLTFKEIIQTAKTYLKPEYMHEVKME
>IFAGANLK_02500 SusD-like protein
MFIKKRIKQIIVVFIASISIACEDFVEVDAPDYKIIRDDVFSSEETAKSAMTGIYNELFR
TSFSNGSPYSVTVLGALSGNLLKNIRETNLTRMEFHQHQITSENTSNLFFWTSAYNMVYI
TNAFLEGLQSSENIGSEVKNQLEGEAKFVRAFTYFYLVNLYGDVPLVLTTDYEQNELASR
TYSEEIYTQIILDLEDAIEVLTSENQDIRTKVNRYTAMALLARVHLYNQQWQMAEELSSQ
VISNNSYVLLGELNDVFLANSQEAIWQISPAGRGAATTHTNEGNYFIIDPVFSFLASVQL
DENFIEYFNENDLRFSNWISYNESLNAYFPYKYKIWNSNEQPSTEYSMVLRLAEQFLIRA
EARLMQDNFTGAIEDINTIRHRAGLAPLSNTNNLETEVLLDEIMEQRSKELFTEWGHKWL
DLKRTGRYEILWENDPLWEDTDLLYPIPAEERMKNPNLTQNPGY
>IFAGANLK_02501 TonB-dependent receptor SusC
MKNNYSRLKWVALIILGGILFFLSKAAFAATTIPLPLQKEISGVVEDKNGLPIPGVTVTV
KNTNRGTVTNLDGEYNITAPANGILVFSYIGFRTVEIAVENNAEINVQLEKDVASLGEVK
INAGYYTTTEREQTGNISRVTAEEIELQPVVSPIQALQGRMAGVEITPGGSNPGTASTIR
IRGTNSLREEGNYPLYIIDGVPINSTPVETNSIIGTAGIDPLNNLNVSNIESIEVLKDAD
ATAIYGSRGANGVVLITTKTGKQRGTGLEARFYTGVATVPNRLDLLNTEEYLEVRRAAFE
NDGVEPTAQNAYDLVTWDQDRYTDWQDFFYGGTAETTNANLSFSGGSDKTFFRLGGSYFS
QGTVYPGDNTYNKITGNFNLDHSSEDEKLKLNFSANYGVDINDLFWSNSISSSTVLLPPN
APDLFTEDGSLNWEEWAVADLENPLAGYYNRGRTETNNLLSNLGLSYQILNNLQVRLNAG
YTYYESQELMKRPGRSYNPSAGEPNNSFHLNSHRKSWILEPQLIFNDNFGDVNLDAIIGG
TFQENTNSQVRYQGAGYVTESLIGNLDAAERVINASSQTNQYRYAAVFARIGTNWKRKIF
INFTGRRDGSSRFGPENRFANFGAIGAAWIFTEEELIKNALSFLSFGKLRGSYGSTGNDQ
IGDYGYLDSYEATPGPGGLYPVSLANPSFSWEVNKKLEAALELGFFKDKLNLGISWYRNR
SSNQLVGYPLPAITGFNTVQANLPATVENSGWEVEISSLNFNSDNFHWQTSLNFSIPKNR
LVSYPGIEQSSYANTYRIGHPVNISLLYRYEGIDPETGLYQIADINGDGSFDYEDRVVIQ
DLTREYYGGINNNLSFKNFSLQFLLQYVKHEGMVSFFNAGRPTNQRDVVLDALNSNEDYQ
RISQLPAFSQAYNNAINSNLTIQDASFLRLKTFSLGYNLPESLLQSTGLRLRDGKFFLTG
QNLFTISPYEGLDPELSYSSTSFGNLRTVTAGLQFNF
>IFAGANLK_02502 hypothetical protein
MPMTTKIFIKEKKALGLRIIELREKIIDPRTNKVISQEELGLRTGHAKKTIGEIERGNTN
PTLETLLLIAKELNVTINELFQFNMKDY
>IFAGANLK_02503 hypothetical protein
MTLYEFKLLLDEEQYRLLFNKGDFLTYRLEPNSRFALYALEKFFVEVEYNRKNNKIVNKV
SFVSGEKLDIYSSKF
>IFAGANLK_02504 Nucleoid-associated protein YejK
MQLNKIIIHELAKESGSNETDLQRSKELVDIDENSMGLIDALNKSYNRDKVLYAIFDDEE
GKHFPEKFEEYVATDQNDEQFIALTRNLIGNLEGFIKPVNLATGGYFVFADYESIDNNYI
GIFLIRDTEGKTLSKTANSFSINSIEYVDTGNLAMACRINLDRYTEDEDHYLSLTQLRQQ
EISEYFKNWISIKQLESSSEYTKQLYNIITQIERPINPETDEEYEIENFRNLVFNYVSSN
PNKIVNLRDLSQHFYDDPDTINDYANENNIIIDTEFRYNTRQLKRFVKLEVNRDGISFKI
SRGTFEDKVRFSDDDQSLVIIESNSFANALRNELNNANNQNK
>IFAGANLK_02505 hypothetical protein
MIEIQKKLLEFIHALKYELKSDYIHFPFNQPLQEFLDDKKIDKEKIRDKELNIQYKDLGF
KIYNSQEDFLTIDNVKRNEDVLIIDYDGKTLSKISTEIFVDFVSQENYYFFKNAQSFLEF
IELIKSKDKESEDGFHFIDYVNDVTRKIVITSLKERSRLILNYDKKIPNFDPLFDYSNAL
LQFEKCFDSEKNNLPRFLKSSLIEQAQRYDSKERMKLLFQNLDKVIEDAKITFEVYINNL
SIDQIRKDYDEYKSKYFSEVSDILKKITQQIIGFPIVVASTLFALQRIKDNNDFLYVLAI
VLFLTTIYLILLLNMNFRDLDYIKHLSKEDYKTLEKNRFFTKFPEQIESFKKIKSRVSTR
ITNLEIICESYFWILSVGHTFIIGLILNYLGLNSTALFMICLGILFLMGITKNKVWQEKN
VA
>IFAGANLK_02506 hypothetical protein
MKKEFIKKLHRLAMDNAEMAILSKRKGDLEKFDYYSKDALEYEKQAAIELFSEQVEPTRS
VLFRSAGYLALDNADYVEAQKLYEYALEGNPPTEIISELRELKVEIDTIRLKNEQFTEFV
ITLLKGKKIPINEEDLDGVFKQALLAFSKSEINESHIRQYIEQQYTIESDPYTILDDGYS
PWIDKSIKQNWKYWNRYKQFLQKEEQYAPDTIDKIDDITDDVLDHLKNPAEEGSWDKRGM
VVGHVQSGKTSNYLALINKAADTGYKIIVVLTGMYNDLRAQTQFRIDKGFLGFDTQVERR
LVASNKWGVGNYDSTLVPTPLTSSDLDGDFQRSPIPVDGSGPFIFVIKKNKSVMERLIRQ
LASSGESIGDNKKVIKHAALIIDDEADNASINVSKDSVSTINGLIRSLLSLFQKSGYVGY
TATPFANIFIPVPDQFQAIEPGVNVNRPEFFRQSGEDLFPRDFIINISPPSNYIGPKQVF
GIDSTLVGDLDEEYKALPIVKEINDYQDYIPDKHKHWGDLPGSLPSSLDYAIKCFILSCA
IRRTRGHFTKHNSMLVHVTRFVRWQDKIAYLINEELKSFKRQIEYKEGNILSELKEIWEN
EYTSVTDSIIDDDRYDDPFIKKHEWYEIESQLHKATSKIEVRAVHGNKNETELKHKNITP
LDYYDNKKHGLSVIAVGGNKLSRGLTLEGLTISYYLRASKMYDTLMQMGRWFGYRPGYLD
LCRIFTSKELKQWYRFITIASDELREDFEEMNNLRKSPREFGLKVRQHPDVLQVTATNKF
RYSHDMVLSFSDKLRETSRFIRNKSIIENNFNHTVDFINSLGPTVYNSWQPFVWQSVNNY
NLVINFLKGYTREENPIENEKIIEYIEKQAAKYALRNWTICLVSTRKNMNENYFEVAGES
ISVGLTMRSDIEKGEGNYYIMAKSHIIDPRHEFIDIPENSNIYNNAIEDTIKDWELSERK
NKSETPPEYPSGKNVRKYRGIENGLLLIYALDPKPNGWEDSNIDVPIIGYAISFPKNENE
TKVSYSVNQVFKEEYEYETELDEIFD
>IFAGANLK_02507 hypothetical protein
MILDLTELELGKHHNLTPAMGVSLSHAAAVCINDRGHALNVSSIGKGAYTRNYTLKRCEV
TNEISRTWNDMQEATEEGACGVALVQVAKESKYQVIERSKKGTGIDYWLGDKDGFLFQRK
ARLEVSGSLNGDEKELNKRLQTKIEQTKQSDATKLPAIIVIVGFSHPMILTAER
>IFAGANLK_02508 hypothetical protein
MKVINFEKIHDQFTSEKEIVGFLKKNSNGFVFQIIIERARHYSDLAQYYLEAAYIGQNLS
QHSEKISYNLNRSLEYHPIAQLGLRPIATEIEKLGNLIHFYGKVYSGKHEEESETFMEGY
YEYRETLEQQLHTFPELVDDYYANYINGEYYEYSPVENANFFESEFKSFPERRFGFWKCA
FSDMIGEDFFVSLDSWIIPNTSDLPKILKEYSGIDKINFIKADFFALGNISYLMSDGLIT
HFPFASLLQAKHCYSNIFDNWHIENDIFNRDEIWMHRFITFDRSFAKLSPQENYKGYPDD
RSEELINLVTRNEGFFRPPSVVCFYLSEYGDHILVKDEKCSYLFFGTDKLTHSELFSLSN
RLSILFRTTANLAGIHIEIKCPWEKLDDEKFEELCYDIIYHNPKFDNNTIRKMGKSKSRD
GGRDIVVHTHSRPGYLPEKYIFQCKYLKPGSSLTATRVIDISDTIDQYGAQGYGIMTSVV
IDATLFDKLDAISSRKRIETQEFSVYEMERILARYDNIKHRHFNKTK
>IFAGANLK_02509 hypothetical protein
MDLTDLKKFEGEDASPYAGAMIESFRSIGYSLATAIADIIDNSIAAKAKNVWIDFEWKEE
KTYLIITDDGMGMQELDLIEAMRPGSKNPLADRSNEDLGRFGLGLKTASFSQCRNLTVAT
KSKNALKVIYRCWNLDYVAEVNNWKVLKYLADENFISKLNHLSTGTSIIWQDLDRVISSN
LENSKETMNQFLENIEFLKKHIRMVFHQYLENQKLTIWIKDRKITPWDPYLKTEEATTVL
EKTLINDNIEVVPYVLPLHSKIDRQVFENASGNKGWNSHQGFYIYRNNRLLLAGDWLGLY
KQEEHYKLARIYVNIPNSVDIDNAWQLDIKKSVATPPPEVRRRLKEIADKARKEAVEVYR
QIGRTRQGNSQKNNILVWADKKSKGRRFYQINRLHPIIRNFLSKYPDSKAKLNRLLRLIE
ETVPLPLIVTNETENNDFQTTPFEGKASSDMVKMVIQLYEELINDGKSKDDAIEEILNTE
PFNHYPELSVHLSNEGN
>IFAGANLK_02510 Modification methylase BanI
MSIPVIDIFAGPGGLGEGFSSIFENGERVFDIKLSIEKNEHAHQTLLLRSFYRKFPLGKI
PDLYYDYIKENNRKKQQDILASLRKNYEEEWKMAEDEAWNFELPYPEEFDEKGNKKGGYT
EKEIKDRHEKIDIRISDALSENEKFLLIGGPPCQAYSLVGRSRNQGISDGDHRVHLYKEY
LRIIAKHHPAVFVMENVKGLLSAAIDGKKVFDLIKKDLRYLNTIFEGIESPEYCVYSFVK
KPDSTDENGFPVYNADLDYLIRSENFGIPQKRHRVILLGIQKDLIPEELQILQESEEITL
DQVIGSLPKIRSGVSREIVGLNEKEKNIYSKIKNSLDNWKGIIHEYLNKFDEPIKNEFEE
LLDIDYQGASYFKIELEEENNSLFKPWYYDKNLSGVLNHESRTHLKEDLGRYLFSSLYLK
ANGEFPRLKDYPDWLLPEHKNARDGDKFVDRFRTQKPDVAATTVTSHISKDGHYFIHYDS
SQCRSLTVREAARIQTFPDNYYFCGSRTHQYHQVGNAVPPFLANKLAVIVYNIFQQFQDQ
>IFAGANLK_02511 Very short patch repair protein
MADVHNKSTRSYNMSRIKGKNTSPEMIVRKYLHSQGFRFRLHVNKLPGKPDIVLPKHKTI
IDIRGCFWHKHENCKYGKTVKTSSEVITSRRNSAVDRDQSNFIKWQEMGWTIIVVWSDCE
LEPRKKNSEKRKLILKQIKEALKN
>IFAGANLK_02512 Modification methylase FokI
MNYIGSKNKLIPFITENVQNIVGSDLSKLTFCDLFAGTGIVGRNFKPLVKKVISNDLEYY
SYVLNRNYIGNHLLIPEEGDWLKKLNDISPQEGFIYKNYCSGDKAERQYFSDINGKKIDA
IRMQIETWRDKEQIDESTYFFLLASLLESADKVANTASVYGAYLKKLKKSAQKEMVLLPA
SFQLNGNEHEVYNEDSNNLISQIEGDLLYLDPPYNARQYGANYHLLNTIARYDSFIPKGK
TGLREYIKSDYCSKVKVEEAFEDLIEKSNFRYIFLSYNNEGLMPQKNIENIMQKFGHYQL
ASKSYQRFKADKTENRNHKFDKTTEYLHILEKKY
>IFAGANLK_02513 hypothetical protein
MNNETFGITFQYAICKKYKLSHQISSKRISEDILRKIENSGIIEKLFEKIKPVEFLTFSK
KYTSGFVKKCPHNFLLSDGQTFSIRTFGKKNKKFAPKVVGQAGDNTFNHFFGDLAGETID
RENFKTFCLSKVHEILPILIDYALISDETAWIYIDENENLTFKIIPREDLPELTFERKDF
SFTKDTVATWNETTTAKYKGKTIIEFQLHTNRSGYKIRLDRENFPSLLMIEKVLNNSVIG
DSAEMAICEHFLLDPGVDNDRLKNNSNSLVVSLFKKHYQMNEEELFPYKPVKYGGTAARI
RGGNSKSGIDFILEDGKSLSLKTNKNKNAKVCPPEVGQPSPNTFDYYFSGKRWYEGKMNG
SKFRKIVLDRVILAELLSEYLKHLNECDYLLWSIYNDGSKIASKLVKKKFFKDWYFTPDE
LEYSNDFQDKNSVTIRYGKISLGEFQIHSARNSLKFRFHFGNLVSIIDPERN
>IFAGANLK_02514 HTH-type transcriptional activator RhaR
MLLKKEYNKRDQFLWLNLRNEIVMVRSAVFILDEDLEVLDYSYRHPDNEEVESSKIIGKA
FQELLIVKFQGQWQEKIADFLDNNAQSFNLNLEYQFDEYLKISLPSVVSRLKGRGKGKFT
VTSYHLDTSKDFFSELPKDSGIKSYSKWDQKLFHEIHIYIMHHLEETLKPLDQLAELFNT
NEHKIKTVFKEIFGCTPFQYHARERIKRCKFLIETTDLDLAKISDKMGFGSYPHFSKSFK
EKTKVTPKHYQKIIRNS
>IFAGANLK_02515 DNA polymerase IV 1
MFALVDCNNFYASCERVFDPSLRNKPVVVLSNNDGCVIARSNEAKAMGIPMGAPAFQFEK
DFEAKGISVFSSNYSLYGDMSGRVMNILSQFTPDIEIYSIDESFLKFNGFELYDLERIGK
EMVERVARQTGIPISVGLAPTKALAKIANKIAKKFADRTGSVYAIDSEEKKEKALRWTKI
ADVWGIGRQHEKRLLSINVKSAWDFVQLPNEYVLKKMSVVGLRLKRDLSGESTLDFEEVK
NKKNIAVTRSFEKMYSEFDDLRERVATYAAKAATKLRKQDSNCTLLYVFLITNPFRTDLK
QYRANMVVKLSTPTNSTMVLTKAALYGLKKIFKSDYQYKKAGVIIMGITPASERQLSLFS
KEDPRHQMLMKTIDRLNQTENGKVKFAGMDLGRTWKMKQERLSNRYTSRIDEIIRVRCK
>IFAGANLK_02516 LexA repressor
MKIYKKYSLHHLIMPLSSNGISAGFPSPADDHLEDIIDLNHQLIKNKEATFFGRAEGDSM
IGAGIGNGDLLVIDKSLRPKNDNIAVCFLDGEFTVKRIKIEKDMIWLVAENEKYKPIKVT
SENDFVIWGVVTHCIKDL
>IFAGANLK_02517 Putative SOS response-associated peptidase YedK
MCYETSLSKKLKSIEKHTGAVMRYPEVYEPWYHLSGFTHPNMFCIPMDEPDIILPMEWGL
LAPWADDISTFRKKYNTLNAKAETLLTSNMYKEASRERRCLILADGFFEPHYEKMSGPAT
PYYCYLEGRKLFSFAGIYNTYDEDYWTVSLITREANDFFAEIHNKKKRMPLAVDRNFEGE
WLDPDLNDNGIEEVLATSFMREPFKAHPVTRDLYKRGVNTNTPEILEKVEENPNHF
>IFAGANLK_02518 hypothetical protein
MRLNKDHKKSHIIGKLKVPYSLNEPFFRRKKWVDEHDTKKLEEYATGFFVMFLRNIERRK
VLYSSPNPDDDHKNPDTYVHLDGKLDGIQIVQLTLNNHLTNFNQTKRLCEDISRFITNEY
KPPIKINIQIYPPWETERPPKFSTKMRKKVAKEIAATMEKNIQILKEKKEYLNFELDRKI
FGKVADSFNLYPIPSSYHSTFFGDNNVYIDYEFDAIQISEEDIISACNKIYSDKNGGNSE
ILLIWGDKNHFMGTESLIIDNLKQRFQTTTFKSVYFLAFHNLLDVQERIYNCEKII
>IFAGANLK_02519 hypothetical protein
MQGKKDYQEKLFTSFRLIDRIPKGNFYRRLKETLDLDFLYPLTLNFYGRSGQKSIDPVVF
FNICLVGYLENITTDRGVMDHCGMRLDVLSFLGYDVDEEIPWHSTISRTRQLFPDDIFEE
VFTRVLRLCIEAGLVSGHNRLEILLP
>IFAGANLK_02520 hypothetical protein
MKKKNRLSKWKKQEKFSIVFESPMDSDFEKFLKIWNDKNPSNEKNLFGSDYDLMKMTREL
VFDIKKGVPVFHYICPMLDTKKLEISYHHLIDSVFEGDETDIEKEVINTLGIATALEVPI
YPNNEIVEKDLSNYYQKLIQNGFTAPDEKGNDVKLVPVNSKKMEDFKIDKFSKIDLTKFW
SPTDLLMLKQVVKEEFLKLNNAHRTLTMLELAIQQLENLLDTSKRNENNLQKCITENPIL
LGLDYAKIIPKHKLGSEFEVDYALEKFNGLTDLMEIESSNLNIFTKQGNPSSYLVHAEQQ
VIDWLDWIEKNNAYARNGLEGLISPKGFIIIGRSSSLTEKTKASLIRRNKAFNGNITILT
YDDVLIKAKSLRDILKNEKTSYNIGSSQIKRG
>IFAGANLK_02521 DNA replication and repair protein RecF
MNSPYISRIRIENFRNFKEIDVNLNHKQVIIGENNVGKTNFLRAVQLILDRDFSDMDREL
SLSDFHDSIEDPKGNGEEIKIVIEIRNYEHNRQLLAQFQDAVVSTKPPTLRFTYKYFPLI
DENGEILSYKYQIFKGITEDKFFRSEDRNFLNIKVISALRDVERELNANKRSPLYKLVKQ
YDIDKEVLDEISEAMQDAAEDILTLDEIKDVKKIIGDRFETLAGLQHDNEINLRPYDIDT
ERLLYTIQVYMGLKGRPVSELSLGLGNILYVTLMMLLLRDKTVPRIIKKETYDDLIAKEK
STLISENYVVNAKGNNYIQNDNIEAEVRNQLYEFFDQHNHQLHSVTILAVEEPEAHLHPV
LQRLIYREVLQKSETSVIFTTHSPYITAVAPLESIVHCRHEKGESKVFSTANLMIDSKDK
TDIERYLDSKRGEMYFGKGVLLVEGITEEYIVPRTAELMGTYLDDLGILICNVHSTNFKP
YVQILEALDIPWCLITDGDFYDLEIKTEGDKEKRIRHYHRMWQEKESQQYRGLELMNKMN
VDLGIISEAEIQTDNIQGQFDLLEAKGCFVGFYTLEIDVMIKGGDEGKEILKKVYSEVRP
GGERQQRNFNKELDKDNFWAALSKIESNVSKGRFAQRFTSHMTLNSVPDYIKSAINEIIK
KVTTAHE
>IFAGANLK_02522 ATP-dependent DNA helicase PcrA
MNDKFYIDLKLIQSDKSQWNAYNSKGDTVVIAGPGSGKTRILTLKAIKLLKSNIHYPSGL
ACISYSRETVRELKKRLKEYGYRPNGNDFIGTMHGFCLINILQPFTHLFPQYNVPLPLKI
ASDELSNSIFRGVLSSMGIKTDEITTKQFIGYKMNINRQRSLSAIGLSQVNVQIDAFEAA
AAKEYEKRLENAGHVDFVGMINSATLMIREQDFIKTSLEAKFPWMLIDEYQDLGKALHEM
VLELQAVTSIKIFAVGDMNQSIYGFNGAYPDFLEELDGIDDFESIPLTSNYRSNQDIIEG
SLDMLTVAPPRPEYSAKKRIDEEAEFTFIVCESEMRPQYEVVAQKVIPKLKEKGISYNEI
GILVASSNDVVKMATKLNENNIPFYIVKWDFVNSDIVFWLQECAQWCLDNKIQSFDELFS
FWQLQLHVHESERAMWEVIRQRVFFHKVLMESKAKTIVFEWLQFILSELDLKDLLSNSDR
YPEENDNLNALLDEAQNKNLKDAPLRRFAFLGEPEDEITITTRHSAKGLEFEAVIMLGME
EERFPYTYMIEEGSRQMQEAHRLCYVSVSRAKRECILIRSKKHTLQTRRGPWLKKYQPSR
FWDTLYDRFGSDKNIYKSRGY
>IFAGANLK_02523 Tyrosine recombinase XerC
MTNIQVVLRPNKMKKNGTIPLALRISENYKTNYYFLGHSILEKDWDETLKKVKKTHPNHK
KLNYFLNKKITEAQDLYFHSEDDLTPRQIKNKLKGPGGSQSFFAVAAERVKQKYDKGTFS
VAKSELSILYNLEEFLNLKTNQKKEEVIKSIKERRRIRVSKTRKGEYSFGEAITYFKRNT
RLEFREMNESFLNKYKAFCSTHMGHKTRTITNQLIFIRTLFNVAIKDGIVSQKYYPFAGE
KEKIRIGSGNKIGLTAEEVTKIENLAVESHSSIWHTRNVWLVSFYFAGIRISDVVALKWT
DIKDGRLYYVMNKNEKPLSFKVPDKAKTIFNLYLMDKTENNGYIFPFLKDADQQDPKSLF
LKMRNATKVLNKFLKRIADECEIDKNLSNHIARHTFGNIAGDKIHPLMLQKLYRHSDLKT
TLNYQANFIHRDADDALDSVINF
>IFAGANLK_02524 Phytochrome-like protein cph1
MDVKNIDNEFDLEPFFSRSHDYLCIAGFDGYFRKINPAFIKLMGYTREELFASPISHFVY
PQDKKKTAETRAKILEGLPLLHFQNRYITKSGEIVWLTWTSIPVPEKELIYAISKNITHI
KKLEEDRHFRIRDLTSKNSGLTQLSYTTAHDLRSPVNNLISLVNLLDRSKIQDEETLSCL
ELLEISVYKLKDTLNDQVDHLKENNLLKPSVQPVNLKELIYTILSSLRSLIEETGTCVEI
DFSEIEFLKVNQFYLHSIFLNLITNSIKYAKPGFPPRISISSKRNEGGSQIRFSDTGIGF
DMEKNKNKIFGLHQVFTANKDSKGIGLYLVKSYMDSLGGEIDVMSETGVGTTFTLSFKD
>IFAGANLK_02525 hypothetical protein
MKRASETSRAQNIFRILLAIFMIFAGFSHLTFNRVDFQAQVPDWVPLSKDLVVILSGIVE
MALGLALLFWKKQRVIIGWALAIFFILIFPGNIAQYLDRKDAFGALDSDRARLIRLFFQP
VLIAWALWSSGAWEAWRNSKK
>IFAGANLK_02526 Organic hydroperoxide resistance transcriptional regulator
MDDQQLKLNNQVCFPIYSVSRLITKAYKPFLEEMDLTYPQYLVLLVLWENDKLSVNQIGE
KLLLNTNTLSPLIKRMEKMDLLKRTRSKEDERSVFIQLTEKGKALKNNALPIPEKLLNTL
VTEDVTLTEVMLLKDTLDKWIDILSDKKNSR
>IFAGANLK_02527 Alcohol dehydrogenase
MKALQIVKYGEIKDSLSINEIEKPSVKPNEILVEVKAASLNPIDYKMAQGHLKELVSLKL
PATIGFDVSGVVVEKGADVSDFEIGDEIYSRVPHEQMGTVAEFVIIDADKVVRKPENISF
EEASGLPLTGITAIQALEKAGLKKDDRILIHAGSGGVGSFAIQYAKAKGAIVYTTTSTKN
VDWVKALGADRVIDYKTEDYKEVANNLDIVFDTLGDDYTFDAFQIIKEGGTVTSIAGPPD
EESAKIMGIEGYKLPEQLSNLIEDNSVAYKHTWMQPNAAQLKEIKGMVEDGDIKSIVDLI
YSFEDGVNAYEYLATGRAQGKVIISLSKQA
>IFAGANLK_02528 putative sugar epimerase YhfK
MIMSKKKNVLVAGANGSTGRIIIDLLKKSENHQPIAMVRKPEQKEHFEKENVTAVLADLE
EDLNQAVKGADKVIFAAGSGGNKVVEVDQEGAKRLIDAAKNAGVEKFVMLSSMGAGKPEM
SEELGDYLEAKGNADDYLQKSGLTYTIVRPGALTDDDGSGKIQLKKKLEKQESISRANVA
RTLVEVLDDDVKQNQIFEILDGETLIEKAVRD
>IFAGANLK_02529 General stress protein 18
MKVLFVLTSHDKLGDTGEKTGFWIEEFAAPYYNLVDKGVDVTVATPKGGKAPIDPNSESE
DAQTEDTKRYYKDAETQKVIENTLKLDGIKSEEFDAVFYPGGHGPLWDLAEDKTSIALIE
EFNKQKKPIGLVCHAPAALKNVKKENGEPLVKGKKVTGFTNTEEEAVQLTDVVPFLVEDM
LKENGGIYSKSGDWEVYVLEDGNLITGQNPASSEKASEKLYEMLK
>IFAGANLK_02530 hypothetical protein
MRFFEIILLVIATIFPILFLIKLKIPKRKTFAILIGIIFALHLVLEGARWQMSLGYLIVL
GVLFLLWKQTIRVNMNLLVKIFLTTGFGIVLILGWFLPSILPVFKLPTPTGNLEIGSKYI
HIKTDRPESITWDKDDKRELMIKAWYPAQIAGENSENYLDKGSRLGFADKYGLPGWSMDY
LDLIKTSTYKSPEVANGKFPVLIFSHGHYSKAFGYYALIEEIVSQGYIVLNINHTYESTG
SIFPDGDIKLYNTTYDSLNNNQEMANMAWNATQEFNQAESTKEEFKAIKDLMEDYIAAES
IKRWSKDISSVIDHLENEKSFLFLKNHIINSNIGVFGHSHGGAAAGQVLLEDKRVKAAIN
MDGTQWGTMVNSTLNKPFAYISSDWLKEQPNFNKHAFRNKSNADFYNIKIENSGHSNFMD
IPLMVNFSAINEEGSIEPFKAYKITNSLILNFFDKYLLNKSIDILKNEFTGITIESEF
>IFAGANLK_02531 hypothetical protein
MEFRVDPDTWFVFSILFISGLGLFIVGFIAIPYILRKKQIERLQFKFDRKSDRFEKVEKK
ISHRRENQLEKNNQKLKSDLKISLRDIVKNNQLEPESLTFFSDFEKIYPDFTSSLQKKIP
KITSNEIKLCALLRMNLSAKAVSEVLNITPESVNKARYRLRKKIGLKPRDDLYLFLLNIS
NSAN
>IFAGANLK_02532 Phosphatidyl-myo-inositol mannosyltransferase
MKIAYIGTYPPRECGIGTFTQNLAYAMTAKNQDGEKNHKRLIIAMNDFDETYIYPQEVKL
TIRQEQQTDYLKAANFINSNGADICILEHEFGIFGGNAGVYVLPLLHHVKIPIIVTLHTI
LENPSYTEKAILKEICKMADKVVVMSQMAISFLISVYDVPDNKIAFIEHGVPDIQFDRKQ
SKTEFKLKKKKVLMTFGFIGRNKGIETVIKALPQIIKNHPEILYMVLGKTHPNVLRSSGE
EYRNYLQLLIKNLKLQNHVLLLNEFIDETELFRYLSACDIYITPYLHEAQITSGTLTYAM
GSGCAVVSTPYWHAAELLQDGKGRLFNFNDSDDLAVTLGTLLDNPSILKDIQRKAYKYGK
EIKWPRIGEKYLELAKSILKTPKKESLNEEQAIIDPLILPPFSLAHIKRLTDDTGIIQHA
KFGIPNLKEGYCLDDNARALLMSLMAYNQKKNPLALELMPIYLSYIHYMQNEDGTFRNFL
SFNRNFLDIKGSEDSFGRTIWALGYLMRNAPNDAYYQNGKLVFFNAVPVLERLNSIRSIA
NTIIGICYYLQTNPGDEEMVVHLRNLSSKLVTQYENNRTEGWHWFENLLAYDNGILPLSL
LHATQILNDERIKSIALESMDFLTENTLKHGYLSIIGNKNWYVKNEERSIFAQQPVDALA
MVLMYYQAFLLTKDKEFLNKLFLSFMWFLGENDLRMSLYDFDTKGCCDGIEKYGVNRNQG
AESSLAYLISHLTVLQAYEELYQSKEFKSAGLSKTMVNSS
>IFAGANLK_02533 Glycogen synthase
MKIAILSPIAWRTPPEQYGPWEQVASNITEGLVEKGHQVTLFATGNSVTKAKLEWVCKFP
YEVDKNNHPKVLECLHISHLMEQAHRFDIIHNHFDFLPLSYSGLIKTPMLTTIHGFSSSK
ILPVYKKYNSSTSYISISNSDRNKELDYLATIYHGLDPENFTFRGNKENYLLYFGRIHPD
KGAHAAIEIAKKAGLPLKIAGLIQDEAYFNSEIKPFIDNENIQYLGNVGPEVRDKLLGNA
KALLHPIFFEEPFGLSVVEAMMCGTPVTAFERGSMPELIEEGKTGFLTENIAEAVLAVKA
LDKIKPEACRALAVKKFSLDTMVNAYIEAYKTVINNKSSSL
>IFAGANLK_02534 1,4-beta-mannosyl-N-acetylglucosamine phosphorylase
MRVSVERKDVKFMPDSSRVVVRFFMNGDQRTQNLVTRILAMSDFQVNQTLEQTLREFSWR
HRNISKIFLKHCSNIRHIIEAMQVNYAELSEERKLLIGSYCTMEYALESAAFFNPSMIED
FDQTYLEEGEKRVIISFRATGEGHISSLVFRRGILDKNNDLHLMKIGNHIDKAEISHKKL
YDKKRFIERLEEMDIPMKFSKAIMNRLPDRFEYYVLKQEVRKILEDTNMIAERRRALEEI
TWLVDSFYDIEFKHDADLSARVIFPISESESSGIEDARFVRFIDDDGQIKVYATYTAYNG
RTILPKLLSTDDFYTFRIMPLHGDGAQNKNLALFPTKIKGKYAMLARIDGVNNYIMFSER
NTLWKNPILLQKPKYPWEFTQIGNCGSPLYTTEGWLIITHGVGPMRRYCIGASLFDLEDP
TKEIGRLEEPLVTPLENEREGYVPNVVYSCGALIHNQSLILPYAVSDYSSTYAVVKLTDL
FSALKRR
>IFAGANLK_02535 hypothetical protein
MKELVENIQSTFENFQTEANAQLESGNKSAGTRARKSSLELEKLLKEFRKVSVAESKK
>IFAGANLK_02536 hypothetical protein
MACKSDTKKEENKEPESEWVNLFNGENLDGWIAKFHHHEVGENYANTFRVKDSIIQVNYS
DYDEFDERYGHLFYEEPFSSYHLKFEYRFTNEWMEDAPDYAYRNSGVMFHSQAPETILKE
QDWPISVEYQMLADEGDGEPRPTGNMCSPGTEVFFEGEMDPRHCIESSSETFPLEEWVQA
ELIVYSDSLVIHKVNGEKVLEYTKPQIGGGVVSGYDPEIKKDRKLLTEGYIGLQAEGQGV
EFKNIKIKEFN
>IFAGANLK_02537 Xylosidase/arabinosidase
MKRINSGKFILLTLLPFLIISCKNEKKAINDQTDSIKKENSEELISNPFHDGYYADPEII
KEDDTYFIYATMDPWGGEKLAVLETKNFKNFKTHHLNWPTKKDNTSSTSGDAMVWAPDVI
KAKNGKYYMYISVGSEIWAGVSEKPLGPWKNAKEDNTPLIRSNLYPEYHMIDAHCFIDND
GQAYLFWGSGLNWKNGRCFAVKLEGDMISFDGEIKDITPPNYFEAPYIFQENDKYYMTYS
DGKAIDSTYKIRYSISDSPLGPWTEGTNSPIATTNTAINVYGPGHNSIFKEDNQYYLLYH
QIYPQDKDYVLRQLRIDSLNFDQEGNIKKISYEGIKSFSD
>IFAGANLK_02538 Beta-glucuronidase
MKNIVIIILLLVINYPGQAQEGLITNINGRESKSLNGSWNYIIDPYETGFYDYRYKERNE
NDGEAYWSRPQEEKKEDRIEHGYEEPYTLQVPGDWNSQADVFKYYEGTVWYQRSFDLDDL
DKNERYFLYFGAVNYEAHVYLNEKKIGSHKGGFTPFNFEVPKELLQKEDNFLVVKVDNKR
HPEEIPTVNTDWWNFGGITRDVALIKLPNNFVEDYTLRLSPDQDIERSERKNKFTISGSF
KVNESADSNAKVNLEIPELKFKKEFTKDAISEFEFNVKNLELWSPENPKLYDVKISYNNH
TISDKIGFRKIETSGKDILLNGEKIFLRGISIHEEIPQDVRRAKNKEDAKQLFGYVKDLN
ANMVRLAHYPHNENMTRLADSLGIMVWSEIPVYWTIDFESEKVLEKAKTQLQEMITRDKN
RASVIIWSVGNETPVSETRTNFMKSLIERTRKLDNTRLVSAALEVGYNREKNYVDDPLGE
FTDIVSVNEYLGWYGDLPHAKENSNWEVAYDKPLFISETGAGAKGGFYGEKNERWTEEFQ
QWYYEETIKMMKRMPDNYSGISPWILTDFRSPRRNHPKYQEGWNRKGLIDDKGNKKKAFN
ILQKYYEEIEKNKSK
>IFAGANLK_02539 Beta-galactosidase
MRKIISLAIVLFSLTNGMAQEKNDWENPELLDKNKEEGRSYFVLYESEKQAQTKKPKASN
LYQSLNGNWKFNIVKTPAERPKDFYEPNLDDSNWDNITVPSNWEIEGFDIPIYTNVTYPF
PKNPPYIDDAYNPVGSYRKNFSIPKDWKDKEIILHFGSISGYAQVFLNGEELGMTKAAKT
PAEFNITENLKKGENVLAVQVFRWHDGRYIEDQDFWRLSGIERDVFLQAMPKTAIWDYFV
KSELDQEYENGLFNVEVDIREFNKSKIKNPVLSISLKDNEGQEVYTEEKQVTTTDENIIF
SETIQDVKKWSGEHPNLYQYTIQLKDRRNNALAVISGKTGFRTVEIDDAQLKVNGEPITV
KGVNLHEHHGDKGHVPDERITKKDLEVMAQNNINAIRMSHYPHGQYIYDMADEYGFYIVD
EANIETHDMGAEWQGNFDKEAHPAYREEWRNAHLDRIKRMMQYNKNHSSIIIWSLGNESG
NGPVFYDAYDWLKENDPTRPVQFEQAGENRNTDIVAPMYPGIQSMKNYANAEDKTRPYIM
CEYSHAMGNSNGNFQEYWDIIENSPHMQGGFIWDWVDQGLRAYTDEGEEFWAYGGDLGGE
NMHHDQNFNANGLVTADREPHPALFEVKKVHQNIKFSLDGQNLTVQNDFNFTNLDKYQFK
WELVKNGKVVKEEYFNVEAAPNTESKVKLELPELGDEEETYMNVFAYTKEATELIPVGHE
IAREQFPLNKASFFESEKEQIEGNITHHFDNEIFSFSTNNISGKIDAKTGKITEYNYTNS
EEEFISQFPQPYFWRAPTDNDFGNQMPERLKAWKEATNNEPEVQDFKIDDKKEDGVEVQV
TYQLQEVNVPYTVSYFIKNNGEIKVSANINMEGKETLELPRFGMRMILPGEYENLTYYGR
GPWENYNDRNSSAFLGVYEDKVENQFTWTYIRPQEAGYKTDTRWLTLTNTNGKGIKIIGD
QPLGFSALDVKTEDLDPGESKNQMHPTDIPTYDKVFLHVDLKQRGLGGNNSWGAYPLEKY
LLKDNHYSYSYTISLIK
>IFAGANLK_02540 hypothetical protein
MTIDRCCNRKFFLFLSLGCIIVLNACVSSKMAEIYVGDGWANNSVNTVIFREKAITTHKK
NQFTAFYNEEGFMVLAKRKLDRSSWEIHKTRYKGNTKDAHNAISIAIDGDGFLHVSWDHH
DNELRYARSKKALGLELSEKMPMTNNLEDKVSYPQFYNLKDGNLVFFYRSGHSGSGSLIA
NNYSTKTHNWTRLQDNLIDGEDKRNAYWQTTVDSKGTIHISWVWRESWDVATNHDIAYAR
SKDGGKTWEKSTGEKYELPITESSAEYAWKVPQNSSLINQTSITTDAEGNPYIASYWNEE
NIDATQFQVVYLEDGNWKKETTDFRKSFFNLGGGGTKSIPISRPEILIGENVRGKKVYLL
FRDEERDNKVSIAGKSFFSNDKWKVDDLTDYSVGQWEPNYDKELFQIKNDLHIFLQKVIQ
VDGEGIAEEEATPIKILEIKNLP
>IFAGANLK_02541 hypothetical protein
MEYKKIFLIVVGILMNFPAGFSQNRENKIRKNVPLDSIRLSDPAILADDATSTYYMTGTG
GMLWKSKDLKMWTGPFNVVQTDPNSWMGDNPMIWAAEIHQYNDKYYYFATFTNRDVIIDT
VKGNEIERRASHILVSDKPDGPYVPMEDLTYLPPEKPTLDGTFWEDTDGKPYMIYCHEWL
QNWDGTMEKIELKPDLSGSIGKGEILFRASDSPWSKEYDEEDNEVPNKVTDGPWLFRTKT
GKLGMIWTSWDHSVYAQGVAYSKSGTLDGPWEHEKELITPPDYGHGMMFHTFEGKLLMSV
HSHREDENGRYIRIPHLFNVDDSGDKIVINHLRND
>IFAGANLK_02542 Beta-galactosidase BoGH2A
MRKKSFIRVFLLVAFFFTLPDLFSQQMGKEKFNDAWTFHKGDLSIERATSDQVSWRPVNV
PHDWSVEGPFSSEWASGTGFLPGGIGWYRKDFNLKDYDKNKRYAVYFDGIYKNSEVWING
HYLGKRPNGFIPIQYDLTPFLQADNNLIIVKANHTDYADSRYYTGSGLYRNVYLITQEEH
HFSKWGVFFQTPEVSKERATAKVSVELENHGKEISKKTVQIYLKDNDGNSVATSKQDISL
RPGKENYLEFDLEINDPKLWSPGSPYLYDLEVNLVEGSTEVDAWNEKVGFRDFHFDADRG
FFLNGENMLLKGVCFHHDAGALGAAVPKEVWEKRMETLKELGVNAIRMAHYPHQDFIYEL
ADEMGFLVQEEAFDEWEYGKNKWIEGWNVGTPGNEGYHEAFSEWGVKDVQDMVRRTRNRP
SIIMWSIGNEIDYPNDPYSHPVLDEGRNPQIYGKGFNKENPPASHLAKLANELANAVKMY
DTTRPVTAALAGVTMSNHTLYPSVLDIVGYNYQEYRYEEDHKEFPERVIYGSENGDALDA
WLAVVNNDFISSQFLWTAFDFLGEAREWPVRSSGAGIIDLAGQPKPDFYFRKSLWNNQPM
VYIGVANSERDVNRRSNIEEAWIGEEGQTKWITAYTNTEEVELFLNGESLGRKEAVYQND
KMIAWEVPFSPGELLVKGYDKNDSIVSEYKLVTPGTATDLQIQTDKRSSSEGIEEIIHLD
ILLTDKEGNRITDDDREVSIEVEGPAKLLGLESGDLSSHESYQAKERNTYKGQLRAYIET
TGEAKEVNIKISSPGIPEKEISF
>IFAGANLK_02543 Glucuronoxylanase XynC
MRIKTFIVFSIILTSLLFACNNNSDANNQEGDDGEAPSNSITLNIDRDETFQTIDNFGAS
DAWSTQFVGKWPQSKKEKIADLLFSSEKDEQGNPLGIGLSLWRFNIGAGSAEQGENSGIS
DEWRRAEGFLNDNGSYNWEKQSGQIWFAEAAQARGVENLLLFSNSAPVQMTRTGKAYAEN
ENTNLAPENYSRFAGFLSDVVKGFQEKGLDPDYISPINEPQWDWSDGGQEGTPFRNNEIH
SLIRELNKKLEEENLDVKIDIPETAQLNYLYEKDNKPQRGEQIKSFFDESSENYVGDFSK
ISNTISGHSYFTTYPYSEVKEVRNKVKNEIDNYDNLKFWMSEYCILENNEIMKGNGRDLG
IDPALYVAGIIHADLAIANATAWHWWLAVSPYDYKDGLVYIDHQKNDGNFYESKILWALG
NYSHFIKPGFQRVQITASDNTKADTFLYSAYKNPNNDETVIVLINKSNEELSVNLQQADE
SLINLKAFITSSEKDLEVKTVNSEVTIPSKAIVTITTN
>IFAGANLK_02544 SusD-like protein
MKNNILLKLSSIRLGILFLAVTFIGCEKDFLEVNPTDRLSEVAIVQDSTLFEAYVINRYL
GVRLTDKEGDGSVPGFGRGYEYAMMGTVTDEAIYNNDDNTWLIQQGQLSPENTGILGTFW
GRSYRSIREVNYALKNISDVEMSESGKAKLIAELKFIRAFRYHDLIRNYGEVVLMGDRVS
ELGDDFSNPELFEKTSIQESIEYVIEELNQAAEGLPLHNDGEWEDGRATKGAALALRSRL
LLYAASPLYDNDNSDPQKWQRAADAAQDVMDLGIYSLYQDGYADMFLTEGSHSEIIFARY
YNINERHTALEIANGPNGYGGWGGQVPLQNLVDDYEMADGSEFNWDDPEEANSPYENRDP
RFYESILYNGAEYRGREVETFTPGGLDSQDGPDNWNTSKTGYYLRKFINEDLPIQNPWEV
AGTQNWIYFRYAEILLNYAEAQNEVSGPDESVYNAVNQIRSRNGVEMPALPAGLSQEEMR
EAIRQERRVELAFEEHRFYDVRRWKIAMETENVPAYGINIRKAEDGSLSYDRKIALEGRS
FEEQHYWLPIPRQEIQSSDGQLEQNPGY
>IFAGANLK_02545 TonB-dependent receptor SusC
MSKIFLKSEKCQKYLSVFFLLFTTLLFAQQKEVTGLVSDEAGLPLPGVTVQEKNTNNGVV
TDFDGNYEIGVSSSGATLVFSYIGFKTQEVEVNETNSLNVTLVEDLGQLDEIVVVGYGGK
KRATLTGSISEVESEELQRSPQPNLSNSISGRVPGVIANNRSGEPGYDDSSISIRGLATT
GNNDVLVVVDGVPGQIGGLSRLSPEDIESFTVLKDASAAIYGSRAANGVILITTKKGRNA
APQISYKIDVGIASPTRLPDLADAPTYANIRNEIAYYNNPSDGFNQIYSDQEINLFRDGS
DPINYPNTNWPEEGLQNTTIQTQQNLNVRGGGDNARYFFSLGKIGQDGIYKDGANRYDQY
SVRSNLDVDITDRLEVGLSLNGRKEDRQFPTTGAGEIFRSLYRAYPTSPAVFPNGNPSTG
IELSNPLVRATDAGGINENPKYVFNGILRGSYDIPFLEGLSIDGFFSIDESSNRTKNFIT
PYTLYEYRNDEYIPRVVGGGPDQEAALYEEHFNESKTVGNIKLNYNQQFGAHNVDAFIGY
EQSENKSHTMGASRIHFPTTETPELSQGGAAAADYDNYGSSYNFTRLSYLSRIAYDYDEK
YLAELQMRIDGSSIFPEGNRYGVFPSVSVGYRITEEEWFKESISFFNDLKFRASHGKLGN
DNVGQFQYFNNYSFNNRYVIGNQVTTGIDLTRLANPNITWEEAIKTDIAFDARWLDNFTT
EFIYFRQDRSNILTTRNASIPATSGIVNPYDAQSLVPSENIGSVESHGIEAVLGYDYSGE
DFNFGVSGNLTYATNEVIFMDEAPGLPEYQQQTGRPMNTYLLYKTLGIFRSEAELEDYPH
VPGAQPGDLIYEDINGDGEINADDRYRTEYGNIPEITFGLNLYAEWKNFDFSALFSGQTN
VSQYVLPESGTVGNYYSSWADNRWSPDNPNGSYPRVSERASSAVSGGLFRNDFWLDDASF
VRLKNIQIGYSIPSTLLERFSVSSARIYASGFNVFTITEVEDYDPEGASESGQFYPQQRI
INLGLNIQI
>IFAGANLK_02546 Sensor histidine kinase TodS
MKIRYLIFFILILKTSFLVSQNSIKDGSLGDSLHFHLLDVSSGLSHNFINDIKQDSLGFM
WIATIDGLNRYDGNQFVQFKKQRGSSERGLVNNYIQQLELKNGKELVVATDAGLVIYNSR
IDKFQLINTEDGLLNNSVSAIETGPGDNSVIGTYRGGIQFANNKWDLKYSRENFVQNINL
TSNEISSIQLQQDSILWVGTYNDGLNKINLKNGRVSHLFEKNKSTTSRVINSLYEDIDGN
LWVGTRNGLHVITRLNDTISINAKSGSQGLSDMDVLCFEEDLNNNIWIGTRNGGLNILEK
SSLFNDSSNINIRRYLPRNDGSSVYNRTVSVITRDKDNNMWIGTPTGINYVNPLGDPVRL
ITHSADKKSISHNRIGALAQSGEGKVWIGTDGGGLDLYDPQTGIIFNYHHNEEDQSSLSN
NYILSILEDSKDRIWVGTYQGGLNRLDIKNGKARHYLQGSVSNGSDVRVIFESRNGTIWV
GTNRGGLYKYIEGKDRFKYIESLGKIDIRSIVEDQEEGVLWFATFGSGLIKYNPEADDFQ
SFNEDNTKGFNSDIIFSVLLMENGEVLAGTRFGGILRFNPKTKEVLTFSVEDGLSNNTVN
SLIWEDETYIWMGTYNGINRYNVETNEILDVSSLDNLQSGEFNIGAALKNSSGNLYFGGN
NGLNILDPNHFKRVKQDYPLLFQGLKVLNKTVEVRVEEKNSILRQAIFYQDKIKLNHNQN
SFSVEFASLKYPEAHNLTYSYKLENHNKYWIEDQKEGIANFTSVPPGEYILKVRVNSGVN
TKNYKELKFNIVPPIWKTWPAYLLYFIMATILIWISFKYYSERVHLKNSLLFEKKQRHLE
KDLNEERFRFFTAFSHELKTPLTLILAPVENLLEIQNKKIKTDLLFIQRNARKLHHSINK
LLEFRKAEEGLSQLNRREHDISENLKTWIENYLPLAKEKNITLEYSLPVDKKIFNVDIEK
IEVVINNLLSNAIKYCKINGEVKISLICNSDNFKITVSDTGTGISKEELSHIFNWYYRSN
SNVKEKGNGIGLALSKRFAELHGGSIHAESTPEEKTIFTLAVPAVEIKEVEEHLNRDDEK
VVTGQVFSDNIKSRKQTANLKPNKDRRLILIIDDNEEILNFLSNIFKEEYDIIHSRNGRE
GIVKASNYVPDLIISDVMMPEKNGVDLCFELKQQHSTSHIPIILLTAKGNFESINLGYEQ
GADDYIVKPFNPKLLKTRVKNLLFSREQLQHHFKGVRENKSKTEEKVSVLLTKEKEFLSE
LDLIIAKNMGKGTDNVDLISQKVGMSRTSLYRKLKAITGLSINEYIRNLKIERAAELIKN
ENFSVSQASYEVGFTNLKYFRKIFKEKFGKTPREFKS
>IFAGANLK_02547 SusD-like protein
MKRYFKITALVFSFAVIVASCEDSFLEEEVRSAYTPENLTDALGFEAALVGLYQQMGAYQ
GLSWAQGWLAVWQVGTDIVWPTLPQGIEVPYYEYSSLTADDQATTYTWEWNYNLIENANS
IINNVENPELQAPDMNEEDRNRVNAEARFFRAYAYNMLATLYGGVPLVTEALTEPRTDFV
RAPIEDINALIEEDLNFATEHLPEVGGMPAEARINKYAAHQLFAEFYLRTDEPAKAEEEA
DAIIESSAYSLVTERYGVKADEDGDPFSDMFWKGNQRRSQGNTEAIWVLEMENPADVRGG
SVGAPQHRRVWGAQYHSRAGMLPADSLGGRGLSRIRLNNFVLYDLYDQGDMRNSEYNINR
ELYYNNPDYEDYGERVPYEGPDTLFITNPYTMKWKHFDERDTFGWGMWKDFILMRLGETY
LLKAEAQFKQDDFAGAASSINELRERANAPMVDAGDIDLDFILDERVRELIAEENRRMTL
MRTGTLVERANRLNNDAPENMQIRGLSETHLLMPIPLREIQLNKDAELEQNPGY
>IFAGANLK_02548 TonB-dependent receptor SusC
MNVKNLHNAILCVALLFSFQALPFKNAENNKKVQEIITGTVTSAADNLPVPGVTVMEKNT
NNGVVTDFDGNYEIEVSGPDAILVFSYIGFETKEIPVNDQEAINNVVLEEDLGQLDEVVV
VGYGTQKRSDVTGSVSSVPQERLENLPVTNVTQAIQGTTAGLNITEGSSVPGSTGSIQVR
GVNSINANNSPFIVLDGSPFFGTLNDINTRDIKSIEVLKDASAVAIYGTRGSNGVILITT
KEGKLGKPTINYTVYGGVEEIANIFEPRGPDAYVQKYADYMNAMGLEQNRILPNFREVEN
YEAGRTTDWIDEVTRTGVIQEHNLSINGGSENASYYLSGGFLDQKGVIQGYDYQKVTFRT
NLDLDVTDYLKVGVNAFFANNNFNGGRANLLEAAAMSPYSVPYDDEGNMIIFPMEPEQLF
ANPLLPLNTDRMERDNNFSGNAFAELTPGFIEGLSYRFNASYAHNPYTYRFYSGRAANNT
QGGTANLTNSEENNWVIENILSYTKSFGKHNLDFTALYSAQENEYFTSSSNSSGFINDAL
SYYNIGAGENIGGSSNSWKSTLLSQMGRINYNYDSKYLLTLTARRDGFSAFGADTDKYGI
FPSMALGWNVHREDFLQDSDNINQLKLRFSYGETGNQAVGVGQTQTTASTTLYPFGGSAQ
VGTYLGGMGNTNLNWETTTSANFGIDFGFFENRLGGTIEAYRSRTRDILIQRSLPSITGS
NSVWDNLGEMQNTGLEVTLNTVPIRNDNFRWEMDLNFSTFKNELLDIYGDGEDDLGNRWF
IGKPLWAVYDYEMVGVWQEGEDPSNWDPSARPGDLKFADLNGDGVIDPENDRKYLGTGLP
SWTGGLTNRLSYKNFDFSIFVQTIQGVLKNNSDIHFADEGGRRNTPIDVGYWTPENPSNE
FASMGYRNPRGYGFPRDASFVRIKDARLSYRLPADIIENYGVSNFMIYVAGRNLYTFTDW
IGWDPESNQDPRGSGNWTNNYPVVRTFSVGLNVSL
>IFAGANLK_02549 hypothetical protein
MERKVIFLVFLVNSLSITAQETTYPYDAFYPGTIWEDSGENHINAHGGGIMFKGDTYYWY
GEHKGKSSKARVGINVYSSKDLYNWKKEGVALAVEDDPDSEITGGSVMERPKVVYNEKTG
KYVMWFHLELKGQGYAAARTGLAVSDNPTGPFEYLKSFRPNAGVWPKNFKEEWKETPEDG
DAEEWWTDEWYKALNDGMFVRRDFEDGQMARDMTVFVDDDGTAYHIHSSEENQTLHISEL
TDDYLGFTDNWVRVKPGGQNEAPTIFKHKEHYYMITSGLTGWEPNKARSFKAESVMGPWK
GLGNPAKGEEANVTFRSQSTFVLPVQGKENAYIFMADRWKPDNHIDGRYIWLPIEFKNDK
PIIEWHDQWDLSFFNEE
>IFAGANLK_02550 Arabinoxylan arabinofuranohydrolase
MKKKYSVFQYFLLSVLSLLLYACENTEKSEYNKNENVAYLFTYFTGNGEGEEAVRYALSE
DGYNYYALNNNEPIISSEEISNTGGVRDPHILRGANRSFRMVVTDLLTQNGWSNTEMVLL
KSDNLIDWTSTVINIPDTFEEFSDVSRVWAPQTFYDEEKEKYMVYFSMLQPDSYDKIYYA
YANEDFTELETTPKQLFYNPKEMASIDGDIIKKDGKFHLFYKTEGDEDKGIKVAISDSLT
GGYEPMEGNVDQTDQAVEGSGVFKLIDSDKYILMYDVYMDGRYEFAESNDLKNFELVSED
ISMNFHPRHGTVLPITEEEVNQLLEAFPSDDFPVITGSNSSAVKQKNIIIDEAEKSIYLP
VKNGTDLSSFNPELGTFPSIEITNPEAKNFENGVQEYTVKLANGEEKIYKVQVEIANNPV
VEGYYADPEIIYSEREEKYYLYPTSDGFHGWSGTYFETFSSEDLINWKNEGTILDLKKDV
DWADRNAWAPCAIEKEIDGEYKYFYYFTAAQKIGVAVADQPEGPFEDIGEPLISEKPEGV
KGGQVIDPDVFTDPESGKSYLYWGNGFMAVAELNEDMTSLKEGTEKVITPDNTFREGAEV
FFRDGKYYFLWSENDTRSPDYRVRYATSTSPTGPLEIPEENMVIEKDEENEIYGTGHNSV
IQVPGKDEWYIVYHRFTRPKGIDMGREAGFHREVAIDKLEFDEDGTIKKVKPTVKGIESL
KTSE
>IFAGANLK_02551 Retaining alpha-galactosidase
MRKFIASVFGLVILYSCSDQEMKNANFSNPANDIKLEVSVNENGELVYMVSYKDKGILQE
SKLGLSREDSDFTKNLKIIEVSDKEEVSEDYKLFHGKQSEISYTANQYTLKVENGDQKQM
GIDFHLGENSLGFRYRFPEGESGVKIINEEKTTFNFTSEARGWLQPMSKAKTGWAETNPS
YEENYKMNIPLNTKPEIGEGWVYPALIKEGETWILISETAPNRNFSASRLKSEENALKVS
FPQKEEVFPGGELLPNAELPLESPWRTLAFGNLEDVVSNTIVTDLAEPTKQEETDYIKPG
LSSWSWALLKDESVNYYTTKKFIDYAADMNWAYCLIDVNWDENIGWERMQELVDYADEKS
VKLLLWYNSSGDWNSTPYTPKGKLLTKESRENQFKKLKEIGVAGVKIDFFGGDGQSVVDY
YHDILEDAAKYKLLVNFHGATLPRGWHRTYPNLMTVEAVKGHEFITFEQENANRAPAHAA
ILPFSRNVYDPMDFTPMVLDTIPDINRLSTPAFELALPVLFTSGIQHIAETPAGMAKQPE
FVREYLRDIPVQWDESKLIEGYPGQEVIMARRKGETWHIVGINGENESKEFEISFDFIEN
LASAYLITDAKEGFTKQEIEINEPIEIFVQPYGGFVIKIQNN
>IFAGANLK_02552 hypothetical protein
MKKNNNIPLKAFALGVLFLSLSTMSFAQEKPEEVREYYVSSLIKIADPVLTALSKDQLKE
KMPIERSPGAWDDRTHVTYLEAFGRLMSGMAPWLEIGPDDTEEGKLREKYIELSVKSLEN
AVDPDAKDFMNFSEDRQPLVDAAFLAQALLRAPNQLWGNLEEESKENVIEALKSTRKIKP
YYSNWLLFTAMVEAALLKFDEEADMVRMDYALNKHMEWYLGDGMYGDGPNFHWDYYNSFV
IQPMMLDILKTLNEEGIDKEKDLKEVTRRASRYAEIQERLISPEGTYPPIGRSLAYRFGA
FQALSQIALWEELPEEIKPAQVRSALHAVIKKQIEAEGTFDEEGWLKVGFYGSQNNIGEG
YISTGSLYLCSEAFLVLGLEEDNEFWSAPAAPWTQKKIWSGEAIPIDKAE
>IFAGANLK_02553 Unsaturated rhamnogalacturonyl hydrolase YteR
MIKIKTYLLLVVSGLLMACNFGESKNSEENNETTSNTEEKEILPDSKEEVEEIIHRVNKH
WQDKNPDHSWAFWHDAAYHTGNIEAYKVTGEESYLEYSKAWAEENEWMGAKSEDKTEWKY
NYGETDEHVLFGDWQIAFQTYIDIYMLEGENDPSKIKRAREVMEYQMNTSENDYWWWADG
LYMVMPVMTKLYKVTGNEEYLNKLDEYLSYADSIMYDEEAGLYYRDAKYVYPEHKSENEK
KDFWARGDGWVFAGFAKVLQDLPEDAKNRKKYEERFRTMAKALAEAQQEEGYWTRSMLDP
EHAPGPETSGTSFFTYGFLWGVNNGILAKEEYMPTIKKSWQYLTETALQEDGSIGYVQPI
GEKAIPGQVVDKNSTADFGVGAFLLAASEMYRYVNNTQNP
>IFAGANLK_02554 Acetylxylan esterase
MKYQTRQGLRVFHLAILLNLICFPTFYAQESVEIWEGEIPGAILAEDYTQIENKNEAGVV
TGISKVVTPELKIFKAENPNNASILILPGGGYSHLSVEKEGRKVATWANSLGLNAFVLHY
RLPSDEIMEDKRLAPLADAQQAMRFIRKNAGKWDLNPDQIGVLGFSAGGHLAASLSTRFN
EKIVQKDQVVSGRPDFSILIYPVISMEDKLTHKGSQESLLGENAKEDLIKNFSNENLVTA
ETPPAFLVHATDDKAVPVENSLEYYKALKANNVPVEMHIFEDGGHGFGLGKKGTNTFWPN
NLEKWLDQHHLIQNKPMVFSYFTGNGEDGLHLAYSYDGYTWKALNNGKSFLKPELGNEKL
MRDPCIIKGGDGKYHMVWTVGWTEKGIGYASSKDLINWSDQQYIPVMEHEENARNTWAPE
VTYDEENEEYIIYWATTIKGKFRETQIDADDGYNHRMYYVSTKDFKNFSDTKILYEPGFN
VIDASIKEYEDMFVMFLKDETREPAEKNIRIATANNLKGPYSKASEPITGEYWAEGPTSV
KIRDEYLVFFDKYIEKEFGAVRSNDLENWEDISDKVSFPEDIRHGSILKVPAEVLKSLQE
>IFAGANLK_02555 Unsaturated rhamnogalacturonyl hydrolase YteR
MKKHSLLAYLVIFISASSFAQQSIDLDRDEVLSQIELANKYFMEKWPDVGKTIVTNMERP
SHIWTRAVYYEGLMALHEIYPKQDYYNYALDWAEFHDWGFRSKNITRNADDYCAAQTYID
LYQLEPKPEKLKNTRAAMQKFLHTPQNGDWDWIDAIQMGMPVFAKLGVLENDERYFEKMH
KMYMYSRDIEGENGLFNPEDGLWWRDADFDPPYTEPNGEDSYWSRGNGWVIVALAKVLDI
IPEDAQHRDQYIEDLQVMAEALAKVQREDGFWNVSLHDEDHYGGKELSGTASFVYGMTYG
VNNGLLDEEKYTPIIEKAWNAMIDDALHENGFLGYVQSTGKEPKDGQPLSYDKVPDFEDY
GLGLFLLAGTEIYKME
>IFAGANLK_02556 hypothetical protein
MFNKLIFLPLLALCLLPTYAQENPNDQLLETTWQKADITTKTWTRWWWMGSAIDKKNVKQ
NLIELHKAGIGGVEITPIYGVKGEEDNYLDFLSPEYLEILDYTIKTADSLEMGVDMVLGT
GWPYGGPQVDQEHAATKLVTRTYEIKKGERLKQKIEPKDERDQTTAKLKYLVAFNEEGKH
IDITHKVKKDASINWKSKGQDHKVIAVFTGKTGQQVKRAAPGGEGFTVDHYSHEALNQYI
QPFDKAFDKISHKPRSVFNDSYEVYATDFTPDFFEEFQSRRGYNLKTKLHLLLEDNRSEE
GNRVKSDYRETISDLLLEDFNIPWTEWANEKGLKTRLQAHGSPGNLIDMYASADIPECET
FGSMPFDIPGLRREKEDIREGDADPVMLKFSSSAAHIAGKPLTSSETFTWLRDHFKTALS
HAKPEVEELFLNGINHIFLHGTTYSPDRAKWPGWKFYASVNFSPNNTIWQDAPELFTYIE
NSQSMLQAGEADNETLLYWPIHDVWDNFYKGNLFFQLKIHSLDEWLHDTSFYETTNYLMD
NGYATDFISDRFIHRASAEGGKIKLPGGSFKSLIVPASKNMPIETLEKLIELKNNGAHIV
FTGLPETAPGYHNYKERTTRIEKIIDENNIEITKLNNLPEDLKTVNVLPEDLVNTGLKFI
RRKLGNNKIYFLVNHTSKSIDQYIPLQTTSDEIMLFDPLTGEAGKADSKIENGRTMVRVQ
IESGESFFIKTGLEKELQAWFYYEPGKESYDITGKWTLSFENGGPEIPETKKIEEMQSWT
GLGEKAEAFSGTGIYETTFEKPDVDADNWELNLGDVRESASVYINEEYIGTAWAAPFKLK
TGDLLEGINKIKIKVTNLAANRVRDMEIRGEEWKIFHEINMVNKDYEEFDATKWDPMPSG
LLDTLTLTPLHKN
>IFAGANLK_02557 TonB-dependent receptor SusC
MKHLVRKLLMYTGCILFSIPVFAQEKEVTGTVTDENGIPVPGVNVAIEGTTSGTQTNFDG
VYELNASEGDVLVFSFIGMQQTEVTIGDATEYNIVMEEGSSELDEVVVVGYGTRKKSDVT
GAVANVSSEELMTQPVSNAFQALQGKAAGVDITSSERPGTIGTVRIRGNRSLTASNAPLY
VVDGIPLLSASSIETINPRDIESIDVLKDASATAVYGSRGANGVIIVTTKKGKAGRLTLN
YSGTVTASEIVDRAPSMNAADFIEFRRSAAYNLDPETYANPNSPTLENDTNIFDSPLDGQ
TSRDNVLQGWEGGTWDPSRVTNTDWTDFVTQTGILNEHTISASGGTEKMKAYASLGYLND
KGTQKGQFYERYSANVSTNIKPVDWFTLDANFNMSWSEQDYGFSTLGGRSSSGPNAIYGA
AKNIYNMAVPYDSDGNLVINPGGESTIYTIMDEWDKSTQLSETMRALGSVSATFDIGEII
DPLEGLNYQVRFGPDFRYWREGVYLDNTSAHRINSDGSPGTNFARLNNRRDLSWTLDNII
TYNKTIADKHNFDVTLLQTASSWNIENSGMNANNIPKESMLWYNFGEVDITNSENSADMW
SGLNERQLSSYMARLNYGFDDRYLLTVSGRWDGASQLGEGRKWDFFPSAALAWKIDQEDF
LKNSEQINSLKLRLGVGTTGNSAVDPYATKGDITSIFIPFNGMSNRIGYTTNEPYYSANQ
LSLANPLLGWEKTTQYNLGVDFGFFNNRVNGSFNAYRSFTSDLLMSVNIPTLTGFPSTVA
NIGQTNNRGVELSLNVVPIETEEFFWESNINAAWQKDEIDELAYGENDMVDNEWFIGESI
GVIYGFDNEGVWQDTPEDQAEMDLWNANGYNFTPGNVRPMDQNGDYDMTQEDRIILGNRN
PRWTLGWNNSIGYKGFELQALIISRLDYTASIGGQTMTARANQIDVDYWTPDNQDSEFQK
PILGQATSGSQDQFSGLLGIRDAGFVKIRNISLGYNFSSEFTSRIGLSNLKIYAQAVNPG
SIYQAVDWYDFDVNSMIFNRSFSLGLDIGI
>IFAGANLK_02558 hypothetical protein
MKTKIFKNSNKILLIMVAFVLSSCEKDFLDEELKAQYSTEYFDTAEGLEDLTVSLYGNIR
WHFGFEWAYGMTLYGTDEFTNANDLTNEMWNTYDSRLGPMGANPDTGAANWNSTSPAALW
DQMYYGIASANTIIANADIIEDDVQRNRNLAHAYFLRGYNYYRLAAQYGGVVLQLEPAVG
VVRNFERASDEETWAQIISDFRNAFEHFEGEIFTYGKGVTWTKATAGHFLAKALLFRASE
RNDDWNSSYIDADLEEAVQATTYAINARGALADNYRDLYADWTGVDSEAEQLDEILMAAP
HNDDGSTTGRFGNRTYNYFTPQFSAFSGGWVRRGVWIGGMDFQRLRPTEYSYKVFDHVND
SRMWKTFKTVYGINNVIDDELGLEPGDPGIVMILNTEDDNTYNNFTFGASIQNPDWRDVD
GRLPEWELGSRQTETSGSLTSTPGQFVPNSLVLYQNGEYVSPQFKSTPISNFFAGINKTD
DGSRFAEKGDAHRDVTMARLAETYLIRAEAYVRQGQYGSAMDDINTVRNRAEWNEGENRS
YYVDGSQAFENNALNTGSAADNYINSNLDMNTYYLSNPDLEVTTAASDLTLTSFPDNLPE
EDEEILSELGVSGSYERALHFILNERTRELLGEWQRWETLSRTGTLIQRTTTFNEEATDI
TPNKHELRPIPQSFIDGLLNEDGSNLAPDVQDSWQNPGY
>IFAGANLK_02559 Oligosaccharide 4-alpha-D-glucosyltransferase
MNFTKIIVCPALLILLLNIDAIGQTGIGDFEEISSTNDNTVELATTMGRVQIQFCTPSIV
RFRTSWNNSFEEDEHLMVNRYDWPETEYESEEDEGSLIFTTEALKVQIQKKPFAIEIFNK
EGELLNSEKSDNNKLGAFSTEEKIGAKKQLNPEEHFFGFGERMDFLDRRGKKVSLDVGRG
LGKPHIIGAYNVLEANYAPVPFFMSTKGYGIFFHNSYKTTWDMGLSDNKSYSFEAAGGEL
DYYFIYGPKFPKILDGYTSITGKSPLLPKFALGLHVGTYSGGTWGHEEKTSENYPVALVK
KFRELEIPIDILHLDSTWRIFGENGGSGATTFEWRETFDNTEQMFDSIYDMNINMMGLHV
RPRFDNGNKLRLLDEAREAGHVYPEDDNPGEFVNFFDEESVDWWWENGAMNVVKEGAMFF
KTDEGSAFGRKANESNKTGPQGKEIESLHNLFPLAYAKAAFTKFQEHNNMRGMNHTREGY
AGIQRYPFIWAGDWPSEWQYFEPVIKAGLNIGISGVGYWSHNMGGFEHVADPELYIRWVQ
FGMMSPIAHLFGMEHPNYKEPWNYGEEAQKIFKQYDELRYSLIPYLYSNSYEMHKTGMPL
MRALVLEYQDDPNVYEITDQYLLGGDLLICPVTTKDAKTKTVYLPEGKWINYWTGEKFEG
KQYLNVLTPIEEMPIFVKAGAIIPTQEIVHYVGEKEIDEIILDVYPEGNSSFKLYDDDGE
SLDYQNGEFSISEINVQEDENQLVLEIKPPQGEFEVNPRSYKILIHSEQEFSDIKINDSE
DEDLITYDDKVVEILPREKSDKKIKVVLIKKKKTKSS
>IFAGANLK_02560 L-rhamnose mutarotase
MSLRAFKMKLLRGFEAEYKRRHDEIWPELSKLLSERGIYDYNIFLDEETHILFAVQKVKN
EKDLTGLREEPILQKWWDYMSDIMETNPDNSPVEKPLERVFHMD
>IFAGANLK_02561 Exo-poly-alpha-D-galacturonosidase
MRKYFRPANFLKIVSACLFLLFSTSAVMASDNFNIRNYGAVGDGETLDTEAINKAIEAAS
EAGGGKVYFPAGTYLSYSIRLKDDIHLYLGAGAILKAAGENDGGRYDAPGEGAGNEYQDY
GHSYWRNSLIWGENLNNITISGPGVIQGENLSRGFYASENWDKKGIPAGNLMWEGGGNKA
IGLKLCTNVILKDFTIIKGGHFGILATGVDNFTIDNLKIDTNRDGIDIDACRNVRISNCT
VNSPNDDAIVLKSSFGLGFARATENVTITNCQVSGYDVGTMIAGTYQTKEGHLVPDQEGP
TGRIKFGTESNGGFKNITISNCVFDRSRGLALETVDGGLLEDVNISNIIMRNVTNSPFFL
RLAGRMRGPEGVERGKLRRVSISDVTVYNADSHFSSIISGIPGHDIEDIRFNNIDIWYRP
LDSARTQIQKIVPEYVKTYPEPAKFGVMPSYGFFIRHAKGIEMNNINIHYTGDESRPAII
LDDVEEIEFNNVEAQKAENSPVLKTRKSKGIKIKNSNSLQN
>IFAGANLK_02562 hypothetical protein
MMTHTIKHFFQIVLLSLMWGLISGTSQTLKAQSSNIKNDTFWDTKDGEPIYSQGGGIFTF
TDPKDGVEKYYWYGVHYREAELYRDDPSVTQERNYIKAVTCYTSTDLVNWELESNALERS
EVTDHYENTHWMGRMGVAYVEEMDKYAMFIQHNAGVLIALSPTPAGPFKVHNRLDMTDRI
GSPNTGDQTVFTDPDTGISYLVYSYGQGRHIIYLSEIGVKDEKVDLLDVNQIYKGKGREG
NCMVKHNGKYYIFASNLYGWDSSYAYYLVADNIEGPYTPENKMLITPGTYEDYAHITQTG
FFVNVKGSKQETVVYCGDRWADFAGNGLGYNQWCPMSFDGETPYFNSLSSWNLNEATGEW
KVADDNNYVKNASFEADRRQIPSPVKPIKEQLLGWYSKVNQGNVIVIESEDSPVLNYFNS
EEDRKHVIGEKSLNISDNIEFKREVFQIIESTPYVKLKDGYYTLSAKIKNTGKFHKLRMY
AESAGKRHNVEITEQNDEWITIEIENVQVSNEKVEIGFNAYGDAGASAQIDDVSFVLSK
>IFAGANLK_02563 Beta-galactosidase BoGH2A
MKTYKTISCLLILILPHLLFSQKRDIEDIKTWKFFKGENKDAYKIDFNDASWQDVQIPHD
WAIYGPFNKDIDKQIVKIEQNNEEVATEKTGRTGSLPFIGTGWYRTVLSIPESAEGKQIL
LTFDGAMSNAEVFLNGKKIGNRPYGYSYFYFDISKELKIGEDNLLAVRLENESQSSRWYP
GAGLYRKVQLITKDTVSFKHWGPTITTPYITGEMAKVEIKSKVQGKNVRVETTIKDSTGK
AIAFNSNSQRFGDEVEQNIPVEEPNLWSPSHPYLYTAEIKLFKDGELKDSQEMRFGIREF
KYTPEGFKLNGKVTKFKGVCLHHDLGPIGTAINKAALKRQLTILKDLGCNAIRSAHNMPS
LEQLELADEMGFLVIAESFDEWKKPKVKNGYNQHFDEWAEKDVENLVRATKNHPSIIMWS
AGNEVPDQWGSEGVKRLHWLQEIFHREDPTRPVTVGMDQVKAVMENGFGAVLDIPGLNYR
VHLYEEARESFPQGFILGSETASTVSSRGIYKFPVKKGHDITYPDLQSSSYDLEYCSWSN
IPEEDFVQQDDHDWVLGEFVWTGFDYLGEPTPYDNYWPSRSSYFGMIDLAGIPKDRYYLY
RSRWNTEDETLHILPHWNWAGREGEVTPVFVYTSYNKAELFINGKSQGIRIKQKDSLLER
YRLMWNEVLYEPGTIKVVAYDENDKPAMEKEIVTAGKPHHLKLEADRTNLTANGEDLSFI
TVSVVDKDGNVCPTATNQLSFKVDGAGKYRAASNGDPTSLEMFHLPTMKAFSGKLVVLVQ
STTDVGEIELSVSGKGLQTGNIKLQSKTINP
>IFAGANLK_02564 hypothetical protein
MRFKSIKRIRDFRALQKPGLFLFLVFLFPKLYSQDTQFEIFTGTPEFSILYDKKGSPLDS
ISASLLAEDIYKVSHKKPLVTTDVNKTKGNTIVIGQLNSDLISKFVGSNDLPRKFKNQNE
SFLHKVVKDEAKKILVVAGTDPRGTAYGVFELSEKIGVSPWYWWADVPVKKQKEIIIEQE
EFYSKEPSVEFRGIFLNDEDWGLQPWAEKTFEPEVGDIGPKTYAKIFELLLRLKANTIWP
AMHPSTKAFFHYQGNPEMAEKYQIVIGTSHAEPMLRNNVDEWDKEPMGSFNYLSNKENVY
KYWEERVKETKDIDAIYTLGMRGIHDSGMEGVKGIEEAKANLQNVLKDQRKLLKTYSSKE
VTGVPQAFTVYKEVLDVYDHGLELPEDVTIVWTDDNYGYIRRLGNEEERARKGGGGVYYH
ASYWGRPHDYQWLSTTHPALIRNEMMKAYKNNSRKMWILNVGDLKPAEYNMQLFMDMAYD
IEKFEEPEYVDKHMQDFYSNAFGKAKGKPIANIKKEYYNLAFERKPEFMGWSQTEPTTKI
DTTAYTPFSWGDEINRRIDSYEALEEKTEKIQHQIPEVTRDAYFQLVHYPVKAASFMNKK
FLYRDLALKYLKQNRLIVKKYKNLSHTYYDSIASITRRYNEEVSGGKWKGMMDMAPRKLP
VFDKPEISFYLDPNYSTAAGISVENASGVEDLQLPAFYENSPQNHFFDIYLKQPKSVKWS
VQNVPSWLQLSETKGNLTKDGITEKRITVAVDWQKWRQVNRPKNAELNPRLGKRRHKINM
QLRSYKLAETGENIFTEQNGLVVIYAENYSGKTDRDEFKWERIPGLGYSRNLMQSFPLTG
KPLDTLQLQEKSPYLEYTLYTESLTKNAELVLHALPTHPLTNEHGMRIGVQWNDGPVEIV
DFRTYGRSEEWKQNVLRNLAKVHIPVEIQEAGKQILKIYMVDQGVALDFIYVNLQDQSLP
YSLLPETRFN
>IFAGANLK_02565 putative rhamnogalacturonan acetylesterase YesY
MKSLKIFFLVVSVILLIGCSNNNSEKQKPTVYLVGDSTVKNGQGDGAGGLWGWGDYIGQF
LDTSEIEVENHALGGTSSRTFQRQGLWKPVKDSLKKGDYVLIQFGHNDAGPINDDFRARG
TIKGIGDESEEIDNMLTGEHEIVHSYGWYIRKLITDAKEEGAIPIIMSPIPRNNWKNGKV
PRNNDSYGGWAKQVAKEENVTFIDLNEKMAMAIEKEGEDQVTGKYFYRRDHTHTSARGAL
LAASIVVEGIKASENKLRDYMLENPEVELPSKKNVFLIGDSTVANNNDEEAVGWGVPIEQ
YFDTTRVNVINKARGGRSSRTFRNEGLWDAIKDSIKEGDFVLMQFGHNDGGDVTKLKHRA
SLKGMSDSIQEVAKPDGSKEEVHTYGWYMKKYISEAKEKGARPIVFSHIPRNKWANGNVE
RANDSYGKWAREAAEQENALFIDLNDSIAKKYEEIGPEEVSSFFPKDHTHTNMEGAELNA
FIIAKNLKQAKETGIRDYIFIKEKKE
>IFAGANLK_02566 Evolved beta-galactosidase subunit alpha
MKKHLLFTFLILGSLQLTAQQTEKIYLSGKSFEEPVEWDFKVSDGRNSNEWSNINVPSQW
EIEGFGTYTYGRWYKELNLEEPSKEEGFYKHTFEVPVDNKGKAVKIVFGGAMTDTEVKIN
GEVVGPKHQGGFYQFEYDITEFLKYGEENLLEVHVWKHSANPTVNNAERKADWWLFGGIY
RPVWLEIKPNSHIVHFAVDAKMDGSLTAEVDLKNIPDNTKIEAKISAVGEQTQEFETFSF
PVAENTEKEIIEAKWDNVKTWDPESPNLYELKLKLVQNGKTLHETSDRIGFRTLEFRKKD
GIYVNGKKILMKGVNRHTLWPESGRSTSKRISVMDVNLIKDMNMNAVRFHYPADKHFMEA
ADSLGLFVLNELAGWQNPYDTESGSQLVKETVKRDVNSASVIIWDQGNEGGWNYELDSVF
HDYDPQKRIVIHPWADFNGWDTHHYPTYQTGVHRFGSGENVFFPTEFMHGTYDNGHGAGL
DDFWNKYKESPLFAGGFIWDFSDNAVIRSDWEGERKYDSKGNLAADGILGPHRQKEGSFY
TIKEVWAPIQFEPRLITQTFDGSFLVTNDFLFSNLNSAKMKYEVMKAPEEILYSDSEVSE
IASGEINLPDAVPGETRKINFQPGENFFEGDWLEITAWDQHEREIYTWTWPIHRADYFAD
KFLLDEENQQAASAEESENNITLSGNDIKVSFDKTTGLLTSVSSGENEIPFHNGPRPIGM
KAEFQNFQISQDGDKSIFTAKYGGGIESIVWTMYPDGRLHMHMTALTNARGGDGFDGAFY
EGNIDKFGITFDFPEEGVEGFKWFGKGPYRVWKNRLKGTEYSIWQKDYNNTITGESYENL
IYPEFKGYHANFLGGFLSAGDQGFRVFSENDNMFLRLFTPAEPEHAVSKVHPQPEFPEGD
ISFMYEIPAMRAFKPLEHQGPSSQPTNIRIKSGDDGITMKLWFDFRKNQEKN
>IFAGANLK_02567 Rhamnogalacturonan acetylesterase RhgT
MNFIFTILLISLNFSIVYSQAEVKTFDFGLEKSSKEIPISSPLSYHVDRGYGFDFNTCEN
IVFEKNAFTSATPAYFSIKLPEGNYFIEVDLGSEKSTSETTIKAESRRLMRSQVSVKKGG
IKTETFSVDLRGIKISEEESVNLKSREEDDLNWDNKLTLEFSGEVAVKAIRIKPAEDFIN
IFLAGDSTVTDQDVEPWASWGQMITQFFSSDIVVANYAASGESLGSFKGRNRLKKILNVI
QQGDYLFIEFGHNDSKIKGEGNGAYGLYTQLLKEYVTEARKKGGIPVLLTPTERRHFNKE
GKLEPTHGNFPDAMRKVAKSLDVPIIDLTKITTKMYEAWGVEDSKNALVHYQENTFPGQH
KELSDNTHFNGFGANEIALAIIEEIRNSDLELKNHIREETSRYDSNKPNNLKNWTVPLST
HFESTKPEGN
>IFAGANLK_02568 HTH-type transcriptional repressor YtrA
MTQTFQIQINEKSRIPKYKQIVDSIIADISNGNLKVGEKIPSINELSESCYLSRDTVEKA
YKQLKERKVIISVKGKGYYTAKTDLISKANIFFLVNKPSTYKMIIYNSFVDSIGVNGHVN
MFIYHCDESLFIKSLERNMGAYDYYVIMPHFRDENSNHVSYTENVIKVLEQIPKDKLIML
DNTKPGISGNYGAIYQDFQNDIYKALNEGLERIKKYDKIILVYPSKSANPYPRRILHGFQ
QFCWENNLDFEILDEIYDEMDLQSKDAYITIQERDLVNLVRQVRKKKLVLGKDIGIISYN
ETPLKELLGITVISTDFKTMGETAAYMLLKNKKEKVKNVFKYIERNSV
>IFAGANLK_02569 Dihydroanticapsin 7-dehydrogenase
MEKTFKYVDYLWEEKKAADLGDDQVALFLYRSNILGADLRITNYGGGNTSCKTVEKDPLT
NEDVEVMWVKGSGGDIGTLTREGIAGLYTERLRNLKNVYKGIEDEDRMVGLFNHCIYDLN
SKAPSIDTPLHGLLPFKHIDHLHPDALIAVAAAKDSEQVTKEIWGDTMGWVPWQRPGFDL
GLQLEKCLEENPGIRGIVLGSHGLFTWGDTSYECYMNSLDVIETASEYIENKVKEQGEVF
GGKKTDSLPSSGRKEKAAELLPLLRGLASSENRMIGHFTDSDTVLEYINSNDLERLAPMG
TSCPDHFLRTKIQPLILKLDPSEDLSDPEAVLKKLEPDFDQYRKEYKDYYENCKHDNSPT
MRDPNPVIIIYPGVGMFSFAKNKQTARVASEFYVNAINVMRGAEAITEYTSLPRQEAFDI
EYWLLEEAKLQRMPAEQPLSRRVAIVTGAAGGIGKAIADKMVAEGANVVLTDITKESLEA
AVKTYKKDQVSGVVCDVTDEASIIAAYKEANLAFGGVDIIVHSAGLAISKSLEDTSMKDW
NLLQDVLVKGQFLMAQHGAAVMKKQGFGGDIINIASKNGIASGPNNVGYGTAKAAQQHMS
RLLAAELGGDKIKVNIVNPDGVIVGSKIWEGAWAEGRAKAHGIKVEDLPKHYAKRNLLQE
IILPEDVANGVFACIGVLDKSTGNTINVDGGMANAFVR
>IFAGANLK_02570 Xylose isomerase
MKITTDRISEFNKSNHSSYKTELDFLKNKLVKKGIDTEEIISKVADFQVAIPSWALGAGG
TRFGRFSYGGEPASLEQKLDDIGVLHALTQSAGAVSLHIPWDIPKDVKAIKEKAQSHGIV
FDAMNSNTFQDQPEAKETYKYGSLSAVNDAPRDYAIGHNLEVIKIGEELGSKSLTVWLAD
GANFPGQNNFQRVLQNTENSLKSIYGKMPKDWKMFIEYKPYEPNFYSTVIQDWGTSFMLA
NACGERAYTLVDLGHHLPNTNIEQIVATLMLKGKLGGFHFNDSKYGDDDITVGSIKPYSL
FLIFNELVYGMENNPQNPDLAWMIDASHNTKDPLEDLLQSLEAILIAYTQALLVDQKALK
QAQQENDVVTCQEILQDAYRTDVRPLLKAAREKSGAAINPLSAYRNLEVRKYLVKERGTK
SKATGL
>IFAGANLK_02571 L-fuculokinase
MTKVKVTAVFDIGKTNKKFFLFDKNYKELLRKYKRLPETKDEDGYPAEDLVELQNWMKSI
FETILEKDEYNLKAVNFSSYGASFVHLDHNGKVLTPLYNYTKSIEKSVVEEFYKNYGDEL
SIATQTASPQSGFLNSGMQLYWLKKTKPEIFSKIKYSLHLPQYLSYLFTGIPVSEYTSIG
CHTNLWDYYKKDYHDWVYKENIDRILAPLVPTSASMNTSYKGKKLKIGVGIHDSSSALLP
YILSKKKPFLLLSTGTWSIALNPFSKDEITKEDIKHNCLNYLRVDGKPVKASRFFMGNEY
RLQVEKLGEYYGKEYGYHREIKFNKNLYLKLIENPSIYFKFEGISLQRKKLHKTDLEPFQ
TFEEAFHQLMIELMELQIQTIRKAIGNSEIKTIYIDGGFTDNDVFMKLMSHHFSEFKVLA
TQSPLGSALGAAMVISNKKVKTSFLKENYRMKKLVPLLLNQD
>IFAGANLK_02572 (S)-mandelate dehydrogenase
MAFPFNTEYPSIESLRERAEKRMPRFAFEYLDGGCNENINIRRNTDEIREIQLKPRYLKN
YNTSKLETELFGIKYGAPFGISPIGLQGLMWPNAPEILAKASLKHNIPFILSTVTTTSIE
RASELTEGRAWFQLYHPTEEWLRDDILKRAQAAEVPVLVILCDVPTFGYRPKEIRNGLAM
PPQMNFRNILQVMGKPAWAAQTLKHGLPNFATMKPYMNNGMSIKQLGKWMNATFSGRLNE
EKIKPLRDLWKGKLVLKGVVSDEDAEEAIRLGFDGIIVSNHGGRQLDAGESTIKPLVHIS
EKYGDQISVMMDSGIRSGPDIARVMSSGADFSFLGRSFMYGVGALGDKGGDHTIAMLKMQ
LQQVLEQVCCENVKDLPHYLVK
>IFAGANLK_02573 hypothetical protein
MSEAQIETEVSGEFERESVPKSKWKDWKSFLGMYAGEHAAGTEFVIGPLFLTTGVSAFDL
IVGLLLGNLLAVLSWRFLTAEIGTKFRYTLYFHLEKICGTRLVTLYNLANGLLFCFLAGS
MITISATAVGIPFDMQMPRLTDTMPNSLTWIIIVLCIGAVISIIAAKGYNTVAKAANWMS
PIIVLAFIVCGIVALFQLNVNSFSDFWNVWGEGGEPFPGQIKYTFWHVVLWSWFANAAMH
IGMSDLSVFRFAEKPSVGWTTAGGIYVGHYIAWIAACLLYAVYLQSPEAQVFVTNGEAPP
VAPGPLAYNAIGVFGILAVILAGWTTANPTIYRAGLAFQAIMPKASTFWVTITAGAIATI
AGLFPAFAMKLLDFVAIYGFILAPIGAVIVFEYFFGKKAGIQTFYAEKTGIKFNQAVFWA
WAVSFGIFYTLSVQFDIFLSFLTLPAWISCGLLFLLFSRWYQKKIA
>IFAGANLK_02574 Exo-poly-alpha-D-galacturonosidase
MKFYTLILSFFLPIFLFSCKNENNSSKEVEAISKTSQNEPEWVSKVGAEDFQTKEEIYYV
NDYDAIDDGSEITTKAIQRAIDDCAEKGGGTVSFKPGKYLSGSIFIKEGIRFNIPEGVEI
LGSESIKDYPEIDTRIAGVEMEWPAALINVLEQENVVIDGDGLVDGQGKVYWDYYWDLRE
EYEAKGLRSIVDYDAKRPRTFLIQESKNIFLKDLNIQRAGFWTVQVLYSEYITVDGLTIR
NNIGGNGPSTDGVDIDSSKWILVQNCDVDCNDDNYCLKAGRDWDGQRVDRSTEYVVIRDC
IARRGAGLFTLGSETAGDIRHVFVSNVKGIGTSNGLNIKSAMTRGGTVEDIYLQDIEMDS
VRTFIEVSMNWNPSYSYTKLPEEYDIDAVPKRWQTLLKKVEPRSKGIPTFKNIHLSNIDV
KGAERAINVNGVEESYIDNFNLTNVNIEANKAGQISYSRNWNLENVTIKTLDSSKVKLNE
TSGIDFSEEIYSNP
>IFAGANLK_02575 Rhamnogalacturonan endolyase YesW
MRFPANKNCLYIFVCLLAVNTYAQRQMENLDRGVVAVVQQDNSVSVQWRILGTDDENLKF
NLYRRSGENIVRKLNQVPLSGPTHFFDEEVDLSKENTWFVKSVKNGEEAEEPGSYTLEAN
AKPENYHTLQLKHIEGYTPNDASVADLDGDGEYEIILHQTGVSKDNSHRGLSDEPIFQAY
KLDGTFLWKINLGKNIREGAHYTQFMVYDLDGDGKAEFVCKTADGTKDALGNVIGDATKD
WRDTNKNSKTFGKILEGPEYFTVFNGETGEALTTTNYIPGRGNLSGWGGVGGNAGNDRTG
NRVDRFTACVAYLDGERPSVIMGRGYYGRTVLAAWDFRNGELTSRWVFDSENAENPYSGM
GNHNLSVADVDKDGKDEIVFGSMVVDDNGEGLYSTGFRHGDALHVTDLDPDVPGLEVFGI
HENEEGTEGPGVALFSGKDGEVLFRAAENKDIGRGVAANIDSTRIGAQFWWSGSKGLFDT
KGKKIGEQPESINFLIWWDGDSSRELLNRNYIGKYGKGRIFTAEGALSNNGTKATPTLSA
DIWGDWREELILRSEDNKELRIYTTTIPTKIRQYTLMHDPQYRVSITWQNVGYNQPPHTS
FYMGKNMKKAPKPKIKLIPEKLK
>IFAGANLK_02576 hypothetical protein
MRKAILLLGIIFYTACNFSNSENKEHTDEPESKIDRKALVSRHNVKVDGIDTLASLSVGN
GAFAFTVDATGLQTFPDSYQFGVPLGTQSEWGWDSHPNPENYRFDETLVEYDQNGRKVTY
SVQRKELPRSEEAVNYYRENPHRIQLANLGLELLKENGEEVKPEDLQNIQQELNLWTGEI
ESAFEIEGVQVKVYTAVHQSDDVVGIRIKSELIEQDRLQVRIRIPFPTAEWEDLATKWEG
DEDYSSTLSVDGNRAHIKRVMDSITYNIGLQWQGNAAIEEKEEHYFVLKPSKDQTEFEFT
TKFSNGEISEIPDLASVTKSSQNRWEEFWQSGGAVDFSGSTDERAHELERRVILSQYLTK
LQCTGSQPPQETGLTYNSWFGKPHLEMHWWHGVHLPLWGRPELLEKSMPWYDTAFDKAKG
IAERQGFEGARWQKMTDHSGYETPSSVAALLIWQQPHFITFSELLYRADSSEATLNKYKE
RVFATADLMASFPNYNKDKDRYELGPPVIPAQERFPARETFNPTYELAYWEWGLKTAIEW
KERLNEEVPEKWVEVLEKLSEFPVQDDVYLATESATDSYTNPEYKTDHPSVFGTYGMLPE
TSRLDKKIMKNTFDLIWETWSWEETWGWDFPMTAMTAARLGKPNKAVDALFMNPQTNTYL
KNGHNYQEERLTLYLPGNGGVLTAVAMMCAGWDGSEGETPGFPEEGWEIKWEGLEKMP
>IFAGANLK_02577 Xylose isomerase
MSNNKFFKGIDKIQFEGRDSKNPLAYKWYDENKTVAGKTLKEHLRFAVAYWHTFNNKGGD
PFGAETETFEWDKKENVIDRAKDKMDAAFEFIEKLGIPYYCFHDIDVVDDCSSLSEFEKR
METMVDYAKQKQEETGIKLLWGTSNLFSDPRYMNGASTNPDFNVVARASAQAKIAIDATI
ALNGENYVFWGGREGYMSLLNTDMKREQDHLAQFLTTCRDYARKQGFKGNFLIEPKPMEP
TKHQYDYDTATSIGFLKNYGLEKDFKINIEVNHATLAGHTFQHELQTAVDAGMLGSIDAN
RGDYQNGWDTDQFPIDVYEITEAMLVILEGGGIQGGGINFDAKVRRNSTDLDDKFIAHIA
GMDAFARGLIAADNVLQNTDYKKLRKERYASFDSGNGNKFENGDLSLEEISKIAKELGEP
KQISGKQELYEQIIANAY
>IFAGANLK_02578 Xylulose kinase
MYFLGIDLGSSSIKLSVLDAEKGTTIASAKVPEFEMEIAAPQFGWAEQNPQDWWENVKKG
FGILRDKKGVDLKKIKGIGIAYQMHGLVLTDDKLNPVRPSIIWCDSRAVDIGDEAYKAIG
EEISKNQILGSPGNFTASKLKWVKENEPENFKKASIMMLPGDYIAAKLSETPQISTSGLS
EAALWDFSKGKLATEVLDKMGLSQDFIPEIVPSFGDQATVSASIASELGLDPKTKINYRA
GDQPNNAFSLNALKPGDIATTAGTSAVMYAVSAENTFDPESRVNTFLHVNNTEKAKHNGV
LLCINGSGILYQWLRKIISVGREELIPYEKLNEEAAKVEPGSKGLRFYPFGNGVERIFSN
KEVNSGIENLNYNIHQPAHLIRSACEGIVFAMNYGFEVMQSIGVEGKVVRAGKDNLFLSP
VFREIFVNTTQTTLELYNTSGAEGAARGAAVGYGFYKEFDDAFTSLKCLERMEPDAKLSK
QYQEIYQEWKQNIKIKE
>IFAGANLK_02579 D-xylose-proton symporter
MAKLNKSGIVLITIVASLGGLLFGYDTAVISGAVGALENYFIGALETDKDLAIAAIFQFK
VIISICVIALVILFSSFLLKFFSKSKAYLIIGLFVLIGGAVYYFQFLSLPGVLTENLKNS
ILGFMVSSALVGCIIGASLGDNVANSIGRRNGLLIAAMLFVLSAIGSAYPDTMNIFFGDS
LSAFIVYRIIGGMGVGLASMLAPLYIAEMAPPKIRGKLVSFYQLAIVSGMMVVYFVNYFI
VQGQTESWINTSGWRYMFLSEGIPATIFFLALLLVPKTPRFQVMKGNEKDALKVLTNLNG
PDRAPGVLEEIKKSFGKKKAHWLYFGGTVVVIGLLLSIFQQFVGINVVLYYAPEIFRGMG
METDASILQTIIVGAINMIFTVVAISTVDKFGRKKLMMIGSAVMAISMIGLGFALYLETT
GITALMFMLFYIAAFAMSWGPVVWVLLSEIFPNSIKGVMAVAVAVQWLANLLVSWTFPMM
NNNSDLVAMFNNGFPYWIYGIMAILSGLFIWKFVPETKEKTLEEMENIWISK
>IFAGANLK_02580 hypothetical protein
MKNPLPFLPTNDLSAEEVMSSITIDCCVFSFEKGYLEVLLVQHGQGISKGKWGLPGGWIK
KEEDIDVAADRLLSELTGVKDIYLEQVKTFGKPERFPLGRVITIGYYALINREDFKVKAG
FTASEAKWYRIKDIPDLIYDHNEILQASLNRLRGKVKRAPIGFNLLPEKFTLLQLMQLYT
EILDVEMDKSNFRRKFLKMKLLQEAGDKQTGVSHRAAKLYRFDEEIYQNLTRKGFNFEF
>IFAGANLK_02581 hypothetical protein
MRLDLKKKLFVVLFFISVGFTFAQIKLPKLISDNVIFQRNTELELWGWAANGEVVTLQFQ
GKNFTGKANEEGRWEIKLPAQKAGGPYNMTFNASNMVEVQNILFGDVYLCSGQSNMELPM
GRLADTYAEEIENANNSEIRQFEVPDEYEFTGERDDLSFGSWKEVNKTNILEFSGVAYFF
AKAIYEKEKVPIGLINSALGGSPVSAWMDKEALKEFPQFYEEHLKWGNQSFLDSVVNAEQ
KAINNWYGDLDKKDTGLQEDWFKTDVDKTSWKEVEIPGFISAEDRNDSAGVAWFSKKVNI
SQLPESDTVKLHLGRLVDMDYDYVNGKQVGQTGYQYPPRKYKFDSKLLEEGENEIVVRLV
NNGGPTGFIKDKPYHLILDRDTLDISGTWKFKQAATMPNTPGQTFIRWKSGGLYNAMIAP
LTDFELKGVLWYQGESDTDDPELYSETFPKMIKSWREHFKNPELPFLFVQLPNFMEESTE
PQESSWAQMREVQRNTNLNVPHTGMAVTIDLGEWNDIHPLNKKDVGNRLALEARKLIYNE
DIVSSGPAPSDWKIKDGALVVNFENLKSGWKFKNGEKPTGFTISEDGKTFYKAEAEVLHD
NTLKIYNTKIKNPGVVRYAWANNPGNANLYNQEDLPAVPFEIELTKEK
>IFAGANLK_02582 Transaldolase
MKFFIDTANLDQIKEAQDLGVLDGVTTNPSLMAKEGITGKDNILQHYLDICEIVDGDVSA
EVVATDFDGIVREGEELAKLHKQIIVKVPMIKEGVKAIKYFSDKGIKTNCTLVFSAGQAL
LAAKAGATYVSPFLGRLDDISTDGLQLIEDIRLIYDNYGFETEILAASIRHSMHVINCAK
LGADVMTGPLSSIDGLLKHPLTDSGLAKFLEDAKSFNV
>IFAGANLK_02583 hypothetical protein
MNNDLLQQKSWWNRNWKWVLPIFGIIFISIAVFFSSNMDGVAADLAQAYADTELYNNALV
KVKTDQKAKVLLGDIEPIDKMAILEGHVEYSSDNKSVYSSVRIVGTKGKANMDISADRIN
NKWKYNEISIRIKNPPEKKQEWKIYTGEENGG
>IFAGANLK_02584 hypothetical protein
MKKYLHFLIIFVSLPILNCCSDDDDDDSQTCPQTEIASMKINGELKQFDVNRWGINIDND
GTGHTLALGLMTGVFQPQQDTYAITIKLPYKQTGNNIIEEFIYLRVQNGTSSEIDFVAQG
EIESNVLVNTNSCFSVTFSGSVMLNGNEIIIEDGIVEHIYDEPFD
>IFAGANLK_02585 Esterase EstB
MMKNLIPLILIFALAISCKQRQISENNQSKEYSVIKDSLTSDLDKIKDKKNIVGFSASIV
NENGILYNQGFGYSNLETQTKYTKNTIQNIASISKTLIGISLFKAQEMGKLDLDDPINEY
LPFKVINPNHPNIPITIRHLSTHTSTIMDADNFWENTYILKKSDHPKNVSVFGYMKPPDS
KIPLADFLKSLLTEKGQLYVSENFSKLKPGEKFSYSNLGATLCALVIESATETSYDKFTQ
ENILNSLKMDNSGWSIKTVDSTNISKLYGNYESVLADYSLLSYPDGGLLTSSSDLSKLLT
EFIKGYNGNGTLLSKENYKRLFEKQLAEQQIPVGTDDNFGIFLDFSKGFMGDDFKTIGHS
GGDPGVVAGMFFSPETGLGRILILNTDSDFDDRIIPQFKEIWSNLNTYGSKFN
>IFAGANLK_02586 hypothetical protein
MDTQSTASIPKLYVGIDIHKRSWKIHCSTDLFAGKSFSMPPFPEQLFQYVNKHFHGYEVS
TAYEAGCCGYYAHRSFESYGWKSLVVKDIHRKGKERHTKTDKIDAQLISRELKDDRLESI
VVPDKKREELRSLFRRRNDLVKEMRRIKSMIKMQLLYFGIKEPEEFDNDHWSHKYRNWLD
NLSFEFDTARETLNSRMRSFRFTDQELRQVTNQLRAYCRKHYKKDYYLLKSIPGIGGIVA
VGILSELGDLRRFNSLKHLAGFVGIAPGMHQSGASNKAMGMNPRSNRLIRSYFVEASWQA
IRTDPVMQAYYRTHLGKEDKKIIIKIAHKLLSRTLAVIKTETPYEIGVVA
>IFAGANLK_02587 hypothetical protein
MLKLISNRNSLLACSGDCPAENHRRQSPHCFYTDVATNMKNTKIYIALLISSFFVSCIDV
EEKPYEQQFADFQIEKVEKIIVTDKSSGSENRIKDGNELKKITQFLKDSTHYFPSDQIKL
SGQRLTHRIDLIRTADTLTMFLYPTSEPKKIEVGYFDPEELKIQDSYKEYKRFYIHSGIL
DLINSVPD
>IFAGANLK_02588 hypothetical protein
MKVQLVIAVFLFGCLTSIFGQTISKNELKEILQETLIKSRDFVPNATNSWIYDNSEKDYE
TKDTLILNTARSLKRDYCQTINWTFYKWNKFQLEVADYCNEPPTKLASKDKDYFQLLIKE
TDGKIHLMFQNQNNIQDKFEIIELVENLPLENDSSQFAYTLK
>IFAGANLK_02589 Single-stranded DNA-binding protein
MKTLRNTVQLIGNVGEDPKSHRFENGMLVCRFSLATNEQFLKTERKFRKHNGTSW
>IFAGANLK_02590 hypothetical protein
MDLEDVAFYIKEQGHLPGFPSAEEVLAGGISLTQMDKTNLKKIEELSLYLLDQHARMERL
RAPKVEKASAITYSEGKERPYNFVLDQSGLEKGQGQLKTLSVDSLSTGTMYCDEGNVGIG
IGETSGYRLAVSGGILSEGVKVSSVSNWPDYVFSDDYAMLSLDDLRAYISTNKHLPGLPS
AKTIAREGYSLSEMDKLLLEKVEELTLYVIDQESELESLSGELGVILPVADEEVASGKTV
YKSHNVDIESYLNAPIQKEGRIFPDMTSHRSIEASTEALCDVISCDGEGVGIGADPVAGY
RLAVSGGILTDDIQVASVANWPDYVFEADYKLRDLLSLSAYIEREGHLPRVPKAELVEQE
GYRLEIMDGLLLEKIEVLFLYVINQEKQLDRLEILKKL
>IFAGANLK_02591 hypothetical protein
MKQIKTYHFKLNPTRAQEQTFAQWLGSLDMSIIYALIIRSNSIPAIKYQSIKTIYKKNYQ
LLQKK
>IFAGANLK_02592 hypothetical protein
MPDHVHLFVKAQPTDAPHFIVGQLKGYTSFNLRNEFAELKSKLPTLWTRSYYIESVGQIS
EEAVKKYIEDQKNQ
>IFAGANLK_02593 hypothetical protein
MRAMTIDESTKLLADNYIGRLGYISRGRGEIIPITYYYDPEQKSILTYSGQGGKIEAMRK
NPLVTFQVDEISSLEKWKSVLLYGTFEELEGTDAKYILRLFSEGVKKAIKNKGIPCPDFI
ENFSSKSNSDAPIVYRINIDEINGRQRD
>IFAGANLK_02594 Group II intron-encoded protein LtrA
MKGRMQKISKDTWLQKDRAEPDSYAAGQTFMRITENNLTDVTTLEDGLLEQILAPSNLNR
AYKKVRSNKGKGGVDKMEIDSLPDYLVENRDELLQSIRDGKYRPKPVRRVTIPKENGRKR
LLGLPTVVDKVIQQAITQVLSPIYEKQFSTCSYGFRPGRNAHQALKKCRDYISDGYLYAV
DMDLQEFFDKVSHSKLVEVLSRTIKDGRVISLIHKYLRAGVMTGNKFEETKLGVPQGGPL
SPLMSNVILNELDKELQRRGHRFVRYADDLMIVCKSKRSAGRTLRNIIPFIEDKLFLKVN
REKTNVSHVSKIKFLGHTFYRSHGKGRLRAHPTSIRKMKQRLKQLTSRNKGWGENERKKE
LNHYVRGWVNYFKMADIKSLLRNIDRWYRRRLRMCIWKQWKRIRTKGKMLIKLGLNKWKA
WEYANTRKSYWHTANSFILKRTITIHRLRQAGYTSLLDYYLKVRT
>IFAGANLK_02595 hypothetical protein
MDTQSTASIPKLYVGIDIHKRSWKIHCSTDLFAGKSFSMPPVPEQLFQYVNKHFHGYEVS
TAYEAGCCGYYAHRSFESYGWKSLVVNPADIHRKGKERHTKTDKIDAQLISRELKDDRLE
SIVVPDKKREELRSLFRRRNDLVKEMRRIKSMIKMQLLYFGIKEPAEFDNDHWSHNYRNW
LDNLSFEFDTARETLNSRMRSFRFTDQELRQVTNQLRAYCRKHYKKDYYLLKSIPGIGGI
VAVGILSELGDLRRFNSLKHLAGYVGLAPGMHQSGASNKAMGMNPRSNRLIRSYFVEAAW
QAIRTDPAIQAYYRTHMGKDVKKIIVKIAHKLLSRTLAVIKTETPYEIGVVA
>IFAGANLK_02596 hypothetical protein
MDIEDVAFYIKEQGHLPGFPSAEEVLAGGISLTQMDKATLKKIEELSLYLLDQHARMESL
RSGNVQKASVLAKRADKESTFNIILDQSGIAEGQGHLKTLSSDSLSTGTMYCDGDNVGIG
VVQTSGYRLAVAGGILSEGVKVSNVNNWPDYVFSDDYAMLSLDDLRAYISANKHLPGLPS
AKTIAREGYSLSEMDKLLLEKVEELTLYIIDQESELESLSGELGVILPVADEEVASGKTV
YKSHNVDIETYLTAPIQKEERTFPDMTSHRSIEASTEALCDIISCDGEGVGIGTDPVAGY
RLAVSGGILTDDIQVASVPNWPDYVFEADYKLRDLSRLSAYIAREGHLPGIPKAELVEQE
GYRLETMDGLLLEKIEELTLYLIRQERQLASLERYSGKE
>IFAGANLK_02597 hypothetical protein
MDPYIDLLKILLPELLITHFDLTGHQTEGDILHLNFEEKPEIPKEFSSQLVIAHGFHKEI
TIQDFPLRGKKVFLHIKRRRWLGKQDKKVMQRDWNLVAQGTRMTVEFAAFLKVLSQY
>IFAGANLK_02598 hypothetical protein
MESLRSGKVQKASVLAKRADKESTFNIILDQSGIAAGPGELKTLSTDSLSTGTMYCDGDN
VGIGIGQTSGYRLAVAGGILSEGVKVSSVSNWPDYVFSENYAILSLDDLRAYIRANKHLP
GLPSAKTIAREGYSLSEMDKLLLEKVEELTLYVIHQEAELQSLSGELGVILPVADEEFVS
NKTVYQNHNVDIESYLNAPTKKEERTFRDMASPRSIEASTEALCDVISCDGEGVGIGTDP
VAGYRLAVSGGILTDDIQVASVANWPDYVFEADYKLRDLSSLWAYIEREGHLPGIPKAEL
VEQEGYRLETMDGLLLEKIEELTLHLIRQERQLTFLEKHNSRRN
>IFAGANLK_02599 Thiol-disulfide oxidoreductase ResA
MKRLLLLFFIILGLNIQAQTEKSDKLYFSDALVMHLPEYNKEAKAAYRHRRFEEADRLFE
NFVRNKIQGTYIDNFKFLNLKGKKVALYDYKKPVYLLTYASWCIPGKGEIPALNELADKY
RDKIDFVIVFWDKKETVKELSKQFNSHINVLYVDETRNNHAYVVENLKHSLGLPTCYLIA
GDREIMDIKRSIFHPYNLSKEESFELNYEAINSAITNNLIGNSEKQAQVQWSAITPD
>IFAGANLK_02600 hypothetical protein
MFNKNIKLVLAGAVIGLAIWQFIEGNIGNGIMYILLSLIFIFLYFKNEMILLAFLRLRKQ
DFPGAKKWLDKIKNPETALTQKQQGYYWYLHGLMVSQTNITQAEKFFKRAIKLGLAMDQD
LAMAKLNLAGIAMTKRRKREATNLLAEAKKLDKHGMLKDQIKMMKQQMKKI
>IFAGANLK_02601 Carbamoyl-phosphate synthase large chain
MPKNNNLKSILIIGSGPIIIGQACEFDYAGTQSLRSLREDGIETILLNSNPATIMTDPSM
ADHVYLKPLTTKSIVEILKKHPNIDAVLPTMGGQTALNLCIEADEKGIWEDFGIKLIGVD
IDAINITEDREKFKQLMGRIGIPVAPAKTVTSYLQGKEVAQEFGFPLVIRASFTLGGSGA
SFVHGPDEFDEKLTHGLEASPIHEVLIDKALLGWKEYELELLRDKNDNVVIICSIENMDP
MGIHTGDSITVAPAMTLSDTAYQRMRDMAIKMMRSIGDFAGGCNVQFAVSPDEKEDIIAI
EINPRVSRSSALASKATGYPIAKIATKLAIGYNLDELENQITKSTSALFEPTLDYVIVKI
PRWNFDKFEGADRTLGLQMKSVGEVMGIGRSFQEALHKATQSLEIKRNGLGADGKSYTKY
DEIIEKLTYASWDRVFVIYDAIQAGIPLSRIHEITKIDMWFLRQYEELYALDVEISKYDK
DSLPKDLLLEAKQKGFADRQIAHMLDCLESEVYNKRVDLGINRVYKLVDTCAAEFKAETP
YYYSTFEADIETPDGKRYVDNESKVSDRKKIVVLGSGPNRIGQGIEFDYSCVHGVLAASE
CGYETIMINCNPETVSTDFDIADKLYFEPVFWEHIYDIIRHEKPEGVIVQLGGQTALKLA
EKLDRYGIKIMGTSFEALDLAEDRGSFSKLLQANDIPYPEFGTAETAEEALALADELDFP
ILVRPSYVLGGQGMKIVINKDELEETVVDLLRKIPNNKLLLDHYLDGAIEAEADAICDGE
DVHIIGIMEHIEPCGIHSGDSNALLPPFNLGNLVMQQIKDHTRKIALALNTVGLINIQFA
IKDDMVYIIEANPRASRTVPFIAKAYKEPYVNYATKVMLGHKKVKDFKFNPQLEGYAIKQ
PVFSFNKFHKVNKQLGPEMKSTGESILFIDSLKDDAFYDLYSRRKMYLSK
>IFAGANLK_02602 hypothetical protein
MKELVLIIGGIYGTLAVIFGAFGAHALKKRFSEDQLKSFETGLKYQMYHAIMLIISGIVF
PFIGTSQQLIAWFFIIGIFLFSFSIYGLTLSASAGKKIKILGPITPLGGLLLILGWIFFT
KNIAEIAIYL
>IFAGANLK_02603 hypothetical protein
MKFNGFIATIFVAIIIAYLFPEGIVLFPLKTITDIGIGFIFFFYGLKLSPAEFKLGFLNY
KVHIVIQLTTFVVFPLLALLCLPLFETGTGSDLWIALFFLGTLPSTVSSSIVMVSLAKGN
LPTAIFNASLSGLIGIFATPIWLSFFLSGNADFEFLDVLIKLCWQIIIPLILGLFLQKFL
GDFARKHSKKLGLLDKTTIILIVYSSFSNSFTSNIFSSVETVDLLKLTAIVVLIFFVVYF
GLNLICNLLGFDLKDKITTQFCGTKKSLVHGSVMVKVIFGNSANTGLLLLPIMIYHSLQL
ILIAFYAEKYRKRVLSVEASEKAL
>IFAGANLK_02604 putative acyl-CoA thioester hydrolase
MTQFKHVKDSQVDISELMLPSHSNFNGKIHGGYVLSLMDRIAFACASKHSGAYCVTASVD
TVDFLKPIEIGELVTMKASVNYVGNSSMVIGIRVEAENIRTGEKKHCNSSYFTMVAKAED
GKSLQVPGLILTNEHDIRRFAKSIKRNKMKLNRKQEFHETDFSSKEYVHLLEKYKVKIEQ
>IFAGANLK_02605 hypothetical protein
MRKTLFGILGGILLLFIAWFAFIYFVPYSEGTRSGELIKFSKKGVISKTWEGEISQGISG
AQIFQFSVLDSNQEEIEALQQNEGNYVRVRYVERYATFFFWGDTKYFITEVEKSESPHFR
DR
>IFAGANLK_02606 hypothetical protein
MNINTKSFLSLFIFSLFLLNLSAQEIYYPTSGTWEEKDPSAFNLDFSEAIEFAETNEYSE
SKDLRQAILKGFQNEPYHDILGPTKRRGGPAGIILKDGYLVAKWGDTKRVDMTFSVTKSF
LSTTALLARDRSLIKDIEDPVINYVWDDTFEGDHNSKITWKHLLEQNSDWSGELWGSYDW
ADRPSREGGIDDWRNRQLNEPGTHFEYNDVRVNVLAYSLLNVFRKPLPTVLKEEIMDPIN
ASSSWRWFGYENSWTTIDGLKMQSVSGGGHSGGGIFINTEDMARFGLLFLNNGNWNGKQL
ISEDLIEEAVQPSVTNSNYGYMWWLNVDGPRQWKNIDKDIFYAAGFGGNFIIVDRKENLV
IVTRWLEPSKVEEFVQKIYN
>IFAGANLK_02607 hypothetical protein
MNDYLLFALIFIALLLGLYLGKLISGLKSKNKEAILEEKNNQFSLQIDGLKKQINNNLEN
YKSELSDYKNTLHLQTEKLEKEREEIRREKDFLNTELTRRNAEFENLEQRNKEQKTEVEQ
LQKKFEKEFENLANKILEQKSEKFTLQNKENIQNILNPLQEKILHFEKRIEEGNKESIDR
HAMLRQQIIGLKELNEQMSKEATNLTKALKGDTKTQGNWGEMILERVLERSGLQKGSEYT
VQQSFTNAEGKRVLPDVVINLPGDKKMIVDSKVSLNAYERYSNETEENDRKQHLKNHLAA
IRNRVNELGNKNYHQLYQMESPDFVLLFIPIEAAFAVASNEYPGLYSEAFDKNIIIVTPT
TLLAVLKTIDSMWQNEKQKQNAIAIATQAGALYDSFTALTEELTKIGRQLGTVQNSYEGA
MKKLTGKGNLIRRVEKLKKLGAKASKQIDPKMLSAIDEEEFEENNV
>IFAGANLK_02608 hypothetical protein
MNFFRISTYMLCCLLFSCGEYEAQESNKNIDYRQEMREFVIEISETAKAEDPNFIVIPQN
GVQLLARDCSSQQIPALEYLNAINAVAQEDLFYGYPKLNKITPKADNTYLRKYLDLAKDK
GKQVLVTDYSSNFKLMKKSYRLNEENNYISFAAPSRKLDQIPAYPVFNENNKDITELAEA
KNFLYLLNYAEYSSRQDLLAELAFTNYDLIVMDLFFRNQPFTAQDIKKLKKKKNGGERLV
IAYMSIGEAEDYRFYWEERWSSEYPNWLVEENPDWKGNFKVEYWNQDWKDLIYENNNAYL
SKIINAGFDGVYLDIIDGYQYFEAQE
>IFAGANLK_02609 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MAKPSVLLIMEGTYPFNGGGVSTWAHILCNRVSNVDFKLYSINASFEKEYKYTLSDNISE
VIQVPLWTPDEPYDYISYGEEYYKTVAKKEWTNDDIVAQKFIPIFKSLLEFIYSDDRDIE
DLDIIFHQLWFYFEDYDYKETIRNERVWLTYRDTLAKFIIGERNPDASLIDITIGLRWIY
RFLIPLAIVNIPKVDVSHLTLSGFPVIPALIANYKYGTPIILTEHGVFIRERLLAINNSE
YPYFLKSLLIRFSEAITRLVYHKAEVIISVNKFNQKWEKWYGADPDKFRIIYNGIDPEVF
KPGPKPAHLKDIPTVVALARIFELKDILTMIRSCAVVKKTIPEVQYLVYGDNNAVPEYTK
ECLELIAELGLKNNFKLMGPRNNPQEVFLEGDISILTSISEGFPYTVIESMGCGIPVVST
DVGGVKEALDDSCGFTCKPKDAEEIGNNVLKLLLNEDLRKSMGRNARERVLNNFTLSKFI
GEYEAIYDDIVQIPKAEKKLTKIEDFS
>IFAGANLK_02610 hypothetical protein
MTKDQIKAIAKLVVAVKERNGKPVNVYVVAATIESFGIREIDAKEDYGFESIIHLSNYIY
KAYDAITLANLKNNNQRVAEAKTYKRLALTEYITTKNTKRFIVDYTSGLLHLFPVFLQVV
AIILFGFSLWTYSHFNNLQSTAVVLGVIIGFISSAGFVQVLGKQVSYYWYNKDYHMARHS
TIQIIKNGTIAILGFFIFSILINFVIPLYSFLFVVITFIYALFIGFLLLVLAPLYALKQR
WMLSFSVFAGTVLALLLHFYTDLHPYFIHWTGILVASLISVGYIYAFFHFKLKNQTTVKK
KPKVMLSLYRNFNYFLYGTFIFLFVFLDRMVAWSSTLNRDIPYIIYYEKDYEIGMDLAIL
IFFLLGGVMEYAIHSYIRHMDFHQLQTKYSDFQDFNDKMKRMYFKHLRLFAVSAAGIAVL
LYLIVTQPWGYSRGFDEILSPLSIKVCILGSIGYLFLSLGMLNVLYLYTLGRHRKPLVAI
ISAFLVNFIIGVLLSRWVSYEYSVMGMLVGSLLFAILTTRETYSFFKKLDYYYYASY
>IFAGANLK_02611 hypothetical protein
MVTAAICLNTAQSVAQELTQEKQILFTYGDFYPAEVSGYEILVIESAHFDSEDIAVLKQN
NTTVLGYISLGEVNEAAAHFPEIKDFTFGKNEIWNSHILDIANDETRETLMGIFDYNIKK
GLDGMFLDNIDNYTEFGPTPGKKEALIDFLQFLNVVYPNIHLMQNAGVSIIKDTHPFIKS
VAKESIASDYNFQQKKYQLRDEAIFQQLLKELKEAYDEYEVPVVLIEYAETRKLKKDIKH
RLAQTPWPYFIGKIDLQGIPEKG
>IFAGANLK_02612 hypothetical protein
MYLEPYLLTGPLRIILLFVLILLIHRIVSTRISAQSALNFLVPTITLVMAAVLLGSFILI
LIGIFDLFVIISIIIGLAILAFMNLNFNQPLKTQLRKIYTRSLLYITIKLEKGQKFLDRD
NIIKPKHKHPEHGLSQYHRNWQLAIGLLLPVLTYISRSSLFQEDVYTLSSSWFSKLNFIN
GISAHTWFFQTGEMMGDYLLINLYAKLTHITNAQALQSFGLLESALLSLIIYWLVFKISR
KQAPGIFAGLSFALFYAFLPINIDLIAEHKSVFTSLIIALPTMYFCIYPQSFSFNRKAKF
YWLLTLFTAILLLDLFVGVLLVFPYLLILFIFKFRKNFRQITQIFLAYFFSVAFIGIIYG
AAALLTKEDFGAFILSNFYSFDTYTYNPHLVAPFRDLMNYYQIAAVVFLLIIIYNYIKKS
QKWLASLVFLSFINLMIGIYQLDTGLVDLDILSQVLCIFIPIFFGIIVNVMVNLFSVFNF
SPKVGTRLEVVIGTIIIAVLTISTFPRVATLNFKENKTENMVFEAYSKIQSGNLPYSYAV
VNALPYFSFSKNSHYYYNYDYFNNTYIERDRRFNRYKDNLQYLQNNQDIILPETMFVFVY
KQIQESNQGKKAVVEKQRDLTLERIELLKLKGRNVDVYYEDRNLEVYQIENRERASNINQ
LLF
>IFAGANLK_02613 hypothetical protein
MEKLLPTKIFSAVFVVFSFFLTGCEKDIENEEVEGANPRVEYDNLSENPWVVYLVEPGNE
LSFKNSNHIRKALNYAKIPYNEINRFDFNKKPEVGNSVKVIVIYDLEPLNKNAMNFLIEF
VVKGGHIFIPSVGTNKNFGFLAGVRGDANFEIDTISQGFKFQSSFLPALKGKQYRNENKH
FGLQADNYRENIEILATSISEENYPLIIKNKIGNGSVITFNTDQYSQKQERGLFFAAILQ
GLEGVPYPVANASSIMLDDFPAPLYNVKMEPVTSEMDISQARFYTEVWWKDMLKLAREEG
LEYSAYVCFDYSNRTSPPFNFPEWEQSVLTGSNGNNAADKLMVDFQNSTHEVALHGYNHA
SLTGEVWPNKNYMGLSLKAVKKRWAARNYGQLPVSYVPPSNIIDSTGFVALEENIPEIIY
NASIYLGNFEDGGDREFDSEPYNNHFFNFPRITSGFSLTSTRQFNQQSLYLYTGVWTHFI
HPDDIYQIPGEEPRESAGDYTLRNINSYGWRVSEDGSPGLFPRFRQYIKDVKKTFPLIRF
LKVSEAAKITQNWREIPYNFTENDSEVEVAASIQNTENQNFWFAYISEKNTTEAESFLKS
KQFKFTKTPFLDGYLFNIQTREKKLSLPKFENNYSKDFSEITHIYESYLLIEPSEDLGDI
DKEIDELKSKIAESSIFEREDWLKLFQYLGWNNRQNEIWPLLERKYSENKSSVYVNLSSE
FTTQNDYPHLEIRKRWMLRQIDLQPENLKLRKDFIDYFGSNSEVQLSKGELLTLIERTKV
DAELSSYLSLLNEKHPEAALNLVKGIEPCWENFRLAASTISWIFADAKQYSQALQWSTCS
DDIAESAIDYWRVQMGEYEFLKEGNFPLYIEYLIADNNKKAAQKLLEIEACREDLKHLAA
TISYTYSDQGSYRKALEWSSCVPDFPLAERMQWFYSLENFSEVERLYANYSKKDNPKEKE
AIQIFMTEYYLGRSEMLKSWELASELPESNNKERLRRQLNNTVVFLNTKLKRQLLEEYPS
IFYPEVSSKIKQNLRITEGDFVQIGSNIISDRLDPTSVGLEAVFGTRDKKLNQHQFGLSR
YNAYSIPFQGEQENNEDMELHGLVYRFKTRERIEKFNFGLGSRLEFNETGRAYLHVEASA
SIAKDSLYSSFQFFRKPAITGPAYILDIYQTQLNVYEELQFKEKFQAVFYIEGNHYNDED
IMDVQALTSLSMDFKLNKMAKFRPYTEFSGMLGNSNRSNGFPYWTLDERFYGGLGMAYEY
VNENNFWKINLDAGYFLDTFSDEFQRYRGSVVWPVTKYLHLNTQAEFFTLKNFYSNNFTF
GLKYFLKDN
>IFAGANLK_02614 putative siderophore transport system ATP-binding protein YusV
MNPPEKHSILKTIDLDIGYSNKTAKTIITEAINIEVHEGELVAVIGVNGVGKSTFLRTLS
GVQDALKGKVLVKNEQIQQIDSLELASLVSLVLTEQPISKNLSVFELVALGRQPYTNWIG
RLSKNDLRQIKKSLQNVGIEDLQNKKCYELSDGQLQKVLIARAIAQNTPLVILDEPTTHL
DLYHKAYVLKLLKKLTRKTNKAIVFASHEINLAIQLCDKIILMQNKKVTTGSPKELLESG
AFSTVFPEGLIVFDKASASFKINP
>IFAGANLK_02615 Hemin transport system permease protein HmuU
MQSQKYALPLLLLFLGVIILGFLNISLGSVNIPFKDVFASIFNLEVSKETWRYIIVEYRL
PKAITAIITGSGLAISGLLMQTLFRNPLAGPYVLGLSSGASLGVAIVIMGASVFGGAFAG
ILLSKWSLVIASSLGSLLVLIAVMLASLRLRDTMAILIIGLMFASLTAAVVSVLSYFSPA
AQLQQYVFWSFGSLGDLSWNEVGILAMFWFVGIILAISCIKNLNTLLLGEQYAKSLGVSI
RKNRLIIIIATSLLAGSITAFAGPIAFVGLAVPHLIRQIIPVNNHSILVPAVILGGAALM
LICDIAAQMPGQEYTLPINAITSLIGAPVVIWLLVRKRKFLF
>IFAGANLK_02616 hypothetical protein
MKIKTLKALNFLILLLVFSACKNGQKDQNTVSTTSEKTVKLNHAANFSISDFGDYYLLII
ETPWPDAEEAFTYLLAKENAEIPSGLEYDQQVQIPVEKMVVTSTTHIPALEALNEENSLI
GFPGLDYISSEKTRKLINSGKIKELGKNENINTEVLIDLDPEVVIGFAIDGNNKTFETIQ
KTGIQVMYNGDWTEQTPLGKAEWIKFFGVFYDKLDEAEQIFNQIETDYSEAKELAKSSAE
TPKVLSGAMYKDQWYLPYGNSWQAQFIKDANANYIYADTEGNGSMALSFENVLDKAQDAK
FWISVGQYTSFTQLLEESQHYEQFEAVQNKNVYSVSLTKGETGGVLYFELGPQRPDLVLK
DLVSIFHSELLPDYENRFFKALEE
>IFAGANLK_02617 Vitamin B12 transporter BtuB
MKKTQFYILFLGLLCSLTSLAQNDTVNVLDEVFLTDKKLKDFSTGQQVTVLNDSVLKKNG
ALLTSALNFNTNIYFKENGLGMVSSPSFRGTTASQTAVLWNGININSQFNGQTDFNTLNA
GGFDNISVRGGGGSVIYGTGAIGGTVHLNTNLDFTEKTTQDIFVQYGSFNTLDARYKIKT
SGKKWSLSVATARNSSDNDYEWPIEGRENENGEFYNSNLNLGFAYRLNKKNTLKFYSEIF
DGERHFSLIRPSETKTKYQNFDTRNLLEWVGEFDDFISVARLAHLNENYKFYGNIASDNP
SFGEAQTLIGKYDLNYSVSKTLEFNAVLTNTYTDGTGSGIEENTRNIFSSALLMKHKPFQ
KFQYELGIRKEITNNYKSPFLFSAGTNYDFTDFYSLKMNISRNFRIPTYNDLYWAGAGNL
NLRPETSNQVELGNHFKHKDFKFSLTGYYIHIDEMIRWLPSEGGVWRPINEEKVETYGLE
VLGGWEREILKNHQLRFSGTYAYTVSENMNTGYQLIYVPFHKTTGALTYAFKDFSIDYQL
LYNGEVFTRSDNNSRYNMDAYMVSNLGIAYDLGEKNIYKIGGRVLNIFDEEYQSVENRWM
PGRNFNIYLNLNF
>IFAGANLK_02618 hypothetical protein
MKRISKLLTMAILIGFFLNSCSSDDDNIDPEPQPEESYAEGLFVLNEGGFGKNNSSISYI
DNNFSNLESDIFSTVNGSPLGDTGQSITFDDSYAYIVMNASNIVQIVNRYTFEHIHTIEE
GLSNPRYLTLVDDNIYVTNWGDASNDTDDYIAIYNADTYESTETIRVGEGPEKIISDNNK
VYVALQGGYNYNDKIVIIDLISNTVETSIEIGDAPNSIEISNGYLWVMSGGVPSYAEGID
ETAGSISKVDLSTNEITEEFIFPNSTDHPSNFEIEDDTIYYTLNGSVYSMEESATELPEE
SLFTFTGITSFYGFEIENGYLYTGDAGDYSSNGVVRIYNFEGEIISEFDSGGVSPNGFYF
ND
>IFAGANLK_02619 Carboxy-terminal processing protease CtpB
MKINKLILFLFLATGILSSCFKDDDDERFPVEPGGENPNLEIENYIYDAMSLWYVYEADV
PELGDDYFDSEADKEEWLASFDSPEDLFENGLKVPEPKDRFSFILDDYTILENNQSGIST
TTGMDYGLVRFGDNGVLAYVRYVIPGSPADEAGVTRGVIFTDIDGESMTLDNYQSLLARN
GYDLTVAEINDNIVSNTDETISLNRIEITENPVLLNTTINADGINVGYIVYNSFTADFDG
ELNAAFGELKAEGIDELVLDLRYNGGGNVETAVDLSSMITGQFDGEIFSKQTWNNFLQSQ
LSEDRLVDRFNDEIRTGEMINSLNLSKVYIIGTASTASASELVINGLAPYIEVVHVGSNT
VGKFQAAAPLYDSPDWDRQNRNPNHKYVIQPLIYESVNANEDAYSEEGLIPDIEAEENIV
ALKEFGSPEDPLLATALADITGNRMAIPAISHDSRFTKIGESGDTDIDYQRMYVDEIPEE
IRKKAAELKQ
>IFAGANLK_02620 ECF RNA polymerase sigma factor SigE
MKQQAFLEKINPVKDKMYRLALRLLISKEAAEDATQEVIFKLWARKDKLKDYTNVEAFAM
TTTKNYCLDELKAKKNNNLRIVHQNYENNSISLQRELEVKDEMLLINQIVDDLPEQQKII
FQLRDIEQLEFDEIIEITKMKSTAIRVALSRARKKIRESLTNKHNYGITKN
>IFAGANLK_02621 hypothetical protein
MELQKIRGLLEKYDAGETSLAEENTLREYFQHNEVPADLESYRLIFTFSEKTGRQKMERE
VELPSQTKGKKYLWTAIAASIIVVVGLFFFQNKPLEMNHSDLGTVQDKEEALQKSMEALK
MVSELMNEGKEDLIYLKEFNNTKDKFIKTE
>IFAGANLK_02622 hypothetical protein
MKKIAIVIIIGLLPVITQAQSFAKYENMKDVDAMVMTSKMFKMLAKVDLSEDNPEAREYL
KLIENLDEIKMFTSTTASVRNEMQKDVESYLNSNSLEQLMRVNEDGKNIRFYSKGGKNDN
YVSELFMFMEGEKEGELISVILSITGEIDLSQLSRLTSDLKIPGAEELKNVENKS
>IFAGANLK_02623 hypothetical protein
MKSIKILGLALAAAAFVSCSNEPSLQEYYVENQQDNKFIALDVPTSMFTNAEELDENQRA
TLESVKKINVLALPVKENKEEYEAEKTKLNSILQDEKYQLLMKYGSNDRKAEIYFTGDEE
AIDEIIVYGYDDTKGVGVARVLGDDMNPKKLMELMKSLEKGDVDVDGLKGITGMFKTEIE
E
>IFAGANLK_02624 Adenylosuccinate lyase
MTPLTAISPIDGRYHSKTKQLSQYFSEEALIKYRVKVEVEYFIALCELPLPQLKDVNHSV
FSDLRAIYKNFTTIDAQAVKEIEKTTNHDVKAVEYLIKNKFDELGLEAHKEFIHFGLTSQ
DINNTAVPLSLKDAIEAEYIPEIEQIISKLTQLSQDWANVPLLARTHGQPASPTRLGKEL
EVFITRLEAQLDLLNKVPHAAKFGGATGNFNAHKVAYPNTDWKEFGSNFVQEKLGLHHSF
PTTQIEHYDHMAALFDGLKRINTILIDLDRDIWTYVSMDYFKQKIKKGEIGSSAMPHKVN
PIDFENSEGNLGIANAIFEHLSAKLPLSRLQRDLTDSTVLRNIGVPMGHTSIAFKSTLKG
LDKLLLNEEKLNEDLEANWAVVAEAIQTILRREGFKNPYETLKGLTRTNEKINKKSIADF
IETLDVSKEVKEELKKITPQNYTGI
>IFAGANLK_02625 NAD-dependent protein deacylase
MKKIVILTGAGISAESGIQTFRDVDGLWEGHDVMEVASPMGWENNQKLVLDFYNKRRRQL
LTVQPNAAHIALARLEEIFDVEIITQNIDDLHERAGSTKVTHLHGELLKVRSTFNENLVM
DWKQDLKPGDFCEFNYQLRPHVVWFGEAVPMFEKAMEIVAEAEILIIIGTSMQVYPAAGL
VDFAPNGIPVYFIDPKPNISEKGNLHIIAEKASVGVPKLVDDLNNSA
>IFAGANLK_02626 hypothetical protein
MKKFLLAIFIALPFMFMSCSSDDDAVDSDGDGDDFEGETKSFELYSVADPAISGTATFME
NEDNSTTVELELDGTPDGGMHPAHIHYNTAAEGGDIAVSFEPVDGSTGMSTTTFSTLDDG
TSITYEEAINFDGYINVHISADDLGTLVAQGDIGENELTGESKNYMLEERAVEGISGNVM
FQERVNGEALATIMLEGTPEDVEHPAHIHMGSVVEAPGDIAFTFTPVNGATGMSKTNVAA
LDDGTAFMYSDVLDYDGYVNVHLSADDLGTLVAQNDIGGNELTGETKSYELDQRAVEGIS
GTVMFEERVSGAALATIMIDNTPEDGMHPAHIHMGSFSEGPGDIAFTFNPVNGATGMSMT
QVEMLDDDTEFGYEEVLNYDGYVNVHLSAEDLGTVVAQGDIGANELTGESKTYELGERAV
EGISGSVIFEERMSGEALATIMLDGTPEDGMHPAHIHMGTASEGGDIAFTFNPVNGATGM
SMTHVGMLDDDTEFGYEDVLNYDGYVNVHLNADQLGVIVAQGDIGQNELTGESASYDLAG
VDVDGIMGTAMFEERVNGETLVTIMLEGTPDGGTHPAHIHVGSVEDAPGDIAISLNSVDG
DTGMSMTNVSAFDGEDADMIDYNGLLEYNGYLNVHLSADDLETLVAQGNVGSNS
>IFAGANLK_02627 tRNA (guanosine(18)-2'-O)-methyltransferase
MQETSLIDHLETFLTPRRIALFDKVIAARTNHFTVATQDVYQLHNTSAVIRSCEIFGIQN
VHVIEERKPKRIDREIAMGAQKWVDVNRYSTSKECIKELRAKGYQIVATTPYGESTALKD
FDIEKPSAFFFGTEKDGLSDEILNEADCRLNIPMFGFTESLNISVSAAIILQSITSRLKS
SEINWQLSEEDKIKLKYEWLKKCIKNSDSIIAQFKTENH
>IFAGANLK_02628 hypothetical protein
MTLFFYLLIAFITFIAFLHAWAKKRYDISRTMVINTPRDVVFSYVRQLKKHPLWVPWFAK
HPEAVLKHKGEDGKLGAAIYWKSKNNEIGEGLQKIIKVKHPRVFETRVLFVKPVKVSMLT
YFAAKELEPGKSKVVWGIRGNLPFPLSVISLFYSADKLLGQDLEKGLINLKTKMEKGVKV
>IFAGANLK_02629 hypothetical protein
MKKFLFTFLLLFLSLQAFSQDVVSGTVMNAADDKPIEKVHIVNLNQVKGAVSEEDGSFEL
QATVNDTLYFSYLGFRPIKVRVTNDWLKYGNVKVKMTELGIALEEVVLKPVTLTGYLEID
ARNIPIYENNRYSISGLNSGYEGGESSISRTIGAIFNPADLMHNIFGKKPKQMRKLRQMK
EDDEIRTLLRNKFDRETLIALLPINKVEIDEILQRCSYSKDFLRSANDLQILDALSGCYE
EYRVLQRN
>IFAGANLK_02630 ATP-dependent RNA helicase DeaD
MNKFEQLGLNPSILKAVEEMGFTDPSEIQEKAIPVLLNEDTDMVALAQTGTGKTAAFGFP
LIQKINVSKKHTQALILSPTRELCLQITNEIKNYAKFEKGLTPVAIYGGASITDQARQIE
RGAQIIVATPGRMQDMINRNLVDISKIEYCVLDEADEMLNMGFFEDIKAILSHTPKEKHT
WLFSATMPKEVATIAKKFMRTPIEITVGSKNQGTSNVSHEFYLVNSRQRYEALKRLADAN
PDIFSVIFCRTKRDTQKVAEKLIEDGYSAAALHGDLSQNQRDLVMKSFRNKQIQMLVATD
VAARGIDVDDITHVINYQLPDEIETYTHRSGRTGRAGKSGVSMVIVTKSEMRKIKSIERI
IQQKFEQKDIPDGMEICRVQLFHLANDIKETKINHDIDAYLPGINEVLEDFTKEELIKKF
FSVEFTRFFNYYKNSEGLSSPSAPADGGGSGDSTRYFINVGSKDGFDWMSLKDFLKATLD
LGRDDVYKVDVKDSFSFFNTDSKNTETVLSTFKDFKHQGRFINVEETTDTGGRGKRGGGG
GGGRKGGKFNKGGGKPDFKSGGRRRSEGFGDSGKGKKSGNRSKNIESSIKRRRSKN
>IFAGANLK_02631 Non-canonical purine NTP pyrophosphatase
MELVFATHNKNKLIEIKALLPHYIKLLSLDDIGCKEDIPETADTIEGNAILKAEYVKNRY
GYDCFADDTGLEVEVLNGKPGVFSARYAGENKDDAANVRKLLSELENKENRNAQFKTTIA
LNLNDRQNLFTGICKGEIIKETRGEKGFGYDPVFKPNDFEKTFAEMSLGEKSEISHRGKA
FRELIAYLSK
>IFAGANLK_02632 Ribosomal RNA large subunit methyltransferase H
MTIKLLCIGKTDNRELKQLIEVYKKRLQFYNKFEIEIIPNLKKTKNLDENQQKEKEGELI
LAKVQNSDFLVLLDENGKEFSSEKFSVYIQKRLNSGLKQLIFIIGGPYGFSKTVYTRADA
KVALSQMTFSHQMVRLFFTEQLYRAFTILKNEPYHHR
>IFAGANLK_02633 Nicotinate-nucleotide pyrophosphorylase [carboxylating]
MISKEQFEKEIDLIIENALREDVGEGDHSSLACIPADAKGKAKLLVKDKGILAGVDFALQ
VFEKVDPELKIEVFLKDGKTIERGDVAFFVEGSSQSILKAERLVLNAMQRMSAIATKTNT
FVQKLEGTNTKILDTRKTTPGIRALEKWAVKIGGGENHRFALYDMIMLKDNHIDFAGGIS
KAINKTKDYLKSNKLDLKIIVEARNLKEIEEILESEGVYRILIDNFNYEDTRRAVKLING
KCQTESSGGITLDTARKYAECGVDYISSGALTHSVYNLDLSLKAI
>IFAGANLK_02634 hypothetical protein
MAAKKAFLSKLEQFSNWWERKTKAVILPGFDGLSLYDLWEIYSGGIIKGTFSTRASAIAF
SFFMALFPFLLFMLNLIPYIQFIDDFQLQFLLFMESLLPPDTQEYFNDILLDIANTPRGG
LLSIAFLVSIFLMTNGINAIFTGFEFSYHTNANRSIIRQYLVAVGISLIMALLLLLTIIL
VVYLTYAMDDLKELGLATDGSSAFVKYAGFVLLIYIVVAMLYYFGTKEARQAKFFSIGAL
FTTLLIIITTYFFGLYIENFSAYNELYGSIGALLILMVYIWLNSNILLLGFELNASLIKM
KKKIK
>IFAGANLK_02635 hypothetical protein
MKKLLVLLVAVFGLNLTSAQTEIGGATLPQTLEYGSEEMTLNGAGVREKFWMDMYAGGLY
LKNKSGNASEIMNEDEAMAIRLHIVSKMITSDRMIDAVTEGFESSTGGNTAPISAEIKKF
ISFFKEEINKEDVFDIVYLPSRGSVIYKNGKESGSIEGMEFKKALFGIWLSNEPADDDLK
EGMLGKQ
>IFAGANLK_02636 hypothetical protein
MTTKFNLLNLLLFGFILISSGIHAQGVFGKWKVVNDAGRVNSIIEIYEEDDAVHGKVIKI
TKEEDRDQKCTECPGELKNKPIEGLNVIRDFVKDGDEYIDGTLIDPKSGKEYKGKIWVDE
NNPDKLNVRGYIAFFYKTKIWERAE
>IFAGANLK_02637 Primosomal protein N'
MAYFIDVILPLPLQKRFTYSITKAEAEFLEEGMRVAVPFGKSKVYTAIVGKIHQNPPQVY
EAKPINQILDKSPLVTAYQLKFWKWIASYYMCAEGDVLKAALPGAFLLESESIVQLIKDA
EVDENQLKDEEFLVIEALQRQSSVKIQEVMKILDKKAVLPVINALVEKGLVVLNQEIYEQ
YKPKKIRFVKLNPVYDNEAEMHRLLDDLEKAPKQKEALLSFFSIKAQHKKPLKVKDLSEK
SGVSAAIIKNLITKKILEEYYEKTDRVTFTGDASESGIQLSEIQQKAFSEIEAGFKELDV
CLFHGITSSGKTEIYIKLIEKVINQGQQALYVLPEIALTTQLIERLRAYFGDKVLVYHSK
YSVNERVEVYRHILEDSAKARIVIGARSSIFLPFSNLGLVVVDEEHETSFKQFDPAPRYH
ARDAAVVLANFFKAKTILGSATPSLESYFNAQHHKYALVELNRRYGDVLEPEIEIVDIKT
KYKKKEMKGHFSDRMLAEIKDTLNAGEQVILFQNRRGFSPVLECNTCGHSPQCPNCDVSL
TYHSHNNQLRCHYCGYHIAMQKKCMACDSSEITTKGFGTEQIETELKAIFSEYKTARMDQ
DTTRGKYAYEKLINSFEQQEIDILIGTQMLTKGLDFRKVNLVGIMNADNLLNFPDFRAHE
RSFQLMLQVAGRAGRTKKRGKVLIQSYNPHHQIIQQVSMGDYAGMYKDQLEERYNYKYPP
FHRLIRITLKCRDFSKTNDAADWLAVGMKNVFKENVLGPEFPPVARIRNEYYKNILLKIP
QQQSLGKTKEVLQRIMRSFNAIGAFRSVKVVINVDPI
>IFAGANLK_02638 hypothetical protein
MTRQSISFTEPNNEWLKDQIRNKEYSSKSELVNDLIRQARKQQVQVDWINTKLDRAEKSG
FTLDGKEDILTQSKSQLEGCL
>IFAGANLK_02639 Transcriptional regulatory protein YpdB
MEEILLKCIVVDDSSLQRLSIVKLIKDHSNLKLVAEYNNAIETKNGLLDNEIDLIFLDIE
MPVLTGFELLDDLPNKPQIIFVTGKTQYAFKAFDYDAVDYIHKPVTKERFNNAVNKAINL
YKLKHQISAPPEDEDYIFVKSNLKNRKVFLNKLKYIQALGDYVKFVTEKENFVVLATMKS
FEEQLPNDKFLRTHKSYIVNLDKIERYNSKNIEIDKQKLPLSRHKKSNLVEALSAIQ
>IFAGANLK_02640 30S ribosomal protein S6
MNTYETVFILNPVLSDEQIKETVQKYEEFLVSKGAEMVSKEDWGLRKLAYPIQHKKSGFY
HLFEFKAPGEAIEPLELAFRRDERMMRYLTVRLDKHAIAWAEKRRNRRQQEKA
>IFAGANLK_02641 30S ribosomal protein S18
MATSIEQQAKGKKDGEIRYLTPLNIETSKTKKYCRFKRSGIKYIDYKDPDWLMSFVNEQG
KLLPRRLTGTSLKYQRKVAVAVKRARHLALMPYVGDLLK
>IFAGANLK_02642 50S ribosomal protein L9
MELILKQDVDNLGFKDDLVNVKNGYGRNYLIPQGYAHLATPSAKKVLAETLKQRAYKEQK
HIDEAKKQAEKLNNVEVKLTAKAGAGDKLFGSITNADLADALAKEGIEIDKKFITIAGGN
IKRLGQYEATLRFHREVISTYNFDVVAEA
>IFAGANLK_02643 hypothetical protein
MKYSRLTKEQFEEMKQEFINFLATQSITAEEWEDIKKNQPKAAEQELDVFSDLIWEGVLN
KVEYLEHFSPNQIYLFHITEVTIHLIAIKVEHQGVDLTTRKGYSWLQTNLLDESVNIYTS
SKALSEDRNKDIFALIKQGANITKGDLYRYFDNMVESK
>IFAGANLK_02644 hypothetical protein
MKKTLFLLIFSFFIISCEKDEPTYCCTIIDSSIDIKFIDSEGNNLLGEENQFEETDISVY
NKIDGEWKISPENTFLVERENEDYLRVFANLESTDTQISELKLEFPDNEFDILKTEISSQ
NANTFVTKVWYNDELKWETDNNSERIIEVIK
>IFAGANLK_02645 Macrolide export ATP-binding/permease protein MacB
MFGLLKENISIAFNSIKSQLLRTILTVLIIAIGITALVGILSAVTALENTISSDFASMGA
NTFNIQRYEFNSQRQGGGEVEKINPIISYREVKKFEENFQYPQAQTAVSFTGTSAAEVKY
INEKTDPEVSVIGVNENFMENSGLNVEEGREFNIFDIQNNNNVVILGADFAKPEGLFKGS
DPIDKIVSIRGAKFRVIGVLESKGSTFGNNQDLRVLMPIQVARSMFTQPQINYAVSVKVD
DKELLEGAQDEAILTFRNIRKLNPMEENNFGMERSDDLINRIFSITSYLNFAAWIISIIT
IFGSSIALMNIMLVSVTERTREIGVRKALGAKRKTIATQFFMETLIIGQIGGIVGIIFGI
LIGMAVSAAADFDFTTPWVAMIWATAITILVAILAGSYPAAKAARQDPIESLRYE
>IFAGANLK_02646 Histidine--tRNA ligase
MAQKPSIPKGTRDFNPAEVAKRNYIFDVVKTEFKKFGFQPIETPSFENSDTLMGKYGEEG
DRLIFKILNSGDFLKKASLEAYEAKDSLKITSSISEKALRYDLTVPFARYVVQHQNEIDF
PFKRYQIQPVWRADRPQKGRFREFFQCDADVVGSKSLWQEVEFVQLYDAVFSNLKLEGVT
IKINNRKVLSGFAEVIGEKDKLIDFTVALDKLDKIGEEGVKKEMLQKGISESAIEKIQPI
FSLQGNFAEKIAGIKEILSASETGMEGIKELEFVEKAIQEMPLKTAKLDLDVTLARGLNY
YTGAIFEVSAPENINMGSIGGGGRYDDLTGIFGLKDMSGVGISFGLDRIYLVLEELGLFP
IAVTQNTKALFINFGDKEALYALKAVNRLRAENVTAELFPDAAKMKKQMNYANKREIPFV
ILAGGEEIQAEKFTLKNMKSGEQQKVDFAELVKALD
>IFAGANLK_02647 General stress protein 69
MEKVELGKSGLKSAPIIFGGNVFGWTLNEKESFKILDELFELGFNTIDTADVYSRWANGV
PHGTSERIIGKWMKERKLRDKITLITKGGSSLQPGGPKNNTRDYLTGAVKDSLLRLQTDY
IDLYFTHFDDGETPVEEALEAYQKFRENREIKHIGASNFSSERLQKALDIANEKKILAYE
VFQPEYNLMVRYKFEGEIEEICTKNNLGVTPYFSLASGFLTGKYRKKEDFEGKERKMFAD
KFLNNRGEKILKSLDKISEKHGISQAGVALAWLMNRPGVSAPIASATKSSHLKSFTEAVK
VSLSNEDMEVLNKAGETE
>IFAGANLK_02648 hypothetical protein
MKLIAKILLTLGVLAGSFIMIGSFTFDQENIVDAPPKIFALVLGLGTIAAIYIIWRRKSL
TTEDENSTDY
>IFAGANLK_02649 hypothetical protein
MEVFIILISGLVATTSMTLFSYLVSNFKSKQFREPELLNSLISRSEIIELRPSKNHFLGW
VIHYLIGWFFVVVFSLIWEYTQFSTNIISGAVLGLAAGIIGIFGWKTMFKLNQNPPEIDF
SQFYIQLIIAHILFGLSAAIVYAYL
>IFAGANLK_02650 2-haloalkanoic acid dehalogenase
MKPKIIIFDVNETLLNLIPLKEEVNAALENEMGFDVWFPELLHYSLVETITGNYQNFSEI
AAATFKMISGKFDKEFSDSEIKNILSEITRLPPYPDVKPGLEQLKNEGYTLIAFSNGKPD
VLKAQLAFAEIDSYFDGIHSVEEIKKYKPHPESYKYILKKYDAIPKRAIMVAAHAWDIIG
AHGANLQTCFVERPGKKLYYLAEKPDFLVSKITEILEKIG
>IFAGANLK_02651 hypothetical protein
MSSVNVFLRNKVNKSGQFPIAIRISRNRRSIYLYTGQYIEKKYRDGKKTM
>IFAGANLK_02652 hypothetical protein
MRLNHLILTKLTEASEKLLENESTQRKLSVGKLKESIQRQNSCDFKSMADVYLNNIKVRK
KIKSIPHRKK
>IFAGANLK_02653 hypothetical protein
MDLFLSYAGNSIEFHEIDVPLLKNFAAYIEFKKKRAKRTVVNYMICIRAIYNLALVANKA
DRNDYPFGKGKYQIKIPDAKKIGLTIEELKKLENAKDLNEANQHVLSVWLLSLFFRSTDN
RYYSIKMDRLKGLPIILSDEEK
>IFAGANLK_02654 hypothetical protein
MFRTSITLTFGLILGCILCSSQENLQWNPLFNGQDLNNWDFKIRGYKLGNNYGNTFRVED
GIMQVRYDQYKDGFENRFGHIFYKDPFSSYLLGVEYRFSGEQVNNNPGLWAHRNNGIMLH
GQDPQTMDKDQDFPHSLEVQLLGGNGEYDRPTANLCTPGTQYVRDEKLIKTHCSMSSSKT
YHGNQWVRVEVLVLRDSLLVHFVNGEEVMRYGQPQRDDGKLIRKGTISLQSESHPTDFRK
VEIIDLSAYEDKPGKLQKMVNRIINEKNVVK
>IFAGANLK_02655 hypothetical protein
MKSGIFIRKTALSITLLLFMVIQACEKPTMFTELTPDKTGIKFSNTITEDGHNNIMTYEY
TYNGAGVAVGDVNNDGLTDIYFVGNQVPNKLFLNLGDWKFEEITLQAGVQGRSDWKTGVT
MVDVNGDGWLDIYVSYSGNAPSEGYNKGIVKEYSARSNQLFINDGGQKGRIPTFTERAQE
YGIDARGTFTSQAYFFDYDLDGDLDMFLLNHANMFYSAFFNVQKLRSLRHPYFGNKLYRN
DNQRFTEVTETTGIHGSGLNFGLSASISDINKDGWPDIYVTNDYEEQDFCYLNNGDGTFM
EISHIAMGHLSKYGMGSDIADVNNDGLPDIYVADMLPEDNYRQKILKGPDEYNKFSKAVD
SGYHHQYMRNTFQLNRGLAKDSIPRFSEIAQFSGISNTDWSWATLFADFDNDGMKDLFIT
NGYLRDVTNLDFVNFTTSKEISQANSKNQEVDLLPLISKMPATKISNYSFRNTNGIQFEN
RTSNWGLDKPSVSTGAAYADLDNDGDLDLIVSNLNAPATIFQNNQQDFYKNNYIKIKLEG
EGNNTFGLGAKIITTLEDQKQLYHEAYYTRGYLSAVEPLLTIGIGEEKILKKVEVVWPDG
GVSVHHNIEANQELIIKQVDAVDRSRSLIEIEPPLFEDVTTVSGLDFVHRENDYVDFLHQ
GLVPYQLSRLGGRLAVGDVNGDGNDDVFFGGAAGQSGQLYLGRDDGTLVKGPREQPWTAP
EDVAREDIDILFFDADSDNDLDMYVVSGGNEKPSGSSFYKDRLYLNDGTGNFVKTLNSLP
HTSFSGGVVVSADYDKDGDIDLFVGGRHKAKNYPFASQSILLRNDTQDGIVKFTNTEEKA
LQKLGMVTDAVWTDSDKDSWPELFIVGEWMPLTLLKNNRGILTNKTKELDLDTTQGWWSS
IDAEDYDGDGDVDFLLGNAGLNTQLFASKAEPMVYYVQDFNKDGNFDPVLSYYIDGESYP
LPSRDEMLGQVASLRKKYTSYDKYAKATMEDLLKAGNVTTTSILEINELRSLYLNNLGDG
NFNLSPLPGMSQISMINAFAFDDFTGNGVSDIVAVGNFSPYRVNFGKSDALMGVLLNVME
NEVTVDNQFSNLWLSGDIRDVSIMEFNSGAKRIILSRNDDKASLYKYN
>IFAGANLK_02656 TonB-dependent receptor SusC
MNKLLILFFYLPFIISPEVVFATGDSPGVETLNREEFVSDLKLIDNNELEPLEHSSRITP
PEIQQTVRGIVTDPTGMPIPGANVIEKGTTNGVVTDFDGNYEITVAPDAVLIFSYVGFLT
QEMSVDGQSTLEVELQEDQAQLDEVVVVGYGTQKRENIVGSVATVGGEEIQKSANLNVSN
ALTGRIPGVVATQGSGEPGYDGSNIRIRGTNTLGDSSPLVVIDGIPARAGGFERLNPADI
ADISVLKDASGAIYGARAANGVILVTTKRGREGKAQLSYNYNMGFTQPTVIPDLADAVQY
AEMRNDLEVYKLPVNEWESASSAFQSSGVYTRPDGNEVLAPFTPEEFELFRSGEDPWNYP
NTDWFGETLKDWSTQQKHNLQISGGSEDVNLIASIDYQDQDAFYKNSATNYQQYGIRVNM
DAEISDYISTQIGVLGREEDRNYPTQAASDIFRMLMRGSPVSNAYWPNGLPGPDIENGQN
PVVITTDQTGYDRDKRYYFQTNGKVVIEAPWVEGLKFTGTAAVDKYVRQNKTWQTPWYLY
TWQGDYEDDGETPALIRGQRGPAEPNLNQGNEDQLNILLGGVLSYDRDFGDHEINLLAGV
NRETIKNETFGAFRRYFLSNSVDQMFAGGREELNNSGSAWERARLNYFGRVGYNYKQKYL
AEFLWRYDGSYMFPADNRYGFFPGFMLGWRISEENFWKDNISVVNFLKLRGSWGQMGNDN
VYYDDVLQEYQYFATYGLGSYVAGGAVNQTLFESRVPNPLITWEVANNYNLGLDGQMFEG
AINFEFDVFLNKRSNILWRRNASIPQSAGMTLPAENIGEIENRGFDFNIGHSGKAGEVTY
NVNVNGGYAKNKIIFWDEAPGAPEWQRTTGRTINSGLYYIYDGVFVDEEEIANNNLDYSD
ITNTIRPGDMKYLDYDGDGAITPDDRVRRDKNTTPTFQGGLNFGAQYKGFDLSVLFQGAA
GGEIRVGTDEAGSIGNYLEEHYDNRWTVENPSSVHPRITDRGDQYYSYNNTYWLQSTDYI
RLKNVELGYTLPVEIGKKIGMSSLRVYTSGFNLITWSGMTAYDPEVTNSIGHYYPQSRIL
NLGVAVTF
>IFAGANLK_02657 hypothetical protein
MKNYRMKNIGYYLLLLFAVVGCNDDFVDTQPLDEFSQSDVWVDAALAEAFVLEIYNGLGQ
GGFDEQMMASLSDEALFTHPGRGINTITESRSGPADRGFINYTYNWGDLYGRIRATNIAL
ENLEEPGFDDSDMADRLRGEALFLRAYYYHNLLRMHGGVPIVDKVYTLDSEDLEIPRNTF
EETVEFIVSDLDNAKPLLEGLNVDGRASMEAALALKARVLLYAASDLHHIPTASVNSSDI
AGYSNPEYLGYVTGNQQDRWRRAQAAAKEVVDLNRGYRLDLIEPVSAEEGEENYMALSLG
GGSVMADPAAATELLFARYFVAAKNESGQQIGLFNGPNGYHNWAGNAPTQNLVDNYELID
GNEFNWNNSEHANNPYDNRDPRFYATVLYDGADWKPRTADVAGSDPFDQIQTGTYEVKSG
TGETITHNGLDTRNSAIEDWNGTHTGYYVRKFTDPDPAIVDQNVRQQIPFPFLKYTEAAL
NYVEASLELGEEDIAKEWLNKIRFRAGMPAITASGQNLKEQYRQERLVELVYEEHRFHDA
RRWMIAPQTLGEQVRIIDVEGFLKPGANIEVYRYDPSSYDYEYEVRDLSPGIENREWLDK
MYFIAIPRDEMNRNDQLVQNPGH
>IFAGANLK_02658 hypothetical protein
MKNYIAIFALSFLIFSCKGQEEKESRTFSLFNGQDLSGWHVDVPDMDKNSNAPNPFIIRD
GMLVSLGTPQGHLITDAEYKNYRLDVDYRFPGEPGNCGVLVHASTPRALYEMFPQSIEVQ
MMHKNAGDFWCIVENVEVPNMEERRGPKEDWGITEGKERRVKNLTDDSENPLGEWNNMVI
ECRDDTIKVWVNGDLVNEGFNLTTKSGHIALQAEGAEVEFKKLKLTNL
>IFAGANLK_02659 Serine/threonine-protein kinase pkn1
MNFKNRLIIILLVFSVTEGFSQQQELENYTQEIAGSDLIIEMVAIPSGTFTMGSPEKEEN
RLEDEGPANKVKIDAFWMSKYEITWELYNLFVNRAIDKVQSSKASDVDIDVDAVSGATIP
YVDMSLGMGTGEDLPVGNVTQYAASKFCEWLSAKTGHFYRLPTEAEWEYAARAGTTTAFH
FGNNVDLLEKYAWYYKNSDDSYQKVGQKKPNPWGLYDMYGNVAEWTLDQYLPEAYGSRDS
ITDNPFEIPEKDYPRSVRGGSYYDDAEFLRSAARLGSSENWKMRDPQFPKSKWWNTDAPY
VGFRIIRVPNPPKTTDYETFWGPRSL
>IFAGANLK_02660 Inositol 2-dehydrogenase
MNNSKNKHKPILQSSRRDFCKNTALFTAGVMLPGMKMDTMANVFNNKTLKLAVVGCGGRG
TGAANQALKADENVELVAMADAFEDRLSGSLQSLQKEFEGSKRVNVQDKHRYVGFDAYKK
AIDQADVVILATPPGFRPYHFEYAVNAGKHVFMEKPVATDVPGIRKVLEMAKIAKENKLN
VVVGLQRHYQNNYLAIAEKIKQNEVGKILSGQVYWNGAGVWVNPRESGQSEIEYQMRNWY
YFNWLCGDHILEQHIHNIDVANWFIGEYPVSAQGMGGRLVRTGPEHGEIFDHHFVEFKYP
SGAVISSQCRHQPGTWTKVGEAFQGTKGIIDMNDAGAANITDLEGNNIFEYRNRRDPNPY
QVEHDKLFASIRNKGVISDAENGAKSTMTAIMGRMATYSGQVINWEEALKSDQVLMPKEV
TWESTPPTVPGEDGLYPIPTPGKTKVI
>IFAGANLK_02661 hypothetical protein
METIFRTSIRYELIECIKKVNKNDKAKWGQMNVYQMLKHTTYWNGWILGKEDHTYKQILK
EYLAK
>IFAGANLK_02662 hypothetical protein
MIKEEKPFDKNIPTSEQFKAKELNANLESEKSNWISLLNEIIVILNSSTTFLEKCQESRL
GY
>IFAGANLK_02663 Sporulation kinase A
MLEEKIDFKNWSHNDHGFLLLVNLENSKIEYINNIAAAYCGVEPTVFNDLCFYKEFLHPE
DYPGYIAHLKSMKELLPEKEIMRFARLKGKYGNYKKFRFKDRLYKGSTDKKGQVVLSLIN
DVDPENKDKIKNTEKAILKDKGIESEYQQLFNSMDDAFFIAEIIYDSQKNPVDIYFEKTN
PAFEKQINLKDVSGKTVRELFESPRLEWLKTYGEVVESGKPIRFQDTSANLNDSWLDIYV
FKLGDSNCKKIGVLFRNITDRKIVEKDLEQKAIRRQRDLEVSNELLQSVFETTNLAIVVF
QSLFNEAGEVHDFKFLRINQVLRSLYMEQDPIGKTYLEVSKYGVEMGMYDALKEVVKSGK
PMDKELYFDKDTYNHWFRLTARKQGELLIATLEDITERKIKDEELKENIRFKQQLVRTSP
ETIIIFNLSQFNVRYINKDIFKEGGITKEKVQGMPLEKLLPFIHPRDRETVMDMHRKLLK
SSDDDIHDIEIRLKLQRTSWEWFNVRGKVFHRRDESWVEEYVLLVRNIHNLKNTKKALLK
AEKLSIQGELARTFAHELRNPLASIGMATKVIGTKLAGEKENYNTYLEILTRSTKTLNNL
VNNLLNSANYTPAVLKKQNLAEILDETINMASDRIYLSGIKVIKNYIGPYSIMADAAKLK
IALLNIIVNASEATIPEEGIITVEVKKHKTDFQLSITDNGHGLEQEEIDRLFEAFYSKKE
TGMGVGLSSVKNILEEHDAPIKVESKPKEGTTFIFYFHNASME
>IFAGANLK_02664 Ribosomal RNA large subunit methyltransferase F
MPSKNKPHKTRLHNRNRNREPYDLEALINAIPQLKNHIKLNKYGSDSVDFSNPFAVKLLN
KALLKHYYGINNWQFPDENLCPPIPGRADYLHYIADLLSESNADKIQKGSQICGLDVGVG
ASCIYPIIGVTEYDWNFIATDIDPKSIDSAEQVINSNPSLTDKVDCRLQKDPTAIFQGII
ERKDKIDFTMCNPPFHSSIEEAQKGSRRKLRNLSGKKAPEAKLNFSGARNELIYDGGEYQ
FIKNMIRDSEEFAKRCFWFSTLVSKQSNLKGIYKLLDKVKPTKLKTIAMGTGNKSSRIVA
WTFLSKEEQMLWKEEWKAN
>IFAGANLK_02665 hypothetical protein
MKTLCLVFIFIPCFLIGQEVYNSTFTETYPNIFRSQFEKINRRIVFEPNDVTIVTETKEG
KDIEVLNIQETRYIDDRLILLCQNRSKRKITIALPAEHEELLYIDYYYRSLTTNEEVQIR
FHVEEMQIDYGDQIKIGYG
>IFAGANLK_02666 hypothetical protein
MDTKKNCLACNKELEGRPDKKFCDPYCKSAWHYQKTKGGAAGFYAKVDRQLKTNRRIFKS
FNKAGKATVRVDILKQHGFDPNFFTHYWKNSKKEVYLFVYEFDFLTR
>IFAGANLK_02667 hypothetical protein
MDRKYITLKNLILDKEKCIGLKFFTDKVVQAMVNYLPEVKWSEKFRMNYILNTPENLELI
FKTLRGWPGSIAIISIPGPVLDARKNL
>IFAGANLK_02668 hypothetical protein
MQKLFEHINKYTSIDTAAFEEIISFFTIKSVSKKENIYTAESKALHHYFVLNGCIHLYFI
NDRGAEQTLQFAIENWWITDYLAFQNNRSSEFCIQAVEKSEILQITYQDQEELLRRFPQM
ETYFRKVYQTAYGAAMMRIKYIFSYSKEDIYFEFKDAFPNFVNNVPQYLVATYLGLSPEY
VSKLRRKSIS
>IFAGANLK_02669 hypothetical protein
MEQRIQIDRLQPEAFKAMYALEDYLAKSELSKIHKQLIKIRASQMNGCAFCIDMHTKEAL
KIGESHERIFLLNAWNESNQFSEEEKVILLITEEITFIDKNGLTDRTYNKALVIFSETYL
AQLIMAATVINAWNRIAISTNKQIQN
>IFAGANLK_02670 Isonitrile hydratase
MHKSHLIAILLSVTLMSCNTDKSKTNPNVQISAQNESEADTLTKHLKSFKSDLPTIGLLM
YDGVLQSEVVAASDVFSKPSEDGKQLFNVVTIGQSEKPITTEEGLRFLPDYTFEDCPKLD
ALFVPSAYDMYAQVHNENIVDFIRERNNETQYVVSNCAGAQLIGASGIADGKKIVTWIGG
GEQLQKDYPNLKVQDDSSVTYVEDGKFLSSNGNLASYVSALELSEKMTSRQHREFVESYL
YLDRLQEWKKE
>IFAGANLK_02671 hypothetical protein
MRFIIGKDRKQSALFPVSLEESIGIENEVRAIDLFVNSLDLAKMDFKVCFPEGGRPAYHP
SVLLKLFIYGYLNRIRSSRILEKECRRNIEMMWLMEQLSPDHNTIANFRKDNPDAIKRVF
RATV
>IFAGANLK_02672 hypothetical protein
MIGGKIIAGDGTKLRAQKSKKNNFNTKKIDRHLKYIDNKLQQYNEDIANADGDAEKEETQ
NNIKLHSTRKEGYKKLQQELKETGAPQISTSDPESRQMVIRGNTTEVAYNVQSTVDAKNC
IPIVYEVTNQNDKKAMGAMVRRAKSILGTTDFTALFDKGYYTGTELGIVQGLGIKTLVAI
PDQASKAPDPNYNVKNFIYDQHNDTYTCPEGHPLTTSGKLYLKYRGTSNQTEFKQYRTKA
CKSCPVKDLCTKAKNGKVIERNIFTPMYDENRKNMEEDPELYLRRQAIAEHPFGTIKRQW
GFDHILSKKGKKRASADVGFIFIAYNLKRILSLIGKKDFREMYGHFKLCFNVFIQVYRGI
LMTLNSLTTVNLNYLTNSKPNPKMLILVANQQ
>IFAGANLK_02673 hypothetical protein
MKKLLLLIPILISCSTTKEKTEYQHLLDYEGRYEYINQSTLNIVASELDTTLYAVVKKAK
YPLNHISLDSFTNIQDIPVVFKRDKSNKVVGYETSGQSFQQITTDFEKMEVFPRKELFHK
PDNYIYQKPKEISDGLKTGRLEEAFKNPEPIINMVKETIKGNYPDVHSILIYKDNKLVLE
EYFYGYHKDTPHQLRSATKPFIGGILGIAVDKGFIKSEKEKLLPFFKNRYDKIANLDDRK
RKLTIENFLMYRHGMDCENNNPESKGNEQAMMQSNDWVKYTLDLPMFTEPGKFSSYCTGC
ALTLGRLIEIGTKQNIEDFAKENLFGPLGIENYDWTFEPNQASSETFSQMSIRPRDLIKL
AKMYKDGGKWEGEQIISQSWVDKTFDMEDGDYGYLWEHKYIVIDGHQYNSYLASGNGGQK
INIWPELDMITVFTGGNYNSYVLYGKSTPPNDMIPKYILNAVE
>IFAGANLK_02674 hypothetical protein
MNKIREYFENIVEINDSDWRLFSSKLERSDYPKKAILLEVGQTERHLSFIAKGSIRFYIP
KLENDSTFGFCFENQFVSAYDSFLTQKPCAYQLQTLTETTLWRISHKDIQEIYAKSDIGN
TIGRLTAENLFLIKSEREQSLLNETAEERYLALIKKRPNLIREIPLKYLASYIGITPQAL
SRIRTRIS
>IFAGANLK_02675 hypothetical protein
MKPLIVLIFFFLVAIFAVRVITGIYNFPLSARIGISVMLLFTAMGHFIFPEGMVLMIPDF
IPFKKSLVYFTALIEIFGAIGLHIPQFRILTAWLLILFFLAVLPANIKASIEGLDYQKAT
YDGNGLMYLWFRIPLQILFILWIYFSTIRIK
>IFAGANLK_02676 hypothetical protein
MYTSPLKEFSRNDYFDQSVINDDMADFSFDFFFSGKRIGSRKELIDLFVVTWIMDDIENI
FIRYCIYSGDKANWKEKITDQLKILMQDINVSKEIISGRLRYFEVKSEKYLPTEAFEKKF
LDLKSRMKRFQEY
>IFAGANLK_02678 hypothetical protein
MEDKIKYEMEFPIQASPSLLYQYISTPSGLSEWYADNVNSRGELFTFIWEGSEEKAKLVS
KKSDERVKFKWLDDEDTPYFFEIRIQVDEITKDVSIMITDFAEDEDEIEEGKMLWENMIS
NLKQVLGSV
>IFAGANLK_02679 Aminodeoxychorismate lyase
MINLNGNLVEDNQASLSVTNRGFAYGDAVFETIRVISGKIMFWEDHYFRLMASMRIMRME
IPANFSPEFLEDEILDLVKENGLDTTAARVKFSAYRKEGGYYRPATREIGFIITTEELSE
AFYLLNEDDYEVELFKDHYVTSGLFSTIKSNNRAINVLGSIFASENGYENCFLINEKKNV
VEALNGNLFLVKGDKIKTPPLTDGALNGITRKKLLEIIKTLPELTLEETSISPFELQKAD
ELFITNVITGIQPVTKYRKKKFVNKVAKDLLSKLNVKARLD
>IFAGANLK_02680 hypothetical protein
MIALKPTKGHLLVAEPSIIGDVAFNRSVVLLADHSEAGSVGFILNKALDFTLKDLVPDLS
SNFKIYNGGPVEQDNLYFIHKIPDLIPQSVEIANGIYWGGNFDVVTELINQNLISEKEIR
FFLGYSGWDANQLDEELNSHAWIVTNNENPKDIIERPYHSFWKDKMMQLGGEYILWSNAP
ENPSYN
>IFAGANLK_02681 DNA-binding protein HU-beta
MNKTDLIDAMAENAGISKAAAKKALESFLENVEKSLKKGDRVSLVGFGSWSVSKRAAREG
RNPQTGKTIKIAAKNVVKFKAGADLQKAVN
>IFAGANLK_02682 hypothetical protein
MVAERDKNQLNLDLFINKKADLLTKSRISLDITCTAENSI
>IFAGANLK_02683 Methionyl-tRNA formyltransferase
MGTPDFAVASLESILNANYNVVGVITAPDKPAGRGRKLQESPVKKFGVSKGLKVLQPTNL
KDKTFIEELTALDPNVQVVVAFRMLPKVVWDLPKFGTFNLHASLLPQYRGAAPINWAIIN
NETKTGVSTFFLDEKIDTGAMILQKEINIAPEESVGELHDKLMELGSGLVVETLELIEKG
NLTPTPQPFDPLLKDAPKLNRENTKINWDVSLDQIYNLIRGLNPYPAAWSILFNDGKEEK
VKIYHCKKEIVSHSLENGSITIEDKELKVAAPGGYLIIKELQLPGKRKMDVKSLLNGYNF
TKGAKFR
>IFAGANLK_02684 ATP-dependent DNA helicase RecQ
MPTGGGKSLCFQVPALIQEGICIVISPLVALMEDQVNALQQKGIKAMALTGGMAYRDLDA
ALDNCIYGNYKFLYLSPERLQQDLIQERIKLMNVNLIAVDEAHCISQWGHDFRPAYRNIS
LLKDLKPGTAFIALTATATPAVVKDIVKELELEDIEVLKDSFYRPNIAYNVLIAEDKYYR
VYQMLNNKNEAAIIYVRSRKASLEIADLLNEKGYKADAFHGGLQPKEKTRKLSSWLENKH
HIMVATTAFGMGIDKPDVRQVIHLNLPESLESYFQEAGRAGRDGKKAFATMLTNKSDIPV
LKNQFLANLPQLEDVKLVYKKLNTYFRIAYGEGEETEHNFSFSKFCAQYELPFSKTYQVL
QLLDRCSVLKLSKEFHKRTSIHFTISGIQLQYYLEQNQKYESFVKALLRTYGGILENKTA
IDLASVCKKSNIDQGKALKFLEELEKDQVLEYVFAEHDATVLFLVPREDDLVIFPLAPYI
RQHNESKKKKIDSVLAYLENDKVCRSKQLLAYFGEEKAENCGICSVCQKQAVPLTKGLKN
TIYKEIMKTLKTSDASSRQLTEAINYPEEQVLEVLHLLIDKELIARKSGNIYKINK
>IFAGANLK_02685 hypothetical protein
MKKQKIVITGGPGTGKSSIIRQLEKHGHECLHEISRQVTLEAQKQGIDQLFLEKPVLFSE
KLLEGRKIQHREADILPASTIFLDRGLPDVLAYMDYFKTEYSTYFTEACKEYSYDKIFFL
PPWEEIYQSDNERYESFKEASQISKYLFETYKTYGYTPIEVPKTSVVDRTAFILNQI
>IFAGANLK_02686 hypothetical protein
MSGAKDQEEFYNKLRAQLEDTSLWPSEYLYKFIVPAKSNQVKIIDEIFDNMGAVITTRKS
KKGTYISTSVNVRMKNPDAVIEKYKEVAEKVEGVISL
>IFAGANLK_02687 hypothetical protein
MTHALEYNSERKHLIIPEYGRHLQKMVEEAVEIEDDKERNQVAKSIIAVMGNMQPHLRDV
PDFQHKLWDQLFIISDFKLDVESPFPKPTREMLEERPEMLDYPQNFPKYRFYGNNINRMI
NEVKDWEEGPLKEGLVLTIANHMKKSYLNWNRDTVEDEIIFEHLRELSGGKINLKNADED
LSDASSLIRNKKKHTGKNNNPKKSNRKGGGGRKRY
>IFAGANLK_02688 UDP-N-acetylglucosamine 1-carboxyvinyltransferase
MGTFQIEGGQQLSGEIQPQGAKNEALQILCAVLLTSEEVVINNIPDILDVNKLIQLLENL
GVKIKKLGKGSYSFKSDDLDLDYLSSDQFKKDGSGLRGSIMIVGPLLARFGKGFVPKPGG
DKIGRRRLDTHFEGFIKLGAKFRYNKEERFYGVEAPNGLKGSYMLLEEASVTGTANIVMA
AVLAKGTTTIYNAACEPYLQQLCNMLNSMGAKISGVGSNLLIIEGVEDSLTGCEHRILPD
MVEIGSWIGMAAMTKSELTIKNVNWVMLGIIPTTFRKLGITIERKGDDIFIPAHTNGYEV
QSFIDGSIMNISDAPWPGFTPDLLSIVLVVATQARGSVLIHQKMFESRLFFVDKLIDMGA
KIILCDPHRATVIGHDFQSQLKATTMTSPDIRAGISLLIAALSAKGTSTIHNIEQIDRGY
ENIDERLKALGAKIERIA
>IFAGANLK_02689 hypothetical protein
MPITIMGDKEFENVPSIKSKALRINLNENIYGTFSEIGAGQETVRNFFRAGGASGTIAKA
MSAYDKDFSDAIYGVENDRRYVTEARLKKMLSHEIGLIEQRISREKHPNKLFFSYANTVA
TIDFAKKYKGHGWVGIRYQVSPEEDYNEISLHVRFHENDARHQQNTLGILGVNLIYGAYY
KYDNPKKLLRYLYDHIDKDQIEIDTINFSGPRFEGVDNRLMSLQLVKNGMTDAVMFAPDG
NNVLPAKILYKKNILALRGSFRPVTKVNMDMYERSLELFLKESKVEKENTEVIFEITLSN
LRAEGEIDERDFMDRAKLLCSLGQTVMISNFQEYYRVVEYFSRYSKQRMGLTMGVNNLVD
VFDEKYYRHLSGGILEAFGKLFFKDLKVYLYPLKDSETGEITTSDNLKVHPRMKELYKFF
KYNGRVEDIENYNPEILDVYSREVLQMISEGKEGWEDMLPEKTTKMIKEHNLFHYKENKK
KAKTEV
>IFAGANLK_02690 Phosphoribosyl 1,2-cyclic phosphate phosphodiesterase
MEVIFLGTGTSQGIPIIGSKHPVCLSDNPRDKRLRVSVLVKWEAYNILIDCGPDFRMQML
ANPVESLDAILYTHEHNDHTAGLDDIRPFFFRQGDIPVFAHKRVLESLRKRFEYIFTSTN
KYPGAPGVQENEIVNENFYFKDLKITPINYMHNRLQVFGFRLKDFAYLTDLKSIEEEEVQ
KLDGVKVLVVTALRIEPHHSHLNLEEALEFIARVKPERAYLTHISHLLGFHDEVQKQLPD
NVFVAYDNLKITI
>IFAGANLK_02691 hypothetical protein
MRKNLLLYLFIFSLLFTIFIYVNDKKILDARDAEIQKLKAEVERLEVETESAAALDENES
YFSLINNEDAMTYFEDKGIEAEDVREAIENELMNQNKVDIDNSYVPFDGMEGNMHINKIK
VLNHKWVIADFTDGTYWGEVFFTYFIDENGKPELIAEKSFIYPAAN
>IFAGANLK_02692 Carboxylesterase 2
MNTKELSLHHLIRKPKTQTEKAPLLIMLHGYGSDENDLFSFAEELPDELFVISVKAPYAM
QPYGNAWYAIHWDNQNGKFSDDEQAKESREKIAGFMDEAIEAYNLNAENVTLLGFSQGSI
LSYAVALSYPEKVKNIVALSGYINKEIIKPGFEKNDFSKLSFYCSHGSQDQVIPVEWARK
TKPVLDDLNIENSYSEFPVGHGVAPQNFFELREWLKKRI
>IFAGANLK_02693 hypothetical protein
MKTVAEEGKTPAIVAYLTIIGTIIAYFMNNEHKNPFASFHIRQAFGIHVTFYVLGVLVGL
FDSWLISSAFYIFIAVLGIYGLVTAIQGEQKEVPILGAYFQKWFSTIN
>IFAGANLK_02694 Dihydroorotase
MKLLLKSATILDKTSANNNQKLDILIENGIIKKIGKDISTKADKVIFQENLHVSRGWFDS
SVSFGEPGFEERETIANGLDTAAKSGFTNIALNPNTFPIIDNNGAITSVKSKAAHHPVKM
YPTGALTIKSEGVDLAELYDMKQGGAIAFGDYKRAVKNPNLLKIALQYAQNFNGLVQSFP
QEDRIAGKGMVNEEQNSTSLGLKGIPNLAEELQITRDLYLLEYAGGKLHIPTISTKKSVS
LIKEAKKKGLDVSCSVAIHNLIFTDALLQDFDTNTKVLPPLRTKEDIKALIKGLKDGTID
MITSDHTPIDTEHKKVEFDNALYGSIGLESAFGALSTIFSTEEVAEMLSKGKQRFGLEDI
EIKEGNPADLSLFIPNKNYEFTEAHIFSTSKNSIFKGHQLKGKAFGIITKAGDFGL
>IFAGANLK_02695 hypothetical protein
MEFKQPELLYALFLLLIPLAVHLFQLRRFQKEDFTNVKFLKKVIRQTRKSSRLKKWLVLA
TRMLMLTALIFAFAQPYFPAENPEASQSDKLIFLDNSYSMQASGQHGELLAAAIQDLIKN
LPENEEISLFTHNNEFRNLTAEELTTELQNLDFAENSSEFTTLNLRAEQLLKHSTGDKDV
IFISDFQQNLNPEDFSDASNINYHLITAIPENTQNISIDSAFISNRQASEISLKVLLSSS
AEILEPVSISVYNGEELLAKTAVNFEENQSTQTSFKINAEEIPNGIVRIADASLAYDNSL
FFSLNKLKPAEVVVISGNIDSSFLSRILTPPEFNTETFQVDQLDFNKLNTADIVVLNELE
SISGALESNLQSLQNNAVPLVIIPSENIDQNSYNNLLNRLNAPIFSELQTRETLITELAF
DHPLLTGVFEERIENFDYPKVQSYYDVPGENKILSFQNNSGFLLESNGIFLFSAALNSEN
SNFRNSPLIVPVFYNMGLTALKTPDLYYETGKENEINIPFQTQQDEVVHIVSETEDFIPQ
QRALGDNLEILTSGLEIASGNYLLEYKGENQGYISFNAPRTESELEYNIPQEAENVKIYS
SIGSYFNEIKAAGQSNKLWKCFVIFALIFLTAEMLLLKYLK
>IFAGANLK_02696 Phytochrome-like protein cph1
MQHKKVSSNERLRRAALAEYAIFKSGEDKDYDQLTFLAAKICQVPVAKISIIGKNNIWYK
SAYGTQLAELPRENALCEHAIYAGEEIFIINSREHPEFFENAKNIYDREYHFYAGVPLLN
ANGHAIAVFCIFDTKIRKLEEDQKKSLLALATQSMNLFESRKQKTKLQHVQRKLKQKYKE
LEKFASLVSHDIKSPLANIISLTELLKDENKEKLDEQSRQYLDFLVESSYSLRNYVDEIL
SFYRSDHVLEKDYEDVHLPTLLKRITDLYTLEENVEITYPEKGHLKNINKAALSQVFMNL
ISNALKYNTREVRKVNISFKITSSYYCFEVSDNGIGISAADKGKIFQLFATLDAKDRNGN
PGSGIGLATVKKHIEQMNGSIEVISEKGKGSTFKFKIKRP
>IFAGANLK_02697 Aerobic respiration control sensor protein ArcB
MLSPPIPNNESQRLKALEEANILYSPTEEEFDNITQLASFICQTPISLISLVGEHEQWFK
SKYGTDMCTSERDISFCSHAILEPEQLMEIEDTRLDNRFLDNPFVLADTDPIIYYAGMPL
KNFDNMVLGTLCVIDTKPNKLNQEQKKALKSLAKQVEILLELKRKNDYLENIKKQLNEHN
AMLKDFAGVVSHDMKMPLANMIITADILKAKFGNKLGEEGLDYLKNLKQAGLKLSSYING
ILDHYESDNIAASNNEEFDVHQLLEEIIDLLNITEDCVINLPEDNTIISSNRAALEQIFL
NLLGNSLKYNDKDKIVIDIEFSQNPDFYYFSIQDNGIGIPKEKEDDIFKLFTTVAKSDRS
GNKGNGIGLSTVKRLVGNLGGNLKVNSEIGEGTRFDFSIRRKA
>IFAGANLK_02698 hypothetical protein
MKKSELKSFLDFKVEQYNTPEFIDSDPIQIPHQFSKKEDIEISGFLTATIAWGNRKSILK
NANRLMEMLDRSPHDFILNHSESDLKSLTGFVHRTFNETDLIYFISALQNIYKNHRGIET
VFTQNAEKDFLQSAIHEFKKVFFELPHPSRTQKHVSDPLKNSAAKRINMYLRWMVRKDQA
GVDFGLWENLDASQLSCPLDVHSGNVARKLKLLKRKANDAKALNDLDIALRKLDAVDPVK
YDFALFGLGVFEKY
>IFAGANLK_02699 Lipoprotein-releasing system ATP-binding protein LolD
MIIAKNIHKYYGDLHVLKGLDLHIKKSEIVSIVGASGAGKTTLLQILGTLDKPEKNKDST
LEINNTDIYKLSSRELSKFRNKNIGFIFQFHQLLPEFTALENICIPAFIHNTAKEKAEER
AKELLGFLGLKNRANHKPAELSGGEQQRIAVARSLINNPAVIFADEPSGNLDTESAENLH
KLFFKLRDEFQQTFVIVTHNEELADMADRKITMQDGKIIDKKEI
>IFAGANLK_02700 hypothetical protein
MPVKIRLILIFFIFSHQISAQIDSLPRKNYSATKTQESPVIDGILDDNTWRNLTKADNFV
MYYPGDGDPVPQSHNTEVKVVYDNEALYIAAYLYEDKPEKIVKQFTQRDNLEQSDYFQID
INTYDDGENQIRFAVTAAGTRADAKTTGNNEDFGFNIVWEAAVSQDGNGWYAEIHLPYSA
LRFPEKQAQEWGIQFLRQISHRNESYTWNYVDKSVGLMSQQTGLLTGIKNIEPPTRLSFY
PYTSAEVDKFDGQTETNFNAGLDVKYGISKAFTLDMTLVPDFGQVAYDDVELNLGPFEQI
FGENRAFFTEGTELFTKGDLFYSRRVGSAPIGFNNAQREKLENEEILENPERTDLINALK
ISGRTERGLGVGFFNAVTAETKAVFRDTLTGNSREKITEPFANYNILVLDQRFNKNSSIS
LINTNVAREGNFRDANVTGFLFDVFNKSNSFNFVGEAKMSNVNLPRRNETGFASLFSIDR
TKGNFRYGVSHELANETYDINDLGISLTNNYSNFYLNTSYQTFEPTGIFNQYNIELYANH
QRRYRPDVNLASGGGLSIFAMTRDRFAFGGFAEVNSAFKDFFEPRRENTYITFQPNIAAN
AWISSDYRKKLALDVRTTYQTFSESSRESFNFIFEPRIRINNKFLVIYGFEYDNEINRPS
FVTLQPRDVIFGNRDMKSFENSLQANYNFTTKQGLNLSFRNFWSVAQFKDGSFSKLNEDG
GLTSTDYNREENNNPDANFNIWNLDLSYRWQFAPGSEAILLYRNSIFNQDELSYLDFQQS
MDNLFNRPARHNLSLRIVYYIDYNRVKNIFNS
>IFAGANLK_02701 Peptide methionine sulfoxide reductase MsrA
MNSENLELATLAGGCFWCTEAVFQRLKGVEEVFSGFTGGNIKNPAYREIITGRTGHAEAI
QIRFNPEIISFHDLLYVFFATHDPTTLNQQQNDVGTQYRSAVFYHSEKQKETVEKVIAEL
EEKKIFENKIVTEITEAKDFYIAEKEHQDFYNQHRQQPYCQFIIDPKIKKLTEVFSDKLK
>IFAGANLK_02702 GTP cyclohydrolase 1
MAYKFKEEYNIEVTDGLQENYKNILEGIGEDISREGIENTPERAAKAMQFLTQGYKMDAE
TILKKAMFKESYDEMVVVKDIELYSLCEHHMLPFFGKAHIAYIPNGHIVGLSKLPRVVDV
FARRLQVQERLTHDILECINNTLKPKGVAVVIEAVHMCMMMRGVQKQNSATTTSGFRGQF
EKIETRNEFLKLISSDLK
>IFAGANLK_02703 hypothetical protein
MKLLKDKLFVKGLMYDAIGMATMAIPLVGPFLDLLWAPYAARKMGEMYPGRKGKVASVIV
FLEEILPGTDIIPTFTLMYFYTFVWSKKKQPKAQVIEVEIIE
>IFAGANLK_02704 hypothetical protein
MSEFDQDRHTLSNPSKISFSGWKKIAFIIKDKIEENNLTIVSSGVAFYAFLAIFPAVMAL
VSIYGLAVNPAQIEYQLNQLGSMIPDEAFGIVEQRLEAFISTSGRALGWGMAIGILFSIW
SANKGMKSLFTGIDIAYATRSTRGFIKQNALTLLFTFGAIILVILSMGLIVIFPAVVGEL
GLPANIESLISWLRWPILALIVGFFLCLVYKYAPERKNPKLRWVVPGAVVATILWLIASW
GFSFYVSNFGSYGEVYGSIAAVVIMMLWLFISCFTVLLGAQLNSAAERYAKKVTAFK
>IFAGANLK_02705 hypothetical protein
MNNQAAIQKGMKWLKRAVIFKAGKMIMRKPASALGVGALAAGAGIAAYSFIKNSKKNDLT
HIDDIENNNPEVKGKKKIIV
>IFAGANLK_02706 putative TonB-dependent receptor
MKSLLFSLLFIAVSPIIYAQNNFSGQVTNAKNGEPVFSANVYFPELSKGAMTDLDGNFTV
ENIPNGTFKIVVSSVGFGTYSNELDFPETSTLNITLEKSAIEMEEVIVSTPFHQLQSENV
MRVERENVAELNRKGAITLSDGITQIAGVESLTTGVGIGKPVIRGLSSNRVLVYTQGVRL
ENQQYGDEHGLGISSKGIESVEVIKGPASLLYGSDAIGGVLYLNPERYAAANETNAEADV
NYFSNTQGYQGSVMAKTSGEKVKFLARGSYAEHSDYETGSGERVTNTRFNETDFKAGIGY
QDAKFKTDLRYNFNKSNIGIPEEIGVQSKDKDPLLPHQEIDNHILSLENKLYFSNSSLDF
KVGYQYNNRKEFEEHHHEEEEHGAEEHEEEEEHLEEEEGTDHPALEMHLETLNYNLKYNL
PRTGRFETILGVQGMHQTNTNYGEDILIPDATTTDFGVFATTHVHFERWDFQGGLRFDTR
TIDTEAVEAHEEHIEEEQEGEEHEDGHQHESGEIAAVNNTYKSINGALGAKYIVTENLSA
RLNLATGFRAPNLSELTSNGSHHGTNRYEVGDQNLENEQNFQIDLSLEWRNKHFEAFVNG
FHNTINDYIYLQPTGELIDENPVFEYTQNNAELYGGEVGVHIHPHPLDWLHLESSFETVT
GKRSNGEYLPLIPANSLTNTLRLEFENPDDKIYSKYVFLRLKNVFDQNNVNTFETRTGGY
GLLGAGFGGQFAINSSEMRIGVSANNILNKDYISHLSRLKPDGISNIGRNISVSLRWLF
>IFAGANLK_02707 hypothetical protein
MLPVAISFSHIFSGHGHELCVNYADEHFHESSLDCELHSFNQSPVLATDFINFEPLVEKQ
IKKQFFDFYQFLSDYKKLPFELRGPPMPA
>IFAGANLK_02708 hypothetical protein
MKNFIYILLLGLFIYSCASSKNRNLGDSQINEDTVRIANDSLEYEIIIIEPGFNLFINSI
AKPEGYYSQEYLENKNRFLVSEYNQRVRQPQVYNPDLYLQEINYEPNIDYGYEVNYLLYN
YFVFFSRHYNQRFSVPTRI
>IFAGANLK_02709 hypothetical protein
MASILDLLNTQAGDKLVNKASEKTSEDKSKITSVLGMAMPLILGAMKRNAKNPKGAESLD
KALQDEKHNGKILDNLEEKDPEELTNEGSKILSHVLGAKQSGVSKTIAGTLNIDESTVNN
ILEMAAPVIMGLLGQQKRKDNVGSSGLSGLLGSVMGADDSHDQSFLETLLDADGDGSVID
DVAGMAFGGKKGKKGGSLLGGMLGGK
>IFAGANLK_02710 Hydroxypyruvate reductase
MKPEDFFNKPTTTTQPERIKILANDGLAKAGIEQLEKAGFEVISTKVAQEQLADYINSKD
IQVLLVRSATNVDKAIIDACKNLKLIGRGGVGLDNIAVDYAKSKGIKVINTPQAASGSVA
ELVFAHLFSGVRKLFDSNRNMPLEGESRFKELKKSYSAGIELRGKTLGIIGFGKIGREVA
KIALGLGMKVIASDKEDGEVKITLEFYNHQSIEIPIKTEPVEELIKHSDFITLHVPAQTK
PLIGKKELEAMKPGVGIINAARGGIIDEVALLDAIEDGKVAFAGLDTFEAEPRPAIKLLM
NEKLSLSPHIGASTLEAQERIGLELSKQIISHFKK
>IFAGANLK_02711 Phosphoserine aminotransferase
MKKHNYSAGPCILPQEVFKEAAQGILDYQDSGLSIMEISHRSAAFVDVMEEARNLSLELL
GLQNKGYKALFLQSGASMQFLMTAYNLLNKKAAYLNTGTWSSKAIKEAKLFGEVIEVASS
KKKNFNYIPKNYQIPSDVDYFHCTSNNTIFGTQIKDFPQVDAPVVCDMSSDIFSRELDFS
KFDLIYAGAQKNMGPAGTTLVVIKEDILGKVEREIPSMLNYKVHLEKDSMFNTPAVYAVY
VSLLTLRWIKNNGGIAAMEKRNNEKANLLYKEIDRNPLFKGFAEVEDRSAMNATFNITDE
SKKEAFDKLWKDAGINGLNGHRSVGGYRASMYNALDIESVKVLVETMQQLEQQS
>IFAGANLK_02712 hypothetical protein
MTIEERKSYFIQVGKFLSLFGDTTNDSIKITAENERFFNELNDKIDQAVHYNGWFTRGNV
IFSLQQWSKALTQSNLGQWLEPYKLDKTAQKTVAIIMAGNIPLVGFHDFLSVLISGHKVL
VKQSSNDKQLLPVIAGFLMNIAPEFENRIRFTEDRLTDFDAVIATGSNNTARYFEYYFSG
KPNIIRKNRNSAAILTGKESKEELEALGEDVFRYFGLGCRNVSKLYVPKEYDFDSFFKAM
YPWNTLLNSAKYANNYDYNKAVYLMSEFKLLENGFLILKEDESFGSPIATLFYEQYEGEK
ELQEKLEQNKKNLQCVVGTNADVDFGQTQHPKLWDYADGVDTLKFLEKL
>IFAGANLK_02713 Ferredoxin
MAIVITDECINCGACEPECPNTAIYEGADDWRYADGTDLEGNVVLPNGKEADANEAQEPV
SDEIYYIVPDKCTECKGFHEEPQCAAVCPVDCCVPDDEHVESEEELLAKQKFMHENE
>IFAGANLK_02714 HTH-type transcriptional activator RhaS
MLKTSKPSFEKVDPSFGSSFSFKNFNQEHQNKNHTFWHYHPEIELVYVNGGSGKRQIGSH
VSYYQNGDLILIGANLPHCGFTDSLTDNDRETVIQFSPDFLGKNFWEIPEMRNVRVLLER
AKNGIVFHGEDKNLIGEKIEALSSLTNYKRLLGLLDVLNMLENAKDFTLLNAEGFVLDTE
LEDHNRINVIFNFVKNEFKRNIALEEIADVVSMTVPAFCRYFKKTTGKTFVQFVNEYRLV
HAAKLLHEKQISITDVCFESGFNNFSHFNKQFKKFTGKSPSVYRNEIKFAVS
>IFAGANLK_02715 hypothetical protein
MKKLLKNSLLLVVLVTGLNMYAADRVEVSIDKGQTLIVELDNVSTVSLEDASGFILFKDS
PSLDGNYKKQIDFSRIPAGTYYLNTEDLSGIYTTEIKKSSNGISIEDKTAAVIFKPVYKV
ESNKVKFFLTNPAKTYATLKVYDATGKLVGEVKEKGYTMNKTLDFSKMPKGEYTFTLSVA
DKTITEKLSI
>IFAGANLK_02716 Phytochrome-like protein cph1
MINLAQQKEVFLSFPDNCFLLLPDSPKFTIIEVSRAFIKSSGMRREVLVGKGMLEVFERE
NNHDFIEIISEFFREAIESGEPNHIPQVRYDLPDETGILQRKIWEADNIPIKNDKGETEF
ILHRVRDITQVIKTREKGETSLKSLQKNEKFLKETQEIAKIGSWELDVEKNILYWSKVLK
DIHEVPQDFTPELDTAIGFYKAEKNKTAIKNAVSNAIETGKSFDLELEIITAKNNDKWIR
ATGRPDFKNGKCIRIFGATQDITSRKQAQIRLENINDNIPGVVFRYKLRPDGKDQLMYVS
EGVRQVWGIAPEEASRNNNKVWDLYYEDDIPGLKKTINESASNLSLWTNEWRVKHPEKGL
RWNRGFGAPQKLADESIVWDCIVLDVTEEKLAYELLEINESRQRSLLESQTNYVIRTDIK
GNYTYYNSKFDEDFGWIQEEGLIGKTCMIAVVEEDRPKVEETAIKCLENPNETFQIEIGK
PKRDGKVRTTVWDFIALCDADGKPNEIQCIGIDISEKKEAEIALNRAKEQYEGLIHSIEG
VFWEMDAETFEFTFVSEQAKDLIGISPEDWYNDSKFWEDHLHPEDREYAVNFCTSQVKKG
NNHSFEYRMRKTDGSYVWLSDVVSVVKENGRIQWLRGIMTDITKRKQAEEQIQLSEQRFK
GLVQEGGDLITILDKNGDYIYASPTSMNVLGFTPDDFNNRNAFDFIHPHDIPRVQKEFAK
IEQQKRLEISGFRFKHKNGGWRWLETTLTNLSDDPAVNGYVSNARDITDKKRFQELENLE
RKVLEMNFKKTSRLKEILNFYVTNLEEVNPNAFFVIQKLENEQLSYWTSGKIPPTLVEAL
NEQGIEKREKICSVFEDGKPIILKIKTAPDSKLKTIALENEIESCWTYPIIDSKGEKLGI
FTVFYRNDPFPAEKKEQRSIKRSVGLLQLIIEFQLNEIALKRSNQRYEFVNKATEDAMYD
WDVLNDELKWGDGFYKMVGTDRENGKFPLEKWSEGVHPRDFAEVNESLENSLKDKNKKKW
YSEYLFRKTDGSYLSIIDNGYIIRNEKGVAVRMIGVLRDVSDIKAYEKELENANERYRYV
TRATSDAIWDYDVVEGKLFWGAGFETLFGYNLNEFKPKLSSWYNRIHPEDQGKIVNSFQE
FLSSEDIIWEEEYRYSNAQGDYLDVFDRGFVVRDKNNKALRVVGAMQDISRKKQYEISLK
KLNTELNERAKELVTSNAELEQFAYVASHDLQEPLRMVTSFLTQLEKKYADVLDEKGLLY
INFAVDGAKRMRQIILDLLEFSRVGRTEDKLESVELDDILEEIKHLYRKRIEERKVKIIS
KDLPVIKVPKSPIRQVFQNIISNAIKYSKEDVHPEITIDFQETQNFWEFSIKDNGIGIDK
EYFDRIFVIFQRLHHRDEYSGTGMGLAVTKKIIENLGGNIWVESQEGNGSIFLFTIAKNI
A
>IFAGANLK_02717 Response regulator rcp1
MESIHILLVEDNEGDILLTSEALEDGKILNKLSVVRDGKEAMDFLDKKGKHVKAITPDLI
LLDVNLPKMNGHEVLKFVKQHKDLKQIPVIMLTTSSSKEDIDISYQNYANCYITKPIEVE
DFMKAVNQIEEFWVNLVKHPSK
>IFAGANLK_02718 DNA topoisomerase 4 subunit B
MSQETKYTEDNIRSLDWKEHIRMRPGMYIGKLGDGSSADDGIYILLKEVLDNSIDEFVMG
SGKTIEISVQNQRVIVRDYGRGIPLGKVVDVVSKMNTGGKYDSRAFKKSVGLNGVGTKAV
NALSSYFRVESSRDGKSHAAEFEQGELKDEEHLDETSRRRGTKVTFVPDEVIFKNFKFRN
EYIEKMLKNYVYLNPGLTIIFNGEKFYSENGLKDLLKDSIHEDERLYEIIHMRGDDIEVA
LTHSKAQYSEEYHSFVNGQNTSQGGTHLAAFREAIVKTIREFYGKNYDASDIRKSIVSAI
SIKVMEPVFESQTKTKLGSTDMGGDMPTVRTHINDFLKTQLDNYLHKNQETADRLQRKIL
QAERERKDLSGIRKLAKDRAKKASLHNKKLRDCRIHLGDSKKERYLETTLFITEGDSASG
SITKSRDVNTQAVFSLKGKPLNSYGLSKKIVYENEEFNLLQAALNIEESLEDLRYNNIVI
ATDADVDGMHIRLLLITFFLQFFPELIKENHLYILQTPLFRVRNKKETIYCYSETERRNA
VEKLTGKAEITRFKGLGEISPDEFKHFIGDNIRLDPVMLDKEKSIDEMLNFYMGKNTPDR
QEFIIDNLKVELDLIEELGL
>IFAGANLK_02719 hypothetical protein
MRFSNKNEVKIVPSIYIVLVAIFVTNIFVNIELMSSDEPVRFSHYLPNIVVLLLGFYIHR
IGQSFDFDSDGETVNLKNNGVFFSKFMEYRVKKAEFPKRKLGKFRISDYFFYSAVTIYIS
SRRRRGYKKYTFNTTFLHRKKKRGMIASMQKIVDNQKTTA
>IFAGANLK_02720 DNA gyrase subunit A
MEENQEEAKDEHLEQPKEELIKVTGMYKDWFLDYASYVILERAVPAMEDGFKPVQRRIMH
SMKDLDDGRYNKVANIVGHTMQYHPHGDASIGDAMVQIGQKDILIDTQGNWGNILTGDRS
AAPRYIEARLSKFALEVLFNPKLTEWQLSYDGRKKEPVNLPVKFPMLLAQGAEGIAVGLS
TRVLPHNFNELIDASIKHLKGKKFTIFPDFPTGGIADISNYNDGKRGGRVRVRAKISQYD
KNTLAITEIPYGTTTTTLIDSILKANDKGKIKVKKIEDNTAAEVEILIHLPNNISPDRTI
DALYAFTSCENSIAPLGCVIIDNKPIFLGVSEILRSSTDHTLHLLKRELEITLEELEEQW
HFSSLERIFIEKRIYREIEEEETWDGVINAIDEGLKPHIKHLKRAVTRDDITRLTEIRIK
RISKFDLDKAQQKIEALEDEIAKVKHHLDHLVDYAIAYFTKLKKDYGHDKDRKTELRIFD
DIEATKVVIRNSKLYVNRKEGFIGTALKKDEYVTDCSDIDDIICFTADGKMMVTKVDSKT
FVGKDIIHVAIFKKKDKRTIYNMIYRDGKGGASYIKRFSVTSVTRDKEYDLSQGKKDSKV
HYFSANPNGEAEVVTIFLRQVGSIKKLKFDVDFADMLIKGRNVKGNIVTKYAIKRVELKE
EGVSTLKPRRIWFDETVKRLNVDERGELLGEFKGEDRILIVTQDGIAKTIIPELTTRFDE
EMVVLEKWMPKKPISAIYWEPEKERFYVKRFLIENPDREEKFISDHENSYLELVSTDYYP
QAEIIFSKQRGKEQRPNEEVNIEEFISVKGIKALGNQLTTDKVKQINPLDPLPYEEEEEV
PAEDIEVVEEESVSDEKAKLNIVRKKEDSGDSSESQTKLFDE
>IFAGANLK_02721 Large-conductance mechanosensitive channel
MSILKEFKEFAIKGNMVDMAVGIIIGTAFNSVVNTLVKEVVMPPLSLMTDGIEFANKKWV
LREGVAEAEGVTLVEEVAVGYGALIESLLDFLIIGMTIFLVIKFMNRFRSKAENPEDKRE
VTPKDIELLSKMNHLMEEQNQLLKNNFSNKK
>IFAGANLK_02722 hypothetical protein
MKKILAVLSLLFIFTSCFEPERNCTDFKTGTFEYKTYLNGELATSTFKRNDSIEIDEFQG
KSDTSSVRWINDCEYILKNLNPKSMAEEKPVHIKILTTNKDGYTFEYGIVGQDKKQRGQV
DRVK
>IFAGANLK_02723 hypothetical protein
MVNTEDFSKRLHKILEFYELSAAGFADKIEVGRSSISHILSGRNKPSLDFVMKVVKSFPE
VELYWLLNGKGSFPPAEEPSPEPEIKNEVSTAPPQTEPIPENDKVPFTFPQQGKSKPIRR
IVIFYEDGTFEAFEN
>IFAGANLK_02724 Gamma-D-glutamyl-L-diamino acid endopeptidase 1
MFTIVKYVLFTFVNMEKTALFTQLYKDYNSFKNLGISGRYIRQTDIQNLLDNLEEEFTVK
KIGESVLGQPIHSIQFGNGSIKIFVWSQMHGNESTTTKAVFDLLNYVSINKDDALVKSFL
TNCSFCIIPMLNPDGAQAYTRVNANNVDLNRDAQDLSQPESRILRKEFEKFQPDYCLNLH
DQRTIFSAGNQPEPAVLSFLTPSMDKDRQIFPSRIKSMQLIANIASDLSDLLPGRMGRYD
DAFNLNCTGDNFQSTQTPTILFEAGHYPGDYKREETRKYVFLALISVLKAISEESFKEID
YREYEQIPENQKLFNDIILRNAKTENGVVDIAIQYKEGVKDGKLMFLPEIEKIDPKITRF
AHKEFSCENKKIEINEKSKAIENVVVNKITLNDIELPLKCE
>IFAGANLK_02725 Regulatory protein AsnC
MAKFKLDETDHQILDMLIENTRTPFTDIAKKLLISAGTVHVRVKKMEEAGIIKGSSLTLD
YKKLGYAFIAYVGVFLKNTSQTKFVLERINEIPFVTVAHVTTGKFNVFCKIRARNTQHAK
EVIFQLDDIEGVYRTETMISLEESLNDKKRLMHSIFQDM
>IFAGANLK_02726 Phosphoenolpyruvate carboxylase
MHREPKLERFNESVLSKYQVYNSIFLTLPFDDISKTGSLLPLFQEICEAGFKENKNPSEI
IETFFSKYQDDPSEEHQISLLFRFIQYIERQVVLFDAIEDASFPIVNNMDGRGTLRNVKE
EAEAKEKTPELREYLKRFNVRPTLTAHPTQFYPGAVLGIITDLDKAIQKNDITLIKKLLA
QLGKTPFFKKEKPTPYDEAVSLIWYFENVFYQSVSKIYNYIQQNIFDGEDIGNQVINLGF
WPGGDRDGNPFVTTEITLKVAQRLRSTILMNYYRDIRKLKRRVTFSEVDTIITEIETPLY
QSAISKTGKIKMSLEDFKSKLHEIKEIVENKHQGLFVEEIDDLINKANIFGYHFATLDIR
QDSGKHAEVLEEIINTQPDLLPKNYASLSNEEQIEALTKVEGNIDPESYEDGITKSTLSS
IYAMQEIQKKNGENGANRYIISHSEVPQSILEPFAFLRMCGWNKPTVDIIPLFETVPDLK
ASPDVMETLYNNPVYREHLKSRGNKQTIMLGFSDGTKDGGYLMANWSIYKAKEMLTEVSR
RYDIKVVFFDGRGGPPARGGGKTHQFYASLGSGIENEEIQLTVQGQTISSNFGTRDSCRY
NLEQLLSSGVSNEIFSKGKNQLTDEDRETMTRLAEISYETYTNFKQHEKFIPYLEKMSTL
KYYSKTNIGSRPSKRNKDAKLNLNDLRAIPFVGSWSQLKQNVPGFFGVGTALEKFEKAGE
FDKVQQLYNNSVFFKTLLENSMMSLTKSFFALTAYMEQDKEFGEFWKIIYAEYKRSHDML
LKVTGYDALMENQPAGRASIQARERIVLPLLTIQQHALRKVQELQAQGESAEKMLEVYEK
MVTRSLYGNINASRNSA
>IFAGANLK_02727 hypothetical protein
MIANNLNSNEYNAYYDRYLQKIPGNLELGILLLENREEFLRLLDKMKPEDLSYSYAEGKW
TIVEVIQHLIDVERIFQYRSLTLAREPGIKLPGFDHDTYVPASAAKIRTLKSLKKEFKAV
RNAGIFLYQSFSKEMLESEGFISGSSTSCRALGFITAGHTKHHIEIFKEKYQI
>IFAGANLK_02728 hypothetical protein
MEFLKTTWSLFKQAYISWNRNEPYARSATIAYYALFSLPSLLIIVVTIAGYFFEQEAVQG
RLTSEISGFVGQEPADAIEKMIASAALATESTWAIIFGIGMLLFGATGVFFQLKMAMNNI
WNVAAKQTDFLRILLDRLISFGMVMVIGLLLLLSLVISALITILKDEIKQYAPNVTEFMV
EVANAGISFLVITTLFAAIFKLLPDIKLRWRITYLGAAVTTVLFLIGEALISFYFGKSEP
ASVYGGASSVVLILLWVYYTCLILFFGAEFTVQYALLKNERVVPNKYGEPAIYQELEKLQ
QKRTQLEEEKEIIDTLKNNMNWEKNRESGQKTKNKK
>IFAGANLK_02729 General stress protein 18
MEKRIAILATNGFEKSELFSPKEAMESEGFKVDIISLEKGKIKGWEGTDWSGEIDVDYIV
KDVSAKDYNALVLPGGVINPDQLRRHDEVLVFVRDFFKQKKPVGAICHAAWTLINAEVVE
GRTMTSFNSIKKDLENAGALWVDKEVVVDEAFVTSRNPDDLPAFNAKMIEEIREGKHDLQ
HA
>IFAGANLK_02730 hypothetical protein
MKLNLLSLALIFTGNLVLAQQNSDEALLEKAKEIHENVITIDTHADININNFTEERNYTM
DLENQVTLPKMEAGGLDVAWFIVYTGQDELTDEGFKNAYENAISKFDAIHKLVKNFAPDQ
IGLATNSEEVRKLTSEGKKVAMIGVENGYSIGKDIENVEKFYDLGARYMSLSHQGHSQLS
DSNTGEKNDEWLHNGLSDLGKEVIAEMNRLGMMIDVSHPSKEAIKQMFEISKAPLIASHS
SARELCNHSRNLDDELLLLFKEHGGVVQTVAFSAYVNTEKTQAFNEASSKVYEKKAKEMS
FEVLPRDSVRALSNEDRNAYYADFQKVRSAAAPEVELLKEEIEPVGVSDFVDHIDYMVDL
IGIEHVGISSDFDGGGGIDGWQDASETLNITKELVKRGYTEEEIAKLWGENLLRVMDKVD
AVAAELQKA
>IFAGANLK_02731 Ribosomal protein S6--L-glutamate ligase
MNKYIIVNHPEKWKLKLANVEIISAQAYLTNPDFAKIKNARIFNLCKDYSYQSKGYYVSL
LAEARGHLAIPTVKNIVDLREPKLVKIVSEEFDDLMQTSLKSIKSQEFTLSIYFGQNVAQ
KYKELSAMFHRHFQIPFLRVKFNYTTRWNIKSIKAISEAEIPDDHLESMYEFAAQYFAKK
RYDTPRTNTAEYDLAILVQPDDPAPPSNAKALKKFVEIAEKMDFYVEIVSPKDLSRLSAF
DALFIRQSTEVNNEAYAFARKAQQEGIAIIDYPDAILKCCNKVYMAEALENANIPTPKTV
IIHKENKDKVLELTGLPVVLKSPDSTFSFGVKKATTPVEYQELVTMMLKKSELVIAQEFS
PSEYDWRIGILDNKPFYACRYYMAKDHWQIYNWDAKEKDDQDGNADCLPIEKVPKKILEA
ALKSAKLMGKGLYGIDVKEVGGKALVIEINDNPNIDFGVEDAYYGDQVYVEILSALKNRL
VKK
>IFAGANLK_02732 Glutamate--cysteine ligase
MKYHLFEVFGIELEYMFIDASSFKVNPIVDQLFISKNGEITSDIENGEIEWSNELVAHVV
ELKTNGPTGDLDSLDLLFAKNIKEVNSLLKEKNTRLLPSAAHPLMKPATETELWKHSSSK
IYALYNRIFDCSGHGWSNVQSMHINLPFFDDAEFEKLHAAVRLLLPIIPALSASSPILEG
KDTGFKDTRMQVYKTNQKEIPEMTGKVIPEQVFSKDDYYKTIFEPINNKIKPHDTENILD
HHFLNSRGAIARFDRNAIEIRVIDVQECPKADMAIAIFIIECLKLLVSEDLIAIDEQKKW
HENELFEIFDAVIKDAENTKINNKEYLKIFGLSQAIEIKEIWRILFSKVKRNIAEKHQES
IKFLLNNGSLSTRILKSLNDDFSEGNIQKTYFKLADCLEENKFFKL
>IFAGANLK_02733 hypothetical protein
MKLVLTCEHAFNTIPEEYKELFSDAEEILNSHRGYDPGSLDLFRELEVLADFNQVQENGR
LLVEVNRSIGHPNLFSEFTKILSRSQKTEVLNQYYFPYRNSVETNISAFIEKGEKVLHFS
VHTFIPGLNGIVRNTDIGLLYDPAKSGEKEFSKNFKRKLKKENPHLKIRFNYPYFGKADG
FTTYLRKKFPENYLGIELEINQKFVSKNQMDHRIKNAVVFALKGSLK
>IFAGANLK_02734 Peroxiredoxin OsmC
MKRHGTAVWKGNLKEGKGTVSTQSGVLKESQYSFKTRFEDGIGTNPEELIGAAHAGCFTM
QLSANLTEEGFAPDELETKSEITFEDGAVKKSHLILKAKVKGIDKAQFEKVAQDAKKNCP
ISKLLNTEITLESELIQ
>IFAGANLK_02735 FKBP-type 16 kDa peptidyl-prolyl cis-trans isomerase
MSQVKANDTVKVHYTGKLADGQVFDSSVERGEPIEFTMGQGQLIPGFEKGLIDMKVNEKK
TINIPKEEAYGEPREELVQEVEKSQLPEEIKPEVGMGLVSKSPDGQEMNLVVKDVKDETI
VVDGNHPLAGKDLVFDLEVVEIK
>IFAGANLK_02736 Inositol 2-dehydrogenase
MKKEETSKSNSRRSFLKTTALATAGISIIPRHVMGGPGFLAPSDKLVIAGIGVGGKGESD
INSFYQSGKADIGFLCDVDKKRAANSVARFPKAKFYTDYREMLDKEAKNIDAVSISTPDH
GHAVQALAAMELGKPVYVQKPLTHDIYEARQLTEAAEKYKVVTQMGNQGASGDGVRKMRE
WYDADLIGKVHTVYVWTDRPVWPQGIPWPKGKTTAVPEGLDWDLWLNTAPYKNYIEGLVP
FNWRGWWDYGTGALGDMGCHLIEAPYRVLGLGHPKDVQCSVGSVYVDEFQRGYFPESCPP
SSHAVITFPKTEKTSEDVTLHWMDGGIKPKRPEELGPNETFGDGGNGVLFIGDKGKMMCG
TYGRNPRLLPTSKTDEVNVAQKYDRVPGGEEGHYSQWVEGAIAGYGKKELSSPFEIAGPL
TETLLIANLAIRGYDVRNEKKRENGDTYFEYPGRDIKMLWNSEEMRVTNFDEANQFVRRD
YRDGWKLS
>IFAGANLK_02737 hypothetical protein
MRAGIIVFLIIIYFGFLACNFKDKNSIEPSTVWDTLEVTASAYNSLSWQTGAGGANITAW
GDTLKPGLRAIAVSRDLIKKGLDHNTPVKIEGFDSIFLVKDKMHYRWKNKIDIYMDADVQ
KAREFGRKKLKIYYEVPIDSISRNKNTKD
>IFAGANLK_02738 Glutamine-binding periplasmic protein
MIKKYVFLFSLLISSFSFNAQQAPDSLDINQTFVIGVTPTPPFIMKENGEYTGLSIEAWD
LVNEELDFNYEFKEYTSLGNLLNAIENNEVDFSINPVTVTDNRMQRMDFSQPYFISHTGV
AKRSESQVFSYLANLFSWNFISAILILLAVIFVFGFLVWIFERKKNAEEFGGGSRGILEG
FWWSAVTMTTVGYGDKSPRTTGGRIIGLIWMFMAIIIISSLTAGIASSLTVQTMNDEITG
VQDLSKFEVTSVRSSSAQELLNLYNIQHTEVVSEKEGMELLENKETKLFVYDEPILRYEL
KRRGLEDDIEVLPKTLKKDYYGYSFPKNSPLLNKIDPVLIGVMKTMEWNTIMAEYE
>IFAGANLK_02739 hypothetical protein
MKNIIRAILAGWGAKKLGGGCGCIGIIVVFIILWIILGYLGLG
>IFAGANLK_02740 hypothetical protein
MKLNSIKILLLSVFISSGVYAQSTSATLIKKVEGFSHPESVVFNEDENEYYVSNMADNEA
GDGFISRVSADGEIIDLKWIDGLKDPKGLLVKDDKVYVTNNTELIEISIGRSEITKLIEV
EGAKSLNDITVDAVGNIFISDSGKSAIYLMPGDSANMMVPEDKKGEIIEYLNTTRLEYVN
GLYAHKDHLYAAAWGENTDGNFLKIDMDTREIEKVSKEGIGNLDGVQPVGDDAFYISDWA
TGTIYLIKKDGELKEVLTSEKSSGDILFDAKKNQLVLPMNFQNSVWWYQLQ
>IFAGANLK_02741 hypothetical protein
MELKKDEEEKDYILKDNKKTNFGIGFIITILLILVVAVVISGFYFGFW
>IFAGANLK_02742 hypothetical protein
MKTITTCVHDIIRHQPFLDDAIARDIVNFSGLAEDIQPQVEKEMRKPVKQGSIIMALRRY
APRRTKINMQHLRELGDIVVRSGITEYTFLNSNTIIANKAKLLDAVKDQTGVYLNYSSNY
QESNILVSSSLTNLVEDCFRNERRVSIKEELSSITIALPKNSSQFVGLYFYLFKLLAYEG
IPIFEMISTSNYFALFLEKEYVNQAFLLINEIKK
>IFAGANLK_02743 Lysine-sensitive aspartokinase 3
MKVLKFGGTSVGSVESIRNVKNILASREGKKVLVLSAMAGVTNKLVEITENIKLENYSAI
NTIITELKQKHETTIDALIDKPGLNSYAKAFVNNVLEGLQEISRNKYSEKVYAEVVTTGE
TMLTYIFSTFLTNSGIQNNFLDAKDFMQVSNLENPDTDLVGKLFQQNIENLESTDIYITQ
GFVRIDVQNNISTLKRGGSDYSATILATAVQAEEVQIWTDIDGFHNNDPRYVENTHAIAE
LSFEEAAELAYFGAKILHPQTISPVIKRQIPLFLKNTFTPDLPGTKISAEIHSRGLKAIS
AKDGITAIKIKSNRMLMAHGFLKKIFEVFDKYETAIDMITTSEIAISLTIDDDRNLNLIL
EELNAYGEITVEKEHSIICIVGEGLIEDKSTSRLFELLNDIPVRMISYGGSDNNISLLVD
TKNKIKTLQGLNHKLFEEQEVPQFV
>IFAGANLK_02744 hypothetical protein
MSLPKSRLLVIGCVWPEPNSSAAGSRILQLLEFFLAENYEITFVSTAARSEFAVDLEKMN
IASQVIIMNHPSFDELLKKIRPDLVLFDRFMTEEQFGWRVDETCPDAVKILDTEDLHFLR
KTRTEAYKKNISAESLYFDVDITKREIGSIYRCDLSLIISEVEMDLLQKEFKIAKNLLHY
LPFLLETISYENKAKLPPFNERQNFISIGNFLHEPNWNAVLYLKEKIWPLIRQQLPNSNL
EIYGAYPSQKVWNLNNEKEGFIVKGRARNAEYVMKNAKVCLAPIQFGAGLKGKLIQAMQC
GTPSVTTSIGAEGIPGALDWNGFITNDPKEFAEKSVRLYSEEKLWKNSVENGFRIINSRF
NKEAFQQDFSERLTDLVQNLNFYRQKNFIGKMLQHHQHRSTYFMAKFIEEKEKNKKTAG
>IFAGANLK_02745 hypothetical protein
MSLEIAILFFIIIVVIVLFALEVFPVDKIAFFILAALLLSNLVSPEEAISGFSSPATITV
LALMIIAIGLETNGVIDWLAGGLKNLRVLPIFLMIPAFMFIAGSISAFINTTAVVIVFIK
IITELSAKYDIPNSKLLLPVSFAGIIGGSCTLMGTSTNLIVNAVAIDRGVERFSFFEFTW
YGVIFLIITIVIVSALAKLLPATKKTKLSEDYNLDEYITKVIITGDSKVIGKSIGETFLH
DNDDIEVLRLKRNGIINDRPGKFTSLKEDDQLLLRCNLENLIKLKDAEGFTVIKDEDNKK
LADPITDSEELEENVQVVELLMLPNSPLIGKNIKTVGWYDLHGAVPLAIRKRRNFRNPRR
RIFNRGKDEIELRVGDRLLVEVSESAMDELQKIENVTILQQHKNIEVTTKTKKYLSLAIL
LVVIGLSAFSIFPILKSALIGCFLMIFTKCIDLGKIYSQVNWQIIFLLAGMIPLGVAMNN
TGADHWISEQLLLIFQNQTDIIVIGILFLVTMVLSGFISNNATAIIITPIAISIAASMQM
DPKPFILSVLFASNFSFFTPVGYQTNTIIYGMGIYRFRHFFIIGGTVSLVLWVTASLLLS
ASL
>IFAGANLK_02746 Transcription elongation factor GreA
MSRGFVKEDDQEEAPIIPPRAALPAGETNYVTPNGLKELKEEEEELIEERANLDKENETE
RRRAQAVIDGNLKLLRERISTARILDPKEQPEDEVRFGALVELKQNGNTQRFQIVGVDEA
DVKKQKIAFVAPIAKAVTGKKVGNKIDFKLGEETRKLEILKITY
>IFAGANLK_02747 6-phosphogluconate dehydrogenase, NADP(+)-dependent, decarboxylating
MAVYIVMGVSGSGKTTIGKLLATELNLPFYDADDFHPPENVEKMKNGIPLQDDDRNGWLA
VLAANIQKGEQGGGAVLACSALKEKYRKQLTSIPEENLKWIFLSADFEVILERLKSRKGH
YFKPEMLTSQFETLEEPNYAIRINVNTSEENILKEIMAKLNVLEAEIGLIGLGVMGKSLA
LNLLSKNINVSVFNRHVPGQEEDIAKNFVQENAEKYTFQGFDDLKEFVSSLNPPRKILLM
VNAGAAVDAVIESLLPFLEKDDIITDGGNSHYKDTLRREKTLKKQGIHFIGCGISGGEEG
ALKGPSIMPGGSLEAYKQIGPILEKIAAKDKTGNPCCTHIGPDGAGHFVKMLHNGIEYGE
MQLIAETYHFLRYYTNSKPTAIASLFEAWNKEMKSYLLEISVDILRKKENEDFLIDKILD
AAKQKGTGGWSTNAALELGVPLDTITAAVLARNISGMKEIRVNASYLYKNDNQGGNLEEI
KDKLFQAYKTASIINHTVGYDLLRVASSEYSWNLNLSEISRIWTNGCIIRSGLMENLVEI
FKDSNNHLLLNKNISSEIQKNQASLTKTVSIALQSGYAVPVLSAATNYFLNFTSAQNSAN
MIQAQRDYFGAHTYERIDSPRGEFFHTQWKTYN
>IFAGANLK_02748 Low-affinity gluconate transporter
MDIQLLFAVIAGIALLLFLILRLKIQAFLALLIVCIAVGIIAGMPATEILETMKDGMGST
LGFVATVVGLGALFGGVLEQSGGAQRLASFLLKKTGDKKAPWAMMVTGFAVAIPVFFDVA
FIILVPVTYALSKRTGKSLLLYALPLLAGLAITHAFIPPTPGPIAVADILGADLGWVIVF
GFLAGIPAAIISGPIFARYISKRIQIEPKSFTEEIEYDESKAPAPGLIISIILIPIFLIV
ANTLVQSPLFDGISIPEGLLYAIELVGHPFSALIIANLVAWYFLGVRRGMQKEFLLKVAT
KSFQAAGIIILLTGAGGAFKQILIETGGGEMIADALNNAWFNPLVFGFIVAALVRILQGS
STVAMITAAGITAPVLTGGDYSMAQTSLIVIAIASGASILSHVNDSGFWLVGQYLGLTEK
QTFKSWTVMTTLIAVVGLAVSLIIWLII
>IFAGANLK_02749 hypothetical protein
MQTLPCAFPVEFYKKLFSIIFLLLLSFTGIAQEDFPEYDELSVDMNVRDLGTIEIPIAIK
GQDAYIPVKELFDFLKIKNEETTNGVVGFIINPDSTYQINPSENRILYKNEEFSLSEEDY
IQTPLNLYLKSNFFGEIFGLNTNFSFRSLSVTMETEKELPVIKEMRLRKVRENLNRVRGF
VEVDTTMERRYPLFKSGALDWGVVTTQQSEFENDNRLSLGLGTMFLGGETNLMLNYSTRV
PFDSRNQFYQWRYVNNNNRVFKQVTAGRIFTRATSSLFAPVSGVQISNSPFQNRRSFGTY
VLNDYTEPRWTVELYVNNILVEFTQADASGFYTFDVPLMYGNTAVSLRFYGPYGEERIQE
RVINIPYNFVPKNELEYTVSAGIVENEDLDRFSRANFNYGLSNSVTIGGGAEYLAGVTSG
EVMPFVNSSIRFASNFLFTGEYMHGVKGEGILSYRTPGNIQVDLNYIKYDEYQTAINFNY
LEERKLSFSAPIRSKNFSMFSRFSVNQIIMPTTEFTTAQLLLSGAIMGISTNLTTYGIYN
DRVKEPTIYTSLSQNYRLPNKFLFSPQVQYDFSRNQFNNIIMEIERPVFENGFLNVAYEK
NMLRNAHIFEIGLRYAFNFAQTSVTSRLGNRNNSFVQSARGSLMLDDNTGYVMANNRTAM
SRAAISIIPFLDYNTNGKRDPMEPAVRGMEIKNTSGRLSYNEDETILRITELQPYIDIII
EVDPNSLDNIAWKVKNEKIKVHTVPNQFQEIEVPVEVLGEVAGMVYVRKGNSLSGQGRIT
INILDENGSLVKEILTEGDGYFTYLGLKPGNYTAEIDPLQMQKLNYTASDPIEFEIKIDE
YGDIVDTLEFTVEAN
>IFAGANLK_02750 hypothetical protein
MQNRRLFKNTSLLLLLMFSVFEINAQEDPPIPIEVEVRTSRNLNFGSFTAGSAGGNVTVS
YDDQRTVNGDIVELNFGEPVSAALFDVYANPGTIIQIETLGDYILLNQDTGAEIKLTINS
FSTGQRTFVTQTANAQTPNEVFVGGTLTIPPDNSGMLPGTYFGNFTLTFIHQ
>IFAGANLK_02751 hypothetical protein
MIKPPIARILILCIFMLGSYFVQGQVYEPLITQPVVETSSICAGEEINISFQVRNGYTRN
WFFIYYYTDFIPFTTNTNYKILLNTQDGPQEIKSFSSQTAPGVESRNQFQINTRVTIPAE
LSGSNYTLQVQSSSPNSRSALSNTFTINSSTLYQERESGNDSWIGHVYDGTNQNITFDQN
FNNYIGGYIENLNFDQDFGGNTNNFQLGTDICAPSVYTETFAVRYRINSSLEGLYSLNIG
SDDGSRLSVDDELIYNDWSDHGYRNQNILLSLSGNSNLVLDYYENGGGNRISIGEPQLLI
ENILSNNLTQTLNSQNSGQTITGDEFNNLPNGMSRFGNGYQWVYSTVEGGETTEIPGATN
SSFTPNNNLAPFFNTEGTYYIYRIATLSSSNNRLGSAYRARIKSNAAIITVEKPINIIDQ
PENFTTCTGNPINFNVIAEGQNLFYQWQRNNGGNTGFYNINNGENFSGTQTTSLSINVIE
TSLNDSRFRVIISDGNGNTLTSNSAVLNLFQSPQGIYTQPSNQVVCEGNDISFQTYTSND
QRQWQVSADNGTSWIDLSNNQFYENVNSERLDIISTPANFNNNLYRIEVFNQNCRVYSNS
ATLQVDPDPITQQPQDVFAAFGENAIIEAEVSGNNLSYQWQTYSSTWYDINNDENYSGTR
TKRLELITVGYWPEDGSRYRLLITNENGCVSISETAFLNVGENNCPEAPEMTLKAPVNIC
PGEIIIGGSFTGTGPWNISGEINGQQFNLTINERDFNYPFNIQQNTTIEIINITDGNGCE
NNNPNKAVTIDVINSIENNRIIGAQESCGVFDAESLIGEDLGKGYNYEWEISTTSETNGF
TQAPGNNNQPNYNPGTVSQTTWYRRKVNVENCTENISNSIEITINANIANNNISFFNGNT
STLQAIANEYGEVNLEAPEGTVFTYVDFASYGTPFNDAGNFSINEECHANTSLPVTEFYL
LGENLAIIPATNGVFTDPCVGTVKRLNISATYSETFCKGIDPGTVIGTEIDGNNISYSWQ
LSTVGPASGFAPAPGNNNQQNYNPGILNQDIWLKRTVNSGNCSNQSPILYIPVQGENIWR
GSEDTNWNNIANWSCNVLPTLETDVLIPDDLASGNYPEISTGGNAYAKNLFIENNASVEV
HENWLRVAGILTNNGILNTEAGSISLQGASPQIIPEAAFLNNRVRNLRIDNTSGVTSEAI
IEVTGILNVENGNFNTGDNLILISNEEQTALISGAGNGQVIGTVKMQRYLDKAFGYKYFS
SPFQNSVVRDFASYLDLEDPITGFPNFYRYNENRNININDIVRDATGWEVYTTVTNSLNI
AAGYALNFGTSIASQTIELSGEVNNGIIPNRQLENHHREYTRGFHLVGNPYPSPIDWDAT
QGWTKTNIDDGIYFFTASDTSQYTGTYSAYVNQVSTTDGKSSNIIPSMQGFFIKVSDSDT
QDVVTGSFAMDNNVRVNDFDQDFLRTQEDLKSLIRLEAGFNTSNQQDALVVYFSSYATLN
FEKEMDAHKLMNTDLAVPSFYTLTENKKELAINAIPFPEARGYKKIPLGIKVDKNGEMKI
DLASVENLNSNFNIYLIDHEKGKGQNLRNNPEYSFNILAGTHNSRFEIMFSDEKVTSPAI
AFNEPFDVEVENGVVVVKMNLEENQEGILRASTMTGQILQIKDAGGKDEVIFEGITSEGV
YIINLQIGKAQYGKKVLIKK
>IFAGANLK_02752 hypothetical protein
MKKKLLSPLLLFFIFTLLGLATYAQGDLMIMPKRLVFEGSERSQEINLVNTGSDTAVYAI
SFVNYIMTEKGNFEQVEAPEDGQRFAEDFLRYFPRRVTLAPNEAQTIRVQKTRTGDLEQG
EYRSHMYFRAVEDQTALGAEETEESDGISINIKTVFGISIPIIIREGTSTTNITLTDLAL
ATETEYPKLSLVINRSGNMSVYGILKATHIAPNGTQTELGMVKGVSVYTPNVKRIFSFEL
RNATEVDLNSGKLEVSYSEEKGEILASKIYEL
>IFAGANLK_02753 hypothetical protein
MAAFFGFIKSFSELLLKILMKNYHIILFFSLIGLSASAQNSASATVNSRATVIDPIKINK
TVDLDFGNVISAYNPGQVILSPDGSRVAYGVQISNSIPGTVNPAEAVVTHGNNNYSISLP
EQFTLYNQENPNQVLLIDQFTIQPQEGNVIDIIKIGGTLNLEANQTSGFYTNSSGFNVTV
SYN
>IFAGANLK_02754 hypothetical protein
MKKITFTLLVALIFGNAFAQDAETATATANAAADIVSPIGISSQQDLNFGKVANNEAGTV
VVATDSDFSTSTLSQIGSTTPTAASFNVTAADGFSYSITLPGSVDLSNGTDDITVDEFKH
DAEGRTTGTGSAQTVGVGATLNVASAQATGNYTGTFDVTVTYE
>IFAGANLK_02755 hypothetical protein
MTRLYLITLILLFTGMSPVFSQASATANFTASATIIQPIGITTTSNMQFANIDAQNGGEV
ILTPNNTRIITGELVLAEGGNVSAATFEVTGQNDFAFGISLPKGTHRLSSGSESMLIQDF
TTNYDGSSLNGDGKTIRVGASLIVRPNQKPGDYITTGDLQITVNYN
>IFAGANLK_02756 hypothetical protein
MKNSYTTSLNLQNTDFGLLLFRIFISGLILTHGVPKLITFFGSEEIAFADPIGLGETVTF
TFAVFAEFVCAILILLGWATRFAAIPLIITMAVAAIIVHWTDGFGRQELPLLYMGGFLLL
FFTGAGKFSLDYYLLKKK
>IFAGANLK_02757 Melamine deaminase
MKSERRDFLKKTGLLGIGGFINPFYVFSENQQKRFQFEQNSYLIKDASILSMDEEIGDFN
SADVLIDKGKIAKLGKNIEAPSNTETINAEGGILIPGLIDCHWHLWTSLLRSMSGDSPNE
GYFKMTARYSRLYTPEDMELAANYAIAEAIHSGITCISDYNHNARSTEFVQASFDAMAAM
GIRGHVSYGTYRDMPGSQPTDFKEINGLKQLIESDSKYKDISLGLGSRSANYKDIKEDWN
RARDLDLRITIHASSNESQKGQIASLFKKGLLAEDVNIIHGNAITPEEIKILEETGASIT
MTPYSEMRIGYGLP
>IFAGANLK_02758 Melamine deaminase
MDTTALTGNAHLLDTLKLLQNLANANAKDEFHMHPKELLKMATMNGAKNLGIEKETGSIT
PGKSADLVLLKKSDINFSTGNKPYHLVIEAALPDNINMVMAKGKILKYDGKLTGINASNL
INQAKNRFAEMEKEIN
>IFAGANLK_02759 hypothetical protein
MSKQEEKKKYNSDVTAEDKQALNEKGRSMNKGQDKELDREKPVDFTADNLDIPGSSNQTA
KNDKDKLVDEENYQFNKKGTERKNRDLDDIPDPDTTKDN
>IFAGANLK_02760 Outer membrane porin F
MKRTIAVTVLAATMLSSCVSKKKYVTLEEELNDTRSTLQKTQVEKEEIEEKFARIEERVA
DYNSKINSLREENDSKMEMNDLTVMSNNNKAQMRATIAKMDPEKVAGAETLEDSINLAVS
HNLKANISEGSDDADIDITVDETVVMINVSDKLLFGSGSYRVSNNAQPLLKKLAEVINSE
PAMEVMIEGHTDDRTMVEGSYIQDNWDLSVRRATSIVRLLQDKYDVAPEKLIAAGRSSYQ
PLVDNVDNDSRAKNRRTRIVIIPNLDKFFAMLESE
>IFAGANLK_02761 hypothetical protein
MKNSKIFYRLFFALLLAFSLSACSNDDDVDEGDDVTDDLTDDINGSDDDDGNGDGDGEPD
PDAAAVFVFIDEESIDNGNEPNDFSETDVNDDISEIGQREVLAYFNENPGEEITLYTGQT
GDEAWFVLKEIPGSWNEAGPNENGARNFLEAGPGLGQDQTEDLLDEISDITPLRATGLSM
LTGQTIIAVVYDSDISINYDPLEGNLQGENLGVVAFEVLNVTERTDGSSSALPSVNIRIL
DYTAVEALELNLFSNAPMPESSSEPEDTTPPDTIPDIELSPAE
>IFAGANLK_02762 hypothetical protein
MEKEKKKKKKRYRILRILAKFFAGLFIFIILLLLFIRSPWGQDIIKEQVVKNISSKTNTE
ISLDKLFITFGGNIQLDGLYLEDKEGDTLVYSKSLEADIPIWPIIQGNAISIDNLDWEGL
KANITRKDSIEGFNYEFLMEAFAANSTQQSQTATAQDTTATQEINIGDLNFKDFDITFKD
DVMGIDTQVNFEELILELEKTDLKKMDFRASNASITNAQIDYTQNKPFPEPENEEPAPMP
YLVVDNFNLQNVQANYNSIPDGINSNLDINEFLAEVPLMDLKGQEIEVNSVALNNSDIKV
EMKTLEKTQDSTTTEDSAFSWPNWKVTVNEINFSENHLSYLVDDAEPKQGNFNPEALVLD
SLNFNANNLFLKNQNAGAEVAALNFKEASGINLKQLNFNLNLGETQLSLSDLTLALNENQ
LGGEATLQYNSIQELIDNSETAELALDLPTISVDVKDAFRFQPDLRSNPYMKELSTNKVS
GNLLASGKLSAIDISRANFRWKNTSFSANGNIYNATDPDNIRFNIPRFNAKSRKSDLTGF
VSEKDLGISIPENIQLSGNFEGGLEDLSTKALLQTSEGDILIDGNFSNQEEIVFEGIMTS
EKLQLGNILQNESLGALDIEIETSGKGSTINTLDATLDATITSFAYNNYEIKDLNITGDI
ENGSGNITSSYKDDNLELALNSQVELDSVKPRANLNLDLKGARLQELGLASRDIRLAFKL
AAQYEGNAEEYETYADIKDAVVVYDNNTYLPGDLSAHAFVRTDSTSLQISNKILELDLKS
NADPVDFSNALNRHYESYFTEVDPLDTVQKPVNLKLRGTIMDDPVLSEVFLSNLEDLDTI
HIEADFNEKERKLDALVSLPYINYYSSEIDSLEFSLNSDPDNFDFNLGFNAINSGPIAIQ
KTDFHGSLTADKLFLDFTSMQDEERLIHMASEITKPGDSLKFHINPEDLILNKKKWNIAA
DNEMIVYEQEITANNFRLTRNNQEMLLSSELSYSDKNHIGLEFNNFNLGALINYLNPEEE
LATGQLNGHLIFEDPLQKIGILAGMEINQLNVMQVELGKLSLNSTPKADFLYDVGLAIKG
DNVDLDMSGDFQALDSTTVVDMEMQINKISMKTVEGFSMGAINNGEGSFSGNLSLGGTTT
QPEYNGQLQFDEAQFRVALLNAPFNFPSETLEFDKEGIYFNEFKVEDKDANSFVINGEVL
TENLLNPEFDLEFRARNFQVLNSTKEDNEMFYGTATFDADATLTGDLNIPNLDMDVTVGP
NTDFTYVMVEEELAMQERDGIVIFTNRENPDDILTGDEEEESATLTGYDINARININEDA
AFSIIIDEQTGDNFRVKGEGELDFNISPNGRMTLAGRYTMNDGHYEMSLYNLVKRRFDIA
EGSRITWAGDPFDASLDVSAIYRVEASPSSLMATTQGTDNNEFRRELPFLVYLNVDGELM
QPKLSFGLQMPEEDRGSGGGRVYGRLQQLNNQEAELNKQVFSLLVLNRFYPTSGSSGDGG
GNLSIARDNLNQALSDQLNMFSDKLLGDTGVELNFGVDSYTDYQGNTATERTQVDIEAQK
RLLDDRLIVSVGSEVDVQGSNRPGEEASPVIGNVSIEYLLTETGRFRLKGFRRNEFENVI
DGQLIVSGIAFIFTREFNEFQELWDNFFLKEDEEEQTENNEEENE
>IFAGANLK_02763 Outer membrane protein assembly factor BamA
MKLYFKYIAYLCAGLFLLQACNIKKFVPEDELLYKGAKITMESDTSIKRKSRLKAELELV
LRPEPNSSFLGMQPGLYFHYKAQREKPGFINKFLNKQIGEEPVYASDVDPLRTEDLLKNR
LENRGFFYSTVVSNENRNEDKKEMDVAYDIDVPSPYLLENYKLDTDSLKIFKEISNNLKD
SPIEKGMRFDLATLKMERERIDANLKSKGYYNFNPGFLIFEADTNQYEHKNFDLFLRLKK
DVPTESIIPYKLESVNIYPNYDVGTDSSTAKTRYAEKNFFQKEIFFKPKHLDPYILLEEG
QYYNPENSRNTARRLGDIGAYKFVNINYTEIDSLSTDSLGVLETNIYLSPLNKRSLRAEI
QAVTKSNGFTGPSLALGYTNRNLFKGGEILNVTGDFGYEVQTGGGTQAGLNSIQLGLQGD
LIFPRLLFPINFDKNWFSYSIPKTKTSLGFDYLTRSKLFSLGSVSARFGYLWNANRFVTH
EFYPISLNYVNLGNTTQEFQDILDDNPFLERSFNQEFIAGLTYSFLYNGLIDGNSRHQFF
INTTLDVAGNLIDAISGRGEEDPQTFLNLEYAQYAKADVDLRYHLKTGSDSKIATRLFAG
YGIPYGNSDVLPFTKQYFAGGPYSVRAFNTRSLGPGTYTPPNEEGAFFDQAGNIRLEANL
EYRFPLFPYLYGAVFADAGNVWNTGENSTLVGGEFSKDFMNELGIGTGFGLRVDIQSFVI
RVDLAAPLHDPSLLEGQRWEFDYANPVLNFAIGYPF
>IFAGANLK_02764 hypothetical protein
MHKEILKHITSKIELSEEDQREFTGVLTEKRISKKDFVIEPGQAVDYEYYVVQGCLKAFY
LDENGNKHIIQFAVEDWWISDFEAFFGNNPAQLYVEAIEDSVLLGIHRDTLETLYKRIPK
FERFFRIKTTNAFVALRSRILSSLQKNNKERYLEFCETYPQIEKRVPNYHIANYLGIKPE
SLSRLRKELF
>IFAGANLK_02765 N-ethylmaleimide reductase
MSKEQHLLKSYNLNGLELPNRVVMAPMTRSRANNPENKPTEGLHDIYYTQRASAGLIITE
GSQVSKEAVGYVNTPGIYSKEQVEGWKMVNNKVHEANGRIFIQLWHVGRMSHPDFHNGEL
PMSASAINPEAQSFTPEGFKDTVTPKEMTGEDIKRTIQDFKNAAKNAMEAGFDGIEIHSS
NGYLFHQFFNGTSNKRKDEYGGSIENRAKILFETIDAIKEVMPEQKIGLRLNPSLNGIFG
MTMDEETIPTFDYIIKKLNDYDLAYLHLSEPFNDVSDVPHAVTEIAKRYRPMYNGTLMIN
AGFDQESGNIVIEEGNADLVAFGKPYISNPDLVERFAENIPLSGWDTDTFYTPGEKGYID
YEAKARKQEA
>IFAGANLK_02766 Zinc-type alcohol dehydrogenase-like protein
MKAVGIKKSLPIDHSDSFTEFNTEDPTPADSDLLVRIKAVSVNPVDFKVRQNAAKDKELE
QPKILGWDAAGTVERVGNKVTKFKQGDEVFYAGEIDRPGCNAEFQLVNENIVGHKPKNLS
FEEAAALPLTALTAWECIFERLKIEENSGENQDILVIGGAGGVGSIGIQLLKKLTKFNVI
ATASRNETEEWCRNMGADVIVNHKNLEEEMKSKGYENVDYILNFSDTELHWDAMAELIKP
QGDICSIVETKDPVDLNKLKNKSVAFHWELMFTRAKFQTPDMHKQHEILERISKLLEEET
IESTLNKTFSGLKPETFKEVHSLQESGKSIGKNVISF
>IFAGANLK_02767 Uracil phosphoribosyltransferase
MQIHHLLEENSIAGKFVAQLRDTEIQKDRMRFRRNIERLGEILGYELSKTLKFTSKNINT
PLGNAEVQLPETQVALCSILRAGLPLHNGLLNYFDDAENSFISAYRHHPTSDENFEIVVE
YLASPSLEGKTLILADPMLATGRSFVNVMKALEHMGKPKEIHLVAVIGAEEGIAHVAEEF
PESTKLWIATIDKELNDRGYIVPGLGDAGDLCYGGKLQH
>IFAGANLK_02768 hypothetical protein
MKFIYTFLFFCFSLISYGQIDLPATNNTGGILKAEPETKSSGFPILRAEESNEESKYLRE
KPKEIDFREKPNNLKTAGDAVKEKWTEDKEALDKYKEDQYLGDFKTSGKFVELYCRDHQF
VDGDQVNIYVNGNFVKRVVLSSGFHPVLVTLESGFNNIEFEAINQGSSGPNTAQLKVLEE
NGNLVASKEWNLLTGAKASLIVVKE
>IFAGANLK_02769 Universal stress protein A 
MKRILIAIDYHPVSEKVAEAGYKLAKQLDARVCLLHVMANVSYYGIDYPTFMGYSGYDEM
AVNLDIAQEMREVVEDFLETAANHLNDKNVETHLAEGDAATAILEYSKTWNADMVVMGTH
SHSVFEKLLMGTVATNVLEKTEVPVFMVPIKKD
>IFAGANLK_02770 hypothetical protein
MNFQEYSIYFKNIIVKPVTAHQPPYDNTDYLNYTKLNWSRMNRWFKTGKLFDDIVEVVKK
IDQPQHWIIITEPWCGDAAHNIPFIEMITRENPLITVSYELRDAAPYRIEQYLTNGTQSI
PKLIIQNHKGKDLATWGPRPENCQKMYAELLIEKASFEIIKTEIQNWYNLDKGKELQKEL
EDVLSSTRNYNFNFD
>IFAGANLK_02772 Dodecaprenyl-phosphate galacturonate synthase
MEFQFTIIVPVYNEIESLPRLFEYLQAYLKSASLKSCVLLVDDGSGDGSASAIEKFCIDH
EDFNCLLFDKNYGKGAALKAAFDYTKTPLLGYLDADLQTHPEDFELLLPFINDFGLVTGW
RKNRKDTLVKRISSKTGNAVRIFFTHDNIHDTGCPLKIMHTEYAKKIPMFKGLQRFLPAM
ILLQQKEIKEVVINHYPRIEGKSKYNFKNRFLGPLIDCFAYVWIKKSYIDYSIKAKHE
>IFAGANLK_02773 hypothetical protein
MNNSLLIYVIGFTAQILFSSRMIMQWILSEKQKKVLTPILFWELSLLASFLLFIYGYARD
DFAIMLGQSLTYFIYIRNLHWQGQWKRLPFLVRFLILIFPAVVVIYSFFNNEYNLQKLFL
NEAIPLWLLLLGIFAQVVFTLRFLYQWIYSEKQKKSSLPLGFWWLSLVGSSLILIYAIFR
KDPVLLIGHLFGAIMYIRNIIIHHNEIRE
>IFAGANLK_02774 Undecaprenyl phosphate-alpha-4-amino-4-deoxy-L-arabinose arabinosyl transferase
MKLENKYLLLLVLAGIAVFFINLDAIYINIMEARNFITAREMLNDNNWIFTTMNAEPRYE
KPPLPTWLTAISMSIFGMEGLFGLRLPSAIMGLILVVFIYKFLLKITKNIELSFVAGLIA
TTSFYIVFSSRDGQWDIYTHSFMMLAIFWLYKLYNSAKNWYSYAVISGLFIGCSILSKGP
VSLYALFLPFLIAYGVIYKFDGTKERWKALVLLTLVALISGAWWNLYVYLFDTPAVAEIT
SQETGRWLNYNVRPFYYYWSFFIQSGLWTIPSFVALLYPYLKDKVSNKKAYKFTLFWTLA
SVFLLSVIPEKKSRYLLPVLIPMAMNTAFYMEFLFNHFKSLKTKESAVIYFHFGIFAVVG
CIFPVAAYFYFESFLQDILVWYILSSIFLFIIGILMFRFLILKKAKPLFYLSIFFLVSIV
WFGLPMANKINVNQDYNSIANIDRHLNEYDAPVYEIKDFAPEMIWEYGKPIPVLNKRGKI
EIPSEDKFLILSDGDYNRDSLQNIFKNYSTKKIDSVDMNPVSSKHKQRLYRDLFLLERTG
NR
>IFAGANLK_02775 Mannose-6-phosphate isomerase ManA
MLDYPIKFFPILKEKIWGGEKLKTILNKETNRDDLGESWEISGVEGAISVVSNGELKGFS
LKDLLEEYKEEILGKKIYKEFDADFPLLIKFIDANTELSVQLHPNDELAQQRHNSFGKTE
MWYIMQADEGAKINIGFKESVSKEDYISRLEEGKIVELLNFEEVKKGDSFFINTGKVHAI
GAGVLLAEIQQTSDVTYRIYDWDRTDDEGNSRELHTALAIDAIDFEKKDDFKLNYEKTKN
TSSEVASCQYFTTNYLPVEGEIKKDYSNLDSFVIYMCVSGNGEVSVNGNSEKIAQGETLL
IPAQNKEVKLSAENCELLEVYIT
>IFAGANLK_02776 L-glyceraldehyde 3-phosphate reductase
MNKYIANENRYEKMQYRRCGKSGIKLPLLSLGLWHNFGDKDDFENARDILRTAFDNGITH
FDLANNYGPPYGSAEKNFGEIFAQDFKPYRDELLISTKAGWDMWPGPYGNFGSRKYLIAS
LDQSLQRMGLDYVDIFYHHRPDPETPLEETMAALDQIVRQGKALYVGISQYSAKDTTRAS
EILRAQKTPFLIHQPRYNMMDRWVEDGLLNTLEHEGIGSIVFSPLEQGILTDKYLNGIPK
DSRAATQGSYLDESQITADVVEKVQQLNEIAQSRNQSLAQMAVAWLLKDERVTSVLVGVS
KVSQLEDNIKTLENLDFSKNELEKIEGILKNK
>IFAGANLK_02777 scyllo-inositol 2-dehydrogenase (NAD(+))
MKNSRRKFLQQTTLATAGLSLSGSLLANPLSGFSGFGANDQINFGVIGCKGMGWSNMQAH
LKLPNVTCIALADIDQRVLDERTKNVKDITGKAPKQYKDYRKMLENKDIDAVIIGTPDHW
HCLNLVHALEAGKHVYVEKPLANSIEECNTMLKAAKKYNKIVQVGQWQRSGTHYDDAIKY
VKSGKLGNIRLVKCWAYIGWKDRLPHKPNSTPPPGVNYKMWLGPAPERPFNENRFHFTFR
WFWDYAGGLMTDWGVHEIDIALYAMNAKAPKSVLASGGKLAYPKDAAETPDTLQTVYEFD
DFNLLWEHAVGIDGGNYGRNEGIAFIGNNGTLVVNRGGWEIIPEGDNIEGEFIPKVEEIT
LQKPEGNALEKHAANFVEAINTNDSSKLNCGIETGSIAAINAHMGNIAYKTGKKLYWDSE
KEKFDDDEANKLLKANYHNGWELPKI
>IFAGANLK_02778 hypothetical protein
MKISLKSSLIAGSFIIASIPSFAQEQNIDLPPEATEFYEPVPPKIEAGESITTPPSDAKI
LFDGSDLSAFVNEKDGTEPTWNIEGDVLTVNPGTGGIKTKENFGDMQLHLEWRSPSEVKG
EGQGRGNSGVIIMEKYEVQILDSYENETYTNGQAASIYKQSPPLVNATKAPGEWNTYDII
FAAPRFNEDDILLSPAKLTVLHNGVLVQNNYELRGPTEYIGIPNYTAHDEKLPIHIQDHG
NPVSFRNIWVRELN
>IFAGANLK_02779 hypothetical protein
MKFFTAIFFILACIICNAQTSTEKLQHQIDSIFKRTQGDFAIAFKDLSTENHSIFINHHE
DFHAASTMKTPVMIEVFKQASEEKFSLQDSLLIKNEFKSIVDGSSYSMELGRDSGEHLYV
QIGQKRSIEDLVTDMIIYSSNLATNIVIELVDAKNVNKTMRNLGALNINVLRGVEDMKAY
EAGLSNSTTAYDLMLIFEALANGNVVNPEADKKMLEILRQQKHNDLIPHLLPEDLNIANK
TGWITGVHHDSALIELPDGTKYILVLLSKNMKDMDAGTKMLTEVSKMIYDHVK
>IFAGANLK_02780 Purine nucleoside phosphorylase DeoD-type
MSVHIQSKKDQIAENVLLPGDPLRAKWIAENFLENAFCYNEVRGMLGYTGTFQGKKVSVQ
ATGMGIPSALIYCTELITEYGAKKLIRVGSAGSYQEDLNVNEVVLAMAASSNSGFNKAKF
QHADYAPTVDFDLFMKAVKFAESNNIKFRAGNVLSSDVFYEENDQNYKKWADYGVLCVEM
ETAGLYSVAAKHKVQALSVLTISDSLVTGEHLPSKDREQSFNRMVEIALGSI
>IFAGANLK_02781 Deoxyribose-phosphate aldolase
MQLNQYIDHTLLKSTATPANIEKLCKEALEHRFYAVCLSSSYIKLAKSVLENSNVKIAAV
IGFPLGAMTTAAKVFEAKDAIALGADEIDMVINIGMLKAEKIDHIENEIAEIKKAIGSKV
LKVIIETCFLTNAEKKTVCRAALNAKADFVKTSTGFGTGGATFDDVKLMKEIAGDKMQIK
ASGGIKDRETAIKYIELGASRLGTSSGIKLVTSEEN
>IFAGANLK_02782 hypothetical protein
MFRNYFFLFFILISSATFSQNYSEEKIYSWYDKQVGIENSGLFRGIEYVETDRMINEKHK
FFQIQNFQIGSVVYDGQPYYDLPLKYNVYDDLLLINLQYGERNSIFQLFSDKVDLFEING
KKFRYLKADNDSDIIGFYEVINEEGQFKIFKKHLKNRMEIRDRSVAYSEFSTADPDYIFQ
FKNEYFDLDNRRDLFSLFPNLKSEIRSFYNANRKQSRDNPDVFMSKLAAEMNNQISTVPT
DI
>IFAGANLK_02783 hypothetical protein
MRKILLFILLFYISLTYAQTADPVISLSFDNKELPEIIKEIEAKTDFKFFYEEDWFGLNK
YSGEYSEVKLTTVLEDILEETNINYFIKGERIILTRGSLIYDRLPQGFLEIQEEREVVEE
NQSADPVFYNDNEEQAEVVETVLIGKENRQSTRSTYRLSGRVVSEKGDPISGLNILIPNQ
DKGTVTDINGNYEIRLPKGINILETQALGVSKVKKRLVVYNDGVLNLQLKESFEELSEVL
VEANARDNVRTALTGVEKINVAEIKNIPLVLGERDILKVATTLPGITTAGEAASGYNVRG
GKTDQNLILLDEGVIYNPTHFFGIFSGLNPFTTGDVSIYKGSIPAEYGGRLSSVFDLNTK
TGNKEEFAGEVSIGPVTGNLSLEIPIVKGKSSLIIGGRGTYSDWILNLLEEESLKDSQAS
FYDVVAKYNHKFDNNDELNVSGYYSDDVFSITSDSLFSYTNRMFSLSYNKFFNEKHQGEL
VVTNSNYDFNLDFESDFGNDFESGYTINESEVKLKMKYFHSNAHTFNYGISGKYYNVSPG
EINPGSAESLIEELSIPKERAIETAIFIEDSFEVTERLLISGGLRYSFYTAFGPAGINTY
ESGLPRNENTVTGVETYDSGEVIETYGGPEVRVSGRYFLTPTFSTKLSYNNTYQYIHTLS
NNTTAAPTDTYKLSDNYIKPQRANQFALGLFKNFDENIYELSLEGYYKTSDNLLDYKVGA
DLFLNENIETEVLQGEGEAYGAELLLKKNKGRLNGYLGYTYSRSFIKLEGDFQEETVNNG
EFFPTNFDKPHDFSAVLNYKLTQRFSFSANFVYQTGRPVTYPIGKYNFNNSEYVMYSDRN
QFRIPDYYRLDLSFNVEGNHKIEKFAHSFWNISVYNVLGRNNPYSVFFVTDSGEVKAYQS
SIFSIPIPTITYNFRF
>IFAGANLK_02784 hypothetical protein
MKLILKYKSFFTLIALITILASCVEEIPIENESFEKALVIEGSVTNEMKQHQIKLSQAFA
IDTSGPNPLSGANLSVNEFVFEENQPGIYVSRDSFAAQPGVDYQLNISVNENQYESQPMQ
LTGTSSIGELQADRIDYRGEDGVAITLNNQTSAGTANYYRYEYTETFKFNANYFKVNDLI
LVDGEPVEIPKQKEEYTCYQTNESQDLILANTNSLSEDSVNDLLIKFIDSDNPSLSNRYS
LLVKQYVISREAYNYYEILQELSGSDNLFSQSQPGFFAGNISNVNNPNEKIIGYFDVASV
STKRIYFNYEDFYDPESIRPTFVSLSACEVTLPDIPTLIAQLEQNAVKWSETLPGNPPPV
PPYLVVPTQCVDCTLFGTNEEPDFWED
>IFAGANLK_02785 hypothetical protein
MVKKIYIFLFSVLFVNVGNAQIEDQENFLQNEVLKEQVYLHLNSSLLFSGEKLLYKFYCL
DSETRKLSELSKTGWVVLVNSDKEQVFKHKLQLRAGQAYSDFFIPSNLPSGAYKILAYTA
WMLNAEDNYFEQDVYILNPYQSENKGLILKDSIATFSQNITVEKNTSNFNLKLNKSSFSS
RELVTLTSDGPSKLNGNFSISVRRKNNLKKPELLNSTNFNESYENINWDFSDTLIFPEVR
GSLITGKVIRNDDQQVSNNLIVSFPGEENQLNIISTKENGEFNFTIDQAINEEEVLIQIA
NNQNNDYSIELKQNPQPDLGSLNFETPEVYQGFKEYILEKSINNQIENAYSATKADRTIF
HDNSGYFFEENLEKFNLDDYTRFPEVTQTFVEIIENGRVKRNADGSHSILVRNKNTNGEF
TLPALLVLDGVVIQDHDKLVSFDAEGIESIGLLRNKFFFGPEIYQGVVVVETIEGNFPEV
FRDDTIKSQPISTTQNPKKYYSPDYQSENLERIPDYRTQLWWNPTINFEPGKKHLKFYTS
DLTGEFEINLQGFTDDGEPVSLKKYFRVE
>IFAGANLK_02786 hypothetical protein
MTSRSKYSALFLLLAFVVFISSCVEEIPLDSENFEDAIVIEALVTNELKKHEVKLSQAFE
IDSTGPNPLAGADIRVTGDRDYVFQEVEPGRYLSIDSFAAHPGIEYQLNIRVDDREFRSE
PTKLSGNSDIGELEANRINYRGEDGVAITLTNESSPDGANYYKYEYVETFKFNSNYQKFK
DLILVDGEPVEVPKQKEEYTCYQTNDSQEIIVANTNSLSEDSVNNLLIKFIDSKNPSLSN
RYSLLIKQYVISRKSYNYYKILEELSGSDNIFSQSQPGFFDGNIQSTNNPDENVIGFFNV
SSVATKRIYFNYGDFYDPQGIRPRFVSFDLCEETFPDYATLISELERNAVRWSGVTPGGG
FLVVPRICVDCTLFGTNEKPDFWED
>IFAGANLK_02787 hypothetical protein
MKNNGITYLIITTILLVVVTSLVYFNISFPVVFYLTCIGQILLIYTVYKVLTDNYKTKKT
FDDWYEDYPDNKG
>IFAGANLK_02788 Sensor protein kinase WalK
MELPHPPTKTLELKIADNVSAMLAFWDKDLICRFANAAYLEWFGMRQEDMINKMNIQELL
GPLYEQNLPYITGALNGRAQVFEKEITLPDGKGKRYALANYYPEIENGEVKGFYVHVADV
SPIKKLEKKLKKSNAKVKKQNNRLLNFANIVSHNLKSYSGNLESLLNLYETADSDEEKAE
IWNYLQSLSSEFSSTVSDLNEIVKLKNQKDISLTDLSLTQFIQKTKNILRVEIKKSKAII
KSNVDEETIIKANPAYLESILLNILSNSLKYRNPEKPLEIELNCFSSKKRIVLNIKDNGL
GIDLKKYGKDLFGMYKTFHGNADAQGIGLFITKYQVEAMGGEISVESAVGEGADFKVSFR
N
>IFAGANLK_02789 hypothetical protein
MKYILFIALFSVLVFVSCDDKETMPDLLEETAKNQFFVPENIYASSVRAAYFDSLSQVAP
KNQKERYNLKKARALLYAGKTKEAITILENLREASSGGLLLYKLEAQEEESIGPLLALAY
MRLGEQQNCIHHHDASASCIIPINPKGFHQVPKGSRNAIKLYEEFLRQNSHDYNSRWLLN
IAYMTLGEYPEGVPEKWLIPESAFESDYTLKKFKDIAPKLSLNVNELSGGGIVDDFNNDH
LLDVLVSSWSPADNLRYFENNGDGTFTEKTETAGLELVTGGLNMVQGDYNNDGFLDVFVM
RGAWMGTLGKHPNSLLKNNGDGTFTDVTIEAGLLSFHPTQTATWADFDNDGWVDLFIGNE
SEKNNIHTSEFYKNNGDGTFSNLTSRAGLTVSTENEPYYVKGVTSGDYNNDGWMDIYIST
LQATSKNLLFLNNGPDDKGNISFKEAGAEVGLGEQISSFPTWSFDYNNDGWMDIFVAGYR
KSNSYTIVPDIIKEYLGERNNAETMRLYENNKGTFTDVSAEVGLDKIGYAMGANYGDLDN
DGYPDFYLSTGEVSYESIIPNRVFRNNSGKDFQDVTTAGGFGHIQKGHAVSFSDIDNDGD
QDIHVVMGGAFEGDKFFNSLYQNPYEAENNWISVKLEGTEANRAAIGSKIEVTVIEDGRK
RSIFHTVSSGGSFGGSTLRAQMGLGKASEIQEIIIKWAGSDNSQVFKKLKLNTFYKIIEN
KAEAEELNLKTISL
>IFAGANLK_02790 hypothetical protein
MQSNFYLVNKSFEYKTKTTVSQIENRIRSFSDDYDFIRQHESEVVLVNSGIYEALIYPNI
TVAEFLGFSPNTKQLFNKQIITYLNIVLRKSKKTSITTDEVIEILLNEQSENELHGLMCL
FEVEGIDPKFLVYNKNNWLSFHRYFLQQFLLTPEVFFSECKKYFPNLIFHPNILTSLKKI
LRDSYETIIKHLIYLNDILPICIEENKTRQDVLKQFNSSCDLDSNASPEGNIERKSDLTF
DFQNNEGINENIYCELHLKLVFNDNRKVEQNRIYFHEGKYEIGGGKILIGHIGRHL
>IFAGANLK_02791 hypothetical protein
MIFSTELKNFKGFKDEIKFPLKNINLLTGINGRGKSSFLQSLLLIRQSLENQEKFSKLFF
NGSCVNLGTFYDVKNRNTTNDTSIKIKHSFETHNLNLELKSDLDDDMVGVVINDFSHEVL
KKFQNIHYVAADRVGPQEFYLKSSLPEFINVGTKGEFVGNVLLQKRGELVNEIFTHPEEN
LSQELEIQSGKWLSEILDTKKIKTYVSSEESSRLITLTFGIGNNKFRATNVGFGYSYVLP
IIVSGLIAKPGEILIVENPEAHLHPKAQSNLVKFLAKVASIGVQVFIESHSEHILNSLIL
ASLEEEIKLSHNEISILYFMDGQNAFLELKIEKDGSISNWPDGFFDQQEIDLSQIFKLGR
ENAE
>IFAGANLK_02792 hypothetical protein
MLTNKIELTEYSLDILKDELPLNIINKLESLKGKSFQRYDEFKLILHGLLEDQFSDYASE
ILDHVEQIESDEDTLDENDGQSGSIYPYDPTQADIDIREDPQTVYELVERKWERGLIKMP
NFQRNYIWKIEQQSLFIESILLNFPLPPLYINKDTKGKYVIVDGRQRITTLRRFMKDEFS
LSGLKAFPNLNGKNFSALKSLDISYQSRIEDKKLLVYLIQPTVPLEMVYDIFNRINTGGT
QLERQEIRNCIFLGTATEFLQKLSQKEGFKLSIDYGISSNRAKDQEAILRFLSFRIFDYR
LNYKNSMNDFVERAMKYLNRFNINDSEIIALEEEFDKSMRLTYDFFGRNNFRIPTNETRG
RINIAVFETVAGYFASQNEEFLKLNKRTIKKNFKILIDNWDYLDAVRISTGDKKRVSTRF
DLVFDTLNAGCKNL
>IFAGANLK_02793 hypothetical protein
MTTTTKPNHIGRKIARIRELRGMKQETLAEELGISQQSVSHIEQSETLEDEKLEKVAKVL
GVTKEAIENFSEDAVFNIIGNTFHDQSASLNYNCTFNPLDKIMELIDENKKLYERLIKVE
QEKYLELRNYTDNKK
>IFAGANLK_02794 hypothetical protein
MKIKNIPQHVLEQLIEVIRSLVKVHSIYWIGAAKRDSFSSYIFNSKVYDHSKQEYEFTLL
IISYKEICDPKTFMSEVFNKMKERVKLYSIDYSYNDIKRRLEAGDNFLSRLLLPENCLFE
ESPLSLTGYCYHPKKFEEIKKAWEFRLNRGSYFEDKTDTVDMVNDESARMVLVGQTILQT
CAALLGVYWEWKPHYFELDLLLNLCKHFSKSPRIVLPKKSFTSKKVYSQLCHAQYNINFK
TVDDVTMKDSDYASNLAERFLRKVHKEGNKKLKELELLHNRKYTNNYNEMET
>IFAGANLK_02795 hypothetical protein
MPCCLKIYITDTDYKIANVIVIAINLLHSPRVDEVINLFNKKAISSSLSEQLNSLASTSY
LVKYHLKFQVIADGVY
>IFAGANLK_02796 hypothetical protein
MSEIKFEQPTISGQAGAPISIANKSFPYNELADHRRYEELVYSIFSEQIRCKLIASYDSI
SLMSGVRDKGRDCSLNTSSKFTALIQCKKYKNPLSKDQFGKEIVKFLLYSLIYDELHFET
TNFTYFIAASSGYSNECSDFIDSIGNTIDKKKEIDYWIKYCFREKKFHNIPLKKARSFIF
VALKNINIQKISPQDLDKLLVKDPCKKLIPLFFQVRSIVDTEEVRKIHVRLDKIMKESHQ
EIPFKQQLSWGSHSLILEKNEFDEIPDSHIPRKETEELIQWIQKPVATNKEDKALNICIL
AGDAGMGKTVILRDLYERLENDSIPVLGLKADKLYVDSDDDLQKRLGLSLSVIKFLDRCM
LEFDQVVLIIDQLDALSQSMSSERKYLMLFKSLIDYFTHKPNIKIVLSIRLRDLHYDPTL
KSYRHIKSIPVAMLTQQQVLTQLDKIHISKNELPDKLIELLKVPQHLNIFSRIAVTKRNF
SGLHSLHDLYSELWQQQIVEKPERLGLKPQRIRKLLYKIATFFFKHQRTEVHKNHFENFS
RELSYLESEHLIRTENIQLQLFHQTFYDFIFSKKFVENQNDLLVYVISQKQSLLIRSAIK
MIVNYLREFDPVAYHHSLEKLLSDNQIYFHVKHLLISHLAFQQEPTIDEIDLVLKYTKYS
IPLQILFLELAQSPKWLQVLLSEDRLQMLNTPLEENKERENNVAIINQRFLRKTALGYLS
NFVNLRNSDAWKFVLEETTPETKKEILFRLNDWTNPKSYVLFDLCQPMHLDNYGYLSTLA
KIAKEKPETAWENIKITFLSDTYLNQANPHDHILIDTLKSLTERIPEKLIPELTNKMIED
LNSPPKDDDDDFLFAVNPYEFVDLELQEDLNGKSFIFQLLAECLRVAYNKDLPIFERFLN
DHSSSKHFPMLQLVMSSIQDKEPQYADTVFYLLQLFNEREQLDYHGDPGTTFRNLLEKAF
PFFSKRQQQQTLKIIKKIRVSYEAFVIKRQEKSHLNLSWGKSKLALLKRIPEKAIRPRTA
LYKEYQQLQRKFPNLEEAYSNRGLAGIVKRPLTAEAYEHMSEKQWLRSFKKYATERDPFQ
KDFLKGGLHEHSWAFREIVKNNPSEQKIHIIQKSIGQPRIDSSYPILGLSGFCDAKGDPE
IVLGLFKRILATKDYDSQLLPCIGIAAYVIQEERADQEIYDFLFSTCKNTSIKPYEKFRQ
DHEKTSIRGLITTGINSIHGSIAQAVAYSRNEEMASQVYDFMDQIFSNHNESTKAALLFQ
YAQLMHLNKEKTFNLFVKHIADEEDVFLLASSLNALRYLCNYNFDACLPIFKKLVKSPKI
GSEDTNLLFGILFRQALQKHHEAKKLLFEFVKNGPEARKAAFYQVIKNYNYKENHKNFCN
KILCHALKNIQQDEYVHRRKHFYNMDHISLHDIFPFLQEYVKSSEFIPSDKFISYLLQES
HAEPGLAIALFQLSIKQSNEVQHQEYFMYQRNSLVTKFIVGAFHALDQSNPRINKLRLQL
LEILDDILQDMRYWQENSAVLKDLS
>IFAGANLK_02797 hypothetical protein
MKPDREQLEALEPKRVQEMRNLLILHYHQESGFFERRIYIMFFIISGIGLYTSQGTYQLY
QSFMSRILLSVAASLFLLGLVVAIVSHEFARKTRLQKADYFNQVELEKIELYRKSAGKYE
KIEDILKIVVGVLFLISCILIGIVYVNNGF
>IFAGANLK_02798 hypothetical protein
MKPLRILLFIFILVSCEPEETTIIDDEILATDIELYPEEVYSGNDQSLPILKLTLRTSEI
YPCFNYKIDFSKSFEKDEMTVIINNIHKPGICLTAFGPAIGTLELPETTRELKIVRGDQT
DTYEVNINTELIEILPRTTEFTDLINPITFRYPENSFAVVCGTNLEQTELCANFLEKLDD
VPSLSSYTFPENGRTPYPDSSSGNWNNTSSRYFIYENETALIEAVEQFEMFTQENLNRDD
GNSLSIITWDNQSYYSYQLLE
>IFAGANLK_02799 hypothetical protein
MKIKLLNLLILFCAFNLAAQQEVNTSFGTQMQTTFENLEMNRVPHGLLRDFAMEFTALDA
FDGTVSDSSYVHPGTLKQIYKTLLFSRVNTSNQGFVQYEDFTDNWEQEREKGIIILSGLF
YRYSKFLDDAYPNKININNNKISDRYNNGNWQDPYEEKVAFALAPSIITYRNLDFRVQLP
QNLWYSNNPNEIQSVQVDFNDGQGYRNMTSGQAVNVQYSSAGEKVWDYKLVLNTGETLYS
HSKIAVEEGIQAVPYGVKSFSKQQIGDGLGVDTLNIQAIEQYLGKYGSATVLVNYGNTIG
EIRKPLIVVEGFDPGNVTSPEEPYGATDLRDFSREVLSSTSGNLIDIVTGSPNLNDNDQE
YDIIYVNWSNGTDYLQRNALVLKEVIEWVNEEKTGEEENVVIGQSMGGLIARYALKNMED
EGVSHETRTYISQDAPHLGANVPLGYQAAARHANKQYVQSPFQLLAGELVVPLFNDGVAV
SDYLELIDQPAARQLLVNRLDENFQIENNLFDQWQAELQGMGYPGQTRNVAISNGNQCAE
TQGFTPGGNLLSMDGQIKSGWLTDVLSTFTLLGNATNATFFLTLNSFTGELGFLTGLLTG
SSRLNADININSLPNFGGSEQVYSGNITFTKKLLFLININTTITNESYTSPSNILSYDYF
PGGVFSTGIQSSTQNESNVLYNLNVIVNSDPDFSFVPTVSALDIGKGDANLNSADFLKSY
GVDSPPVSPKDSPFTNFISSYRDTPFVINSFEQTNGSIVTINNFNQKHLELFSTNGGWLA
KEIKGENLSDNVTDCSNFCIDLEISGPEGICEGSAIYSFPAENVNWSISNTSIASIEPDG
NEVTVNSEGQGRIKLTAEIENSDCGTKTSSITINLGKPDIYTIDSNGNKNYMGGSFNFST
SYTAKGSFSVFSDTPNTTLTWSGAASLNWWNLNNNTVEFDRNIEGNYFFTVTADNGNCSH
NYFVSLQIGGSGPDPFFTVAPNPVENKTVVVNDISSKSNMQSGQALSQNMSNEITLLLYN
FQGKLVKTKIFRRRNLMGEYRLNVSGFKNRNYFLRIVSGPIKETHQLILNSK
>IFAGANLK_02800 hypothetical protein
MKLYIKLLIVLFLFTGNACDKENDLSPEEQLPEATKTGANTAGCLVDGEVLLPKGGSLNS
GSMLKAQYILNEGKYIFSLSLTDRTTGEFQRTVQIESKNESLKEGETYTLSELNEISTSA
FYLLDAGFVDAFVTTNTIKGEFIFSRLDEESAIISGEFWFDAVNEEGEIVEIREGRFDVR
Y
>IFAGANLK_02801 Tyrosine recombinase XerD
MKASLLSKAEIILKEYQEQVNYLINRYLFPVISNQKMNTYVKEIMKAAKGEKAYYFSFRE
THFCHAVTNWVPIETVSKLLEHTELSTTQIYARVMENKISGDKSMLEKTMAKKNKKILNL
>IFAGANLK_02802 hypothetical protein
MKKASWIILGVLSITIGLYPILYFFIDREFGLLGTKSVDLLSDTLWNIMFYVHIFLGGLA
LLIGWLQFSKKLRSRNIKLHRGIGKIYVVSVLISGICGLYIAFFSTGGITSTVGFSSLAL
IWMISTFLGYKSIKNGKIKLHEDLMIYSYAACFAAVTLRFWLPILTILLDDFIFAYRIVA
WLCWVPNLLVAYLIINYKKPVAHTL
>IFAGANLK_02803 hypothetical protein
MFKKLLLVGAILTGMASFGQEVDFGIQAGYTNVEGKSSNSLDNISSSGNSSGFYVGALAD
FTLSENFHLQPSVNYANADEVNFLVVPVLAQYYIENSGFYLHAGPQATFILDDVSISGVD
VFNTFGLDLAFGAGYEINSNFFVEAKYSLELTNRFSKEIRDAADTENVKVDSQFNALSIG
LGYKF
>IFAGANLK_02804 Tyrosine recombinase XerC
MPDFTTFSVLFFTRKLNRNKKELSIYARITVNGKCAEMSLKRKTSVNEWDSSKGRLKGTS
PRIKTLNSYLDQVYSKLLDTQKRILDKDNLITADKVKASYLGLDEEHKTLKDIIEYHSQT
MKGVLKWGTLKNYNTTAKYLDEFLKKKKKTNDVYLKQIDYQFITEFEMFLRNYRAKKERK
TCGTNGTMKHLERFKKMINLAIKLEWLEKSPFQNYKMKFEKNERQFLSERELKMVEETYF
KSESLERVKDMFLFSCYTGLTYGELKELNKDHIVKGMDGKNWIYTKREKTNEPVKAPLLY
KADIILKKYREKRFDLFSKYLFPVRSNQKMNQYVKEVMKASKVRKHITFHSARHTFATTV
TLSNGVPIETVSKLLGHTKLSTTQIYARVLEHKVSGDITALEKRMTKKERKRSDSSNGTN
ESD
>IFAGANLK_02807 Kynurenine 3-monooxygenase
MKQLNTQILIIGAGPSGMVAAGYLKKQGVDCLVVEKSIFPRFSIGESLLPKSMENFEESG
LLEAIKAAGFQKKYGARFIKASKVGEFDFSEKYGEGWDWTWQVPRADFDLVLANEIQRKG
VKIFFNAEVNNVDFCGKKSTTKILINSEEKIEINADFIIDASGNGRVLANQLELNTSPKI
TGNSSIFTHIKETDRPKGKEGELITFEVLDTKTWFWYFPFSNGNASLGFVSNHDWFKDFS
NDNSVAFKRMLKKLKYYLGRFDDELFLFEPVKMPNISRNVKKIYGDGFALSGNSAEFLDP
IFSSGVAFATESGLQAAKLAKLEVEGNNVDWEKDYTEYMQSGISVFSSYVKEWYTGNLQK
LFFHEMPRTEIKEQICAVLAGYVWDKTNPFVKNHQRIIKNVARLIDQEEINF
>IFAGANLK_02808 Tyrosine 2,3-aminomutase
MLQINDALSLEDFYKVLFENTEIQSSSQNLSKIDASFEFLKEFSQNKVIYGVNTGFGPMA
QYKIKEKDRIQLQYNLIRSHAAGSGEPMEPLYVKALMLARLNTLSLGKSGVHQSVVEVMQ
QLINKNITPLIFEHGGVGASGDLVQLAHLALVLIGEGEVFYKGKLRETKAVFAEENIQPI
EIEIREGLALMNGTSAMTGIGIVNIIFAKRLLDWSVFCSSAINEIVQAYDDHLSEELNTA
KKHLGQQRIAEIMRNHLKDSRLTRDRNEHLYNDAADKNTYFKEKVQEYYSLRCVPQILGP
VYDTLEHTAKILIEEVNSANDNPIIDVQNEHVYHGGNFHGDYVALEMDKLKLVVTKLSML
AERQLNYLLNHKLNDILPPFVNLGKLGLNFGMQGAQFTAVSTTAENQTLSNPMYIHSIPN
NNDNQDIVSMGTNAANITKTVIDNTFEVLSVELITIVQALRYLDFDEKLSKKTQEVLEEM
NKIIPEIKEDFPLYKTNAKVKDYLKNNEVY
>IFAGANLK_02809 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKYALITGASRGIGKAIAINLAKELGYNILLNFHSNTEAATATKELIEEEGVKCELLQFD
VADTEKTKISIENFSKNYPEVEIEVIVNNAGITRDGLFMWMKPEDWHSVINTSLNGFYNV
TQPLIKNMLKRRYGRIINIVSLSGLKGNAGQVNYSAAKGALVAATKALAQEIGKRKITVN
AVAPGFITSDMTAEFDENELKKLIPLNRFGEAEEVAHLVSFLASKKTSYITGEVININGG
LYS
>IFAGANLK_02810 Lipid A biosynthesis lauroyltransferase
MSNWKGQSRGTVLGLKIYVFIIKTFGLSASYFVLLFVALYFVFFAFNSTKSVYYLFRKRL
GYSRIKAVLNIYKSYFTFGRIQLDRIAIASGLKHKYSFEFDGIQHIENLLQQKKGGILLT
AHIGNFNLAKHFFDDRNNYQIVNLVVTDLEHEEIKNYLDSVTGKSAIKLIVLKEDLSHIF
EMNRALQNNELLVFATDRYTENTKTYTQNFMGKFVQFPQGPFKLAARNKIPVLFVHIMRE
KNFHYHFYARPYNPEKNDAKNLLKAYLENLETMLKKYPHQWYNYYDYWNDFS
>IFAGANLK_02811 hypothetical protein
MAENLLKEPILELDRILQLIPQKPPFVMVDSLLEYTDKTGTTGFTIPEDNILVENSIFSE
PGLIEHMAQSMSLWRGYEGFLSGLDKPKTGFIGAIKSVEILELPKAGNKLVTYVEILQEF
MNVTSVGARTFDEEGNLLATSEMKTVTVD
>IFAGANLK_02812 Putative esterase
MLEKSLTTITNLRVRFHECDPLQIVWHGNYLKYFEEGREDFGREHGISYLDAQAEGFSTP
IVKSVCEHKLPLKYSDVFRVETTFENSEAAKINFSYKIFKGEDLVCTGETLQVFLDEKRE
LVLNNPPFFLDWKKKMKLL
>IFAGANLK_02813 3-oxoacyl-[acyl-carrier-protein] synthase 2
MKKLYLLDDAIISPLGFSTKENIQSIREGNSGLKLQQRPEITENPFFAGIIDETLLNQAF
SEIGSSEKFTKLEKLIILAVKLILNKNRNLDPTKTALIIATTKGNIDLLNEPGGFPINRL
KLSELGKVVANFFGFAQTPIIVSNACISGGLGLAVARRLGNSEKIKNAIVVGADLVSDFV
ISGFNSFQALSTKACKPFSKDRDGISLGEAAAAIMVSTEKPEISNVISLIGDASANDANH
ISGPSRTGEGLYKSIQKALKEASISAEEIGFLSAHGTATVYNDEMESMAFQRSALQKSPL
HSLKGFYGHTLGASALIESIITKHSMLNNEIFASKNFEELGVSKPLNVIQKNEKKEIRYA
LKTASGFGGCNLALVFKAEKQ
>IFAGANLK_02814 hypothetical protein
MSNQFHIQNWVKIKNGKIFNSEKLIFDSSEKELNFFLKACYDFLDLKYPKFHKMDGLSKM
GILASEIIFRKNKPTEDTALVISNNASSLEIDRQFQESTETFASPSLFVYTLPNIVLGEI
SIKYKLQSENAFFVSEDFNAKLLKDYTESLLISGKSHQVLSGWIDLQNGEYDVFLCLVSK
ERNIPFSEENLRKLYCAENDKPTH
>IFAGANLK_02815 Acyl carrier protein
MTNLHTELKESIIEQLNLEDMDPADISNDEPLFGDGLGLDSIDALELIVLLEKDYGIKLT
DPAQGKEIFVSINQMAQFIEENRTK
>IFAGANLK_02816 3-oxoacyl-[acyl-carrier-protein] synthase 2
MNKGVAVTGMGIFSAIGNNTAANYRSLILGKHGISSSEILETIHKNLPVGEIKISNESLA
EDLNLPENHSFSRAALLGAFAVKEAVTQSSWKIDNETGFISGTSVGGMDATETYFKDFTE
GKTDNNRFIRAQHPGFTTEKIAEYFGITEFVSTISTACSSGANAIMLGARMIKAGKLKRV
IVGGTDCLTKFTLNGFNSLMILSDEQCKPFDESRNGLNLGEGAAYLVLEGEEELNGKPVL
GRISGYGNANDAFHQTASSENGEGAFLAMQKALKTAGISSKKIDYINAHGTATRNNDSAE
TEALKRIFSKNLPDFSSTKAFTGHTLAAAGALEAVYSLLSLQNQQVFSNLNFSDPMQSSG
FIPVTNLKEKPIKYVLSNSFGFGGNCTSLIFRKNGE
>IFAGANLK_02817 hypothetical protein
MGNKIYINGIGIVSAQEEDLFSEGFASTYYENIFPVISPNYRDFIKPMALRRMSKAIKMG
ITSAKIALKEAEIEVPDAIITGTGEGCKQDTEKFLENMLDQNEKLLTPTSFIQSTHNTIG
GQIALNLGCKNYNVTYTQNSVSLETALLDAQMQFDEDPFLNSILVGGVDEISEKITSFRK
LDGQLKSVPIKNLDLLKEDSTGTITSEGAYFFALSNKRKENTYAEIQNVSIKNTIPPEKI
NEEIEAFLETNKLDPADIDTMILGMNGDNRYDYFYKNLQQKLFKNTTQLAYKHLVGDFDT
ASGYAIYLAGNILKSGKIPSILKLNDIESKAPKNILIYNQYLGRDHSLILLSAF
>IFAGANLK_02818 Peptidoglycan-N-acetylglucosamine deacetylase
MRFKIINTVIVLLLCAALVLAFFGFASFWYVLTFIVFYLLFLLTVSTNVRFNFFVKSISE
NRRIKDKQIALSFDDGPVENTLEILKILEKYEVKAGFFCIGKNIKDHPEIFRKIIEEEHL
VGNHTYSHTRKMGALSVSTIIREIEDCNKIAKETAGIKMRLFRPPFGIVSPKTQKALRKT
EMQSIGWSIRSFDAVLSSEEIILNRIKKRLKPGAVILLHDNNANTVNILEQLLLFLKNNH
YKVIRPDKLLEINAYS
>IFAGANLK_02819 Outer-membrane lipoprotein carrier protein
MRILNILLLFLSLNLAAQDELSKEEISHFQEEMLTKANELTTLEADFIQTKKIEMITEES
VSRGKLYYQNPEKLKWEYAEPQDYVILFIEGELHINDAGDKSVRNTSSNKLFDKIAKLIT
GSVNGKLLQDNENFDISYTRKNNLIAALIIPKDKNLKAMFAEIHLFFNGENIVEQVDLKE
EAGDMTTLEFRNIKINQEIPATFFEP
>IFAGANLK_02820 hypothetical protein
MILKNFYSVLNSSEENGKQLTQIKINKDHEIYDGHFPGRPVTPGVILMNLFKEEAERRCG
CKLQFKKGNNVKFMAVVDPNTDAVLNLETEITEENQEIRLKGIAKNSAGISLKINSLYKK
FQS
>IFAGANLK_02821 Undecaprenyl-phosphate mannosyltransferase
MNQEPIHQYKFEALNCCILIPTYNNEKSLASVLQDLLLYTSNLLVINDGSTDATEEILKG
FSGINIHHFEENRGKGEALKHGFKIAEELGYEYAITIDSDGQHYPDDLDVFLSHLEEKSP
DSEILLVGDRNMGQDGIPGKSTTGNKFSNFWFLVVTGTQLTDTQSGYRLYPLKVINQIKL
YTSKFELEIEIIVKAAWRKVKVRNVPIKVFYEENRVTHFRPFWDITRITLLYIWFVLVSF
FYIHPRDTYQDFRKKGFKRFWKENIIKSQEPAHKKAAAIALGVFVGILPFWGLHTLLVFS
LAAMFKLNKVVAFLFSNISIPPLIPFIIYASYQAGSLLTGRGFAWELRPEDFDSTADIFL
GLWQYIIGSFALAGIAAILLWIVFYFLFSVTNQKQVVKP
>IFAGANLK_02822 Siderophore exporter MmpL4
MHKFFLKLYYFFRRQKAIGFLLLILFVLTGGYFASQIQLEEDITKLIPSGEKQDALRKVL
DNTEFSDKLIIAISSEEKNSEELTAYASKLTDSLDKKLPEYITKIQGEISEEGILEVYDF
VYQNLPLFLNSRDYEEIDSRLQQDSIQERLESSYRDLISPTGFITKQFLFKDPLSLTNLG
LEKLQELQVDDSFKIYNNYLVTKDEKHLLLFITPKYPASETRNNEVFVEKLDQIVSDLNE
NSEVKAEYFGGVLYAIANAKQIKSDIQFTLSIAFSILLVLLILFYRRFYVPLLLFLPSLF
GALAAITLLYFLKGSVSAISLGIGAILLGISLDYALHILTHFRNNADVKILYREVSKPIL
MSSFTTAIAFLCLLFLKSEALNDLGIFAAVSVITASVFALILIPHFYKPQKNKKKVKNNW
IDKLATQRFYQNKFLVGFVLLLFLFGLFFFTKVEFNVDLSQVNFEPKNIKQTEEKIKQIA
GEAANTTYLVSYGNDIDEALSRNNELYQELKNLEETDKIKRFSSIGGVVLSTDKQTERIE
AWEEFWSDSKKENLKNSLLNESSELGFKAESFNRFYEQLNKDFNGIFLEDYRNVSTLYLD
DFINNNPGFSTVTSTLSFTESNPAILEKLEEEEGIIAIDRKQMNQDFLGDLKSEFNQLIL
FSLIAVFIVLLLFYRNLLLSLLTLLPIAITWIIALGIMAVLGIEFNILNIIISTFIFGLG
LDYSIFITNACLKEYEIGKPALKTYQASILLSVLTTLLGIGALVFAQHPALQSVSVVSVI
GVLTALLVAFVIQTKLFDLLFFRRKLAQKAPFSFYSLVKKSGSKEQLYLKNALLGNYRYK
SVYSAAKKEFTQNRERFLKVSGFLNPGEKIFMLNSNYGILPVFLSLKNQENKFFVLDTNK
ENRKISNNTGQSNAENINFSKEWPENLITYPVFIISKKPSEEITSTLKENISRYAEKVII
LSSEYENRWLIDLNFEIIYRQDNILVLKRMD
>IFAGANLK_02823 hypothetical protein
MEDRPDITGIEKIDTTRTKINDNHYRIGKNSLYKNKYGIWELYVEGDALERGVISGSLTQ
ELMHKQETAFMEKIYDLVPKTGYRNFLKKTVAWFNRKIYLHVPEEYKQEIYGTSLFGLEE
YNDFAPAYIRMLYFHGAHDIGHALQDLMLVGCTSFAAWDSKTEDGQLLLGRNFDFYAGDE
FAEEKIAAFINPDEGHKFMMYTWAGMIGTVSGLNEKGISVTINAGKSKIPLQAKTPISLV
AREILQYAASNEEAIEIAKKREVFVSESIMVGSANERKAILIEVAPGNFGVYDVENSNEL
VCSNHFQSEAYVKDNRNLKTIKESHTQYRFDKMQELLSEKELLTPEKAADILRNKEGLGG
SKLGMGNEMAINQLLAHHGIIYKPEERKVWVSANPYQLGAFLSYDLDKAFNSFERGNISG
SVMTDETIAEDPFVNTEAYKNYEKYRKLSQEITDAILAEEKVSAEKINKLKFLNPYFWEV
YKIAGDYYFQQKDYKKAVINYKQAKIREVTTLPDEEYLEKMIKKSYRRL
>IFAGANLK_02824 Phenylacetate-coenzyme A ligase
MTSFYEINGNKILLKQQLSYVAANSPFYKKHFQSNKINIAEIESYEDFKQIPITTKEDLQ
HFNKEFISVPGDEIIDYVTTSGTLGNPVSFALNDADLDRLAENERRSFEMLGVKKSSVVQ
ITTTLDRRFMAGMAYFLGLRKLGAGIIRTGSGLPGLQWESIERFKPEFLVAVPSFLLKLI
DFAIQNGIDYKNSSVKAAVCIGEPLRNPDFSLNSLGRRIKELWDIDLFSTYASTEMGTAF
TECEFHEGNHSLLKLIFAEVLDENQEPVDKGEIGELVVTPLQTKTMPLIRFATGDMVKFY
GKNCKCGRESLRISTPVGRKQQMIKLRGTTLYPQQIINLLTAFQSLKIFVIEARLNKTKT
DEILVRIPEDFAEVNELQEHLQAGLKVKVVLKKASVEEIEKLKFPRESRKPKLFHDFR
>IFAGANLK_02825 Gamma-D-glutamyl-L-lysine endopeptidase
MVSQVLYGEHFKILEERAQWSRIRVAFDNFESWISNKQLLKIPEETYYRLDEVIPNYSAD
LFDFVTDQNGHLITVPIGASLNATDLLNHHFEGHSVSGEKLKVEIVKAALLYLNSPYSWG
GKSPLGIDCSGLTQMVYKLNGYQLNRNSADQAKQGEALSFIEESEAGDLAFFDDKDGVID
HVGIMMNDNYIIHVDGKVRIDRIDHSGIFNAELKRHTHKLRVIKKII
>IFAGANLK_02826 Acetyl-CoA acetyltransferase
MMNNEVVIVSAARTPIGSFLGSLSTVEATDLGAVAIKGALNKINLKPELVQEVLMGNVVQ
AGVGQAPARQAALKAGIPDSVPCTTVNKVCASGMKAVMQGAQSIMLGQNSIVVAGGMENM
SLIPHYLYHRKGQKFGPAKMEDGMQKDGLVDAYDHNAMGVCADLCATEHNFSREDQDAFA
IKSYERSAQAWADGKFDNEVVPVEVPQRKGDPIVVKEDEEFKNVRMDKITSLRPAFSKDG
TVTAANASTINDGAGAVVLMSREKAEELGLEILASIKGFADAAQEPKWFTTAPAKALPLA
LKNAGVAQDDIDFFEFNEAFAVVGLANMKILGISDEKTNVHGGAVSLGHPLGCSGVRILI
TLLNVLQQNNAKLGAAAICNGGGGASAMVIERNS
>IFAGANLK_02827 Cyclic-di-AMP phosphodiesterase PgpH
MKKFVNNLYKNQALFYKVFLFALTAVLIVYLLPKGGNFKYEIPKGKPWQYENLYAPFDFA
ILKSEEEIQEERQQIINNHTPYFQFNQEIPNQVESEVPEVVQEVFPDSILSNREIQIIGF
VNETLEDVYEYGLLQANNRLEDNQLVYLRKGNEAFEISYKNILKQDQVRDFLNSEIEESN
LSEFENELLEVFFNLIEPNVSFDSEFTQKELQSKLDNISYTRGNIEQGSRVIARGEVVEG
NKYNILRSLKNEYESQVWSESNYKWIIVGYSVLVALALLMLLLFIRKYREEIFENNVKVT
FIFFNILFMVLLTTLVVNFNIDYVYVVPLCILPLTLKAFFDARLGMFTHVITVLLLGFIV
PNSYEYMFLQIIAGIVTILTVSELYKRANLFISVGQITLVYIISYFAFTVIQEGNIADVE
AEVLLTFLLGGLATLFVQPLIYIYEKIFGMVSDMSLLELSDTNAKLLKELSEKAPGTFHH
SLNVANLAEAAANEINANAMLVRVGALYHDIGKMKNPTYFSENQTSAVNSHDELAPRESA
QIITDHVINGIEIAKKHNLPDRVIDFIRTHHGTTTVYFFYMKEKEQNENAVAEDFRYPGP
IPFSKETAILMMCDSVEAASKSLKEPTAGVIDNFVEKIINKQMKEEQFLNANITFKEIQV
VKKILKRKLKNIFHLRVEYPE
>IFAGANLK_02828 hypothetical protein
MVSNKKELYLNCLDTVNEQIERYQKQMDQIKESMEANDIKTDYDEDNKGQLLSDFEKYAG
RLSDSQKMKESLSRIDPDHYSEAINFGSVVETSGNYYFVSVPIGEIAMEDGSSVYAISTE
APIYKEMEGKKEGQTFKFNGEEVKITAVG
>IFAGANLK_02829 hypothetical protein
MIAVITADLVDSSNYSERLLDEILKNLNSEFEILQQEYAEEEIDFKIYRGDSFQGVIAKY
EDSLQIALRLKSLINKVKLEDQKTAGPLADVKIAIGIGSFDYKGDSMAESNGKAFQFSGR
TLDAMKNESRKIRLKTPLESLNSEFEASLFLLDTVMEKWSQASAEVVYYLLKGMKETEIA
EVLKISQSAVNQRKKACGWEAISVLLKRFKNVTEQSF
>IFAGANLK_02830 hypothetical protein
MEETTLILLQLFLAHILTDFVLQPTKLVKHKREKRVGSWFLYFHSFLAGFLTYIFLQEWY
LWYIPIIISVSHFFIDLWKLQHKKDTLKLFLIDQFWHSVIIILVWIYLIDGFSELIPFIA
DVFSSPQILAIVIGYLLVIFPAGFLIGKATKRWHNELQPNGESHSLEAAGRYIGIFERIL
VLTFILTHNFSAIGFLIAAKSILRFSDKTDASARKQTEYVLIGTLMSFAITILIGLLVRY
FLF
>IFAGANLK_02831 hypothetical protein
MTPRDLQLVALRPEIPSARVSENMSLDEQFQNKTLRPIAKLQDGLLLEVFRNYTKKHKNK
FYELNIEKRFIYIENAIQKDIKFRNSLKGIIIGQFTLEEYATYIKNSSALNKRMMNIVKE
RLQSNIQLLEEEVTY
>IFAGANLK_02832 Succinate-semialdehyde dehydrogenase [NADP(+)] 1
MIISKNPYTGEEISSHHELSDAEVEKAIKKAHSRFKSWRETSFAERSNLMIKAAKELKDN
SREYAEAITNEMGKPITQAIAEVEKCAWVCEYYAENAESHLENEKIKTDAKNSYVKYEPL
GVVLAVMPWNYPFWQVFRFAAPALMAGNVAILKHASNVMLSANNIQKIFERAGFPQDCFQ
NLVIGSKKVENIIRNKKVKAVTLTGSGGAGSSVASIAGEEIKKSVLELGGSNALVVFKDA
NIAESVKTCVMARFQNTGQSCIAGKRLLLHKDIAEDFLEEFTRQVRELKSGDPMDEETFI
GVMAKESLAEDLEDQVKDSVKKGAKIILGGKRDGTYFEPTIITGAKEGMPVFDEETFGPV
ISVTEFKNAEEAIELVNSSSFGLGVSIFTEDEDFALKMVPRFEDGAVFLNELVKSDPRLP
FGGTKISGYGRELSHHGIQEFTNRKTVYFNKY
>IFAGANLK_02833 hypothetical protein
MNFGKVEHPENIDFTLPETHPDTIKVLNKNGNKSGFKDVRIGCAKWSRKDLKNFYPRGTK
DELVYYSSQFNSIEFNGSFYRMYPEEQFEKWYGKADDNFKFFPKVPRLISHRKWLNETEE
LTDDFVKNLFQLKDKLGMVFLQMAENFAPKFIDRLDGFFAHWPKEIPLSTELRHTDWYAD
EKVANELYDVLKKRDVAHIITDTAGRRDLIHMRLSNTTAFIRYNGANHSSDYTRLDEWLD
KLEEWHKEGLENVYFFIHQNVEEASPLLSAYFIERFNKRFKTDIKIPKTLN
>IFAGANLK_02834 Bifunctional NMN adenylyltransferase/Nudix hydrolase
MKQQEVAVTVDSVVFCNANNEFKVLLIKRKNDPYGDQWALPGGYINESEDLETAAKRELE
EETGLAVKTMEQVRAFGAPGRDPRGRTISIAFVSRIFCEEELKAGDDAGEASWVNVDDLP
ELAFDHAQIIDAAKNYL
>IFAGANLK_02835 putative acyl-CoA thioester hydrolase
MRFHTRKWIKPEDLNPNGTLFGGKLLAWIDEECALYSIIQLENSKCVTKYMSEINFQHSA
RQGDIVEIGIQVLKFGTTSLTLKCEVRNKMTRSTIITIDKVIMVTLDEEGKPTPHGKTKV
EFVKDRLQNKV
>IFAGANLK_02836 hypothetical protein
MNKAILNEEIQEFLRNNLKTTAADLALRGSPFAGISSSELAQQLTGLQKAENKLPTWFKN
FQIYYPPKLNLEQTSSETTSEYKASLVKGKTLIDLTGGLGIDDFFFAENFEEVIHCELNA
ELSEIAAHNFKQLGRRNISVKNVDSIEYLKGTNQNFDCIYVDPARRDNTGGKVFRLADCL
PYVPENLNLLFSKSNCILIKTSPLLDLQAGISELQFVAEIHIVAVHNEVKELLWLLKKEN
SSEIKIRTLNFTKKGLEEFDGIFINLTAKVEYSLPQNFLYEPNAGIMKSGLFNEIASQTQ
TAKLHTNTHLYTSEKEINFPGRKFKIIDIERYKPGILKKKFSNLKANITTRNFHESVSTL
RKKFKIKDGGKNYLFFTTNMNNDKIVLVCEKL
>IFAGANLK_02837 hypothetical protein
MVGIVLLLYFLWEIQSVLVYIAIAAVISLIGRPVVIFLRQRLKIPNQLSVVIVLVLVLSI
FAGIILVFVPIVIEQSQYLSRIDMDAFRNDLNELNNQINSYLGIEEINIIEGLKQSEFVR
NFDIGAVPRILNNLFSILGATLIAIFSILFISFFLLKDSKLMLNSILVFANQGDEKKFQR
VFNKIKILLSRYFVGLTLQITVLFVLYAILLSVFEINNPIAIAFICAFLNLVPYLGPLFA
GILMALFVISSNLGADFQLVILPKLGYIMLGYGVCQLIDNMISQPMIFGASVKSHPLEIF
LIILIAGIMFGITGMVVAVPFYTALKVIAKESLSEYKIVKRLTRDL
>IFAGANLK_02838 tRNA (guanosine(18)-2'-O)-methyltransferase
MEQLSHFEEKFSKEKFPVILLLDNITGEANVGSIFRLADAFNVEKIVFAGTEPNLNSRRL
QKTARNTHTTVVYEFTEDTPGYIKSLNHNSEVYALEITSVSIPVEDFQYSEEKKGVILIL
GNEVSGISKELLEISDKHLHINMFGQNSSMNVAQAAGIALYEISKTIFAFTKK
>IFAGANLK_02839 hypothetical protein
MLNLKKISLLIVFLVFGQILTAQEIALLKYNGGGDWYANPTSLPNLIKFANNNIGTNLKA
KPATVTPENSDIFQYPFVHMTGHGNVVFNDKEAENLRNYLLSGGFLHIDDNYGMQQYLEK
ELKKIFPEKTLEELPANHPVFNSAFNFPRGLPKIHEHDNKPPQALGFFDENRLVLLFTIE
SDLGDGWESPDVHNDPEEVRLKALQMGANILKYVFEN
>IFAGANLK_02840 Ribosomal RNA small subunit methyltransferase E
MQLFYTPDIEKTDKQIVFPKDESRHIAKVLRKSAGDILKVTNGKGFLFTAEIITADSKQC
LAEIIEVEAEKPKKHQLHLVVAPTKMNDRFEWFLEKATEIGIDEITPIICDHSERKTIKF
NRYERVLQSAMKQSLHFSLPIINEVISFSEFITTETEGQKFIAHCEDGMERFSLKNQAKP
KENITILIGPEGDFSPEEIKSAIKNDWKPVSLGDSRLRTETAAIVACHTVALINQN
>IFAGANLK_02841 tRNA N6-adenosine threonylcarbamoyltransferase
MASQNIYILGIESSCDDTAAAVLHNGKILSNIVATQEVHKQYGGVVPELASRAHQQNIVP
VIHQAIARANIGKKDISAIAFTRGPGLMGSLLVGTSFAKSLSLGLGIPLIEVNHMQAHIL
AHFIEEEHFKKPTFPFLALTISGGHTQIVKVSNYFEMEVIGETTDDAVGEAFDKSAKILG
LPYPGGPLIDKYSKEGNPKAFPFPNPKVPDLNFSFSGFKTSVLYFIQKQTKENPDFVAEN
LKDICASIQFSIVRILMDKLKKAVKQTGINQIAIAGGVSANSEIRNALMEAEKKYSWNCF
IPKFEYTTDNAAMIAIAGHYKYLEKDFSDYSITAQPRYKF
>IFAGANLK_02842 hypothetical protein
MVALVLLFVIILIVFSIPAVQTGIANRITTSINENNKVNISVDRVSLTYFGRVKINGIYI
EDHHNDTLIFTKELRTSLLGVSNLFSNNPHLGKTYLDGLELNMRKYKGEDRDNLAYFIQQ
LSTEPTGDSTQFELLVDRVEVNNGYYSFVNEESENPEFVVLDDLNIYATDLKIKGSEVNV
NIEGLKGYEKRGLRIDNLSTDFFYNPQRMIFDDLTIQTPQSLVKADLEFNYETEYFSDFV
NKVEVTGTFTESIISSTDLQTFYSNFGDDQIMQLTTDITGTLNDFVLPNLQLTGMDRSSI
QGEVNVEGAFSRGGEDFKLTGDFENFTTNYYDLVNLLPGDLEGKLPENLRDFGNLRMRGD
AIVTGSNLDADVIINTQLGSAEADLVLRGFDNPREVTYEGKLIFENVNIGKLANNENLGK
TSFNLDIDGSGFDAESLNAELKGQISKLQFNGYTYQSIRVIGNLRNPVFNGLLMASDPNL
KMEFNGLADLSEDINNYDFEASVGYADLNALNFVSRDTLSIFKGDVIMNMKGTDIDDAFG
EILLLNTSYQNQNDLYFFDDFSITSSFEGRERTLSINSPDVISGEIIGDFNLSEIRPLIE
NSLGSIYTNYQPRTITNNQYLEFDFDIYNKIIEVFYPEINLAPNTFIRGHLASDESEFKV
NFRSPRIDIFGNMMETVNLNVDNTNPIYNTYFEADSVATDFYNFSEFSFINVTQRDTLFI
RSEFQGGNNNEDFFNLNLFHTINEENKSVIGVQRSDLTFKNNTWFVNEESNKSNKIVFDL
DFKDFAIDSLVMSHKNEEIRLSGVMRDSTYKDFKMEFDNVDIGKITPHVDSLDLAGTLNG
KFDLLQENGAYYPNTNLRVDSLNINDNLLGNLVLAVEGNENLTKYDINANLRKNGNESLN
AIGSINVSGSEPTIEMDVDLDELNLAAFSPLGGEVLSNIRGGASGNAQVSGNYKNPDFSG
EISLENAGLRVPYLNIDLDFKDEAVVNLTQQEFVFDDVEIEDTKYKTTGTLNGSIGHTNF
KEWDLNLNIDTDRLLVLDTEGDEDALYYGTAFISGDASIAGPTDQLVIDVTATTERGTVF
KIPLNDTESVGDNSYIHFLSPEEKAAREAGESIELPEVTGLELIFDLDVTNDAEVEVVVD
QTSGSTLRGRGSGNLLLEINTNGKFNMWGDFVVYEGVYNFKYAGLVQKVFNVESGGSINW
NGDPTDAQLDVSAIYALNANPAVLLENPSINRKIPVEVVINLQGEIEQPDITFDIAFPNA
SSVVRSELEYRMDDRSSKELQALFLVTQGAFYSEFGLRQNAITGTLAERASSIVNDIFAG
DDGKFQVGVNYVQGDRTPDQQTVDRFGLTLSTQINDRVIINGQVGVPIGGVTESIIVGDL
EIDFLLNEDGSLRAKVFNRENNIQFIGEEIGFTQGVGLSYSVDFDTFKELIRKIANTEIQ
SLNSETENEETSSRPQSPDYIRFPDEN
>IFAGANLK_02843 ATP-dependent 6-phosphofructokinase 1
MTSGGDSPGMNAAIRAVARASSYYRVECLGFMRGFQGMIENDYIELNARSVRNIINLGGT
ILKSARSKEFLTEEGRAKAAANLKKANIDAMILIGGDGTFRGGKVFSEEHNIPVIGVPGT
IDNDIFGTHYTIGYDTALNTVIDAVDKIRDTASSHNRLFFVEVMGRDAGFIALNSGIGAG
AEEILIPEEDLGLDRLLNSLERSRRSGKTSSIVIVSEGDKIGKNVFELAAYVKDNLPYYD
AKVTVLGHIQRGGSPTCFDRVLASRLCVKAVELALDGQQDIMVGMMNNEIKAIELVNALK
SKPTINKELLRISDILSV
>IFAGANLK_02844 Methylglyoxal synthase
MKTVAIIAHNGKKAEMVQFLNNHKEALQAKNITLIATGTTGAKTESAGFEVEKLLSGPLG
GDAQIASRIAEGKVDMVIFFRDPLDKHPHEPDIFMLMRLCDVHDIPLATNPASARLLMQA
F
>IFAGANLK_02845 hypothetical protein
MISTSSLRSQSNNTEAAIFNIGIGSIFSGVGAVINKEPQEKLGKVLFKGMAQGALGGYLV
YESKVIAGRISKQENLTYGWPAKFMNSAGTSIIENAASNRNFWEQWNLNIGFNRIEFHTK
DRFQLKYRIQPVSFLLTAYTAVQNKFEPELSLRVGEFVFSGNNTFGYEDNNDYYLGRAIS
TAILLNPEAGGFNYTTMAHELIHVFQYYDFNVLNTYLNKPLEEFKDGSGFFRKMDKIFYY
DFNIFAFAGLYKMEHFGKDQKSFEGYYSNYFEREAYLFSTY
>IFAGANLK_02846 2-iminobutanoate/2-iminopropanoate deaminase
MKKIIKTDKAPAPIGPYNQAVLTGNMLYISGQIALNPETNKLETGELQAETTRVMQNLKA
ILAEAGMDFENVIKTSIFISDMNNFAKINEVYASYFNAETAPARETVEVANLPKFVNVEI
SAIAVKD
>IFAGANLK_02847 LPS-assembly protein LptD
MQTNIPNILFRCIFILLPIVCLNAQEIGNNQEIDIEAQERDSLVTVGDSLPLAETIKLTD
SIVGDSLQTPQQGNQLISDAVKYQATDYMRISQKENRMYLYNEAQIIYGDMQINAGLIIM
DNEKNEVYAYGIPDSTGAYSQKPVFVQGNQTVEPDSIRFNFDTERALVYNSRTQQANFNV
RGEVTKRENDSVYFMQNVRFTTDEDLDNPDYYFYARKIKFVPDKKIVAGFVNMYLADVPT
PLGLPFGYFPLTEEETSGFIIPSFGDSRRGYFLQNGGYYFAISDYVDLLTLGDYYTNGSY
AVRLESNYAKRYNYRGNVRIRYENLFQSERGFPDFAEQSVYNIQWSHNQDAKANPNSRFS
ASVNLGSSTYYQNSVNQMNTGNFLTNTLSSSVSYSKTFPGEPQVNLSLAARHQQNTRTQT
INMSLPTLQASMTRIYPFAPKTGAKKGLIENINFQYNIRAENQIRTTDSLFFKPEMFQDA
NYGAQHSIPVTTNFKLFNYLSVSANANYEENWVFRTFEQSYDEFNNEVVIDTINGFDSYR
TYNFGASVGTTLYGLKSFGKDKKIQAIRHVMRPSISYNVNPAFDQYYDTYERIDPANPIE
TNMVDYSRFDGSLYGAPGNRFSSSLGLSLSNTLEAKVRSKDSTATEPEKITLLNNFSMST
AYNLAGEDGQPKLSPIALRGSIPIVRDKLDINVAGNMDIYALDNNNRRTDKLNINNGGSL
FRFTNANVSFGYAFSSKDFEDEGEDESEDEIDNDTYRGGGRRDDLFGKGSDLEGKFYDEE
EDPFDDEERGERNDNWYNYKIPWDLRLSYTMTYNNTARQNEITSHSIMFSGDVELSPKWV
VGASSGYDLKELGFTYTQLRFQRDLNTWRLSFNWVPFSERRSWYFFIGIKSSILSDIKYD
KRNEPDRRL
>IFAGANLK_02848 N-acetylmuramoyl-L-alanine amidase AmiC
MRTNLLKLFVFFFIFLASLQGLFANNDKPRDRFVVVLDAGHGGKDPGNMGNGFKEKDIAL
SIILKIGKALEKQDGIEVIYTRDSDVFIPLDKRAHIANEADADLFVSVHCNSHNSQAYGT
ETFVLGLHKTAENFEVAKKENSVIFLEEDYEVTYGGFNPNSPESYIGMALMQEEYLNQSI
LLADFVQKNFTNELKRKNRGVKQAGFLVLKNAVMPSVLIETGFLTNNHEGPYLNSTGGQN
KMAAAIVEAIDKYANTINLSNLESVGSNSSSNMPVQSQIYEGITFKIQLAAGSKRLETKA
YNFKGLQNVERAREDGMYKYYYGATSDYIKINELHNEAKRNGYPSSYIVAFKDGSKITVN
EALKSKVN
>IFAGANLK_02849 hypothetical protein
MKFTREVKTALLAIIAILLLIFGYSFLKGKNLLDSSRTFHAVYNDVEGLSPSSAVTINGL
KVGQVTEINFLDAQGTLVVSFTVENDFDFSKNSTAQIYGGSIIGGKSLAIIPDYEIDEMA
KSGDTLQSDTEEGIMELVNDKLTPLQDKVENTIVSADSLVTAINKILNDSTRHNIQNTFK
DLNATVASFKVTANTLEGIVGRNSGKIDNTFTNLDEMTTNFNSFSDTLTKMDIGKITADL
EKVVADFESVSDKLNNKEGTAGKLINDDAVYNNLDNATKQLEQLLQDVKLNPKRYVHFSV
FGKNPKPYKEPKEKDSIK
>IFAGANLK_02850 Lactate utilization protein B
MQIISQVLFLIALVVGIGFFIRNIRRLLRNIKLGKEVDRSDNKGERFAKMARIAFGQSKM
VKKPVSGFLHVIVYVGFIIINIEVLEIIIDGLFGTHRVLSFMGGFYNVLIASFEVLALLV
LIGVIVFWIRRNILNIYRFLSRELKGWPKNDANYILYFEMVLMVLFLVMNATDYQLQLNG
APHYASEAGITGSFPVSQFLLPIFEGMSNATLIIIERAAWWLHILGILFFLNYLYYSKHL
HILLAFPNVYLSKLQPQGEMNNLQAVTDEVKLMMDPDADPFAAPAEEEEGAEPDKFGASD
VFDLNQVQLLNSYTCTECGRCTAECPANQTGKKLSPRKIMMDTRDRLEEVGEIINTKGKY
EDNGKQLLDDFILREELWACTTCNACVEACPVGIDPLSIILDMRRYLVMEESAAPNELAI
AMTNIENNGAPWPYNQQDRLNWAKEN
>IFAGANLK_02851 Lactate utilization protein A
MAEALKVPTMAEYMAEGKKPEVLFWVGCAGSFDDRAKKITKAFVKLLHEAGVDFAVLGTE
ESCTGDPAKRAGNEFLFQMQAATNIEVLNGYEIEKVVTACPHCFNTIKNEYPALGGNYEV
MHHTQFLKALLNEGKLKVEGGKFKGKRITFHDPCYLGRANGEYEAPRDLLRKLEVELVEM
RKCKSNGLCCGAGGGQMFKEPEPGNKDVNIERTEQAMEVKPEVIAAGCPFCNTMMTDGVK
GKNKEDSVEVMDVAELIANAHDL
>IFAGANLK_02852 hypothetical protein
MLVPFESLPDSSRVWIYQANRSFTTEELEEIKSRLDQFVTQWTAHGADLQAGYLIKYKRF
IVLALDQEMNAATGCSIDASVHFIQQLEKEFNVDLLDKMNVSYKQGEFIAYKTLSDFRKM
AKEKAVSSKTIVFNNLVNNKAEFLSDWEVPASESWHKRFVS
>IFAGANLK_02853 Beta-hexosaminidase
MKFTFAPKIFVLTFFLLVCSTLSAQNNPLLAEDTVAQKEWVDSTYNAMSLKEKIGQLLMI
SVASESSNTYIEKAKKQISEEYIGGVIFSKGGPLRQAKLTNEFQELSRTPLLIGMDAEWG
LAMRLDSTFTLPWNMTLGAIQDNNLIEEAGAAISRHTKRLGVHINFAPVVDINTNPNNPI
IGNRSFGENKINVAEKSLAFMQGMHRVGTLSSAKHFPGHGDTDTDSHKTLPTIPFSKERL
DSLELYPYYPLITHGLSSVMVAHLNVPAIQENSRTPSSLSKVIITDLLKEKMNFEGLIFT
DALNMKGLTNNAEAGDAELRAFLAGNDVLLMPEKVEVASEVLINAYKNNIITPGRLAHSV
KKILQAKYKAGLNEQESVQENFIFEELNSVRDKVLLEELFENALTLIKNNKAVLPVKDIA
DSRIAYVNFGDADGSMFLNELKRYTHIDWVSATRLSDLQKKLEEYDLVILGYHKPNSSPW
ASYKFSSGELHWINQIATENKTVLSLFSSPYALRELLGINELEGILVNYQNHPVAQEKAA
QLIFGAVEARGKLPVSIGNNFPEGTGYQTQNIDRLAYGLPESVGLNSYKLNRIDSIITEA
IDKEMTPGAQILIARKGKIVYNKNFGYHTYDKKIPVSDTSVYDLASLTKILATLPLIMEQ
EEEGIVSFDSRLGEMMPVFQNSNKANIRLQDMLMHYARLKSWIPFHINTIDRKTRLPSED
YFHKRPSAEFNTKVANEMYLRNDMKDTIINIIKDSDLERSLDYKYSDLPFYILKYYLEGY
YGQTLHNLTQEKIYKPLGATHTGYLPTSRFPLEQIVPTEIDKLWRRQLIHGVVHDQGAAL
QGGIGGHAGLFSTANDVAKIMHVYLNNGMYGGKQYLKEETISKFNTCYYCEKNVRRGVGF
DKPQLGSSGPTCNCLSMESFGHSGFTGTFAWADPEEEIVYVFLSNRTFPDSTNRKLIRED
VRSRIQEVIYESIDF
>IFAGANLK_02854 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKIAIVCYPTFGGSGVVATELGLALAKRGHEIHFVTYSQPVRLDQLSSNVRFHEVHVPEY
PLFHYQPYELALSSKLVNVVKQFDIELLHVHYAIPHAYAGYMAKKMLAEEGINLPMVTTL
HGTDITLVGNHPFYKPAVTFSINNSDIVTSVSKSLKEDTLKFFKIRNEIEVIPNFIDCSK
YDNKAFTDCQREMMADNKEKIITHISNFRKVKRIDDVIKIFYEIQKEIDAKLMMVGEGPE
KEMAEDLVDELNIADKVMFLGQSHEIDKILCFSDLFLLPSEKESFGLSALEAMVNGVAII
STNTGGLPEVNQNGISGYLSDVGDVQAMAANALKILENDETLEKFKNNARSVAEKFDIKN
VMPLYEDIYQRALHTTL
>IFAGANLK_02855 hypothetical protein
MKKLVLLAVFVIGATFYNQAEAQTISDNAIGVRFGGGDGVGAEISYQRALGTNNNRLELD
LGWRDNSDYDAFKLTGLYQWVWNIEGGFNWYAGAGAGILGVDGQRGDGFDDDGTYLFLAG
DIGIEYNFDIPLLISLDFRPEFGFFSDNDVLNEFSPDIALGVRYQF
>IFAGANLK_02856 Anaerobic glycerol-3-phosphate dehydrogenase subunit C
MKEKLNQLSQQIDGQLYDDKLWRSIFATDASVYREMPLAVCYPKSEKDLKKLIKFAKTNK
TSLIPRTAGTSLAGQCVGDGIVVDVSKHFTKIIKIDQEAKTVTLQPGVIRDDLNRVLNES
GLFFGPNTSTSNRCMIGGMVGNNSSGTTSIKYGTTREKLVSLKTILSDGSEAEFKDITAE
EFQEKLKLQNLEGEIYRNINKHLSSEENKEELIEKYPPKSLHRRNTGYAIDELLYAEVFS
EDSTEPLNLCKLLCGSEGTLAFTTEITLKLDDLQPPEAAMIAAHFDSIESCMQAVVPVMK
HSLYTCEMMDKTILDCTKQNLKYKENRFFIEGDPKAILMLEIRANTAEEVQEQSQRVLET
LKASNLSYAFPVLMGDQIELAMELRKAGLGLLGNIIGDKKAVACIEDTAVAIPYLANYIA
EFAEIMKNYGQDAVYYAHAGAGEIHLRPILNLKKSEDVKLFRSITTDVAKLVKQYNGSLS
GEHGDGRVRAEFIEMMIGPKNYQILRDIKYTFDPDNIFNPGKITDTAPMDTSLRYKADRK
EPEISTLMDFSESEGILKLAEKCNGSGDCRKSAEAGGTMCPSYRATKDEKDTTRARANTL
REFLTNSDKSNRFDHEEIKEAFDLCISCKGCKSECPSSVDVAALKAEFQYQYQKEHGKSL
RSKAFANNGKMNSLASKTPGIANFFFKNSLTSSIAKKMMGVAPERSLPILAKRTLANYYK
KNKKRFQLENPIKTVYFFNDEFTNFLDSEIGIDALELLHYLNYRIEFVKHEESGRSHISK
GFLEEAKVFANKNINTFKDLISDETPLIGLEPSAILTFRDEYLRLANDKTDAENLAKNSF
IIEEFLKKEIALGNISPEQFTSEEKNIKIHGHCHQKALSNTAVTFDVLNLPKNFKVSIIP
SGCCGMAGSFGYEKEHYEVSMNIGEQTLFPAVRKATEETLISANGTSCRHQILDGTKRNA
LHPVSILREALV
>IFAGANLK_02857 HTH-type transcriptional regulator CdhR
MKKHISILIPRGHTSLVNIVGAHQIFNQVNGFLEQRGKKPLFEVELVGVSNPTEQTNGLF
SVKPEKMIDEIAKTDLIIIPAIHDEPEVALERNKDFIPWLKKHYEKGTEIASLCVAAFFL
AETGLLDGKQCSTHWIHAENFKSRYPEAHLVADKILTEDSGIYTSGGAYSYLNLLLYLVE
KYAGREMAILTSKAFMIDMDKAEQSAFRIFEGQKSHEDSTVKKVQEYIEAHFPQKINVDD
LARKFALSRRSLERRFKKATDNTISQYTQRVKVEAAKRSLETSRENVGEVMFEVGYSDEK
AFRNTFKKITGISPVQYRNKYNRARAST
>IFAGANLK_02858 hypothetical protein
METTNVKKEVQVINAEELLTHLKGHRKLTRRTIEIFPEEQLFTYSIGGMRSFAELIQELL
GIAAPGIKEIATGNPAELQENFDHQNKKANLLEAWDKATVEIEKYWLQIEQERFQETIKS
FGQYEGKVWENIFYFIDNEIHHRAQAFVYLRALGIDPPFFWDR
>IFAGANLK_02859 hypothetical protein
MDVLVFKTSVKNELQASQLQPKLDKLIQQGECWNFDLEDCDRILRFEANQIRAEKILKTL
HQSGFECEELL
>IFAGANLK_02860 hypothetical protein
MENKKYIAFLRGINVGGHKKVPMADLKKMMTSFGLENVKTLLNSGNVVFSAPATTEKKLE
EKMSVALEKTFGFPVPVLIRTSTDFQELLKSNPFKKIEVHKDLRLYITFLKNRIENSPIK
TPWSSEDKSFQILNFTGVEIISVLNVSEKRTIEAMKLLENTFGKDLTTRNWNTVLKIGKL
L
>IFAGANLK_02861 Bifunctional ligase/repressor BirA
MSFDTLKRFDRIVAILIQLQSKRIVKAQELADRFEVSLRTIYRDIRTLEASGVPIYSEAG
VGYSIVDGYRLPPVMFTSKEAQSFVAAEKLMQKFTDKTLGSHYESAMFKLKSVLRGSEKD
MVSAIESKVFINPSEELFNENVPDALEILFESIAEKHQVFLLYHSQDSEIPTERKIEPVG
IFHENRHWYVTGFCHLRKDYRLFRTDRIQKITRTETLFQQEHPPLDHFLKNHTSTHNTKI
RILVAKEVVKYIKSERNYYGFISEKICGNQVEMTFMSRDLEDGFPRWYLMFGDYAKILEP
EGLKIRVKEILKNTEKGIE
>IFAGANLK_02862 hypothetical protein
MFKYSSVFSGFSVNDLDKAEEFYREILEFSVKNNPMGHIELEIPDHNNIIIYPKPDHQPA
VFTVLNIPVENIDKTVDQLVKKGVQFEQYEGEIATDEKGICRSDAKGPIIAWFKDPAGNI
LSILEE
>IFAGANLK_02863 hypothetical protein
MTEKENFIKELNEAFAEGDVPFILDCMADDIVWEMIGGNTSRGKAEIEKEMAAMKDVEML
EMKLDKVITHGKSAASNGTFRLKKNGKEKAYGFCDLYEFNGFKKAKVRKMTSYVIPMK
>IFAGANLK_02864 hypothetical protein
MKTQKITPHLWFDNKKNSAEEVVDFYKSAFRNVEIKNISRYGKAGQEIHKQKPGSVMTVE
FSIENYEFVGLNGGDYFQLNPSVSFFVLCHTKKEIEDLWAKLKENGEVLMPLDNYEWSPK
YGWVQDKFGVNWQLMLEESQSTKEKIVPLFFFTGRSHGQAEDAIKFYNSVFKNSQIEGIL
KYTQGDKNEYALGMVKHAQFQLEEQTFMAMDSGIKNDFPFSEAISFIIDCQTQEEIDYYW
LKLSTVPEAEQCGWLKDKFGMSWQVVPSTLLNKMLQDPDNEKRERAIASFMQMKKFDIQQ
LKKDFEGK
>IFAGANLK_02865 hypothetical protein
MNTKQIWSNLSVKDLERTTSFYTSLGFKSNNSRPSTELTSFIVGVNSFVIHFFIESKLKT
ALKGELANLKKGNEVLFTLAASSPEEVNQWKIEVENAGGTIVSKPQEFGDGYYGFVFSDP
DGHKFNVFYMEGF
>IFAGANLK_02866 hypothetical protein
MERKEFISTINASREKVWEVLWSDDTYPKWTAPFSEGSRAESD
>IFAGANLK_02867 hypothetical protein
MVALIDKRKDPEIMNFKHIGMVDKYGNEDYESEKVKSWAGVMENYRLEDKNGKTNLTVNM
DLEDEYKDYFLKTWPNALEKLKEIAENDSQMQNPITISAKVNAPIEKVWEVWNAPEHIEN
WNTASEDWHTTSAKNDLKKGGKLSYRMESKDGSRGFDFEGVYDEVKPNKSFSYKLTDGRK
VSANFKEKDNTTLIEENFEAEQQNSRELQQQGWQAILNNFKKYVENLK
>IFAGANLK_02868 hypothetical protein
MATLNPYLNFNGNTEEAFNFYKSVFKSDFSHIMRFTDMPPEEEGADKIPKEYENQILHVS
LPIGDSVLMGSDCIEAFGQKAVFGSSNYISVTPTSEEETRRLFIELSADGEVEMPLEEMF
WGDLFASFSDKFGIKWMLNYPIEK
>IFAGANLK_02869 hypothetical protein
MKNLILGIALFLIASLPLTAQQNTNNKEFLFNYFEETTEQLEDEISGLSEEQMHFKPSEE
EWSISQCIEHIILTEIMLYEMAKTELDKPENPERKGDVKFKDEDLIEGIKDRSKKAQASD
ELTGEGQYNSPEIAIADFKEQRQLILDFIETTPVETFRNHISDSPFGAVDTYQSILFIAG
HTARHTLQIEEIKASEGFPDRP
>IFAGANLK_02870 hypothetical protein
MVRVFKTNITDTNLADEFIDSIHLNFSNYIANFDLEDCDNILRIESFNNEICRDSIINLL
AEKGFYAEELPD
>IFAGANLK_02871 UDP-2,3-diacylglucosamine hydrolase
MIYVLCKEKKIKHLSSKRKPEIVVISDVHLGTFGAHATELMEYLESIQPKKLVLNGDFID
IWQFRKSYFPKSHLEVIKKIIDLSAKGTEVIYITGNHDEFLRKFSDTQIGDLRITDKLVL
ELDGKKAWFFHGDVFDVGIHKAKWIAKLGGWGYDLLILINRLLNRILVKMGKNKYSLSKK
IKNSVKNAGKFIAGFEKTVSDLAIENGYKYVVCGHIHQPKIIRKTNKKGTCLYLNSGDWV
ENLSVLEYEDKKWNLTYYHQLQKQSEKSLLAAITVIK
>IFAGANLK_02872 Chorismate synthase
MAGNSFGKLFKLTTFGESHGQAIGGIIDGCPAGIQLNLEEIQNELNRRKPGQSAIVTQRK
EPDTVEFYSGIFEGETTGTPIGFVIKNANQKSKDYSHIKDTYRPSHADYTYDEKYGVRDY
RGGGRSSARETACRVVAGAVAKQFLKDIQFNAYTASVGKIELDKNIKELDFSLIETNAVR
CPDPASAEKMEDYIKQIRKEGDTVGGTVQCVIRNMPKGLGEPVFDKLHAELGKAMLSINA
VKGFEYGSGFEGTKMKGSEHNDLFNEDGSTKTNLSGGIQGGISNGMDIYFNVAFKPVATI
MQKQETINKKGENVEMQGKGRHDPCVVPRAVPIVEAMAALVIADYFLQNKSSKI
>IFAGANLK_02873 Proton/glutamate-aspartate symporter
MKKLALHWQILLGMAAGVIFALILTNFSWGAEFIGDWIKPFGNIFINALKLIAVPLILAS
LVKGISDLKDISKLSKMGARTIGIYIFTTIVAVTIGLGMVNLIKPGNAITEETQQDLITS
YEGDASGIKANADKQRESGPLQALEDIVPENIFAAAGDNANMLQVIFFAIFFGIGLILIP
EKAAKPVKDFFDGFNEVILKMIDLIMLAAPYGVFALLAALVVESPSTDLFAALAMYGVTV
LIGLALMIGFYILLVWITTKNKPSFFVNGIAPAQLLAFSTSSSAATLPVTMERVEEHMGV
SREVSSFVLPIGATINMDGTSLYQAVAAVFIAQAFGMDLSVGAQLGIIATATLASIGSAA
VPGAGMVMLVIVLAQAGIPEAGLALIFAVDRPLDMCRTMVNVTGDAAVSLMVAKSVDKMG
PPNVKEWDDHYDPDSDNTESELEKREKA
>IFAGANLK_02874 hypothetical protein
MELPKDNKIVLFDGVCNLCNNAVTFIIEHDKKDVFRFASLQSEIGKKLVEERGMDPNELD
SIVLIDPGVAYYRKSTAALEISRELSGGYSLLKHFNFIPEGLRDGIYNFVANNRYKWYGK
KESCMIPTPELKSKFLD
>IFAGANLK_02875 Endonuclease MutS2
MIKIASKSLIDLEFPVVCQQISDLCITGPGKEKALNLQPYKTGKKTIFGLHQTNEYVSSK
TRESRIPNHGFDSIKNELRTLEIEDSILEIGSFRKISSLSDTVNTHIKFFRKFEEYYPSL
FETTAEVEYTDEITDSIGAVINKFGELKDDATPHLQQIRRSINQVKGQINSSFAKALTTY
HSYGYLDEIRESVVENVRVLAVTAMHRRKVKGGILGNSKTGSIVYIQPEATYQYTRELNN
LEYEEKEEIKRILKELTNKIRPFKPLLIDYQDLLCEIDVIAAKAKYAEMTNGLLPKITKE
RELQLKDAYHPLLYLSNKKKGDKTYPQSIELAKDNRIIVISGPNAGGKSITLKTVGLLQL
MLQSGILVPVHEYSRMCLFEKILTDIGDNQSIENHLSTYSYRLKNMNYFLRKCDDKTLFL
IDEFGTGSDPELGGALAETFLEVFYEKESFGILTTHYANLKKLANEMPNMSNANMLFDSN
SLEPIYKLQVGEAGSSFTFEVAQKNGIPYSLINRSRKKVEKGKIRFDRSIAKLQQERSKL
QKTTDSLKTKEQKAALEKDKLEETNTRIQQKLESYQELYDSNQRLIYMGQKVNELSEKYF
QNKKKKELIGEFLKFVEIENSKRKKESAKERKIQKEKEKKVQQEVKKKVDVIRKKKKEEK
EKTTEKERQEANKPKIPPKIGDRVRLQDSRSVGTLDKIEKGKATVNYGMFTTQVDVDKLE
LVQAMKKK
>IFAGANLK_02876 Uracil-DNA glycosylase
MKVDIHPTWKKELAEEFEKDYFKNLAEFVKNEYTENTCYPKGKDIFSAFEHATFPNTKVV
ILGQDPYHGPGQANGLCFSVNDGIPAPPSLQNIFKEIKDDLGKPVPDSGNLERWADQGVL
LLNATLTVRAQQAGSHQKKGWERLTDRIIEIVSAEKENVVFLLWGGYAKKKGAKIDSSKH
LILTSGHPSPLSANRGYWFGNKHFSKANAYLKKKGKQPIDW
>IFAGANLK_02877 hypothetical protein
MKKLLLLSLVLISSVTFAQDSQNTQTTEPDKRDVTQNELSIGALNLVAFGAIDLTFERII
DQNSSWAIEGFIKALDRDNENIDDAFYKDFSLTGKYKYFFGDRYARGFYVHGFGMLSSGE
YDDNWVVDSEGYGYYEYEDYTDFALGFGIGGKFVSKGGFFLDLGAGIGRNLLSENSPTIV
GQFNVNLGFRF
>IFAGANLK_02878 hypothetical protein
MKTIKVGGVPEHFNLPWHLCIEEKLFEARGINVIWKDFPGGTGAMNKALRSGEIDVAVIL
TEGVLKDIISGNESKIIQTYIGSPLVWGIHVAAGSKYKSVEELKNTKAAISRKGSGSHLM
AYVNAQSHEWNTKELQFEIVKDLDGAVEALKDDKAQYFMWEHFTTKPLVDNHTFRRLADC
PTPWPCFVVAARNESLKNEPDRLKTMLEILNRETQGFKNLPKIAEKLAERYDQRLEDIEK
WMDITHWSQEQITEAEIEKVQDKLLELNLISKKQRSSEFIHNL
>IFAGANLK_02879 Polyphosphate kinase
MQEPQEIPLRHRDLNWLSFNARVLQEAEDKINPLYERIRFLAIFSSNLDEYFRVRVAQLR
QMKRVEKSIRKKLALKPTKTTKEILEEVKRQQHKFGEIYQKQILPELAKNDILLIDGEHF
NSVQKEFAFNYFQRNVKAHIQPEVIDLEEANELFLKNAELYFVVSFTNKEKLGIVNIPVD
ACGRFVNFEGDGEDNSITYLDEIVRSQVSSIFKDQKIEGVYEIKLSRDAELYIEDIYEGV
LAEKIYDSLAQRTDGQPTRLLYDAEMPDFLHKKIRKLLKLGKIDMMPGGKYHNFNDFFSF
PDPTNNPELHYEKLPSIEHKALSKSKDYFETISKKDQAVHFPYMSFAYVENFLEQAVNDK
NVTAIKISLYRVADESRLTSLLLKALENGKQVTVFVEAKARFDEENNIIWGRKFEEKGAN
VIYSYPKIKVHSKIMLVQRIEGEDLVNYSYIGTGNFNSETSEIYCDHAIFTSNKQIAKEL
SRLFKVLEGELIIPREKNLLISPFSTRQEFIKLIYNEIDFAREGKKARITAKMNSLEDPE
IIELLYKASNAGVEIRLLVRGFTCLIPGVKGLSENIYITSIVDRYLEHGRIYIFENGGDE
KMYYGSADWMTRNLSRRIEVLSPILDKDIAHEFKEILEIQLNDNVKARIQDADENNVYVK
RKESEKPVRSQYEIYNYLKKKHSK
>IFAGANLK_02880 Uridine phosphorylase
MPIEASEFIQNNDGSVYHLNLLPEHLAKTVILVGDPHRVERITRHFDKVEFKLKKREFYT
QTGYYKGKRISVISTGIGPDNIDIVLNELDALVNIDFETRELKDEISSLDIIRIGTSGSI
QKEVPVDSFLISERAIGFDGLLHFYESEHIQDTEFAEVFSQHLDWFKKKAAPYVVDGSEN
LISRMESSRVHKGVTATNIGFYGPQGRILRLALQDNKLNDKLASFSFNNKKITNLEMETS
AIYGLSKLLGHNAISMNAIIANRAAGTFSKDPRNTVDELIQYSLEQLVK
>IFAGANLK_02881 hypothetical protein
MENKALHIVNGDSLTEQVEELNLPGQIIVWRELLCEGPSLKEVGTLKFIRKREKFLKEAY
NISSEEYKERFVSQLKLLKKAKDYDHVILWFEFDLFCHINMLATISFYREHKPKVPFYLV
CSKRQKGEDEFLPLSRLPQKHLLNHFNKKIQLEEEDLEIATLVWELYCSNDPMKLKKQIK
KTSNFEYLSSCIRAHIERFPNSKTGINSLEKNVLKLVENQQISSINQLLGYALQYQGYYG
YSDSQMERVLKKLSIFYTLEDNRVVLTSKGKDALSQKKNFYQELKNEECLGGARIFDFLY
DAESHKVLKL
>IFAGANLK_02882 hypothetical protein
MAKKKLGLEDLGGFVFSTNDDFEGNEHKETEETLAPEDQQLEAHFSSKGRGGKTVTIIKG
FEGTNEDLVILGKKLKKKCGVGGSAKDGEIIIQGDDREKIMELLIKDGYNVKRVGG
>IFAGANLK_02883 hypothetical protein
MAMNNIPSVDLADFLSDDQSRKQKFVEEIGKAYEEIGFVALKNHFLDSELEENLYKEVKS
FFALPLDTKKKYEIEGLAGQRGYISFGKEHAKGKKEGDLKEFWHFGQEPAEDANLTEKYP
ENVQVSELKDFNKVGMEAYRMLEKTGIYVLRALALYIGLDEHYFDHWASNGNSILRPIHY
PPITEEPKGAVRAGAHGDINLITLLMGASTGGLQVLRKDGEWIDALPKEDELVINVGDML
ERHTNNKLRSTIHRVINPPKEEWGKPRYSIPFFMHPRSEMPLDCLEECIDKENPKQYEDI
TAGEFLHQRLVEIGLLKK
>IFAGANLK_02884 2-oxoisovalerate dehydrogenase subunit beta
MQPNSSQPPSIKFEKENLSSAQLLDLYAALLKPRLIEEKMLILLRQGKISKWFSGIGQEA
ISIGVSKSLNADEYILPMHRNLGVFTSRNVPLNRLFSQWQGKQNGFTKGRDRSFHFGTQE
YKIVGMISHLGPQLGVADGIALAHKLKDENKVTAVFTGEGGTSEGDFHEALNIASVWDLP
VLFCIENNGYGLSTPTNEQYRCKDLADRAQGYGMESHIIDGNNVIEVYSRVSKIAESIRQ
NPRPVLLEFKTFRMRGHEEASGTKYVPEDLMNFWQKKDPVENFRGFLIDENILSEEQDAH
FKNEIKAEIDENLREANEEDASRYDETNELNDLYQDFVYEEVMPNSETETIRFIDSIAQA
TKQSMQRHNSLVLMGQDIAEYGGVFKITDGLLEEFGKERVRNTPICESAIVGTAMGLSIN
GMKAMVEMQFGDFVSSGFNPIVNYLAKSNYRWNQNADVVIRMPCGAGVGAGPFHSQTNEA
WFTKVPGLKVVYPAFPYDAKGLLNTSFNDPNPVLFFEHKALYRSIRQEVPVDYYTLPFGK
ASVLKEGDKLTIITYGAAVHWALDTLEEAELENIELIDLRSLQPLDRETIINSVKKTGKV
LVLTEDSLFGSLASEISAIISEECFEYLDAPVMRLGSGETPIPFAAALEEGYLPKKKLKE
KLKELIDY
>IFAGANLK_02885 hypothetical protein
MIRLIVIFLIIALVAAIFGFGGIAEGFADIAKIIFYIFLVLLVISLVSRLFRR
>IFAGANLK_02886 hypothetical protein
MKKIFILGFIAVLLAACGPSKTAKEARKSFNGDWTLTSVTYPNSSGEFDVTLLNDANASC
FENSTWNFVSNNNRGAYNVQGPNCSTGQRYFIWSIDEENTPEGIFDFLLKPTDDDYNSTT
GDQGFRMNLKSLSETQMVWEQSVMLEGSPFVIRMNFSKL
>IFAGANLK_02887 putative lipoprotein YiaD
MKTTINRMFAILFAATMLFGCEATKNANNKQKGAVIGSAGGAVIGGVVGNNTGDGNTALG
AIIGGVVGGAAGAIIGDRMDEQAKEIEQEIPGAEVERVGEGINVTFDESSGVYFDTEKYN
INSKSQATLNKLADIFKEYPDSNVLVEGHTDDTGSESYNLTLSKNRAQAVTNYLTSQGLS
SGRFDTKWYGEAQPKYDNETAEGRAKNRRVELAIVASEELKEEAKRKAEEQN
>IFAGANLK_02888 hypothetical protein
MKFLDSYWVFILLLGTSITAQELEGKWIVSGNKSFGGFPGIHLMEVSEDSLLHYNFDEFI
TKTSYTTEENKLKIDTLAFADFSFKNPNRLIISSERLERPIDYIRLVPTKTDLNVEEIKQ
KKYNLERGGKSFEIDFKNHPDSKIMHSYLKKIDQTYFLVIHRYGNAITAVPIEEITEDKL
FLYGFSRGPNKLVATAIE
>IFAGANLK_02889 Dipeptidyl carboxypeptidase
MKKEIIKSLGILALVAGFQANAQEQKPEQNMDNILLAEWTGPYAGVPAFDKMKVELVKPA
MLTAMDKHLAEIDKITENSEPATFENTIVPFEDSGDLLNKVFTYYGIFSSNVSSPEFREI
QRELSPEISEYSSKISQNTQLFERIKTVYENSVENPLPAPEQRVIELIYEEFAMEGANLN
EEDKKRYAEINSELSELYTKFSNNVLAEEENYIVYLTEGQLSGLPESYVKSAASTAEANG
EAGKYAVTNTRSSMDPFLTYSDERELREKVWKNYYSRGDNDDEFDNNEVIKKILKLRDER
VELLGYDNFAQWRLQNRMAKNPENAMELMEAVWPAALARVEEEVKDMQAVADREGANITI
KPWDYRYYAEKVRKEKYDLDSEEVKQYLELGNLTDALFYTAGELFNFEFKPVEEGSVPVF
HEDVKVWEVTDEDSGELIGLWYLDPFARQGKRSGAWATTYRSYSELEGAKPVLSSNNSNF
IKPAPGEPVLVSWDDATTFFHEFGHALHFLAADIKYPTLNSGVRDYTEFQSQLLERWLST
DEVINRYLKHHETGEVIPNELVAKIKKASTFNQGFATTEFLASALMDMKYHTTDPDKIEP
REFEKETLDELGMPEEIVMRHRSPHFGHVFSGEGYATGYYGYLWADVLTSDAAEAFAESP
GGFYDENMAEKLVKYLFAPRNAMDPAEAYRKFRGRDAEIDALMRDRGFPVPEGE
>IFAGANLK_02890 Azurin
MKFLSKTVLILGAVAMIACGDKKEEKEDKITIGDGTSPQSQTEAATDKSASEMNSSDEDV
VEVTIEGNDQMRFNKDEIKVKAGQTVRLTLKHVGEMEKSVMGHNWVLLTKGTVINEFGQK
AVQAKDNDYIPQGTDAVITHTKMIGGGEEVTIEFEAPEAGEYDYICSFPGHYSVMKGKFI
VE
>IFAGANLK_02891 D-3-phosphoglycerate dehydrogenase
MSENKHFVIDFDSTFTQVEALDVLGEISLANDPDKQKNLDEVEALTDQGMKGEISFRESL
VERIRLLKANKSDLPKLVENLSERVSSSFVRNREFFNDYHENIYIVSNGFKEFIVPIVEP
YGVKPENVFANTFEFDEEGEIVGFDKENVLSSNNGKVEQLKRLKLKGDVYVIGDGYTDYE
IKAAGLANKFYAFTENVERANILEKADHITPSLDEFLFVHNMNKAISYPKNRINVLLLEN
VHQDAVDIMKKEGYNVTVHPGAMDEDELCEKIKDVSVIGIRSKTHLTEKVLENANRLIAV
GAFCIGTNQIDLQACLKKGVAVFNAPYSNTRSVVELAIGEIILLMRNLPDKMRLMHEGKW
EKSATNSFETRGKKLGIIGYGNIGAQLSVVAESVGFDVYYYDVEEKLPMGNVTKCNSLKE
LLETVDIVTLHVDGRKENKNIISEKEFGYMKDNVIFLNLSRGHVVDIQALKKNIESGKIM
GAGIDVYPQEPKTNNEEFVSELRNLPNVILTPHIGGSTLEAQENIGNFVPGKIIEYINTG
STTNSVNFPNLQLPVLQNAHRLIHIHENRPGILAEINRILAGHDINIEGQYLKTNETIGY
VITDIDKKYDKKVIKDLKGLKGTIRFRVLY
>IFAGANLK_02892 hypothetical protein
MLQRFILFIGIILFTFSCGEDDSGECNGICTEEFKSINVEITDSEENPVVLDSTSLTDIT
NNREVDLNSTGDIENGFYTIFNDNLLPEYKNEEIDLLFKGFQEENLIVEQEYRIGADCCH
VYPISGPLVIQLE
>IFAGANLK_02893 putative amino-acid racemase
MNLLGMIGGTSWHSTIEYYRLLNELVGEKIGKQQNPPLLLYSLNVKLMRENDPRKIKKSY
LEIAQKLENAGVGAIIICANTPHLVYDFVQPKIDIPILHIADAIAKEAKQKGFKKLALLG
TKPTMTGDFIQGRLKDQHQIETIIPAQEYIDETHRFISEELTQGNFTDTAKNFYLEQMQL
LKDRGADAIILGCTELPMLIKEKDTEIPLLDTTKLHAQLATEFILKD
>IFAGANLK_02894 hypothetical protein
MKATMLLEELNVGNCITYITRELSKIKDICDIYADSEASKITFTYNSEFAALEAVGILSS
FRNKENDEEFNETLKIA
>IFAGANLK_02895 putative FMN/FAD exporter YeeO
MRKKRQPIKYTEGRIFSSLANLAWPIILANILQTAYQLIDTFWLGRLGADAVAAVSISFP
ILFLILSLGAGLTLAGTVIVSQYKGAENQDQVNYSSSQTVFVIFFISVLLAIVGYFSSEP
LMRLIGAGPEILSDSVSYFKVSSLGFIFLFMFYVFQSLMRGIGNVLLPMYIVLATVFLNL
ILDPLFIFGFGPIPGFGVAGAAVASVITQGLSALIGLLILFRGNKGIKISFSRMKFDFGW
TRSMFNIGIPSSIEMSTRAGGMTVMVMLVTSFGSEVVAAYGIGSRVLSLIVVPALGFAIA
TTTLVGQNVGAGKIKRAEKIGNLSAKIAFFGLTAVGLILFFLAEPITAFFVPNDPGVIRD
GSLFIKIMAPSFGVLGVQQVLNGVFNGAGFTKASLLISVFALWIVRFPTAFILSNNTDLS
FEGIWWAFPISNVIAAIVAFTYYKMGYWKLRTIRYRHRQL
>IFAGANLK_02896 Inner membrane protein YbjJ
MKIENQQRIALSTYFFLSGFCFSTWASRIPTIKMAFDFNEAELGNLLMVMPISSLIGLPV
SGWLVSRFESRYPLIVSYILLAASLSIIGIADSLFLLITGIFCFAFSMRIFNIAMNTQSL
TLQKNFKRKIIGSFHGLWSTGGLLGVAFSTILIKFDVPIYQHLPAVAIFTLVIAFSSFSF
LLKKDRSTQGNKLRIGKPDKPTMYLGFIVFLAAITEGGMFDWSGVYFKEVVNEDIFTLGY
LIFMVFMALSRFSSDRIVEKIGMEKNYIISACLVCLGVLLMVIFPYFWPALIGFCLVGIG
VAAIIPMTFLLAGSSKKYSPGMAISIITTYAIVGMLLGPPLVGYLAHLFNLKVSFILFFI
SALMLIPISQLFFKKQKENIEE
>IFAGANLK_02897 hypothetical protein
MKKILFFLTILAFGFQGIAQDKYLSEEIQVKMASMAAPEEDRDAVTVYGYDREGKPVLLK
EGTNNLVCIADNPNMNGISVSCYNKKLDDFMSRGRELSAEGKDMMETRAIRQQEVESGKL
KMPDAPSMTYILSGKEANLNRETGELKDAKLRYVIYMPYATTEETGLPDKPHTPGMPWLM
DPGTHRAHIMITPADKE
>IFAGANLK_02898 hypothetical protein
MQQKIIIIFLIFSSINLSAQITGKLTDTENKILPYVNIYTEDGKFGTTSNENGVYELKIN
QTGDYNLVFQYLGYQTQKKTISVEAFPYELNISLKPETTSLDEVNISSGENPANAIIRKA
IDFRKRNAEKLEAYTADYYSRGLWRIKNAPEKILGQEVGDLGGGLDSTRSGIVYLSETIS
EISYKRPDDFKEKIIASKVSGDDNGFSLNSAQESYFSFYENTIEINSEMVSPIAEYAFNY
YDYKLDGIFYDENGNLINKIKVSPKREKDRVFSGHIYIVEDLWQIFGVELQTNGQAIQVP
PIETLDFKQNYRFSEENGFYVQISQTVDFKFAMFGISGDGRFTAVYSDYNFEPEFNKDDF
GREIMSFAEAANKKDSVYWEKLRPVPLTDEEIGDYVKKDSIQTLRNSKPYLDSIDNVRNK
FNLTDPIFGYSWQNSHKDRYFNISSPLMGTHFNTVQGWNTSTTISYRQNDKEDENSGKFW
RLYSTINYGISDDRFRIKGGFQKQFNNSSRPVLSISGGIEATQINDRTPISERLNDITTI
FFERNYLKLYERSFAEIAYQQEIFNGFYLLGDVSYENRNPLINSTDQVIIDNDDIQYTSN
NPLQPDNFSSLPFREHDIFKLNLNTRFRFGQKYMSYPSGKFNINNEKYPTMYLGYEKGFG
ASIEEYNFDQFKASVTQTLKLANKGEFGYNLNGGTFLNAQDMAFVDYRHFIGNQTRVNNG
FSNLSRFNLLPYYSMSTNKTYAEAHAEHDFKGWVLGKIPFLNQLNYNLVVGAHALYTQDN
KPYSEYSVGIDNLGFGKYRLLRLDYVVSNQDGNREGAFVFGLKFLGVLD
>IFAGANLK_02899 hypothetical protein
MQPAKQILPLIVFSQFCCTSLWFAGNAVMPELYLNFNLNDEALGHLTSAVQFGFIFGTLI
FAFLNLADRFSPSKLFFISAVFGAVFNLGIILENNSLNTLLLLRFLTGFSLAGIYPVGMK
IAADYYDKGLGKSLGYLVGALVLGTAFPHFLKTFTGAENLPWRWVIIATSGFAFLGGLLI
LLFVPNGPFRKAKRKFKTDAIFSVFKNKNLRSAAFGYFGHMWELYTFWAFVPIILAAYKI
SFSDSNFYIPFWSFIIIGIGGLSCVLGGYISEIFGVIRTAATALLLSGLCCIIFPFVFLQ
PSASILIAFLCFWGVVVVADSPLFSTLVAGNAPPEIKGTALTIVNSIGFAITIGSIQLIT
YLNQIEPVYSMSLLAFGPVLGLWGLFQKKKV
>IFAGANLK_02900 SsrA-binding protein
MFLMKKTSNTINIKNRKARFEYEILDKYVAGIKLAGTEIKAIRQGKASIAESFCEFQNNE
LFVINMHVEEYSHATHFNHNPKSERKLLLQRRELRKLEKEVKNSGLTIIPLRVFINDRGL
AKMQIALAKGKKLYDKRETIKDRESKRKLDRIKKEYK
>IFAGANLK_02901 hypothetical protein
MKKQILLLAFLSFGLFTACDTDDDSPDETPQINEELVGIWYIDDMIVDGEKIPYNDHEDC
GKDYIEFNEDGTYRQIDIWGCEEDVDEEGTYTATDNTITLTISGNDVVVMDIVTLNSETL
LVEGMDDVDDDGEEEVVQQRFTRE
>IFAGANLK_02902 hypothetical protein
MGFQQPSIFIVLKMKKYFLGALIIAVTFACNSDKENAQQIIDKAIEKAGGDNYKNAEISF
DFRKGSYKSEREGGKFHLERVLADSTGTQYRDVVTNEGFTRYYKDTVVQLSDSMKNVYAN
SVNSVHYFVQLPFGLNDDAVNKELIGKDTIHDKEYYEVKVTFNVEGGGADHEDVYMYWID
TQNYNVDYLAYSFEVNDGGLRFRKAYNPRTIEGIRFVDYENYKTDDLDTPLTQLDDLYEA
RQLELLSKIENKNIEVKRLE
>IFAGANLK_02903 Succinate semialdehyde dehydrogenase [NAD(P)+] Sad
MKEKTLKTINPATGKELDTYNYFTDQEAKDAVEECHQAFLKWREKSPKQRAEVIQAIGEK
LTEHKAELVKLMTAEMGKLLKQGEQEIDLCAGICEWTAANGPENLKDEERELPDGGRGII
TYSPIGVIYGIQPWNFPAYQVIRYTIANLMAGNGVLLKHAESVTGSGLLLEKIFKEAGLP
KDLFKVLLIDHDQSDSIIEHDLVRGVTLTGSPGAGKIIGEKAGSELKKTVLELGSNDAYL
VLEDANIKKAVEWCVKGRIYNNGETCVAAKRFVVTEKVYDEFKEAFVEKMKNIKAGDPTS
DDSDLGPMAREDLREELHEQVEDSVKKGAAVLCGGNIPDGDGFYYPATVLANVKPGQPAY
DDELFGPVASLIKAKDDEDAMRIANDSRFGLGGGIFSEDVDKAVELASKHFDTGMVFINS
FGLAQPNMPFGGVKNSGYGREHGGFGLKEFVNAKAINILNG
>IFAGANLK_02904 Light-activated DNA-binding protein EL222
MNVDFNSIAHYWKHSYCKPIESKKYANTEQFKKMAKLMAPGKSYYYIANFQTLEIEMISD
SVTHFIGKNPGSIERKIEIQNLLALALPEEIEKIQRKEQVIRDFFMDYLPSEKVQDYKVL
YTYILKDYEDSRRVMLHQATPLSQDSEGQFVHVFSIHTDISHLTNQSVEEVSFLNINGDT
SYLNVCTKNGRFDPKTDRERNIKNNLSERELEITKMLAKGLNADEIAGKLFISSHTVRTH
RKNILKKTNSRNTTQLVSRCIAAGFIIPEI
>IFAGANLK_02905 hypothetical protein
MLLSSGIFLSSTTIFDQERNTVREGYENVRPFRIVVKSGIPNLLSGHIEYVLPLLNRKFA
VSADYSKINMDTGDFGFEAEGDNEILEQEFDCLELGLHYYFLKREKVCMPVSLIQIMV
>IFAGANLK_02906 hypothetical protein
MYAGITYSNYGLKGTVPNIAENQNEALGDGYVDFSNNSVNIKAGAKWGGFFYFRPEIGYA
FNPFPSSLPMLVEFEDGTSENQELDLSADSGFLDLIYEGMIFNIGIGFSF
>IFAGANLK_02907 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MKRYLLVLCLIILTSCNFGDKEPEEIMEDAKDPSEEITTYYFIRHAEKDTTDTKNEDPDL
TEAGRKRTQDWVKTFKDIDFDLVYSSDYKRTLNTAEPIADSKNKEVKFYNAEKLNDKDFQ
ENTKNKTVLVVGHSNLNPEWVNYILGRKKYQDLDEKVYGSLFIVTIHPDDSRTSQVLYLN
>IFAGANLK_02908 hypothetical protein
MKKLLLFLLATGLIGCATTKKIDDSNIKLRYLDDVVIPQNLEVEGTKVGGLSGIDFHHGN
YYLVCDQPSNPRIYKAEIPLINRSIDTVLITEVIKLDKNDEFYKKNTPDLEGIRFDAEKN
ELVISAEGSIQNGKDPSVFHISTEGNFISAYEIPEYFKALGEQKPRNNGVFEGLAESYDK
KAYWVAMELPLEKDGPKPKIYATNSPVRITKFNKNTQKAERQFAYKLDGISKLPINWFAV
NGVTEILEYADDKFLVLERAFSAGYGSNGNTVKIFDVDASNATNTLEMENLRKSDYQYAE
KKLVFDFKSVKNSLTEETIDNIEGMTFGPDLPNGKKSLILVSDDNFSSFSDQITQFILLE
LEIN
>IFAGANLK_02909 hypothetical protein
MNNDQLEGKWKQVRGQFKQKYGDVTDDDTTYSEGKFDEMLGRLQERTGKTKEELKREIDS
M
>IFAGANLK_02910 Chaperone protein ClpB 1
MNFNNFTIKSQEAIQQAQQLAQELGHQQIENEHIFKAISIVDENVAPFLLKKLNINVNLF
NEILDKTLQSFPKVSGGDIVLSREAGRSVNEASTIAKKMNDEYVSIEHLILAIFKSSSKV
AQILKDQGATEKSLKAAIEELRKGDRVTSQSAEETYNSLDKYANNLNRMAEEGKLDPVIG
RDEEIRRILQILSRRTKNNPMLVGEPGTGKTAIAEGLAHRIIAGDVPDNLKDKVIYNLDM
GALIAGAKYKGEFEERLKAVIKEVTSSDGNIVLFIDEIHTLVGAGGGQGAMDAANILKPA
LARGELRAIGATTLDEYQKYFEKDKALERRFQKVTVDEPDTESAISILRGIKEKYETHHK
VRIKDEAIIAAVELSQRYITNRFLPDKAIDLMDEAASKLRMEINSKPEELDVLDRRIMQL
EIEIEAIKREKDETKLKTLRAELANLKEERNELHARWQNEKGVVDNIQNLKSDIENFKIE
AERAEREGDYGKVAEIRYGKIKEAQEKLEELQTSVAKNQNEKSLIQEEVTNEDIAEVVAK
WTGIPVTKMLQSDREKLLKLEDELHKRVVGQEEAIIAVSDAVRRSRAGLQDQKRPIGSFL
FLGTTGVGKTELAKALAEYLFDDEAAMTRIDMSEYQERHSVSRLVGAPPGYVGYDEGGQL
TEAVRRKPYSVVLLDEIEKAHPDTFNILLQVLDEGRLTDNKGRLADFKNTIIIMTSNMGS
HIIQEKYENVKDLDTAMESAKTEVLALLKQNVRPEFINRIDDIIMFSPLTQKNIRQIVSL
QLKGVKKMLEKQHIVLEATEEAISYLAGRGFDPQFGARPVKRVVQREVLNKLSKEILAGN
IQTDHIILLDEFDDQLVFRNETNPVETE
>IFAGANLK_02911 hypothetical protein
MGLLDKLFKSDGDEAKEKSEFPWTDLTDKDQITIAKEESKEKTIAIFKHSTSCGISKMVL
RNFEREYEENEKTKLYFLDLRKHRDVSNAVADDLSVRHESPQLIIMQNEEVVHHASHQDI
NATKLKDLT
>IFAGANLK_02912 hypothetical protein
MAKKEDIKKMEENWESLKKEDKDREQEEFRDLKQKERDRDKSKSKNKDSKEDSAKTGKAS
AREEREFMDQSQKEKTAKKDKR
>IFAGANLK_02913 hypothetical protein
MSENGKRKKYRKKRYVLPILIVSLVIIARIALPYILENYVNKTLNNIPGYEGSVSDIDLS
LWRGAYQIEGLILREENSLGEKPLLDFPYSDISIDWASLFKGKIVSEIEMQDPNFNYIFE
NQEEEDEADVEDWTKALTNLVPIDINHFVVHNGTANFVEVSADPQISLFLEKISLEAHNL
SNVVNKEKELPSHLWANAVSMGGGDVEIHGNLNLLKQIPDIDMEFSLQKAEATSLNDITR
RYAGVDFESGTFELYSEVAIADGFLKGYIKPMLINTKLLSKDDDGGFFKKLWEGFVGFFK
FVLKNQGTDTLATRVPLEGDLKNVESGVWTTVLNIFKNAWIEAFKGSVDEDIEFEDAKQE
SAEE
>IFAGANLK_02914 hypothetical protein
MHELQNEYLSIKVNPVGAELSSLKNLESGIEHLWQGNPEFWASRAPNLFPVIGVLKNGEF
IFEGKSYKMPKHGFVRYNEEIQLKEKTSNALGFQLEYSEKTLESYPFKFKFEISFILKDK
SLEVHHKVFNLDEKPLYFSLGGHPAFNAPISKNEVYEDYYLEFDQKMDLRTHVLSENGLI
SDKTEGILDNEDKIRLHKDLFAKDALIFKNIPSKKVALKSKNSGTILSVAYSDFKNLGIW
AKPGAPYVCIEPWLGIADIEGTDQNLKTKEGIEILEAHTTFEATYTIHIN
>IFAGANLK_02915 ATP-dependent RNA helicase RhlE
MTFQDLNITTPLRNALEDIGITTPTPIQEESFSTIMSGKDMVGIAQTGTGKTFAYMLPIL
RMLKYSEQKNPRVLVLVPTRELVVQVVEEIEKLTAYMNVRVTGIYGGVNMNTQHQSLLQG
QDIIVATPGRLYDLVLRRALQLKSIQKLVIDEVDVMLDLGFKFQINNIFELLPQNRQNIM
FSATITENVENLIEANFKSPETISVAASGTPLDNIKQTGYKIPNFYTKVNLLKYLLKDKE
TYSKVLIFVAYKRMADRLYTELQQHFTDECTVIHSNKTQNYRLRSIKQFGSGFCRILVAT
DVMARGLDIESVSHVINFDTPKYPENYMHRIGRTGRAEKEGNSILMTTEAEMEYLDKIEA
LMKMEVPQEELPEEIVVSSELIPEEQPKVFEINNPGKNKDEDAPGPAFHEKKEKNRKENL
GGSYRREIAKKYKKPKTRGDKNANRKRKK
>IFAGANLK_02916 Chromate reductase
MKKILAFAGSNSSTSINFQLLKHVANRIQGHEVKIQDLKQYDLPIYSADREKEKGMPIGA
TIINNIIKEHDALVIAVNEHNGNVSAYFKNIIDWLSRLDRNFLDGKKILLISTSPGKRGA
ASALEYTKGILPRFGGEVIESFSFPSFNDNFKDGEMLNEVLDMGIQDVLTTFSHQLEE
>IFAGANLK_02917 hypothetical protein
MFTDTEKLTLADIENLDFTTVIWIAAPLMFLFVLIEFLIGRKKYKNLYSGKDFLASSAIG
IGNLILNGFMKIGVFMIFLFFFNLAPFKIPPTWWSYVLCLILLDFSRYWSHRLAHEQRFW
WSTHVVHHSSEHYNLSTSFRLSWTQNLKIIFFLPVVLLGFHPLVFFIVHQLEVLYQFWIH
TELIKKLPKPIEYIFTTPSHHRVHHSVNERYLDKNYGSTFIFWDRIFGTFQEEDEKPRYG
ITKPVNSYNPFFLVFHEWIDISKDIWKSKSLKEAWIILFGSPVDKHKEDMGIKGKSDAEL
ANIGKANEEFNIKKAR
>IFAGANLK_02918 Aminodeoxychorismate synthase component 1
MLRQIVLTFALQIKSQVRTKSTYTLEEPLKFKQQLLQWSREFEEIAWLDSNNYQQEHGEF
DALLALGAFTAIKTDYHQAFAKLQEYQQTTKDWVFGYLSYDLKNDIEALSSKNHDRLGFP
DLYFFQPQKLFLLKGDQLEMHYLNMLDDEIEDDFNEILNLTITDNRPPTTDNREPIQARI
SKEDYLKKVGKMLAYIQRGDIYEANFCQEFFAENREIQPFNVFQELNEISGPPFATFLKL
EEHYLLSASPERYLKKSGDKLISQPIKGTARRSQNSTEDAEIANQLSTDPKEKSENVMIV
DLVRNDLSKIAKKGSVKVDELCKVYSFKQVHQMISTISAEIDHGIPPVEALRATFPMGSM
TGAPKISAMKIIEELEETKRGLYSGAVGYFTPNGDFDFNVVIRSILYNSAKKYVSFSVGG
AITAGSDSEKEYEECLLKASAMRKVLS
>IFAGANLK_02919 tRNA(Ile)-lysidine synthase
MEKAFKNEIKTRFPYLCNTKLLLAVSGGVDSVVLAHLCSVAKLDFALAHCNFNLRDEESD
ADEDFVADFAKKLKVKLFVENFDTEQYAKDNGLSIQMAARDLRYEWFEELRLKYQYDYTL
TAHHANDSLETFFINLLRGAGLEGLSGINSDSNKIIRPLLNFSRKEIEAYAIENNISWRE
DSSNTSTKYLRNKIRHDIVPVFEELNPQFLETFLKTQSHLKENEELVEDYMSLLYPKIIE
KTKYGYSMDIGYLKKVPNTSAVLYQLLKSFGFTEWNDVYNLLDAQPGKMVFSASHRLVKD
REYLILTEKSQVEDKVYKIAEDEDFAMLPMGTFSFSEVKEIKEKASNCIYVDPEKLDYPL
TVRKWQEGDLFYPFGMKGKKKLSDFFKDKKLSLPEKENSWLLCSGDKIVWVINQRADRRF
SISSPDQKIIKITFSL
>IFAGANLK_02920 Thiol:disulfide interchange protein DsbD
MKYLASLLLFLIPLLQLQAQYFDDGSGDSQMADPITWEASVEKENDSVFTLIFTANLEDG
WHLYSQKEADIDIAPIATTFSYNSEGNFELIGETTEPEIEPIYDKVFEADITYFEDEAVF
TQKIKVPGESKPEIVAEIYFSVCDDEKCLPPETERFTISLDGNEVTEGFTDLEISEKDKE
LTEALNIEVSGMEKFAPEEEEGNNFLNIFLLGFIGGLIALLTPCVFPMIPLTVSFFTKGA
KDRKKGLVNAILYGFFIFIIYLLLSLPFHLLDSVNPEILNNISTNVTLNIIFFIIFIIFA
FSFFGYYEITLPSSWSNKMDDKASSVGGFVGIFFMALTLALVSFSCTGPILGSLLGGSLT
SDGGAMQLSMGMGGFGLALALPFALFALFPNWLNSLPKSGGWLNTVKVTLGFIELGLAFK
FLSNADLVEHWGLLKREIFLGIWILVGLGLMAYLFGFIRFPHDGPKKRISKARFGVGVIT
FLFVIYLIPGLTNTSAANLKLLSGFPPPLFYSIYDKGTEAPLGLEAYKVWDKGLEAAREQ
NKPIILDFTGWACVNCRKMEEQVWSNPEVFDVLNDDYILISLYVDDRKDLPEDEQFNYLK
PKGGIKPIQTIGDKWATFQTLNFKNNSQPFYVLLDNDVNLLNEPVGYTPNESEYLSWLKE
GLAKFQETARK
>IFAGANLK_02921 Cocaine esterase
MKLLRLSFILLFLSFLPVHLISQEEYDVKEHYNKTEVDIPMRDGTLLHTTIYSPKDTSKE
YPILMQRTPYSSRPYGEDQFRSLISPNEYLMKEGNIVVYQDVRGRWMSEGKYDNMRAIIP
NKSGDEFDESSDTYDTIEWLIENVDNNNGRVGTWGISYPGHYAVASLVDAHPALKTSSPQ
AGIGDFFFDDFHHNGAYLLSYWRVTALFGYDKTGPTTEAWYDLPDLGTQDQYQFFLDVGP
LSNLDEYYGEDNVFWQQLKEHPNYDEFWQSRGIIQHLEDIEPAVMVVGGLFDAEDLYGPF
NTYKKIEETSDNYNIMVFGPWSHGDWARQTERQAVGNVYFGDNLSEDYQRNIETKFFNHF
LKGDGDGDVDLAEAYVYDTGARKWNSYEAWPPKNTEEKVFYLGDDQELTGEATDNEETFV
SDPDKPVSYNDEIKAVFTPREYMTGDQRFAARRPDVLVFETEVLEEDMKLTGKILARLNV
ATTGTAADWVVKVIDVYPPDAENYEETMKHLDMGNYHMMVRSEVMRGRFRNSFENPEPFE
ANKKTPVNITLQDINHTFKKGHKLQIQVQSTWFPLIDRNPQTYVPNIFEAEEEDFQKQTH
TVFGDSVIEFSVIKE
>IFAGANLK_02922 hypothetical protein
MSIRIIHKLLFISLLVLGVSCDQKEENYSEAEIAEHSAELNDYFEEEFQKDVEESPMMQT
QLGQKTNYGKWDDFSHLKYAEDRKKAKKRLEYIKKVDVSALNEQTRLSYDLYKQKLENEL
ADYDFRFYNYPVNQMFGHHAELPAFLINMHRIDSVSDAEAYIARLKGIPKVMEEVIGNIK
IREQNGIVPPVFVFDRVLESSRNVIKGKPFGKSVENSALLSDFKSKISNLEISEEQEKEL
ISKAENALVKEVKPAYENLISFLETQQKRANNDAGAWKFPKGDEFYASALKRTTTTNLSA
EEIHRIGLDEVARIHGEMEKIKEDVDFEGTLQDFFEFMRTDEQFYYANDSIGKQKYLAEA
TDVINSMKANLDELFLTKPEAELVVKAVEPFREKSAGKAFYQQPAKDGSRPGTYYANLYD
MAAMPTYQLEALAYHEGIPGHHMQIAIAQELEEIPQFRKFSFYTAYVEGWGLYSELLPKE
IGFYKDPYSDFGRLAMELWRSCRLVVDTGIHAKKWTRQEGIEYYKENTPNAESDCVKMVE
RHIVMPGQATAYKIGMNKILELRENAEEKLGEDFDIREFHDVILLDGALPLNILEEKVDD
WISGKTN
>IFAGANLK_02923 Aldose 1-epimerase
MTGFPVKPTKKLILKTQKEDLKTVNLINNHGSELQVLNYGAAVLSFKIKDKAGNKINVVV
SPRAEEFITSVYKEHNKCFGASVGRYAGRIANGEFQLDNTTYKLSETNNVHLHGGESGFQ
YKIWKVEEQEAAPNPSVKLSYFSKDGEEYYPGNLQVEVKYTLTENDELLIEYSAKTDKKT
VINLTNHTYFNLNGSGSISDHFLKIAAEKILEVDKNLLPTGNLTKLKKHPKNFIEGKLIG
NRSLDDTYVLKSDKDEVAARLFAPLTGIKMEVKTNQKGLVAYAPENLPEDLTYHTEIAKE
YPSLCLEAQNFPDAPNFRNFPEAVLKPGEQYYNWISYKFSVSGQ
>IFAGANLK_02924 putative symporter YidK
MVGILSFIGFTLLVAIIAYLATRKTNESTSDGYFLGGRSLTAGVIAGSVLLTNLSTEQIV
GLNGQAFSEGILVMAWETLAAIAIVITALFLLPRYLKGGLTTVPQFLEKRFDKGTKTLVS
GLFLSGYMIIFLPIVLYSGALAISTMFGIPEMLGVSSNTALWLTVWGIGIIGSIYAIFGG
LKAVAVSDTINAVGLLIGGLLIPIFGLMAIGDGGIINGLEVLVDSNPEKFNSIGGPDASV
PFSTIFTGMMLVQLFYWGTNQAIIQRALAAKNLREGQKGLMLAAFIKILGPIIVVLPGII
AWHMFQGDLDNADQAYPALVNAVLPPVLTGFFAAVLFGAILSSFNSALNSSVTLFGIDIY
KQYFNKDASEAKVVKQGKRFGIFLAIGAMLIAPFIANAPQGLFGYLQEVNGSYSIPILTI
VIVGYLTKRIPAIAAKVAIFSGVGFYLIYLGLKYFVVGEDALPHYLHVMAILFVLNVLIM
FIIGKWKPRIEPFILDYTRQVDIQPWKLVKPVGLGIVVLVVFIYVYFAQ
>IFAGANLK_02925 hypothetical protein
MKPFQKDFYIQEDKMYVATDCVIFGFDEGNLKLLIFKRRVKPLMGTWSLIGSFVKLDEDV
KEAAKRVLKEITGLENVFMEELKTYGTTFRDPGYRTISIAQYALIRIGEYDKELVERHGA
HWYDIEDVPDLVLEHNQMVKDALVRIRRKARYKPIGFELLPEKFTIPQLQRLYEAVYHKE
IDARNFRKKVLSLNVLVKLDEKDMSTSRRGAFLYKFDRKKYLKLQESGFNFEIA
>IFAGANLK_02926 Hydroxypyruvate isomerase
MDKKFSRRDALKSIAIGSGVLSLGGVASSFAAMNYIDNNNLPTSKRNNIKHSVCRWCFQD
IPLDEFAKTCANMGIQAIDLLKPSEWATVEKYGLVCSMATDDFANIENGFNEPKNHKDLQ
EKYKGLIDKASKRKIKNVIVFSGNRRGMDEQTGINNCSKGLKPLLKYAKEKNVTLVMELL
NSKVNHPDYMADHTEWGVALAEEMGADNFKLLYDIYHMQVMEGDVIATIKKHHKHINHYH
TAGVPGRNEIDDSQELFYPAIMKAIVETGFDGFVAQEFIPTHPDEISSLKKAIEICDV
>IFAGANLK_02927 hypothetical protein
MKKRFFLTFIFFVISFISFAQEKQDVYVDDEGLMRWGHNDEEVKGFGVNYSVPFAHGYRS
GEQLGVNLKEAIDKDVYHFSRLGFDLFRIHVWDTEISDEEGNLIENEHLKLFDYLLKKLK
ERDINFVITPIAYWGNGWPEPDEDTPGFSNKYGKAGSLTEPGAIEAQENYLAQFLNHVNP
HTGVAYKNEPNLIAFEISNEPHHKGKPEEVKEFIEKMVKSMKSTGTEKPIFYNVSHSIHL
AETYFDAGIDGGTFQWYPTGLGFQKELEGNLLPNVNEYQIPFNDVIEENNAAKLVYEFDA
ADVMKSYIYAAMARSFREAGIQIGTHFAYDPTYLAFGNTEYNTHYMNLAYTPQRALALMI
AGEIFHQVPVNSDFGVFPKNLEFQDFTIDYENDLAVLNSEGKFIYTNTNEVQPKSIENLN
HVAGFGNSEVIKYEGKGAYFLDKLTDGVWRLEVMPDAILVDNPFGSNSLDKTVAVINWEN
WQMDLNLPGISDNFSLEAINENNSFNPEIEGKSFKIRPGTYLLKNNGAELDKNTELDLRV
ELEEFTAPESTVEKTYVLHEPVKEITANSSLEITAEIVSDKEIEGVEAWLKNGNTYDSVE
LENDRTYNFSAQIPENLLKNGFLEYRIIVTTDKGKETFPGEVSGSPEDWDFHSEAKYTTR
VVREEKPLYIFNASQDEDYIVGEWSPQNNLVPTNNPGEAEYQVKVEKLFEEDVENPEAEP
VYDYSFRYNFSRKIEGRKTELDSKEKIIIKARALTESTDKFQVAIIMKNGAAFGTLIDLD
AETETYEIELSSLKPVKTVSLPRPYPSFLPYYFKHSYEGDLELENAEALQFSIGPGIEDN
ELENPHGVGIISVSLE
>IFAGANLK_02928 Vitamin B12-dependent ribonucleoside-diphosphate reductase
MGVNTTTAAPKTYSQDEAFKASLDYFKGDDLAARVWVNKYALKDSQGNLYELTPNDMHRR
IAKEIARVEQRYPNPMSENEVFDLIKDFKYIVPQGSPMAGIGNPYQIASLSNCFVIGNDG
DSDSYGGIMKIDQEQVQLMKRRGGVGHDLSHIRPKGSAVKNSALTSTGIVPFMERYSNST
REVAQDGRRGALMLSVSINHPDSEDFIDAKMEQGKVTGANVSVRIDDEFMRSVKEDRNYV
QKYPIFSKNPKKSKEIEANKLWKKIVHNAWKSAEPGILFWDTVINESVPDCYADLGYKTV
STNPCGEIPLCPYDSCRLLAINLFSYVENPFTENASFNFELFKKHIAAAQRIMDDIIDLE
LEKIDAILAKIEADPEGLEIKGVEYNLWKNIQTKAKEGRRTGIGITAEGDMLAALGIKYG
SDEGVDFSVKIHKTIALEAYRASVYAAKDRGAFGIFDSEREKENPFILRLKEADEKLYYD
MLEYGRRNIALLTIAPTGTTSLMTQTSSGIEPVFMPVYKRRRKVNPNDKDSRVDFVDEVG
DSWEEYVVFHHRFKEWMKVNGHEITDDYSQEELDKLVKASPYYKATSNDVDWLSKVRMQG
AVQKWVDHSISVTINLPNDATEELVGQLYLEAWQAGCKGVTVYRDGSRSGVLISNEEKKE
EAEEENNTPFPTTRPETLTADVVRFQNNKDKWIAFIGLIDDRPYEIFTGFADDEDGILLP
RWVTEGAIIKARNEDGTSRYDFQYENKRGYKTTIEGLSHKFNPEYWNYAKLISTTLRHGM
PIEKVVDLINSLQLDSESINTWKNGVARALKRFIADGTVAKKQKCSNCNSSNLIYQEGCL
TCQDCGSSKCG
>IFAGANLK_02929 Cytoplasmic alpha-amylase
MKKTKLLFPFLFGLLLVLSGCSKDDDEVVDETDDITGGEEEEIPTPQDPEALDLSQYTSG
QKVMMQTFYWDVEPRFEWWNNLSDKVEGWADAGIDRLWLPVATKGQSGGYSMGYDPSDYF
DFGEYDQHGTVPTRFGSRDELENLISKSHDLGLEVIADIVLNHNSGGGLEYNPYREKETY
TNFDEENGNASGMFNRSYEHFHPNDISESDEGDLFFSEQDLDHDVPYVQEWLWEKENSVA
KYYKNEMGFDGWRFDYVKGFGTWVIKEWMDEVGGFAVGENFDGNPDVLVDWVDATGVSAF
DFAAFYKMEEAFDRFDDLNYLDGGMLRKVYPDKAVTFVANHDTEKDENEDNRIASENKMK
AYAYILTHDGYPTIFYSDYENETFNEEIKQLIEIHNSLAVGDVEVLHVDKDEYLMKREGN
AENPGLIIYISTGSTTKRRNVQTNWNNVTLLDYSGNTTYTPTSDENGMVTIEAPANGYSI
YSITK
>IFAGANLK_02930 hypothetical protein
MKKFSILFLAFVALLSFNACTQDDDIVFVAQPDPEGIQFSNSFQNTYVLPAGNPDNLAER
FVWNEVDFEAPTTITYELQGSADEAFGDLMVIGSTDNNNLGVTIGQMRELAEDAGLDNDP
ETEAPNTGMVYFKVRAFAGDGEGNALEEFSETIALNVELPEAEEEGEAPKMELFLVGDAT
EAGWEPDNNNTPLFRDGENESVYYFEGRFAGGGDTEGFKFLQTTEWQPQWGISNGELTNS
EILGDDPDAFPVEDDAYYSLMVNVDEMTYTWEEIDESSATVYETVGLVGEGTSVGWPTED
NETPDIVMNQSEFNPHIWYAEDIVLSDGPIKFRADLAWDVSWGGTTFPSGEAAGDDIQAT
AGTYDVWFNTLDGRYIFIPQGEE
>IFAGANLK_02931 Starch-binding protein SusD
MLKTLKPFLILFISAGFFWSCEDDLDLQPEDNRLTAETTFEDPESYKQFLAKLYAGLAVS
GQEGPAGDPDLIGLDEGFSQYLRLYWSMQELTTDEAVIGWNDGTIQDLHAQNWTAGNEFI
RTMYSRIMYQVALTNEFLRQSTPELLESRGLASEERENVARYRAEARFLRALHYYHALDL
FGNVPFVTEEDPVGAFLPQQIQRPELYDFVESELLAIENDIVAANSNEYGRADQAAVWML
LSKLYLNAEVYTGEGRYADALNYSEKVINANYTLADNYQNLFLADNDSNGAQTEVIFPIA
FDGQQTQSYGGMAFIIHAAVGGDMEPEDFGVSSGWAGLRTTAALVDKFPNGAESEDERAL
FFTEGQTKEIDEISSFNDGFAIAKFKNVTVDGEWGSDDTGEFPDTDFPMFRLADAYLMYA
EAHLRGGGGSQSAALGYVNELRERVDADQIGGSDLSLDFILDERARELYWEAHRRTDLIR
FNQFTENGIWPWKGDVPQGATTQSYRDLMPIPASDLGVNTNLEQNPGY
>IFAGANLK_02932 TonB-dependent receptor SusC
MKTLFKSTLMLLLMLPMSFFAQETVSGVVSESATGLPIPGANVIVKGTTNGAVTDFDGNY
TIQNVSEDDILVFSFLGFASEEIPYEGQETLDVQLDEDQATLEEVVLIGYGSTSEQDATG
SVEKISSESFNQGAVVSPEQLISGKSAGVRITPGSGEPGGGSEIRIRGGSSLSGNNSPLI
VVDGVPLDQRGVQGVRNQLNSINPNEIEDFVILKDAAATSIYGSRASNGVILITTKSGKK
DSPLALSYDLKVSAGRIIDKVDVLDADQFRNLINDTPGTDPSLLGDANTDWQDQIYQTAV
GAIHNFTATQGFENFSYRVNYNHTSQTGVLKTDVYERNALNIALNQDLFDNHLKLSLTSK
GIVDENRFADQGAIGAAVGFDPTQPVYEEGSYFGGYYEHTLSPGQQQIQATRNPLALLEQ
LDGRGVTKRNITNLNAEYKFHFLPELKFNVNAGFDYSENDGYNRRPLTSAANNQDIPYFE
DYGGFNRNTLLDFYFNYKNDIDFLDTEIDLTAGHSYQEFFITSKTTETVSNNILESPRDT
DRNALESYFGRASFDIANKYLISGSVRRDGSSRFGGDNKWSIFPALSVGWKLHNENFLAD
SNVLNQLKLRAGYGVTGNQEIGPNYGYFGTYNPSVGGARYQFGNQFYNTLRPEAYDSDLK
WEELQTYNVGIDYGLFNNRISGTVEAYYRETEDLLATVPVPAGANLTDLLVTNVGSTVSK
GLEFGINGAIIQQEDFNWDINYNLTFQDLEITNLTLGDNPNFQIPQGEISGGVGNNIQLW
KEGYDPTTFNVFRQVYNEDGQPIEGAYVDVNGDNEITEEDRVAYKKATPDYFMGLTNTMR
YKNLDFSFTFRGNFGNYMYNNTQSSNGFVGAGTVTPQPYYSNFNSNVLESNFNNNQFFSD
YYIQKADFVKLDNISVGYSFPGEELDIRTSLTATNVWTITDYEGLDPEIANGIDNNFYPR
STTIVLGLNLSF
>IFAGANLK_02933 HTH-type transcriptional regulator DegA
MKPKLTLKQIARELDVSISTVSKALRDSSEIGEETRKKIKAFAKLYNYRPNNIALSLKNR
KTKTIGIIIPEIVHYFFTTVISGVEQVANEMGYNVIVCLSNNSFDKEVLNLEMLANGSTD
GFILSMAKETMQKEDYHHLTEVTNQGMPVVLFDRVVDEIHCDKVIIDDVLGAKKAVQYLL
DKGSKKIGLVSTVDYVSVGKLRTRGYLEVLRENNVEIDDKLILKIEDMDNSETEIKDFID
KNEVDAVFAVNEHFAIYAIKAIQEKGLKVPEDVSVIGFTDGELSKRFIPSLTTVSQHGER
MGAEAARLLIDKLERKPEEEESYRTVIVETNLIERNSTKL
>IFAGANLK_02934 hypothetical protein
MQKRRLSFWEIWNMSFGFLGIQMGFALQNANASRILQIFGADIHELSWFWLVAPVTGLIV
QPIIGYYSDRTWTSLGRRRPFFLTGAILAAIGLILMPNADWFIAILPSLWVGAGMLFIMD
ASFNVAMEPFRALVADKLPSDQRTLGFSVQTVLIGIGAVIGSWLPYVLTNWFDISNRAVI
GEVPLNLLLSFVIGAAILVGSILVTVITTKEYSPEELEKMDDHVPETVDEKEKSSLMDIF
SDFAKMPHTMRQLSWVQFFSWFGLFGMWVFSTPAIAHHIYGLPLSDNSSETYQDAGDWVG
VLFGVYNAVSAVFAFFLPAIALKIGRKSTHIVSLFIGALGMLSIYIMPNEYWLLLSMFGI
GIGWASILAMPYAILAGSIPAKKMGVYMGIFNFFIVIPQIVNALVGGLMVKYLYDGNPIY
ALVTSGIAFLIAAILTFRIDDVDEPVKA
>IFAGANLK_02935 Beta-phosphoglucomutase
METNKGVIFDLDGVIVDTAKFHFLAWRKLANDLGFDFTKAQNEQLKGVSRVESLKKILEW
GELELSKTEFKRQMALKNENYLSYVAKMEEDEILPGVQKLIDYLIENNIPFALGSASKNA
RVILKKINLLEKFDAIVDGNDVSKAKPDPEVFLIAAEKINIKPENSIVFEDSVAGVQAAN
NANMISIGIGEQKTLGEADYVFKDFTEIDIDFIKKLLTK
>IFAGANLK_02936 Maltose phosphorylase
MNQDYIQANEWSILEEGFDVERVKSSESLFSIGNGVMGQRANFEEQYSGPSFQGSYIGGV
YYPDKTKVGWWKNGYPEYFAKVLNAPNWIGINVFINDEALDLFTCKKVEDFKRELNMKEG
FHRRSFVATLPNELEISVKATRFLSIVEDELGAIDFEIEVLNSDAEVRFDPYLDGGITNT
DANWEERFWKTLEVKSEGNRGFVLSKTLKTEFHVNTYMHSEVLLNGEKQDVDFTETKTED
SLTFSYSVKAEKSQKLSLRKYAGYVTDMNHKRSELHEAASKVLDYAKKTGFSKLLQEQKE
AWGKIWEMADITIEGDVKAQQGIRFNIFQLNQTYLGKDERLNIGPKGFTGEKYGGSTYWD
TEAYCIPFYMATKDQQVARNLLTYRYNHLDKAIENAEKLGFKNGAALYPMVTMNGEESHN
EWEITFEEIHRNGAMVYAIYNYVRYTGDFEYIPEKGLEVMIAIARFWQQRVNFSKDRNKY
VMLGVTGPNEYENNVHNNWYTNYLAKWCIEYCLETIDKVEDAYFEDYKRIMGKTKLNEGE
LAKWKEVAENMYFPYSEEHKVFLQQDGFLDKEIVPIAELDKSQRPINQKWSWDRILRSCY
IKQADVLQGFYFFEDHFSKNELEKHFDYYEPITVHESSLSPCVHSIQAALLGRTKQAYDF
YLRTSRLDLDDYNKEVEQGCHITSMAGTWMSIVEGFGGMRVKNDQLSFNPTIPEDWKSYS
FKVNFRDQILKVKVSAEKTVFHLEGENTIEINVKGKAVEVHPNQEFAV
>IFAGANLK_02937 Neopullulanase 2
MKKILITLMLFAGFTGFAQIERIEPPNWWTGFEESELQLMVYGEHIGNATPKIDYPGVSI
ENVKKADSPNYLFIDLQIGQAQAGTFDITFELENGSEEVYKYELKEREKPASEYVGFDNS
DAIYLITPDRFANGDKSNDSFDYLNEKTIDRQDDYGRHGGDIRGIISHLDYIDEMGFTAI
WPSPLVINDMKSGSYHGYAMTDFYKVDPRFGTLEEYRELADKAAERGIKLVMDQVANHAG
VEHWWMDDLPFDNWINFQEKFENGEDLVYSNHRRTTNQDLYASETDKKGMTEGWFVETMP
DLNQENPFMAKYLIQNSIWWIETLGLGGIRQDTYPYPDKQFMSEWAGAIMTEYPNFNIVG
EEWSLNPLLIRYWQDGVDNGYDSNLKSTMDFAMQEKIVTGLKAEETWGTGLVEIYEALAN
DFAYADPENIMIFPDNHDKSRIYTQLGEDVAKTKMTIAYMSVLPRIFQMYYGTEILMDDT
ANPGDHGLIRTEFPGGWDDSEVNAFTGEGLSEEKTGMQEFVKKLMNYRKNSDAIHSGETK
HFAPEDGTYLISRKSGDEVVVLILNKNEESVTLDLERFSELNLEGKSFKNLISEEPFQWE
DSLELPEEGVYFFTTKMQ
>IFAGANLK_02938 Cyclomaltodextrinase
MKKTLIMLLAFTALFSCKENEKQEQPEQEEKQNIDPVSNEALESAVIYEANIRQYSQEGT
FDAFTKDIPQLKELGVKVIWLMPIYPISMKNRKATGDLSVEDIEDPEERKKYLGSYYAIS
DYTEVNPEFGNFEDFEELVETAHENDMYVILDWVANHTGWDHKWIEEKPEYYHKNEDGEV
TDPINPATGESWGWTDVAHLNFENQELHKAMGEEMKFWVEKYDVDGFRADVAGEVPTEFW
EGIVPQLKDIKPVFMLAESEDKDLFENAFDMGYNWEGHHIMNEIAQGKQTAEDWDEYMQK
IDTTYQDDDYLMNFVTNHDENSWNGTVKERMGDASETMMALTYTLPGMPLIYSGQEYDMD
KRLLFFEKDTIPKEKGKVWPLLEKLGKLKNENKALHGAKEAASYENIDTSEEEKVLAFKR
EKDGAELIYIANMNDEKTSFSIQLNGSFEDYLSGETIEISEDKNIDLEPWQYFILINN
>IFAGANLK_02939 ATP-dependent 6-phosphofructokinase 1
MAKKINKIAVLTSGGDAPGMNAAIRAVVRSCSYYNLECVGVYRGFQGLIEADFEPLTARS
VRNIINKGGTFLKSSRSEEFKTKEGRAKAHKNLIDAGIDALVAIGGDGTFTGGLYFNNEF
NFPIVGIPATIDNDINGTDYTLGYDTALNTVVEAIDKIRDTASSHNRLFLIEVMGRDAGD
IALNSGIGAGAEEILLPEEDQGIQRMMDSLEKSKKSGKTSSIIVVAEGEKSGKNIFQLAE
FISQSHEEYDIKVSVLGHIQRGGSPSCFDRVLASKLGVGAVEALTDGKTNIMLGVHHQKV
VHVPLETALKEDREFDQELRRVANITSV
>IFAGANLK_02940 Glyceraldehyde-3-phosphate dehydrogenase A
MSTKIGINGFGRIGRIAFRIAAEKDNVEVVAINDLLDVDHLAYLLKYDSVHGKFKGDVDV
KDGNLVVNGNTIRITAEKNPADLKWGDVGVDVVIDCTGIFKEKDSAQAHIDAGAKKVVIS
APSKTAPMFVMGVNHKDVKPEDTIVSNASCTTNCLAPLAKVIDDEFGLVEGLMTTVHATT
ATQLTVDGPSAKDFRGGRSALLNIIPSSTGAAVAVGKVIPKLDGKLTGMAFRVPTADVSV
VDLTVKTEKSVSYDDVKAAFKKASQGAYKGVISYTDDAVVSQDFVSDAHTCNFDADAGIA
LNDNFFKLIAWYDNEYGYSAKLLDLAAHVNSI
>IFAGANLK_02941 hypothetical protein
MILIADGGSTKCDWILLSATGEELLRTRTKGLNPAVFPEVILEQRIEENADLKEIKDKVE
RVHFYGAGCGTETPRKLLEGIFTNFFTNVEEVIILEDMVAAVYAATTEPGIVCILGTGSN
SCYFDGKDIHQAVHSLGYILMDEASGNYFGKRLIRDYYYKRMPPELAEEFGKLYNMESDE
IKKNLYRKENPNTYLASFAEFIFSNERNGYFYKLVHEGITDFMHSRVMCYKQAQNTPVHF
IGTIAYFSEDIIRAVAQPYGIEIGNIVRRPIDALIEYYRKDVLAPN
>IFAGANLK_02942 hypothetical protein
MVCERAVFGVEATTITIEVNVATCIGYHLMGLPGNAVRESSFSIAAALHYNGYKFPG
>IFAGANLK_02943 hypothetical protein
MKRQLLNQRKAWESETQHSQECDCGETIADCDRTRRA
>IFAGANLK_02944 hypothetical protein
MDKLTQSDFEKLAKGITAAGTAYFILYGLYKDIRSRY
>IFAGANLK_02945 Competence protein ComM
MKPSIRRVFYCVEFTSTVTFITITDFALVGGGAYPQPGEISLSHNGVQCLDELPEFKRGV
LEVMCKTLEDREVTISRAKFTVTYPSSFILVASMYPSPSGYFNDPDAPATSSGRNAGIFE
>IFAGANLK_02946 hypothetical protein
MLPQLLLAEMQEYLSKISGPMLDSIDIHIEVTPVPFEKLSEERRLESSVEIRKRVTCANE
REANS
>IFAGANLK_02947 Competence protein ComM
MVRLNLSARTYARILKVSRTIADLENSENMKGNHISEAIQYRSLDRNGWLG
>IFAGANLK_02948 hypothetical protein
MKKSLLLLIVVSVFACKGEPEVKEVSEIESDTIEEENSLTGDLLGENRVEFTKEAANRLA
ELPLNCINTEYPNKLNQTLENEEALGEPSELHPAFYGCFDWHSSVHAHWSMVSLLKQFPD
MEKAETIREKLKESLSEENIQGEVAYFNREQSDSFERTYGWAWLLKLAEEIETWNDPLAK
ELKQNLDPLTNLIVNKYLEFLPKLNYPIRVGEHANTAFGLSFAYDYAVAAENKDLEELIS
NRAKDFYLKDDDCPISWEPGGFDFLSPCLEEVNIMRRVLPKNAFEMWLEDFLPQLKTEDF
EMEVGEVSDRTDGKLVHLDGLNFSRAWVFYGLINQYPDKFSHLQEIADEHVAYSFPNLVG
DSYEGGHWLGSFAIYALQESKDM
>IFAGANLK_02949 Divalent metal cation transporter MntH
MRNFLKNLGPGILVSAAFIGPGTVTVCTLAGVEFGYSLLWALLLSIFSCIILQEMAARLG
VVSQKGLSDVIRDEIRKPVFRILAIILIFSAIVIGNAAYEAGNITGAVLGAEAIFGIQNL
QIGSFTLNLWSILIGAVAFLLLFTGSYKTLEKIFIGLVLLMSISFVLTAILTKPNILEIL
KGLIPTGNTAGLLTVMAIVGTTVVPYNLFLHASLVSEKWKEASYLPVARKELVVSIILGG
TVSMAILISAAASGLTNVNSAADMAVSLEPLFGKFATWFMSLGLLAAGITSSITAPLAAA
YVVKGCFGWKGGMKSAKFKTAWAVVLILGVFFSSLQINPIEIIRFAQIANGILLPVIAIF
LFWVANKASVLGTHRNSKLQNLLGIIVIAIAIFLGVKSIISVVQGL
>IFAGANLK_02950 hypothetical protein
MKEIHINCDLGEGGDFDAELMPHISACNIACGGHAGTLETMQQTIKLAAEYDIEIGAHPS
YPDKENFGRNPMNISAEELQRSIVAQILSLKQLAEAEGVKLTHVKPHGALYNEAAKDEKT
AQVIIDSVLEFDQKLALFCPPNSVISELAEGKIPVVFEAFADRNYELDLSLVSRSKPNAL
ITEKEAVFNHLYSMFSEEKVTSENGKNISLKADTFCLHSDTPNSVEIIKFLEQKFAESNI
KIRNTK
>IFAGANLK_02951 Kinase A inhibitor
MGERGILIEFQPEISEKLLEKLLFYKNKLEEFYTEVNVEVINTYNSLLISYMFSIENLYD
EILTVKKLFDEAKIGKINNQQVFHLPVCYDEEFGWDLELIAEEKELSKEEIIKLHTAPFY
TVYFTGFLPGFLYLGGLDKKLQISRKNQPRMKIEKGAVGIGENQTGIYPKSSPGGWQILG
NCPVQLFDKNNDPPCGISAGDKVKFYSVSKAEFEEISAQVSEGKFQLKKENYAR
>IFAGANLK_02952 KipI antagonist
MHAEVEVIHPGLFSTIQDFGRRGFQKYGVPLSGVMDRIALKTANLILQNQADAAVMEITQ
MGPKLKFSAATKIAISGAYLSPKLNDREIENNEVVKINKDDVLSFGKPELGMRAYLAILD
GFKTEKVLGSRSWYEDITQHSKLEKGIKLLYEASEEEKYETHAALKFDNTYLNSEEIEVF
PGPEYEKLHETLKSHLRQSKFSIDKNNNRMAIQLSEILENVLDPIITGPVLPGTVQLTPG
GKLIVLMRDCQTTGGYPRVLQLSEKGINMMAQKRAGDKIRFLFKF
>IFAGANLK_02953 hypothetical protein
MKKPKKCISVEEARKEQDEWVKTRGKDIRECEGYEDTREFWYSLDELQEYLDYVREKSKE
QGVEKPGIRFYLGAYPTTKEKKSFTTMFLSPTKEAKGETESAQEDSDPNNYEIEPYNTIG
SGWPPMEY
>IFAGANLK_02954 hypothetical protein
MQDFRFLVFLLEGIAAICGLYFYQKNPADKAVGFFSYFLLLTFFVESIGLFPAAIYWNEE
LHFLKQTFLYRTYWLYNPYLIISFVVYILFFKWNISNNKTTQLIDKALLLYVIICIANLI
FSDVFFKSNSVVTYLLGSFFLLGVIFYYYFEILLSPKILNIKREISFYISFAALLYFLTT
SPIFIYFEYFNDKSPEFVEFSSLIMIAMNIFMYSSYSIAFLWLANKKKPTSKNLKNAF
>IFAGANLK_02955 Signal transduction histidine-protein kinase/phosphatase DegS
MLSKEEILLIIYFVLVILLLTAFVILFFVIYQRRKNKLLEEKFEAKQRFEREISQSRLEM
QEQTLKNVGWELHDNIGQLLSVANMQLNIFSKNLPEAEKTSVLEIKETVASSLQEVRSLS
KSLNNQVIGYAGLVVSVENELERFQRMGVIETQLEITGERQEIPQQHSIILFRILQEFFA
NVIKHAKASALEVHIAFTSEEIIITAKDNGQGFDLEEVQKNSGLFNMESRAALIQTKFKL
ESAMGAGTFLSLRYSLMGQQDE
>IFAGANLK_02956 Transcriptional regulatory protein DegU
MNNTVAIVDDHTLFAQSLKNLVNSFENYEVSGIYKNGQELVEQFKANKPKPHLVLLDIRM
PIMNGPETMAWLKENHPNQKVLALTMEDDEETVTFMVKLGCRGYLLKDIDPDEFKFALDE
VVKEGFFYTDAVSEAIKNRNKEKKFTNLTKREIEFLELACTEMTYKEVANEMNLSPKTID
GYRESLFQKLNVKSRTGLVLYAIKHRILLL
>IFAGANLK_02957 (R)-stereoselective amidase
MTSVNETPKIELRNLKLKDYQELKVSMIKSYQKMPEEYWSKDEIRNLVNKFPEGQFCIII
DNKIAGCALSIIIDSKKFDEDHTYDEIIGGENFSTHTNNGDILYGIDVFIHPDYRGMRLG
RRLYEARKEVCEQLNLKSIVFGGRIPNYGTYSKELTPKKYIEKVKLQEIHDPVLSFQLSN
DFHVKKVIKGYLPGDAESKEYAVLMEWNNIYYTKTTKLIDTPKTVVRLGLVQWQMRLFKD
YDALVSQIEFFVDAVSDYQSDFILFPELFNAPLMAQFNELTEPEAIRGLSTYTERLLETF
QEFAVNYNINIITGSMPMVIGEHMYNVGFLCRRDGSYERYEKLHITPAEEAAWGMKGGSK
LQTFDTDCGKIGVLICYDVEFPEVGRILAEEGMNILFVPFMTDTQNGYSRVKICAQARAV
ENECYVAIAGSVGNLPKVNNMDIQYAQSAVLTPSDFAFPVNGIKAEATPNTESTLLVDVD
LDLLKELHAFGSVRNMKDRRKDLYSLKKKK
>IFAGANLK_02958 Dihydroxy-acid dehydratase
MHNKFSKVLTQSDSQPASQAMLHAIGLTKEDFKKPFVGIASTGYEGNPCNMHLNDLAKLV
KKGANENELVGLIFNTIGVSDGISMGTPGMRYSLPSRDIIADSMETVIHAMSYDALITVV
GCDKNMPGALMAMLRINRPAILVYGGTIASGCHNGKKLDVVSAFEAWGAKTAGDIEKEEY
ESIIEKACPGAGACGGMYTANTMASAIEALGMALPYNSSNPAVGEEKKTESEEAGKAIRL
LIEKDIKPRDIVNRKSLENAIRLLTVLGGSTNAVLHFLAIAKSAEVDFDLADFEKICDST
PFLADLKPSGKYAMEDVHRIGGIPAVLKYMLKNDMLHGDCLTVTGKTLAENLADVPEMEE
GQDVFRPLDNPIKKTGHIRILYGNLAEGGSVAKITGKEGLQFTGTAKVFNSEYEANDGIS
EGKVKKGDVVVIRYEGPKGGPGMPEMLKPTSAIMGAKLGKDVALITDGRFSGGTHGFVVG
HITPEAQEGGLLAFLKDGDEITINAETNRIEARLSAEEIKKRKENWKAPALKFNKGVLYK
YARTVSSASNGCVTDEF
>IFAGANLK_02959 Acetolactate synthase large subunit
MEVKTASFEKVSSPKKTTVSGAEAVIKCLLEEGVDTLYGYPGGAIMPVYDELYKYQTQIH
HVLTRHEQGATHAAQGYARVSGKVGVAMATSGPGATNLVTGIADAQIDSTPMVCITGQVG
SHLLGSDAFQETDIIGISTPITKWNYQITKAEEIPEILAKAFFIARSGRPGPVLIDITKD
AQFATLDFSYKKCSGIRSYKPKPEINLVEVEKAAEAINNAKKPMIVFGQGVILGGAEELF
KQVVEKSGIPAAWTILGLSAMPTDHPLNVGMVGMHGNYGPNVLTNECDVLIAIGMRFDDR
VTGNLEKYAKQAKVIHFEIDPAEINKNVHADIPVLGNVNETLKILLELLKPNKHEAWHQK
FKDYYQIEFDKIIKNDLNAQRGKIGMAEVIDEINKCSKGDAVIVSDVGQHQMVACRYSKF
NQTRSNVTSGGLGTMGFALPAAIGAKMGAPDRDVVAVIGDGGYQMTIQELGTIFQTKVPV
KIVVLNNDFLGMVRQWQQLFFEKRYASTEMINPDFITIAKGYHIKAKQVSKRENLKEAVT
EMMESREAYFLEVKVEQEENVFPMVPTGASVSEIRLE
>IFAGANLK_02960 Putative acetolactate synthase small subunit
MEKKNFTVSVYTENNIGLLSRIAAIFQKRHINIESITASRSEVNEVMRFIIVVQVTEDQV
KKIVGQIEKQIEVIKAFYHTDEEMIYQETALYKINSADFVEDLNIQDFIKESNARIVTVT
PKFFVIEKTGKRHETDSLYEKLKPYGLMQFVRSGTIAVTKNEMPISNILEQFDTTN
>IFAGANLK_02961 Ketol-acid reductoisomerase (NADP(+))
MTNYFNSLSLREQLAQLGTCRFMGSDEFSDGVAALKGKKIVIVGCGAQGLNQGLNMRDSG
LDISYALREGAISEKRQSFKNASENNFKVGTYEELIPTADLVINLTPDKQHTSVIKAIQP
HIKKDAVLSYSHGFNIVEEGMKIREDITVIMVAPKCPGSEVREEYKRGFGVPTLIAVHPE
NDPQGIGFEWAKAYAVATGGDKAGVLESSFVAEVKSDLMGEQTILCGLLQTGSILSFDKM
VAEGVEPSYASKLIQYGWETITEALKHGGITNMMDRLSNPAKIKADEISEELKQIMRPLF
QKHMDDIISGAFSSRMMKDWENGDKELLEWRAATGETAFEKSEATSEEIKEQEYFDKGVL
LVAFVKSGVELAFETMVEAGIVADSAYYESLHETPLIANTIARKKLFEMNRIISDTAEYG
CYLFDHSAKPLIKDYVSGLPKEVIGHSFGTDYTGVDNQQLIAINDEIRQHPVEKVGGRLR
KAMTAMKKIQE
>IFAGANLK_02962 L-threonine dehydratase biosynthetic IlvA
MDTLLADKKIYKPQLEAVKEAAQRISKVVVKTPLMQSFTYSKKFSANVMLKREDLQQVRS
YKIRGAYNKISSLPQEQLDKGVICASAGNHAQGVAFACNKLQVKGVIYMPITTPRQKVEQ
TKMFGGEWVEVVLKGDTFDDSFKSSMKHADKFGLVFIHPFDDEKVIEGQATIGLEILEQA
TEPIDYIFAPLGGGGLLAGLSSMFKELSPNTKIIGVEPEGAPSMTSSLKEGKLVELKSIE
RFVDGAAVQKVGSRNFEICKQNLDKMITVPEGKICQSILDLYNQDAIVVEPAGAMAISAL
DFFAEEIKGKNVVCIVSGSNNDITRTAEIKERALLYAGLKHYFVISFPQRAGALKDFLEK
VLGPKDDITHFEYSKKHHRENAPAVVGIELNDPADFEPLVARMKAKNFYGEYLNDKPNLF
QYLV
>IFAGANLK_02963 hypothetical protein
MKIVIANKSHAQYAEIICTTIEESAKVRGTGIARRTPEYIIGKMEKGNAVIALDGEKFAG
FCYIETWSHERYVANSGLIVHPDFRKQGLAKDIKEVVFNHSRKMYPNAKIFGITTGLAVM
KINYELGYQPVTFSELTDDEAFWKGCQTCKNYDILTRTERNMCLCTGMMYDPERKKDAKK
GDKKESLNDKAFKRLKNIKQTLFYKKEKNGSSN
>IFAGANLK_02964 Argininosuccinate synthase
MKKVVIAYSGGLDTSYCAKYLSKEENFEVHAVSVNTGGFSEEEVKKIGENAQKIGAKTYK
NIDAVSSFYQKVVKYLIFGNVLKNNTYPLSVSAERIVQAIEIVNYAKSIDAKYIAHGSTG
AGNDQVRFDMIFQIVAPGIEIITPIRDKQLSRQEEIEYLKQNGVEMNWEKSKYSVNKGLW
GTSVGGAETLTSEKPLPESAYPSQLREKEAKQISLTFTKGELSAVNGKGNSPEKNIEILE
NIASKYAIGRDIHVGDTIIGIKGRVGFEAAAALITIKAHHLLEKHTLSKWQLQHKDYLAN
WYGTHLHEGQYLEPVMRDLEAFLESSQQQVCGQVFLTLHPYRFTLDGIESDNDLMNSSFG
NYGEENKAWTADDAKGFIKISSNAGKIYQHVNGKK
>IFAGANLK_02965 N-acetyl-gamma-glutamyl-phosphate reductase
MIKAGIIGGAGYTAGELIRILMHHPEVELDFVYSTSQPGKPVAGIHQDLLGDTDLQFSGK
INKNVDVVFLCLGHGNSVKFLSENQFSENTKIVDLSTDYRMSGEHSFVYGLPEFNIEKIE
KASFIANPGCFATAISLAILPLAKAGLLQEDVHINAVTGATGAGTSLSATTHFTWRDNNF
SSYKAFEHQHLNEIGQSLKILQHNKLPEINFIPNRGNFSRGIHATAYTKFEGSLEKAKAI
YAETYQDSAFTFVVEEDLHLKQVVNTNKCLLKVQKFGDKILITSIIDNLLKGASGQAVQN
MNLMFGFEETSGLKLKASYF
>IFAGANLK_02966 Pyrroline-5-carboxylate reductase
MKIAIIGAGNLGLSIAKGLIVNNAFTTLYLTKRKTEEIQGYEEYAKVKVTSDNREAVKNS
DILIFAVQPTQMQRILEEIKDDLHEKHVLISTITGFKIAAIEAIVGEEQFIVRSMPNTAI
AVGKSMTCLCSNEKGKKRIAIAEAIFNRLGTSIIIPENKMQAATVICASGIAFWMRLIRA
TTQGAVQLGFDAKDAHQLAMQTCLGASSLLIESGKHPEEEIDKVTTPRGCTIEGLNEMEH
NGLSSSLIKGIQASFKKINTITTD
>IFAGANLK_02967 Acetylornithine aminotransferase
MDLFDVYPLYDITPIKGDGAYVFDKENRKYLDLYGGHAVISIGHSHPAYVNAVSKQVGEL
GFYSNSVKNPLQEELADKLENVSGLKNYSLFLCNSGAEANENALKVASFQTGKDRVIYFA
NAFHGRTSGVVAVTDNENIKAPFNQNHKATKIAFEDAVALENELKKSDVAAVIFEVIQGV
GGLDEASTQFYQKTAELCKKYDSILIADEVQSGYGRTGDFFAFQKHEIRPDIISIAKGMG
NGFPVGGILIHKSIQAKSGMLGTTFGGNHLACAAGISVLEVIEKENLLANATELFEFVKE
KAAEIPQIKKIKGRGLMIGLEFDFEIAQLRKELLFKHQIFTGASANKKLLRILPPLNIKI
EHFDELFKALKIVLN
>IFAGANLK_02968 N-acetylornithine carbamoyltransferase
MTRFRTFRLIQKKENRMKNYTELSDIEDLQQLITEALELKKATSTLEIGKGKTLGMLFFN
PSLRTRLSTEKAGKLLGMDVMVMNAGSDSWKLEFGDGAVMDADKAEHIKEAAAVLSQYCD
IIAVRAFPDLQDKEEDEAETVLNSFKKYASVPVVNLESATGHPLQALTDAITISELKKKN
RPKVVLSWAPHPKSLPQSVPNSFTEIMQTMDVDFVITNPEGYDLNPQITKNVPVIHNQGE
ALKDADFVYVKNWSSYETYGQKLSEDKTWTFSAEKLIKTRNAKVMHCLPVRRNMVIADDV
LDSENSVVIQQAGNRTFAAQAVLKRILEEKVKETELGKNA
>IFAGANLK_02969 Acetylglutamate kinase
MKKEVLKVVKIGGKLIEDEVKFAEFLNDFVALEGPKILVHGGGNLATEIAGKLGYKTQMF
EGRRITDADSIKVITMVYGGFINKNIVAKLQALQNNAIGLSGADGMSIVSKKRPLKEVDF
GFVGDVEKVNSEFINSLLKQNITPVFSAISCTAEGLLLNTNGDSVAAEIAKAMSSIFETE
LYFCFEKKGVLADAENDDSVIDKINKEKYQQLLEEKVISDGMLPKLHNCFQALEGGVKNI
FLGDFRLLKNESVYTKISN
>IFAGANLK_02970 Acetylornithine deacetylase
MKLEELQSGAIELLKKLIATQSFSKEEDKTGDLLEGWFRENEMAFFRHLNNVWATNKYFD
PNKPSLLLNSHHDTVKPNSAYTRDPFEAKIEDGKLYGLGSNDAGGCLVSLLATFTWYYEA
KDLKYNLIFAGTGEEEINGKNGIACMLPKMPKINVAIVGEPTLMQLAIAEKGLVVFDAKV
KGTPSHAAHPNDNNAIYKTAEVLKWFEEFDFPKESVALGKVKLTVTQINAGSQHNVVPGH
VDLVIDVRVNDAYSNAEIEQILQENAPIDEITARSLRLNSSSIPPDHELVKAGISLGMET
YGSPTLSDQAMLDCPSLKLGPGDSTRSHSADEFIYVKEIEEGIEKYIKLLDKAFR
>IFAGANLK_02971 Argininosuccinate lyase
MKLWDKGLAIDKKIENFTVGNDRELDMQLAEYDLKASKAHAKMLGKVGILTSKEVKDIEG
ELANLQQQLQNGSFEIEEDFEDVHSKIEFELTKALGDTGKKIHTARSRNDQVLVAMQLYF
KENLQEISGKTKQLVDVLLGLAYEHQEKLLPGYTHLQVAMPSSFGLWFSAYAELLIDDLY
LLEAGLKVVDQNPLGSAAGYGSSFPIDREFTTKELGFSTLKYNVVAAQLGRGKCERTVTS
NIASVSNTLSRFAMDICLYMSQNFDFIAFPDELTTGSSIMPHKKNPDVFELIRGKCNKLQ
SIANEMILITNNLPSGYHRDYQLIKENSIYAVENIKEILDVFIHSIALIKVKDINLQDKK
YKYLFTVDSINDLVLQGKSFREAYQIIGEQVQEGTYEATEGKKHSHLGSKDNLALEEIRR
KKDQI
>IFAGANLK_02972 3-isopropylmalate dehydrogenase
MKLKIAVLPGDGIGPEITQQSVKVLKAVADRFDHLFQFEDALVGAAAIDLLDNPLPEATL
ELCKKSDAVLFGAIGHPKYDNNPDAKVRPEQGLLQLRKGLGLFANIRPVKAYDKLIEQSP
LKADRIAGADMVIYRELTGGIYFGDKFTAEDGQSATDVCTYSVEEISRVAHLAFKAAEKR
SKKLTLVDKANVLETSRLWRKTVTAIGKEYPEVELDFLFVDNAAMQMILNPTQFDVILTE
NMFGDILSDEASVIGGSIGLLASASVGNENAMFEPIHGSYPQATGKGIANPVASILSAAM
LLEHFGLIEEAEAVKKAVELSIKLNVCTIDINKDNHYTTEKVGDFLEGLISEVDNISINN
ENLNLGQMTII
>IFAGANLK_02973 3-isopropylmalate dehydratase small subunit 1
MEKFITLTDTAVPLEIENVDTDQIIPARFLKATDKAGFGENLFRDWRFDKNDEPNPEFAL
NKPEYKGSILVAGDNFGCGSSREHAAWAIKAYGFTVVVSSYFADIFKGNALNNGLLPVQV
SPEFLDQLFVEITKDPSVEIKVDLEAQKIGIPKQDISEHFDIDPYKKTCMINGFDDIDFL
VSKLDAIKEYEQKKSQKLQASTPL
>IFAGANLK_02974 3-isopropylmalate dehydratase large subunit 1
MKKTLFDKIWDAHVVESIPDGPDILYIDKHLIHEVTSPQAFNELKEREISVFRPDQIVAT
ADHNTPTENQHLPVKDLLSRKQLKELTQNCEENNITLYGLGHPYNGIVHVMAPELGVTQP
GMTMVCGDSHTSTHGAFGTIAFGIGTSQVSQVFASQCVLVQKPKKLRVNVNGKLKKGVLP
KDVILYIISKLGTNSGTGYFCEYAGNVFEEMSMEGRMTVCNMSIEMGARGGLIAPDETTF
EYVKGKEFAPKGEEFEAAKVYWKTLKTDEDAEFDQEYAFDAEDIEPMITYGTNPGMGIKI
TGAIPMEGGKSDAKALAYMGFKPGESLLEKTINWIFIGSCTNSRIEDFRQAAAYIKGKQK
AANVNALIVPGSRQVAAQIEAEGLREVFENAGFTLRQPGCSACLAMNDDKIPAGEYCVST
SNRNFEGRQGQGSRTILASPLTAAATAVSGKLTDFTKHLN
>IFAGANLK_02975 2-isopropylmalate synthase
MSTEKVEIFDTTLRDGEQVPGCKLNTAQKLKIAARLDELGVDVIEAGFPVSSPGDFQSVY
EISKLAKNAAVCGLTRAVKKDIEVAAEALKYAKKPRIHTGIGTSDSHIKYKFNSTREEII
VRGVAAVKHAKNFVDDVEFYAEDAGRTDNEFLARVCTEMIKAGATVLNIPDTTGYCLPDE
YGRKIKYLKDNVKDIDKVRISCHCHNDLGLATANAIAGVQNGARQIECTINGIGERAGNT
ALEEVVMILRQHPTLNLNTNIDPKFLFDTSCMVSREMGMFVQPNKAIVGANAFAHSSGIH
QDGVIKNRETYEIIDPAEVGVTESAIVLTARSGRAALAYKAKKMGYNLTKLQLDEVYAEF
LNYADARRCVEDHDIHEIMEISERKIRAIA
>IFAGANLK_02976 hypothetical protein
MTNDLTDNLFSLIKSLSPSEKRQFSLYVGRIGVNTDSKFLNLFKVMTKLKKYNEKEILLK
TKISKQQLSNVKAHLYKQILISLRLNPAHQSIPVQIREQFDFAYILYRKGLYKQSLKLLD
KIKVQALEYEEKNLAYEILELEKIIESQYITRSIENRAESLIQQTRDLSDLNLISSKLSN
LSLQLYAIFLKMGYARTQEEADSIRNYFYQSLPEYQIKNIGFREKLWLYKAHLWFSFITQ
DFLACYRYSMKWIDLFNENKHLVPIHPVSYLKGNHYLLESLFYLNHTNLFEKTLKNLEGM
LKDAKIPDDDNIKALAFLYLYSNKLNLRFMQGNFANGDELVEKIQKRIKKYKDRIDEHHI
MVFYYKIACLYFGDGNNKKCIEFLNKIINNKSLEMREDLMCFARILSLVAHYEAGLDYHL
DRLVKSTYKFLIKMNDLHEVQKEMIRFLRNLPEVSPLKIKDEFMKLHSKLKEYEDHPYER
RAFLYLDILSWLESKIENRPVADVIAEKVALVSR
>IFAGANLK_02977 hypothetical protein
MKNFYLSLIFSGISISAFAQDTIYMDKDYQELDTKENAEFFKIITPNAEDADFLNTTYFM
DGTKKAEQSYDLKEEKKVYQGLHKHYYESGELFYQLPFKNGKKHGHLLAYWENGTKRRHD
VFKKDELKEGKVWNEEGEELDYFAYHIPASFPGGQEKLQAFLKENINMPQEQERGTVVKV
ILKFTINPEGDLSEIQIVEGAPHRYNAESVRVLANMPKWNPSIRFGEQVATRYSLPIIFR
K
>IFAGANLK_02978 Ribosomal large subunit pseudouridine synthase C
MGKIISDKNNLQVLYEDNHIIVVNKRPGDIVQGDKTGDKPLSEVVKSYIKEKYNKPGNVY
LGVVHRLDRPTSGIVLFAKTSKALPRLNKLFQEKEAQKTYWAIVKNVPSKKSDILIHFLK
RNSKQNKSYAHIKEVPESKKAILEYRILKELDNYFLLEVDLHTGRHHQIRSQLSAIGSPI
KGDLKYGFDRSNKDASIHLHARELKFIHPVKKEEIHIIAFPPDEVLWNNCLN
>IFAGANLK_02979 3-methyl-2-oxobutanoate hydroxymethyltransferase
MSVAKKEYKRVTTKSLVDMKKNGEKIAMLTSYDFSMAKIVDGAGIDVILVGDSASNVMAG
HETTLPITLDQMIYHATSVVRAINRALVVVDLPFGSYQSDPKEALRSAIRIMKESGGHAV
KLEGGKEIKESLKRILHAGIPVMGHLGLTPQSIYKFGTYTVRAKEEAEAEKLKSDAILLE
RLGCFAIVLEKVPAKLAKEVAESISIPVIGIGAGNGVDGQVLVVHDMLGMTHEFNPRFLR
RYADLHKEMTKAFEDYRDDVKSKSFPSDDEQY
>IFAGANLK_02980 Chitinase A1
MKKVTIVFWCIFCSFLFSNHSVQAQEKQQKKIIGYIMGDNVDDKFGKISPDKLTHINYAF
ANINEGKIIEGNPKDKERLKKLNSLKEENHDLKILISVGGWTWSGGFSEAVATKTDREKF
ANSGISFLQKHKIDGIDLDWEYPGLPGAGNPHTPEDKQNFTSILKLFRKKLDSLGKIDQR
NYLLTIATAATQEYLDNVELDKIHPYLDFINIMSYDYQGGWNDSTSHHTNLFVSETDPED
YKQSTKTAVREHLETGVPSDKIVVGVAFYGRGWHETANKNFGLHQKASGNAFSINYRELK
DSIVTGEYKRHWDKTAKAPFLWREDTKTFITYDDPESIKEKAQFIKENKLGGAMFWQYHG
DDGELLETLYTELQKQ
>IFAGANLK_02981 hypothetical protein
MKKLFIISFLLLGPAGWSQNTEKENLQSLIENFFEAFHVQDSTRLKSFAHPDIKMQSVAI
DAEGNTELSTSEYSHFLKSISSIPTSTKFEEKLHDFDININGMIANVSTPYSFYVNDDLS
HCGVNTFQLMKLKGEWKIIYLVDTRSKSGCK
>IFAGANLK_02982 Serine/threonine-protein kinase pkn1
MYSSYLRFFLFTFLISSFLSCKNEEKKTAETSEENIQKPEKSYHEKYMEEIAEIEERASV
STAGMLKIEGGEYMMGGNSQQARRDEFPQHKETIKTLWVDETEVTNAEFREFVEATGYVT
TAERSFEINGETFPPGAMVFDAENPQAWWKFKEGANWKHPQGPESSIEGKEDHPVVQVSW
YDAMAYAKWAGKRLPTEAEFEYLARGGKENQIYHWGNDFEKATEFVNFHQGDFPVSNAIK
DNFEKTAPVKSFPKNGFGLYEISGNAWEWVLDTYYPNAYSKMDQRTDGYFKEYFNSEQQK
VIRGGSFLCSESYCTGYRNATRMSSTPESGLEHLSFRCVKDVE
>IFAGANLK_02983 hypothetical protein
MQFPKIPPKVSNLFRNYWFMIGTYFLFFFLLGFLNTFLPELDLEKYQQTELFDLMHESPL
AFVIMAVIIAPLLEESMFRTLIRPSFTEIHIFTCAVLAFIGLGFIPQEAHSLLKYALVIL
SAIIVFLFLQSLKPGRAMRKFRVFLYRNYKVIWLLSAVIFGLVHIWNYVEGWQLDLILFI
LIFPRIIAGYFFGKIKIENGNLLWPIAMHAMNNGIVVFFLLPKLL
>IFAGANLK_02984 L-serine dehydratase 1
MRKIECISVFDMMKVGVGPSSSHTLGPWRAAQRWITELKQKGIFNDVEHIHIDLYGSLSL
TGIGHATDIATILGLCGHDPVTMDISIIDAEIEKIRESKKLQLNAEREIDFSIADDVKFN
RKFLEFHPNGMTFRARLKNGKKTSSSFYSIGGGFVVKKERKNASNKMKSFLEFPFPIEKA
TELLAYCKAENKPISEIVLENEKSLRSEEEIDVGLKQIWDVMLESMYIGCHTEGTLPGGL
NVKRRSFEMHQRLIGDQQYNSPEEWIKAIRRTEVKFRQILKWVSCFAISVNEVNASLGRV
VTAPTNGSAGTVPSVMMYYMVIENHEATFEDMKRFMLVAGEIGSLFKKGATISAAMGGCQ
AEIGVSSAMAAGGLTELLGGTPEQVLMAAEIAMEHHLGLTCDPIAGLVQVPCIERNAMGA
IKAINAAEIALESDATKAKVPLDKVIETMWDTAKDMNSKYKETSEGGLAVKVNLSDC
>IFAGANLK_02985 Chaperone protein DnaK
MSKIIGIDLGTTNSCVAVMEGNEPTVIPNAEGKRTTPSVIAFVEGGEIKVGDPAKRQAVT
NPTKTVASIKRFMGNKYSESSKEAGRVPYKVVKGDNDTPRVEIDGRKYTPQELSAMVLQK
MKKTAEDYLGQDVTEAVITVPAYFNDSQRQATKEAGEIAGLKVSRIINEPTAAALAYGLD
KKSQDQKIAVYDLGGGTFDISILELGDGVFEVLSTNGDTHLGGDDFDEVLIDYLADTFQK
AEDIDLRKDPMALQRLKEAAEKAKIELSSSTQTEINLPYVTATSSGPKHLVETISRSKFE
QLASELVTRSMDPVKKALSDAGLSKSDIDEVILVGGSTRIPKIQEEVEAFFGKKPSKGVN
PDEVVAIGAAIQGGVLTGDVKDVLLLDVTPLSLGIETMGGVNTKLIESNTTIPTKKSQTF
STAADNQPSVEIHVLQGERPMAADNKTIGRFHLDGIPPAPRGTPQIEVTFDIDANGIIKV
SATDKATGKSQDIRIEASSGLTEEEIEKMKKEAEANADADKKTKEKVDKLNEADAMIFQT
EKQLKEFGDKISEDKKKPVEEALEELKKAYETKELDQITPALDKLNEAWKTASEEMYKAQ
AEAQGGQAGPQQGATGAQGGEQAGGDAKSGDDVEDVDFEEVK
>IFAGANLK_02986 Divalent metal cation transporter MntH
MRQKSTSKTSILKSIGPGFLLAGAAIGVSHLVQATRAGADYGFILIWVLIIACISKYPFL
EFGPRFAAGTGNHLITGYKKLGKFPYWIYIFITLGSMFIIQAAVTIVTAGLAERLFNFGW
SPFLWSGIILISCIALLLIGKYPGLDKSMKVIVTLLTLATLAAVIMAFGAGTVTDAVTTE
PPSLWTTASLGFIIAFMGWMPIPLDASVWHSIWTKEKAVQNKQKISVKGAFADFNVGYLS
AAFIGLLFFLLGVLVMFGSGTSFSNNSVEFSSQLVELYGKTLGEWSKPLISVAAFITMLS
TVLTVTDAYPRVISELKNPEKDNPEDKKDKWKIYRLSIFIIPVLSLSILYFLSGSFTILV
DFAAGLSFLSAPFLAWFNYRLVTGKQMPEKHRPGRNYKIFSLICLALLVIFNFVYLYYTF
LA
>IFAGANLK_02987 hypothetical protein
MSTEKQLSYQITNTYSVLNDFTERTQTVWLVCHGIGYLSRYFLRHFHHLNSEENYIIAPQ
AQSKYYLNNEYKHVGASWLTKERTEAETENVLNYLDEVYKTENLKNAPRLIVLGYSQGVS
VATRWISRRKIECDELIMHSGKVPAELKPEDFKFLKNTNFTFIYGTEDAYLKDGIIKVEE
KRLKEIFPTNFKIKTYKGGHEVNTKLIAEFA
>IFAGANLK_02988 Alpha-agarase
MEIFIRRLFLSVLLCVVCFSCSEEEDVPGVTEKATLSFSPILNDLLRNQQNKQESPELPA
CSDDTPSYVEIILLQGEEEVVGSSETPFAIDLVADENYTEYSPELELEPGTYTLDHFAVY
NSDGELIWLAPKGGAIGDLLQNTLPLEINLRSGVKKYVDVTVVCFDDRIVNEYGYLFFDL
IPTELFEYCFFANYCNEAGRHYTAAYTVDIWLGTDDSGTPLYTGVENVKSTEDEDPWADP
LCFDLPNLQDYEDDEPYLYYEVTLKGWPDVYGEVSEIVIDGTLSRADIQANFDGDDNVEY
EHLFFGCGDDGEPLDSDQDGIPDSEDNCPNVPNPDQADENEDGVGDACENGSDDDGDGVP
NDIDECPGTDPGVEVDEVGCESIQVPGRDVVVLNDINIFDNDALEDPDNVRFVQNLVNYT
TTGVRNSGDVVWIDRGRNARCYSNGECNETGWATTESVMADEGFTVESIFSSVGSLTNIP
SDVKIVMLVMPTSQYTVEEINTLKQFAADGGRIIFVGEHDVFYLNIDVENQFLANMGAVL
FNSGGAVDCGYNELPPASNRDHPIMAGIEDLTIACASVIEPGEGDFALFYDISNTLVLGG
VAKIDTAPISELKQVRRSKFRETKQLPNGSSSTGY
>IFAGANLK_02989 Putative esterase
MMTKEEILALSKKVCKNTLMETLEIEFTEVGDDYLIAKMPVTPRVHQPDGVLHGGASVAL
AESVGSMASYVFLDTEEFFIRGIEISANHLKSITEGFVYARASFIHKGRTTQLWEIRITD
EDENLISIVKLTTIALPKKK
>IFAGANLK_02990 Isochorismate synthase EntC
MNSEEFFIKLDAQIQNGNPFVVYRNPNAKNGLTKALLQDSAETYKTSNFTENGFVFAPFE
NAENAFLIPSENAELITTEYPAENSEEVKKENQDFPPAYTNNQAKIKHEELVQKGIEEIE
KGEFKKVVLSRKEDVQTQLEALVIFRNLLKKYETAFVYFWFHPKTGIWLGATPETLLNVE
REKFKTMALAGTQSFKGTSSVNWGEKEIEEQQIVTDAILENLEHKVSGKIHKSEPYTSKA
GNLLHLQTDITGMLDPEKSSLKSLILALHPTPAVCGLPKEKAKKFITENESYKREFYSGF
LGELNMKKEVKRNSNRRNQENQAYGSILKQTSLFVNLRCMKLNEGKARLFIGGGITKYSN
PAEEWEETVNKSHTIKSVLVK
>IFAGANLK_02991 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase
MKYSKIPVARSIVALCVAKNINHVVISPGSRNAPLTIGFTHHPEIKPYSIVDERCAAFYA
LGLAQQLQKPVALVCTSGSALLNYYPAIAEAFYSDIPLVIISADRPVERIDIGDGQTIRQ
KNVFENHILYSANLHSELVLDSEATDKKLQQKQFESQKHNEREVNLALNKAIEGKGPVHI
NVPFYEPLYDLVENVEVKPIQILPEIKERTYSENQLGAYADLWNKAKRKMVIVGVAHPNV
VEQEFLEKLATDDSVIVLTETTSNLNHPEFFTRIDTLIGPIEKDENREELFKTLQPEILL
TFGGMIVSKKIKAFLRNYQPQQHWHIDPKKAYNTFFCLNKHFETTVNSFFTHFFPLTQKS
KSDYGKFWKEVKSKRQVRHEEYMDKIPYSDLKAMQEIIPSVPENYIVHLGNSSTIRYAQL
FKWKESLRIFCNRGTSGIDGSISTAVGAACLNGEPTLMIAGDLSFFYDSNALWNNYIPKN
FRIIILNNNGGGIFRILPGNKHTENFETYFETTHQLQAKSLSEMYGFEYCSAKTSEEINE
QLKFFFSDTVQPKILEIFTPRKINDEVLLEYFNFMKS
>IFAGANLK_02992 hypothetical protein
MSTKTDEKVGKYIQDVKDKTGDEPDVGLLRKVTESCGPSIFRNDAETVSSSSESEMETVK
RNFLIKKLGLKDDEKLDVGLNAVMEKYGKSNRNKFRAVVYYLLTKYFKKESVFK
>IFAGANLK_02993 Conserved virulence factor B
MLRIGENHTLNIVRETEPGLFLTDTEGNEVLLPNKYIPETFEIGDEIEVFVYLDHEERPV
STTLEPLVKLDEFAFLKCVEVTEFGAFLDWGLEKHLFVPFKEQAYPMKKGGRYLIFCYLD
EETDRLVASSKVHAFLDNSELTIEPFEEVDLIISNKSDLGYNVIINQLHLGLIYHDDVFQ
EINVGDEMRGFITKTRPDGKIDVSLQRPGYRSIEPNAELILNKLKKNEGYLNLTDKSSPE
AIHSQLGISKKSFKRAAGNLYKQRKIDIKEDGIYLKED
>IFAGANLK_02994 hypothetical protein
MKFRLLFLSLFLFSITSVSAQEYWDVADFEISNYSIEPSWSDLSFGQQFFKGDFDLPSGE
FINVDDGKRASVDMVGILESQRNMKKRTVDIGSPLPTTNQKKKAFEISNNYRLRDNDEVY
NDALNSNPYYQNQRIYQNALHRQTQRRMYYGSQYYSPRGSYFY
>IFAGANLK_02995 1,4-dihydroxy-2-naphthoyl-CoA synthase
MSEINWKTVKEYEDITYKKSGGVARIAFNRPDVRNAFRPKTTSELLDAFHDAHEDTEVGC
VLLSAEGPSSKDGKWAFCSGGDQKARGHQGYVGEDGYHRLNILEVQRLIRFMPKAVICVV
PGWAVGGGHSLHVVCDLTLASKEHAIFKQTDADVTSFDAGYGSAYLAKMVGQKKAREIFF
LGRNYSAQEAYEMGMVNAVIPHDELEDTAYEWAQEIMAKSPTSIKMLKFAMNMTDDGMVG
QQVFAGEVTRLAYMTDEAKEGRDAFLEKRKPNFDKKWIP
>IFAGANLK_02996 hypothetical protein
MDPVAKDFSNEQIDLASLPKYESVAFSSVSSKYLIKMNIQTGIFMLVLTIALGVFWFFQL
NYIQSGIIFGFVFVAFIFRFWNNYKLLQSLGYAIREKDIIYKRGFIFSKTTVIPFNRVQH
ASISRGIWDKLLGISSLNIFTAGGGASDISIPGLEPDKAVQLKEAIALKISNDES
>IFAGANLK_02997 hypothetical protein
MNPEVYSKPQRQSIAGVLLIFISSIYKLFRSFWAIGAYLLVSGPSRTTLLYIGLALLLIG
FLTLIYSYLYYRKFIFYIDYKREEFVLEKGIFSTENTAIPFDKIQQVYFKRSILQRIIKV
YSLVIETAGSNLKEVEIKAVSEEDANILSKILLKAKAENTEKDSLKEESEEAEENKEVFW
THKVGFLTLLKIGISTNYLRGLSLVFAFVMTIYNRVNTYFKDQVEDVEVYFDQFSGVLQS
LGFLALLFVLLLLLSISITIIEVFIKYYGLTIQQNRDKMEVEMGLKTNTKVSLQPRRLQL
MRIKTNPVQERLNLYEAQISLSSSENELQKNKIKIPGLGKEIIKKIKYFLYPESSKSSFC
TIFKPDKLLLFRKISLAMLPVMIFLAIWYFLDFINLKLGAVLAIAGVYTFAALTLQILAF
RARKLIITEEFLQKKTGFWNKTEETLELFKIQSISVKQPIWYRRKNLVNVVFHTAGGDLR
FYAVETGIIQYVNYVLYKAEVSSKHWM
>IFAGANLK_02998 Pyruvate dehydrogenase E1 component subunit beta
MQSETKTKDSISFEDFKTEVLADYKIAVTSRECSLLGRREVLTGKAKFGIFGDGKEVPQL
AMAKAFKNGDFRSGYYRDQTFMMAINQFSIEQFFSGLYADSNLENEPMSGGRQMGGHFTT
HSLNEDGSWKNLMEQKNSSADISPTASQMPRLLGLAQASKIYRNVEGLSAENFSENGNEI
AWGTIGNASTSEGHFWETLNAAGVMQVPMVLSVWDDEYGISVHARHQTTKENISEIIKGF
QRDEENKGYEIIVVNGWDYVALIEAYEKAEKIARKEHCPVLIHVVELTQPQGHSTSGSHE
RYKNEQRLSWEREYDCNVKFREWILENNISTDEELQSIEKEIKREVREGKKVAWNKYAEP
TKAKQKELLAVLSKLAKNTEEKETVINLAKDLNSNKEPLKKDLAVAARKTLRAIRRENSE
EKSQLLNWLKDFNKDMADDYNSHLYIKSNGIQSEVLPEYDEGSTEVDGRIILRDNFDQIF
GNIPETLIFGEDAGEIGDVNQGLEGLQKKYGKQRVADVGIREATILGQGIGMAMRGLRPI
AEIQYLDYVMYALQGMSDDLATLQYRTKGKQKAPLIIRTRGHRLEGIWHSGSQMGGILNL
VRGMYVLVPRNMTKAAGFYNTLLEQDTPALLVECLNGYRLKEKRPSNLPELRTPIGKVET
VREGTDITLISYGSTLRIVCQTAEELSEYGINSEVIDVQSLLPFDLDHDIVKSVEKTNRL
LVIDEDVPGGASAFILDKVLNEQNAWRYLDSKPQTLTAKEHRPAYGTDGDYFSKPSAEDI
FEKVYAIFNEVNPEEYPAIR
>IFAGANLK_02999 hypothetical protein
MRFYLFYLFFFVGIGWGFTQNSIALQAHLNDSTHTFTIEQELVYTNSSKDTLTQIYLNDW
ANAFSAKDTPLAKRFAEEFARRFRFAKDEERGATHINKLTNTENESLIWERPYLAQDLIR
VKLYKPLLPGKSITINLDYQVKIPIDKFTRYGVDSNNNYKLRYWYITPGVYKNGNWEVFS
HKDLGDQYNAMHNVEITLTTPPKYYVGTALDFESVSTRNGFKTVKLSGKDQLDTKLYLTN
SFIFESIRTENHEILTNVDDEDLQPEIKRILLERILKYYNKRLGEYPHHNIFVTQDDYLS
SPIYGLNQLPGFIRPFPDGFQYDIKQFKTITNNLLKNSVHINPRKEQWVHDAILVSLMID
YVNEYYPKMKLLGNLSDIIGIRWFHAADLEFNDQYQFLYMNMARMNLDQPLRTAQDSLVK
FNKNIANAYKAGVGLKYLEDYLENSKVKDAVKDFYQENNMRPTTAEDFEQNLKNHATKDI
SWFFQDYVGSNKKIDFTIHRLRKTKDSLRVTIKNKRKTDFPVSLYGLKDGEIIFKKWVEN
IDKTKTIEIARQDVDRLALNYEQKIPEFNQRDNYKAVTKLFNKPLQFRLLQDIEDPKYNQ
LFFMPEFSYNLYDGISIGPKLYNKTVLSKTFNFNISPKYGFNSETIVGSASFSNTHQFEN
KELYKISYGLGGTRYSYGYNLFYEKYTPFLNFSFRDKYLRDNERQNLLIRNINVRRDSDP
DKTLDEPNYNVFNINYRYSKPHLVDYYSASFDFQLAEKFSKISMSLEYRKLFRNNRQINL
RFFTGTFLYSDNMETDYFSFALDRPTDYLFDYNYYGRSQGSGLFSQQIIVAEGGFKSQLQ
PEYANQWLTTLNGSTNLYKWFFIYGDVGLVKNQHQNARFLYDSGVRLSLVDDYFEVFFPV
YSNLGWEVAQENYDQKIRFIVSLDLNTLIRLFTRRWY
>IFAGANLK_03000 Cytokinin riboside 5'-monophosphate phosphoribohydrolase
MNKNLKNKAWNEIKTNDSWAIFKIMGEFVNGYEKLSQIGPCVSIFGSARTKPDQKYYKLA
EKISKKIVENGYGVITGGGPGIMEAGNKGAHLGGGTSVGLNIDLPFEQHDNPYIDNDKSL
DFDYFFVRKVMFVKYSQGFVVMPGGFGTLDELFEAITLIQTHKIDKFPIILVGKDFWGGL
VDWVQKTLLDTFQNISAPDMDLVQVVDTEDEVIEILNEFYGEYNLSPNF
>IFAGANLK_03001 UvrABC system protein A
MAKTEEFIEVLGARVHNLKNIDVNIPREKLVVITGLSGSGKSSLAFDTIYAEGQRRYIET
FSAYARQFLGGLERPDVDKIEGLSPVIAIEQKTTSKNPRSTVGTITEIYDFLRLLYARAG
EAYSYKTGEKMVSYTDSQIKDLILKDFKGKKVSVLAPVVKSRKGHYRELFEQIAKQGFLK
ARVNGEVRDLVKGMKLDRYKTHDIEIVIDRLKIDDKTDAQKRLDETIKTAMYHGSDTLMI
LDQETESVRYFSRNLMCPTTGISYPNPEPNTFSFNSPKGACPSCNGIGTLYQVNTDRIIP
DSSKSIKNGALAPHGPQKKNWVFSQLELIAERWDFKLTDPVSKIPDAAMKFILHGGKETF
TKESKSLGITREFKINFEGVATFIETTFNNNDSTSLRRWAKEYMDKVECPVCEGSRLKKE
SLYFRISEKNIAELSLMDIEDLAKWFVGLEKKLSEKQNQIASEVIKEIRTRIGFLVDVGL
TYLSLNRGSKSLSGGEAQRIRLATQIGSQLVGVLYILDEPSIGLHQRDNEKLINSLIALR
DIGNSVIVVEHDKDMIERADYVIDIGPRAGKHGGEIISEGPPSELLKHDTLTASYLNGSK
EIAIPKERRKGNGKHIELKGATGNNLKNVSIKIPLGQMIAVTGVSGSGKSTLINETLYPI
MNAHYFNGVKEPKPYKTIKGLDNADKVIDINQTPIGRTPRSNPATYTGVFSEIRSLFAKT
PESLIRGYKPGRFSFNVKGGRCETCRGGGLRVIEMNFLPDVYVECETCQGKRFNRETLEI
RYKGKSIADVLEMTINDATTFFEPIPKIYRKLKTIKDVGLGYITLGQQSTTLSGGEAQRI
KLATELSKRDTGNTFYILDEPTTGLHFEDIRVLMDVLNELTNKGNTVLIIEHNMDVIKMA
DYIIDIGPEGGKNGGKVIAKGTPEEVAKSKKSYTAGFLKKELH
>IFAGANLK_03002 Oxygen regulatory protein NreC
MITEKKQLLLITNKQSMVDCVQEGVSMQFEVAHANSLHTGFNMALNLLPDVILLDYSSFR
SGRNFKNIANFKSNHFLTKAWLVVYAEERYRAEAESRFRKVVDEFLYSPTIEALCGKIIK
LVYSNRSLSNFWKDAFMGMFNIISQPVVLLDQNEIVAMNDAFKQSFDVRDKKGLKLTDFV
KCENIQKVKDSLRNFARGKHIKASTKTALLLRNDKVRNARINFSKLNRNFGHQFVMFIDL
MEENDVINDRIGTASEEVEDCFKQNSQLTDFKFTNREKEIIELLIKGYKTKDISEALFIS
PKTIEKHRSNIIKRTNSDTILESIIYAINHKLIDYQKV
>IFAGANLK_03003 hypothetical protein
MKNLKNYLSSLVIVAMLFTSCSKDESTNNVGTDGEMASISLGAVLNDLDRQGLLKQAIPE
CSEDAPMYVRVVLTHDLGEEDVVVPVNFDGTTYFTDYDEELAIPIPAGETTTSISVSDFW
VYSEEPGESTLPIWVAPKEGSEYENFVNDPLPMNFELRAGSKKYVDVEVLCFDDRDVNLY
GYQFFDLIPIPMIKFCLFGNFCPSEDGRHYVAGYTVNVWQGDAPVGDPIYTESNVVDEDD
ATGDYYSDPLCFWLPDTDETDTYYFEITLDNTDEYSSDDAGEVILAGPITDDEIKMFYSE
DDDSTMDYYHFNYGCGNDNPPPFDDPRTEAKRYKACLKNLGDSNAVGFAYLKLQGNQLTA
TTAATELTPGDVPQHIHENATCADYGSPIWDLDYTGDVWPEADGAGNLFYTRTFTLTPAQ
VAAANLDFRTAVLHESDMTPLACGEFEEY
>IFAGANLK_03004 hypothetical protein
MKSLKLILAIFVATGMLFSSCSKEETNEPAGNEEMGSISIGAILNDLVDDNRQAISDEIP
ACSDDTPMYAWVVLTHELGTEDVVMPILFDGETYFTDYDEDLEISIPVDQTTTAVSLTTF
MVYAEEPGEGVSPIWVAPTDEGEYKNFVNDALPINFDLRAGSKKYLDVEVLCFDDREVNL
YGYQFFDLIPIELYKFCVFANYCTDNGRHYTANYNVNIDYIREGEDDINLYTNKSPETGN
TEDDNSGDWYAEPLCLAIPSPMYDELDTDNYLRVTVTLAEWDDNYGSPEPEEPEVIYLSW
NDVQSYFGDNDTIDYEHIFFNCGDDPILDCPVTEEDTDGDCVPNEDDLCEGYDDDEDMDE
DGVPDGCDQCPEEAGDPLDGGCPIDDCTGDADSDGLNDCEDECPYQAGPESNNGCPEDGG
DTCQTAYMEGDTELNTLANSNRWGWAEHYQIDTDGTNKTFDIWAGAGQNDTSKGDQIGTA
EISVDDDEITLEITLNPGVSLNDLHINLSENAPSGNDVFAPGQYNLNDEVDVNTLTYTWE
RGYSEDFYIIIHAVACY
>IFAGANLK_03005 hypothetical protein
MKLLRKYLALVAVFSLFFTSCTKDEDGTLNNDPGSESFAELSLGATLNDFVNRAALKQSL
PDCSSETPAYAHIELTHNAGTDLEGVINLNVPVLSEDGSFYTDYDEDLKIPVANADDKTA
TVSVTTFLVYDGDPDNEGSAVIWVAPATTSEYGAFVNQGLPYDFPIRAGSKKYVDIEVLC
FDDQEVNLYGYQFFDLVPEVLHEVCIFANYCDDDGRHYTANYSLEVIYTGGDQDRTLYTS
MDLPEDSYGFDEESGDYYADPFCFAVPAPMFEENSTTDYIRIIATLSDWQGNYPTPAEEE
IVLNLSWSDIMESVREDGTIDYFHILFCDDDPGNGNGEECDLDDPAADCDNDTIPNGQDN
CPSTSNTDQADLDEDGVGDVCDPDIDGDDILNENENPGCVRDPDPTCGEDVAECPTLPSS
GDCERVYVAGTDISDLTDWIAVTDSEPLPLFISDNPTVALGLISFDADGDRLLINTNTTF
YLKDYKLEIVDELGETITCVYEDNLIAPEDTNEADVDMEVTGDFSGTVYVRFSANVCSRS
DT
>IFAGANLK_03006 Flavastacin
MKKSKFLLLPVLAILACSKDPISENQESETQLKPEEISDQQSEMAFPNDLGSVSQIYYAG
QKMPVEDHGDDYVYQGDILIPKNQSSKSPQSIVYKNKEAIPQEKSTGRTSGMWPDNTVYY
SINSSLPDKNRIHDAILHWENKTPLKFVERSGQSNYIYFTTGSGCSSYVGMIGGRQNITL
SDYCSTGNTIHEIGHAVGLWHEQSRVDRSNYITVHLDNVRSGTEHNFHTYEASGFDGDEY
TTSLDFESIMMYGAYSFSKNGEPTITRTNGSTYQVQRSALSSGDISGIKSMYTDDGSEPK
YVNGEYYTLNGLTVLRNYDRWYYNSKWGWKEVEIKYGYWFFV
>IFAGANLK_03007 hypothetical protein
MKKNIRFSLGIILILFCVISCTKEEVGKELEESHAVGKLSFGSVLSDLTNRNKLFKQATP
DSYDIPQCSDENPLFVRVAIKVKDESGNWIWYKNSHQDKIEIEVNPNGTDLDNDGNLDAW
FTQESADLELEEGEYRIEYFAIAAAAGNNQSDIIYMAPRVPKGDLDYSQSIQYHNFVDKP
LPIEIKIRPGVKYYQPVEVLCYEEHYAFAFGYLFFDFNTTNLIYLCTYGNVCEEDQRHMP
AQFKMKVWEDSNDGDLLVVAQNERNTFNDDNGTHYYADALCFPLPEIEEYYAKIWLIEDE
TESLIREGNFNAEDLTNVYQEEQEHYYYHFREACCGEEDNSELLNDLTENEGECEEEPQD
PEEPGDCEECKGKISKLTFKYLGSGDPNIRVHQKTNGNNRMEIFSEIVNSGDTFTVIGDF
SQGNQPKTLWTDIYIKEGHNEEIHIHTSCSDENVVPGFVVGNFEIISGESAEGGLLCPVP
N
>IFAGANLK_03008 hypothetical protein
MKNFKIYLAYVALLAMVMTSCSKEDNPDSPDGPAGDEMATLGFTALLEDFDRAMATKQAN
PGNEGEDAIPACSDEQPAMVRVALQDSDGNWVLDRDGEEDFIEIPVVPGEEGDTNWITDE
GSNDELELLAGTYSLEYFDVVDSDGNPIYIAPRENDDYGPAEYQNFVSDALPIENIVLQN
GVKKYIDVEVLCYDEHYVQEYGYLFFDFTEVDIVYLCLFGNYCDEDGRHTPAEFQFSVWN
YTENTIPDTSDDNLLYRDVNETGVYENGDAYARPLCVALPARGEEDENVYYGELSMQNEE
GEWEVIRLGAFSQDDVETLDLSEVPEGYDSGSNYYHFREGECGNQDDSDPCLFSEYVTVE
NDFESGDFINSISFEDDTDYDIFDPNNPYGSYLITETPSDLYGPFTSHADDDGMMLVLDG
SPEGYADRAYYTVRTPELCAGATYFVTMRLRDLSQPDVNNARLSINYQSEDDPNGVVLTQ
FTITDLDGGSDPQGWKEVGFIMEAKADGQMIMRVRDVEDANSGNDFAMDDITLSNDPAIL
GGLSADNINPAN
>IFAGANLK_03009 Acyl carrier protein phosphodiesterase
MNFLAHIYLSGDNKHLKIGNFIADSVKGKQYLDYPPEIQKGIILHRAIDTFTDTHPIVSK
SVERLFERYGHYSRVIVDILYDHFLAANWEEYCEIPLKEYTEDFYKLLQDNFEVLPKPVQ
NFLPYMVTDNWLYNYRKIEGIEKILFQMNRRIKYRAKMHLAVEELREFYEEFENEFRMFF
EELRSYVKSEINA
>IFAGANLK_03010 Phosphomannomutase/phosphoglucomutase
MSLIKSISGIRGTIGGKTGDNLTPIDTVKFAAAYGTWLKNNSEDKKLKVVVGRDARISGK
MVQDLTMNTLTGLGIDVIDIDLSTTPTVEIAVPLENADGGIILTASHNPKQWNALKLLNS
KGEFLDGAEGAKILEYAEQDNFNFSEVDDLGSITRKDNYMDLHIEEVLKLKLVHAEKIKK
AGFKVVVDGVNSSGGIVIPNLLKKMGVEVVELYCEPNGHFPHNPEPLKEHLSDICELVKK
ENAHFGIVVDPDVDRLAFIDENGEMFGEEYTLVACADYVLSKTPGNTVSNLSSSRALSDV
TKKHGGEYKASAVGEVNVVKLMKDSNAVIGGEGNGGIIYPESHYGRDSLVGVGLFLTHLA
EKNISVSELRKEYTAYFMSKNKIQLTPEIDVDSILKAMEEKYKNEKVSTVDGVKIDFPEN
WVHLRKSNTEPIIRIYTEAKSQEKANELAEDMIKEIKKIIA
>IFAGANLK_03011 Lipid A biosynthesis lauroyltransferase
MQAVVFWLAYPLLWLISILPFPLFYLVSDVVYFIVYHIIGYRKKTVTNNLKLVFPEKSDE
EISKIRKKFYSHMCDMFLEMIKSISISEEELKKRFVYTNLEELRRIEKLDKSIMLMCGHY
ASFEWLFALQLHDLKHSAFGIYKKIRNPGFDKLINDIRQRFGAELVQNSKASVRIAQNEK
QGVRGAYAMIADQSPKTPSYKFWTDFMGKKVPFYTGSERIATEFDMVVLYLHVEKVKRGH
YKASLINIADNPAETKNNQITLDYIQHLEKQIREKPELYLWTHKRWKHVGKEIPTNAVVR
>IFAGANLK_03012 Rhomboid protease GluP
MGELNLVTLIIIGVNVLVSFKGFKDDSFFQKYKFNIADINRGAKYQILTSGFLHVNTTHL
LVNMLTLYFFANSVIFFLGTVGFIIVYLASLVLGNLLSYYFHKKDMHYTAVGASGAVMGV
LYSAILLRPDMMLGLFFIIPIPAYIFGIGYLFYTIYGMKRQVGNIGHDAHFGGAVGGYLL
TLLLASWVFEEHLLMVLLLALPIVFLFVLQKMGKI
>IFAGANLK_03013 26 kDa periplasmic immunogenic protein
MKKLILLIAVVTGFGMQAQTENNNTGIHVTGEGVVKVAPDKVTIKSQIEHEGQSATSVKS
QNDEVVDKVIKYLKSEGIAEKNINTNYINLNKRYNYNDKTYTYVANQAISITLEDISKYE
SIMKGLLENGLNGINGIEFESSEIDKHKAEARRKAVLNAKEKAEALAEPLGQTVGKAFKI
SEGSSNNNQPVYRAMEMKASSDQASNQETIAPGEMEISIEVNVAFQLLME
>IFAGANLK_03014 Thiol-disulfide oxidoreductase ResA
MLAVATVFASCQEDKGYFISGSVPDMENGKMVYVSEIDENTNRPKRIDSTTLEDGEFELD
LEDPETPNLSFLEFEGLQGNVIYIAENEKINFKVYKDSLRTSEVNGGKENRLLYDYLGHL
KNVNEEVTKGRSEMQSAFQEQDSTKLATLQETETEIIDNDKVYKKKIVKENPDSFVSIMV
ISDMLRMKSYPANEIKEMFDGLSEEVKNTAIGKQIAQNLEKENKVAVGSKAPNFTAPTPD
GDELSLKEAMGKVTVIDFWAAWCKPCRVENPNLVRTYNKYKDDGLSVIGVSLDRPGQKDR
WIQAIEEDGLPWHQVSNLKFWQDPVAQLYRIQAIPAAFVLDEKGTIVARDLRGDDLDNKI
GELLNKG
>IFAGANLK_03015 hypothetical protein
MKEQKQNLPFEIQISFHKVVEQYKKQLECEENEISRNYIKSILEHVEAFPALTEGIKDFE
ELKNYKEPVRVLLDDLFPNVLTNNEIKAASIPFQNFLFNRSKRLKKIMEATPDDFALEIR
NLDNKTVYVQECINILNDYYGYKIDYSRPLYFDIPDEQGIVRRYRIALNGDFIDIYPKEN
AKKITDEDVDELLQNVEDIDLWRKKFPPNSWVFKGFTIVNLTDVTMDDAISELKTALLFE
KSSEKDELQKLEEIFRSIYKIPDLRVGFTIYNPQDEMFEKMEYKEANSYILNDELVGECR
EGVCEEGFNNIFKNHSFFSIANVDEYAKKTENNILSRRLKEGDVKSCILAPVVKNNRLLG
ILELVAKEKNQLNSINTIKLDEILPYIATAVDRNRSDFENRVKAVIQSECTSIHPSVLWV
FEKEAKKYIKDYDDDGLASFKDIVFKDIYPLYGQIDVVASSDARNDAIQKDLLHQLKIIQ
SIIDKAYNIEELPIYEQVKFRISDFMEELESSLNASSEQKVFNLLQKEVNPIMSHLSKQS
SELKKAVEEYQNQLNPETGIIYDHRKKYDETVQQINRTMSRFLDRKQIAAQKIYPHYFER
YKTDGVDHNIYIGASMVKDRPFNKVYLYNLRLWQLSTMCEMENRFYQLQQTTPIKLDAAS
LILVYNSTMSIRYRMDEKKFDVDGTYNARYEIIKKRIDKSFIKGTEERITQKGKIAIVYS
QRGDEKEYLRYIKYLQTKNYLGEDLELLELEDVQGVVGLKAIRINVLYTPDTNEPDRTIT
YENLMEELH
>IFAGANLK_03016 hypothetical protein
MNNLIEKADDFVLNLFKEKLPNTYIYHNYKHTERVVKSTKELIANSEINVKQEEALLLAA
WLHDTGYTRTFKGHEDESIKIAEDFLKQNNATPELIEDVLNYINATKFDSKPESLPEKII
KDADSSHFAKEYFEETSELLRQELELHNIKNFTTREWIQENIRVFTEKHQFYTDYAIEEW
EPKKEENLLELIGDKNKQEKKLKKEEAKARMKARYKNDNPERSIQTLFRVTLRNHIKLSD
IADTKANILLSVNAIIISLALANMIPKLDAASNKHLLIPTLILILFSVASIILSVLSTRP
QVTSGEFTKEQVKNREVNLLFFGNSHKMPFEQFKWGMKEIIKDKDYVYESLMLDLHLLGK
VLHRKYKILRITYTVFMIGIIVSVIAFVGAFYLM
>IFAGANLK_03017 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MSLTALLVIFSCVSSDPKYREGEATSNFGYPYDKEIEKSFYLLGDGGYSPIGGSSEGLIA
FKSYLDSVKQSDNYTIFLGDNIYPDGMPEEGHPDREAAEYRIDAQLDAIEDYDGNVLFIP
GNHDWYNERIDGLEREEKYLKEKFGEDLLWSPKTGCGLEIMDIGDEITLIVIDSQWYLED
WDKSPTINDDCAEIKTREAMFLEIETEFKKSQNKNIIVALHHPLFTNGIHGGQYNFNRHI
YPSQKKIPVPILGSLATLIRTTGGVSIQDAQNERYKSLVKRLETLGQKSDRLMFVSGHEH
SLQYIEHGKIKQIVSGSTSKATYATLSNDGVFAYPEQGFAVYDVFKDGSTWVSFYGNKEN
KPNLLFQKEIFEAPKEFDVSEFPQEFDETITTSVYPEDETDKGSVHRSVWGERYRELYGT
DITLEVADLETLYGGLTPMRAGGGHQTISIRMKDSLDREYNFRRIKKKAVQFLQTVAFKN
TPIETQLENTVAEDIISDFYTAAHPYAFLAIPTMADAIGVHHTNPEIYYLPKQPRLGKYN
EEHGDAIYMIEERPEDHWLGVESFGSPNHDIQSTAGMFDRLRRDEKYSLDEPAYVKARIF
DMLIGDWDRHQDQWRWAEIEDEEGNRLFEPIPRDRDQVFSNFDGAFFGTLRALTGFASQF
AVYGEDINDVEWFNVSATGLDRSLLQNVGKETWREQAEYIQENMTDAVIEEAFSKLPSET
YDDTTKELIKKVKARRDNIVDIAMRYYDHFADLAIVTGTDKDDFVDVTRMKDGKTRIKIS
RNKGGERADVLSDKIYHKEDTDEIWLYALDDDDKIQVDGEGDNYIFLRIIGGQNNDIYTI
NNNNRLKIYDHKSKPNTIEEGGGAKFRFTDDYEINTYDKDKKNFTTGSILPGFGFNPDDG
FKIGLEVVSTKNAFKRNPFTAQHTFGGGYYFATNGFDLYYEGEFANILGNYNLKVGADYA
SPNFARNFFGFGNQTPNFDGDLDFDYNRVKISRFGVKAGFENATPFGSLFRYMATFEGNK
VEATEGRFITEEFETDDPEFFDRKYFAGLDALYRYESYDNNLNPSRGMKFELNLGGQMNT
TDPDQVYGYFKPYWGFYNALTTNRKLVLKTRVQAHLNMGDDYEFYQAAHLGGESGLRGYR
LQRFAGKSAFATGADLRYGFDQFTTRFLPLQIGVFGGYDLGRVWADFEDSNQWHDSYGVG
FWVNSAEAVNGTFSLFRSDDGYRFAFGFGFQF
>IFAGANLK_03018 Small-conductance mechanosensitive channel
MEDEFNLRESLEGITAKLVSWLDALILNLPNFLLAILVFIIFIFLAKYTGQLLSKLLGKQ
VKQDSIRQIAVKVSKAIVILIGFFIALGILDLNKVLTSVLAGAGVVGLAIGLALQGTLNN
TFSGIILSFLPELQIGDWIETNSYAGEVTEINLRNIVVKQADNNYVIIPNSKIVEEPFKN
FSRTNRSRVMLNCGVAYSSNLEKVKEITIETISKHFPSRGNEQVEFMFTEFGDSSINFVI
RFWADATKNRDLLIARDIAIIEIKKIFDKNGINIPFPIRTIDFSNTLNMKKPD
>IFAGANLK_03019 DNA protection during starvation protein
MSYLGLDKEKTSKTVDELNVLLADYHLYYQKLRNFHWNVIGKNFFDLHEKFEELYDDAKL
KVDEIAERILTLRYTPISNLTDYLKTSNLKESKADLTDYEMIETLLKDHGTLLKQMRSVV
ETADKAGDEGTIDLIGAYIRELEKTSWMLDAWKMKTTDSHKSSK
>IFAGANLK_03020 hypothetical protein
MKDYGTLSQAINKLKLEEGYEHDFNLLDEEIELKSKKETFGVEDFDVDKVLRFEGMSNPD
DNAILYAITTSKGYKGVLVDGYGISSGQVSKEMMAKLDLKDNRPIN
>IFAGANLK_03021 hypothetical protein
MKFRKSYWLYIIAAIITIVGLVTGWYFFLLLVFPLGFFSFGNNKNEENN
>IFAGANLK_03022 Catabolite control protein A
MKNKITLKELAKLLNVSVSTVSKALHDSPEISPKTAERVKELAKLHNYRPNPVAVNLKSS
KSGTIGVIIPNISNTFFANVLLGIEARAQKSGLQVITYISNEKLEREQQIAEMLTSGFVD
GVLIAISEETQRKKEYDHLFNLVDYDIPVVLYDRINIDLAVDKIGVDDEQSLEIATRLLQ
TKGIKKIGVASSIHHLGVGKLRITGYRNALKNEEDFYIANSSKPDTLREKTQQLLVEDKV
EAVLCTDFVSTMMVYRLAYENKISIPRDLKVIGFLNADVARFLTPSISYVEQFPEEIGEE
AVDLLVNRIENRIAGKQPINKTINTKLIHLESTDF
>IFAGANLK_03023 dTDP-glucose 4,6-dehydratase
MKSLKRNILITGGAGFIGSHVIRLFVNKYPDYQIFNLDALTYAGNLENIKDIENAENYNF
LKADITDADKIKALFQEYKFDSVIHLAAESHVDRSISNPKIFVETNVTGTMNLMEAALGI
WKENLEGKLFYHVSTDEVYGTLGETGLFTETSSYAPNSPYSASKAASDHFVRAYGETYNL
PYIISNCSNNYGPNQFPEKLIPLFINNIIGNKDLPVYGDGKYTRDWLYVMDHATAIDLVF
HKGKNKETYNIGGFNEWQNIDLIKLLCKIMDGKLDRRKGESEALITFIKDRPGHDKRYAI
DANKINKELGWEPSVTFEEGLMKTVDWYLNNPQWIEAIVSGSYKEYYKEQYL
>IFAGANLK_03024 Glucose-1-phosphate thymidylyltransferase
MKGIILAGGTGSRLFPLTKSVSKQLLAVYDKPMIYYPLSVLMLAGIREILIISTPEDLPN
FQKLLGDGKAWGLNLSYAEQPRPNGLAEAFIIGEEFIENDDVCLVLGDNIFYGQGFSGLL
ENAVRNCKEAGQATVFGYYVNDPKRYGVVDFDASGNALSIEEKPEKPKSHFAVTGLYFYP
NSVIEIAKKCEPSARGELEITSINQEYLNQKELKVEIMGRGYAWLDTGTHESMLEASNFV
QTIEKRQGLKIACPEEIAFRKKYIGKDQLQELATELEKSEYGRYLLGLIR
>IFAGANLK_03025 UDP-N-acetylglucosamine 4-epimerase
MTEFQQRLENKKILVTGGAGFIGSNLCETLINLNAEVVCLDNFATGYKHNLDAFKRHKNF
MLIEGDIRNLETCHKACEGVDYVLHEAALGSVPRSLADPITSNEVNISGFLNMLVAARDA
GVKRFVYAASSSTYGDSQKLPKVENEIGKPLSPYAITKYVNELYADIFQDAYQLDTIGLR
YFNVFGRKQDPNGAYAAVIPKFVMQFMKHESPVINGDGTYSRDFTYIDNVIQMNLLALTT
GNEDAVNEIYNTAVGDRTNLVELTQLLKKHLSEFDTKISAVEVKHGSNRAGDIPHSLASV
EKAKELLGYEPSHRIDDGLKEAVAWYWENLR
>IFAGANLK_03026 Acetyltransferase YpeA
MMGNYEILKWDSDFFGFKVAKIEEQVFKNKTTDPEDFFWHLKQENVHLIYCYSSKPIDVL
KFNKHYSFDHIVTRIPLIMKLNRKFDFHPKISFYNEDNVNESLKELAVLAGLKGRFGKDK
KIPKSSCEGVFKSWIENSLLNKEPVLIYKIDNEIVGMITFKIEGESGFGGLLAVYPEFEG
KGISFALLRAMMYVLQERGCNFFYSGTQQLNTKALKVFERFGLIPQEPQFVYHLWKKN
>IFAGANLK_03027 UDP-N-acetyl-D-glucosamine 6-dehydrogenase
MKNKKLAVIGLGYVGLPLARLFATKYPVIGFDINKARVKELMSGHDSTLEVEDDVLQSAL
VQKDGFKNGKGLFCSADLEDILDCNYYIITVPTPVDKNNRPDLTPLYKSSETVAKVLKKG
DIVIYESTVYPGVTEDECVPVLEKHSGLTFNKDFFVGYSPERINPGDKEHTVDKILKVTA
GSTPEIGKKVDALYAEVITAGTHLAPTIKVAEAAKVIENSQRDINIAFVNELAKIFNMMG
IDTQDVLEAAATKWNFLPFKPGLVGGHCIGVDPYYLAQKAQEIGYHPEIILAGRRMNDSM
GQYVASEVVKLMLQNDQKVKGANILIMGITFKENCPDVRNTKVVDVIKNLKEYGTNVTIY
DPLANPEEVNHEYGLKTVRELPGEKYDAVVLAVAHSEFLEMDLDQLKNGNTVIYDVKGVL
GDRCDKKL
>IFAGANLK_03028 UDP-glucose 6-dehydrogenase
MKIKNICCIGAGYVGGPTMAVIAQKCPEINVTVVDINDQRIAAWNDEDVENIPIYEPGLS
AVVQEARGRNLFFSTDVDAAIDKADMIFISVNTPTKTYGIGKGMAADLKFIELCARQIAR
VSKDDKIVVEKSTLPVRTAEALKNILDNTGNGVNYQILSNPEFLAEGTAVDDLMNPDRVL
IGGDIETPVGKEAVEALVDVYAHWVPRERLLTTNVWSSELSKLTANAFLAQRVSSINAMS
ELCEKTGADVNEVSKAVGMDSRIGSKFLKSSVGFGGSCFQKDILNLVYISKSFGLHEVAD
YWEQVILMNDHQKRRFAAKIVQTLFNTVSGKKIALLGWAFKKDTNDTRESAAIYVADYLL
NEQAEIVVYDPKVSTEQIYTDLDYLNSRSSEENRARAKVVNTPYEATKDSHAVAILTEWD
EFKDLDWQKVYDEMLKPAFLFDGRRLLQRETKEAIGFEFYAIGS
>IFAGANLK_03029 3'(2'),5'-bisphosphate nucleotidase CysQ
MKEIFNIAIAAAIEGGKKIMEIYNDNDFQIENKEDDSPLTIADKKANDIINKYLLPTDIP
IISEENKQLDFSERKKWRNCWIVDPLDGTKEFIKKNDEFTVNIALIDNNKPVFGVIYVPA
KNELYFGDVLNKKSFKGVIKEEKFEFRQSDFREIHPTSVGEKIKVVGSRSHMNQATLDYI
EILKTQFNKEVEIVSKGSSLKFCLVAEGKADVYPRYAPTMEWDTAAGQAICNAVGLEVID
KQTGTSMEYNRKNLLNNYFLVSNLG
>IFAGANLK_03030 hypothetical protein
MDKSYKRHIAKSITWRIIGTIDTILLSWLISGDPYTGMQIGLAEVVTKMLFYYVHERIWF
KIRAGVTKNGDSKKRHIAKTVTWRVVGTIDTMILAWLISGDPMIGLQVGAAEVVTKMILY
YFHERAWYKIDFGLEKRRREKRET
>IFAGANLK_03031 putative adenylyl-sulfate kinase
MENIIPQNFHIDKEERNKLNGHNSFVVWFTGLSGSGKSTLANLVEKKLFETGIKTFSLDG
DNIRSGLNKDLRFSADDRKENLRRIAEVAKLFIESGTVVIASFISPLKKDREYLKKTIGR
QNFIEVFVNTSLDECERRDVKGLYKKARAGEIKNFTGIDAPYEKPENPDLEIKTEEENLE
DALKRIVLHLEDKLKISVT
>IFAGANLK_03032 Sulfate adenylyltransferase subunit 2
MSKYYLNYLDELESEAIYILREVWAQFENPVILFSGGKDSILVTHLAKKAFYPSKIPFAL
MHVDTGHNFPETIQFRNDLVEKLGVKLIVGSVQDSIDQGRVAEEKGKNATRNALQITTLL
DAIETNKVDCAIGGGRRDEEKARAKERFFSHRDDFGQWDPKNQRPELWNLLNGKHFEGEH
FRAFPISNWTEMDVWNYIKRENISIPSLYYAHEREVVFRSNSWIPVSEYLKLEEGEKVEK
KKIRFRTLGDITITGGIESDADTLEKIALEVSAMRKTERGDRSDDKRSETAMEDRKKQGY
F
>IFAGANLK_03033 Bifunctional enzyme CysN/CysC
MEINNNQLLRFTTAGSVDDGKSTLIGRLLFDSKSIFEDQLESVSNTSAKKGHDGVDLALF
TDGLKDEREQGITIDVAYRYFTTPKRKFIIADTPGHIQYTRNMVTGASTANAAVILIDAR
HGVIEQTKRHSFIASLLNIPHLIVCINKMDLVDYSEEVYNNIIGQFEEFSSKLLMKDVRF
IPISALLGDNVVNRSKNMDWYQEGTLLSTLEKLHISSDINKIDARFAVQTVLRPQNEDFR
DYRGYAGRIASGIYRVGDEVAVLPSGFQSKIKSINAGEKEVKEAYAPMSVSITLEDDIDV
SRGNMIVKQNNQPEQEQEFDVMLCWLNNDPIKPRAKYTIMHTSNEERAMVKEVVYKMNIN
TFERDSEDATLEMNDIARVKIRTTRRLMLDSYRDNRNTGSIILIDENTNETVAAGMII
>IFAGANLK_03034 hypothetical protein
MNKYTVYRFLSRSSFIIYIYRKYLKIKKKIVLKTLKPQYNSKVFCIGFQKTGTTTLGKSL
EILGYNHSSFDHTLYLKHYKKNRNISKIIDYTSKFDSFDDMPWSKTDLIPILDYTFPGSK
FIYLTRDEESWKKSMKNWGYKKFGKHLDVEALYKEYLKHNEFVLSYFKDRIGEDLIVLNI
GDKKGFKKLANFLSRKTHLESFPHYNKTSDIRIKI
>IFAGANLK_03035 hypothetical protein
MNKIKKKLRNLLTKNNDEEIASSSLEYLYDIIQSSALDKMQHMDINDLSFLSIEYNNLEN
QFEQATSILKNYGIVLIKNAISEKLSDDVFENFKKIQKDFKSSDRLIRDQVTETYYIDSE
GLKFKTYQEKANYSKTIFSIRNGADKGMIDVFNYDYIDKKNSSNLRKVYENPRIVDLINS
ASEKKYSPKNLNIYYNQDIQNTRGFHVDAYSKGKIKAFIYLTDVKDISYGPYSYVIKSNT
DSEAEKLNKTFAKLSDKKHTEAFCFKIENAYPILGTKGTLVISDQAGIHRGHPQAKERER
MVAVMNYEYEKE
>IFAGANLK_03036 hypothetical protein
MIRINKKKWISNNINLIPDFIISGAMKSATTTIHEVLSYHPDIFIPRSEIRFFELDNILQ
HPRFHSFDKNTKSWTGRLDGKKLEESWNWYHNLYKGNESKIKGEDSTSYLASRTAAQRIA
SQNKNIKMIFLLRQPSLRAFSQYLHMLRSGTAMWSFEDTLVHNPYSVLTRSLYKEQLQHY
YDVLPSNQIKVILFEDLVSDPERVLINLSTFLKIDFNLFPKDIFNTHANRAKLPKFPELQ
MQGNKIIENLGPRYINDLQNRKYQPISHKVFEKIYDNFNPSIAKAAPKINRSTKDYLDSY
FYKELFEIEELVGQKILTKWFN
>IFAGANLK_03037 UDP-N-acetylglucosamine 4,6-dehydratase (inverting)
MHILKDKSILITGGTGSLGKALTSHILTNFPEVKKLVIFSRDEQKQFEMAQDYPSKDFPQ
VRFFIGDVRDEARVKRALKGIDYVIHAAAMKHVPIAEYNPMECVKTNIMGAENIINACLE
TSVERVVALSTDKAAAPINLYGATKLASDKLFVAANNITGWNPIKFSVVRYGNVMGSNGS
VIPFFLKKKKEGVLPITEPTMTRFNISLRGGVDMVMHALENAWGGEIFVPKIPSYKIMDI
AEAIGPECEKPVVGIRPGEKIHEEMITDSDSYYTYDLGKYYTILPATHKWKLEDFVKKFN
AKKVTPGFQYNSGENEEWETVEDLRKLIKEHVDPTFEV
>IFAGANLK_03038 UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase
MKNPIPYGRQNITEEDIEAVVNTLKSDYLTQGPRIAEFEDDFSDYVGSKYAVAVSNGTAA
LHLCAIALNIRPGDKVITTSITFAASANCVRYCGGEVVFADIDPETYLLDINKVRELLEN
APQGTYKGVIPVDFAGRAVNLQEFKQLAEEYDLWIIEDSCHAPGGYFIDSKDQKQLCGNG
EFADLAIFSFHPVKHIASGEGGMITTNDKKLYEKLLQLRTHGIVKDDNKYINTPDFANGF
TVNSSVDETYPAWYMEMHDLGYNYRLTDFQAALASSQLKRADEGLEKRSVIASRYQEAFK
NKYFIKGQSGVIDGHAYHLYVLEVEDRLGLYNYLRENQIFSQIHYIPCHLMPYYREFGWK
EGDLPVAEKYYKTCISLPIYPTLLKEEQEYVIEKINSFYED
>IFAGANLK_03039 hypothetical protein
MKISEKLGLGTVQFGLPYGISNNSGQTTAEEVVKILETAKSYKIDVLDSASAYGSSEDVL
GENDLSAFKMVSKFLPPSKGESISIQLEDSLKKLGVQSFYGYLAHRPIELIGHSEHWEEL
IEFKSEAKINKIGFSLNEPEELELLLEKGYFPDLVQVPYNYFDRRFENAMKILKSGGCEI
HARSAFLQGLFFMDPQQLDGFFEEVKPLISQLQKNIPLNGTLLKFVLDKQFVDKVIIGVE
SELQLKENIKSLTKADSLPELENRITDNILIPSRWPKN
>IFAGANLK_03040 Inositol 2-dehydrogenase/D-chiro-inositol 3-dehydrogenase
MAEKLKIGIIGMSEGNGHPYSWSAIFNGYDKEKMKYCPFPIISEYLAKQNFPEDGLGKFG
VVTHIWTQDIATSKHIAASAKIEVVVENLEDMLGKVDAVLLARDDAKNHYKMAFPFLKAG
IPIFIDKPLALSVKEANKILKEQQYENQVFSCSSIRFAKELDLTEKEKDQIGEIVHVEAA
IPKKWDTYAIHIIEPIIARLPHRGKLLGVKCLQSVAITNCIVKWENTTAYLKVTGTIPIT
VSLNFYGEKGCVTKEFSDSYTCFKNSLHKFVKVINKEEENIKREETLEIIKILEKGRK
>IFAGANLK_03041 Dihydroanticapsin 7-dehydrogenase
MKSILITGGSGKVGFQLVKHFLKKRFTVITSSTDKERFLDNKEKELSHYKLEALHVIEVD
FNTENAKNIILEYLQLHNIVLTDIIHNARSLNFLKLEDDKTISNENFSGEFYMDVVFPYQ
LSMAVKNQMFHKLQNIIFISSMYGVVAPTPALYDDFENSSAIHYGVSKAAQIHLTKELAV
RLAPEIRVNCVSFGGIKGRTDEHFENRYKKLTPQQRMLEEEDVIGPVDFLISKSSTNMTG
HNLKVDGGWTIW
>IFAGANLK_03042 CMP-N,N'-diacetyllegionaminic acid synthase
MDNLVNKKIIAVIPARGGSKRIPKKNILEINGKPMLAWTIEAALKSKYINEVLVSTDDEE
IAEVGRKYGAKVPFLRNENADDHSPISLATIKALNQWEETGMQSHEVVVQLMANCPLRDN
NDIDEALEHFFNNDVEYQISCFKYGWMNPWWAHKLDPSGKATPVFDEKERMKRSQDQPDL
YCPTGAIWIAKKEALINTKSFYGPNYSFFPLHWIKAIDIDEYEDLEMAKYFLKLSKS
>IFAGANLK_03043 hypothetical protein
MSVYKILDQQVFSSGEYSIVPIRMEDRYDIMKWRNEQMYHLRQNEPLTKEKQDIYFESVI
SNLFELDKPSQILFSYLKDEECIGYGGLVHIKWTDKNAEISFIMNTSLEKEYFEFHWVNY
LKLLEKVAFNEINLHKIYTYAFDLRPRLYNALGQAGFGFELDLKEHCFFQQKYIDVKIHS
KFNKKNELRHVEISDFYLTYSWANNQKVREFSFNKDKITLKEHANWFFSKLENTNFEYYL
LEVQGVAAGSIRFDLEKESIAKINYLLDPKFTGKGLGTYLLENGIQFLIENRPLVQVVYG
YVLKENIPSIKIFKKLSFKEISKNASELKFEKFI
>IFAGANLK_03044 Pseudaminic acid synthase
MKIGNKVIGEPEPVFIIAELSANHNGSIETALKTIKAAKRAGADCIKLQTYTPDTITINS
TKKDFIIKGTIWEGKNLYNLYEQAYTPWEWHKAIFEAADEEGLICFSSPFDKTAVDFLED
LNVPAYKIASFEITDIPLIEYVASKAKPIIISTGIAGQEDIELALDACRRMGNNDIALLK
CTSSYPAPIEEANMVMIKDLAERYDVISGLSDHTMGSTVPIVAAAMGAKIIEKHFILDKS
IGGPDASFSMDEEEFTEMVKAVREAEKAVGKVDYTLTEKQKKGRDFSRSLYVVEDIKVGE
KITEKNVRSIRPGFGLHPKYLIDILGKRINKNVEKGTAFNLDLIEHGQK
>IFAGANLK_03045 hypothetical protein
MAKSKIDLTNLSIFFAEWEKQYPVETWEVGGVHVWPIIKKKIFFITLVKGVGQTKRPSLI
YSKIFNKVRKLVKAWVYIKKLKLEEATFLFSSIYEQRIIYKNKEFNRFIEPLMDYLEGEG
ENSYFLEYPVVKENCANRPDRIVDINSMLPLYSSSRDKNRYVEELKQLPEFEAFLESVHE
KTGIDARYHKNKLIRTILSIKSWEKVYTKIIKLTKPKYAVSLVYYSDAHYGFNLAARKLG
VSSIDLQHGGLGKAHPAYYFSKIPVEGYNILPNIFWVWSKSSYKDINIWTNNTPHKTLLG
GNPWIGFLKQKKKNNIKLQKLKPVVLFTLQPINDIIPSYLYKVIEETKEEFEWWLRFHPR
MSEMEKKSVEDKFKDLGILENITIEYSSSAPLPLVLEECDLHLSFSSGSITEAAILQRFS
LILSETGINYYKNLIEEGWAFPCKEKDIQIIKNKIRNILDQKRNLVSEKEVDYRETLKLL
LKQN
>IFAGANLK_03046 General stress protein A
MGKVNIITYADGFYIQHACIMLMSLKNIISATREYEIFIFYTNCDKKSLDNFNRSLTNFL
PENINFQLVECDFNISSKLKAKSKHLNASIYDKILIYDRVPSHITKVVFFDADIVLQKDP
AIIFDENLDENYVAAVRDQVFENFSEEAKKTLGINAHQYFNTGVMLVNLNKWRADDISKK
SLKFALEKWNLTPYHDQDAFNYVIKGNWKEISPLWNPRILNKIVLDGKEKVYKKMEVYEK
NISYLIHYSGPEKPWLYMSFHPQKGEYLKYLRISEFKNYKFPDYNLKNLIKKQIVALRRK
FYFFRKRLKFT
>IFAGANLK_03047 Heterocyst differentiation ATP-binding protein HepA
MDKLKKIIKNNFEYFFYFYGFLRYRIFIAFFLSILKGTLDGFGLAMFIPLLRMSNTDNET
TAANGGEELGKLSFLPEFLESIGITLNIVSVLLIILVFFCLKGIVTFIEGYYRVVYQQLF
MREIRITNINLLNTYSFKSFLKSDPGMIQNTFSSEVGRVNIAYRSYFKAIEYGVLITVYL
LLAFSANAEFAIIVAVGGALSNYLFKWLFKKTKYLSRKYTVSAHRFQGFLIQHVAIYKYL
KATGINKYYGGKLKYQINDLENLQRRLGIVDSTLKAMREPITMLVVIVAILIQVTYFNSD
IGLIILSLLFLYRAMTYLMSLQEHWNKFLGASASLENMKDFTNELRKNKEKNGKTKFANL
KQGLKLNNVDFYYNSTPILRNINFEVAKNESIAIIGESGSGKTTLMNVLAGLILPEKGEL
LIDGVSTRNLDLYDYRKRIGYISQEAPIFNDTVYNNVSLWAEKTEENIQKFNRVLKQAAI
YDFVYDLENKEEEFLGNNGINISGGQRQRLSIARELFKDVDFLFMDEATSALDGETERAI
QQNIDNLKGKYTIFMIAHRLSTIINADRIILLNNGVIEAIGTFMELLEKSDKFREMISLQ
GMSIEKEQYLNK
>IFAGANLK_03048 4-hydroxy-2-oxovalerate aldolase
MNIKILDCTLRDGGYYTNWDFDKILVKKYFNAFNSLPIDYLEIGYRSNPMNSYLGEYFYC
PQYVLEESKELSSKKLVIILNEKDVRAEHVPNLLEPCVGYISMVRIAIDPKNFKRALDLA
AAVKKLGFEVGFNVMYMSNWENEKEFLGQIKEVNGIADYFYMVDSFGGVYPEDVKKTFDI
VRNQTNTKIGFHGHNNLQLALINTLTAIECGVSIVDATVTGMGRGAGNLQTELLLTALNG
KGELDLDFNALSKVVDPFEDLRRAHDWGTNLPYMVSGANSLPQKEVMSWVTKRYYSLNSI
IRALSNQSKGIEDNIDLNNLEEEKKFKSALIIGGGPSGKKHSKAINEFIKRQEDICLIHS
SSKNSQEFKDVHTLQIHCLAGNEGHRLEDSYNEMNIKDKLVILPPYPRTMGTYIPESLKE
VAFQLQAIKFTDKFHESVTSLAIETALKLGVEKFYFAGYDGYSGEIKTQELELFNENEYI
FERLRENSSYIPLSITPTLYDSLESQSVFALI
>IFAGANLK_03049 N-acylneuraminate cytidylyltransferase
MSISIFLPTRKGSERVKNKNTRKFSNFEGGLLELKLHQLSNLDVDEVILSTNDDESIAVA
RNFKKDFPKLKIDLRPDYLALSTTSLSDLIAYVPTITNSEYVLWTHVTSPMVTAETYENS
IKSFYTGLKKGFDSLMSVTTFQNFLWKKELNDIINRVGNERWPKTQELELLYEINSAIFI
TPKDIYEKKGDRVGEKPYLFEMNKLTSLDVDWEDDFKIAEAVYDTIKK
>IFAGANLK_03050 hypothetical protein
MIQLKNKKNILWDFDGVIMDSMPVRNKGFELVLKDYPQEQVQELMKFHLKNGGLSRYVKF
RYFFEEIRKEKISEEEVTVWASRFSEVMKRELLNKKLLIEDTCNFIKRNYNNFEMHIVSG
SDQEELRFLCKKLKLDSFFISINGSPTPKKKLVEELLMEFRYKTDETALIGDSINDYEAA
VASDIDFLGYNNPSIQDKGRSYINSFSVL
>IFAGANLK_03051 hypothetical protein
MKIFRAFFGLLIMPFRIRIFKPKKIFYNKSVAVVGPADSAYDQENGPIIDTYDYVIRMNK
ALVTWNPKNEKYLGSKTDILFHNFHENMDSGGGGPLDWNLFNKFGVQYLIQPRFDKNGWQ
WMFNYFKKYLNTNNAIYMLPYSDYKKISKLFDEYHPTRGFYVLYSALTSQCEEVFITGFT
FFKTPYAEGYRDNIRDVKANKMHIQNQGLHNPDLEYEYFLKLVKKSPIKRISVDEKLYDI
LKFDSPELIKKVKKI
>IFAGANLK_03052 Putative pyruvyl transferase EpsO
MNEKNIFISNIKDQQKLLFACLGRLLNKGTKVALLDFPNHNNVGDNAIWLGEKAALREIG
VDIVYQCDIYGFSEKALRKRLGNEGVVLLHGGGNLGSVWPEHQLFRERIIKLFSDMKIIQ
LPQSVHFDDDSKKEKFGQIARAHKDLHILMRDHASLNTLKELDLNVELCPDMALAMGPVA
QSGKPVVDVVWLSRTDHESAGEKRENFNFKTEKLDWLKGEPGRFYSRFSPKFTVRVRRFI
QGVFRKSELIRDHFWSINAASFDLLAKRRFNRGTRILCRGKIVLTDRLHGHIVSTLLGKP
QVLLDNHYRKIGNYIDCFESEQEAIFYIGNDKSNIEAKVSNALDIVEKNNKND
>IFAGANLK_03053 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MVSVPLVAPGFNRLRADAVWVTIANWADGFDDHYGSAEVLAGESSYSAGQIRARCFPADI
GKAKKSKPNWFRHTYLAKLFEMFAKDLRWYHEEQKTFSIDLERFKNAPFVWQHHDLFQTR
GLKLAKKLGVPSVLFVDAPYVWESKKWGVHRLGWEWFAKRRGDAHPCKKADLILVVSEDV
KRAVMDLGIPESRILITPCTVSQKMFDKAKGSVVRESLGLTNNFVIGWVGSFRKFHSLDL
LVEAFLDVSSTMPEAKLLLVGEGPERLRLQEKVENYGLHDRVIFSGNVPHNEIHSYISSF
DLAVLPSQSNEGFHYSPLKLREFFAAGVPVIASAVGDVETVVRESHGGWLVRPGSKEAIT
EMIGKIEKDRTARISAGEKAKSYAITEMGILKQIRMIEDYFGIST
>IFAGANLK_03054 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKILQIIQKPQLRGAEIFACQLSNHLIKLGHEVLVLTIFKGDSDLPFSGKIIHLNRSLSK
RFFDLKGWKELDEVIKEFKPDIIQANAADTLKFAVSSKIVYSWNVPIVFRNANKMGDFID
STLKFYLNRFYLKKISHVISVSKECQKDFEKTFLWPSENISTIEIGVEEKKIGNVPADLQ
RIFQKGYVLSHIGGFAPEKNHSGLLEIFNELKIQFPNIQLLLIGKGRLENEIKDEVRKLN
LEDSVHFLGYRNDVLEILSFSSIFVLPSLIEGLPGVILEAMYCETPVVAYNVGGVGEVVE
TNKTGWLINKGSNQQFIESLYDILSQIESDKKLPEVVEAKKLVNNSFLNNQIAKRFETCY
EEILN
>IFAGANLK_03055 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MAKIKVLHIIKSLGRGGAEMLLPETLKIHDKEKFEFHFIYFLPWKDQMVEALKEAGGKVT
CFEARDNIRLILQYKKIVTYCEAHQISLIHCHLPWAGFVGRLVFKKLGIPVLYTEHNMQE
RYHIVTKTINKLSFNSQSFAFGVSNDVTSSIKNNINPNIPVMTLLNGVNTGSFVRQESFL
VRKKLGIPENTIVIGNVAVFRFQKRLVEWLKIIDNLRKSNDNVYGIIVGAGPLEDEIKTE
WERLNLEGIVFFAGLQTNVKPYFEAMDIFMMSSSFEGLPIALLEAMSMECAVVSTDAGGI
KEVIRDKKDGLICPTSNWAQLSHLCQSLIDEPNELKKYKLAARERVVNSFSLKRMVGELE
VYYSKFKKV
>IFAGANLK_03056 hypothetical protein
MIIREASHKDIPEILKVLKASLGETSSKKTEQVWRYKHIDNPFGESLVLIAEENDVIIGV
RAFMRWQWQLGKNIFSAFRAVDTATLPAHQGKGVFKKLTLKALELGKERGDHFVFNTPNQ
QSKPGYLKMGWKEISQLNTQIIPVLPIFWNSNTFQKYATSSIDLCLALLSSWNSKLEHSS
NLYTPKTKDYLEWRYINNPLQEYRIESTKDYFIAGYVKQHNNFKELRISELILVDPKYKE
TCRALIRKWAKQYGVHFISLNYPLDLSIFRMKLSGKFGPVLTFKDLDGCEIDTKVYNIEN
WAYSLGDLELF
>IFAGANLK_03057 hypothetical protein
MIGALVLILFLFGINQAIFNAYSSKHKWFSKDLMNKLYFYHLFFFGVYYTYASFNNSDSK
AYYERPQLNDDWFYYFGTSTTFIDFLSWPFINLFGFSYEMMMVLFAWLGYLGFVYAYMFF
RENIPIKIKVFKNFDLLILTLFLPNMHFWTASLGKGAPIFLGLMMFAYALKNPKSRLVTL
LIGSAIIYFIRPHVFLFVAVGTVLGYMTGKEKISFGKKLLIYVGMIGGLVLVQDQILGMA
GLENSDNLVSDFDNFSEDRSQGLSESGSGVAISDYPLPLKLFTFWFRPLFFDAPGILGLI
VSVENLLYLLLFIKILKKDFISFLKNSPISVKMSLVVFFLSSFALTFVMSNLGIIMRQKS
MVMYFLFFVIYYYLAQKKYDRIIKLKKKRKAMLRRKFEYEEVVNA
>IFAGANLK_03058 hypothetical protein
MENGSLVISLDFELLWGVFDKVDYNKKIDYFENTRQLIPSLLQVFEKYKIHCTWATVGML
FNSNWDDWNANIPANLPNYKNQNLSAYTYGKSIQSKKTEKLCFAPNLIKKIKNTKGQEIG
THTYSHYYCLEPGQDSLAFKADIEKAIELASIMGIDLKSLVFPRNQYNSAYLEICEKSGL
NTVRTNPENWYWQNTQKDSIFHKIFRTGDAYFGAQDKTYKSSQIHRLSSQLTGQKASRLL
RSYSGRKVLDNLKLKRIYWEMEYAAKNKENYHLWWHPHNFGNNPLQNLEELKLILDYYCI
LRDKYGFKSRSMGELAMEYIE
>IFAGANLK_03059 Putative glycosyltransferase EpsE
MDFTEFKSRFQREQVEEYPNEVDPKPLVSILVLTYNHVAFLPQCLDSILGQKVNFKLEIL
LADDESVDGTQEICLQYAKKYPGLIRFFQHKKINNIQINKLDTGIFNALYSLYQAKGEYI
AYCDGDDLWGDKTKIHRQVNFLQQNPDYILSYHPVIYFNDQSSLPIKNKNILNKDLSSEE
LKKVIQQPLLNTVCFRNNMKNYPAEITTILNSDNFLISLLGHFGKGKYLESIKPSTYRIH
SGGIWSMISKEKKFLSKIQSLKTIAHYYGQNNQKELSKYFTTEVYMYQKSLIFINWKNKT
YIKMLKNLLDYSIYSIANSPILLDLKPYLSRKMQ
>IFAGANLK_03060 N,N'-diacetylbacillosaminyl-diphospho-undecaprenol alpha-1,3-N-acetylgalactosaminyltransferase
MPKKLIRITTIPLSLEKLLEGQLTYMNHYYEVTAVAAEKDRLEKYGRKNGVKTFWVEMTR
AITPIKDIKAVWKLYNYFKKEEPDIVHTHTPKAGIVGMLAAKMAGVPVRLHTVAGLPLLE
TTGNKRKVLNAVEKFTYKLATKVYPNSRGLQDIILKEEFANQSKLKVLGKGSSNGIDTGY
FNPSQFDEIQKRNKRHLLGIPQEDFIFIFIGRLVSEKGINELVEAFKSLQAENKNISLLL
VGPFEKELDPLKEETFKTIQKHEKVFTTGYQEDVRPYLAISNALAFPSYREGFPNVVMQA
GAMNLPAIVSNINGCNEIIVEGINGVIIPVKDTSALFTALKLFVENKNYTERLSSNARDE
ICKYYERKEYWQLLLKEYKSLEQEYIKS
>IFAGANLK_03061 Undecaprenyl phosphate N,N'-diacetylbacillosamine 1-phosphate transferase
MYRHFFKNLLDFFIAFMALLVLSPLIIPIVVLLALANRGNPFFFQNRPGKNERIFNIIKF
KTMTDEKDKNGNLLPDDKRLTSVGKFVRKTSIDEIPQLINVLKGDMSLIGPRPLLPQYLS
LYSERQKKRHEVKPGITGWAQVNGRNAISWTKKFEYDVWYVENLSFGLDVSIIFKTIKKV
VISEGINTANMATTEAFNGKN
>IFAGANLK_03062 Putative acetyltransferase EpsM
MNIYGASGHGKVVFDILSSRNIQVDSVFDDNTEIEEFLGFKVTHEPNEHQLKAPSILAIG
NNTIRKQVARRFTGLIAEAVSHSSAILSKEIELGDGSVVMPGAIINAGSKIGKHCIINSG
AVVEHDVRLENFVHIAPNAVLTGNVSVGEGTQVGTGASIIPGIKIGKWAAIGAGTVIIED
IPDFAVVVGNPGKIIKYLNE
>IFAGANLK_03063 Putative pyridoxal phosphate-dependent aminotransferase EpsN
MNRDKIWLSSPHMGGNEQKFVNEAFEQNWVAPLGPNVNGFEEDIRNYLFKDSGKEGSVAA
LSSGTAALHLALIMLGVKAGDEVICQSMTFAASANPIAYLGATPVFIDSEEETLNLCPKQ
LRIAIEDRISKGKKPKAIIAVHLYGMPYQVEKINEIAREFDIPVIEDAAEALGSTYKGEK
CGTFAEYAILSFNGNKIITTSGGGALVAISQTKKEKAVFLATQARDDAPHYQHSEIGYNY
RLSNISAGIGRGQMEVIDNRVSARRQMHQFYVNLFSEIEGVKVFEAPNKDYFANHWLSVI
TVDEKKTGGVNREELRLYLEKLNIESRPLWKPMHMQPVFENAAFYGTGVAEQLFENGLCL
PSGSNLTEKERTRIKAGILSCFNNRS
>IFAGANLK_03064 UDP-N-acetyl-alpha-D-glucosamine C6 dehydratase
MGNKVNKALRNILSGTDNALDLRNIKYLPRWAVYLIDLSLVAISTLFTVLIIVDLTPNYY
TFLSFYNKAFIVIGVHTFYFYVFKTYAGIIRYSSNIDALKLLLATISSFITLLIINYVTF
FIVGQKVFLVGGLLINLCISFSLLFLFRLGVKQIYEYFKLVSRDEDILNAVILGADENAI
SIAGALDIEIPRRFKIVGFLTNERHNKSIRLLDKPVINYSAEIHKAVESVNAQAIILSEN
NFTAEEKFNFVEDCLENNIKVFNAPIVATWGEDTLPIAKKVKSLQIEDLLEREPIRLNPE
NKIEQLTGKTILVTGGAGSIGSEIVRQVAKYNPKKLIILDQAETPLHSLSLEIQAKFPEL
NCKFIICDVGNFKRLELMFQNQGIDVVYHAAAYKHVPLMEENPHEAVFVNIQGTKNLADL
SLKYRVSHFVMVSTDKAVNPSNVMGASKRAAEMYVQSLYHFHAKENLDTTKFITTRFGNV
LGSNGSVVPLFKKQIEKGGPVTITHPDIIRYFMTIPEACQLVLEAGAMGKGGEIFIFDMG
EPVKIMDLAIKMIKLAGYDPNKNIKVKITGLRPGEKLYEELLNDECKTVPTHHKKIMIGQ
EVVRDYEHISERIESIIKSANTLKADKMVKKLKTLIPEFKSNNSMFESLDNKEEVISK
>IFAGANLK_03065 hypothetical protein
MFKSIRRLGLFLISSIIISSCATKDDVVYFDGSESLEGKENLLDYEPRIEANDVLRINVS
SSSVNEEIVEPFRMNQQGQGSGGGGGGQNLSLTGYLVNPQGTINFPVLGPVEVEGLTRTA
IQQKLEDQISEYVRDPVVDVRIVNFSVTILGEVGSPGRVQITDGRITMPELIAMSGDITY
NGRRENIKIIREVNGVKTVGHIDMTESDLFDSPFFYLKQNDLVYVEPTYRAVKSAGFFTS
YQGIISVGTTIISLYFLINSL
>IFAGANLK_03066 Putative tyrosine-protein kinase in cps region
MEELNDFNEEKEESSFDLKAEIYKYLAYWKWILLGFLIGGLLAYLYNRYTIPKYNTSASM
IIVDDQEKNAMNATPSGGGAIFSLSDDGIQNHIEKLKSKQLVESVVAELDHNILYYIEGN
IITVEAYKSSPIVMQFISEDSLVDQVTGNLLVTPTSETSFRLEVEDMDYNKIHEIGEIIE
LQGLKFTILPRKGGESGTLEKTKAVNIRLYPVTTVANHYINQLQITQKGQAKDILSLSIV
QESSERSEDFLNKLMERFNEEGVKDKQEVAENTTKFIQDRLEMITTELDSVEVGIAEFKR
ENRLMDISSGASEFQSKFSEAEQEIFALETELSLLESIEEVLRNQGNYELLPEVGISKGG
VSGLITSYNTLVMERNMYLKGGTEKNPLVETLTEQLDSLRENLYENIESTRRSLNVQLRE
LSQRENVAQGQFSNFPGLEKGMRSIERQQQIKEQLYLFLLQRREEAAISFAATASVARVI
DDAFTNNWPVEPKPWLILIGGFVIGLIIPILIIFLKNMLDTKVHHKGELQSLIKHIPFIG
EVPRIANEQSEQIELNDRSPLAESFRILRTNLAYLIQNKDKDRGEIIFITSTIKGEGKTF
VSYNMARTLGSTGKKVLLIGADIRNPKLHRYADVTMGEKGLSDYLYDFEVSEEQIISRDQ
SGSIKMDMVLSGPIPPNPAELLMNDRMEQLVKYASKMYDYVLVDTAPTMIVTDTLLISPL
ADTTLYVVRADLTDKKMLDFPKELKQQGKIKSPAIILNDVDYSKFSYGAKYGYSYGYGYG
YGVDKESRWQRIKNRMFGKK
>IFAGANLK_03067 Tyrosine-protein phosphatase YwqE
MLSIFQKKIFLADLLEGFTDFHNHLLPGIDDGAKELDDSLAMIRKFNEFGITNFVASPHV
MGEFYPNTPQTILPALEEVKKALPKGNSIKAAGEYMMDQFLIDQLEDENVLNVVTNYVLV
EMSYFQAPINLAEILFKIQNKNLKPILAHPERYAFYHGNSLNKYEDLKARGCKFQLNMLS
LSTHYGTGIHKKALQLLENGMIDFISSDAHRMEHLEKIQQLKLKKTQVKLIEPVIEKSKA
LFN
>IFAGANLK_03068 hypothetical protein
MKHFYLTFLFLLLFLSVNAQQIDLQGNVNTTGLLFSEDNSPFWLHTNQRGRIDELTNFSG
FANVSGIYRFSENANLEGGLGVLYQDGYTDKLQLDEAYLAFNNSWLGIVAGRKQRKELYR
GLSATNQSILWSLNARPLPGIRFFTKQPIFFKDNRGLGFEASLEEYFMDDERYVEDTRLH
HKSFHLVYKSSPRFQISAGLRHFVQWGGTHPEFGDLPSDFEAYTRVVTGRGVSDDTGEGV
SEQEINGLGNHLGSYEINIKTILAQYNVEIIYNHLFEDGSGSVLRNTPDGRYGIFIEDPT
AAVDSWFQAVMYEFYYTKNQSKNTPTTDGQDNYFNNNLYRSGWTYENRVLGLPFITLGPD
RFRINNNKVVAHHIGLNGMAFKKVPYRFLGSFRQNYGAKGGENIEEHHLLSTYLDLNLFQ
NIVNLNLQLGADFNEIEGPNFGAGISVSKSFL
>IFAGANLK_03069 Phytochrome-like protein cph1
MKKITTPVVKINEAYRIISWNSSAEGFVKLNFSESLETQLSILKVFPSEISTQFKSDFFS
ESFFHKPYSFSKSENLEIFCSPCLDGDGNLEAFSICLKLVPKKESVSPENIIQAKNIVEN
SSMAIFLSDPKGPVIQVNKAACRMFGYTYEEFKHLNREDIILNNAELKSALNQRILAGEL
RYELTGIKKNAETFPCEVHSVIYTNHNGEKRTSTAIIDISARKNQELIAENSKLAFQSLF
DHNPDAVYSFDLKGNFLSINDSALKLGEGTREVALKTNFLSLIPAEDKAKVMDHFTKAVA
GEIQHYETGFISLKGKKKLLQVTNFPIYVNKKITGVYGIGKDITKQVEIEQKLREERNMF
RAIIDYIPDHIFVVNQNHETILTNNSFYKKYFGAEIEENSLGLTPIDYFPKEEALEIIED
NSRVMNSGVPILNREEIISDFNNKIEYTLLTKVPFKFGDNKKGLVGISRNITEIKQKEEA
LELLNQELKKHTEELALSNKELEQFAYIASHDLQEPLRMVTSFLTQLKKKYSDQLDEKAQ
QYIYFAHDGATRMRQIILDLLEYSRIGRGEYKVIDVNTNNLVSEVLLLQKRCIEAKNAEI
KLGELPNLKVEETPLRQLFSNLIGNALKYHSKVRRPVIEISAEEKETFWEFKVTDNGIGI
EKEFQEKIFVIFQRLHQREEYEGTGIGLAICKKIVDHFGGEIWVESAYGKGSGFYFTIPN
QF
>IFAGANLK_03070 Aerobic respiration control sensor protein ArcB
MTKDSGELKILVIEDNPGDFILIEDYLSEEHHALEIQRAENFKIAKAILKKTSDFDTVLL
DLSLPDINNTELLVKEILSFSNETPVVVLTGYTNKDYGVKTLSWGVSDYLLKDEINASIL
SKSIHYSMERNKVQHQLYESEEKYRTLFDSSPLPMWVLDRNSLEFLSVNQAAVNLYGYTR
EEFMQMSVRDLWADDEARIEETVEENLHDFFNIKVKHYTKNRNLLYIDVQSNPILFGGRE
ARVTQAHNITEKIKAEEKLRHSQERFKALVQDGSDLISIIDENFHYAYVSPSVKHILGVD
PEKIEGRNVFDFIHREDRDKIEGKIQYLGRRKSFQLPSYRYKDGKGEWRWLETIISDLRD
DPAVNGLIANSRDITKSKVQEQQLRESLERYDIVAKATSDLITDFDVEKNEFQYSNAIYD
IFGYSQEGLAPSKEWWQDRIHPEDKQRVIEAAKGIYEHGQKILGIEYRFRCANGEYKYIL
DRSYVITDAIGKPSRIIGSMQDITERRKYINAIERSNERLREIAWTQSHVVRAPLARIMG
LIELLKNQRNNLDNIEEIIDNILNSSEELDKVIRKITIKTEEEF
>IFAGANLK_03071 Chemotaxis response regulator protein-glutamate methylesterase
MLEVLIVDDDQIVVFIQKKMINNHEIAQNPISFSKAADALSYLVEDQKHPQQRDFLILLD
INMPNMNGWDFLKCLEGHPQKSRYHVIMVTSSIDVKDKKEAENYSTVRSFIEKPISASDC
EKIKEISEISHFFKPA
>IFAGANLK_03072 hypothetical protein
MEISEIIMLVFCGILLIPSLASATRFDHWWIRAFDFPRIQISLLISAVIIIAIIVFDFSE
TIHFIAIALLILSLIYQLHKIFPYTWLAKKEVMQFEDGDPSDNISILVSNVLTPNTKYHK
LLEIVNRRQPDILLTLESDKKWEEALEELEEDYKYTVKVPMDNLYGMHLYSKLKLEETEI
RYLVKGDIPSIHGFVRLDDNTKVRIHCMHPRPPSPSEADTSTNRDAELLMLGRDVREQDE
SVLVFGDLNDVAWSRTTRLFQQMSGLLDPRIGRGFFNTFHADYRFFRWPLDHVFHSNDFT
LIEIAREKPMGSDHFPMYINLNFERRAEEQQEKPKADEEEKEWAQEKIDDAEPRENGV
>IFAGANLK_03073 hypothetical protein
MKKLLLLSFCFVLSYNSFSQNSPYKTDGWKDGAYIAGTVGLNVLGFTFIQNKDALTEAEI
TALDKNDIWGIDRWAAGNYSEKADSFSYIPFYAALAAPLAFLPGEAGRNNFGQISILFVE
TMATTGVFYTMTAGLIDKSRPLVYNENLPFDERASGGAQRSFIAGHTAVAAAGSFFAAKI
FNDFHPESKAVPYVWGGATGISVLMGYLRTKAGKHFLTDNIIGAVVGAASGILIPELHKK
GKENIDLYPTANFNINGTGINTKGLALSYKF
>IFAGANLK_03074 hypothetical protein
MKKKDYRQGKGFVFNKFEEPEKSPFDRLFEVFKELITHTSGDLDEALDWLKQLDDEYKLT
TEDYTLDDFVEDLKKKGYIKEETEDQGGGMAITAKTERAIRKQALDQIFGKLKKSASGSH
RTNHVGRGDEHTGDFRNFQFGDSPDKISVTESLRNAQINHGIGNFNMTEEDLVVEETHYK
SRMSTVLMIDLSHSMILYGEDRITPAKKVAMALAELITTRYPKDSLDIIVFGDDAWPVSI
ADLPYLKVGPYHTNTVAGLKLAMDILRRKRSTNRQIFMITDGKPSCLRERDGSYYKNSMG
LDPYILGKCYTMARQARKLHIPITTFMIAQDPYLMQFVREFTYANQGKAFYTGLKGLGEM
IFEDYETNRKKRIRGN
>IFAGANLK_03075 hypothetical protein
MKIENINTLGELKKSGYKSRGIKEELRENLIEKIKKNEPTFPGIHGYEDSVIPEMERAIL
SRHNINLLGLRGQAKTRLARLMVNLLDEYMPVVQGSEINDDPLDPISRYAIELVKEKGEE
TPISWVHREERFFEKLATPDVTVADLIGDVDPIKAANLKLSYADDRVIHFGMIPRANRSI
FVINELPDLQARIQVALFNILQEGDIQIRGFKLRLPLDLQFVFTANPEDYTNRGSIVTPL
KDRIGSQILTHYPDSIKIAKTITAQEAKLDKRQSDLVYVPELAKDLLEQISFEARESEFI
DEKSGISARLSITAYENLLSTAERRSLKSGDDKTLLRFGDFLGVVPSITGKVELVYEGEE
EGAASVALQLIGDSVKTLFPQYFPKIEKLQKPDETTPYDDLVEWFFEQSGFELPDDLSDA
EYKEKLDSVAPLNELIKKYQPETSEKDSYFLKEFLLWALVEYKKLSKHRFATGVQFKDLY
GSYISDL
>IFAGANLK_03076 hypothetical protein
MTLWDKNYDFLFIQQKKYPINNLTGYFFVLF
>IFAGANLK_03077 Bifunctional aspartokinase/homoserine dehydrogenase 1
MKVLKFGGTSLASPERIKLVAKTVQKHLKEDKTLVVFSAFGGVTNDLLEMADLASREDLA
YKEILIKNEKRHLEAVRELIPVNAQSSILSKVKTELNRLETLYEGVYLLNELSNKTRHVV
AGFGEVLSSLIIAEYFKNLGINSQYIDSRELIVCKNTNEKVQVNYAQTNANIEKYFEAKD
ASLYIAPGFVSRNEQGVPSTLGRGGSDFTAALYGAALDVKEVLIYTDVNGMYTANPQIVP
HAYPLKDISYQEAMELSHFGAKVLYPPTLQPLLDKQINILIKNTFKPDETGTLISKSSEK
NFRWVTGITHIDSIKLLNIEGSGMVGIPGFSKRFFEVLFQENINVVLITQASSEHSICIA
VKDDEAELAKEALDEAFEVEIQYKKIKPVEIEDNVAIVALVGDRMKSHHGLSGKMFSALG
NNNINIRAIAQGSSERNISAVISKKDVKKALNTLHEQFFEVPSKELNLFITGVGNVGSKL
LNQLKKQEKFLLEKLRLKVRVHGLSNSRKMLFDENGIDLQNWEEVLEKGEKADKAEFFKK
VDEFNLRNSIFVDNTASPEISAWYKEYLANSVSVVTCNKIACADSFENYQELQNLAREYG
ASFLYETNVGAGLPIIDTLKNLVASGDRVTKIQAVLSGSLNFVFNTYKAEDPFYKTVEMA
MEEGYTEPDPKIDLSGVDVARKILILARESGYEMELEDIESEDFLSQESLATTNNEDFFE
LLKKDEPKFQEIYRSAAKKGEQLKYVAQLEDGKAVVGLQSVDSQHPFYNLSGSDNIVLFF
TERYPEQPLIVKGAGAGAEVTASGIFADVIRIGKK
>IFAGANLK_03078 Homoserine kinase
MDKIKLFAPATVANLSCGFDVLGCCLDGVGDEMIISKNSDQKLRITKITGQDLPLNIEEN
VAGVSAKAMLTELDEKQGFNIEIKKNIKAGSGIGSSAASAAGTVFGINKLLGEPFSANEL
IKFAMEGERLASGNAHADNVAPALLGDFSLVKSYDPLEIISLPSLPELRMLILHPLIELK
TRDSRSVIRHNVELTKAISQWGNLAALVSALYTQDYELLGRSLKDEIIEPVRSILIPYFD
ELKDLAAKNGALGFGISGSGPSVFAMCKGDAVAEKVKAEFQEFYQDKNIDFDLHLSKINP
EGIKILN
>IFAGANLK_03079 Threonine synthase
MKYFSLNDKNHKVSFEDAVVRGLAPGKALYFPEEIPDLPKAFFQKLNKLPKEEIAFEAIQ
PFVGEEIDKNGLQEILKKTLDFEFPVVQISETIGTLELFHGPTLAFKDVGAGFMAGCLGH
FVKKGNLGKITVLVATSGDTGGAVANGFLGVEGIDVVILYPKGKVSEIQEKQLTTLGQNI
TALEVNGNFDDCQDMVKKAFSDEDISDKRQLTSANSINVARWLPQMFYYFFAYKQLAGKQ
QKLAFSVPSGNFGNICAGMLAKKMGLPIDHFIASNNENNVVTRYLQSQEYSPKPSVQTIS
NAMDVGNPSNFVRILELFKGEFNPLSQQLSSYSFSDVETRKAIKEVKDKYNYVMDPHGAV
GYLGLQQFLIENNDYYGTFLETAHPVKFLKTVEDVIEEKVGIPASIKEAMNKEKKSIEIS
DYSELKEYLMQ
>IFAGANLK_03080 hypothetical protein
MKNIFTPLFLLVFITTAWSQKVEIPVDTTVTTNHSVTINSENIDYTATTGMQPLWNNDGE
PIASLFYTYYKRSDVKNTENRPLVISFNGGPGSASVWMHVAYTGPRVLKIDDEGYPIQPY
GIKENPHSILDVADIVYVNPVNTGYSRPIPDEDGKVDRKKFFGVQADIKYLAEWLNTFVS
RNKRWLSPKYLIGESYGTTRVSGLALELQNSQWMYLNGVILVSPTEIGIDRDGPVGIANR
LPYFAAAAWYHDALPADLQNRELEDLLEEVESYTINELTPVLVKGGFTETAKKEEAAEKM
AYYSGISKEVILQNNLDVDYRFFWKELKRKDGVTVGRLDSRYLGIDAKEAGDSPDYNAEL
TSWLHSFTPAINHYLRQDLNFETDLKYYMFGPVHPWDRSGDNSGENLRQAMAQNPNLDVM
IQSGYFDGATTYFNAKYTMWQMDPSGKMKDRLSFKGYESGHMMYLRAEDLKNANDDIREF
IEKSLPKEGAPAKY
>IFAGANLK_03081 putative protein kinase UbiB
MSVLPDDLLRYQKFIGFMLKYWNSDLFANTASQAMDVKSDKDNSQNTYDQTPDELVEDLK
NMGPTYIKMGQLLSTRPDLLPDAYLKALATLQDDVPPISYEEVHRIVEEEIGTRISKAFG
SFDEEPLASASIGQVHRATLRSGKPVAVKIQRPGIKKQFLSDLDTLKELADLAVKHSTTA
KKYAFDDVLTELRRILLQELDYHREAQNLITLGDNLKGFKYLIVPQPIRDYSAAKVLTME
YIEGQKITSISPLKQIEVDYSPLVDELVNAYLQQVINDGFVHADPHPGNIKFTKDDKIAL
IDLGMVAKFNPAIKQYILELLLAISNNNGEETARVLLSMSEVTEDANLKFFKKTITDIIM
DSEHSTAKDMQTGRLLIQLNRLAAESGIHLPVEVNILGKILLNMDQIIAVLDPEFDLRDA
IKRHSTKIMSDKMYEELKPENFFSSLLASKKFLEYLPDRLNTISKNLSENEFKIKIDAID
EKRVTDGFQKVANRITLGLIIAAMIIGASMLMQVPSDFTIFGYPGLAMLFFLLAAVGGII
LSYIIIFRDENLNNKD
>IFAGANLK_03082 Bicarbonate transporter BicA
MSKNGNFNFKERVDQAALSKPLFSRLDKDIPSSIVVFLVALPLCLGIALASGAPLVSGLI
SGIIGGIVIGSVSHSSVSVSGPAASLTAVVLASIASLGSFDVFLMAVVLGGIFQFILGIL
KAGLIADYMPSNIIKGLLAAIGIILIIAQLPYAIGFIEDSGANFGARENLFEQATAMFKN
FFYSLHPGAVVLSLISLAIIIFWEKSPLKNFKLLPPSLIVVILGVFLNLLFKYTVPVLHL
GEEYLVNIPKIDRVSELVTFPDFASITNPEVWGVAITITLIASIASLLAIEAADEIDPHK
RKTPPNRELVAQGVGNTIAGLVGGIPLTSVIVRSSVNINAGAETKLSTILHGIFLLLSVL
FLSSILNLIPLSSLAVILLVVGYKLASWDVISTMYKKGWNQFIPFVVTVVAIILTDLLIG
IFIGSLVSIFFLLRSNYHNAFFIENTRIFKGETIRLELSNEVSFFNKASIKNSLWNVPQN
SNVIIDATFASYIDHDILEIFEDFKSTFAEENNINVSVIGLKDKYSAGKELDFVREDIEE
SKEKSTPQEILEYLKDGNSRYVDGKLVSRRLRNKELMDFINSPPLATVVNCIDLREPLNV
MMNTGIGDLIPIRAAGNLVDSHIIKSIEIACKQQGARFILLMGNSSNKIYLEALNEYMKN
GYQNPDSLIAEALKAKQIPAKFEEKDLYTYADLITRWSVKESQQRIIKQNTYLKERISQG
KLGLATAFFNRENGKIEFSELFNPAMIS
>IFAGANLK_03083 Inner membrane protein YbaL
MEIPILQDIVIILGLSILIILLFQKIKVPSILGFLLAGIIAGPHAFNLISSSHEVELLSE
IGIIFLLFVIGIELSIKELISMKNTVLIGGGLQVGGTILFTTIVAYFFGLPLNSAIFLGF
LFSLSSTAIVLKLIQERGEITAPHGRVALGILIFQDIIVVPMMLLTPILAGDGGDLLTTL
LILIIKIVGVGLVIYLLARYIVPRIFSMVVKTKSKELFILTTVVFCFAIAWLTSSVGLSL
ALGAFFAGLIISESEYSHQATVNVLPFREIFISFFFISVGSLLNLEFFINNILMILLLVI
GVVFLKMLVVGATVMLLKYPPRTVLLSLFSLFQVGEFSLLLSGVGLDNNIIPDSIYQYFL
AISIITMGLTPFLIAAAPKITYSILKARVPSSVRHRLESLNKLKTTEETAEPKKLDDHLI
IIGYGINGENIAKAARNAEIPYIILDTDPVTFKKAKNNNEPIIFGDATNSLILKHLHVQE
ARVVVIAISDPGATKKIISNVRLYSKTAFIIVRTRYVREIEENIKLGADEVIPEEFETSI
EIFNRVLKKYLVPYNEIMDFTASIRSSDYEMLTSVKGRPHKPSLQHLHIPNREIVTLSVQ
HNNRDIVGKSIQTSGIGKNFRVTVLAIKRDTQYITEILPNTKIKQGDLLYIFGNPININK
LNEALSY
>IFAGANLK_03084 hypothetical protein
MKKAIYTLAFIGALYSCKTTQTSKKDQPVVASIDLVNVEEDKVSVTVDPDKFTSENTSFY
IPKTVPGTYSTDNYGKFIENFKALDYEGNELEFEKIDDNSWTIPNAENLDKVSYQVNDTY
DIEGEEGVFSPSGTNIEAGENFMLNLHGFVGYFENEQEEPYRLEIKRPQGLIPGTALSKT
VAASEDMSFKEDIYSLGRYFEVIDNPIMYAKPDTTSFMVEGMEVLINVYSPNEIYTSESI
KPGIEEMISAQKRFLGEVDNTGKYAILLYLSDSEKQDARGFGALEHHTSTVVVLPESMQP
EQLQKTMTDVVSHEFFHILTPLNVHSEEVHYFDYNDPKMSQHLWMYEGVTEYFANLFQIN
QELIEKQDFYDRISDKIKSAQQFDDTMPFTEMSQNILEDPYKDSYYNVYQKGALIGMALD
IRLRELSDGTMGILDLMKALSDKYGMDKPFVDDELFDDIIELTYPEIRTFLETYVSGTTP
IPYNEFFAKVGLEETETEVNTGYFIKGQTPYIDGDPAKGELFFRKNIQFNSFLKKLGVEG
GDIIKSVNGEEYNIQNVYNLIMKAESWEEGEEVSFVVTRDGEELELTATTAQPTDTDTTI
KEKDLPESSEEVKLRNAWLKG
>IFAGANLK_03085 Gamma-glutamyl phosphate reductase
MKLLDSKTKNNVLQSMINILDKRREEIVAANKKDLDAFGEGDQAMRDRLVVNNAKVDDMI
RSVKEVMDQEDPVGQTIEHRRLDTGLDITNKTAPFGTIMIIYESRPDVTIEAAVLAFKAN
NKIYLKGGKEANHSNRILEECWHEALKENGLEKDWIELLQMNRTETQEFLKNPPQHIDLV
VPRGGEKLIAFVKEHSTGAVLVSGRGNNFLYVSKNADFNTAKKVMLNAKIDKISGCNALD
KVLIDKNLPDFEKRVKELYDMFTENKVHIQVDDDIAKVLPNEEKIPSEDTWYEEFLAMRI
VLGAVDGNDAAMDKINKYSGGHSAVIITKDKEEAANFMEQVDSAAVYHNASTRFTDGGQM
GVGAELAISTDKLHHRGPLGLKQLVTNKYYVLGEGHIRE
>IFAGANLK_03086 Glutamate 5-kinase
MEKKRIVVKVGTNVMTNKDNRILGPVLKHLVEQIATLYEEDIMVVLVSSGSAIAGKEVLG
DVDIKDASKRRQVFSAVGQPRMMRHYYSIFHDYGMRCAQVLATKRDFSPGIHRENMINCY
ESLLSEGIIPIANEDDAVSVTMSMFSDNDELASLVAELINADSLIILSDTDGLYTGHPGD
DESEKLNKVTVDENVEKYVQESGKGEGEGRGGMESKIKIAKGTAAKNITTYIANGKQHNV
ILDIVAGKPVGTKFTA
>IFAGANLK_03087 Pyrroline-5-carboxylate reductase
MKVLVIGAGNMGLTYAEGMAKSSFLNHRNLMIFDKSAEVITTLSKIDHFDVYDDIEECLP
KADIVFLAVKPYHCDALFEEIKPLVNDQQIFVSLMAGVTIDKIQEGLGVKKVVRSMPNLP
AQVGKGVTSFTEAKEISRVELLMVRNLLDTTGASIHVETEKFIDASTGISGSGPAYVFYF
MNSMMEAALKMGFSKNDSKVLVSQTFEGAVKLFNESDLSPTTWMDRVASKGGTTRAALDS
MDDNNVEELIKDAAYAAFDRAVELGKE
>IFAGANLK_03088 Ribonuclease
MENQVKIHFLGGSGTVTGSKFLIETPELNLLIDCGLFQGVKSLRELNWKDFPFDPKNIDL
IFLTHAHLDHTGYLPRLVKQGYKKPILGTPPTLGIAGVILRDSAKIQEEDAERANKEEYS
KHQPALPLYTSSDAEKTIGLFKSIKLNEWHRISENIKYRYQTNGHILGSTFIEFEIFEKY
FVFSGDVGREKDLLLEAPNRPEWADYLFLESTYGDRLHPEDDSDEILIETIKETINQKGN
LIIPSFAVERLQGIMYKLYLLIKKNKIPEIPIYIDSPMGNEVLGLFEGFSKWHKVEPDEF
RKMLSYFKIITSYRDTWKTIDENMSKIVIASSGMVTGGRVLTYLRYLIGKPETTVLLAGY
QAEGTRGRQLENGASEVKIFGKYCPVKAKILKMESLSAHADQQELLDWISEIKNIPEKIF
LIHGEPTALDSLRVKIKDRYKYPVSIPAINDVITLKL
>IFAGANLK_03089 hypothetical protein
MDISKLQIIKASGEKAKFSIDRVAESLRRSGANEELIQATLEKLKTELYEGITTKEIYNR
AFNLLKTGNKTSASKYKLKTAIYELGPTGFPFEKFIAALLSHSGYKTQIGQFYQGKCVTH
EIDVEARTDSKLVLIECKFHNAGRNCDVKIPLYIDSRFQDIKNFRNNGENKLHFEEGWVV
TNTRFTSDAVKYAKCANLKLLSWDYPKGEGLKDRIDQLGLYPITVSTLLSEREKNFLLSR
DVVLCKELINDNFFLDHLGINNPRKKRILEEMKDLCKH
>IFAGANLK_03090 hypothetical protein
MKNILIPTDFSANAWKATVYAFSLFQNELCNFYFLNACKPEFYTPDINGDSLAQAKSENK
ILMNKLLKEVTTINKNQNHRFKPVIIESWLNDAVVEIQDEIIFDLIVMGTKGETEPDDRI
FGTNSMNVIETVDHMPVLLIPDNCVYVPEVKKELVLATRFDKSFSDYEINFLIDMAKKFK
ASIRILYIQDTENLSEEQKNTKEGLHDYFKDVSHSFHTLTNIEVTKGIHSFIQSRNSDVL
VLNHKKRGFFQNLFSKSLLKELGKKPQIPMLFMPSDL
>IFAGANLK_03091 hypothetical protein
MKKILLPTDFSENAYNAISYAIKAFIDEKCTFYLLNTYTPVLYDSEYILYNSTQPNLAEV
YKKNSISGLRKVERKINRDFNNPNHQFEKISSFNLLIDEMKEQVKSKEIDLVIMGTQGAT
GAEEILIGTNSVHALNKLKVPLLMIPSGYEYQSPVNILFPTDFELNFSPAQLEPILNLAE
KHTSRLNILHVYFGKDLDENQEKSKRNLSKILEDTPHQFYTIEDKSVPKAIKKYQEQHEV
DLLFMVNNKRSFFENLLFRPVVNKIGFHIKVPFMVIQSGKFN
>IFAGANLK_03092 hypothetical protein
MRKIILPTDFSENAYNALRFACQLFKYEKSEIILLNTYAEKVYTDERLLSKELIDELKAV
TKAKAEMALNEISSKIHDEFCNPRHKLRSIAAFGDLVDEVNSLVNSENADLVIMGTRGAT
NDRELGFGSNTLLVLKYVQSPVLAIPANFSYQEPKNILFPTNFLIPYQKRELKVVGEIAR
DFKSVIHFLYLSKYKATSARQRDNLEFLQEQFYNIRLEKHQSEELQKEKAIEEFIAENKI
DLLVMVNSRHTYLEDMLLTSTIDKVGLHPKVPLLVLQNFNREYI
>IFAGANLK_03093 Cyclic AMP receptor-like protein
MKCILYISDRNSGHPIPGELTEKQDYEFIYSNSASDLRGLLLKNKPDLLIWAKKNPIPSE
LLDENPELLKLPILTITKAKIKTQKSFHIKHHFLPPTVSDQKLMRKIDFLTNAKSDNFKI
IKNFEKSAVPDIEALKSYMEIKGELINLDKHTILFRENRHSSFIYLIKQGLVKTSRMDQL
GKELITGVYRKNDLLGLYGFHKNPVATEMATTLEPSEFYRILHTEFREILQKNQELSLDL
AQYLTDTVLALKSQLLEMAYASVLKKTSNTILQFKDELQNPEFKGLNISRTDLASMAGIS
TESFIRSLSSLKKEGIIAIKGKKINILKPDKLQEIL
>IFAGANLK_03094 hypothetical protein
MELSKKHVFTEEFYQNIGMLFYAIAASDKVVRTEEIKTLNDLVQKKWVPIDNQIDEFGTD
EAYKIEMIFDWLEEKAPEAEWAFNEFRQYKKDNEELFTSPINQLIWETADAIAASFAGKN
KSEVIMLSKLKMLLSK
>IFAGANLK_03095 hypothetical protein
MKTLICQSCGWPFTKATGGTSRDKSINTDYCRDCYQDGAFTDKSLNLHELEVKLLEMAEM
HEDISLEEAQELIKKLPELKRWRMDHI
>IFAGANLK_03096 hypothetical protein
MKLEHLKERINEYKSSIKIVVNKRIIWENSTKKLIVETLKKAEATYPIGWKVQELKWIHT
NEAVNITFDSFPADLIDFTNKIPNYQFLQGGALVFSQLHNGDIEIIVTFPILENWILSEN
EIVELGVFSPRDITERLIVEKIDEFLKEMIKWEVPIIKNKMGFKAQ
>IFAGANLK_03097 hypothetical protein
MKSNSVQNIKLGVLIVTGLIIFTLGVFFIGNKQNLFGDSILVSSVFKNVNGLQSGNNVRY
SGVNVGTVKEIKFLNDTAICVDMLINREAGNLIKNNSLATINSDGLVGSMVLNILPTNQA
PSPTIQEGDTLASISQVATADMLNTLNKTNENAALLTEDLLKITNSINSGEGVLGDLLKD
KILAKNVQESVENLNETTRAARSGMTKLNGILNKVDYENSVAGLLLSDSSAQNSFRIIIA
DLQTASTQIKEISADLGQFSNNLNSEKGALNYVVKDTSFVNQLDQSMENIEEATHRFNQN
MEALKHNILFRGYFRKLERQKAREEKQN
>IFAGANLK_03098 putative ribonucleotide transport ATP-binding protein mkl
MENRAVIEIKNLSKSFGDVEVLKDFNLNLFEGENLVLMGKSGSGKSVMIKCLVGLINFDQ
GSIKVLGKDISKMKQHELDELRTDIGFLFQGSALYDSMTVRENLEFPLRRHRKNSERKTE
ELVKEALENVGLPKTIDLMPAELSGGMQRRIALARALILKPKIIIYDEPTTGLDPITAKE
IILLMMTIQKKYATSSIIITHDVDCARVISNRMILLLGGTNYAEGTFKELAASGDPKIKA
FFK
>IFAGANLK_03099 putative phospholipid ABC transporter permease protein MlaE
MKTLSSYQSGLSSFFQEIGEMGRFTGRYFRELFSTPFEFREFLKQCYQMGNKSLLLVSVT
GFILGLVFTLQSRPTLMEFGAASWMPSMISISIVREIGPVIIALICAGRIGSSIGAELGS
MRVTEQIDAMEVSGTNPFKFLVVTRILSATCMLPILVIVGDFVALIGSAIIENIKGDVSF
TLYFNQVFAALEFTDLIPATVKTFFFGFAIGLVGCFKGYNSKKGTAGVGKASNSAVVFTS
MLLFVLDFIAVFITDIFYN
>IFAGANLK_03100 Phytochrome-like protein cph1
MTKVNNYPSKSELETKLKIDEPRVIAVGASAGGLEALKAFFKDIPETDKNAYVVIQHLSP
DYKSMMAELLKKSTNLPIREINDKMKMKQGHIYLIPPANNLSFADNKLNLVEKPKDQSLN
LPIDMFFEALSKERKGKAIGIILSGTGSDGTRGVRAIKERDGMIMVQDPEESKFDGMPKS
AINTGLVDYVLPISKMAQELKNFIDSPAVFHFKDGDYNYNESELMKILRFIDEKTGLDFR
EYKHATLARRIARRVNVCKCNSLSDYYQFLLNNDEEVEILHREFLIGVTKFFRDSKVWKV
LREEVIPKLVEKKKDGEVIKLWDVACSSGEEAYSFAMMINEEIEKQRKSVDLKIFATDIS
QKHLDIGSEAFYPESIVADIDSDLLMKYFISEPNGYKVIDKMRRMVVFSRHNIITNPPFS
NMDMVACRNLLIYFQPGIQNKALNFLQYALKVGGYLVLGTSENVSSQKNTFKVIHRSAKI
YQNENADKRLNSNISPATSQTRSLSNTKEVQRPTYRKSSNPVKNKLAEELNETILETFGG
ASVFIDNDFNILQAVGEFRKYANLPVNGFSVNLLDMLGVDLKYIIQSSVKKAKKNNEKLR
YQDAAFDHNGEKKSVDIIIKPYQQQVEDSNASFVITFIEKEVNLKEVKTLEKLTLTNRTK
EFVADLEDELKETKEELQTSMEEIETSNEELQAANEELLASNEELQSTNEELQSVNEEIN
TVNAENLQKVEDLAALNADMNNLLESTEIGVIFLDEELKIRKFTPAIQRHFNLIESDEGR
PIEHFTSSMGKSNLITRCKRVLRTGKILEKQVMTKDGSYYLRRISPYINSNEEVSGVVIT
FIDVGLLQRSKERLVASEKRFKSFYEEDPVIHISVDPQTQLIVQCNEMAVSRLGYNSKED
LIDKPVFDLYNEESQLKALKSNKEFKNTGVIVNMEQEMLTATGDTLPVILNATAEKEVDG
KIMTIRYTCVDISAQKDAELKLKQQHEDLERANKDLEQFVSICSHDLQEPLSTIKFGSDV
LGKMYSAQLDEKGKDYVKYIKDASTRLSEQIKALLEHSRIGRNGEKSLVNIKEVVEVVKY
DLGKRIKDTNAKVNAGTLPKIMGYEVELRLLFQNLISNAIKYTPKERNPDIRIAAYREGK
FWVFSVMDNGYGISEEDKKNIFTIFNRVKETNGNDGTGVGLAHVEKIVQLHEGSIWVDSQ
VGVGSTFYFKLKA
>IFAGANLK_03101 Phytochrome-like protein cph1
MSSEQLSYPEKIDIQNCEKEPIHLIGKAQAHGVILAVDPETFKITQASENTFKYFGLLHK
HLLGDSFENLIGKSAFERITKAIDQKTGFKAEELKIGNKHFVVLPHFSEEHLIIDFEVLG
EYWEPMFLQQQLTNTINGLDANETIPKLCNTAAKLMKSIFDYDRVMIYRFDEEWNGEVVA
EEREEYLESWLDLHYPASDIPSQSRNLFLKHKVRIISDVDYEPVPISPEISPITKKPLDL
SKSTLRGVSPIHIEYLQNMKVGASLTAAIIVHGKLWGLIACHHYSAKFINYFQRETCKFL
AQVFSNNIASIQTGIFNKKFNENSELRAKILTDLKIENTLGDGLENTEIPFTSLIESGGG
AVVLDDEIKLFGNTPTEAEVIDLSNFLAENDEILFYTKHLKNHYSAAENYKKSASGILSF
KLGRAKNNFIIWFRPEVVETVSWGGNPNKKITYNEEKQRLSPRNSFERWTEKLDGISNSW
QDYEIETAKAFRENLNQFILKKQKEEISRLNQNLQEANKDLELFSYGISHDLRSPLRGIT
GYAQILKEDFSENLSAEALETIETILKSSNRMEGIIDDILSFSKITGGELQKKNFSTNKL
LQELLMTFNIKANYPNLKIEIAENLPDSYGDRRMLFQLWSNLLGNALKYTEQAPYPQIEI
GSFAQENKDVFYIKDNGIGIAENQKDKIFQMFSRFAKKDFKGTGIGLAIVARILEKHNGK
IWVESEPGKGSTFFFHL
>IFAGANLK_03102 Chemotaxis response regulator protein-glutamate methylesterase
MITTPLRIILVEDEETDAVLIKRQIAKIVEKPEIKVVKDLPGFEGIFTSFLPDVIISDYN
LPTSTGLDIMQLAKSIDETIPLIFVTGALDDDELAADTILSGASGFILKKHMNKLHEKLE
PLLRQVVYNMVQHEELRERIRKNKIAVHQIYSYLDSMKADDREQRENIAKIRKNLDKFNV
DDAE
>IFAGANLK_03103 hypothetical protein
MMLNNLREATRKLHEELEKENLAGQIISHKISLEVYKLLLLQNYIAYKITEAEILKFIPS
YKSDKSDQLAKDLENLNVDTSISEEFQDKFSINSHEEALGAAYVVLGSALGGMYISKEIP
NCPELTEISKPHFFNGDRDGVKSWNKFVKELKAEDFTETQIAVASKKAQETFEFFGLVFR
QTSVIPQNS
>IFAGANLK_03104 Gamma-glutamyltranspeptidase
MKQNFKSLLCLFLAFSLYFPTLAQTGRTPVRAENGMVVTSHYLASEVGAHILNNGGNAID
ASVATAFTLAVTLPSAGNLGGGGFLVYHGSNGDKTSFNFREKAPLASSPNMFLGEDGKIK
DNSNHEGLLSVGVPGTVAGLYKAHQKMGSLPWEELVRPAIELAEYGFESTYNMNWFLNWV
KEKKDDDLYSATAKAFLKDGEEIYKPGETWKQPDLAETLKRIQKNGADGFYKGKTAKLIA
DFMKKHGGLITKEDLAKYEAEELEPVTGTYRGHEIVAMPPPSSGGVALIEMLNILEGFDL
EEAGHNSAASLHLLTEAMRRAYADRALHLGDPNFNPEMPIEKIISKEYAAELREGIEIKK
ASVSDSANFNNAHLQYESPQTTHISVVDKEGNAVSLTYTLERSYGSKIVVEGAGFLLNNE
MGDFNPIPGHTDTRGLIGTKPNLVAPEKRMLSSMTPTIVAKDGKPLLVIGSPGGRTIINT
VLQVIVNTIDHKMNVAEAIESPRIHHQWLPDRTRFEDWGISLDTKRIYEEMGHEVYEAGN
QGQAMGIYIDWENNLIYGAADSRSYDGKGVGN
>IFAGANLK_03105 hypothetical protein
MRLSEVVIFGYLGPKATTNRSFKNFNSLARKTKAYRIFYKLEEHLEIPMFLLALCWLYLF
IAELVSGLTATQENLIIIIWILFITEFLIKLVVAPRKLDFVKNNWITVIALLIPALRVFR
IFYALRLLQSVRVINSTRIIRALTSGKRFFSALKEAQGPKPEKEMNVCFLIACGKKENEE
SVTNFGKQLIQDVKSELQESTGIKWFFNIEHAELDSRKPRRPSDFLDVASQRMAEGPYDM
LSVITDVSLISRKNKTEPGLSSSVARIMVLSTRKLLTSGRDEPTYKLTENRVRHNAALLF
LYLTGQILGLKKSSSRRNKIMGATSFSEERNEIPSFNTEDRKILKEKANNAPDRELKEGN
VLESLVFHILMTFRHPAAFFTPLLRNWAIFLPLSLPGLATAAVAPALILIFTAETWDVGF
GMTNVTAGLFAVISIMFASFYLVRIQSLFLPRREKRIITEHLAVANTVIYFSIFLACIGL
FAMLTGLMLIIEIYVFPADLIQTWPTLEKQEITNADKIRLAVFISTIGVTTGALAGGLES
RTVIQHLAFFRNEV
>IFAGANLK_03106 NAD(P)H dehydrogenase (quinone)
MSQPKVAVIFYSATGTNHQLAQWAGEAAKQTGAVEVRVKKIQETAPQEAINQNESWKKYA
AENKDFPTAELDDLEWADAIIFSTPTRYGNLPSQLQAFFDTTGGLWQSGKLANKIVSGMT
SAANPHGGQESTLLSLYKTVMHWGSIIVAPGYTDPCLFEAGGNPYGISVTADGNAPGDNI
KKAVTHQVKRTVEMAAKFKS
>IFAGANLK_03107 hypothetical protein
MQEKHLYEYAVIRLVPKVEREEFLNVGVILFSKQSKYLKAFFDVDENRLAVFCKDLDKDE
LCTNLDSFKKICEGSKNGGPIAQLDLPSRFRWLTAVRSSIIQTSRPHPGMTNDLDKTLNR
LFTELVL
>IFAGANLK_03108 hypothetical protein
MQNAELRTVTVTRYITPLREGGSLPALTEADDDFKYVLKFKGAGHGVKALIAELLGCEIA
RALGFKVPELVYAHLDEAFGRTEGDEEIQDLLQASQGLNLALHFLSGAINFDPVATEVDE
FEASKIVWLDAFITNVDRTYRNTNMLIWHKELWLIDHGASFYFHHSWTNVEEKAKTRFSF
IKDHVLLPRATKLKEAEDFCKELITPEKIKEIVSLIPSEWLQWEDTDETEEEIKNVYTQF
LTTRLAHSEIFIKEAENARKALI
>IFAGANLK_03109 N-acyl-D-glutamate deacylase
MKLTLYLFLILPSLLSSQHKDETEYDLLIQNATVIDGSGRESYNAHILIFEDEIAKIEKD
LHKNFTAKEVIDASGLVLSPGFIDSHAHGDPVETPEFKNFLAMGVTTIALGQDGYSPKEK
DLITWFQKVDEINPATNISIFAGHNTLRELSGVNYDTLPDEKGLLAMEALLSKAFDAGVF
GMTTGLEYNPGNFSKREELQRLAKIVGKNNGLIMSHMRNEDDLEVENSIRELLAQGEYCP
VHVSHIKSVYGKGEERAEEILNLLDSARTAGVQVTADLYPYNASYTGIAIVFPEWAKKPN
DFEEVVKNRRSELEEFLRNKIMQRNGPEATLIGSGKFKGKNLKQISEELDKPFEDVLIDD
IGPYGAGGAYFIMDGVLQERLVQNEFINICSDGSPSMRHPRGYGSFAKVIETYVLGKKLF
TLEEAIHKMTGLSAKIIGLEDRGLIREGFKADLLIFNPTEIKETATYEEPHQLARGFKYV
FVNGRLAKQGEDFSKVRNGKMLRKNAD
>IFAGANLK_03110 Ribosomal large subunit pseudouridine synthase E
MHRHFKIYKPYGYLSQFITNERPRKKKKLLGDLGDFPAETMSVGRLDQDSEGLLFLTTNG
KISAEINGNKIEKEYYVQVDGQITYEAIEQLKHGLEISINGKSYETLPCKAYILQERPTF
PERARKIRDERHGPTSWISVTLTEGKFRQVKKMTAAVGFPTLRLVRVRIGNEKLDGMDAG
EVIELTEFSY
>IFAGANLK_03111 hypothetical protein
MKMKKRNSENQSLSEVLKEFVDHNKLQGGLDKVSVKDVWYREMGPAIEKYTTAIKLQNET
LFVQLSSSVLREELSYGKEKIINMLNRELGKDLIKKLVLR
>IFAGANLK_03112 hypothetical protein
MNKKILLFLFGIVLLGCEKNNPEEQLEHLSGYWEIDRVEITEDSVINYKVNATVDYIEFN
GEEGFRKKVKPQFDGSYKTSEDVEEISAKIENDSLRLHYKTPFDEWTETVISAKEDKFSV
LNRDGKIYHYTKFTSLLDENEEEK
>IFAGANLK_03113 DNA replication and repair protein RecF
MFLKQLSLVNYKNLDSASFEFDTKINCFVGNNGVGKTNVLDSIYHLAFGKSYFNPITSQN
INHEADFFVVEGHFEKSEKDEHILVSAKRGQKKVIKRNNKAYEKFSDHIGFTPTVIISPA
DRDLIIEGSETRRKFMDGVISQSDNVYLNKLIQYGKINAQRNSLLKYFAANHSFDRDTLE
VYNLQLSELGQYIFEKRKDFLEEFIPIFNKRYADITKNQEQVDISYKSQLFDSDLASLLE
ANLQKDMALQYTSVGTHKDDLGFEIEGHPIKKFGSQGQQKSFLVALKLAQFDFIKAISKV
NPILLLDDIFDKLDEQRVAHIVALVATDQLGQIFISDTHADRTEAVVKSSNQSYKLFKL
>IFAGANLK_03114 hypothetical protein
MATYKKKGYKPSNKEEQQKQVEDESTTAEVFNTLDEGAGRTETWVAENQKYIYIIVAVAI
VAVLGYLGYERFVSEPKQEEAANEMAQAQNYFASALNASGAERDSLFTMSLNGGEGKYGF
LDIIDNYGSTDAANLATYNAGFAYLNTGNYQEAINYLEDFNSDDEVLAALATGGIGDAFM
QLEQPEEALDYYEKAASMRSNEFTTPKFLLKAAITALEVGQPAEAEEHLQKIKDEYADAP
EAEQVPIYMGQARAAKQ
>IFAGANLK_03115 6,7-dimethyl-8-ribityllumazine synthase
MATEGNNLSDYDKDKLPDASDFRIGIVVSEWNDKITEGLYEGAYNTLIENRVQEKRIVRW
NVPGSFELIYGCKKMQESFDMLDAIIAIGSVIEGETKHFDFVCEGVTQGIKDLNVQNDTP
IIFCVLTDQNMQQAIDRSGGKHGNKGTEAAIAAIKMAKLRQDARF
>IFAGANLK_03116 hypothetical protein
MRLKIYNPRKNARYNYTPRYYKGKDAGNIYSFDSKFNKYKETTNAIDFGSQWAEVRKSSR
TRGNREINKRLLIIIMVLVFIFLWIIDFDLSIFSNQP
>IFAGANLK_03117 DNA mismatch repair protein MutL
MTDIIQLLPDHVANQIAAGEVVQRPASVVKELVENAIDAGSENIQVVIKDAGKTLIQVVD
DGKGMSLTDARMCFERHATSKIKSAEDLFSLQTKGFRGEALASIAAIAHVELKTKPEDEE
VGTHIKVEGSKVVNQDVCVCPKGTSVSVKNLFYNIPARRNFLKSDAVETRHIIDEFQRVA
LAHPQIAFSLFHNGSELFQLPETNHRQRITNIFGGKTNEKLVPVTEETEIVEISGFVGKP
EFAKKSRGEQFFFVNNRFIKSPYLNHAVVVAFEGLLKDKSYPSYFLFLKVDPKSIDINIH
PTKTEIKFDDEHALYAILRSAIKHSLGQFNVAPVLDFDRDSNLDTPYEYKNKSAEVPQVE
VDRNFNPFQEENARTHKTRSNSFSSNFIKERGESWESLYTGLQTEDEPKPDTDFREIEFE
SEEVTGNLFQPSEDSQEKSTFQLHKKYIVSTLKSGILVIDQHRAHTRILYEEMLKNITVS
AAVSQQLLFPLNLQFNTHEIEIIKQLQDSLEQTGFVFSEVKSDSVQIVGIPTLISESEVE
ILLEQLIADFENDVPDNGFSQTDLLAKSLAKGMAVKSGTLLNNTEQQHIVNRLFACKEPG
LSPSNRSVFVTLTVDELDKKFM
>IFAGANLK_03118 Rhomboid protease GlpG
MGRITETVKVLLIINIIFFVGSQFLGDYAYQLFALWFFENDNFMAWQFVTHMFMHGGLMH
IVFNMYALWAFGGPIEQMLGQKKFIFFYFSAGLGAAFLHTLVNYIEFKTGYNALLDAGMS
MGSIEQLLKTGEYSTAILDSVPRETLQGLYQSVNTPAVGASGAIYGILVAFGMMFPNVEL
FLLFVPVPIKAKFFIPALILLDLFSGLTGYSLFGGGIAHFAHIGGALFGFIMMWYWKKNQ
FNQNRWD
>IFAGANLK_03119 hypothetical protein
MKGSDKFKYKLQTATVVEKLIAINVLVFVLFYLFRTLTFLFQLPSDFLLEWFSFPKELGE
FIFKPWSIITYSFLHGGIWHILSNMLILYFSGIYFLNYFSPKRLLNYFFLGVIMGALVYM
LSYNLFPAFEATGRSYLIGASAGVMAVLVGIASYIPNMRVRLLLIGSIKFWYIAAFIVAL
DVIQIPMGNAGGHLAHLGGAALGYTYTKQLQKGNDIGAWFEKIMDSFAAMFQPTERKAKM
KTVYRKTSNKKSAAAQRKSSFSKKLDKDEKQKQIDAILDKISKSGYDSLSKSEKDFLFKA
GKED
>IFAGANLK_03120 hypothetical protein
MKNLGLIDKIVFIFNSLAATALLLSYLLAFIPPKSFPLLSVLSLGVPVLILINLVFMVYW
IIRFKRQFLLSLIILLVGYNYATNLYQFTGDTQTSEEELSIMSYNVRLYNSYGWTDEKNI
PEKITKFVKEKNPDILLTQEHTVDEIGINALYPYKFVHKKGRNSEFGMAIFSKYPIIGQS
SIDFPHNGNNNSIYTDVVVRKDTLRIFNVHFQSLNIKPEIDELRKADSKKLLGRIGQGFS
LQQEQAEMMMKKVNETPYKTIIAGDFNNTAFSYVYAMVNKEDRFTDAFLHSGEGFGQTFK
LNYFPLRIDFIWVDNKIQINDYKRFKNEFSDHYPILTKIKI
>IFAGANLK_03121 hypothetical protein
MEEILIHPAYFGPVSQFVALAKADKVFFENEDNYQKQTYRNRMYIYDSNGKLLLNIPIKH
RSALTGEPKEAGKHQLYKEVKIENDFEWQKQHWRALKASYQTSPFFEFYEDEIYPLYHKQ
FNYLLDFNYACLEFVTDSLQLDLDFEKTSEYILQPEDKKDVRPLIKAKGKLKFQQEEYTQ
VFKEKHGFLPNLSILDLLFNEGPNTTNYLEAQDLKF
>IFAGANLK_03122 Signal peptidase I
MTFTQWFLFFLLVQVIHFAGTWKLYQKAGRQAWEAAIPIYNAVILMKIINRPWWWVILLF
IPIVNLIMFPVIWVETIRSYGRHSTTDTILAIITLGFYIYYINYATDVKYIEDRSLKPRT
DAGEWISSILFAVIAATIVHTYVMQPFTIPTASLEKTLLVGDFLFVSKFHYGARLPRTAV
AFPMVHDTIPVLGVKSYLTKPQIPYLRLPGFEEIERNDIVVFNWPVDTVNAFQQYGDGKY
YYKPIDKKSNYVKRAVGIPGDSLEVRAGKVVVNNEPLQLPGRAKTQFTYIGTTNGQGFNP
RYLYEEYDITDGYYHDSNTNQFYIKALTESAYNRIKNHPNVTSIERYSDSLGSKDRSIFP
NNGKLNWNNDYMGPIYIPEEGVTVDLTAESMPFYKRIIETYEGSEMGINNKLSLNGTQVL
LNGQPTNSYTFKQNYYWMMGDNRHNSEDSRTWGFVPENHVVGKPVFVWMSWDANAQGFFN
KIRWDRVFTTVKGDATPTSYLPYFLILLVILIAFNYFKKRRKNA
>IFAGANLK_03123 4-hydroxy-tetrahydrodipicolinate reductase
MKIALLGYGKMGKTIEEIALNRDHEIVLKIEEDIDTYEIDKMEIDVAIDFSVPKAAFKNI
TTCFKNNIPVVCGTTGWLDDYEKAVEICKKEDSAFIYASNFSVGVNLFFELNKKLAKMMN
GMDDYAVEIEEIHHTQKQDAPSGTAISLAQQIVTENVKKNSWQLDHAAADEIPIKAKRIE
DVPGTHTVSYKSKIDSIEIMHTANSRQGFALGAVIAAEWLKDKKGIFTMQDVLSSQF
>IFAGANLK_03124 hypothetical protein
MKNNRVLSFLFFLLLVFTLTAQEDSLMVETPVNQDTISEEKDYKPYNALAPAKAAFYSAI
LPGLGQAYNGRYWKIPLVYAGIGTGVYFYINNNKEWNRYRDAYKDRLAGRKDEFTVNGDQ
RITDDGLIRAQEFYRRNKEISILVTAGFYVLNIIDANVDAHLQQFNVSEDLTLQPNMELD
NYTGKSRYGLSLNYRF
>IFAGANLK_03125 putative chromosome-partitioning protein ParB
MAKATKKQALGRGLSALLKDPQNDIQSAEDKNADKLVGHIVELELGSIEVNPFQPRTSFN
EDNLKELASSIRELGVIQPITVRKLDYDKYQLVSGERRYRASKLVGLETIPAYIRIANDQ
ESLEMALVENIQRQDLDPIEISLSYQRLIDEINLTQEQLSERIGKNRSTIANYLRLLKLD
PIIQTGMRDGFMSMGHGRALINVSDPQKQLDIYEKILQKSLSVRETEQLVREVNEGSKTS
KTAKKSAAVPTTYKKGIKEFSEYLGTKVDLKVTKKGSGKLSIPFSSEEDFIRLKKLIQGE
E
>IFAGANLK_03126 Sporulation initiation inhibitor protein Soj
MGKIIAIANQKGGVGKTTTSVNLAASLGVLEKKVLLIDADPQANATSGLGIDVEEVELGT
YQLFEDSIAPEDCIQKTSSPNLDIIPAHIDLVAIEIELVDQDQRESMLKKAITPLKERYD
FILIDCAPSLGLLTLNALTASDSVVIPIQCEYFALEGLGKLLNTIKSVQKIHNNKLDIEG
LLLTMYDSRLRLSNQVVEEVQKHFGEMVFDTIIQRNVRLSEAPSYGESIINYDAGSKGAS
NYLSLANEIIKKNP
>IFAGANLK_03127 putative zinc protease
MKKLLLNSLILLLSANVGILAQESENIPVSPKVKMGKLENGLTYYIRNNERPEDKLELRL
VINAGSILENENQQGLAHFVEHMNFNGTENFQKNELVDYLQSIGVKFGADLNAYTSFDET
VYILPIPSDDEETLNTGFQILEDWAHKATMTDEDIDEERGVVMEEYRLGLGPDKRMMQEY
LPKVMYNSHYADRLPIGKKEVIEEADYETVRNFYKDWYRPDLMAVVAVGDLDVETIEKKI
KDHFSNLEPIENPRERKTYDLPNHEETFVSIASDKEAPFSQVRVYYKDHEESEDVITKED
YIDQMERSLFSTMINNRLSELTNSSNPPFNYGYSYYGGTFARNKNAYQSFAMTGENQQLE
SLKALLEENERVKRHGFTESEFKRAKSEYLARLEQQYKDRDKQESGRLVNQYVNHFLENT
PIPGTEWQYNFAQENIDAIELDEINGLISEFLHEDNRVIVLTGPKKEGLEPVKEEEVMAL
LEEIENSEIASYEEETLRDELMTKIPNAGSVVETEKNEEVGFTRLKLSNGAEVVYKKTDF
KNDEILFSAKSMGGTSLYSDEDYLNTALANSGLSQAGIADLSVNDLNKMMSGKIVQVRPE
ISGITEGFSGSSTPKDLETLFQMVHLYFTELNMDKEAYTAFVNKQKAFLGNLMSNPNFYF
QNELGKFRNQGNTRYVGFPTPEKYDSQNYELAYKKYQERFANAGDFTFYFVGNIDEEKVK
ELASTYIASLPSSEKNEEFKAPEFRTSTSGEKKVVYKGTDPKSMVNILWNGETNYEAEED
FTMKALGEILTIKLVEQLREEEAGVYGVGARGNLSKIPYGSYNFTISFPCGPENVESLTE
AALAEVEKIKENGPTDKDLDKIKETFLVQRKDQLQENRFWLSQLETADMEERDLSEILKY
EEKVADLSKDEIKEVAKKYLDKNYLLGILMPEKKGEAAEDGE
>IFAGANLK_03128 putative 2,4-dienoyl-CoA reductase
MDFTKKMLREDALKGKTIIVTGGGSGLGKAMTKYFMELGANVAITSRNLEKLQNTAKELE
DETGGKCFAVQCDVRHYEQVENMRDEVLKEFGSVDVLLNNAAGNFISPTERLSANAFDTI
IDIVLKGSKNCTMALGKHWIDEKQKDKTVLNIVTTYAWTGSAYVVPSATAKAGVLAMTRS
LAVEWAKYGIRFNAIAPGPFPTKGAWDRLLPGDLKDKFDLAKKVPLKRVGEHQELANLAA
YLVSDFSAYVNGEVITIDGGEWLKGAGQFNLLEAIPEEMWDNLEAMIKSKKGS
>IFAGANLK_03129 Methylmalonyl-CoA mutase large subunit
MQRKELQHIELQQPELGKRQKEGENNTFETPEEIDLQPSYSKTDIQDLQHLNFAAGIPPY
LRGPYSTMYVSRPWTIRQYAGFSTAEESNAFYRRNLAAGQKGLSVAFDLPTHRGYDSDHE
RVVGDVGKAGVAIDSVEDMKILFDQIPLDRMSVSMTMNGAVLPVLAFYIVAAEEQGVKPE
KLSGTIQNDILKEFMVRNTYIYPPTPSMKIISDIFEYSSKNMPKFNSISISGYHMQEAGA
TCDIELAYTLADGLEYIRKGLDAGMDIDSFAPRLSFFWGIGMNHFMEIAKMRAARMLWAK
LVKQFNPKNPKSLSLRTHSQTSGWSLTEQDPFNNVARTCIEAAAAAFGGTQSLHTNALDE
AIALPTDFSARIARNTQLHLQQETKITKTVDPWAGSFYVEKLTNEIAKKAWKLIEEVEEL
GGMTKAIEEGIPKMRIEEAAAKKQARIDSETDIIVGTNKYRLEKEDELVTLEVDNQTVRK
QQVERLEKIKAQRNSEKVHKALEDLTKCAKKENGNLLSLAVEAARHRATLGEISDALEEV
YGRHIAKVQTFSGVYSKEMKDNTSFKKARELADKFAEQDGRRPRIMIAKMGQDGHDRGAK
VVATGYADLGFDVDIGPLFQTPKEAAKQAVENDVHILGVSSLAAGHKTLVPQVLEELEKL
GREDIMVIVGGVIPSQDYQFLFDAGAVAVFGPGTKISDAAIQLLEILIEEE
>IFAGANLK_03130 Methylmalonyl-CoA mutase small subunit
MTESLFQEFEEVSAKQWKQKIQFDLNGADYNEKLVYKSLDGINIKPFYNAEDVEASIKTP
SPKNWNICERLYVGSAEKTNRRALEVLEKGAESLWFIIPKKEIAIEDLLKGLNLEDTIIY
FSFNFFSESYFKRLREFFKGKENKVFLQFDIVGNLARSGNWFHNLQKDHEILDAIFDNSE
AFKSVISVDATLYQNAGATIPQQLAYALAHINEYLNHFQKKPNFEKFQAQFLIAAGPNYF
FEIAKIKALRWLYATLASEYKIPETCHILAQPTKRNKTLYDFNVNLLRTTTESMSAVLGG
ANTFYNMPYDAIYHKNNEFGDRIARNQLLVLKHEAYLDKVANAAEGAYYIESLTKQFAEM
ALDIFKEIEKGGGFLKQLKEGVIQRKIKESAKKEQEQFDKGELVLIGTNKFENPQDKMKN
ELELYPFLKQNPRKTLIEPILERRLSEQLEQERLKQEKAD
>IFAGANLK_03131 hypothetical protein
MFFLDSNSWFVHNELNQEIDELEENRQYYENEISKDKATIDQLQDSVEMEKFARQQYYMK
RPNEEIFIIEYDTIED
>IFAGANLK_03132 Uridine kinase
MLIIGITGGTGSGKTTVVRQIIDELKNEEVDVISQDSYYKDLSHLSKEERVKTNFDHPKS
IDFDLLVAHLKELKAGNTIQQPVYSFTEHNRTKQTLETQPRKVVIVEGILIFAHPDIREM
FDIKIYVHADSDERLIRRLKRDISERGRDLDEVLWRYQTTLKPMHQQFIEPTKEFADIII
PTNRYNTVAVDIVQTIIKDRLT
>IFAGANLK_03133 Aldose sugar dehydrogenase YliI
MLITKKNIMKRILLLLGLIFTFSACGDNQKSEEKAEVEEPTETDNQDSDNPVPEEMQEAV
SPENEYEHEVIAENMSIPWGFDFLPDGSILATEKGGDIYHFKDGKRVAINGGPEVYNQGQ
GGLLDIALHPDFENNNWVYITYSSDEGEGEGGNTALMRAKLENNELINREDLYKAEPNST
RGQHFGSRIVFDGEGHLFFSIGDRGNRDVNPQDLTRDGGKIYRLNLDGSIPSDNPFVGEE
NAKEAIYSYGHRNPQGMIFNEETGEVWVNEHGPKGGDEINVIKAGKNYGWPVVTYGENYD
GTTITEDRTGPEFQNPLTYWVPSIAPSGFEKVTSDKYPELKGNFLVGALKFQYLEHLAIE
NGEVTKREKLLEGLGRLRDVQQGPDGFIYAAVEGTGIVKLLPLEQTE
>IFAGANLK_03135 hypothetical protein
MSCENVGENQVTLTLTDNNGNVSEGTAIVRVEDSVVPLALTQNITVRLDVDGYATITPED
IDNGSSDNCKITSMSLDIESFSRSNVDNPVTVTLTVTDFSGNETSESAIVTVEDFEAPIV
DVPEITGVTFEGNTFTYDGTEHSIFVDGLPEGATVEYDNNEQTKAGTYIVTATVSLEGYE
DLMLTANMSIDKASQSITFDELEDLNQLTDEHLQLNATSTSGLPVIYSYTYETANPAATV
GPRGFVRILGGGQVVITATQEGNQNYEAADPVVRTLTINGSEALLNTAIINGVTYSNPDE
DIYYLIGCGNSENEVQIELEQNQGSSIDQNNSFTMNTPTPGIYRETLTVTSEDGNSTRTY
NITVEKNFNFEDIVIQKFNNVMLVNNNPETNGGYNFVSYRWYKDGSVIGNEQYFSAGKNA
DDLLDAGSSYYVVLETEDGEILKTCTSEIQLRSSLNVSLAPNPVSSGGTMELLADFPKEE
LETMQLSIHNLNGMLIKEMKSNRKITSITLPYTLQMGVYVLKIRTENINRSVKFIIR
>IFAGANLK_03136 hypothetical protein
MKINNIKSTNKLGVLRLVIMFTLICVSGQVLAQSNNEVSFYLQGSFSELSYEALGNNSEL
ENGFGVGAKYAYYLSDNWSIGTGAEFQYMEGSVFLPNIQGAFMTQDPEGEEFEFRYNANN
FSENQEVYFLHIPLKIQYESTGMTRFYAAAGVKAGLVLDSKYRSSATSLETIGYYPQYDV
ELADPQFAGFGEFGVVNSVKSGLDLQTNFVAHLESGVKLMLENSQSLYMGLFMDYGLNDI
KPGVSGERLIDYNNQNPTAFTTGSLLSSRSDMNSVLYVEEVRTLAFGLEIQYAFQF
>IFAGANLK_03137 hypothetical protein
MLDNKPPERSRKNETVLHSGGKRLFFNKEYIGEFVYGGIDGAITTFAVVAGAEGASLGIS
VVIILGLANLIADGFSMSVGNFFSTKAEKDNFDKHRQVEYWEIENLREKEVQEIREIYSA
KGFSGELLEQVIEVITANKDVWVDTMMKEELEMVRGEKTPYKTAGVTFISFIVVGAVPLL
SYVFMSDDTSNINSQLFLYSCILTAVALSIVGALKSLVTEKNVIIGILETLLLGGIAAFL
AYYVGDVLEKMFL
>IFAGANLK_03138 hypothetical protein
MLFLFQGFTLSLRDLAQIGDLVEHVNFHASTYGDSFEIFLSKHYGELKEKHTRDNQEEKD
EHEKLPFSHQCNIHNFIVFVHIPNDYFSSKVILGSNTSPIFFYSESYSSIRESEIFQPPR
LA
>IFAGANLK_03139 Cobalt-zinc-cadmium resistance protein CzcA
MLSKIIKFSLENKLIVLLFTLFIAGYGVYSLTQIPIGAVPDITNNQVQVITTSQNLSTQD
MEQFITYPVELEMANLPGVKEIRSVSKFGLSVVTIVFEDNLGTYLPRQLISEKIESASQN
IPEGFGTPEMGPITTGLGEIYQYILDTKPGYENRYSATELRTMQDWIVRRQLSGIPGVVE
VNSWGGKLKQYEVAINTEKLMAMNISTTDVFTALEKNNSVAGGGYIEKVNQAYFIRGEGL
VTSLEDIENIVVTRIGSNPVYIKDIASVGFGNATRYGAITANGEGEKVLGQVMMLKDANS
NKVIEAVKERVETISANLPEGVYINGFLDRSVLIGKTTFTIAENLILGCLIVIFVVVLLL
GNFRSGLVVASVIPLCLLFALSLMYIFGVDANLMSLGAIDFGIIIDGAVIIVEFIAFKIT
AKKGELQNLQSQERRLVKDRITFSGASKMMNSAVFGQLIILIVFIPILSLSGVEGKMFKP
MALTFSFALIGAMILCFTYVPVMSSLFLKPSNLSDKNISVSLMRFLARVYDPAIRFALNA
KKLVLVLALLILAISIYIFNSMGGEFVPTLDEGDFVIQPVLKTGTSLSETIKLTTQIENI
LLDNFPEVDQVVTRIGAAEVPTDPMSMEESDVIITLKPKGEWVSAESKDELAGKFKEALA
VIPGMGVEFTQPIEMRFNELITGVRADIAIKIFGEDLSVLGTKANEIENLISNVEGAADI
TVEKVEGLPQMNVKYNRSKIARYGLNIADLNDLVSMGFSGKTVGNVFEGEKRFDLVVRLD
QAKRKDLESLQNLYADTPSGDKIPLRELADISYQTGAAKISRDDTRRRIVVGVNVRNRDL
QSVVDDIQLLINNNIELPVGYNIAYGGQFENLESARKRLLIAVPIALILIFILLYFAFKS
VKEALIIYSAIPLASVGGILLLWIRDMPFSISAGVGFIALFGIAVLNGIVLIEHFKELKK
EGVPHNNDLIISGAKDRLRAVLLTASAAALGFLPMAVSSNVGAEVQRPLATVVIGGLVSA
TLLTLIVLPVLYSIFGNTTRIKPAKNKLRGGTMLILLLFSVPGFAQKKDLNFEQIKQLAR
ENNAGLKASKLSTKEAEAMINTAFDFSNTEVYYHYDQNNLAVNNEPLEVWGVQQDFSFPT
VYTSARSRNKAEFNLQSLIYELTEMEFEGALASAYYRLQYEMEREQVYAYLDSIYKRFSH
SATRRFELGETNYLEKITAQAKQRELQTRYEQAGEAVNIARQHLQRLVQANESLDVAKIE
LPKLEIENMGVEAHLVLDYHKARISLFEADARYRKQQLFPDISINYFTGTNSRLNNYLYG
YQVGLKIPILFTGKAARIKATDIAEERALQEAEDAKAFLESKYLTLSADLRKYSQALSYY
ENEGSDLSAEILKTANSSYQNGEIDFLEYIQSLESANQILLSYLENLNAYNQTVIAINYL
IPQE
>IFAGANLK_03140 Nickel and cobalt resistance protein CnrB
MKNIKFTLFILFPILLLSCRNVEENKDHAGKLGSNEVFVTSNQFSSNQMQLGNLVEKSFP
EVVKTTGEIDVPPESRVAINAFIGGYVKRIPLLIGDEVKIGQAVVTLENPEYIEIQQEYL
EVAEQLTYLKADFDRQETLLKEKITSEKKFLQAESEFRKNLARYNGLKQKLRMLNINPTK
VEEGSITSEVTIFSPINGRVTNLGISRGMFVSPTDRIMEIIDKEHMHLELIAFEKDILKI
KEDQDITFRIPESSSESFNAKIYLVGTSIDRDSRTLKIHGHLPDSLVDQFSVGMFVEADV
LTNKSTHFALPEEAVITQNEISYVLHLEEENKEGYIFRKQSVNVINTFEGFIGIANESEF
TKKDRFLVKGGFRLID
>IFAGANLK_03141 hypothetical protein
MNDIHRFKINTSATIKAEGQAHVLSRLEGEKIEIITKDSISFFHYAESFVIPAAAEEYII
RNLTKEPVMMVKAFVKN
>IFAGANLK_03142 Glycerophosphodiester phosphodiesterase
MKKSIFYLWTFCIAIFCITGCKVKQDSSISPPETAIKSFPKFLNEGHRGASGLMPENTIP
AMIKAIEEGANVIEVDVHISKDNQVVVTHDPQINRSISLLPNGEELEEGDTKKQFVYQMK
YSEIRKFDVGTRFYSKFPDQESKKAYIPLLSELIDSVEQFTADYNYPQVIYNIEIKATPG
KDGIYQPAPSEFVDLVMEVVRKKDLGNNRYYLQSFDIKLLQQIKRQYPNVITGFLTGSKE
FSLEKNINLLGFTPQIYSPNFSLAKIELIEKSHRLGMKFVPWTVNSKADMERLIEMGVDG
IITDYPDRLNQLINLNK
>IFAGANLK_03143 Beta-galactosidase BoGH2A
MKLIRICFLFVFVLFSYSAFSQWQPAGEKLKTEWANKVHPDNVLPEYPRPVMEREEWKNL
NGIWEYSIAGRSTNKPSAHDGEILVPFPIESSLSGVMRRVEPSQVLWYDRNFTIPQEWDG
KNIKLNFGAVDWEAEIWINNVKIGSHTGGYTPFSFDITPFLKDGEQEISIRVWDPTNEGP
QPRGKQVREPEGIYYTPVTGIWQTVWLEPVNRKSFKKVNFTSDIDNNTVKLDTETTDFES
GDIVEVIILEDDKEINRSKFTAGESLDIILSDPKLWSPDSPFLYRTIVKLISDKEIVDEV
KSYFAMRKISKKRDENGIVRMQLNNEDYFHFGPLDQGWWPDGLYTAPTDEALKYDIVKTK
EMGYNMIRKHVKVEPARWYTHCDELGILVWQDMPSGDQQKDWQMRKYFEGNELVRSAESE
EIFRKEWKEIMDYLMPYPGIVVWVPFNEAWGQFKTEEITEWTSNYDPSRLINSASGGNHF
QTGDILDLHQYPDPQLYLYDANRVTVLGEYGGIGLPMDGHLWATDKNWGYVQFESTKEVT
DKYIEYAETLKDLIRAGFSGAVYTQTTDVEGEVNGLMTYDRKKDKMNIKRISKINREVIN
ILKE
>IFAGANLK_03144 HTH-type transcriptional regulator KdgR
MKKAKKHSVKGIAEKLNISPTTVSFVLNGKAKEKKISDEMIEKVLAYVKEINYKPNQLAQ
SLRTGKSKIIVFMVEDISNHFFASIARKIEDLAYEQDYKVLFCSNENKDKKSRDLIQLFK
DRQVDGYIINPSPGIRNDVEALIQDDIPVILFDRYFPGLKTHYVGIDNEEASYKATLHLI
ENGFKKIGFITLATTQTQMANRKKGYLKATKEHALASKVLEIEFDSGNPKIKKELIKEFI
FKEDLDAIYFSTNYLTQSGLEVFKENSPELIDKFGILTFDDHEFFKIHTPTISAIAQPKD
EMASELMKLMLVLLNKSSKDLSPKEIILKTTLFPRNSTLVKNH
>IFAGANLK_03145 hypothetical protein
MRILNFGVFFFSSLLFLISCSSDDDSLEEIQEEEEEEQQPVDPGEEEKEEVGDWGEVAEN
LQEQTYSIYLTSNETFRQDNEGNENFNYWWNAHMLDVLIDGYERTGDESYLSKMKSLLEG
IKIKNGNKYENVFIDDMEWLGIACLRAYKLTDDEEYKEVADLLWEEVKKGWSEVHGGGIA
WKTDTPNSKNACSNGPAAIFALYLYEIDQDQEDLEWAKKIYHWLKDTLVDPESGLVWDNI
NYHDGEAVINSDWIFTYNVGTYIGAANLLHQATGDDMYLDDALKSASSVVGPGQLTTGGV
LKNEGQGDGGLFKGILVRYFTQLTLNTDVPDDKQEEFEEFIQFNAETLYHNGLTNAGLAG
PNWNDEPSGRVDLSTQLSGVMLMEAQALLERQ
>IFAGANLK_03146 hypothetical protein
MNLAKHPYFQAGKFILVFVSFFFISCNSTSQGSKDKEDDEPQKSYTSLVNPFIGTAPLID
PEFIGYPPPEGWRVWAGLVFPGSSLPNAMVQLSPITEYGTGAGYEYEDTEIIGFTHTNKG
HWNLCNIPILPVSGNAEAPFKSSFSHNTESASPGYYEVKLDDYRIKVRLTSTLRSGFHEY
TYENESDRKILFDLAKANHGVSNWEITQVDDYSISGLQHVGGDKIHFYAESNVNIKKLDV
QEMGEKDGYAILSLEDGKDAVNLKIGLSYVSVENAAENLKEEIGKADFEEIKKRANDSWE
DLLSTIEVAGGNKKQNEMFYSSFYRSFLWPALRSDVNGEFKDVKGEIQKKDFNYYTNPSF
WDTYRNKLVLLSIVSPDVTTDIIKTLIDKGEKTGFIPTFFHGDHAAPFIAGTYLRGNAEF
DVDKAYQFLLNNAYKEGGPRPHIKEYIEKGYISDPDVKNPKVETKAKAGVSKTLEYAYDD
YSVAQLAKALGDEKKYEDLIKRSENYKNVFDTSSNFMRGRLENGDWISPFNSEHPYYEYM
YREANAWQVSFFAPHDMPELVKLYGGKENFEEKLDSLFTLPWNPNHIARNVASFIGQYSH
GNQPAHEAPFSYYFVDKPEKSQAIIDEILEDFYGVGEDDLALSGMDDAGEMSAWYVFSAM
GLYPLSPADPEYLVTVPIFKEVKWNLPNGKTFTIDAPNSGRNLKQIMVNDEELEGYFISH
ELFKDGGEVEVISE
>IFAGANLK_03147 Cellobiose 2-epimerase
MKSISSNLSLAGLLKPYLPIFILFTLGFHSLVFGKEKRSSAPSLVTVENNNKWSQLANSL
QESTYKNYLGEKGVFIQDNKGQDKFHYWWNAHMVDILIDGYLRTKDKSYLPKIKDLVRGI
KISNQDNFQIFFNDDMEWLGIACVRAYQATGDEEYKQVAEYLWEEIKKGWTEVHGGGIIW
RTDTPEEKNACSNGPGALLALNLYNINNTQAELEWAKKIFEWQKNTLVDPVTGLVWDNIS
YQNAEPVINKELVLSYNQGTYIGAATQLFNHTGNKEYLEEAWKTTKSLITSPKLTYEGIL
RSEGQGDGGLFKGILVRNLTLLAENPSLENQRKESLLNFLTYNANTLITFGLDKEEMVVG
PNWAQKPKEHTDLSTQLSGVMMMEMAARLDLKQKKIKRYCQKNDKIHEKPHFINLSKEEV
VIAVLGSSTAEGIGPSKKENAWVPRFMDYLQKSDTNFKIINLAKGGFTTADLLPGGHPDK
NISKALSYNPDAIIINLPSNDAAQGRSATDQIENYRKIFSSIKNEIPVWVTTPQPRNFEK
AKVNIQKDMVDATYAFFDEEFIIDLWTYFSTEESLIKKEYDSGDGIHLNDEAHQLIFKRV
VFSLSNFLKQA
>IFAGANLK_03148 hypothetical protein
MTYLPKIKKKTIALPLLLLGVIFTGCKDQKETNEDQDNPEIEANSEELKDEAGLNELSEK
EKEEGWELLFDGESTDGWRGYGKDSFPQGWVIEDGALKVQGSGAGEAGGGGDIIYKEEFK
DFELSLEWKVSEGGNSGIFYLAQEIDDEPIYTSAPEFQILDNEKHPDARLGKDGNRQSAS
LYDLIPAEPQNAKPAGEWNKASIIVYRGTVVHSQNGENVVEYHLWTENWKEMVANSKFKD
WENFLNAGGDDKKGYIGLQDHGDDVWFRNIKIKQL
>IFAGANLK_03149 Inositol 2-dehydrogenase
MDKKNKDLNKFSRRKFISRTATVAAGISIVPRHVLGGVGYTSPSDKLNIAGIGVGGMGRA
NLREMAGENIVALCDVDWKYAQRAFNDYPQAKKFKDYRKMLDEMGDDIDAVVIATPDHTH
AVTAAESMKMGKHVYLQKPLTHSIYESRYLTELAKETGVATQMGNQGHSGEGTRLFAEWI
RNGEIGDPIEAHCWTNRPIWPQGLERPENEPAIPSTLDWDLFIGPAEYRSYHPAYTPWNW
RAWWDFGTGALGDMGCHIMDPVYFALDLDHPKAFEGSSSQVNTESAPIAEKVIYYFPEQS
KLNKINRPELKLTWYDGGLMPERPEGIKPGKVLGDNDGGAMVVGTKGTIICGTYGRNPYI
IGREDNPPQTNKVIPRVETSHEMDWVRACKESKNNRVEASSHFGYSGPFNEVVVMGNLAV
RLQDLNKKLNWDGKNMKITNIGESEEIKVVTTDKFTVVDGDPKFNTQYATINAQEAAEQY
IKHNYREGWKL
>IFAGANLK_03150 TonB-dependent receptor SusC
MEKKTSLFLRSIYLRLNRKYFLFFLFMVFQIVQAYPNALNQNTVTGTVTDSDGLPLPGVT
IQEKGTNNGAQTDFDGNYSITLENQDAVLVFSFVGMQTVEQDVNGQSSIDIEMEASQESL
DEVVLVGYGTQNRRSVTTSITKVTEDDFNQGVVTNALSLIQGKVPGLSITRPAGNNPNAG
TSIQLRGVTSITGNTEPLIVIDGIPGGSLDLVQQNDIESFDVLKSGAASAIYGTRGNNGV
ILITTKKGKAGITSFEYSTFLSRDFVNAKPDFLSAAQYRQAMEDGVFSSNDFGYSTDIFD
ELVNDTNLSQYHNFVASGGGENSNYRVSLYYRNLEGIALENEREEFGVRASFNQSAFDDR
LNFQSSIVTNFNNANLLGGGQFGIVTDWNPTAPIYAPYSVDEGTDLYNEGKFGFYQPQRG
YNPFSEYENRFNKRQQQTFSGDAKASFEITEGLIVAAFGSYQRNTWNDRQHRSIQDWNQY
NDGSEYLGTGYAYKSNLLDHTTTFEPTLTFEREIGDHTFDLLGGYSYQYTTQETFDMNNS
GFTTDAFLDWNFGAGNAIIDTDLPRPSLNSFKNDNTLIAFFSRVNYSFKDRYFLQASMRR
EGSSKFGANNKWGNFPAVSAAWLISDELFMEDTDFVSNLKLRADYGITGNQGIPNYQSLV
TLGTGGRYPIYPDSPNADGQYIPTFYQTYGANKNPNPDLRWERKKEWNVGLDFGLFNNRL
TGALDVYNRRTEDLLLSYEVPQPPFVQRTIYTNVGTITNKGVELGMSFRAINSEDFSWTI
DMAGSYQENELTTLSNDQFIASEIFGGNIGNPGNLGDAIRNTEGGPIGNFYGKRFAGFTQ
EGEWLFYKADGSVATASEISPEEDNAIIGNGMPKYNASLTNTFRYKNFDLTIFLRGKFDY
DILNTVDLFYGNPNIGGNVLTSALDQYSHISEQPQYSDYYLESGDFVKLDNVTLGYNFKF
GENSPFNALRVYANARNLAVITGYTGRDPEVQDTGLYPGVDDRNFYPRTTTITAGINVKF
>IFAGANLK_03151 Starch-binding protein SusD
MKNLLNIKNLACFTLVFSFFGCMDLDESPYSELEESNFYNNELEIIQATLRPFTHMQAWL
SWSGQNGYYYHNELSADQVAWPQKGPHGFDGGDHIRQHYHTWTTQEGRLANTWSLMWTGV
GYVNSAITDIQNIDPESANISQERLESLVAESKVLRAYHYMKLMDLFGNIPIVTQVGEPQ
NPATASREEVFAFVESELLENVESLQPLSQSLLGRVSKAVGYAMLSELYLNAEVWSGEPR
WQESIEYANKVIDGEGGALMGSMALDQDPLGPFNNQNELSPENIFQFPFSRENGFGYDWR
AFYSGFSNMAPALDVNYSGWNAFVVIPSAFDEYRESDIRKQEWFLFGPQYRFGTDQPILG
SEEYNGEPLVYVNNIRRNSEGQTGEGSMTDGEENSGARFHKYRSGTQTDENYLENDFVIY
RLTEMYFNKAEALMRLNGGSATAEAVDLINESKSRYFNDEDWAEASYTTATLTLDELLEE
RGREFIFEGKRRTDLIRFGEFTTGTWWDHEPSEDYRTIYPIPLRQVQTNPNLEQNPGY
>IFAGANLK_03152 hypothetical protein
MNTKIFNLKNIILSTFLVGLFSCEGRRDFPDLVETGVTLDNTDILLISGETEDIKARFVP
NIFPARDYVWEIDDPSVADLVMNEDKSVTITAVGAGETVLRIVSQDQESISAEAQLKVIA
SAPIDITDEAEISVNRENSGGPTGNEGSLKLIDGDLNSKYLSGYEQPFWVNLEFEEEKVV
SFYQLTSGNDAPDRDPRDWQIEGSNDGENWEVLDERVDQTFSGRNLTREFYFENETGYTH
YRFNVINNNGGGLFQMSEWRLLSIPE
>IFAGANLK_03153 hypothetical protein
MKNNYILIGLFTIFMVSELHAQRPEVFQEKDKTLIFTNDDPLLDKEVKSGLIKTFFKVYP
ELVRDFNSEVSDTIYVKIDTSYSGVAYAHNGKITISSQWLKKKPNDLDVITHEAMHIVQS
YPHKAGPGWLTEGIADYVRYKYGVNNEDAEWFLPDYSAGQSYKNSYRITARFLAWISNNY
NRNLVVTLDRNMRENTYSEILWKEITGNTLEELWEAYAENPDISKK
>IFAGANLK_03154 hypothetical protein
MKRRKFIQNTALAGGLTMLDPFHLNASEITGFFKKFPVVRTPKGDRNFESKVIEKVIAEF
QKNVQDEELGWLFNNCFPNTLDTTVTYSEINGKPNTYVITGDIDAMWLRDSVAQVWPYMT
FVEKDQKLKKLIAGVINQQTQYILKDPYANAFYDDPEKKGEWFSDLTDMKPGVHERKWEI
DSLCYPIRLGYHYWKSTGDTSPFDEDWIKAIDSILKVFKDQQKKDDRGAYSFQRETPKAT
DTRALQGYGYPVNPVGLICSAFRPSDDATVFSFLIPSNFFAVVSLEQAAEMLTEIHGDAE
RATELKNLREEVKTALDEYAVVDHKKYGKIYAFEVDGFGNQLLMDDANVPSLLSLPYLGA
VAPDDPIYQNTRNYIWSKDNPFFFEGTAAEGIGGPHVALDMIWPMSITMKGLTSNDDKEI
KWCIDTLKNTHGDTGFMHETFHKDDPTNFSREWFAWANTLFGEFLWKTYQEKPHLLK
>IFAGANLK_03155 N-acetylmannosamine kinase
MKIFQDERIVLTLDAGGTNFVFSALKGGKPITPFITLPSNSTDLEKCLKNIIEGFRKVKK
LILPAKAVAISFAFPGPAEYEKGIIISPPNFPSFKGGVALGPMLEEHFNLPTYINNDGDL
FTYGEAIGGFLPEVNKGFKQFEIKKEFKNLIGITLGTGFGAGVVINQEICKGDNSAGGEI
WLMRNLLEPEIIAEESVSVRGIQSYYKKYSQESYELSPKDIFEIALGEKKGNREAAIMAY
DSVAKVVAEALANVINIIDGGVVIGGGIAGSSKLLLPQILKHLNGKIENRNKDKFNRIVS
QAFSFEEQDTKQAFYKKAIRKIKVPFSSREIEFVQDKRVPVGISRLGTNNATMLGAYAVA
LSKSGRVVQKMEKV
>IFAGANLK_03156 Fructose dehydrogenase large subunit
MSFQIKKQSTKYDVCIVGSGAGGGMAAKLLADAGFKIALLEAGPDFDPANKEQRTQLRWP
WESPRRGAATTRPFGDFDMAYGGWELEGEPYTQNGNTEFAWFRSRMLGGRTNHWGRISLR
FGPLDFKRKDFDGKGDNWPIGYEDVKPYYDKVDKLIGVFGTKENLPNEPDGFFLPPPKPR
LHELYIKKGANQAGVPMIPSRLSILTRPVNKERGACFFCNQCSRSCMAYADFSSSSVLVK
PAVKTGNVDLYVNAMVREVLTNGEGEATGVSYIDKDDLRDYEIKAKVVILAASACSSARI
LLNSKSAQHPNGLANSSGVVGKYLHDSTGSSRMGFIPQLVDRERYNEDGVGGMHLYTPWW
LNDSKDLGFTRGYHIEYWGGMSMPAYGFGFNTQALKEITGDTSRNAYGTGLKKDVKKFYG
ATFGMAGRGESIPRKENYCEIDSNTVDKYGIPVLKFNYTWSDEEVKQARHMQDTFEEVMH
NMGAVPLGDKPGKETNYGLENPGKIIHEVGTTRMGKDSKNSVVNEFNQAHDVPNLFVMDG
GPFVSQADKNPTWTILALAWRATDYLTEQLKKGNV
>IFAGANLK_03157 Gluconate 2-dehydrogenase subunit 3
MDRRESLKALVLGGVGSSLFLSSCVTDKKSPIVEGDIIEEKEGYGRTPAEEKRDEDLYSK
TFFSKEEMATISILADIIIPEDEESVSATEAGVPEFIEFIVKDIPEHQIPMRGGLMWINR
ESNKHFEAAFNEISKENQMEIIDNMAYPRAFEENSPGPVFFRNIRNLVVTGYFTSEPGFK
YLDYRGNTPNVWDGVPAYVLEKHGMKYDEGFLKVAMDPATRNEVMDWNNYEV
>IFAGANLK_03158 Xylosidase/arabinosidase
MKNSYKTLLLLVFVALGVTSCKMNAEDNKGKEEKTEEETVQNNNPVFPGWYADPEGIVFD
DEYWIFPTYSAPYEEQVFLDAFSSKDLVNWEKHERIIDTAEVEWAKRAMWAPAIIRKNEV
YFLFFGANDIQSDDELGGIGVAKASSPEGPYEDYLGEPLIGKFHNGAQPIDQFVYEDDGE
YYMFYGGWQHCNVAKLNDDFTGFKPFEDGETFKEVTPEGYVEGPFMFKRDGKYYFMWSEG
GWTGPDYSVAYAIADSPTGPFERIGTILQQDPDIATGAGHHSVIKTPGKDDYYMVYHRRP
KGETDRNSRETCIDRMYFDENGHIKPVVITHEGVKPNPINK
>IFAGANLK_03159 hypothetical protein
MKTNFFVLAFCFFATFVNAQDYLVEVVENPVDWVKPLMGTDSKPSMSNGNVYPAIARPWG
MNFWTPQTGKMGHGWAYQYTADKLRGFKQTHQPSPWMNDYGQFAIMPITGEIRFNEDARA
SWFSHKSEKVNPHYYSVYLADHDVTTEITPTSRAARFRFTFPESDSSHIVIDALDMGSYV
KIIPEENKIIGYTTKNSGGVPDNFKNYFIIKFDKEFTASHTFSGEEISEELEVEAEHVGS
VISFKTEKGEIINAKVASSFISYDQAELNMEEIGNDDFETVKEKGREEWNQELSRIKVEG
GTPDEVATFYSALYRSLLFPRKFYEYNAEGEVVHYSPYNGEVLPGYMFTDTGFWDTFRSL
FPFLNLMYPELNANIQKGLANAYKESGWLPEWASPGLRNIMVGNNSASVVADAYLKTDGK
FDYDIDLLYEALLNGANNEGPMTAVGRAGAEYYKELGYVPYDVGINENAARTLEYAYDDF
AIYQLAKKLNRPKEEIELYKERSLNYKKLYDPETKLMRGKKENGEFVEDFNPFKWGDAFT
EGNSWHYSWSVFHDPQGLIDLMGGKKEFVAQLDKVFEMPPVFDESYYGGVIHEIREMQVA
DMGQYAHGNQPIQHMIYLYNYAGEPWKAQYWVRETMDRMYQPTPDGYCGDEDNGQTSAWY
VFSAMGFYPVAPATDEYVMGAPLFKKVTVELENGNELIINAPQNSDSNKYIQKMELNGKE
YTKNFLSHKELMKGAVIDIEMGDTPNKKRGTEESDFPYSLTNEL
>IFAGANLK_03160 hypothetical protein
MKFNNNFITSTGTFLVFLLFFSCGKEEKTTESNNLSSTQDLKDLAQFVDPMIGTAKMGHT
YPGATVPFGSVQLSPDTDTIPYAVDGKYNPDVYKYCAGYQYDDSTIIGFSHTHFSGTGHS
DLGDFLIMPTTGELKLNPGTEANPNSGYRSRFSHKTETAEAGYYKVFLEDYDIEAEMTAS
SRVGMHRYTFADKEEAHVILDLMSGIYNYDDKNVWTFVRVENDTLITGFRQTNGWARTRK
VFFAMSFDRPIKNYGRARYDKQPYNGFWGKFDQDENFPEVAGEKIRMYFDFDMEAEEKLQ
VKLAISPVSSEGALNNMKTEIPHWDFDKVKDDAREKWNEELNKVVVEAENDAEMTNFYTA
MYHAFLGPTEYMDVDGKYRGIDMNIHQAEDFVNYTSFSLWDTYRALHPLFNILQPERNSD
MVEAMLAHYDQSVHKMLPVWSHYANENWCMIGYHSASVISDAIVKGNAGFNEERALDAMV
QTAKTGYYDGLEYYMEKGYVPEDKNSASVSKTLEYAYDDWAIAQAAEKIGNSEVYDEFFK
RSENYKNVFDSKTGFMRPKLDDGSFKKEFDALNTHGQGFIEGNAWNYSLYVPHQPAEMIE
MMGGKQQFSQHLDSLFSMELPDKYFEHTEDISREGIIGNYVHGNEPSHHVAYLYNWTNTP
WKSQDKIRMILKDQYQTGADGLGGNDDFGQMSAWYIFSSFGFYPVAPGSTQYALGSPAIS
KATINLDNGNTFTVIADNQSAENVFVSKVELNGKVLDDPFIDHNDIMAGGELKFYMSSEP
NKEIYREN
>IFAGANLK_03161 L-fucose-proton symporter
MNQKKSYRTAFIFVTILFFLWGFITVLVDSLIPRLREVFTLSYFQAGMVQFAFFGAYFLL
SIPAGYILSKIGYKKGIILGLVTMAVGCLLFYPAASYRIFGIFMFGYFTLAAGITILQVA
ANPYVTILGSEKTASSRLNLSQAFNSLGTAIAPALGALFILQDKVKTTAEIEALDPTAQT
SYYISEASAVQTPFLGIAAFIIIIAIVFFFVNLPKVGDKEASNDYRGVLKNRNLILGAIG
LFCYVGAEVALGSYMVNYFLSLDLAETVRETSFMRTIASWILSTGVSASSDMAVVGVFVT
FYWTGAMIGRFIGSYLTTIFNPAKVLSVFAIGAISMILISTFSVGLAAMWTIIAVGLFNS
IMFPTIFSLALDGLGDDKAQGSGVLCTMIVGGAIIPPAYGFLTDSYSFKIALILVMICYA
YIFYYAWTNKRRTVVIE
>IFAGANLK_03162 Hydroxypyruvate isomerase
MDRRKFIKQNIAATSLAGLGPYLGYAGNFEEVSTFVKNQFKLSYAPHLGMFKELAGEDPI
DQLNFMADRGFTAFEDNGMKAKPVELQEKMAKTMANRNIRMGVFVAHNIYWTEPNLASGD
ENLREEFLNQIKESVEVAKRVNAKWITVVPGYVDQRQNLQYQTAHVIETLKRASEILEPH
GIIMVLEPLNFRDHPGLFLSGSPQAYQICKAVDSPSCKILFDIYHQQIQEGNLIPNIEAT
WDEIAYFQVGDNPGRNEPTTGEINYKNVFKFIHNKNYDGIVGMEHGNSKPGKKGEKSIIE
AYKQSDDF
>IFAGANLK_03163 Sensory transduction protein LytR
MSLRCVIIDDEPLAVNVIKNHLSQIKDVKIEVSFNNAVEALEFLRDNPTDVIFLDIDMPV
LDGFSFLNSLEKKPAVIITTAHQEYAVRGYELDVLDYLVKPISFPRFLKAIDKIKRLQFN
QSSEKEHLFVKVDKKKMKKIYLDDILVVESLKDYIKIITRSGKHIVHQTLSSFTDSLPKN
KFLRIHRSYTIAIEKVDAVEGNSVEINGSLYVIGRSYLTEVKAKILDLD
>IFAGANLK_03164 Sensor histidine kinase YehU
MLTRKQFLKGFSIQNQGEYKITAWHHLIFWLAYFLFNTLRWGSYYDDFLLSLKGNLIGFP
IHMFLCYFTIYFLIPKFIFKRRFISFSFILIGSIFLMVVAKFYLTLFLISNNVWPEGPEA
TSQFTFNYALTMMLGEFYVISFVTAIKITLDWLSASKRAARLEKEQLQTELRFLRSQISP
HFFFNTLNNIYSLSLEQSKKASETVLKLSELMRYLLYETKNNQQPLDKEILCIQNYLDLE
RIRYGEQVKINMEVTGNIEGKKIPPMLFIPFIENAFKHGASKNIGNVCMSIKLQVKDDDI
YFTVSNTMPDKRIGDKMKKESGGIGIENVKKRLALGYSENDYNLDIYTKDENFIVALKLK
SK
>IFAGANLK_03165 hypothetical protein
MILNNRFQAPENLIVVFLLLVFVSCEQTEKKKEADQKENLTSYVDPFIGTGGHGHTYPGA
AQPFGMLQPSPDNGRSGWDWCSGYHISSDTIAGFSQLHLSGTGIGDLADLLFMPITQEID
LSQKVNSQKDIPYASEFQHDSEIAIPGFYSVFLDKPQVKVELTTLDRTAYHKYEFWENSE
QAVVLDLGFAINWDKPTETAIDIENKTTISGFRHSTGWANNQKVFFIAEFSKPITEHRFF
QDYQLVEGEKISGEKTSAQFYFDKDSGQEIKMKIAVSSVSVENARQNLAKGDFDFEKIKE
DAIQNWEEELSGIKVKTPRDSLKTIFYTALYHTKLSPVIFSDSNGEFRKENDSIVKVDYT
AYSTLSLWDTFRAQQPLLTITNPDKVTDIIKSMLEYYKVEKSLPVWTLYGNETNTMTGYH
SIPVIVEAYFKGIKGFDPEEVFEAMKSTMMQDARGLEAYKEHGFIPYDASDESVTMTLEY
AYNDWCVAQMAKALGRDEDYEYFSNRAKAYKKVFDKETGFMRGRKSAENSWNEPFDPKHS
NHRVNTDYTEGNAWQHSWFVLHEPEKLIELQGGEEAFNEKLEQLFTESSEITGDHISADI
TGLIGQYAHGNEPSHHIAYLFNKSGKPWRTQYWVREILKSQYSAQPDGLSGNEDAGQMSA
WYVFSSMGLYPFNPASATYEIGSPIFEESEIRLENGKTFHIKAQNVSDKNIYIQSARLNG
EEFNQTNISHESILEGGELIFKMGKEPNKGWGTNNSTAN
>IFAGANLK_03166 Sodium/glucose cotransporter
MAFWDVFIIIIYVAVTLGLGIYVSRRASKGLDSYFLGGKSIKWYYLGLSNGSGMFDVSGT
AWMVGILFLYGAKSFMFMWMWPIWNQIFVMMFLAVWIRRSGVMTGSEWILTRFGDDRAGR
ASHLIVAIFAVVAAIGFIAYFFEGVGKFMTVILPWSLDLFLGDFLLLTSEQSYALIIIFL
TTIYTIKGGMFSVVATEVLQYVIMVLAGILIAGYTFFVITDVEISAAIPEEWKNVAFGNE
LEGFWSGKKDVFNELIDNEGYKMFGAFVGMTLFKGFFASVAGPTPSYDMQRILSTRTVRD
AAYMSGFTNLVLFIPRYLLVGGIVVLGLVFLAPEIASLENLNGGDMELVLPQVINYEVPV
GIKGLLLAGLLAAFMSTFSAFVNSGPAYIVNDIYKKYFKPQATDKHYIRASHISSFLVVV
LGVIMGFFADSINSITLWITSALYGGYIAANFLKWVWWRFNGWGYFWGMLSGLIIATFQF
VVDKNKEHYIEGSWLFEIAGTPAIYLFPVIFGFSLLGCILGTWLTPATNRTTLKAFYKNV
RPWGLWKPVRKMMEEDGDPVEKNKDFGIDMFNCAIGILWQSSMILMPIYLVVRDYYLVLV
WLIVFIITTVVLKFTWLDKVKHYKD
>IFAGANLK_03167 1,4-beta-mannosyl-N-acetylglucosamine phosphorylase
MENLKNIPWQEKPENCNTVMWRYSENPIIDRYAIPSSNSIFNSAVVPFEDGYAGVFRCDN
KAVQMNIFAGFSKNGIDWDINHEPISFKAGNTEMIDSDYKYDPRVVFIEDRYWITWCNGY
HGPTIGIGYTFDFKEFFQCENAFLPFNRNGVLFPKKINGKYAMLSRPSDNGHTAFGDIYI
SYSPDMKYWGEHRCVMKVAPFEQSAWQCTKIGAGPIPILTNEGWLVFYHGVIATCNGFRY
SIGASILDENEPDKVKYRSQPYLMAPAELYELTGDVPNVIFPCAAVHSEKEDKLALYYGA
ADTVTAMAFGKLSEIIDFVKNNSL
>IFAGANLK_03168 hypothetical protein
MMRRYLFFFVTISFFFQLKIYAQSEKAPRTYVAHKTSEKIIIDGKAEEAAWKSAPKSQDF
IDIEGDKIPTYQTNMKMLWDEDYLYFYAKMEEPHIWATLKQRDTVIFYNNDFEIFIDPDG
DTHNYYEFEMNALNTVWDLFIVKPYREPAPIVDSWDIQGLKSEVFVEGTLNDASDKDEYW
SVEVAIPWEVLKEANTHKEIPKGEFWRINFSRVNWDFDLDNGTYSRAKDEKGEFKHEYNW
VWSPQGVINMHEPEHWGYVYFSEKAPGEEDDFNIQIDENIKWELYRLYRAQKVYKEKNGN
WAKKLSAINGESVNVEGKKLQPKLEVHKTGWNIWVKSPFTGDRLLIKEDGDFIKQKK
>IFAGANLK_03169 hypothetical protein
MKYIYYLLLAFTVTACGNSSAENDLATTEKTEEKPNPSTKDFKYWTWITASSEKSEEEYS
AEFKKYKEHGIDAVLINTEADAQLLSELAPLATEEGLEVHAWMFTVNRPGDKEAEKHPQW
YAVSRDGKSTYDAPPYVDYYKWLCPTREESKNHILSLVEGLAKVEGVESVHLDYIRYSDI
FLPIGLLPKYGLEQNEELPEFDFCYCEVCTAEFEKEHHKNPNDFDNPAIDMEWKQFRLNK
VKAIVDEAYEIAHENGKYLTAAVFPYPEMADHMVRQRWDKWNVDMVLPMIYQNFYNEEID
WIGFATGQGVKDLEGTNTELHTGIYIPELNAEELKEAINYARENGAKGAAFFDGGAFTPE
KLEAIQAVKEGD
>IFAGANLK_03170 Beta-hexosaminidase
MKLVKILLCSFVLLMIGCGEKENPSFTKEDLVLIPEPQSIEINNGSFRVNTETKLIIPGD
SIKPLTNILNDLFEKSAGFQMAVSNESAEDNFIQLKKNTELAEEAYELSVATNQVLLEAS
SRLGFVYGLETIRQLLPKEIESASKISEIDWLIPNVEISDAPQYSYRGNMLDVSRHFFGK
DYIKKHIDRMAFLKLNTLHFHLVDDQGWRIEIKKYPKLTEVGGFRVDQEDTHWNARTENE
PEDEATYGGFYTQEDIKEIVAYAREKGIRIIPEIEMPAHVMSAIAAYPWLSCTGEPIAVP
SGGVWPITSIYCAGKESTFEFLEDVLTEVMELFPGEYIHVGGDEATKTNWESCPDCQRRI
REEGLADEHELQSYFMKRIEKFLNKNGRTLIGWDEILEGGLPEEATVMSWRGFEGGWEAS
KQGHDVIMTPTSHLYFDYFQGSPDHEPVAFNAFTPLNRVYEFRPVLDSMTAEQKNHVLGG
QANLWSEYVPNEEHSEYMLFPRLAALAEVVWTPENKLHWQDFSVRIQKMMERFDIMGINY
ARSAYAIQPDSEINLETGEVTIELKAEFPDVEIRYGMNDSELSANSNIYKEPIKINSNSH
LKAAVFKNGEIMGPILDKDFQFHKAVAKPVTYKYSYNDNYKGGEEKGLVDVLRGSKYFKD
GRWQGWINNPAIITINLEEPTEINEVVVGSLEEQGTGIYFPQKIKVEVSKDGKTFEKAGE
ITREFQNNTSAKIENFRIGFDTQNNIELVRVTVEPLEHNPKGGGSWLFLDEIQVK
>IFAGANLK_03171 hypothetical protein
MVSVLRVVFLGLLILVSLRMTAQDFDPVNYVNPFIGTSNYGATNPGAIAPRGMASVSPFN
VAGRIDLNPLEKDSQWLSNPYVYENTFLTGFSHVNISGVGCPDLGVIITMPTTGALETNH
QKYGSTYTEETAKAGYYSTKLKKYDVEVQATASTRTGVTRYSFPAGKSNILLNLGLGLTN
EQGAMAHIVSPTEIEGMRMVGSFCYNNPEAAYPVYFVAKFSKPADNFGVWKTPYKNEGEE
AQWMAYNGKTRIKERFSREVVGDSIGAYMTYDFSSPEQVEVKIGVSYVSIENARDNLENE
VGDSSFEEVYAQTKTEWKKKLRVVEVEGGTEDEKTIFYTALYHTQIHPNIFNDVNGEYPE
IATGKIGKTEGTRYTTFSLWDTYRNYHQLMSLLYPQEQLDMVKSMLEMYDENGWLPKWEL
NSTETFTMVGDPAAIVLADTYLRGLTDFDVDKAYEAMLKSATQIEENPLRPGLEEYLKKG
YVSVDAGVPGPVSVTQEYNAADYAIALLAKELGKEEDHEVFKERSVSYRKLYNSDSKFLQ
PKHIDGDWLEGFDPLAGANFTKNPGFIEGNAWQYLFMLSHDAEGLIQLMGGKVAYEKKLD
AVFNEGQFDMANEPDFAYPYLYNFIPGSEHKAQKKVQELLKEYYKNSPDGLPGNDDTGTM
SAWAVYSMMGFYPQVPAETTYSLTAPIFDKIKINLNTDFYPKENLVIIKEEVSGKNKAGE
IFIDNSPLNTFFIKHETLINSNELLFFQDLE
>IFAGANLK_03172 TonB-dependent receptor SusC
MNKKIILFTSLFLCCIQLVLAQQRVSGSIVDAENGMPLPGVNVIEKGTNNGVSSDFDGNF
SIEIEEGSTLQFSMLGYITQELEPDGSDIQIELAPDTEALDEVVVTALGIKRSERALGYS
LTEVGGEELSDVKQVNAINSLQGKVAGLNITGAATGPAGTSNVLIRGISSVGGNNQPLYV
VDGIPIDNTNLGSASQWGGSDFGDGISSINPDDIESMSVLKGGAAAALYGSRASNGVILI
TTKTGKEQAGLGVEYSGSGSI
>IFAGANLK_03173 TonB-dependent receptor SusC
MSDIYDFQNEYGQGINGEAPTSREEALAAGMQSWGGRLDGSSVIQFDGEERPYADQGDNL
DRFYRTAHTIINTVAITKGGEDYNLRFSATDLSNEDIMPNAGLNRKSFSLNGGAQLADKL
SLDVNTKYILEDVRNRPRLSDSPGNANFAVVLSPPNINVEDYRPGSNEENTELRISSSNY
HQNPYWSAYEFMNNSLKNRFIGSSTLRYDITDWMYVMARAGLDQYTSRITSVEPFGTTYI
PLGSMTEIAYNTKLVDADAMLGFEKSVDKFSGQLILGANNNDRKIERTELRGTEFVIPNL
VDINNLTNKNYSYDFSQVKRNSLYFSTELSYDNFLFLNITGRNDWFSTLSLAGKTSPNNY
FYPSANTSFVFTDAFDTPEWMTFGKIRLGYSDVAGGGEDPYQLALAYGIFDTYNGRGSSV
PLGSISSSTLPNQELKPFSKQEYEVGLNLQLFDNRLGLDLAYYTNKTTDDIVPITISNST
GYSTAVVNIGELTNNGVEMLLTGKAIKNENLSWDIAYNLGYNENEVVRTDADGNPLFPDG
SQATNVSSGAIVGEPFGAIYGTTYIRDEQGRIQYDSNGTPSVGPREVLGNGVAPWTMGLT
NTFRYKNWNLSFLIDAKFGADIYSGTSAFANYYGASQNTLAGRENGLEINGFDSNGDNYS
TTIEPENVETYYKRLYEIAEEHIQDADFIKFREFSLGYNLPGEILQNTFITSANISVIGR
NLFFLKRETENIDPESSFNSRGARGLERFGLPQSRSYGLNLNVKF
>IFAGANLK_03174 hypothetical protein
MKNKLYISLFLVITMVLQACDKDFEDINIDPTTASQVDLSYKFPTAVLYASGQRYESWRA
NLIYSSTMIQHLANTQTYWSGDKYLLNTAYAEAFWTAQYPQTIKAVEDMKYGLESQGDST
SVDYAIVKTLRVFAYHRMTDLYGDIPYSEAGKGFIEGDMRPAYDPQEEIYADMLNELEEA
VMIMESGGTSSLGTADIIFEGDVNKWRKWANSFMLRLAIRMTKVDEAAAEEWSRKAIEAG
VMESNDDIAYVMHEEGNGIVQNGNGETFTADGTPRISDTFIEFLQGDPRLTIYASLPEDS
GETDADGNTILRSEEERLDSDAQRGLPNGLDNALLREQTGETNTLDYSEPNRLYLTSEAA
PMFFQTYAEVEFMLAEAAYRWGLGDGDVEGHYKAGVRAAMNYLELYSPRAIISNEAIDDY
LSENPFDETNALEQINTQYWAATFLNELESYANWRRSGYPDLTPVNYPGNVTNGTIPRRL
TYMTSEQSTNAENYNAAIQSQGPDLLTTRIWWDVEQ
>IFAGANLK_03175 Thermostable beta-glucosidase B
MKKICLCFLLISNVLFSQDQDSAYKNASLSVEERVDNLLSLMTLEEKIGQLTTPLGWKMY
SKNGDEVDISELYKEEIRARHIGGLWGLLRADPWTQKTLETGLHPREAAKITNEIQKYVI
ENSRLGIPLLLEEEAMHGHMAIGTTVFPTAIGQASTWNPELIKRMAETIAEEVRAQGANV
GYGPIVDLARDPRWSRVEETFGEDPYLISEMGKSMVSGFQGNTAEDLKSGKHIAATLKHF
AAYGVSEGGHNGGAVLVGERDLFQNYMYPVKEAVNSGILSIMTAYNSIDGIPSTAHKELL
TNTLRQEWGFDGFVISDLGSIEGLQGSHHIVTTEVDAAAVAMNAGVDADLGGNGFDDALM
NAVKADKVSEDRIDEAVRRVLKVKFKLGLFDNPYVDVENAEKVVRNPEHIELAKEVALQS
VTMLKNENKLLPLSKNLKNIAVIGSNADLQYNQLGDYTAPQAEDNIVTVLEGIKNKMPQA
NIQYIKGTAVRDTTQTNIPAAVEAAKNAEVAIVVLGGSSARDFKTEYQETGAATVSASED
EILSDMESGEGYDRSTLQLMGKQLELLQAVVASGTPTVLVLIKGRPLLLNWPSENVPAIL
DAWYPGQQGGNAIADVLFGDFNPAGRLPVSVPKSVGQLPVYYNHWFPERRDYVEMDAKAL
YPFGHGLSYSEFEYSDLIVSVEGEGINTRVNLSVKVKNISDKDGDEVVQLYLRDMVSGVL
SPVKQLRGFERVSIKSGETKNVHFEILPKELSLFNVDMEQVAEAGEFKVMIGASSEDIRL
KTIFQLSENITINK
>IFAGANLK_03176 hypothetical protein
MLKINNIKAVLVFAVAFSFQFIQAQEEQGVHQRSEAYMAPTDPLVKEKLSKWENQKFGML
IHWGVYSVPGIMESWNLCSEDWIDRDSTMAYNDYKKWYWNLDKIFNPVNFDPESWADAAD
AAGMKYMVFTTKHHDGFNMFDTQQSDYKITNGPFQNHPKANVAKHIFEAFRKKDFMVGAY
FSKPDWHSQYFWWDKYATPNRNANYDIEKYSWRWNKFKEFSFNQISELMHDYGSIDILWL
DGGWVRPKETVNDEVRAWGAPIPEASQEIDMPKIAEMAREAQPGIIFADRTVHGPYENFL
TPERTIPETKLENPWESCLPLGNNWGYVPYDPFKSPTAVIHSLIEVVAKGGNLLLGVGPK
PDGTLPLEVVDKLGKIGNWLDKNGEAIYDTHAIDNYQDQNTYFTAKGNKTYAIVVFEEGK
EIPRSVNWSKNLPSDKAKIKLLQTGKKVDFKIKGDRVEITLPKEIRSAKNSVAIAFSIEN
>IFAGANLK_03177 hypothetical protein
MIQKLRKAIEGIFILALAFSCQQNNQVESPEAIEPTPTQEQLAWHNMEMNAFIHFTTNTF
TDKEWGYGDESPEVFNPTALDVDQWMQTLKKAGFKGVILTAKHHDGFALYPSDYTEHDIT
NSPYKDGEGDLVKEVAESAREHGLKFGIYLSPWDRNRADYGETSYVEYYRNQLQEVFTNY
GDIFEMWFDGANGGDGYYGGADEERRIDKQNYYDWPTTLSMVEEIQPSVMFFSDAGPDLR
WVGNEEGIGGKTNWNMISPDTLYAGKAGIGDILQTGSKDGTEWIPAEVNTSIRPGWFYHE
HEDSLVKTPQELFQVYLQSVGRGSTLLLNVPPDKRGLFHENDVEALLGMRRLIDSVFANN
LAENAQISASSYRGEKENYSADNLIDGDPQTYWTTNDNIIQSSVEVNFEKEHEVNYVLLQ
EYIKLGQRIKSFNVEAKVNEKWEQVVEGTTIGYKRILEIPSVKTKAIKINFKDARGNPVV
SNLEIY
>IFAGANLK_03178 Copper homeostasis protein CutC
MSESRPYVKEACIETLEQAIAAENKGADRIELCSNLQLEGLTPSNDLIVQVLDKINIPVR
VMIRPRTGNFLYSEKEITEMKRTVITCKNLGVEGVVFGVLKADKTLDIDIISMLTNLAFP
LNVVIHKAIDNTPDLLKEFEKLKAIKGISTILTSGGAKTAIEGCGVLKEMIATSQNAIEI
MPAGKITFENLSEIHCLLGASAYHGKQIVGKLS
>IFAGANLK_03179 Blue light- and temperature-regulated antirepressor BluF
MRHAICYVSNKTEETSDMQVEQLLEGSFTNNTSSGVKGLLLYSEGNFFQIIEGEKVFILD
LFETIKKDPRHYGIIQVIGRDIEQGAFDGYKTDIITGDIKYLTVIPKEYTDTLEGLPWDL
RKIMERMLKTFIDTH
>IFAGANLK_03180 hypothetical protein
MAINIKRILLVLFTGFLVCLAGWSSFLVYKYSSEAAEIKKDYSELNSITHGLLSVNIWRD
HLTNMVLNRIDEFEFTPAQEDTLVLQVENILMAGIDKGDSLMDLKQKSLKGKLRKFAVRT
LVPEEKIRALVPMFAQTIVDEIQQPENKEALKYVIKSKLQEYSDMTHADSETAVVRLNSL
FDKYEVTGLKDFNRKTSERLKTLEDQTYNHTYILLGIIVAFLFIWWLLRNQFFLHTPMFI
ISVILSLVVLFAGLTAPMIEIDARFQQVNFLLIGEQITFNDQVIFFQSKSILQVIDILFQ
TGKVDSFFVGILILAFSIIFPVAKLVSTQIYLAGSEKIRRSKILKFFAFKSGKWSMADVY
VIAIFMAYIGFQGILDHQLTNANVETESLVSISTNQTSLQPGFIIFIAFVLFSLVLSTIL
KKITVLDKSGLEGKSA
>IFAGANLK_03181 Aerobic respiration control sensor protein ArcB
MSKQLKKDIGQLRKLDFDLANYFSNTIIPQLFVDADMVLRIFTPPAMAQFSLSYDDIGKK
IEHVEDNIRYPTFVNNIQEVMNTSEIFEKEIQTTDGNWFQMNIIPYVDHEQNKVNGVIIT
FVNITVRLNSIKELEKINAKHNVLMFALSHDMKQPISTIKLLSSGLLETYKRQDSEKFHS
MIERLQTVSNGLNTMLNEFTSEGEANLQNKVELKPQNIVKSCGNILNALREEIVSENIQV
LKDFKISEVIFPRNTLRSIIYNLIHNAIKYRNNDQQLVIKLKTYTIRDFVIFSVEDNGVG
IAEEHQEVVFEKYARINSKIEGTGMGLYVIKKMIESHGGKIELESTLGQGSKFKVFFKKE
IEETD
>IFAGANLK_03182 hypothetical protein
MLIKCLRLCNRLQFICHFLSLFNPQDENFTKTIETNLTKFLKYEVLVKKKLIV
>IFAGANLK_03183 TonB-dependent receptor SusC
MLLLLFPLGSLIAQEGITITGVVTDGESQTPLPGVSVVEKGTNNGTATDFDGNYSLELSN
ANAVLQVSFMGYETQEIEVGGQTEIDITLSPDMGGLDEVVVIGYGTMKKSNVTGSIVSVD
QQELTQVPSTNVMESLQGKLPGVDITRSSGQAGAGINIAVRGNRSLTASNSPLFIVDGIQ
YSNIQDLNPNDIESMEVLKDAASTAIYGSRGANGVIIITTKQGRQGETRVTFNAYAGVSE
VTNYPEVQTPMEYANLRREARRATGDWNSPEDDPSIFNDWELDAVNNNGGTVWPDLFLSK
GAQQDYQAGVSTATENSRFYVSLNYFNEQGNQRMDELNRYSLRANIDHDINDKITIGTQN
QVTYYDQNFHRDPMNIANKINPLLTPYDDEGNVEFQPNNWKDVNPLIDEEPGHYENNNRT
TRVFTSAYFDYDILEDLNFRTNLGVTLQNSRTGIYRASETVDRAGQASEAVYQTGNDVGI
NWENIINYDTEFGGGDHSLTLTGIQSYLSGQNEAQSARGRNQLLDYQLFHSLGNASEQLA
IQSNYEETSLLSFTGRVHYSYKDKYIFMATGRGDGASQLSDGNKWAFFPSISGAWRLIEE
DFMADTETFTDLKIRASYGVAGNAAVQAYSTQSLLNRIPFGFNEEPAIGYTFGSRIGNTN
LGWEISKTYNIGVDFGLLRNRITGTIDVYDTRTDDLLMDRFLPPTSGVRSITENIGATRN
RGIEISLNTTPVQQGIVEWNVGLNWFRNKEEIVELATGSNDIANGWFIGEPTQAFYDYEK
DGIWQLGQEAEAESYGQEPGEIRVVDQNNDGEIDSNNDRIVLGSPRPDWSGNLTSDLTVG
NFDLNIQVFARVGQMMEYEFYDIYDPSGNENSHRHDYWTPENPTNAYPRPNAGRTQGSTQ
YYSSILYEDASFLKLRNVTLGYTIPKSFLDRVGISKLRVYATGRNLWVKSEVDNYDPERG
GAMSNPIPRLLVGGINLEL
>IFAGANLK_03184 SusD-like protein
MKNINFKLFFIALVLLGGTSCEKELEEFNPSGVTAEGVYTQPDGFESLVNAAYAYTRWWY
GKEDGFNLGEMGTDLWIQGVDGGANVALLHYENLQPDQASVDVLWARMYEGVNLTNAGIE
FVGDSGLSEELKVEREAELRFLRAFFYWHIVETWGGVHLSTERTATAQTEANRTPESEFY
NLIKSDLEFAIANLPQYPSQDGRIGKGGAEAFKARVHLGIEEYEEAQELAENVIQDYNYE
LVESYDDLWDMENIQNSEVIYSVDYHRDLNLNDQQNSILYPNGHPRGAHNGHLMFLSTYD
RNGVVGMVRDLENGRPFARYMPTRFLLELFNEDVDSRFEGSFETTWFSNNPGTYTKTVDG
QEREYTLELGDTAIWATKEVLSPQEELSRPYLVYDMESMYNEDGTYNNNRQYIALNKFLD
PTRPSIAEMQSSRDAFVIRLAEMYLIAAESAFMQNDLSTAEEYINVIRERAAYPGNEEEM
MISEEDLSLDFILDERARELAGEQLRWFDLKRTGTLVERVREYNPEAADNIQDFHMLRPI
PQSQIDAVVNKDEFTQNEGYQ
>IFAGANLK_03185 hypothetical protein
MMLQNWVTVFLIFLFSGLLYSQDFQNLTWKEIQHQNRNWYGSEQAIRIADNVILHQNVNG
GWLKNTDLTKEITPNEKHELKEKKTKTIGPTIDNGTTHTQLRYLAKVYFETQIEKYKNGF
LKGINYLLKAQYENGGWPQYYPIREGYYEHITFNDNAMIGVMNLLRNVASEDENYRFVGE
DIKKESEKAIQKGLDVILKTQVRIDGQPTLWCAQHHHKDLSPAKARAYELPSLSGAESVG
IIRYLMQIENPSEEVKESIRSAISWFEKHKITGKKVIIKDAPDLPGGKDRVVVENSKAGP
LWARFNEIGTGRPIFVGRDGIPKNKLNEIEHERRMGYSYLGNYAEKLLKEDYPKWEKRIS
TE
>IFAGANLK_03186 Unsaturated rhamnogalacturonyl hydrolase YteR
MKTIKLFQKSLFLLLLTGILFSCKSGEENKDSAQVETEDSTETKEYSTWMADSEIKRNPE
GWTLDFNEKPKWEYTHGLIMTSMEILYKETGDEKYLDYIKNFADFMVKEDGSIKTYKQSD
YNIDRVQGGRFLIGLYKETNEEKYKEAVEMLRDQMREHPRTEEGGFWHKKIYPSQMWLDG
LYMGSPFLARYAKNFDEPELFDDVANQISLVNKYHYSEDSGLFHHAWDESKEQRWADPET
GLSSNYWGRSIGWFSMALVDVLDFLPEDHPERENIMEVAQKLADGILKYQDETGAWYQVV
DQGEREGNYLEASATSMFSYFLLKGAENGYLTEAHKQAGIKAYEGILEEFIRENEDGTIS
LTKVNGVAGLGGDPYRDGSYEYYINEIIRDDDPKGVGPFILASIYYENLNQ
>IFAGANLK_03187 Pectinesterase A
MLYRLSIILFFTITCLPAQDYDIVVAADGSGDYTKLQEAFMSVPDFRSNATRIFLKPGTY
KEKLILPESKTNVHLIAENAEETIVTYDDYASKKNKFGEEMGTTGSTSFFVFSDGFQAKN
ITFENSAGPVGQAVAVRVDGDKVVFENCRFLGYQDTLYPHGRDSRQYYKNCYIEGTTDFI
FGWSTAVFEDCEIYSKDGGHYITAASTEENTEYGFVFINCKLTGDASKEGVYLGRPWRDY
AQTVFINTEMGDHIKKEGWHNWSKPEAEKTAFYAEYNSKGTGGNSNERVSWSKQLSEEEV
ERYSVENILKGEDNWQPKTIKNE
>IFAGANLK_03188 hypothetical protein
MNLRLKLFTLAVVVLTFSCKENKENKAEETSQQEETDNQNDQKTYAEISIKKGGNWEGRE
YIDGEFENVSHVEVPEEHTDHSWYIRYEGPGWENSQVGYRLYLDWRNAIDIFGKKTDTMV
LHKVGQDGFDSYHDEADWGMDILKAGKSLGIGSYGRYMNDTVAHFRVVENTVAKVSNSEN
SSEVKIEYSGWNTGDKTIDLTSTLTIYPEDRFTKAELAPSEAISGLTTGIVKFENIALMQ
KESENGEWGYIATYGAQTLVNEEDQLGMAIFYKTKEVKEIIEGPHDHLVVFEEQEAPVTY
YFLAAWEQEPGGITSKEGFEADLNQKLETLNSEGKLEQ
>IFAGANLK_03189 Non-reducing end alpha-L-arabinofuranosidase BoGH43B
MIKLKPYKLSLLICGFIITGISSLCAQNDEVSEVWVSDQGDGTFKNPVLHADYSDPDVVR
VGDDYYMTASSFNVAPGLPVLHSKDLVNWELIGHALERQVPTEHFKTPQHGNGVWAPAFR
YHNDEFYIYWGDPDFGIYMVKSKNPEGPWEEPVLVEEGKGLIDPAPLWDDDGKAYLVHAY
AGSRAGIKSILVVKPMNEEGTKTTGQGRIVFDGHENHPTVEGSKFYKKDGLYYIFAPAGG
VSTGWQLILRSENVYGPYEEHISLAQGETDINGPHQGAWVDTESGEDWFIHFQDKGAYGR
IVHLQPMEWNDGWPTMGEDPDGDGTGQPVMSHKKPDTGEHPIKTPADSDEFGGDELGLQW
QWHANPKATWSFLNPSKEQLRLYTQQIPDDSENLWEAPNLLLQKFPAEEFTTTTKLTFNP
NEDLENEKAGLVVMGMKYAYIAVKSKEDGLYLVYSFNEDAENGAEEKEEIITKLTDNTVH
LRVKVDKDAQCTFSYSENGRSFKEINDEAFKSVEGKWIGAKVGIFALKEDKINDSGYADF
DWFRFSK
>IFAGANLK_03190 Exo-poly-alpha-D-galacturonosidase
MKKLGLSILAMLFISTISAQQMTMDEVYEGVEFDMPRVPEPEFPDYSVEITDFGAEAGGL
TKNTKAIADAIADVHDNGGGKVVIPRGIWLTGPIEFKSNINLHLEAGALLLFSRDFDDYE
LVETSFEGLETVRNQSPISAREVENIAITGKGTIDGNGDAWRPVKKGKMTSGQWSKLVNS
GGVLSEDEKMWFPSEKSKRGYESSSNFNVPDLIDEDELASVKDFLRPVMVSISASKTILL
DGPTFQNSPAWNIHPLMSENVIIRNLNVRNPWYSQNGDGLDLESCKNVLIYNNTFDVGDD
AICFKSGKNEDGRNRGMPTENVIVKNNIVYHGHGGFVVGSEMSGGVRNVHVSKCTFIGTD
VGLRFKSTRGRGGVVEDIFISDIDMINIPTETIRFNMFYEGNSPVLEEDQNAEDEARDEK
LVPVTEETPSFKNISMKNIRATGSKKAAFFMGLPEMSLKNVSLENAVFEAEEGITAIDAD
GLKLIDVKVLSKDAALTIYNSKNVDVKDLKFGDNHQPAVRIMGRSSENINLSRSDFSDLD
KQLELRDEVSESVINLD
>IFAGANLK_03191 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase
MTNSEFRFAHHPDDVKKYTTEELREHFLIPELFKKDEINLTYTMYDRYIAGGAFPVSKKI
KLDTIDDLKADYFLERRELGVINVGGKGKVTVDGEVYELGHKEALYVGRGNKEVFFEAAD
GEQPYFYLNSAPAHKEYPSKKVTLAEAEVVELGDSKTSNKRKINKLLVNSIVDTCQLQMG
MTELKEGSVWNTMPPHTHTRRMEVYFYFNLEEGQTISHFMGQPHETRHIFMKNHQAVISP
EWSIHAGAGTSNYTFIWGMAGENLDYGDMDKVSPEELK
>IFAGANLK_03192 2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase
MIEELFSLKGKTALVTGCKRGIGFAMAEALAEAGADILGVSASLEPEGSKIEKRIKEIGR
SFKGYQCDFSDRKSLYEFIEKVKSENSQIDILVNNAGTIMRKPAAEHPDEYWDKVIEVNQ
NAQFILTREIGKEMVKRESGKIIFTASLLTFQGGITVPGYAASKGAIGQLTKAFANEWAS
KGIQVNAIAPGYIATDNTQALREDEDRSESILSRIPAGRWGEPKDFKGPTLLLASAAGNY
MNGSVMLVDGGWMGR
>IFAGANLK_03193 Uronate isomerase
MSKEKFIKDNFLLENKYAEELYTKYASKQPIIDYHCHLSPKEIAEDRVYENITQVWIAGD
HYKWRAMRTLGIEEKFITGDASDKEKFMAWAKTVPHTLRNPLYHWTHLELKRYFGIDELL
NEDSAERIYEEVNKQLQQPENSCRGLLKQMNVETVCTTEDPVDTLKYHQQLAESDFEIKV
STAFRPDKSIMIDAENYNDYLDKLSEVAGISIDSYEDLRNALRKRIEHFDENGCKLCDHG
LNFISSENFTENEVNQIFSKKREGEDVSDLEAEKFKSAILLFLGETYHEFGWVQQFHLGA
LRNNNKRMLRQLGPDTGWDSIGDYKQAENLSAFLDALDGKDKLTKTILYNLNPSDNEVFA
TMIGNFNDGSIKGKVQLGSGWWFLDQKDGIIKQLNALSNMGLVSCFIGMLTDSRSFLSYP
RHEYFRRVVCNLFGQEMASGELPDDIELVGKTVADISYHNAKEYFEF
>IFAGANLK_03194 2-dehydro-3-deoxygluconokinase
MGESSENKGKVVTFGEVLMRLSPAGNKKLQQAESLEFFFGGTELNVAESLSYFGLEVSHV
STVSNDLVGDAALAFIRQFGVDVSAIKKVAHPLGLYFLEVGAAMRPSQIAYNRLNAAFAN
ISPEDVDWPSIFKDAAYFHWTGITPGISQSAYETLKAGLEEAKKQGVTVSADPAYRSNLW
KYGREGREVLAELTGLSNIFVGGVNEINEILKSDFEFSEEGFISASKKLMRTYPSIEKVF
DKVRTGLSASWQKIYGQAWTGTEYLTTGELEITDVVDRIGTGDAYAAGILYGLQHFDDQK
TLEFANAACALKHTILGDANLVSVEEVMEVTRGNTGGRIKR
>IFAGANLK_03195 KHG/KDPG aldolase
MAKYTRIDTVQVMKETGIVPVFYHKDLEVCKKVIKACYEGGARVFEFTNRGDFAHEVFGE
LNKYVSEELDGMILGVGSVIDEGATSLYLQLGANFIVSPIVQAEMAKTCNRRKVAWMPGC
GSVTEISYAQELGAEVVKIFPGAQVGGPSFVKAVKGPMPWSSIMPTGGVSPSEENLKEWF
DSGVHCVGIGSKLFQKNSDGTFDYKEISNKVKSALEIVQKMKA
>IFAGANLK_03196 Solute-binding protein
MRNSKIFRALKISLCLLVIFSLSACDAIKRDVTVIKLGHGLDTSHPVHEAMLYMGERAKE
KSNGSIEIDIYPNQQLGSERESLELLQIGSLGMTKVSTGVLENFIPSLKVFGLPFLFRDR
EHRFKVLESELGEKLLNDGLGKRLKGLTFYDAGSRSFYGKEPMESPEDLEGLKLRVMESN
TAMNMVKMLGGSPTPIAWGELYTALQQGIVDGAENNLPSFYLSRHYEVCKYYMVDEHTAL
PDELLISTMVWDKLSEEEKVWLKEAAMESSEYEKKLWREAELEALEEIQKAGVKVTYPDK
EDFREMVQPMYEEFSKDPEMKKIIEAIQAVK
>IFAGANLK_03197 Sialic acid TRAP transporter small permease protein SiaQ
MKLILDKILGSLLVFLMAVMVTAVSWQVFSRYILQSSSSFTEEIARYLLIWIGILGAAYI
AGQQQHLSIDILAPKLKPKNRIKLRMGINLLIILFCLLVLVIGGSNLVYLNYLLGQTSAA
LNIPLGAVYTVIPISGVLVIIYKINELLNPKQYLV
>IFAGANLK_03198 C4-dicarboxylate TRAP transporter large permease protein DctM
MMLEVLILVISFIILLSIGVPVAWSIGISCVLTMLVSIDSMAAYTTVAQRMATGLDSFSL
LAIPFFILAGQIMNQGGIATKLIDFAKALIGALPGGLIYVNVIAAMLFGAISGSAVAATS
AIGGILGPRMEKENYSKEFGAAINVTASTTGLVIPPSNVLIVYSLASGGVSIASLFLAGY
IPGILMGLALMLTAAFWIKKKKYPPGESSSFKRIMFTFLDAFPSLFLLIVVIGGIVSGIF
TATEASAIAVLYTLILSGIYRQLNMKKLYNIFLSSVGTTAIVMLLIATSMSMSWVMSFEN
IPQSVSEVLLGLSDNKFVILLIINLLLLFVGTFMDMTPAILIFTPIFLPVMESLGIDPVH
FGIIMVMNLCVGLCTPPVGSVLFIGVSVAKTSIQKIIKPLLPLYIVMAIVLLLITFIPAI
SLWLPALFE
>IFAGANLK_03199 Altronate oxidoreductase
MKRLNRENTGINKELPIKVVQFGEGNFLRAFVDYVIDKLNEQANFNAGVAVVQPIASGMV
SMLNEQDGLYNLFMRGIKNGKQIQEQRTISCIQKGINPYENYAQYMALAEEEQLQFVISN
TTEAGISFDEKDTLEGVPHNSFPAKLTAILYKRFQHFNGDNQKGLNIIPCELINHNADTL
KEIILKYAELWNLEKEFKDWLDQANSFHNTLVDRIVPGYPKDDIENYQKELEFEDKLVVT
AEVFLLWVIEGGKELKQKIPFDKIDENILVVEDMQPYRTRKVRILNGAHTTMVPFSLLYG
NETVKETIDNSFTGEFIKEAVFEEINSTLSLRKEELETFASEVFDRFRNPFIKHQLTSIA
LNSISKFKVRVLPSLLAYQRKNNELPLRLTYAMACLIIFYRGQWEGKLLPVKDDAQITDF
FQRVWEQNSYKDIARDVLQKKEYWGEDLTEIPGFKKNIAYALELIENKGIEEGFLIFSEE
LRVQ
>IFAGANLK_03200 Altronate dehydratase
MEKKAIKVHPQDNVAVALIDVWKDNVVQVEADEVKLVTDTKAKHKFSMVDLVEGDKIFMY
GVLVGKAMKPIKRGEVLTVNNVKHESNQAYKKTEVTSWDAPDISKWKNRTFNGYHRPDGQ
VGTKNVWLFFPLVFCENKNIEKLKDVFENELSFHKSSRQRLLLRKLIHGEDSDVMIDTEP
EESAIFDNIEVKFITHQGGCGGIRQDSASLARLLSGYVNNPNVAGATVLSLGCQNLQIDI
FKNALKRINPDIQKPVLIYEQQQMGTVEEMMDTIIKESFDGIKKANEIKRKPAPLSKIKL
GLECGGSDGFSGISANPALGYASDLLAALKGSPILSEFPELCGIEQELVNRCVSDETAER
FIELTRAYEKAAIASGSGFDMNPSPGNIKDGLITDAMKSAGAAKKGGTSPIEDVLDYGDY
VTKPGLNLLNTPGNDVESTTAMVGAGASVVVFTTGLGTPTGNPVAPVIKVSSNSTLARTM
PDIIDIDSGGVIRGEKTIEEMGEEILEFIIQVASGEVESKADQLNQDDFIPWKRGVSL
>IFAGANLK_03201 Glucose-6-phosphate 3-dehydrogenase
MVRKKAIKAGIIGSGFAAKFHFDAIQRVFSCDVEVVGVYSKTPSRSKSFSKERGLKSFSS
LPELIRASDIIHLCTPPVTHENIAVEVLKLDKDIIIEKPLTGYFGEGETDFSGDDFQKKP
DLKKL
>IFAGANLK_03202 hypothetical protein
MYAENWIYAPAIQKEREILEKTGGQIHWIQAQQSHAGSHSQDYGKWHLSGGGSLMGKGCH
PLAGALYLKAVEGKVHNEKPIRPKSVTCRTHAITRLENFKNKGHLRDSYTDVEDYAFTHI
VFEDGSVADIVASELLHGGVKNYLEVHANDHRTICNLTPNNAMQTYNPDEDNFKDIYVVE
KTGTKQGWSNISPDEAWFNGYQHEMEAFYRSLVFGEAIESDSSLAANVISTIYSAYVSAE
KKGIEVAIQNF
>IFAGANLK_03203 Catabolite control protein A
MQQIAQFNFLLFITMKDKVTIYDISKKLNISAATVSRALNNNTKISLSTRELVLKTAKEM
NYKQNRLAQALKSGKSNNVGVIVPYINRSFFSSVIRGIEEELTPHGYHVIICQTHENYKN
EIEQINTLINTQIDGIFMSVSKTTINTEHIEKALAEGTPLVFFDRKKEVPGVSSVIIDDF
KAGYLATQQLIGQGCKRIAHLSGDLNLEIYKNRHDGYTKALEDNNLEVDSNYIIKTNSKI
ESGASAIEELWKLKKKPDAIFSASDYTALGAIQELKKMGLKIPKDICVTGFSNEPFTKYM
ELPISTVDQTPQTMGKIAAQVFLEQMGENKKVSIEKKVVLTPELIIRESSNRSIKPVSA
>IFAGANLK_03204 Polygalacturonase
MVFSCKNKTEDKAETSKDSEISESENAWKNADEIIENIKVPQFKDTVFNVRDFGAVADGE
TNNTEAFADAITACSESGGGKVLVPEGEYLTGPIHLKSNVNFHIEENTEILFTKDKKAYL
PVVHTSYEGMEFMSYSPMIYAYKQKNIAVTGKGVFDGQADNENWWPWSGAERYGHTEGEP
HQRDEHNLPRLSKMVEDGVAVEERIFGEGHQFRVPFFEPFECENVLIKDVKFVNAPFWVM
HPTKSNNVTVDGVTVESHGPNNDGCNPEYSQNVHIKNCLFDTGDDCIAIKSGRDNDGRRV
GISSENIVVEDCVMKDGHGGVVMGSEISGGVRNVYVRNCEMNSPNLDRAIRIKTNTRRGG
TIENIYVKNLKVGQVKEAVLKINTHYAIYDNQEGEHMPVIRNIFLENVDVENGGEYGILI
RGREESPVTGIHLTNVTIKKTETPLSIENADPIVFKNTSINGKQITNE
>IFAGANLK_03205 Pectinesterase A
MNVKKLIFIPLFFLISNLSAQSTEEVYWSITVDKSGTGDFTKIQQAINSTRDLGPGFVEI
HIKNGMYNEKLKIPSWKHKLRLIGEDRDKTIIANNDFSGKKDSINGKTLSTFTSYTLLVS
GDEIEIENLTVKNNSCGEGQAVALHVQGDKFISENVNILGCQDTIYAATGSSRQYYKNCY
IEGTTDFIFGQATALFEECTIKSLRNSYITAAATTQNQDFGFVFLDCKLIADDDVNEVYL
GRPWRPFAKTVFINSEFGEHILPEGWDPWHGDEMFPDKQKTTFYAEYNNSGPGADISHRI
KWSKQLTKAEVKKYTTEKIFKSEDSWNPAE
>IFAGANLK_03206 Rhamnogalacturonan acetylesterase RhgT
MKTFRNIFLFICLAFGCISLQAQELNLYLIGDSTMSDKKDPEHNPEHGWGQVLPELLTDK
IKVENHAKNGRSTKSFIEEGRWQTVLEKLRAGDYVFIQFGHNDQKYKAPSRFTNPFTGYR
SNLERFVNEAREKGANPVLFSSIVRRNFNEHGTLVDTHGEYPLVVRMVADDLEVPFVDLQ
RATEKLEMFYGVKDSKSLHLHFEPGAQDYYENGKEDDTHLSRKGALLVATLALQEIAAQD
LALANYIKKEVKQKEVFSKKE
>IFAGANLK_03207 hypothetical protein
MTKMSSKNIYFKEAENRWKAVDKGIQRQLVNHNSQIMQVKVKFEEGAIGYEHSHFHSQST
YVAAGKFEVVIDGKKEILKAGDGFLVQPNLKHGVKCLEVGMLIDVFSPLREDFLE
>IFAGANLK_03208 Mannonate dehydratase
MIFEQSWRWYGPKDPVSLDMIKQAGANGVVTALHHIPVGEVWTVAEIEERIAELKESNKK
NPFKLHWNVVESLPLHDAIKRGKPERDKFIENYKISLRNLGKCGVKTVCYNFMPVLDWLR
TNVKFKLEDGSTALLHDKVELAVFDLFILKRENAESDYSEEIQKEAKQRFKAKTSEELEV
LKQSMLMALPGDEKGFTIEKLKNELAAYDGISAERLREHLVYFLKEVIPVAEQSGVNMAI
HPDDPPWPVFGLPRIVSNAEDLDYLFETVPSTANGLTFCSGSLGASATNHLTEIISKYYE
RIHFVHLRSVQREKSDYFYEANHLEGSAGMYDLVRTFFELQQKNDRKPLPMRPDHGHEMM
CDQKKQFYPGYSAIGRMRGLAELRGLEAGISTTLNKTNS
>IFAGANLK_03209 putative oxidoreductase UxuB
MFNLDGKTAIITGGNGVLGGAMAHGLAAQGVKVGILGRSTDTVEKRVKEIEDAGGTAMSL
VADVLDRKSLEEAKDKVLKAWGTIDILINGAGGNMKGATIGPDQNFFDLSLDDFSKVNDL
NFKGTVLPTYVFAKPMADAKKGSIINISSMAAQQAITRVLGYSAAKAAVDNFTKWLAVEM
AQKYGGGIRVNAVAPGFFIGEQNRDLLLNKDKSLTARGETIVSNTPMKRFGEAEELQGVT
NWLASDAASFVTGIVVPVDGGFSAFSGV
>IFAGANLK_03210 hypothetical protein
MTGLGKYSFGTGDRFGKEGVAQLKALLQARENGVEVTPVWNKSHREHETVNSKPHLVREE
ADAAVKSLDYSGKYFVDADHINLDIVDEYLAVSNFFTIDVADYIGKGAAEKEKDEFLKFI
AKFKQKVSIPGIFAEFKISGAELNQILDTFLFAAKKASEVYRYIKENKPEEFVVEVSMDE
VENPQTPEELFFVLATFAFYEIPVNTIAPKFTGRFNKGIDYEGDLEKFAKEFEEDLLVLD
FAKKEFGLPEDLKLSIHSGSDKFSIYPIMNRLIKKHGAGLHVKTAGTTWLEEINVIAESG
EDGFEFALSIYKEALDRFDELTSPYPDVLDIDKSKIPEVSDLQTAGREKMAKMLRHNQKE
KAFNPHFRQLMHCAYKLAAEKEEIFFKLLKKYRQQTEEAVTQNLYEKHLKKNFE
>IFAGANLK_03211 Galactose-1-phosphate uridylyltransferase
MKELKLRKFKKEKMNTELNKQPHRRYNILTGEWILVSPHRTKRPWQGKTEKNNQEKRETY
DPSCYLCPGNSRMGGETNPDYNGVHAFENDFPALLPNGPTEDFDNGLLKAESESGICKVV
CFSPDHSLTLPLMDVEDITKVVGLWKKEFEELGSKENINYVQIFENKGSMMGCSNPHPHG
QIWSQRSVPTEILKKSKHFKEYWNKNKSSLLSDYLKQELELDERILAKNEHFVALIPYWA
VWPYEAMIVPKKHYQHIGQLNAEEEKAFAEIIKKLTIKYDNLFETSFPYSSGIHQAPTNG
EEYSEWHFHMSFYPPLLRSATVKKFMVGYEMFAGPQRDITAEQAADNLKELSEVHYLER
>IFAGANLK_03212 Galactokinase
MKPAENNHPIPEDFKDFKTEVKVASPGRINLIGEHTDYNQGFVMPSAIDKKIYFKLRKNE
SNSCRIYSETFDTYIEFELGKITKSKNSWENYLLGVIDEIQNFGKKLQGFDCIINSELPI
GAGISSSAALECGFAGGLNSLFSLNLSQMEIVKLSQRAENNFVGNNCGIMDQFASVMSRK
NHFIKLDCESLEAEFIPAEIQNCKLLLLNTNVSHNLADSEYNTRRQECERAVAIIQQKYP
QVGSLRHVSFEMLEEFKEKIDPISLKRCRYVLEENKRVQQTEKALRSGDLKELGNLMYAS
HRGLQHQYEVSCTELDFLVDFSEGKSFIYGSRMMGGGFGGCTINLIESDKIDEYIAEVEK
VYQQKFNITLTPIIVVPDEGTQITKV
>IFAGANLK_03213 Sensor histidine kinase TodS
MKFLGLVLVIAGFLFFGSCANEPEQDEFQIGFSQAMTTDNWRKEMNRAMQVETSMHPGFY
LEIKDAQNDVSRQIKQIEELISNEIDVLIVSPIQSVPITPVIEKAMNAGIPTIVIDRKIE
GSNYTAYVGANNVEIGKNAANYIVSNSKPNQKLELIEITGLQTSSPAFERSQGFNEVISN
QGNMDIVASIAGDWEKTSVGDNLKSILDSVGIIDYIFAHNDRMAMSAWEVARSKNLEDSI
QIIGVDGLFGPSGGIQLVKEDVLAATVLYPTGGAEAIKLAVKLLEGDQIDKNNILSTVVI
DKVNVEIMQNQFNKMNQQQNDIEQQQSIINEQVATYNSQSNLLKIMVGLSVLLLLLGFWA
VYLVFKLRKRKRRLELNNEKIITQRNQIEKFAEQLKISNEVKINFFTALSHEFKTPLTLI
TSAIESISQNPYKQLKDFAYETNLISKNSGRLLRLINELLDFRKLESGSFRLKPLKTNLY
EFISNIYEDFETEAVRKSIDLHLETDNKEIMIYMDRDMMDKVFFNMLSNAFKFTPKNGQI
NIKIEETGADKVGVLFKDSGIGIPKEDFQKIFDPFRQAGNNTKPSSGLGLYITRQFVELH
KGNISVSSHQGAEFKIELLKGKSHLSEYEFSEDTSEIRKEESEKALKSTFIPEELSQSLN
GNAETILIIEDNEDLSYLLKKRLLGDYRVELSDGTDAIEKAYEIIPDVIICDINLPEKSG
FEICQELKRDLRTSHIPTLILTALGDEESRIKALKVGADSYITKPFNFEILKESLRAALF
NREKLRYYYTNKIDQVKDNKFEDSEQTFLKDLNQIIEKNLKHANFNVEDLAQQMGISRVQ
LYRKVKAIIGISISDYINSQRLSKAKSLLQETNLNISEIAYEVGYASPGYFSTSFKNKYG
TTPKKFRN
>IFAGANLK_03214 putative metabolite transport protein CsbC
MSKIFAWSISAALAGFLFGFDTVVISGADKQLQELWGTSDAFHGSVVMAMALWGTVVGAI
FGGIPTNKFGRKNTLIIIGVLYLLSALGSAFANDPITFAIFRFLGGLGVGASTIAAPTYV
SEIAPPKDRGRLVSLYQFNIVLGILIAYLSNYLLRDTGAQPWRWMVGVEAIPAFIYILFV
VFIPRSPRWLISKSRNEEAARILQDINPKADLEKRMIEIKKQSESQITGENIFMKKYRFP
LILAFLVAFFNQLSGINAFLYYAPRIFESAGLEANTALLSSIGIGVVNLLFTLLGVFLID
KVGRKKLMFVGSIGYIISLSLVAAAFFLNWGGLWVPIFLFLFIAAHAIGQGAVIWVFISE
IFPNHLRASGQAFGSSTHWVLAAIVPSLVPVLFTTIGPGYVFGFFAFMMVLQLFFVIFMM
PETKGKTLEELGEELSPGHNKQAFQQ
>IFAGANLK_03215 Levanase
MKNKFIFLSSCLLSAMLLFSCKDNNKESVEKTPEVTAQSDTDFRPAFHFTPNENWMNDPN
GMFFLNGTYHLFFQYYPEGNTWGPMHWGHATSKDMIKWEGQPIALEPDEQGYIFSGSAVV
DTENTSGFGDGETAPVIAMFTYHDPKGEEEGRADYQTQAIAYSLDEGNTFTKYEGNPVIE
NPGLRDFRDPKITRDEVHDQWVMVLSADDITMFYTSQNLKDWELASEFGKGIGAHGGVWE
CPDFIQMKVEGSDEKKWVLIQSLNPGGFNGGSGTQYFVGDFDGKTFTLDKSMSDLGEDHH
YWLDFGKDNYAGVTWANIPQEDDRHLFIGWMSNWQYANEVPTETWRSAMTIARELKLTKK
GDAYRIVSTPVAELQNYTGEKFTKSTVSVEGETQIATSEEIDISNSVISFEIQDLKDQEY
HFSLSSKGDDVLKFGYDHNTEEFYLDRSNSGLTDFNENFGDKVSTAPRLSKASNLKVKAV
IDNMSIELFFDNGETVMTEIFFPEQPIKSLNAEGNEFIIKNLKINQVNLN
>IFAGANLK_03216 TonB-dependent receptor SusC
MNSKLLILFLLPLSMWSQAIDVSGNVISEDDQMPLPGVSIQVEGTNEGVITDFDGNYIIE
NIDPQATLVYSYLGFQTKRVAVNNQTNIDVSLIMDDQQLDDVVVTGYTSQRRTDITGAVS
VVDMDELNKQPEPNPIRGLQGRLPGVQITSDGSPSGANTQVVIRGVGTLNNTDPLYVIDG
VPTKAGMHELNPNDIESIQVLKDASSASIYGSRASNGVIIVTTKKGKEGRMQVNLNTYVS
TSTYANSQEVLNAEQYGRVLWQAQVNDDIDPNSNNLRYQFDWDNNENGVAVLNSIIVPEY
LDEEQTLLSADTDWFDEISQTGFAQSYDLSVSNGTEKGNYLFSLGYYDNQGIVKTTEFNR
ISARMNSSYKLFNDRLEIGENFTFNKTQEIENPGVLDLALKASPIIPVRTADGEGWGGPV
GGMNDRQNPVRLLEYNKDNGYEYHRIFGNAYADLEIIENLHLRTNLGIDYSNFYRRSLQR
SYKSGYLQNDETAVDIEDWKSLKTTWTNTATYELKIKKHDFNLLAGTEMFRDDYKNINLR
REGFILETPEYMYPDAGSGEAYNGGSATSYSLLSFFGKIDYTFDKKYLLSGTIRRDGSSR
FGENNRFGTFPAFSAGWRISEEDFIQDNYSFLSDLKLRLGWGQTGNQEIDNNAIYSLYVS
DYAGGDPTWETSYGTAYDLSGAGSGLLPSGFRGIQLGNDNLKWETTTQTNVGLDFGFFGY
KLFGNIDYYFKETEDILVLPPYLGTIGEGGNRWVNGASMENEGWEFALTYRDKTEGDFSY
EISANISTNRNEITYLPEEVQNNYGGDGSEDNILGRPINSMYGYVTDGLFTSEEEVMNSA
EQGGKGLGRIRYKDLDGDGVITDDDRTWIGIPHPDFNYGFNITLGYRNFDFTSFWQGVGN
VDVINERKFQTDFWSVDDVGSNKGTRLLDAWSPENVNSSVPALTTIDDNAESRFSTYYVE
NGRYLKLRNLQVGYSLSEELLESMNFTNARLYVSGQNLLMITSSDFTGVDPENAGWGYPQ
PLTLTLGLNLSL
>IFAGANLK_03217 hypothetical protein
MKKITYLLGIVLLTISTACSDFLEEEPYGVLSEEQLTTPENVDGFVTSAYAALGNDHYDI
PFSLWPYGNVRSDDAYKGGSGTNDIQVFHFFEVSENIRTDFGELDAFWYNSFVAISRVNK
ALAALNQIDEVDFPEKSTRIAEMKFLRGHFYFMLKIMYKYVPYVTEDIPVEEYGTISNRA
LNNDDLWSAIAGDFEAAAQVLPSSQPQVGRADKTAAYAYLAKTRLYQAYEQDENHNVVNI
NQQRLQQVLDATEQVMGTHQLEEDFAYNFLPGSFENGQEAVFSIQFSDNDGTLHGRLNYS
DVLATPQGIGCCDFHKPSQNLVNAYKVDEQGLPLFSNYNESNIDFNSLENYRVDPRLYHT
VAIPGLPWKYDQENIYQENWVRSPSTYGYTASLKENVTEDSEHLVNIDPFYGNSKNRIEI
RYADVLLMRAEALIELGRQNEALPLINEVRERANQSTTLISSYATNTGISPYLDGENINW
TQGVAREALRWERRLELAMEGNRFFDLVRWGIADETLNKYYSEEAEEAVYYEGASFDEGR
EEYLPIPQAQINFSQDVYVQNTGY
>IFAGANLK_03218 Fructokinase
MVNRKAVCFGEILYDVFPDRERIGGAPLNVASRLSGLGISTEMISKVGDDEKGEKLISYL
ESKNIKTDNISKDTEFPTGVVNVKLSESGSATYDIAHPVAWDKIEISEGIKYSVQNADTF
IFGSLICRDQVSRKVLFELLPEAKYRIFDINLRPPYYEKEVLVKLMEQADFIKFNDDELF
EIADMMGSKYNSLEQNLHFVSKRTNTRTICVTKGRHGAVLLKDGNCYYNSGFKTKVKDTV
GAGDSFLASLIAGMLKNEDPQSSLDFACAVGALVAGEEGANPEISKERIQKFIYP
>IFAGANLK_03219 Pantothenate precursors transporter PanS
MQQFANIFMPLSIALIMFGIGLELCLKDFGRVFAHPKAIITGLASQIFLLPLIAFLLIFF
WPIDPIYKIGIMLLAGCPGGTASNLVTKMLKGRVALSVSLTAFNSLIILFSIPLVIEFSF
AVFGNNGATVELSFGQTMGDVLLTVVLPVMSGILINELFGHKFGESFHIALRYILPGIML
IAFIVVIFFDENQKGVEYLKHLNLLIPLIILNFATIVAGYFAARRMKLQHSSAYTIAVEM
GLQNSVLALFIANQLLKNKDISLVAILYGSFSLITTFVGGWILKHYFGKEQNEKA
>IFAGANLK_03220 hypothetical protein
MDKLFDDDNIILNLPVKISYRVLEDVLQEKLVGEQIGMEDSKGTVKNYAEVLGANLGKSQ
EPNFDLTLNLKLKTLTTLFKNKEVTLLVHIRLGFDEVEQVIDVEEYELEGQSKSWLMDNS
LETLANTLIYKKIKNKMKLDLKPHINEQLGKANQKLGDEMEAAPGVFLSGNVNTLKVAEI
IPGDSLLLILLEISAYGFIDVKEIKL
>IFAGANLK_03221 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MKTALIHQRFLVSTGISTDTRNIEPGSIFFALKGANFNGNEFAAQALAKGAICAIVDDKE
AALNDKEYIVVKNTLEALQSLGKFHRKFLSIPIIGITGSNGKTTTKELIFNVLSKKYAVT
ATHGNLNNHIGVPLSLLAMDEETEIGLIEMGANHPGEIEFLSNIAMPDYGLITNFGKAHL
EGFGSLDGVIQAKTELYRHLKDHKKLIFLNLDDEVQRLEINYKHTFSFGNNRKAQVKVDY
PDSSDSAELIFNDTRFKSQLSGSYNAKNMAAALCVGLYFKVPFDEIKEAIESYIPSNNRS
QLIERDSNKIYLDAYNANPTSMMAALQHFNNSKTNTTKIVILGDMGELGAASETEHQVVV
NYLENADISEIYLVGKQFKKTTTSRPNIIKFENTENIKKHLQLAELKNCSILIKGSRSMA
LEEILEVFEPTT
>IFAGANLK_03222 Hercynine oxygenase
MNMRINIAFRAFLTLVLGVGLLSCNNSRDYEDNSRATGWDINSDEGGFQYNTDYKEQEAG
PGLVFVEGGTFTMGQVQDDVMHDWNNTPTQQHVQSFYMDETEVTNMMYMEYLDWLKKVFP
PTQENFRNIYNGAVPDTLVWRNRLGFNETMVNNYLRHPAYGNYPVVGVSWVQAVEFSKWR
TDRVNELLLEEGGYTKEGARYTDVEAGSTFNTQTYLNAPSQAYGGNTEISQGGDESQDMI
DNQNTDAEGNALGGQTYVQRKDGVLLPEYRLPTEVEWEYAASALVGIRDYNVYRGRKKYP
WDGQYTRSGDVKRQGDQLANFKQGAGDYGGIAGWSDDGADITAEVKSYEPNDFGLYDMAG
NVAEWVADVYRPIVDDEFNDFNYYRGNVYTKNAINEDGSVKIVGLDEIEFDTLATGRLVA
RSYPGDIAQIPVTEEDTYMRTNYTDSDQRNFRDGDKSSSRYYQSFQQADEESERMYNSPT
YNVANTTDTTGTGRGYDTGDRTTLISDEVRVYKGGSWRDRAYWLDPAQRRYFPQDMATDY
IGFRNAMSRVGSKSLDDNKKARN
>IFAGANLK_03223 hypothetical protein
MMKKITFLLLGLILSSQFKMTAQEERDRVITTAVPFLLVAADARAGGMGDQGVATSADVF
SQQWNPAKYAFASSEHAIGVSYTPYLSDIVSDIFLGNISYYHRINDRSAVASSLRYFSLG
SIERRASFEQAPLVVNPNELTFDVSYSLRLSDNISMAVAGRYLHSDLGLQDEEDLGAANS
FGVDVAAYYQSNQMVFSNFNGVWKAGANISNIGPKMKYEDAGQENFIPTNFKVGTGFDFI
FDIENRLGAYIEFNKLLVPTPRDFNDDGEIDAEDDAEYNDIGAIEGIFTSWGDAPGGFGE
ELREVTWALGAEYMYREAFAFRAGYFSESLTKGSRRFASFGAGFKYEQVNIDISYLFSTS
PVPSPLEGTLRFGLTFNFGDQFPVY
>IFAGANLK_03224 Cytidine deaminase
MKPLKVTSNFEVYDSVEELPQAIQDLMKTAVEARDKAYAPYSQFKVGAALALNNNEVVTG
SNQENASYPSGLCAERTAIYYAGATFPEAQIKDIAISAKSMKHMVEAPVPPCGACRQALV
EYEVKQKADIAVYFMGETGKVMKANSIKDLLPLIFENSVL
>IFAGANLK_03225 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MKKVTKATYLKWYEDMLFWRKFEDKLAQVYIQQKVRGFLHLYNGQEAILAGALHVMDLEK
DKMITAYRNHVQPIGLGVDPKRVMAELYGKATGTSQGLGGSMHIFSKEHGFYGGHGIVGG
QIPLGAGLAFADKYFKRDAVTLTFLGDGAARQGSLHETLNMAVKWNLPVVFCVENNGYAM
GTSVARTSKGTDIWKLGNGYEMPCGPVDAMDPVKVAEALDEAIKRARKGDGPTFLEMKTY
RYRGHSMSDAQKYRTKEEVAEYQELDPITTVLNIIKDKKYASEDEIKKINKRVKDKVSEC
EKFAEESDFPEKNVMYDVVYEQENYPFLAHKPQ
>IFAGANLK_03226 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAEVINMPRLSDTMEEGVVAKWLKQKGDKVEEGDILAEIETDKATMEFESFYEGTLLHIG
IEEGETAPVDTLLAIIGEEGEDISDLLKGDGDSKKDEKKDKSDSNDEDEGEDEAESDGDS
DDGGIPEGVEIITMPRLSDTMEEGTVASWLKKEGDKVEEGDILAEIETDKATMEFESFYE
GTLLKIGLEEGETAKVDSLLAIIGPEGTDVSNVSVDGKSKKKSSEKSDKKKEDKSEEKEE
NKSSEKKTSDSTKDGGRIFASPLAKKMAEDKGIDLSDVQGSGGNGRIVKKDIEDYKPSEK
PAEAKESKGDAAAAPQPYVPAGEESFEEIKNSQMRKTIAKRLGESKFNAPHYYLTIEVDM
ANAMASRKQINEMPDVKVSFNDMVIKASAMALRKHPQVNSQWTGESMKIAKHIHMGVAVA
VEEGLVVPVLKFADQMSMTQIGNNVKDVAGKARNKKLQPNEMEGSTFTVSNLGMFGIVEF
TSIINQPNSAILSVGTIVEKPVVKNGQIVVGNTMKLTLACDHRTVDGATGAAFLKTLKTY
MENPVTMLA
>IFAGANLK_03227 Bacterial leucyl aminopeptidase
MRDFFIFNGMRKITLNFAMLAAILLFSSCGNSQAVTNSEEVKTSLNTNVQQAEVEELLYY
LSSNELKGRQTGKEGIELAAQKIESIFKESGIEKYFDTYRHNFEIDGVKGFNVVGMLEGN
DPELNDEFIILGAHYDHIGIQDPVEGDSIANGANDNAAGTVAVVELAKKFAEIDNNKRSI
MFVLFSAEEMGLVGAKKIAQRLKQDELDLYALFNFEMIGIPMNDKDYIGYLTGYENSNFA
EKFNEYSGKKVLGFLPQAKEYNLFKRSDNYPFFEEFNVPAQTISTFDFTNYDYYHHVADE
AEKLDITHMTNVIESVIPGILKMTNTSEKEIKLSK
>IFAGANLK_03228 Diacetyl reductase [(S)-acetoin forming]
MKQIVITGTSRGMGYEMVKLFAEKGHKVLALSRNDKPVSELSLDNVTTFSCDVSKAEDLE
KVSAFIDAKWIKVDILINNAGALINKPFEEITAEEFQKIYSTNVFGVIGLTQKLLPFMNK
NSHVVNISTMGGVQGSVKFPGLSAYSSSKAAIITLTELLAEEYKENGPSFNVLALGAVQT
EMLEEAFPGLEVPLSAKEMANYIADFSLTGHKYYNGKLLQVSNSTP
>IFAGANLK_03229 Protein SprT
MREILERYIPERAVPPVFEMIKANNVHLKIVNERKTRHGDYRRMPNGAQQITVNANLNKY
RFLITLVHEIAHLLAFEKFGRQIKPHGQEWKFTFRELMLPFIRPEIFPSGLLPVIAQHFR
NPKASSDTDAKLSVALKSFDPENDKNYIFEIPFGGIFRIYNGKTFKKGERRIKRYECLEV
DTGKVYLFQPNAEVELLKN
>IFAGANLK_03230 Alginate biosynthesis protein AlgA
MKNTNHYAILMAGGIGSRFWPVSTSRYPKQFQDILGAGSTLIQTTFHRLAKLMPVENIII
LTHKEYKDVVKDQLPQVKDEQIVLEPEMRNTAPSILLGALKIKKKNKDALILVAPSDHWI
QGDLEFQENIEEAFNIVAEEDKLITLGIAPTFPNTGYGYIKYKDDEGKGAKPVLKFTEKP
TFKKAETFLKEGNYVWNAGIFIWSASFILENFKKYQPETFRLFEAGNDSYNTENEQEFLD
KNYHKAQNVSIDYAIMENSDSVFVIPAKFKWNDLGTWKSLEDELPQDEHNNTIVNGRLLP
FEASGNIIKTQNNKAVVLEGLKDFVVVENDAVLLIFPKEKIQEIKGIREKAIEKFGEDLG
>IFAGANLK_03231 hypothetical protein
MENNQKPENNQPLASQENSEDLGKSAKGIWQNIKSLIKELLEIRHDTDRESTVEAVKKDI
SFKGHNAWILIFSIFVASVGLNVSSTAVVIGAMLISPLMGPIVGVGMSVAINDVLTLKKS
FINLGLMVGLSVLTAYIYFLVSPVKTETPELIARTYPTILDVLVAIFGGLALIVAKTKKG
TIASVILGVAIATALMPPLCTVGFGLAIGNWSYAGGALYLFSINAVFIALSTFVVTKVLG
FPLVKYVNSKKRRRTAQIASTIAVIVMIPSVILFVFLLQEQLFETKAKEFIATVMRYEGT
ETIKSSYDYNEKSIEVYLIGNRVPQATISTWQQQIDDVEALKETELIIHQGADPTGDIDQ
LSTQVRSGILEDLYMKNQELIEDKDEKIALLENEISKYRGDGFSFSDLSQEAKINYEGID
ELGYSNLITTNFSKTDTIPTFTVGWKENLNNRQINQEKQRFEKWLKVRLKLDTLQVKSVN
>IFAGANLK_03232 putative ribonucleotide transport ATP-binding protein mkl
MIEIENLHKGFDGEEILKGINYTFEKSKTNLIIGGSGSGKSVLLKCMLGLLTPEKGIIKY
DGKPYSEFTEDEKKDLSKQIGMIFQGGALFDSMTVEENVMFPLRMFTHRKKKKQNLERVR
EVLKRVNLEGSEKKLPSEISGGMQKRVSIARAIVNRPKYLFCDEPNSGLDPKTATVIDQL
IQEITHEYDITTIIITHDMNSVLEIGEKIAFLKDGVLAWKGDKSQIFKTDDEAVTDFVYS
SNLFQKVREAQKQGL
>IFAGANLK_03233 putative phospholipid ABC transporter permease protein MlaE
MNYLHSIGEYFLMLKGTFNRMTKGSVLRGLILKELDDLIIGSMGIVAFLSFFIGAVVALQ
TALNLNNPLIPKTLIAYAARQSIILEFAPTFISIIMAGKVGSYITSSIGSMNVTEQIDAL
EVMGINSLNYLIFPKIIAMLFYPFVIAIAMFLGVFGAYAAAVFGGFVPPDLFVQGLQEDF
IPFHLVYAFIKTFLFAFILATVPAYHGYYMKGGALEVGEASTTSFVWTSVVIIITNYAVT
QLLLS
>IFAGANLK_03234 Calcium-transporting ATPase
MKRFAFLLLATFLAFQGFSQAKVEEKPKLVVGIVVDQMRYDYLTRFWERFGENGFKKLVN
EGYNFKNNHFNYVPTYTGPGHASVYTGTSPMNHGIIGNGWYDKFIHESVYCAGDASVEPV
GTEDEAGKMSPHRMKTTSFADENRLHTQMRGKTIGVALKDRGSILPAGHTANAAYWFHGA
DEGKWISSSFYMDELPDWVKDFNDSDKVEAYFKTWNTLYDIDTYKESGSDVNEYEGGYKG
KETASFPYNLTRLADSINKFEILKATAYGNDITTDFALAAIDAEELGRDEDTDVLTLSYS
STDYIGHNFGVNSKEIQDAYLRLDQNIADLLKHLDEKVGEGNYTIFLTADHGGVDVPAYL
ESVNIPAGYFETNEFIEELEKFTAEEFGVEELIESVYNSQIFFNYEVMEESEINSSELQS
KLAHYILQLDQIDKVYTRDQLSSGSFTTGAGAAIQNGYNQKRSGDVVYVLDPATIVYSRT
GSTHGSGLMYDTHAPLIFYGNGVKKGSTTQRTEIVDIAPTVSAILGISFPNGTTGKPLFM
MLDTEESE
>IFAGANLK_03235 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MKINIIIPAYNEAEFIGETLQSLINQSFQAEKIVVVDDGSSDATPDIVTRFAAKHPEISL
VKNTSEGIHLPGSKVINAFNTGLDSLDDSFDIICKFDADLIFPKDYLEKIMLHFEENSKI
GMLGGFCEIQKKGEWILENLTGKDHIRGALKAYRKSCFKDIGGLKPAMGWDTVDELLAQY
HGWEIKTDDSLRVKHLKPTGKNYSKTSKYKQGTAFYRLRYGIVISVIASAKLAFNKRDLG
YFWDCIIGFLRAKNEKRPYLVNKDEGRFIRNLRWKKMQKKLF
>IFAGANLK_03236 hypothetical protein
MYEKTFPNKRYKETLEFLEANVPAPAKILDLGVKNPFSEIMEAHNYQVKNTKGEDLDLNT
EAVQNSDCNVVTAFEIFEHLVAPYNVLANIKAEKLVATVPLKLWFSSAYRSKTDMRDRHY
HEFEDWQFDWLLEKAGWKITNRKKWTNPVNKLGIRPVLRYFTPRYYAVYAERI
>IFAGANLK_03237 3-oxoacyl-[acyl-carrier-protein] synthase 3
MNIKITGTGSYIPKVITANADFDNHEFFNLDGTGFPQDNKTTIAKFKAITGIEERRYLEE
NLNTSDMAVIAAQQALETSNTDPETLDYIIVAHNYGDVQHQSVQSDTVPSMATRVKYHLR
IKNPKCVGYDVLFGCPGWIEGMIQAQAFIKAGMAKKCLVIGAEALSRVVDKHDRDSMIFS
DGAGAVVVEETEQEGGILAHESGTYAFNEANYIYFGKSNRTEAPEDLRYIKMNGRKIYEF
ALMHVPGAMKTCLENSGKDIKDLKKIFIHQANEKMDEAIIKRFFKLHKQEVPDKIMPMTI
QELGNSSVATVPTLYDLVVKNKIADQHLEKGDVVMFASVGAGMNVNAIVYQY
>IFAGANLK_03238 Glycine dehydrogenase (decarboxylating)
MRTDSFALRHIGPRESNLQAMLDTVGVDSLEQLIYETIPDDIRLKSPLNLPSALSENQYA
EHMGKLAAKNKVFKSYIGLGYHQGILPAVIQRNILENPGWYTAYTPYQAEIAQGRLEALL
NFQTMVSDLTGMEIANASLLDESTAAAEAMGLLFAVRDRKQKKNEVNKFFVSEQALPQTI
DLIKTRADFMGIELVVGNHEEFDFSDKFFGALVQYPGKFGQVFNYTDFVSKCKDADIKVA
VAADILSLVKLQAPGELGVDVVVGTTQRFGIPLGYGGPHAAYFATKEEYKRNLPGRIIGV
TKDVDGNHALRMALQTREQHIKRDKATSNICTAQVLLAVMAGMYAVYHGPDGLKYIADTV
HFSTVTLAEELEKMGIKQLNSAYFDTLQVKADAQKIKAEAEKNEINFYYPDAETVCISLN
ETTTQDDINNILKVFASVLDKNSADIESLKEEETIPSALQRKTDFLTHKVFNLYHSETEL
MRYIKKLERKDLSLNQSMISLGSCTMKLNAASEMLPLSNPQWGNIHPFVPVEQAEGYQIV
LKRLEDQLTEITGFSATSLQPNSGAQGEYAGLMTIRAYHESNGEGHRNICLIPSSAHGTN
PASAVMAGMKVVVTKASENGNIDVDDLREKAIKHKDNLAALMVTYPSTHGVFESAIKEIT
QIIHNNGGQVYMDGANMNAQVGLTNPGVIGADVCHLNLHKTFAIPHGGGGPGVGPICVAE
QLKPFLPGNPVIKTGGKKAIGAISSAPWGSSLVCLISYGYITMLGSKGLQKATEYAILNA
NYVKERLNEHYKTLYSGERGRAAHEMILDCRPFKEKGIEVVDIAKRLIDYGFHAPTVSFP
VAGTMMIEPTESESKAELDRFCDALISIRQEIEELDSEEDNVLKNAPHTITMLTSDEWKF
SYTREKAAYPLNFVSENKFWPSVRRVDEAFGDRNLMCTCPPIEEYMEA
>IFAGANLK_03239 hypothetical protein
MKGLKNILDFYINSSVHLALAVVSLSLMSFLEFNIKIDKNLLYFIFFGSISAYNFVKYAG
IAKLHHASLARNLKVIQIFSFFCFLGLVYFTFQQDFETLIVSGILGLFTLLYAIPFGRNR
RNLRNIGGIKIFIIALVWAGVVVILPLLNVVSLKEISFTFLQRFFFVIAITLPFEIRDLK
FDSGQLNTIPQQIGIVNTKKIGYILLGIMLLLEFLMPFSSVVNFTALGLTLLVSAYFIKA
AEVNQGAYYSAFWVEGIPVFWLICWVFTKILF
>IFAGANLK_03240 hypothetical protein
MPKRKFFIFDCSKAENCCDKSQYNEAGTREKISMLFHLLFCGPCRKYTSRNTKLTRLIKK
SKLKTCSEEEKKAWKNRIEKEIAKKES
>IFAGANLK_03241 ECF RNA polymerase sigma factor SigX
MPTHKLDPTKWVDKYSDYLFNYAIVRVNDREVANDLISETFLAGLNSKDNFEGRATERTW
LISILKRKIIDHYRKINSQKGQAEVRINYSDSENNGDWLEEQVADTFDRTAEDEMENTEL
GLAILECLEQINEKHAAIFKMKTIDGADTEAVCKEFNISPSNLWVIIHRARTALAACLEK
NWY
>IFAGANLK_03242 Oligopeptidase A
MTTHNNPLLQEFNHAPFSKIKNEHFKPAIRKAIEMAREEINGISTNTKEPSFYNTIETLE
FSGEKLDRVTSIFFNLNSAETNEEIQQIAQEVSPLLSEFRNDIILNKALFERVKSVYNKK
DELNLNTEQKTLLDRKYKAFSRNGANLPIEKQNELRDIDKKLSKLSLDFGQNVLAETNKF
ELHLTDENDLKGLPESFKEEAAQVANSKEKKGWIFTLEYPSYLPFMKYAENRELRKKMAL
AFGSKAFHGDELDNRENVLQISKLRYQRAQLLGYKTHAHFVLEERMAETPEKVNSFLEEI
LEKAKPAAEREFAELENFAKDLDGIDQLQKWDAAFYSEKLKQKLFNLDDEKLKPYFKLEN
VIDGVFTVANKLYDLKFQEVFDVDKYHEDVKTYQVIDENNKDIALFYADFHPRPGKRDGA
WMTGYKSQYKKDSEEERPHISIVCNFTKPSKKQPSLLTFNEVTTLFHEFGHALHGMMADT
QYPSLSGANVYWDFVELPSQLLENWCYEKEALQLFAKHYETGEVIPMELIQKIKESANFQ
EGMATVRQLSFGMLDLSWHGVDPSAITDVKANEDKAFERTKLFPNVTENCMSTAFSHIFQ
GGYSAGYYSYKWAEVLDADTFEYFQQNGIFSREVANKFKTNILSQGGTDHPMTLYKKFRG
KEPKPDALLKRAGLIKK
>IFAGANLK_03243 N5-carboxyaminoimidazole ribonucleotide mutase
MNKVAVIMGSTSDLPVMQDAIDILKGFDLEVEVDIVSAHRTPEKLFEYGKTAHERGIKVI
IAGAGGAAHLPGMIASLSPLPVIGVPVKSSNSIDGWDSVLSILQMPGGVPVATVALNGAK
NAGILAAQIIGASDKCTLDKILVYKEGLKEKVIEGAKKVKR
>IFAGANLK_03244 N5-carboxyaminoimidazole ribonucleotide synthase
MINYFSSDFKLGILGGGQLGKMMLYETRKYDIQTNVVDPNPEAPCKIACDYFETGDLMDF
DTVINFGRKVDVLTFEIEGVNVEALKQLQKEGIKTYPSAETLEKIQNKGIQKDFYKKHQI
PTADFEVFSNKKELIPALESSKINMPFVWKSTTGGYDGKGVSVIKSKEALYDLPDAECII
ETLVPFKNELAVIVARSASGEVKTYPVVEMEFHPTANQVEYVICPARIEDSVALKARELA
VKVSEAFEHVGLLAVEMFQTEKDEIIVNEVAPRPHNSGHYSIEASYTNQFEQHIRAILDL
PLGNTESKVGGIMVNLVGDAHHEGEVVYENIEKIMEMPGVTPHIYGKKITRPFRKMGHVT
IVNKDLAEARKIAEEVKNSIKVISKK
>IFAGANLK_03245 Adenylate kinase
MIKLHDLEFEPYISEEEINVAIDKVADKLNKDYKDANPIFLGVLNGSFMFASEVIKRFNE
DCEVSFVKLGSYEGTRTTGNVKTLLGLNQSLKGRKVILLEDIVDTGNTLEEINKILLKEE
VDNYEVATLFYKPEAYKKDFNIKYIGVEIPNKFIVGYGLDYDGLGRNLTQIYKLKENNMT
NLVLFGPPGAGKGTQADILKEKYKLIHISTGDVFRDNIKSETEVGLHAKSFMDKGQLVPD
EVTIKMLNAEVDKNEGANGFIFDGFPRTAAQADALAELLKLKNTEVTAMIALEVDDEVLV
ERLLERGKTSGRKDDADESVIRNRIKVYYDETAILKEYYKKQDKYYGVDGVGSIDEITQR
LSAVIDKLQA
>IFAGANLK_03246 GTPase Obg
MTEGNFVDYVKIHVASGKGGSGSSHLHREKYVAKGGPDGGDGGRGGHVIVKGNKNLWTLY
HLKFKRHIRAEHGSNGSKQRSTGAEGSDEYIEVPLGTVIRDTETQEIIHEITEDGKEYLI
AEGGMGGRGNWHFKSSTNQTPRYSQPGIDGTEVDITLELKILADVGLVGFPNAGKSTLLS
VITAAKPKIADYEFTTLKPNLGIVEYRDFKTFVVADIPGIIEGAAEGKGIGHRFLRHIER
NSTLLFLVPADAPNISEQYEILLDELRRYNPEMLDKDRLIAISKSDMLDTELKLEMKHEL
DKNLGAPYLFISSVAQQGLTELKDRLWEMLNKETS
>IFAGANLK_03247 hypothetical protein
MKLIKLLLICALISSCNTPKAVYDYDDTVSFNNYKTYQLFPDFQSGLSQLDETRLITSLK
NGMEEKGFSTSEEPGLYVNIYSREFKDQNRSSIGVGIGGGGRSGGVGVSGGIPIENNSVI
LELTIDFIDVAEDSLIWQAVVETKFNPNASPEQRRAMFDKIVEKALEGYPPKD
>IFAGANLK_03248 Outer membrane lipoprotein Omp16
MKNLYSTLFILFIGLAAFGQSAEIKKAEKLFAQRAYIDAAEAYEKVVDKDQEVLQNLGDA
YFYTNQMESAAEVYRTLFLRHDDITEPEYKFRFAHSLRAIGEQEEADENMSDYTGDDINY
EDFARELDTVAPHVYTTEQIMNNSASADFGIAFYGDRITFASTRNQERPVYPWNKQPTLD
LYSAEMSEDGELSDIVLFSDEINTDEHESSATFSEDGQVMYFDRNSEKRVKNEEGIRVGH
IKIFRAEMLDGEWSNIEALPFTSDEYSTEHPSLSADGSKLYFASDMPGSEGSFDIYVVDV
NEDGTYGEPQNLGTVVNTPHREQFPYISEEGVLYFASDGHQGFGNLDVFRAEGDFSEVQN
LGNTVNSGHDDFAFIIDEENQKGYLASNRRGSDNLYVFTREDYVPPVVDYDDRETNLETG
RQQLRDVGNIYFDFDKATIKDESKPTLDKVVTIMNKYPELQIEIGSHADARGSDQYNMGL
SERRAASTLEYLVENGIDRSRLTSKGYGESMPLNDCTEPTGCTAEQYAKNRRSEFTIMND
ENNTDSEEMED
>IFAGANLK_03249 hypothetical protein
MKKTIKYLIFAGIILFSIKGMSQQDPLFTQYMYNMSVINPAYATDDPGMLNLGGIYRSQW
QNVDGAPSTANFFAHTPVSERVELGLTVVHDEIGGIVKENNITADFAYVIPTGGESKISF
GLKGGLTTFDANLSGLAVNDPTDPALENVNEVFPVFGVGAFWFGDNYYLGASAPNLFTSK
YIENEQGLAALGEEAIHYYLTGGYVFQLNPDLKLKPAFMARGVQGAPLAVDVTANVLLYD
RLEAGVGYRFNETLTGLVNFKITPSLRVGYAYDHFTSDFANYNLGGTHEIMLLFDLDLFG
LTKGYDKSPRFF
>IFAGANLK_03250 hypothetical protein
MQNFTFGRKGTNWFLFAFVLLIGTLPSFGQADCPDPDNFSFSQTQTVCFTQTVSELNTDG
YPVYQTDENENDTQIIPEDELLVDGEIYYVGGESGQCERIAITVTVESVERPLNDVTNNQ
ANGFEITSCTPADFNAEDLAELFDETIGGYNIEVYDSEFGTSPMADGDNLLPGGSYYVAQ
VPGTNVPGCPSLRTAVGFNPNQIEAPTAATEQSFCEDATVADLEAAGTYDDTQAIRWYRS
QNANSPLADNTELINGATYYVGQVVNERGSPLPPCETPSEDRAAVMVTLGEPIENTPISA
EVCTSQILPNPTAADFEDFYRGLLGNVEGGSFTRDFEDLVDQYENNPIGTFTNTYTSSEE
CESTEVTVEITDTEDANAGGFDNFTLTCATEESFDLQTLENTDDNATGGGTFSGTGVENN
QFDVSVGPGVYPITYTVNDESADCITPDTESTTTFEITINDNPQEVDDISTVICSDDLLG
NPTANDVRTYLRNLISSRTDLPLDGTFTNNTPEDIFDQFQEDRFQRFVSSYTVDTNCGEV
TVGITIDIFESEDAEAGEIDDFTIACDAQNIIVLDESLLDETATRNGSFSAAEGVLNDEG
NFDPSIGPGTYTITYSVDDNANPCITPNTSDATEFTIEVEESNQVSTVSETFCVSEIQEL
LESEDDLETILEGILGQPVDTDGTFEPGLDELEADLLSFFFNPSLSFDTFEATYTTDCSA
TDIELTIIKDGDAEAGEIDDIDIACFATDVVALDNSLLDNTATPNGVFTAEEDVLNEDGN
FDPSLATPGTPYTITYSVDENSSDCVNPGTSDFTTFTITISEELAEQPDDIFNTICSEDL
LANPTVNDVRSYLRNLISRRTELPTNGIFTNNSPEEILGQFQQNRFQTFNSVYTVETSCG
DVTVDITLDIIESGDANAGEIDDITLVCFDTGEIVLDDSLLDENANPGGTFTAEEGVLNE
DGNFDPSIGAGTYTITYSVDDSADCVIEGTSDFTTFDIIVGEDLEELNPVSVVICEDQVL
ENPSEAQIRSYFTNLVNNNTSLETGGNFDPSPAEILTQFENQNGLGIFETEYTVDTGDCG
IVSVMLTAEVTPLQQADAGEFGDIELCTTDDEIQLSAGQTGGIEGGFFTINGEVIEGGIF
NPAVMEEGDYDVSYTINEDTACVEGEASTSFTISIFEGPNAGSDLTLSYCETEIEELIAN
PGEAQNFLITLLENQEEDVDLSGDFDANVEELFAYYNAGDFSEPFVTTYRVSNENCEDTS
EISITINEIEEANAGDFENYTFCSTDNDVNLNNEITGTAGGTFTVDGEPIENGIFSPSTF
EASIYTITYTVNENIDCVEGEDFTTFQIEVIQGIELGENRSVELCINEVIQNPTVSDVRN
YFRNLLGENSEAEGIFNPSIEELRASFQENPINTLTTTFTVENGECSDSVDLSVNIVATE
EAEAGEIDPLTICDTTEDIDLFSLISDEANENGYFEGYEDGIFSPSMMDAGSYEITYTVD
STTACVEGEDSTTFTIEILQGADAGEDMDVTVCSNDGQQDLFSLISADADMDGEFTLDGD
VIADGIMDPSQFETGTYEVIYSVTAEGDECGGDDSATITITLGNAPDAPTTGEAIAFCAI
DGETATRLEADGTNLTWYSDAELSMMVSEEDLLVDGDYYVTQSSDEGCESEAAVLTVNIV
DSPAPTISSDYELCEFDNPTIADLSAEINESGEITWYESADSMTALSNNATLTDGTTYYA
TLISDNGCESSERLAVTVTLEDCALLFPEAITPNGDGRNDRFVIENIEREYPNFNITIFN
RWGNAIYKGNASTPTWDGTSNQSGSLGDDVLPVGVYFYVVDFNDGSTEPRQGKVYLNR
>IFAGANLK_03251 hypothetical protein
MTNKFLIFGIILFSFLTPVWAQSSIETGEKYLKENQINKAKKVFEENKDNAKAVEYLGDI
ASFEKKWDEAIDYYEKLVENQPNSSGYNFKLGGAMGMKAMEASKFKAALMLGDIKTYLNK
AAELDENHAEVRRALVELYMQLPAIIGGSKERAQQYVKELQSINKVDAYLAQAYIHKIEE
DREAMKVAVNKALEAASNDKSLVERNYQNYELGERAALLNLKPDLAVDFLEKYVRNYNYQ
DLKSPAWAHFHIAKIQASRNNQDKALSHINKALASKFNFPEAEKLKQEILEM
>IFAGANLK_03252 UDP-N-acetylmuramate--L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptandioate ligase
MKLHFIAIGGSAMHSLAIALHKKGNNTTGSDDAIYEPSKSALEEEGLLPAELGWFPEKIT
RDLDAVVLGMHAKKNNPELKQAEELGLKIYSYPELLFEISKEKTRVVIGGSHGKTTITAM
ILHVMHYHGKEIDYLLGAPVRGIENTINLSDENDFMLIEGDEYPASAIDLRPKFHLYQPN
IALLSGIAWDHINVFPTFENYVEQFQIFISSIVKGGILVYNEEDETLKNLAENTENQIRK
HPYFTPEYHIEDGETILETSEGDMPLEIFGKHNMNNLAGAKWICQHMGIDEDDFYEAMVE
FKGASRRLEKIYENENGIIFKDFAHSPSKVKASTQAVKDQYPGKKLIACLELHTFSSLNS
EFIQQYKDTLNEADEAIVFYSVEAISQKQMQSISTEEIKNAFNNPNLEVVSDTSALKNLL
ESKDLKDSVLLLMSSGTFGNLELEELKALF
>IFAGANLK_03253 hypothetical protein
MGQENQIGFGIKSWAEDDRPREKLLQKGKLSLSNAELIAILIGSGSRNESAVQLSKRILA
STGNQLSDLGKLSVKKLCEFKGIGPAKAVSIVAALELGRRRRTEEALEKKKITSSASVFE
LMQPIIGELYHEEFWIIYLNNSNKVIEQLQLSKGGITGTLVDVRITLRKALEVGATSIIL
THNHPSGTLRPSEADKQLTQKLKTAAQSLDIKVLDHLIVTEKSYFSFADEGVL
>IFAGANLK_03254 hypothetical protein
MLLIYTQKITPRIVYIFKHVCTNVLGISIKFTTKIEEFIAHEGMKLSYGKQALGNELFVQ
KVDLLLEQGLSEVEIKVQPWGDNYCFFPVSENSALPFDIFAASFFLLSRYEEYLPHVKDD
LGRFPASESVGFQEGFLKTPVVDIWAYKFKEILMERFPEISLTNREFHTRAVIAVEHVFN
FQNKGFLRSLAGMHLDIIKLQFNKVLDRIQVLMRVKKDPINIFEDLIAFIKEYKVPLLFM
FQLSDFSIYDRNINYNRNPYRSIIKYVGDYAEVGLMPGYFALEDFKTLRKEKLRMENTVH
TPLDSVINVKYNLNIPEFYNFLSELEIPQDYSMGYPETAGFRAGTCSPFLFYDINTESTL
ALKIHPYVFNSNIVEHTDFGQLTSDIGKMLSEVKKVGGSFKAIFKNQDFSEYSNYQAYYA
LLKQIYEIR
>IFAGANLK_03255 Pyrimidine 5'-nucleotidase YjjG
MKLGNINHIFFDLDHTLWDFDRNSALAFERVFKFRNIPLEINDFLEIYMPVNFKYWERYR
NDQVTKEALRYGRLKDSFDLLKFEADKDLINDIAIDYIEYLPDHNHLLDGSKEVLDYLHK
SYELHIITNGFEEVQHKKLNNSGISKYFTTITTSEEAGVKKPNKLIFEAALKKSSATPES
SIMIGDNFEADCTGAQNCGIKPIFFDYYGNKENIDVMHIKTLNELKTYL
>IFAGANLK_03256 hypothetical protein
MKLLLKFLLRSIGVMLITGGLCGCVKDVDLDQREEISLSPDVQIDLLIYDIDQSQFKDPS
TGNLKTHISDTVRLEFLDDDYIQEDLTTVEFYFRHINTFPREIESKIRFLSDGNREQFAV
NYTIKPGVDGNPVTTEQFEFIEEDRIHLVRRTIKMVVELEVQPGSAKFEGELDFASKGLF
SFEF
>IFAGANLK_03257 hypothetical protein
MMWRLIGLFLVISGTVVGQNKPLLFNVDDLPQTLMSNPGAQINFTGHLGIPFFSQIHLSA
GSTGADLYDVFANDGTNINTRIQEAMRNMDSRDYFSVNQQLEIFSMGWKLDGKNYLSTGI
YQELDVFSYFPKDPAILANEGNNDYLNEPFDFSDVSFTGEIMTVYHLGINHKFDNRLTVG
ARAKFYSSIFNAESTGNTGKFTTYTTPEGRNVYNHEVVDMNILINTAGFAPLKEEEGMTV
DQATAELLSRSFFGGNVGFGLDLGLSYILHEQFILSGSVQDLGAVFHRDEVENYRYFGAY
ETSGIEPLFPELDANDEALPYWDDFEDEVDRNLRDETTNESYTTWRPIKANFAMEYGFGP
AFLPCHYLSVKKGRYMNLLGIQLRGVKRPKGFVYSFTTYWDRKINNNQRFKVSYSLDDYS
LTNIGLMYTRTFNKFNVYLAANNLLAFPNLAKAHSASLQLGMQLIFND
>IFAGANLK_03258 hypothetical protein
MKRIIFILTFFVCSFPMLAQDLDQYKYVIVPEEFEFSKEKNQFQLNALTKFLFEKYGFET
LMKNEEKPADLQENYCLGLNAKVKDNSGLFVTKLVVQLEDCRGNIVYETQEGRSREKDYK
TAHHEALRNAFSDIEELNYSFNPGEVSAAAPSSDKQPQAAEKAEVAQSEPETRAPEATED
VETPATAPTEQAEPAEVVVENPMIDNESAKELEFEKDGTSYFLEKSDSGYSFFQENSEEP
FAVLAKSGGENSFLYKSLTRQGVAYFGEDGNLVVEYLNEENKSVKLVYKASASQ
>IFAGANLK_03259 Replication-associated recombination protein A
MSKPLAERLRPQTLDDYLSQQHLIGPKGALRHQLKQGIIPSMIFWGPPGVGKTTLANIIA
STSDRPFFTLSAVSSGVKDVREVIEKAKKSDGLFTTKNPILFIDEIHRFSKSQQDSLLGA
VEKGWVTLIGATTENPSFEVISALLSRCQVYILKPFSKEDLVALLERAMREDKIIASKNI
KLKETEALLRLSGGDARKLLNIFELLVTSSQGNIEITNDLVFNSVQQNTVLYDKAGEQHY
DIISAFIKSIRGSDPNAAVYWLARMIEGGEDVKFIARRLLILASEDIGNANPTALVIANN
TFQAVTTIGFPEARIVLSQCVTYLATSPKSNAAYMAINQAQSAVKKTGNLSVPLSIRNAP
TKLMKDIGYGKDYKYAHNHENNFVEAEFLPDEIKNTKFYDPGNNPRENAQREFLKKRWKS
KYDY
>IFAGANLK_03260 hypothetical protein
MKQSNPFVFTTGVLGYPILFVLLIWIVFWFEIRFGISFNNFGVRPGEVKGLRGILFSPFI
HGDIKHLFNNTIPLFVLSMSLFYFYRKISWPVLIIGLLLTGILTWSIGRPANHIGASGII
YMLATFLFFKGIFSKYYRLVALSLIVVFLYGGMLWYVTPIDPEISWEGHLSGLISGFILS
IVYRKNSIKSPKYEWEKPEYKEEEDLFMQHFDENGNFIERRFEIEEEATDPRDGEDDTQF
NKNSDKITYRYFYKKSEEKKE
>IFAGANLK_03261 Putative TrmH family tRNA/rRNA methyltransferase
MEETTRIFGIRAVIEAIQGGKSIDKVYVQKGLSGPLFQDLNHLLQKGSYNISFVPEEKLY
KLSKGNHQGVVATISPIKFGNLEETIEKILEEKPTPLFLLLDQITDVRNFGAIIRTAECT
GVDAIIIPEKGGAPLNADTVKTSAGGVFNLPIVKVNHIKDAVFYLQSSGVQLVAATEKTD
DTVYDVDFNQPSAIVMGNEAKGVSNSILKSVDKKAKLPMFGKIESLNVSVACGVFLYEAI
RQRQSS
>IFAGANLK_03262 hypothetical protein
MKNILKYISFCLIAVVGLSSCEPDDNGYREDPRDVGGYAYLQTQSLTVFDYDQDLSIELF
TDEGVTVESVEIIEDGSTLTTANISGDMATFNAADLGSFAVDSTYSVRVRANLSNGNVSD
DPATISVVEAVALGDDNPEEAPINKLDDVELEYSVSTTSAPIDEVNLWVKNGEDAEYMMI
EGLDLATEEGSVSMSDFDYSGLNLEVGDVIFYQFEATRGELTEGAEGEITVLEEEDDSED
ED
>IFAGANLK_03263 hypothetical protein
MKKYILTFIALATLWSCQTDEQYEDLNKDPKNPTDVAADFLFTNATVELTSQMANPNVNL
NIFRFVAQYWTSTTYLDEPNYDLTNRGIPQNHWNRLYRWVIFNLEDAKTKVQEDETLSEG
EKTARIAQMEVLEVYAWQILVDTFGDIPYSEAFGTSENIDPAYDDAATIYEDLISRIDAA
SGNLSAGQGFAGATDAIYGGDMAKWEKFANSLQLRLAMQISDADGYEMLAQETAEDAYSD
GVFESNADNATLEFQAAPPNTNPLWEDLVQSGRSDYVAANTAVDALNELDDPRRSAYLDD
NLSSGEYIGGTYGGSNSFQNYTHVGEAFREPTHPGILMDYAEVRFLLADAASDDNNFAVG
GTAEEHYEAAITASMEYWGVSEGEIEDYLSDGDVAYDGSDEQFATQFWLAMYDNPFQGWN
VWRRFDAPSFNLPEDTGKEVPLRYTYPVNEQNLNNANWSAASDAIGGDDQQTPLFWDEE
>IFAGANLK_03264 TonB-dependent receptor SusC
MRTKFSSILTLLLVLAVQITFAQERTITGTVVDEDGLPLPGVTVLIQGTNTGTQTDFDGN
YSIGASEGDVLVYSFVGMETAEYTVANNDTIDVTLTTDSAQLDEVVVTALGIQREKKSLG
YATQEVQGSEVSDVPTQNFMNSLSGKVAGLSIKSSGTMGGSTNIVIRGNASLTGNNQALF
VIDGTPISNNTPNTTDQQEGRGGYDYGNAASDINPNDIESINVLKGAAATALYGARAANG
AIIIETKKGSKKEGIGISINSTFMTTSVDDNTLPVYQDQYGAGYGPFYDTPFFNTYGNLD
LPDGFDPNIPFTPFTEDASFGAPFDGQLIHQWNSIYPQLGTYQQATPWQAAENTPNDIWE
RGYTAINSVALDGGSETSSFRLGVTNLNNQGNLPNSRIKRNTIKFSGTHEFTDKFSAGAN
ITYTKTDGKGRYGTGYDSENPMQSFRQWNQANVDVYAQRDAYFETGQNITWNPNSPLNRT
PIYSDNPYWTRYENFQTDTRNRYFGNFNLNYEINDVFSVLGRFSFDTYDEIQEERRNVGS
VGVSSYSRYNGRAAEYNYDLILNANTDITDGLNFDGNLGWNLRRNKMNTITAETNGGLNA
PSFYALSNSVDPILPPDEYDETRMIDGIYARASLGYLDTYFVEGTIRRDRSSTLPAENNT
FYYPSISTSVLLSNVVEADWLSFAKLRANYAEVGNDAVPFSVLNTYELSTPFGGAGVAGN
NETLNNESLKPERTKSYEVGIEANFLDRRIGFDVSYYNSQTEDQITPVPVSMASGFTEIF
FNAGTVENKGFEASLRLNPIRTEDFNWNMNINWARNRSEVLNLAQGIKNLQLAGLQGGVS
INATPGEPYGTIRGTDYIYDDSGNKVVGSNGYYLTTPNSNEIIGNILPDWTGGVQNTFQY
KNLSLGFLIDVQKGGDIFSLDTWYGQATGVYDQSVGTNDLGNPMRNTLANGGGIVLPGVN
ENGEPNSTRADFSTYANPYGYARDANAGHVYDASFVKLREANLTYAFGEEMIERLPFTRA
SVSLIGRNLWIIHKNIPYSDPESGLSAGNVQGYQSGAYPTFREIGASLKLNF
>IFAGANLK_03265 30S ribosomal protein S12
MPTISQLVRKGRAQITKKSKSAALDSCPQRRGVCTRVYTTTPKKPNSAMRKVARVRLTNG
KEVNAYIPGEGHNLQEHSIVLVRGGRVKDLPGVRYHIVRGALDTAGVEGRSQRRSKYGAK
RPKK
>IFAGANLK_03266 30S ribosomal protein S7
MRKRQAKKRPLLPDPKFNDQLVTRFVNMMMWDGKKSVAFKIFYDSIAIIEEKKQDDEKTG
LEIWKDALSNVMPHVEVRSRRVGGATFQIPMQIRPDRKVSTAMKWLISFARKRNEKSMAQ
KLASEVLAAAKEEGAAVKRRVDTHKMAEANKAFSHFRF
>IFAGANLK_03267 Elongation factor G
MAQRDLKFTRNIGIAAHIDAGKTTTTERILYYTGISHKIGEVHDGAATMDWMEQEQERGI
TITSAATHCKWMYRDQEFTVNIIDTPGHVDFTVEVERSLRVLDGVVALFSAVDGVEPQSE
TVWRQADKYKVPRLGFVNKMDRQGADFFNVCKQVREMLGGNPVPLQVPIGDEIDFKGVVD
LISKKAIIWNDEDHGMTYDTIDIPEELMEDVNKYRTQLVEAVAEYDEALMEKFFEDEDSI
TEDEIIAALRAATIDMSIIPMMCGSAFKNKGVQAMLDAVMRYMPSPVDVEAIVGTNPDTN
EDESRKPHVDSPFSALAFKIATDPFVGRLAFFRVYSGALDAGSYVLNNRSGKKERISRIY
QMHSNKQEPINRIEAGDIGAAVGFKDIKTGDTLTDEKNPIVLESMTFPEPVIGIAVEPKT
KADVDKMGMALAKLAEEDPTFQVKTDEISGQTIISGMGELHIEILVDRLKREFKVEVNEG
QPQVEYKETVTKTAEHREVYKKQSGGRGKFADIVFEMGPVDEDFEGKGLQFVDSIKGGRI
PKEFVPSVEKGFKEAMKNGPMAGFQMDTLKVILKDGSFHPVDSDQLSFELAAKMGYKAAA
KKAGAVVLEPIMKIEVVTPEENMGDIVGDLNRRRGQVSNMSDRSGAKIIKAEVPLAEMFG
YVTTLRTLSSGRATSTMEFSHYAETPSNISEEVIKAAKGTNE
>IFAGANLK_03268 30S ribosomal protein S10
MSQKIRIKLKSYDHNLVDKSAEKIVKTVKTTGAVVTGPIPLPTHKKLFTVLRSPHVNKKA
REQFQLSSYKRLLDIYSSSSKTIDALMKLELPSGVEVEIKV
>IFAGANLK_03269 50S ribosomal protein L3
MSGLIGKKIGMTSIFDENGKNIPCTVIEAGPCVVTQVRTKEVDGYEALQVGFDDKKTANK
AAEGHAKKAGSVAKRKVVEFQGYEADYKLGDAITVEHFNEGEFVDIAGTSKGKGFQGVVK
RHNFGGVGQATHGQHNRLRAPGSIGAASYPARVFKGMKMAGRMGGERVKVENLRVLKVVA
DKNLLVVKGCVPGHKNSYVIISK
>IFAGANLK_03270 50S ribosomal protein L4
MEVAVLDIKGKETGRKAKLSDSVFAIEPNDHAVYLDVKQYLANQRQGTHKAKERAEITGS
TRKIKKQKGTGTARAGSIKSPIFKGGGRVFGPRPRNYGFKLNKNLKRLARKSALSIKAKG
ESIFVVEDFSFDAPKTKSMIDVLKALGIQDKKSLIVLGDSNKNVYLSSRNLKGLEVVNSS
ELSTYGILNAKNIVLLEGSLEGIESNLSK
>IFAGANLK_03271 50S ribosomal protein L23
MSILIKPIITEKATGDSELNNRFSFVVDSKANKIEIKNAVEAAYGVSVEKVRTINVRPDR
KTRYTKSGMITGKTKAFKKALVQVTEGETIDLYSNL
>IFAGANLK_03272 50S ribosomal protein L2
MSVRKLKPITPGQRFRVVNGFDAITTDKPEKSLIAPLKKSGGRNSQGKMTIRYKGGGHKR
RYRIVDFKRDKHGIPATVASIEYDPNRTAFIALLNYQDGEKRYVIAQNGLQVGQNIVSST
DSAAPEIGNAMPLSSIPLGTVVSCIELRAGQGAVMARSAGAFAQLLAREGKYATVKLPSG
EIRRVLATCMATIGAVSNSDHQLQVSGKAGRKRWLGIRPRTRPVAMNPVDHPMGGGEGRA
SGGHPRSRKGLPAKGFKTRSRTKASNKYIVERRKK
>IFAGANLK_03273 30S ribosomal protein S19
MARSLKKGPYVHYKLDKKVAQNVESGKKAVIKTWSRASMITPDFVGQTIAVHNGKQFVPV
YVTENMVGHKLGEFSPTRSFRGHSGAKNKGKR
>IFAGANLK_03274 50S ribosomal protein L22
MGVRKRERAEQIKEAKKQVAFAKLNNCPTSPRKMRLVADLVRGEKVEKALQILKFSSKEA
SGRLEKLLLSAIANWQSKNEDASIEDAELFVKEIRVDGGAMLKRLRPAPQGRAHRIRKRS
NHVTLVLGENNNTQS
>IFAGANLK_03275 30S ribosomal protein S3
MGQKTNPIGNRLGIVRGWESNWYGGNDYGDKLAEDDKIRKYIHARLSKASVSRVIIERTL
KLVTVTITTARPGIIIGKGGQEVDKLKEELKKITDKEVQINIFEIKRPELDAHLVASSVA
RQIENRISYRRAIKMAIAAAMRMNAEGIKIQISGRLNGAEMARSEAYKDGRIPLSTFRAD
IDYALVEAHTTYGRLGVKVWIMKGEVYGKRDLSPLVGMSKKQGGKPGAGRGGNKSRRRK
>IFAGANLK_03276 50S ribosomal protein L16
MLQPKRTKYRKQQKGRMKGNAGRGHRLSNGTFGIKSMDSSFITARQIEAARIAATRYMKR
EGSIWIKIFPDKPITKKPLEVRMGKGKGAVEYWAAVVKPGRIMFEIGGVPMDVAKEALRL
AAQKLPVRTKFIVARDYQA
>IFAGANLK_03277 50S ribosomal protein L29
MKQSEVKELSVAELQEELGKSRKAYSDLKMAHAVSPLENPIQLRAVRRTIARLATELTKR
EQQ
>IFAGANLK_03278 30S ribosomal protein S17
MEKRNLRKERIGVVTSNKMQKSIVVSEVKKVKHPMYGKFVLKTKKYVAHDETNDCNEGDT
VRIMETRPLSKSKCWRLVEIIERAK
>IFAGANLK_03279 50S ribosomal protein L14
MVQQESRLRVADNTGAKEVLTIRVLGGTKKRYASVGDKIVVSVKEATPNGNIKKGAVSTA
VVVRTKKEVRRQDGSYIRFDDNACVLLNPTGEMRGTRVFGPVARELRDKQFMKIVSLAPE
VL
>IFAGANLK_03280 50S ribosomal protein L24
MRKLKIKTGDTVRVIAGDHKGQEGKVQKVLIDKNKAIVEGVNTISKHEKPSASNPQGGIV
KKEAPIHISNLSLLDKDGNTTRVGYKEEDGKKVRFSKKSNEVI
>IFAGANLK_03281 50S ribosomal protein L5
MAYVPRLRSEYAERVKPALKEEFSYANVMEIPKLEKIVLSRGVGAAVADKKLIDHAVDEL
STITGQKAVQTISKKDVASFKLRKGMPIGAKVTLRGYRMYEFLDRLITSALPRVRDFNGI
KANGFDGRGNYNLGVTEQIIFPEIDIDKVNRINGMDITFVTTAKTDKEAKSLLTELGLPF
KKN
>IFAGANLK_03282 Alternate 30S ribosomal protein S14
MAKESMKAREVKRQKMVKKYAEKRAALKEAGDFEGLQKLPKNSSPVRLHNRCKLTGRPKG
YMRQFGLSRVMFREMANKGLIPGVRKASW
>IFAGANLK_03283 30S ribosomal protein S8
MNTDPIADYLTRVRNAVAANHRVVEIPASNLKKEITKILFDQGYILSYKFDDDASAQGTI
KIALKYDKITKEPVIKDIQRISKPGLRKYSGADELPRILNGLGIAIVSTSHGVMTGKQAK
AEKVGGEVLCYVY
>IFAGANLK_03284 50S ribosomal protein L6
MSRIGKNPITIPEGVNVDLKDGVVTVKGKLGELKQEINDIDVKIEDGVITFERSSEKSDQ
KAKHGLYRALVNNMIEGVSNGYTKSLELVGVGYRASNQGQKLDLAVGFSHNIVIDLAPEV
KVEAISEKGKNPVVKLTSYDKQLVGQVAAKIRSFRAPEPYKGKGIKYVGEQLRRKAGKSA
>IFAGANLK_03285 50S ribosomal protein L18
MAVSKQDRRNKIRKRVRKSITGTASRPRLSVFRSNKEIYAQIIDDVEGKTLAAASSRDKG
VSVEGDKSKQAELVGKALAEKALKAGVETISFDRGGYLYHGRVKSLAEGAREGGLKF
>IFAGANLK_03286 30S ribosomal protein S5
MYQDYKNVEHVKPGGLELKDRLVGVQRVTKVTKGGRAFGFSAIVVVGDENGVVGQGLGKS
KEVADAISKAVEDAKKNLVRIPLHKGSLPHEQKGKYGGARVLLLPAATGTGIIAGGAIRA
VLEAVGVHDVLSKNQGSSNPHNVVKATFDALLQLRSADTVAKQRGISLEKVFKG
>IFAGANLK_03287 50S ribosomal protein L30
MGKIKVTKVKSAINRSKNQKLVLESLGLKKIGQTVEHNDTPNILGMVNKVKHLVSTEETK
>IFAGANLK_03288 50S ribosomal protein L15
MELNNLKPAKGSVKSNNKRVGRGEGSGKGGTATRGHKGAKSRSGYSKKIGFEGGQMPLQR
RVPKFGFTNRNRVAYQGVNLDTLQRLVDEGKIKDTVDVDALIENGLVSKNKPVKILGRGE
LKAKLKISVHKFTATAKEAIEAAGGEVVTL
>IFAGANLK_03289 Protein translocase subunit SecY
MKFINTIKNIWKIEELKNRILVTLGLLLVYRFGAQVVLPGIDASQLSNLASQTDGGLLGL
LNAFTGGAFSNASVFALGIMPYISASIVVQLMGIAIPYLQKLQKEGESGRRKINQITRWL
TIAITLVQGPGYIYNLFATLPQQAFLLGDTVTFVASAVVILTTGTIFAMWLGEKITDKGI
GNGISLLIMVGIIATLPQAFIQEFASRVFESNGGLIMILIELVIWFAIILASVMLVMAVR
QIPVQYARRTASGGYEKNVFGSRQYIPLKLNASGVMPIIFAQAIMFIPAAVAGLSDSDAA
QGVTAAFSDIFGFWYNVVFALLIIVFTYFYTAITVPTNKMADDLKRSGGFIPGIRPGTET
AEFLDRIMSQITLPGSIFLALIAVFPAIVVQLLGVQQGWALFFGGTSLLIMVGVAIDTMQ
QVNSYLLNRHYDGLMKTGKNRKAVA
>IFAGANLK_03290 Translation initiation factor IF-1
MAKQPAIEQDGTIIEALSNAMFRVELENGHVVTAHISGKMRMHYIKLLPGDKVKLEMSPY
DLSKARITYRY
>IFAGANLK_03291 30S ribosomal protein S13
MARIAGVDIPKQKRGVIALTYIFGIGRSRAQKILSQAKVDESKKVSDWDDDEIGRIREAV
GEFTIEGELRTEVQMSIKRLMDIGCYRGIRHRSGLPLRGQRTKNNSRTRKGRRKTVANKK
KATK
>IFAGANLK_03292 30S ribosomal protein S11
MAKKTVQKKRKVTVESVGQAHVTASFNNIIVSLTNKKGDVIAWSSAGKMGFRGSKKNTPY
AAQLAAEDASKVAHEAGLRKVKVYVKGPGNGRESAIRSLHNNGIEVTEIIDVTPLPHNGC
RPPKRRRV
>IFAGANLK_03293 30S ribosomal protein S4
MARYTGPKTKIARKFGEAIFGDDKSFEKRNYPPGQHGNNRRRGKKSEYAIQLMEKQKAKY
TYGILERQFSNMFKKATRAQGITGEVLLQLCESRLDNVVYRMGIAPTRSAARQFVSHRHI
TVNGELVNIPSYQLKAGDVVSVREKSKSLQAIQDSLANNSSVYEWITWNNETKQGTFVSV
PGRIQIPENINEQFIVELYSK
>IFAGANLK_03294 DNA-directed RNA polymerase subunit alpha
MIDSTDFEGKFEFRPLEPGYGLTVGNALRRVLLSSLEGYAITSIRIEGVDHEFSAIPGVV
EDVTEIILNLKQVRFKRQIDEIDNEAVTISVSGEEQITAGHFQKFISGFQVLNPDQVICT
ADKKVNLNMEMTIEKGRGYVPAEENKKANAPLGTIFTDSIYTPIKNVKYSIENYRVEQKT
DYEKLVFEIVSDGSIHPKDALTEAAKTLIHHFMLFSDERITLEADEIAQTETYDEESLHM
RQLLKTKLVDMDLSVRALNCLKAAEVDTLGDLVSYNKNDLMKFRNFGKKSLTELEELVSN
KGLNFGMDLSKYKLDKD
>IFAGANLK_03295 50S ribosomal protein L17
MRHGKKTNHLGRKTAHRKSMLANMACSLIEHKRINTTVAKAKALKVFVEPLVTKSKEDTT
HNRRLVFSKLRQKEAVAELFREVAPKVGDRPGGYTRVIKLGNRLGDNADMALIELVDYNE
TYNLSKTEKKKSTRRAGRKKSSDATPNAPKAEGKTEEKSSENKEDKKEE
>IFAGANLK_03296 Carbamoyl-phosphate synthase small chain
MKYQTRKKAIILLEDGTIFHGKAVGDKDGKAVGEVCFNTGMTGYQEIFTDPSYYGQLMVT
TNAHIGNYGTLAEESESDKAKIAGLICKNFSYTHSRPAADKSLQEFLDDSNLFAISDVDT
RALVTYIRENGAMNAIISTDVDNIKGLKKELAEVPDMNGLELASKVSTKEPYYFGNENAT
YKIAALDVGIKKNILRNFDQRDVYVKVFPYNATYEEMSEWNPDGYFLSNGPGDPAPLNSA
INLTKSIIEKDHPLFGICLGHQIIAIANGIKTYKMHHGHRGINHPVKNLKTGKGEITSQN
HGFSVDKAETEANTEVEITHICLNDDTVGGIAMKNKNCFSVQYHPEASPGPHDASYLFDE
FMDRIKGAKA
>IFAGANLK_03297 hypothetical protein
MKRLLLLSFCILSFLSINAQDQASVEEGLLSINILTPGLEYEYGLTNSTTLDLRAGTGFA
YWENTYFGEDFGIYPIFNVQYRHYYNLEKRLDKEKNISNNSANYIALSAAIESGKPIIGG
LEYSEAYFGTIGPVWGLQRYYGSGFKLDLNLGAGYGFNESGESYLSLLIGFRLGWLLSN
>IFAGANLK_03298 hypothetical protein
MASFKLIAFCFLFLFVSKLQAQKHPVLYAGFEAYRHTGFEDNSFGKFSVGSQIYQIKFLA
PEIGFDYGGGTLPERTVFGKNFNIQDPRKGLLRQRFKFSVLILNPKLKFGEEDAYITFSP
KYHIGTLRGEAAYLEYSDDNRYIGLKESENSKIDLSFWSFAIGFEGLQITSKYWFALSLH
YTLVNANDVWDTMGFSAEDAFMQSASTSTIGLGFRFYYNPFGSEND
>IFAGANLK_03299 Enolase
MSVIINIHARQIFDSRGNPTVEVDVLTENGILGRAAVPSGASTGEHEAVELRDGGDDYMG
KGVTKAVENVNDIIAEELLGYSVFEQNLIDKAMIEIDGTPNKAKLGANAILGVSLAVAKA
AANELGLPLYRYIGGVSANTLPVPMMNIINGGSHSDAPIAFQEFMVMPVKAESFSHALKM
GTEIFHHLKKVLHDRGLSTAVGDEGGFAPKLDGTEDALETILKAIKNAGYKGGDDVMIAL
DCAAAEFYENGKYDYKKFEGEGGKIRSSEEQAEYLAELSEKYPIISIEDGMDENDWDGWK
ALTDKIGDKVQLVGDDLFVTNVERLSRGIEEGIANSILIKVNQIGTLTETIAAVNMAHNA
GFTSVMSHRSGETEDNTIADLAVALNTGQIKTGSASRSDRMAKYNQLIRIEEELGEVAYF
PKRKAFKI
>IFAGANLK_03300 Citrate synthase 1
MSKVATIEIDGKKYEFPVVEGTENEQGIDIKKLRAEAGVITLDRGYKNTGSCESAITFLN
GEEGILRYRGYSIESLAEKADFLEVAYLLIFGELPTKTQLDKFYADIKEESAVDEEMKKI
LDGFPKSAHPMGVLSSLTSALIAFNPSSVNVDSEEEMYKAIVKILGKFPVLAAWTLRKKN
SLPLNYGDDSLGYVENLHKMMFEKPGKSYKVDKEVIDALDKLLILHADHEQNCSTSTVRM
VGSSHAGLFASISAGISALWGPLHGGANQAVIEMLERIKEDGGDTKKFMAKAKDKEDPFR
LMGFGHRVYKNFDPRAKIIKKSADEVLGQLGVDDPVLDIAKGLEKEALEDQYFVDRKLYP
NVDFYSGIIYRALGIPVEMFTVMFALGRLPGWIAQWREMRLMKEPIGRPRQIYTGANLRE
FKEVEKR
>IFAGANLK_03301 Arginine deiminase
MKLFLYLVKILLVNLNINNETSRLKAVVLGTAESNGPVPSLEEAYDPKSAEFIRMGSYPK
EEDMREEMEAVAGILEKYKVQVFRPKVIKDYNQIFTRDIAFVIEDKFVKSNILPDREQEI
EAISHVIEQIDPSKILQLPEEAHIEGGDVMPLGDYILVGTYRGEDYKDYITARTNVQAVE
ALQELFPHKKVVSFNLRKSNTEPRDNALHLDCCFQPVGKGKAIIHRNGFLEEDEYNWLVN
LFGKENVFEISRDEMYYMNSNIFSIDEDVVISEKNFTRLNSWLREQGITVEEVPYAEISK
QEGLLRCSTLPLIRE
>IFAGANLK_03302 hypothetical protein
MRQITDTILMVRPVAFRMNEQTAVNNYFQKDLTADNVNERAQAEFDEFASKLKKVGVNVI
VVDDKQEDDTPDSIFPNNWVSFHENGHIALYPMFAENRRKERRMEYFAKLEENGFKITQV
VDYTSAEEHDLFLEGTGSLLLDRENQKAYCALSPRADEDLLIEFCEDFEFTPVIFNANQS
VDGKRKAIYHTNVMMCLAENFAVICLDTIDDSKERKNVLKHLKDDGKEVIAITEAQMHEF
AGNMLQVQGAFDKKYLVMSVKAHTSLNQDQINKIEKHCEILSSDLDVIETCGGGSARCMM
AEVFLPKA
>IFAGANLK_03303 Glycine betaine transporter OpuD
MKQLFRAFLRNPLLYFASGVLFFLALFIFFFTELFYELIEIGSLWVREYFGGFYLWLGIL
CVFFLIFIAFSRFGKLKLGNSPPEFDRLSWIAMLYSAGMGAGILLRAVQEPVFMFLNSPI
ETGSTPEVIALEYTFYQWGFTAWAFYGIFALLIAYALFVRKSDILLGTSLPQLKKIKYLS
QSVNLLTILTTVFGLVAAIGLGTTQIEGGISHLTSKPAGTLWITILLVFIVCLLAFISAF
AGIKKGIKRISNWNIYLTVVLMFFVFFQVDIFNVFSQFFESLYNYIIDFVPLSLALGKYN
PGKQFLTDWTYYYWAFWLAWAPFTGIFIARISKGRSIREMILGVLLIPSLGSFFWFSVFG
SASFDLIENMNSYNGEFENVFTSLFRFFEAFPLSNFTNIVTIILLISFLVTSVDSAIYVL
SMFSDKGKEHPRKKFRLIWAVLILIFSEAIILLGNIKPESDVLTAMQKFLIISSLPFALF
TAGIMVLFLRELYKKY
>IFAGANLK_03304 hypothetical protein
MRILLTGANGYIGMRMLPELLQKGHEVICAVRNKNRFTSNEELLEKVEIVELDFLKDEEA
PDIIKNIDVAYYLIHSMSGSTDNFDTQESQAAENFNKIMAGTSVKQVIYLSGIINEEELS
KHLKSRKKVEEILYKGDFNLTVLRAAIIVGSGSSSFEIIRDLCEKLPVMITPSWVETKCQ
PISIRDIIKFLTGVIGKEECYNESFDVGGPDVLTYKEMMLKYAEVRKLKLWILSVPVMSP
KLSSYWLYFVTSTSYKLAQNLVDSMRVEVITNDTRLQEILKIDPISYTEAIELAFYKIEQ
NQVISSWKDSLSSGRFRKELNKYIQVPKYGCLLDKQSAEVDNPDEVLERIWAIGGLNGWY
YGNWLWKFRGYIDKLFGGVGLRRGRTHPNKIASGDSLDFWRVLLADKEERRLLLFAEMKV
PGEAWLEFCIDKENVLHQTATFRPKGIWGRFYWYAMYPFHYFIFEGMLNKIAKGEPKKQI
A
>IFAGANLK_03305 hypothetical protein
MNNVLKIVLLVIGIGMIAYGLYRLITPEFALDAGPLQIEAHGDNTQSYAMIGFGVLALIG
GLAFGKR
>IFAGANLK_03306 hypothetical protein
MELFIYVFAALFSVINPLGTVPIFVGLTQEYSAPERSKTSLLTAINIFVILTISFFTGRF
ILHFFGISIESLRIAGGLIIVTSGFALLTGSFSKHKGMEKERVKDDAFQRDSVSLTPLAI
PMLAGPGSISLLIGMYEDYTIISEKILTICAILGVCLATFLVLKSSHYIVKMLGASGINA
ISRIIGFIVIAIGIEYISSSVITVLNSALN
>IFAGANLK_03307 hypothetical protein
MLLNISYNRSKTKEKIDKEVGKPFTLLARMKLNGTGSPKLHITDTSIDIHNLLVLDNNAN
TCNVEMRPKGIIVMFRSLLETYALVIPYYKLHLYKGKAEEYSIYRDHSKIKVKADTPAIH
KYFKKILDYKADNALTQVGDL
>IFAGANLK_03308 Arginine--tRNA ligase
MNIQSTLAAHVKDAVKKIYDVEIENLEFQPTRKDFEGDITLVTFPMLKILKTNPVKLGEE
IGNYLAENVTEVSGFNVVKGFLNIVLSDAYFLDFFNEMKNREDFGILPAAEDAQGIMVEY
SSPNTNKPLHLGHIRNILLGFSVAEILSAAGNKSYKTQIINDRGIHICKSMLAWERFGNG
ETPDSTGLKGDKLVGNYYVKFDQEYKKEISELMETKGISEEAAKAEAPIFVEAKQMLLKW
EAGDPEVVALWEKMNQWVYDGFEKTYDALGVDFDKNYYESDTYLLGKDVVNQGLEKGVFY
KKEDGSVWIDLTDEGLDEKIVLRSDGTAVYMTQDIGTAIQRVKDFDINGMVYTVGNEQDY
HFKVLFLILKKLGFDWADYLYHLSYGMVDLPSGKMKSREGTVVDADDLIAEMTETARNIS
EELGKLDSYNEAEKEELYRMIGLGALKYYILKVDPKKRILFNPEESVDFQGNTGPFIQYT
YARIQSIIRKADFDFKKSIEDYQFHEKERSLIKQLQLYPETIQLAAENHSPALIANYTYE
LVKEFNSFYQNVTILGTEDLSEKTLRVQLANSVGNVIKSSFGLLGIQVPERM
>IFAGANLK_03309 Signal recognition particle protein
MFDSLSDKLDNALHVLKGHGQITEVNVAETLKEVRRALVDADVNYKIAKDFTNTVKEKAL
GQDVLTALKPGQMMVKLVKDELTQLMGGEAEGINLSGDPSIILMSGLQGSGKTTFSGKLA
NYLKTKKTKKPLLVACDVYRPAAINQLHVVGDQVGVEVFSDEGNQDPVAISKAAIAHAKQ
NGHNVVIIDTAGRLAVDEAMMTEISNIHEAIQPHETLFVVDSMTGQDAVNTAKTFNERLN
FDGVILTKLDGDTRGGAAISIKSVVNKPIKFIGTGEKMDALDVFYPDRMADRILGMGDVV
SLVERAQEQYDEEEARKLQKKIAKNQFGFDDFLKQLQQIKKMGSMKDLMGMIPGAGKMLK
DVDIDDDAFKGIEAIIHSMTPDERSNPKIINSSRKKRISKGSGTTVQEVNQLLKQFNQMG
KMMKMMQGGGGQKMMQMMKGMK
>IFAGANLK_03310 Bifunctional protein FolD protein
MTILDGKKTSNDIKDEIAAEVEKIKKRGEKIPHLAAIIVGNDGASLTYVNAKVKSCKRVG
FESSLYRLPNTVSELELLDKIEELNQNDDIDGFIVQLPLPPQIDTQKVLNAVDPDKDVDG
FHPTNFGKMALDMTSFIPATPFGILELLERYDIPTKGKHTVVIGRSYIVGRPMSILMGRS
GFPGNSTVTLTHEFTKNITQITSQADIIIIAVGIPDFLKAEMIKDDAVIIDVGITRVPND
EVEKGYVIKGDVDFENVSKRASYITPVPGGVGPMTVSMLLKNTLLATERHKKRAKENSKA
RTV
>IFAGANLK_03311 hypothetical protein
MNMFSKKKEEIDEKYLKKGATQIKDGDIDIAVDNQKEIDDKINNSGALRKYTELGKVMFG
MLTDYRKGVYNHVPWFSIAAIAFALLYVLNPLDIVPDFLPGIGYIDDFALLTITIRFIET
DLHKYLDWKLEEE
>IFAGANLK_03312 hypothetical protein
MDRLKPALVRQIFVLMLILFLTVLIFKEIIPYLSGVLGAITLYVLLRNWMKKLLARGWKP
PVAAALLMAGSFVGILVPIILIVIMLTSKISKAVANSERVIRAVKEQLTEAETYVGYSLS
ESIDTSSVTNWMSGNLQSLAGGTFNAFIAIGIMYFMLYYMLVKRDSMKSSLISYIPLGND
NLEIIAKESDQLVKSNALGIPLVAIFQGIIALIGYLIFGVPDPFFWFVITAIGSMIPFIG
TAIGILPVVILLIAQGDNWQAIAMLIYGFVVVGSTDNIIRLYILDRLAAVHPLITLFGVI
VGVQLFGFIGLIFGPLLISLFLLILKIYKKEYGNAHDRL
>IFAGANLK_03313 hypothetical protein
MLILIAYNNVILLSFMKVQPFHLAIPVSDLEKSRKFYKETLGCGEGRSSDHWVDFNFFGH
QLVIHYKPAEETEKAHSNPVDGKDVPVPHFGVVLEWDVFQEFANLLRSKNIEFEIEPYIR
FEGQVGEQATMFFKDPSGNALEFKAFKNKDQLFAK
>IFAGANLK_03314 23S rRNA pseudouridine(2604) synthase
MSEPKLTRINKYLSEIGYCSRRAADKLIDQGRVTINGAVPEMGTKIGHDDVVKVDGKAVS
EAEKKEPNVYIAFNKPVGIVCTTDTRVEKDNIIDYINYPKRIFPIGRLDKPSEGLIFLTN
DGDIVNKILRARNNHEKEYIVSVNKPITSDFIRRMGNGVPILGTTTKKCEVEKLGKNDFR
IILTQGLNRQIRRMCEFLGYEVTALKRIRIMNVSLDVPVGKWRDLTQEELDTINKMVDES
SKTEEASRLKASSLISNAKPRSGKRPRKD
>IFAGANLK_03315 ECF RNA polymerase sigma factor SigW
MKVIQLFKNETQLIKRAAKKDRKAQRELYELHSGKMLSVCRQYIKDIHHAEEVMLNGFLK
VFTHLNDFESKGSFEGWIRKIMVRESISFLRSRKKIVFSDEEITDPGFSAEMDTALNVAH
IQNIIDNLPEGYRMVFVMYAVEGYKHAEIAKMLKITEGTSKSQLSKARKMLQEQLKTQNT
SDYGIK
>IFAGANLK_03316 hypothetical protein
MELNKFEENAREKMGKRQIQPSVQSWEKLEAKLNAEENITSQTPWKYIAAAVAVLLIAGT
FMRNNNFSESPQVVEEPVNEIIEKPEVKQEFTQENNTQIASEESKEGEEVSVEKNGKNEI
AAKAETFVKEEIAKTPISEENKYEEAIALETISLEPPISEEKLIQSKLEEVIAATAKNEE
ISEDEIDGLLAQAASEISRERNNSQFYNSNTEINANALLAEVEDEIYQSFKAKVFEVLKE
GYLKAKTAVANRNY
>IFAGANLK_03317 hypothetical protein
MKTLTFYVTLLVFSFAHQQVAAQEVASAETEISSEEKAREFFEKQKAEIIEKEKTKLKYQ
IERINGELERGELTKEEAEKQKKEYAEKHAKNIENKIAILENEMELRDRNDDTSENYIAI
GGKGKALDININKKNKYDNRTTSDLVVAVGFNNALEEGQSLNDSDFKLGGSRFFELGWAW
KTRVFKETNWLRLRYGVSFQFNGLKPTENRIFVEDGDETYLQEFALDLDKSKFRMDNLVV
PVHFEIGPSTKTETEDRLHFSTYKMLKIGFGGYAGFNIGERQKLKYKEDGDKVKEKLKNN
YNTNDLVYGVSAYLGWGGATLYGKYDLNPIFQDPNKELHNFSLGLRFDVD
>IFAGANLK_03318 DNA primase
MRFRGLNKTDLISKSTIDNVFETARVEEVIGDFVQLKKSGSNFKGLSPFSDERTPSFMVS
PVKQIWKDFSSGKGGNVVAFLMEHEHFTYPEAIKYLAKKYGIEIEETQQSDEQKQQADER
ESMYLVSEFANKHFQKNLHKTDPGKAIGLSYFKERGFTLETIKQFELGYSLDEWDDFTKE
ALAEAYKLEYLEKTGLTIVKGEKQFDRFKGRVMFPIHSMSGRVLGFGGRILSNEKKAAKY
LNSPESDIYHKSKVLYGINFAKQAIAKEDNCFLVEGYTDVIQFHQSGIENVVSSSGTALT
PDQIRLINRLTKNITVLFDGDAAGIRASLRGIDLILEQGMNVRVCTFPAGEDPDSFAKNN
SDEALAEYLQKNAQDFISFKASLLMEEAKKDPVKKAELIRDIVNSISKIPDTIQQEVYLQ
ECSRIMDISENVLFSSLAQLNAKSGRTSPQNQQNKSFNVVKEEPQPKTAKVDEQYELEKK
IISLLLQYGTVEEEFEDLVLKEKEDGELGLEKEIQRTRVFEKIFLDLQEDEIAFTNPKFR
DIYTELMTRLNSEEKFEVKNFINDIDPEQASEITSILMEEEQYKLHEWDRQNIFVKAKTE
TISRHVSETILSLRRFLINQKINELSEKVKTPDEEQNTQHVLEDVKDYLSLKKVLSEKLN
RVM
>IFAGANLK_03319 Transcriptional regulatory protein DegU
MSTVLIADHHPVVHEGIRGILRNNPALEVVGSVHSGMELYGFLSESQPDVLIIEIDLPEI
NGINALRTIKTDYSKVKILVFTGHPEEVYALSAIKAGAAGYISKLAKPDELEKAIYQVAR
GGIYLNKKITEKLNAGMSPGRNLIAKFKKLSTRESEVLNLIASGKRNKDIAEALSINEKT
VSTYKTRLLKKLQVDNIADLITRSRLLQINTT
>IFAGANLK_03320 NH(3)-dependent NAD(+) synthetase
MQTEKVVDHIVNWLKEYATNAGMNGFVLGISGGIDSAVTSALCAKTGLRTLCVEMPIHQH
TDQVTRAQQHIDWLKQHYANVTNLEVDLTPVFDEFKKAAPQVEASDTLDLTLANTRARLR
MSTLYYFAGLHGYLVAGTGNKVEDFGVGFFTKYGDGGVDLSPIADLMKTEVTEIAKFLGI
GSAIVSAAPTDGLFGDSRTDEDQIGASYPELEWAMKEAENGKTADDFDGRKHEVFKIYKS
RHSANLHKMKPIPVCDIPVNLKK
>IFAGANLK_03321 hypothetical protein
MYKKIIFLLCTIVLVSCNEDAKIEKEIAAVPVDFEVIRFDREFAEATPQKLMDLKQEYPF
LFPQQFSDSVWIEKLNDTIQKEINIEVGKEFSSFENQRAQLHSLFQHIKYYFPKFEAPKV
FTVTSEVDYKNKVILQNDYLFISLDTYLGEEHHFYVGIQEFLKKNFRKDQIIPDVANAYA
EKYVERPKSRTFLAHMVYYGKLLYLKDKFIPETPDSEKIGYTEEEFSWAQKNEAQIWRYF
VENELFFDTDTELYSRFLYPAPFSKFYLQLDAESPSRLGQYIGWQIVRSYMDKTDASLEE
MINTDAETIFNKANFKPRK
>IFAGANLK_03322 hypothetical protein
MSEFKKSEINIEVVTDENRVPEGITWSAEDGNVYKEDAKALMLSVWDSKSQETLRIDLWT
KDMPVDEMKKFFHQTLVSMSDTFNRATQDEKMTATMKDFCDYFAEKLEITQK
>IFAGANLK_03323 hypothetical protein
MEKLIFVYNAYSGTRHVVLDALHKLIRPNAYACSICKVTHGVFSENSRWKKYRQASEVEM
EFLHIDKFQKRYASKFGYKYTFPIVLWEDEGEMGIFISTEELERIKNEKDLIKIVEERLL
ID
>IFAGANLK_03324 putative GTP-binding protein EngB
MKIKSAEFVVSNTRVDQCPDSKLPEYAFIGRSNVGKSSLINMLTGRKALAKTSAKPGKTQ
LINHFLINKNWHLVDLPGYGYAKVSKSTKRTFQKFITAYFEKRAQMVCAFVLIDSRHEPQ
PIDMEFMQWLGEHNVPFCIIFTKADKMKPKALERNINFYQEKMLESWEEMPEFFISSATS
KLGQEEILDYIEAINTELNSSSSG
>IFAGANLK_03325 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase
MKNNLRQEGKFTYLEQGEGTPIVILHGLMGGLSNFDGVTEYFPKHGYKVVIPELPLYSMS
LLKTSVQTFAKYLKEFVDYKGYDKVILLGNSLGGHIALLATKLYPEIVQGLVITGSSGLY
ENSMGESYPRRGDYEFIKKKAQDVFYDPKVATKEVVDEVYETVSDRNKLVKTLAIAKSAI
RHNMAKDLPKMKTPTCIIWGKDDNVTPPEVAEDFHRLLPDADLYWVDKCGHAAMMEHPNI
FNELLHDWLKKRNFK
>IFAGANLK_03326 Transcriptional regulator MraZ
MVNLIGTYECKADAKGRLMVPSALKKQLAPMLQDGFVLKRSVFQPCLELYPMQEWNVLMQ
KINGLNRFKKKNNDFIRKFQAGVKMVEVDSNGRLLIPKDLVGFAGINKEIVLSSAVNIIE
IWDKDKYENTIDETSDDFAELAEEVMGNDDLDAIS
>IFAGANLK_03327 Ribosomal RNA small subunit methyltransferase H
MQYHNPVLLKESVDGLNIKEDGVYVDVTFGGGGHSREILSRLGPKGKLFGFDQDKDALQN
TIEDSRFTLIHENFRFLKRFLRFYGIKEVDGILGDFGVSSHQFNEAERGFSTRFDARLDM
RMNQGSKLSAYEVINEYGEEQLKMLFYDYADLKNAPKLASLIVEARKEKPIESSEQLNDL
LKPHLFKGKENKILAQIYQAIRIEVNQEIEALKEFLKQTEELVVKNGRISLISYHSLEDR
LVKRYIRSGLFEGEPEKDFYGNISVPFKKVGGLIVPSAEEIKENNRARSAKLRVAKKL
>IFAGANLK_03328 hypothetical protein
MKKGFYNILRANFLISRDAVNNWRFIVFCTLLAIIMIASSHSAERKVHKIAKLHTEVREL
KSEFVDRRSALMRIKMESTITQKMKDRGILPSENPPYKIKVNIKE
>IFAGANLK_03329 Stage V sporulation protein D
MATSEKGILNRLYVVAACMFIFAVGVGVKLLDIQFVEGDHYRNLAEERTVRSFKIPASRG
NLYDAKGNLLATSVPKYDIRFDAVTVSDKNFQENIVPLSNNLTEMFGKSAAYWSQYIRQA
RANGQRYLPIAKNLGYSEYMKVKSFPMFNLGTYRGGMIVEQRTVREHPLGKMGERTVGYE
RQDENGYFTRVGLEGAFSSYLRGTDGRRLKQKIAKGQWKPISDNNEVEPKDGYDVISTID
VNIQDIAHHALLKQLEYFEADHGTVVVMETKTGEIKAMSNLGRTETGSYFEKRNYAVYES
HEPGSTFKLMAMTAALEDNVIDTSSVIDTENGVVRYYGRPVRDSRHGGYGKISAAKAFEV
SSNTAFTKIITEGYKDNPAKFVDRLYDMGLNSKIGLDIKGEGSPRIPHPNDKNWNGLSLP
WMAFGYGVSITPLQTLNFYNAIANNGEMVKPRFIKEVKEWDKSILKVEREVMNPRICSPE
TAKKLQKMMQQTVERGTAANIYTPNFSMAGKTGTCQVEYWIEPGRYISSFAGYFPAEDPK
YSCIVIIHKPNKSKGYYGNIVAAPVFKQIAQKIYTDTPVMDTLPSLDIQNDKVTDDFEAY
FAKIDNEKIVMPDVTGMPAMDAVSLLENLGLKVIFQGTGKVSGQSISAGQKIKTNQRVNL
NIG
>IFAGANLK_03330 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase
MRVLKDILYKVQIDAVVGNTSVTINKLQFDSRKVELNDAFVAIRGSISDGHKFIEQAINQ
GALAVICEEFPNEIVNGITYIKVGNAQQALAYMAANYYDNPSEKLKLVGVTGTNGKTTIA
TLLYNLFIKAGFKVGLLSTVKVMVAENSYDAVRTTPDSITINRYLKQMNDEGVEFCFMEV
SSHGIDQHRTTALEFAGGIFTNLSHDHLDYHSSFAEYRDVKKRFFDELPASAFALTNTDD
KNGQVMLQNTKAQKYTYALKSYADYKAQILENSFTGLLLKVNDQELWTRLIGSFNAYNVL
AIYATAELLGLENLESLKIISELNSVSGRFQYIISEKEKITAIVDYAHTPDALKNVLETI
NSIRTKNEELITVVGCGGDRDKTKRPKMGHIASALSTKVIFTSDNPRTEDPEKIIEDVEA
GVEPQNYKKIMSVTNRKQAIKTACQIAKENDIILIAGKGHETYQEVNGERKDFDDLKIVT
EFLKHLNK
>IFAGANLK_03331 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MLYYLFQYLDAEYQVPGARLFEYISFRSAMAIILSLAISTIYGKRIINYLQAKQVGESVR
DLGLRGQSEKAGTPTMGGVIIIFATLIPVLLFAKLENIYVILLIVTTLWMGAIGFIDDYI
KTFKKDKEGLQGKFKVLGQVGLGLIVGGTLFFHPGVTVKEETNEPAPEQQELVDSFQKVR
EMGPEIKTTTTTIPFVKNNEFDYSSLISWIDPALKNYAWLIFIPIVIFIVTAVSNGANLT
DGIDGLAAGSSAIIVLTLGIFAWVSGNIIFSDYLNIMYIPDSGEMTIFISAFAGSLVGFL
WYNTYPAQVFMGDTGSLTIGGIIAVLAIATRKELLIPILCGIFLMENLSVVMQVGWFKLT
KRKYGEGRRIFLMSPLHHHYQKKGYHESKIVVRFWIIGIFLAIVTIITLKVR
>IFAGANLK_03332 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MKTEIQNTNNSGKKLVILGGGESGAGTAILGVKEGFDVFVSDKGKIKEKYKSIFEGLKID
WEEETHTEAKILDADVVMKSPGIPDSVAIVKRLLEKGIPVISEIEFAAAFTSAKIIGITG
SNGKTTTTKFVYHILKNAGINVGMAGNVGDSFAKQVAETTPDWFVLELSSFQLDGIKEFR
PDISVLTNITPDHLDRYEHKLENYVFSKFRIAENQTGEDFFIYDLDDELITDWLIKNPVK
AQKLPFSLQQKVENGSFIENENIIVNIKNNQFNMPTTKLGLQGKHNTKNAMAAATVSQLL
RIRKETIRESMESFQGVEHRLEKVLKINNVQYINDSKATNVNATFYALESMESETVWIVG
GVDKGNVYDDLLPLVNEKVKAIICLGVDNQKLMQNFGNCVDTIVETESMKEAVRMAYSLA
ERGDSVLLSPACASFDLFENYEDRGRQFKDAVRDL
>IFAGANLK_03333 putative peptidoglycan glycosyltransferase FtsW
MSNIFSNLKGDKVIWATAALLAIFSFLPVYSSSSNLAYLYGDGSTFQYVVVHFFHLLLGF
CLLFAVHKIPYHYFRGLSILFLPVVIVLLIYTVAQGTMIDGAYASRWIQIPGLGVSFQSS
TLASVVLMIYVARYLSKKTNENLTFKESILPLWLPVGVVLSLILPANFSTTAIVFAMVLV
LMFLGGYPIKYLGIIVAAGLILLTMFILTAKAFPGLLPNRVDTWASRIESFSNDEDTEAD
YQIEKAKIAIATGGVAGTGIGKSVQRNFLPQSSSDFIYAIIVEEMGLIGAFGVMLAYLLL
LFRIVIVATKSNTVFGKLLVMGVGLPIIFQALINMGVAVELFPVTGQTLPLISSGGTSIW
MTCMALGIILSVSAKREEMKEREEAEKELDNENPLDILSEAI
>IFAGANLK_03334 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MMKKDLRVILSGGGTGGHIYPAIAIANEIQARHPEAEILFVGASDRMEMEKVPQAGYKIE
GLWISGIQRKLTFSNLMFPFKLLSSLAKSRRIIRDFKPDVVIGTGGFASGPLLKAANSKG
IPSLIQEQNSFPGITNKLLAKEAGKICAAYEEVKRFFPAEKTIITGNPVRQDLLKIDQNR
EKALAHFGLDKDKKVVLVLGGSLGARRINQLVEANLERFKKENIQLIWQTGKLYYDEYKK
YNSGLVQTHLFLNEMNLAYGAADVIISRAGAGTVSELSIVGKPVFFVPSPNVAEDHQAKN
AMAVVKINAAMMLKENDLEEKFETEFFALMASDEKQKVLGENIKKLALPNATARIVDEVE
KLINN
>IFAGANLK_03335 UDP-N-acetylmuramate--L-alanine ligase
MQDLNHIQNIYFIGIGGIGMSALARYFKFQGKNVAGYDKTSTSLTRTLEAEDIVVVYDEK
INSVPAEFQDKENTLVVYTPAVPEAHEQLAYFRNNEFTLNKRAAVLGLISKGKTTLAVAG
THGKTTTTAILGHLLKETGAKVTGFLGGISEDIQSNLILKGDDVIVVEADEFDRSFLHLS
PNIAAITSMDADHLDIYGKKEELEDTFRQFAKLVPENGTLFIKNGLPIEGKTFGIEDDAD
YSAQNIKIENGTYHFDLKTPNGVIEGFMFNLPGKHNVLNAITALAMAIQFGSPIPKLARA
LYGFKGVKRRFSYKIKSDRLVLIDDYAHHPAEIAAVNQAVREMHPGKKVLAVFQPHLFSR
TRDFADDFAESLALFDELLLLDIYPARELPIEGITSSWILEKVSTNSKKLIQKENIIDEI
KRSNPEVVVLMGAGSIGEEVESIKNALQDEA
>IFAGANLK_03336 hypothetical protein
MKLKLNYIKLPVLLILVGFLFGFAEKRNNSRKVSEVKVQFVTGENLYVTEEAVNKLLIQN
DVAAAGIDKEILDLNRVESLLNNHDMIENAEAYLSLDGKLQTKISQRKPIGRIVGNSSFY
LDRNGHVMPLSSYYAARVPLVLGVDSSNVNTAYPLVDYIQKDEFLTRHITGVKRLPGDKF
ELEMRKLDFKVYFGKAENIALKFNNFKAFYKKALQDEKLETYKKVNLQFGDQVVCTKK
>IFAGANLK_03337 Cell division protein FtsA
MEHNEIAVGLDIGTTKIVAMIGRKNEYGKVEIVGIGKSKSLGVHRGVVNNITQTIQSIQQ
AIQEAEADSGLKISDVVVGIAGQHIRSLQHSDYITRSNPEEVIDADDIHSLCNQVHKLVM
LPGEEIIHVLPQEFKVDGQAEIKEPIGMYGGRLEANFHVVVGQVSSIRNIGRCVKSAGLE
LSAVTLEPLASANAVLSQEEKEAGVALIDIGGGTTDLAIFKDGIIRHTAVIPFGGNVITE
DIKEGCSIIEKQAELLKIKFGSAWPGENKDNEIVSIPGLRGREPKEITLKNLSKIIHARV
VEIIEQVYLEIKNYGHEEQKKKLIAGMVLTGGGAQLKHIKQLAEYITGMDTRIGYPNEHL
AGNNDTETTSPVYATAVGLVMNSLEHGEKKFQEEVVLKSKEERDREEEELKQDFEQNPPE
GDNLKQDPEAPKRPPKKSIFDKWAEKFKDFLDNAE
>IFAGANLK_03338 Cell division protein FtsZ
MSSTEFDNIAFDLPKNQSNVIKVIGVGGGGSNAINHMFQLGIKGVDFVVCNTDAQALDNS
PVPNKIQLGVSLTEGLGAGANPLIGEQAAVESFDEIKQMLDVNTKMVFITAGMGGGTGTG
AAPVIAKQAKDMDILTVGIVTIPFQFEGKMRNEQAQLGVEKLRSHVDSLIVINNNKLREV
YGNLGFKAGFSKADEVLATASRGIAEVITHHYTQNIDLRDAKTVLSNSGTAIMGSAQATG
ATRAQDAISKALDSPLLNDNKITGAQNVLLLIVSGGEEITIDEIGEINDHIQAEAGHSAN
IIMGVGEDEALDDAISVTIIATGFNVEQQNEIVNTETKKIIHTLEDDQKAEQKLDPKKRG
FYPKYNQQIEEPKQEEEPTAQEPDSTIVHTLDDSVEEVDEVGNIQVKEDELYKTPKSARD
MEVSYEEINPDDFIINDTSEEIKSMEVNEPEEVQNDNEEQIMFTFDFPINQEKKEEPKKE
QPKREEPKAQTQQPKPEQKEVRHQLEEDESKNIEVNEPVEIVPVTESSTRGVKRYSLDDY
MEFEQSLDRSKPQPKKKEEPKDETIAFEKKTLKPEPQTPEKKQEENGGEEDPFNNPISEV
LIERAAERRAKMKEFNYKFRSNAAQIDEIEKQPAYKRQGVDLDKNQPGEGKLSRTTLGKD
DNDDLHFRRNNSFLHDNVD
>IFAGANLK_03339 hypothetical protein
MIKVLGIILTVGGAIALVMGILGIFGSIALMLSPWALSIIGFIFFISGISLIKRRKDTED
IEAEKKT
>IFAGANLK_03340 Inorganic pyrophosphatase
MKIFRFTIYLGIFLIFSSCKTPEDLGKLPTKTSNGNYRAVIEIPAGTNKKIEYHKSKKKF
LVDQRDGKDRIINFLPYPGNYGFIPSTFSDPEQGGDGDAVDVLVLGESQKTGSIVEIIPI
AVVKLIDENELDFKIIAIPAELNDQIISIENYKTFSSDYPEVIKILESWFTYYDKSQVLE
IEGWGDETEAISEIEKWIAEP
>IFAGANLK_03341 hypothetical protein
MKKSLLLILGLTLGLTSCQKDEDNPFLITANQVGPVNRDIKINQLDSLFSEDSLVKQKSG
AEEFRATSEIKVFEKGGQPLMILEPLQEFDSTSTIGYIRVLDPRYETKSGLSTASTFKDI
MEDYNISRIENTLNAAVVFLDEINAYITIDKKELPSDLRYDTDSKIRASQIPDEAKIKYF
MIYWD
>IFAGANLK_03342 hypothetical protein
MDKTQEFVDHIRNAYQPKGDYIHLGAAMLNGETFADAAVKIPLKTMNRHGLIAGATGTGK
SKTLQILAENLSQKGVPVLLMDVKGDLSGIAKPSAGEEFLHERHQKIGFPFEASKSPVEF
LTISEQDGVRLRATLSEFGPILLSRILDVTPTQEGILAIIFKYCDDHQLPLLDLKDLKKM
LQYVTNEGRETIENEYGRISSASTGAILRKIVALEQQGAERFFGERSFDVTDLTRKDENG
QGYVNIMRLTDIQDKPKLFSTFILSLLAEIYTTFPEEGDSDKPKLVLFIDEAHLIFKEAS
GPLLDQIESIVKLIRSKGVGLYFVTQNPTDVPSEVLGQLGLKIQHALRAFTAKDRKAIKL
SAENYPISEYYDTKNQLTSLGIGEALVSALDEKGRPSALSATMLRAPRSRMDILTDTELE
ELIFQSKLRPKYNEEIDRESAYELLNKKIEEAEAKEAKEKAEAEASEREKASSKTSRKTT
NKTQGAVIKVLTSATFIRGVMGVLNKLLK
>IFAGANLK_03343 putative murein peptide carboxypeptidase
MQRRKFIQNIGIGSLAFPLTNITEIDKIAPSNNSVIIPQGLEEGDTVGVVSPSSAIFETE
PYLIAKESLEAMGLKVKFGKFVKSSYGHLAGTDEERAEELNNMFRDDSIQAVMALRGGSG
AARILNKLDYEAIKNNPKIFIGYSDITALHLAIFEKTGLVTYHGPLAVSTWNTFSFDHFK
RLLFDNEKITFTNPTDKGDHLAQTKNRIRTIQPGEATGRLIGGNLSVLTGIMGSEYFPTN
WENNILYLEDVGEQIYAVDRMMSQLQLGGVLNKISGFVFGKCTSCNPGGSGYGSLTMEEV
MDHYIKPLHIPAFSGAMIGHIDDNITVPNGLKAKINATKGSIELLENPVK
>IFAGANLK_03344 D-alanyl-D-alanine carboxypeptidase DacB
MKIYPTFNLSVKNTFFLLIIIALSSCSTTRKISKPLDKILNESTVFKQGFAGFMLVDPEK
DKTIYSHNADKYFTPASNTKLFTFYAGLKILGDSIPALKYAIENDTLYFKATGDPTFLNG
NLPSSTVFEFLKNNKNHLAYVAPTYTEKYQGPGWAWDDYNAYYSAERTAFPIYGNMVGFK
FEKNEEFPVVSPPIFKDSLVSSKDSLVSARLRRDIVKNSFLFNNQQKQSDFSQSVPFKYS
SEILLKLLNDTLQKPVSLVQNSEINKKLDKTRYSIPSDSVYKEMLKVSDNFIAEQILIMA
AGKLSDTLKSDIAIDYMKKNHLKDLPDEPMWYDGSGLSRYNLFTPRSIVKLLTKIKAEVP
EKELLDMLPTGGHSGTIKNYYKAEEPYVFAKTGTLKNNHSLSGYLKTKSGKILIFSFMNS
NYIVPTPVLKAEMEKVLLNIRDNY
>IFAGANLK_03345 TonB-dependent receptor SusC
MRNKLTIMALLAFFQISGMLAQQNEVTGTVTVASDGMTLPGVNVMEKGTRNGTVTDMEGN
YSIEVAADAVLVFSSLGFERQEQAVNGRDIIDVIMTEDLEGLDEVVVTALGITRDRKSLG
YATQEVDGENFTLTNEQNVLGSLSGRVAGVQVTGASGSSMGGTQKIKIRGINSLSGGGEP
LLVVDGTPISNANFAGSSGADYGNLGQDINPNDIESVNVLKGPTASALYGIRGQYGVIMI
TTKDGGKGIKDTRVQLSTNVSVEKAGNFMPVQNMYGAGSSQSFSTLPNGDPYVALGVDES
WGPRMDGTPVRHAWSFYTQDPGYGELAPFSPQPDNIKNFYETGHNINNNVSVSGGNENTS
YRLSVNDTRIEGVEPNTYLKRNNIGLNTSLDINDKITVNSNVNYARNDAQRPQQGSEYGT
GYFVQWFQRNVDMNKLENYQYSDGTFQHWNLRSPSSTTGEITNFNPLYWNNPYFEAYENT
NNDRRDRFFGNIGVTYQVLPELEISANVRSDMYTQNIETRRGFGGTGVPGYTVGKYQNTE
MNYELLAQYNKEFGDFSINGTLGGNIFDRRYSYVYQGTQGGLTTPGFYNIDASIDRPTTT
SYLLRKQIRSGFAMASVGYQDTYFVEASIRNDNSSTLPEENNSYWYPSFSGSMVFSEFTD
WKPLTFGKLRASYAQAGSDLAPYQTSNFYTVGTVYNNINTLSVPNSLPNPNILPSFAHSY
EIGVDLRFLNNRLGLDVTYYEQRNKDQIIDLDISGATGYSSRVLNAGEITNNGIELSLTG
TPVKTDNFRWDATLNLNRNRSEVVELHPGIDVYQYGSTTYSSVNSYLNSYEGEPFGSLIG
QAYQRDEATGQILLDANNMPLYTDATHNFGSVLPDLTGGFQNNIQFGNFNLAAMIDFQKG
GQFFSRSKMLAVRTGQDPVTVATNSNGANVRDPLEEGGGVEVSGISADTGEEVTAFVDAR
SYYRNVVGRRIYEEWLYDASYIKLREVRLGYTFGPGVMEKLPFEAVNLAFIARNPAMLWQ
NAPEGIDPSEISTGSQDISWYESGQLISVRSYGLNLNITF
>IFAGANLK_03346 hypothetical protein
MKRIYIILLSSLFIWSCNKFDDEINTNPNRPSEASGTQLIASAQLSLPGLSSSPKGAFMA
QYLAETQYVGQSLYPQESTSFYSWYQSPLINLQTVIDSEELNGNDGPVANQKAVAKILKA
YYFWNITDRWGDVPYFDALQGGDNYTPTYDPQEEIYNDLFSELQEAGDMIVSGSINNDIV
YNGDMAKWEKFANTLRMLMALRLSEVDPDKGSTEFNAAVNDGVFESNSDNLVYRHLADAD
NQSYWFGQVVNQNREWWALTETLVEEMKPVDDPRLAVYGEPARSSGEYVGLEFGKEEVTG
TETEEYSLLGSDIYAQDAPVYLVTYGQVLFAMAEAVERGWITGDAEEYYNMAVEASIEQW
TGNTDEVDEFLNNPEIAFDADNAIESISNQRWVHLYMFGYEAWSEWRRTGYPNDLVEPNG
MAVPTRLSYPDNEAFNNEENYYEAIDRQFGGDDSIYGNVWWDE
>IFAGANLK_03347 hypothetical protein
MGFKNIRFLIFLIGFLTVSVSSAQEKELYKELYSSYENFKENSIEKRRFTQAEIQPLIEK
FQEKINFEVVQVGESIEGRPLQLISIGEGDIDVFLWSQMHGDESTATMAIFDILNFLDSE
EFSEKKERMLKKVRLHFLPMLNPDGAQRFQRRNLLGVDINRDAVRLQSPESKTLKRVRDS
LDADFGFNLHDQSTYYNAERTPKPATISYLAPAYNYEKSINDVRGAAMQVIVQMNNILQE
YAPGQVGRYNDDFEPRAFGDNIQKWGTSTILIESGGYPNDPEKQEIRKLNFVSILAAVFS
IAEEDYKNADISKYEEIPNNDRKLFDLKLTGLTYELLGEDYILDFGINRREVQDENLEYY
YDAYIADRGDLSTFYGYEEFDASGYELVQGKIYPETFEDLAEFQRQNISQILREGYAYVV
LKELPEENFTELPVNIVSKDFKISENLQPHFFLQKDENLEYAVINGFLIDLSKENFGLEN
ALILE
>IFAGANLK_03348 7-carboxy-7-deazaguanine synthase
MITEETKALVDDGIMLPLMEEFYTIQGEGFHKGTAAYFIRIGGCDVGCHWCDVKESWDPS
IHPPTHIGEIVEKAVASSKTIVITGGEPLTWDMTRLTGALKAKGCDIHIETSGAYKLTGQ
WDWICLSPKKIKLPTEEIYPLAHELKVIIFNKHDFKFAEEQAEKVSENCILYLQPEWSNR
EKMMPLIVDYVMKNPKWKVSLQTHKYLNIP
>IFAGANLK_03349 hypothetical protein
MKKILLTTLCLIGFLGFQNVNAQETESTNGPNFPKLDTSPMDMIVHRDQNDEVVMRIIYS
RPQTRDREIFGKLVPYGEVWRTGANEATEVTFYKDMEIGNEVVKAGTYSIYTIPEEKEWT
IILNKSTHTWGAYEYTDKQDYVRIKVPVRNSSQKIENFSMAIEQKEDEAGANLLMGWADK
YIKVPFSPAG
>IFAGANLK_03350 Asparagine synthetase B [glutamine-hydrolyzing]
MCLYNVISDAYLYGIIKANVMCGILAVIGKRLSEEKIGGLSKRMSHRGPDESDVHVTEEG
YVLSHERLSIVDLETGKQPIQGTSTAWMIHNGEIYNHQDLRNNELKDHTFRTTGDSEVIV
HLYEEYGVDFLDKLDGVFSFVVVDGKDFIAARDPIGVKPLYYGTDDEGSIWFSSEMKTLV
DQCSSFAAFPPGHYYTPETGFVEYYTPDWFDYKKATKELDLSKIRESLIEATRKRLMADV
PLGVLLSGGLDSSLTSSIAARLMKDSGQKLHSFSIGLDETAPDLVAARKVAEFLGTEHSE
FHFTVEEGIDILKKLVWHLETYDVTSIRASTPMYFLSKGIKEKGVKVVLSGEGADEIFGG
YLYFKNAPTADDFQKETIRRVQRLATADCLRADKSTMAHGLEARVPFLDKAFLKTAMETE
AVHKLPKTYDGVEKYILRKAFDTPEQPFLPDEVLWRQKEQFSDGVGYSWIDELIAFASAR
VTDEQMATAAEKYPYNTPATKEAYFYREIFHSHFPQENAAKTVKRWIPKWQEDLDPSGRA
NTSHVATNAKKQLEELAQL
>IFAGANLK_03351 DNA gyrase subunit B
MSEEPKKHSYSADSIQALEGMEHVRLRPSMYIGDTGVRGLHHLVYEVVDNSIDEAMAGHC
DTIRVTINEDGSVTTEDNGRGIPIDLHKKEGVSALQVVMTKIGAGGKFDKDSYKVSGGLH
GVGVSCVNALSSSLKATVYRDGQIWEQEYEIGKPLYPVRQAGETDLNGTVITFKPDTSIF
QQTVDYSYETLSSRMRELAFLNKGIQITLTDKREVNEKGEFLSERFYSDEGLKEFIKFLD
GNREPIIADVIAMEGEKNDIPVEVAMVYNTSFSENLHSYVNNINTHEGGTHLSGFRRGLT
TTLKKYADASGLLDKLKFEIVGDDFREGLTAIISVKVAEPQFEGQTKTKLGNREVTSAVS
QAVSEMLENYLEENPNDAKTIIQKVILAAQARNAAKKARDMVQRKTAMSIGGLPGKLSDC
SEQDPTQSEVFLVEGDSAGGTAKQGRDRRFQAILPLRGKILNVEKAMTHRVFDNEEIKNI
YTALGVTIGTEEDSKALNTDKLRYHKVVIMCDADVDGSHIETLILTFFYRYMKELIEGGH
IYIATPPLYLVKKGSRKRYAWSEEERDEIAESYSGGVQIQRYKGLGEMNAEQLWDTTMDP
ERRKLRQVNIDNSGEADRIFSMLMGDEVPPRREFIEKNAKYANIDA
>IFAGANLK_03352 Menaquinone reductase
MGGGLAGLTAAIHLSREGKRVLLIEKKAYPRHKVCGEYLSNEVLPYLNSLDIDIQKDLKP
VKIHELLYSTQKAKSIETSLSLGGMGLSRYALDDFLFKKAEEYGAETLINSVENINFEKD
KFNLKLSSGKELSAPIVLGAFGKRSNIDKSLEREFIQEKSSWLAIKSHYEDVEFPENLVA
LHNFEGGYCGLSKTETGVVNACYMVSYKSFKKYRNTEEFKEKVLFQNAYLKGFFKRAKPL
FEKDLSIAQISFQEKSLINNHILMLGDAAGLIHPLCGNGMAMAIHSGKIASEAVLNNFQG
NNLDRKNLENQYRQNWSTYFENRLKTGRILQRILINPILASTSQQLVKKFPYLLEKIISK
THGQPIV
>IFAGANLK_03353 Ubiquinone biosynthesis O-methyltransferase
MSIDTSKRTNAVEIMDDFDLQGKELDKTLRDLDNINKWLGGNKITLEGVKNIVRNYPKTK
EFHIADVGCGNGAVLREMARWGRSSGYKFRFTGIDANTHAIKIAEEMSIGYPEINFESTD
IFSPEFKNFHCDIILCTLTLHHFKDGEISALLNLFNQQSRLGVVINDLHRSKLAYRLFQA
FCAVFINNEIARKDGLISILRGFKKEELKDFAGKIPQTNHQISWKWAFRYQWIIQKVKI
>IFAGANLK_03354 Alpha-pyrone synthesis polyketide synthase-like Pks11
MSVKIIGVEKELPQYARETKDILPLVETWLQEQDDRYRRKVLKIFEGAGVDKRYSIMDPE
EVFTATSFEDKNNIYTREVKKLGKNVLQKALQSNNWEANSVDFIITVSCTGIMIPSLDAY
LINELELRKDITRLPVTEMGCAAGISGIIYAANFLKANPGKRAAVIAVESPTATFQLNDF
SMANMVSAAIFGDGAACVLLSSEESASGPKILGEEMHHFYEATHLMGFDLTNHGLKMILD
ESVPQTIASHFPEIVHPFLQKFNSNIEKVDYLIFHPGGKKIVQTVEDLFGNLGKNIDTTR
EVLRQYGNMSSATVLYVLEEFMKKQPKPGEQGLMLSFGPGFSAQRILLEW
>IFAGANLK_03355 Enoyl-[acyl-carrier-protein] reductase [NADPH] FabL
MVTEFKDHNYWAIILGGSTGLGFATARKLAHHGMNIIIVHRDRRTDIAEIEEAFEDIREH
DVQFESFNVDATNAEKRQNLIEEISKILGKDGKIRTLVHSIAKGNLKPMSGEEPTLDNVD
FQITIDAMAISLYDWTKAIFKAKLFAKDARIISFTSEGNKKAWANYAAVSAAKVALESIT
RNIALEFAPYGIRANCIQAGVTVTRSFQMIPGNETLRNHALKHNPFKRLTVPNDVANVVY
LLSKDEAGWITGTIIPVNGGEHLK
>IFAGANLK_03356 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
MDYKNILEKLPYSTPFLFVDELLKVNEISAEGIYTFPEDSFFYIGHFKNNPVTPGVILTE
CMAQIGVVCLGIFLLENENSDSKNIKLALSSSEVDFYLPVFPGETVKVVSEKLFYRFNKL
KCEVRMYSKEDKLICRGKIAGMIKNELA
>IFAGANLK_03357 3-oxoacyl-[acyl-carrier-protein] synthase 1
MKKRVVITGMGVVAPNGVDLVNFEDAIQKGKSGIRFEEELDRLKFSCQIAGKPQLSEEKI
AEYFTPLQLRGLNSSGIVYGVIAGTDAWKDAGLEIQENEAPDWDSGIIFGTGILGVDKFR
EAIHLIDAGKTRRLGSTSVMQTMASGISAYLGGILGCGNQVTTNSSACTTGTEALLMGFE
RITAGKAKRILVGSCSDHGPYVWGGFDAMRILPSKYNANPTEASRPMSASAAGFVPGSGA
GALVLEDYESAMERGAKIYAEVLGGAVNSGGQRGGGSMTAANSEAVIRCIEEALRFSEIS
AEEIDVINGHLTATTKDALEVESWKKALNSKDFPYINSLKGMTGHCLAASGSIECVASVL
QMDKNFIFGNVNCEDLNSEISDLISEEKIPRKTLEKPINILAKSSFGFGDVNSVVIFRKI
>IFAGANLK_03358 Acyl carrier protein
MKEKEILNAIKKIVTPYTQRQEGLEDFSEETDFIKDLEVNSANLVDVILDVEDEFNIEID
NESMEGMLTVGDAKNIIEQKLASA
>IFAGANLK_03359 hypothetical protein
MIGNDIIDLNLIRAQSNWQRKGFLQKLFSEEEQTFIQNSEDPELNVWLLWSMKEAVYKAV
QRKYTLKRFYNPKQFISEQIKINPGKARGVVCYKEDVFVINSILFPNMIHTSTGNTEFSL
ISENKNSRFRLLQKIAEHKDIRLEYLNISKDREGIPFVSYRGDNLQIPFSLSHHGNFSAY
AVSLNMS
>IFAGANLK_03360 hypothetical protein
MKTVDKMEVLHSQSAEFVEKGETGKFLKLIPDTFIIKGEEKDGVFNQGYAIRHINRQDIL
LIDVVEKSTKDAVKKLITDGYKIKGILITCDAILKDAYADLKTISEDADGAPIFAHPRNN
FKDSFKTKDITERKGVLKDFGLKVFDLPGNGGASVIIHSEVNDGMLFPGEDAEGSPYDSD
LNTFKRPKMDKSNDDFGLAGSWSAFDQEFSYLFPRKGKPGFNIEEGQQTDILNALSRS
>IFAGANLK_03361 2,3-dimethylmalate dehydratase large subunit
MSKLNVTQKLIKEHLLKGEMTPGKEIGIKIDQALLQDATGTLVQLELEAMGLEKAQTEVA
VQYVDHNLLQTDFKNADDHLFLLSAAQKFGLWYSRPGNGVSHPVHMERFGKPGKTMVGSD
SHTPAAGSLGMLAIGTGGLDVAAAIAGQPYFVKMPQVWGVKLTGNLPDWVSAKDVILEML
RRHDVKGGVGKVIEYYGDGLKNLSAMDRHVIANMGAELGATTTVFPSDNETRRFLKSQER
EDDWIELIADEGCEYDLHEEIILDELVPLIALPTSPGNVVPVSEVAGKPISQVVIGSSAN
PGLRDFWVAGAIVEDKSVSSDVSFDINPTSRQIIQNMIENRAFANLIKAGARFHQSGCMG
CIGMGQAPASNTISLRTMPRNFPDRSGTKDDQVHLCSPETAAASALTGKITDPRDMEKLY
NMKYPKFEYPEFQIIKEDMLVAPPEDGSKVELQKGPNIKSLPYIEPMQNKYSVPVMLKMG
DNVSTDEILKAGAEVLPFRSNLPEISKYSYTVIDETFYDRAMKAKGEHGGHIVVAKDNYA
QGSSREHAAIAPKYLGQVAVIANSYARIAWQNLVNFGILPLEFLDIADYEKIDQDDQVIF
RNLREDIKNRNNIKVIVRKANGNKLEFETKHSMSDRQINILLKGGIINEFKERIEANELG
EDQAKDAEEADVK
>IFAGANLK_03362 hypothetical protein
MEAIYQFVKLDKSEKLQDFAQKKLDKLETKYDWIVKAQVYFKKEEAQDPKGYICNIKLSA
PGPQIFAESNENSFEAATSETIRDLERQLSKRKGQMKTHSN
>IFAGANLK_03363 hypothetical protein
MRVPMKLHIKYLSIIFALILLQACGSSADTTKIAETKALIESREFEIEHDWLSPMAGGRV
NLIGNPNFIRFKKDSVNLFLPFFGERFSGGGYNSEGGIIYNGPLQDFEISSGRNNSQIIK
FTTDQNSENLDFSINIFPEGDVNTRVNSSQRSFISYQGKIGELEEDE
>IFAGANLK_03364 hypothetical protein
MRNFVMILALVAIGFTSCNDNAGKDLEKQQQELTKANDSIVSTHEELTQKHQELMNNHNQ
VSQELRGLEELEDSTQLEKLAELEGQIRDHQATLASHEEMIRSHNELNQEYGSLSADEKK
AQLDEMQKTHDRIMGEQDEMKSEHDEIEKGHQSIKDVISQSTVEDSESGM
>IFAGANLK_03365 Co-chaperone protein HscB
MKRVNQYKKLFNVEKEIDLKELKTSYRNLVKEWHPDKFRETDEKHAEAEIKSKEIIDGYH
FLVSIAPHTRDANLEEYNRTINEAGIADYQHKGNLLEISFTNGTTYEYFGVNKKLFIKFI
SSDKQVRFAKRNIYNSFLYRKSKKDLELETA
>IFAGANLK_03366 DNA-binding protein
METKQPNNPLHGVKLAEILDFLVTRYGWEEMGNRINIKCFTQDPSIKSSLKFLRKTPWAR
TKVERLYLDSL
>IFAGANLK_03367 ATP-dependent RNA helicase DbpA
MQTKNLQEILDKLEISQLNAMQQEAYKTINDNPNTVLLSPTGSGKTLAFLLPLLDILDPD
LAEVQALILVPSRELAIQIEQVTREMGAGFKANAVYGGRAFSKDKIELQHAPAILIGTPG
RIADHFRRETFSTKNIKALVLDEFDKSLEVGFENEMKEIIGELSGLDTRILTSATQNINI
PGFVGLKNPKRIDYLKGEQPSLEIKTIQVNPKTKLQSLVNLLSENAKGSGIIFCNLKDSI
AEVSDFLDRKNIEHGIFSGGMEQKDRERSLIKFRNGTHRILIATDLAARGIDVPEIDFII
HYQLPFKASEFTHRNGRTARMHQEGTAYVLSDRRTLPDFIKANDYKIQNEKTNTDVVEKT
TLFISGGRKDKISKGDIAGLFLKQGNLKKEELGLIELKQDCAFVAVPEEKAEALIETLNN
SRLKKKKVRVRYI
>IFAGANLK_03368 Cold shock protein CspC
MGKSQQTFSKTEKEKKKIKKRKEKEAKKQERKENSNKGGNFEDMIAYVDADGNLTDTPPD
PSQKVEVEADSIEIGVPKKEDMPEEDPQRKGKVSFFDHSKGFGFIIDSENNEKYFVHVTG
LIDEIDENDKVTFELERGMKGMNAVRVKQQ
>IFAGANLK_03369 TVP38/TMEM64 family inner membrane protein YdjZ
MPDSVETTSVKKSKAPLIVSGIIIAALIAAYFFIPGVQEFFTNAWEVLTSNDEERITEWV
SEFGWMGPTMLILAMVAQMFLIVIPSVALMVVSILAYGPFFGSLIIFAAIFSASSVGYFI
GRYFGPVIVQKLIGPKNENKIEDFIDDYGFWAVIVTRINPFLSNDAISFVGGILKMGYWR
FIGATLVGIAPLTIFIAIIGKSTDGLKTGLLWGSIVSLFIFILYVWWDKKKRKK
>IFAGANLK_03370 hypothetical protein
MKMNKIVIGIVAGVFILAGLIFWAFKNNSYLSFDDDNKTYVIEEKWNLPPILQEVSGISY
LGNNEVACIQDEDGIIFIYNLETSEITSRIPFGEGGDYEDISVIEDTAYVARSDGKLYKV
VNFREENPKIDTYHVSGLDINEMESLEFDATNNRLLFAVKEYNNRKATKGIYTFDLLTKK
VNKERHFTLDGSNEIYVKLRGGRSSEIIRPSSIRFHPTNGELYVLEGNQPKLIILDRKGN
EVKIHLLDPEFFPQPEGLTFDEENRLYISNESRRQPANILRVKLND
>IFAGANLK_03371 Penicillin-binding protein 1A
MLKKIKKSPKIKWAIIILLSLLAIFLLFFASIYFGAWGKLPSSTELKELKQNRATEVLAK
NGELIGKFYVFDRQPITYKELPPHLINALVATEDARFFEHDGIDNRSLLRVVFKSILLQD
DSAGGGSTISLQLAKNIYGRKDYGALGIVVNKFQEAIIAKRLEDIYSKEEIIRLYFNTVP
FSDNTFGIESAAMKFFGKHTSEINLEEAAVLVGTLKASHSYNPRIFPERSRLRRDVVLEQ
MGKYGYLTEEEVQEAKQRELVLNYKSYSHDKGLAPYFREQVRKDVSKILDTLKNKDGKKF
NIYRDGLSVHTTLDVKMQTLAEEALKEHLQNLQKQHEDAWGSAAPWLTNREIVNDALKKT
SAWKNLEKEGNSEAEIMEVLNKEHPTEIFSYDGTETKNISTRDSVAHYLKFLNAGMLAVT
PETGSVQAWVGGVNFEHFQYDHVSQSKRQVGSTFKPFVYAAALENGIEPCEYFSAREVTY
AKGWTPSNSGSEEEDPHMNYNLKEALSNSMNTIAVKVLMETGIENVVNQAKAMGIKSDLP
QVPSIALGTASLNLTELTEAYTPFLNNGKTSKAFYITKIEDGEGNILAEFKPEISDSRSI
SKTNRKIMIEMMKATVNEGTATRLRTTYGLRNDIAGKTGTTQNNKDGWFVGITPNLLAVT
WVGADDHRIGFRNTYIGQGANSALPVFAKLMQKMNSDPAFNDITQAKFAPLPAEIKEMMD
CDPEKRDGFFKRLFGGGDKDETKQPEKKEKKEKKGFFKRLFGGKDKD
>IFAGANLK_03372 Catalase HPII
MKDDGKKKASKNKKHEDLEKNREDGQEQFLTTNQGVRINDNQNSLKAGDRGASLLEDFIL
REKITHFDHERIPERIVHARGSGAHGYFQVYESMEKYTKAGFLQDPSKKTPVFTRFSTVA
GFKGSTDLARDVRGFSVKFYTEEGNYDLVGNNIPVFFIQDAIKFPDLIHAVKPEPHNEIP
QAASAHDTFWDFISLMPESTHMIMWAMSDRAIPRSLRMMEGFGVHTFRFVNKEGKGTFVK
FHWKPLLGTHGVAWDEAQKISGNDPDFHRRDLWEAIENGQFPEWELGVQLIPEEDEHKFD
FDLLDATKLVPEEMVPVKKIGKMVLDRNPDNFFAETEQVAFHPGHIVPGIDFTNDPLLQG
RLFSYTDTQLKRLGGPNFHEIPINRPIAPLHNNQRDGHMRQQINKGQTSYQPNSLGNGCP
FQAKIAEGGFDSYPEKVDAKKVRERSESFKDHFSQASLFYNSQTAVEQQHIINALSFELG
KVDAVEVRERMLGLLNEVNKDLAKEVASNLGMPVPKKKTQLNHGVPADFDPERYEPTKSN
PSLDKDPALSMMHNGFGNIATRKVAFLCADGVDDNSVNEMKKALDKEGAMVKILGPNSTE
VKTADGKSIKVDEAFRTSASVVFDAFYVPAGDKANMALKKIPKAIHFLNEGYKHCKPIAT
AQENGLIEETYFWNKLDKKNLAEDGVIVGKDKSSEFIKAIGQHRFWKREEKDSIPA
>IFAGANLK_03373 hypothetical protein
MKENTAKFNKLDYQIGQWMYKYGKPILRFSLAINFIWFGALKVVWDSPAQELIAATVYWF
DPDFFIPFLGIWEVLIGLFLLSKRTLRLAIALLVLQMPGTFLPFIILPEVCFENFPFVLT
TEGQYIIKNLVLISAAIVVGGSVREREFIERDIKSADTD
>IFAGANLK_03374 Putative DNA repair helicase RadD
MAVETFGIEDKKVDKELYDYQQKDIDKIFNVIDKHPEHYNLLYQLPTGGGKTVIFSQMVR
EYIQRTQKKVLILTHRIELCKQTSNMLDGFGVRNKIINSKVKELPDQEDYMCFVAMVETL
NNRLHDEKLEIKDIGLVIIDEAHYNSFRKLFKFFEKCFILGVTATPLSSNIKLPMKDNYR
ELIVGDSIGSLIEKGFLARANTFSYNVGLTSLKVGMNGDYTVKSSEELYSNISMQEKLLT
AYYERSKGKKTLIFNNGINTSIEVYETFRNAGLPIRHLDNTTSKQDRKDILKWFKHTPDA
IVTSVSILTTGFDEPTVETIVLNRATKSLTLYFQMIGRGSRVLPGKSEFNVIDLGNNLAR
FGEWSSPVDWKQIFRAPDFYFENLLSDEEIEREFKYVMPPEIREQFSNTEDVDFDVEEAY
DIVIKKGLKSKAVLEWSMEQHVKMCVENSEDVFDARILAKELKDDISSRIKQYSYCISKS
TKNYRDWLEEDYSRKLRMSINKEF
>IFAGANLK_03375 Cysteine synthase B
MNDSILDLIGNTPLVKAQTLVKNPKVMLYFKLEGQNPGGSVKDRAAYNMIKSALDRGDIT
KETKLIEATSGNTGIALAMIAGIFKLDIELVMPENSTIERVQTMRAYGAKVTLTDADVGI
EGARDHAEEKMAGGDYFMINQFSNNDNWQAHYNTTGPEIWNDTKHKITHFVSSMGTTGTI
MGTSAYLKEKNKDIQIVGVQPTDDSRIPGIRKWPEAYLPKIFKPERVDRILEVSEDEAVA
MTKKLAVEEGVFGGMSSGGAAAAAVRLCNELEEGIVVSIVCDRGDRYLSSNIFD
>IFAGANLK_03376 Serine acetyltransferase
MSQNEVIKQIKAQKKLPNLKFSIKEKTEAFTNNLFYTLFDEETPVEENIIKLGKDFEELA
DLVCWEPKTPCRDIWQEYLDRLPGILEKLNKDARAISENDPAANSLEEVILSYPGFFAIA
IYRFSHEFYKFGLPLVPRLMTECAHGLTGTDINPGAQIGTPFFIDHATGVVIGETAVIED
NVKIYQGVTLGALFVDRNLKDVKRHPTIEKNVTIYANATILGGETVIGANSIIGGNVWLT
ASVPKDSMVSHTPQINIKKTSK
>IFAGANLK_03377 hypothetical protein
MAQQGNHKKDDAKKEPKKPQASKKQPAREEKPKK
>IFAGANLK_03378 hypothetical protein
MKDYFYFLRENYRKVSFGWLLTFLSSFGQTFLISLYVPEIVKAFSITEGTFGAIYAGCTV
AASVIMLSVGHTVDHKPVKKVTAFTVLSLGLSSILLGLSYHIAILFLALIGLRLCGQGLM
SHISMTIISKYFDKNRGKALSISSLGYSMGEAVFPIIITSIIAFFDWRMAAIISGIALLL
YLIRLKFTNLIAFDQQLSTEGKPSTWSLLKDYKSVVADKRFGIMMPASFILSFTNTAIFF
YQYVFVENKGWSPQLYATFFTVYAVSRFIFSLVGGTWVDKFTAKKLFRIYLVPMTLGLIP
FALMDSIIGALLFLITAGITGGMAGTVKTSLIAEIYGTEKMGAIRSVFTMFMVISTALGP
LLVGFMIDGGFDFSTIILVLFAAMLLISINSQRIKNISKTASPL
>IFAGANLK_03379 hypothetical protein
MGFTLYLMKVFFLFCFLIICTSGFAQLGFCEGSKGDPIFYEDFETVSQLPTGTTNYTYVD
QDPHDGEYTLSSQIGGVITSWHSSLPNGTVSNRDALIVNASFSSGRFYRTEISGLCENTT
YEFSAYLINIYNRSSTVCPDGGIPINVRFEIWDENDENLLKEGNTGNIPSKSSPEWEQYA
LTFQTEVGQDAVILKMFNNGDGGCGNDLAIDDIIFRSCGDLTTVTAENDEKKIDVCAEET
PVNLRLEATPDNTVYNTHAYQWQESNNNQTWTNIPGENNEIYNTPPLNNSRYYRVKVAED
PVNLNANLCSSVSEIFTVNILQTPSPPHSAGNISICSHEEIPTLNVEVEENEVANWYDEN
SNLLAQNTSSYLPESPGTYYVEAINEGLECTPSAKTAIEFTINETPQVEDEVLQICAGAS
LILEAGLSALSYEWSTGENSYQIEITSEGNYSVVLTTAEGCSATKNFEINRVDIAEIETV
TSDEENIVITSANEGDFEYSIDGTNFQSSNIFTMVPGGIYTIYMRDLSSCNTVVQKFPHI
VIPKFITPNGDGYNDNFSIDGLEYFPSSEIRIFDRYGKLLKAEDGKTFNWNGTLDGRSLP
SDDYWYHIKIEGFKTLKGSFSLKR
>IFAGANLK_03380 hypothetical protein
MSKRQLKKYLQELDKEQLEEQIVDLYERFKPVKIFYDFVFNPREEELIRKAKLKISKEYF
PETRRKPKARRSIAQKEIKHFQQLGVEPHLTADLMLFNIEIAQTFAEEKSNLKEAFCKSI
FKSYEEVVKFILKEGVLPDFKNRILKIAAEAENQSWPNAYRFEKIEMQFQEAP
>IFAGANLK_03381 Inner membrane protein YccS
MPNIILTYWQEFLKYIRSTDFSKAMVLTFAIGSPVGVFIWLGNFEIGVALAMGALLSSPS
DIPGSFRHRNIGVILAALLAGIVSIIMGYASAYLWLVLPLLGILMFGIAYLAVYGFRASL
VAFAGLFAIVLSFANISTEILPWERGLLIVGGGLWYLLLSNIWNFLNPKHHTEQLLAECL
ELTAKYLKTRAHLLTETAEREKLQKELFILQTDLNEKHESLRNILINSRRASGNSNYARK
RLLIFIELVDILELAMANPVDYNKMDEVLQEDRELLERFKKLIKKIASQLDEISVVIEKK
KKSTTKEIRQYLKAVEENFKEVRVLISLENNEKTFLLQNLFDYLEKQGQKINTIVRVLHN
LDTREPVLLKNKEVSQFITPQDYDPKMLIENFNFGSPIFKHSLRLAIVILVGFSIGLYFS
FENAYWIILTIVVIMRPNYGLTKDRSKQRIVGTLIGAVIALGIVFITKNQVVYGILGLFS
LTLAFSLIQRNYRTAAVFITLSIVFIYSLLKPDVFNVIQFRVIDTVLGAGLAALGNFVLW
PAWESQHIKNVIKESIGANKKYLEEIDRFYHKKGTLPTSYKLSRKKAFLEMGNLSASFQR
MTQEPKYKQKELAQLYKIVGLNQTFLSALASLGTFIQNHKTTAASKNFDVFVSHICTNLE
NAIKGLAEEETLKDFDAARTEKAASALLKTYKELLAERENQLKEDPDKDQKDVQLRLQEA
QLVSSQVQWLLEISENLQKTIAKTKFS
>IFAGANLK_03382 Putative NADP-dependent oxidoreductase YfmJ
MNKSILLKNRPKGKPSLSDFEINEIEKPSPKDGEILLETKYISVDPYLRGRMRDEESYIP
PFELNEPIESMLVTEVIESNNKNFKKGDFVSGMLKWELFQTHSGENLNKIDTNLAKPSAY
LGILGLTGLTAHLALKHIGKPEKGETLVVSGAAGAVGSVAGQIGKIKGCKVIGIAGTDDK
IDHIKEKFGYDAGINYKTTENMKKAIAENCPDGVDVYFDNVGGEILDAVMMNINQFARII
NCGAISIYNEKEMPTGPRLEGILIKKSALMQGFLVRNHFDEFESSIKELAGWLNEGKLKY
DETIVKGFDETPQAFLDLFEGKNTGKMVVKV
>IFAGANLK_03383 putative oxidoreductase
MSIKGKTIIITGASSGIGEATAKKLSQEGANVVLSARREDRLKSLKDEIEKNGGRTLVIP
GDVTKKEDFKKIVSSTLEEFGSIDGIINNAGLMPLSYVKNLHVEEWDKMIDVNIKGVTNG
VSAVLPTMMEQKSGHIINISSSAAHKYYPGGAVYCATKAAVKMFTEGLRAELAPNYGINV
TSIDPGFVSTELTDTITDDEIKKDMEPMFKELTPLQAEDIADAIFYSLSQPKRANINDVY
IMPTDQEQ
>IFAGANLK_03384 putative oxidoreductase CzcO
MAEVYDVIIIGGGQSGLACAYYLRRTGLNYLVLDEQETCGGAWLQTWDSLRLFSPADHSS
LPGWLMPKNENGFPPKDHVINYLCKYEERYEIPVKRPVKVENVEKESGVFKIKTSAGEFS
AKAVISATGTWKAPFTPKIQGIDIFRGKQIHSAHYKNANNVEGKNVLIIGEGNSGAQILA
EVSKVAKTSWATLNAPEYLPDNVDGRVLFNVATAKYKAEKEGKKFNPAQYSLGNIVMVPT
VKDARERGVLQSNGSFIEFTETGVIWENGTKEDFDAVIWCTGFHYATSHLNKIVEPDSKG
KIKTAGTKADNIDGLWLVGYGGWTGYASATLIGVGRSARETVKEITEFLKE
>IFAGANLK_03385 Arsenical-resistance protein Acr3
MARKKMNFLDKYLTLWIFLAMFIGVAIGYYAPESAGIIDSYSVGTTNIPIAVGLILMMYP
PLAKVNYKYLPKIFKNVKILSVSLLLNWIIGPILMFFLAIIFLQDHPEYMVGLILIGLAR
CIAMVLVWNDLAEGSSEYGAGLVALNSIFQVFFYSFYAWIFISVLPPYFGFEGAIVDISI
GTIAESVAIYLGIPFLAGYLSRFFLVRAKGETWYRENFLPAISPLTLIALLFTILVMFSL
KGETIVEIPIDVVLIAIPLVVYFILMFFISFFVSKFFGAGYRQNASISFTATGNNFELAI
AVAIAVFGIDSGQAFAGVIGPLVEVPVLIGLVSVAFWLKHKYYPKEKLV
>IFAGANLK_03386 Biofilm growth-associated repressor
MGVTKSEIFSPLQNELAGIAKVLGHPARIAILQEIIKSKSCICGDLVQEVGLAQPTISQH
LKELKNIGLIKGDIEGTRVCYCINPEKWNQIKELFTTFLNSNISPGDECC
>IFAGANLK_03387 Putative ketoacyl reductase
MSSLKGKVAFITGGSKGIGYGVAKSLLDLGMNVAITSRSKDAAEKAAKELSATDAIGLEA
DVRNYESQEKAVKAAIDKFGQLDVMVANAGIGHFGSIDELSPEKWQETIDTNLTGVFYSV
KASLDALEKSKGYLITISSLAGTNFFAGGAAYNASKFGLTGFTQAVMLDLRQKGINVSTI
MPGSVATHFNDHTPNEEDAWKIQPEDIGELVVDLLKMNKRTLPSKIEVRPSQPPKK
>IFAGANLK_03388 hypothetical protein
MNNIKAQKLLNKIQRDLMRNGIITNTLVNDLKELRTLVVEEGQPLLAKTIRLTYEHVDAY
DSFNIAIPEDDPVEEGEEAPVQEEATGQESLDYLLSLMADPSNRVNELELREYVKAFNEY
ADEN
>IFAGANLK_03389 hypothetical protein
MKKDAKSKKKSRIRLLHQYYSYTGFYSFVWKSVKKAILPIVLFVAALWAIDRWVLDIEQM
LVTVTETYSPLGIISVFFASESLLGLIPPELFIAWSGKSSSPILYLSLLALASYLGGVIS
YFIGRWMTKIPAIHEAIEVKMAQHIKNTRKWGGFLIIVGALLPIPFAMTSIAAGIIKFPF
PSYLMFGLLRFVRFYLYALVIFEMV
>IFAGANLK_03390 hypothetical protein
MDSKLKKIARVGYVAKATVYGIMGILTFLAAFNMGGQKSSNLQVIEFLQKQAFGNALLVL
IGLGLLCYSAWRFIQSIQDPENIGDDKKGKGKRVAYFISAVLYLGLAVYAFMKLINAGSS
SGGGSGGGLTGTLGVVVFSIIGVGLVVASIAQFNKAKTKKFLDDFGYNSITDEKKRKTVK
NTGYLGLIARGIIFGVLAYIFIRAAVESNTSDMKGTADAFSFLQDSPYGSWLMGLVAAGL
VCYSIYVFMLAKYRKFKA
>IFAGANLK_03391 hypothetical protein
MLTIILNILLPPLAVFMKHGLGVTFLISLLLTALGWIPGVIHAFIVNGSR
>IFAGANLK_03392 UDP-glucose 4-epimerase
MSSKILVTGGLGFIGSHTVVALQEQGYEVVIIDNLSNSSIDVLGGITKITQKTPIFENID
LRNKNQVKEFFEKYPDIEGVIHFAASKAVGESVENPLLYYENNLASLIYLLQELQLKENA
YFIFSSSCTVYGQADSLPITENAPVKKAESPYGNTKQIGEEIITDTAKINKNFKAISLRY
FNPIGAHPTAEIGELPIGTPQNLIPFITQTVIGKRKELSVFGDDYPTPDGTCIRDYIHVM
DLAKAHVVALERLQQNKEKSNFEVFNLGTGKGSSVLEVINSFERSTGEKLPYKIVGRREG
DIVAAYADTQKANEELGWKTEKHLDEALKSAWEWQKEVVKREEEEN
>IFAGANLK_03393 hypothetical protein
MPLEKQKKVFKYVSILEGLSFLLLLFIAMPLKYIWEMPQMVQQVGMAHGVLFIAYVMGAI
WLFKPLNWNFKELLIILGCSLVPFGPFYVEKKYL
>IFAGANLK_03394 Miniconductance mechanosensitive channel YbdG
MNIEEGFKNLICLFETFLIDQGVNPTLALYLNLLLNILVLIMIIIGVNYLIKTFVIEAFK
SFSNKTKTTFDDFLIQTNFPKYIGQILPLVIIYFTVPYILVDFPLAIKAFYFLIDIYIIF
LIVWLIRSFLRTTKSYLRTLESFKDKPVESYIQVVMIIVWLFAFIFIIAEITGKDVLNFI
ISLGAASAILLLIFKDTILGFVASIQVSVNDIVRIGDWITFSKYGADGTVTEITLATVRV
QNFDNTFTSIPTYSLISESFQNWRGMQESPGRRIKRSVFIKQNSVKFITPEDFEKYKNIQ
LISSYLDDRQNEINAYNTTNEIDKNLPLNGRNQTNLGIFRKYIDTYLNTHSAVHKEMYII
VRHLQPTEHGIPLEILCFSRDKRWENFEYITADIFDHIIAAVSYFDLQLFEAPSGDDIRD
YFSKMNPESPKKEDE
>IFAGANLK_03395 hypothetical protein
MTLKGFLQVFGIIAIVMTLVPLVAADFWWIRIFDYLHIQLSLLTLTAISAYFIRFDIKRA
EDYIFMVALVACFTFQVIKIYPYFPHKNYEVGQVTEENFSNKFSLYAANVLQKNENPKLV
LADIKKQNPDILLFTETNTRWKDDLSPITDTYPYKVEIPLDNTYGMLFYSRLELKNPEIK
YLVDDSIPSVHSILKLRSGEEVMFHAIHPTPPMPQHNPSSSDRDAEMMKIAFMAKDSELP
VIVAGDFNDVAWSSTTALFQNVGGLLNTRIGRGFYNTFDATSSIMRWSLDHVFVTEEFRV
ADFKLGSSIDSDHYPLYIELNLEPEKAEEQKPEPATEEEIKTAREQIEAQEEESKEDAQN
N
>IFAGANLK_03396 hypothetical protein
MLNISELSEKSIKQILTILEEDGKISASLPGAGLIHIEDNLPYLVVYRKREDDPGTERIV
ISEASYLLIGNKFFEAYQRLIYALADKLSSDFKSYMIFEIYTGDPNNCFTIKAPAQKLPS
SVKVLEKELNNINDTFSGLYLKAEIKDTPHRQKEGDEDILSIDEAKKSGAVIVGLEIPPV
FRNENNEVYPVFLRQFKDYLITSIHKALFDYVRVQTTSGVGSYLALGRKHLKEKVFEIDK
ALAKIERSYQFLWLVSPANIQDIKQNFFESNYEKVLDYHYRLLPIDPDLLKRELYNLKVE
EIDDPAMSHIFREKREELDQQITMLSERGTPNFFYNSIRLYKGLDSNLSQEAGQILREVD
EVAEEDNAEFIDAKGFSSLARREFDYFAEQDENFKSKVHIRKDVNIMMVNKGELYIPADY
RMNKTEATALIQHEVGTHVLTYYNGTRQPLELLSSGLADYDPLQEGLAVMSEFLVDGLTG
NRLRTLAGRVIAGSALMEGAEFPQLFRLLKMDYGFTAERAFNITSRIMQGGGFLKDIIYL
KGLVQLRDHLQNGGDYEPLLAGKFGLKHTKIIEELTERKVLKTSALRPSYLLTENVTNKL
NLIREGLPLSQMIT
>IFAGANLK_03397 Glutathione synthetase
MKICFVLNDIKNEKCGTSVLLMNTAHARGHEVYAMGVGDFNFHHDAPISINSVQVPKNTK
TKSPAKFLEALQSSKARKKTIAANKLDVLFIRNNPTEEESGREWAEHAGVAFGRMIQQEG
VLVLNDANALSNAFIDKLYFEELPQEIKPDSLITRNKEDILKFWEKNNKKIVLKPLEGSG
GQNVFLIDENEKNINQIIETISQHGYVIAQEYLPAVKDGDVRILLMNGRVMVKDGKQAII
RRVSGEGEFRSNFALGATADSSDLTPEMQRIVDLTAPKLIRDGLFFVGLDVVKDKLIEIN
VLSPGGMERFKDIGLPDFTPMVIEAIERKVEYKELYGHQFDNREIACME
>IFAGANLK_03398 Succinylglutamate desuccinylase
MSNKPEKHIPRIIGKYTSNNKGPLLFVTAGIHGNEPSGVKALEEVFKQLEKSKPEINGTL
VGVSGNHKALNQNKRYIDEDLNRVWTEENIEQKKSETHEQKEMWEIIDILKQFPEEDYTK
RYFLDCHTTSSASLPYVSVQEVNDNDEWAHNFPTFIVRGFSDIITGDIDHYLSRTGMTGF
VFEAGQHEDKTSVENHEGVIWLALKEACKLDLSKIETYPECVNRFAEKNAPDQKTFELIH
RHGLEDSDEFEMEQGYGNFQKIKKGELLAKQNGKEVKSEWDARIFMPLYQSQGNDGFFVI
EEVEGK
>IFAGANLK_03399 6-phosphogluconolactonase
MIKITLISLAVILTTTCAAQHAETPVYIGTYTKKEGHVDGKAKGIFLAMQDSENGSLHPE
KTVAKITNPSFVKASRDGKNLYAVSELGGGDAESGFIYSFKRNKDNSLEELGRISTESFA
PCHIELDQTEKFVFVSNYMGGVVLVYKRGGDGTLEKQQKIQLENPEASHAHSVSITSDNK
SAYISDLGNDKIWIFNFDAKTGKLNPKEKPFLELEKGSGPRHFSFSKDEKFAFSMNELNS
TLSVLKIEEDGMEIIQNISTLPEDFKGENSGADIHLHPSGQFVYSSNRGHNSIAAFKVDE
NTGKLNVIGHYPTKGETPRNFAISPEGKFLYAANQDTSTISSFKVNLETGELGEHLLPVE
VMSPVCVEFAEN
>IFAGANLK_03400 Cobalt/magnesium transport protein CorA
MVKKITQSLRRPKMKSVNQPPGTVTYVGRKESGGTRLEVIDYNKDNYEKHISSSTEDAFK
FEAEDRITWFNIDGLSNTAEIEKLGKYYDLHPLIIEDIVNTTQRPKIDEYEDYLFIVAKM
LYHQDGKLVNEHISFVLGKDYVLTFQEAGGDVFDGVRGRLEKAYGRIRTNGSDYLVFALL
DAIVDHYFLVVDELSEKVEKLEEQLFESQPSDDITYEIQDLKRAILRVRRAVFPLKEVIS
RFQNLENDLIKDRTKNYINDLHDHILQVSENIDLYREMAWGLMDMYMTTISNKMNEVMKV
LTIMASIFIPLTFIAGIYGMNFEYIPELQWEYSYFVLWGVMIVIFLLMIYYFKRKKWL
>IFAGANLK_03401 Na(+)/H(+) antiporter NhaA
MKKSPLDLYLLLPIKNFIEKKTSVGLLLIFSAILAMIVANSPLADAYHNLWKQYIHLGIN
DFVIRKNLLHWINDGLMSIFFFMIGLELKREILQGELSSFRKSILPIAAAIGGMVFPALI
YFYFNTGLDSISGWGIPMATDIAFALGILYLLGDRVPLPLKVFLTAIAIVDDLGAVLVIA
FFYTSDISVQSLAIAGVFVLILAAANLIGIRNTLFYAIMGIGGLWLAILLSGVHATIAAV
LAAFAIPNTKRINTPLFLRKTKLLAYEIKEEFRNRNKTPKEADDHISHTIQKFTSLTEDA
TPPLQRLEHALYPFVSFVVLPIFAFANAGVSLGDVSFKTLVSPVTIGVMFGLIFGKFIGI
VVFSRIMVWTKIASLPNKVKWKHVYGIGFLAAIGFTMSLFITELAFKNENYLAQAKIGIL
SASLIAGLIGYFYLRKTGNE
>IFAGANLK_03402 putative copper-transporting ATPase PacS
MNSCFHCGEECKEDHIVFQEKDFCCTGCKTVFEILNESDLTFYYDIQEKPGISPGASEGK
FDFLDNEEITEKLLEFNENNNQIVNFLIPSMHCSSCIWVLENLGKLNTGVKSAQVDFPKK
TVRISFSSEKISLKELVYLLSRIGYEPYISLKDYDEKDHSVNRSLIYKLGVAGFAFGNVM
FLSFPEYFEVKEFWLEQFKHLFRWLMFAFSLPVVFYSGSGYFVSAYKGLRAKILNIDVPI
ALGIAVLFIRSTTEILLDLGTGFFDSLTGLIFFLLLGKFFQQKTYSYLSFERDYKSYFPM
AVTRLKINTSKEVIEEQVQVYHIQPGDRILIRNGELIPIDSVLMKGKANIDYSFVTGEAE
AVKKESGETLYAGGRQQGGILEIEAIKAIDQSYLTKLWSNEVFKKDRKGQFQSLINQISK
RFTAGVLSIAFLSTLFWLIYDPSIALNVFTAVLIIACPCAIALATPFTLGNLLRIYGRNK
FYLKDAVVIEQIAKIDCLVFDKTGTITSNKTTEVFYEGLKLNAEEEQLLSSSLRASGHPL
SRQLYQILDKNNILSLDEFNEHTGKGISSGSNGSKMKIGSSSFVRETETKELNKTAVHIS
SNEEYKGCYVFKNSYREGLADLFKELGENKKLFILSGDNDGEKERLENMLPLNTKFYFNQ
KPDDKLNFIKKLQEEGKSVMMIGDGLNDAGALAQSDVGIAVSENINVFSPACDGILEASN
LNRLSEYFNLSEKGMKIIKWSFALSLCYNLVGLAFAVTGNLMPVIAAILMPLSSISIVAF
TTLATNLAGKKLKPVLTKT
>IFAGANLK_03403 hypothetical protein
MNIIYLLLALSVLVALIFFVAFIFSVKKGQYDDVYTPSVRMLFDDELVKEKSDKSNSTKN
KKSN
>IFAGANLK_03404 Cbb3-type cytochrome c oxidase subunit CcoN1
MEVEQFHYDNKIVKKFTMATLFWGIVGMSVGLLLAFMFIFPDITDGIPWLSFGRLRPLHT
NAVIFAFVGNAIFAGVYYSTQRLLKARMWSDFLSNFNFWGWQAIIVAAAITLPMGFTSSK
EYAELEWPIDIAITLVWVAFGANLIGTMIKRRQRHLYVAIWFYLATFVTVAVLHIVNNIE
IPVSAFKSYSIYSGVQDALVQWWYGHNAVAFFLTTPFLGLMYYFVPKAANRPVYSYRLSI
IHFWSLIFIYIWAGPHHLLYSTLPDWAQNLGVAFSVMLLFPSWGGMINGLLTLRGAWDKV
RTDPVLKFFVVAITGYGMATFEGPMLSLKNVNAIAHFSDWIIAHVHVGALAWNGFLTFGM
VYWLVPRLFKTKLYSIKLANAHFWIGTLGIIIYTLPMYVAGFVQASMWKQFNPDGTLTYG
NFLETVTSIMPMYWMRAIGGSLYIVGAFILLYNIIQTVRQGSAVEDELAEAAPLQKVTRK
RTKGEAYHSWLERRPVKLTIFATIAILIGGVVQIVPSLMVDEYVPVISSVKPYTPLELEG
RDIYIREGCVGCHSQMIRPFRSEVERYGEYSKAGEYAYDYPFLWGSKRTGPDLMRVGGKY
SDNWHLNHMYDPQSTSSGSIMPSYKWIITDELDKSDTEAKLRALSKLGVPYTLEEIENAQ
QWMAEQGTQIEKNLYADPDFVKTYEAEKEFAEQNGTEFVEMRNREIVALIAYLQRLGTDI
NAKDSEVSTTKTN
>IFAGANLK_03405 hypothetical protein
MFKFVKGHMESIDGVMIYPLISLLIFFIFFVVLFLWVITAKKKDIEEVSKLPLDINPETE
EL
>IFAGANLK_03406 Cbb3-type cytochrome c oxidase subunit CcoP
MKTVGYLRILGFLILALVLIELTIETESGWAIEEYPVIWWVLGVVLVIAVAIEISIAALE
NMVFKSMNSEAQQHYTKLKIEKSDKQFIGLKKFYKKMLNQQPVEKEEEILLDHNYDGIKE
LDNDLPAWWLYGFYVSIVFAFVYMAYYHIFDGENQTEEYLASVAVAEEEIEAYKAANPDL
IDASSVELLTDAADLEAGESIYMASCMACHRADGGGAIGPNLTDDHWILGGGISNVFQTV
SEGGRDGKGMVAWKSELNAQEIAQVSSYVLSLQGTNPPDAKAPEGEVWEGETE
>IFAGANLK_03407 Putative electron transport protein YccM
MENKEEFRDSIATADDRGKRLWVFPKKPSGRFYEYRKYVSYVLLILLFAAPFVKINGNQF
MMFNILERRFNIFGFPFWPQDFHIFVIMMVIGVVFIILFTVAFGRIFCGWFCPQTIFMEM
VFRRIEYWIEGDRGKQMRLEKQKWDAEKIRKRSLKWFLFFVISFLIANVFLAYLIGSDRL
IQYVTDGPLNHLSTFISLLIFTAVFYFVFAWFREQVCVIACPYGRLQGVLLDNKSIVVAY
DHKRGEKEKGRAKFKKNESRVETGKGDCIDCFQCVQVCPTGIDIRNGTQLECINCTACID
ACDSMMEAVDLPKGLIRYASEENIEKKAKFKFTPRLKGYSIVLGILTAVLVGMLFIRSEV
EARILRLPGQLYERKADNIVSNVFTYKLVNKTTADFEDIEFRLLSHKGEIKPVKTSNITV
PGQELTEGTLFIEIHTAVLEDEKEKLKIGVYSGGRLIETTSTMFMGPRSFN
>IFAGANLK_03408 hypothetical protein
MKINWGTGIVIGMALFITFIMYLVINMLTDTKFDHDLVTEEYYQKELHYQEEIDAENNAF
SLEENISDRRVKDGWIVEFPKNLELSKISGNLNFYRPSDAELDFNIPLELTSHQIFISDK
NLVNGRWNINIHWEYEETPYLYKNEIVY
>IFAGANLK_03409 hypothetical protein
MWISALIFGLLGSFHCVGMCGPIAFLLPVDHKNSFKKLGQISLYHFGRISSYALIGILFG
LLGKSFRLFGLQQQLSILVGVLMIVVILIPYKKFSDYNGSKLIFKIVSKVKSNLGKQLKQ
KSPDTFYTIGFLNGFLPCGLVYMAVFGAIASGTALEGSLYMALFGLGTVPLMTAAIYLGN
FINLNLRSKIRKAVPVFVVIMGLLFILRGMGLGIPYLSPMEITPEITAAQSCH
>IFAGANLK_03410 hypothetical protein
MNLFETLALVNWELGTFLIAMFVVVCAGLVLIVLNMIGSGNDKE
>IFAGANLK_03411 Oxygen-independent coproporphyrinogen III oxidase
MSSNFISKYNVPGPRYTSYPTVPYWDDNTFSTSAWKSSLKRSFKGNREISLYIHLPFCES
LCTFCGCNKRITKKHSVETPYIETVLREWDLYLEVLEEKPIIREVHLGGGTPTFFAPENL
KLLLNMLFRKAERDCKAELSFEGHPNNTTKEHLKVLAELGFRRVSYGVQDYSEKVQKAIH
RIQPFQNVKNATEHAREAGFTSVGHDIIFGLPFQTKDDIIDTIEKTKQLMPDRIAFYSYA
HVPWIKGNGQRGFKDSDLPGGDEKREMYETGKKMLEDAGYIEIGMDHFALKTDSLYKAVE
NKTLHRNFMGYTTSSGASMIGLGVSAISDSWYGFAQNEKSVETYQELIANGIIPVFRGHI
LNEEDLVIRKHILNLMCRLETSWAAPEDYFEELPDVLIKLREMEADGLVIFSEKGLTIPE
KGRPFVRNICMAFDLRMQAQKPNTQLFSMTV
>IFAGANLK_03412 hypothetical protein
MSRKINKEIRINENGSKVFKALVTPNLIKEWWGASQAIVVPDENGVFALSWGENPDKADY
IAAATISEFKPHVKLTLSDYIYLADNEYLPFKSKFKVKFRIHCETKYCVLKLEHSGFPNK
SEADQFYSDCESGWEENLESLKNLVEKENVPVYN
>IFAGANLK_03413 hypothetical protein
MNSAQKTLLYPLVALIVGAYFLFTGLVDAKGFLAPLVTAIILALLLIPLANLMEGKLNRL
FSSLLSTVLLLLFSFGVFILLSFQIKNFVDDWDKIKETMTPKIEQLQSYAYEHTALSSED
LEEYKKENDIKSMLTSGGNSGQQAFNFLNSVTSFLSNYLLTFIYIFFLLNYRRRFKIFIL
KLFSNQRKKQVKQIIDETARVAQFYLRGKLILIIILSILYSIGLGISGVNNYILIAVIAS
FLTLIPFIGNIIGMGLALIFGYLTQGETSILIGVILTFTLVQFIESYVLEPFIVGDKVDI
HPFFVILAIILGNMIWGVMGMILAIPVLGILNVVFNHVPALEPFGYLLSTDEEKD
>IFAGANLK_03414 hypothetical protein
MQNRAAKQFEGFLKTPPLWTNSFLKIDQFLLPEIEEPLKQPITEDLPSLASNFVMGKRVE
RFFEWIIRKNLNYKLLAENMQISRNKITLGELDFLLEDLITRQVFHIEMVYKFYVYDPSF
STEMKRWIGPNRRDTLLQKTEKLREKQFPLLYKPDTKDLLNSLGLKAEEILQQTCFKASL
FVPKHLQDKQFQEINNDCVAGIWLHLKDFISAEYRDFQFYAPRKQDWPMLPEHGENWVNH
SDIITKIENSFQRKKAPLIWVKKPGHKFERLFVVWW
>IFAGANLK_03415 Ferrous-iron efflux pump FieF
MDQNTNEAIKASWLSIIGNALLAIAKFITGVFGNSYALIADAIESTTDVFSSFLVLLGLK
YSSRPPDKNHPYGHGKAEPLMTFAVVGFLVVSATVIAYESIQHIRTPHKVPEPYTLIVLA
VIIIIKEYFYRKVSKKGDETKSTSLKADAWHHRSDAITSLMAFIGISIALFMGKGYETAD
DWAALFASGFILYNAYLILRPALGEVMDEHMYDDMIGDIREISGRVPGVLDTEKCYVRKT
GMTYHVDLHITVNAEISVKEGHDIAHNVKNELLAHFPEIYDVLIHVEPDDFAKPVS
>IFAGANLK_03416 hypothetical protein
MSLINEKDLQKLSTQDNKTCISIFIPTQRAGKEVLEEKNKTHLKSLWKEVGNELKKKEIS
EEKIQEIGKPIEELLNDKSFWRHQSDGLAIFAAEGFFEKYTLPVNFETHSYISNEFYIKP
LVPMFSEDTRFYLLALQLEDVVLYEATKYSIGKVEVDDLTPTRLEERVGFDYKQKHLDFR
TQGSGGEKTIFHGHGSGSEEERKEEILKYFRAIDKGLETILHDENVPLVVSTQDYLFPIY
KDVNTYKHLFDKVVPGNPADTDMFGLHEKALQTIEPYLEKTKREKMKKFEELNNTDNTGT
SVTDILPAIQQGKVDTLFLENRSEIWGTYNNDNMNVSIDDEQTSQNYSLMNWAAKEVLRQ
GGNVFLIPGAQMPEKQSKMNALYRFN
>IFAGANLK_03417 hypothetical protein
MDTNLAVLIDGDNIPSAYIKEMMEEIAKYGNPTIKRIYGDWTKPHLVKWKNVLLENAINP
IQQYGYTQGKNATDSAMIIDAMDILYSDKVDGFCLVSSDSDFTRLATRLREAGKNVIGIG
EKKTPEPFIVACDRFIYIEILKNSEKDSEQETEKGGKTTKKKNVDKITPKVVRLISQTIS
DVADEDGWAFLGDVGSLLQKKQPNFDSRNYGFQKLTPMIHSIDKFEIESRTNQSSKFKLI
YVRNKD
>IFAGANLK_03418 hypothetical protein
MNITLAQAQKVIAAAEKKSKELDVKMDIAVVDSGANLTAFARMDGAWLGSVDIAIKKAET
ARFFDMNTGEIGKLSQPGEALFNIEHSNNGLITFPGGVPLKNKSGDIIGAVGVSGSSVDN
DHAVATFAAESI
>IFAGANLK_03419 Phosphoribosyl-AMP cyclohydrolase
MNIDFNKNNDGLVPAIIQDASTKNVLMLGYMNEEAFLKTNETKKVTFFSRTKKRLWTKGE
ESGNYLHLVNIKNDCDNDALLISVNPKGPTCHKGTDTCWGEKNEPNFGFLTKLEGIIAKR
KRMSEVEPELREDKNSYVVSLFDAGMNKIAQKVGEEAVETVIEAKDDNAELFLNESADLL
FHYLILLKAKGYSLKDISEVLEKRH
>IFAGANLK_03420 Imidazole glycerol phosphate synthase subunit HisF
MLTKRIIPCLDIKNGRTVKGVNFEDLRDAGDPVELAEIYAKSGADELVFLDISATEEKRK
TLANLVRRVAEKVNIPFTVGGGISSVEDVDILLKNGADKVSVNSSAVKNPDLVNELAAKF
GSQCITVAIDAKEINGEWMVHLVGGKVPTDLNLFQWAKEVEERGAGEILFTSMNNDGTKA
GFANKALAVLSSELNIPVIASGGAGNMQHFCDTFIEGKADAALAASVFHFKEIEIKDLKE
ELRRNGVEVRL
>IFAGANLK_03421 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase
MRIIPAIDIIEGKCVRLSKGDYNTKKIYNENPLEVAKNFEAHGIQNLHLVDLDGAKSKHI
VNHKILEEIASKTGLKVDFGGGLKTDKDLKIAFECGANQITGGSIAVKDPETFKSWLQKF
GSEKIILGADANNEKIAVSGWQEESTKELIPFIQEYQQEGVNYVICTDISKDGMLEGPAF
ELYQRILKETTSEDKELNLIASGGISTFSELPKLAELGCEGTIIGKAIYEGRIQLKELEK
FILNN
>IFAGANLK_03422 Imidazole glycerol phosphate synthase subunit HisH
MNIVIIDYGAGNIQSIKFAIKRLGYDAILSSNAEEIRLADKVIFPGVGEASSAMKMLKST
GLDKVIPTLKQPVLGICLGMQLMCTYCEEGDTDGLGIFHANVVKFDNKLKVPQIGWNRIY
DLKSELFTGISEQEFVYLVHSFYVKECEETIASTEYGVEYTSAIQKDNFYGVQFHPEKSS
DAGEKILENFLKAT
>IFAGANLK_03423 Histidine biosynthesis bifunctional protein HisB
MKKVLFIDRDGTLIHEPEDYQVDSIEKLEFYPEALYYLKKISSELDFEFVMVTNQDGLGS
EAYPEEKFWPIQNFILQTFKNEGVEFSEILMDRTFAKENSPTRKPNTGLLEEKYLNNEKE
YDLKNSFMIGDRLTDIEFAYNFDGKGIFIDTHEDLATDEVQNDQEKVKRTIALKTDSWKK
IYEFLKLNDRTAEISRKTNETDIFIRLNLDGTGKSEISTGIAFFDHMLDQIARHGQMDLI
VDVKGDLEVDEHHTIEDTAIALGEVFSKALGNKLGIERYGFCLPMDDCLSQVAIDFGGRN
WIVWETEFKREMVGKMPTEMFYHFFKSFTDGAKANLNVKAEGQNEHHKIEAIFKAFAKAI
KMAVKRDAEKMILPSTKGML
>IFAGANLK_03424 Histidinol-phosphate aminotransferase
MKNFNINNLVRPNVAGLKPYSSARDEYQSTGSEMVFLDANENPFQTDVNRYPDPQQRSLK
VELAKLKNVVQGNILLGNGSDEVLDLLFRAFCEPGKDNIITLPPTYGMYKVLANINNIEN
REVLLNADFEPNVEEILKWVNQNTKMIFLCSPNNPTGNSFSEENVSEILNNFNGLVIIDE
AYIDFSAQESWLNKLEQYPNLVITQTLSKAYGMAGIRLGICYASAEIIGILNKIKPPYNV
NELTQLRALDRVLNSDKVNSEVSDLLEERDAVGKALVEVKFIEKIYHSDANFILVKVDNA
NKRYDQLIQKGIVIRNRTTQPLCENTLRFTVGTEAENRKLIEVLKSIE
>IFAGANLK_03425 Histidinol dehydrogenase
MKKFYNPTRSEWSEILKRPTQTVEDIEETVNQVFAEVKAKGNDAVSKYTELFDGINLEET
RVSKEEVSSAEFQISEDLKQAINLAKTNIEKFHSAQKTERIEVETTNGVKCWQEKRPIQK
VGLYIPGGSAPLFSTILMLAAPANIAGCKEIVLCTPPDREGNVHPAILYTAALCGVTKIF
KIGGIQAIAAMTFGTENVPKVYKIFGPGNQFVTVAKQLATRHNVAIDMPAGPSELLVFAD
DTANAAFVASDLLSQAEHGTDSQVILVSNSKELIENVEAEVENQLNDLPRKSIAEKAIAH
SRLIYTEDKNDALELINEYGPEHFIICAEDETFYTEGIQNAGSVFIGNYTPESAGDYASG
TNHTLPTNGYAKQYSGVNLDSFMKSMTFQKISENGIREIGPAIKLMAEAEGLQAHKNAVS
LRLKELRTK
>IFAGANLK_03426 ATP phosphoribosyltransferase
MSQEKLRIAIQKSGRLNEDSLKILKDAGISVDNGKEQLKASSRNFPLEVMYLRNGDIPQY
LRDGVVDVAIIGENVLIEKGKDIIQGEKLGFSKCRVSLAVPKSMKYTGIEDLDGKKIATS
YPNTVNEFLEKKGITAELHIINGSVEIAPNIGLADGICDIVSSGSTLFKNGLKEVEVMLK
SEAVLAISPKISSERKTILEKLQFRLKSVLNARTSKYILLNAPNDNLDNIIKLLPGMRSP
TVLPLADKGWSSIHTVINEERFWEVIDELKQNGAEGILVAPIEKMVL
>IFAGANLK_03427 Esterase EstB
MRSIFLNIARLSIFIGSLAISAQTSSINNSGTLETAAPAEVGMSSERILKIEEMLKSAID
ENQIPGAVALIARDGKIVFHEAYGEADASGKELEKDAIFRLASQTKAITATAVMMLWEEG
KFRLDDPVSKYIPEFKDPNILKDFKESDSTFTTTPAENEITIRHLLTHTSGLGYGMIDSD
DRIKKIYAKAGITELFTEDEVSIGENVKKLATLPLHHEPGEKFTYSLGLDVLGYFIEVIS
GQDFDEFLKKRIFDPLQMDDTRFYQPSEKKDRLVAVQHKKEGEWENYPNTFYNTNYPLAE
NGSFFSGGAGLSGTAEDYAKFLQMYLNGGEYNGTRLLSRKTVDIIMGNQSGEKFNYPNQY
YGLSFGIVSETGEIAGGQGSAGTFDWGGYFNTQYFADPEEQIIGILLKQTQGNTGDETGW
KFRQMLFSAVDD
>IFAGANLK_03428 hypothetical protein
MERLPKLGIPIIIGIVLLIIFVAKSTVTIGSGEAGVLYKTFGGGVVTDEPPLNEGFHLVA
PWNRVFVYEVRQQSLEEQMQVLSSNGLEINIDASTWFQPSYANLGSLHREKGEEYIRRLL
QPAVRSAARAVVGRYNPEQLYASKREAIQKEILEETQILLQDQYVQVNEVLVRDVSLPDN
IKEAIERKLRQEQESLEYEFRLTKATQEAERQRIDAEGKARANEILNASLTPNILKEKGI
QATVELAKSNNAKTVVIGSGEGGLPLILGGSN
>IFAGANLK_03429 hypothetical protein
MNISTIILIAPAIIIALGFAFFQYLFKNKNKSRETYIYLALRFLSVFILLLLLINPKITS
TTYELQKPNLILAVDDSESIAHLEQADTVQNILEELKSNEIIQERFELIQYNFGNELLNS
TTPEFKATQTNISASLEAVKEFSRKKPTAVLLISDGNQSTGRDFRYFKPGNNQEIYPVVV
GDTTQYSDLELSQLNVNTYAFLNNRFPVEAFISYSGEEQVDSKFIIRSGENVILSEEISL
DSEDNSAVIRAELPASSLGVLSYEAEIIPLENEKNKANNTVQFAVEVIDERSKILLISAA
PHPDIGTFKKSIETNKQRQLDIKYLEDDLSNLEEYQLIILYQPASGFTPVFEDLEENNQN
YLLVSGTQTNWNFLNRIQDFVKKDFANQLQEIFAVKNPNFNQFQFEETGFSEFPPLEDKF
GNISVQNNNFESIYFQEIENLGTSQPLMGIAGEGQNKYAFIFGENIWRWRSNTYLENKSF
EKFDNFIGKLVQNITSTQQRERLTIDYNSFYYENEAIKLTANFFDQNYQFDPNADLVIAV
EYSEERIESQLVLKHNGYEVDLGNLPAGKYDFKITETGSQIARSGSFEVIAYNIEQQFIS
ANKNAMEALAENSGTQVHYQNQLQQLSNALLSNDKYKPVQKSRQKIVPLIDWYYLLFLLV
LILAAEWFFRKYKGLI
>IFAGANLK_03430 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKLLEGKNAIITGGSRGIGKGIAKVFAEHGANVAFTYNSSAESANALAEELSKLGVKSKA
YQSNAASFKEAEQLVKDVAADFGEIDIVVNNAGITKDNLLMRMSEEDFDKVIEVNLKSIF
NMTKAVQRTMLKQRKGSIINMSSVVGVTGNAGQANYAASKAGIIGFSKSMAQELGSRNIR
TNVIAPGFIETEMTEKLDEKVVDGWRQAIPLKRGGAPEDIANACVFLGSDLSSYITGQVL
HVDGGMHT
>IFAGANLK_03431 Succinate--CoA ligase [ADP-forming] subunit alpha
MSVLVNKNSKIIVQGFTGSEGTFHAEQMIEYGTNVVGGVTPGKGGQKHLNQPVFNTVSDA
VEKTGADVSIIFVPPAFAADAIMEAADAGIKVIITITEGIPVADMVKAYDYIQDKDCRLV
GPNCPGVITPGEAKVGIMPGFVFKKGKVGIVSKSGTLTYEAADQVVKQGLGITTAIGIGG
DPIIGTTTKEAVELLMNDDETECIVMIGEIGGQLEADAAKWIKENGNKKPVVGFIAGETA
PAGRTMGHAGAIVGGSEDTAQAKKAILKENGIHVVDSPAEIGKKVAEVMKG
>IFAGANLK_03432 hypothetical protein
MGLKSKEIVEKFYTSLFNDEKGTLDNFLHPNVDLTWYGTTGLKKLDFDEILAIRNDMAKN
YESLKAEIEKTVEEDHQIAIQFTYHVKTIENPDEEMPLAHFMAIWELKDEKLFKGVQISQ
LGEEIDESPWS
>IFAGANLK_03433 UDP-3-O-acylglucosamine N-acyltransferase
MKFPQEHTLQQIATIIDAQYIGDANFPVLGMNEIHVVTPGDIVFVDHPKYYDKALNSAAT
VILINKKVDCPEGKALLISENPFSDFNKLTQYFKPFKKAEKSVSDSAQIGEGTHIQPNTF
IGHNVRIGSNCLIHSNVSIYDNAVIGNNVIIHSGTVLGGDAFYYKTRPQGFDKLRSGGRV
VIEDNVEIGANCTIDKGVTGDTTIKEGTKLDNLIQVGHDTVIGRKCLIASQVGIAGAVTI
EDEVTVWGQVGMRSGITVEKGGVLMGKAGITKSTKANKIYTGNPAMEARAKLKELALLRQ
LPKLLEKLK
>IFAGANLK_03434 Elongation factor P
MASTSDIRNGLCIRYNHDIYKITEFLHVKPGKGPAFVRTKLKSVTTGKVIENTFSAGHKI
EDVRVETHKFQYLYNDDEFYHFMNVEDYTQIRLTENALDQPKLLKEGEVVTVIINTEDNA
PLSVEMPASVVLEVAHTEPGVKGNTATNATKPATVETGAEVNVPLFINEGDKIRIETEKG
TYKERIKE
>IFAGANLK_03435 Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase
MNQPLAYVHPGAKIAKNVVIEPFTTIHNNVVIGEGTWIGSNVTIMEGARIGKNCSIFPGA
VISAIPQDKKFDDEDTITVIGDNTTIRECVTINRGTTDRMKTVIGENCWIMAYCHIAHDC
IVGDNCIFSNNSTLAGHINVGDYVILAGMAAIQQFCSIGRHAFVTGGSLVRKDVPPFVKA
GREPLSYVGINSIGLRRRGFTTEKIREIQDIYRILYQKNYNNSQAVAIIEAEMQATAERD
EILEFIKNSQRGIMKGYFSSN
>IFAGANLK_03436 UDP-3-O-acyl-N-acetylglucosamine deacetylase
MAYKQAKQHTIDKEISLEGVGLHTGQKVKMTFKPAAENTGYVFKRMDLEGEPEIEADVSY
VVNTQRGTNLEKKGVKIQTSEHVLAACVGMDIDNIVIELNASEPPIMDGSSKFFVEALEK
AGVVAQEAEREEFVVEEVITYHDDESGSEIIVMPADEYQVTTMVDFETKVLGTQNATISR
LSEFKDEIANARTFSFLHELETLLDHGLIKGGDLNNAIVYVDKEINEETFKKLRIAFNRD
NISVKQNGILDNLTLHYPNEAARHKLLDVVGDLALVGTRIRGKVIANKPGHYVNTQFAKK
LAKIIKAEKRNNVPKIDFDQKPLMDVTDIMDILPHRSPFLLVDKIYSCTDTCVIGLKNVT
MNEPFFVGHFPGKPVMPGVLQVEAMAQTGGILALKSVPDPENYLTYFMKIDNVRFKQQVV
PGDTLIFKLELLAPIRRGICQMQGYAYVNGKLATEAILMAQIVKSK
>IFAGANLK_03437 UDP-3-O-acylglucosamine N-acyltransferase
MKFTAAQIAEILDGKIEGNPEVEVSELAKIEEGGEGSLTFLSNPKYTSYIYSTQASITIV
NSDFEAEEPITTTLIKVKDAYKAFSKLLEYYNQIKLNKQGIEQPSFVSDSAEFGENLYLG
AFAYIGENVKIGKNVKIYPNVYIGDNVKIADDVIIFPGVKVYSETVIGSNCVLHSGVIIG
ADGFGFSPGEDGIYSKVPQIGNVIIEDNVDIGAGTTIDRATLGSTIIREGVKLDNQIQIA
HNVEIGSNTAIAAQAGIAGSTKIGENCLIGGQAGIAGHLQIGDRVKIQAQSGIGRNVKDD
EMLQGSPAFGYGDFAKSYVHFKNLPKTIDTLNQLEKKIKNGL
>IFAGANLK_03438 hypothetical protein
MTSTNKLKILNDPIYGFITIPSERIFSIIEHPYFQRLRRISQMGMSYLVYPGAHHTRFHH
AIGCVHLMQKAVQILRHKGVIISEAEEEALQIAILLHDIGHGPFSHAMEHSIVEGVDHES
ISLLFMEEMNRDFNQSLTLALQIFRGTYNRRFLNQLISSQLDMDRLDYLKRDSFYTGAAE
GNINSERLITMLNVVKDDLVIEEKGIYSVEKFLVARRLMYWQVYLHKTSLVAEQLLIRVL
KRAKELVEKGEKLNASKALSYFLYNKIGPENFSSETLSIFARLDDYDIISAMKEWQDHED
FVLSNLCNMIINRDLLKVKIKKKKPSVAKLEKRRKALQEKENISAIEADYFVFSGEVTNT
AYKSENNNINILHKNGKISDVAKASDQLNLKALSKTVVKYYICYPKAKH
>IFAGANLK_03439 Transcriptional regulatory protein ZraR
MNKIKILWVDDEIDLLKPHILFLESKDYEVVTSQSGTEALEQIEEESFDIVFLDENMPGL
TGLETLAEIKEKRENLPVVMITKSEEEYIMEEAIGSKIADYLIKPVNPNQILLSIKKNLD
HSRLISEKTTSNYQQEFRKIAMDLSQVNTFEEWAELYQKLIYWELQLEGLEDSGMFEILE
SQKNEANTQFCKFIDKNYPSWFEKGVEAPIMSHTIFKEKVVPEINDKQPTLLVVVDNLRY
DQWKALEPVIANYYKKEKEEPYYSILPTATQYARNAMFSGLMPSEMEKLFPQYWKNDTEE
GGKNNHEAEFLNEQLKRLGKSFKHEYHKITSLKAGRKLAENFKTQKDNDLTVVVYNFVDM
LSHSKTEMEVIKELASNDKSYRSLTYSWFKNSPLLDIIQQARQLGFKLILTTDHGTINAK
NPSKVIGDKNTSLNLRYKTGKSLTYEEKDVLAASNPKSIHLPSINMSSSFIFAKGDLFFA
YPNNYNHYVSYYRNTYQHGGVSLEEMIIPFVVLEPK
>IFAGANLK_03440 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MPVTYNLAQIDEAVQYIIKNAKNNVLLFYGEMGAGKTTLIKALVKALGSEDRVSSPTFSL
VNEYHTPREPIYHFDFYRLEDPNEALDIGLEEYLNSNGWILIEWPQKIQEFLEENFQKIE
ISIQGENTRMLNLC
>IFAGANLK_03441 hypothetical protein
MNQLSRNKQWKDQRSKYLLTGSILGLVIAFSPYIFYLYEIFPSGPVWENSFFTYESKYYE
DVLTVAWTYLGKIVPLILLFIWFFTCKHWWYHTILIPISMYSFQLVTIFYEDVYLEVNLM
DTNQLIYLAPFFIIILSLVYLIRIKIFDRIYGIDLSEIDETDVSVFSPISESDRREVKSF
QEEEEYWEPTQEEYYTRL
>IFAGANLK_03442 Alanine dehydrogenase 2
MGKQVSPFTKEQLIPQEETLEIYKNKGQLFIGVPKETSYQEKRICLSPDAVAAITAHGHR
VMIESGAGKWARFSDKDYSNAGAEITKDTSKVFSCPTILKIEPPSIEELDLINPQTILIS
ALQLKTQCKEYFQKLASKRITALGFEFIRDDDGSYPIVRALSEIAGTASVLIASEIMSNN
VNGNGLMFGNISGVPPVEVVILGAGTVGEFAARSALGLGASIKVFDSSLTRLRDIQTNLN
QTFYTSTIQPKNLSKAIKRCDVLIGAVRGKNRSPVLITEDMVTSMKRGAVIIDVSIDMGG
CIETSEITTHDKPIFTKHNILHYCVPNIPSRYARTSSLSISNIFTPYLLHIAEEGGLENT
LRFNKGLRNGLYFYHGILTNKSIADWFDLSYRDINLLIF
>IFAGANLK_03443 hypothetical protein
MKLIHRIGYFSVGLFFGIMILLFFLSGKKTSCDYSPDARVLKNIRIKERVFTEEAFSYFE
NNKLDTALVSLSLEDGDVDFSRSNTETGPCNIYLITNEVDSAILELQIENCDSTATIQKA
VLKD
>IFAGANLK_03444 Putative peroxiredoxin bcp
MTTLEAGDKAPEFSVKDQDGNTVNLSDFKGKKLVLFFYPKASTPGCTAEACNLRDNWERF
REKGYSILGVSADTQKRQSNFKNKYEFPFPLLADEDKEVIQAYGVWGQKKFMGKEYDGIH
RTTFIIDEEGKIEEVIKKVKTKEHTAQILSE
>IFAGANLK_03445 Endonuclease III
MINRRVSPEVLIIKFPKFINQLEIPFNLTYRVNLNNMTKQEKVQFVIDTLNDIYPEIPIP
LDHKDPYTLLIAVLLSAQSTDVKVNQITPKIFEIADNPKDMVKLSVEEIRGIIKPVGLSP
MKSKGIHGLSEILLEKYNGEVPASFEALEALPAVGHKTASVVMAQAFNVPAFPVDTHIHR
LMYRWNLSNGKNVIQTEKDAKRLFPKDLWNKLHLQIIWYGRQYSPARGWDLEKDIITKEI
GRKSVVSEYYKKKK
>IFAGANLK_03446 hypothetical protein
MRKLYTKKLSKKDQFKDLKPQKETVQFLLNYSKALRVVENNGIKFGTILN
>IFAGANLK_03447 RNA polymerase sigma factor CarQ
MNNVEITDAVLVREYMQGNEIALSKLINRHQHRIYSFIFSKVFDRDVAEDIFQDTFIKVI
NTLKRGKYNEEGKFLPWVMRIAHNLVIDHFRRNKRMPKFDNSGDFNIFSVLSASELNIET
QIIKDQIENDVKELIKELPEDQLEVLTMRIYKDMSFKEISERTGVSINTALGRMRYALIN
LRKIIEKHNLVLTN
>IFAGANLK_03448 UvrABC system protein A
MNIDVAKVNPKENIIIKGAKLHNLKNINVVIPRNKLVVITGLSGSGKSSLAFDTLYAEGQ
RRYVESLSSYARQFLGRLNKPKVDYIKGIAPAIAIEQKVNSTNPRSTVGTSTEIYDYLKL
LYARIGRTYSPVSGNEVKRDRVADVIDHVKSFEEREKLLLLAPIYIEEGRTLTEKIKVLA
QQGYSRIKVKDEVLRIDEADLTKINAKDTLLVVDRIITKDEEDFYNRLADATDAAFFEGK
GELYIENLKSGIKRHFSNKFELDGISFLEPNVHLFSFNNPYGACPKCEGYGDVIGIDEDL
VIPNTGLSIYENAVFPWRGDSMSWYRDQLVNNSHKFDFPIHKPWFKLTDEQKNLVWNGNK
HFEGLNDFFQFLESKAYKIQNRVMLSRYRGKTRCSTCKSKRLRPEAEYVKIADHSITDLV
GKPLDKVREFFADLKLNEYDQQIAKRLLTEINNRLKFLSEVGLDYLTLNRKSNTLSGGES
QRINLATSLGSSLVGSMYILDEPSIGLHPRDTERLIGVLKNLRDIGNTVIVVEHDEDIMN
AADEIIDIGPEAGTHGGEVVATGTLKQILKSNSLTAQYLNGKEEIPVPKERRKASGEIRI
LGARENNLQNVDVTIPLRTFTAITGVSGSGKSTLVKKILYPAVQKKIGGYGEKAGQYTDI
EGDFNNLGSVEYIDQNPIGRSSRSNPVTYIKAYDDIRNLFSDQKLSNIRGFKPKHFSFNV
EGGRCEVCKGEGEVTIEMQFMADVHLECEACNGKRFQKDVLEVQFTGKNIDDVLNMTIDD
ATNFFADNNLDKIVRKLKPLQDVGLGYVQLGQSSSTLSGGEAQRIKLASFLVKGATKEKA
LFIFDEPTTGLHFHDIKKLLKSFNALIDKGHSVVVIEHNMDLVKCADYIIDIGPGGGEKG
GNIVAQGTPEELVKSKKSFTAKYLKEKL
>IFAGANLK_03449 hypothetical protein
MLFLEVFYFGTPFVFYVLIISESHFNNTKTQTMKNIAFLFSFLFIGISATAASEAMPRNA
YNNAFIFVENGVEFAVYPNGEFDFYFNPEFRSTSIVNISTPNMNISYNAGHNYDAYVQYD
DYGAVIQIENVPVFYDYYGRIIRAGDVFIDYNRRGRIARVGGLHIQYNRFNRITNYSGFI
NHYNNSYVYRPWHQYYSRPRSSVSIVFGQPYRAYYQPNRVTYVQHVNYYNNHYSNNVHQN
FYRPNQQAVSYNKGRRTSERRDIKDIRGNENRVASNTRNVRSNANSERSNNTAKRSRTIR
SEKNSSTNSRGNAVRLSRSVNNNDVVKNRNSRSRTEANSSGNTRRAAVNTSRSSNTKVNS
SASNSRTVKSTPTRQTSRATTAPSPRKTQATTRSSNRSNNTRAVKSSTNTRSSARTSNSS
SRGGSSARNVNNR
>IFAGANLK_03450 hypothetical protein
MGIIIKQSFKNLITTYFGFAIGAINTLFLFTYFLEPEYYGLITFLLSAASLLWPFMGFGV
HSTLIKFFTFYKTKEEKDKLLNLVLFLPLIVSLILGISVAFAYSFLISYFTQGNGLVRPY
IWLIFLIALATAYFEIFFAWSKLFYKSVFGNFMKEVFHRFCISLLLLAVYFNWITVHQFI
YCIAGVFILRLIAMKIYAFSLYLPRLNFKFPDNLSPVLKYTSLILIAGSVATALLDLDKV
MIEYFMPIENVAIYGIAIYIATVISVPQKAMHQITNPMTAEFLNTKNKKSLKDLYKKSSL
NLLIISLLIFILILTNVKQLYELIPDEYELSVLAVLLISLVKLYDNLLGNNNSILFNSDY
YRIVLFIGVLLVFVAFALNLVFIPTFGIEGAAIASFIAYFIYNSSKIWLVHKKFNFLPFT
SKTWLVLFTGVILSFGFYFWDFSYHPILNIALKSILIGISYIGLAYFLKFSSEVNEIINN
VLGIKTS
>IFAGANLK_03451 hypothetical protein
MEKVLIITYYWPPAGGPGVQRWLKFVKYLRDFDIEPVVYIPENPNYPILDKSFEAEIPQE
IIILKKSIFEPYQLARIFAKDQTKTISKGIIAAEKNQSILQKSLLFIRGNMFIPDARKFW
IKPSVNFLKNYLEEEGIKKIITTGPPHSLHLIGLKLKQEFDLKWIADFRDPWTQIGYHKK
LKLTETSRKKHLNLEKEVLSSADQIITTSFTTKAEFTAKTCKPISVITNGFDGNLNEKRG
SDLDKKFSISHIGSLLSERNPENLWLAISELVKENSNFAEDLELKLAGTVSEEVIASIKS
VGLGKKLQLPGYVSHTQAIALQQKSRLLLLIEIDSEETRGIIPGKLFEYLSAKRPILALG
PEKWDVQQILEETGSGEFFQYSEKSRLKSLILKHYEAYRNGDFNFLKENIQQYHRKNLTQ
KLANLIKSV
>IFAGANLK_03452 hypothetical protein
MANLKKFLPHLLVLVGFVIVSLFYFSPVLEGKKIFQSDIVQYIGMAKEQNDFRDQTGEEP
YWTDSAFGGMPTFQLGAYYPHNYVKKLDSVLRFLPRPADYLFLYFIGFYILLLCLKLDFR
LAFLGALAFGFSTYLIIILGVGHNAKAHAISYMPMVLGGIILTFRQRYLWGFLVLAIGMA
LQIGANHFQMTYYLLLLVIVLGIAYLIDAYQKNILPKFFKALGVMVVAVVLAIGANATNL
LATQEYTAHSTRGDTGLTITPDGSDKPASGLTYDYITTYSYGIIESLNLFVPRFMGGSNA
EDIGRDSQIYDSLLKLGASPAQAANFTENAPTYWGDQPYVGGSPYIGATVLFLFIFALYL
VKGRLKWWIVGGSILALLLSWGKNFGFFTEFFIHYVPLYNKFRAVSSIQVIIELCVPVLA
VFGLYKLFDSKIQKEAKVYALKWSGIIVGVIGIALLLFRSVLFDFSGAGDSALIQQMGAD
FVRSLKEDRKAIYTEDLIRSLIFSALTAAALWLYIEKKITQNWLVPALALLILVDLIPVD
KRYVNDDDFVNARQMDRPFQPNEADQQILQDDAHYRVFDVSADPFNSSRASYFHNAIGGY
HAAKPGRMQDLYDFYISQNNMEILNMLNAKYFIVPSEEGQPQAQQNPNAFGNAWFVNDIL
WVESANEEILNLQEVDLQNTAVINSEFKNEVSEDFNYSGNAEVTLESYQPNELMYKTNAS
APQLAVFSEMYYQPGWQAYLDGVEVDHVRANYVLRAMNIPAGEHTVTFRFEPEVVNTGSS
IALASSIILVLIILGGFYYKSRKRE
>IFAGANLK_03453 hypothetical protein
MLEASFSDVLQTILIILLVYFAFKMLIKWFGPLILKYFLRKMGKRFEEQFRQQQGPASQK
KEGKVSIDKKPKSGKKSNKNVGEYIDYEEID
>IFAGANLK_03454 hypothetical protein
MHYLKVGIAFIFLGIFSANAQYTETINSNRPGESQGAYAVGKNVLHLEAGGYLGNDKHSL
FNSDTDILGASYGLRYGFLTEILELNFFGSFQDQVTSVPVGNGADEFRTTNFRSNTIGAK
FLVFDPGISVKERKVNLYSWDANQRINLRSLIPAVSVYAGANFSWWENPYMFEGESIISP
KAALITQHNWGRWVLVMNFIADKFTEEYPSYGGIFTLTHAITPKFAVFGEFQTYISDLYA
DDLVRGGAAYLFGKNFQVDISGLVNFKDTPSRWQVAAGVSYRFDFHEDDEYIEDTYEGDR
NQRGEELEETGFYKENEDDDGSNE
>IFAGANLK_03455 Putative pyridoxal phosphate-dependent acyltransferase
MRDLFEKIYKDKGPLGKWAEQAEGYFVFPKLEGPISNRMKFRGKEVITWSINDYLGLANH
PEVRKVDAEAAAEYGSAYPMGARMMSGHTQLHEKLQDELASFVHKQSAYLLNFGYQGMVS
TIDALVSKADVIVYDVDAHACIIDGVRLHLGQRFTYKHNDLESIEKNLQRATKIAEQTGG
GILLISEGVFGMRGEQGRLKEIVELKKKYNFRLFVDDAHGFGTLGKTGAGAGEEQGVQDE
IDVYFATFAKSLASTGAFIAADKEIIDYLKYNLRSQMFAKSLQMQLVVGALKRLEMLRTM
PELKEKLWENVNALQNGLKENGFDIGTTQSCVTPVYLKGSIPEAMALVKDLRENHGVFCS
IVVYPVIPKGLILLRMIPTATHTLQDIEETLTAFSAIRERLENGTYKRLSASVSAAMASK
E
>IFAGANLK_03456 Putative cystathionine beta-synthase
MKEDLQVYDNVLQLIGNTPLIKLNKITREFKGEFFAKVEAFNPGHSAKDRIALYIIEEAE
RKGILKPDSTIIETTSGNTGFSIAMVSVIKGYECILAVSSKASNDKIDMLKTMGAKVYVC
PAHVSADDPRSYYQVAKRLHSETKGSVYINQYFNELNIDAHFNSTGPEIWKQTEGKITHL
VACSGTGGTISGTARYLKQQNPEVKVIGIDAYGSVLKKYHETKEFDSGEIYPYRIEGLGK
NLIPSATDFEIIDRFVKVSDEDSAHTARELAKTEGLFVGYTSGAATQGLKQLAEEGEFDE
NSKVVVIFPDHGSRYMGKVFSDDWMEEQGFFDTKNEIEAQPIEFIK
>IFAGANLK_03457 Dipeptidyl aminopeptidase BI
MKKEILPPKAKKIPKTLEFHGDVRIDNYYWMNNRDNPEVIDYLNKENEYNQKMTAHTKDF
QQRLFEEMKGRIKEDDESVPYKLNNYWYLTRFETGKDYPIYSRKKRELNAPEELLFDVNH
MAEGFEYYSLGGLNVSPDNKMVAFGVDTLSRRKYTIQIKDLQTGEIYPDKIENATGGSTW
AADNKTLFYTKKDEQTLRSYRIYKHILGTDSAEDELVYEEEDETFNTYVYKSKSKKYIII
GSHSTLTTEYRILKADDPSGEFKVFQPRERGLEYSIAHYEGDFYVMTNKDKATNFKLMKT
PVDKTTKENWVDVIPHREDYLLEDIDIFKKYLVVSERHNGLNKIKVIRWDDSEEYYIPFD
NETYTAYTSINPAFNTDILRFTYNSMTTPTSVVDFNMGTREKTVLKEQEVLDENFDKNNY
LSERIWANAKDGTKIPVSLVYKKGTKLDGNSPLLQYAYGSYGSTIDPYFSTVRLSLLDRG
FIYAIAHIRGGEYLGRIWYEDGKLFNKMNTFTDYINVSEYLIQEKYTSAAHLYAMGGSAG
GLLMGAVINMAPQLYNGVISAVPFVDVVTTMLDDSIPLTTGEYDEWGNPNEKDYYEYMMQ
YSPYDNVVAQDYPNMLVTTGLHDSQVQYWEPAKWVAKLRELKTDNNLLLFHTNMDAGHGG
ASGRFEALREVAEEYAFLLDLEGIDH
>IFAGANLK_03458 Nucleoid-associated protein
MFGDMMGMMNKIKETQQKVEETKERLKTVTIEEKSSDGLLKVTISATREIKNISVADELM
EDKEQLEDYLVLTLNKAISKASDIHEAELAAVAKDGMPDIPGLDQLK
>IFAGANLK_03459 Thiol-disulfide oxidoreductase ResA
MKNVLPRKEVPRLRVETTSGMQWDLRDQKTENFTIVIFYRGLHCPVCKSYLEELNKKAEK
FQDRGVDVICISANNKSLAEKTVKEWDVDNLTIGYDFNPEDARKWDLYISEGMKDEPEVF
FEPGLFLIQPDNTLYAASIQTMPFARPKFNELLKAIDFILDKDYPARGEA
>IFAGANLK_03460 L-allo-threonine aldolase
MKEIDLRSDTVTRPTSGMLKAIMSAEVGDDVYKEDPTVNALEEKLAKMFGMDEALFFPTG
SMANQAAIKLHTQPAEQLICDKWAHVFNYEGGGASFNSGVSCKLVDGDRGMITAAQVEEN
INPPDFYHSPLTSLVCLENTTNKGGGACYDLEEIKKVRKVCNTHKLGLHLDGARLFNALV
ARNEDPKDYGKLFDTISVCLSKGLGIPMGSVLIGDKKIMKNAIRVRKILGGGMRQVGFMA
AAGIYALDNHVERLTEDHKRATEIAETLDAGSYVGEVEPVETNIVIFYLKNASDETAFMK
KLQQENIRISNMGQGKLRIVTHLDYPEEMHQKFLKVLRETKL
>IFAGANLK_03461 hypothetical protein
MKQFLLILLLVSFSVPVTAQFLSEKENLQEYEGFFNFHYNEEKDEIYLEVDKLETEFLYV
HALTSGLGSNDIGLDRGQLGNEAVVKFQKAGNKLLLVQPNQKYRAETENELEKRSVEQAF
AKSVIYGFEIKEEKDSVYVIDFTPFLMEDAHDVAVRLKKGNYGTYKLDKSKSALSLERTK
AFPENVEFEALLTFEGEPKGRTVQSVAPNAKNLSVIQHHSFLKLPDDNYEKRIFDPRSGS
ISISYLDYSTPVYEPIEKKFAIRHRLKKKNPEAEISEAEESIIYYLDPGTPEPVKSALLE
GARWWDQAFEEIGYKNAFQVKMLPDDADPLDARYNMIQWVHRSTRGWSYGASVVDPRTGE
IIKGHVSLGSLRIRQDFMIAQALLNKPFAESDKNHEKMMEMAVARIRQLSAHEVGHTIGF
AHNFAASVNDNASVMDYPHPQYRWENDEISIDNAYDTGIGEWDKVTVKYSYADIPKNTSE
REFLNSVLEEAQEKGLQFISDADARAQGGAHINAHLWDNGQNATEELEEILKIREKGIEN
FSEDNIRTNEAYSVLEDVFVPLYFLHRYQVEAAVKIIGGLDYNYAVKGGKDKLWESADLK
MQDNALSSILKTLDAEVITIPKEKLELFPPRAFGYNRSQESFKSNSGVAFDALGAPVTAA
NLSLSLLLHPERMVRLVQQKALDKKQIGPEEVLEKLISETIKKSHRDEYLNEVQQAINYQ
VLLQLIKLAENESATTKVKALANVQIDDLKDWLRNKDAALHQQMFREIENYRENPSEYKS
KMNVPKIPDGSPIGSFRCERMDF
>IFAGANLK_03462 Peptide chain release factor 2
MRDLNTEKQWVDEFEKGETLVEDLDVLYEFYKEDEATQEDVEEKYKQAVDLIEDLEFKNM
LSEEGDKLSAVLQITAGAGGTESCDWAEMLMRMYLMWAEKRKFKIKELNYQAGDVAGIKT
VTLEIEGEFAFGWLKGENGVHRLVRISPFDSNAKRHTSFASVYVYPLADDSIEIDINPSE
ISWETMRSSGAGGQNVNKVETAVRLRHAPTGIVVENSETRSQLENKTKAMQLLKSQLYEI
ELQKQQAQRREIEDSKMKIEWGSQIRNYVMHPYKLVKDVRTAEETGNVDAVMNGDIDIFL
KAFLMMMGQRQED
>IFAGANLK_03463 Arsenate reductase
MITVYHNARCKKSREGLEIVKNTGKEYEVREYLKEPLSEAELKQILDKLSFYPMQLIRTN
EKIWKEEYKNKDLSDKELITVMVKNPKLIERPIVETKNKAVVGRPGSKIEDLLQ
>IFAGANLK_03464 hypothetical protein
MKTQHKIAIIGAAGFLVAGFIFSHFYLHRKSRKELLEIARELAYTWKRELELDFEQTGKL
EDLIIEYTLKKNEILNTTALTEDEIIFKLKEIQKAEHKKLQKLMSKKQFEKYLELNKKIS
RKS
>IFAGANLK_03465 hypothetical protein
MTTKILSTLSIAFFLFFSLSGFAQSGPHKVSGKVMDEEMDAPLEFATVSIVNANDPADVT
GVVTNSQGNFSIEVPEGTYNVIVEFISYETKRFNDRKVDSDLSLGTITLGLDSDSLDEVL
VQAETTQVSVQLDKKIYNIGKDLTTAGGTVSDALNNVPSVSVDVEGGISLRGNQNVRILI
NGKPSAMAGFGDTNVLSQLPAEAIERVEVITSPSARYDAEGTAGILNIILRQKETLGFNG
SVNLNLGHPDNAGLSANLNYRTNDFNIFTNIGWRYFDAPQNNFSDTEYLRRFNSDGEIIR
PEYERIREERETERLNRNYNGNIGIEYFLTEQSSLTASLFYRYGEDEDETLNNSDRYNGG
SLVEETLRRELQSEEDNSYQISINYQNKFNDEGHELTADFQFENDAEVQNTYINEDYIST
DQDNPGAFQREEVYTEEDQKEYLIQADYVLPLGENARFEAGYRGNFENEVTDYRLQQEDL
ATGNLVTNDTLTNIFDYEENVNALYSQYGTKFGKFSFLLGLRLENTQLKGDIDSRLSDEE
LVAAFGFPIQTEFDNNYLGLFPTVNLIYELSSDGGEEENITVGYNRRINRPRGWYINPFP
SRSSRTNVFQGNPNLQPAFASAFDIGYLKRWEKLTFTTSVYYQHETDSFERVEENTGQET
TDGIDIIRTIPINLATNKRTGGELGILYNPADWLRLNSSFNFFQFETEGEFNGIDYGAKN
TSWFARFSSKVTLPGAVDWQTNAFYRGPQENAQTKNEGIFSIDLALSKEILNESVTLSLN
VRDLLNSRKRKSFTSTEFFNRESEFQWRQRQINFSVIYRFNQQKREQRRGSDEDFDDPGF
EG
>IFAGANLK_03466 hypothetical protein
MFEFDQYLGFLAFLVILTMGFWLMIFLMAILPYWIGGSVAELLKEKKEARKKAKEEKA
>IFAGANLK_03467 Fumarate hydratase class II
MDYRIEKDTIGEVKVPADKLWGAQTERSRNNFKIGPAASMPLEIVYGFAYLKKAAAYTNC
ELGALPVDKRDYIAQVCDEILEGKHDDQFPLVIWQTGSGTQSNMNVNEVIANRAHQLAGK
TLGEGDKTLQPNDDVNKSQSSNDTFPTGMHIAAYQKITKVTLPGVRQLRDTLKKKSEEFK
EVVKIGRTHFMDATPLTLGQEFSGYVAQLDHGINALENTLPHLAELALGGTAVGTGLNTP
KGYSKRVSEFIAKFTELPFISAGNKFEALAAHDAFVETHGALKQIAVSLNKIGNDIRMLS
SGPRSGIGEINIPANEPGSSIMPGKVNPTQCEALTMVCAQVMGNDVAIGVGGMQGQFELN
VFKPVMAANLLQSAVLIGDACVSFDVNCARGIEANTPRIKEHLNNSLMLVTALNTKIGYY
KAAEIANKAHHDGTTLKKAAVELGHLTEEQFDEWVQPKDMVGNIK
>IFAGANLK_03468 Cytochrome c biogenesis protein CcsA
MQNKIASVIFSTRIMAVLFVVYAIALAFGTFIESWYSIETARVLIYNAWWFEAIMVFFVI
NFAGNIKRYNLHKREKWSSLLIHLSFVLILVGAFITRYISYEGVMPITEGETTNIMLSEK
TYFTAFIDGEIDGEPRRRVLEEPVLFAPETENDYVLNTDYNGQPVTIEATNFIYGAKEEL
VPADDGENHLKLVEAGGGNRHDHYLKEGEVQNIHNVLFALNEPTDGAINITYEEETGKYT
INSPFEGDYMRMADQEKGDLAKDSTQNLMLRSLYNIGTMQFVIPEPVVKGKYDIVKTPEK
TDGQSDALTVKVTSEGEFETVTIMGGQGIPSEPHKVEVAGLELFLNYGSKEIELPFALKL
NDFIANRYPGTENSYSSFKSKVEIVEEGKENVPYEIYMNHVLDHKGFRFFQASFMPDESG
TVLSVNHDFWGTWVTYIGYFLLYLGLMLILFDKGSRFGNLKDMLEKVKDKKKKLTTVLIF
FMATGSMFAQIPGDEHEHAESAKREVDSIIKSNAISEEHAADFGRLVIQDAGGRMKPANT
YSSELLRKLSKSDSYEGLNSDQILVSLTQNPMIWYNVPIIYVEKHNDSLHNLLGVKQGKK
YLTLSSFFDETGNYKLSPLLEEAYQAAVPNKFQKDFINTDKKVNLLYRALQGKILRIFPI
PEHKNNKWVSYPELEDEEGAFKGMDSVYTKQILPLYMTSLSDAVETGDYSKANQFLESIK
GFQKKFGSEVLPSQDRIDAEIAYNKYDIFRNLFWMYMVAGLFMLVIVIVKIFKENNLINW
LVKISAGVIILLFVLHTLGLIARWYISGHAPWSDAYESMIYVAWATMFFGLAFGRKSTLT
IASTAFVTSMILMIAHWNWMDPSIANLQPVLDSYWLMIHVSVIVGSYGPFTLGMILGAVA
LLLMIFTTEKNKKKMDLNIKEITIITEMALTVGLVMLTIGNFLGGQWANESWGRYWGWDP
KETWALISIMVYAFVIHMRLVPGLRSRWFFNLMAVVAFASIMMTYFGVNFYLAGLHSYAS
GDKVITPTFIYYAIAVVALLGAVSYWRFQKFYAKKSKKKIEK
>IFAGANLK_03469 hypothetical protein
MTEVVILGAGNVAFHLFKAFSKAENTRVIQVYNHRKESLKYFEEHTDTTSNISDLKPAYF
YLLALKDDVIYEISENLKDIPGIALHTSGAVSIKTLERLDNFGVFYPLQTFSKNKSVDFA
EIPVCIEANSAKNLGKIKKLALEITKDVREIDSEQRKALHLAAVFVNNFSNHLYTIGAEI
CEKNQVDFSILKPLIKETASKIESLSPEAAQTGPAIRNDQKTIEAHLALLSKNHKDIYSL
LTQSIQHFHGKKL
>IFAGANLK_03470 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC
MEKNYKEYLNQINTFVFDVDGVLTDGSIQISTEGELLRTMNIKDGYALKAAQNAGYTVCI
ISGGKNEGVRKRLKDLGITDIYLGIHDKVEQMDEFFDIYEINAEDVLYMGDDIPDYYPMK
LVGLPCCPQDAVTEVKEISKYVSHRKGGKGCVRDVIEQVMKVQGKWIDKE
>IFAGANLK_03471 Quaternary ammonium compound-resistance protein SugE
MNWIILIFAGLFEVGFAFCLGKMKVTSGNTSTLWFVGFLVSLTLSMLLLYKATQTLPIGT
AYAVWTGIGAVGTVLLGIFIFKEPAHFWRIFFLSTLIISIIGLKFVSE
>IFAGANLK_03472 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MAYLKLIRWSNLIFIALTLILVKFSFFEEFGAAITLSTFGYALLTLATLCIAASGYVIND
IYDVQADKINKPEKLIIGNKISEKKANNLFIILNVIGVGIGFYLSNLLGKPGFVAIFIFS
SALLYLYASYLKQIPVLGNVLISLLVGFVVLLPSVLDLFPAINAQNKQIQSLLFSILLDY
AIFAFLINFLREMVKDQEDVNGDYNVGIQTLPIILGHRRTNKIIFAIGILPVAAIVSYTY
NYLIENTFLVIYALVFILAPLLYFQVRIWEAKKKKDYAHLSLILKIILFFGLISIGFYQF
ILTS
>IFAGANLK_03473 Septum formation protein Maf
MLKALLKNKEIILASGSPRRHQFFKDLDIPFKTDVRPVKEVCPDYLKKEEITDFLAQLKA
EAFQKELKKDQILITSDTIVYNKEKAMGKPETAAEAKEMLRSLSGKTHSVFTSVCFTTRH
HQSTVNCETKVTFKDLTSGEIDYYVENFKPFDKAGGYAIQEWIGLIGISNLEGSYFNVVG
LPTHLVYNELLDLASF
>IFAGANLK_03474 Low conductance mechanosensitive channel YnaI
MLEVFTQYRTEITYTIITVFALLIVQFLLKKAAHRVGKRSEIDFTRTRLMFKYINILILF
IAVFLLAIAWGMGLTELSLIFSSVFAVLGVALFAIWSILSNITSGVILFFSFPYKIGDKI
KIHDKDMPIEAIIEDIKAFHLHLRTLEGELITYPNNLILQKAVSLIAKDVYLDGDKSSL
>IFAGANLK_03475 Mycothiol S-conjugate amidase
MRKLFSLLFCFFLLNLHAQEPEKLNASEIFQEIKKLNFLGSVLYIGAHPDDENTRLISYF
SNEKNARTAYLSLTRGDGGQNLIGPELREQLGLIRTQELLAARRIDGGEQFFTRANDFGY
SKTPEETLEIWDKEKVLSDVVWVIRNFKPDVIINRFDHRTPGSTHGHHTSSALLSLEAFD
AAANPEKFPDQLDYTETYQPKRAYFNTSSWFYEGEEAFEEASKDRFISFDTGVYFPLLGL
SNPEISSLSRSQHQSQGFGSTSSRGRQIEYLEPIKGDTIRSQDVFEDIDISWNKLKGGAE
IGEILNEVEENYSFTDPAASLPKLLDAYKLIQELPNEHWRKLKTKEIKKIIFASAGLFLE
AVASQPSATPEDSVVVNLEAINRSDFPVTLSSVELSPNNSKIQPDVKLKNNEDWQNEIAL
KVPGRTSYTTPYWLKEESKNGMYIVKDRELIGLPETPTHTKAVFNLDFNHVSLSFEKPIV
YKYNDAVFGETYQPFEIIPQVSLAFEDDVIIFENQESKKVSIKLTSGKPNIQGEVSLSAG
KNWNIKPENHKFQLQQKGSSVTVTFEVSPPKDQDETFIIPTATINGKEFSEKLISIDYKH
IPKQNLVVPSKLKVARLEIEKKGELIGYIEGAGDVVPESLEQIGYRVNKLNVASISQASL
RKYDAVVLGIRALNTVEALKYKQQVLLDYVKNGGNLIVQYNTNRGLVTKNISPFPLELSR
DRVTDETAEVRFLAEDHPILSSPNKITEKDFDNWVQERGLYFPDSWSEEFTPILSMNDEN
ETPKDGSLIVAKYGEGYFIYTGLSFFRQFPVGVPGAYRLFANMISIGK
>IFAGANLK_03476 Sodium/glucose cotransporter
MQLIDWIVLLGTLAFIVIYGVYRTRNTQGAQDYIRGGNETRWWTIGLSTMATQASAITFL
STPGQAFHDGMGFVQFYFGLPIAMVVICMFFIPIYRRLNVYTAYEYLESRFDRKTRTLTA
VLFLIQRGLAAGLTIFAPAIILSAVLGWNLSGLTVLIGSLVIIYTVAGGTKAVSVTHKQQ
MAVILTGMFAAFFIILSYLPENINFSNALEIAGASGKMDILDFSFDFENRYTFWSGIIGG
SFLALSYFGTDQSQVQRYLSGRSVNESRMGMIMNGMLKVPLQFFILLVGVLVFVFYQFNN
APLNFNPAATETVLNSDYGNQYEDLMLEHDEIQQEKQNLHLQFAENNNFTPENNSTYREN
LATLNASENETRQKARKLIDASDKDAESNDKDYVFIHFILNNLPRGLIGLLLAVILSAAM
SSTASELNALSSTTSIDLYKRSRKTEMSDEHYVKASKWFTLLWGAIAIAFASFANLFDNL
IQLVNIIGSIFYGNVLGIFLLAFFIKIVNSNSVFVAAIITQLIILILYKINVMPYLWLNL
VGCILVMALALILELFIKTPEHKIKKNS
>IFAGANLK_03477 1,5-anhydro-D-fructose reductase
MKNIKWGILGLGKIAGKFATGLKDVEGAELYAVASRSKTKAETFAKEHNATKLFSSYEAM
LQDEELDVVYIATPHVFHYEQTLLCLDHKKAVLCEKPFAMNKKQVEKMIAKAKKEKVFLM
EAMWTQFLPHFKFVIEQIKSEKYGKIKNLKADFGFPAPVDLDKRLYNKKLGGGSLLDIGI
YPIFMAMSALGIPERIQAKAGFHETGIDEDCDIIFEYKNGVEAELGSSIIKQTPTTAIIQ
FEKATITIKTRFHEPSSLIIQTSEGEEIKEFEVNSNGYNFEAEHVQNMLREGRTESSEMT
FEKSLRLIALLDKVRTEIGLEY
>IFAGANLK_03478 Thioredoxin reductase
MSDKIERIKTLIIGSGPAGYTAAIYAARADLKPIMYTGMEPGGQLTTTTEVDNFPGYADG
VDGPKMMMDLQKQAERFGTEVRMGMVTEVELSDKPGGIHKACVDNATWVEAESIIISTGA
TAKYLGLPSEQRLRGGGVSACAVCDGFFYKGQDVAIVGGGDTAAEEATYLANICSKVTML
VRGDQMRASKAMQHRVNSTKNIDVRFNTEVDEVIGEQVVEGLRMINNETGEKEQIEITGL
FIAIGHKPNTDIFKGKLTMDDTGYLITEGKSTKTNIPGVFASGDVQDKIYRQAVTAAGTG
CMAALDAERYLAEIESEEGEEVKTTKKVEA
>IFAGANLK_03479 hypothetical protein
MELTLFNILDILGTIAFAISGALAAMDRRLDLFGIFIIGFVTAIGGGTLRDTLIGNTPVT
WMENTIYIYLIGAVTILAIIFRNKINYLKKSLFLFDTIGLGVFTITGVEIGIRNGLDPII
CVALGAMTGTFGGVIRDILCNEIPVIFRKEIYATACIFGGLVFVIMHEFGVNRDIIYLTT
TLIVISIRLVVVKYHISLPYFYISSENKN
>IFAGANLK_03480 hypothetical protein
MRSIGYLLIGIFFGIVMFKSEAASWFRIYEMFQFQSFHMYGIMGSALLLGVIGVQIIKRK
NLKSFFGERISFIPKEKGFSRYMYGGIIFGLGWALAGACPGPIFTLIGAGFLPILIVFIG
SLLGTFLYGLLRKRLPH
>IFAGANLK_03481 hypothetical protein
MEWIFEPWPWYVSGPLIAFTMFLLIFIGKQFGMSSNLRTMCTMCGADSKADFFDFDWKSQ
RWNLIVVAGAIIGGFIGANLLSDDLSVAINPDTVTILEDLGFNSAGKAYLPTEIYSWEAV
GGIKALIILLVGGILIGFGARYAGGCTSGHAISGLSNLQLPSLIAVTGFFIGGLVMVHLL
FPLIF
>IFAGANLK_03482 Hydroxypyruvate reductase
MQKFNKIICVDHTKLEDWAIEELQEYSESKVEVYRESPDSEKELLERIGEAEAVIVSWKT
QIPESVIKECGNLKYIGMACSLYDDESANVAVDFARDQGITVKGIFDYGDPGVIEFIVSE
LIGLLHGFGKHQWREMPVELTDKKIGIIGLGTTGQMLAEALLPLGADLYYFSRSRKKEWE
TKEVKYLNLKELLKITEIISLHLPKNTKLLGEEEFKAFGSGKILINTSLGLPFEEKAFVN
WIKPDGNYAIFDGDGGASLSEETKKINRVTSHTKSAGWSAETQRRLSEKVLENLKSYFKK
>IFAGANLK_03483 hypothetical protein
MENNELANRVLELRNRKGFSQEFLAEESGVSLRTIQRVENGETQPRGDTLQRIAKGLGVT
SEELIDWKLEKNNSYLTQLNSSAISFLFFPFLGILIPLVMWISKKNEIHNINKTSKEILN
FEITWCLLLSFCFIIYIGSNFYRVKSASEISPSLLLNPAFLWLSVCFLYLLNLVLILFNS
SRLKSGKEALYYIRIPFLK
>IFAGANLK_03484 Propionyl-CoA carboxylase beta chain
MSHNIEKLNDKIKQAHLGGGEKRIAKQHEKKKLTARERVDYLLDEGSFEEIGILVTHRTT
GFGMEDQKIPGDGVVTGYGTINGKLVYLFAQDFTVFGGSLSETHAEKICKVMDLAVKVGA
PMIGLNDSGGARIQEGVKSLGGYADIFHRNVKASGVIPQISAIMGPCAGGAVYSPAMTDF
TLMVQDTSYMFVTGPNVVKTVTNEEVTSEELGGASTHATKSGVTHITSFNDIACLEDIKK
LVVYMPQNNKKAPEKLPYELGDEVRNELDSIVPDSSNKPYDMHEVIKGIIDEDSFFEIHK
DYADNIIVGFARLGGRSIGIVANQPMSLAGVLDVDSSKKAARFTRFCDCFNIPLLVLVDV
PGFLPGTDQEWNGIILNGAKLLYALSEATVPKVTVITRKAYGGAYDVMNSKHIGADLNFA
WPTAEIAVMGAKGASEIIFRREIQAADDSEAKLAEKEAEYAETFANPFEAAQRGFIDEVI
MPRDTRRKLLKGFSMLENKEVLRPKRKHGNIPL
>IFAGANLK_03485 Acetyl-/propionyl-coenzyme A carboxylase alpha chain
MKKILVANRGEIALRVMKTIQKMGIKTVAVFSKADRNAPHVKFADEAVCIGEAPSNESYL
KGDKIIEVAKELGVDGIHPGYGFLSENAVFTENVEKNGITWIGPGSKAIKIMGSKLAAKD
AVKDYDIQMVPGIDEAITDPEKAKKIAKEIGFPILIKASAGGGGKGMRIVEKEKDLEDQM
KRAISEAESAFGDGSVFIEKYVSSPRHIEIQVLADAHGNYIHLFERECSVQRRHQKVVEE
APSVVLDSKLRKQMGKAAVKVAKACDYVGAGTVEFLFDENQNFYFLEMNTRLQVEHPVTE
YITGVDLVEQQIKIARGEKLRLLQEDLKITGHAVELRVYAEDPLDNFMPSVGILEKYTIP
KGENIRVDNGFEEGMEVPIYYDPMLAKLITYGKTREEAIQLMLKAIKQYEVEGVMTTLPF
GKFVFEHEAFRSGNFDTHFVKNYYSAEKLENEIEEEAKLAAIVALKQYLKDQQELRLPAN
>IFAGANLK_03486 Glutaconyl-CoA decarboxylase subunit gamma
MKKKYKVKVNNSFEFEFTKDQITALDTQEIATKHYHLLKENRSFKAEVLTENFLQRKYDI
KINSNTYKVAISNELDLLIEEMGLSLGTAQMINDIKAPMPGLILEVNVEEGAEVKEGDYL
LVLEAMKMENTLTAPRDGVVKSVSVKTGQTVEKNQLLIEME
>IFAGANLK_03487 Hydroxyacylglutathione hydrolase GloC
MKIKQFKDDPLAHYSYALVSNGEMALVDPSRNPMQYYKYAEENNAKLVAVFETHPHADFV
SGHLQIQQETGSTIYISKKVGVEYTHTPFDEGDEVKIGNASIKAIHTPGHSPDSLTFIAE
ENGETIMFSGDTLFIGDVGRPDLREKAGNMKAKRVELAKQMYKTMQTKFNDLPDDTIIYP
AHGAGSLCGKNMSDASSSTLGNERQGNWAFKDQTEEEFVKEILKDQPFIPSYFGFSVELN
RKGAINVQKAKYEVPVKLYVDSVKKEGITVVDTRDGDAYKKGHLPNSINIMARSESDKFE
TWLGAIIEPEEEFYLVAEGVDQIDELLERTAKIGYEKQMKGVVTLSEKVSKSSDEFNLED
FKANKDKYTIVDIRNESEIAEGKIFDDAKAIPLNELRNRADELPDDKPFMVHCAGGYRSA
AGSSILENKFKNTKVYDLSEAIKEFS
>IFAGANLK_03488 hypothetical protein
MEKYLNIIADSFSGYFNYLVNEISNPSWTNYFYWLIGLSLLVWILEIIIPWRKAQKIFRK
DFWLDTFYILFNFFLFSLVGYNAISNVAVELFNDFLGLFGITNIVAIEVQNFPIWVQLLI
MFVIADFIQWNVHRQLHKQPWLWEFHKVHHSVKEMGFAAQFRFHFMETIVYKTVQYIPLA
MIGFGIQEFFVVHMFAVFIGHLNHANVGWNYGVFGYLLNNPKMHIWHHSKALPEDRPYGM
NFGLSLSIWDYLFGTAYIPQEGKDIELGFEGDEDFPKDFKNQMVFPFRKKNAQKTVYNLK
ESKK
>IFAGANLK_03489 D-threo-aldose 1-dehydrogenase
MSQFKLQRKFGLGGVAIGNGFKPLSDAEAEKTLEGAWEAGVRYYDTSPWYGLGLSERRFG
HFLHNKKREDYVLSTKVGRVLKATKNVPETMWNNPAPFDYKYDYSAEAVRRSIEDSLQRL
GVESIDYAFIHDLSPDHNDDYEEGTTWEDHFEVARTGAIPELQRMKEEGLIKAWGMGVNT
LDPILKLLEVSKPDVFLSAIQYSLVHHKDALERLLPAIEKSEATLINAAPFNAGLLAGQK
RYNYAGEMPDDISERYKNILKIAEKHKVNLVAASLQFSLAPKVAGTVLAGASKPEQVQEN
IKALEEKIPAEFWSDLKKEKLIEEKAEVPA
>IFAGANLK_03490 hypothetical protein
MILPAGYETQALEGARQFVPPNAQKVSGLYGELVDFTYKNPLLLNDIELAMVFHHKFVWI
HPFFDGNGRTVV
>IFAGANLK_03491 Inner membrane transport protein YnfM
MNDIKLGLKENWKQFSLLVLVNAFVGGMVGLERSILPEIAEKEFGIAATSAILSFIVVFG
VVKAITNYYAGALANRFGRKNLLVLGWIFAIPIPFILIYAENWNWIIVANVLLGINQGLA
WSSTVVMKIDLVGEKQRGFAMGLNEFAGYFAVAVVAFLTGWIASEYGVRPYPFYLGIVLM
ILGLLFSIFFIKDTRHHVAKEEGSSGMSRLKNIFWDTTWKDKNLGSVSQAGLINNLNDGM
AWGLFPILLSGKGFNLEQIGIVTALYPAVWGIGQLFTGKMADIFSKKDMLFIGMLLQAIM
LVILIWAETMTHFVILSSLLGWGTAMVYPTFLATIADNTHPQDRAKSIGIFRLWRDMGYA
IGAVLTGVIADLVNIEAAIMLIGILTLISAIIILFRMDYKDNKALKLLKLKN
>IFAGANLK_03492 hypothetical protein
MLLWQAGRFRTFAFRIYKFNYLKSLQLPTFLFIFLLNLHLSAQNKEIVKEDEPKLKDDFT
EGHFHGHIRNFYMNTINRGELKDYYTNATGGAVSFTTGNFKGFQFGVKGIFTYRTFGSDL
GVRDAVTGKNAKWEYELYDVLNKGNFQDLNGLQGLFIRYRFGNSYISYGKLETEFSPLLN
NSNGRMKPFAHRGAWSHLNISENHQLNLGWLDGVSPRSTTGWFAMDEAIGLFYNGFQPNG
EVAVYREIYSTTGIGILNYHFRKDNFQMNFYDFYLDKVMNTIWTELGYDLADFNLGFQYV
YQNPLSYSEDLASVNRYVQPYENGQVLSSQLSWKKTRFNVAFAYTHAFDSGRFLFPKELG
RDRFFTSIPRSRLEGLGNTDVFTIKAEYHLPKPNLHFGLEMQQLDGPETGKLKFNKYNID
ESFQVNSHLSYQAHGFLEGLSFDILWIFRENQNHTDAQSIFNKSNFNQLNFVTNFNF
>IFAGANLK_03493 Alpha-acetolactate decarboxylase
MGIQKTFFLFSLLIGFSALAQNSSVNVAGAMKNVMMKGELGGSISLDSLANKGVYGLGPI
EFLRGELLLLDGIIYNSSVGDENSMQVEEIESVKAPFFVYAEVSKWKSVSLPSSVTSLKS
LEDFLDKLTPKNHEAFPFRLKGKINSADIHIVNLPKGSKVSSPKEAHEGLTNYNLTDKKV
EILGFFSRKHQAIFTHHDTFIHLHLITEDQKEMGHLDQVDFDPKNLKLYLPE
>IFAGANLK_03494 hypothetical protein
MQLKSYIAIFLAVVFFGKFLMLDAKVLNSILDTEEIALVNPFCKKKIHPLGSTDTYSQES
SILIISSDALCNSPFHLSKISLPEPQKVNNHLDFGYLNPTVISIYFLKNYPPPKVLVA
>IFAGANLK_03495 hypothetical protein
MNTKILVSRRSIQVLRGMLSGIFLVASFNHLLNLEKTVNRIDQANFKGIAYFFGNPELLV
MISGIVMLIAGVALLLGFKTRWTAAVLLAILIPITLTVQVGQITTLGPLFKNVAISGGLL
FFILNDFKDQQKT
>IFAGANLK_03496 hypothetical protein
MKKIILIFTAFLMLFSVKTQAQKHDTEKNNYVVLTKKIPQLQPILITAEELKKEDGHHFG
DFQVIVCGQTVKGLINLEEMKKFTHRAEKAGVELKACGFSLKKFGVDPEKIPSEMEIVEN
GILYDFQLQKKGYFSIEL
>IFAGANLK_03497 Trifunctional nucleotide phosphoesterase protein YfkN
MIFNKKIKSILLLFSGVLGLTLFTSCLNAEGKDKEDRKENATKITILQTADIHGQLDAHP
ELFWENEEIVFKERGGLAHIQTLFEEERAKNPNTIILDGGDLIQGSGYAALSEGKIFPDI
IKNMDYDLIVPGNWEVVYGKQVMMDVLQGFETPVIVQNMFHDKDQKELFPPYWTKEIEGV
KLGFIGINDPDVPVRQNPIFSEGIGFSGLEDGVEEVIQKVKNEEKVDALFLVTHFGIFKQ
VELANSQIAKDVDYIFGNDTHERVREPIQGKYAKVTEPGAFGSFVGKLDLYFKDGEIVDQ
KYELMEVDPERYPAAPEIAELVKKAKAPYEEYLETVVGYTETPLYRYLTVENPMDNMITD
AARWKTGADISISNGFRFGNPIVPENGEAAPITRANLWNLLPVNEKVKTGKASGKQIKNW
LENEMHNAFAQNSIERFGGWLVRFSGMEVDFDSQNEKGERIQSVTVNGAEMQEDEYYTIS
ACVRPGDPIDNLCRMSNVKDVEVKDYTIHEVVEEYLQKHSPVSPKLDGRAYCEYLGEKSF
STVPGTDYEFQ
>IFAGANLK_03498 hypothetical protein
MKEFWNERYADADYVYGKAPNEYFKEKIDEMQPGKILLPAEGEGRNAVYAAVLEWEVSAF
DISIKGKEKALKLAQTENVEIDYKVGGLPQLDYKEEQFDCIALIFAHFSEDKKDNYLKRF
KQLLKGGGVIIFEAFSKEQIDIQKDNPKSGGPKNAEMLFSKEELQTCFSGYEFEEFEDLI
TELSEGKFHQGKAAVIRFVARKPLN
>IFAGANLK_03499 Trans-aconitate 2-methyltransferase
MKETKSHWEEVYDKKSHQDASWYQETPATSLEFIKELELSECSKIIDVGGGDSNFVDHLL
KEGFRDISVLDISERAIEKAKKRLKEDAERVNWIVADASEFEATQVYHLWHDRAAFHFLT
ESKQIENYIRTLENSVASGGFVILATFSTEGPEKCSGRTIKQYSKKDLQELLKHKFQLLK
FKNIDHKTPGGAIQNFTFCCFKKK
>IFAGANLK_03500 Cytochrome bd-I ubiquinol oxidase subunit 2
MLYVVLFFLLFSLLLYVLLGGADFGAGIVELFSSARNKEHTRDTIYRVMGPIWEANHIWL
IIMLVILWVAFPAYFNVMIIYLHIPLSLVLLGITLRGVAFVFRHYDAVLDKSQFWYNWLF
RIGSFVTPVFLGMSFGALIGGEIIITEDYETYGFYDLFMQHWLSIFALLVGLFYAALCAF
LASTLLIGEADGKARKHYAKNSAFFTIVLVVLGFILISYGYFSEIKFAEDFIHNPISLAC
VGLSGILLFPLWKFIKKEYRIASRYLAGFQVVLILFAALYAHFPYIIITAEKEISLLENL
APESTISNLAIMLLIGGFIILPGLFHLMKSFNMIKLLEKPEKD
>IFAGANLK_03501 Putative cytochrome bd menaquinol oxidase subunit I
MENLDYARLQMAFTLGFHIIFACIGMVMPFFMVVSHYKWLKTRNPIYKRLTMAWLKGVAI
FFVTGAVSGTALSFELGMLWPEFMKHAGPIIGMPFSLEGAAFFVEAIALGFYLYGWNKLP
EKFHWFTGVIIGVAGVASGILVVSANGWMNAPSGFEYINGEFTNIDPVAALLNPAWFTQA
LHMTLAAFVATSFGVAGIHAFQIFRKRNVELHTKAFKIAIVFGAIAAFLQPISGDLSAKD
VAERQPVKLAAMEAHYETSKGAPLYIGGIVDEENRTVSNKIEIPKALSFLAFGDFNAEVK
GLNDFPDNELPPVAIVHYAFQTMVGIGTLLMFAGLIYFISLRKKSWLQNKYYWLLFIIIA
PLGFVAIEAGWIVTEVGRQPWIIHQIMRTEDAVTPMPGMKYSFFYYLFLYTILAITVTWL
MNRQIKSLNQETSEEKGTGNTLKKSFKPTGGNKNKD
>IFAGANLK_03502 hypothetical protein
MEILEILGYVGGLVIGIVLGLIGGGGSILTVPVLVYLLAINPVTATAYSLFVVGASSLVG
AFKNMQKKLVDFRTAIVFSIPAFIAVYATRKWMVPAIPESLFSVGDFEITKNIGIMLFFA
IIMILASVSMIRENGKKKTENEKISYNYPLIVLEGIVVGVLTGIVGAGGGFLIIPALVLL
AKLPMKKAVATSLLIIAIKSLIGFIGDVQNMDINWLFLAIFTGLSMVGMFIGIYLNKFID
GKKLKKGFGWFVLIMGIYIIWAEIS
>IFAGANLK_03503 Global nitrogen regulator
MLQELKEAYGFIFEDDLIEEIGEVGSLQQVAAGEKIIEIGDYVKMMPLLIEGAIKIMRED
KDGDELLLYFLERGDTCAMTLSCCLGQTKSEIRAIAERDTKLIMIPIEKMEEWTSKYKSW
RDFVFESYHARLNEMLETIDTIAFMNMDQRLMKYLQDKAKINQNEVIAATHQQIAYDLHT
SRVVISRLLKKLEIDGRIKLQRNSIEIMEL
>IFAGANLK_03504 hypothetical protein
MSFNQYEPFEEKLNVISHAFGFALSILGLVLLILRANEFGEMVHLVSFIIFGASMILLYA
ASTLYHSATNKNWRYRLNILDHASIYVLIAGSYTPFALVTLEGWVGWTIFGVVWGCALTG
IILKLFYIGKYRTLSTIMYVVMGWIIVFAIKPLYDNLSSEGLWWLIGGGLSYTIGAVLFS
LDKVKFNHAIFHIFVLFGTFCHYLSIYFYVLPG
>IFAGANLK_03505 Nuclease SbcCD subunit D
MKILHTADWHIGKKLHKHGLHPDFDLFTDWLCDCIAENKVEVLLVSGDVFDLANPSSEAR
QQYFKALMKLKRLDCKIIITGGNHDSPTMLNAPQEVLRELDIHIIGGLPNEISDCIIPIK
NKENQTELVIAALPYLRDADLRTASQGNAYEDRLEALRKGIQQTFLDAAEICKTQYPGVP
AIAMGHLFAAGAETSKSERDIQIGNQAAFNALQFGDYFNYIALGHIHKPQRVNAATPTFY
SGSPIPLSFSERSNRNRILLLNNETGWEPQNIEIPGFRKLLKIAGTLEILQQKLWELQPR
SGLASLIEIELKEENFDSNKIYELDQLVDNFKVEGYEIVKHRATFENKISGSGELYEEKQ
QLEDIKPLDVFQKLVDRQEEDEDTRQELLSAFNEILEEVHQSKQV
>IFAGANLK_03506 Nuclease SbcCD subunit C
MKILSIAFKNINSLKGENFIDFEASPFSGNTLFAITGPTGSGKSSILDVISLALFNQVPR
LGKISKKEIREKGAILTRNQKEAYAKVTYQTNAGRFTSSWSIEVNRNGNLNDYNMEIANL
QDNSILDLKKSEIPAKNEELIGLNYDQFIKSVLLAQGDFAKFLSAKKEERGELLEKITGT
GIYRQLGIMAYERFKAETSEIEKQQDEIKLINSYLLSDEDLEIFKKDLKAKTTQTESLQK
DLRLIEKQLELKQNIQKQEKEIIGIQAEELKLNAQLKEFENQYGESLKQHEKLQPITEEI
QSWKRFQQDLGDLKTGLNKTSEKIELNKENTSNFIQEVRSFIHEEVYVENLKEKLTDFTE
KIRKLQEEKTSLAHDYKSKLQLFKTEIREINLEFPENDLKAGKEILQNLKAEKTQQKQQL
ENDLKEVDLENIASEKNRLKTELEKSREARSFSEKNLEQKQKQSDLKKEIESLKPEIENL
PKTIQEEKTILISLKKDLEILQLKKENQLKTAQLKDLRKSLKTGEACPLCGSKEHPYSEH
FPDFEDDLAVKISAKSLEIDEHNSKLTQVQSKLLHLEDSLENVKKQLSEIEAKISKNEDN
FKKKNPEFEKPETINWERQIATLKAKIENIESFEAINPQLKAIAGGLPVLEELKKILQRG
KLLQQQLLEQYPGKNIGEDSQQLMDNWNSLLQEKKYLQENEKQQREQFHKKSKTYEDLKE
KLQQQVLEKDFESIENAYQSLLPGNKFFDLKKQKDDFLKQKSIVETGISTLKKQLKQFKE
NESERSTEDLTREQQQKQEAFESTQSNCEELRRKLNNNTENISHLKSLENQIAEKEKDCK
RWRLLNTLIGDRQGKKFNDFAQDLTLSQLIYLANIRLKDLSERYKIDKAMNGEDDGLVAI
DEDMGGQRRSVKTLSGGETFLLSLSLALALSDLASRNVEINSLFIDEGFGTLDPETLDQT
LDTLEKLQVESGKTIGIISHVASLKERIGTQIQLTRNGQGYSSLVVK
>IFAGANLK_03507 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
MGHHHHKNSSEKNLRLVFFLNLGFTIIEFIGGVYVNSIAIISDAVHDLGDSLSLGTSWYL
DHKSKQKSNSKFSFGYRRFSLLGALLNSLILIAGSVYVIYEAVGRLMAPEHSDAEGMMIF
AIIGVAVNGFAAWKLSSGKTLNEKVISWHLIEDVLGWTSILVVSIILQFKDIHYLDPALS
LVITLYILWNVFKRLKETLFIFLQGTPSDINLDEIKQNIEKIPGVASTHHVHIWSQEGEH
HVFTAHVKLEDINSVKEYLNRKSEVLESLKTYNFEHFTIQFELDSETCSLE
>IFAGANLK_03508 hypothetical protein
MLFLVGMLIYYAPLNASPFLQDSDQDYVEYKGEVINSNNEDVIVNAHLSVNETNISTVTN
SEGKFSLKVPKGSSPATVNISYLGYQSKNLPLSYFKPRGTIIYLEPVVEELSEVKVYEAG
DARRLVRNMLDNRGDNYIDDPTQMTAFYRESISKGNRNVSLSEAVVKIHKKPYSDFGEED
IELVKARKTADYERLDTLALKLRGGPFNTLFIDVMKYPDYLFYERDLDNYEFSFEEPTQI
DNRYLYVVSFEDMNKNMPWFFGTLFIDAETQSLVRAKLNMNVDNRRAATNMFVNKKPGGT
KVYPIEVMYDIDYHQQDGKWYFGYSNAQLLFVVNWKRKLFNSRYLVDSEMAVTNWHPQSE
DRIKKRDNFINKRVVMADDISGFTDLQFWGSNNIIEPDKSIQNAIEKIQENIQ
>IFAGANLK_03509 Monoacylglycerol lipase
MNRTLKQIFIFLIINCILFFSVVLILIYWPIPTKKSIENFNYSSIDTTATNSLSKAQEVW
IKTRNTQKLFTRIYASNTKTAVILIHGSGTESRYLAHLANSLSSTNLATVITPDLRGHGR
NISTEVDIDYIGQLEYDIEDIIHYAKENLGAEKVILAGHSSGGGLVLRYIGNTRLTNVDK
AIMISPYLGHDSPTVKPNSGDWITVGVKRWVGISLLNPIGITYFNEMPVLFFNRPRAYND
SLQVESYSYKMAVNFAPKDFEDEVKQLSTNSLVIVGERDESFYPNRFEKVFEPANSFVTV
NLIPEAKHLDIVKNDEVLAEIKNWISN
>IFAGANLK_03510 hypothetical protein
MDDNLNRIKTEIYEKCGFKISDFLLETESKEYEACRFDLNGRKIISRNAKITPKKVGQFV
TFWKRNGNGPIEPFKENDQFDFFTVNVKSENELGQFVFPKSVLMKKGIISTEKKEGKRAI
RVYPSWVNANNKQAERTQKWQLNYFYEITYPTDFKKVVGLYNTE
>IFAGANLK_03511 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
MANNHEHINCNRDNHNHNPAGNKRSKKSALSLAFWLNFFFSIIELIGGILTNSTAIIADA
FHDFMDAGAIGLAILLENVSDKKRTAKFSYGYKRFSLLAALGLSIFLLAGSVTMVFAAYN
SFINPKEIHSVGMLWLAVLGLAVNGFAFLRIKNEGGHHHQGHNHNSESIMLHLFEDVLGW
AVVLIGAAIIHFTGWNWIDGFLTIAIALYIGINASKNLINTLKVMLQSVPENVDLSHLET
DLHKIEGITNIHDLHVWSLDGSYNVGSLHAVVNNATGKAEQDILNKIIKLMRKHRIQHPT
VQIETNFNRCQLKHC
>IFAGANLK_03512 hypothetical protein
MDKVTVNKLLNRSTKPTSMRILVYDFLVTQNVALSLSEIEEQLFTADRTTIYRTLKTFEE
KGIVHSIQENTTTKYVLCDDECSESTHKDWHLHFYCKICKQTTCRENILLPNQIEGDFRI
DEIRFFAKGICENCLDESLQ
>IFAGANLK_03513 hypothetical protein
MDTQSTTLIPKLYVAIDIHKRSWKIHCSTDLFAGKSFSMRPVPEQLFQYGLVP
>IFAGANLK_03514 Gamma-glutamyltranspeptidase
MDVFNKFNFNFAITIHSMRLYILILISLLTLSCKESPEQLSSNSQSSKALVTPNAMVVSA
RAEASDIGVLIMQKGGNAFDAMVATEMALAVTYPFAGNLGGGGFMVYREANGNKGSLDFR
EKAPLAATKTMYQNEKGEVNSMASRYGGLAVGVPGTVAGIFAVHEKFGTLPIDTILKPVV
ELAKKGFVVTENQQNRLKKYQNEFLENNEDTIMFALDHKLGDTIKNEALAATLERVIRNG
RDEFYGGSTGNKIVAFLDRKGGIITLQDFKDYQVRWRNPIEVDYKDLKIISMPPPSSGGI
VLGQILKMLEHYPLTEYGHNNLPYIQLLTEAERRAYADRSYYLGDPDFVEIPTDSLLSDY
YLKNRMESFTPNQATPSNEIDYGRISGFESMETTHYSIVDSLGNAVSVTTTLNGAYGSKM
YIEELGFFLNNEMNDFSSKPGVPNMFGLIGAEANAIAPEKRMLSSMTPTIVERDNELFMV
LGSPGGSTIITSVLQTILNVQTFDMSMQEAVDAPRFHHQWLPDEILFEPKAFEEELLDSL
ELRGYEINQQDSQIIGKVNAIKVLSNGMLEGGADRRGDESARGY
>IFAGANLK_03515 TonB-dependent receptor SusC
MIKNYLVICFLFFGTLVFSQETEISGTVIDDQSQPLPGVSVAIKGTNQGTITDFDGNYSI
NASMGETLVFTFVGFDAREIVIDQTTIDVKMVAGTALGEVVLVGSRSRSRTVTESAVPVD
VLDMQEIQTAVPQVNLNQMLNYVAPSFSSNTQTIADGTDHIDPASLRGLGPDQVLVLING
KRRHNSSLINVNGSFGRGSVGTDLNAIPAAAIQRIEVLRDGAAAQYGSDAIAGVINIVLN
EEVGELNLNVTSGANFSKNANKQTGGIDGETVNVAASYGIGLGENGGFVNFAGDFDYREP
YNRMAEWEGSIFNAYNAIERVATNSGADISDLSDNQIKQFAQQVSYFDSDFQNDIASAED
RSALQGLLGMNVTEAELEARGQQRSDYNMRVGQSALRGGRFFANLSLPLDDNGTELYSFA
GISSRRGESAGFYRLPNQSRTYTPIYINGFLPRINSKIKDKSLSAGIKGMIGEWNVDFSN
TYGQNRFDYLISNTSNASLEGASPTSFDAGGFSFSQNTTNLDISKYFEDVFDGLNVAFGA
EHRWENYEINAGERASYEQYTEEGDVITNASQVPAQDFFGNARAGGSQVFPGFSPQNEIS
RERSSVAGYFDVEADFTDKFLLTFATRFENYSDFGSTINFKLASRYKLSENVNIRGAANT
GFRAPSLHQLNFNSTSTVFNDEGVPVEVGTFSNDSRAAQLLGIPELKEETSQSVSVGLTA
KIPDANLTFTVDGYFVAIDDRVVYTRQFRGPGTGTELDQLLSQANATAAAFFANAIDTES
KGIDAVITHNAVFGENLQLKSDLAATFSKTKQVGNIQASPELERAGLVDTYFPEDSRIYL
EEAVPRTKVNLSNSLVAGKFNFFLRNVYFGKVTEAISDPLRQQEFDGKVITDLSVGFKAT
DVLTLTLGSNNIFDIYPEAADPGFGNRSDGRFDWSRSAQQFGFAGRFLFARLSINLK
>IFAGANLK_03516 General stress protein 39
MEKDNKRLKNPVEKYKSEPFKEQEVPVVEKEMDPKPDHKEESYLGCNKLLGRKALITGGD
SGIGKAVAIAFAYEGVDVLISYLNEHEDAKETAKYVEETGKKAILAPGDIQEESYCKELV
EKAVKELGGLDIVVNNSAFQRFRESLQDISTEEWDRTFKTNLYPLFHIFKAAEPHLKPGS
TVINTTSVNASNPKPTLAPYTATKGAIQNFTASLGQLWAEKGIRVNCVASRPIWTPLIPA
TFPADEVSKFGQDKPLGRAGQQAEMAPI
>IFAGANLK_03517 hypothetical protein
MYHFVKGIANCISCNKEVQNALYNSNFLPNLLTIISGFLLLFIIVVLFTYFSTRRFQKNR
SLIRDKKILNPVPLSTASVVIGLGLGGFIDGILFHQILQLHGMVSNKLPITDLVGKAVNM
FWDGIFHATTFMAVLIGFVLLVRLLKRKNINPSPKLATGGALIGWGIFNTVEGIIHHHIL
KFHNVNEFAMNTDLWNYGFLLSGVLLLVIGYRVVYNRDHYPSRLE
>IFAGANLK_03518 Membrane-bound lytic murein transglycosylase F
MKIPILVVFLILFMACDFPKDPENSYQQAESGHLLVGITINPPFTQKTEDSLFGKEVSFI
KEFAEENKLKVEFMEGSESELIKKIEKFKLHLIIGGFDKKTHWKKKVGLSAPYDQKHVII
VPKGENKLLQKLETFIFNQKPKR
>IFAGANLK_03519 Ferrous-iron efflux pump FieF
MKSIHDFELPENLKKTLSKAIKLEWITLFYLLSVVILMYLVMGSSQAMKSAWLEDVLSLI
PSIAFLISTKIFRKKPNKEFPYGYHRVFSISFLTGAVALLGMGIFLVFDSSMSLIKAEHP
TIGNKMFFGQQIWMGWIMIAVLLYSALPAMVLGFKKLPLAKELHNKILFTDASAQKADYM
TAFAAILGIIGVGIGYWWADAVGALFISFSVLKDGVNHVKTSILDLMDRHPKTIKEQKDD
EKIEEIKQLVTSWEWVKDANVRFRENGQVYFGEIAYIPNGDIDLDQLHQGYEILRNHHWK
IHDFTIGPVKELPKW
>IFAGANLK_03520 hypothetical protein
MFEIKDIPKLFLAFFIILPIISLIHESGHVFFARILGAKNIQIVVGTGKTITRKWFFEIR
KYYFWYGFCYFDNIDESQRWRNILIYLGGSIFNIIAAFLMVYLVNTEWLEQGIFSYQFVY
FSLYYVFFAFFPMKYPDGNFSDGKILLDLLKNNYSLINQKKYRLAWEKEQHLWKLYDNQK
QEIKNFETLEEGLKKSVETAKRNRPSRLEIIKEKGLDEVKSFPRNPL
>IFAGANLK_03521 hypothetical protein
MRPEEILKHTEHRPWPIPDSSWKIYQEWQDVIFLHYKVDIDALKNYVPAELSIDTFDGDA
WISVVAFTTRNVKPRGLPSFSPLSDFHEINIRTYIKDGKRSGIYFLSLEAAKIISAELTK
LITELPYIFTEINREKGLFSGKNKDYNSFFDVKYEVKEIKEKDKLDSWLMERYALFQDGR
EHIIVFEVLHQPWELRNLNLTSKMIKYPPFAGFFINEPDRLGYSPGVEVLVWGKEKWKSS
IV
>IFAGANLK_03522 hypothetical protein
MRQVIIKIPKGNQDKIFQAISKYEGKNTFHFSSDEKEVYFTYLPNEKVNNFLKKIDELEE
PEIVLIPRGVVTLYPPASEAPHQATDVQIKSSLEIYLGGIQSVGSLFGLVAYSFVAGIIV
WIGLFTTTTYLLVAAMLVAPFAGPAMNAALGTAAGKMGLLKSSLGRYGVAIGTGIIASIL
MSLFFPLNTLTPLMEEVSQVSKFAIFLPLVSGLAGAINICQSERDSLVSGAAVGILVAAS
LAPPVGLIGIGIYMGDWQVVFSSFYRIVLQLLGIHLAATLVFYFYGKVTPNGIRFINGKK
RAGIITTAIVVLAIGSMMFWQFKQPPFYLKASLNTELTDELNSQLKKLDTSIAILNKSVS
FTNTKYKNTPVAIFKSTVMKKDPNISDSQLKTEIINHLKENMEYEIDNLYEVYQIDVVRE
>IFAGANLK_03523 hypothetical protein
MLQYNSSAITPTANFIDNLHTGIFQEILPGIFIIKGAKNDRGFDQAYMILNQKKELILID
AVEEAYQKAIANLLSNGFIIRAILITGKDVLNDCYIDPDSLSKSLGNAEVYISTDISPQG
VETKDLTDEDSLLKKFELEGYKVPKKEGQIILYCDRHNGIIFTGNSAMGSDYGGDEFIFT
RGREEDKEIALAVEEFWKGFIKEFEFLFPRQGKLGIQIDDRTRVTLLKRLSSGESGLK
>IFAGANLK_03524 hypothetical protein
MEQKEGDVQKYVFRIVGLSRSGNHAIINWIINQLQGDYLFLNCTEPKYNPYDTARPLDKE
GYTYRTNLYNFELNREKKGNFSKKKYLLFSHEDCFLGSLNKKEERKKIAGWVGSSEVQKD
ILIIRDPFNLFASRAKAGLLLGNIADHTTRPISEKVLCRIYKQHAREFLGENNNLRNKVI
INFNTWSSNENYRLKVAKALNIPFSDAGYREVTTVAGGSSFDGTNLSGMAHKMKVNERWK
NYAKDDNYWSLFDQELLEFSRKIFGNTPPAQFFEERNRK
>IFAGANLK_03525 hypothetical protein
MNKSGFKLGHRILIISVILIVGNYFLFLGLAKAKVFLAPFLTAVILSLVVLPLCKKFEKS
GAKRSLSSFTNTFLLFIISLGFIALVFFQMQSMVSKWPKIKETMKPKIEQLKTFAAEKTP
ISKEKIESKSTSSSIIESGSGQGKKSVSFLTKIMSFSGTYLLVFIYIFFLLNYRDRFKKF
LIRLFPDEKRKKVKNVIHQSAQVVQNYLLGKLILMGLLAVVYSIGLGLSGVSNFILVSII
AALLTIIPYIGNIIGLILAMAFGYLTSGEMGVLIGVAITFTVSQFLESYVLQPYVVGDKV
DLHPFFVILVVVIGNALWGVIGMILAIPVTAIITIIFLHVSPLHPFGFLLSKKSASEENS
GS
>IFAGANLK_03526 2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase
MDTRNKIVLITGVTSGIGKALAQEFAKNEFDIIGVSQHQQDLDQVEKLITSTYQQKVYTI
SQDLTTEDGASIIYEEVKKMGMEIDILVNDAGVGQRGYFNDIPIEKYEELIRLNILALTR
MTKLFINDMIERDYGKILQLGSIAGFEPGPLMAVYHATKAYVVSFSEALITELEDMDSNV
SITCLCPGPTDTNFFSRGDLEDTNVVEHKDQFMASAEEVAKGGYKALMDNERIYIPGAKN
NVTTFIRRVIPKSTQSKLQMKFYEHSSE
>IFAGANLK_03527 putative metallo-hydrolase YflN
MEEGKDQHTIPITSIRSGKGEAVSNDVFYYTNKIVNVIMIGEPHSDDWVLIDAGMPNSGQ
EIQNAAEKRFGKNNPPKAIILTHGHFDHVGGIIHLLDVWNTTVYAHPLEFLYLTGEKRYP
EPDDSVEGGMLAKFSSIYPIEPINIKCRLNELPENGSVPGLPEWKWYHVPGHAPGQIALF
REKDRFLIAGDTFTTVKQDSLYKVLIQKKGVYGPPVYLTTNWEMAQESAEKLQQLEPEMV
ITGHGEYMEGTELTEGLLELVRNFEKEAIPSHGKFVRNENKKTSG
>IFAGANLK_03528 putative manganese catalase
MFYHDGKLQFDVKVDKPNPQFAKMLQQAIGGIEGEMKVCMQYMFQAWGARGPEKYRDMLL
ETGTEEMAHIELLATAVALNLEGATNDLKDEVAKDPFMEQIMGGANPRHILSSGMSAMAV
DSSGVPFSGAYVVATGNLAADMYANVTAESAGRILATRLWKSTDDKGMKDMLAFLIARDT
MHQNQWLAVLEELGGVKGNHPIPNSFPQAEENPDFNYNFISTHIDGESKAKGRWSEGQSI
DGKGSFTFEKAKPLGKKPNLGKPHPDGFAQKEQMKANPSMAEDTINKLK
>IFAGANLK_03529 hypothetical protein
MIPTKIHGYIDYLVGLFLIIIPFILVINNPTAKWLLIGLGVSTIFYSAITDYEMGLVGII
NFKIHLFIDILAGLFLAVAPWLFGFADEIYWPFLIIGIGEILISFITAKKPRYPEKA
>IFAGANLK_03530 hypothetical protein
MKTLKDLFEHQIKDLYSAEYQLIKALPKMLEQATNENLKNSFRNHLEETRSQKKRIEEVC
ENLNIEPSGEDCKAMKGLIEEAESFLAEDAEDDVKDAGIIAEAQRIEHYEISGYGTLIRY
AKELGYDKEAEKLVQSLEEEYKADEDLNDLAKDKINKKAEA
>IFAGANLK_03531 hypothetical protein
MEDEGKFLRIGIIGASRFGVNQISRLKNEQNLNIDFVVLDKNLNNPKEIINEIPSAEFLS
CEKEFFKSATNGIILADYVDLQLKKYQPSFKKATSFFCNANFLSQLEGLEHFLQIAKSKN
ILVCFNLPFRFTRGFLELNDIVRKGKLGKIHQIDLTYYKNQSDEGTASCKNHTNFFGGFM
DTGVHLLDIALKSLNYPEIKYLTAIPYKRGKKIEKQNPFCEDYLLLTCITANGTLINLRC
SRNLPRTRKRTIEADYHGEKGDLRLRNHDKSEHDLIVEEYKNEYLSIVSSPPDVFVDAAI
KEWIWSLRAEKGYDKKIAKEMLALAGVVHQIYNQPSP
>IFAGANLK_03532 Xylose operon regulatory protein
MLVIKVNAIPLDDVMLDLGKAFGVEVEETCKELKLKLPTSLGTGNISGIQFPNGLGFIQY
DCKFHKNTEIHFIKSEVHPLKFIYVTEGQLKHRFSNGDQLHKIDQYQHAIVASEKNNGHI
LKFEKGKETCFSSIELNRIEFEQKLACKLLGVSSSLTQVFYDVKALNSFYHNGYYSLKIA
DLFEDMNSYKKENFIRKLFLEAFTIQMLAEEILQYEDALREEGNAEILTRYELGAVKDAA
EFIEENIFKNLVVRGISIEVGINQNKLQNGFKTLYGLTVHDFIKRHRLQLVRDLLLNTDL
QINEISDRVGINSKSYFSKVFKEKYGLTPKEFKKKAELAK
>IFAGANLK_03533 Regulatory protein PchR
MKPIKIFTFPAFKTFNKLANHLENRTINSPLPILEISEKLGKGNILALDIYNDISVILVS
GHFKNDLLLHLITNVENPLNFIYNYNTPFDYKHGNNNTWRELDQFQHAIISNSPKTNTKV
KLKANKLYYSYIISISKAVYLNNRNYCTQTVADYLKIIFEEKDSTPDFFHNGTYNLQIAN
ILKEINLQNFSSFEHHIFLEAKIHELINQHLLQYKRDIDNSANTSNLFSYEVKAIHTAAV
YIQNHMDEIKTVEQVARYVGLNSNKLQRGFNQLFNISVNSFIRNARMSKAEELLINSEET
VCQIVSKIGLNSNSYFSKLFKEKFKVSPSQFRIKNRTVS
>IFAGANLK_03534 UDP-glucose 4-epimerase
MKTILITGAAGFIGSHLCDRFLNEGYRVLGMDNFITGSPANIDHLADNPNFIFYENDIIE
SIDVQANVDYILHFASPASPIDYLKIPIETLRVGAMGSYNVLELARIKNAKVLIASTSEV
YGDPLSHPQKEEYLGNVNTIGPRGVYDEAKRYMEAITMAYHTTYNLPISIIRIFNTYGPR
MRLNDGRVIPAFLGQVLNNEPLSIFGDGSQTRSFCYIDDLVEGIYTALFNDYPYPINLGN
PEEITINELSREIIKIAGEEKEILFKPLPKGDPVKRKPDTSVARKILNWEPITGRDKGLR
LTLDYFKNLSNPTLLNKNPRNFEPLNM
>IFAGANLK_03535 hypothetical protein
MSESKKTKDHQEIKEWVEERKGKPALVKSNENTGTADGLLRIKFSKDQSEENLETITWPK
FFTIFDENRLEFLYQDETKEGNTSRFFKFVRT
>IFAGANLK_03536 Demethylrebeccamycin-D-glucose O-methyltransferase
METEKKIEELAPWFHNLHLPDGLQTAPNHFLGDFPQFKWEKIKHEIPEDLQGMEVLDIGC
NAGFYAISLARRGAKVTAIDLDDHYLNQAKWAAEKFNVSNQIEFKNMQVYDLAQEDKTYD
LIWFMGVFYHLRYPLLAMDIISRKTSDYLVFQSLSLQGSSGQEVPENVDFEERHLLESED
WPSMAFIEKKFAGDLTNWWVPNAAAIKGILNNCGFKIIASPEDETYIARKNNAISHQERW
NNSEYLSAIGKNWRDEVKDKINKY
>IFAGANLK_03537 hypothetical protein
MNIVIIGLSITSSWGNGHATTYRSLLKALSARGHEIHFLERDVPYYAQHRDLPNPSFCKV
NLYKDLEELKKGHTHLIESADVVIVGSYVPEGVAVGNWVIDSAKGLKAFYDIDTPVTLGK
LEKKDYEYITPELIAKYDLYLSFSGGTVLEFLEEKYGSPRAKDLFCSVDPDLYYPNQKEE
EYLLGYLGTYSKDRQSTLSKLLFETAWNYPNEKFILAGSQFPDKLHWPTNLNHIDHLPPA
EHCNFYNSQRYTINVTRADMIKFGHSPSVRLFEAAACGVPIISDFWEGIDDIFSIEKEIL
IAKDAKDVACFIEEINESERLALAENAREKVLIHHTSQARAKQLEAHINEVLQPSQ
>IFAGANLK_03538 hypothetical protein
MAKKNLKIAFFGSSIVSAYWNGAATYYRGIVKSLNKMGHSVTFYEPNIFERQKNRDIEDP
DWCEVIIYEKDKLNLRSLLRGVQEEADVIIKASGVGVFDEFLEYEVAMMKEEDNLVIFWD
VDAPATLERMEEDNSDPFIPLVPEYDFILTYGGGKPVIETYESFGAQKCIPIYNALDTET
HFPVEEEEKFNATLAFLGNRLPDREKRVEEFFIKPANELTNENFILGGSGWGDKNLPSNV
NYLGHVYTIDHNAFNSSPRAVLNISRNSMATFGFSPATRVFEAAGAAACIITDYWEGIEQ
FFEPGKEILVVKNGDELTKILKELNDAEARKIGKAALKRVLGEHTYQHRAKLLEKIFSKE
LFGEESVK
>IFAGANLK_03539 hypothetical protein
MKLVMFYHSLYSDWNHGNAHFLRGIVREFKNKNYDVQVYEPQNGWSLENLIQDHGAEKLQ
ELKEYYPGLETNYYDPAEPDLTTALEGADYVIVHEWNDKNLIKTIGEQKKTQGFRLLFHD
THHRAVSDPESLDEIDLSNYDGALVFGDIIKKIYEEKKWAKQIWTWHEAADTVLFKPNRD
EDKEGDLVWIGNWGDDEREDELMEFLINPVKELGIKAKVYGVRYPKHAIKALEDAGIEYG
GWLPNYKVPEIFSKYKLTVHVPRRPYVEMLPGIPTIRPFEALACGIPLISAPWKDVEGLF
TSGKDYLMVKNGDEMAYRISEVIKSAQLAGSLSENGVEVIKEKHTCVHRVDELEKIFNEI
GEKMVSPRDN
>IFAGANLK_03540 D-inositol-3-phosphate glycosyltransferase
MEGSKLKILMTTDTIGGVWVYSMHLCQYLSKFGTEVILLSFGGNPSSDQLDEVQAIENLK
YYPTTYKLEWMENPWEDVEKAHIYVKQLCELHKPDVIHLSNFMDLENILTPIVNVYHSCV
LSWWESVKGNPAPEEWLRYKELVQASLKNADIVVGPTQSILKSARELYGNDFHGICIPNA
TDYNYPEEDKQEFILCAGRIWDDAKNLKLLETIAPKLSYPVVVAGSNEHPNNGEKLNIEN
VIFLGRLPQKELLKWMSKSAIFFSPVLYEPFGLTILEAARSRCALVISNIDTLKENWSHA
AIFFDPRIPVQALEALNKLIANSRYRQHLGKVAYNRSNKFSSEKSTRTYLDIYKKLNKVN
QLLKLNL
>IFAGANLK_03541 1,5-anhydro-D-fructose reductase
MFRPVNQKINLGFLGVGWIGLDRLKALNAFDGINITSFYEPLEENIKRVHEVVPEAKSLN
SPEDLYNYPDLDGIVIASPSAMHKEQSINALKSGKAVFCQKPLGRTEKEVSEILKTAETA
NKNLAVDLSYRYTDAFKKVLQVIRNGEIGELRQINLIFHNAYGPDKSWFYQYEKSGGGCI
IDLGIHLIDIALLGLNFCEIKEVKSYLFANGQILEPDDRKVEDFASVSMIAETGTLINLQ
CSWNLPAGKEAIIEASFYGSEGGVAFKNVNGSFYDFTAEKLNNTTTETLVEPPDLWGGKA
ALKWADSLIEGKTYDKPFAEQLVMNAAIIDRIYGR
>IFAGANLK_03542 Starvation-sensing protein RspB
MFSNKTTEVIDKKTECVEVKGKSLSLEAPKKFQLQEVTYRQPKKNEVRIALEGCGVCASS
QPIWEGRPWFNYPVEDGNPGHEGWGFIDAVGPEVKNLEIGDRVTGMSFNSFAQYDYAPEQ
NLIKIPNFIKNKPFPGEPLGCVANIYTRSDIQKGQVIAIVGCGFLGLMLVQLAKSRGAKV
IGVSRSESSLTEAKKEGADYLIKLDKTEDVVAKVKEITKDQLCDRVIECTGKENALNTAI
EITGVKKKLIVAGFHQGGFRSVNMQMLNWRGIDMINAHEREIPVYLEGIRMALDEIQKGN
LKPFHLFTHRFSLQQADRAFKLMEERPEGFIKALLINKKAEDV
>IFAGANLK_03543 CDP-paratose 2-epimerase
MKEIATKERAKLGILEWFRPGEYKEVKAAINDLNRLGIKHLRTGISWADWHVEGTKEWYD
WMIPELSKHFEVLPCFLYTPPSIGEAPKTSSPPKDLKSYSDFTSLMIDTYGNHFDWVELW
NEPNNKIEYDYTLDFSWNKFSEMIQLAAYWAKKKGKKTVLGGMSPIDPNWLQMIIEKGTL
ENIDAVGIHGFPHVFDQQWQGWETNIKEVKAVLSRFKLQKELWISEVGFSTWQNDQVKQY
DEFVKVLNCDADRIYWYSLKDLDPKNATVGGFHLDEREYYFGLKTKSFTPKLLYKLLEKE
GLGKIGDLNYIQKFYDVEKLGPFILITGGAGFIGTNLAERLLSSGKRVMIYDALVRDGVE
KNLKELKHNYGRQLMVQIADINEEYLLKKCIEMADEVYHFASQVAVTTSIEEPETDFDVN
LKGTIKLLEAIRKSEKKPPLFFTSTNKVYGDLSNSEFKESKTRYYPKDSDLAKNGINELQ
PLSFHSPYGCSKGAADQYILDYTRTYDLKCVVFRMSCIYGPHQFGTEDQGWVAHFLISAL
KGKDITIYGDGKQVRDILYVDDLVDAFMLASQNIEKLSGEAFNIGGGIHNSVSLIELLKK
IQKITRSSLDLSFNRWRQGDQLYYVSDTQKFQDATGWKPEVEVDKGIENLTRWLTKNRSF
KKQTKISTKKLIDVQQ
>IFAGANLK_03544 dTDP-L-rhamnose 4-epimerase
MSKKVLITGGAGFIGSHLADDLLKEGYEVRALDCLSPQVHGEKRDRPNYLHKDVELIIGD
IRDKEIVSLALQDVSIVFHLASMVGVGQSMYEIRKYTDVNNLGTAILMECLIDSSVEKLI
TASSMSIYGEGAYQDGFGTIHHNSKRYVSDLKNKKWELYNDGQELQPVPTSENKVPALSS
VYALSKYDQERLSLITGEAYNIPTTALRFFNVYGTRQALSNPYTGVLAIFASRFINNKPP
VIFEDGNQQRDFIHVSDVARACVLAMESEKANGEVFNIGSGKQYKISFVAQKLAHVMGKE
IKPEISGEYRVGDIRHCFGDISKARKLLSFEPQKNFDDGLLELSQWLEHQIANDSIEKAN
QELSKRGLTI
>IFAGANLK_03545 putative oxidoreductase
MSVRNKKVLITGGSSGIGKAIVKKLYSHNHIVIVDKVSPEISHPNISFLNIDLEDQKEIA
LALPKIAKEFGVFDLLLLNAGRGIQEKLTEGDPERWQEIINLNLMAPLRFIRKFVPQMMS
KKAGDVVIISSVAAHQPHPYGGIYSATKTALEIIADTLRLEVVPFVRVTTIVPGITDTRF
FQNQISGFTSVENLNMGAISPDEIADDLIYALTKKKDTAINKIITRPVKQSF
>IFAGANLK_03546 hypothetical protein
MNSNLNFETFKQEAHEYINDLATELEHPEEKERVLRIWRSVMFTIRDRIDFNEAFLLMQP
LPTILRGIYIESWEYSKKPKLDYSTLEEMKSEVKKNQRKKGEKDFPWKLSTEEIITITIK
SLNKYISLFQITDIINQMPGEIKTYLNQKIKAE
>IFAGANLK_03547 hypothetical protein
MIVRDKNGSPIRSVGSALYVTTSRQQIKKIRKQNKKLREIAWMQSHLVRAPLTSIMGLIY
LAKETDKNEESFEEILDMLSESAEELDKIILDIAHKTEKLQIKSPRN
>IFAGANLK_03548 hypothetical protein
MKNLELKELEKIYKWNFKWGMFYKQCILSSKKPYIKNLYKKLVCQKISFHKLLMEQLLKK
VDQKYLQKLDRECKNELREIHQKYHPDLNNKHSLMCCQIEKKLYSAYCESLRKITDGKIR
ALILNQKYQIKLLQHEMEKIEKYLI
>IFAGANLK_03549 hypothetical protein
MYIMKKVFKLLMCVLLFVPIYSCNNNQQGNIEDEDDQDIRIEGHQKQTAGDDAYPENAVG
EYLNYISQERSADYPDPEKALKLLASAISEKNEAAGVNSSNELQKLTNINEAENYSISKT
DFVTLLNAFKDSSNSGSFEGAIDTKELEKTVEEISVNKNDKSNNKIKNFFDEAGELLQKM
NAKGS
>IFAGANLK_03550 Fructose-bisphosphate aldolase class 1
MEAFERIQELLGNNADYYLSHHSKKIVKDNLTIPGPSIIDNFRNSDRSIPVLKSLSQLYN
NGRLKGTGYLNILPIDQGIEHSAAFSFYKNQDYFNPENVIKLALEGGCNAVASTKGLLAM
HSRKYADKVPFIVKINHNELLTYPNTYDQIKFSSVVEAWNMGATGIGATIYFGSEQSDRQ
IQEIAMAFEKAHELGMATILWCYIRNKQFKRDDADYHTAADLTGQANHIGVTIKADIIKQ
KLPTLNYGFRDLNSGKFDDEMYDALGTEHPIDLCRWQVSNCYMGQIGLINSGGASKGGSD
LKEAATAAIINKRAGGSGLIMGRKAFQKPLKEGVEILNLVQDIYLDSKITIA
>IFAGANLK_03551 hypothetical protein
MIPPRVHGYLDYLIGGLLILIPLIFSKTYYLPSWILLGFGIGTILYSILTDYEMGIAGLI
SFKLHLIIDIIIGFFLALSPWVFGFQKEIFIPFLLLGIGEVIISLFTNRKFYNARAIF
>IFAGANLK_03552 hypothetical protein
MLGFLLAFMTAISEALKDIASKYNLHHIDEYTAAFSLHLIQSILLVPIVLYLGIEVMSSK
FLLALLASSILQLIVILLYFKAIKRSELSVTVPLITLTPLFMLITSPIMIGEFPNALGIL
GIVLIVTGTYISNLDSNQKNIFAPFVSVVKNQGSRYMLIVAFLWSITANIDKIGVEETSP
VFWAFSKDFLILFYLIPILAIKSKRPLKQIKNRKVGLLLVGMFKSTSVLTQMYAIQFILV
AYVISIKRASALFIILFAFFFLNEKHNFRNRMIGIITILLGLFVIAIS
>IFAGANLK_03553 hypothetical protein
MKAIGKLDWAFSAGKIPLQSIGEEPKFTSNDKLAILNTSEEKAIIELFIFYENRKPMGPY
SVTIKPLRLKKIRFNDLIDPEAIMLEQNYSCYIKTNVKVVIQFSRMNTGNNKVSEMSSMA
FPVES
>IFAGANLK_03554 L-gulono-1,4-lactone dehydrogenase
MTDFRWKNWSGSLSFTPGKIVTPESEEEVVALVKTAQRENRKIRVVGAGHSSSPLVKTKD
ILLSLKHFQGAEEPDTDSHRLTILGGMTVKDAGKEAFRYGLAMHNTGDVDVQTIAGAIGT
GTHGTGVKLKNLSSMLVGVRMVTGTGEILETTSDNDKELFRALQLAMGTCGIFLKMRLQL
EKTYHLHRKEWCVPIEKCLENFNDLKKNRNFDFYWYPRSDLAKIRVMNKVEQEVPEIFYG
SLEMEKKGPSHEILPRSRPLKFDEMEYVLPADKALDCFLEVRELIKKYWRKRVAWRVLVR
TIKSDEAYISPMAGRESVTISLHHNAGLRFWDYFQGIEPIFVKYGGRPHWGKKHTLKADK
LRDLYPHWDKFHDIRKQLDPTAVFLTPYMEKLLITK
>IFAGANLK_03555 hypothetical protein
MKTFGKRTWVIAEGYIPSYGTGPEPEMTSHETVCILNTSNKGAEVELTLFYSDKDPVGPY
KIKVEAQRTKHLRINDLENPEPVPRDTDYACVIESSVPIVVQHTRLDSRQAENAILTTIA
YSE
>IFAGANLK_03556 Trehalose synthase/amylase TreS
MNKYWYKNAVIYCLDVETFKDSNNDGVGDFKGLKNALTYLSSLGITCLWLMPFFGTPDED
NGYDVRNYYEVDPRLGDLGNFTELLDAASEVGIRVLIDLPVNHTSEQHFWFQEARKGKKN
KYHNFYIWQDEKPKDDGENIMAENGEGSNWKYDRKAKAWYYHTFFPHQPDLNISNPDVQK
EIFRIMHFWLKLGVSGFRMDAAPHMFTEKGQVDFQEDPHEIFRNFREFVETQKPDAILLA
EVDIEPENYQNFFGDEDQMHMLFNFYVNNYLFLSLAREEATPVAKALKEMAQTQEKEQMA
MFIRNHDELNLDRLSEKERTEVIKAFAPNENMQMLGGIRRRVASMLNNDRKRIELAYSLL
FTLPGTPVLRYGQEIGMGEDLNLDGRDSVRTLMQWSSAKNGGFSDAAKKKLVTNLVSKGE
FGYKKVNVNDQHRTKESLLNWMTSAIRFRKEFPEFGWGNYKVLDVDDKRVLAVYRKSQKG
LALSFHNFSNEEITVKIDIEDPEDIEDIFGDERYEGFNPSEQKVKLNAYGYRWMHKSTNF
V
>IFAGANLK_03557 F420-dependent glucose-6-phosphate dehydrogenase
MKIGFHASHEQFTPRHLLELVQKAEVAGFESILSSDHFHPWSNQQGESGFAWSWLGAAMQ
VTNLEYGIVNAPGQRYHPAIIAQAASTLGQMFPGRFWLCQGSGQALNENITGQKWPSKEL
RNARLKESVQVIRELWKGDYVTHHGLINVEKAKLFTQPVKKIPVYGAAITSKTARWLGDW
VDGLITVSKPLKELKNVVEAFKEGGGGEKPMVLKVQISYDENEEKALVKAWKQWKNNIFP
SKLLSDINTADQFDDLGEKVRKEDLRKHVIIGNKPEIFISRIKEYQDLGFEKIIIHNVNK
EQEKFIDFFGNEVLSSF
>IFAGANLK_03558 Dihydrolipoyl dehydrogenase
MAKNDKKELVIIGAGPGGYAAAFHAADLGIKVTLIDPEVNPGGVCLYRGCIPSKALLHLA
KTKEEAMKASAWGLKFEEPKIDRKKIANWKKNVVKKLTEGLGQLSKSRKIEYVQGIARFT
GKNELEVSPKKGKKFKLNFEKAIIATGSSAMDLPDIEIDHNKTWDATDALELKEIPKKML
VIGGGYIGLELGSVYAAFGSKVSVAEMTPGFLPGTDRDLIKVFEQNEPFKNVYFETKIEK
VKMTKKGVRVTLKGKEEEQSKKFDCVLVAVGRKPNTKNLGLDKLGVSPNENGFIEVDPKR
RTKLEHIFAIGDITGEPMLAHKASHEGRIAAEVIAGKRGAGYDPKVIPAIVFTNPELAWC
GLTEKEAKEKDRKVKIVKFPWAASGRAAAIGENKGLTKLLIDPESEVILGGAVAGKNAGS
LIPEIALAIEMGSTASDLALTIHPHPTLSETIMESAELFYGGATHYKK
>IFAGANLK_03559 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAKEIKIPQISEGVDTATISEILVSKGDKIEEDQSVIAVETDKASTEIPSTFAGTVKEIK
VSEGEEVSVGDVIIILEEADEDSEENEESGDDKEKEASEEKGKKEKKEKEGTSEEKEKKK
KKTSEGKKEEKSEEKSDEEEDETKNGDEEIEKKKSFEKSEKDESDDKKSSKKVYASPGVR
RLARELGVNIQEIEGSGQSSRITEKDVKKYKEGGGEKSGSTQLELPDFSKWGAVETKPLN
NIKKITAKNVLQSWQSIPHVFQFGEADISGIENYIEEHKEKVEEAGGKLTLTAILTKVVA
TALHKFPMFNASVDMNKEEMILKKYVNINIAVATDEGLLVPVIENADQKSIKDLSVEISQ
IAQKARDQELSKENMEGGNFSISNLGGIGGTNFTPIVYHPQVAILGVSRARIKPVYIDNN
FEPRSILPLSLSYDHRLIDGADGASFMNWMVKALEDPYEALLG
>IFAGANLK_03560 Pyruvate dehydrogenase E1 component
MTDSKNDNIQKENQEWIDSLTWIIENKSTKRAEELLLILQEEAEKHNIQLPESLNTPYEN
TISKDEEEEYPGNLEIEEKLFSYIRWNAMAMVVKANKADPGIGGHISTYASIAQLWEVGF
NHFFKIDKNNIADQVYFQGHASPGIYARAYLEGRLTKKNLEEFRHEIQSEKGLSSYPHPH
LMPDFWNNPTVSMGLGPIEAIYRARFNKYLYNRELIDEDNSKVWAFIGDGEMDEVEARGA
INIASRDKLNNLIFVIDCNLQRLDGPVRGNAKIIQELEGLFKGAGWNVIKVLWGKEWDKL
IEKDSSGKLRKKLNELTDGQLQKYAFSDGEFLRKDLFENDDDLNKLVEDYSDEELENLKR
GGHDSEKIYNAYKVAVEAKEKPTIILAQTIKGYGQGSAGEASNVSHKTKEFDEDQLKYFR
DFFKVPVSDKDLKKIPFIKPEKDSKELKYLQEKRKDLGGYIPQRSDKSLAIKAPDTKIFE
NFLKGSGKDEVATTMAMVQILGKLMKDENLGELIVPIIPDESRTFGMESLFRQAGIYAPH
GQKYDPVDEESLLYYKEAQNGAIMEEGITESGCMAEFIAAGTTYLTHGINTIPFYFFYSM
FGFQRTGDLMWAAADAGAKGFLMGGISGRTSIPGEGLQHQDGQSHLYALAFPNLRAYDPA
FAYELAVIVEKGIKEMYIDKEDIFYYITISNDTYPMPEMDKDLDKEAIFKGLYKFKKSKS
RRRTRKAHLFGSGAIMKEVLEAAEILEDKFNVGADIWSITSYKALYDNAIDTERDNRLKA
QLNKEQNYIEQQLQDEKGSFVAASDYVKALPESIAAYFPDELISLGTDGFGRSDNREALR
GFFEVNAAHIAYAALYGLANQEQISLEELKKAAKKLKIDPQKTNPRTA
>IFAGANLK_03561 Bifunctional transcriptional activator/DNA repair enzyme AdaA
MTIYQAEINRIKRNCYSNKSRINTVVEARRSIEHSFDKALTLNLLSHHCFTSKYHLLRLF
KRYYGQTPTQYLTEKRISIAKELLTNGYNVTDTCYEIGIESPSSFSTLFKMHTGVTPSQ
>IFAGANLK_03562 hypothetical protein
MEISTFLKFQNDNAEQAMNFYAATFNGMEKKNPVQPKRNL
>IFAGANLK_03563 hypothetical protein
MDNKGQKQHQKEDENQASSTSSKTPTEDNWEG
>IFAGANLK_03564 hypothetical protein
MMLRKPSEIDYLENYYITTYTSAIYYKHSIMTTKKTFLKKLFKSLYNQKKAIKSDLDKHI
LEARDQDYLDELQLKCKKEVLKMDRYLRDNTNPKYGQICTKIEGRFFHHLQESLKLLTDG
SLRNTLLSHKYKSQILREKLLLVNKYLI
>IFAGANLK_03565 Phosphate regulon transcriptional regulatory protein PhoB
MVLNRILFYVTSLCPGVSRYEVLKNLAKNKETANIPFIFLSAKSDNREKSKGINLGSDDF
ISKPFSAKDLLEAIKSRLA
>IFAGANLK_03566 Acid shock protein
MSLTRSNNRKVPALGSSFLAKDPFFADLMDTKRGIFNLNRFFNGYFDEDLFPALNVKEKE
KEFEIELAAPGLSKEDFKISIEDGILSITAENENKIEEEKEGFVRKEFSYNSFSRNITLP
GEVDVEKDVEAKYKDGILKMNLKKREMDKTKETKTVNVS
>IFAGANLK_03567 hypothetical protein
MKTLKACFIGIILLFSTVNLSAQEKWSAELRPGINFATSDLGDAELKTGYGAEVALGYRF
MPHLGAYVGWGWNQFSSDNNSFAGTGDTDYEETGYTFGLQFIHPIAESATSYLIRIGGIY
NHIEVENSTGDITADSDHGLGWEIGAGIQVDLGGDWNLRPQVGYRALSRDLDLGSVTTNV
DLNYFTIGIGIAKLF
>IFAGANLK_03568 hypothetical protein
MKNKKLFVIKSIHTLIWLFYNVVIFYLFYAVIVDKIDKWVWICIGLVVAEGIVLLVFKWF
CPLTLIARKYSDSIKDNFDIFLPNWLAKYTKVIYTSIFGLAILILIYRIFTSQS
>IFAGANLK_03569 Putative NAD(P)H nitroreductase
MQIASEIRKIIEYGTKAPSGHNTQPWKFRLCENEIQIHPDFERALPIVDPDNHALYISLG
CAAENIILAGRNLGCNPDLKIEKDTDGVNFISIKVQRDSAAQKDDLFNYIEKRQVTRNAY
DDTSIVSKDLKQLIDAAEFKGVHIRSFSTQEEIDQLVPFIIEGSNLQFHKKAFVNELVSR
IRFSKKEVEEKRDGIWHSSMGMPGVGLVLGNLIMKKFVDTKSEAKRWKKIIRSTPTFILF
LAEKDDVVHWVNTGRALQRFGLMATKLQINHAHVNMPCEEIEVRKKMALALGIEKQHPLL
LVRLGYSKRMPYSYRRPVEEVFG
>IFAGANLK_03570 Thiol-disulfide oxidoreductase ResA
MDIPVFFGALLIENKMKKKTKKSFIEYGVIIAIFSGFYFTGLHTEVLGFLQRGILATGLM
DPDFDKDSGHAVNTDYPEADFSMKLIDSKGENVAMEELKGKVIFINVWATWCPPCVAEMP
GINKLFQDIDKDKTAFIMLSVDQDFQKAIDFNKRKGYDFEIYKSNGGIPSMFSSQSLPTT
YVINSQGELVLTHMGMGDYNTNEFKEYLKELY
>IFAGANLK_03571 Beta-lactamase
MKNSKIILIIFLIISGKFQGQEDLHTSNEKNLPPEVVEAIEERIKEDYTPSIAIAIIDST
GIQYFNFGKISKEGRKVDANTIYEIGSVTKVFTGILLAQQVLDGDLKLEDEINNFMPNDI
NVPVIGDTEITFGHLTDHTSGFPRIPANLNSTNPGNPYADYTVSQMYEFISDYQPVRTVG
SEYEYSNLAQGLLGHLLALNKNSNYEELVIQTIAKPLGMNVTRIEMNNRMKENLALGHSN
GKIVENWDISILAGAGALKSSTSDMAKFIAANLGYIKTSLTEAMKLSHKIRHNKAGDMRV
AMGWHIKKGSKGDIIWHNGGTGGYRAFTGFLKETGQGVVLLSNSSQSFDDIGFHLLDPGS
ELTDIKYKSDVVDLPEPTLEKYVGLYELQSEFKIKITKEGKQLFAQPTGQDRFEIYPEND
TVFFLTVVKAKIIFNIKSGVVESMTLIQGGQETLGKKIEQ
>IFAGANLK_03572 hypothetical protein
MKTKIIRNIFLFLLAFLGVGALYGGGVLILYPSGEILKMPLSLLEKSPFNDYLIPGIILF
SILGLVPCLLIFSLVKKPVSKFLEKFNVFKDLHWAWSYTIYIAFVLIIWIQVQMMFLQKV
SWLHTFYIFLAICILIIGISPQMRELYKK
>IFAGANLK_03573 Small ribosomal subunit biogenesis GTPase RsgA
MIEVRIAVSTSGLEITFDKIIRLSQDCKFKNYTHTNEIGCSVLEAVEKGEIDKASYENYL
KIERENAHFKSTIAERHKKDKEFGKSLKKYKIDMNRKKY
>IFAGANLK_03574 Putative ribosome biogenesis GTPase RsgA
MNKKKSTIKKGKTYSMLGSSGVGKSTLLNNLSGKTIIKTNTISQSTNRGGISQVTGS
>IFAGANLK_03575 hypothetical protein
MFGVIQGDTEMKLEDFGYNDIFEKFRIENDLEGFEAGRIVSEHKERYIVKTSKEELEA
>IFAGANLK_03576 Alcohol dehydrogenase
MIPEKMKAAVVNQFGKPLSIENVPVKKPGRGEVLVKVFASGICHTDLHAAEGDWPVKPSL
PFIPGHEGIGEVLALGEDVDFLEKGDIVGMPWLHTACGHCEYCITGWETLCDHQQNTGYS
VNGTFAEYVLADAAFVGKFPKDVNYFEMAPILCAGVTVYKGIKETDLKPGEWIAISGVGG
LGHLAVQYAKAMGYHVVAVDISQEKLDLATKHGADFVVNGKDPKATEEIKKRTKGGVHGV
LVTAVAPVAFEQAIDMLRKRGTIAMVGLPPGSINLPIFQMVLNRFTIRGSIVGTRKDLQE
AIDFAVEGKVHTTAHKVKLEDVNKVFEDMKQNKIEGRMVIDMQA
>IFAGANLK_03577 hypothetical protein
MKNFILGILISIPVVLLAQESDEFDFVSNQEEGYSAVRQGVNWSFLNSSGELVFDFRNDL
ISNEDPRTGIIGVAGMQYPQLKDERAIIKEQKDGVNYYGFINSEGKTIIEPEFLNVSNFH
NGKALALKLEEERLGENALLGKNVISYKYDVVLINKKGDILKYLEGPFPVSVSKQKLREA
PQINAKWLGKNVLTVKGPNKKWRVHKI
>IFAGANLK_03578 Phosphoenolpyruvate synthase
MLIKKFSEIGIGDVSQVGGKNASLGEMYNKLSGKGIRIPDGFTTTADAYWLFLKENHLKE
HLENLMKNLDKNKFSNLSIIANQARECILKGNFSKNLKESILDAYHHMGNNNNIPVAVRS
SATAEDLPKASFAGQHDTFLNVNGDESVLLAVKKCMASLYTDRAIKYREDKGFFHHDIAL
SVGVQKMVRSDLACSGIGFTIEPESGFENIIQLSGVYGLGENIVQGAVNPDEFFIFKPSL
ELGKYSIIQKKLGTKDKTMTYAQSFEHSSVINMVTPLEKQNQFVLTNPEITTLAQWALII
ERYYKRPMDIEWAKDGITQELFITQARPETVHQTKNKKVHNIYSLKERSTIVVSGNAIGN
KIYAGPARLLTSPSQAGLLQDGEILVTDTTSPDWDPLLKKAGAVVTNRGGRTSHAAIVAR
ELGVPAVVGTINATENIKDGELITVSCSEGKTGFVYRGALSFEENQVDFNKLTLPDTEVK
FILSDPEKAFQLSFLPNNGVGLLRMEFIITHQIKIHPMALIKFNEIRDNEVRTIIDELTQ
NYSRKDEYFIDKLSQGIGVIAASFFPKEVIIRMSDFKSNEYANLIGGKQFEPIEENPMLG
FRGAARYYHELYREAFALECKAIKRVRDDMGLTNVKIMIPFCRTLVEGRKTIEVLEKNGL
VRGKDNLEIYMMVEIPSNVILLEEFAKIFDGFSIGSNDLTQLTLGIDRDSELMSSHFDEN
DAAAKKTIATAIRKAKVSGKKIGLCGQAPSDFSDFAEFLVIEGIDSISFNSDALLDGINN
INKAEKLRKITK
>IFAGANLK_03579 Glucokinase
MKTSLQAGMRWRINMEINPELQNKRGLLLAADIGGTNARFAIFNFENGNLSLVRENSYKT
KEYYSFKELVIKFCGNDTLKIKSVCIGAAGPVKDGKVLGTNFTWEIDKKDIIDITKNSSI
RIINDLEATAYGLKNIESSHFTEIKSGSSDSGNLAILSPGTGLGEAGIFWDGNKYHPIAS
EGGHCEFSPRNELDIELWRYLHYKYDHVSWERVISGPGIINIYQFLKWYRQVSEPKWFQE
RYLNEDPAFLISQCAMENTYNTCVETMALFLRFLAIESAQLALKFKATGGIYIGGGIVPK
NIQIINKKKFANDFVNSNRMKSLLNLIPIQVILNPNTALLGAAFSAAQNID
>IFAGANLK_03580 hypothetical protein
MKAQGCVAIRHFSSSIGNELESNLLGKGDFQVGMNYRYFKSFRHFKGTEEEPDRVSNNTE
VINYSHSWDFSLNYGLTDRLYAGITIPTVLNERSSLYEHGREERHKTFSRGLADIRVGMG
YWLFDPETHLNGNLALGLGLKLPTGNYNATDVFYNVGPEASPQTRPVDQSIQPGDGGFGL
TVDFQFYQTITDDLFMYGGGFYLFNPKETNGIRTFRETLSPILDNESIMSVPDQFALRAG
LGYALSHTFSASLGARFEGVPVEDVIGGSGGFRRPGNVLSIDPGISFMKHNFSVNLNVPV
ALRRDRPQSVTDLETQLATGEPRNGDAAFADYLINLGISYRIGGGKSISEIEPESDLQFD
>IFAGANLK_03581 Signal-transduction histidine kinase senX3
MKRRKIYIAIFIISVVGLFVVQFQYLRIGLNLAELQFEQKIERAGSDLKEDLSNENQLSF
LIAQSLEGSNYFTLSQDSLQDASKHFLNDFIRDRLVTNRIKTDFSYNLYSKDGSIDLKSP
VNFSPEDSIIKYPVQLEGYLPETLEKDVTLELHFKDLNSYFLSQLHGLLIPGLLFLAIII
FVVIWMLRLFYWQRNLIIITNDFINNLTHELKTPVFSIGVATKILEKDLNENQKPIVFHI
RKQVDRLNKHILQVLDLASLETKKRFIDYKVLDLRPKLLQWCEDFKMQSDLENFTFNFEL
QSGEYKVKVAVPHFENAINNLLDNAKKYSDNPQISLTAYSEKSKLHICISDNGKGISEKE
KQRIFKKFYRVPEGDLHTVKGYGLGLSYVQEVIKRHQGRIKLESELQKGTQITLIIPLKN
AG
>IFAGANLK_03582 Transcriptional regulatory protein SrrA
MPDKKHKILLVEDDDSLGYLLSEYLKIKEFEVFWAQTGKKALELIEADTHDLIILDVMLP
DIDGFSLANKLKINYPETPFIFLTARSMKIDVLKGFSLGAVDYLKKPIDEEELVVRIHAL
LSRVHSFQKESEPEEYIFKIGEYDFNSKSQELIFNKEIIYLTARENELLNYLVQNKNKLC
SHKDILVQLWGKNDYFNRKSLNVFISHLRKYLKKDSKIKIENLHKKGFILKTD
>IFAGANLK_03583 UDP-glucose 4-epimerase
MNILITGGLGYVGGRLTSYFSQKGNQVYALSRHKSLDEYYENVEVLSNVDVLEKNKLENI
SIQCIIHLASMNEHECIDFPLEAIDVNVKGTLNWLMWAKKNNVKQFIFFSTAHVYGSPLV
GNLNEYTQAVPSHPYSITHRCAEDYVIAYFHKHNLNTKVVRLSNSFGYPAFPTANRWTLL
INDICKSIVEDRSFKIKSNRLQERDFISLSNVCKAIEKLIDYSIPEGDNRIFNLSNGKSR
TLFEIGLWIKKIAENYFGEEIQFSFDASKDLPIIPLKLSSQKIKKSGWNPTPHKDVDEIQ
QTFDFFIKKNKM
>IFAGANLK_03584 hypothetical protein
MDSEKIILEDVYLTSLKIIENPKGNILHGLKNTEEVFSQFGEAYFSKIKKGEIKGWKKHS
KMKLNIIVPLGAIKFYLIDHKKGSSTYNMNMKVELSLLNYSRLTVPPGCWIAFEGMEEDN
MLLNIASITHDPSEAETRDFSYFSI
>IFAGANLK_03585 CDP-glucose 4,6-dehydratase
MFESVYKNKKVLITGNTGFKGAWLSIWLHELGADVYGLSDRIPTEPSIFESLSLKDIIKH
HFCDIRNLGETKKIINEIAPNFIFHLAAQPIVGLSYQNPVETIETNVLGTTNVLETFRLL
QNECTGIFITSDKCYENVEWTYGYRETDPVGGKDIYSASKGACEVIIHGYYESFIKNIRH
LKLASVRAGNVIGGGDWADKRLVPDCIRAWSENRKVEIRNPYSTRPWQHVLEPLSGYLRT
GQKLSQNKIPNGNSFNFGPPGDHSHTVEKILEKIAHYWNPVHSEGLFEVNEEGKFHEAGL
LKLNCDKALADLNWISVLSFDDTARFTAEWYKTYYERNENMMDYTKKQINEYTNKAFEKK
LAWTQRK
>IFAGANLK_03586 Glucose-1-phosphate cytidylyltransferase
MKVVLLAGGFGTRLSEETDLKPKPMVEIGGKPILWHIMKIYSHYGFNEFVICLGYKGYVI
KEYFFNYFRHLSDISINLGTNTVEILNTTCEPWKISLIETGLHTMTGGRIKRIKPFVNNE
PFLLTYGDGVGSVNIKELIDFHKSKNKLISVTAVQPSGRFGAMSITDGNDVDSFLEKPRG
DGGWINGGFFVCQPEVFDYIKNDHTVFEKEPLESLAKEGEMAAYKHMGFWKPMDSLRDKR
ELETLWSEEKAPWKVW
>IFAGANLK_03587 hypothetical protein
MVVAEATTVKLYPNPAQFDVYLQFSDPKLKISNISVYDFNGRFLKFFDKFQIIEKGKGEY
RFNISGMSDGVYILKIFTENFDVFTLRLIKKD
>IFAGANLK_03588 hypothetical protein
MNKILLITVFTLTSLNFYSQSNKDELLEKDIAGIVEEIKFMYHYDQATREYLHFQTFDKN
ITDSIESLSKEMRDNRSNFTPVNSDSLKNKIWNTYINPMDQIHTERMIEITQKYGFPSAQ
RLKKFSKDSIDFNPLILLIHSPSRFSKELIEIAEYEKSKDRIKKCDFGYLLWHLKGRSDF
QPMLDKGYEMAKNEDGTFSLKAVDCE
>IFAGANLK_03589 hypothetical protein
MKKIQLLFKKCIQDSQDYGSDNEHMISRIFYEVDGVDYECNVRQPYGESFSFDEDPIEVE
APKELGKKINYGQFRDEVENYYKQIVGSSGRGINIQGGTNIRMQNNTFEMEYRTEIDEAG
YSGGW
>IFAGANLK_03590 hypothetical protein
MLILGLLMMGCKERVSDQKESEKKVQFNQGLVQELQEMAQIDQLAASNAFPPEKYSQLSQ
EEWEAYKDSIFRHHQKRAEKMLDKYGFIGYDLAGKEGSRNFWLIVQHSDHNPDFQNEALE
KMEIEVKKENAEPSSFGLLVDRVKLNTGEKQIYGTQVAYDTVTGQAYPRKLADSANVNQR
RKSLGLEPLEIYLNRMSEMHFEMNKKRYIKKGITEPKLYKVSEMPAGNNI
>IFAGANLK_03591 hypothetical protein
MKNTLTFILLTLIFLCSCNKPKQKTTDNTPISDYYSSDYIAFQGKDNFEVINIDSLSNFS
DLSITIDEMNCDNKIPGLTFSLDKSQYNFVGCSDCKKAKLKSCKGASSFIFIENDSIIRD
LATKKKIHISDLHKVLNEINNGEYKYRTGKSSDFPIILNLNVDNKLPISMTKNVLSIIIG
EFEQIHQSYKILKYNYEIHFEPYEVL
>IFAGANLK_03592 Tyrosine recombinase XerD
MDRKYITLKNLIIDKKKCIGLKFFTDKVVQALVNDLPDVQWSEKFRMNYILNTPENLELI
FKTFRGVAWINCSHFYSNASFGREEEPVNIQQLQNREEVSGKRYCPGSYLRKLELKRYAN
STIKTYVSCFETFINHYSDREIKDLNEEDIRLYLQKLIREDFSHSYINQAINAIKFYYEV
VLEMPNRFYSIERPRPIEQLPKVLAKEEIMAIIEHTNNIKHRCIVGLLYSAGLRRIELLN
LKLDDIDSKRMVIKVRSGKGNKDRFTILSEKLLGDLRKYYKEWRPTNFLFEGPGRKAYSP
EVFRV
>IFAGANLK_03593 hypothetical protein
METVKYCLACNKKLEGRPDKKFCDPYCKSAWHYQKTKEGAAGFYAKVDRQLKTNRRILKS
FNKAGKATVRADILKQHGFDPNFFTHYWKNSKKEVYLFVYEFGFLTRYENGKKKYILVTW
QAYMEKSKIL
>IFAGANLK_03594 hypothetical protein
MDEEYKKEKFETLKIKTSVAKKFRRFSRSLSKSQSMTLLSMVDFFEMNSISPNEMMGPKM
ETLENLIKKRINAVIAILKDMEKNKVNPTLGILEALMEAADSKNNYENRKRDYEQDDTHP
DFYK
>IFAGANLK_03595 hypothetical protein
MYITITPQKLGANYSQSAADYVDYLEKENQIPGIEERDQELFFNQEEDEISPEEVVKEID
ANTAKLEKNEPKFYSITVNPSQYELKKLQNSSEALKQYTRAIMKDYASSFNREINSRPIN
VNDIKYFAKIEHHRAFKGTDFQVKENQPYASKILQLKNEVRKIEHGELEGDIKAIELQIL
KLEREAPHQQNGQRIVQGMLKDGNQNHIHIIISRKDISNSHSLSPGSKYKSSEVLMNGKL
VKRGFNRDDFFQKAEKTFDKQFQYQRNFVETYRARKDFVKSPKTYFSAIMGLPASEKALA
IKILRETGIPLPPVIPLSKAQLSVKLIKTIQKSILTASRSASIGI
>IFAGANLK_03596 hypothetical protein
MEINILNIILCIAIGSGIFFRMYKITSFAFPKNLLVCSLFLWALLPDDPSLKEIANIALY
LGCPLILSNTVLYVFIPKKEISNTETKYQVQFKTQSGSFKINNIKRGVSVIGAAGSGKTE
SVVYNLLEHFSRNSFCGLIHDYKDFEITEMAFPLFKSQNLKFYILSFDKIIHRVNPIAPR
YMEKDATFGL
>IFAGANLK_03597 Tyrosine recombinase XerD
MRTKNTFSVHFWVKPTNEKINNGIIYVRITVNQRRVLVSLKRKISFDLWDPSKKRAKGTS
SEVKQINHYLESAKSRIFQCYQELNSKGKKVTAQLIKATYLGEVENSKSLRDLIEYHSRK
IKNTHAAGSIRNYRVSEKYFFKFLNKERKTSDIYLKELDYKFLCDFEDFLGGYYPKRHPK
AMGHNTIMKHIQRLRKMVTLAYNMEWIDKDPFRRWKNTFEKKDREFLTVGELSNLETYEF
LVERLDRVRDLFVFSCYTGISYTDIMKLTKDNITIGLDRNKWIISKRQKTNTPIKVPLLD
PVLELIKKYEDHPMTLVSGTLLPKITNEKLNVYLKEVAILCGIKKNLTFHMARHTFATTV
TLSNGVPIETVSKLLGHTKISTTQIYARVLENKISQDMIALRGILKQKKDEDSTQSPNVA
SFSIYLGAIGFTR
>IFAGANLK_03599 hypothetical protein
MSLQDKVMAEMKAAMKAKDSEKLEALRSVKSAILLANTESAAKDGLTEDEELKILQKLVK
QRKESAAIYREQNRADLAEPEEKQAAVIESFLPEQLSEAEIEAKVDEIIAKTGASGMQDM
GKVMGMASNELAGKADGKTISTIVKSKLSK
>IFAGANLK_03600 Acetyl esterase
MKNLIFIGLFLLSFSISAQQRFTDDSFELKDTETKTYATKNGDALKLDIYQPKNDTMQQR
PLIIFMHGGGFSGGTRTNPGEVNFAESAAKKGYVAVQISYRLTRKGQSFGCDYEASGKME
TFKLAAEDFMDAVNFMVKNQEKYSINPSKIIAGGSSAGAEAVLNAVYNERLMFDDFSNYK
DFNFTGVFSLAGAIVDARYITEENAIPGVFFHGTEDNLVPYATGPHHWCDRRQPGYIMLD
GSKSITEKLRKLNTSYLLYSFEGGKHEHSGMPFDYFPEVFEFFNSVFLNEEKQQTEVWK
>IFAGANLK_03601 Beta-glucosidase BoGH3B
MKNFNLSVALLFFIGVSSLYAQEKVPQVEELLEKMTLEEKIGQLNLLTPGGGVATGSVVS
EDVETKIRNGNVGGVFGVSSPEKVRQAQKLAVENSRLGIPLLIGSDVIHGYKTTFPIPLG
LSSSWDMELIKETAQIAAKEATADGINWNFSPMVDIARDPRWGRIAEGAGEDPYLGSQVA
KAMVEGYQGDDFTAPHTMIATVKHLALYGASEAGRDYNSVDMSKIKMFNEYLPPYKAAVD
AGVASAMTSFNDIHGVPASGNKWLLTDLLRDRWGFEGFVVSDYTSVNEMIAHGMGDLQDV
SALAINAGLDMDMVGEGFLTTLKKSVDEGKVSEEQITKAARRILEAKHKLGLLDNPYLYS
DESRPEKDILSEENRTVARKAARQSFVLLNKHGNTLPLAKDAKIALVGPLADNKNNMLGT
WAPTGDPQLSIPVLEGIKNVAPDAKISYAKGANISNDTTFAKNVNVFGPRIEISKESPET
LLEEALEVSENADVIVAVVGEATEMSGEAASRTDLNIPESQKHMIRELVKTGKSVVLVLM
SGRPLVISEEMEMPVSILQVWHPGVEAGNAIADVLFGDYNPSGKLTATWPRNVGQIPIYY
SMKTTGRPAASPSEFEKFKSNYLDVENTPQLPFGYGLSYTEFEYGETTASSDELSQSGSI
TITTTITNTGEYDGEEVVQLYTHDKVRSITPPMKELKAFKKISLKKGESKEVSFEITVED
LKFYNADLEFVVEPGEFEFFVAGSSDHEFTGSFTVGE
>IFAGANLK_03602 hypothetical protein
MKFFKSLLTPTVLLFGYLIQAQEVVPETYINPLDIDYTYMVYNSSKNISYRSGADPAVIE
YRGEYYMFVTRSFGYWHSKDLINWEFIKPEKWFFEGSNAPTAFNYKDSLVYFAGDPAGYG
SILYTDDPKSGKWKPTASISNNIQDSELFIDDDGETYLYWGSSNVHPLKVKMLDKDDRFL
ETGVQRELINLVEEEHGWERFGENNYHPTLKEGYMEGASMTKHNGKYYLQYAAPGTQFNV
YADAAYVGESPLGPFKYMKNNPMSFKPGGFANGAGHGVTMKQTNGQYWHFATVALASNSH
WERRLSMFPTYFDEEGLMYSITSYGDYPLFGPDHPTKAGLHNGWMLLSYKGKATVSSSMK
QTSKSTSTDGDFDITEMPLEKNSEGEIISKLLTDESPKSFWVAEANDDKQWVEIEMLSPG
NMYAFQLNFHDEESGIYTRTEGLRHRFTLEVSEDGENWETVVDRSESYEDAPNAYLTLSQ
PVRGKFVRYNNVEVPGQNLALSEIRVFGKGLGKKPAKVKGFEITRQEDRRDASFTWDPVK
GAQGYNIRWGIAPDKLYHSWLIYDENEHFMRNLDRDTKYYFSIEAFNENGISEKTEVQEV
K
>IFAGANLK_03603 hypothetical protein
MKKTYLYSLVCFLLVLPLSVTAQDQEAFKKENFIKNTDTLKYRILFPKDFSEEKEYPVVL
FLHGAGERGNDNQAQLTHGSELFLNNQEKFPAIVIFPQAPKDDYWAKVEVNRDTIPMQFD
FINKEPATKSLQLVMDLMEEITSKDYVNKDRIYLGGLSMGGMGTFELIYKKPEMFTAAFA
ICGGANPEIAKEYPQGFNIWLFHGKKDDVVLPKYSETMARAINHYGGNAKLSLYPDDNHN
SWDSAFAEPNLLPWLFSHTRAQ
>IFAGANLK_03604 hypothetical protein
MMTNYKSILSFLIISLILFSCKNESDKEKIEQKEPDSETLSEEALLDTVQKQTLKYFWDY
AEPNSGMARERYHPDGEYPKDDAHVVTTGGSGFGLMAIVAGMEREWIPRDSAVARLDKIA
NFLDNAPRFHGVWAHWLNGETGETQAFSDKDNGGDLVETSFLAQGFIVVREYLKNGNEEE
QAVAAKYDELWKGIEWEWYTNNKDGLYWHWSPDYEWEMDFMIEGYNECLITYVMAASSPD
HAIEPSAYHKGWARGGDIVTDKEAYGIPLILKHNTRGDKAGPLFWAHYSYLGLNPKGLED
KYANYWDLNVNHTKINYEYTQENPNDFETYNENSWGLTASYTRNEDDGIGYTAHSPDDDK
GVVSPTAAISSIPYTPELSLGAMRYFFEDQNELLWGPAGFYDAYSLEGENWVAPKYLAID
QGPQVVMIENYRSGLIWDLFMGAPEVQKGLENLGFNVSE
>IFAGANLK_03605 hypothetical protein
MLKSLYFIGLMLIFYSCSSDDGPGYQEPFDPDSENEEEEKLSDEDLLDKVQEQTFKYFWD
FAGTNSGLARERSQADAYGGEGRNIVTTGGSGFGLAAFPVAVERGWISRAEAVERLDKIL
DFLEEVPTYHGAFSHWYLDDVAQTRQFGDMDDGGDLVETAFLMQGLLINREYFAEEENIT
ERITELWEAVEWDWYTQGENVLYWHWSPTYSFQKDLKIQGWNESLMVYVLASASPTHSVD
PEVYHQGWASNGNMVNNRQHYGIDLPLGPSYGGPLFFAHYSFIGLDPQNLSDEYANYWEQ
NTAHSLIHYNYAIDNPKDFEGYGENSWGFTASDNYEGYSAHSPDNDLGVITPTAALSSFP
YTPEESMKALRYFYEEMGDELWGPYGFYDAFSEEENWVANGYLAIDQGPIISMIENYRTG
LLWDLFMQDEEIQAGLDKLGFNY
>IFAGANLK_03606 hypothetical protein
MKKINKYYFGIFSFILLLTSCEYDGIDPLTQVDPGEDAGAPEVTINYPNEGTTIQVPEPV
ASINIRFEVVDDIEVDMIEVLVNGDQIATFNEFLDYRIVKEEVSFENVTNGEHTLTINAT
DIAGNTTSKTVNFSKEPPYTPKYAGEFFYMPFDADFTELVNIYMADETGDPAISGDAFLG
TGAYEGVAESYIDVPLDQENLGSEFSGAFWYKVNTDEADRAGILVAGAEGSGDSESRQQG
FRLFREGSAEEQTIKMNVGTGTGESWNDGGIINVTNNEWVHIAFSVTPTETILYFNGMPV
NTGTMTAAIDWTGVEQLTIGAGGDTFSYWDHRSDINSKIDELRLFNTTLTQEDIQALINA
SSITLHMPFNGDYRDMVSNREVTEVGSPGFAGESVEGNNAYAGTEGSYLQLPSDGLLSEE
FSTTFWYKVNADPERAGIITISPEDEENPDAQNNRTSGFRLFREGNADEQRIKANVGNGS
ADSWNDGGVIDVAAGEWVHVALVITETESHIYLDGELVNTGDVPGGIDWTGTNIVSIMSG
APRFTGWDHLADLSYMDNLRFYNKALTAEEVEAAMGE
>IFAGANLK_03607 SusD-like protein
MKRYSFTKIFLLCLILGFGVNSCTDKLEEREGQLDTGDLDVTDASNMVQPLIGAYYEFAT
RGWEEPLLLGVRGDDVNAGGLGDQQQFADTDRYEYDQGYWMYNSLWNVHYNDIVNMNSAI
LQLESFKEFADAEDIDRADQYIAEIKVLRAYLHFNLARTWEEVFIITSNQPEEELEQGVS
SKADVMQFISDEMDMAIENLPDARPNERTDIQGGVTQYTAYALKALAHQELENYQEVADA
AGAIISSGKFSLYPDFYQLFKDPGELSNESLLEIQYSDYGTEAGGELYHEYSPFGPQNWT
PARENAQSGWGFYEPSNKWIEFMIDRGEETRLETSVLFTDRGIADLEAEGVEVPGFVSNT
TPSGDVINDYARAKFASGKHYLPSTQLTDGRNNYSAGKNMIIIRYAEVLLMYAEAITLGA
NGSSISADEAVNTVRDRAGMPPLSGVTHEDVLDEKFAELAMEWGIRFYDMIRHDMYGELS
YDGRNFTADKEYLPYPQEQLDALPIEATAVDRNTVMNDILSELN
>IFAGANLK_03608 TonB-dependent receptor SusC
MKLKLFAICMVLLSSFGFAQETKSITGIITDQNDMPLPGAEVKVIDKEIFDVTDFDGNFS
LDNVEVGDAVRVTFLGFIPQEFTVGENNEYTISLEEDADQLEEVVVIGYGTQEKRDLTGS
ISTVSAEEIEKTPTANVMQSLQGKVSGVQIVNSGSPGESPTVRIRGLGTFGDGTNVLYVV
DDVLYDNIDFLNTKDIKSINVLKDASSSAIYGVRAANGVVIIETKSGRKNQKPQFEYDGY
TGFQRAQNVMKLANTEQFATMARESGSAPDAQFIENAIQRYGRSRINPNVPAVNTDWYKE
ILREGLIQNHSISASGGGESVVYAVGANYTGQEGILDMKNDYERFNIRSKVDIDLTDRLK
IGVNSIFSNATKHAPEDGAWFRAYFAVPTMPVIDETNTEAGPTRYSNAQLLGYRSTQNPF
QDLAYNENRLKIRKQLTSAFLQYELIEDKLDIKTTYSHDYSSIEVREVNLPYTLGNNFER
RSSIKRENNNFSNQYWDNVLTYEDTFGDHDLTLMAGTSFRDEASNEFEATGFDISGVGLE
TSWYLDFADPDSFANNVEELGRRYYGLSYFGRVAYTFKDRYIFYGTFRADGSSKFTLDPW
GYFPSVGLGWVVSEEEFLVDNDLIDFFKLRASWGKLGNDNVAASAGSNTIEVVTAPIGDQ
PRTGLTSTSVFSNNTWEVIEEYNFGLNLEAFDRRLSIDADYYIRDTHDAILPVFIPIVNR
SIDRNSGVIRNEGLELVANWNQQVTEDFSFRIGANFTTLKNEALEIEDERGYIDSGSAEF
RQRTTIGGPLLGFYGYERIGVYQNQQEIDADPVAVENDLVPGDLIYRDQNGDGVIDDSDR
VILGSFLPKYTFGGNIGVSYKAFDFSMDFYGQAGNKILNRKRGEIIYTQDTNIDADLAIN
RWHGEGTSNTYPSSAGLRKAWNQRLSDFWVEDGDFFRIQNIQIAYNIEAAGLPETRIYFT
AEKPFSFFNYNGFNPEVADGVDRQTYPVPAIYTMGVNLKF
>IFAGANLK_03609 hypothetical protein
MKFSQLKILVILLFGFQYYSLFSQQLTPPIHNYSSTDYEAASQNWDIDVDKDGVIYAANN
QGLLSFDGQAWELHPLPSGSIIRSVFVHKDMIFTGSYKEFGYWKKDATGELFYTSLIPKL
GKYAMQSEEFWEILEFNGDIYFRSFGAIYKYDNEVIKPIQNIISNKMLVYKDKLLFAVRK
NGLHFLDENNELQKLPNQEILDEEIIVDMAIQGDDLIIGTREKLFKYDGNICILLDDPEL
MEELKSSELNHVMTLDKHRLLLGTVKNGIINYDETNQSHTIFNRNSGLQNNTILGFVEKQ
GNIWLGLDNGIDRIEIDSPVEFYTDDTGELGAVYDLVFHKDKMILASNTGVYTFSNNQLE
IINGAEGHTWNLEILNDTLYVNHNTGTYYLLQDRLMPVETSTGSFKISNLPYSRNEYLIS
SYTGIRNLSQKDDSIYSLDSLNFPVKNVVFENESILWAAHPYEGLYRVGLKNSFRETQFI
DKINIPDGGNSINTNVFLINNQIAVFNGDQWFKYNSFKDSLLVFEELDAFRKHKMLLKDG
DSYWFSHTENNSLKYTNFDDKNIVIAPGNLNNRLVKNYEEILKNGDSLYYIALNDGFARI
DLAKFVNNLDEVHISKPTVKGFLDLERRHSLENNPEVPYKSSRELNIYTSFPVSEAMGLR
YRLRGEDTLSGEVKNGVINLQNLNHGDYQLQLLAVGPQAKIAKKNSFNFSINPPWYLSNL
MKLVYMLIILSLVVLVYWYNQLKLRKHQRVLEEKFEKEHQERLNNLEKERLKNQITLKRK
ELANTTMVAAKKNEMLMEIQNELNKDKGSFPNQFKMKHILNKINRAIKNKDEWQVFETNF
NELHQDFFKDILDSYPHLTSKDLKLCSYLKMNLTSKEIAPLMGISVRGVEVHRYRLRKKM
NLDKKENLTNFLIKNF
>IFAGANLK_03610 Choline-sulfatase
MISKKIFPLVFSFFLVGISLISCKNNTSEKEEDKDPETKRPNIVFIMTDDHAAQAISAYG
HPVSKLAPTPNIDRIAQNGVKFNNNFCTNSICGPSRAVILTGKHSHENGFRMNGEVFDGS
QPTLPKFLKEVGYQTALVGKWHLHGLPEGFDHWNILVDQGNYYNPDFIKGKDTTRIEGYA
TDIITEMGLDWLKNNRDEDKPFMLMVQHKAPHRNWMPALRHLNKYDSIEFPLPDSYFSDH
EGQVAAQQQLQTIYEDMYEGHDLKMSVEKGSDSLRHNPWKTDFERMTKEQRDTWNAAYRP
KNDAFHEANLTGKELAKWKGQRYLRDYLATVASVDEGVGEILDYLEESGLDENTLIVYTT
DQGFYLGEKGFFDKRFMYEESLAMPMLMQLPGEIEAGSEISALTQNLDFAPTFLDFANAE
IPQDMQGKSLRTLMNNSVSDEDFRNAIYYHYYDFPAFHMVKRHYGIRTNRFKLMHFYDNI
DEWELYDLKEDPKEMTNIYNHPDYAEVREEMHQSLDSLQEEYNITDAEFKTTPEEKVERA
YRNFAKLAGEDPENYPDFKN
>IFAGANLK_03611 hypothetical protein
MIELRLIKNHFTTRYSDQEWIIYDLKRKYGLYYNLPTTDIINIDFAKNSGSSEENDYFLD
SHEQEFQKLWKNYFEATTIKFRINIKLHHQHVPKRYWKYLIEKNPLHN
>IFAGANLK_03612 hypothetical protein
MKKLFLLFAVATMSLSIYSCRETTEEKTEDAMESAGEDIENAADEAGNEMEEAGNEIEAE
AEEAEQEMEEEMNEDDNM
>IFAGANLK_03613 hypothetical protein
MKNLILLLVCIFALSLYSCRDTTQEKTEDAVEAIGKDIEDNVNKAGEKVKEGAKKVEEGA
EKVEREIDEEIHEDDN
>IFAGANLK_03614 All-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific)
MKVISQIKLPVEKEMELFEKKFLESMSSKVALLNRITHYIVNRKGKQMRPMFVFLVAKMV
SDGSVNERTYRGASVIELIHTATLVHDDVVDDSNRRRGFFSINALWKNKIAVLVGDYLLS
KGLLLSIDNNDFDLLKIISVAVREMSEGELLQIEKARRLDITEAVYYDIIRQKTATLIAA
CCSLGAASVKPDSDAIAKMRRFGELIGMAFQIKDDLFDYGDEQIGKPTGIDIKEQKMTLP
LIYALNNSTKKEKDWVINSVKNHNKDKKRVKEVIQFVKDKNGLDYAVTRMEEFQREALLI
LEDYPPSPYRESLELMVNYVIERKK
>IFAGANLK_03615 Dual-specificity RNA methyltransferase RlmN
MKNKKKDIRALTKAQLQEFFVANGDKSFRGSQVYEWLWNKGAHSFEAMTNISKATREMLD
ENFVINHIRVDKMQRSSDGTIKNAVKLHDQLTVESVLIPTASRTTACVSSQVGCSLDCQF
CATAKLKRMRNLNPDEIYDQVVAIDNESRLYFDRPLSNIVFMGMGEPLMNYNNVMKAVEK
ITSPEGLGMSPKRITISTSGVPKMIKKLADDEAKIKLAVSLHSAIDEVRTQIMPFNETFP
LDDLREALEYWYSKTKSRITYEYIVWKDINDTRKDAEALVRFCSYVPCKVNLIEYNPIDD
GNFQQASSNATDMYQQILERNGITVTVRRSRGKDIDAACGQLANKSA
>IFAGANLK_03616 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MGMKLSHFNFELPDELLAEYPSENRDEARLMVLNRKEQTIEHKQFKDILDYFEPEDVMVL
NNTKVFPARLYGNKEKTGARIEVFLLRELNPETKLWDVLVDPARKIRIGNKLYFGEDESL
VAEVIDNTTSRGRTLRFLYDGSYEDFRKKLKDLGETPLPKYIKRNVEPEDQERYQTIYAK
EEGAVAAPTAGLHFSKHLLKRLEIKGVDFAEVTLHVGLGTFSPVEVEDLSKHKMDSEEAF
IERKATQTINRAKLENRRVCAVGTTVMRVLESAVSSNHTLNEFNGWTNKFIFPPYDFSIA
NCMITNFHTPKSTLLMMISAFAGHDFMKRAYEEAVKEKYRFYTYGDAMLII
>IFAGANLK_03617 3-phosphoshikimate 1-carboxyvinyltransferase
MNLKISNTTKHLSGTIKVTGSKSESNRLLILQALYSNLKISNLSNSDDTHYLQKALKSED
ELVDIHHAGTAMRFLTAYFSTLEGREVVLTGSKRMTERPVKLLVDALKQMGADISYEQNE
GYPPIRIKGKKLTANRVTLQANISSQYISALMLIAPSLPNGLEINLEGEITSTPYIKMTL
EILQRLGIPGVFEGNTIKIEPTQEVERQTLAVESDWSSASYYYSLAAISDSADLKLSTYR
KTSLQGDSCLAEIYKQFGVTTKFEDDHIILKKRPGTKPKHIEENLQNSPDIAQTISVTCL
ALSVPCKLTGLHTLKIKETDRLVALKTEIEKFGSKVKVTNNSLELLPEKKFSENVSVATY
NDHRMAMAFAPLGLKVPFKIEDAEVVSKSYPGFWEDFEKLSFKIEKTSI
>IFAGANLK_03618 hypothetical protein
MKFKEMISQRAFWKSVLFLGLGFLIVYDIVSMLFEYGGFHFEAYFTERTEDGKLFRFIAG
QFLAAFVYGFIISFGQFRARKKKDAEN
>IFAGANLK_03619 hypothetical protein
MNIENAQKAVDDWIKEHGVRYFNELTNMAQLTEEVGEVARIIARRYGEQSEKESDKEKDL
GEELADVMFVVLCLANQTGVDLQEAFDKKLDIKTKRDHDRHHNNEKLK
>IFAGANLK_03620 hypothetical protein
MKQFYFFIISLFSVCLLQAQDYKFGKVSKEEVQQKEHPTFDEANAAILFRKHRVYYEINK
NTGISLVTNVHERIKIYNKDGFDWANKTISVYQNGSQRESVSDIKAYTYNIIDGKLVDEK
LRKNGVFQEEASKYSLKTKFTMPAVTAGSVIEYKYTIKSPFVTSIDDVPLQFEIPVDRLE
AEVKIPEFFGFKMHYNPRSPIIFPIDKSRESFRYNYTQKRRSGDHVSNTQYNQKSIDYIL
NVYNFQKDGIPPLKKEIYVDYLQNYAAYLRWELQYTKFPDSPVESYSRTWEHVAKSIYDD
AGLKQEVNKTNFFDDDIDELLAGTQEQPAKLEKVYNYVKNRITWNDFIGFQAENGGKSAY
KDGKGNTGDINLMLVSMLRYAGFDANPVLVSTKSHGIPFYPTRNGFNYVIAAVETQDNIV
LLDATDKNVAIGELPERAMNWRGRIIREDGSSDWVDLMPSVKSQNTTILNMQFDEEMVLK
GKSLSNINGLHAKKFRDSYVGLAENDYLQVLEKDKGNILISEIDISNENAIGQDIKQSYN
FELRDAMEVINEKIYLRPMVFTALDENPFKGEERNYPIIFDFPSSETKVINFLIPDGYEV
ESLPESAIVKLKDGDGIFKFIVNFGGKFLRIESSLELNNIVYTSLDYEGLKNFYGHMVNK
HSEAIVLSKAEK
>IFAGANLK_03621 hypothetical protein
MRKVFLLLFLFFQLGISSIYSQDYSISSLPANLLSNANAIVRNESIEISILAVDKMRVKT
MRVVTVLNEYGEQHVQAYDFYDENTKIKHQEVIVYNSSGEKIDKIKERDFYDRSLNGSGT
LFSDNRLSYLNYTISDYPLTFAYESEVETNSTIFIQPWKPLGNYNLSVEKTSYKLLNLNA
IPFRFEERNLEELDLEKNNSTSELFYKTGNILAVKNEVLSPDLSTFTPQVLVALNEFALV
GVEGKASSWKELGKWQYDYLLNNKTDLPEETTLKIKELTSKAISNREKAEIIYNYVQENT
RYISVQLGIGGWEPMAAADVDKLGYGDCKALTNYTKALLESQNIPSYYTVVYGGKKNNID
PDFASMQGNHVILNLPLAEEDVWLECTSQSTPFNYLGDFTDDRKVLKISAEGGEIISTPN
YSTASNLEESLCEIQLNEDGGFLAEVTRSNSGIAYGDTYGIRNQKLDHQKIYYRENWGHL
KELEIGKIAFVNNRESVIFTENLEIKGTKFASKAGNRLLLPLNFLPAKSFNLPRNESRKL
PLVIDRGETYKDNFQFKLPAGFKIESIPEPVVIENDFGKLSIKTSLTGISKNELNVERLL
ILNEGSWNSSEYNAYREFMNQIKSNTNQKAVLVSN
>IFAGANLK_03622 D-aminoacyl-tRNA deacylase
MRVVLQRVSKASVQINHEINAVMRTGLLILLGIENEDSQEDIDWLCNKIVKMRIFSDDND
AMNLSLLDVDGDAIVVSQFTLHASTKKGNRPSFIKAAKPDVAVPLYEKFIEKLEETLGKR
VGTGEFGADMKVELINDGPVTILMDSKEKS
>IFAGANLK_03623 Small ribosomal subunit biogenesis GTPase RsgA
MKGIVYKSTGSWYQVKSEAGTFYDCRIKGKFRIKGIKSTNPVAVGDRVEFDIEDKEGAEQ
GVIKKIDERENYIIRKSVNLSKQTHIIAANIDQVFLLITLNNPPTLTTFIDRFLVTAEAY
HVKAVLLFNKVDTYNEDELLEIKYLAAIYRNAGYDCIGISASTGKNVDKVKDMMLGKTSM
FAGHSGTGKSTLINAIEPGLNLKTSQISEQHKQGQHTTTFAEMFDLNFDARIIDTPGIKG
FGVVEIEREELGDYFPEFFRIKQDCKFHNCLHLEEPKCAIKDALEEGEIAWSRYKSYLQI
LEGEEDNYRTDIYPKK
>IFAGANLK_03624 hypothetical protein
MNKFTFKLFITGMICLFAFSANAQTRLFEHPQFDEISKNHKSLAILPFEASIKLRPKQMK
EITAEQLKEMAQNEGLAIQNSMYTWFLTRQKRGKLSLNVQDPKRTRILLQDNNITDPTRH
TPEELAKILGVDAVVSGTFETDKPMSDGASIALGLLVGFWGSTNTATVNMSVNNATDGEL
LWNYNKRVAGSLGSTTDALINKLMRKASRRLAYTN
>IFAGANLK_03625 Phospho-2-dehydro-3-deoxyheptonate aldolase
MENKKELRNWLDDFGLDHPLVIAGPCSAETEEQVLKIAHQLKDTDATVLRAGIWKPRTRP
GNFEGVGALGLKWLKKAKEETGMLTTTEVANAHHVDLALENDVDILWIGARTTVSPFIVQ
DIADALKGTDKTVLVKNPVNPDLSLWLGAVERFHTADIKNLGVIHRGFSAYEKTKYRNNP
EWQIAIELQNKFPDLPLILDPSHIAGRRDIIFDLCQTALDLNYDGLMVETHHTPDDAWSD
AAQQITPATLVQIMKDLKIRKEVSESEDFKNKLNTLRAKIDVADNQLIELLSKRMKISDE
IGKVKKAQNVSVLQTKRWNEILGNMVLEGEQHGLSEEFILRLFKAVHQESINHQEKIMKA
>IFAGANLK_03626 T-protein
MKVQIIGIGLIGGSFALDIKSAFPDAEIYGSDADEKNLKKAKELGIIDDLAHIEDVQHAD
VVLVAVPVDVANKVVTEVLDLVNENTLVFDTGSTKSGLCKEIANHQNRRNFLAAHPIAGT
EFSGPEAAISNLYRNKTNIICEVEKTAFKLQERALDIFQKLGMRIRYMDPVSHDRHIAYV
SHLSHISSFMLGKTVLEKERNERDIFDLAGSGFASTVRLAKSSPAMWSPIFQENKENVLE
TLKEYINNLTHFKDLIEKDDFQEVYNEMQRTNHIKSILNGIN
>IFAGANLK_03627 LL-diaminopimelate aminotransferase
MIEQAKRLSNVKEYYFSTKLKEVRAMAAAGKDIINLGIGSPDLAPPQQVISALNEALVNP
GAHQYQPYKGTADFRNAIAEFYLNHYQVNLNAETEILPLMGSKEGITHISMAFLNEGDEV
LIPNPGYPTYSSVTELVGAKAVFYDLNAEGNWLPNLEELAKKDLSKVKLMWVNYPHMPTG
ASANDKLFEEVVAFAKTHKILIVNDNPYSFILNNNPKSILKAEGAKDVVLELNSLSKSFN
MAGWRIGMLCGSEKNLNTVLKVKTNMDSGMFYPLQAGAAAALRLNGEWFSAQNEIYQSRK
EKILELAAALQCEPEKEQTGMFVWAKVPKGTDAEAFVEFLLNKYHIFTAPGFIFGSNGEG
YIRFSLCASEENINRAIKRVTS
>IFAGANLK_03628 P-protein
MDKIIAIQGVQGSFHHLVAQEYYHKEVEVLECMSFAELTKSLLKGEANEGVMAIENSIAG
SILPNYALIDENNLKVVGEHYIPIDMNFMAMPGQKIENIKKVYSHPMALLQCKEFFKKHP
HIKLIEDTDTAEVARRISEKGSTKVAAVASKAAAQLFGLEILAESIHTKKSNATRFLIIS
TKKKEPNGDKIDKASLKFELESKRGSLVSVLNILRDFNLDMTKIQSMPIIEFPWKYSFFI
DVVFEDYPEFQKAMDILEVMTERLTILGTYKNSL
>IFAGANLK_03629 ABC transporter ATP-binding protein NatA
MSIHVEGISKFYGEQKALDSVSFKLNKGEIVGFLGPNGAGKSTLMKILTGYLAASEGKAE
VNGISLEEDLHKIQQQIGYLPEHNPLYTEMYVREYLEFNAKVYKTDKSRIEEVIALTGLK
PEANKKIEQLSKGYRQRVGLATALLHDPEVLILDEPTTGLDPNQLVEIRNLIKNIGKEKS
GKTIFLSTHIMQEVEAICDRVIIINKGKVVADKNLKDLREENEQVILVEFDYRVEQIALQ
KIPHLLSAKNVGGFAYELTFDTKKDMRPAVFDFAHDNGLKTLQLNQKTKNLESLFAELTQ
K
>IFAGANLK_03630 hypothetical protein
MKKVILSIAVLIFISLGCDSEEAPTCIQTSGEIISEEFTVDSFEEIMVYERVKLFVEQGD
EYKVKIETGENLKENVYAEVVNNRLELRNENSCNLFRDYEITKIYVTTPTLNWLQNSSGS
AIESIGTLNFPELWLRSFNQERDPDIHTNGDFILDLEVENLRITNDNISNYFLTGNAENV
NLFFANGDGRLEAGEFLVQHYDILHRGTNKLIINPQQSLKGDIFGFGDIISKNRPTDVDI
EEHYTGRLIFE
>IFAGANLK_03631 hypothetical protein
MKKITALIFLFILGSISAQDSGKNYYSFDANYFYGTIAEHNPDIAHLITGHPTGLILGFN
KKSFGFEDWEKRYNYPDVGVSFTYQDMKNPSLGENYGLYAHMNFYLFKRNLMFRIGQGLA
YASKPYHPDDNYKNNAYGSRLLSSTYLMANYKKENIFEGLGVQAGLSLIHYSNADFKSPN
ASTNTITFNLGVNYTLDHQNLPNYIPKGSKEKYTEPIHHNFALRSGVNTMGIIGSKQYPF
LTFSAFADKVLNHKSTLQAGTEVFFSKAMQERIYYQSVAFPSGDTSGDEDSKRVGVFVGH
QLNFNKLSVITHLGYYVYYPYEHFVDQLYNRIGLQRKITENLWVSLTVRSHYANAEAVEL
SIGYRL
>IFAGANLK_03632 5,10-methylenetetrahydrofolate reductase
MKVTEHINRAKGETLFSFEIVPPQKGRNIQDLYNNIDPLMEFNPPFIDVTTSREEHVYIK
KEDGLLERKITRMRPGTVGICAAIKQKYNVDTIPHVLCGGFTREETEYLLVDCHYLGIEN
VMALRGDAMKHQRYFEPTNGGNCFASELVTQIKDLGAGKYLNEVIESDNNADFCIGVAGY
PEKHLESPSLQTDLKRLKEKIDAGADYVVTQMFFNNQAYFDFVEQAREAGITVPIIPGIK
PIAVKRHLQLLPQVFSIDMPEELIKDVEACKSNVEVRKVGIEWAIAQSKELKAAGVPVLH
YYSMGKSTNIQKIAEAVF
>IFAGANLK_03633 Methionine synthase
MIETVKKENKQEEISSEKQQQEVRPLKLSGLEPLIITPDSNFVNVGERTNVAGSKKFLRL
IKEENFEEALEVARDQVDGGAQIIDINMDDGLIEGKEAMVKFLNLIVAEPDIARVPIMID
SSKWEIIEAGLQVVQGKCVVNSISLKEGEAEFIDHAKKIKRYGAAVIVMAFDEVGQADNY
DRRIEIAKRSYDILVNKVNFPPEDIIFDLNIFPVGTGMDEHKRNAIDFIEATRWVRENLP
HCSISGGVSNVSFSFRGNNPVREAMHSVFLYYAIKAGMNIGIVNPALLEVYDNIPKDLLE
HVEDVILDRREDATERLLEFAETVVGSKRESKVDLSWREKPLQDRVTHALVKGIDAYILE
DIEQARQEAEQPIEVIEGHLMIGMNVVGDLFGSGKMFLPQVVKSARVMKKAVAYLLPYIE
AAKKAPQPPKGEDYWKKAEPELFASMKEFAEKQRYNKETKAENVLWESLKDKQLEDFKFR
KQHIIGDYIADFVCLNKKLIIEIEGLSHQLPENKKGNEERTTWLRDNEFRILRFTNGDVL
TNFDHVLDKILRTLKKAPASGSGGAGKVLMATVKGDVHDIGKNIVGVVLSCNNYEIIDLG
VMVPPEKIIETAKAEGVDAIGLSGLITPSLDEMVFLAKEMQRQNFDVPLLIGGATTSKAH
TAVKIDPQYKNAVAHVNDASRAVTVIGDLLKENTRQKYMSDLKAEYDKFRLNFKKRSKVK
SFLPIDEARKNKYKIDWKSTNITKPNKPGIQQIDDFDLRELEPFIDWSPFFRSWDLHGRY
PDILEDKVVGEQATSLFEDAKVLLKRILDEKLLKAKAVYGLFPANTVNDDDIEVAYEEDS
EEKTILFRTLRQQLKKHGGKPNFALSDFIAPKETGIQDYIGCFCVTTGFGTAELAKKFEE
DFDDYNSIMIKALADRLAEAFAEYLHKKIRREDWGYAPEENLSNEELIKETYKGIRPAPG
YPACPDHLEKLSIWEVLKVKERIGVELTESLAMWPAASVSGYYFANPEARYFGLGKIKDD
QVRDFAERKGIPLKKAEKWLNPNIVD
>IFAGANLK_03634 Methionine synthase
MSKLEEQLQKNILILDGAMGTMLQEYKFSEEDFRGKRFVDWPVSVQGNNDLLSITQPEAI
ATIHRKYFEAGADIVETNTFSATTIAMADYKMEELVDELNYESARIAKEVAVKMTEENPE
KPRFVAGAIGPTNKTASMSPDVNDPGFRAISFEELRVAYKQQAKALIKGGVDILLVETVF
DTLNAKAALFALEELKEELQLDIPIMVSGTITDASGRTLSGQTAEAFLISVSHIPLISVG
FNCALGAKQLTPHLEVLNRFASCGVSAYPNAGLPNAFGEYDQDAEEMARQIREYLEKGLV
NILGGCCGTTPEHIKAIAEIAKDYNPRKIEKPEFSTAL
>IFAGANLK_03635 hypothetical protein
MKVNLKRLNKDYHFETVNERGDIVHLDNKTDADPKGASPMDLLLRAIAGCSSIDIVMILK
KQHLELEDLQVEVEGFREDGAVPNVFKKIQLNFLLKGDVPAAKAKRAVDLSMEKYCSVSK
MLEKAAEINYAITLNGELIN
>IFAGANLK_03636 hypothetical protein
MADKAFITSEILKWARESANISLEDGAKKAEVSSERLETWENGTGYPTIRQAKLLAKGYR
RPFSLFFLPEIPKDFQPLQDYRRDDSKKLDTASIFIIRDIQEKQNWISELFEETGEDQLD
FVGKFSINDNPETVARDILNTLKINPNDYSKRPISEWIDKAESAGIFISRTSYLHSKLVL
NRDLIQGFAIADKYAPFIFINTKNWDAPQLFTLVHELAHIWIAKSGISNEIDIDYSEKPK
SKFHPVELFCNQVAANALMPRELIVQMGEEVYSSNKNVFKQAKELGVSSFALLVRFLKLN
LISNNSYQFLKNEAQEEFEKFVAKEEERKLRQKKKDSGPDTYLLRLNKNSKLFTRIVMDS
FKNGTISPSIASNLLNTQINKFQKFEKLLA
>IFAGANLK_03637 hypothetical protein
MFEDERTIFCIDANILIQAWQKYYSPEICPSYWQVLNELGKKGIIFIPEVVFEEIEKGED
DLFEWLKKSDIPIRKIDGSVANCLKEIYATNPNHKYLVSSNQIHSKADPWVIAHAMNEKA
IVVTKEQKDFIKKQTKIKIPHVCENMKVEWIDDFEFIKKVNINFVCHL
>IFAGANLK_03638 Ferredoxin--NADP reductase
MIKTDILIIGAGPTGLFTVFEAGLLKLKTHLIDALPQPGGQCSEIYPKKPIYDIPAFPEI
LAGDLVGNLMEQIKPFEPGFTLGERAETLEKLDDGTFIVTTNKGTKHHAPVVAIAGGLGS
FEPRKPPIANITDFEDKGVSYFIKDPEVYRDKKVVIAGGGDSALDWAIYLADVASEVALV
HRRAEFRGALDSVERVSELAKLGKIEMITNAEVVGLRGEDQLEQVVIRHKDEARGEEFKD
VDEFIPLFGLSPKLGPIGSWGLEIEKNAIKVDNSYDYQTNIPGVYAIGDVNTYKGKLKLI
LSGFHEAAIMCQSAYQRIFPDKKYVLKYTTVGGVTGFDGSKKEAKKEVVQSIGV
>IFAGANLK_03639 Siroheme synthase
MEERNELYPVFLKVNKLNILVVGGGQVGHEKLHFLFKSSPNANVEIVAKWFLPETEELAK
KHGAKLTKGRYRRKYLKNRHFVIAATNDAKLNKRVYKHAKKRYLLANIADTPELCDFYMG
GIVNKGHVKIAISTNGKSPTAAKRLRQFFEEVIPEDVNQMVENLNEYRSTIKGDFEAKVE
QMNSITESLKVKNKSDD
>IFAGANLK_03640 Uroporphyrinogen-III C-methyltransferase
MHLERRRYRMYNSPKLSVVGAGPGDPELITIKALNTLKDAKVVLFDALINRDLLEYAPQA
EHIFVGKRKDKHRYSQDEINELIVRYALERGHVVRLKGGDPFIFGRGSEEINYAKSKGLE
TAVVSGITSSIAVPANVGIPLTQRGTSESFWVITGTTTQKKLSEDVRLAAQSTATVVILM
GMAKLAEIVKVFSHYGKENVPVGIIQNGTTANEQSGFGTIKSIEKVVAEKQLTAPAIIVI
GEVVRESGQLKAVFKNVKEYEFRNSPILD
>IFAGANLK_03641 Sulfite reductase [ferredoxin]
MQSFRTEIENPIVEQDILDLEKKIRLFREGKADEEKFRSLRLARGVYGQRQAGVQMVRIK
LPFGKVTSEQLHRIADVSDEYSKGRLHITTRQDIQIHHVSLDRTPELWAQLERDDITLRE
ACGNTVRNVTASPTAGIDVNEPFDVSPYAHGTFQFFLRNPICQEMGRKFKISFSSSDEDT
ALSYIHDLGFIAKLKEGKRGFKVMLGGGLGSQPRHADELYDFLPVEETLPLIEGVLRVFD
RYGERAKRLKARMKFLVKDIGKEAFMELVAEQNTALSKNHPKFDIEKFEVAPSLQNVEVP
AVTIEDQEDFETWKSTNVLPQKQEGLFAVGIRVPLGDFYTGGARKLADLVKKYAGNEIRL
SLRQDILVRHVREEFLPFFYTELKKLGYADTGYDKTVDITACPGTDTCNLGIASSTGIAD
VLEDVLKEEYPQFINGKDITIKISGCMNACGQHNMAEIGFQGMSVKVGKTVAPALQVLLG
GGTLGDGQGRFADKVVKVPSKRGPQALRLLLNDFEANSTSEEKFAEYYDRQGKTYFYDLL
KELADTSNLTENEFVDWGHEEPYIKAVGVGECAGVVIDLIATLLFESEEKIDNAKSALER
KAWADSIYHSYTSIVNSAKALLLAEEVKTNTQAGIISQFDELFVDTGKIELSTSFKEFAY
QMNEHEPTEAFANKYLEDAHLFLKRVDAFRTKEVQNV
>IFAGANLK_03642 Phosphoadenosine phosphosulfate reductase
MKRYSEKELKILNQQFKGITPAEIVQWVISNSARPVITTNFRPYEAAILHAVSEIDPVIK
VIWCDTGYNTPQTYKHAKQVIDQLSLNVKLYTPKQTAAYRDAFFGGIPDINNPQHEEFTK
QVKLEPFLRAMRQQNPDVWFTNLRKGQTSFRDSIDILSYSKDGILKVSPFYHWGDEKLDA
YLEQHDLPNEFKYFDPTKVLENRECGLHA
>IFAGANLK_03643 hypothetical protein
MILDQAKSKTTYKKDRTSEKPLRSILKTVSWRIVGTIDTIVISWLLTGEIETALAIGSVE
LVTKMILYFGHERLWNMISFGKE
>IFAGANLK_03644 HTH-type transcriptional regulator CymR
MVISAETGLFDFSVENSIMNAKKSIFKYIRNMLSKKTKYGIKALAFIAKKGNKKPVQTSE
ISKSENISQKFLESILLELRKSGFLGSKKGKGGGYYLIKEPEDIRMTSVIRVLEGPIAMV
PCVSLNYYEKCDDCPSEEACSVHSLMIQVRDSTLKVLGDNTLADISAKK
>IFAGANLK_03645 O-succinylhomoserine sulfhydrylase
MHFETEAIRTQNERTHFQEHSTPLYLTSSYVFDDAEDMRASFSEEKERNIYSRFTNPNTS
EFTEKIAKMEGAEAGFAFATGMSAVFSSLAALLNSGDHIISARSVFGSTHSLFTKFFPKW
NISHTYFNVDEVDKIESLIKPETKIIFAETPTNPGVDVLDLEVLGKIAKKHNLILIIDNC
FATPWLQNPIKFGAHLVIHSATKLIDGQGRVLGGVTVGNADLIREIYLFSRNTGPALSPF
NAWVLSKSLETLAVRLDKHCENAEKVAEFLESEANAENVKYPFLKSHPQYEIAKKQMKKG
GNIVSFEIKGGIEAGRKFIDAIKLCSRSANLGDTRSIVTHPASTTHSKLSEEDRLEAGIK
PGLVRVSVGLEHVDDVIADLKQALNSI
>IFAGANLK_03646 Bifunctional aspartokinase/homoserine dehydrogenase 1
MKKVNIILFGIGNVGSTLIQQLLDAKKQWEKHSGVSVSIPVIANSRKALFNAAGISENWQ
KDFKKSAEKYKLEDILDFTKENDLEHLIAIDATASKEFVDLYIRLIQNGFNLVAANKVAN
TLSAEFYNKLRKELDYHGKYFYYETNVGAGLPIVQTVQGLHQAGEKVTKIRGVFSGSLSF
IFNTFSENKEKFSDVLRKAGRLGYTEPDAREDLSGNDVGRKLLILARELQLEKEFQEIKI
QSLIPEKLNGQTSAEEFQRRIGELDEIFFQHKKDQNKDHVLRYIGEIEVGSANLEAKLIS
EPKSTALGQIKGADNIFEIYTESYGDQPLVIQGAGAGAAVTARGVVSDVLKLSQRLN
>IFAGANLK_03647 Homoserine O-acetyltransferase
MLQELCLKDFENSAGTVQDIYLSFQQFGQNPENAPVVLINHALTGNSQITGKLGWWTKIV
GPQRCIDTDKFSILAFNIPGNGFNGKKEHLIENYKEFTLQDIARIQALGLQKLKIDKLFA
IIGGSIGGALAWELAALKPDLAENIIPIATDYKATDWVLANCKVQEQILNNSKEPVKDAR
MHAMTFYRTPQSLSKKFNRTKEEVKPCYKVEGWLQYHGIKLEERFQLASYKFMNHLLTTI
DISKGSGNYLETAKKIEGDIHIVTVNSDWFFLADENWETYVNLSLIKNNVSIHEIRSIHG
HDAFLIEASQLSRFLKPVFITNNKKNEESEHHLVWNR
>IFAGANLK_03648 L-methionine gamma-lyase
MSTQKFSTNALHAGHDTKENGGTRAVPIYQTTSYVFNNSDHAANLFSLAEPGYIYTRLNN
PTNDILEQRLAALEGGIAAVVTASGTAAINTTLLTLLKSGDHIVASSSLYGGTYNLLSVT
LPRFGITTTFVDPEYPENFKKAAKENTRAIFVESLGNPKLDVLDLKAISAEANALKVPFI
VDNTVATPSLLKPIEHGADIVIESLTKYISGNGTSLGGAIIDAGNFNWANGKFPEFTEPS
PGYHGLVYHEALKEAAFIAKVRIEGLRDHGAALSPYNAFQILQGLETLEIRIKQHSQNAL
ELATWLEQQEEVKWVNYPGLESSKYNKLANEYLSKGQSGVVTFGVEGGFESAKVVADETK
LFSLVANIGDTKSLIIHPASTTHQQLDEKQQATAGVTQDLIRLSVGLEDVEDLKTDLKEA
FSKIQKKALV
>IFAGANLK_03649 S-adenosylmethionine synthase
MAYLFTSESVSEGHPDKIADQISDTLLDNFLAFDENSKVACETLVTTGQVVLAGEVRSDT
YLDVQNIAREVINDIGYTKGAYKFSGDSCGVISLIHEQSQEIYQGVDRENKEEQGAGDQG
MMFGYATNETENYMPLALDISHKILIELAKLRREGKDIPYLRPDSKSQVTIEYSDDNVPQ
KIVAIVVSTQHDDFDEDDDAMLNKIKKDILEILIPRVKEQLPEYVQKLFNDEITYHINPT
GKFVIGGPHGDAGLTGRKIIVDTYGGKGAHGGGAFSGKDPSKVDRSAAYASRHVAKNLVA
AGLADEVLVQVSYAIGVVEPTSISVETYGTSNVDMKDGEIAKKVAEIFDMRPWAIESRLK
LRNPIYRETAAYGHMGKEPRTVTKIFKSSYSGEIKKEVELFTWEKLDYVEKVKEAFGL
>IFAGANLK_03650 Glucose--fructose oxidoreductase
MMDKNNNKNPRRNFIKNTGLGMGGVILAPSLLSFTEQESVNIARDNKKLGIALVGLGRYS
TNQLAPALEKTKNCRLSGIVTGSPSKEKAWKKKYKLPDSNIYNYENFDEIAGNEDIDIVY
VVLPISMHKEFTIRAAKAKKHVICEKPMALNAEEAQQMVKACKDNGVLLAIGYRLHFEPF
NQRVMELGQQEVFGKVKSIKAVDNSNMTGGSLDLWRLDKERAGGGPLMDLGIYCVQAAIY
TMGKPPVAVRAKFGEVTHPAYFRDVEQSITWEMEFDEGVVANCEASYADEEEKNSLSGKA
EDGWWKLEPAYSYEGKKGETSNGKMEFPNIYEQVKQMDAQAESFRNNQNPKTPGEMGLRD
MKILMAIYNSAKKEGTRVEITY
>IFAGANLK_03651 General stress protein 39
MKMQDPQKKYPQPPYSDDKQEEPGVEKKMNPMVDHGEESYRGSGKLEGKNAIITGGDSGI
GRAVAIAFAREGANVLISYLEEHEDARETEKYIKEAGKEAVLMAGDVSEESHCKEIIKKA
LEEFGQIDILVNNAAFQMARESLQDISSEEWDYTFKTNIYSMFYLCKEAVPNMKPGATII
NTSSINAYSPHPKLLAYAATKGAIQNYTANLAQILAEKGIRVNCVAPGPIWTPLIPATMP
QEKVEKFGKNTPLGRAGQPAELAASYVLLASEDSSYTTGSTVQITGGRPTI
>IFAGANLK_03652 Acyl-CoA dehydrogenase
MDQLAKINEQIDLSEAMKSLGQLDERQLKGLMKMLKTKQKKGQSDLPPITGDFYNLDLKL
TEEQRKLQMDVRNFMEDEVRPLVNDHWNRAKFPHEIIEKFKKLNITGVPYEGYGCPNLPF
LMEGIIAQEIARVDVSISTFFGVHSGLAMGSIYLCGSEEQKQEWLPKMQKLDAIGAFGLT
EPNVGSGVAGGLETTCKFDGENWILNGQKKWIGNATFADVIIIWARDEDSNQVKGFLVRK
GNPGYKAEKMEDKMALRIVQNAIITLTDCVIPESDRLQKADSFKDTAKVLRMTRAGVAWQ
AVGCARGAYESALKYTRKREQFGRPIASYQLIQNHLVEMVSNLTAMQTLVFRLSEMQDAD
LLTDEHASLAKVFCSMRTRDVVSRAREVMGGNGILLEHDVARFVADAEAIYSYEGTKEIN
SLIVGRAITGYSAFVS
>IFAGANLK_03653 Glyoxylate/hydroxypyruvate reductase A
MSLLIVSPGKDPKAWVEALKNQHPGLNIYVYPEDHDKEEVDFALTWNHPRGIFQNYPNIK
VVASMGAGVDHITSDPELPENIKITKVVDDRLAEDMGTFVLTLVLAHQRNLLHYRESQIN
EKWEPVPYTRNNDVKVGILGIGNLGQSVSKCLLKNGFQVIGFSKHKKDFENVDSYAGEDE
FDEFLEQSDILVNMLPLTSETEKILDLELFEKLPKGAYVINVARGEHLVEQDLLAKVDDG
HLSGAALDVFWEEPIRDEHPFWKHPKIRVTPHIASVTHPNSVVPQIIENYERLQEEEELK
NVVERDRGY
>IFAGANLK_03654 Universal stress protein C
MKTFKNILVAVDFNDAVGELMSYAESIAEKFGAKIWVVHVAAPDPDFVGFDAGPQYIRDM
RADELRDEHRELQQIRDMFINKNIESDALLIQGSTVESVLEEAKKLKADILIVGTHKHSF
FYNLFAESVSVELFKTAEIPVLSIPIEEEK
>IFAGANLK_03655 L-threonine dehydratase catabolic TdcB
MISKEEFTKLHSEISPFIHRTPVLTSALLNKLAETEIFFKCENFQKMGAFKMRGATAAIL
ALSEKERAKGVVTHSSGNFAQAVSLSAKSLGIPAYIVMPSSAPQVKKDAVKTYGGQITEC
EPNLKAREAAAEKIQKETGAIFLHPSNDLNVIYGQGTAAKELIEDFPGLDMIITPVGGGG
LIAGTALAVNFYTENCKTIGAEPFKFDDAYRSLESGRIEFNETNNTIADGLKTNLGDKNF
PIIKDKVSEIIRVEEDEIIAAMKFIWERMKIVVEPSSAVAFAAVLREKDKFRGKKVGIII
SGGNVDLSNLPF
>IFAGANLK_03656 hypothetical protein
MNKPEVWLRGKVVEVPDLLQPAAHALLQSREEVEEYMRDFPEGLLWEKPAGRASVGFHLQ
HLSGVIDRMLTYAKAEKLSETQFQYLKNEGKFNEEISVEFLVNNFQEKVDEAIDSLKNTP
ENILTEFRPVGRKALPSTVIGVLFHAAEHSQRHVGQLLVTVSVLKDLDSR
>IFAGANLK_03657 Dipeptidyl-peptidase 5
MFKKFLPAIFILLATPNLISQEKEEKKWDVNDPYSDDWNIKEVSLQTDEGTWINLDVSPD
GKTIVFDLLGDIYKMPIGGGKAEILRSGMAYEVQPRFSPDGSKISFTSDAGGGDNIWIMN
ADGEDAKQLTKEDFRLLNNAVWTPDGNAIVARKHFTSGRSLGAGEMWLYHIGGEGGLQLT
ERKNDQQDVNEPSTSPDGRYLYYSEDMYPGGMFQYNKDPNKQIYVIKRYDFETGENTTIT
GGPGGAARPQVSPDGKKLAFIKRIRTKSVLYIHDLETGEEWPVYDKLSKDQQEAWAIFGV
YPGFSWIPSGKEIVFWSEGKINRVNIENYDAEVIPFEIDNTIEIAETHRSEHQVFSEEFN
PKVIRHAVTSPNGKTLVFNAVGYLWKKSLPNGKPQRITNTEDFEFEPAFSPDGKEIVYVT
WNDTEMGALMKVGLNGRNPQKLTSEKGIYRNPAFSNDGEQIVFVKERGNSDQGQTFSKEP
GIYTISASGENKKKIHDSGDFPIYSKDDSRIFFQTGGALMGSLEKSLKSIDLSGNDERTH
INSKHANRLVPSPDNKWVVFSHLHQAYLAPLTLTGRPLDLDNNTKTIPVTQITRDAGMNL
HWSNNSENVHWTLGDEYFTNKVSERFTFLKNSPDSIPDITEKGTKIGLELKTDVPEGKIA
FTNARIITMNGDKVIENGSILIEGNKIVSIGEASEIKPPNNAKVYDLEGRTIMPGIVDAH
AHIGAFRYGLTPKKHWPLYANMAFGVTTVHDPSALSESIFSMAEMVKSGEMVGPRIYSTG
IILYGAEGDFKAVINNLDDARSALRRTKAFGATSVKSYNQPRREQRQQIMQAAKELDMNV
VPEGGSTFLHNMNMIVDGHTGIEHNIPIAPVYKDVKTLWGNSNTGYTPTLIVNYGGINGE
YYFYDKDKVWENERLLNFTPRQIVDPRSRRRETLPEEEYEQGPILVSETAKTLSDMGVKV
NLGAHGQLQGLGAHWELWLLQMGGMTNMEALQAATINGAEYIGMGSEIGSLEEGKLADLI
VLEKNPLEDIRNSESVIYTMVNGRLYDAETMNEIGNDPKERGEFYWEDNKYNAAFPWHES
TQSFTAPGCTCNKLNN
>IFAGANLK_03658 hypothetical protein
MRRVKFGKLFTHRKIDESIIREHLALERTKLANERTLLSYTQAALYFLLGGLALIQLKEY
EEMHYIGYLALVFSVLFVTVGIWRFIVLRNKMKDLLKGKIESSAEEEEEPEHN
>IFAGANLK_03659 hypothetical protein
MQTFTHYFLHFIATGAIAWFYDKKNWKKNWLILLATMAVDIDHVVAEPLFDPMRCGIGYH
PLHSHFAIITYVLGVLFIKNNFLKLIFIGLLFHMLTDFIDCLWMFSKCGECYTSSEIYKW
FN
>IFAGANLK_03660 hypothetical protein
MEFKRVEITPEADKLLQELKQQHGEVIFHQSGGCCDGSSPMLLPKEDFYIDDNDILMGEV
GGVKFYMSHDQFEYWKHTHLTVDIVKGRGGSFSLDIPTGYRFLIKSRMLNDEENKNLNP
>IFAGANLK_03661 Acetaldehyde dehydrogenase 2
MSYSAPKFKEKYGNFINGKFQDPIDGQYFENHSPVDNKLLAKYPRSNEKDVNSAIEAANK
AKHEWGNTSAAERAGILHKIADVIQENLETFAQMETADNGKSIRETMNADVPLAVDHFRY
FASAIRAEEGSATELNENTLSLIINEPLGVVAQIIPWNFPLLMLAWKVAPALASGNCVVL
KPAEQTPASATFLAEKIADLLPPGVFNVIHGFGPEAGKPLASSPNVDKVAFTGETTTGQL
IMQYASKNLHPVTMELGGKSPNVFFNSIMDHDDAFLDKCIEGAVLFAFNQGEVCTAPSRI
LIQEDIYDEFIKRVIERTKAIKMGNPFEESTMMGAQASSDQHQKILEYIKIGKDEGAEVL
AGGDAAKLDGDLANGFYIQPTILKGHNKMRVFQEEIFGPVVAVCTFKDEAEAIEIANDTM
YGLGAGVWTRDAHQLYQIPRAIKAGRVWVNCYHDYPAHAPFGGYKKSGFGRENHLMMLNH
YRQSKNMLISYDKNKLGFF
>IFAGANLK_03662 HTH-type transcriptional activator RhaS
MNTNLSNYNRNLKLNTSIENRTIYSADYAELNVFETQKVAEKVNLQFGFPIIASMLTGKK
VMHLEGMKSFEFFPGESVVLPSEKKMVIDFPIANAKNPTRCLALGIDPDKIKETVQIFSE
NTRIDFENDNHSFDASAIHLANNHQVQFVLDRIFSTFLEDGTAKDALLDLMVKELIIRLL
QTKAKVMLVDNETLFDNNRMAFIVKYMREHLTENINVDKLADKACMSTSNFYRNFKNTLG
ETPIDYLNGERIKFAKKLIQKTAWKFSDIAYKSGFNNTSYFNRQFKRFEKITPNQYRKLV
KGNLT
>IFAGANLK_03663 hypothetical protein
MITESKYGFESTVSRLESVLKQNEALSLFTKIEHSKNAEKADLELDKASVLIFGNPKQGS
LLIQKDQLAGLDLPLKMLVYKNEDKTEVTYSSVNYLKSRFDFKGVKNLSEVKNGLKNMAS
KASGGKVKKSGKFNVDTHEGIISEISEFDFQTTYDRLITAIEENLNLNIFADIDHFKNAE
QVGLGLRPTRLIIFGNPNIGTPIMQENSRIGLEFPVKFLVWRDEAGIVKISYNDPAFLAR
RFNLTQNIAQLETMKTALENLSKNAAKY
>IFAGANLK_03664 Deoxyadenosine/deoxycytidine kinase
MHVAIAGNIGAGKTTLTKLLAKHYNWEAQYEDVLENPYLEDFYNKMERWSFNLQIYFLNS
RFRQILQIRESGKNIIQDRTIYEDAHIFAPNLHAMGLMTNRDFKNYSSLFDLMESVVQGP
DLLIYLRSSIPNLVSQIHKRGRDYENSISIDYLSRLNERYEAWVHNYNKGNLLIIDVDNI
NFVDNPEDLGDIINRIDAEIHGLF
>IFAGANLK_03665 hypothetical protein
MESTKLKRPKHKGSPKLFDNPILEKLTHTHISLPLIIFGLIATALIYYGIIEKGFETPLM
VGLFLAGLFFFTFVEYIMHRYLYHIPATSERKKKISYTMHGVHHDYPKDKSRLAMPPVLS
LIIATVLFIIYRAVLGDYVFGFLAGFLIGYAGYLAVHYSIHAFKVPNNFLKTLWHHHSIH
HYRESDRAFGVSSPLWDHIFRTMPRKAPASRKTAVGQSIDD
>IFAGANLK_03666 hypothetical protein
MKKRLRKLAGRYKLIDQVLITPYRSYGTHSHLYIKGRVLDNEPLKITQDANIFKTIKTTY
KQFDTFEIPEAQIDLSLPGKVQATTKSDDEGFFLFDDIIETNLAEHADEEGWLDYAVYYN
GPLGKKTELLEDPFKGDFLIPDPTAEYGVISDIDDTILHTGVTSFLKLRLLKNSLLTNAY
NRIPLKGAAEFYQKLHTGRDGTPNNPIFYLSNSPWNLYEYLKLFLDHNAFPKGPILLRKF
RTPFDGSIKPEKPHKQKEIANILKTYPAMNFILIGDSGEHDASIYTEIAAQYPDRILAIY
LRSVKHKKQMNRVRSIIDNFETTPVLMVETSQEAVEHAREHGFI
>IFAGANLK_03667 Multifunctional non-homologous end joining protein LigD
MGLEDYKKKRDFNNTPEPGADFSTENRGRFVIQRHEATRLHYDLRLEMEGVLKSWAVPKG
PSMNPKDKRLAIETEDHPVKYLHFEGTIPKGNYGAGEMQIWDNGTFKAAAKTKDNLEEQW
EAGNLKIVFSGKKIKGEFALVKTKRGDKKNQWLLIKKKDDFSTDLDYDAEVFSEKSSKNK
DTGKSKGKVRKIKPSEFIKPMLATTGKKIFNDPDWIYELKWDGYRALANIEDGKVDLYSR
NGISFNSKFSKLVKDLEQIENDVILDGEIVVLNKDGIPQFQALQNYDENTPGALRFYVFD
MLFLNGHSMLDLPLLERKSLIPEVVENLDLVQYCDHIEGMGTAFYNKAIDLGLEGVIAKK
ADGTYSPGYRTEKWLKLKGENTREVLICGYTTSEGSVFGSLIMGAYEGEELKYIGNCGTG
FSNDEQKELLKKFKRRERKTSPFPEKINLKGREPVWMRPDLIAEVKFSEITKTGKLRHPV
FKALREDKEPEEISAEEIVENKVSEEKKSKKSSSKRKSGESLEIDGIDVPFTNLDKVYWP
DSGFRKYDLIDYYIQVSEVMLPYLKDRPQNLHRHPNGIKKQGFYQKDNEGNLPDWIATTD
IYSESSEKDIEYLLCQDEPTLLYMANLGCIEINPWNSRVENLDFPDYTVIDLDPSDKNTF
EEVIEVAQAAKEVMDLAKIEGYCKTSGSSGLHIYIPLGGNYSYDEARDFTKLLCYYIADK
VPEITSMDRAKKKRKDKIYLDYLQNRRGQTLASAYCARPKPGAPVSTPLEWKEVKSGLKI
LDFTIKDMPQRIQKKGDLFRKVLEKGIDMEKAMQNLESS
>IFAGANLK_03668 Non-homologous end joining protein Ku
MRSIWNGSISFGLVSIPVKLYSASESRKLDLDMLDKHDNARIRYKRVNEDTGKEVEWKDI
VKGFKKDEDYIVLEKEDFENANLKKSKTIDIEEFVAEDDVAEVLYKKPYFLEPQKEGGKS
YNLLRDALKKTGKLGVATFVMRQKEHLSLVGVYDKALVLHVIRFSDEIRETKDLKLPKTK
VAKKEVDMAISLIEQYTTEFDPDKFKDVYNDQLMKIIESKSTGKKPKPQKFKDEPTQAKD
LMAKLKASLDKKKKSKAS
>IFAGANLK_03669 hypothetical protein
MAKDHGPSIKNDEQYEELRDKGMSKSKAARIANESKSGEKGGKADKYEERSKEELYEKAQ
EVGIEGRSDMTKDELIKALRNH
>IFAGANLK_03670 hypothetical protein
MKKLEDLFEHQLKDLYSAESQLVKALPKMAKAANDEKLKKAFEDHLEETKEHKKRLEEVS
KDLGFKPTGEECKAMKGLIEEAESFLKEDAEDDVRDAGLIADAQRVEHYEISGYGTLVRY
AKELGHKDAAKTLKKTLDEEYTADEDLNKLAEKRVNKKAK
>IFAGANLK_03671 Putative K(+)-stimulated pyrophosphate-energized sodium pump
MESMMIYMPAILAVIGLIFMWVKRSWVLKQDAGDGKMKDIASHIYEGALAFLNAEYKLLS
FFVIGASIALAGIAYIVPTTHYLIIVAFIFGAFFSALAGNMGMKIATQSNVRTTQAARTS
LPQALKVSFGGGTVMGLGVAGLAVLGLTAFFILFFHYFMGGVWTDTTQMTVVLETLAGFS
LGAESIALFARVGGGIYTKAADVGADLVGKVEAGIPEDDPRNPATIADNVGDNVGDVAGM
GADLFGSYVATVLAAMVLGNYIIKDMGGNIVDAGFGGIGPILLPMAIAGAGIIISIIGTL
LVKISSNSAKEAEVQKALNIGNWTSIGLVAVASYFLVTWMLPKETLTMGFFVGGAEGFEY
MDISSIRVFYACLVGIVVGGVISAVTEYYTGLGKKPVLSIVQNSSTGAGTNIIAGLATGM
ISTFFSVLLFAFAIWASYAFAGFYGVALAASAMMATTAMQLAIDAFGPIADNAGGIAEMS
ELPAEVRERTDILDSVGNTTAATGKGFAIASAALTSLALFAAYVTFTGIDGINIFKAPVL
AMLFIGGMVPVVFSALAMKSVGKAAMKMVEEVRRQFKNIPGIMEGTAKPEYDKCVAISTE
AALKEMLLPGVLTIGFPIAIALIPMLFGYENVLIAEMLGGYMAGVTVSGVLWAIFQNNAG
GAWDNAKKSFEAGVLINGVMTYKGSEAHKAAVTGDTVGDPFKDTSGPSMNILIKLTCLIG
LVIAPILGGHTETDIPNEGASIEMEQNINANDAEDLSEEIQVNMTSEGNKTIAKVRITTT
RKGETKVQQKTFTGTKAEVEKQVQALKDKA
>IFAGANLK_03672 Inorganic pyrophosphatase
MSESFDVLIEIPKGSRNKYEYDFKLKKVRYDRMIFSSMMYPADYGFIPNTLAQDSDPLDV
LVLVSEPTFPGVVMEVKAIGVFHMADEKGPDEKIICVPVSDPIWNRLNDLNELNGHMVKE
IEHFFKVYKDLEKKKVDVGGWGDAKEARQIIDQCVKRYEDYDGDKDRFGILP
>IFAGANLK_03673 TonB-dependent receptor SusC
MGIAQTKVGGVVKDSTGQALPFVTVIFNNSSEGTTTEEDGEFYLQSENDHTELKISSVGY
KTEIIPLQQKTNLDLEIVLNEETSSLAEVRILRGKTSKKNNPALDILRKIWENKRSNGVS
AFKQYEYKKYEKLEFDLDGIDSSVVKNPVFNGMEFIFDYADTNRISGKTYLPVFINESVS
KVYGDNVENEKREDLLGNKNSGFEQNQNLIAAVKDVYDEYNVYNNYIKVFDKSFVSPLST
TGINNYNYILSDSAYIDNKWCYNIIYYPRRENELTFKGDFWVNDTTWAVKKINLNASRDA
NINWVKELYIEQEFEVLNDSVFLISKDYFQANFSLTKKEDSKGVYAKRTRVFEEYQFNLK
KEKSFYDKRAYTFNEDIYKRDKAFWEENRLEKLNSEEEDIYVMLDSLTKVPAFKRIYDLA
TIAESGYVEFNGWDFGPVYSLFDYNEVEGFRTRVGGRTYFGQHDPWRIEGYLAYGFKDDK
FKYGISGKWLLDPRSRLIASAGKRRDIDQLGASLTNNTTDVLGRSLASSGLVSVGDNNKL
SNIDLTTFNLEIEPWYNFNVRVGTSYRELSSASPAFSLDYYTNETLAETASEIKQTEIST
TFTYTPGRQTSGFGVERNVVNDEEFPTFFLNYSLGLKDVFNSDFDYKRLQFFYDQPLRIG
GFGRANASLEAGKTFGAVPLGLLNVVPGNQTYFAMYNSFPVLNFYEFVTDTYVSAHFNHN
FNGRLFARIPLLRELNLRELVGVRAVWGEISEENKTLNASGIPLRAPNREPYYEYSFGVG
NILKFLSLEAHFRGNYLEIPESRNFAITASFGFHF
>IFAGANLK_03674 2-oxoisovalerate dehydrogenase subunit beta
MKTIQFREAVQQAMSEEMRKDESIYLMGEEVAEYNGAYKASKGMLDEFGPERVIDTPIAE
LGFSGIGVGSAMNGNRPIIEFMTFNFSLVGIDQIINNAAKMRQMSGGQFNIPIVFRGPTA
SAGQLGATHSQAFESWFANCPGLKVIVPSNPYDAKGLLKSAIRDDDPVIFMESEQMYGDK
GEVPEEEYVIEIGKADIKREGSDVTIVSFGKIIKEAYKAADKLAEDDISCEIIDLRTIRP
MDHETILESVKKTNRLVILEEAWPFGNIATEITYQVQSKAFDYLDAPIVKINTADTPAPY
SPVLLKEWLPNSDDVIKAVKQVMYID
>IFAGANLK_03675 Electron transfer flavoprotein subunit beta
MKILVCISHVPDTTSKINFTDGDSKFDTNGVNFVINPNDEFGLTRAMWFKEKQGASVDVV
NVGGAETEPTLRKALAIGADNAIRVDTPATDGFQVAKQLAKVAKEGEYDLIIAGRESIDY
NGGMVPGMLAALLDANFINTCISLEIEGDKATAIREIDGGKETLTASLPLVIGGQKGLVE
ESDLKIPNMRGIMQARKKPLNVVAAEEVSTRTEAAKFEKPAPKGAVKLVDPENLDELIDL
LHNEAKAI
>IFAGANLK_03676 Electron transfer flavoprotein subunit alpha
MSVLVYTETEDGKFKKAAFEVASYAKEVAGGDDVVAVSFNATDASELGQYGVSKVLNIQN
DKLSKFNAEAYADALKQAAEKEGSKIVVVSQSANSKYLAPLLAVHLNAGYVSNVMAVPES
TEPFTVKRSAFTNKAFNFTKITTDVKIVGLSQNAFGLKENQGDPTVEDFSPELKEGDFTV
NVESVDKAKDKVTIADAEIVVSGGRGLKGPENWGMIEEMADILGAATACSKPVSDMGWRP
HSEHVGQTGKPVASNLYIAVGISGAIQHLAGINAAKTKVVINNDPEAPFFKAADYGVVGD
AFEIVPKLNEKLKEFKAKNA
>IFAGANLK_03677 hypothetical protein
MSLVRLNIKGISYSQTQNGAYALILSEVEGERKLPIVIGAFEAQSIAIALEKEIKPPRPL
THDLFKNFADRFDITVKQVIIHKLVDGVFYSSLICERDKIEEIIDARTSDAIALALRFDA
PIFTYKNILDKAGIFLKGDEAEQEASEKQEEEIISEELLPDDIDIKSDDTNYKKLSLDEL
KTLLSQAVNNEDYEKAARIRDEISKRK
>IFAGANLK_03678 Putative nucleoside permease NupX
MNKTWFCLILVLFSVTSTFSQDISKTWTLDEDRQDSGQENFINGNTLDLDEGVFSIRKTD
DTLAKGDYIFQNKLLVLFYNTPQDSIANYRVSTLSDSSLVINQANKEFHFKDTAFNDPKE
VIPAPTVKEMIPSAGLSVSSIARGALGMLTLLIIAFLFSNNRKAINWKTIGIGLGAQLLL
AIGVLKITFIQNIFEFVGNIFVLILDFTAAGSEFLLGGMMDVDSFGFIFLFQVLPTIIFF
SALTSVLFYLGVIQIVVKGMAMILTRLLGISGAESLSVAGNIFLGQTEAPLMIKAYLERM
NRSEILLVMIGGMATVAGGVLAAYIGFLGGDDPELRLQFAKHLLAASVMAAPGAIVVSKI
LYPQQNKINTNVDVSSDKIGSNILDAIANGTTEGLKLAANVAAMLLVFIAFIAMINYILN
WTGSWTGINAFLAENTPYSGFSLEAILGTIFAPLMWLIGVAKEDMMLMGQLLGIKLAASE
FVGYVQLADLKNTANALSLSYEKSVIMATYMLCGFANFASIGIQIGGIGSLAPGQRKTLS
EFGMKALIGGTIASLMSATIAGMIIG
>IFAGANLK_03679 Thymidylate synthase
MKQYHELLQHILDNGTDKGDRTGTGTRSIFGHQLRFDLSEGFPMVTTKKLHLKSIIYELL
WFLKGDTNIEYLQENGVRIWNEWADEKGDLGPVYGKQWRNWNNEDIDQIKEIIETLKKNP
NSRRMLVSAWNPSVLPDSSKSFSENVANGKAALPPCHAFFQFYVADGKLSLQLYQRSADV
FLGVPFNIASYALLTMMMAQVCGYEAGDFIHTFGDVHIYSNHMDQVKLQLSREHRSLPTM
KINPEIKNIFDFDYKDFKLEDYNPHPGIKAKVAV
>IFAGANLK_03680 hypothetical protein
MKKLMLIACFVIGGLTSAQAQQTSPVWPGCEDAEDVKACFNQKLSQHVRENYEYPQTEDG
DYIRGKVKISFTITDEGKAVVNSVEGAEPKVNAAAKAMIQKIPDMKPGTLQGEPDDRDFT
VPFNF
>IFAGANLK_03681 hypothetical protein
MFCFFLFTGAFTFAQDDVDVEGNTVTVREKAPVWPGCEGSEDQKNCFNKKLMEHVKNNYK
YPRNDKGEFIRGKVVVKMHIDEEGKAVVTSVKGDQKPVIAAVEDMLKKIPEMKPGTRGNS
PTKISYTLPLNL
>IFAGANLK_03682 Hercynine oxygenase
MQSQEQLLDFFKKTRAHSELICSFLETEDYVVQPIVDVSPPKWHLGHTTWFFEEFVLKPH
ARNYKLFDKNSAYVFNSYYESVGDKVIRTNRGNLSRPTVAWVYEYRNYVSKAMQKFLKEE
KISEELCGVIEIGCHHEKQHQELLLTDIKYILGNNPLFPEYNDQFKENPIQDFKRDWISV
SEGVYEVGHKTDDFCYDNEQGVHKVYLNDYQISNKLVTNAEFIEFIEAGAYKNALLWHAE
GWDWVNNNNIEAPFYWHKIDGEWHQYTLNGLTKLIPEAPLSHISYFEAFAFAQWKNLRLP
TEFEWETAQQHFKWGERWEWTESAYSPYPNYTKPEGALGEYNGKFMVSQKVLRGASVATS
PNHSRATYRNFFHPHLRWQFTGLRLAK
>IFAGANLK_03683 Histidine N-alpha-methyltransferase
MKTTPTTFQSAFEEDVYKGLTSFPKYLLSKYIYDEKGDKLFQQIMAMPEYYLTNCELNIL
KKHKSAIAEIINKKGGFDLIELGAGDGKKTKVLLKELVDKEYDFNYLPIDISQSVLEELE
NSLKNEIPEINVKIQQGTYFKTLENLADYSNRRKVILVLGSNIGNLLHENAIEFLRNIQE
AMTAEDMLFMGFDQKKDPQKILDAYNDATGITEAFNKNLLTRINKELDADFNTDNFIHWE
TYDPESGTAKSFLVSKENQKVAINKLDLEVSFDAWESIHTEISQKYDDAVVEWLAKEAGL
EIQTSFQDNNNYYKNYIFRKKM
>IFAGANLK_03684 hercynylcysteine sulfoxide lyase
MENLRKGFPVLEQYTYLNTAASGLLSEAVWEFRQNHDLDFLLGASVFKENQAKILTETRE
LLGETFGCPHAQVALVPNFSYGFNTLLEGLEKPQKALLLKNDYPSLNWAVESRNFEISYA
EINESLEKNIAEAFEKRQPDFFAFSVVQYINGIKIDLEFLQNLKKEYPDTLFIADGTQFC
GTEAFHFDKSAIDILICSTYKWLNAGYGNAFILFKKEMEEKIAPKAIGFGSLQGKYKAHE
GNFIGKFEPGHQDTLNYGSLAEALKLIKKIGIAEISSRIEALSTKAKSEFTKMNLLEESV
VNRAEHSSIFNIKGNDKLFEYLRSKQIIVSQRGEGIRVSFHYFNTEKELDFLLKELKKFG
V
>IFAGANLK_03685 hypothetical protein
MFSKKKNTSKLDAEQRELYEYARKRTLQKKRLFQHFIIFLIGAVFLIVLNVGIGYQEDFM
PLGYNWFVWAILLWTFILLVHVFNVFITNKFLGKEWQDKQMAKLVQKQKEKIAKMQTQAE
KDFPANPPQKDTTQKPENTPELKKENERFKPKTNDPEKPDQPYNT
>IFAGANLK_03686 Dihydrofolate reductase
MITMIAAAAENNALGKDQDLVWHLPDDFKRFKKLTTGHHIIMGRKTFETFPKPLPNRTHI
VITRKDNYLKKDATVVSSLEKALEFAKNDEQPFIIGGGEIYELGMEMADKIELTRVHGTF
EADTFFPEIDEEKWKLIAEEFHPKDENHDYAFTYLTYVRK
>IFAGANLK_03687 hypothetical protein
MLENEVLHKIAKENKLTNPKFSRLTGGDINDVFLINAEGKKQVVKINNAEKFPGMFAAEK
AGLEALQKPKVIDVPSVLGLGEIENTAYLLLEFRESAAKTKDFWETFGKQMVDLHKTTSE
EFGFHQDNYIGSLPQRNNASTSAADFYISERLEPQLKLAKDKGYELGVQSSFFRNISAII
PDEKPSLIHGDLWGGNYLVNEEGNPCLIDPATAFAPREMDLAMMKLFGGFDKKLFEVYNR
EFPLEPGFEDRIPLWQLYYLLVHLNLFGVGYKSQVTSILTQYI
>IFAGANLK_03688 hypothetical protein
MSTENLNKDQALDKMKSMVKDIKTCMLVTDFGNKPLSAVPMTTKEVDKEGNIWFFSRLDS
DHNGDIAKDNDVQLLFSDTSDMEFISIYGKATIETNKNVLEEFYGKMDDAWFNGVDDPNL
TAIKVVPKEAYFWDNKQNKFVTFLKIGAAAVTGDKKGDIGEKGKLNL
>IFAGANLK_03689 Malonyl CoA-acyl carrier protein transacylase
MNAYIFPGQGAQFSGMGLDLFEKSSKAQDLFKKANAILGFSITDIMFEGSAEDLKQTKVT
QPAVFLHSVILSKVLGEDFKPDMVAGHSLGELSALVANNTLSFEDGLKLVYKRAMAMQEA
CELEPSTMAAVLGLEDEVVEAVCAETEGIVVAANYNCPGQLVISGDVKAVEAACETLKER
GAKRAMILPVGGAFHSPLMEPARKELAAAIENTTFNTPTCPIYQNVSTFAVTDPEEIKKN
LVFQLTAPVKWTQSVQNMIKDGATNFTEVGPGKVLQGLVKKIDRQMETASASV
>IFAGANLK_03690 Adenine deaminase
MKKLLIFCFGIFLSTGLQAQDFYIQAGKLVDTKSGKVLTEKTIIVSEDKIKSVEKGFVNP
ESENDSVIDLRDKTVLPGLTDMHVHLESETNPQKYMERFINNPEDAAFNSVGFAKTTLMA
GFTTVRELGGSGVNIALRDAINKGKIDGPRIFTAGKSLATTGGHADPSNGMNKELTGDPG
PKEGVVNGPEDAAKAVRQRYKNGADLIKITATGGVLSVAKSSSNPQFTEDEIRAIVKTAN
DYDFHVAAHAHGDEGMQRAIRAGVKTIEHGTKMSEETMDLMKEHGAYLVPTITAGKEVTQ
NAEIENYYPELVVPKAREIGPQIQDMFARAYKRGVGIAFGTDAGVFKHGENAREFVYMTE
AGMPAMEAIQSATITAGKILKMEDKIGQIAEGFYADIIAVDEDPVENIETLKDVKFVMKE
GKVYKN
>IFAGANLK_03691 UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase
MVDLKGQYEGIKDQVDASFQQVIENAAFINGPEVQQFQKDLEDYLQVKHVIPCANGTDAL
QIAMMGLDLKPGDEVITADFTFAATVEVIALLQLTPVLVDVEPDSFNIDPEAIKKAITPK
TKAIVPVHLFGQAANMDAIMEIAEEHNLYVIEDNAQAIGGNYHSKKGKTQKTGAIGHIGA
TSFFPSKNLGCYGDGGAILTNNDELAHTIRGIVNHGMYERYHHDVVGVNSRLDSLQAAVL
RAKLPKLDSYNEARKKSGNKYSEAFKGEEDIITPVLLDKDDTHVYHQYTLKIKNGKRDAL
AKHLQERGIPFGIYYPIPLHKQKAYADSRYNEADFPVTNQLVQEVLSLPMHTELDDEQID
YITGTIKEFLNA
>IFAGANLK_03692 3-deoxy-D-manno-octulosonic acid transferase
MKPLYNLATKIAEKALPLAGRFNHKLKLFTEGRKSVFDKLQAEIDPAEDYLWFHAASLGE
FEQALPIIEEVKKEFPKYKVLITFFSPSGYENKKNHPLADVITYLPLDTANNAKRFLALV
KPKIAFFIKYEIWPNFLTELKKQNIKILLVSGAFRENQVYFKPYGGFMRKALSNFDHFFV
QNETSAELIKSIGFNNITQSGDTRFDRVSRQIQYNNTLDFAEEFINNKTCLVAGSTWPED
EEILLPFINQTSAGIKIIIAPHEIKEEKIKALEQKIKRKSIRYSAKENQELANFEVLILD
TIGLLGKVYSYANIAYVGGAAGTSGLHNILEPATFGIPVIIGKNYNNFPEAIRLRQLAGL
FSVETSSEFSEVIEKLLANKEYREKTGMIAGHFINSNTGATQTIINYLKRLPGFS
>IFAGANLK_03693 hypothetical protein
MKRVLITGVILLFTAMSFTSCRETTEKETVVREVEVEKEETPEPEEERKGILERAGEKVD
GKVNEEIDEEIDKIDDN
>IFAGANLK_03694 hypothetical protein
MLAMFFTLSTAFTSCREVNEEENEMEMEGEEMEREMEGEMHEMDDDMDNVGDDIEDAAND
AGNAVEDAANETGDAVEDAANEVEDEVEGNDDY
>IFAGANLK_03695 hypothetical protein
MKKLILMLAITFSTAAVFTSCREEKSGVEQAADDIEDAADDVGDEIEDATDDME
>IFAGANLK_03696 hypothetical protein
MGQPPSIDIKHFKEVREENNFTQSEFAELLGIKNSTADIERGRTKLSGKVVAELLSQFGI
NPLWLFGQSGQKFLQLSKGDVSPKVVTVDSSDNENMVMVNQKAAAGYPHNVQDVEWYQQL
PAFDIPLPEFRNATYRGFQIEGDSMLPNYYPNEWVLAKAVPDLDQASNNKIYVVVLQDSV
LVKKLQKLPDASKVLLISLNEEYLPIEVNINEIQELWQVNSKLTFNLDNPSESGLFRELK
QSMEDLKRELKSFKKQA
>IFAGANLK_03697 Response regulator MprA
MEKNTKILVVDDDSGIGEMLKTLLEFYGYKVIVTEKPLIAEELIQQENIDIVLLDMLISG
VDGTDVCAGIRKNPEIEKTPVLMMSALHDAGPKCKDAGANDFIAKPFEVEELTEKIEKIL
AAEND
>IFAGANLK_03698 Alkaline phosphatase synthesis sensor protein PhoR
MIESDTSKLPKEELDSLKNYAHGLIKTVREPLLVLDRNQNIVAYNANFEKKFKINESEGG
VSVFNFNQKQLHTDEFREILEELQNSEEPISDRTVEVKFSENEKKKFSVNASLLSLPTKT
SLTLLSFKRLKSGRLSRQEKVFNKVVDNILSNAPAAICILRGPEHTFEVANENYLKLIAH
RNIIGKTVKEALPEVGNQGFIDLLDTVYSTGEPYIGNEIAINLQDENGAFRNSYLNFVYE
PTRNKKSKIDGVFVHAIDVTEQVLARKKVEESEDRLKEVIDAVPGIIWITNEKGESIFFN
KNWYSYTGQNVEEAKVFGWLETIHPEDYERAKAIFLEAQKERKPYSSTFRLQSANGDYRW
VIDKGSPKFHSNGEYEGMIGTVIDVHDEKLKENLVREKEHRMQGIVKEATVATAIYTGLD
MNIELANNAMLKLWGKDDSVLRKRLDQALPELDGQPFLELLRNVYRTGETYWGKEDKVDL
LINGEMQTGFYNFTYKPLRDKNGEIYGILNMAIDVTESVKSKMLLKESEFHFRQMADLMP
GMVSKTDARGSDIYFNKNWLDFTGKASESLKEIGWVEFIHPDEKQTYLDAWENCLGTGCD
LEMQLRLKNKEGKYIWHLSRCEAVKEDDGSVKMWIAANTEIDKIKEEEKRKEEFLKMVSH
ELKTPVTSIKGYVQLLLSLIKKQQEAEVSKLPLQPSLERINHQVSRLTRLISEILDLSRI
RENQLELKKEEFNLNELVAETIQDINYTNTQHKIDLESEVQSLVRADRDRIGQVIINLIM
NAIKYSPGSLNINVKVVQEARDKVKVIIKDFGIGISTENHKKIFKRFYRVGVKSEETYSG
FGIGLYLANEIMERHNGEIKVKSRLGEGSEFSFILDATQITS
>IFAGANLK_03699 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase
MELKGKVALITGAASGIGESTALLFAKEGARVFLTDIDVEKGEKLAKKINKNGGEAMFFK
ADIAKAQDSENSVTEAVKKFGKLDIAVNNAGVGGPQHPVGEYPIEAWDKVIAINLSGVFY
GMRYQIPEMLKNGKGSIINVASILGSVGFANSAAYAAAKHGVLGLTKSAALEYSAKGIRV
NSVGPAFINTPMLKDLDKDLLAQLVNVHPIGRLGEADEVAQLFLWLAGEKSSFATGAYYP
LDGGYLAQ
>IFAGANLK_03700 D-alanyl-D-alanine dipeptidase
MKNLTYLLIFLFSFNFVLAQQKKLPEGFVYLKEQIPDIKLDIRYAGNNNFIGKPVNSYNK
PTAILTEEAATALQKAQKDLMAEGYCFKIFDAYRPQTAVNHFIEWARKPEDTLTKQRFYP
EVAKKDLFQLGYIATKSGHSRGSTVDLTIIDAQNGEELDMGSGYDFFGDISHHSTNKITK
EQRANRSLLKRIMIKNGFRPYPEEWWHYTLRNEPFPETYFDFPVQ
>IFAGANLK_03701 hypothetical protein
MIRKLPILGLAAFLVASCGSEKSVFGGKDISAENTSKRSTNGLKSYNEVITSEAESDEGL
FTTHFVDDKLYFEIPVAMLDKEMLLVSRIAGVPDGYGGGYVNAGSKVNEQVVRWTKRKGS
IDVKVISFENMSDEESPIYKSVQANNYFPILFSSKIEAYNQDSTSVVIEASALFENEVEA
INGLSSSLRKRYKVKKLDQSRSYIESAKAYPKNVEIKHVMTYEAEEPPTRDQAGTISMMM
NQSMILLPDEKMQPRIADHRVGWFTIDKYDYNSEELKADDYELIRRWKLVPKDIEAYKRG
ELVEPEEPIVYYLDPATPEKWRPYFKQGIEDWNVAFEEAGFKNAIIAKDPPSEEEDPEFS
PEDVRYSVVRYVASTTRNAVGPSVTDPRTGEIIESDIIWYHNHLRSYRNRFMIEAGAQTE
DARTLNTPESEIGEMMRMVIAHEVGHALGLPHNMKASAAYPTDSLRSPEFTQKYGLTPSI
MDYARVNYVAQPEDEGVRYIRMMGPYDKYAINWGYRYLPEADSPEAEKGKLDEWILEKAG
NPWYEFGNGYGGVDPQSQRESLGDDQVKASEYGLANLKKVVPNLIEWTSKDGYGYDDLEE
VYRELTYMWRGYTSHVVANVGGVYETRKTSNQDGVVYENVPKKKQEEAVNFLVEEAFTTP
DWLLNQEILNRIEASGAIERIQGLQTRALNSLLDEDRLYRMIANEEVNENEAYTAVSLME
DLRKGIFSELYSRNKVDAYRRNLQRSYVDIASEYLKKLNAEDNEALLKSDILPLMRGEMQ
TLKRELNRRKSGTNHSLTQYHWEDLIARIDAALDVES
>IFAGANLK_03702 hypothetical protein
MIFFEINNPGLFLVCVGIFFAAVFLRYLISAGIFYWYYYSFKSKKFRNKRLSKRGFRKGQ
LKKEIYWSMWSSVIFGFFGALTYFLWQKGFTAIYLDLEKFGFWYLPLSFILLSLFHETYY
YWVHRWMHHPKVFRKIHKVHHDSLVPSPWTAFSFHPWESLLEALIVPAILIVLPVHPIVI
GVYLIFMTLSSVINHLDIEIYPQAFIKSRLGKLFIGATHHHFHHAEFKTNFGLYFTFWDR
WMNTESDSEISSE
>IFAGANLK_03703 Low conductance mechanosensitive channel YnaI
MKKKIDLFYLKFILLIGFLLVSSIPAEAQFPLGNNQNNEAESQEIPEDILGRRTPRGTIS
GFIDAVAGQNYNRASRYLNFPHTITSEEEKERVVLVLQRLFDQKGSILPYYLISDDPTGK
TDDDFEPNLEKVGSVSPDDELIEIFLKQHEDETGYPIWLFSAETVEAVSSVSLQNSALVD
QIVPGFINKYIWGGVPAGQWIVALLLIGLSYLISFVVISSLIFLLKKLWKRIREEPISGI
ITAIKLPLKLYVAVWIFVAFTRNLELSIILRQKFSAITIIVGIVAILILLWRLSDFIGKF
SQEKMLLRGNPAGVSIVLFLQRAAKIAIVIFGIIFSLGAIGIDVTTGLAALGIGGIALAL
GAQKTIENFVGSVTLIADRPIRVGDFCRVGEVTGNIEKIGIRSTRIRTLDRTVVTIPNGA
FSSDTIENYAHRDRFRFVSVLNFRYETSTDQLRYLLTELRKVLYAHPKVYEDPARIRFIG
FGAHSLDLEVFAYLDAKDFNEFLEIREDLMLRMMDVVDQSGTDFAFPSQTIYFGKDQGLS
KEKTAEAEAAVENLKKEREMPLPQFTREQIDALKNKSSYPPEGSSTSI
>IFAGANLK_03704 Sensor histidine kinase TmoS
MKTPNFKSAFLKRGYLLLTIILLFPIFTYSQVGNLFSTDAELSSSLINQIFQDNKGYIWI
ATEDGLDRYDGAKFSIYKQDREDSTSILNNYVKSIFQDSQGVLYFGFFNGLQYFDHATEE
FHEIPLLTEDETPYPAHVTSMLERENGEILIGTSGQGILKLTRKNGKPIARKFPEMVPSS
FLERIFEDKNENLWALSQDKGLFKITPQGEIIEYFNENDETQISSIAEDQKGNLYVGSLS
KGLFKYNRENDKFNFIEDSKNLPVKTLYVSKENEILVGTDGMGLKIYDPVREKMSVNDFS
IANFSFKKTKIHSVMQDKADNLWLGIYQKGVLLIPDKANNFSYIGYQSVKNNIIGSNSVV
SIFKDRQDILWVGTDGDGLYGVTEEKKQRYHLGNNGIQGSASIMSIYQDSEDELWIGTYL
NGLAKVNRENQVLEYIEPFKDEQNNTVERVYSLTEDDQKNLWIGTLGYGLYSYNLETEER
TNHNTIENGAPFDQLYNKWINCLLLSNTNKLYIGTYDGLATLDLEKNSYLNQKGENHILT
NKIVYSLYEDEGNNLWIGTSEGLYYKPKNDSITQVYTMDHGLPSDVISAIEADTDNNLWI
STNNGISKFELRTKEFKNYYFRDGLQGNEFNKNASYAEHNGRLYFGSTNGVTFFDPSEIT
SKGSNVDLRITGFYLQDEPVKKGMKSGSYSITEKAIIDADTMELAHNDNDFSIEFSSFAF
KNQQWITYSYSLNSENWIKLRPGMNTVTFNNLEPGTYHFKVRAKDYGEYSNVQELSIIIH
PPWYFSSWAKLGYLLLLVIISYIIVQEVLQRRKTKNELQEHLRAEQINEAKLQFLTNISH
DIKTPISLIINPLKKLIKTDPEEDRQKLYRIMERNSERILHLLNQLINARKFDQGKIELK
FQKTEIISFVKSITSLFDDQIESHGIKFQINHPDSEIIAFIDPNHFDKIIQNLISNAIKF
TPQNGTIEVNIGADERKKEFYIIVKDNGVGIKESELNNVFNRFYQVSNNESRQLEGTGIG
LHLTKSIAELHHGTVKVENNENQEGCKFIISAPLGKSHLKESVIVEETPATANNKETLPF
NTIQKRDEVESTLEKNKPTVLIVDDDSEIRNYIAIELQNHYNIIKKENGKLAFPEVIKKA
PDLIISDVVMPEMDGITFTRKIKKNIHTNHIPVILLTGKTDKETNLEGLEIGADAYINKP
FNTDILKKTVKNLIKNRNVLKNTYSGNQLHEEKIKHLDLKSGDETLVEKFMEVVNNNISN
PNLNVEMVASELGISRVHLYRKLKQLTNQSAGELITNIRLKEAANLLASKKINIAEVAYA
VGFSSTSKFSTKFKDLYGMTPTNYRQKETQT
>IFAGANLK_03705 Endo-1,4-beta-xylanase/feruloyl esterase
MKHYKLILFLCLAFLSHLVTAQNQEVDNEEEFKPSPVNQPGSEYPMVNEKGQVRTQISAP
EAKKVQLDIGGVKYDMEKDEEGVWTGESAPQDEGFHYYQLNIDGASVPDPGSLYFYGANR
WGSGIEVPAQDQDFFALKNVPHGKVEQILFPSKSTDTSRRAFVYTPPEYDLEPNKSYPVL
YLQHGYGENETSWPNQGRANLIMDNLLAEGKTKPFIIVMTYGMTNEIEFGGLRDFDIEPF
QTVLVNELIPYIDTHYRTKANKENRAMAGLSMGAFETKLITLNKPEVFSYYALFSGGIYE
SKELQDRSKPELIFISTGSKERPDAVKSAVSELQKEGFNAVSYVSEGTAHEFHTWRRSLH
QLAPLLFQIEE
>IFAGANLK_03706 Endo-1,4-beta-xylanase Z
MKKFSTLLIFLLTLGFSSSAQEISKEMPQGFDEERTGIATGKIDSISYTSKTVGNARKAL
IYTPPGFSKEKEYPVLYLLHGIGGDEKEWLKGANPQVILDNLYAENRLEPMLVVMPNGRA
MKNDRAEGNIFAPDKIEAFSRFEDDLLNDLIPFIEKNYPVLTDRENRAIAGLSMGGGQSL
NFGLGNLDKFAWVGAFSAAPNTKEPEALLPNPQEAKEKLELLFISCGDKDDLINVSQRTH
NYLFQEGVPHIYYLEPGGHDFKVWKNGLYMFSQFLFKPVDKSSFSEYTVLGTPASTNIRS
ADYPQILPDNRVRFRIDAPEAKKVQIDLGRKYDMEKDSSGAWTVTTDSIGQGFHYYSLVI
DDVAVADPASETFYGMGRMASGIEIPSREGEFYALKDVPHGDVRIRRYFSDITNSWRRMY
VYAPPGYDASSEDYPVLYLLHGGGEDERGWSSQGRADLILDNLIAENKAEPMLVVMMDGN
LGSRNSFQQSLQTFEQELKQAVIPFVENNFRVAPGAENRALAGLSMGGLQTLYAGIRNTD
MFSHLGVFSSGWFTDNPELTKPEYAFMKENAAKINNNLESFWLSMGGEEDIAYNNNKAMM
TKFDEMGIKYDYSEYPGGHTWPVWRHNLFSFAPLLFK
>IFAGANLK_03707 Carbohydrate acetyl esterase/feruloyl esterase
MKAKYFLLALFLTGSLGFAQDSNFHVYLSFGQSNMEGHAKFEPQDTLGTGRFQVVQSVDC
PELGREAGKWYTAIPPLSRCDTGLTPTDYFGRTMIQNLPENVKVGVINVAVGGCKIELFD
KENHKEYVDNAPDWMLPAINKYDGNPYGHLVNLGKIAQEKGVIKGILLHQGESNTGDEQW
PEKVKAVYDNLLKDLNLNPEEVPLLAGEMVSEEQGGKCASMNKILAKLPQKISNAHIVSS
EGCEAVDDGLHFSAAGYRELGERYAEKMLPLLK
>IFAGANLK_03708 Reducing end xylose-releasing exo-oligoxylanase
MTKKFYIPVLCIFCLLFFTTEITAQNCDEEVEDPRGKMEPWTKGAWETGEYRNLFLEAGY
SQADIDAKLKKAYYDLFEGPDRVYFEVEDSLAYVSDLKNRDARTEGLSYGLMVAVQFDKK
EVFDKLWRWTVKYMQHQEGPSEAYFAWSVDPKTGKKNAEGSASDGELFFVTALLFASNLW
GNETGINYYAEARRILDAMWNKDGTDGVRNVLNEEHKQITFVPHDGGYDWTDPSYHVPAF
FEIWAEYANDGRDEFYRATADTARTFLHRATHPETGLTPDYAEFSGEPHSRGKMGDAFRY
DSWRVPFNIAMDYSWFAKDREWQQEYAHRIQNFLYCEGLDTYVDQYNIDGSTPDWILPAG
GFQKLRHSLGLVSTAATASLMTTHPKGWKFVDEIWEAKLEPYGDGYFDPYFDGLLYLFSL
MQLSGNYEIITPQAN
>IFAGANLK_03709 Non-reducing end alpha-L-arabinofuranosidase BoGH43A
MRKNQFGLITILLALFVFTGCNAQKNIPVFSSVVYEGDDDIYNENPLESNEFYNPILQGA
YPDPAIARKGDDYYLVSSSFAMFPGVPIFHSNDLVNWTQIGHVLDRKSQLKVQDTEISLG
IFAPDIRYNPHNETFYMITTQFAGGFGNIVVKTQDPKEGWSDPIKLDFQGIDPAIFFDDD
GKAYVTHNDAPDEGEELYQGHRVIKIWEYDVENDQVIEGTDKIIVNGGVDLSKKPIWIEA
PHIYKKDGRYYLMCAEGGTGGWHSEVIFVSDDPMGPYEPAPNNPILTQRHFPKDRENKVD
WAGHADLVVGPDDKYYGVFLGIRPNEKDRVNTGRETFILPVDWSGEFPVFVNGLVPMEPT
LEMPEGVENKTGEGDFFPNGNFTYTEDFSSEKLDYRWIGLRGPREDFIEFTKNGLKINPF
EVNIKEMKPTSTLFHRQQHKDFSFTTTMDYKPKSEKDLAGITALQSETFNYVFGITKKDN
KDYLVLERTEKGSSEILATKEIELEGGLQLRVEADGDDYKFSYALNGDDFENLGGTVSGD
ILSTNVAGGFTGTLIGLYATSANDVVPEE
>IFAGANLK_03710 Arabinoxylan arabinofuranohydrolase
MNIIRILLCLGLMLTFKAGISQNPLVQTNYTADPAPMVYNDKLYLYTSHDEDESTWFTMN
DWRLYTTEDMVNWTDHGAVLSYDDFEWAGRNAWAPQAIERDGKFYMYVPITSREGKNGIG
VGVADSPYGPFIDPLGKPLISNSQDDIDPSVFIDDDGQAYLFWGNPVPYYVKLNEDMISY
EGEITQIPNTIEAFGKREGEENARRPTTYEEGPWLYKRDATYYMFFAAGPLPEHIGYSTS
ENITGPYEYQGVVMPEEGGAFTNHPGVVGFKGNTYFFYHNAALPGGSGFTRSVAVEEMNF
NEDGSVKQMKMTDGIEEALQTLNPYVKNEAETIAWSEGLKSRENEVVGNFIVATRNNSFS
KVREVDFRENGASQFTARVGTTHNGNVSLEIRLDAVDGELIGTLEVPLTGGSDRWELITT
EVEKVTGVHDVYFVFKAKAASEILYFDYWMFSE
>IFAGANLK_03711 Carbohydrate acetyl esterase/feruloyl esterase
MRHQLLLLFILSVSFSFAQREQEKIAEDFEPSSVNQFGKEFPKVNSEGRVRVQIEAPEAN
RVQLDIGGVKYDLEKNKEGVWIGESAPQDEGFHYYQLNIDGASVPDPGSKYYYGAGRWGS
GIEIPAGDKEFYALKDVPHGNVSENLYFSEITQQWRRNFIYTPPGYFENLEKRYPVLYLQ
HGSYEDETGWSSQGHANLILDNLIASGDAEPMIIVMDNGYAYKPEDLEKVEGNRPRSSFE
EVLIKEVIPKIDNKFRTIPNRENRAIAGLSMGASQTMSIIMNNLDHFSYYGGFSGTANFP
GDKELDADTFLNGAFSNAEEVEQKLNVLFLGLGTKEAEVFFNTVKAFRDMLEKQDIDYTY
YSSPETAHEWLTWRRSLYQYAQLLFNQNQ
>IFAGANLK_03712 Xylosidase/arabinosidase
MTITDNYKIMRLKIKIFTLCGLGLMLAPQLLKAQNPIITDVFTADPAPLVYDDTVYLYTS
HDTASVSSTNYEMKDWLVFSSTDMKNWKNHGPKLSPKDFSWATGDAYAAEVAERDGKFYF
YVSTFHKDDDRSNGGAAIGVAVADSPLGPFKDAKGEALIYNEMTTDNPHGWDDIDPSVFV
DDDGQAYMYWGNGSLKMVKLKDNMIELDGEIQYYNPKNFIEGPWVYKRKGLYYLVYASKG
EERERVEYATSDSPEGPWEYRGILADSAPNSFTIHPGIIEYKGKDYFFYHNGVLPTGGSY
RRSIAVDYMYYNEDGTIQKVEQTEEGVEAVE
>IFAGANLK_03713 hypothetical protein
MRIGKIKILKSSNSSLGFSVFLGLLFLISPFESWSQEDSQLKLWYDKPAEKWVEALPVGN
GRLGAMVYGDPNEEIIQLNENTVWAGGPNRNDNPEAKEYLPEVQKLLFEGKSAEAQELVN
QHFISKTSHGMPYQTVGNLKLSFPNHQNYTEYFRELDLETAVTTTRYKVGGVGYETKVFA
SHPDQVIVIEITADKPGVLNFTASMDRPGGAEVSVENRLIKLNGKTSDFEGVEGKVKFQA
ITKILTEGGELISENNTLKIQNANSATIYISIASNFKNYKNLSIDEEVKAAEYLSAIEKK
DSEEIYQAHLDDYQTYFNRVSLDLGETEAAKLPTNERIINFKTGDDPALVSLYFQFGRYL
LINSSRAGTQPANLQGIWNDQLTPAWDSKYTININAEMNYWPAEVTNLPEFHEPLIQMVK
DLSEVGKKTARDMYGAEGWVMHHNTDIWRMTGAIDGSYWGMWPMGGVWLSQHLFDKYDFS
GDKEFLESVYPIVKEASKFYLDFMIREPENNWLVVSPSISPEHGPTAHPGSSLSYGTTMD
NQLIFDLFSRTAKAAEILGDDEDFIAELNEKLKEFPPMQIGSWGQLQEWIKDWDDPNSDH
RHVSHLYGLYPSNQISPYRNPELFEAAKTSLVARGDESTGWSMGWKVNLWARLLDGDHAL
KLIKNQLTPSEQEGHSEKGGTYPNLFDAHPPFQIDGNFGCTAGIAEILLQSHDGAIHLLP
ALPEAWSEGKVSGIRARGGFEIDIEWDDNKPKNILVKSELGGVARIRSYTQLEGDGLEDA
QGDNPNKFYNLPEIKQPLISKKADLKEVEIQKVYEYDLKTSEGKKYELKIKK
>IFAGANLK_03714 Xylosidase/arabinosidase
MKNKNSYYKMSKTIPVNLFLLFLTVNAFAQNPLIMDQFTADPTARVFNGKLYVFPSHDIV
PPKEKGRAEWFNMADYHVFSSENLTHWTDHGKILDQKDVPWADPEAYSMWAPDAVSKNGK
YYFYFPTRLKEGGDGENGFSIGVAVADKPEGPYKPQPNHIEKVEGIDPNVFIDKDGQAYL
YWSRGQIYGAKLKDNMLELDSEIKTFEEIPQKGHIEGPFVFEKNETYYMTYPHVANNTER
LEYGTSDNPMGPFTHQGVIMDESASGTWTNHHSIVNYQDQWYLFYHDNDLSPDFDKNRSI
RADSLFFEENGDIKKVIPTKRGVGITSSTSEIQIDRYSAKSNYGAASVFLDRLDPFLGWK
VVLNKPDAWVRYNKVDFGTEGPKNVKIRARSLTGCRVALKLPGDNEMEISEVIIPKGGEW
GEFTAPVNNGITAVQDMLVQLKNGAGVEVDWVQFEK
>IFAGANLK_03715 Non-reducing end alpha-L-arabinofuranosidase BoGH43B
MKKGYLFIILLCLFLENPGVAQERAQNPIIHADVPDASIIRVDDTYYMSSTTMHMSPGVP
IMKSKDLVNWEIVNYAYDNLGDVDALNLENGKNAYGAGSWASSLRYHNDTFIVSTFASTT
GKTHIFKTKDIEKGPWEEISFSPSLHDNTLFFDDDGKTYLIWGGGKLKIVELKDDLSGVK
EGTERVLIENATEPIGSNYILPAEGSQLFKVKGKYYLFNIAWPRDGMRTVIIHRADKITG
PYEGKLAFQDKGVAQGGLIDTPEGDWYAYLFRDYGAVGRIPYLVPVKWENGWPVLGENGK
VPETLDLPANEGWIPGIVASDDFSRNSGDRDLPLVWQWNHNPQNNYWSVKDREGYLRLTT
DRVDTSFLDTRNTLTQRTIGPESSGITKIDLSGMKEGDYAGLGLLQKNFGFVGAKMVNNK
KHIIMVNGASEAPDEVESIPLNQEELYLKAVGDFKDRKDTAEFYFSLDGENWKAIGNELK
MSYTLPHFMGYRFALFNFATKEAGGYVDFDYFKIDDQKDK
>IFAGANLK_03716 Multidomain esterase
MKQLLILIIYFGIVDQSVAQFSQQERDSIYRLSAQDHQLMLKKLGIDSLRPGPSGNPNDP
NAANSDESKVLAYNLPDLMVFKDGSKVSSVSEWEKRRLEILEDFNAEVYGRFPENIPAVN
WKIISKKNSVIGEYPVQVEELLGVVDNSAYPEIEVEIQMTLTLPKNSDKPAPVILKFDWN
FPASFNPPEEKNPWQERLLAENWGYASLIPTSYQADNGAGLREGIIGLVNKGAPRKLDDW
GALKAWAWGAGRALDYFESHSKINTNNVAIEGLSRYGKAAMVTMAYDDRFAVGFIGSAGA
GGTKILRRNFGEQVENLVSSSQYHWFTPNFIKYSGPLETKDLPVDAHHLVGLAAPRPVFI
SSGDPKVEGNWIDAKGMYLAGVHASPAYEIYGEKGLSKTEFPEVEEFLSEGKLVFRIHED
GHTVVPNWPYFIDFAKRYFK
>IFAGANLK_03717 Retaining alpha-galactosidase
MKNILLLFWLMGIFPFVVAQESTVKSPDEALKLEVYLESGQPTYSVFYNNEVVLERSRLG
LKTNISDYSKALNFAGSKTNSVEKNYESPKLKDSEINYSAQELTATFTTQKGRKMDVIFR
VSNNDIAFRYHLHKYSDTIAHVVTKEFTGFNFPETAKSFLTPQSKSMVGFQRTKPSYEEG
YYLDQDITAASAHNMGYTFPGLFKTEDRWILISETGVDGTYVGAHLSDPNAEGEYTIAFP
DSTENNDFGSTGAAISLPFSTPWRTITVGENLKPIVETTIPFDVQEPLYEATQDYEFGRG
VWSWIMWQDASMNYDDQITYIDFAAEMGYEYILIDALWDQKIGYDRMEELIEYAKSKNVD
VFLWYNSNGVANDAPMTPRHKMHRAITRKQEMKWLQKNGVKGLKVDFMGGDKQETILLYE
DIMSDANDHGLMMIFHGATLPRGWEIMYPNFISTEAVLASENLMFSQYANDQEARSAAIH
PFIRNTVGSMDFGGTVLNERYNRNNDGGNVRKTSDAFQLATAVLFQTPVQFFALTPNNLE
DAPEFAVDFMKNVPTTWDETIFIDGYPGEYSIIARRHKEQWYIAGINASKKAKKVSFSLP
ELEGNKFSIINDFGKGQSEKKEIKQKKGKFEVTIQPQGGFIITN
>IFAGANLK_03718 Endo-1,4-beta-xylanase A
MLKRKNFSIFILLLSVFFTVYSCNSNKSAVDKSELSKTSLKDAFEGKFHIGTTLNAWQIM
GRQPEEIKVATENFNSIVAENIMKSARIQPNEGEFNFELADEFVKIGEENNMHIHGHTLI
WHSQAPDWFFKDEDGNTVSKEVLTQRMKDHIHAVVGRYKGRIHSWDVVNEAIEDDGSYRK
SKFFEILGEDFIKLAFEFAHEADPDAELYYNDYSMAIPGKRAGVVRMVEKLQYEGITVNG
IGMQGHIGLNNPSISEFEKSIEDFGKLGKVMITELDLSVLPSPWGDAGAELSDTYEYEDK
MNPFPDGLPANVEQQFTRRYVEYFELFLKHQDKISRVALWGVNDGNSWKNNWPVRGRTDY
PLLFDRENNAKPVVKELIELAAAN
>IFAGANLK_03719 Endo-beta-1,4-xylanase Xyn10C
MKYLNRFLVYSGLLALVFSCADPDPLAFEVEKPEGLEAQEEINSYASLKSYIDSTSNANF
TLGGAVSISDYINKGVMYRLINKNFDELTVGYGMKHGAIVQNNGSMNFAQVNELIAAADQ
AGTSIYGHTLTWHANQNASYLNGLLEPLVIESPSFPNDLDKTGLIDSTFSGFSFYPENAI
TIAENEGMGDGSHAIKLTAPSTAAEPGDLQFSTPEISVVEGHEYEVIFYIKSDSPGEGRV
SFEGLNNNMPLIDYYSEGAAVETFQTDFSWKEVRFRVSDFAGDSFSLNLDLGYQPGVTYY
IDINNLYVYDTEGDPIVSNLIENGDFESGTGWGGWGNNSERGVTEDGLGFGNEGKAFYVT
NPSVTSGFWEVQTVYEFPETLDNGEVYTLSFWVKGDAEGIIRPELQSPDYSSDGFGQVSV
TQEWQRIEMATTATADDRGRLIFSYGEFAGTVYIDNVSLASASGGGGSTTILEREPAVKQ
AIIEEELERWISAMLGTASYVDAWDVVNEPMDDGNPYELKSGETDSDITSDEFYWQDYLG
KDYAVKAFKLARQYGDPEDLLFINDYNLEYNLDKTRGLIEYVEYIDSQGATVDGIGTQMH
ISVDSDRNNIAEMFQLLAETGKLIKVSELDVRTNVSEPTDEVLQQQADMYSYVVEAYKEF
VPQAQRYGITVWGISDSADDATWLPGEFQGLWDENLNRKPAYKSFAEALEEL
>IFAGANLK_03720 hypothetical protein
MKNKIYLIALIILSGLTSCENDKWEFDDYEYQTVYFAYQYPVRTITLGEDIFDTSLDNEG
KAKIMATTGGTYDNDQDVFIDFEVDNSLTEGLVFDDSGQPVQAMPENYYTLESNEIRIPE
GELTGGVEFQLSDAFFADSLAIGRNYVIPLQMTNVVSADSILRGIPLAPDPRKAIAEDWD
VLPKDFILYAVKYVNPWHGNYLRRGVDVIEGTAGNENLDDTVIREEEYVVDDQVVTLTTR
SLDEVELDLVFQNSEGYAVNCTLILSFDDSGNCTVRAASNEYTASGSGQFVKDGEQNSWG
GKERDALYLDYEVNLEEINVSTTDTLVLRDRGVRMETFSPVFE
>IFAGANLK_03721 hypothetical protein
MKSKLLLLLFMVFAITSCDDLIEPAIENNRGLEDMYAEAEYAQGILLNAYTRLPNNGYSF
SEVATDDAVSNVNNNAYREIATGQWTAQNNPFDQWQNARAAIQYINIFLAETDKVTWSED
EEISSMFNDRLKGEAYGLRALYMYYLLRQHAGWANGELLGVPILLEPEGTASDFNQPRAT
FEECMQQLYADVEQAEALLPLDYETLSDLPEGYSDLGDYNRVFGEYAKQRMTGRIAKTVR
AQAALLAASPAYADGNTTTWADVANYAGEVLAENGGASGIASDGHTWYKNDSQISGIGGG
DNPPEIIWRTDVVETSDLEQQHFPPTLFGDGELNPTQNLVNSFPMANGFPITDPASGFDP
DNPYENRDPRLDHYVVVNQSTAGPNNSNIVTAADGSTNDALNAVETSTRTGYYLKKLLRQ
DVNLDPVTSNTQQHYTARMRYTELYLIYAEAANEAWGPEGTGTFGFSAYDIIAGLRERAG
ITQPDAYLESIGSDQNSMRELIRNERRLELSFEGFRFWDIRRWGDDFTVPARGVSILDGN
HETITVENRVYEEYMRYGPIPFSEVLKYDAIIQNQGW
>IFAGANLK_03722 TonB-dependent receptor SusC
MNIIKFKVVFCALIALMPFIGVAQTSEDIDVEAIVRGKEGKPLVGATVTTEAGNTVVTDS
IGSFSLSTGLYSSLAVEALEYKPTSVIVTPFLDNISLEPAEGYEDVNVAFRKVEKRNLIS
GVSFVDLDELMEKNYNTGTLENMEGFANGFHGNIWGMDEYLVLIDGVPREAGSIMPTEID
QISFLKGVSAVALYGSRAAKGVVQITTKRGKIQKQEIDVRVNAGMIVPKSYPKYLGSAEY
MTLYNEARANDGLSQRFDDETIYHHAAGDNPYRYPDVNYYSSDYLQETYNRYDATAQISG
GNETAQYYTNLGFYSAGSLLNFGEAENNRTQRFNIRGNVDIDITETLYATVNASAVYYNG
WGVNTDYWSGAANLRPNRFSPLIPTSMIEESDENSLQFVNNSSNLIDGQYLLGGTQLDQT
NPFAAIYAGGNNNFTSRQFQFNTGIGADLGNLVEGLSFHSNFGVDYSTSYNQSYNNEYAV
YEPSWTNYDGEDLIAGLTQYGQDARSGVQNISDSWYRQTISFSGQFNYDTKIEEDHNVSA
MLIANGFQQSISEEYHRTSNANLGLYLGYDYLDKYFVNFSGAMVHSAKLPEGNRQAFSPT
FTLGWRLSEENFLQNSTVFDELKLTASAGILHTDIDIQEYYLYESIYTQTDGAWFNWRDG
ALSRSTDSRRGQNDDLTFSKREEINLGVEASLFDNLFQVQGSVFANRITGGVVQASVLYP
NYFETEWPNSSFIPYVNYNEDQRVGFDFRADWNQQFGELKTTLGVVGTYYDTKATKRAEM
YEDQYQTREGNPIDAIWGLESDGLFASAEEIENAPSQSFGQVAPGDIKYIDQNGDGVIDN
QDEVYLGKAGWSGSPLTLGVNFTAEWRDFTFFALGVGRFGAHAMKNSSYFWMDGEDKYSI
IARDRWTPETSETATYPRLTTTNSNNNFRSSDFWLYSTDRFDLAKVQISYNFPKELFAQS
FVQELGVYVNGANLLTVSPEREILELSVGSTPQNRFYNLGVKAIF
>IFAGANLK_03723 hypothetical protein
MKNYIKNIIKFSLAIVALVFISSCEDYLDREDESIVSEDEAFKNFTNFQGFTEELYHCIP
DFTNAYWTNSWNWGDDEIESTARDFHFINKIENGNFWGWQAEFDGWQAGWMDRNNTSTDD
DRMTKSLWQLGWYGIRKANLGLANMDRLTDATQEEKDLIRGQLLFFRGWFHFQFIQYFGG
LPYINEVLPSDEQLQLPRLSYHEAADLAAQDFRAAADLLPTDWDETDAGSATLGKNQLRI
NKIMALGYLGKNYLWAASPLMNQESTGNAVYNTSYAQKAAEAFAELLNLTESGEADYSLV
PFSDYHLNFYTTGQNWQIPGSTEAIFRGPYFGAHGSTYGTAKQYQPSPILTDGDVKFLPT
ANYVDFYGMANGLPIDDITQPDPESGYDPEYPWKDRDPRFYNDIVYDGVRTVQGSMPADE
EFNRYANLFTGGSYRNIRTGSRTGYMLYKFIPMTANKYDEGYGYGNNLNIHLPWMRLSDV
YLMYAEAAAQAYGSATGQVSGYSKTAVDAINFVRDRAGVGHVADEFLGSLDTFMSEVRRE
RAVELAFERHRFNDLRRWLLLTESPYTLKKSVEFDRAGELNTDDPSQNRVLNLREEVILE
RNFSSKHYWLPLKNVDVNMYLEFSQNPGW
>IFAGANLK_03724 TonB-dependent receptor SusC
MKINLLNLPYLTRSMVFGLLIQLLFFSSVYANDNKPKNGSEQQTIRGTVSSSEDNLGIPG
VNILVKEVPNRGAVTDMEGNYTIEAPADATLVFSFIGYKTIERKVNDQSEINVIMDPDQD
ALEEVVIVGYGEQKRETVVASIAEVSGDVLERAGGVTNIGAALTGNVPGVITSASTGMPG
EEDPRILIRGQSTWNDSSPLILVDGVERPMSSVAISSVESISVLKDASATAVYGVRGANG
VILVTTKRGEKGEAVIRARVNTTMKRPSKLPGKYDAYDALRVRNDAIENELGLNPSAWND
YMPLDIIDKYRNPANQAERERYPNVDWANTLFRDYTMSYNANVNVSGGTDFVKYFTTADF
LREGDLMKQYDNNRGYEPGYGFNRLNVRGNLDFQITPSTLFQVNLAGSHGVKKSPWGATG
DEYSMWVAAYSTAPDVFLPRYSDGAWGYYAPNEGAATNSVRVLGISGIQYMTTTRLTTNF
TLDQDLDMILDGLNFNGTIALDNTFVEADRGINDLYNDTQEKWIDPETGTELYQQAYDPN
SRFDFQEGVKWSTSPGAVQNWSSHRKLFYQLQLRYAKNFDGRHDVSVMGLMNRNENATGS
QIPRYREDWVFRTTYTLDNKYTFEYNGAYNGSEKFSPENRFAFFSSGGIGWILSRENFLD
SASFLDMLKLRANYGEIGDDNVAGRFLYMTQWGYEGQSRMGVTGEAAEQSPYTWYSEESV
GNPDVSWEKVKKTNIGVDFGFFDGFIEGSFDYFIDERTDILINGGDRAIPSYFGTEAPVA
NLGHVRNEGYEFDIDLSYRFENGLRLWSNFNMTHSKNEVIDADDPSLLPAYQQNAGLQIG
QAYSHVTPGYYNTWDDLYASTIHNANDNQKLPGNYHIIDFNGDGVIDAYDNIPFGFTGNP
QNTYNATFGFDWKGFSSYVQFYGVNNVTRQVVLGSLASQNHVVYEEGSYWSKDNFNADSP
VPRWLTTPSEYNAANRYMFDGSYLRLKNAEIAYTFDAGSSLVDRLGVKNLRVFLNGNNLF
LWSDMPDDRESNFAGTGWASQGAYPTVSRYNLGLNITF
>IFAGANLK_03725 hypothetical protein
MKLFRIILLLFFIHLFLGCDPSIINPDSYGKKWKNTFLWFNPDNLETIYVSKNGDPDSAV
ESKNNTDYTLSWSTTGDTYDLSFSSKNHPIHFAFFDGYPVESINEEIPWLKDDGKFHLSS
ERLLPPANGLYRIMLSEDLTK
>IFAGANLK_03726 hypothetical protein
MKKILLLAVVTVLGFTNVKAQEIEFGAKGGLNFASVSGDNTEGIDVVTSLNFGVLSEIPV
SDKFSFQPELMYSGQGYSFNENTIALSYLNLPLMGKYYITKGLSVEAGPQIGFLLSAKNE
ETDVKDSFNSFDFGVNFGLGYKFDNGLNFGARYNLGLTDINNLDNSSSKNKNGVFQLSVG
YFFF
>IFAGANLK_03727 Regulatory protein SoxS
MIFTLSIILLNHVFEIEEASTSYPFLRFIEHVEWVFLIPAFLFLFIINRTDDTVKSKQKR
YLYFIPFAYSAILNITYDLDRVAGIYTIPQLGLDLIDILGLIHLTLAVIFIPFLSLHSYF
MIRYLENSHEKKWIITLLTIVSTLLFAWLTTCLAGLFLQYDISSIMNVLAISATLIVHWT
AYIGIYKYKLAKNKDAIYNFLNKDLALSYTNPQFEGNSEPAEYRESITADNLYFQKLEIL
CKDHHIYTDTTLNREKVAQKLGISAGYVSQIINTITGDNFAYYINQYRVEAVKEMISNSE
YENYNFLAMGLESGFTSKTTFYKAFKKVTGQTPNEYKSTRK
>IFAGANLK_03728 hypothetical protein
MINTLKSSGLKVIETGKKKGYINIPNVPSFEGKVFEWGYANDHSAYNYTTYELRSDSKRS
VGSNGSNEKNSTGILVAGGVLVALPFLLPMIKSGAVSKVA
>IFAGANLK_03729 hypothetical protein
MKPYQLVFFYREYIEDGLLEKRHIYRFKTRLDRVYFIEVEEYKNHVYFAKFYCRIHKNLK
DRYKIQLEDGDGFRIFSTCINLAAIILKEDALASFGFIGESSKGEEPQHTRRYKIYKTLS
ERYFSPKAFIHERDDYNSTYFIINRKNKIDPKLLERKFSEYYIR
>IFAGANLK_03730 hypothetical protein
MKTKVQFDKKPSSNDKGKARPLKLKRVSAKEIENSRSKAYDYLFT
>IFAGANLK_03733 DNA mismatch repair protein MutS
MAAKKSPKVTPLMKQYNAIKVKYPDALLLFRVGDFYETFGEDAVKTARILNIICTNRNNG
SERTELAGFPHHSLNTYLPKLVKAGERVAICDQLEDPKMTKTIVKRGVTELVTPGVALSD
EVLQSKSNNFLCAIHFGKKTFGISFLDVSTGEFLTALGNSEYIDKLLQNFSPSEVLIPKK
NKKDFTQIFGEDFHTFFQEDWVFKQDFAYETLNEHFQTKSLKGFGVEDLEEGIIASGAIL
HYLAETQHRKLQHITAINRIAEEEYVWMDRFTIRNLELYHSNSANAVTLLNVIDKTISPM
GGRLLKRWLALPLKNSDKVKKRHEVVGFLLKNSSVLAEIQQNIKKISDLERLISKVATGK
VTPREVIQLNHSLQAIIPIKELALKSKNEAIKVIGDNLHSCEVLRGKITESLHQDAPVNI
LKGNCIAEGFSEELDDLRKIAFSGKDYLDNMLKRETHNTGISSLKIGSNNVYGYYIEVRN
THKDKVPESWIRKQTLVNAERYITEELKEYEAKILGAEEKILHLEQQLFGKLVIWMNDYI
QPVQQNAQLIAQLDCLCSFAEQAKAENYCQPEIEEHHNLNITEGRHPVIEKQLPIGESYV
TNNVTLDRESQQVIMITGPNMSGKSAILRQTALIVLMAQMGSFVPAKAANIGLVDKIFTR
VGASDNISMGESTFMVEMNETASILNNISDRSLVLLDEIGRGTSTYDGISIAWAISEYLH
EHPAKPKTLFATHYHELNEMCDTFERIKNFNVSVKELKDNVLFLRKLVPGGSEHSFGIHV
AKMAGMPQQVLHRANKILKKLEKSHKMQDSGEVLKKSAEEEMQLSFFNLDDPILQELKEE
LLHIDIDTLTPVEALMKLNEIKRTLVGKEKAKAKA
>IFAGANLK_03734 putative ABC transporter ATP-binding protein YlmA
MNLKHYAIFGNDLSVKGKWIQNLLKGENCSELKEFSGKKGLLFSETVLNQLIEEDYKHGD
SVLIPNENRALRTFSSGEKRKAFLEYLLKQKPDFLVLDNPYDSLDKASVADLKTTLRNIS
ETTVIIQIFNRKEDLMPFVDLILNVENEKIVKTIEVSEFLKNHTITSISAIKTIPPAPRN
FKGIPEVLVEMKNISVSYEDQPILNKISWKIKKGDFWQLTGPNGSGKTTLLSMVYGDNPK
AYGVDLYLFANKKGSGESVWEIKKKIGYFSPALTELFNRRNTVLEMLISGLMDSVGLYQK
SGDKDIRLAKEWLKTLNLEDKSNKIFTELPEFQKRMILIGRAMIKHPPLLILDEPTTSLD
DKSALKITSLINLFAKESDTAVVFVSHRKEKGLQPEAIYRLIPSKNGSKGEILLE
>IFAGANLK_03735 Putative multidrug export ATP-binding/permease protein
MPRSKKSLEANKVTLRGSFASLKFVPRFFKEIRKVNPLLFYANVLARTVNAVLPVIILIV
GKLIIDEVVLQIDTEEKDLDRLWLLVAAEFGLAILSDLMSRAISLTDGLLGDQYSIDTSV
RIIKKTSELNLDQLEDSEFYDKLERARQQTTGRVGLMSNILTQAEDLIVIFTLLAGVVAF
EPWLIILLVVSVVPTIINEIKFSGTSYSLARSWTQERRELDYLRYVGASDVTAKEVKLFG
LSDYLANRFKILSDTYYLMSKKLAKQRAGWGSVFNVIGTGAYYAAYLLIVFRTVAGIFTL
GDLTFLSGSFNRLRSKLQGFFTRFTAITESALYLQDYFEFLDLKYSDETSDEKLPLPKKI
RKGFEFKNVGFKYPKSETWVVRNINFELKAGEKLAFVGENGAGKTTLIKLLLRFYEPTEG
EILLDDIPVKEYIQTQYQQYFGVIFQDFVKFELTLRENIAMGEIEEIKNQNRIDSAAQKS
LANEVISEMPRGYDQQLGKRFKQGKDLSGGQWQKIAIARAYMKDAEVLILDEPTSALDAR
AETEAFDRFIKLTEGKTAVIISHRFSTVRIAGRIMVLKDGAVLEIGTHQELMKNDKLYAE
LFNLQAQGYQ
>IFAGANLK_03736 hypothetical protein
MVVNRYTEECLGESEGNCLLVQEGEQIGTDECSLFFYKDSIEGFDYEPG
>IFAGANLK_03737 Adenine deaminase
MNKFFCFLLVMISLSSCQSKDIKNYDLVIYNARIVDVESESIIENQAIFISEGEIVDVRK
NIEKEQIVADWFFDAEGKFVMPGLWDNHVHFRGGDTLIQENKDLLPLFLAYGITTVRDAG
GDITPSVLKWKDQIAKEELDGPTIFSSGPKLDGDQPAWPGSIKVSDSSDIVTALDSLEKL
DVDYVKMYDGNLSAENYYGIIEAAEKRGLKTTGHMPMSADFMKAVSLGLDGAEHMYYPLK
AGSPVADSLTKLNLGYGMIEPLIDTYDAGLGDKVFAKMSKENVFVTPTLYIGKTLAEILE
VDHQQDSLLNYIGPGIQKTYQGRIEGAKRAKASGSEMREKMEEISNRMIEPMQNSGVKIL
AGSDCGAFNSYVYPGESLHGELNALAEAGLSNAQVLKSSMINGPKFLDLEDKYGSVEEGK
IADLLLLEKNPFENLQHLNTITTVVKSGKVFNREDLRDMLQEIKRTKALD
>IFAGANLK_03738 Tricorn protease 
MIYKAPSLLIFLLVSFTLSAQDINKKDTRLLSKPAISDSQIAFIYAEDLWVANKDGSFPK
RLTVDDGIESNPVFSPDGSLIAFNAEYDGNTDVYVVSADGGVPERLSWHPGSDQVRGFTP
DGSAVLFASQRSVFTNRYMELFEVSVSGGQVKQLDIPNAFWADYSDDGRYIAYTPLYEVF
NQWKYYRGGTASRIWIYDTNDHSVTEIPKPESGSNDTRPQWLGDKIYFRSDRNGEFNLYS
YDMNSAEVAQHTNYEDFPVLDLSAGDNEIIFEQAGYLHTFNPTNNNASRLQIGIATDLLE
LRPRFVKGDEYIRSASISPTGARVVMDFRGEIVTLPGDKGDVVNVTATPGIHEQDPVWSP
NGKFIAYFSDESGEYALHVHDQSDEKQPQKFELDGTGFYAYPKWSPDSKKISFVDNGRNL
YVLNTDSGRVTKVAQDKRYMPGVFRDLFGSWSHDSSWISYTVVTETSFEQAYVYSLSENE
SYPISDGFSSVSSPVFDPSGKYLYMLASTDAGPVVNWFDQSNQDMEMTSSIYLVTLQKDV
ESPFARENDVEKIEQAEKEEEKKKKAEEEDKEIKAPDLKIDFSGIESRIVDVPVPAGKYA
SLSSPKEGNLYYLSFPPHEQDKGTLNMYDLKERENKEIMPATAYEISANAKMILYKAEDK
WGIAEIEKIEEKHPLNTEDIQVKIDPIAEWPNIFNEAWRVNRDYFYDPGMHGVDWDEMKE
KYKPFIGDVTSRGDLYRVMEWMFSELGVGHHRFSSRGDRLHSKESVKGGLLGADYSIENN
RYRFKKIYGGLNWNPNLRSPLTEPGVDVQEGDYILEVNGKELKAEDNIYKFFENTAGKIV
MLTVGPNSNMKNSRKVKVTPIENEGALRNRDWVEGNIEKVHEATDGKVAYVYVPNTATAG
HEYFKRYFFPQANKQAIIVDERFNGGGQLADYVIDILKKPEQAHWRFRYGKDLKSPSASI
QGPKVMITDETAGSGGDYLPWMFRKFDLGTIVGKTTWGGLVGVLGYPEFLDGGSVTAPNV
AFYTEEGFKVENEGVAPDVEVEQWPEEVIEGKDPQLEKAIEIVLKQLEENPPGEVASPVY
PKKGN
>IFAGANLK_03739 23S rRNA (guanosine-2'-O-)-methyltransferase RlmB
MFIKGFSGYQTVLLFLPTASMFSNLNYHIPCILTNFATMKNRKLKNSELERKSIEEFKEA
EKTPIIVVLDNIRSLNNIGSVFRSADAFLIEKIYLCGITAQPPHKDIQKTALGATETVAW
EYVENTLDVVEKLQKEQTKVFTIEQAEGSVMLNDFKAQVGEKIAVVFGNEVKGVQQKVVS
ASDGIIEIPQLGTKHSLNISVSVGVVLWDLFSKISQNNREQSYMSH
>IFAGANLK_03740 Deoxyguanosine kinase
MFYLICCEIYRISFNNFSPFSLNSPKIAYIALGSNVGNRFELLQDALHKIYLEIGEIQQV
SLVYETPAWGFSGHAFLNACVAVSTRFSAENVLRKLLKIETRAGRVRSDAKNYQNRSLDL
DILLFGNETLKTEDLVVPHPEMQNRKFVLLPLVDIAAKEIHPVFKISIEKLLKQVEDDSQ
IKAIPEKLEIPQKAFNFNKLNYIAVEGNIGAGKTSFSTMVSEDFNAKLILERFKDNPFLP
KFYENKERYAFPLEMSFLADRYQQLSDDLAQYDLFKDFVISDYDVFKSLIFAKITLHEDE
YALYHKLFHLMYKELVKPDLYIYLYQNTERLLENIKARGRDYEQNIQPDYLVEINKSYLN
FIKTQTSMRVQIIDISGKDFVNNRADYLAILEEIKAH
>IFAGANLK_03741 hypothetical protein
MAKLLLKEKLTAQRIYLILAGLFIASLVVSNLIFQKFFSWDFFGIYTFEISVGILPYPVT
FLITDIISEIYGKQKANQVVTTGIFASFFSLLIIYTADAVPATEWSPIGNALFTKVFGAT
TIAVFASMVAYLLAQYIDIQLFHFWKRLTKGKHLWLRNNFSTFLSQFVDTFSVLFLLCSF
NKIEWDLFGGLLLSGFLFKVIVAALDTPLLYASVYAFRKRFNLKQGEELKYD
>IFAGANLK_03742 hypothetical protein
MKKIFKIIGIVLLVIVVILVAAPFLFESQIKDYVRKTANESVNAEVEFRDISLSFFRSFP
QATVVIEDFSVINNEPFKGDTLALGEELQLEMSIKELFKGADEPKVLDDIKINNTFLNIR
VDSLGNANYDIAVEDTTTVASDSASTGFSFDLKHYEINNSRVKYIDEGQKLLLDVEELNH
QGTGDFSLAESELDTESTALVSLDYDGVNYLNRNNVSLDAVIQMDLENMRYTFLENEAMV
NQLPLTFEGFVQVNEDNNEIDLSFKTPSSDFKNFLAVIPETYAKNIENVETNGDFIVNGK
IQGIVDDNYIPKMDIKVSSNNASFKYPDLPKSVEDINIDLQILNETGILEDTYLTFDNVT
FRIDQDRFATNGSVKNLMGNMLVDMALNGTLNLANLEQAYPLELEQDLNGILTADVTTQF
DMNSIENEQYQNVKSSGTASIKNFSYKSPEIPNEVKIANATMNFNQGNVRVPELKLTTGQ
TDLTASGNIENLMGFLFTEQNLKGNFNVNSNVFAVNDFMIAQAETESENETNSEETPGEI
PNPGTNEAVKIPSFLDTELAFNVNTVIYDNLELKNAKGTIILRDETATLKNITTNIFGGN
IALAGNVSTKGATPTFDMDLALNALNIAESFNGLEMLQGLAPVAQALQGKLQTSLKLNGN
LNNDLTPQLSTLAGNALAEILTAEVNPEKLALLSRLDEQLEFINLKDIDLDKLKTRLTFN
DGMVQIEPFNFDVKGVNVEVSGGHGFDMNMNYNLSLDVPARMLGSQVGNALSRLSGDELQ
NMMLALPIGLKGTFQSPQININMEQAVSNLTQKIVAKQKENLQERGQDAIRDIINKQTGR
NQQQETDTTVVEDSTQTETPKTDQTPKSQEEEVKDAARNILGGILKNRTQKKDTTGN
>IFAGANLK_03743 hypothetical protein
MEFTNGIGIILYIFIADNASAGWLAKINLNCEAYKSTSVKNREKKMRYEGVFRKMRTEIT
DKVQYYLIFEDDFINMNQILGKKISLNFLRFQCLNCGLQKKIFRQGYCYDCFTSIPQAGD
WIMSPELSKAHLDEEDRDLDFEKEAQLQPHVVYLANSSNVKVGVTRKTQIPTRWIDQGAH
EAIEIVEVPNRYLAGITEVALKSHVSDKTNWRKMLTNEVLDLNLAEERDKLKDFIPEEAK
EYYLGDRKELEIEFPVLEFPKKIKTLNLSKNPFYEGVLKGIKGQYLIFEDGTVFNVRAHE
GFVVELGVK
>IFAGANLK_03744 hypothetical protein
MELFIKYPHEVQHELLRHLLSKAKNTEMGRKYGFSEIKTHSEFARRVPIQQYEDYQACIE
RSRQGEANIFWPTPIKWFAKSSGTTSAKSKFIPVSEDSLEHCHYNAGKDLLCMYLNNNPQ
SQLFTGKSLRLGGSKEIYKNNGTAYGDLSAILIANMPFWAEFSSTPSNEVSLMNDWEVKM
QAIVNETIKENVTSLAGVPSWMLVLLNNILEKTGNENLFEVWPHLEVYFHGGVSFDPYAP
QYQKILPKEDFRFYEIYNASEGFFACQDQNDSKELLLMLDYGVYYEFIPMDIYGSAAEKA
IPLSEVETGKNYAVVITTNAGLWRYKIGDTVKFTSISPYRIKVTGRTKHHINVFGEELII
ENAEAALKKTSLVTNCEIVDYTAAPIFMEGKEKGAHEWIIEFKNPPRDFEKFKNELDLAL
QQVNSDYEAKRYNNMTLNMPKIHQAREKLFYDWLKKNDKLGGQHKIPRLSNSRSYVEELL
GMNQ
>IFAGANLK_03745 hypothetical protein
MKQEILLLFCIFLLYGSFSVFGQGSSCESLDPFCAGDEELVFPNSNANNSNIVNGEPGPD
YGCLLSQPYPAWFYLQVEETGNLRFDISQFQNEDGGGSQYDVDFIVWGPFDRTEDYCTND
SLSELNIVDCSYEPDTVEQMYIPNAEAGQVYVVLITNYEELPGFISLRQTNSDQANSGST
DCGILDEVLGPDRFLCGEEETTLDATTDGVERYEWYRFDENTNDFDIIANEENPTLTVND
SGRYKVIVYENITAQADEDEIEITFYNAPVATVPEDLYICDPNQTTIDLSDASAEILTGN
TSEEDYRVNFYESTQDLEDENPISNPTAFPMEEAREILAQVQGVESGCLSNEVRFNVDLT
FVPENFLPGESVVCVDLDGTVLAQQGIGEDLGADYDYEWIAEGNTIGSEAVLNFTETPDF
NNVSLIVTDNRSGCTIEFNTILLIYSRPESVEVEIEGSDFTGGYIISAEAIAGVGDETTY
EYRADNGGWQESPVFRNLDPGNHTISAREINGCGITTSEQFYLVGYPRFFTPNSDGYNDT
WNIENTTEIQITKLYVFDRYGKLIKELTPGGEGWDGAYNGRTLPADDYWFRVEFEMQDGT
NDHYGANFTLKR
>IFAGANLK_03746 GTP cyclohydrolase 1
MKIDKILNEIDEQGDAHVGSSAQTPIREDAFELSDIEKVALINKDVKHIMETLGLDLTDD
SLKGTPQRVAKMFVNEIFAGLNPDKKPIASTFENKYKYGEMLVEKNITVYSTCEHHLLPI
VGKAHVAYISKGRVIGLSKMNRIVDYFAKRPQVQERMTMQIVQELQKALGTPDVACVVDA
KHLCVNSRGIRDIDSSTVTSEFGGAFKEQSVKREFLDYIKLDTSF
>IFAGANLK_03747 Cysteine--tRNA ligase
MALYQEQRLKMYNSMSGEKEIFEPINEGNVGMYVCGPTVYSNVHLGNCRTFISFDLIFRY
LKHLGYKVRYVRNITDAGHLENDADSGEDRIAKKARLEQIEPMEVVQRYTIDFHNILQKF
NNLPPSIEPTATGHIVEQIEIVKTILEKGFAYEVNGSVYFDVKKFNETNHYGKLSGRDID
NMIANTRELAAQSDKKNPQDFALWKKAEPQHIMRWPSPWSDGFPGWHLECTVMSTKYLGE
EFDIHGGGMDLKFPHHECEIAQGEAATGKNPVNYWLHANMLTLNGKKMAKSTGNNILPEE
IFSGNNDILDKPFSPNVTRFFMLQANYRSILDFSDEALKASEKGFNRLMDAFHAIDELPV
SEKSSVDVKAWKQSCYDAMNDDFNSPILIAKLFDAVKMINNIKEEAAKITAEDKDELQKT
MSAFMFDVLGLLDKVSENNDTSDKLSSTIELLIKLRAEARNNKDFALSDQIRDQLQEMGI
QLKDGKEGTTFSIK
>IFAGANLK_03748 Putative membrane protein insertion efficiency factor
MLKKWLAYPFILLVKFYRNFISPLTPATCRYTPTCSQYSLTALQRFGVFKGGWLSLKRIF
SCNPWGGKGYDPVPEKTETKI
>IFAGANLK_03749 Prolipoprotein diacylglyceryl transferase
MLFNAITWSPSEGLDLGFFTLHYYSLMFLIAFGLGWYIMKSIFVKEKIAIEKLDSLFIYT
VLATLIGARLGHVIFYDWDYFQNHLLEIFLPVRFEPEFEFTGFRGLASHGAAIGIIIAMY
LYRKRVLDKPVLWVLDRIVIPVASGAIFVRIGNFMNSEIIGKPTNSDYGVIFANLGETFP
RHPAQLYESFCYLLIFVLLWYLYWKTEKRHKVGYLFGLFLVLLWTVRFFVEFVKEPQVEE
RTTWLLNTGQWLSIPFIIAGLYFMYRPTKPRTV
>IFAGANLK_03750 hypothetical protein
MIRKSIILSALVAVSFLSSCKDDNTTEAPIETEEITFTKEGEATLLKPNGDTIKQIDIEI
ADNTYERETGLMYRESMEDEQGMLFIYENEAPRAFYMKNTYIALDIIYFASDSTAVSFQK
NAQPQDETSLPSEEPAQFVLELNAGLANDWNIEVGDKIDFQRID
>IFAGANLK_03751 hypothetical protein
MVLFWKHQRILLVFGLNLNIWVVQQVLEHFEETVTIQRKCIELNRKIHIKIFKNSFLNQG
NDYERTFTFLDVIEDCQEAIDECISIPDENITQRTSLYI
>IFAGANLK_03752 hypothetical protein
MQNKGLIKVFAILFGLVCIYQLSFTFITNNVESEAEDFARQRISENVEDYSALRDAEEER
YLDSVANNEVIAGITYTDAKDKELNKGLDLKGGINVILQISVKDILAGLANNTDDPAFNQ
AIAEADEAATDSQDDYIDLFFEAFNDIPDARLASPDIFANKTLSDEINFDMSNDDVETVI
RRKVDESITSAFEVLRKRIDKFGVTQPNIQRLGNSGRILVELPGAKDINRVQGLLQSTAQ
LEFWHVYKNTELGNFLSQANNVLKDVVNEDEVEAETQTDTTATESDSDIDELLAESEDDT
TEVATGNNPLFELVQSPGFQGGPVIAYFSVQDTAKVNNYLEMSQVRSVLPADQRYAKFAW
GIPEDEEGVVGLYALKGNRNMEPPLSGDVITDAQQTYDQMGRVAVSMQMDGRGAKMWEEM
TGEASTQQSNIAIVLDNTVYSAPGVSTGPISGGRSEISGDFSITEGQDLANVLRAGKLPA
SADIIQSEIVGPSLGQEAIDSGIWSFGIALIFVLIWMIFYYGKAGLFADVALAVNILFIF
GILAGLGAVLTLPGIAGIVLTIGISVDANVLIFERIREELAKGKMQKDAIKDGFNNALSS
ILDANITTGLTGFILLILGTGPIKGFATTLLIGIATSLFTAIFITRLFIDGYGKNGKSLE
FSTGATKNLFRNVKVDWLGKRKVAYVISGILIILSVGSLLVQGLNQGVDFLGGRTYTVRF
DQDVNPTDVEQDLIAEFGSAEAKTFGPNNQLKITTKYKVDEESTAVDNEIQQSMFDALQS
YLPADLTFDEFTTGGAEKEIGIMQSMKVGPTIADDIKNDSFWAILGSLVVIFLYILLRFR
KWQFSIGAVAAVAHDVIIVLGIFSLLYKVMPFSMEINQAFIAAILTVIGYSLNDTVVVFD
RIREFVNEHTSWPLGRTVNSALDSTISRTLNTSLTTLIVLLAIFIFGGESIRGFMFALII
GVIVGTYSSLFIATPVMFDSVTDRSKLEEKKKIEEDSEATTV
>IFAGANLK_03753 Malate dehydrogenase
MKVTIVGAGAVGASCAEYVAIKDFASEVVLLDIKEGVAEGKAMDLMQTATLNGFDTKITG
TTNDYSKTAGSDVAVITSGIPRKPGMTREELIGINAGIVKEVSSNLIKHSPNVTLIVVSN
PMDTMTYLVHKTTGLPKNKIIGMGGALDSARFKYRLSEALECPPSDVDGMVIGGHSDTGM
VPLTRLATRNSVPVSAFLSEDRLNQVSEDTKVGGATLTKLLGTSAWYAPGAAVSALVQAI
ACDQKKMFPCSAMLDGEYGLSDICIGVPAILGKDGLEKIVEIELNDAEANKIKESAEGVK
KTNALLEL
>IFAGANLK_03754 hypothetical protein
MKFKAKYLILFLLFSVNSFAQEDVNRFVNEMLFIADEFATPAAEGASYQAGAGWFTSATA
IKPWKVEVSFHGNALFVPSNRQTFTISNNELQNVHEDGSAILSLRGDESNAVIPTAFGGE
TDVYFEGNVLGQSFEFQALEGVNKSMVAYPFVQASVGLPHETEFAARFLPQLTVDGVAFT
TYGAAIKHNFSQYFRFNQEEDFQAAAIIAYNKFNVEYEFPAIDIPNVANLNLIDVNANLW
MASVMGSKLYGDSFEVFGALGATNSNFHYAMGGSGPVLGQINSALGGLDQSQAQFKADLG
FNFYFDRFKISTMATAGKFFHLNAGLHFRI
